67 FR 251 pgs. 79966-80184 - Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2003 and Inclusion of Registered Nurses in the Personnel Provision of the Critical Access Hospital Emergency Services Requirement for Frontier Areas and Remote Locations
Type: RULEVolume: 67Number: 251Pages: 79966 - 80184
Docket number: [CMS-1204-FC]
FR document: [FR Doc. 02-32503 Filed 12-20-02; 11:52 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Medicare Medicaid Services
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare Medicaid Services
42 CFR Parts 410, 414, and 485
[CMS-1204-FC]
RIN 0938-AL21
Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2003 and Inclusion of Registered Nurses in the Personnel Provision of the Critical Access Hospital Emergency Services Requirement for Frontier Areas and Remote Locations
AGENCY:
Centers for Medicare Medicaid Services (CMS), HHS.
ACTION:
Final rule with comment period.
SUMMARY:
This final rule with comment period refines the resource-based practice expense relative value units (RVUs) and makes other changes to Medicare Part B payment policy. In addition, as required by statute, we are announcing the physician fee schedule update for CY 2003.
The update to the physician fee schedule occurs as a result of a calculation methodology specified by law. That law required the Department to set annual updates based in part on estimates of several factors. Although subsequent after-the-fact data indicate that actual increases were different to some degree from earlier estimates, the law does not permit those estimates to be revised. A subsequent law required estimates to be revised for FY 2000 and beyond.
Although we have exhaustively examined opportunities for a different interpretation of law that would allow us to correct the flaw in the formula administratively, current law does not permit such an interpretation. Accordingly, without Congressional action to address the current legal framework, the Department is compelled to announce herein a physician fee schedule update for CY 2003 of -4.4 percent.
Because the Department would adopt a change in the formula that determines the physician update if the law permitted it, we have examined how proper adjustments to past data could result in a positive update. The Department believes that revisions of estimates used to establish the sustainable growth rates (SGR) for fiscal years (FY) 1998 and 1999 and Medicare volume performance standards (MVPS) for 1990-1996 would, under present calculations, result in a positive update.
The Department intends to work closely with Congress to develop legislation that could permit a positive update, and hopes that such legislation can be passed before the negative update takes effect. Because the Department wishes to change the update promptly in the event that Congress provides the Department legal authority to do so, we are requesting comments regarding how physician fee schedule rates could and should be recalculated prospectively in the event that Congress provides the Department with legal authority to revise estimates used to establish the sustainable growth rates (SGR) and for 1998 and 1999 and the NVPS for 1990-1996.
The other policy changes concern: the pricing of the technical component for positron emission tomography (PET) scans, Medicare qualifications for clinical nurse specialists, a process to add or delete services to the definition of telehealth, the definition for ZZZ global periods, global period for surface radiation, and an endoscopic base for urology codes. In addition, this rule updates the codes subject to physician self-referral prohibitions. We are expanding the definition of a screening fecal-occult blood test and are modifying our regulations to expand coverage for additional colorectal cancer screening tests through our national coverage determination process. We also make revisions to the sustainable growth rate, the anesthesia conversion factor, and the work values for some gastroenterologic services.
We are making these changes to ensure that our payment systems are updated to reflect changes in medical practice and the relative value of services.
This final rule also clarifies the enrollment of physical and occupational therapists as therapists in private practice and clarifies the policy regarding services and supplies incident to a physician's professional services. In addition, this final rule discusses physical and occupational therapy payment caps and makes technical changes to the definition of outpatient rehabilitation services.
In addition, we are finalizing the calendar year (CY) 2002 interim RVUs and are issuing interim RVUs for new and revised procedure codes for calendar year (CY) 2003.
As required by the statute, we are announcing that the physician fee schedule update for CY 2003 is -4.4 percent, the initial estimate of the sustainable growth rate for CY 2003 is 7.6 percent, and the conversion factor for CY 2003 is $34.5920.
This final rule will also allow registered nurses (RNs) to provide emergency care in certain critical access hospitals (CAHs) in frontier areas (an area with fewer than six residents per square mile) or remote locations (locations designated in a State's rural health plan that we have approved.) This policy applies if the State, following consultation with the State Boards of Medicine and Nursing, and in accordance with State law, requests that RNs be included, along with a doctor of medicine or osteopathy, a physician's assistant, or a nurse practitioner with training or experience in emergency care, as personnel authorized to provide emergency services in CAHs in frontier areas or remote locations.
DATES:
Effective date: This rule is effective on March 1, 2003.
Comment date: We will consider comments on the definition of a screening fecal-occult blood test, the critical access hospital emergency services requirement, the physician self-referral designated health services identified in Table 10, the interim work RVUs for selected procedure codes identified in Addendum C, the practice expense direct cost inputs, and on how physician fee schedule rates could and should be recalculated prospectively in the event that Congress provides the Department with legal authority to revise estimates used to establish SGRs for 1998 and 1999 and the MVPS for 1990-1996, if we receive them at the appropriate address, as provided in the addresses section, no later than 5 p.m. on March 3, 2003.
ADDRESSES:
In commenting, please refer to file code CMS-1204-FC. Because of staff and resource limitations, we cannot accept comments by facsimile (FAX) transmission. Mail written comments (one original and two copies) to the following address ONLY: Centers for Medicare Medicaid Services, Department of Health and Human Services, Attention: CMS-1204-FC, P.O. Box 8013, Baltimore, MD 21244-8013.
Please allow sufficient time for us to receive mailed comments on time in the event of delivery delays.
If you prefer, you may deliver (by hand or courier) your written comments (one original and two copies) to one of the following addresses: Room 445-G, Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20201, or Room C5-14-03, 7500 Security Boulevard, Baltimore, MD 21244-8013.
(Because access to the interior of the HHH Building is not readily available to persons without Federal Government identification, commenters are encouraged to leave their comments in the CMS drop slots located in the main lobby of the building. A stamp-in clock is available if you wish to retain proof of filing by stamping in and retaining an extra copy of the comments being filed.)
Comments mailed to the addresses indicated as appropriate for hand or courier delivery may be delayed and could be considered late.
For information on viewing public comments, see the beginning of the SUPPLEMENTARY INFORMATION section.
FOR FURTHER INFORMATION CONTACT:
Marc Hartstein, (410) 786-4539, or Stephanie Monroe (410) 786-6864 (for issues related to resource-based practice expense relative value units).
Jim Menas, (410) 786-4507 (for issues related to anesthesia).
Marc Hartstein, (410) 786-4539 (for issues related to the sustainable growth rate).
Gail Addis, (410) 786-4522 (for issues related to PET scans).
Craig Dobyski, (410) 786-4584 (for issues related to telehealth).
Terri Harris, (410) 786-6830 or Pam West, (410) 786-2302 (for issues related to physical and occupational therapy).
William Larson, (410) 786-4639 (for issues related to fecal-occult blood test).
Regina Walker-Wren, (410) 786-9160 (for issues related to clinical nurse specialists).
Dorothy Shannon, (410) 786-3396 (for issues related to services and supplies incident to a physician's professional services).
Joanne Sinsheimer, (410) 786-4620 (for issues related to updates to the list of certain services subject to the physician self-referral prohibitions).
Mary Collins, (410) 786-3189 (for issues related to the critical access hospital emergency services requirement).
Diane Milstead, (410) 786-1101 (for all other issues).
SUPPLEMENTARY INFORMATION:
Inspection of Public Comments: Comments received timely will be available for public inspection as they are recorded and processed, generally beginning approximately 4 weeks after the publication of the document, at the headquarters of the Centers for Medicare Medicaid Services, 7500 Security Boulevard, Baltimore, Maryland 21244, Monday through Friday of each week from 8:30 a.m. to 4 p.m. To schedule an appointment to view public comments, phone (410) 786-7197.
Copies: To order copies of the Federal Register containing this document, send your request to: New Orders, Superintendent of Documents, P.O. Box 371954, Pittsburgh, PA 15250-7954. Specify the date of the issue requested and enclose a check or money order payable to the Superintendent of Documents, or enclose your Visa or Master Card number and expiration date. Credit card orders can also be placed by calling the order desk at (202) 512-1800 (or toll-free at 1-888-293-6498) or by faxing to (202) 512-2250. The cost for each copy is $10. As an alternative, you can view and photocopy the Federal Register document at most libraries designated as Federal Depository Libraries and at many other public and academic libraries throughout the country that receive the Federal Register .
This Federal Register document is also available from the Federal Register online database through GPO Access, a service of the U.S. Government Printing Office. The Web site address is: http://www.access.gpo.gov/nara/index.html.
Information on the physician fee schedule can be found on our homepage. You can access this data by using the following directions:
1. Go to the CMS homepage (http://www.cms.hhs.gov) .
2. Click on "Medicare."
3. Select Medicare Payment Systems.
4. Select Physician Fee Schedule.
To assist readers in referencing sections contained in this preamble, we are providing the following table of contents. Some of the issues discussed in this preamble affect the payment policies but do not require changes to the regulations in the Code of Federal Regulations. Information on the regulation's impact appears throughout the preamble and is not exclusively in section XIII.
Table of Contents
I. Background
A. Legislative History
B. Published Changes to the Fee Schedule
C. Components of the Fee Schedule Payment Amounts
D. Development of the Relative Value Units
E. Delay in the Effective Date
II. Specific Provisions for Calendar Year 2003
A. Resource-Based Practice Expense Relative Value Units
B. Anesthesia Issues
C. Pricing of Technical Components (TC) for Positron Emissions Tomography (PET) Scans
D. Enrollment of Physical and Occupational Therapists as Therapists in Private Practice
E. Clinical Social Worker Services
F. Medicare Qualifications for Clinical Nurse Specialists
G. Process to Add or Delete Services to the Definition of Telehealth
H. Definition for ZZZ Global Periods
I. Change in Global Period for CPT Code 77789 (Surface Application of Radiation Source)
J. Technical Change for § 410.61(d)(1)(iii) Outpatient Rehabilitation Services
K. New HCPCS G-Codes From June 28, 2002 Proposed Rule
L. Endoscopic Base for Urology Codes
M. Physical Therapy and Occupational Therapy Caps
III. Other Issues
A. Definition of a Screening Fecal-Occult Blood Test
B. Clarification of Services and Supplies Incident To a Physician's Professional Services: Conditions
C. Five-Year Review of Gastroenterology Codes
D. Critical Access Hospital Emergency Services Requirements
IV. Refinement of Relative Value Units for Calendar Year 2003 and Response to Public Comments on Interim Relative Value Units for 2002
V. Update to the Codes for Physician Self-Referral Prohibition
VI. Physician Fee Schedule Update for Calendar Year 2003
VII. Allowed Expenditures for Physicians' Services and the Sustainable Growth Rate
A. Medicare Sustainable Growth Rate
B. Physicians' Services
C. Provisions Related to the Sustainable Growth Rate
D. Preliminary Estimate of the Sustainable Growth Rate for 2003
E. Sustainable Growth Rate for 2002
F. Sustainable Growth Rate for 2001
G. Calculation of 2003, 2002, and 2001 Sustainable Growth Rates
VIII. Anesthesia and Physician Fee Schedule Conversion Factors for CY 2003
IX. Provisions of the Final Rule
X. Waiver of Proposed Rulemaking for Definition of a Screening Fecal-Occult Blood Test and Critical Access Hospital Emergency Services Requirement
XI. Collection of Information Requirements
XII. Response to Comments
XIII. Regulatory Impact Analysis
Addendum A-Explanation and Use of Addendum B
Addendum B-2003 Relative Value Units and Related Information Used in Determining Medicare Payments for 2003
Addendum C-Codes with Interim RVUs
Addendum D-2003 Geographic Practice Cost Indices by Medicare Carrier and Locality
Addendum E-Updated List of CPT/HCPCS Codes Used to Describe Certain Designated Health Services Under the Physician Self-Referral Provision
Addendum F-Codes Refined by the PEAC for 2003
In addition, because of the many organizations and terms to which we refer by acronym in this proposed rule, we are listing these acronyms and their corresponding terms in alphabetical order below:
AMA | American Medical Association |
BBA | Balanced Budget Act of 1997 |
BBRA | Balanced Budget Refinement Act of 1999 |
CAH | Critical Access Hospitals |
CF | Conversion factor |
CFR | Code of Federal Regulations |
CMS | Centers for Medicare Medicaid Services |
CNS | Clinical Nurse Specialist |
CPT | [Physicians'] Current Procedural Terminology [4th Edition, 2002, copyrighted by the American Medical Association] |
CPEP | Clinical Practice Expert Panel |
CRNA | Certified Registered Nurse Anesthetist |
E/M | Evaluation and management |
GPCI | Geographic practice cost index |
HCPCS | Healthcare Common Procedure Coding System |
HHA | Home health agency |
HHS | [Department of] Health and Human Services |
IDTFs | Independent Diagnostic Testing Facilities |
MCM | Medicare Carrier Manual |
MedPAC | Medicare Payment Advisory Commission |
MEI | Medicare Economic Index |
MSA | Metropolitan Statistical Area |
NCD | National Coverage Decision |
PC | Professional Component |
PEAC | Practice Expense Advisory Committee |
PET | Positron Emission Tomography |
PPS | Prospective payment system |
RUC | [AMA's Specialty Society] Relative [Value] Update Committee |
RVU | Relative value unit |
SGR | Sustainable growth rate |
SMS | [AMA's] Socioeconomic Monitoring System |
SNF | Skilled Nursing Facility |
TC | Technical Component |
I. Background
A. Legislative History
Since January 1, 1992, Medicare has paid for physicians' services under section 1848 of the Social Security Act (the Act), "Payment for Physicians" Services." This section provides for three major elements-(1) A fee schedule for the payment of physicians' services; (2) limits on the amounts that nonparticipating physicians can charge beneficiaries; and (3) a sustainable growth rate for the rates of increase in Medicare expenditures for physicians' services. The Act requires that payments under the fee schedule be based on national uniform relative value units (RVUs) based on the resources used in furnishing a service. Section 1848(c) of the Act requires that national RVUs be established for physician work, practice expense, and malpractice expense. Section 1848(c)(2)(B)(ii)(II) of the Act provides that adjustments in RVUs may not cause total physician fee schedule payments to differ by more than $20 million from what they would have been had the adjustments not been made. If adjustments to RVUs cause expenditures to change by more than $20 million, we must make adjustments to preserve budget neutrality.
B. Published Changes to the Fee Schedule
In the July 2000 proposed rule, (65 FR 44177), we listed all of the final rules published through November 1999. In the August 2001 proposed rule (66 FR 40372) we discussed the November 2000 final rule relating to the updates to the RVUs and revisions to payment policies under the physician fee schedule.
In the November 2001 final rule with comment period (66 FR 55246), we revised the policy for-resource-based practice expense RVUs; services and supplies incident to a physician's professional service; anesthesia base unit variations; recognition of CPT tracking codes; and nurse practitioners, physician assistants, and clinical nurse specialists performing screening sigmoidoscopies. We also addressed comments received on the June 8, 2001 proposed notice (66 FR 31028) for the 5-year review of work RVUs and finalized these work RVUs. In addition, we acknowledged comments received in response to a discussion of modifier-62, which is used to report the work of co-surgeons. The November 2001 final rule also updated the list of services that are subject to the physician self-referral prohibitions in order to reflect CPT and Healthcare Common Procedure Coding System (HCPCS) code changes that were effective January 1, 2002. These revisions ensure that our payment systems are updated to reflect changes in medical practice and the relative value of services.
The Medicare, Medicaid, and State Child Health Insurance Program (SCHIP) Benefits Improvement and Protection Act of 2000 (Pub. L. 106-554) (BIPA) modernized the mammography screening benefit and authorized payment under the physician fee schedule effective January 1, 2002. It provided for biennial screening pelvic examinations for certain beneficiaries and expanded coverage for screening colonoscopies to all beneficiaries effective July 1, 2001. It provided for annual glaucoma screenings for high-risk beneficiaries and established coverage for medical nutrition therapy services for certain beneficiaries effective January 1, 2002. It expanded payment for telehealth services effective October 1, 2001; required certain Indian Health Service providers to be paid for some services under the physician fee schedule effective July 1, 2001; and revised the payment for certain physician pathology services effective January 1, 2001. This final rule conformed our regulations to reflect these statutory provisions.
The final rule also announced the calendar year 2002 physician fee schedule conversion factor (CF) of $36.1992.
C. Components of the Fee Schedule Payment Amounts
Under the formula set forth in section 1848(b)(1) of the Act, the payment amount for each service paid under the physician fee schedule is the product of three factors-(1) A nationally uniform relative value for the service; (2) a geographic adjustment factor (GAF) for each physician fee schedule area; and (3) a nationally uniform conversion factor (CF) for the service. The CF converts the relative values into payment amounts.
For each physician fee schedule service, there are three relative values-(1) An RVU for physician work; (2) an RVU for practice expense; and (3) an RVU for malpractice expense. For each of these components of the fee schedule, there is a geographic practice cost index (GPCI) for each fee schedule area. The GPCIs reflect the relative costs of practice expenses, malpractice insurance, and physician work in an area compared to the national average for each component.
The general formula for calculating the Medicare fee schedule amount for a given service in a given fee schedule area can be expressed as:
Payment = [(RVU work × GPCI work) + (RVU practice expense × GPCI practice expense) + (RVU malpractice × GPCI malpractice)] × CF
The CF for calendar year (CY) 2003 appears in section VIII. The RVUs for CY 2003 are in Addendum B. The GPCIs for CY 2003 can be found in Addendum D.
Section 1848(e) of the Act requires us to develop GAFs for all physician fee schedule areas. The total GAF for a fee schedule area is equal to a weighted average of the individual GPCIs for each of the three components of the service. In accordance with the statute, however, the GAF for the physician's work reflects one-quarter of the relative cost of physician's work compared to the national average.
D. Development of the Relative Value System
1. Work Relative Value Units
Approximately 7,500 codes represent services included in the physician fee schedule. The work RVUs established for the implementation of the fee schedule in January 1992 were developed with extensive input from the physician community. A research team at the Harvard School of Public Health developed the original work RVUs for most codes in a cooperative agreement with us. In constructing the vignettes for the original RVUs, Harvard worked with expert panels of physicians and obtained input from physicians from numerous specialties.
The RVUs for radiology services were based on the American College of Radiology (ACR) relative value scale, which we integrated into the overall physician fee schedule. The RVUs for anesthesia services were based on RVUs from a uniform relative value guide. We established a separate CF for anesthesia services, and we continue to recognize time as a factor in determining payment for these services. As a result, there is a separate payment system for anesthesia services.
2. Practice Expense and Malpractice Expense Relative Value Units
Section 1848(c)(2)(C) of the Act required that the practice expense and malpractice expense RVUs equal the product of the base allowed charges and the practice expense and malpractice percentages for the service. Base allowed charges are defined as the national average allowed charges for the service furnished during 1991, as estimated using the most recent data available. For most services, we used 1989 charge data aged to reflect the 1991 payment rules, since those were the most recent data available for the 1992 fee schedule.
Section 121 of the Social Security Act Amendments of 1994 (Pub. L. 103-432), enacted on October 31, 1994, required us to develop a methodology for a resource-based system for determining practice expense RVUs for each physician service. As amended by the BBA, section 1848(c) required the new payment methodology to be phased in over 4 years, effective for services furnished in 1999, with resource-based practice expense RVUs becoming fully effective in 2002. The BBA also required us to implement resource-based malpractice RVUs for services furnished beginning in 2000.
E. Delay in the Effective Date
On November 5, 2002 we published a notice (67 FR 67319), delaying the publication of this final rule due to concerns about the data used to establish the physician fees and the need to further assess the accuracy of the data. We have concluded our review and are moving forward with our proposals unless otherwise indicated in this preamble. This rule is effective on March 3, 2003.
II. Specific Provisions for Calendar Year 2003
In response to the publication of the June 28, 2002 proposed rule, (67 FR 43846), and the interim final rule, (67 FR 43555), we received approximately 236 comments. We received comments from individual physicians, health care workers, and professional associations and societies. The majority of comments addressed the proposals related to the enrollment of therapists, anesthesia services and the SGR.
The proposed rule discussed policies that affected the number of RVUs on which payment for certain services would be based. Certain changes implemented through this final rule are subject to the $20 million limitation on annual adjustments contained in section 1848(c)(2)(B)(ii)(II) of the Act.
After reviewing the comments and determining the policies we would implement, we have estimated the costs and savings of these policies and added those costs and savings to the estimated costs associated with any other changes in RVUs for 2003. We discuss in detail the effects of these changes in the Regulatory Impact Analysis in section XIII.
For the convenience of the reader, the headings for the policy issues correspond to the headings used in the June 28, 2002 proposed rule. More detailed background information for each issue can be found in the June 2002 interim final rule with comment period and the June 2002 proposed rule.
A. Resource-Based Practice Expense Relative Value Units
1. Resource-Based Practice Expense Legislation
Section 121 of the Social Security Act Amendments of 1994 (Pub. L. 103-432), enacted on October 31, 1994, required us to develop a methodology for a resource-based system for determining practice expense RVUs for each physician's service beginning in 1998. In developing the methodology, we were to consider the staff, equipment, and supplies used in providing medical and surgical services in various settings. The legislation specifically required that, in implementing the new system of practice expense RVUs, we apply the same budget-neutrality provisions that we apply to other adjustments under the physician fee schedule.
Section 4505(a) of the Balanced Budget Act of 1997 (BBA) (Pub. L. 105-33), enacted on August 5, 1997, amended section 1848(c)(2)(ii) of the Act and delayed the effective date of the resource-based practice expense RVU system until January 1, 1999. In addition, section 4505(b) of the BBA provided for a 4-year transition period from charge-based practice expense RVUs to resource-based RVUs. Further legislation affecting resource-based practice expense RVUs was included in the Medicare, Medicaid and State Child Health Insurance Program (SCHIP) Balanced Budget Refinement Act of 1999 (BBRA) (Pub. L. 106-113), enacted on November 29, 1999. Section 212 of the BBRA amended section 1848(c)(2)(ii) of the Act by directing us to establish a process under which we accept and use, to the maximum extent practicable and consistent with sound data practices, data collected or developed by entities and organizations. These data would supplement the data we normally collect in determining the practice expense component of the physician fee schedule for payments in CY 2001 and CY 2002. (In the 1999 final rule (64 FR 59380), we extended, for an additional 2 years, the period during which we would accept supplementary data.)
2. Current Methodology for Computing the Practice Expense Relative Value Unit System
Effective with services furnished on or after January 1, 1999, we established a new methodology for computing resource-based practice expense RVUs that used the two significant sources of actual practice expense data we have available-the Clinical Practice Expert Panel (CPEP) data and the American Medical Association's (AMA) Socioeconomic Monitoring System (SMS) data. The methodology was based on an assumption that current aggregate specialty practice costs are a reasonable way to establish initial estimates of relative resource costs for physicians' services across specialties. The methodology allocated these aggregate specialty practice costs to specific procedures and, thus, is commonly called a "top-down" approach.
a. Major Steps
A brief discussion of the major steps involved in the determination of the practice expense RVUs follows. (Please see the November 1, 2001 final rule (66 FR 55249) for a more detailed explanation of the top-down methodology.)
Step 1 -Determine the specialty specific practice expense per hour of physician direct patient care. We used the AMA's SMS survey of actual aggregate cost data by specialty to determine the practice expenses per hour for each specialty. We calculated the practice expenses per hour for the specialty by dividing the aggregate practice expenses for the specialty by the total number of hours spent in patient care activities. For the CY 2000 physician fee schedule, we also used data from a survey submitted by the Society of Thoracic Surgeons (STS) in calculating thoracic and cardiac surgeons' practice expenses per hour. (Please see the November 1999 final rule (64 FR 59391) for additional information concerning acceptance of these data.) For 2001, we used these STS data, as well as survey data submitted by the American Society of Vascular Surgery and the Society of Vascular Surgery. (Please see the November 2000 final rule (65 FR 65385) for additional information on the acceptance of these data.)
Step 2 -Create a specialty specific practice expense pool of practice expense costs for treating Medicare patients. To calculate the total number of hours spent treating Medicare patients for each specialty, we used the physician time assigned to each procedure code and the Medicare utilization data. We then calculated the specialty specific practice expense pools by multiplying the specialty practice expenses per hour by the total physician hours.
Step 3 -Allocate the specialty specific practice expense pool to the specific services performed by each specialty. For each specialty, we divided the practice expense pool into two groups based on whether direct or indirect costs were involved and used a different allocation basis for each group.
(i) Direct costs-For direct costs (which include clinical labor, medical supplies, and medical equipment), we used the procedure specific CPEP data on the staff time, supplies, and equipment as the allocation basis.
(ii) Indirect costs-To allocate the cost pools for indirect costs, including administrative labor, office expenses, and all other expenses, we used the total direct costs combined with the physician fee schedule work RVUs. We converted the work RVUs to dollars using the Medicare CF (expressed in 1995 dollars for consistency with the SMS survey years).
Step 4 -For procedures performed by more than one specialty, the final procedure code allocation was a weighted average of allocations for the specialties that perform the procedure, with the weights being the frequency with which each specialty performs the procedure on Medicare patients.
b. Other Methodological Issues
(i) Non-Physician Work Pool -For services with physician work RVUs equal to zero (including those services with a technical and professional component), we created a separate practice expense pool using the average clinical staff time from the CPEP data and the "all physicians" practice expense per hour.
We then used the adjusted 1998 practice expense RVUs to allocate this pool to each service. Also, for all radiology services that are assigned physician work RVUs, we used the adjusted 1998 practice expense RVUs for radiology services as an interim measure to allocate the direct practice expense cost pool for radiology.
(ii) Crosswalks for Specialties Without Practice Expense Survey Data -Since many specialties identified in our claims data did not correspond exactly to the specialties included in the SMS survey data, it was necessary to crosswalk these specialties to the most appropriate SMS specialty.
Because we believe that most physical therapy services furnished in physicians' offices are performed by physical therapists, we cross-walked all utilization for therapy services in the CPT 97000 series to the physical and occupational therapy practice expense pool.
Comment: We received several comments objecting to our policy of cross-walking all utilization for therapy services in the CPT 97000 series to the physical and occupational therapy practice expense pool. One commenter stated that we are currently employing an arbitrary utilization crosswalk methodology to determine the resource-based practice expense RVUs for physical and occupational therapy. Commenters also indicated that this departure from the standard methodology has not been previously published for review and comment. In addition, one commenter challenged our assumption that most therapy services billed by physicians are furnished by therapists and stated that it is neither supported by explanatory text nor accompanying data. The commenter indicates that if we did not employ this assumption to change the resource-based practice expense methodology only for therapy services, payments for these services would be as much as 18 percent higher. Other commenters stated that use of the "altered methodology" has resulted in inappropriate reductions in payments for physical and occupational therapy services. One commenter expressed concern that the adjustment affects SNFs, home health agencies, outpatient hospital departments and CORFs in addition to therapists in private practice. Other commenters also objected to use of a crosswalk for physical and occupational therapy services stating that the policy is inconsistent with the "top-down" methodology that bases the final RVUs for a service on a weighted average of the practice expenses of the specialties that bill Medicare. Another commenter indicated that there is no evidence to suggest that practice expenses for therapy services provided by physicians are any different from the practice expenses of all other services they provide. This commenter indicated that physician specialties were also disadvantaged because all therapy services that a specialty billed were not included in calculating the practice expense pool for that specialty, thus decreasing the dollars that could be allocated to the services performed by that specialty. The commenters strongly recommended that we discontinue use of the crosswalk and employ the standard top down methodology for computing the 2003 PERVUs for the 97000 CPT code series.
Response: We carefully reviewed comments on this issue. As indicated in our proposed rule, we do not believe that physicians provide most therapy services that are billed by physicians. We believe that the practice expenses for therapy services provided in physicians' offices by therapists are more likely to be comparable to those of therapists than physicians. For this reason, we crosswalked utilization for the therapy codes (CPT codes 97010 through 97750) to the physical and occupational therapy practice cost pools. We used the physician utilization data for the therapy evaluation codes (CPT codes 97001 through 97004) since we believe these services would be much more likely to be performed by the billing physician. In the meantime, we welcome further public comments on this issue. We note that physical therapy was the only specialty for which we used their supplemental survey data (as noted below). Use of such survey data increases payments for physical therapy by 2 percent.
3. Practice Expense Provisions for Calendar Year 2003
a. Supplemental Practice Expense SurveysCriteria for Acceptance of Supplemental Practice Expense Surveys From the June 28, 2002 Interim Final Rule with Comment Period
On June 28, 2002 we published an interim final rule with comment period (67 FR 43555) in the Federal Register , which made revisions to the criteria that we apply to supplemental survey information supplied by physician, non-physician, and supplier groups for use in determining practice expense RVUs under the physician fee schedule. While this rule was effective upon publication, we provided a comment period on the revision to the criteria and are responding to the comments received in this final rule.
The following criteria had been in effect:
• Physician groups must draw their sample from the AMA Physician Masterfile to ensure a nationally representative sample that includes both members and non-members of a physician specialty group. Physician groups must arrange for the AMA to send the sample directly to their survey contractor to ensure confidentiality of the sample; that is, to ensure comparability in the methods and data collected, specialties must not know the names of the specific individuals in the sample.
• Non-physician specialties not included in the AMA's SMS must develop a method to draw a nationally representative sample of members and non-members. At a minimum, these groups must include former members in their survey sample. The sample must be drawn by the non-physician group's survey contractor, or another independent party, in a way that ensures the confidentiality of the sample; that is, to ensure comparability in the methods and data collected, specialties must not know the names of the specific individuals in the sample.
• A group (or its contractors) must conduct the survey based on the SMS survey instruments and protocols, including administration and follow-up efforts and definitions of practice expense and hours of direct patient care. In addition, any cover letters or other information furnished to survey sample participants must be comparable to the information previously supplied by the SMS contractor to its sample participants.
• Physician groups must use a contractor that has experience with the SMS or a survey firm with experience successfully conducting national multi-specialty surveys of physicians using nationally representative random samples.
• Physician groups or their contractors must submit raw survey data to us, including all complete and incomplete survey responses as well as any cover letters and instructions that accompanied the survey, by August 1, 2002 for data analysis and editing to ensure consistency. All personal identifiers in the raw data must be eliminated.
• The physician practice expense data from surveys that we use in our code-level practice expense calculations are the practice expenses per physician hour in the six practice expense categories-clinical labor, medical supplies, medical equipment, administrative labor, office overhead, and other. Supplemental survey data must include data for these categories.
In addition to the above survey criteria, we required a 90-percent confidence interval with a range of plus or minus 10 percent of the mean (that is, 1.645 times the standard error of the mean, divided by the mean should be equal to or less than 10 percent of the mean).
Based on a review of these criteria and concern that the this language had created confusion, in the June 2002 interim final rule we revised this language to indicate that we will accept surveys that achieve a sampling error of 0.15 or less at a confidence level of 90 percent. We noted that this change refines both the measurement of precision and the level of precision we will accept and could result in our acceptance of more surveys than the past criteria. In addition, we stated that we would allow specialties that have submitted surveys previously rejected under the present criteria to resubmit these surveys to be evaluated under the revised criterion.
We also amended § 414.22(b)(6) to reflect the 2-year extension in the deadline for submitting supplemental data. Specifically, we will accept supplemental data that meet the established criteria that we received by August 1, 2002 to determine CY 2003 practice expense RVUs and by August 1, 2003 to determine CY 2004 practice expense RVUs.
Comment: We received comments from several specialty organizations on the change in the precision criteria for supplemental surveys. Specialty organizations representing audiologists, physical therapists and radiologists expressed support for the revised precision criterion. The American Academy of Audiology indicated that the revised rule makes it easier for specialty groups to submit information for our consideration. The American College of Radiology (ACR) supported the proposed change by suggesting that the previous requirements were not reasonable. The ACR indicated that radiology and radiation oncology did not conduct surveys previously because of concerns about the strictness of the original criteria. The ACR also indicated concerns about averaging the supplemental survey data with existing SMS survey data and the requirement that the survey sample would have to be selected from the AMA Masterfile. According to the ACR, the AMA Masterfile does not adequately represent radiologists and radiation oncologists that own and operate their own centers and equipment. The American Physical Therapy Association (APTA) supported the new criterion and our decision to allow previously completed surveys to be resubmitted and considered using the new precision standard. The American Society Clinical Oncology (ASCO) objected to the use of any precision criteria and outlined a number of reasons why they opposed the use of this test. The ASCO indicated that there may be wide variation in oncology practice patterns (for example, hospital based versus non-hospital based, or differentials in provision of chemotherapy) that could lead to wide variation in practice expenses among surveyed practices. They suggested that "at least in the case of oncologists, a survey that is conducted in accordance with the CMS rules should not be excluded from consideration because of failure to meet the precision criteria."
Response: If the data from physician and practitioner surveys is to be used as the basis for physician payment, it is necessary that we have assurance that the survey is both representative and reliable. Applying numerical criteria for the statistical concepts of confidence and precision give some basis for believing that the data accurately represent practice costs for the specialty nationwide. We set the criteria for precision and confidence after lengthy consultation with our contractor, the Lewin Group, and agency experts on statistical surveys. We believe the levels set are both fair and reasonable. In addition, as indicated in the proposed rule, we are attempting to be as flexible as possible consistent with our goal of obtaining new surveys of practice expense that are scientifically sound and methodologically consistent with our existing estimates. We indicated that a specialty may include different types of physician practices that exhibit different patterns of practice expenses. We welcome stratified sampling of these different types of practices and, would, as appropriate, apply the precision criteria to subgroups of surveyed practices.
We considered the comment that suggests the AMA Masterfile may not adequately represent radiologists and radiation oncologists that own and operate their own equipment. However, since the AMA Masterfile is the most comprehensive listing of physicians that practice in the United States, we still believe it should be the best source of information for selecting a representative sample of physicians. We do acknowledge that there may be special issues related to diagnostic and radiation oncology services. For instance, radiologists and radiation oncologists that predominantly practice in hospitals may have fundamentally different practice expenses than those providing services in free-standing clinics and private offices where they likely incur far higher costs for staff, supplies, equipment and indirect costs. In addition, office-based radiologists and radiation oncologists may have substantial but irregular expenses associated with medical equipment. That is, they may purchase equipment one year and amortize the costs over several years. It is possible that modification to the survey instrument may be necessary to accurately identify annual equipment costs for some specialties. Further, independent diagnostic testing facilities also bill Medicare for diagnostic services affected by the non-physician work pool calculations. A sample of physicians selected from the AMA Masterfile is unlikely to include independent diagnostic testing facilities. We believe that all of these issues can be addressed in a supplemental survey with stratified sampling, relevant modifications to the survey instrument and augmentation of the AMA Masterfile with a listing of independent diagnostic testing facilities. As we indicated in our supplemental survey interim final rule, we are attempting to be flexible to achieve our goal of incorporating the best possible practice expense survey information into our methodology. We believe all of these issues should be considered carefully. We advise any party interested in conducting a supplemental survey to consult the Lewin Group and us before proceeding with a survey.
Comment: We also received comments from two organizations representing emergency medicine. The Emergency Department Practice Management Association (EDPMA) is concerned that the requirement that supplemental surveys be based on the SMS survey instrument will preclude us from obtaining data on uncompensated care and emergency physician practice expenses. The EDPMA suggests that we extend the criteria to include data regarding indirect emergency medicine practice expense or uncompensated care cost. The American College of Emergency Physicians (ACEP) stated that we have failed to recognize the legitimate practice costs associated with uncompensated care pursuant to requirements imposed by the Emergency Medical Treatment and Active Labor Act (EMTALA) and that these costs should be recognized by us. Despite our acknowledgement of these costs, the commenter argues that we have not made any movement in making payment for EMTALA's uncompensated care costs.
Response: As we indicated in the November 2, 1998 final rule (63 FR 58821), we made an adjustment in the practice expense per hour for emergency medicine because of our concern that emergency medicine physicians could spend a significantly higher proportion of time than other physicians providing uncompensated care to patients. We are currently using a practice expense per hour of $33.00 for emergency medicine. If we had not made the adjustment for uncompensated care, the practice expense per hour for emergency medicine would be $14.90. Our adjustment assumes that 55 percent ($14.9/(1-0.55)=$33.00) of emergency physicians' time spent treating patients is uncompensated. This has the effect of raising the practice expense per hour to reflect only the physician's time spent in revenue-generating activities. If emergency physicians believe that they spend more than 55 percent of their time treating patients for which they are not compensated, we would welcome specific data on this subject from a supplemental survey.
Comment: The American College of Cardiology (ACC) and the AMA, who wrote in support of the ACC, indicated they are aware that we would like data on practice expenses that shows the six categories of practice expenses used in the practice expense methodology. However, the ACC indicated that the AMA no longer collects data in this disaggregated fashion and suggested that this data limitation can be overcome by simply apportioning practice expense reported in the most recent survey to the separate pools based on historical distribution patterns.
Response: We will continue to require disaggregated data from supplemental surveys because apportionment based on historical distribution patterns might not reflect actual or current cost patterns. Further, to accept this data would be inconsistent with our clearly stated rule. In both the original interim final rule published on May 3, 2000 (65 FR 25666) and in the interim final rule published on June 28, 2002 (67 FR 43556), we indicated that "* * * code-level practice expense calculations are the practice expense per physician hour in the six practice expense categories-clinical labor, medical supplies, medical equipment, administrative labor, office overhead and other. Supplemental survey data must include data for these categories."
Result of Evaluation of Comments
We are retaining the change to the precision and confidence levels for supplemental surveys to reflect a confidence level of 90 percent and a precision level of 0.15, as stated in our interim final rule.
(ii) Submission of Supplemental Surveys-We received surveys from the American Physical Therapy Association (APTA), the American Society of Clinical Oncology (ASCO), the American College of Cardiology (ACC), and the American Academy of Pediatrics (AAP). The National Association of Portable X-Ray Providers (NAPXP) also provided us with cost data for their industry. Our contractor, the Lewin Group, has evaluated the data submitted by each organization and recommends that we use the survey information from APTA. We reviewed and agree with their analysis; therefore, we are using the APTA survey to determine practice expense RVUs for CY 2003 and subsequent years. The data supplied to the Lewin Group reflects a 1999 cost year. As indicated in our June 2002 interim final rule (67 FR 43556), we are deflating the figures by the MEI to reflect a 1995 cost year. The revised practice expense per hour figures that we are using for physical therapy (specialty code 65) and occupational therapy (specialty code 67) are as follows:
Clinical staff | Admin. staff | Office expense | Supplies | Equipment | Other | Total |
---|---|---|---|---|---|---|
10.4 | 6.5 | 13.4 | 2.4 | 2.2 | 7.7 | 42.5 |
The Lewin Group raised significant concerns about the data received from ASCO. Specifically, the Lewin Group is concerned about extraordinarily high expenses associated with clinical and clerical staff and a more than 300 percent increase in "other" practice expenses compared to the SMS value for oncology. As a result, the Lewin Group carefully examined the underlying data. They report that compensation (including salaries and fringe benefits) would average out to $71,014 for clinical staff and $87,253 for clerical staff. They believe it is unlikely that the average annual salary for clerical staff would be higher than for clinical staff. Further, the Lewin Group indicates that the average clerical compensation from the ASCO survey is approximately 400 percent higher than the figure reported by the Bureau of Labor Statistics for "Office Clerks, General." While the Lewin Group indicates that the high payroll expense for clinical staff may be explained, in part, by recent changes in labor markets, we remain concerned that the compensation reported in the survey is far higher than independent information on oncology nursing salaries provided to us by the Oncology Nursing Society. The Lewin Group also indicated that "other professional expenses" increased more than 349 percent from the SMS to the supplemental survey and the contribution of this category to total practice expenses increased from 9.4 percent to 22.3 percent. They believe that such a large increase in practice expense per hour needs further examination. The Lewin Group believes that we should confer with ASCO and request a rationale for the high values found in the survey results or validate the data in some other fashion. Therefore, at this time, we are not using the supplemental survey received from ASCO. However, we would like to further examine the data with the Lewin Group and discuss the survey results with ASCO and will consider using the data in the future if our concerns are addressed.
In the June 2002 proposed rule (67 FR 43850), we discussed an adjustment made to the medical supplies practice expense per hour for oncology. We made this adjustment because of a concern that the inordinately high practice expense per hour includes expenses associated with separately billable drugs. We expressed an interest in reconsidering the adjustment consistent with a recommendation made by the GAO in their October 2001 report. If we resolve concerns about the oncology survey data, the adjustment for medical supplies will no longer be necessary since the supplemental survey collects information on medical supplies practice expenses net of separately billable drugs.
The Lewin Group indicated that the surveys from the ACC and the AAP do not meet requirements established in regulations for supplemental surveys. As a result, we will not be incorporating data from the ACC or the AAP into the practice expense methodology. We will be making the Lewin Group's full recommendations available on our website.The National Association of Portable X-ray Providers (NAPXP) did not provide us with data as part of the supplemental survey process. However, they requested that we use their data to develop practice expense RVUs for the physician fee schedule services they provide. Since we were provided with survey information, we asked the Lewin Group to evaluate the data using the same standards of review applied to other specialty survey data. The Lewin Group evaluated whether the cost information supplied by NAPXP meets our criteria for acceptance of supplemental surveys. The Lewin Group found that (1) More information is required to determine if the data are broadly representative of the portable x-ray industry and (2) the data as presented are not adequately detailed to support a practice expense per hour based on the current practice expense methodology.
Comment: Health Trac, a supplier of portable x-rays and other imaging services, commented that the practice costs associated with set-up of portable x-ray equipment are not included in the SMS and there are sufficient differences among geographic regions in the performance of this procedure that warrant reclassifying this service as carrier-priced.
Response: At this time, we are not making portable x-ray set-up (Q0092) a carrier-priced service. However, we will continue to work with the suppliers of portable x-ray services to find the best ways of developing payment rates for these services.
b. CPEP Data
(i) 2001 PEAC/RUC Recommendations on CPEP inputs
In the November 2001 final rule (66 FR 55256), we responded to the PEAC/RUC recommendations for the refinement to all or part of the CPEP inputs for over 1,100 codes. These included refinements of large numbers of orthopedic, dermatology, pathology, physical medicine, and ophthalmology services. In addition, these recommendations confirmed that there were no inputs for over 150 ZZZ-global procedures that are performed only in a facility and no supply or equipment inputs for almost 700 facility-only services with an XXX or 0-day global period.
We accepted almost all of the recommendations with only minor revisions. We received the following comments on our responses and modifications to the RUC recommendations on the CPEP inputs.
Comment: Specialty societies representing radiology and orthopedic surgery both expressed appreciation about our willingness to work with the RUC and PEAC on practice expense refinement, as well as for our implementation of the refinements already submitted by the PEAC. Both societies agreed with our establishment of revised practice expense values as "interim" until the refinement process is complete.
Response: We are also pleased with the progress of the refinement of the CPEP inputs and thank the PEAC, RUC and all the involved specialty societies for the hard work and dedicated commitment that has led to a successful refinement process.
Comment: A specialty society representing surgeons expressed support for our decisions on CPEP revisions in general and commended our staff for our efforts to develop appropriate and acceptable inputs for a large number of codes. The commenter also agreed with the use of the refined evaluation and management (E/M) inputs to refine post-surgical visits, but recommended that the process should allow for exceptions.
Response: We understand that the PEAC has developed a standard approach to estimating the clinical staff time involved in post-surgical visits in which the times associated with the assigned E/M visits are applied to the post-surgical clinical staff times. It is also our understanding that, as with all the standards and packages that the PEAC has developed, a specialty would be free to argue that something other than the standard should be applied to a given service.
Comment: One commenter representing family physicians noted that we had accepted most of the practice expense recommendations submitted by the PEAC/RUC and commended us for our willingness to accept these recommendations. The commenter also suggested that the PEAC recommendations for the fine needle aspiration CPT codes 88170 and 88171, which were deleted CPT codes for 2002, should be applied to CPT codes 10021 and 10022 that replace these deleted codes.
Response: We agree with this suggestion. When CPT codes 10021 and 10022 were originally valued by the RUC, the practice expense inputs were crosswalked from the then unrefined inputs for CPT codes 88170 and 88171. Now that these inputs have been refined, it is appropriate for us to crosswalk the inputs for CPT codes 10021 and 10022 from this updated CPEP data.
Comment: A commenter representing dermatologists was pleased with our acceptance of PEAC revisions for the phototherapy codes. However, the commenter expressed concern about the decrease in the practice expense RVUs for the code for the application of an Unna boot, CPT code 29580, and for the cryotherapy code, CPT code 17340 and requested that we explain the decrease. A specialty society representing podiatrists agreed with decision to retain the Unna boot in the list of supplies for CPT code 29580.
Response: Both CPT codes 29580 and 17340 were refined by the PEAC in October 2001 and were included in the PEAC/RUC recommendations for 2002. We accepted these recommendations without change, except that we retained an Unna boot in the supply list for CPT code 29580. The recommendations contained lower direct cost inputs than the original CPEP panel data, which explains the decrease in payment for these services.
Comment: A specialty society representing urologists requested an explanation of why the bougie a boule was deleted from the equipment list for the cystourethroscopy code, CPT code 52281 and requested that it be added as a supply.
Response: Since the inception of resource-based practice expense, the supply list has been used for disposable items and we have only included as equipment those items that are more than $500. The bougie a boule is not a disposable item, and at a cost of $105 it does not meet the definition of equipment. These definitions have applied across the spectrum of physician fee schedule services and, therefore, we do not believe that any specialty has been disadvantaged. If we did include a $100 item in our equipment list with a five-year expected life, it would add only $0.0004 per minute of use to the input costs of any associated procedure and, thus, would have no effect on the practice expense RVUs for that service.
Comment: Two organizations representing physical and occupational therapists argued strongly that the revisions we made to the PEAC recommendations on the practice expense inputs for the physical medicine and rehabilitation (PMR) codes were inappropriate. The physical therapy comment commended the specialty societies participating in the PEAC, as well as AMA and our staff, for their time and assistance as the clinical inputs for the therapy codes were developed. However, the commenter also expressed concern that we did not accept the PEAC's recommendations in their entirety despite the fact that we state in the rule that the PEAC refinement process is working. The comment from the occupational therapists shared this concern and both commenters urged us to revisit our decision and accept the PEAC recommendations for the CPT codes in the 97000 series without revisions.
Specifically, both commenters objected to the deletion of the PEAC approved clinical staff time for obtaining vital signs and measurements, patient education and phone calls. One commenter contended that our decision is contrary to the standardized times that we have allowed for physicians' clinical staff and to the survey data presented which demonstrated that clinical staff do perform these services in therapy practices. The other commenter argued that, because we have allowed such clinical staff time for other specialties, our revisions disrupt the resource-based relative value scale on which the physician fee schedule is based. Further, the occupational therapy comment states that the addition of 7 minutes only in the evaluation and reevaluation codes for aide services is insufficient to counteract the deletion of the physical therapy assistant time, and that this has created anomalies in the practice expense RVUs within the PMR family of services.
Response: We deleted the times assigned to the physical therapy assistant for taking vital signs, and for phone calls and patient education because we were concerned that there could be an overlap between the work of the physical therapist, which is reflected in the work RVUs, and the work of the assistant, which is considered as practice expense. However, the commenters are correct that we have allowed such tasks to be considered as practice expense for other services, even though there could also be some potential overlap between practitioner and clinical staff work. We still believe that this can be more problematic with therapy services because of the broad range of clinical activities that the physical therapy assistant can share with the therapist, but also believe that this issue might be better addressed as a general issue across all specialties. Therefore, we are revising the clinical staff times for all codes in the CPT 97000 series to reflect the 2001 PEAC recommendations for these services.
Comment: The specialty society representing physical therapy commented that the relatively high practice expense of 0.45 RVUs for CPT code 97530, therapeutic activities, cause a rank order anomaly with other codes in the CPT 97000 series. For example, therapeutic exercise (CPT code 97110) only has a PE value of 0.25. The commenter speculated that this might be due to inclusion of the environmental module in the equipment list for this code.
Response: On analyzing the differences in CPEP inputs between these two codes, it became apparent that the major contributor to the possible anomalous practice expense values lies not with the equipment for CPT code 97530, but with the supplies. For the timed codes that are billed in 15-minute increments, the PEAC recommendations generally assumed that two 15-minute sessions would be performed during one visit. Therefore, for all of these codes, including CPT code 97110, the PEAC recommendations divided the supplies by half because they would not have to be replaced for the second 15-minute session. However, inadvertently, the recommendation for the therapeutic activities code, CPT code 97530, did not make this adjustment, and the full cost of the relatively expensive woodworking kit was assigned to the code. In addition, it seems unlikely that a supply like a $13 woodworking kit would necessarily be discarded after one visit. Therefore, we are apportioning the cost of this kit over four sessions, and are assigning one-fourth of a kit to CPT code 97530.
Comment: The comment from the physical therapy specialty society raised the concern that there may be an inadvertent error in the printing of the values of physical therapy and occupational therapy evaluation and reevaluation CPT codes in the final rule. First, the values for the occupational therapy codes are significantly higher than values for the physical therapy codes, which did not change from the 2001 values, despite the refinement of these codes. Second, the practice expense RVUs for the occupational therapy evaluation and re-evaluation codes are the same, which appears inappropriate.
Response: The practice expense RVUs for the occupational therapy evaluation and re-evaluation codes are higher than those for physical therapy because the PEAC recommendations, which were based on the specialty societies' presentation and which we later accepted, assigned higher cost supplies and equipment to the occupational therapy codes than to the physical therapy evaluation and re-evaluation services. In addition, although the occupational therapy evaluation code had higher cost equipment than the re-evaluation code, the opposite was true for supplies. We would certainly consider information that might point to specific problems in any inputs assigned to these codes, but, at this point, have no basis for making any changes in the direct cost inputs.
Comment: A medical electronics manufacturer commented that the practice expense RVUs assigned to short wave diathermy treatment (CPT code 97024) may not take into account all of the resources required to provide the service, because the cost of the equipment alone is not covered by the practice expense reimbursement. The commenter suggested that the cost of the diathermy machine has increased greatly since 1995, when the equipment was last priced, and stated that the current price is between $18,000 and $30,000. The commenter urged us to reevaluate and increase the 2002 fee schedule reimbursement to ensure that diathermy continues to be available for beneficiaries.
Response: We accepted the PEAC recommendations for the direct cost inputs for CPT code 97024, except for the deletion of one minute of physical therapy assistant time. The PEAC recommendation was based on a presentation that was made by the physical therapy specialty society. The current CPEP inputs consist of 2 minutes for a physical therapy aide and 3 minutes of physical therapy assistant time and 15 minutes of a low mat table and diathermy machine. There were no supplies assigned because the supplies are included in the procedures that are typically delivered with this modality. We have seen no evidence that would indicate that any of these inputs are incorrect. Therefore, we will make no revisions to the inputs at this time. However, we have two diathermy machines in our CPEP input database. We currently have assigned the machine priced at $2850 to the diathermy code, but will substitute the higher priced machine, which we have priced at $3120, until we have more definitive information regarding the typical cost of the equipment. We have a contractor who is currently updating the prices of all the supplies and equipment listed in the CPEP database, and will soon be proposing updated prices for all the CPEP inputs, including the diathermy equipment.
(ii) PEAC/RUC Recommendations on CPEP Inputs for 2003
We have received recommendations from the PEAC on the refinement to the CPEP direct practice expense inputs for over 1200 codes. (A list of these codes can be found in Addendum F.) These include refinements to codes from almost every major specialty. In addition, the PEAC has continued to standardize inputs to streamline the refinement process. Previously, the PEAC created standardized inputs for 90-day global services as well as supply packages for evaluation and management, neurosurgery, gynecology services, ophthalmology and postoperative services. The PEAC has also established standard times for certain clinical staff tasks, such as greeting and gowning the patient, the taking of vital signs and post-service phone calls. These current recommendations include standardized times for office-based clinical staff for services provided during a patient's hospitalization and for discharge day management services, as well as pre-service clinical staff time data for 323 neurosurgery procedures. At an early PEAC meeting a list was drawn up of the codes most in need of refining. Of the 122 codes on this list, only seven have not yet been refined, which is one important measure of the success of the PEAC's efforts.
As stated above, we are very pleased with the progress that the PEAC has made so far and appreciate greatly the contributions that have been made to our refinement effort by the PEAC members, as well as by the staff from the AMA and the specialty societies. We have reviewed the submitted PEAC recommendations and are also pleased that, because of the expertise gained by the PEAC in evaluating the practice expense inputs, we are able to accept all of the recommendations without any revision. The complete PEAC recommendations and the revised CPEP database can be found on our Web site. ( See the SUPPLEMENTARY INFORMATION section of this rule for directions on accessing our Web site.)
(iii) Other Comments on the Refinement of the CPEP Inputs
Comment: We received comments from specialty societies representing vascular surgery, radiation oncology, rheumatology, physical therapy and internal medicine agreeing with the update we made to the clinical staff categories and to the revised salary data. Several of these commenters also thanked us for our analysis and use of the additional data that was supplied by the specialty societies.
Response: We appreciate the positive response to our repricing of clinical staff salaries.
Comment: The specialty society representing radiology expressed appreciation for the establishment of new clinical wage rates for CT technologist, MRI technologist, medical physicist, and dosimetrist. However, the comment expressed disagreement with our decision to merge the x-ray technician and radiation technologist staff types under the title of "radiologic technologist," because the education and scope of practice for these staff types are different and merging them will reduce the radiation technologists wage rate. The specialty society also opposed the decision to blend the staff types of RN and sonographers because they are trained to provide different services and are not interchangeable.
Response: The original CPEP data listed both "x-ray technician" and "radiation technologist" and seemingly made no distinction between these two staff types because the same wage rate was assigned to both. We used the Bureau of Labor Statistics' salary data to determine the wage rate for the "radiologic technologist." Therefore, we do not believe that the salary assigned has been reduced in any way. If some of the radiology procedures typically use staff that are paid at a lower rate than the radiologic technologist, this information should be provided by the specialty society when the practice expense inputs for the services are refined. Regarding the second concern, we did not make a decision to blend the staff types, "RN" and "diagnostic medical sonographer." This blend currently exists in the original CPEP data and has also been contained in several PEAC recommendations. Both staff types are priced separately and we were merely listing what the pricing would be when such a blend was applied to any service.
Comment: Three specialty societies, representing surgeons, thoracic surgeons and ophthalmologists, commented on the issue of our previous exclusion from the CPEP data of all claimed time associated with staff brought to the hospital by the physician. The commenters from the surgical and the thoracic surgery specialty societies claimed that a recent report by the Office of the Inspector General (OIG) confirms that over 70 percent of cardiac surgeons bring staff to the hospital, but that only 19 percent are being reimbursed by the hospital. The commenters further argued that this is an inequitable arrangement that requires corrective action by us. The commenter from the ophthalmology society claimed that ophthalmologists bring their staff to the facility setting 50 percent of the time and some cost for this should be built into their practice expense.
Response: In the November 2, 1999 final rule (64 FR 59399), we adopted a policy to exclude all clinical staff time in the facility setting from the input data used to develop practice expense RVUs. Among other arguments, we indicated that Medicare should not pay twice for the same service. That is, Medicare's payment to the hospital includes payment for clinical staff and we should not also compensate a physician for using their own staff in the hospital. In addition, we argued that we also pay for physician-extender staff used in the facility setting, such as physician assistants and nurse practitioners, through the physician work RVUs, and we pay physician assistants directly when performing as an assistant-at-surgery. In response to this argument, thoracic surgeons contended that hospitals are no longer providing the staff to furnish adequate care. While we did not change our policy, we asked the Office of Inspector General (OIG) to conduct an independent assessment of staffing arrangements between hospitals and thoracic surgeons ( see November 1, 2000 final rule 65 FR 65395). In April, 2002 (OEI-09-01-00130, page ii), OIG concluded:
Medicare pays for non-physician staff even though surgeons do not receive additional payment for some of the staff they bring to the hospital. Instead, services of these staff are paid to either physicians through the work relative value units, to the mid-level practitioners directly, or to the hospital through Part A or the Ambulatory Payment Classification system for outpatient services. Recognizing this, some hospitals and cardiothoracic surgeons have entered into arrangements whereby hospitals provide some compensation to surgeons who bring their own staff.
We believe the OIG report clearly supports our position to exclude the costs of clinical staff brought to the hospital from the practice expense calculations. While it may be common for thoracic surgeons to bring staff to hospitals, the OIG report makes clear that Medicare pays for these costs either directly to physicians or the hospital. Since the OIG report supports our position, we are not making any revisions to our policy to exclude practice expense inputs associated with bringing clinical staff to hospitals.
Comment: One commenter representing an independent diagnostic testing facility commented that a review of the practice expense inputs for the 24-hour cardiac monitoring HCPCS codes G0005, G0006 and G0007 and the corresponding CPT codes 93270, 93271, and 93272 revealed the CPEP input lists contain items that are not needed to perform these services. The commenter suggested the following deletions: G0005 and CPT code 93270 (for the hookup of the equipment)-delete the ECG electrodes, laser paper, king of hearts-20, computer, life receiving center; G0006 and CPT code 93721 (for the monitoring and transmission of data)-delete the razor, gloves, alcohol swab, and tape and exam table; G0007 (interpretation and report)-delete all the supplies (G0007 currently has no equipment and CPT code 93272 currently has no equipment or supplies assigned.
Response: We agree that the changes to the practice expense inputs suggested above divide the inputs more appropriately between the two TC codes and the PC code for this cardiac monitoring service. However, as discussed in section IV, we are deleting the referenced G-codes for CY 2003 and these services will be reported using the CPT codes. On an interim basis, until these codes are refined, we will make the recommended revisions to the CPEP data for the CPT codes for these services. It should be noted, however, that the TC codes are currently in the non-physician work pool and that the CPEP data is not currently used to calculate their practice expense RVUs. In addition, we do not assign direct cost inputs to PC codes. Therefore, these changes will not at this time have any effect on the payment for these codes.
Comment: A specialty society representing radiology commented that the review cycle for pricing "high tech" equipment and supplies may need to be reviewed more frequently than every 5 years and suggested a 3-year cycle.
Response: We plan to propose current pricing for all the supplies and equipment in our CPEP database in next year's proposed rule. We have made no final decision on how often this pricing update should be done and will consult with the medical community on how best to ensure that we have appropriate pricing for all of our direct cost inputs.
(iv) Proposed Changes from June 28, 2002 Proposed Rule
(A) Ophthalmology Services-Rank Order Anomalies
Based on a request from the American Academy of Ophthalmology we proposed revisions to the CPEP data for five ophthalmology services: For CPT code 67820, Revise eyelashes, we proposed to remove ophthane from the supply list. For CPT code 67825, Revise eyelashes, we proposed to remove the bipolar handpiece from the supply list. For CPT code 65220, Removal foreign body from eye, we proposed using the supply list and clinical staff time assigned to CPT code 65222. The exam lane is the only equipment assigned. For CPT codes 92081 and 92083, Visual field examination(s), we proposed to assign the same supplies and equipment as CPT code 92082 and to assign 35 minutes of clinical staff time to 92081 and 70 minutes to 92083.
Comment and Response: Commenters were supportive of the proposed revision to the CPEP inputs for the ophthalmology codes and we are finalizing the revisions as proposed.
(B) Practice Expense Inputs for Thermotherapy Procedures
There are three CPT codes for transurethral destruction of prostate tissue: CPT 53850, by microwave therapy, CPT 53852, by radiofrequency thermotherapy, and CPT 53853, by water-induced thermotherapy (WIT). Based on concerns expressed by a manufacturer of WIT equipment that practice expense inputs were underestimated for CPT code 53853 relative to the other two codes, we made a comparison and agreed that the WIT procedure had not been assigned many of the basic supply and equipment inputs that were included in the CPEP inputs for the other two procedures. Therefore, we proposed to add, on an interim basis, the following inputs: Power table, ultrasound unit, mayo stand, endoscopy stretcher, light source, chux, sani-wipe, patient education book, sterile towel, sterile gloves, specimen cup, alcohol swab, gauze, tape, lidocaine, betadine, 10 cc syringe, 30 cc syringe, sterile water, leg bag.
We also proposed to change on an interim basis the staff type for CPT code 53853 from the RN/LPN/MTA blend to RN in order to make the staff type consistent among these three similar procedures. In addition, we corrected, for all three procedures, the minutes assigned to each piece of equipment to reflect the intra- and post-clinical staff times only, rather than the total clinical staff times.
We have also requested that these three procedures be reexamined by the PEAC at the same time in order to ensure that there is a consistent approach to the assignment of direct cost inputs.
Based on questions we received regarding the large disparity in prices used for the three different thermotherapy machines and indications that the prices have decreased dramatically since these were initially priced in 1999, we proposed to set the price for thermotherapy equipment at $60,000 for CPT code 53850 and $30,000 for CPT code 53852. We also requested any additional available price documentation that would assist us in ensuring assigned prices accurately reflect actual costs.
Comment: Commenters were generally supportive of the proposed revisions and in agreement that the PEAC should review the CPEP inputs for these procedures. A specialty society representing urology agreed that the best way to handle the CPEP inputs for these services is to have the PEAC review the direct cost inputs for all the heat therapy procedures concurrently and the comment from the RUC stated that it plans to review these codes in time for inclusion in the physician fee schedule for 2004. However, a few commenters also suggested that the review be extended to other codes for treatment for benign prostatic hypertrophy, such as the code for transurethral resection of the prostate, CPT code 52612, and for laser coagulation of the prostate, CPT code 52647.
Response: We agree that it would be advantageous to have the PEAC review the CPEP inputs for all codes pertaining to the treatment of benign prostatic hypertrophy at the same time. This would help ensure that the same standards are applied to developing the direct cost inputs for these codes so that the resulting practice expense RVUs appropriately reflect the relative costs of each service. We will request that the PEAC include for review all the codes suggested by the commenters.
Comment: One commenter, representing a manufacturer, also indicated that, as part of any review, it is imperative that cost data for all medical devices that fall within the CPT code should be evaluated. The commenter suggested that we work with the specialty groups to obtain pricing information rather than using invoices for pricing. The comment from the specialty society argued that we should maintain all the proposed input changes unless we receive compelling data from urologists or manufacturers that varies from the proposed inputs. Another commenter stated that, while there has been a reduction in the price of the thermotherapy control unit over the past few years, the proposed price of $60,000 for thermotherapy equipment for CPT code 53850 was not representative. The commenter included an invoice that indicated that the current price is closer to $80,000, after the application of discounts.
Response: We will finalize the revisions to the CPEP inputs as proposed with the exception of the price for the thermotherapy equipment that we will increase to $80,000 on an interim basis. As part of the practice expense refinement process we have awarded a contract to update the pricing for both the supplies and equipment represented in the CPEP inputs and we anticipate that the proposed pricing revisions to the inputs will be included in next year's proposed rule. Pricing of the thermotherapy equipment will be included in these proposed changes and we will be seeking input from the specialty society to help us in this endeavor.
(C) Revision to Inputs for Iontophoresis
It had been brought to our attention that the electrodes assigned to the supply list for CPT code 97033, Iontophoresis, were not the type required for this procedure. We proposed to substitute two electrodes with a medication vesicle as the appropriate supply for iontophoresis.
(D) Correction to Price for Sterile Water
We proposed to change the price for 1000 ml of sterile water from $40.00 to $3.00.
Comments and Responses: No comments were received on our proposals to substitute two electrodes with a medication vesicle as the appropriate supply for iontophoresis or to correct the price of sterile water. Therefore, we are finalizing these as proposed.
b. Non-Physician Work Pool For Practice Expense
Comment: We received a comment objecting to use of the phrase "zero work pool." The comment acknowledges that our preamble refers to "zero physician work pool" but stated that the vernacular used by the agency, Congressional staff and other stakeholders is "zero work pool." While acknowledging that we do not intend to connote a zero value for oncology nurses' contributions, oncology nurses, social workers, radiology technicians and others take offense to the use of "zero work pool" because it suggests that the work done by oncology nurses and other clinical staff is without value. The comment suggested four appropriate alternative titles: Non-physician clinical staff time, Non-physician work components, Non-physician work pool or Non-physician health professional pool.
Response: We did not intend to devalue the contribution of clinical staff involved in providing physician fee schedule services. In fact, we created the special methodology to value services that are provided by clinical staff without a physician because of our concern that these services could be valued inappropriately low under the top down methodology. Nevertheless, it is clear that there are objections to the nomenclature we have used. We appreciate the suggestions for alternative nomenclature and will refer to the special methodology as the "Non-physician work pool."
(i) Discussion of Alternatives to the Non-Physician Work Pool
In our June 2002 proposed rule (67 FR 43850) we summarized alternatives to the non-physician work pool that have been included in reports prepared by our contractor, the Lewin Group. Included in the alternatives were: elimination of the non-physician work pool; development of specialty specific non-physician work pools; making the TC equal to the global less the PC RVUs; and, development of proxy physician work RVUs for physician fee schedule services provided by clinical staff without physicians. While we included a discussion of each alternative and their feasibility, we did not propose eliminating or replacing the non-physician work pool. We indicated that specialties whose services are affected by the non-physician work pool may conduct supplemental practice expense surveys if they believe there are shortcomings in the practice expense per hour information that we use as part of the basic methodology. We referenced the interim final rule also published June 28, 2002 in the Federal Register . The interim final rule modified the criteria for acceptance of supplemental data. ( See section II.A.3.(a) of this rule for a summary of the interim final rule, the public comments, and our responses.) We also noted that while the non-physician work pool is of benefit to many of the services that were originally included, we have allowed specialties to request that their services be removed.
As part of our analysis of alternatives to the non-physician work pool, we proposed a change in the computation of practice expense RVUs for some PC and TC services. Since it is far more common to receive a global bill than a TC only bill, we believe that using the global to value the TC service will result in a payment that is more typical of the relative actual practice expense associated with the service. Therefore, we proposed to make the TC value equal the difference between the global and the PC for procedure codes that are not included in the non-physician work pool. That is, we used the practice expense value produced by the methodology for the global and subtracted the PC to derive the TC practice expense RVU. As a result of concerns that we had about the impact of this change on services that are affected by the non-physician work pool calculations, we proposed continuing to make the global value equal to the sum of the professional and the TC values for non-physician work pool services.
Comment: One commenter, representing oncologists, argued that the "normal top-down methodology discriminates against [non-physician work pool] services * * * by assuming, without any basis, that indirect costs are lower than comparable services that do involve physician work." The commenter stated that both the GAO and Lewin reports provide support for the conclusion that the indirect cost allocation is biased against non-physician work services. According to the commenter, our assertion that "the indirect cost allocation must be correct because not all of the services without a physician work component are disadvantaged by its use is not a sound basis for maintaining the current methodology." The commenter argues that estimates of practice expense per hour and physician time may be overstated for some non-physician work services resulting in an advantage outside of the non-physician work pool. Furthermore, the comment argues that an increase in payment resulting from services being "withdrawn from the [non-physician work pool] does not demonstrate that the normal top-down methodology results in an appropriate payment amount for services that do not have physician work components." The commenter also objected to our rejection of the Lewin Group's idea to develop specialty-specific non-physician work pools on the basis that a single methodology must apply to all services. According to the commenter, our refusal would only be appropriate if the methodology was not biased against non-physician work pool services. Another comment suggested that we allocated indirect costs by deeming direct costs as 33.2 percent of total costs. Indirect costs would then be added to direct costs to determine a total practice expense RVU.
Response: We do not believe the practice expense methodology is biased against non-physician work services. The methodology allocates indirect costs based on physician work and direct costs. While the comment suggests the use of physician work in the indirect cost allocation is biased against services that do not have physician work, it ignores that direct costs are also used. Most services that do not have physician work have significant direct expenses. Thus, any bias against non-physician work services in the indirect cost allocation is offset by the use of direct costs. Similarly, the use of physician work in the indirect cost allocation will offset any bias against services predominantly performed in facilities where the physician will have few, if any, direct costs associated with the services. For example, surgical services furnished in a hospital have few direct expenses, thus the allocation of indirect expenses according to both work and direct expenses helps offset any bias against surgical services.
We also disagree with the comment that suggests "deeming" direct costs to be 33.2 percent of total costs for purposes of developing practice expense RVUs. The proportion of costs attributable to direct and indirect costs will be different for each service. Such a proposal would be inherently unfair to services that have few direct costs (and impossible to use for services that have no direct costs) and would create a significant bias in favor of services that have high direct expenses.
We further examined the assertion in the comment and in the Lewin Group and GAO reports that the indirect cost allocation is a possible explanation for the adverse payment impact that would occur under the top-down methodology for some non-physician work pool services. It is important to distinguish between the different types of services that are affected by the non-physician work pool calculations. Professional/TC services are the largest category of services included in the non-physician work pool. While many professional/TC services were not adversely affected by the adoption of the top-down methodology, the ones remaining in the pool are the services that would be most adversely affected by its elimination. Some "Incident to" services are also included in the non-physician work pool. Elimination of the non-physician work pool may cause payments for these services to go up or down depending on the specialty that provides them.
Based on 2000 utilization data, the specialties with the largest amount of Medicare allowed charges affected by the non-physician work pool calculations are: radiology ($2.8 billion), cardiology ($2.1 billion), internal medicine ($568 million), radiation oncology ($465 million), multi-specialty clinics ($313 million), independent diagnostic testing facilities ($309 million) and oncology ($226 million). Radiology receives 87 percent of its Medicare revenues from services that are affected by the non-physician work pool calculations. The figures are 47 percent for cardiology, 9 percent for internal medicine, 65 percent for radiation oncology, 17 percent for multi-specialty clinics, 86 percent for independent diagnostic testing facilities and 26 percent for oncology. There are other smaller specialties that also receive a significant proportion of their revenues from services in the non-physician work pool (portable x-ray suppliers, 100 percent, interventional radiology, 63 percent, allergy/immunology 35 percent). The specialties that receive the highest proportion of their revenues from professional/TC services remaining in the non-physician work pool would be most adversely affected by its elimination (independent diagnostic testing facilities, portable x-ray suppliers, radiology, radiation oncology and interventional radiology). Cardiology also receives substantial Medicare revenues from professional/TC services remaining in the non-physician work pool but would be less adversely affected by its elimination. Allergy/immunology receives substantial revenues from "incident to" services in the non-physician work pool and would experience a more modest decline in payment under the top-down methodology. Payments to oncology for "incident to" services would increase if the non-physician work pool were eliminated.
Radiology, radiation oncology and certain other diagnostic services with professional and technical components are likely to be the services most adversely affected by elimination of the non-physician work pool. We do not believe the allocation of either direct or indirect costs explains the effect of the top-down methodology on these services. We examined this issue further by modifying the indirect cost allocation using an idea suggested by the Lewin Group that would retain work and direct expenses to allocate indirect costs but create proxy physician work values for services that do not have physician work (the Lewin Group, pages 22-23). As indicated earlier, we proposed to modify the practice expense methodology to calculate the TC practice expense RVU as the difference between the global and the PC RVU for services unaffected by the non-physician work pool. To analyze the Lewin idea, we followed this same approach for all services. However, we further modified the methodology to use proxy work RVUs for the TC (or non-physician work portion) of the global service for the allocation of indirect costs. (We did this for TC services as well, but it makes no difference whether a proxy physician work RVU is used for the indirect cost allocation since the RVU produced by the practice expense methodology for the TC is not used). By developing a proxy work RVU for the global, in effect, we imputed physician work RVUs for the technical portion of the global service and added it to the existing work RVUs for the physician interpretation. If such an approach were adopted, the indirect cost allocation would favor the global service at the expense of professional component. That is, the practice expense RVUs would increase for the global and decrease for the PC but the overall impact for the specialty would be about the same. Modifying the indirect cost allocation in this way would not offset large decreases in payment for radiology, radiation oncology and other specialties most adversely affected by elimination of the non-physician work pool. In fact, such a methodological change would not even raise payments to these specialties.
As we indicated in the June 2002 proposed rule, we believe a relatively low practice expense per hour, and not the indirect cost allocation, explains the adverse impact on diagnostic services that would occur from eliminating the non-physician work pool. We encourage radiology, radiology oncology and other diagnostic service providers affected by the non-physician work pool to undertake a survey of the practice expenses. Since practice expense methodology uses a weighted average of the practice expenses of the specialties that bill Medicare, we believe there are significant advantages to the survey being undertaken with collaboration among the different providers of diagnostic services. As indicated earlier, we advise any party interested in conducting a supplemental survey to consult the Lewin Group and us before proceeding.
Comment: Most comments we received supported making the TC practice expense RVUs equal to the difference between the global and PC practice expense RVUs. We received a number of comments from pathologists and organizations representing independent laboratories, pathologists, dermatologists, and others expressing concern about the effect of the proposal on payment for pathology services. Some of the commenters indicated that we did not provide an explanation of the necessity for the change or indicate why a simple arithmetic change should result in such a large difference in the proposed fee for TC services. Several of these commenters stated that practice expenses for physician pathology services are increasing, not decreasing. According to some of these commenters, it is inequitable to apply the methodology to certain specialties or groups of services that would experience significant reductions while sparing other specialties or services that would experience reductions under the same change. There were also comments indicating that the reduction in payment for pathology services was related to the mix of specialties that bill for global services; specifically, there is concern that independent laboratories bill for a higher proportion of global than TC services. The commenters noted that we do not have a practice expense per hour for independent laboratories and use a crosswalk practice expense per hour from "all physicians." While this comment acknowledges our need to use a crosswalk when we do not have a practice expense per hour, the comment indicated that there is no reason to conclude that independent laboratories that provide pathology services have practice expenses per hour similar to the all physician average. The comments expressing concern about the impact of the proposal on pathology services requested a one-year moratorium on its implementation to allow for a survey of independent laboratory practice expenses under the supplemental survey process. There were a number of comments indicating that organizations representing pathologists would undertake a survey of practice expenses for independent laboratories that could be used to develop 2004 physician fee schedule rates.
Response: We agree with the comments that suggest a one-year moratorium on implementation of the proposed change for pathology services paid under the physician fee schedule. Based on a consultation with the College of American Pathologists, we will continue to determine the global practice expense RVUs as the sum of the professional plus TC for all of the global codes in the CPT 80000 series that are paid using the physician fee schedule, as well as the following HCPCS and CPT codes:
CPT/HCPCS | Description |
---|---|
G0141 | Screening c/v, autosys, interp |
P3001 | Screening c/v, interp |
10021 | FNA w/o image |
10022 | FNA w/image |
36430 | Blood transfusion service |
36440 | Blood transfusion service |
36450 | Blood transfusion service |
36455 | Exchange transfusion service |
36460 | Transfusion service, fetal |
36520 | Plasma and/or cell exchange |
38220 | Bone marrow aspiration |
38221 | Bone marrow biopsy |
38230 | Bone marrow collection |
38231 | Stem cell collection |
CPT codes and descriptions only are copyright 2002 American Medical Association.
As we indicate in the background part of this preamble, the practice expense methodology essentially takes a weighted average of different specialty practice expenses to determine a practice expense RVU. The methodology will independently produce a value for the global, professional and technical components. For instance, CPT code 88305 (Tissue exam by pathologist) is a commonly provided pathology service. The methodology produces a value of 1.60 for the global, 0.34 for the PC and 1.39 for the technical component. The sum of the professional and TC RVUs (0.34 + 1.39 = 1.73) is not equal to the global RVU (1.60). The values are not equal because the mix of specialties that provide the global and the TC are different and each specialty has a different practice expense per hour. The specialties that bill CPT code 88305 to Medicare for the global service most frequently have the following practice expense per hour:
Specialty | Practice expense per hour | Percent of total volume |
---|---|---|
Independent Lab | $69.00 | 56 |
Pathology | 66.30 | 29 |
Dermatology | 119.40 | 13 |
The specialties that bill Medicare most frequently for the TC are:
Specialty | Practice expense per hour | Percent of total volume |
---|---|---|
Independent Lab | $69.00 | 47 |
Dermatology | 119.40 | 33 |
Pathology | 66.30 | 16 |
As shown in the tables above, dermatology has a very high practice expense per hour relative to independent laboratories and pathology. However, dermatologists bill Medicare for a smaller portion of the global services. As a result, dermatology contributes less weight to the global value than the TC value. Our practice has been to make the global RVUs equal the sum of the PC and TC values. If the methodology results in PC and TC values that do not sum to the global value, we must change either the global or TC value. To date, we have used the PC (0.34) and the TC value (1.39) to determine the global value (1.74). However, in the proposed rule, we used the global value (1.60) minus the PC (0.34) to obtain the TC (1.26). Using the TC to value the global component for this code (88305) produces a higher RVU for both the technical and the global components than using the global component to value the TC.
As we have previously indicated, it is far more common for Medicare to receive a global than technical-component-only bill. For this reason, we believe it is valid to rely on the global to produce a value for the technical rather than use the technical to value the global. Nevertheless, since independent laboratories predominantly bill the global for pathology services and we are using a crosswalk for the practice expense per hour, we believe it makes sense to allow for a one-year moratorium on implementation of this provision for pathology services to allow for use of a supplemental survey that provides us with specific data on practice expenses for independent laboratories.
Final Decision: We are not adopting the proposed change for pathology services paid using the physician fee schedule at this time. For all professional/TC services not included in the non-physician work pool, excluding pathology services, we will make the TC value equal the difference between the global and the professional component. We will continue with the current practice for pathology services and non-physician work pool services and sum the professional and TC values to determine the global.
(ii) Other Proposals for Changes to the Non-Physician Work Pool
(A). Change to Staff Time Used To Create the Pool
In the November 2, 1998 final rule (63 FR 58841), we indicated that average clinical staff time was used in the creation of the non-physician work pool. Since the cost pools are created using physician time and, by definition, services provided by clinical staff have no physician time, we need staff time to create the non-physician cost pool. If our database indicates that multiple staff types are typically involved in the service, we have used an average of the different clinical staff times. We proposed to create the non-physician cost pool using the highest staff time in place of average staff time.
Comment: We received many comments that supported using the highest staff time to create the non-physician work pool. Some comments suggested that we should consider using "total" staff time especially if we will use the clinical staff times being provided by the Practice Expense Advisory Committee (PEAC). The comment indicates that the PEAC has been particularly careful to avoid duplications of time. If the PEAC has limited or eliminates concurrent staff time, the comment suggests that "total" rather "maximum" staff time should be use to determine the non-physician work pool. A number of comments expressed concern about PEAC refinements of clinical staff times associated with codes included in the non-physician work pool. These comments requested that we not incorporate any PEAC revised clinical staff times for non-physician work services until there has been an opportunity for public notice and comment. There were two comments objecting to this proposal. One comment indicated that the maximum staff time is not the "typical" time associated with provision of the service and urged us not to implement the proposal. We received another comment that noted that physician times used to establish practice expense cost pools for physician work services use average or median times from RUC or Harvard surveys. The comment indicates that the proposal to use maximum staff time represents a step away from the stated goal of developing a consistent method for all services. According to this commenter, the proposal will penalize specialties that do not perform a large volume of services in the non-physician work pool.
Response: We disagree with the comment that suggests we are not using a time that is typical of the service and the one that implies our staff time proposal is inconsistent with how we determine physician time. For a physician's service, we develop time based on surveys. While the comment is correct that we generally use average or median time estimates from surveys to determine the typical time, the time reflects the service of a single physician. For non-physician work pool services, we are also using estimated average staff times to represent the typical service. However, multiple clinical staff are frequently involved in performing non-physician work pool services. The staff may be working concurrently, consecutively or overlapping time. Given the special circumstances associated with non-physician work pool services that do not apply to physicians' services, it was necessary for us to select among multiple time estimates to develop the pool. We are currently using an average of the estimated staff times but proposed to use the maximum. Once we address issues related to the non-physician work pool, this will no longer be an issue since we will use a single methodology for all physician fee schedule services and staff time will not be used to create cost pools.
In response to the comment that refined clinical staff times not be used at this time for non-physician work pool services, we agree that there are special circumstances that apply to these services. Because the clinical staff times are used to create the pool and can result in RVU changes across all services, even those where no refinements have been made, we are not using the revised clinical staff time to create the non-physician work pool at this time. However, as indicated above, this will no longer be an issue once we address other issues related to the non-physician work pool.
(B). Removal of Non-Invasive Vascular Diagnostic Study Codes From the Non-Physician Work Pool
We proposed to remove the non-invasive vascular diagnostic study codes (CPT codes 93875-93990) from the non-physician work pool based on a request from the American Association for Vascular Surgery (AAVS) and the Society for Vascular Surgery (SVS).
Comment: We received support from vascular surgeons and others for removing the non-invasive vascular diagnostic studies from the non-physician work pool. These comments requested that AAVS/SVS should be able to modify the request if CMS does not finalize its proposal to calculate the TC practice expense RVU as the difference between the global and professional components. We also received a number of comments requesting that we remove other codes from the non-physician work pool. The Society of Vascular Technology and Society of Diagnostic Medical Sonography) requested that we remove 26 ultrasound codes in the CPT code range 76506 through 76977. The American Society of Neuroimaging also requested that some of these codes be removed. The American Urological Association (AUA) also requested that we remove CPT codes 76857, 76872, 76942 and 96400 from the non-physician work pool. While there were no objections to removing the non-invasive vascular diagnostic study codes, we received many comments that suggested limiting the financial impact that removing codes from the non-physician work pool have on the remaining codes. In particular, many of these commenters expressed concern about the impact of removing chemotherapy administration codes from the non-physician work pool. Some comments provided suggestions for modifications to the non-physician work pool (for example, using a different practice expense per hour) that could be used if adverse impacts result from codes being removed. One commenter suggested that we maintain the existing RVUs and provide a downward adjustment to the CF to ensure no increase in aggregate payment results from removing chemotherapy administration services from the non-physician work pool.
Response: At this time, we have not received any requests to remove chemotherapy administration from the non-physician work pool. Nevertheless, if there are sound suggestions that could be adopted consistent with changes in the composition of the non-physician work pool that will improve the practice expense methodology, we may consider adopting them in the future. Of course, as stated elsewhere, our goal is to eliminate the non-physician work pool and apply a single methodology to all physician fee schedule services so further adjustments will be unnecessary. We expect this to be a top priority in CY 2003 for determining CY 2004 physician fee schedule rates.
We have reviewed the comments to remove specific services from the non-physician work pool. While our general policy has been that "families" of procedure codes should be removed from the non-physician work pool (see the July 22, 1999 proposed rule (64 FR 39620)), we will allow individual codes to be removed if the requesting specialty predominantly performs the requested code and other specialties predominantly perform the other codes in the family. We have reviewed 2001 utilization for the codes requested by the AUA. Since urologists predominantly perform the requested codes and other codes in the family are predominantly performed by other specialties, we are removing the following codes from the non-physician work pool: CPT codes 76857, 76872, 76942 and 96400. We are not removing other codes requested in the comments because they are predominantly performed by radiology, neurology or obstetrics-gynecology and the specialty societies representing these physicians have not requested that the codes be removed from the non-physician work pool.
Comment: The American College of Rheumatology (ACR) acknowledged that the current average wholesale price (AWP) methodology provides for a "healthy margin overall" in the provision of these services [infusion agents and infusion therapy] through "cross-subsidization." However, they indicated that payments for infusion therapy services are "woefully insufficient." The comments from ACR and many rheumatologists expressed concern about reductions in payment for infusion agents in combination with maintaining the current payment amounts for infusion therapy (CPT codes 90780 and 90781). The comments indicated that a reduction in payment for infusion agents without an increase in the payment for infusion therapy services will likely result in Medicare beneficiaries being unable to receive infusion services in physicians' offices. One commenter from a society representing gastroenterologists indicated that we should consider increasing the payment for non-chemotherapy infusion services. Other comments suggested that we should use the rulemaking process to establish HCPCS G codes to increase payment for non-chemotherapy drug administration to a more appropriate level.
Response: We currently determine the practice expense RVUs for CPT codes 90780 and 90781 using the non-physician work pool methodology. One commenter suggested establishing a G code for non-chemotherapy infusion services. While this option would allow infusion therapy to be valued outside of the non-physician work pool, we want to avoid establishment of G codes for services that are already described by existing CPT codes. Another option for addressing these comments would be to remove infusion therapy from the non-physician work pool and allow for resource-based pricing under the top-down methodology. However, oncologists predominantly perform these services and have not requested removing the codes from the non-physician work pool. We are reluctant to remove infusion therapy services from the non-physician work pool without a request from the specialty that predominates the data. As we previously noted, oncologists provided us with a supplemental practice expense survey. At this time, we are not incorporating the survey into the practice expense methodology because of concerns raised by our contractor, the Lewin Group, about the validity of some of the data. However, we hope to work with the Lewin Group and ASCO to either get an explanation of the survey results or use alternative data to validate the results. As we work to resolve issues related to the ASCO survey, we will consider removing the infusion therapy codes from the non-physician work pool.
In the interim, we note that Medicare pays for drugs based on 95 percent of AWP. This system has been widely criticized for paying physicians for drugs at far higher rates than prices paid to obtain them. Oncologists receive more than 70 percent of their Medicare revenues from drugs. While we would prefer a statutory change to address Medicare's drug pricing methodology, we are contemplating administrative actions that may be taken under current law to address this issue. As we consider options for changing Medicare's drug payment methodology, we will continue examining the ASCO survey to determine whether the data can be used to calculate the practice expense per hour for oncology.
(C). Removal of Immunization CPT Codes 90471 and 90472 From the Non-Physician Work Pool
We proposed to remove immunization administration services from the non-physician work pool. We indicated this change would nearly double payment for CPT code 90471 and slightly reduce payment for CPT code 90472. Procedure CPT code 90471 is used for immunization administration of one vaccine and CPT code 90472 is used for the administration of each additional vaccine. Since CPT code 90472 must be billed in conjunction with CPT code 90471, the total payment for these procedures would increase when billed together.
We also explained that we have not assigned immunization administration physician work RVUs because this service does not typically involve a physician. The nurse that administers the vaccine typically provides the necessary counseling to the patient and this time is accounted for in the practice expense RVU.
In addition, we noted that not all services represented by CPT codes 90471 and 90472 are covered by Medicare. For example, medically necessary administrations of tetanus toxoid (such as following a severe injury) would be covered whereas preventive administration of this vaccine would not be covered. We also indicated we would consider whether coding changes might be appropriate to reflect the differences in counseling of the patient and/or family for childhood immunizations.
Comment: Commenters supported our proposal to remove CPT codes 90471 and 90472 from the non-physician work pool. However, commenters indicated elderly patients are at higher risk to acquire pathogens and viruses and are in greater need of vaccinations. Medicare must recognize that as part of their practice of medicine, physicians take the time and responsibility to explain to their patients the benefits of vaccination and the potential side effects. Physicians question the patient about previous reactions to the vaccine and provide information material. These comments indicated that we should assign work RVUs of 0.17 for the administration of vaccines as recommended by the RUC.
Response: The RUC has recommended that we both establish a work RVU for CPT code 90471 and include 13 minutes of clinical staff time to value the practice expense RVU. Further, our understanding from the RUC is that these immunization services are also provided in conjunction with a separately billable visit. We believe the clinical staff time for these services is intended to account for patient counseling and some of the activities described in the comment. Other activities attributed to the physicians are likely being provided as part of a separately billable office visit. For these reasons, we continue to believe that these codes should not be assigned physician work RVUs.
Comment: Several commenters expressed concern that we did not propose any change in the payment rate for the administration of influenza (G0008), pneumonia (G0009), and hepatitis B (G0010) vaccines. The commenters are concerned that we continue to link payment for the administration of Medicare covered vaccines to a therapeutic injection CPT code (90782) that pays at half of the proposed rate for CPT code 90471. Other commenters recommended that Medicare use the CPT codes 90471 and 90472 in place of the Medicare-only alphanumeric codes (G0008, G0009, G0010). These comments indicated that if we are to retain the G codes, we should publish RVUs for them that match CPT code 90471.
Response: We considered the comment to eliminate use of the G codes and allow use of the CPT codes for the administration of Medicare covered vaccines. However, we have decided that we will maintain these G codes at this time. It is important that we be able to closely monitor patient access to these important preventive services. However, since CPT has established similar codes for immunization administration that can be covered by Medicare, we will consider this issue further in 2003.
With respect to payment, we agree with the commenters. Rather than link payment for procedures codes G0008, G0009, and G0010 to a service paid under the physician fee schedule, we will develop practice expense RVUs for these codes. Using the top-down methodology to develop practice expense RVUs will nearly double payment for these codes and make Medicare's payment for vaccine administration using the G codes more consistent with the rates paid for the CPT codes. Since the statute does not include the administration of pneumonia, influenza, and hepatitis B vaccines within the definition of physicians' services in section 1848(j) of the Act, the increased payment for these services will not result in reductions to the practice expense RVUs associated with physician fee schedule services. That is, there is no budget-neutrality adjustment to be made for revisions in payments for the administration of pneumonia, influenza, and hepatitis B vaccines.
Comment: One commenter indicated that Medicare does not pay for the administration of influenza and pneumonia vaccines provided on the same day as another physician's service.
Response: The commenter is incorrect. Medicare will pay separately for the administration of these vaccines and other physicians' services on the same day.
(D) Utilization Data
Medicare utilization is an important data source used in determining the practice expense RVUs. Our current policy has been to use the latest utilization data to develop each successive year's fully implemented practice expense RVUs during each year of the transition. While substituting the latest year's utilization data into the practice expense methodology generally made little difference on total Medicare payments per specialty, there has been a larger impact on services affected by the non-physician work pool. Based on suggestions made by specialty organizations, we proposed to use the CYs 1997 through 2000 utilization data to develop the CY 2003 practice expense RVUs and not to update further the utilization data in this year's final rule to incorporate the CY 2001 utilization data. Further, we proposed to continue using the CYs 1997 through 2000 utilization data in the practice expense methodology until we undertake the 5-year review of practice expense RVUs.
Comment: We received comments both supporting and opposing use of multi-year utilization data in the practice expense methodology. The comments that "applauded CMS's efforts to ensure the stability" of the practice expense RVUs largely came from organizations affected by the non-physician work pool methodology. We also received support from specialties that are largely unaffected by the proposal because of its potential to provide more year-to-year stability in the practice expense RVUs. Other commenters indicated that use of new utilization data with a different "mix" of services produces unpredictable changes in RVUs even though resource costs have not changed. There were comments that indicated use of multi-year utilization data will restore the unanticipated and extraordinary reductions experienced by diagnostic imaging centers in CY 2002. These commenters urged that we adopt our proposal in the final rule. One comment stated that "utilization data adjustments should not change annually until the [non-physician work pool] is eliminated and/or CMS undertakes the 5-year review of practice expense RVUs."
One commenter stated that it is unclear whether the multi-year utilization will be used to develop practice expense RVUs for all services or only those in the non-physician work pool. Another commenter stated it is difficult to assess the impact of the proposal and urged the agency "not to make such a change, at least until it has conducted extensive impact comparisons" that can be evaluated by physicians and other stakeholders. Other commenters suggested that we should not update the practice expense methodology with new utilization data without giving an opportunity for public notice and comment. A number of commenters argued that application of a 10-percent payment reduction in CY 1998 and the per beneficiary per facility payment cap of $1500 cap in CY 1999 (in settings other than outpatient hospital departments) make utilization data unreliable for therapy services during the CYs 1997 through 2000 period. Commenters also noted that outpatient physical and occupational therapy services provided in facility settings were paid under cost-based reimbursement before CY 1999. The commenters questioned the accuracy of the utilization data for Part B therapy services from CYs 1997 through 2000 and suggested that the utilization data during this period would be biased by the implementation of policy changes. One commenter recommended that we use the most current available data as the base for examining therapy utilization and should commit to an annual review of the data until it can be established that a longer time horizon accurately reflects utilization. Other comments requested clarification of how we use data from this period for physical and occupational therapy.
Response: With respect to therapy services, we do not use claims of institutional providers (rehabilitation agencies and comprehensive outpatient rehabilitation facilities) in developing payment rates for therapy services paid using the physician fee schedule. We only use the claims for therapy services from physical and occupational therapists in private practice. The proposal was intended to apply to all physician fee schedule services, not just those in the non-physician work pool. We are finalizing our proposal to use the CYs 1997 through 2000 utilization data to develop the practice expense RVUs for all services. However, we believe the comments raise important issues about policy changes that were occurring from CYs 1997 through 2000 that could lead to changes in utilization patterns during this time. We may analyze this issue further. In the interim, we welcome public comment about using the latest utilization data in the practice expense methodology.
(E) Site of Service
As part of our resource-based practice expense methodology, we make a distinction between the practice expense RVUs for the non-facility and the facility setting. This distinction is needed because of the higher resource costs to the physician in the non-facility setting where the practitioner typically bears the cost of the resources associated with the service. In addition, the distinction ensures that we do not make a duplicate payment for any of the practice expenses incurred in performing a service for a Medicare beneficiary. Currently, we have designated only hospitals, skilled nursing facilities (SNFs), and community mental health centers (CMHCs) as facilities for purposes of calculating practice expense. An ambulatory surgical center (ASC) is designated as a facility if it is the place of service for a procedure on the ASC list. All other places of service are currently considered non-facility.
We proposed site-of-service designations for several new places of service as well as revisions to the site-of-service designation for several existing places of service. We proposed to assign a facility site-of-service when a facility or other payment will be made, in addition to the physician fee schedule payment to the practitioner, to reflect the practice expenses incurred in providing a service to a Medicare patient. We proposed to designate all other places of service as non-facilities.
The following lists the place of service numerical code, the place of service and the proposed site of service designations:
04Homeless Shelter-Non-facility
15Mobile Unit-Non-facility, however, if a mobile unit provides a service to a facility patient, the appropriate place-of-service code for the facility should be used.)
20Urgent Care Facility-Non-facility
26Military Treatment Facility-Facility
41Ambulance-Land-Facility
42Ambulance Air or Water-Facility
52Psychiatric Facility Partial Hospitalization-Facility
56Psychiatric Residential Treatment Facility-Facility (NOTE: the chart included in the June 28, 2002 proposed rule at 67 FR 43854 incorrectly listed this as "NF"-nonfacility)
We would also clarify two items in the chart published at 67 FR 43854:
61Comprehensive Inpatient Rehabilitation Facility was listed as a non-facility. This is currently considered a facility setting and we did not propose changing this designation. The reference to non-facility was in error.
We also made reference to four place of service codes for Indian Health Service and Tribal 638 facilities and clinics. We were considering these place of service codes to implement section 432 of the BIPA that authorizes physician fee schedule payments to Indian Health Service and Tribal 638 facilities and clinics. At this time, we do not believe these place of service codes will be needed for implementation of these provisions and do not expect them to be in use. We are implementing section 432 of BIPA by using specialty codes, not place of service codes to identify HIS providers.
Comment: One organization expressed appreciation for our efforts to update the list and had no comments. Others commented requesting clarification of site-of-service designations for the provision of Part B therapy services in nursing facilities. One commenter expressed particular concern about the use of place of service code 32 (Nursing facility) in conjunction with outpatient therapy services in nursing facilities. This commenter suggested we reiterate in the final rule the current policy that fee schedule payments for Part B therapy services delivered in a nursing home are classified as "non-facility." They also suggested we redefine "site-of-service" for physicians services to non-Part A patients in nursing centers as "non-facility," thereby applying the higher PERVUs to those services. We received one comment from a carrier medical director that indicated that physician practice costs for treating patients in skilled nursing facilities (POS 31) and nursing facilities (POS 32) are the same and that both should be designated as either facility or non-facility. This comment also suggested deleting the POS 32 designation (NH), or changing its meaning to a "SNF or NF stay not covered by Medicare." A physician who practices in nursing facilities also argued that our current policy makes no sense because physician practice costs are the same regardless of whether Medicare makes a payment to the SNF for institutional services. This physician would like us to pay at the higher non-facility rate for physicians' services in both entities, but acknowledged that using the lower facility rate would be more consistent with the practice expense methodology.
Response: We regret any ambiguity or concern that we may have created in our proposed rule. In general, for purposes of the physician fee schedule, we will consider a site to be a facility if the site also receives a Medicare payment for institutional services (that is, a payment under the inpatient prospective payment system (PPS), outpatient PPS, and SNF PPS). Thus, since there is a payment for institutional services to a hospital when a beneficiary receives care in an inpatient or outpatient setting, we consider the site to be a facility site and make a payment under the physician fee schedule using the facility rate. For entities other than those that receive a payment for institutional services, we consider the site a non-facility site and pay under the physician fee schedule using the higher non-facility rate. However, there are special provisions with respect to outpatient physical and occupational therapy services. These services are paid under the physician fee schedule even when provided in institutional sites like skilled nursing facilities. For this reason, for these services we calculate only a non-facility rate. Since there is no facility payment under Medicare, we use a non-facility rate to determine payment.
Place of service code 32-Nursing facility-was designated as non-facility in our June 2002 proposed rule. Place of service code 31-Skilled nursing facility-is designated as facility. We have instructed physicians to use place of service code 31 for patients who are in an inpatient stay in a skilled nursing facility. Since Medicare is making a payment for institutional services that includes compensation for staff, supplies, and equipment, we are paying physicians using the lower facility rate when place of service code 31 is used. If the patient exhausts eligibility for SNF benefits and Medicare is no longer making payment to the SNF for institutional services, we have instructed physicians to use place of service code 32-Nursing facility, to allow Medicare to provide compensation to the physician for the costs of staff, supplies and equipment that would otherwise not be included in our payment. However, since it may be burdensome to the physician to determine when a patient is entitled to SNF Part A benefits, we always allow the physician to use place of service 31 and receive the lower facility payment for physicians' services.
While we acknowledge the arguments of those who have written and contacted us both prior to and as part of the rulemaking process, we are reluctant to make any further changes in our policy at this time. We believe existing policy is equitable in that it does not overly burden physicians to have to determine whether a patient is in a Part A SNF inpatient stay. Physicians can always bill using place of service code 31 and be paid at the facility rate. Further, we allow use of place of service code 32 and our payment will be at the higher non-facility rate that includes compensation for staff, equipment, and supplies that would not otherwise be paid since there is no payment for the institutional services. In response to the request that we change the nomenclature describing place of service code 32, we will consider this further as updates are made to place of service coding. However, we note that Medicaid uses the place of service codes as well and the needs of this program will also need to be considered.
Comment: One commenter suggested the descriptor for place of service code 23, "emergency room-hospital," should be changed to "emergency department."
Response: We will consider this comment when further updates are made to place of service codes.
Comment: One commenter expressed concern about the proposed designation change of site of service from non-facility to facility for both psychiatric facility partial hospitalization and psychiatric residential treatment facility. The commenter felt this would negatively impact physician reimbursement and could provide disincentive for psychiatrists to treat patients in these settings.
Response: By developing practice expense RVUs that differ by site, we intend to reflect the relativity of resource costs incurred by physicians between sites. Our policies are not intended to provide financial incentives for a physician to select one site over another. Physicians should make these decisions based on the clinical needs of the patient. We believe that both psychiatric residential treatment facilities and psychiatric partial hospitalization programs are institutional sites that provide staff, equipment and supplies used in providing medical services and physicians will not incur these resource costs when providing services in these settings.
(F). Other Practice Expense Issues
(1) Budget Neutrality
We received several comments suggesting that budget neutrality for changes in practice expense RVUs be applied to the physician fee schedule conversion factor. The comments indicated that payment for CPT codes with significant practice expense RVUs are reduced when there are aggregate increases in work RVUs but services that are predominantly composed of work RVUs are not significantly affected by aggregate increases in practice expense RVUs. According to the comments, such a modification would "help assure more year-to-year stability in the practice expense RVUs." Since affected professional groups have not had an opportunity to consider and comment on this important issue, one comment suggests that we include this issue in the proposed notice for the CY 2004 physician fee schedule.
Response: We will consider this idea for the future.
(2) Computerized Tomographic Angiography
Comment: We received a number of comments about Computed Tomographic Angiography (CTA). The comments indicated that, before CY 2001, CTA services were billed as a CT scan of an anatomical region plus an add-on code for 3-D image reconstruction. New codes specifically for CTA that incorporated the image reconstruction were developed for use in 2001. The comments indicated that the TC RVUs for CTA established in the November 1, 2000 final rule appear as though they were calculated by cross-walking the RVUs from the anatomically analogous existing CT procedure codes without accounting for the 3-D image reconstruction.
Response: Based on this comment, we have adjusted the current CTA codes to incorporate image reconstruction.
(3) TC for Cardiac Catheterization
Comment: We received several comments that noted the TC RVU for cardiac catheterization declined in the notice of proposed rulemaking even though the codes are included in the non-physician work pool. These comments noted that the practice expense RVUs for all other non-physician work pool services increased in the proposed rule. One comment expressed concern over our proposal to derive the TC RVU from the global RVU service. The comment indicated that we currently have no direct cost inputs for these services and it is unlikely that the PEAC will be able to provide them since cardiac catheterization is generally provided in hospital settings. According to the commenter, there are only 80-100 non-hospital facilities that provide cardiac catheterization services. It is unlikely that we will have physician survey information that reflects the costs of these providers since they normally bill for the TC service and not the global service. The comment stated the cardiologist normally bills independently for professional services.
Response: We have addressed the comment regarding the TC for the cardiac catheterization. The TC RVUs for these services are changing by the same percentage as all other non-physician work pool services. We understand that the PEAC may consider providing inputs for cardiac catheterization services. This will address one aspect of the commenter's concern. With respect to valid SMS data for cardiac catheterization services, we will consider this issue along with others as we address issues related to the non-physician work pool in CY 2003.
B. Anesthesia Issues
1. Five-Year Review of Anesthesia Work
Section 1848(b)(2)(B) of the Act indicates that, to the extent practicable, we will use the anesthesia relative value guide with appropriate adjustment of the anesthesia conversion factor (CF) in a manner to assure that the fee schedule amounts for anesthesia services are consistent with the fee schedule amounts for other services. The statute also requires us to adjust the CF by geographic adjustment factors in the same manner as for other physician fee schedule services. Unlike other physician fee schedule services, anesthesia services are paid using a system of base and time units. The base and time units are summed and multiplied by a CF. The base unit is fixed depending on the type of anesthesia procedure performed, and the time units vary based on the length of the anesthesia time associated with the surgical procedure. Thus, our payment will increase as anesthesia time lengthens. The same anesthesia service provided in two different surgeries will be paid different amounts if the associated anesthesia time is different. This system differs from other physician fee schedule services for which RVUs for physician work, practice expense, and malpractice are summed and multiplied by a CF to determine payment. Payment for these non-anesthesia procedures will not vary based on the length of time it takes to perform the procedure in a specific instance.
In the June 2002 proposed rule (67 FR 43855) we explained that the law requires that we review RVUs no less often than every 5 years. There is a fundamental difference in how the 5-year review applies to anesthesia services versus medical and surgical services. In general, for medical and surgical services, the relevant physician specialty society and the AMA's RUC review the current and proposed work RVUs on a code-by-code basis. The RUC will make recommendations to us on work values for specific codes and, if we accept or modify them, the new physician work RVUs will be used to determine payment. However, each anesthesia service does not have a work RVU. Therefore, adjustments for anesthesia work (and practice expense) are made to the anesthesia CF and payment for all anesthesia services is affected.
The second 5-year review (with the exception of anesthesia services) was completed and revised work RVUs were implemented in 2002. For the second 5-year review, the American Society of Anesthesiologists (ASA) contended that the work of anesthesia services remained undervalued by almost 31 percent. They subsequently argued for a 26 percent increase in work RVUs based on additional discussions with the RUC. More recently, based on their further analysis and discussion with the RUC, the ASA asked for a 13.6 percent increase in work.
The ASA derived a work value for an anesthesia code by dividing the anesthesia service into five uniform components. The five components are preoperative evaluation, equipment and supply preparation, induction period, postinduction period, and postoperative care and visits. These components were assigned work RVUs based on a comparison to non-anesthesia services paid under the physician fee schedule. The work of these components is then summed. Using this method, the ASA proposed new work values for 19 high volume anesthesia codes. These work values can be compared to imputed work values derived from current anesthesia payments for these services.
Under the CPT coding system, anesthesia for various common surgical procedures is reported under a single anesthesia code. For example, CPT code 00790 is used to report anesthesia for over 250 intraperitoneal procedures in the upper abdomen.
The ASA studied one surgical procedure for each of the anesthesia codes. The 19 codes represent a range of surgical procedure types, including general surgery, vascular surgery, neurosurgery, urology, orthopedics, cardiac surgery, and ophthalmology. The 19 procedures reviewed account for about 35 percent of Medicare allowed charges for anesthesia services.
During the second 5-year review of work, several RUC workgroups reviewed the ASA comments and received supplemental information from them through presentations. Most of these workgroups expressed concerns about some of the work intensity values the ASA assigned to the individual anesthesia components, most notably, the induction and post induction time periods. For about 50 percent of the codes, the RUC was confident that the anesthesia work value of the surveyed service was similar to the anesthesia work values for all of the other surgical services assigned to the given anesthesia code. For the remaining codes, the RUC was not confident that the work values of the surveyed code could be applied to other anesthesia services that would be reported under that anesthesia code.
The workgroups also expressed concern about extrapolating the results from the 19 surveyed codes to all anesthesia services. At its April 2002 meeting, the final meeting addressing anesthesia work values for the second 5-year review, the RUC concluded it was unable to make a recommendation regarding modification to the physician work values for anesthesia services. Specifically, the RUC stated:
The RUC, having carefully considered the information presented, and having a reasonable level of confidence in the data, which was presented and developed by the ASA, is unable to make a recommendation to CMS regarding modification to the physician work valuation of anesthesia services.
While the RUC did not make a recommendation to us regarding extrapolation, it forwarded its analysis to us for review.
In the June 2002 proposed rule (67 FR 43856), we indicated our intent to review the information forwarded by the RUC and all comments we received during the comment period.
Comment: The ASA commented that, based on work values accepted by the RUC anesthesia workgroup, the final RUC data show that anesthesia services are undervalued by a weighted average of 13.57 percent. The ASA urged us to adjust the anesthesia CF accordingly. The American Association of Nurse Anesthetists (AANA) endorsed the ASA's comments and provided similar comments. Several certified registered nurse anesthetists and anesthesiologists also wrote in support of an increase in the anesthesia CF. We also received several comments alleging that the ratio of Medicare payment to private payer payments for anesthesia services is considerably less than the analogous ratio for medical and surgical services.
Response: The ASA and the AANA have requested that we apply the RUC's analysis of the 19 codes to all anesthesia codes. They believe that the weighted average increase in anesthesia work values that results from the RUC's analysis is representative of work values for all other anesthesia codes.
For some codes, the RUC seemed confident that the anesthesia work value of the surveyed code was similar to the anesthesia work values for all of the other surgical services assigned to the given anesthesia code. However, for almost half of the surveyed codes, the RUC did not have confidence that the work values of the surveyed code could be applied to any other anesthesia services that would be reported under that anesthesia code.
Due to the uncertainty of the RUC with regard to extrapolation, even within the family of surgical procedures assigned to a single anesthesia code, we have weighted each of the 19 anesthesia codes only by the anesthesia allowed charges associated with the single surveyed surgical procedure. Using this methodology, anesthesia for the surveyed surgical codes account for approximately 23 percent of all anesthesia allowed charges. This results in an increase in anesthesia work for the 19 codes of 9.13 percent. However, because we will apply a payment increase only to these codes, we are increasing the physician work portion of the anesthesia conversion factor by 2.10 percent which reflects a 9.13 percent increase in payment applied to the 23 percent of total anesthesia charges represented by the 19 codes. We provide more detail on how this increase is applied to the anesthesia conversion factor in the section VIII of this final rule.
Final Decision
We are increasing the physician work component of the anesthesia conversion factor by 2.10 percent to reflect a 9.13 percent increase in payment applied to 23 percent of anesthesia allowed charges. This as an interim adjustment that is subject to comment.
2. Add-On Anesthesia Codes
Payment for anesthesia services is based on the sum of an anesthesia code-specific base unit value plus anesthesia time units multiplied by an anesthesia CF. Under our current policy at § 414.46(g), if the physician is involved in multiple anesthesia services for the same patient during the same operative session, payment is based on the base unit assigned to the anesthesia service having the highest base unit value and anesthesia time that encompasses the multiple services.
Claims processing manuals instruct the carrier on the method for handling anesthesia associated with multiple or bilateral surgical procedures. Under the Medicare Carrier Manual (MCM) 4830 D, the physician reports the anesthesia procedure with the highest base unit value with the multiple procedures modifier-51 and total time of anesthesia for all surgical procedures. Thus, the carrier is recognizing payment for one anesthesia code.
In CYs 2001 and 2002, the CPT included new add-on anesthesia codes. The objective is that the add-on code would be billed with a primary code, each code having base units. We believe that anesthesia add-on codes should be priced differently from other multiple anesthesia codes. We proposed to revise the regulations at § 414.46(g) to include an exception to the usual multiple anesthesia services policy for add-on codes.
Comment: The ASA, AANA and the AMA expressed support for our adopting a payment policy for add-on anesthesia codes. The ASA asked that we clarify the policy for recognition of base or time units or both for add-on anesthesia codes.
Response: Of the 259 anesthesia codes, there are two codes, called primary codes that may have add on codes, under certain circumstances. These are:
Primary code: CPT code 01967
Add-on code: CPT code 01968 or 01969
Primary code: CPT code 01952
Add-on code: CPT code 01953
Based on comments received, we understand that the ASA is seeking to bill only the base unit of the add-on code (01953) when it is billed with the primary code 01952. The time of the add-on code is to be included in the time of the primary code. Thus, all anesthesia time is attributable to the primary code.
The ASA is seeking to bill both the base and time of the add-on code, 01968 or 01969, when either is billed with the primary code 01967. Thus, the anesthesia provider would report the base and time units of both the primary and the add-on code.
We recognize that the general policy for add-on codes is that the carrier should allow only the base unit of the add-on code. As with multiple anesthesia services, the anesthesia time of the add-on code would be reported with the time of the primary code. In other words, anesthesia time is reported for all the underlying surgical services.
However, in discussions with the ASA, we have learned that many third party payors have more restrictive time units policies for obstetrical anesthesia codes than for other anesthesia codes. If the time of the add-on code, such as 01968 or 01969, were reported with the primary code, the time units of the add-on code might be undervalued. To prevent this result, we are requiring that (for the two obstetrical anesthesia add-on codes) the anesthesia time be separately reported with each of the primary and the add-on code based on the amount of time appropriately associated with either code.
Further, we think the policy on multiple procedure codes as well as add-on codes is an operational policy and should be addressed only in program operating instructions. As a result, we are revising the regulation text at § 414.46(g) accordingly.
Final Decision
We are allowing the carriers to recognize the base unit of the add-on codes. However, for the obstetrical add-on codes, the carrier may recognize both the base unit and the anesthesia time associated with the add-on code.
C. Pricing of Technical Components (TC) for Positron Emission Tomography (PET) Scans
Currently, all components of HCPCS code G0125, Lung image PET scan, are nationally priced. However, the TC and the global value for all other PET scans are carrier-priced. To keep pricing consistent with other PET scans, we proposed to have carriers price the TC and global values of HCPCS code G0125.
Comment: We received comments from one specialty organization in support of carrier pricing. We received comments from another specialty organization and a few providers stating that they were concerned that, contrary to our stated purpose, this change would lead to inconsistent payment by carriers. The commenters believe that some carriers use the nationally-established TC RVUs for G0125 as a reference for payment for the other PET scans.
Response: While we understand the commenter's concerns, we believe the RVUs assigned before CY 2003 for the TC of G0125 do not accurately reflect the resources used for furnishing this service, which is why we proposed carrier pricing. Thus, using G0125 as a reference code for pricing could lead to inappropriate pricing for all services. We believe that adopting carrier-pricing, instead of a national fee schedule amount, for the TC of G0125 will result in more appropriate pricing for the TC of all PET scans. Carriers have a variety of methods that they use to establish payment for codes. We believe using some of these alternative methods will lead to more accurate pricing for this service.
Final Decision
We will finalize our proposal to allow carriers to price the TC and global values of code G0125.
D. Enrollment of Physical and Occupational Therapists as Therapists in Private Practice
In the November 2, 1998 final rule (63 FR 58814), we defined private practice for physical therapists (PTs) or occupational therapists (OTs) to include a therapist whose practice is in an-
• Unincorporated solo practice;
• Unincorporated partnership; or
• Unincorporated group practice.
The term "private practice" also includes an individual who is furnishing therapy services as an employee of one of the above, a professional corporation, or other incorporated therapy practice. Some carriers and fiscal intermediaries have interpreted the regulation to mean that OTs and PTs employed by physicians cannot be enrolled as therapists in private practice. In these carrier areas, therapy services provided in a physician's office must instead be billed as incident to a physician's service.
A specialty society representing OTs has requested that carriers be able to enroll OTs in physician-directed groups as OTs in private practice. A group representing PTs believes that provider numbers should be issued only to PTs working as employees in practices owned and operated by therapists.
We proposed to clarify national policy and revise §§ 410.59 and 410.60 to state we would allow enrollment of therapists as PTs or OTs in private practice when employed by physician groups. We believe that this reflects actual practice patterns, will permit more flexible employment opportunities for therapists and will also increase beneficiaries' access to therapy services, particularly in rural areas.
Comments: We received many comments from associations, specialty groups, therapists, and the public that strongly support the proposed clarification that would allow carriers and fiscal intermediaries to enroll therapists as PTs or OTs in private practice when they are employed by physician groups. However, one association urged us to confirm that this policy extends to therapists employed by a non-professional corporation.
Response: We agree and will change the regulation to reflect that carriers and fiscal intermediaries can enroll therapists as PTs or OTs in private practice when the therapist is employed by physician groups or groups that are not professional corporations, if allowed by State law.
Comments: Several commenters suggested that we state clearly that carriers and fiscal intermediaries are required to enroll physician-employed therapists, who are otherwise qualified, and that carriers and fiscal intermediaries may not refuse to enroll therapists simply on the basis of employment. They requested that the regulation state specifically that Medicare contractors must enroll therapists as PTs or OTs in private practice when they are employed or under contractual relationships with physician groups or groups that are not professional corporations.
Response: We agree and will change the Medicare Carriers and Fiscal Intermediaries Manuals' to reflect that carriers and fiscal intermediaries "will" enroll Medicare therapists as PTs or OTs in private practice for purposes of Medicare when the therapists are employed by physician groups or groups that are not professional corporations. However, we do not believe that we need to specify further employee-employer relationships, which are detailed in the Medicare Carriers Manual, Part 3, Chapter III.
Comment: One commenter believed that we should not enroll PTs who are employees of physicians' offices as PTs or OTs in private practice but, instead, should establish a separate section of the regulations that would govern the issuance of provider numbers to PTs who are employees in physicians' offices, and give these therapists a different designation. The commenter suggested we also include protections that currently exist when a non-physician practitioner provides services in a physician's office and the physician bills for these services under the physician's Medicare provider number.
Response: We disagree with this comment. We have established procedures for issuing provider numbers that we believe are adequate. The proposed changes to the regulations reflect actual practice patterns, will permit more flexible employment opportunities for all therapists, and also increase beneficiary access to therapy services, particularly in rural areas. Therapists still have the flexibility of providing outpatient therapy services incident to a physicians service if they so choose. However, the services must meet the incident to requirements at § 410.26.
Final Decision
We will finalize our proposal to revise §§ 410.59 and 410.60 with the modifications noted above.
E. Clinical Social Worker Services
In the June 28, 2002 proposed rule, (67 FR 43846), we indicated we would be addressing comments received on the October 19, 2000 proposed rule entitled, "Clinical Social Worker Services," (65 FR 62681), in this final rule. Upon further review, we have determined that we will not include this issue in this final rule, but will address it in future rulemaking.
F. Medicare Qualifications For Clinical Nurse Specialists
Currently, the qualifications for a clinical nurse specialist (CNS) include a requirement that a CNS must be certified by the American Nurses Credentialing Center (ANCC). We proposed to revise this particular requirement under the CNS qualifications because of concerns expressed that the ANCC does not provide certification for CNSs who specialize in fields such as oncology, critical care, and rehabilitation. Additionally, we noted that the proposed revision of the certification requirement for CNSs is consistent with the certification requirement under the nurse practitioner (NP) qualifications. Accordingly, we proposed specifically to revise section § 410.76(b)(3) to read as follows:
"Be certified as a clinical nurse specialist by a national certifying body that has established standards for clinical nurse specialists and that is approved by the Secretary."
Comments and Responses
We received comments on the proposed revision to the CNS certification requirement from professional nursing societies, a specialty nursing certification corporation, a college of radiology, a major nurses association, a provider of health care and elder care and, several independent clinical nurse specialists.
Comment: We received comments indicating that the current CNS certification requirement poses a serious threat to ensuring Medicare beneficiary access to quality care because it restricts CNSs who are not certified by the ANCC from qualifying for Medicare payment. The ANCC does not certify CNSs in oncology, rehabilitation, acute care or critical care. Since the current CNS certification requirement inherently precludes CNSs who are certified in oncology from Medicare payment, the number of nurses available to care for Medicare beneficiaries with cancer is limited. The proposed change to the CNS qualifications is more inclusive, and it will enable the 415 oncology CNSs who hold Advanced Oncology Nursing Certification (AOCN) provided by the Oncology Nursing Certification Corporation (ONCC) to meet the certification criteria for CNSs and therefore, qualify for Medicare payment. An independent CNS stated that as a palliative care CNS, her institution required advanced certification that is not offered by the ANCC in many specialty areas of practice. However, the American Board of Nursing Specialties is the credentialing board for the ONCC, which is the only national certification that an advanced practice nurse can obtain specific to his or her field of expertise. All of the commenters support the proposed revision to the CNS certification requirement because they stated that overall, the certification criteria for CNSs will be consistent with the certification criteria for NPs and the requirement will ensure that Medicare beneficiaries receive services from advanced practice nurses who are certified by a national certifying body.
Response: It has not been our intention to be overly restrictive in our program requirements and consequently prevent qualified CNSs who specialize in areas of medicine other than those certified by the ANCC from participating under the Medicare program's CNS benefit and rendering care to patients in need of specialized services. The intent of the revised CNS certification requirement is to recognize all appropriate national certifying bodies for CNSs as the program does for NPs.
Result of Evaluation of Comments
We are implementing the proposed revision to the CNS certification requirement under the CNS qualifications at § 410.76.
G. Process To Add or Delete Services to the Definition of Telehealth
In the June 2002 proposed rule (67 FR 43862), we proposed to establish a process for adding or deleting services from the list of telehealth services, and to add specific services to the list of telehealth services for CY 2003.
We stated that we would accept proposals from any interested individuals or organizations from either the public or the private sectors, for example, from medical specialty societies, individual physicians or practitioners, hospitals, and State or Federal agencies. We also mentioned that we might internally generate proposals for additions or deletions of services.
We stated that we would post instructions on our website outlining the steps necessary to submit a proposal. Please see the June 2002 proposed rule for the items that were to be addressed, the assignment of categories, and the outcomes.
We proposed to remove a service from the telehealth list of services if, upon review of the available evidence, we determine that a telehealth service is not safe, effective, or medically beneficial when performed as a telehealth service.
We proposed to make additions or deletions to the list of telehealth services effective on a CY basis. We proposed to use the annual physician fee schedule proposed rule published in the summer and the final rule published by November 1 each year as the vehicle for making these changes. Requests must be received no later than December 31 of each CY to be considered for the next proposed rule.
Based upon further review of the comments submitted in response to the proposed rule for CY 2002, we believe that the psychiatric diagnostic interview is similar to the telehealth services listed in the statute. Specifically, we believe this service would meet the criteria set forth in Category 1 of the proposed process for adding services. Therefore, we proposed to add psychiatric diagnostic interview examination as represented by CPT code 90801 to the list of telehealth services and proposed to revise §§ 410.78 and 414.65 to reflect the proposed addition to the list of telehealth services.
Comment: We received many comments expressing support for our proposed process for adding and deleting telehealth services. The commenters indicated that our proposed criteria for reviewing submitted requests are reasonable and provide a viable mechanism for adding existing services to the list of telehealth services. However, as part of our review, one specialty college suggested that the CPT editorial panel be an integral part of our process. The commenter stressed that reviewing codes and determining how these services can be furnished is the CPT editorial panel's area of expertise. With regard to deletion of services, one association urged us to consult with the appropriate medical society members to obtain clinical evidence based on peer-reviewed information and medical journal articles before deleting services from the list of telehealth services.
Response: Section 1834(m) of the Act requires us to develop a process specifically for adding or deleting telehealth services on an annual basis. The mandate for this statutory provision is separate and distinct from the role of the AMA CPT editorial panels in developing new codes and/or defining services for the CPT compendia. It would not be appropriate to make the CPT editorial panel an integral part of the process to add or delete services from the list of telehealth services. We will review submitted requests for addition and deletion based on the criteria discussed in this final rule and welcome input from medical professionals with expertise in the service being reviewed as part of the rulemaking process.
We are clarifying from the proposed rule that a decision to remove a service from the list of telehealth services would be made using evidence-based, peer-reviewed data which indicate that a specific telehealth service is not safe, effective, or medically beneficial. Such determination would not be made under section 1862(a)(1)(A) of the Act. Therefore, a decision to delete a service under this process would only apply to the list of Medicare telehealth services.
Comment: One commenter suggested that we publish a summary of any requests that are rejected.
Response: As stated in the proposed rule, we will use the annual physician fee schedule as a vehicle to make changes to the list of telehealth services. As part of the rulemaking process, we will publish a summary in the proposed rule of the requests that we receive with an explanation as to why a service is added, deleted, or a request is rejected.
Comment: One commenter requested that, if possible, we look for ways to shorten the time frame between the submittal of a request and the actual implementation. The commenter stated that actual implementation of an additional telehealth service could take a year or more from the date of the request.
Response: The statute requires us to establish a process that provides for the addition or deletion of telehealth services on an annual basis. We understand that in some cases our review and subsequent implementation of a decision to accept a request may take up to and possibly more than a full year. However, we believe that using the annual physician fee schedule rulemaking schedule would be the most efficient and time sensitive mechanism for publishing changes to the list of telehealth services.
A national coverage determination (NCD) is a possible alternative to the rulemaking process for adding or deleting telehealth services. In formulating the proposed process to add services to the list of telehealth services, we considered using the NCD process. For instance, under this option, all requests for addition, whether the request is considered an existing or new service, would be required to complete the requirements for an NCD. We rejected this option because we believe that many telehealth applications are existing services provided through a different delivery mechanism. We believe that subjecting all requests for addition to the evidence-based requirements of an NCD would be unnecessary, and would be contrary to the public interest.
Comment: A large number of commenters applauded the addition of the psychiatric diagnostic interview examination to the list of telehealth services. Commenters generally agreed that the psychiatric diagnostic interview includes components that are comparable to an initial office visit or consultation, which are currently telehealth services.
Response: We agree with the comment.
Comment: We received two comments regarding general telehealth policy. One commenter urged us to expand the definition of an originating site. For example, the commenter believes that hospitals with inadequate physician ratios relative to the treatment of acute ischemic stroke patients should be considered as an originating site, regardless of geographic location or whether the hospital is located in a designated health professional shortage area. The other comment pertained to the physician or practitioner who provides the telehealth service at the distant site. In this regard, one association encouraged us to support the addition of speech language pathologists and audiologists to the list of practitioners that may provide and receive payment for telehealth services.
Response: The statute permits hospitals to serve as originating sites for any Medicare telehealth service as long as the hospital is located in a rural HPSA or in a non-MSA county. Thus, the commenter would be able to serve as an originating site for the treatment of acute ischemic stroke patients if the hospital is located in these geographic areas. The statute is explicit regarding the types of practitioners who can provide and receive payment for telehealth services. Speech language pathologists and audiologists are not included within the list of medical professionals that may provide and or receive payment for telehealth services at the distant site. We are reviewing these issues as part of a report to the Congress as required by the BIPA.
Result of Evaluation of Comments
We are adopting the process to add or delete telehealth services and adding the psychiatric diagnostic interview examination to the list of telehealth services as stated in the proposed rule. Additionally, we are referencing the process to add or delete services at new § 410.78(f).
H. Definition for ZZZ Global Periods
Services with ZZZ global periods are add-on services that can be billed only with another service. Before CY 2003, we paid only the incremental intraservice work and practice expense RVUs associated with the add-on service for a code with a global indicator of ZZZ. Any pre-service or post-service work associated with a service with a global indicator of ZZZ is considered accounted for in the base procedure with which these add-on services must be billed. However, based on comments from the RUC and specialty societies that some add-on services contain separately identifiable post-service work and practice expense RVUs, we proposed to revise the current definition of a ZZZ global period as follows:
"ZZZ = Code related to another service and is always included in the global period of the other service (Note: Physician work is associated with intra-service time and in some instances the post-service time)."
Comments: The commenters supported this change. However, several specialty organizations, as well as the RUC, stated that there are instances when pre-service time should be considered, and they recommended that we amend the definition to include pre- and post-service time.
Response: We agree with the commenters and will revise the definition to consider pre-service time as well post-service time. However, when a code with a ZZZ global indicator is considered by the RUC or PEAC, we will require that all base codes with which the ZZZ codes are billed are also considered by the RUC and PEAC to assure that both physician work and practice expense RVUs are appropriate for the base and add-on codes and to assure that no duplicate payment is made.
Result of Evaluation of Comments
The definition of a ZZZ global period will be revised as follows:
"ZZZ = Code related to another service and is always included in the global period of the other service (Note: Physician work is associated with intra-service time and in some instances the pre- and post-service time)."
I. Change in Global Period for CPT Code 77789 (Surface Application of Radiation Source)
Based on a suggestion from the RUC, we proposed to change the global period for CPT code 77789 (surface application of radiation source) from a 90-day global period to a 000-day global period. We stated that we did not need to adjust the current work values or the practice expense inputs for supplies and equipment, but we would adjust the clinical staff practice expense inputs to reflect that there is no post-procedure visit.
Comment: The commenters supported this change and noted that the PEAC attributed clinical times for this CPT code of 34 minutes for the registered nurse and 6 minutes for the physicist. The commenters did not believe the practice expense RVUs should change significantly, if at all, as a result of this adjustment in the global period.
Response: We had not received the PEAC recommendations at the time the proposed rule was written, and we proposed a change to the original CPEP inputs that included time for a post-procedure visit. We have reviewed and accepted the above PEAC recommended clinical staff times.
Result of Evaluation of Comments
We are changing the global period for CPT code 77789 (surface application of radiation source) from a 90-day global period to a 000-day global period as proposed.
J. Technical Change for § 410.61(d)(1)(iii) Outpatient Rehabilitation Services
Based on comments received that § 410.61(d)(1)(iii) incorrectly references "physical" therapy when it should reference "occupational" therapy, we proposed to revise § 410.61(d)(1)(iii) to correct this error.
Final Decision
No comments were received on this proposed technical correction. We will correct § 410.61(d)(1)(iii) by replacing the word "physical" with "occupational" as proposed.
K. HCPCS G-Codes From June 28, 2002 Proposed Rule
In the June 28, 2002 rule we proposed the following new HCPCS G codes.
1. Codes for Treatment of Peripheral Neuropathy
Effective for services furnished on or after July 1, 2002, Medicare will cover an evaluation (examination and treatment) of the feet every six months for individuals with a documented diagnosis. This policy is a national coverage determination.
G0245: Initial physician evaluation of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (LOPS) which must include the procedure used to diagnose LOPS; a patient history; and a physical examination that consists of at least the following elements -
(a) Visual inspection of the forefoot, hindfoot and toe-web spaces;
(b) Evaluation of protective sensation;
(c) Evaluation of foot structure and biomechanics;
(d) Evaluation of vascular status and skin integrity;
(e) Evaluation and recommendation of footwear; and
(f) Patient education.
We proposed to crosswalk work and malpractice RVUs and the practice expense inputs from CPT code 99202, a level two, new patient office visit code. We proposed to revalue the practice expense RVUs using the practice expense methodology once we have utilization data for these codes.
G0246: Follow-up evaluation of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (LOPS) to include at least the following , a patient history and physical examination that includes-
(a) Visual inspection of the forefoot, hindfoot and toe-web spaces;
(b) Evaluation of protective sensation;
(c) Evaluation of foot structure and biomechanics;
(d) Evaluation of vascular status and skin integrity;
(e) Evaluation and recommendation of footwear; and
(f) Patient education.
We proposed to crosswalk the work and malpractice RVUs from CPT code 99212, a level two, established-patient office visit code. We also proposed to crosswalk the practice expense inputs from CPT code 99212 and to revalue the practice expense RVUs using the practice expense methodology once we have utilization data for these codes.
G0247: Routine foot care of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (LOPS) to include if present, at least the following -
(a) Local care of superficial wounds;
(b) Debridement of corns and calluses; and
(c) Trimming and debridement of nails.
We proposed to crosswalk the work and malpractice RVUs and the practice expense inputs from CPT code 11040, Debridement; skin; partial thickness. We would revalue the practice expense RVUs using the practice expense methodology once we have utilization data for this code.
Comment: The American Podiatric Medical Association (APMA) believes that the RVUs assigned to HCPCS codes G0245 and G0246 are too low. They do not believe that the assigned RVUs account for the physician work and practice expense required to perform those services. They recommended that we crosswalk the RVUs from CPT codes 99203 and 99213 to these codes instead of the crosswalk we actually used, from CPT codes 99202 and 99212. They also commented that the RVUs assigned for G0247 were too low and should be increased as the assigned RVUs did not account for the required physician work. Alternatively, they recommended that we delete G0247 and allow a physician to report CPT codes that described similar services. A large medical clinic commented that they were not sure why CMS had implemented these codes. They believe that if the only reason for creating codes was to permit us to track the services, this reason is insufficient because the codes cause significant administrative burden to physician practices. They believe that providers could use other CPT codes to report these services instead of the G codes. A carrier medical director familiar with these services commented that G0247 is overvalued because the most common service provided using this code will be toe nail trimming and debridement and that the CPT code for toe nail trimming and debridement is valued much lower then G0247.
Response: These G codes were created to implement a national coverage determination (NCD). The coverage determination was very specific with regard to the required components of each service. Furthermore, the NCD specifically allowed these services to be performed no more than every six months and allowed the initial visit to be performed only once per physician for the lifetime of a beneficiary. Creation of these G codes allows us to implement the coverage decision, especially with regard to the required frequency limitation and to track the utilization of these services while minimizing provider burden. Reporting these services with CPT evaluation and management (E/M) codes and procedure codes would have resulted in numerous post-pay audits while creation of a modifier to be used in conjunction with such CPT codes would have been quite burdensome and resulted in just as many post pay audits. Therefore, we plan to continue requiring these G codes for reporting of these services.
With regard to the valuation of these services we will finalize the proposed RVUs. This service is provided to those diabetic beneficiaries who are "at risk" for foot-care problems but who do not have an injury or illness of the foot. Any service provided to a diabetic beneficiary with an illness or injury to the foot (for example, foot pain, foot ulcer, foot infection) should be reported using the appropriate CPT codes (for example, E/M service, debridement service). Furthermore, the requirements for provision of care to LOPS patients are clearly set forth in the NCD. Nothing beyond those requirements need be performed in order to report a LOPS HCPCS code. Careful scrutiny of the requirements for provision of initial LOPS services shows that they are most similar to the requirements of a level 2 E/M service. The lack of illness, injury, or deformity in these patients and the requirements that the practitioners need only to take a history and to examine the foot are quite similar to the requirements of CPT code 99202: an expanded problem focused history, an expanded problem focused examination, and straightforward medical decision making. For follow-up patients who do not have an illness, injury, or deformity, the requirements of the NCD are quite similar to the requirements of CPT code 99212: a problem focused history, a problem focused examination, and straightforward medical decision making. With regard to G0247, we agree with the carrier medical director who stated that the most commonly performed procedure would be toenail trimming and or debridement. However, review of the work RVUs for CPT codes 11719 (0.17), 11720 (0.32), 11721 (0.54), 11055 (0.43), 11056 (0.61), 11057 (0.79), and 11040 (0.50) shows that we have properly valued this service. We believe that a work value of 0.50 RVUs appropriately accounts for what is likely to be the typical combination of services provided to eligible beneficiaries.
Result of Evaluation of Comments
We will continue requiring these G codes for reporting of these services and are finalizing the RVUs as proposed.
2. Current Perception Sensory Nerve Conduction Threshold Test (SNCT)
G0255: Current Perception Threshold/Sensory Nerve Conduction Test, (SNCT) per limb, any nerve
We proposed a G-code that represents SNCT as a diagnostic test used to diagnose sensory neuropathies. This test is noninvasive and uses a transcutaeous electrical stimulus to evoke a sensation. However, we determined that there is insufficient scientific or clinical evidence to consider the use of this device as reasonable and necessary within the meaning of section 1862(a)(1)(A) of the Act and indicated Medicare will not pay for this type of test.
Comment: One commenter requested that the descriptor for this code be revised, as the current descriptor "Current Perception Threshold/Sensory Nerve Conduction Test" is very similar to other codes for example, the short descriptor for CPT code 95904 is "Sense Nerve Conduction Test". The commenter recommended changing the descriptor for this G code to "Current Perception Threshold Test".
Response: We appreciate the commenters bringing this to our attention and have revised the short descriptor for this G code to address the concern they raised. The short descriptor for this G code will be "Current perception threshold test".
Result of Evaluation of Comments: We will finalize our proposal for G0255 but will revise the short descriptor as discussed above.
3. Positron Emission Tomography (PET) Codes for Breast Imaging
Medicare has expanded the coverage indications for PET scanning to include imaging for breast cancer, and we have created codes that describe staging and restaging after or prior to the course of treatment of breast cancer. We also created a PET scan code to evaluate the response to treatment of breast cancer.
PET imaging for initial diagnosis of breast cancer and/or surgical planning for breast cancer are described by a CPT code, but Medicare will not cover the procedure for this diagnosis.
G0252: PET imaging for initial diagnosis of breast cancer and /or surgical planning for breast cancer (for example, initial staging of axillary lymph nodes), not covered by Medicare.
We stated that this code is not covered by Medicare because there is a national non-coverage determination for the use of PET imagery for the initial diagnosis of breast cancer and initial staging of axillary lymph nodes.
G0253: PET imaging for breast cancer, full and partial-ring PET scanners only, staging/restaging after or prior to course of treatment.
G0254: PET imaging for breast cancer, full and partial-ring PET scanners only, evaluation of response to treatment, performed during course of treatment.
We proposed that the TC and global for both of these codes be carrier-priced. For the PC for codes G0253 and G0254, we proposed to make the PC work RVU equal to 1.87 and use practice expense RVUs of 0.58 and malpractice RVUs of 0.07 since there are no direct inputs for PC services.
Comments: Commenters expressed appreciation for creation of these G codes; however, one commenter was concerned that the TC and global component of these codes will be carrier-priced which, the commenter contended, could lead to widely varying and unjustifiably low payment rates, particularly if there is no national benchmark.
Response: Carriers use a variety of methods and resources when developing payment rates for services that they are responsible for pricing. We do not believe that having the carriers price these codes will lead to unjustifiably low payment rates.
Result of Evaluation of Comments: We are adopting the proposals for these G codes; however, we have made editorial revisions to the descriptors for G0252 and G0253 to more accurately describe the service provided. The revised descriptors are as follows:
G0252: PET imaging, full and partial-ring PET scanners only, for initial diagnosis of breast cancer and /or surgical planning for breast cancer (for example, initial staging of axillary lymph nodes).
G0253: PET imaging for breast cancer, full and partial-ring PET scanners only, staging/restaging of local regional recurrence or distant metastases (that is, staging/restaging after or prior to course of treatment).
4. Home Prothrombin Time International Normalized Ratio (INR) Monitoring for Anticoagulation Management
For services furnished on or after July 1, 2002, Medicare will cover the use of home prothrombin time or INR monitoring in a patient's home for anticoagulation management for patients with mechanical heart valves. A physician must prescribe the testing. The patient must have been anticoagulated for at least three months prior to use of the home INR device, and the patient must undergo an education program. The testing with the device is limited to a frequency of once per week.
G0248: Demonstration, at initial use, of home INR monitoring for a patient with mechanical heart valve(s) who meets Medicare coverage criteria, under the direction of a physician; includes: demonstration use and care of the INR monitor, obtaining at least one blood sample provision of instructions for reporting home INR test results and documentation of a patient's ability to perform testing.
We proposed that this code be assigned no work RVUs and .01 malpractice RVUs. For the practice expense inputs, we proposed 75 minutes of RN/LPN/MTA staff time; a supply list including four test strips, lancets and alcohol pads, a patient education booklet, and batteries for the monitor; and equipment consisting of a home INR monitor. These proposed inputs result in an estimated practice expense RVU of 2.92.
G0249: Provision of test materials and equipment for home INR monitoring to patient with mechanical heart valve(s) who meets Medicare coverage criteria. Includes provision of materials for use in the home and reporting of test results to physician; per 4 tests.
We proposed this code be assigned no work RVUs and .01 malpractice RVUs. For the practice expense inputs, we proposed 13 minutes of RN/LPN/MTA staff time; a supply list including four test strips, lancets and alcohol pads, and equipment consisting of a home INR monitor. These resulted in an estimated practice expense RVU of 2.08.
G0250: Physician review/interpretation and patient management of home INR test for a patient with mechanical heart valve(s) who meets other coverage criteria; per 4 tests (does not require face-to face service)
We proposed this code be assigned 0.18 work RVUs and .01 malpractice RVUs. We stated that there would be no direct practice expense inputs for this code, and the use of the practice expense methodology to develop the indirect practice expense of the physician performing this service resulted in an estimated practice expense RVU of 0.07. Note: Subsequent to the publication of the proposed rule, we updated the payment rates for home PT/INR monitoring via Program Memorandum AB-02-112 (July 31, 2002). Based on a correction in the practice expense methodology used to calculate the practice expense RVUs issued in the Program Memorandum AB-02-064 on May 2, 2002 and included in the June 28, 2002 proposed rule there was an increase in practice expense RVUS for G0248 to 3.06 and to 3.28 for G0249 effective for services performed after October 1, 2002.
Comment: A manufacturer of equipment used to perform INR monitoring at home was concerned that the proposed RVUs for the HCPCS codes used to report Home INR monitoring services were inconsistent with the RVUs published in Program Memorandum AB-02-112 issued on July 31, 2002. (This program memorandum was issued to correct an error that had resulted in the original RVUs for these codes being too low.) The commenter also requested that we clarify the descriptor for the HCPCS code used to report provision of Home INR materials to assure that Medicare only paid for properly controlled INR tests that were consistent with FDA labeling.
Response: The aforementioned program memorandum was issued after the Proposed Rule (NPRM) was published. We agree with the commenter that the physician fee schedule for 2003 should reflect the RVUs as published in the July 31, 2002 program memorandum and will make this change.
With regard to changing the descriptors for the HCPCS code used to report provision of home INR test materials, we will review this issue and, if appropriate, clarify the descriptor as requested for CY 2004.
Comment: Several commenters asked CMS to expand the covered indications for home INR monitoring.
Response: We direct these commenters to the published process for requesting a national coverage determination. In order for the covered indications to be expanded on a national level this process must be followed.
Comment: A manufacturer of equipment used for home INR monitoring pointed out that there were several companies who manufacture test strips. Producing a test result may require one or three test strips depending on the manufacturer. Additionally, the cost of test strips from each manufacturer is different and Medicare based its payment on the cost of a test strip from only one manufacturer.
Response: We agree that there are several types of test strips available. However, we also understand that not all manufacturers are currently providing new home INR monitoring equipment and that the market share for each product is in flux. We will review the appropriate payment for this service, including the appropriate amount to include for test strips, after we have sufficient experience paying for this service. The earliest time that we could consider proposing a change in payment rate would be for the 2005 physician fee schedule; at that time, we would have 18 months worth of payment data upon which we could base a proposal.
Result of Evaluation of Comments
As indicated above, payment for CY 2003 for these services will reflect the corrections made in the Program Memorandum AB-02-112 issued on July 31, 2002.
5. Bone Marrow Aspiration and Biopsy on the Same Date of Service
We proposed a new G code (GXXXX) that reflects a bone marrow biopsy and aspiration procedure that is performed on the same date, at the same encounter, through the same incision, based on our understanding that the typical case involves an aspiration and biopsy through the same incision.
We proposed physician work RVUs of 1.56 and malpractice RVUs of 0.04. We also proposed to crosswalk the practice expense inputs from CPT code 38220, Bone marrow aspiration, with the assignment of an additional five minutes of clinical staff time. These proposed inputs in the practice expense methodology resulted in an estimated practice expense RVU of 3.32 in the nonfacility setting and 0.60 in the facility setting.
We also noted that if the two procedures, aspiration and biopsy, are performed at different sites (for example, contralateral illiac crests, sternum/illiac crest, two separate incisions on the same iliac crest or two patient encounters on the same date of service), the CPT codes for aspiration and biopsy would each be used along with the -59 modifier.
Comment: Two commenters, one representing a provider and the other a specialty organization, agreed with the proposal to create a G code for bone marrow aspiration and biopsy on the same date of service. However, another specialty organization and the AMA did not agree with the creation of this new G code and felt its creation was unnecessary. These commenters indicated that CPT currently has sufficient and accurate coding for these services that is, CPT codes 38220 and 38221 which when performed through the same incision could both be reported with the modifier 51 (used in reporting of multiple procedures performed in the same incision) appended. In addition, the commenters stated that the descriptor for this code does not adequately describe the procedure for which it is intended as it does not specifically state "through the same incision." This could lead to a denial of services of all bone marrow aspiration and biopsies performed on the same date of service.
Response: After review of the comments, we agree that this code should go through the CPT process. Therefore, we are withdrawing our proposal to create this code. We will submit a code for "Bone Marrow Biopsy and Aspiration performed in the same bone" to CPT in time for the 2004 CPT cycle.
Result of Evaluation of Comments
We will not proceed with a separate G code for bone marrow biopsy and aspiration procedure that is performed on the same date, at the same encounter.
Creation of G Codes
Comment: Several commenters expressed concern about the increasing frequency of G codes being issued by us. Commenters believed that, in the interest of coding standardization, accuracy, and clarity, G codes should only be developed as a last resort and should be temporary. Commenters believed that an annual meeting with us to discuss codes that may be necessary to accommodate new payment and coverage policies would help reduce the number of G codes. Some commenters also asked for greater physician involvement in the HCPCS editorial process (for example, direct representation of the physician community on the panel).
Response: We agree that, where appropriate, G codes should be temporary. Unfortunately, it is sometimes necessary to develop G codes to accommodate changes in legislation, regulation, coverage, and payment policy. The timetable for such changes is not necessarily consistent with the timetable for CPT publication and frequently these changes must be made on a quarterly basis.
In 2002 CMS and CPT staff, working together, reviewed all existing G codes and agreed to transition over 20 of them to CPT codes. Therefore, for 2003 many G codes are being deleted in favor of newly created CPT codes. (See section IV for a discussion of deleted G codes). We believe that an annual review of G codes by CMS and CPT staff is the best way to determine which G codes should be transitioned to CPT codes and the process to use for such a transition. Therefore, we plan to continue working with CPT staff on an annual basis to continue transitioning existing G codes to CPT codes. We believe such an annual comprehensive review will address the commenters' concerns. However, we do wish to emphasize that we, when appropriate, does consult with interested providers prior to the creation of G codes in order to facilitate coding clarity and minimize physician burden.
L. Endoscopic Base For Urology Codes
Cystoscopy and treatment CPT codes 52234, 52235, and 52240 were inadvertently identified in the Medicare Physician Fee Schedule Database as services subject to the reductions for multiple procedures as opposed to the procedural reduction rules specific to endoscopic services. This has resulted in our overpaying for these services. We proposed applying the endoscopic reduction rules to these services and identified CPT code 52000 as the endoscopic base code for these services.
Comment: The American Urological Association was in agreement with our proposal to apply the endoscopic reduction rules to CPT codes 52234, 52235, and 52240.
Final Decision: The endoscopic reduction rules will be applied to these three codes as proposed.
M. Physical Therapy and Occupational Therapy Caps
Section 4541(c) of the Balanced Budget Act of 1997 required application of a payment limitation to all rehabilitation services provided on or after January 1, 1999. The limitation was an annual per beneficiary limit of $1500 on all outpatient physical therapy (PT) services (including speech-language pathology services). A separate $1500 limit was applied to all occupational therapy (OT) services. (The limitation amounts were to be increased to reflect medical inflation.) The annual limitation did not apply to services furnished directly or under arrangement by a hospital to an outpatient or to an inpatient who is not in a covered Part A stay.
Section 221 of the Balanced Budget Refinement Act of 1999 (BBRA) (Pub. L. 106-113, enacted on November 29, 1999) placed a moratorium on the application of the payment limitation for two years from January 1, 2000 through December 31, 2001. Section 421 of the Medicare, Medicaid, and SCHIP Beneficiary Improvement and Protection Act of 2000 (BIPA) (Pub. L. 106-554, enacted on December 21, 2000), extended the moratorium on application of the limitation to claims for outpatient rehabilitation services with dates of service January 1, 2002 through December 31, 2002. As we explained in the June 28, 2002 proposed rule, outpatient rehabilitation claims for services rendered on or after January 1, 2003 will be subject to the payment limitation unless the Congress acts to extend the moratorium.
Comments: We received comments from associations and societies urging us to support the permanent repeal of the $1500 financial limitation on PT, including speech language pathology, and a separate $1500 financial limitation on OT. All commenters stated that this financial limitation would adversely affect nursing home beneficiaries who receive Part B therapy services.
Response: As stated before, we will implement the outpatient rehabilitation therapy financial limitation via a Program Memorandum to Carriers and Fiscal Intermediaries, unless the Congress acts to extend the moratorium or repeals the legislation.
III. Other Issues
A. Definition of a Screening Fecal-Occult Blood Test
One commenter suggested that the current definition of a screening fecal-occult blood test at § 410.37(a)(2) that limits coverage to guaiac-based tests should be expanded to permit coverage of another test. The commenter suggested that this change be made in the final rule because the June 2002 proposed rule added a variety of new HCPCS G codes similar to the G code for which the commenter has requested for its new fecal-occult blood test.
Based on our analysis of the preliminary information we have on the new test, we believe that it may have the potential for effective screening for colorectal cancer, and thus, we have agreed with the commenter to broaden the definition in § 410.37(a)(2) to permit coverage of non-guaiac based tests. However, in order to establish national coverage of the new test under the Medicare colorectal cancer screening benefit we must first compare the clinical utility of the test to the existing guaiac-based test. If, for instance, the test is not as effective as the currently covered test, it would not make sense to authorize coverage as permitted by section 1861(pp)(1)(D) of the Act.
To facilitate our consideration of future coverage of other new types of fecal-occult blood tests, we have decided to amend § 410.37(a)(2) to provide that in addition to the guaiac-based screening test, other types of fecal-occult blood tests may be covered under the screening benefit, if we determine that this is appropriate through a national coverage determination (NCD). This change will allow us to conduct a more timely assessment of other new types of fecal-occult blood tests that may have been approved or cleared for marketing by the Food and Drug Administration (FDA) than is possible under the standard rulemaking process. We intend to use the NCD process, which includes an opportunity for public comments, for evaluating the medical and scientific issues relating to the coverage of additional tests that may be brought to our attention in the future. Use of an NCD to establish a change in the scope of benefits is authorized by section 1871(a)(2) of the Act.
In accordance with section 1861(pp)(1)(D) of the Act, we have discretion to determine that additional tests or procedures are appropriate and can be used for the early detection of colorectal cancer. This authority is currently reflected in § 410.37(a)(1)(v). We are amending that section to announce that approval of any new tests or procedures for use in early detection of colorectal cancer will be made through an NCD. The use of an NCD, authorized by section 1871(a)(2) of the Act, will permit public participation. The NCD process, however will allow Medicare to expand coverage for additional tests or procedures when warranted more rapidly than the notice and comment procedures of the Administrative Procedure Act would normally permit.
B. Clarification of Services and Supplies Incident to a Physician's Professional Services: Conditions
In the November 2001 final rule (66 FR 55238) we revised regulations on services and supplies furnished incident to a physician's professional services. In the revised regulations at § 410.26(a)(7) we defined such services and supplies as " * * * any services and supplies * * * that are included in section 1861(s)(2)(A) of the Act and are not specifically listed in the Act as a separate benefit included in the Medicare program."
We are clarifying that services having their own statutory benefit category are covered under that category rather than as incident to services. This means that they are subject to manual and other program operating instructions pertaining to their specific statutory benefit category. In addition, they are not required to meet incident to implementing instructions such as those in section 2050 of Part III of the Medicare Carriers Manual (MCM). For example, diagnostic tests are covered under section 1861(s)(3) of the Act and are subject to the requirements for diagnostic tests in MCM section 2070. Depending on the particular test, the supervision requirement in section 2070 may be more or less stringent than that in section 2050 for incident to services. When diagnostic tests are furnished, the requirements for diagnostic tests apply, and not those for incident to services. Likewise, pneumococcal, influenza, and hepatitis B vaccines are covered under section 1861(s)(10) of the Act and do not need to meet incident to requirements.
While we believe our regulations are clear on this point, one of the comments and responses published in our November 2001 final rule has caused some confusion on this issue. The comment and response were as follows:
Comment: "Many commenters wanted us to re-emphasize that incident to services set forth in section 1861(s)(2)(A) of the Act do not include Medicare benefits separately and independently listed in the Act, such as diagnostic services set forth in section 1861(s)(3). Some requested that we not permit these separately and independently listed services to be furnished as incident to services."
Response: "We realize, as did the Congress with the enactment of section 4541(b) of the BBA, that many services-even those that are separately and independently listed-can be furnished as incident to services. However, this fact of medical practice is not inconsistent with our policy. We maintain that a separately and independently listed service can be furnished as an incident to service but is not required to be furnished as an incident to service. Furthermore, even if a separately and independently listed services is provided as an incident to service, the specific requirements of that separately and independently listed service must be met. For instance, a diagnostic test under section 1861(s)(3) of the Act may be furnished as an incident to service. Nevertheless, it must also meet the requirements of the diagnostic test benefit set forth in § 410.32. Specifically, the test must be ordered by the treating practitioner, and it must be supervised by a physician. Thus, if a test requires a higher level of physician supervision than direct supervision, then that higher level of supervision must exist even if the test is furnished as an incident to service. Accordingly, we decline to prohibit a separately and independently listed service from being furnished as an incident to service. Instead, we reiterate that a separately and independently listed service need not meet the requirements of an incident to service."
The intent of the above response was to state that for a service having its own separately and independently listed statutory benefit category, Medicare carriers should apply the requirements of that separately listed benefit category and not also apply the incident to requirements. We interpret § 410.26(a)(7) literally. That is, incident to services and supplies covered under 1861(s)(2)(A) of the Act means services and supplies not having their own independent and separately listed statutory benefit category.
Perhaps it could be argued that any service provided under the direct supervision of a physician could be considered an incident to service. However, the Congress specifically provided for the many separate benefit categories of medical and health services in the Act. We believe that the Congress intended for incident to services to be a catch-all category to allow payment for certain services and supplies commonly furnished in a physician's office and not having their own separate benefit category. The billing of services with their own separate and independent coverage benefit categories as incident to may circumvent the coverage and payment rules applicable to those other categories. Therefore, only services that do not have their own benefit category are appropriately billed as incident to a physician service. Examples of benefit categories are diagnostic X-ray tests (section 1861(s)(3) of the Act) and influenza vaccine and its administration (section 1861(s)(10)(A) of the Act).
However, since section 4541(b) of the BBA allows certain services with their own benefit category (that is, outpatient physical therapy services (including speech-language pathology services) and outpatient occupational therapy) to also be provided as incident to services, we cannot prohibit physicians and practitioners from billing these services as incident to. However, when these services are billed incident to, requirements in Medicare Carriers Manual section 2050 must also be met. Note that the personal (in-the-room) supervision requirements for physical and occupational therapy assistants apply only to the private practice setting. The services of nurse practitioners, clinical nurse specialists and physician's assistants may be billed as incident to a physician's service if the incident to requirements are met, or those practitioners may bill their services separately under their own benefit.
C. Five-Year Review of Gastroenterology Codes
In the November 2001 final rule, (66 FR 55246), we finalized work RVUs for several gastrointestinal endoscopy codes that were reviewed by the RUC during the five-year review of physician work. However, we asked the RUC to review several families of gastrointestinal endoscopy codes to ensure that no rank order anomalies existed within those families. The procedures for gastrointestinal stent placement were among those families. Although we have not received further RUC recommendations for any gastrointestinal endoscopy codes, several specialty societies have submitted further information regarding the physician work required to perform gastrointestinal stent placement services. We have reviewed this information and are making several adjustments to the RVUs for these services. These adjustments are interim and we will respond to comments concerning these adjustments in next year's final rule.
CPT code 43219Esophagoscopy, rigid or flexible; with insertion of plastic tube or stent
Based on the information we have reviewed (including physician intraservice time data), there is no compelling evidence that the physician work of this procedure is inappropriate. The work increment (1.21 work RVUs) beyond the base procedure CPT code 43200, Esophagoscopy, rigid or flexible; with or without collection of specimen(s) by brushing or washing (separate procedure ) is appropriate. Therefore we are maintaining 2.8 work RVUs for CPT code 43219.
CPT code 43256Upper gastrointestinal endoscopy including esophagus, stomach, and either the duodenum and/or jejunum as appropriate; with transendoscopic stent placement (includes predilation)
This code currently has 4.60 work RVUs. We reviewed physician time data for this service and believe that it is overvalued compared to the value of other stent placement procedures. Therefore, to place it in the proper rank order to other stent placement codes, we are assigning it 4.35 work RVUs. This makes the incremental work (1.96 work RVUs) above the base procedure CPT code 43235, Upper gastrointestinal endoscopy including esophagus, stomach and either the duodenum and/ or jejunum as appropriate; diagnostic, with or without collection of specimen(s) by brushing or washing (separate procedure ), in line with other stent placement codes.
CPT code 44383Ileoscopy, through stoma; with transendoscopic stent placement (includes predilation )
This code currently has 3.26 work RVUs. We reviewed physician time data for this code and compared it to other stent placement codes. The incremental work value (2.21 work RVUs) above the base procedure CPT code 44380, Ileoscopy, through stoma; diagnostic, with or without collection of specimen(s) by brushing or washing (separate procedure ), is high. Therefore, we are reducing the work RVUs to 2.94. This gives it an incremental work value of 1.89 work RVUs which is similar to the incremental work value of CPT code 44397, Colonoscopy through stoma; with transendoscopic stent placement (includes predilation ), and places it in the proper rank order with other stent placement codes.
D. Critical Access Hospital Emergency Services Requirements
Section 1820 of the Act provides for a nationwide Medicare Rural Hospital Flexibility Program (MRHF). The Act also provides that certain rural providers may be designated as critical access hospitals (CAHs) under the MRHF program if they meet qualifying criteria and the conditions for designation specified in the statute. Implementing regulations for section 1820 of the Act are located at 42 CFR part 485, subpart F.
Section 1820(c)(2)(B) of the Act implements specific conditions of participation (CoPs) that a facility must meet to be designated a CAH. The statutory criteria for State designation as a CAH require, in part, that the facility makes available 24-hour emergency care services that a State determines are necessary for ensuring access to emergency care services in each area served by a CAH. To help protect the health and safety of Medicare patients who seek emergency medical care at a CAH, our regulations at § 485.618 require CAHs to provide emergency care necessary to meet the needs of its patients.
In 2002, we received letters requesting a special waiver from the current emergency services personnel requirement (specified in § 485.618(d)) for CAHs in frontier areas and remote locations. The requests included the following comments; (1) A number of remote CAHs have been struggling to comply with the current CAH requirement; (2) the personnel requirement places a hardship on isolated frontier communities that have only one medical practitioner; and (3) often these remote facilities have a very low volume of patients which makes it difficult to recover all of their costs and to recruit other practitioners.
As of September 2002, the Cecil G. Sheps Center for Health Services Research at Chapel Hill, North Carolina has identified approximately 173 CAHs that are located in frontier areas (identified as having six individuals per square mile). The average population for a frontier CAH community is 7,024. We have no empirical data to indicate which of these 173 CAHs are currently experiencing workforce issues that create a hardship for the facility or any sole provider. However, the University of Washington conducted a survey of CAHs in May 2001 and learned that, of the 388 CAHs that responded to the survey, 146 facilities are in an isolated small rural census tract. Of these facilities, 10 have no physicians, 24 have only 1 physician, 39 have 2 physicians, and 26 have 3 physicians. Of the CAHs with no doctors, 6 have only 1 mid-level provider (4 of these are in Montana), and 3 have 2 mid-level providers (1 apparently had no physician or mid-level provider at the time of the survey). Of the 39 CAHs that had 2 physicians, 3 had no mid-level providers, and 12 had only 1 mid-level provider.
The Rural Health Research Center at the University of Washington, through its CAH National Tracking Project, reported that CAHs frequently cite problems with recruitment and retention of emergency medical personnel. Based on 2002 data, more than half of the designated CAHs are serving counties dually designated as both a Medically Underserved Area (MUA) and a Health Professional Shortage Area (HPSA). Less than 1 in 10 CAHs are located in counties without a HPSA or an MUA designation.
The delicate balance of providing access to care in very rural and remote areas without jeopardizing quality of care continues to be challenging. We believe that if a small CAH is forced to close because of the lack of qualified personnel, adding RNs to the list of approved personnel would greatly help CAHs with nogreater than 10 beds, in frontier areas or remote locations to serve the emergency health care needs of residents of these areas. Often CAHs in frontier or remote areas are located 50 miles or farther from the nearest health care facility. We believe that allowing RNs, as needed on a temporary basis, to work in CAHs with no greater than 10 beds, with training or experience in emergency care to be included in the list of personnel to be on call and immediately available within 60 minutes is the best means of ensuring that patients in frontier or remote areas will continue to have access to high-quality emergency health care services. However, we are requesting comments on other viable alternatives on how CAHs that are currently experiencing workforce issues can provide emergency care in frontier and remote areas.
Our regulations at § 485.618(d) require a doctor of medicine or osteopathy, a physician's assistant, or a nurse practitioner with training or experience in emergency care to be on call and immediately available by telephone or radio and to be available on site within 30 minutes, or 60 minutes if the CAH is located in a designated frontier area or a remote location designated by the State in its rural health plan. In addition, § 485.618(e) requires that the CAH must coordinate with the emergency response system in the area and ensure the 24-hour telephone or radio availability of a doctor of medicine or osteopathy to receive emergency calls, provide information on treatment of patients, and refer patients to the CAH or other appropriate locations for treatment.
We understand that it may be difficult for small CAHs in frontier areas or remote locations to meet the personnel requirements set forth in § 485.618(d). However, section 1820(c)(2)(B)(ii) of the Act requires a qualifying CAH to make available the 24-hour emergency care services that a State determines are necessary for ensuring access to emergency care services in each area served by a CAH. Although the statute does not provide authority to waive the requirement for continuous emergency care services, we believe that the statute provides the flexibility for States to assess their emergency care service needs and permit small CAHs that experience the absence of emergency personnel required by § 485.618(d) to nonetheless provide emergency services. Accordingly, this final rule with comment provides a mechanism for States with CAHs with no greater than 10 beds, in frontier areas and remote locations to include registered nurses (RNs), with training or experience in emergency care, as authorized emergency services personnel under our current general emergency service personnel requirements at § 485.618(d). Therefore, in this final rule with comment we are revising § 485.618(d) to add the possibility for States to include RNs among authorized personnel, at § 485.618(d)(3). This will permit State Governors, following consultation on the issue of using RNs on a temporary basis as part of their State rural healthcare plan with the State Boards of Medicine and Nursing, and in accordance with State laws, to request in writing the inclusion of RNs to our current personnel requirements, so that RNs may fulfill the emergency personnel requirements of § 485.618 for frontier area or remote location CAHs with no greater than 10 beds. The letter from the Governor must attest that he or she has consulted with State Boards of Medicine and Nursing about issues related to access to and the quality of emergency services in the State. The letter from the Governor must also describe the circumstances and duration of the temporary request to include the RN on a list of emergency personnel specified in § 485.618(d)(1). The request for such inclusion, and any withdrawal of a request for this inclusion, may be submitted at any time, and will be effective on the date we receive the request. In addition, once a State submits a letter to us signed by the Governor requesting that an RN be included in the list of specified personnel for CAHs with no greater than 10 beds, a CAH must submit documentation to the State survey agency demonstrating that it has not been able, despite reasonable attempts, to hire a sufficient number of physicians, physician assistants, or nurse practitioners to provide 24-hour emergency services on-call coverage. In a frontier or remote area when a CAH has only one physician or mid-level provider, we would expect the facility to provide relief to the sole provider by using an RN with training or experience in emergency services to provide emergency on-call services.
IV. Refinement of Relative Value Units for Calendar Year 2003 and Response to Public Comments on Interim Relative Value Units for 2002
A. Summary of Issues Discussed Related to the Adjustment of Relative Value Units
Section IV.B of this final rule describes the methodology used to review the comments received on the RVUs for physician work and the process used to establish RVUs for new and revised CPT codes. Changes to codes on the physician fee schedule reflected in Addendum B are effective for services furnished beginning January 1, 2003.
B. Process for Establishing Work Relative Value Units for the 2003 Physician Fee Schedule
Our November 1, 2001 final rule (66 FR 55294) announced the final work RVUs for Medicare payment for existing procedure codes under the physician fee schedule and interim RVUs for new and revised codes. The RVUs contained in the final rule applied to physician services furnished beginning January 1, 2002. We announced that we considered the RVUs for the interim codes to be subject to public comment under the annual refinement process. In this section, we summarize the refinements to the interim work RVUs published in the November 2001 final rule and our establishment of the work RVUs for new and revised codes for the 2003 physician fee schedule.
Work Relative Value Unit Refinements of Interim and Related Relative Value Units
1. Methodology (Includes Table titled "Work Relative Value Unit Refinements of the 2002 Interim and Related Relative Value Units ")
Although the RVUs in the November 2001 final rule were used to calculate 2002 payment amounts, we considered the RVUs for the new or revised codes to be interim. We accepted comments for a period of 60 days. We received substantive comments from many individual physicians and several specialty societies on approximately 19 CPT codes with interim work RVUs. Only comments on codes listed in Addendum C of the November 2001 final rule were considered.
To evaluate these comments we used a process similar to the process used in 1997. (See the October 31, 1997 final rule (62 FR 59084) for the discussion of refinement of CPT codes with interim work RVUs.) We convened a multispecialty panel of physicians to assist us in the review of the comments. The comments that we did not submit to panel review are discussed at the end of this section, as well as those that were reviewed by the panel. We invited representatives from the organization from which we received substantive comments to attend a panel for discussion of the code on which they had commented. The panel was moderated by our medical staff, and consisted of the following voting members:
• One or two clinicians representing the commenting organization.
• Two primary care clinicians nominated by the American Academy of Family Physicians and the American College of Physicians/American Society of Internal Medicine.
• Four carrier medical directors.
• Four clinicians with practices in related specialties, who were expected to have knowledge of the service under review.
The panel discussed the work involved in the procedure under review in comparison to the work associated with other services under the physician fee schedule. We assembled a set of reference services and asked the panel members to compare the clinical aspects of the work of the service a commenter believed was incorrectly valued to one or more of the reference services. In compiling the set, we attempted to include-(1) Services that are commonly performed whose work RVUs are not controversial; (2) services that span the entire spectrum from the easiest to the most difficult; and (3) at least three services performed by each of the major specialties so that each specialty would be represented. The set listed approximately 300 services. Group members were encouraged to make comparisons to reference services. The intent of the panel process was to capture each participant's independent judgement based on the discussion and his or her clinical experience. Following the discussion, each participant rated the work for the procedure. Ratings were individual and confidential, and there was no attempt to achieve consensus among the panel members.
We then analyzed the ratings based on a presumption that the interim RVUs were correct. To overcome this presumption, the inaccuracy of the interim RVUs had to be apparent to the broad range of physicians participating in each panel.
Ratings of work were analyzed for consistency among the groups represented on each panel. In general, we used statistical tests to determine whether there was enough agreement among the groups of the panel and whether the agreed-upon RVUs were significantly different from the interim RVUs published in Addendum C of the November 2001 final rule. We did not modify the RVUs unless there was a clear indication for a change. If there was agreement across groups for change, but the groups did not agree on what the new RVUs should be, we eliminated the outlier group and looked for agreement among the remaining groups as the basis for new RVUs. We used the same methodology in analyzing the ratings that we first used in the refinement process for the 1993 physician fee schedule. The statistical tests were described in detail in the November 25, 1992 final rule (57 FR 55938).
Our decision to convene multispecialty panels of physicians and to apply the statistical tests described above was based on our need to balance the interests of those who commented on the work RVUs against the redistributive effects that would occur in other specialties.
We also received comments on RVUs that were interim for 2002, but which we did not submit to the panel for review for a variety of reasons. These comments and our decisions on those comments are discussed in further detail below.
The table below lists the interim code reviewed during the refinement process described in this section. This table includes the following information:
• CPT Code. This is the CPT code for a service.
• Description. This is an abbreviated version of the narrative description of the code.
• 2002 Work RVU. The work RVUs that appeared in the November 2001 rule are shown for each reviewed code.
• Requested Work RVU. This column identifies the work RVUs requested by commenters.
• 2003 Work RVU. This column contains the final RVUs for physician work.
CPT code1 | Description | 2002 Work RVU | Requested work RVU | 2003 Work RVU |
---|---|---|---|---|
53853 | Transurethral destruction of prostate tissue; by water-induced thermotherapy | 4.14 | 8.75 | 5.24 |
1 All CPT codes and descriptions copyright 2003 American Medical Association. |
2. Interim 2002 Codes
CPT Code 00797 Anesthesia for Intraperitoneal Procedures in Upper Abdomen Including Laparoscopy; Gastric Restrictive Procedure for Morbid Obesity CPT Code 01968 Cesarean Delivery Following Neuraxial Labor Analgesia/Anesthesia (List Separately in Addition to Code for Primary Procedure
The RUC recommended that 9 base units be assigned to CPT code 00797 and 3 base units be assigned to the add-on code CPT code 01968. We did not accept the RUC recommended values for these two anesthesia services and assigned 8 base units to CPT code 00797 and 2 base units to the add-on code CPT code 01968.
The AMA and the RUC disagreed with the reductions we made to the base units and the reasoning as stated in the November 1, 2001 final rule behind these reductions. No other comments were received on these codes.
Final Decision: Given that the only comments received were from the AMA and RUC and these provided no additional information, we are maintaining the base units of 8 for CPT code 00797 and 2 base units for the CPT code 01968.
CPT code 47382Ablation, one or more liver tumor(s), percutaneous, radiofrequency
We had not received recommendations from the RUC for this procedure and assigned work RVUs of 12.00 to this service.
Specialty organizations indicated that the value assigned was inappropriately low and that this would be revisited by the RUC in February 2002. They recommended that we take the RUC values into consideration for the 2003 Medicare fee schedule.
Final Decision: We did receive a RUC recommendation of 15.19 for CPT code 47382 and are in agreement with the recommended work RVU.
CPT code 52001Cystourethroscopy with irrigation and evacuation of clots.
The RUC recommended 5.45 work RVUs based on a comparison to certain reference procedures. We had concerns about the descriptor associated with this code and based on the descriptor of this CPT code for 2002 assigned 2.37 RVUs to this procedure. We felt the time and intensity of the physician work for this procedure as described was comparable to CPT Code 52005. Commenters acknowledged that the descriptor was being revised and felt that this would enable us to accept the original RUC recommendation of 5.45.
Final decision: The descriptor for CPT code 52001 has been revised for 2003 and the RUC provided a new recommended work RVU of 5.45. We agree with the RUC recommended work RVU of 5.45 for CPT code 52001.
CPT code 53853Transurethral destruction of prostatic tissue; by water induced thermotherapy).
The RUC recommended 6.41 work RVUs for this procedure. We did not agree with the RUC recommendation and based on an analysis of intraservice activities, we believed it more appropriate to compare CPT code 53853 to 90-day global procedures with less than 30 minutes of intraservice time. Based on this we assigned a work RVU of 4.14 to this code.
Commenters disagreed with the RVUs assigned. One commenter provided detailed information in support of an increase in work RVUs. Based on these comments we referred this code to the multispecialty validation panel for review.
Final decision: As a result of the statistical analysis of the 2002 multispecialty validation panel ratings, we have assigned 5.24 work RVUs to CPT code 53853.
CPT code 76490Ultrasound guidance for, and monitoring of, tissue ablation
We did not receive a recommendation from the RUC for this procedure. We compared the time and intensity of this procedure to other radiologic guidance codes and to radiologic supervision and interpretation codes and assigned work RVUs of 2.00 to this code. Two specialty groups expressed concern that the assigned RVUs were not appropriate and indicated the RUC would be revisiting work RVUs for this service in February 2002. They recommended that we take the RUC values into consideration for the 2003 Medicare fee schedule.
Final Decision: We did receive a RUC work RVU recommendation of 4.00 for this service and are in agreement with this recommendation.
CPT code 90471Immunization administration (includes percutaneous, intradermal, subcutaneous, intramuscular and jet injections); one vaccine (single or combination vaccine/toxoid) and CPT code 90472 Immunization administration (includes percutaneous, intradermal, subcutaneous, intramuscular and jet injections); each additional vaccine/toxoid (List separately in addition to code for primary procedure) one vaccine
We disagreed with the RUC recommended work RVU of .17 for CPT code 90471 and .15 work RVUs for CPT code 90472. To the extent the physician performs any counseling related to this service, it is considered part of the work of the preventive medicine visit during which the immunization was administered. If the vaccine is administered during a visit other than a preventive medicine service, any physician counseling should be billed separately as an E/M service. Commenters disagreed that there is no physician work associated with this service particularly in light of the required counseling that must be provided by the physician concerning possible reactions to vaccines. Commenters also continue to be concerned that Medicaid and private payors will base their payment amounts on the "incomplete" RVUs established under the physician fee schedule, which do not include physician work for these services.
Final Decision: We have addressed the issue of immunization administration in a separate section of this rule. We continue to believe that there is no physician work associated with this service. Please see Section A.(3)(c) (Practice Expense provisions for CY 2003) for discussion of this issue.
CPT code 90473Immunization administration by intranasal or oral route; one vaccine (single or combination vaccine/toxoid); and, CPT code 90474 Immunization administration by intranasal or oral route each additional vaccine/toxoid (List separately in addition to code for primary procedure)
The RUC recommended a work RVU of .17 for CPT code 90473 and .15 work RVUs for CPT code 90474. Medicare does not cover self-administered vaccines. We did not assign work RVUs to these services as these are noncovered services. Commenters disagreed with our assessment that there is no physician work associated with these codes.
Final Decision: As we had previously indicated, Medicare does not cover self-administered vaccines. Since these services are not covered under Medicare, RVUs are not listed under the physician fee schedule.
CPT code 93609Intraventricular and/or intra-atrial mapping of tachycardia site(s) with catheter manipulation to record from multiple sites to identify origin of tachycardia
We did not receive a recommendation from the RUC for this service. The descriptor for this service did not change, but the AMA CPT editorial panel changed the global period for this service from a zero day global to a ZZZ global. This means that this is now an "add-on" code and the physician work RVUs no longer include any pre- or postservice work. (It previously had a work RVU of 10.07.) To appropriately value this add-on service, we compared it to several other electrophysiology services and assigned a work RVU of 4.81 to CPT code 93609. Commenters disagreed with the assigned work RVUs and stated that this code would be presented at the February 2002 RUC meeting. Commenters encouraged us to reconsider the work RVUs for this code based on the forthcoming RUC recommendation.
Final Decision: We have received a RUC recommendation of 5.00 for CPT code 93609 for 2003 and are in agreement with this recommendation.
CPT code 93613Intracardiac electrophysiologic 3-dimensional mapping
This was a new add-on code for 2002 for which we did not receive a recommendation from the RUC. This is a service that does not include any pre-or postservice work. Based on a comparison to similar services, we believed the intraservice time and intensity of 93613 was slightly less than that of CPT code 93619 and therefore assigned 7.00 work RVUs to CPT code 93613. Commenters disagreed with our rationale and stated that this code would be presented at the February 2002 RUC meeting. Commenters encouraged us to reconsider the work RVUs for this code.
Final Decision: We have received a RUC recommendation of 7.00 for CPT code 93613 for 2003 and are in agreement with this recommendation.
CPT code 93701Bioimpedence, thoracic, electrical
We did not accept the RUC recommendation of 0.00 work RVUS but assigned this service 0.17 work RVUs based on the value assigned to HCPCS code M0302 which is the code used to pay for this service in 2001. We did indicate that we would consider the RUC recommendation but that, if we considered revising the work RVUs, we would discuss any proposed change in a future proposed rule. Commenters expressed concern that we would revisit this issue as we had addressed valuing of this service through rulemaking in 2000. While we retained the work RVUs that had been assigned based on rulemaking in 2000 for this service, we did want to indicate that, in consideration of the RUC recommendation, should we determine that any revisions to the RVUs are necessary, we would address revisions in future rulemaking.
Final Decision: We are retaining the work RVU of 0.17.
CPT code 95250Glucose monitoring for up to 72 hours by continuous recording and storage of glucose values from interstitial tissue fluid via a subcutaneous sensor (includes hook-up, calibration, patient initiation and training, recording, disconnection, downloading with printout of data)
We agreed with the RUC recommendation that the physician work value for this service was 0.00. Though the physician can bill an E/M code for the physician review and interpretation associated with this service, commenters believe that use of the E/M code to reflect the physician work is not adequate and that the present reimbursement for this code will discourage its use.
Final Decision: The CPT descriptor for this code indicates that it is for the "TC" only and that, to report the physician review, interpretation and written report associated with this code, the practitioner should use the E/M service codes. Based on this, we believe that the assignment of 0.00 work RVUs is appropriate.
CPT code 97602Removal of devitalized tissue from wound(s); non-selective debridement, without anesthesia (e.g., wet-to-moist dressings, enzymatic, abrasion), including topical applications(s), wound assessment and instruction(s) for ongoing care, per session
The HCPAC recommended a work RVU of 0.32 for this service. We disagreed with this recommendation and stated that the services of this code are bundled into CPT code 97601 and did not establish work RVUs for this service. Commenters disagreed with our determination that this service should be bundled. Commenters felt that, despite the fact that there may be some elements of the service that are common to both codes, these codes describe distinct services that are not used simultaneously. We have re-examined our determination but have not changed our decision. As we explained in last year's final rule, CPT code 97602 describes services that typically involve placement of a wound covering, for example, wet-to-dry gauze or enzyme-treated dressing. It also includes nonspecific removal of devitalized tissue that is an inherent part of changing a dressing. This service is already included in the work and practice expenses of CPT code 97601. In the typical service described by CPT code 97601, the patient has a dressing placed over the wound. We would add that the services described by CPT code 97602 are also included in the work and practice expenses of the whirlpool code, CPT code 97022. For this reason, we consider this a bundled service that is not paid separately.
Final Decision: As discussed above we will continue to consider this a bundled service that is not paid separately.
CPT code 99091Collection and interpretation of physiologic data (e.g., ECG, blood pressure, glucose monitoring) digitally stored and/or transmitted by the patient and/or caregiver to the physician or other qualified health care professional, requiring a minimum of 30 minutes of time
The RUC recommended work RVUs of 1.10 for this code. We disagreed since this work is considered part of the pre- and post-service work of an E/M service and payment for this code is bundled into payment for the E/M service. Commenters objected to our bundling of this code and believed that the work associated with this service is not captured in other services, as this is not a face-to-face service. Some commenters felt that the work involved in this code was similar to care plan oversight codes, for which we provide separate payment.
Final Decision: Some portion of both the pre- and post-service work of an evaluation and management visit will not be face-to-face. We still conclude, as discussed above, that this a bundled service that is not paid separately.
CPT codes 99289Physician constant attention of the critically ill or injured patient during an interfacility transport; first 30-74 minutes, and 99290, each additional 30 minutes (List separately in addition to code for primary service)
We did not agree with the RUC recommended values of 4.8 work RVUs for CPT code 99289 and 2.4 work RVUs for CPT code 99290. We also had concerns as to whether the code descriptors for these two new codes, as written, met the requirements for critical care. Based on the concerns outlined in the November 1, 2001 rule, we decided not to recognize these codes for Medicare purposes and created two HCPCS Level II codes for use in CY 2002 to describe critical care services provided to patients during inter-facility transport. These codes (G0240-Critical Care Service delivered by a physician; face-to-face, during inter-facility transport of a critically ill or critically injured patient: first 30-74 minutes of active transport and G0241-each additional 30 minutes (list separately in addition to G0240) were valued at 4.00 work RVUs and 2.00 work RVUs, respectively. Commenters indicated that the descriptors for the CPT codes were being revised and requested that we reconsider the work relative values for these codes in light of the changes that CPT will be making to these codes.
Final Decision: Based on the changes the CPT Editorial Panel has made to the descriptors for CPT codes 99289 and 99290, we are in agreement with the RUC recommended work RVUs of 4.80 for 99289 and 2.40 for 99290 and will use these CPT codes for Medicare purposes. We are also eliminating HCPCS codes G0240 and G0241 that had previously been used to report these services.
RUC Recommendations on Practice Expense Inputs for 2002 New and Revised Codes
In the November 2001 final rule (66 FR 55310), we responded to the RUC recommendations on the practice expense inputs for the new and revised CPT codes for CY 2002. We have received two comments on this issue.
Comment: The AMA commented that it was pleased that we accepted nearly all of the RUC's recommendations for direct practice expense inputs for new and revised codes for CPT 2002.
Response: We are also pleased that we are receiving recommendations on the practice expense inputs that need no modification and thank the RUC for the time and effort expended on developing appropriate recommendations.
Comment: Two organizations representing radiation oncologists were opposed to the reduction of the recommended clinical staff time for a radiation therapist from 123 to 60 minutes for CPT code 77418, intensity modulated treatment delivery. One of the comments argued that there is no overlap of clinical staff time with other services and that the typical time is over 60 minutes for this procedure. Both comments contend that for quality of care purposes two therapists are required.
Response: In the November 2001 final rule (66 FR 55310), we accepted, as interim, the RUC's recommendations for practice expense inputs for CPT code 77418, except that we reduced the staff time from 120 minutes (60 minutes for each of two radiation technologists) to 60 minutes (for one radiation technologist). We still believe that this reduction in staff time is appropriate. IMRT is currently delivered in multiple fractions on a daily basis and is usually administered to patients with prostate cancer or tumors of the head and neck. Most of the treatments take considerably less than 60 minutes and only one technologist is required to actually deliver the treatment, as the parameters are preprogrammed into a computer. Further, any time spent adjusting the radiation fields using ultrasound or computed tomography is separately payable. We believe that 60 minutes of staff time adequately accounts for the pre-, intra-, and post-service staff resources used to provide this service.
We received the following comments on HCPCS codes established in the November 1, 2001 final rule.
• Respiratory Therapy Codes
G0237 Therapeutic Procedures To Increase Strength or Endurance of Respiratory Muscles, Face-to-Face, One-on-One, Each 15 Minutes (Includes Monitoring); G0238 Therapeutic Procedures To Improve Respiratory Function, Other Than Described by G0237, One-on-One, Face-to-Face, per 15 Minutes (Includes Monitoring); and G0239 Therapeutic Procedures To Improve Respiratory Function, Two or More Patients Treated During the Same Period, Face-to-Face (Includes Monitoring).
Note that we have revised the descriptor for G0239 for clarity, and discussed this in section IV(C).
While several organizations expressed appreciation for the establishment of these codes, they requested clarification on the following points:
Comment: Commenters asked whether nurses could also use these codes.
Response: Physicians can use these codes if nurses are providing services "incident to" a physician's service, with the physician in the suite in his or her office, and the codes may be used in a comprehensive outpatient rehabilitation facility (CORF) or a hospital outpatient department. Since there is no respiratory therapy or pulmonary rehabilitation benefit, respiratory therapists can provide these services only in a CORF or under the "incident to" provision in a physician's office or in the hospital outpatient setting.
Comment: Commers requested clarification of the term "monitoring" used in all three of these code descriptions.
Response: Monitoring provides physiologic or other data about the patient during the period before, during, and after the activities. It can represent, for example, pulse oximetry readings, electrocardiography data, pulmonary testing measurements, or measurements of strength or endurance performed to assess the status of the patient before, during, and after the activities. An example would be pursed-lip breathing which involves nasal inspiration followed by slow exhalations through partially closed pursed lips to create positive pressure in upper respiratory tract, and improve respiratory muscles action. If, after this training, the practitioner were to check the patient's oxygen saturation level (via pulse oximetry), peak respiratory flow, or other respiratory parameters, then this would be considered "monitoring." Payment for this monitoring is bundled into G0237 and not paid separately as a diagnostic test.
Comment: Another asked about the differences between the G codes.
Response: G0237 involves therapeutic procedures specifically targeted at improving the strength and endurance of respiratory muscles. Examples include pursed-lip breathing, diaphragmatic breathing, and paced breathing (strengthening the diaphragm by breathing through tubes of progressively increasing resistance to flow). G0238 involves a variety of activities including teaching patients strategies for performing tasks with less respiratory effort and the performance of graded activity programs to increase endurance and strength of upper and lower extremities. G0238 does not include demonstration of the use of nebulizer or inhaler or chest percussions because these services are described by other CPT codes (94664 and 94667, respectively). G0239 represents situations in which two or more patients are receiving services simultaneously (such as those described above in G0237 or G0238) during the same time period. The practitioners must be in constant attendance but need not be providing one-on-one contact. For example, a therapist provides medically necessary therapeutic procedures to two patients (A and B) in the same gym, for a 30-minute period. Both are performing different graded activities (described by G0238) to increase endurance of their upper and lower extremities while the therapist divides his/her time-in intermittent, brief episodes-between patients A and B. In this scenario the therapist would bill each patient for group therapy (G0239) because the treatment was provided simultaneously to two patients, and not one-on-one, as required by G0238.
Comment: Commers requested clarification concerning use of G0237, G0238, and G0239 codes and whether these codes can be billed more than once a day.
Response: G0237 and G0238 are timed codes, reported for each 15 minutes of one-on-one face-to-face treatment. They can be reported with more than one unit per patient per day, depending upon the duration of treatment. G0239 is not a timed code and thus should be reported only once a day for each patient in the group.
Comment: Clarification was also requested about whether the physician must certify the services every 30 days.
Response: The 30-day certification and recertification of the plan of care requirement applies to the services of physical therapists, occupational therapists, and speech language pathologists as described in section 1861(p) of the Act. Since we expected G0237, G0238, and G0239 typically to be provided by respiratory therapists, the 30-day certification and recertification of the plan of care requirement does not generally apply. If the services are performed by either a physical or occupational therapist (or by a therapy assistant under his or her direction), the requirement for the 30-day certification and recertification applies. Additionally, all services provided in the CORF setting including G0237, G0238, and G0239 require 60-day certification and recertification of the plan of care.
Comment: One commenter asked whether the "NA" in the facility total column indicated that these codes are not for use in the hospital outpatient setting.
Response: As stated above, these codes are appropriate for use in the hospital outpatient setting. The "NA" refers to the fact that in the hospital outpatient setting, these codes are paid under the hospital outpatient prospective payment system and are assigned to an APC, rather than being paid on the physician fee schedule.
Comment: Commenters also asked for the specific clinical situations in which the use of these codes is appropriate.
Response: All services must meet the test of being "reasonable and necessary" pursuant to section 1862(a)(1)(A) of the Act. Determinations of medical necessity have been made by carriers and intermediaries on a claim-by-claim basis in their local medical review policies. We believe that this is the appropriate manner to address these questions, and many of our contractors have already developed these policies. We note however, there is no explicit pulmonary rehabilitation benefit.
Comment: Commenters asked whether respiratory therapists would be precluded from using additional CPT codes to bill for their pulmonary-rehabilitation related services.
Response: We reiterate that codes G0237, G0238, and G0239 were developed to provide more specificity about the services being delivered. Thus, CPT codes 97000 to 97799 are not to be billed by professionals involved in treating respiratory conditions, unless these services are delivered by physical or occupational therapists and meet the other requirements for physical and occupational therapy services. Also CPT code 99211, (office or other outpatient visit for evaluation and management), should not be used by practitioners providing outpatient respiratory or pulmonary therapy services.
Revisions to Malpractice RVUs for New and Revised CPT Codes for 2002
Malpractice RVUs are calculated using the methodology described in detail at Addendum G of our November 1, 2000 final rule (65 FR 65589). Because of the timing of the release of new and revised CPT codes each year, the malpractice RVUs for the first year of these codes are extrapolated from existing similar codes based on the advice of our medical consultants and are considered interim subject to public comment and our revision. The following year, these codes are given values based on our malpractice RVU methodology and a review of any comments received.
The malpractice RVUs for new and revised codes for CY 2002 published in Addendum B of the November 2001 final rule, were extrapolated from existing similar codes. The malpractice RVUs for these codes in this year's Addendum B were calculated by our consultant, KPMG, using the same methodology used for all other codes. Likewise, the malpractice RVUs for new and revised codes for CY 2003 are being extrapolated from existing similar codes and will be calculated using the malpractice RVU methodology next year.
Comment: The American College of Radiology continues to be concerned about the increasing liability costs for radiology and radiation oncology. They would like us to explore and ultimately implement a change in the malpractice methodology. They stated that radiologists and radiation oncologists bear the majority of costs for liability insurance; therefore, the larger proportion of malpractice value should be included in the PC and the smaller portion in the TC.
Response: While we can understand the concern about rising liability costs, we do not believe that radiology and radiation oncology are the only specialties facing such increases. We also do not agree that the larger proportion of malpractice values should be associated with the PC component of the service. As we have explained in previous physician fee schedule rules, the total TC RVUs (practice expense and malpractice) for the TC of radiology diagnostic tests represent the expenses required to perform the test-equipment, supplies, and technicians plus malpractice insurance. The total PC RVUs (work, practice expense and malpractice insurance) represent only the interpretation of the test by the physician. Generally, the TC RVUs for radiology services are significantly higher than the PC RVUs because of the very expensive equipment and supplies. The malpractice RVUs are generally split in similar proportion between PC and TC as are the practice expense RVUs. In cases when the physician or group provides both the TC and PC and bills for both components, the split is not a significant issue since the physician or group would receive the total payment. In many cases, the TC is provided by an entity-hospital or free standing imaging center-other than the physician providing the interpretation. The entity providing the TC, which includes a supervising physician who is most likely a radiologist, assumes the risk, such as excessive irradiation of the patient, of providing the TC. We can think of no reason to transfer any portion of malpractice RVUs from the entity (which would include a supervising physician) providing the majority of the service, the TC, to a physician who is providing only the interpretation. The malpractice liability associated with interpreting the test is reflected in the PC malpractice RVUs.
Comment: The American Occupational Therapy Association indicated that for computing malpractice RVUs, occupational therapy was incorrectly crosswalked to occupational medicine (Insurance Service Office (ISO) code 80233). They suggested the appropriate crosswalk is to physical medicine and rehabilitation (ISO 80235).
Response: We agree with the commenter that a more appropriate crosswalk for occupational therapy is to physical medicine and rehabilitation as opposed to occupational medicine. The original data that were used to calculate malpractice RVUs were based upon 1993 to 1995 malpractice premium data. These data were replaced with more recent premium data (1996 to 1998). The resulting risk factors are published in the November 2000 final rule (65 FR 65594). These more recent premium data place occupation medicine, occupational therapy, and physical medicine and rehabilitation into the same risk classification. Due to this update to the risk classifications, revising the crosswalk for occupational therapy will have no effect; nonetheless, for purposes of accuracy, we will change the occupational therapy crosswalk at the next scheduled update to malpractice premium data in CY 2005.
Establishment of Interim Work Relative Value Units for New and Revised Physician's Current Procedural Terminology (CPT) Codes and New Healthcare Common Procedure Coding System Codes (HCPCS) for 2003 (Includes Table titled American Medical Association Specialty Relative Value Update Committee and Health Care Professionals Advisory Committee Recommendations and CMS's Decisions for New and Revised 2003 CPT Codes)
One aspect of establishing RVUs for 2003 was related to the assignment of interim work RVUs for all new and revised CPT codes. As described in our November 25, 1992 notice on the 1993 physician fee schedule (57 FR 55983) and in section III.B. of the November 22, 1996 final rule (61 FR 59505 through 59506), we established a process, based on recommendations received from the AMA's RUC, for establishing interim work RVUs for new and revised codes.
This year we received work RVU recommendations for approximately 249 new and revised CPT codes from the RUC. Our staff and medical officers reviewed the RUC recommendations by comparing them to our reference set or to other comparable services for which work RVUs had previously been established, or to both of these criteria. We also considered the relationships among the new and revised codes for which we received RUC recommendations. We agreed with the majority of the relative relationships reflected in the RUC values. In some instances, when we agreed with the relationships, we nonetheless revised the work RVUs to achieve work neutrality within families of codes, that is, the work RVUs have been adjusted so that the sum of the new or revised work RVUs (weighted by projected frequency of use) for a family will be the same as the sum of the current work RVUs (weighted by projected frequency of use). For approximately 96 percent of the RUC recommendations, proposed work RVUs were reviewed and accepted, and, for approximately 4 percent, we disagreed with the RUC recommended values. In the majority of these instances, we agreed with the relativity established by the RUC, but needed to adjust work RVUs to retain budget neutrality.
There were also 22 CPT codes for which we did not receive a RUC recommendation. After a review of these CPT codes by our staff and medical officers, we established interim work RVUs for the majority of these services. For those services for which we could not arrive at interim work RVUs, we have assigned a carrier-priced status until such time as the RUC provides work RVU recommendations.
We received 22 recommendations from the Health Care Professionals Advisory Committee (HCPAC). We agreed with approximately 86 percent of the HCPAC recommendations and disagreed with approximately 14 percent of the HCPAC recommendations.
We have also included, in Table 6, 34 codes for which the RUC has submitted revisions to their original 2002 recommendations. These CPT codes are identified with an "L" in Table 6.
Table 6, titled "AMA RUC and HCPAC Recommendations and CMS Decisions for New and Revised 2003 CPT Codes", lists the new or revised CPT codes, and their associated work RVUs, that will be interim in 2003. This table includes the following information:
• A "#" identifies a new code for 2003.
• CPT code. This is the CPT code for a service.
• Modifier. A "26" in this column indicates that the work RVUs are for the professional component of the code.
• Description. This is an abbreviated version of the narrative description of the code.
• RUC recommendations. This column identifies the work RVUs recommended by the RUC.
• HCPAC recommendations. This column identifies the work RVUs recommended by the HCPAC.
• CMS decision. This column indicates whether we agreed with the RUC recommendation ("agree") or we disagreed with the RUC recommendation ("disagree"). Codes for which we did not accept the RUC recommendation are discussed in greater detail following this table. An "(a)" indicates that no RUC recommendation was provided.
• 2003 Work RVUs. This column establishes the 2003 work RVUs for physician work.
*CPT code | Mod | Description | RUC recommendation | HCPAC recommendation | CMS decision | 2003 Work RVU |
---|---|---|---|---|---|---|
11400 | Exc tr-ext b9+marg 0.5 cm | 0.85 | Agree | 0.85 | ||
11401 | Exc tr-ext b9+marg 0.6-1 cm | 1.23 | Agree | 1.23 | ||
11402 | Exc tr-ext b9+marg 1.1-2 cm | 1.51 | Agree | 1.51 | ||
11403 | Exc tr-ext b9+marg 2.1-3 cm | 1.79 | Agree | 1.79 | ||
11404 | Exc tr-ext b9+marg 3.1-4cm | 2.06 | Agree | 2.06 | ||
11406 | Exc tr-ext b9+marg 4.0 cm | 2.76 | Agree | 2.76 | ||
11420 | Exc h-f-nk-sp b9+marg 0.5 | 0.98 | Agree | 0.98 | ||
11421 | Exc h-f-nk-sp b9+marg 0.6-1 | 1.42 | Agree | 1.42 | ||
11422 | Exc h-f-nk-sp b9+marg 1.1-2 | 1.63 | Agree | 1.63 | ||
11423 | Exc h-f-nk-sp b9+marg 2.1-3 | 2.01 | Agree | 2.01 | ||
11424 | Exc h-f-nk-sp b9+marg 3.1-4 | 2.43 | Agree | 2.43 | ||
11426 | Exc h-f-nk-sp b9+marg 4 cm | 3.78 | Agree | 3.78 | ||
11440 | Exc face-mm b9+marg 0.5 cm | 1.06 | Agree | 1.06 | ||
11441 | Exc face-mm b9+marg 0.6-1 cm | 1.48 | Agree | 1.48 | ||
11442 | Exc face-mm b9+marg 1.1-2 cm | 1.72 | Agree | 1.72 | ||
11443 | Exc face-mm b9+marg 2.1-3 cm | 2.29 | Agree | 2.29 | ||
11444 | Exc face-mm b9+marg 3.1-4 cm | 3.14 | Agree | 3.14 | ||
11446 | Exc face-mm b9+marg 4 cm | 4.49 | Agree | 4.49 | ||
11600 | Exc tr-ext mlg+marg 0.5 cm | 1.31 | Agree | 1.31 | ||
11601 | Exc tr-ext mlg+marg 0.6-1 cm | 1.80 | Agree | 1.80 | ||
11602 | Exc tr-ext mlg+marg 1.1-2 cm | 1.95 | Agree | 1.95 | ||
11603 | Exc tr-ext mlg+marg 2.1-3 cm | 2.19 | Agree | 2.19 | ||
11604 | Exc tr-ext mlg+marg 3.1-4 cm | 2.40 | Agree | 2.40 | ||
11606 | Exc tr-ext mlg+marg 4 cm | 3.43 | Agree | 3.43 | ||
11620 | Exc h-f-nk-sp mlg+marg 0.5 | 1.19 | Agree | 1.19 | ||
11621 | Exc h-f-nk-sp mlg+marg 0.6-1 | 1.76 | Agree | 1.76 | ||
11622 | Exc h-f-nk-sp mlg+marg 1.1-2 | 2.09 | Agree | 2.09 | ||
11623 | Exc h-f-nk-sp mlg+marg 2.1-3 | 2.61 | Agree | 2.61 | ||
11624 | Exc h-f-nk-sp mlg+marg 3.1-4 | 3.06 | Agree | 3.06 | ||
11626 | Exc h-f-nk-sp mlg+mar 4 cm | 4.30 | Agree | 4.30 | ||
11640 | Exc face-mm malig+marg 0.5 | 1.35 | Agree | 1.35 | ||
11641 | Exc face-mm malig+marg 0.6-1 | 2.16 | Agree | 2.16 | ||
11642 | Exc face-mm malig+marg 1.1-2 | 2.59 | Agree | 2.59 | ||
11643 | Exc face-mm malig+marg 2.1-3 | 3.10 | Agree | 3.10 | ||
11644 | Exc face-mm malig+marg 3.1-4 | 4.03 | Agree | 4.03 | ||
11646 | Exc face-mm mlg+marg 4 cm | 5.95 | Agree | 5.95 | ||
L 11981 | Insert drug implant device | 1.48 | Agree | 1.48 | ||
L 11982 | Remove drug implant device | 1.78 | Agree | 1.78 | ||
L 11983 | Remove/insert drug implant | 3.30 | Agree | 3.30 | ||
17304 | 1 stage mohs, up to 5 spec | 7.60 | Agree | 7.60 | ||
17305 | 2 stage mohs, up to 5 spec | 2.85 | Agree | 2.85 | ||
17306 | 3 stage mohs, up to 5 spec | 2.85 | Agree | 2.85 | ||
17307 | Mohs addl stage up to 5 spec | 2.85 | Agree | 2.85 | ||
17310 | Mohs any stage 5 spec each | 0.95 | Disagree | 0.62 | ||
L 20526 | Ther injection, carp tunnel | 0.94 | Agree | 0.94 | ||
L 20550 | Inj tendon sheath/ligament | 0.75 | Agree | 0.75 | ||
L 20551 | Inject tendon origin/insert | 0.75 | Agree | 0.75 | ||
L 20552 | Inject trigger point, 1 or 2 | 0.66 | Agree | 0.66 | ||
L 20553 | Inject trigger points, =/ 3 | 0.75 | Agree | 0.75 | ||
L 20600 | Drain/inject, joint/bursa | 0.66 | Agree | 0.66 | ||
L 20605 | Drain/inject, joint/bursa | 0.68 | Agree | 0.68 | ||
# 20612 | Aspirate/inj ganglion cyst | 0.70 | Agree | 0.70 | ||
21030 | Excise max/zygoma b9 tumor | (a) | (a) | 3.89 | ||
21034 | Excise max/zygoma mlg tumor | 16.17 | Agree | 16.17 | ||
21040 | Removal of jaw bone lesion | (a) | (a) | 3.89 | ||
# 21046 | Remove mandible cyst complex | 13.00 | Agree | 13.00 | ||
# 21047 | Excise lwr jaw cyst w/repair | 18.75 | Agree | 18.75 | ||
# 21048 | Remove maxilla cyst complex | 13.50 | Agree | 13.50 | ||
# 21049 | Excise uppr jaw cyst w/repair | 18.00 | Agree | 18.00 | ||
21740 | Reconstruction of sternum | 16.50 | Agree | 16.50 | ||
# 21742 | Repair sternum/nuss w/o scope | (a) | (a) | carrier | ||
# 21743 | Repair sternum/nuss w/scope | (a) | (a) | carrier | ||
23410 | Repair rotator cuff, acute | 12.45 | Agree | 12.45 | ||
23412 | Repair rotator cuff, chronic | 13.31 | Agree | 13.31 | ||
L 24344 | Reconstruct elbow lat ligmnt | 14.00 | Agree | 14.00 | ||
L 24346 | Reconstruct elbow med ligmnt | 14.00 | Agree | 14.00 | ||
25320 | Repair/revise wrist joint | 10.77 | Agree | 10.77 | ||
27425 | Lat retinacular release open | 5.22 | Agree | 5.22 | ||
27730 | Repair of tibia epiphysis | 7.41 | Agree | 7.41 | ||
27732 | Repair of fibula epiphysis | 5.32 | Agree | 5.32 | ||
27734 | Repair of lower leg epiphysis | 8.48 | Agree | 8.48 | ||
27870 | Fusion of ankle joint, open | 13.91 | Agree | 13.91 | ||
29806 | Shoulder arthroscopy/surgery | 14.37 | Agree | 14.37 | ||
# 29827 | Arthroscop rotator cuff repr | 15.36 | Agree | 15.36 | ||
# 29873 | Knee arthroscopy/surgery | 6.00 | Agree | 6.00 | ||
# 29899 | Ankle arthroscopy/surgery | 13.91 | Agree | 13.91 | ||
# 33215 | Reposition pacing-defib lead | 4.44 | Disagree | 4.76 | ||
33216 | Insert lead pace-defib, one | 5.39 | Disagree | 5.78 | ||
33217 | Insert lead pace-defib, dual | 5.75 | Agree | 5.75 | ||
# 33224 | Insert pacing lead connect | 9.05 | Agree | 9.05 | ||
# 33225 | L ventric pacing lead add-on | 8.34 | Agree | 8.34 | ||
# 33226 | Reposition L ventric lead | 8.69 | Agree | 8.69 | ||
# 33508 | Endoscopic vein harvest | 0.31 | Agree | 0.31 | ||
L 33979 | Insert intracorporeal device | 46.00 | Agree | 46.00 | ||
L 33980 | Remove intracorporeal device | 56.25 | Agree | 56.25 | ||
34812 | Xpose for endoprosth, femorl | 6.75 | Agree | 6.75 | ||
34825 | Endovasc extend prosth, init | 12.00 | Agree | 12.00 | ||
34826 | Endovasc extend prosth, addl | 4.13 | Agree | 4.13 | ||
# 34833 | Xpose for endoprosth, iliac | 12.00 | Agree | 12.00 | ||
# 34834 | Xpose, endoprosth, brachial | 5.35 | Agree | 5.35 | ||
# 34900 | Endovasc iliac repr w/graft | 16.38 | Agree | 16.38 | ||
# 35572 | Harvest femoropopliteal vein | 6.82 | Agree | 6.82 | ||
36415 | Routine venipuncture | 0.00 | Agree | 0.00 | ||
# 36416 | Capillary blood draw | 0.00 | Agree | 0.00 | ||
# 36511 | Apheresis wbc | (a) | (a) | 1.74 | ||
# 36512 | Apheresis rbc | (a) | (a) | 1.74 | ||
# 36513 | Apheresis platelets | (a) | (a) | 1.74 | ||
# 36514 | Apheresis plasma | (a) | (a) | 1.74 | ||
# 36515 | Apheresis, adsorp/reinfuse | (a) | (a) | 1.74 | ||
# 36516 | Apheresis, selective | (a) | (a) | 1.74 | ||
# 36536 | Remove cva device obstruct | 3.60 | Agree | 3.60 | ||
# 36537 | Remove cva lumen obstruct | 0.75 | Agree | 0.75 | ||
36540 | Collect blood venous device | 0.00 | Agree | 0.00 | ||
# 37182 | Insert hepatic shunt (tips) | 17.00 | Agree | 17.00 | ||
# 37183 | Remove hepatic shunt (tips) | 8.00 | Agree | 8.00 | ||
# 37500 | Endoscopy ligate perf veins | 11.00 | Agree | 11.00 | ||
37760 | Ligation, leg veins, open | 10.47 | Agree | 10.47 | ||
# 38204 | Bl donor search management | 2.00 | Disagree | 0.00 | ||
# 38205 | Harvest allogenic stem cells | 1.50 | Agree | 1.50 | ||
# 38206 | Harvest auto stem cells | 1.50 | Agree | 1.50 | ||
# 38207 | Cryopreserve stem cells | (a) | (a) | 0.00 | ||
# 38208 | Thaw preserved stem cells | (a) | (a) | 0.00 | ||
# 38209 | Wash harvest stem cells | (a) | (a) | 0.00 | ||
# 38210 | T-cell depletion of harvest | (a) | (a) | 0.00 | ||
# 38211 | Tumor cell deplete of harvest | (a) | (a) | 0.00 | ||
# 38212 | Rbc depletion of harvest | (a) | (a) | 0.00 | ||
# 38213 | Platelet deplete of harvest | (a) | (a) | 0.00 | ||
# 38214 | Volume deplete of harvest | (a) | (a) | 0.00 | ||
# 38215 | Harvest stem cell concentrte | (a) | (a) | 0.00 | ||
# 38242 | Lymphocyte infuse transplant | 1.71 | Agree | 1.71 | ||
# 43201 | Esoph scope w/submucous inj | 2.09 | Agree | 2.09 | ||
# 43236 | Uppr gi scope w/submuc inj | 2.92 | Agree | 2.92 | ||
43245 | Uppr gi scope dilate strictr | 3.18 | Agree | 3.18 | ||
# 44206 | Lap part colectomy w/stoma | 27.00 | Agree | 27.00 | ||
# 44207 | L colectomy/coloproctostomy | 30.00 | Agree | 30.00 | ||
# 44208 | L colectomy/coloproctostomy | 32.00 | Agree | 32.00 | ||
# 44210 | Laparo total proctocolectomy | 28.00 | Agree | 28.00 | ||
# 44211 | Laparo total proctocolectomy | 35.00 | Agree | 35.00 | ||
# 44212 | Laparo total proctocolectomy | 32.50 | Agree | 32.50 | ||
# 44701 | Intraop colon lavage add-on | 3.10 | Agree | 3.10 | ||
# 45335 | Sigmoidoscope w/submuc inj | 1.46 | Disagree | 1.36 | ||
# 45340 | Sig w/balloon dilation | 1.96 | Disagree | 1.66 | ||
# 45381 | Colonoscope, submucous inj | 4.30 | Disagree | 4.20 | ||
# 45386 | Colonoscope dilate stricture | 4.58 | Agree | 4.58 | ||
# 46706 | Repr of anal fistula w/glue | 2.95 | Disagree | 2.39 | ||
L 47370 | Laparo ablate liver tumor rf | 19.69 | Agree | 19.69 | ||
L 47371 | Laparo ablate liver cryosurg | 19.69 | Agree | 19.69 | ||
L 47380 | Open ablate liver tumor rf | 23.00 | Agree | 23.00 | ||
L 47381 | Open ablate liver tumor cryo | 23.27 | Agree | 23.27 | ||
L 47382 | Percut ablate liver rf | 15.19 | Agree | 15.19 | ||
# 49419 | Insrt abdom cath for chemotx | 6.65 | Agree | 6.65 | ||
# 49904 | Omental flap, extra-abdom | 20.00 | Agree | 20.00 | ||
49905 | Omental flap, intra-abdom | 6.55 | Agree | 6.55 | ||
# 50542 | Laparo ablate renal mass | 20.00 | Agree | 20.00 | ||
# 50543 | Laparo partial nephrectomy | 25.50 | Agree | 25.50 | ||
# 50562 | Renal scope w/tumor resect | 10.90 | Agree | 10.90 | ||
# 55866 | Laparo radical prostatectomy | 30.74 | Agree | 30.74 | ||
# 51701 | Insert bladder catheter | 0.50 | Agree | 0.50 | ||
# 51702 | Insert temp bladder cath | 0.50 | Agree | 0.50 | ||
# 51703 | Insert bladder cath, complex | 1.47 | Agree | 1.47 | ||
# 51798 | Us urine capacity measure | 0.38 | Disagree | 0.11 | ||
53440 | Male sling procedure | 13.62 | Agree | 13.62 | ||
53442 | Remove/revise male sling | 11.57 | Agree | 11.57 | ||
# 56820 | Exam of vulva w/scope | 1.50 | Agree | 1.50 | ||
# 56821 | Exam/biopsy of vulva w/scope | 2.05 | Agree | 2.05 | ||
# 57420 | Exam of vagina w/scope | 1.60 | Agree | 1.60 | ||
# 57421 | Exam/biopsy of vag w/scope | 2.20 | Agree | 2.20 | ||
# 57452 | Exam of cervix w/scope | 1.50 | Agree | 1.50 | ||
# 57454 | Bx/curett of cervix w/scope | 2.33 | Agree | 2.33 | ||
# 57455 | Biopsy of cervix w/scope | 1.99 | Agree | 1.99 | ||
# 57456 | Endocerv curettage w/scope | 1.85 | Agree | 1.85 | ||
# 57460 | Bx of cervix w/scope, leep | 2.83 | Agree | 2.83 | ||
# 57461 | Conz of cervix w/scope, leep | 3.44 | Agree | 3.44 | ||
58140 | Myomectomy abdom method | 14.60 | Agree | 14.60 | ||
58145 | Myomectomy vag method | 8.04 | Agree | 8.04 | ||
# 58146 | Myomectomy abdom complex | 19.00 | Agree | 19.00 | ||
58260 | Vaginal hysterectomy | 12.98 | Agree | 12.98 | ||
58262 | Vag hyst including t/o | 14.77 | Agree | 14.77 | ||
58263 | Vag hyst w/t/o vag repair | 16.06 | Agree | 16.06 | ||
58267 | Vag hyst w/urinary repair | 17.04 | Agree | 17.04 | ||
58270 | Vag hyst w/enterocele repair | 14.26 | Agree | 14.26 | ||
# 58290 | Vag hyst complex | 19.00 | Agree | 19.00 | ||
# 58291 | Vag hyst incl t/o, complex | 20.79 | Agree | 20.79 | ||
# 58292 | Vag hyst t/o repair, compl | 22.08 | Agree | 22.08 | ||
# 58293 | Vag hyst w/uro repair, compl | 23.06 | Agree | 23.06 | ||
# 58294 | Vag hyst w/enterocele, compl | 20.28 | Agree | 20.28 | ||
# 58545 | Laparoscopic myomectomy | 14.60 | Agree | 14.60 | ||
# 58546 | Laparo-myomectomy, complex | 19.00 | Agree | 19.00 | ||
58550 | Laparo-asst vag hysterectomy | 14.19 | Agree | 14.19 | ||
# 58552 | Laparo-vag hyst incl t/o | 14.19 | Agree | 14.19 | ||
# 58553 | Laparo-vag hyst, complex | 19.00 | Agree | 19.00 | ||
# 58554 | Laparo-vag hyst w/t/o, compl | 19.00 | Agree | 19.00 | ||
# 61316 | Implt cran bone flap to abdo | 1.39 | Agree | 1.39 | ||
# 61322 | Decompressive craniotomy | 29.50 | Agree | 29.50 | ||
# 61323 | Decompressive lobectomy | 31.00 | Agree | 31.00 | ||
61340 | Subtemporal decompression | 18.66 | Agree | 18.66 | ||
# 61517 | Implt brain chemotx add-on | 1.38 | Agree | 1.38 | ||
# 61623 | Endovasc tempory vessel occl | 9.96 | Agree | 9.96 | ||
61624 | Transcath occlusion, cns | 20.15 | Agree | 20.15 | ||
# 62148 | Retr bone flap to fix skull | 2.00 | Agree | 2.00 | ||
# 62160 | Neuroendoscopy add-on | 3.00 | Agree | 3.00 | ||
# 62161 | Dissect brain w/scope | 20.00 | Agree | 20.00 | ||
# 62162 | Remove colloid cyst w/scope | 25.25 | Agree | 25.25 | ||
# 62163 | Neuroendoscopy w/fb removal | 15.50 | Agree | 15.50 | ||
# 62164 | Remove brain tumor w/scope | 27.50 | Agree | 27.50 | ||
# 62165 | Remove pituit tumor w/scope | 22.00 | Agree | 22.00 | ||
62201 | Brain cavity shunt w/scope | 14.86 | Agree | 14.86 | ||
62263 | Epidural lysis mult sessions | 6.14 | Agree | 6.14 | ||
# 62264 | Epidural lysis on single day | 4.43 | Agree | 4.43 | ||
64415 | N block inj, brachial plexus | 1.48 | Agree | 1.48 | ||
# 64416 | N block cont infuse, b plex | 3.50 | Agree | 3.50 | ||
64445 | N block inj, sciatic, sng | 1.48 | Agree | 1.48 | ||
# 64446 | N blk inj, sciatic, cont inf | 3.25 | Agree | 3.25 | ||
# 64447 | N block inj fem, single | 1.50 | Agree | 1.50 | ||
# 64448 | N block inj fem, cont inf | 3.00 | Agree | 3.00 | ||
64450 | N block, other peripheral | 1.27 | Agree | 1.27 | ||
# 66990 | Ophthalmic endoscope add-on | 1.51 | Agree | 1.51 | ||
# 75901 | 26 | Remove cva device obstruct | 0.49 | Agree | 0.49 | |
# 75902 | 26 | Remove cva lumen obstruct | 0.39 | Agree | 0.39 | |
75953 | 26 | Abdom aneurysm endovas rpr | 1.36 | Agree | 1.36 | |
# 75954 | 26 | Iliac aneurysm endovas rpr | 2.93 | Disagree | 1.36 | |
76070 | 26 | Ct bone density, axial | 0.25 | Agree | 0.25 | |
# 76071 | 26 | Ct bone density, peripheral | 0.22 | Agree | 0.22 | |
L 76085 | 26 | Computer mammogram add-on | 0.06 | Agree | 0.06 | |
L 76362E | 26 | CAT scan for tissue ablation | 4.00 | Agree | 4.00 | |
L 76394 | 26 | MRI for tissue ablation | 4.25 | Agree | 4.25 | |
L 76490 | 26 | US for tissue ablation | 4.00 | Agree | 4.00 | |
# 76801 | Ob us 14 wks, single fetus | 0.99 | Agree | 0.99 | ||
# 76802 | Ob us 14 wks, addl fetus | 0.83 | Agree | 0.83 | ||
76805 | Ob us = 14 wks, sngl fetus | 0.99 | Agree | 0.99 | ||
76810 | Ob us = 14 wks, addl fetus | 0.98 | Agree | 0.98 | ||
# 76811 | Ob us, detailed, sngl fetus | 1.90 | Agree | 1.90 | ||
# 76812 | Ob us, detailed, addl fetus | 1.78 | Agree | 1.78 | ||
76815 | Ob us, limited, fetus(s) | 0.65 | Agree | 0.65 | ||
76816 | Ob us, follow-up, per fetus | 0.85 | Agree | 0.85 | ||
# 76817 | Transvaginal us, obstetric | 0.75 | Agree | 0.75 | ||
# 92601 | Cochlear implt f/up exam 7 | 0.00 | Agree | 0.00 | ||
# 92602 | Reprogram cochlear implt 7 | 0.00 | Agree | 0.00 | ||
# 92603 | Cochlear implt f/up exam 7 | 0.00 | Agree | 0.00 | ||
# 92604 | Reprogram cochlear implt 7 | 0.00 | Agree | 0.00 | ||
# 92605 | Eval for nonspeech device rx | 0.00 | Agree | 0.00 | ||
# 92606 | Non-speech device service | 0.00 | Agree | 0.00 | ||
# 92607 | Ex for speech device rx, 1hr | 0.00 | Agree | 0.00 | ||
# 92608 | Ex for speech device rx addl | 0.00 | Agree | 0.00 | ||
# 92609 | Use of speech device service | 0.00 | Agree | 0.00 | ||
# 92610 | Evaluate swallowing function | 0.00 | Agree | 0.00 | ||
# 92611 | Motion fluoroscopy/swallow | 0.00 | Agree | 0.00 | ||
# 92612 | Endoscopy swallow tst (fees) | 1.27 | Agree | 1.27 | ||
# 92613 | Endoscopy swallow tst (fees) | 0.99 | Disagree | 0.00 | ||
# 92614 | Laryngoscopic sensory test | 1.27 | Agree | 1.27 | ||
# 92615 | Eval laryngoscopy sense tst | 0.88 | Disagree | 0.00 | ||
# 92616 | Fees w/laryngeal sense test | 1.88 | Agree | 1.88 | ||
# 92617 | Interprt fees/laryngeal test | 1.10 | Disagree | 0.00 | ||
# 93580 | Transcath closure of asd | 18.00 | Agree | 18.00 | ||
# 93581 | Transcath closure of vsd | 24.43 | Agree | 24.43 | ||
L 93609 | 26 | Map tachycardia, add-on | 5.00 | Agree | 5.00 | |
L 93613 | Electrophys map 3d, add-on | 7.00 | Agree | 7.00 | ||
L 93619 | 26 | Electrophysiology evaluation | 7.32 | Agree | 7.32 | |
L 93620 | 26 | Electrophysiology evaluation | 11.59 | Agree | 11.59 | |
L 93621 | 26 | Electrophysiology evaluation | 2.10 | Agree | 2.10 | |
L 93622 | 26 | Electrophysiology evaluation | 3.10 | Agree | 3.10 | |
# 95990 | Spin/brain pump refil main | (a) | (a) | 0.00 | ||
L 96000 | Motion analysis, video/3d | 1.80 | Agree | 1.80 | ||
L 96001 | Motion test w/ft press meas | 2.15 | Agree | 2.15 | ||
L 96002 | Dynamic surface emg | 0.41 | Agree | 0.41 | ||
L 96003 | Dynamic fine wire emg | 0.37 | Agree | 0.37 | ||
L 96004 | Phys review of motion tests | 2.14 | Agree | 2.14 | ||
96530 | Syst pump refill main | 0.00 | Agree | 0.00 | ||
# 96920 | Laser tx, skin 250 sq cm | 1.15 | Agree | 1.15 | ||
# 96921 | Laser tx, skin 250-500 sq cm | 1.17 | Agree | 1.17 | ||
# 96922 | Laser tx, skin 500 sq cm | 2.10 | Agree | 2.10 | ||
# 99026 | In-hospital on call service | (a) | (a) | 0.00 | ||
# 99027 | Out-of-hosp on call service | (a) | (a) | 0.00 | ||
99289 | Ped crit care transport | 4.80 | Agree | 4.80 | ||
99290 | Ped crit care transport addl | 2.40 | Agree | 2.40 | ||
# 99293 | Ped critical care, initial | 16.00 | Agree | 16.00 | ||
# 99294 | Ped critical care, subseq | 8.00 | Agree | 8.00 | ||
99295 | Neonate crit care, initial | 18.49 | Agree | 18.49 | ||
99296 | Neonate critical care subseq | 8.00 | Agree | 8.00 | ||
99298 | Neonatal critical care | 2.75 | Agree | 2.75 | ||
# 99299 | Ic, lbw infant 1500-2500 gm | 2.50 | Agree | 2.50 | ||
(a) No Final RUC recommendation provided. | ||||||
# New CPT codes. | ||||||
*All CPT codes copyright 2002 American Medical Association. | ||||||
L Revised 2002 RUC recommendations. |
Table 7, which is titled "AMA RUC ANESTHESIA RECOMMENDATIONS AND CMS DECISIONS FOR NEW AND REVISED 2003 CPT CODES", lists the new or revised CPT codes for anesthesia and their base units that will be interim in 2003. This table includes the following information:
• CPT code. This is the CPT code for a service.
• Description. This is an abbreviated version of the narrative description of the code.
• RUC recommendations. This column identifies the base units recommended by the RUC.
• CMS decision. This column indicates whether we agreed with the RUC recommendation ("agree") or we disagreed with the RUC recommendation ("disagree"). Codes for which we did not accept the RUC recommendation are discussed in greater detail following this table.
• 2003 Base Units. This column establishes the 2003 base units for these services.
*CPT code | Description | RUC recommendation | CMS decision | 2003 base units |
---|---|---|---|---|
# 00326 | Anesth, larynx/trach, 1 yr | 7 | Agree | 7 |
# 00539 | Anesth, trach-bronch reconst | 18 | Agree | 18 |
# 00540 | Anesth, chest surgery | 12 | Agree | 12 |
# 00541 | Anesth, one lung ventiliation | 15 | Agree | 15 |
# 00640 | Anesth, spine manipulation | 3 | Agree | 3 |
# 00834 | Anesth, hernia repair 1 yr | 5 | Agree | 5 |
# 00836 | Anesth hernia repair, preemie | 6 | Agree | 6 |
# 00921 | Anesth, vasectomy | 3 | Agree | 3 |
# 01829 | Anesth, dx wrist arthroscopy | 3 | Agree | 3 |
# 01991 | Anesth, nerve block/inj | 3 | Agree | 3 |
# 01992 | Anesth, nerve block/inj, prone | 5 | Agree | 5 |
*All CPT codes copyright 2003 American Medical Association. # New CPT codes. |
Discussion of Codes for Which There Were No RUC Recommendations or for Which the RUC Recommendations Were Not Accepted
The following is a summary of our rationale for not accepting particular RUC work RVU or base unit recommendations. It is arranged by type of service in CPT order. Additionally, we also discuss those CPT codes for which we received no RUC recommendations for physician work RVUs. This summary refers only to work RVUs or base units.
New and Revised Codes for 2003
CPT code 17310 Chemosurgery (Mohs micrographic technique) including removal of all gross tumor, surgical excision of tissue specimens, mapping, color coding of specimens, microscopic examination of specimens by the surgeon, and complete histopathological preparation including the first routine stain (e.g., hematoxylin and eosin, toluidine blue); each additional specimen after the first 5 specimens, fixed or fresh tissue, any stage (List separately in addition to code for primary procedure).
This add-on code is used to report specimens generated during Mohs surgery. Prior to the changes made for 2003, the code was reported once for all specimens over five, generated during a particular stage of Mohs surgery. In 2003, the code will be used to report each specimen over five during a particular stage of Mohs surgery. The RUC recommended maintaining 0.95 work RVUs for this code as an interim value. We disagree. We share the concerns of the RUC that the specialty society recommendation was based on a survey that did not take into account the ZZZ global period of this code. Additionally, in order to determine whether the current work RVU for 17310 was appropriate, we analyzed the current work RVU for 17310 in the context of the work RVUs for other Mohs surgery CPT codes. Mohs surgery work RVUs are based on Harvard data which is depicted in Table 8 below (all codes have 000 global periods for 2002):
CPT code | 2002 Work RVUs | Total time (minutes) | Intra-service time (minutes) | Work intensity (work RVU/total time) | RN Time (minutes) (CPEP data) | Histotechnician Time (minutes) (CPEP data) |
---|---|---|---|---|---|---|
17304 | 7.6 | 89 | 50 | .085 | 202 | 50 |
17305 | 2.85 | 62 | .046 | 101 | 25 | |
17306 | 2.85 | 62 | .046 | 101 | 25 | |
17307 | 2.85 | 62 | .046 | 101 | 25 | |
17310 | 0.95 | 31 | .031 | 32 | 8 |
These data clearly show that the Harvard data appropriately rank these services in terms of intensity. We note that, because intra-service times are not given for all codes, it is impossible to calculate intra-service work intensity. The RUC recommendation of 0.95 work RVUs which is based on a median time of 20 minutes yields a work intensity of 0.047 which is higher than the work intensities for CPT codes 17305-17307. This would create a rank order anomaly in this family of codes.
We also note that the 2002 descriptor for CPT code 17310 says that this code should be reported only once for all specimens more than five for a given stage of Mohs. Therefore, we believe that the current work RVU represents the total work required for the typical number of specimens obtained (beyond five) per stage of Mohs.
We compared CPT code 17310 with CPT codes 88331 Pathology consultation during surgery; first tissue block, with frozen section(s), single specimen, and 88332 Pathology consultation during surgery; each additional tissue block with frozen section(s). CPT code 88332 has a work RVU of 0.59 and total physician time of 15 minutes. We note that if the RUC survey time (20 minutes) for CPT code 17310 is multiplied by the Harvard intensity (.031) that a work value of 0.62 is obtained.
Therefore, we are assigning a work value of 0.62 work RVUs to CPT code 17310 pending further recommendations from the RUC. We believe this value is appropriate for the new descriptor, which allows reporting of CPT code 17310 for each specimen rather than once for all specimens. We also believe this work value places this code in correct rank order with CPT codes 17304-17307 and with CPT codes 88331 and 88332.
We also note that a work value of 0.62 RVUs will not require any work neutrality adjustment because it already takes our claims data for CPT code 17310 into account.
CPT Codes 21030, Excision of benign tumor or cyst of maxilla or zygoma, by enucleation and curettage, and 21040, Excision of benign tumor or cyst of mandible, by enucleation or curettage.
CPT changed the descriptors for these codes to make the procedure more specific, and we have not yet received RUC recommendations for these codes. We compared these services to CPT Codes 21555, Excision tumor, soft tissue of neck or thorax; subcutaneous (work RVU of 4.35), 28043, Excision, tumor, foot; subcutaneous tissue (work RVU 3.54), 28108, Excision or curettage of bone cyst or benign tumor, phalanges of foot (work RVU 4.16), 21501, Incision and drainage, deep abscess or hematoma, soft tissues of neck or thorax (work RVU 3.81), 26115 Excision, tumor or vascular malformation, soft tissue of hand or finger; subcutaneous (work RVU 3.86), and 24075 Excision, tumor, soft tissue of upper arm or elbow area; subcutaneous (work RVU 3.92). We believe that 21030 and 21040 are most similar to 24075 and 26115 in terms of physician work and are assigning interim RVUs of 3.89 for both of these procedures. We are crosswalking the malpractice RVUs from current CPT Code 21030 (0.60 RVUs) to these procedures.
CPT Codes 21740 Reconstructive repair of pectus excavatum or carinatum; open and 21742 Reconstructive repair of pectus excavatum or carinatum; minimally invasive approach (Nuss procedure) with thoracoscopy
We have not received the final recommendation from the RUC on these services and carriers will price these services in 2003.
CPT codes 33215 Repositioning of previously implanted transvenous pacemaker or pacing cardioverter-defibrillator (right atrial or right ventricular) electrode and 33216 Insertion of transvenous electrode; single chamber (one electrode) permanent pacemaker or single chamber pacing cardioverter-defibrillator
We received a RUC recommendation of 4.44 work RVUs for CPT code 33215 and a RUC recommendation of 5.39 work RVUs for CPT code 33216. Previously, both the insertion and repositioning of the electrodes were billed under CPT code 33216. Effective January 1, 2003, CPT code 33215 will be used to report the repositioning of a previously implanted transvenous pacemaker or pacing cardioverter-defibrillator electrode, while CPT 33216 will be used to report the insertion of a transvenous electrode. Although we agree with the relativity established by the RUC, in order to retain work neutrality between these two services, we have scaled the total relative values that will be paid in 2003 to what would have been paid in 2003 if CPT code 33215 had not been established. This results in work RVUs of 4.76 for CPT code 33215 and 5.78 work RVUs for CPT code 33216.
CPT Codes 36511 Therapeutic apheresis; for white blood cells, 36512 Therapeutic apheresis; for red blood cells, 36513 Therapeutic apheresis; for platelets, 36514 Therapeutic apheresis; for plasma pheresis, 36515 Therapeutic apheresis; with extracorporeal immunoadsorption and plasma reinfusion, and 36516 Therapeutic apheresis; with extracorporeal adsorption or selective filtration and plasma reinfusion
We have not yet received the RUC recommendations for these CPT codes. We are assigning 1.74 work RVUs to all these procedures. This is the work RVU for both CPT codes 36520 and 36521 (deleted for CPT 2003) which are currently being used to report these procedures. We are also crosswalking the malpractice RVUs for CPT code 36520 to these procedures (0.06 RVU).
CPT Codes 38204 Management of recipient hematopoietic progenitor cell donor search and cell acquisition, 38205 Blood-derived hematopoietic progenitor cell harvesting for transplantation, per collection; allogenic, 38206 Blood-derived hematopoietic cell harvesting for transplantation, per collection; autologous, 38207 Transplant preparation of hematopoietic progenitor cells; cryopreservation and storage, 38208 Transplant preparation of hematopoietic progenitor cells; thawing of previously frozen harvest, 38209 Transplant preparation of hematopoietic progenitor cells; washing of harvest, 38210 Transplant preparation of hematopoietic progenitor cells; specific cell depletion within harvest, T-cell depletion, 38211 Transplant preparation of hematopoietic progenitor cells; tumor cell depletion, 38212 Transplant preparation of hematopoietic progenitor cells; red blood cell removal, 38213 Transplant preparation of hematopoietic progenitor cells; platelet depletion, 38214 Transplant preparation of hematopoietic progenitor cells; plasma (volume) depletion, 38215 Transplant preparation of hematopoietic progenitor cells; cell concentration in plasma, mononuclear, or buffy coat layer, 38242 Bone marrow or blood-derived peripheral stem cell transplantation; allogeneic donor lymphocyte infusions
We agree with the RUC work recommendations for CPT codes 38205, 38206, and 38242. We disagree with the RUC recommendations for the CPT code 38204. CPT codes 38207 through 38215 were reviewed at the April RUC meeting but final work RVUs were not established. We did not receive final recommendations on work RVUs for these services in time for publication in this final rule, but will review any RUC recommendations for next year.
CPT code 38204 is reported by the physician managing a search for potential hematopoietic progenitor cell donors. We are giving this code a status indicator "B," meaning that we will not make separate payment for this service. We believe we are already making payment for any physician work associated with this service as part of our payment for other bone marrow transplant codes (that is, CPT codes 38205, 38206, 38240, 38241, and 38242). Furthermore, we have significant concerns about how this code would be used in actual practice. Would beneficiaries be billed for failed donor searches, and, if so, how many? How would beneficiaries be able to determine whether one or more searches had actually been conducted? This problem is compounded by the fact that the beneficiary would probably never meet the physician conducting the search. Additionally, it is unclear from the specialty society vignette what is actually physician work and what is the work of clinical and administrative staff. It would seem most appropriate that any payment would be made to the physician who is performing the cell harvesting or bone marrow transplant services (that is, CPT codes 38205, 38206, 38240, 38241, and 38242). We welcome RUC's further review of these codes to determine whether any physician work associated with a cell donor search is already included. If the RUC determines that such work is not included, we would review recommendation for changing the RUC values of these codes to include such work.
CPT codes 38207, 38208, 38209. These codes represent an unbundling of CPT codes 88240 Cryopreservation, freezing and storage of cells, each cell line, and 88241 Thawing and expansion of frozen cells, each aliquot. Both codes 88240 and 88241 are paid under the laboratory fee schedule. We also note that CPT 2003 has added a parenthetical note under 88240 and 88241, which implies that, starting in January 2003, they should be used only for diagnostic services, and codes 38207, 38208, and 38209 should be used for therapeutic services.
• It is unclear from the specialty vignettes whether any physician work is typically required to perform these services. The descriptions of typical physician involvement in these procedures indicate that the only physician services are laboratory oversight or quality management services for which we do not make separate payment to physicians.
• We also believe these services will be reported on a "per aliquot" basis. However, even though blood-derived stem cells are usually stored in aliquots, the processes of freezing, thawing, and washing are done in batches. This means that the physician oversight of these processes does not occur on a "per aliquot" basis and therefore, it does not seem appropriate to pay for physician services on a "per aliquot" basis.
• We believe that the analysis the RUC was using to arrive at its interim recommendation for assigning physician work to CPT codes 38207, 38208, and 38209 was flawed. The RUC discussed assigning physician work to these services based on its review of 38210 which it compared to CPT code 86077 Blood bank physician services; difficult cross match and/or evaluation of irregular antibody(s), interpretation and written report (work RVU 0.94). The RUC then used the specialty societies' relative ranking of services 38207-38215 as the basis for recommending work values for CPT codes 38207-38209 and 38211-38215. With regard to this analysis, we note: (1) the descriptor for CPT code 86077 requires a physician service and an "interpretation and written report," while CPT code 38210 is not described as a physician service, nor does it require an "interpretation and written report." Therefore, we believe it is inappropriate to compare 38210 with 86077, (2) 38210 is currently reported as CPT code 86915, Bone Marrow or peripheral stem cell harvest, modification or treatment to eliminate cell types (e.g., T cells, metastatic carcinoma) which is paid under the laboratory fee schedule, and (3) 38207, 38208, and 38209 describe entirely different services from 38210, 86077, and 86915, thus making it difficult to understand how a work value for 38210 could be extrapolated to 38207-38209.
At this time we are assigning status indicator "I" to 38207-38209 making them not valid for Medicare purposes. We are creating two G codes, G0265 Cryopreservation, freezing and storage of cells for therapeutic use, each cell line, and G0266 Thawing and expansion of frozen cells for therapeutic use, each aliquot. These codes will be paid under the laboratory fee schedule at the same rate as CPT codes 88240 and 88241 respectively. The descriptors will allow us to continue to recognize CPT codes 88140 and 88141 as described in CPT 2003 for diagnostic use, thus making it unnecessary for us to change the status indicators for these services. The G codes will also enable us to track the utilization of these services. We believe that continuing the status quo with regard to these procedures will not affect beneficiary access to transplantation services and will give us more time to analyze the services and recommendations.
CPT codes 38210-38215. Currently CPT codes 38210-38213 are described by CPT code 86915, Bone Marrow or peripheral stem cell harvest, modification or treatment to eliminate cell types (for example, T cells, metastatic carcinoma). Currently, CPT code 86915 is paid under the laboratory fee schedule. With regard to CPT codes 38210-38215, we have many of the same concerns as we have for CPT codes 38207-38209.
• It is unclear from the specialty vignettes whether any physician work is typically required to perform these services. The descriptions of typical physician involvement in these procedures indicate that a significant portion of the physician work is procedure oversight or quality management services for which we do not make separate payment to physicians. In fact, the only references in the specialty society vignettes for these procedures to services paid under the physician fee schedule are references to performance of flow cytometry. Therefore, if there is any physician work associated with these services it is currently payable under the CPT code 88180 Flow cytometry; each cell surface, cytoplasmic or nuclear marker.
• We do not believe that unbundling of these services is warranted because CPT codes 38210, 38212, 38213, 38214, and 38215 may be performed together on a single harvest of stem cells during an allogeneic transplant. Further, when these services are performed together, if there is any physician work associated with these activities, it must be allocated to each service and it is not clear that this can be accomplished.
• As discussed above, we have concerns about the RUC's preliminary discussions for work RVUs for these codes. CPT code 86077 to which 38210 was compared requires physician services, an interpretation and report, and has forty minutes of intra-service time associated with it. In contrast 38210 has no requirement for physician work, and it is stated that the physician will only perform this service in an emergency. Further, there is no requirement for interpretation of data or a written report, and the intra-service time is 23 minutes. We do not believe the stress involved with these procedures is any greater than the stress involved with 86077 or other pathology services that require correct interpretation of clinical laboratory data or surgical specimens to make a correct diagnosis essential in determining appropriate treatment. Furthermore, we know the RUC is continuing to review these codes and we also require further time to review them.
Therefore, we are assigning status indicator "I" to CPT codes 38210-38215, making them invalid for Medicare purposes. We are creating G0267, Bone marrow or peripheral stem cell harvest, modification or treatment to eliminate cell type(s) (for example, T-cells, metastic carcinoma). This G code will replace deleted code CPT code 86915, and it will be paid under the laboratory fee schedule.
We welcome any comments from the RUC or other interested parties concerning these codes and ask that such comments specifically address the concerns discussed above. We will continue to review these codes internally, obtain payment and utilization data for CPT code 86915, and track utilization of all three G codes.
CPT code 45335 Sigmoidoscopy, flexible; with directed submucosal injection(s) any substance and 45381 Colonoscopy, flexible, proximal to splenic flexure; with directed submucosal injection(s) any substance
The RUC recommended work RVUs of 1.46 for CPT code 45335 and 4.30 for CPT code 45381. For CPT code 45335, the RUC used CPT code 45330 as the base code (0.96 work RVUs) and added an increment of 0.50 work RVUs based upon the increased pre-, intra-, and post-service work associated with CPT code 45335 as compared to CPT code 45330. For CPT code 45381, the RUC used CPT code 45378 (3.70 work RVUs) as the base code and added an increment of 0.60 work RVUs based upon the increased pre-, intra-, and post-service work associated with CPT code 45381 as compared to CPT code 45378.
In order to review the RUC recommended values for CPT code 45335 and 45381, we compared these services to the analysis and recommendations provided by the RUC for CPT codes 43201 and 43236. We agree with the RUC recommendations for CPT codes 43201 and 43236, which are also new submucosal injection codes. We further note that the intra-service intensities of CPT codes 43201 and 43236 should be higher than the intra-service intensities of CPT codes 45335 and 45381 because of the increased risk of complications, and the fact that several sites are being injected instead of one.
In reviewing the pre-, intra-, and post-service times for CPT codes 43201, 43236, 45335, and 45381, we are unsure why these times vary so much. The pre-service time for CPT code 45381 is 25 minutes longer than the pre-service time for CPT code 45378 and there is nothing in the RUC vignette to indicate the reason for the increased pre-service time. Moreover, it is unclear why the post-service time for CPT code 45381 is 9 minutes less than the post-service time for CPT code 45378. Interestingly, less than 10 minutes of extra pre- and post-service time (beyond the base codes) was allotted for the incremental work of CPT codes 43201 and 43236 that we believe are more intensive procedures than CPT codes 45335 and 45381. Therefore, we believe that the pre- and post-service time increment for CPT codes 45335 and 45381 should be less than for CPT codes 43201 and 43236. In short, we had a great deal of difficulty interpreting the RUC time data.
In assigning work values to CPT codes 45335 and 45381, we compared them to the incremental work values and times for CPT codes 43201 and 43236 because we agreed with the RUC recommendations and times for those codes. The intra-service intensities for CPT codes 43201 and 43236 are 0.05 RVU per minute and 0.035 RVU per minute, respectively. We believe the intra-service intensity of CPT code 45335 is less than the intensity of CPT code 43201. After accounting for a few minutes of extra post-service time and an intra-service intensity of 0.04 RVU per minute, we are left with an incremental work value of 0.4 work RVUs for CPT code 43201, which is what we will apply to CPT code 45335. We also believe the intensity of CPT code 45381 is less than the intensity of CPT code 43201. Therefore, accounting for approximately 10 minutes of extra pre- and post-service time, and assigning an intra-service intensity of 0.04 RVU per minute leaves an incremental work value of 0.5 work RVUs, which is what we will apply to CPT code 45381. Therefore, we are assigning work RVUs of 1.36 and 4.20 to CPT codes 45335 and 45381, respectively.
CPT code 45340Sigmoidoscopy, flexible; with dilation by balloon, each stricture
The RUC recommended a work RVU of 1.96 for this CPT code. This includes 1.00 for the incremental work based on the need for conscious sedation to perform this procedure (other flexible sigmoidoscopies do not require conscious sedation). This means the incremental work for CPT code 45340 is greater than the incremental work for other endoscopic dilation codes (CPT codes 43245 and 45386) because those codes have base procedures that include use of conscious sedation. The RUC has been considering the issue of conscious sedation in general for some time and has not been able to conclude that there is any incremental physician work associated with conscious sedation. In the absence of a specific RUC recommendation affirmatively stating that specific physician work is associated with conscious sedation, we do not believe it is appropriate to assign a work RVU for CPT code 45340 that is based on the presumption that a portion of the work value is for using conscious sedation. Therefore, we compared the RUC recommendations for work and physician time for CPT code 45386 to the incremental times for CPT code 45340. We believe that the intra-service intensity of CPT code 45340 should be no greater than the intra-service intensity for CPT code 45386. Therefore, we calculated the increment in pre- and post-service work (.341 work RVUs) and the intra-service intensity (0.036 RVU per minute) of CPT code 45386. We multiplied this intensity by 10 minutes to arrive at an intra-service work of .36 RVU for CPT code 45340 and added .341 RVUs for pre- and post-service work to arrive at an RVU of 0.7 for the total incremental work of CPT code 45340. Therefore, we are assigning an interim work RVU of 1.66 to CPT code 45340.
CPT code 46706Repair of Anal Fistula with fibrin glue. The RUC recommended 2.95 work RVUs for this service based on a comparison to CPT codes 46020, Placement of Seton (work RVU 2.90) and 46940, Curettage or Cautery of Anal Fissure, including dilation of anal sphincter (separate procedure); initial (work RVU 2.32). The intra-service time for CPT code 46706 is less than the intra-service time for CPT code 46940 and requires similar physician work to CPT code 46612, Anoscopy with removal of multiple tumors, polyps, or other lesions by hot biopsy forceps, bipolar cautery or snare technique (work RVU 2.34). The post-service work for CPT code 46706 is comparable to that of CPT code 46940. Therefore, we are assigning a work RVU of 2.39 to CPT code 46706. Malpractice RVUs are crosswalked from CPT code 46940 at 0.17 RVUs.
CPT code 51798Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, nonimaging. The RUC recommended 0.38 work RVUs based on a comparison of this procedure to CPT code 76857, Ultrasound, pelvic (nonobstetric), B-scan and/or real time with image documentation; complete. The RUC recommended 0.38 work RVUs based on a urology survey that reported that this procedure is performed 75 percent of the time by the physician and based on a comparison of this procedure to CPT code 76857, Ultrasound, pelvic (nonobstetric, B-scan and/or real time with image documentation; complete. We disagree. This code has been a HCPCS level two code that was assigned 0.00 work RVUs because we believe that it is typically performed by a nurse or other clinical staff. We continue to believe that this is a non-physician service and are assigning 0.00 work RVUs to this service. We will accept the practice expense inputs recommended by the RUC and will crosswalk the malpractice RVUs from G0050. It is not appropriate to bill CPT code 51798 in a SNF, hospital, or other setting in which nursing care is provided by the facility, since it is a routine nursing service, not really a diagnostic test.
CPT code 75954Endovascular graft placement for repair of iliac artery (for example, aneurysm, pseudoaneurysm, ateriovenous malformation, trauma) radiological supervision and interpretation.
The RUC agreed with the specialty societies and recommended a value of 2.93 work RVUs based on comparing this code to CPT code 75952, Endovascular repair of infrarenal abdominal aortic anuerysm or dissection, radiological supervision and interpretation (work RVU of 4.5) and CPT code 75953, Placement of proximal or distal extension prosthesis for endovascular repair of infra renal abdominal aortic aneurysm, radiological supervision and interpretation (work RVU or 1.36). The recommended RVUs are midway between the RVUs of the reference procedures. The specialty societies presented the following to the RUC: "Unlike many of the other radiological supervision and interpretation (SI) codes, 75954 includes all routine supervision and interpretation of the endovascular iliac graft placement procedure with the only exception being that 75953 is added if an extension prosthesis is required. This more inclusive approach makes 75954 very similar in concept to the inclusive SI for endovascular aortic aneurysm repair CPT 75952." The specialties go on to say that survey respondents believed that the code should be valued less than CPT code 75952 but more than CPT code 75953. We disagree. First, we note that CPT code 75953, which was reviewed by the RUC in February of 2001, is not an "add-on" code. It is a stand-alone code that is billed with a stand-alone surgical procedure. Furthermore, total procedure time for CPT code 75954 (85 minutes) is less than the total procedure time for CPT code 75953 (95 minutes), and the intra-service times of CPT codes 75954 and 75953 are identical (45 minutes). This is consistent with the specialty societies' description of the work of CPT code 75954, which is virtually identical to the description of the work for CPT code 75953. Therefore, in order to maintain correct rank order in this family of codes we are assigning a work RVU of 1.36 to CPT code 75954.
CPT codes 92605Evaluation for prescription of non-speech generating augmentative and alternative communication device and 92606Therapeutic service(s) for the use of non-speech generating device, including programming and modification
We will consider CPT codes 92605 and 92606 bundled for Medicare payment purposes. The RUC's evaluation of these services implied that they are similar to the new CPT codes for speech generating devices. We believe that CPT codes 92605 and 92606 typically do not involve the same type of highly specialized equipment as the codes for speech generating devices. We believe that the work associated with these services is already contained in CPT codes 92506 Evaluation of speech, language, voice communication, auditory processing, and/or aural rehabilitation status and 92507 Treatment of speech, language, voice communication, auditory processing disorder (includes aural rehabilitation); individual, and will consider CPT codes 92605 and 92606 bundled.
We note that CPT also created new codes to describe programming and analysis of cochlear implants. These CPT codes are 92601 Diagnostic analysis of cochlear implant, patient under 7 years of age; with programming; 92602Diagnostic analysis of cochlear implant, patient under 7 years of age; subsequent reprogramming; 92603 Diagnostic analysis of cochlear implant, age 7 years or older, with programming; and 92604 Diagnostic analysis of cochlear implant, age 7 years or older, subsequent reprogramming. Codes 92601 and 92603 describe post-operative analysis and fitting of previously placed external devices, connection to the cochlear implant, and programming of the stimulator. CPT Codes 92602 and 92604 describe subsequent sessions for measurements and adjustment of the external transmitter and re-programming of the internal stimulator.
An existing CPT code, 92510Aural rehabilitation following cochlear implant (includes evaluation of aural rehabilitation status and hearing, therapeutic services) with or without speech processor programming, will no longer be used for Medicare services since it represents services which have considerable overlap with the services described by the new CPT codes, 92601, 92602, 93603, and 92604. For the remaining services that do not involve reprogramming of the cochlear implant, CPT code 92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder (includes aural rehabilitation); individual describes the services, so a code specific to cochlear implant patients is no longer needed. The use of CPT code 92507 for this service is consistent with the note in the CPT manual under CPT code 92602.
CPT codes 92613Flexible fiberoptic endoscopic evaluation of swallowing by cine or video recording; physician interpretation and report only, 92615Flexible fiberoptic endoscopic evaluation, laryngeal sensory testing by cine or video recording; physician interpretation and report only, and 92617Flexible fiberoptic endoscopic evaluation of swallowing and laryngeal sensory testing by cine or video recording; physician interpretation and report only.
Effective January 1, 2003, CPT created several codes to describe fiberoptic endoscopic evaluation services that are currently described by temporary G-codes. For specific information related to both the former G-codes and the new CPT codes that will replace the deleted G-codes, refer to the end of this section. We agreed with the RUC recommended values for all of the fiberoptic endoscopic evaluation services (CPT codes 92612, 92614, and 92616) with the exception of CPT codes 92613, 92615, and 92617. For these three services that refer only to a separately identified physician review and interpretation of the fiberoptic endoscopic evaluation, we consider the physician interpretation and report bundled into an evaluation and management service. We believe the physician who does not perform the testing should only bill the patient when performing an evaluation and management service, not as the supervisor of another professional performing and reviewing the initial fiberoptic endoscopic evaluation. The interpretation of this test is an integral part of the testing itself. If a nonphysician professional has the credentials and experience to perform this testing, then that professional should also provide the interpretation of the findings.
CPT codes 93784Ambulatory blood pressure monitoring, utilizing a system such as magnetic tape and/or computer disk, for 24 hours or longer; including recording, scanning analysis, interpretation and report, 93786Ambulatory blood pressure monitoring, utilizing a system such as magnetic tape and/or computer disk, for 24 hours or longer; recording only, 93788Ambulatory blood pressure monitoring, utilizing a system such as magnetic tape and/or computer disk, for 24 hours or longer; scanning analysis with report, and 93790Ambulatory blood pressure monitoring, utilizing a system such as magnetic tape and/or computer disk, for 24 hours or longer; physician review with interpretation and report.
We have not yet received RUC recommendations for these codes. We established RVUs for these services during this past year in response to a national coverage determination. We will maintain these RVUs until we receive a RUC recommendation.
CPT code 95990Refilling and maintenance of implantable pump or reservoir for drug delivery; spinal (intrathecal, epidural) or brain (intraventricular).
We understand that performance of CPT code 95990 requires the use of an expensive kit, the cost of which may not be reflected in the RVUs for CPT code 96530, the code under which it was previously reported. CPT code 96530 has practice expense RVUs of 1.01 and malpractice RVUs of 0.05. We are assigning 1.50 practice expense RVUs because we estimate that the practice expense for CPT code 95990 is 50 percent higher than it is for CPT code 96530. We are crosswalking the malpractice RVUs from CPT code 96530 to CPT code 95990.
We are not assigning work RVUs to CPT code 95990 for 2003 since we believe that this procedure is typically (greater than 50 percent of the time) performed by a nurse. We understand that there has been discussion with the CPT Editorial Committee about revising this code so that it would be billed only when performed in the presence of a physician. If the code were to be so revised, we would consider any RUC recommendations regarding work RVUs for this service.
These values are interim for 2003 and we will address comments about the RVUs for this code in next year's final rule.
CPT codes 99026Mandated On-call service; in hospital and 99027Mandated physician on call services
No RUC recommendation was received for these codes. Note that stand-by and on-call services are not covered by Medicare and we would not pay for these services billed using these codes.
Establishment of Interim Practice Expense RVUs for New and Revised Physician's Current Procedural Terminology (CPT) Codes and New Healthcare Common Procedure Coding System (HCPCS) Codes for 2003
We have developed a process for establishing interim practice expense RVUs for new and revised codes that is similar to that used for work RVUs. Under this process, the RUC recommends the practice expense direct inputs, that is, the staff time, supplies and equipment, associated with each new code. We then review the recommendations in a manner similar to our evaluation of the recommended work RVUs.
The RUC recommendations on the practice expense inputs for the new and revised 2003 codes were submitted to us as interim recommendations. We, therefore, consider that these recommendations are still subject to further refinement by the PEAC, or by us, if it is determined that such future review is needed. We may also revisit these inputs in light of future decisions of the PEAC regarding supply and equipment packages and standardized approaches to pre- and post-service clinical staff times.
We have accepted, in the interim, all of the practice expense recommendations submitted by the RUC for the codes listed in the following table titled "AMA RUC and HCPAC RVU Recommendations and CMS Decisions for New and Revised 2003 CPT Codes."
C. Other Changes to the 2003 Physician Fee Schedule
We are establishing the following HCPCS codes for CY 2003.
GO262Small intestinal imaging; intraluminal, from ligament of Treitz to the ileo cecal valve, includes physician interpretation and report
We are creating this code to describe a new diagnostic test for which we will make separate payment under the physician fee schedule and the Hospital Outpatient Prospective Payment System (OPPS). The procedure involves ingesting a small camera through the mouth. As the camera traverses the gastrointestinal tract, it produces two images per second and transmits those images to a receiver worn by the patient. After eight hours (the battery life of the camera) the belt containing the receiver is removed from the patient. The images are then developed and reviewed by a physician who interprets them and makes a written report. The capsule is excreted in the patient's stool and discarded. Images taken in the esophagus, stomach and large intestine (colon) are hard to interpret; therefore, current use of this imaging modality is limited to evaluation of the small intestine. The G-code descriptor is designed to ensure accurate reporting of this diagnostic test. Although this test has been referred to as "capsule endoscopy", the term "endoscopy" is a misnomer because "endoscopy" refers to physician-controlled viewing the gastrointestinal tract through an endoscope.
Physician Work
We understand from recently published clinical studies that the average small intestine transit time was 257 minutes and the transit time from ingestion to the cecum was 302 minutes. Review of the images includes a first pass overview to mark areas of special interest, a review of the entire video recording, and a focused review of abnormalities, if any are found. The average time to review the capsule images in two recently published studies was 50 and 56 minutes. Therefore, we believe that, typically, 53 minutes of physician time will be spent reviewing the video. To assign a work value, we compared the work of this code to the work of other diagnostic tests and procedures that require review of significant amounts of data. Specifically, we reviewed the work RVUs and intra-service times for electroencephalography (EEG) reading and interpretation, magnetic resonance angiography (MRA), computed tomographic angiography (CTA), Holter monitor reading and interpretation, prolonged esophageal acid reflux testing, echocardiography, duplex scanning of the carotid arteries, and anorectal manometry. Based on these comparisons, we are assigning a work value of 2.12 RVUs. This results in an intensity of .04 RVU per minute and places it in correct rank order with the procedures to which it was compared. We note that this assumes that a complete study from the ligament of Treitz to the ileocecal valve was performed and that the camera functioned normally throughout the procedure and produced two images per second. If an incomplete evaluation of the small intestine is accomplished, this code should be billed with a CPT code 52-modifier indicating reduced services, and the payment amount would also be reduced. The amount of reduction is determined by the carrier. Until such time as we make a NCD for this service, coverage is at the discretion of carriers and intermediaries.
Malpractice
We are crosswalking the value from CPT code 74230 with the same PC/TC split because they have similar physician times and intensities.
Practice Expense
For the physician fee schedule we are assigning the following inputs for practice expense:
• Staff Time-RN/LPN/MA mix-90 minutes-includes pre-service education, attachment of the receiver, administration of the camera, removal of the receiver, and processing of the images
• Supplies-Single use camera; Razor
• Equipment-Workstation
GO268 Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing
This code was created in order to allow payment to a physician who removes impacted cerumen on the same date as his or her employed audiologist performs audiologic function testing. We will assign the same physician work RVUs, practice expense inputs, and malpractice RVUs to this code as are assigned to CPT code 69210, Removal impacted cerumen (separate procedure), one or both ears.
First, we emphasize that routine removal of cerumen is not paid separately. It is considered to be part of the procedure with which it is billed (for example, audiologic function testing). To assure the appropriate reporting of this code, we note that it should only be used in those unusual circumstances when an employed audiologist who bills under a physician UPIN number performs audiologic function testing on the same day as removal of impacted cerumen requiring physician expertise for removal. This code should not be used when the audiologist removes cerumen, because removal of cerumen is considered to be part of the diagnostic testing and is not paid separately.
GO269 Placement of occlusive device into either a venous or arterial access site, post surgical or interventional procedure (for example, angioseal plug, vascular plug)
We are creating this G code to assure proper reporting of this service. It has come to our attention that this service is being inappropriately reported with codes for such procedures as "blood vessel repair" and "repair of arterial pseudoaneurysm." We are assigning a status indicator of "B" (payment bundled into payment for other services) to this service, as the work, practice expense, and malpractice risk of closing an arteriotomy or venotomy site at the conclusion of an invasive percutaneous procedure, whether by manual compression, suture, or use of a closure device, is included in the main invasive procedure. Therefore, there is no separate payment for this procedure.
GO270 Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition, or treatment regimen (including additional hours needed for renal disease), individual, face-to-face with the patient, each 15 minutes and
GO271 Medical nutrition therapy, reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition, or treatment regimen (including additional hours needed for renal disease) group (2 or more individuals), each 30 minutes
In our NCD dated May 1, 2002, we established basic coverage for medical nutrition therapy billed under CPT codes 97802 through 97804 as 3 hours per year for beneficiaries with either diabetes or renal disease. However, we also pay for additional hours if a physician makes a second referral in the same year based on a change in the beneficiary's medical condition, diagnosis, or treatment regimen. These new codes allow us to edit for basic coverage and reimburse for additional coverage when appropriate.
We are crosswalking the RVUs from CPT code 97803 to G0270 and CPT code 97804 to G0271 because these are the corresponding CPT medical nutrition codes.
GO272 Naso/oro gastric tube placement, requiring physician's skill and fluoroscopic guidance (includes fluoroscopy, image documentation and report)
We are creating this code for one year until an identical CPT code becomes effective.
Physician Work
We compared this code to other gastroenterology and radiologic procedures including CPT codes 91105 Gastric intubation, and aspiration or lavage for treatment (e.g, for ingested poisons) (work RVU of 0.37); 44500 Introduction of long gastrointestinal tube (e.g., Miller-Abbott) (separate procedure) (work RVU of 0.49); 74340 Introduction of long gastrointestinal tube (e.g., Miller-Abbott), including multiple fluoroscopies and films, radiological supervision and interpretation (work RVU of 0.54), and 76000 Fluoroscopy (separate procedure), up to one hour physician time, other than 71023 or 71034 (e.g., cardiac fluoroscopy) (work RVU of 0.17).
This procedure is most similar to CPT code 91105 (16 minutes of physician time), but requires less work because it is done in a controlled setting with fluoroscopy to aid in placement. It is not similar to CPT codes 44500 and 74340 because placement of Miller-Abbott tubes is a more lengthy and involved procedure than placement of naso/oro gastric tubes. In fact, the physician time for placement of Miller-Abbott tubes is over 30 minutes, while placement of a naso/oro gastric tube takes about 15 minutes. We are assigning this G code a work RVU of 0.32, which is the sum of the work RVU for CPT code 76000 and the work intensity of CPT code 44500 times 15 minutes.
Malpractice
We are assigning 0.02 malpractice RVUs to this procedure.
Practice Expense
We believe this procedure will only be performed in facilities, so we are not assigning any practice expense inputs to this code.
GO273 Radiopharmaceutical biodistribution, single or multiple scans on one or more days, pre-treatment planning for radiopharmaceutical therapy of non-Hodgkin's lymphoma, includes administration of radiopharmaceutical (e.g., radiolabeled antibodies).
We are creating this code to describe radionuclide scanning to determine the biodistribution of Zevalin. The procedure encompasses administration of Indium labeled Zevalin followed by whole body radionucliide scanning 2-24 hours and 48-72 hours after the administration of Zevalin. Rarely, a third scan is necessary. The purpose of the scanning is to ensure that the biodistribution of Zevalin is normal, thus decreasing the risk of toxic effects from the administration of a therapeutic dose. The published criteria for determining appropriate biodistribution involve making a qualitative comparison of isotope uptake in several organ systems between the two scans. Therefore, these scans cannot be read in isolation, and this code should only be reported once, no matter how many scans are performed.
Physician Work
We are assigning 0.86 work RVUs to this code which is equivalent to the work for CPT code 78802, Radiopharmaceutical localization of tumor; whole body. We believe the total physician time of 41 minutes for CPT code 78802, and the intensity are similar to the time and intensity required for this service.
Malpractice
We are assigning 0.28 RVU to the global procedure, 0.25 RVU to the technical component, and 0.03 RVU to the professional component. These are identical values to CPT code 78802.
Practice Expense
The TC of this code is being priced in the nonphysician work pool, where we crosswalked it to the charge-based practice expense RVUs for CPT code 78802, taking into account that the radiopharmaceutical is administered once, but that there are two scans obtained.
We wish to emphasize that this code is only reported once and includes the administration of the radiopharmaceutical and performance and interpretation of all scans. We also note that the infusion of rituxumab prior to the administration of Zevalin is separately payable.
GO274 Radiopharmaceutical therapy, non-Hodgkin's lymphoma, includes administration of radiopharmaceutical (e.g., radiolabeled antibodies)
We are establishing this code to allow appropriate reporting of this new service. Radiopharmaceutical therapy using radiolabeled monoclonal antibodies is a new form of treatment for non-Hodgkins lymphoma and is not currently described by any existing HCPCS code.
After review of information regarding this service, we are assigning the following RVUs:
Physician Work
We believe that physicians typically take 60 minutes to perform this service on the day of the procedure. Of this time, 45 minutes is spent counseling the patient and family, while 15 minutes are spent setting up and infusing the radiopharmaceutical. Additionally, there is post-procedure time spent reviewing platelet counts, which requires calling the patient or another physician 25 percent of the time. We compared this procedure to the physician work RVUs, physician times, and intensity (RVU per minute) of other nuclear medicine and radiation oncology procedures CPT codes 79400, 77790, 79030, 79035, and 79100; infusion procedures CPT codes 36520, 36521, 37201, and 37202; hemodialysis CPT codes 90935, and 90937; evaluation and management CPT codes 99214 and 99215.
Based on this comparison we are assigning a work RVU of 2.07 to this code. This represents the work of CPT code 99214 (counseling a complex patient), 15 minutes for infusion at an intensity of 0.05 RVU per minute (similar to the intensity of CPT code 77790), and 10 minutes of post service work (at an intensity of 0.022 RVU per minute). This also places the code in the correct rank order with all of the above procedures.
Malpractice
We are assigning malpractice RVUs of 0.20 to this procedure, with 0.12 assigned to the technical component and 0.08 assigned to the professional component. These are identical to the RVUs for CPT code 79400.
Practice Expense
The TC of this code is being priced in the nonphysician workpool where we crosswalked it to the charge-based practice expense RVUs for CPT code 79400.
GO275 Renal angiography (unilateral or bilateral) performed at the time of cardiac catheterization, includes catheter placement in the renal artery, injection of dye, flush aortogram and radiologic supervision and interpretation and production of images (List separately in addition to primary procedure) and
GO278 Iliac artery angiography performed at the same time of cardiac catheterization, includes catheter placement in the iliac artery, injection of dye, radiologic supervision and interpretation and production of images (List separately in addition to primary procedure)
We are creating these add-on codes to assure proper reporting of and payment for renal and iliac angiography performed at the time of cardiac angiography. These procedures are performed frequently on Medicare patients and are currently reported using codes that describe placement of a catheter in the renal and/or iliac artery(s) (CPT codes 36245 and 36246) and radiological supervision and interpretation of renal and/or iliac angiography (CPT codes 75710, 75716, 75722, and 75724).
Physician Work
Based on the information we reviewed, the typical performance of these procedures involves the use of a pigtail catheter positioned in the aorta (not the renal or iliac artery(s)), injection of a minimal dye load (because of the heavy dye load already used for cardiac angiography), and viewing the dye run off into the proximal main renal or iliac arteries under fluoroscopy. We determined work values for these procedures by using the work values for CPT codes 75625, Aortography, abdominal, by serialography, radiological supervision and interpretation (1.14 work RVUs with 22 minutes of physician time) and 93544, Injection procedure during cardiac catheterization; for aortography (0.25 work RVUs and 5 minutes of physician time) and adjusting for a procedure time of approximately two and one half minutes. This process yields a value of 0.25 work RVUs, which is what we are assigning to these two add-on procedures.
Malpractice
We are crosswalking the 0.01 malpractice RVUs for CPT code 93544 to these procedures.
Practice Expense
We are not assigning any practice expense inputs to these procedures because the incremental increase in staff and room time to perform these procedures is negligible.
GO279 Extracorporeal shock wave therapy; involving elbow epicondylitis.
GO280 Extracorporeal shock wave therapy; involving other than elbow epicondylitis or plantar fascitis.
CPT code 0020T Extracorporeal Shock Wave Therapy; involving plantar fascia
We are creating and establishing a national payment amount for two G-codes describing extracorporeal shock wave therapy for the musculoskeletal system and establishing a national payment amount for CPT code 0020T. We are doing this in response to multiple requests from our contractors to establish a national payment amount, though creation of these codes does not imply that services will be covered by Medicare. We also note that this form of therapy was recently approved by the Food and Drug Administration for treatment of lateral epicondylitis. Our staff has reviewed the method of treatment and we are establishing work, practice expense, and malpractice RVUs for these codes.
We believe these services are similar to other physical therapy modalities and are designating it to be paid on the therapy fee schedule. Based on the information we reviewed, these services are typically performed by a technician similar to a physical therapy aide and take about 20 minutes to perform.
Physician Work
We compared these services to other physical therapy services and believe they are most similar to unattended physical therapy modalities such as diathermy. We are assigning a work RVU of 0.06 for these procedures in order to place them in proper rank order with other unattended physical therapy services.
Malpractice
We are crosswalking the malpractice RVUs (0.01) from CPT code 97024, Application of a modality to one or more areas; diathermy, to these procedures.
Practice Expense
We are assigning the following practice expense inputs:
• Staff/Time: Physical therapy aide; 30 minutes.
• Supplies: Ultrasound Gel.
• Equipment: Shock wave machine.
We note that, for lateral epicondylitis, the typical treatment regimen is up to 3 total treatments at weekly intervals.
Electrical Stimulation for Wound Care
GO281 Electrical stimulation, (unattended), to one or more areas, for chronic stage III and stage IV pressure ulcers, arterial ulcers, diabetic ulcers, and venous stasis ulcers not demonstrating measurable signs of healing after 30 days of conventional care, as part of a therapy plan of care; and
GO282 Electrical stimulation, (unattended), to one or more areas, for wound care other than described in G0281 and
GO283 Electrical stimulation, (unattended), to one or more areas, for indication(s) other than wound care, as part of a therapy plan of care.
These three new G codes have been created to implement the coverage determination on use of electrical stimulation for wound care.
The work, practice expense, and malpractice values for CPT code 97014 Application of a modality to one or more areas; electrical stimulation (unattended) will be crosswalked to these new G codes, but G0282 will not be covered by Medicare. In addition, CPT code 97032, Application of a modality to one or more areas: electrical stimulation (manual), each 15 minutes, should not be utilized for any wound care.
The coverage determination that allowed coverage for the use of electrical stimulation for certain types of wound care also stated that another similar modality, electromagnetic stimulation, would not be covered. A G code, "G0295: Electromagnetic stimulation, to one or more areas " will be created to describe this service, since this service would otherwise have been coded using CPT code 97039 and would have required manual claims review. The new code, G0295, will be listed as non-covered by Medicare.
GO288 Reconstruction, computed tomographic angiography of aorta for surgical planning for vascular surgery.
We are creating this code to assure accurate reporting of this service by independent diagnostic testing facilities (IDTFs) that perform this service. Facilities that perform this service (either at the facility or under arrangement) report this service through the use of a "C" code specific to hospital reporting.
This code is a technical component code only since the service provided by the IDTF includes receipt of a Computed Tomographic Angiogram (CTA), post CTA processing using specialized software, and burning the 3D model onto a CD and returning it to the operating surgeon. This 3D model is used to assist vascular surgeons in planning for, or monitoring the results of, endovascular aneurysm repair. The service is a technical service provided under the general supervision of a physician according to the supervision requirements for IDTFs. We compared this procedure to CPT codes 74175, Computed tomagraphic angiography, abdomen, without contrast material(s), followed by contrast material(s) and further sections, including image post-processing and 76375, Coronal, sagital, multiplanar, oblique, 3-dimensional and/or holographic reconstruction of computerized axial tomography, magnetic resonance imaging, or other tomographic modality. Based on this review, we developed practice expense RVUs using the nonphysician workpool methodolgy. The malpractice RVUs will be crosswalked from CPT code 76375 directly and will be set at 0.15 RVUs.
GO289 Arthroscopy, knee, surgical, for removal of loose body, foreign body, debridement/shaving of articular cartilage (chrondroplasty) at the time of other surgical knee arthroscopy in a different compartment of the same knee.
We are creating this code to permit appropriate reporting of arthroscopic procedures performed in different compartments of the same knee during the same operative session. This is an add-on code and should be added to the knee arthroscopy code for the major procedure being performed. This code is only to be reported once per extra compartment, even if both chondroplasty, loose body removal, and foreign body removal are performed. The code may be reported twice (or with a unit of two) if the physician performs these procedures in two compartments in addition to the compartment where the main procedure was performed.
This code should only be reported if the physician spends at least 15 minutes in the additional compartment performing the procedure. It should not be reported if the reason for performing the procedure is due to a problem caused by the arthroscopic procedure itself. This code is to be used when a procedure is performed in the lateral, medial, or patellar compartments in addition to the main procedure. However, CPT codes 29874, Arthroscopy, knee, surgical; for removal of loose body or foreign body (e.g., osteochrondritis dissecans fragmentation, chondral fragmentation) and 29877 Arthroscopy, knee, surgical; debridement/shaving of articular cartilage (chrondroplasty) may not be billed with other arthroscopic procedures on the same knee.
Physician Work
We examined the work RVUs, the intra-operative work intensity, and the intra-operative times for CPT codes 29874 and 29877. We also compared these intensities and times to those for CPT code 29870, the base procedure for this family. We determined a work value using the intra-operative intensity for CPT code 29874 (which is higher than for CPT code 29877) and the mean intra-operative times (for CPT codes 29874 and 29877) beyond the time required for CPT code 29870 (14 minutes for CPT code 29874 and 27 minutes for CPT code 29877). This code represents approximately 20 minutes of extra work at a high level of intensity. Therefore, the work value we are assigning to this code is 1.48 RVUs.
Malpractice
We are assigning 0.27 malpractice RVUs to this procedure. This is the sum of the malpractice RVUs for CPT codes 29874 and 29877 beyond the malpractice RVUs for CPT code 29870, divided by two.
Practice Expense
We are not assigning any practice expense inputs to this code because it is an add-on code that will only be performed in the facility setting.
Revisions to G Codes
We are also revising the descriptors for the following existing G codes as follows:
G0179 Physician recertification services for Medicare-covered services provided by a participating home health agency (patient not present) including review of subsequent reports of patient status, review of patient's responses to the OASIS assessment instrument, contact with the home health agency to ascertain the follow-up implementation plan of care, and documentation in the patient's office record, per certification period and
G0180 Physician certification services for Medicare-covered services provided by a participating home health agency (patient not present), including review of initial or subsequent reports of patient status, review of patient's responses to the OASIS assessment instrument, contact with the home health agency to ascertain the initial implementation plan of care, and documentation in the patient's office record, per certification period
Comment: Individuals have requested clarification as to whether a review of OASIS data is required when a physician bills for the certification and re-certification of home health plans of care.
Response: The review of OASIS data, although not required for the performance of either a certification or re-certification of a home health plan of care, is considered a valuable tool to be utilized in the performance of both a certification or re-certification of a home health plan of care. We agree that the current HCPCS code(s) descriptors are unclear and will revise the descriptors to identify the review of OASIS as an option as opposed to a requirement. The descriptors are being revised as follows:
G0179 Physician re-certification for Medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implementation of the plan of care that meets patient's needs, per re-certification period.
G0180: Physician certification for Medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implementation of the plan of care that meets patient's needs, per certification period.
G0236 Digitization of film radiographic images with computer analysis for lesion detection and further physician review for interpretation, diagnostic mammography (list separately in addition to code for primary procedure)
Comment: Individuals have requested that we establish additional G-codes that would specify the use of computer-aided detection with direct digital image mammograms. Currently, the descriptors associated with HCPCS code G0236 (diagnostic) and CPT code 76085 (screening) refer not only to the application of computer-aided detection but also to the conversion of film images to digital images.
Response: When the computer-aided detection codes were originally assigned, we intended that they would be used for the application of computer-aided detection to both direct digital images and to standard film images that were converted to digital images. The current descriptors of both HCPCS code G0236 and CPT code 76085 do not explicitly state that the code can be billed in conjunction with either direct digital images or standard film images converted to digital images. We have revised the descriptor associated with the application of computer-aided detection to diagnostic images (HCPCS code G0236) to incorporate both direct digital images and standard film images converted to digital images. Additionally, we will request that the CPT editorial panel review the current definition associated with the screening computer-aided detection code (CPT code 76085) for future revision. Until such time as a revision is made to CPT code 76085, physicians should use CPT code 76085 for both direct digital screening images as well as for standard film screening images that are converted to digital images.
G0236 is revised to read as follows: Digitization of film radiographic images with computer analysis for lesion detection, or computer analysis of digital mammogram for lesion detection, and further physician review for interpretation, diagnostic mammography (List separately in addition to code for primary procedure).
G0239 Therapeutic procedures to improve respiratory function, other than services described by G0237, two or more (includes monitoring).
For clarity, and to address concerns expressed by individuals about how to code group treatment of patients with procedures described in G0237, we are revising the descriptor for G0239 to read as follows:
G0239 Therapeutic procedures to improve respiratory function or increase strength or endurance of respiratory muscles, two or more (includes monitoring).
Deletion of G Codes
We will be deleting the following G codes for CY 2003: G0002 Office procedure, insertion of temporary indwelling catheter, foley type (separate procedure)
Services formerly billed under G0002 will be billed under CPT codes 51702 Insertion of temporary indwelling bladder catheter; simple (e.g., Foley) or 51703 Insertion of temporary indwelling bladder catheter; complicated (e.g., altered anatomy, fractured catheter/balloon).
G0004 Patient demand single or multiple event recording with pre-symptom memory loop and 24 hour attended monitoring, per 30 day period; includes transmission, physician review and interpretation; G0005 Patient demand single or multiple event recording with pre-symptom memory loop and 24 hour attended monitoring, per 30 day period; recording (includes hook-up, recording and disconnection); G0006 Patient demand single or multiple event recording with pre-symptom memory loop and 24 hour attended monitoring, per 30 day period; 24 hour attended monitoring, receipt of transmissions, and analysis; and G0007 Patient demand single or multiple event recording with pre-symptom memory loop and 24 hour attended monitoring, per 30 day period; physician review and interpretation only.
Services formerly billed under G0004 will be billed using CPT code 93268, Patient demand single or multiple event recording with presymptom memory loop, 24-hour attended monitoring, per 30 day period of time; includes transmission, physician review and interpretation; services billed using G0005 will be billed using CPT code 93270, Patient demand single or multiple event recording with presymptom memory loop, 24-hour attended monitoring, per 30 day period of time; recording (includes hook-up, recording and disconnection); services billed using G0006 will be billed using CPT code 93271, Patient demand single or multiple event recording with presymptom memory loop, 24-hour attended monitoring, per 30 day period of time; monitoring, receipt of transmissions and analysis; services billed using G0007 will be billed using CPT code 93272 Patient demand single or multiple event recording with presymptom memory loop, 24-hour attended monitoring, per 30 day period of time; physician review and interpretation only, and services billed using G0015 will be billed using CPT code 93012 Telephonic transmission of post-symptom electrocardiogram rhythm strip(s), per 30 day period of time, tracing only. Unattended monitoring of patient demand single or multiple event recording with presymptom memory loop, per 30 day period of time and unattended telephonic transmission of post symptom electrocardiogram rhythm strip(s), per 30 day period of time should be billed using CPT code 93799, Unlisted cardiovascular service or procedure.
G0050 Measurement of post-voiding residual urine and/or bladder capacity by ultrasound
Services formerly billed under G0050 will be billed using CPT code 51798.
G0131 Computerized tomography bone mineral density study, one or more sites; axial skeleton (e.g., hips, pelvis, spine) and G0132 Computerized tomography bone mineral density study, one or more sites; appendicular skeleton (peripheral) (e.g., radius, wrist, heel).
Services formerly billed under G0131 will be billed using CPT code 76070, and those billed under G0132 will be billed using CPT code 76071.
G0185 Destruction of localized lesion of choroids for example, choroidal neovascularization; transpupillary thermotherapy (one or more sessions) and G0186 Destruction of localized lesion of choroids for example, choroidal neovascularization; photocoagulation, feeder vessel technique (one or more sessions).
Services formerly billed under G0185 will be billed using CPT code 0016T, Destruction of localized lesion of choroids (e.g., choroidal revascularization), transpupillary thermotherapy, and G0186 will be billed using CPT code 0017T, Destruction of macular drusen, photocoagulation.
G0193 Endoscopic study of swallowing function (also fiberoptic endoscopic evaluation of swallowing (FEEST)), G0194 Sensory testing during endoscopic study of (add-on code) referred to as fiberoptic endoscopic evaluation of swallowing with sensory (FEEST), G0195 Clinical evaluation of swallowing function (not involving interpretation of dynamic radiological studies or endoscopic study of swallowing), and G0196 Evaluation of swallowing involving swallowing of radio-opaque materials.
Services formerly billed under G0193 will be billed using new CPT code 92612; services billed using G0194 will be billed using new CPT code 92614; services billed using G0195 will be billed using new CPT code 92610; and G0196 should be billed using new CPT code 92611.
G0197 Evaluation of patient for prescription of speech generating devices, G0198 Patient adaptation and training for use of speech generating devices, G0199 Re-evaluation of patient using speech generating devices, G0200 Evaluation of patient for prescription of voice prosthetic, and G0201 Modification or training in use of voice prosthetic.
Services formerly billed under G0197 will be billed using CPT code 92607 Evaluation for prescription for speech-generating augmentative and alternative communication device, face-to-face with the patient; first hour, and, if appropriate, CPT code 92608, Evaluation for prescription for speech-generating augmentative and alternative communication device, face-to-face with the patient; each additional 30 minutes; services billed using G0198 will be billed using CPT code 92609 Therapeutic services for the use of speech-generating device, including programming and modification; services billed using G0199 will be billed using CPT code 92607, using the -52 modifier if the service is less than 1 hour; services billed using G0200 will be billed using revised CPT code 92597 Evaluation for use and/or fitting of voice prosthetic device to supplement oral speech; and services billed using G0201 will be billed using CPT code 92507.
G0240 Critical Care Service delivered by a physician; face-to-face, during inter-facility transport of a critically ill or critically injured patient: first 30-74 minutes of active transport, and G0241- each additional 30 minutes (list separately in addition to G0240)
Services formerly billed under G0240 and G0241 will be billed using CPT codes 99289 and 99290.
V. Update to the Codes for Physician Self-Referral Prohibition
A. Background
On January 4, 2001 we published in the Federal Register a final rule with comment period, "Medicare and Medicaid Programs; Physicians' Referrals to Health Care Entities With Which They Have Financial Relationships" (66 FR 856). That final rule incorporated into regulations the provisions in paragraphs (a), (b) and (h) of section 1877 of the Act. Section 1877 of the Act prohibits a physician from referring a Medicare beneficiary for certain "designated health services" to a health care entity with which the physician (or a member of the physician's immediate family) has a financial relationship, unless an exception applies. In the final rule, we published an attachment listing all of the CPT and HCPCS codes that defined the entire scope of the following designated health services for purposes of section 1877 of the Act: clinical laboratory services; physical therapy services (including speech-language pathology services); occupational therapy services; radiology and certain other imaging services; and radiation therapy services and supplies.
In the January 2001 final rule, we stated that we would update the list of codes used to define these designated health services in an addendum to the annual physician fee schedule final rule. The purpose of the update is to conform the code list to the most recent publications of CPT and HCPCS codes. An updated all-inclusive list of codes was included in the November 1, 2001 physician fee schedule final rule in Addendum E and was subsequently corrected in a notice that was published in the Federal Register (66 FR 20681) on April 26, 2002.
The updated all-inclusive list of codes effective for January 1, 2003 is presented in Addendum E in this final rule. It is our intent to always use Addendum E of the annual physician fee schedule final rule for the physician self-referral update. The updated all-inclusive list of codes will also be available on our Web site at http://cms.hhs.gov/medlearn/refphys.asp.
B. Response to Comments
We received three comments regarding the code list. The comments and our responses are stated below.
Comment: One commenter agreed with the additions and deletions to the list of designated health services as published in the November 1, 2001 physician fee schedule final rule (66 FR 55312). The commenter expressed the understanding that we would address the comments regarding the original list of designated health services (published in the January 4, 2001 final rule) in a second final rule on the physician self-referral prohibition. A second commenter raised concerns about our decision (announced in the January 4, 2001 final rule) to exclude nuclear medicine from the definition of "radiology and certain other imaging services."
Response: The first commenter is correct in understanding that we intend to address substantive comments on the designated health services that are defined by reference to HCPCS and CPT codes in a second final rule concerning the physician self-referral prohibition. We will also address the second commenter's concerns regarding nuclear medicine in that final rule. As noted above, this update to the code list merely reflects changes to the most recent publications of HCPCS and CPT codes.
Comment: One commenter noted that we post on our Web site ( http://www.hcfa.gov/stats/cpt/rvudown.htm ) an Excel spreadsheet file containing all of the CPT/HCPCS codes with accompanying RVUs. The commenter suggested that we add a column indicating whether a code is considered a designated health service for purposes of the physician self-referral law, as well as in which category of designated health services it would be included. The commenter stated that, as changes are made, they would be scattered throughout several physician fee schedules.
Response: We believe that the commenter was concerned that updates to the list of designated health services under the physician self-referral law would be published in various fee schedules throughout the course of a year. This is not the case. We publish the annual update and the entire list of CPT/HCPCS codes in the physician fee schedule final rule. (Addendum E contains the updated all-inclusive list of codes.) We have no plans to publish an updated list of codes for physician self-referral purposes in any other fee schedule. We chose the physician fee schedule, as opposed to one of the other fee schedules, because we believe that physicians would be more likely to see it. We maintain a current list of codes used to define certain designated health services for purposes of the physician self-referral law on our Web site at http://cms.hhs.gov/medlearn/refphys.asp. We have decided not to make any changes to the RVU website at this time because we believe the updated all-inclusive list of codes used for purposes of physician self-referral is readily available to all physicians.
C. Revisions Effective for 2003
Table 9, below, identifies the additions and deletions to the comprehensive list of physician self-referral codes published in Addendum E of the November 2001 physician fee schedule final rule and subsequently corrected in the April 26, 2002 correction notice (66 FR 20681). Table 9 also identifies the additions, deletions and revisions to the lists of codes used to identify the items and services that may qualify for the exceptions in § 411.355(g) (regarding EPO and other dialysis-related outpatient prescription drugs furnished in or by an end-stage renal dialysis (ESRD) facility) and in § 411.355(h) (regarding preventive screening tests, immunizations and vaccines).
We will consider comments with respect to the codes listed in Table 9 below, if we receive them by the date specified in the DATES section of this final rule.
HCPCS | CPT1 /Descriptor |
---|---|
Additions: | |
51798 | Us urine capacity measure |
76070 | Ct bone density, axial |
76071 | Ct bone density, peripheral |
76801 | Ob us 14 wks, single fetus |
76802 | Ob us 14 wks, addl fetus |
76811 | Ob us, detailed, sngl fetus |
76812 | Ob us, detailed, addl fetus |
92601 | Cochlear implt f/up exam 7 |
92602 | Reprogram cochlear implt 7 |
92603 | Cochlear implt f/up exam 7 |
92604 | Reprogram cochlear implt 7 |
92607 | Ex for speech device rx, 1hr |
92608 | Ex for speech device rx addl |
92609 | Use of speech device service |
92610 | Evaluate swallowing function |
92611 | Motion fluoroscopy/swallow |
92612 | Endoscopy swallow tst (fees) |
92614 | Laryngoscopic sensory test |
92616 | Fees w/laryngeal sense test |
0010T | TB test, gamma interferon |
0019T | Extracorp shock wave tx, ms |
0020T | Extracorp shock wave tx, ft |
0023T | Phenotype drug test, HIV 1 |
0026T | Measure remnant lipoproteins |
0028T | Dexa body composition study |
0029T | Magnetic tx for incontinence |
0030T | Anitprothrombotin antibody |
0041T | Detect UR infect agnt w/cpas |
0042T | Ct perfusion w/contrast, cbf |
0043T | Co expired gas analysis |
G0256 | Prostate brachy w palladium |
G0261 | Prostate brachytherapy w/rad |
G0262 | Sm intestinal image capsule |
G0274 | Radiopharm tx, non-Hodgkins |
G0279 | Excorp shock tx, elbow epi |
G0280 | Excorp shock tx other than |
G0281 | Elec stim unattend for press |
G0283 | Elec stim other than wound |
G0288 | Recon, CTA for surg plan |
J0636 | Inj calcitriol per 0.1 mcg |
J1756 | Iron sucrose injection |
J2501 | Paricalcitol |
J2916 | Na ferric gluconate complex |
Q3021 | Ped hepatitis b vaccine inj |
Q3022 | Hepatitis b vaccine adult ds |
Q3023 | Injection hepatitis Bvaccine |
Deletions: | |
76830 | Us, exam transvaginal |
76872 | Echo exam, transrectal |
76873 | Echograp trans r, pros study |
86915 | Bone marrow/stem cell prep |
90744 | Hepb vacc ped/adol 3 dose im |
90746 | Hep b vaccine, adult, im |
90747 | Hepb vacc, ill pat 4 dose im |
92510 | Rehab for ear implant |
97014 | Electric stimulation therapy |
G0026 | Fecal leukocyte examination |
G0027 | Semen analysis |
G0050 | Residual urine by ultrasound |
G0131 | CT scan, bone density study |
G0132 | CT scan, bone density study |
G0193 | Endoscopicstudyswallowfunctn |
G0194 | Sensorytestingendoscopicstud |
G0195 | Clinicalevalswallowingfunct |
G0196 | Evalofswallowingwithradioopa |
G0197 | Evalofptforprescipspeechdevi |
G0198 | Patientadapationtrainforspe |
G0199 | Reevaluationofpatientusespec |
G0200 | Evalofpatientprescipofvoicep |
G0201 | Modifortraininginusevoicepro |
J0635 | Calcitriol injection |
J1755 | Iron sucrose injection |
J2915 | NA Ferric Gluconate Complex |
Revisions: | |
76085 | Computer mammogram add-on [when used in conjunction with 76092] |
1 CPT codes and descriptions only are copyrighted in the 2002 American Medical Association. All rights are reserved and applicable FARS/DFARS clauses apply. |
The "Additions" section of Table 9 generally reflects new CPT and HCPCS codes that become effective January 1, 2003. The one exception is the addition of the following emerging technology codes, referred to as Category III codes, which the AMA first included in the CPT effective January 1, 2002: 0010T, 0019T, 0020T, 0023T, and 0026T. CPT codes 0010T, 0023T, and 0026T represent clinical laboratory services while CPT codes 0019T and 0020T are therapy codes. These codes were addressed in the November 2001 physician fee schedule final rule with the clarification that coverage and payment of these services is generally at the discretion of the carrier. However, the portion of the November 2001 final rule that concerned the list of codes for physician self-referral purposes failed to address these new codes. Thus, we are adding the Category III codes that should have been included in last year's update. We also are adding the following new Category III codes issued for 2003 to which the physician self-referral prohibition applies: 0028T, 0029T, 0030T, 0041T, 0042T, and 0043T. CPT codes 0028T and 0042T are radiology services; CPT code 0029T is a physical therapy service; and, CPT codes 0030T, 0041T and 0043T are clinical laboratory services.
Table 9 also reflects the addition of 4 new codes (J0636, J1756, J2501 and J2916) to the list of dialysis-related outpatient prescription drugs that may qualify for the exception described in § 411.355(g) regarding those items. The physician self-referral prohibition will not apply to these drugs if they meet the conditions set forth in § 411.355(g). Table 9 also reflects the addition of 3 vaccine codes (Q3021, Q3022 and Q3023) to the list that identifies preventive screening tests, immunizations and vaccines that may qualify for the exception described in § 411.355(h) for such items and services. The physician self-referral prohibition will not apply to these vaccines if they meet the conditions set forth in § 411.355(h) concerning the exception for preventive screening tests, immunizations, and vaccines.
With the exception of CPT codes 76830, 76872 and 76873 for ultrasounds, the "Deletions" section of Table 9 reflects changes necessary to conform the code list to the most recent publications of CPT and HCPCS codes. We are deleting CPT code 76830 for transvaginal ultrasound and CPT codes 76872 and 76873 for transrectal ultrasounds because these codes should never have appeared on the list of designated health services. Our definition of "radiology and certain other imaging services" published in the January 2001 final rule (66 FR 956) specifically excludes any ultrasonic procedure that requires "the insertion of a needle, catheter, tube, or probe". Thus, although the deletion of these codes is not a change to conform to an annual change in CPT or HCPCS codes, we are making the change at this time so that the list of codes will accurately reflect the regulatory definition for "radiology and certain other imaging services."
Table 9 includes one revised CPT code. That is CPT code 76085, "Computer mammogram add-on." In the CPT publication effective January 1, 2003, the CPT long descriptor was changed to delete the word "screening" so that the digitization no longer refers only to screening mammography. Because our exception under § 411.355(h) applies to preventive screening tests, we have revised the list of codes that may qualify for that exception to indicate that CPT code 76085 may qualify for the exception only when it is used in conjunction with CPT code 76092, "Mammogram screening."
VI. Physician Fee Schedule Update for Calendar Year 2003
A. Physician Fee Schedule Update
The physician fee schedule update is determined under a calculation methodology that is specified by statute. Under section 1848(d)(4) of the Act, the update is equal to the product of 1 plus the percentage increase in the Medicare Economic Index (MEI) (divided by 100) and 1 plus the update adjustment factor. For CY 2002, the MEI is equal to 3.0 percent (1.030). The update adjustment factor is equal to -7.0 percent (0.930). Section 1848(d)(4)(F) of the Act requires an additional -0.2 percent (0.998) reduction to the update for 2003. Thus, the product of the MEI (1.030), the update adjustment factor (0.930), and the statutory adjustment factor (0.998) equals the CY 2003 update of -4.4 percent (0.956).
The Department believes that the negative update is inappropriate because the current update system does not reflect actual, after the fact, data from earlier years. Instead, the Act requires the Department to rely upon estimates made in past years, even though the Department now has actual data for these particular years. Even though after-the-fact data show that for certain years actual increases differed to some degree from earlier estimates, the Department is unable to revise estimates without congressional action. We have exhaustively searched for a different interpretation of law that would allow us to revise estimates for earlier years administratively, but unfortunately, we had to conclude that current law does not permit such an interpretation.
Without congressional action to address the current legal framework, the Department is compelled to announce a physician fee schedule update for CY 2003 of -4.4 percent. The Department's calculations are explained below.
We have, however, also identified reasonable adjustments that could result in a positive update in physician fee schedule rates if the Department were permitted by law to make those adjustments. Revisions of estimates used to establish the sustainable growth rates (SGR) for fiscal years (FY) 1998 and 1999 and Medicare volume performance standards (MVPS) for 1990 through 1996 could, under present estimations, result in an increase in the update.
The Department intends to work closely with the Congress to develop legislation that could permit a positive update, and hopes that such legislation can be passed before the negative update takes effect. Because the Department wishes to take action immediately in the event that Congress provides the Department legal authority to make the corrections, we are requesting comments regarding how physician fee schedule rates could and should be recalculated prospectively in the event that Congress provides the Department with legal authority to revise estimates used to establish the sustainable growth rates (SGR) for FYs 1998 and 1999 and the MVPS for 1990-1996.
B. The Percentage Change in the Medicare Economic Index
1. Medicare Economic Index (MEI) Productivity Adjustment
In the June 28, 2002 proposed rule, we reviewed the history of the MEI productivity adjustment, described the current MEI productivity adjustment, identified and evaluated possible alternative MEI productivity adjustments based on the individual contributions we solicited from experts on this topic, and proposed changing the MEI productivity adjustment to reflect an economy-wide multifactor productivity adjustment. In this final rule, we repeat this research information, respond to public comments on the MEI, and determine the CY 2003 MEI using the proposed methodological change.
a. History of MEI Productivity Adjustment
The MEI is required by section 1842(b)(3)(L) of the Act which states that prevailing charge levels beginning after June 30, 1973 may not exceed the level from the previous year except to the extent that the Secretary finds, on the basis of appropriate economic index data, that such higher level is justified by year-to-year economic changes. S. Rep. No. 92-1230, at 191 (1972) provides slightly more detail on that index, stating that:
Initially, the Secretary would be expected to base the proposed economic indexes on presently available information on changes in expenses of practice and general earnings levels combined in a manner consistent with available data on the ratio of the expenses of practice to income from practice occurring among self-employed physicians as a group.
Consistent with section 1842(b)(3)(L) and legislative intent, in 1975, we determined that the MEI would be based on a broad wage measure reflecting overall earnings growth, rather than direct inclusion of physicians' net income. We used average weekly earnings of nonagricultural production (non-supervisory) workers, net of worker's productivity, as the wage proxy in the initial MEI. We included the productivity adjustment because it avoided double counting of gains in earnings resulting from growth in productivity and produced an MEI that approximated an economy-wide output price index similar to the Consumer Price Index (CPI). The productivity adjustment we used was the annual change in economy-wide private non-farm business labor productivity, applied only to the physicians' earnings portion of the MEI (then 60 percent).
As noted, the productivity adjustment in the MEI serves to avoid the double counting of productivity gains. Absent the adjustment, productivity gains from producing additional outputs (procedures) with a given amount of inputs would be included in both the earnings component of the MEI (reflecting growth in overall economy-wide wages) and in the additional procedures that are billed (reflecting physicians' own productivity gains). Therefore, general economic labor productivity growth is removed from the labor portion of the MEI.
Although the basic structure of the MEI remained relatively unchanged from its effective date (July 1, 1975) until 1992, its weights were updated periodically and a component was added for professional liability insurance. Section 9331 of the Omnibus Budget Reconciliation Act of 1986 (Pub. L. 99-509) (OBRA 86) mandated that we conduct a study of the structure of the MEI and prepare a notice and offer the public an opportunity to comment before we revise the methodology for calculating the MEI. Based on this requirement, we held a workshop with experts on the MEI in March 1987 to discuss topics ranging from the specific type of index to use (Laspeyres versus Paasche) to revising the method of reflecting productivity changes. Participants included the Federal government, the Physician Payment Review Commission (PPRC), the Congressional Budget Office, the AMA, and several private consulting firms. The meeting participants concluded that a productivity adjustment in the MEI was appropriate and that an acceptable measure of physician-specific productivity did not currently exist. Many alternative approaches were discussed, including the use of a policy-based "target" measure and several existing economic productivity measures.
Using recommendations from the meeting participants, we revised the MEI and the productivity adjustment with the implementation of the physician fee schedule as discussed in the November 1992 final rule (57 FR 55896). While we retained an adjustment for economy-wide labor productivity, this adjustment was applied to all of the direct labor categories of the MEI (70.448 percent), not just physicians' earnings, and was based on the 10-year moving average percent change (instead of annual percent changes). This form of the index has been used since that time, and was most recently discussed in the November 1998 final rule (63 FR 58845) when the MEI weights were rebased to a 1996 base year.
The BBA replaced the Medicare Volume Performance Standard (MVPS) with a Sustainable Growth Rate (SGR). The SGR is an annual growth rate that applies to physicians' services paid for by Medicare. The use of the SGR is intended to control growth in aggregate Medicare expenditures for physicians' services. Payments for services are not withheld if the percentage increase in actual expenditures exceeds the SGR. Rather, the physician fee schedule update, as specified in section 1848(d)(4) of the Act, is adjusted based on a comparison of allowed expenditures (determined using the SGR) and actual expenditures. If actual expenditures exceed allowed expenditures, the update is reduced. If actual expenditures are less than allowed expenditures, the update is increased. Specifically, the SGR is calculated on the basis of the weighted average percentage increase in fees for physicians' services, growth in fee-for-service Medicare enrollment, growth in real per capita Gross Domestic Product (GDP), and the change in expenditures on physicians' services resulting from changes in law or regulations.
When the SGR was enacted, the Congress specified continued use of the MEI. By 1997, the MEI, including its productivity adjustment, had been used in updating Medicare payments to physicians for over twenty years. We did not propose any changes to the productivity adjustment used in the MEI when the SGR system was enacted because its continued use was consistent with the newly mandated formula. If we did not make a productivity adjustment in the MEI, general economic productivity gains would be reflected in two of the SGR factors, the MEI and real per-capita GDP (which reflects real GDP per hour worked, or labor productivity, and hours worked per person). We believe it is reasonable to remove the effect of general economic productivity from one of these factors (the MEI) to avoid double counting.
As noted previously, since its original development, the MEI productivity adjustment has been based on economy-wide productivity changes. This practice arose from the fact that the physicians' compensation portion of the MEI is proxied to grow at the same rate as general earnings in the overall economy, which reflect growth in overall economy-wide productivity. Removing labor productivity growth reflected in general earnings from the labor portion of the MEI produces an index that is consistent with other economy-wide output price indexes, like the CPI.
b. Research on Alternative MEI Productivity Adjustments
In the June 2002 proposed rule we presented the research we completed on evaluating the most appropriate productivity adjustment for the MEI. This research included evaluating the currently available productivity estimates produced by the BLS to develop a better understanding of the strengths and weaknesses of these measures and reviewing the theoretical foundation of the MEI to understand how labor and multifactor productivity relate to the current physician payment system. We also studied the limited publicly available data to begin to develop preliminary estimates of trends in physician-specific productivity to better understand the current market conditions facing physicians. Finally, we solicited the individual contributions of academic and other professional economic experts on prices and productivity. These experts included individuals from the MedPAC, the AMA, the Office of Management and Budget (OMB), Dr. Uwe Reinhardt from Princeton University, Dr. Joe Newhouse from Harvard University, Dr. Ernst Berndt from MIT, and Dr. Joel Popkin from Joel Popkin and Company. Below we repeat the findings on each of the six options we investigated and detailed in the proposed rule:
• Option 1-Using a physician-specific productivity adjustment.
This option would entail using an estimate of physician-specific productivity to adjust the MEI. This option may have some theoretical attractiveness, but there are major problems in obtaining accurate measures of physician-specific productivity. First, no published measure of physician-specific productivity is available. The Federal agency that produces the official government statistics on productivity, BLS, does not calculate or publish productivity measures for any health sector. Nor are there alternative measures of physician-specific productivity that would conform to the BLS methodology for measuring productivity. Second, it is not clear that using physician-specific productivity within the current structure of the MEI would be appropriate. Because we believe the MEI appropriately uses an economy-wide wage measure as the proxy for physician wages, using physician specific productivity could overstate or understate the appropriate wage increases in the MEI.
We do believe, however, that it is important to understand the rate of change in physician-specific productivity. Toward this end, we have performed our own preliminary analysis of physician-specific productivity, using the limited available data on physician outputs and inputs. Our analysis attempted to simulate the methodology the BLS would use to measure productivity. To help achieve this we have been in contact with experts at the BLS to obtain their feedback on our methodology. While this information cannot be interpreted as an official measure of physician productivity, we do believe it provides a rough indication of the current market conditions facing physicians. We used this information to aid in forming our determination of the most appropriate productivity adjustment to incorporate in the MEI, fully recognizing its preliminary nature and other limitations of our analysis. The results of our preliminary analysis suggest that long-run physician-specific productivity growth is currently near the level of economy-wide multifactor productivity growth. Prior to the recent period, however, our preliminary estimates suggested that physician productivity gains were generally significantly greater than general economy-wide multifactor productivity gains and more in line with economy-wide labor productivity.
As we have emphasized, our rough estimates are inadequate for establishing a formal basis for the productivity adjustment to the MEI. In addition, the underlying economic theory is not sufficiently compelling, at this time, to adopt a physician-specific productivity measure, even if a suitable one were available. We conclude, however, that economy-wide multifactor productivity growth appears to be roughly comparable to our estimates of current physician-specific productivity growth.
Comment: A few commenters urged us to develop a measure of productivity that more accurately reflects the conditions facing physicians. The commenters suggested that we consider issues like increased regulatory burden on physicians and the service-oriented nature of physician services.
Response: As we stated in the June 2002 proposed rule and repeated above, no publicly available measure of physician productivity exists. In addition, no publicly available measure of service-sector productivity exists. Because of this it is not possible at this time to incorporate a productivity adjustment in the MEI that explicitly reflects physician marketplace characteristics.
However, we do believe that it is important that the productivity adjustment included in the MEI be consistent with the market conditions facing physicians. As we have discussed in this final rule, we attempted to understand the trends in physician productivity by researching and making the most optimal use of the sparse data available. We will continue to refine this research, including soliciting contributions both from experts at BLS and outside experts on measuring productivity. In addition, we encourage the commenters to work with BLS to pursue the development of official measures of physician and health sector productivity.
• Option 2-Using economy-wide labor productivity applied to the labor portion of the MEI.
We have applied economy-wide labor productivity growth to a portion of the MEI in some form since the inception of the index in 1975. For the 2002 update, we applied the 10-year moving average percent change in economy-wide labor productivity to the labor portion of the MEI. This adjustment was developed based on the contributions of a 1987 expert panel. That panel concluded that applying labor productivity data to the labor portion of the index was a technically sound way to account for productivity in the physician update. This method made optimal use of the available data because labor productivity data were, and are, available on a more-timely basis than economy-wide multifactor productivity. By applying this measure to the labor portion of the index, the mix of physician-specific labor and non-labor inputs is reflected. Also, the use of a 10-year moving average percentage change reduces the volatility of annual labor productivity changes.
Our research, however, has indicated that using multifactor productivity applied to the entire index is a superior method to using an economy-wide labor productivity measure applied only to the labor portion of the index. The experts with whom we consulted believed it was more appropriate to reflect the explicit contribution to output from all inputs. The current measure explicitly reflects the changes in economy-wide labor inputs but does not reflect the actual change in non-labor inputs. Instead, it implicitly assumes that non-labor inputs would grow at a rate necessary to produce an economy-wide multifactor measure that is equivalent to the current MEI productivity adjustment. That implicit assumption is less precise than a direct, explicit calculation.
In addition, while the implicit approach produced an MEI productivity adjustment in most years that was reasonably consistent with overall multifactor productivity growth, it now appears less consistent with the actual change in non-labor inputs in the economy. In recent years, economy-wide labor productivity has grown very rapidly. This acceleration is partly the result of major investments in non-labor inputs that have helped to create a more productive work force. Also, the Bureau of Economic Analysis (BEA) adopted methodological changes in accounting for computer software purchases in measuring GDP. These changes have significantly increased the measured historical growth rates in real GDP and labor productivity. As a result of these developments, the current MEI productivity adjustment, applying labor productivity only to the labor portion of the MEI, has increased very rapidly. Because the multifactor definition is an explicit calculation of the change in economic output relative to the change in both labor and non-labor inputs, it better reflects the overall productivity trend changes.
Finally, as noted previously, our preliminary estimates of physician-specific productivity suggest a current growth pattern that is similar to growth in multifactor productivity in the economy overall. In consideration of the economic theory underlying productivity measurement, especially in view of the recent developments in labor versus non-labor economic input growth trends, we concluded that using a multifactor productivity adjustment is superior to the current methodology for adjusting for productivity in the MEI.
• Option 3-Change to using economy-wide multifactor productivity.
The option we proposed in the June 2002 proposed rule was to adjust for productivity gains in the MEI using economy-wide multifactor productivity applied to the entire index, instead of labor productivity applied to the labor portion of the MEI. This option would better satisfy the theoretical requirements of an output price, in this case the MEI, by explicitly reflecting the productivity gains from all inputs. In addition, the use of economy-wide multifactor productivity would still be consistent with the MEI's use of economy-wide wages as a proxy for physician earnings. While annual multifactor productivity can fluctuate considerably, though usually less than labor productivity, using a moving-average would produce a relatively stable and predictable adjustment.
Each expert with whom we consulted believed that using a multifactor productivity measure was theoretically superior to the previous methods used to adjust the MEI because it reflects the actual changes in non-labor inputs instead of reflecting an implicit assumption about those changes. These experts also believed that the lack of timely data on multifactor productivity was not as important as would have appeared initially. Instead, they believed it was more appropriate that the adjustment be based on a long-run average that was stable and predictable rather than on annual changes in productivity. Thus, if a long-run average were used, the increased lag time associated with the availability of published data on multifactor productivity becomes less significant. Finally, one expert believed that changing to economy-wide multifactor productivity applied to the entire MEI would make it easier to understand the magnitude of the productivity adjustment.
However, use of multifactor productivity to adjust the MEI poses two concerns. First, multifactor productivity is much harder to measure than labor productivity. Economic inputs other than labor hours can be very difficult to identify and calculate properly. The experts at BLS, however, have adequately overcome these difficulties, and we are satisfied that their official published measurements are sound for the purpose at hand. Moreover, use of a 10-year moving average increase helps to mitigate any remaining measurement variation from year to year.
The second concern relates to the timeliness of the data. BLS publishes multifactor productivity levels and changes annually (as opposed to the quarterly release of labor productivity data) and with an extended time lag (about 1 1⁄2 years). These timeframes arise unavoidably from the difficulties of measuring non-labor input as mentioned above, but would result in a misalignment of the data periods for the data used to adjust the MEI and of the historical data on wages and prices underlying the MEI. For the CY 2003 physician payment update, for example, we would use data on wages and prices through the second quarter of CY 2002, but would have to use multifactor productivity data through CY 2000. Although the misalignment of data periods is a concern, we believe it is a reasonable trade-off in view of the improvement offered by an explicit measurement of non-labor inputs. Also, because use of a 10-year moving average is intended to reduce fluctuations and provide a more stable level of the productivity adjustment, availability of the most recent data is of less importance.
The 10-year moving average percent change in economy-wide multifactor productivity that would be used for the CY 2003 update (historical data through CY 2000) is estimated at 0.8 percent. Our preliminary internal analysis of physician-specific productivity gains suggests that these economy-wide multifactor measures are consistent with those trends. Thus, using economy-wide multifactor productivity for MEI productivity adjustment theoretically would be superior to using labor productivity growth applied to the labor portion of the MEI.
• Option 4-Change to using economy-wide multifactor productivity with physician-specific input weights
Another option we explored was using economy-wide labor and capital productivity measures (which, when weighted together, produce multifactor productivity), but with physician-specific input weights. This method would better reflect the proportion of labor and capital inputs used by physicians, and reflect the explicit contribution to productivity of labor and non-labor inputs. The experts with whom we discussed this option thought it was theoretically consistent with a measure of multifactor productivity, even though different productivity measures would be applied to different components of the MEI.
A weakness of this method is that the BLS capital productivity series is not widely used or cited; therefore, we are unsure of the accuracy and reliability of this measure. This method also adds another layer of complexity to the formula, making it more difficult to understand the adjustment. We would prefer that any method we choose be straightforward so that it can be readily understood. Moreover, the labor and capital shares for the overall economy do not appear to vary enough from the physician-specific shares in the MEI to result in a significantly different measure. Overall, we believe that this method does not provide enough of a technical improvement to justify the added complexity that would be required to implement it.
• Option 5-Adjusting productivity using a "Policy Standard".
In its March 2002 Report to the Congress, MedPAC suggested establishing a policy target for the productivity adjustment. Under this methodology, the level of the policy target would be based on the productivity gains that physicians could reasonably be expected to attain. This level would be set through policy and would likely be based on a long-run average of either economy-wide labor or multifactor productivity (but could reflect other, possibly judgmental, factors). Generally, the level of the policy standard would remain constant for several years, and periodically would be reviewed and adjusted as needed.
Some of the experts we consulted believed that a policy target would lessen the volatility of the adjustment because the target would not be changed often. Conversely, others noted the large, abrupt changes that could result if actual economic performance deviated from the policy standard requiring subsequent adjustments to the standard. Some believed that this method adjusts for the problem of precisely measuring productivity. If we used a policy standard we could avoid having to develop an exact measure. Using a policy target, however, may appear arbitrary without a theoretical basis to support its use.
The policy target recommended by the MedPAC was 0.5 percentage points per year. The MedPAC's justification for this number was that the long-run average of economy-wide multifactor productivity was close to 0.5 percent (the most recent 10-year average is now 0.8 percent). We do not believe this is a preferred option for adjusting the MEI for productivity improvements. Our preference is to use a data based approach that automatically reflects changes in actual economic performance over time, and not through abrupt periodic, possibly large adjustments. Thus, we conclude that a policy target does not provide an improvement over any of the data based methodologies.
Comment: One commenter recommended the productivity adjustment be removed from the MEI to make the index more consistent with our other market baskets.
Response: Since its inception in 1975 the MEI has included a productivity adjustment. By including the productivity adjustment in the MEI and using a general earnings proxy for physician wages, the index approximated an economy-wide output price index like the CPI. This original intent was different from that for the other market baskets, which are defined to reflect pure price changes in inputs associated with providing care. Thus, the MEI appropriately includes an adjustment for productivity changes.
As we described earlier, practically it makes no difference whether productivity is adjusted for within or outside the MEI, as long as an adjustment is present. However, given the historical precedent regarding the definition of the MEI, the apparent legislative intent behind recent legislation that did not prescribe a change to the MEI definition, and the specific update formula that must be used under the SGR, we do not believe it would be appropriate for the productivity adjustment to be made outside the MEI.
• Option 6-Eliminate Productivity Adjustment from the MEI.
Questions are raised occasionally as to the possibility of eliminating the productivity adjustment from the MEI. We did not consider this to be a viable option. Our research concluded that adjusting for productivity in the MEI is necessary in order to have a technically correct measure of an output price increase, free from double-counting of the impact of productivity. Every expert with whom we consulted agreed that a productivity adjustment is appropriate. They believed that the important question is which measure is the most appropriate for the adjustment.
c. Use of a Forecasted MEI and Productivity Adjustment
In a March 2002 Report to the Congress, the MedPAC recommended the use of a forecasted MEI value, rather than the current historical increase. However, implementation of this option raises several legal as well as practical issues. The 1972 Senate Finance Committee report language reflects the intent of the Congress that the MEI should "follow rather than lead" overall inflation. As a result, updates to the physician fee schedule have always been based on historical, rather than forecasted, MEI data. In this way, increases in the MEI do not lead the current measures of inflation but follow them based on historical trends. Furthermore, at the time of implementation of the SGR system, the Congress specified that the SGR system should use the MEI that existed at the time, which was based on historical data measures. The law did not recommend or specify a change in the MEI methodology. Thus, the assumption is that the Congress was satisfied that the MEI was functioning as designed. If we were to use a forecasted MEI and productivity adjustment, there are several practical issues that would need to be addressed. One issue is that a change from a historical-based MEI to a projected MEI would cause transitional problems because there would be a period of data that would not be accounted for in the year of implementation. For example, the CY 2002 MEI update was based on historical data through the second quarter of 2001. If we were to use a forecasted MEI in the update for CY 2003, any changes between the second quarter of 2001 and the first quarter of 2003 would not be accounted for in the update. Additionally, changing to a forecasted MEI and productivity adjustment raises additional questions about correcting for forecast errors. Based on these problems, we will continue to use historical data to make updates under the physician fee schedule.
Comment: One commenter urged us to use a forecast of the MEI change for the update in the upcoming year. The commenter believed that we had the legal authority to make such a change and that the transition issues cited in the proposed rule were not relevant.
Response: We do not believe that it would be appropriate to use a forecast of the MEI for the 2003 update. Since the inception of the MEI, and more recently the implementation of the physician fee schedule, the MEI increase for the upcoming year's update has been based on as much historical data as is available when the update is determined. For the 2003 update this means using data that is available through June 2002.
Our interpretation of the legislative intent is for the MEI update to be based on historical data, and does not contemplate a MEI based on projections. As we stated above, the MEI update has always been based on historical data and we believe that the legislative intent when the SGR system was implemented was to continue using this methodology. In addition, we believe that the transition and forecast error issues described above are legitimate concerns that, at this time, would outweigh the benefits of making such a change. Therefore, we will continue to use historical data in developing the MEI used for the 2003 fee schedule update.
d. Productivity Adjustment to the MEI
Based on the research we conducted on this issue, we are changing the methodology for adjusting for productivity in the MEI. The MEI used for the CY 2003 physician payment update will reflect changes in the 10-year moving average of private non-farm business (economy-wide) multifactor productivity applied to the entire index. Several commenters agreed with this methodological change.
We made this change because-(1) It is theoretically more appropriate to explicitly reflect the productivity gains associated with all inputs (both labor and nonlabor); (2) the recent growth rate in economy-wide multifactor productivity appears more consistent with the current market conditions facing physicians, and (3) the MEI still uses economy-wide wage changes as a proxy for physician wage changes. We believe that using a 10-year moving average change in economy-wide multifactor productivity produces a stable and predictable adjustment and is consistent with the moving-average methodology used in the existing MEI. Thus, the productivity adjustment will be based on the latest available actual historical economy-wide multifactor productivity data, as measured by the BLS.
We currently estimate the MEI to increase 3.0 percent for CY 2003. This is the result of a 3.8 percent increase in the price portion of the MEI, adjusted downward by a 0.8 percent increase in the 10-year moving average change in economy-wide multifactor productivity. Table 10 shows the detailed cost categories of the MEI update for CY 2003.
Cost categories and price measures | 1996 Weights2 | CY 2003 percent changes |
---|---|---|
Medicare Economic Index Total, productivity adjusted | n/a | 3.0 |
Productivity: 10-year moving average of multifactor productivity, private nonfarm business sector | n/a | 0.8 |
Medicare Economic Index Total, without productivity adjustment | 100.0 | 3.8 |
1. Physician's own time3 | 54.5 | 3.9 |
a. Wages and Salaries: Average hourly earnings private nonfarm | 44.2 | 3.7 |
b. Fringe Benefits: Employment Cost Index, benefits, private nonfarm | 10.3 | 5.0 |
2. Physician's practice expense3 | 45.5 | 3.6 |
a. Nonphysician employee compensation | 16.8 | 4.2 |
1. Wages and Salaries: Employment Cost-Index, wages and salaries, weighted by occupation | 12.4 | 3.7 |
2. Fringe Benefits: Employment Cost-Index, fringe benefits, white collar | 4.4 | 5.5 |
b. Office Expense: Consumer Price Index for urban consumers (CPI-U), housing | 11.6 | 2.8 |
c. Medical Materials and Supplies: Producer Price Index (PPI), ethical drugs/PPI, surgical appliances and supplies/CPI-U, medical equipment and supplies (equally weighted) | 4.5 | 2.0 |
d. Professional Liability Insurance:CMS professional liability insurance survey4 | 3.2 | 11.3 |
e. Medical Equipment: PPI, medical instruments and equipment | 1.9 | 1.5 |
f. Other professional expense | 7.6 | 1.8 |
1. Professional Car: CPI-U, private transportation | 1.3 | 2.3 |
2. Other: CPI-U, all items less food and energy | 6.3 | 2.6 |
1 The rates of historical change are estimated for the 12-month period ending June 30, 2002, which is the period used for computing the calendar year 2003 update. The price proxy values are based upon the latest available Bureau of Labor Statistics data as of September 19, 2002. | ||
2 The weights shown for the MEI components are the 1996 base-year weights, which may not sum to subtotals or totals because of rounding. The MEI is a fixed-weight, Laspeyres-type input price index whose category weights indicate the distribution of expenditures among the inputs to physicians' services for calendar year 1996. To determine the MEI level for a given year, the price proxy level for each component is multiplied by its 1996 weight. The sum of these products (weights multiplied by the price index levels) over all cost categories yields the composite MEI level for a given year. The annual percent change in the MEI levels is an estimate of price change over time for a fixed market basket of inputs to physicians' services. | ||
3 The measures of productivity, average hourly earnings, Employment Cost Indexes, as well as the various Producer and Consumer Price Indexes can be found on the Bureau of Labor Statistics Web site http://stats.bls.gov. | ||
4 Derived from a CMS survey of several major insurers (the latest available historical percent change data are for the period ending second quarter of 2002). | ||
n/aProductivity is factored into the MEI compensation categories as an adjustment to the price variables; therefore, no explicit weight exists for productivity in the MEI. |
Comment: Several commenters requested that we ensure that the costs of medical liability insurance are adequately reflected in the MEI by making available all information that is the basis for measuring medical liability costs in the MEI.
Response: We agree with the commenters that it is vital that the MEI accurately reflect the price changes associated with professional liability costs. Accordingly, we continue to incorporate into the MEI a price proxy that accomplishes this goal by making the maximum use of available data on professional liability premiums. Below we describe in more detail the annual CMS data collection from commercial insurance carriers, which are designed to maximize the use of publicly available data.
Each year, we solicit professional liability premium data for physicians from a small sample of commercial carriers. This information is not collected through a survey form, but instead is requested from a few national commercial carriers via letter. The carriers provide information on a voluntary basis, and generally between 5 and 8 carriers volunteer this information.
As we require for our other price proxies, the professional liability price proxy must reflect the pure price change associated with this particular cost category. Thus, it should not capture changes in the mix or level of liability coverage. To accomplish this result, we obtain premium information from commercial carriers for a fixed level of coverage, currently $1 million per occurrence and a $3 million annual limit. This information is collected for every state by physician specialty and risk class. Finally, the state-level, physician-specialty data is aggregated by effective premium date to compute a national total using counts of physicians by state and specialty as provided in the AMA publication "Physician Characteristics and Distribution in the U.S."
The resulting data provides a quarterly time series, indexed to a base year consistent with the MEI, which reflects the national trend in the average professional liability premium for a given level of coverage. From this series, quarterly and annual percent changes in professional liability insurance are estimated for inclusion in the MEI. This data produced an 11.3 percent increase for professional liability insurance in the MEI for the 2003 update. We believe that, given the limited timely data available on professional liability premiums, this methodology adequately reflects the price trends facing physicians.
Comment: One commenter urged CMS to use the most current professional liability insurance data available when developing the MEI update.
Response: The professional liability data used to develop the 2003 MEI update was based on premium rates effective as of June 2002. We believe our methodology ensures that the MEI update includes the most recent data available. In the spring of 2002 we collected professional liability insurance premiums from commercial insurers as described in the previous comment. These data included both the premium amount and effective date, which we use to create a quarterly time series. Thus, the professional liability insurance component of the 2003 MEI update includes effective premium rates through the 2nd quarter of 2002, which is consistent with the timeliness of other data used in determining this update.
The most comprehensive data on professional liability costs exist with the state insurance commissioners. However, these data are available only with a substantial lag. For instance, when we developed this final rule the most recent professional liability data available from the state insurance commissioners were for 2000. Hence, the data currently incorporated into the MEI are much more timely.
Comment: Several commenters requested that we make an ad hoc adjustment to the MEI to account for recent increases in medical liability insurance.
Response: We disagree with the commenters that an ad hoc adjustment should be made to the MEI to account for recent increases in professional liability insurance. As detailed above, the current methodology reflects recent data collected directly from commercial insurance carriers and specifically reflects the conditions facing physicians. Thus, the MEI adequately accounts for the recent increases in professional liability insurance prices, much the same way it reflects the price changes associated with other inputs, such as office expenses, wages or benefits. Thus, we believe the MEI appropriately reflects the price changes as measured by reliable and relevant data sources, and should not be adjusted through an ad hoc mechanism.
Comment: Several commenters suggested that physicians' earnings more closely follow the wage changes faced by professional and technical occupations. The commenters suggested that we use the employment cost index (ECI) for professional and technical workers as the physicians' wage proxy in the MEI.
Response: As we stated in the November 2, 1998 final rule (63 FR 58848), we believe that the current price proxy for physicians' earnings, average hourly earnings (AHE) in the non-farm business economy, is the most appropriate proxy to use in the MEI. The AHE for the non-farm business economy reflects the impacts of supply, demand and economy-wide productivity for the average worker in the economy. Using the AHE as the proxy for physician earnings captures the parity in the rate of change in wages for the average worker and for physicians. In addition, use of this proxy is consistent with the original legislative intent that the change in the physicians' earnings portion of the MEI parallel the change in general earnings for the economy.
The suggestion to use the ECI for professional and technical workers has a major shortcoming in that, in many instances, occupations, such as engineers, computer scientists, nurses, etc., have unique characteristics that are not reflective of the overall economy or the physician market. Specifically, wage changes for these types of occupations can be influenced by excess supply or demand for these types of workers. We do not believe it would be appropriate to proxy the physician earnings portion of the MEI with a wage proxy that reflects these unique characteristics.
C. The Update Adjustment Factor
Section 1848(d) of the Act provides that the physician fee schedule update is equal to the product of the MEI and an "update adjustment factor." The update adjustment factor is applied to make actual and target expenditures (referred to in the law as "allowed expenditures") equal. Allowed expenditures are equal to actual expenditures in a base period updated each year by the SGR. The SGR sets the annual rate of growth in allowed expenditures and is determined by a formula specified in section 1848(f) of the Act.
Since the inception of the physician fee schedule in 1992, physician payment rates have been updated using two different systems. From 1992 to 1998, physician fee schedule rates were updated using the Medicare Volume Performance Standard (MVPS). From 1999 to the present, physician fee schedule rates have been updated using the sustainable growth rate (SGR). While there are significant and important differences between the MVPS and SGR, both use the same general concept that expenditures for physicians' services should grow by a limited percentage amount of allowed expenditures each year. If expenditures exceed the amount in a year, the physician fee schedule update is reduced. If expenditures are less than the amount of allowed expenditures in a year, the physician fee schedule update is increased.
We determined the annual percentage increase in expenditures using the formulas specified in the statute. One important feature of both the MVPS and the SGRs for fiscal years (FYs) 1998 and 1999 was that the percentage increase was based on estimates of the four factors specified in the law, made before the beginning of the year. Under the MVPS and the SGRs for FYs 1998 and 1999, the statute did not permit us to revise the estimates used to set the annual percentage increase. Beginning with the FY 2000 SGR, the statute specifically requires us to use actual, after the fact, data to revise the estimates used to set the SGR.
For some of the component factors of both the MVPS and the SGR, there have been differences between the estimates used to set the annual MVPS and SGR and the actual increase based on actual, after the fact, data. For instance, under both the MVPS and the SGR, we are required to account for increases in Medicare beneficiary fee-for-service enrollment. There have been differences between our estimates of the increase in fee-for-service enrollment and the actual, after the fact increase because it is difficult to predict, before the beginning of the year, beneficiary enrollment in Medicare + Choice plans (or Medicare managed care plans as they were known under the MVPS). Under the MVPS, we generally estimated higher growth in beneficiary fee-for-service enrollment than actually occurred. For the FY 1998 and FY 1999 SGRs, we estimated lower growth in beneficiary fee-for-service enrollment than actually occurred. (For subsequent years, the statute has required us to revise our estimates.)
Under the SGR, the statute also requires us to account for the increase in real per capita gross domestic product (GDP) to determine the annual percentage increase in expenditures for physicians' services. In both FY 1998 and FY 1999, we estimated lower real per capita GDP growth than actually occurred. Because the statute did not permit us to revise estimates for these years, the SGRs for FYs 1998 and 1999 are lower than if we were authorized to revise estimates as required under current law for the FY 2000 SGR and all subsequent SGRs.
Because the physician fee schedule CF has been affected by a comparison of the actual increase in expenditures to the level of allowed expenditures calculated using the MVPS and the SGRs for FYs 1998-1999, revision of our estimates would have resulted in different CFs than those we actually determined. Revision of the estimates used to set the MVPS would have made the physician fee schedule CFs established under the MVPS lower than those we have actually determined. As a result, higher expenditures in 1997 were higher than if we had revised estimates with actual after the fact data. The actual amount of expenditures in 1997 forms the basis for the calculation of allowed expenditures under the SGR.
In contrast, revision of the estimates used to set the SGRs for FYs 1998 and 1999 would have resulted in higher physician fee schedule CFs for CY 2000 and all subsequent years than those we have actually determined. If the statute authorized revisions of the estimates used to establish both the MVPS and the SGRs for FYs 1998 and 1999, the physician fee schedule CF would be higher than it is currently.
We have analyzed the effect that revision of the estimates used to set the MVPS from FY 1990 through 1996 and the SGRs for FYs 1998 and 1999 would have on the physician fee schedule update for CY 2003 and subsequent years. The Department believes that a positive update could result if the statute authorized revisions of the estimates used to establish both the SGR for FYs 1998 and 1999 and MVPS for 1990 to 1996.
As noted above, however, current law does not permit the Department to adopt the positive update for 2003. In the event that Congress enacts legislation permitting the Department to make such an adjustment, the Department wishes to make the adjustment as promptly as possible. We therefore are soliciting public comments regarding the proper adjustments in the event that Congress authorizes the Department to make such an adjustment.
1. Calculation Under Current Law
Under section 1848(d)(4)(A) of the Act, the physician fee schedule update for a year is equal to the product of- (1) 1 plus the Secretary's estimate of the percentage increase in the MEI for the year, divided by 100 and (2) 1 plus the Secretary's estimate of the update adjustment factor for the year. Under section 1848(d)(4)(B) of the Act, the update adjustment factor for a year beginning with 2001 is equal to the sum of the following-
• Prior Year Adjustment Component. An amount determined by-
-Computing the difference (which may be positive or negative) between the amount of the allowed expenditures for physicians' services for the prior year (the year prior to the year for which the update is being determined) and the amount of the actual expenditures for such services for that year;
-Dividing that difference by the amount of the actual expenditures for such services for that year; and
-Multiplying that quotient by 0.75.
• Cumulative Adjustment Component. An amount determined by-
-Computing the difference (which may be positive or negative) between the amount of the allowed expenditures for physicians' services from April 1, 1996, through the end of the prior year and the amount of the actual expenditures for such services during that period;
-Dividing that difference by actual expenditures for such services for the prior year as increased by the sustainable growth rate for the year for which the update adjustment factor is to be determined; and
-Multiplying that quotient by 0.33.
Section 1848(d)(4)(E) of the Act requires the Secretary to recalculate allowed expenditures consistent with section 1848(f)(3) of the Act. Section 1848(f)(3) specifies that the SGR (and, in turn, allowed expenditures) for the upcoming calendar year (2003 in this case), the current calendar year (2002) and the preceding calendar year (2001) are to be determined on the basis of the best data available as of September 1 of the current year. Allowed expenditures are initially estimated and subsequently revised twice. The second revision occurs after the calendar year has ended (that is, we are making the final revision to 2001 allowed expenditures in this final rule). Once the SGR and allowed expenditures for a year have been revised twice, they are final.
Table 11 shows annual and cumulative allowed expenditures for physicians' services from April 1, 1996 through the end of the current calendar year, including the transition period to a calendar year system that occurred in 1999.
Period | Annual allowed expenditures (Dollars) | Cumulative allowed expenditures (Dollars) | FY or CY SGR |
---|---|---|---|
4/1/96-3/31/97 | 48.9 billion | 48.9 billion | N/A |
4/1/97-3/31/98 | 49.6 billion | 98.5 billion | FY 1998=1.5% |
4/1/98-3/31/99 | 49.4 billion | 147.9 billion | FY 1999=-0.3% |
1/1/99-3/31/99 | 12.5 billion | Included in 147.9 above | FY 1999=-0.3% |
4/1/99-12/31/99 | 39.6 billion | Included in 187.6 below | FY 2000=6.9% |
1/1/99-12/31/99 | 52.1 billion | 187.6 billion | FY 1999/FY 2000 (see note) |
1/1/00-12/31/00 | 55.9 billion | 243.5 billion | CY 2000=7.3% |
1/1/01-12/31/01 | 58.4 billion | 301.9 billion | CY 2001=4.5% |
1/1/02-12/31/02 | 63.5 billion | 365.4 billion | CY 2002=8.8% |
1/1/03-12/31/03 | 68.3 billion | 433.8 billion | CY 2003=7.6% |
*Note:
Allowed expenditures for the first quarter of 1999 are based on the FY 1999 SGR and allowed expenditures for the last three quarters of 1999 are based on the FY 2000 SGR. Allowed expenditures in the first year (April 1, 1996-March 31, 1997) are equal to actual expenditures. All subsequent figures are equal to quarterly allowed expenditure figures increased by the applicable SGR. Cumulative allowed expenditures are equal to the sum of annual allowed expenditures. We provide more detailed quarterly allowed and actual expenditure data on our Web site under the Medicare Actuary's publications at the following address: http://www.cms.hhs.gov/statistics/actuary/. We expect to update the web site with the most current information later this month.
Consistent with section 1848(d)(4)(E) of the Act, table 12 includes our final revision of allowed expenditures for 2001, a recalculation of allowed expenditures for 2002, and our initial estimate of allowed expenditures for 2003. To determine the update adjustment factor for 2003, the statute requires that we use cumulative allowed expenditures from April 1, 1996 through December 31, 2002, actual expenditures through December 31, 2002, and the SGR for 2003, as well as annual allowed and actual expenditures for 2002. We are using estimates of allowed expenditures for 2002 and 2003 that will subsequently be revised consistent with section 1848(d)(4)(E) of the Act. Because we have incomplete expenditure data for 2002, we are using an estimate for this period. Any difference between current estimates and final figures will be taken into account in determining the update adjustment factor for future years.
We are using figures from table 12 in the statutory formula illustrated below:
ER31DE02.000UAF = Update Adjustment Factor.
Target 02 = Allowed Expenditures for 2002 or $63.5 billion.
Actual 02 = Estimated Actual Expenditures for 2002 = $69.1 billion.
Target 4/96-12/02 = Allowed Expenditures from 4/1/1996-12/31/2002 = $365.4 billion.
Actual 4/96-12/02 = Estimated Actual Expenditures from 4/1/1996-12/31/2002 = $381.9 billion.
SGR 03 = 7.6 percent (1.076).
ER31DE02.001
Section 1848(d)(4)(D) of the Act indicates that the update adjustment factor determined under section 1848(d)(4)(B) of the Act for a year may not be less than -0.07 or greater than 0.03. Because the calculated update adjustment factor of -0.134 is less than the statutory limit of -0.07, the update adjustment factor for 2003 will be -0.07.
Section 1848(d)(4)(A)(ii) of the Act indicates that 1 should be added to the update adjustment factor determined under section 1848(d)(4)(B) of the Act. Thus, adding 1 to -0.070 makes the update adjustment factor equal to 0.930.
VII. Allowed Expenditures for Physicians' Services and the Sustainable Growth Rate
A. Medicare Sustainable Growth Rate
The SGR is an annual growth rate that applies to physicians' services paid for by Medicare. The use of the SGR is intended to control growth in aggregate Medicare expenditures for physicians' services. Payments for services are not withheld if the percentage increase in actual expenditures exceeds the SGR. Rather, the physician fee schedule update, as specified in section 1848(d)(4) of the Act, is adjusted based on a comparison of allowed expenditures (determined using the SGR) and actual expenditures. If actual expenditures exceed allowed expenditures, the update is reduced. If actual expenditures are less than allowed expenditures, the update is increased.
Section 1848(f)(2) of the Act specifies that the SGR for a year (beginning with 2001) is equal to the product of the following four factors:
(1) The estimated change in fees for physicians' services.
(2) The estimated change in the average number of Medicare fee-for-service beneficiaries.
(3) The estimated projected growth in real GDP per capita.
(4) The estimated change in expenditures due to changes in law or regulations.
In general, section 1848(f)(3) of the Act requires us to publish SGRs for 3 different time periods, no later than November 1 of each year, using the best data available as of September 1 of each year. Under section 1848(f)(3)(C)(i) of the Act, the SGR is estimated and subsequently revised twice (beginning with the FY and CY 2000 SGRs) based on later data. Under section 1848(f)(3)(C)(ii) of the Act, there are no further revisions to the SGR once it has been estimated and subsequently revised in each of the 2 years following the preliminary estimate. In this final rule, we are making our preliminary estimate of the 2003 SGR, a revision to the 2002 SGR, and our final revision to the 2001 SGR.
B. Physicians' Services
Section 1848(f)(4)(A) of the Act defines the scope of physicians' services covered by the SGR. The statute indicates that the term "physicians' services" includes other items and services (such as clinical diagnostic laboratory tests and radiology services), specified by the Secretary, that are commonly performed or furnished by a physician or in a physician's office, but does not include services furnished to a Medicare+Choice plan enrollee. We published a definition of physicians' services for use in the SGR in the Federal Register (66 FR 55316) on November 1, 2001. We defined "physicians' services" to include many of the medical and other health services listed in section 1861(s) of the Act. For purposes of determining allowed expenditures, actual expenditures, and SGRs through December 31, 2002, we have specified that "physicians' services" include the following medical and other health services if bills for the items and services are processed and paid by Medicare carriers:
• Physicians' services.
• Services and supplies furnished incident to physicians' services.
• Outpatient physical therapy services and outpatient occupational therapy services.
• Antigens prepared by or under the direct supervision of a physician.
• Services of physician assistants, certified registered nurse anesthetists, certified nurse midwives, clinical psychologists, clinical social workers, nurse practitioners, and clinical nurse specialists.
• Screening tests for prostate cancer, colorectal cancer, and glaucoma.
• Screening mammography, screening pap smears, and screening pelvic exams.
• Diabetes outpatient self-management training services.
• Medical nutrition therapy services.
• Diagnostic x-ray tests, diagnostic laboratory tests, and other diagnostic tests.
• X-ray, radium, and radioactive isotope therapy.
• Surgical dressings, splints, casts, and other devices used for the reduction of fractures and dislocations.
• Bone mass measurements.
In the June 2002 proposed rule (67 FR 43861), we announced a change to our methodology for determining the "weighted average percentage increase in fees for all physicians' services" for the 2001 and subsequent year SGRs. We use a weighted average of the price indices that are used to increase payment for services included in the SGR to determine the percentage increase in fees for physicians' services. Physicians' services are updated using the MEI. Clinical diagnostic laboratory services are updated using the CPI. Drugs furnished "incident to" a physician's service under section 1861(s)(2)(A) of the Act, are also included in the calculation of the SGR. Under section 1842(o) of the Act, payments for drugs are based on 95 percent of average wholesale prices. We are currently using the MEI as a proxy for growth in drug prices. In the proposed rule, we indicated that, rather than using the MEI as proxy for growth in drug prices, we would use growth in actual drug prices to determine the weighted average percentage increase in fees for all physicians' services. In response, we received many comments suggesting that "incident to" drugs should not be included in the definition of physicians' services.
Comment: Comments indicated that the administration of a drug is a physician's service that, by statute, must be included in the definition of physicians' services. The drug itself, however, argued the comments, is not a physician service and should not be included in the SGR. A number of comments indicated that rising Medicare expenditures for drugs are due in large part to the introduction of costly new cancer drugs and not to the failure of physicians to control their use. Many of these comments stated that the increase in drug spending is due to government policies that encourage the rapid development of new drugs, as well as government efforts to urge Americans to be tested and seek early treatment for cancer and other diseases. Some comments indicated that physicians should not be forced to pay for the rising cost of drugs covered by Medicare through reduced fees. Other comments stated that including drugs in the SGR has not led to controls on drug spending and, as a result, removing them would not lead to increased spending. Other comments indicated that the SGR has not been increased to reflect the growing cost of drugs. These comments indicated that the SGR should either account for the growing cost of drugs or exclude them completely. One comment indicated that the SGR should account for the cost of new drugs approved by the FDA and covered by Medicare during the prior year and the cost of covered drugs that have the same biologic effect as non-covered drugs. Several comments indicated that the Secretary does not have the legal authority to include "incident to" drugs in the SGR because the section 1848(f) of the Act refers to physicians' services and not "medical and other health services." Others provided copies of a detailed legal opinion arguing that drugs may be included in the SGR under section 1848(f) of the Act but cannot be included in the definition of physicians' services for purposes of determining the update adjustment factor under section 1848(d) of the Act.
Response: The statute provides the Secretary with clear authority to specify the services that are included in the SGR. Section 1848(f)(4)(A) of the Act indicates "the term 'physicians' services' includes other items and services (such as clinical diagnostic laboratory tests and radiology services) specified by the Secretary, that are commonly performed or furnished by a physician or in a physician's office". We disagree with the comments suggesting that the Secretary does not have the authority to include drugs in the definition of physicians' services for purposes of determining allowed expenditures, actual expenditures and the SGR. In reviewing section 1861(s) of the Act, we decided to include items and services in the SGR that are commonly furnished by physicians or in physicians' offices. Since "incident to" drugs covered under section 1861(s) of the Act are commonly furnished in physicians' offices, we are including these items in the SGR.
C. Provisions Related to the Sustainable Growth Rate
Section 211(b)(1) of the BBRA amended section 1848(f)(1) of the Act to require that three SGR estimates be published in the Federal Register not later than November 1 of every year. In this final rule, we are publishing our preliminary estimate of the SGR for 2003, a revised estimate of the SGR for 2002, and our final determination of the SGR for 2001. Consistent with section 1848(f)(3)(C) of the Act, we are using the best data available to us as of September 1, 2002 for all of the figures.
D. Preliminary Estimate of the Sustainable Growth Rate for 2003
Our preliminary estimate of the 2003 SGR is 7.6 percent. We first estimated the 2003 SGR in March and made the estimate available to the Medicare Payment Advisory Commission and on our website. Table 12 shows our March estimates and our current estimates of the factors included in the SGR:
Statutory factors | March estimate | Current estimate |
---|---|---|
Fees | 1.7% (1.017) | 2.9% (1.029) |
Enrollment | 1.3% (1.013) | 1.2% (1.012) |
Real per capita GDP | 2.9% (1.029) | 3.3% (1.033) |
Law and regulation | 0.0% (1.000) | 0.0% (1.000) |
Total | 6.0% (1.060) | 7.6% (1.076) |
Note:
Consistent with section 1848(f)(2) of the Act, the statutory factors are multiplied, not added, to produce the total (that is, 1.029 × 1.012 × 1.033 × 1.000 = 1.076.) A more detailed explanation of each figure is provided below in section H.1.
E. Revised Sustainable Growth Rate for 2002
Our current estimate of the 2002 SGR is 8.8 percent. Table 13 shows our preliminary estimate of the 2002 SGR that was published in the Federal Register on November 1, 2001 (66 FR 55317) and our current estimate:
Statutory factors | 11/1/01 estimate | Current estimate |
---|---|---|
Fees | 2.3 (1.023) | 2.5% (1.025) |
Enrollment | 0.7 (1.007) | 2.8% (1.028) |
Real per capita GDP | 1.7 (1.017) | 2.3% (1.023) |
Law and regulation | 0.8 (1.008) | 0.9% (1.009) |
Total | 5.6 (1.056) | 8.8% (1.088) |
A more detailed explanation of each figure is provided below in section H.2.
F. Final Sustainable Growth Rate for 2001
The SGR for 2001 is 4.5 percent. Table 14 shows our preliminary estimate of the SGR published in the Federal Register on November 1, 2000 (65 FR 65433), our revised estimate published in the Federal Register on November 1, 2001 (66 FR 55317) and the final figures determined using the latest available data:
Statutory factors | 11/1/00 estimate | 11/1/01 estimate | Current estimate |
---|---|---|---|
Fees | 1.9 (1.019) | 1.9 (1.019) | 2.1% (1.021) |
Enrollment | 0.9 (1.009) | 3.0 (1.030) | 3.0% (1.030) |
Real per capita GDP | 2.7 (1.027) | 0.7 (1.007) | -0.7% (0.993) |
Law and regulation | 0.0 (1.000) | 0.4 (1.004) | 0.1% (1.001) |
Total | 5.6 (1.056) | 6.1 (1.061) | 4.5% (1.045) |
A more detailed explanation of each figure is provided below in section H.2.
G. Calculation of 2003, 2002, and 2001 Sustainable Growth Rates
1. Detail on the 2003 SGR
A more detailed discussion of our preliminary estimates of the four elements of the 2003 SGR follows. We note that all of the figures used to determine the 2003 SGR are estimates that will be revised based on subsequent data. Any differences between these estimates and the actual measurement of these figures will be included in future revisions of the SGR and incorporated into subsequent physician fee schedule updates.
Factor 1-Changes in Fees for Physicians' Services (Before Applying Legislative Adjustments) for CY 2003
This factor was calculated as a weighted average of the 2002 fee increases for the different types of services included in the definition of physicians' services for the SGR. Medical and other health services paid using the physician fee schedule account for approximately 83.5 percent of total allowed charges included in the SGR and are updated using the MEI. The MEI for 2003 is 3.0 percent. Diagnostic laboratory tests represent approximately 8.0 percent of Medicare allowed charges included in the SGR and the costs of these tests are typically updated by the CPI-U. The CPI-U for 2003 that will be used to update clinical diagnostic laboratory tests is 1.1 percent. Drugs represent 8.5 percent of Medicare allowed charges included in the SGR. Medicare pays for drugs based on 95 percent of AWP under section 1842(o) of the Act. We calculated the weighted average fee increase for drugs to be included in the SGR, we estimate a weighted average fee increase for drugs of 3.3 percent in 2002. Table 15 shows the weighted average of the MEI, laboratory and drug price increases for 2003:
Weight | Update | |
---|---|---|
Physician | 0.835 | 3.0 |
Laboratory | 0.080 | 1.1 |
Drugs | 0.085 | 3.3 |
Weighted Average | 1.000 | 2.9 |
After taking into account the elements described in table 16, we estimate that the weighted-average increase in fees for physicians' services in 2002 under the SGR (before applying any legislative adjustments) will be 2.9 percent.
Factor 2-The Percentage Change in the Average Number of Part B Enrollees From 2002 to 2003
This factor is our estimate of the percent change in the average number of fee-for-service enrollees from 2002 to 2003. Services provided to Medicare+Choice (M+C) plan enrollees are outside the scope of the SGR and are excluded from this estimate. Our actuaries estimate that the average number of Medicare Part B fee-for-service enrollees will increase by 1.2 percent from 2002 to 2003. Table 16 illustrates how this figure was determined:
2002 | 2003 | |
---|---|---|
Overall | 37.986 million | 38.321 million |
Medicare+Choice | 5.070 million | 5.012 million |
Net | 32.916 million | 33.309 million |
Percent Increase | 1.2 percent |
An important factor affecting fee-for-service enrollment is beneficiary enrollment in Medicare+Choice plans. Because it is difficult to estimate the size of the Medicare+Choice enrollee population before the start of a calendar year, at this time, we do not know how actual enrollment in Medicare+Choice plans will compare to current estimates. For this reason, there may be substantial changes to this estimate as actual Medicare fee-for-service enrollment for 2003 becomes known.
Factor 3-Estimated Real Gross Domestic Product Per Capita Growth in 2003
We estimate that the growth in real per capita GDP from 2002 to 2003 will be 3.3 percent. Our past experience indicates that there have also been large changes in estimates of real per capita GDP growth made before the year begins and the actual change in GDP computed after the year is complete. Thus, it is likely that this figure will change as actual information on economic performance becomes available to us in 2003.
Factor 4-Percentage Change in Expenditures for Physicians' Services Resulting From Changes in Law or Regulations in CY 2003 Compared With CY 2002
As indicated below, section 101-104 of the BIPA added Medicare coverage for a variety of new services. We estimate no additional costs for these services in 2003 relative to 2002. We will continue to monitor utilization of all of the new benefits provided in BIPA and modify our estimates (up or down) and the SGRs accordingly.
Comment: We received many comments indicating that we should adjust the SGR to account for the addition of the psychiatric diagnostic interview to the list of covered telehealth services.
Response: We agree that the addition of the psychiatric diagnostic interview is a change in regulation that should be accounted for in the SGR. However, since there is such low utilization of the telehealth benefit, we believe the addition of the psychiatric diagnostic interview to the list of covered telehealth services will have no impact on the SGR.
Comment: Several comments noted that section 112 of BIPA changed Medicare's drug payment policy. Prior to the enactment of the BIPA, section 1861(s)(2) of the Act allowed Medicare to pay for "drugs and biologicals, which cannot, as determined in accordance with regulations, be self-administered." The BIPA amended the Act to allow Medicare to pay for drugs which "are not usually administered by the patient." The commenters believe that this new drug payment policy will result in an increase in expenditures that should be accounted for in the SGR.
Response: The amendments to Medicare's drug payment policy contained in section 112 of the BIPA constitute a change in law or regulation that is taken into account in determining the SGR. We estimate a 2002 cost for this policy change that will be accounted for in the 2002 SGR described below. At this time, we are not estimating additional Medicare costs in 2003 relative to 2002 for drugs not usually self-administered by patients.
Comment: We received many public comments that argued for adjusting the SGR for changes in expenditures resulting from NCDs. According to these comments, any changes in national Medicare coverage policy that are adopted by us pursuant to a formal or informal rulemaking, such as a Program Memorandum or a national Medicare coverage determination, constitute a regulatory change for purposes of computing factor 4 of the SGR. The comments indicate that our authority to make any regulatory change is derived from law-whether it is a law specifically authorizing Medicare coverage of a new service or a law that provides general rulemaking authority. According to these comments, any new coverage initiative is a direct implementation, by regulation, of a law that should be taken into account in determining the SGR. One commenter indicated that we effectively compare actual expenditure data that include additional utilization resulting from NCDs with a spending target that does not include this additional utilization, making it more likely that the target will be exceeded.
Response: We carefully considered this comment. If the Congress adds a new statutory benefit (for example, medical nutrition therapy), we are required by law to increase the target. Medicare does not have authority to pay for a service lacking a defined statutory benefit listed in section 1861(s) of the Act (for example, prior to January 1, 2002, there was no authority for Medicare to pay for medical nutrition therapy). However, we do have the authority to establish national coverage policies for items and services that are included in a benefit category listed in section 1861(s) of the Act. Further, we contract with Medicare carriers who may establish local coverage policies for items and services that have a statutory benefit category.
The statute requires that real GDP per capita be used in setting the SGR target. We believe that use of real GDP per capita was intended as a proxy for a number of factors that may increase the volume and intensity of physicians' services (other than beneficiary enrollment and statutory changes that increase expenditures, which are separately accounted for by the statute), such as those associated with coverage of new items or services and other miscellaneous factors that cannot be specifically identified, such as any spending associated with NCDs.
The large majority of Medicare spending is for services that are covered at local carrier discretion. While we may establish national coverage (or non-coverage) for a new item or service with a defined statutory benefit category, this NCD does not necessarily increase Medicare spending to the extent that the service has or would have been covered at local carrier discretion in the absence of a NCD. For instance, there was widespread publicity in 2000 about ocular photodynamic therapy (OPT), a new treatment for macular degeneration, a common cause of blindness in the elderly. Prior to our NCD, Medicare carriers had the authority to cover OPT at local carrier discretion as a physician's service under section 1861(s)(1) of the Act. Given the widespread publicity about the effectiveness of this new treatment, it is likely that, in the absence of a NCD, OPT would have been covered at local carrier discretion. That is, application of existing Medicare law and regulations would have allowed Medicare coverage for OPT at local carrier discretion. Because it seems likely that Medicare would covered this procedure in any event, it is unclear whether there are any additional costs associated with the NCD. Indeed the NCD limited the coverage of OPT to a defined subpopulation of Medicare beneficiaries. The local contractor determinations may not have done so, and therefore, the NCD may actually have resulted in a net savings to Medicare. Moreover, we did not change the law or regulations by making a national coverage decision for OPT. Rather, we applied existing law and regulations to a new service to make a national statement about coverage where one did not previously exist.
We may also issue a NCD to clarify Medicare coverage for existing items or services. Such a decision may establish national policy that replaces differing local practices. In such a case, there may not have been consistency among Medicare carriers as to whether an item or service qualified for coverage based on existing law or regulation. Thus, our NCD would not change law or regulation, but replaces differing local practices with a national determination that, based on existing law and regulations, clarifies Medicare coverage for an item or service. Spending may increase or decrease depending upon the degree to which the particular item or service is currently being covered by Medicare carriers and whether the decision is to establish coverage or non-coverage of the item or service.
For the reasons previously discussed, it would be very difficult to estimate any costs or savings associated with specific coverage decisions. Further, we believe any adjustment to the target would likely be of such a small magnitude that it would have little effect on future projected updates.
1. Detail on the 2002 SGR
A more detailed discussion of our revised estimates of the four elements of the 2002 SGR follows.
Factor 1-Changes in Fees for Physicians' Services (Before Applying Legislative Adjustments) for 2002
This factor was calculated as a weighted average of the 2002 fee increases that apply for the different types of services included in the definition of physicians' services for the SGR.
Services paid using the physician fee schedule account for approximately 84.5 percent of total allowed charges included in the SGR, and are updated using the MEI. The MEI for 2002 is 2.6 percent. Diagnostic laboratory tests represent approximately 7.5, and the costs of these tests are typically updated by the CPI-U. However, the BBA required a 0.0 percent update in 2002 for laboratory services. Drugs represent 8.0 percent of Medicare allowed charges included in the SGR. Pursuant to section 1842(o) of the Act, Medicare pays for drugs based on 95 percent of AWP. Using wholesale pricing information and Medicare utilization for drugs included in the SGR, we estimate a weighted average fee increase for drugs of 3.3 percent in 2002. Table 17 shows the weighted average of the MEI, laboratory and drug price increases for 2002:
Weight | Update | |
---|---|---|
Physician | 0.845 | 2.6 |
Laboratory | 0.075 | 0.0 |
Drugs | 0.080 | 3.3 |
Weighted Average | 1.000 | 2.5 |
After taking into account the elements described in table 18, we estimate that the weighted-average increase in fees for physicians' services in 2002 under the SGR (before applying any legislative adjustments) will be 2.5 percent.
Factor 2-The Percentage Change in the Average Number of Part B Enrollees from 2001 to 2002
Our actuaries estimate that the average number of Medicare Part B fee-for-service enrollees (excluding beneficiaries enrolled in M+C plans) increased by 2.8 percent in 2002. Table 18 illustrates how we determined this figure:
2001 | 2002 | |
---|---|---|
Overall | 37.633 million | 37.986 million |
Medicare+Choice | 5.608 million | 5.070 million |
Net | 32.025 million | 32.916 million |
Percent Increase | 2.8 percent |
Our actuaries' estimate of the 2.8 percent change in the average number of fee-for-service enrollees, net of Medicare+Choice enrollment for 2002, compared to 2001 is different from our preliminary estimate (0.7 percent for 2002 from the November 1, 2001 final rule (66 FR 55318)) because the historical base from which our actuarial estimate is made has changed. We now have complete information on Medicare fee-for-service enrollment for 2001 that is different than the figure we used one year ago. Further, we now have information on actual fee-for-service enrollment for the first 8 months of 2002. We would caution that our estimate of fee-for-service enrollment for 2002 may change again once we have complete information for the entire year.
Factor 3-Estimated Real Gross Domestic Product Per Capita Growth in 2002
We estimate that the growth in real per capita GDP will be 2.3 percent in 2002. Our past experience indicates that there have also been large differences between our preliminary estimates of real per capita GDP growth and the actual change in this factor. Thus, it is likely that this figure will change further as actual information on economic performance becomes available to us in 2003.
Factor 4-Percentage Change in Expenditures for Physicians' Services Resulting From Changes in Law or Regulations in 2002 Compared With 2001
As indicated earlier, sections 101 through 104 of the BIPA added Medicare coverage for a variety of new services that will affect the 2002 SGR. We included an adjustment in the 2002 SGR based on previous estimates of the costs of these new benefits, but are reducing our estimate of the costs of the new telehealth and medical nutrition therapy benefits based on lower utilization of these services than we had originally anticipated. This change will have little effect on this factor and we are not changing our estimate of the costs of any of the other provisions described earlier. In addition, as explained above, section 112 of BIPA made changes that will result in additional Medicare coverage for certain drugs. Prior to the enactment of the BIPA, Medicare only paid for drugs that cannot be self-administered by the patient. BIPA allows Medicare to pay for drugs that can be but are not usually self-administered. Accordingly, we are accounting for the increased Medicare drug expenditures that will result from implementation of section 112 of the BIPA. After taking these provisions into account, the percentage change in expenditures for physicians' services resulting from changes in law or regulations is estimated to be 0.9 percent for 2002.
3. Detail on the 2001 SGR
A more detailed discussion of our current estimates of the four elements of the 2001 SGR follows. Pursuant to section 1848(f)(3)(C) of the Act, we will be making no further revisions to these figures.
Factor 1-Changes in Fees for Physicians' Services (Before Applying Legislative Adjustments) for 2001
We are using a weighted average of the fee increases that apply to the different services included in the SGR for 2001. Services that are updated by the MEI represent 85.7 percent of allowed charges included in the SGR. The 2001 MEI was 2.1 percent. Pursuant to the BBA, laboratory services were updated by 0.0 percent in 2001 and represent 7.0 percent of allowed charges included in the SGR. The weighted average percentage increase in average wholesale prices for drugs included in the SGR in 2001 was 3.4 percent. Drugs represent 7.3 percent of allowed charges included in the SGR. Using these figures, the weighted average percentage increase in fees for physicians' services is illustrated in table 19:
Weight | Update | |
---|---|---|
Physician | 0.857 | 2.1 |
Laboratory | 0.070 | 0.0 |
Drugs | 0.073 | 3.4 |
Weighted Average | 1.000 | 2.1 |
Factor 2-The Percentage Change in the Average Number of Fee-for-Service Part B Enrollees From 2000 to 2001
We estimate the increase in the average number of fee-for-service enrollees (excluding Medicare+Choice enrollees) from 2000 to 2001 was 3.0 percent. Table 20 illustrates the calculation of this factor:
2000 | 2001 | |
---|---|---|
Overall | 37.330 million | 37.633 million |
Medicare+Choice | 6.233 million | 5.608 million |
Net | 31.098 million | 32.205 million |
Percent Increase | 3.0 percent |
Our calculation of this factor is based on complete data from 2001.
Factor 3-Estimated Real Gross Domestic Product Per Capita Growth in 2001
We estimate that the growth in real per capita GDP was -0.7 percent in 2001. This is a final figure based on complete data for 2001.
Factor 4-Percentage Change in Expenditures for Physicians' Services Resulting From Changes in Law or Regulations in CY 2001 Compared With CY 2000
As described above, the BIPA makes changes to the Act that affect Medicare expenditures for services included in the SGR. Some of these provisions had no effect on Medicare expenditures in 2001 because they did not go into effect until 2002. Other provisions became effective at some time during 2001. These provisions relate to coverage of new technology mammography, coverage changes for screening pap smears, screening pelvic exams, screening colonoscopy, expanded access to telehealth services, and Medicare payment for services provided in Indian Health Service hospitals and clinics. After taking these provisions into account, the percentage change in expenditures for physicians' services resulting from changes in law or regulations is estimated to be 0.1 percent for 2001.
VIII. Anesthesia and Physician Fee Schedule Conversion Factors
The 2003 physician fee schedule CF will be $34.5920. The 2003 national average anesthesia conversion factor is $16.0353.
The specific calculations to determine the physician fee schedule and anesthesia CFs for 2003 are explained below.
Detail on Calculation of the 2003 Physician Fee Schedule Conversion Factor
• Physician Fee Schedule Conversion Factor
Under section 1848(d)(1)(A) of the Act, the physician fee schedule CF is equal to the CF for the previous year multiplied by the update determined under section 1848(d)(4) of the Act. In addition, section 1848(c)(2)(B)(ii)(II) of the Act requires that changes to RVUs cannot cause the amount of expenditures to increase or decrease by more than $20 million from the amount of expenditures that would have been made if such adjustments had not been made. We implement this requirement through a uniform budget neutrality adjustment to the CF. There is one change that will require us to make an adjustment to the conversion factor to comply with the budget neutrality requirement in section 1848(c)(2)(B)(ii)(II) of the Act. We are making a 0.04 percent reduction (0.9996) in the CF to account for the increase in anesthesia work resulting from the 5-year review.
We are illustrating the calculation for the 2003 physician fee schedule CF in table 21:
2002 Conversion Factor | $36.1992 |
2003 Update | 0.9560 |
Budget-Neutrality Adjustment: Increase in Anesthesia Work | 0.9996 |
2003 Conversion Factor | 34.5920 |
• Anesthesia Fee Schedule Conversion Factor
Because anesthesia services do not have RVUs like other physician fee schedule services, we are accounting for the increase in anesthesia work through an adjustment to the anesthesia fee schedule conversion factor. As indicated earlier, we are increasing the physician work component of the anesthesia conversion factor by 2.10 percent to reflect a 9.13 percent increase in payment applied to 23 percent of anesthesia allowed charges. The 2002 anesthesia CF is $16.60. The physician work portion of the anesthesia conversion factor is 78 percent. We applied a 1.6 percent (1.016) increase to this part of the anesthesia conversion factor. Similarly, we also simulated the effect of practice expense refinements on the practice expense portion of the anesthesia conversion factor. The refinements reduced this portion of the anesthesia conversion factor by 4.04 percent (0.9596). In addition, we are also applying the physician fee schedule update and the budget neutrality adjustment for the increase in anesthesia work that that also apply to the physician fee schedule CF. To determine the anesthesia fee schedule CF for 2003, we used the following figures:
2002 Anesthesia Conversion Factor | $16.6055 |
Adjustments for work and practice expense | 1.0106 |
2003 Update | 0.9560 |
Budget-Neutrality Adjustment: Increase in Anesthesia Work | 0.9996 |
2003 Conversion Factor | 16.0353 |
IX. Provisions of the Final Rule
This final rule adopts the provisions of the June 2002 proposed rule, except as noted elsewhere in the preamble. The following is a highlight of the changes made from the proposed rule.
For immunization administration, we are developing practice expense RVUs for influenza, pneumonia, and hepatitis B vaccine G codes. This will increase the payment for these codes and make Medicare's payment for vaccine administration more consistent with the rates paid for the CPT codes.
For anesthesia, we are revising the regulations text at § 414.46(g) to incorporate that the policy on multiple procedure codes as well as add-on codes.
For enrollment of PTs and OTs as therapists in private practice, we are revising our regulations text at § 410.59 and § 410.60 to reflect that carriers and fiscal intermediaries can enroll therapists as PTs or OTs in private practice when the therapist is employed by physician groups or groups that are not professional corporations.
We are adopting the process to add or delete telehealth services and adding the psychiatric diagnostic interview examination to the list of telehealth services. In addition, we are referencing the process to add or delete services at new § 410.78(f).
For the definition of a ZZZ global period, we are revising the definition to show that physician work is associated with intraservice time and, in some instances, the pre- and postservice time.
For the definition of a screening fecal-occult blood test, we are revising the definition at § 410.37(a)(2) to permit coverage of non-guaiac based tests.
For the critical access hospital emergency services requirement we are modifying § 485.618(d) to include RNs.
X. Waiver of Proposed Rulemaking for Definition of a Screening Fecal-Occult Blood Test and Critical Access Hospital Emergency Services Requirement
We ordinarily publish a notice of proposed rulemaking in the Federal Register and invite public comment on proposed rules. The notice of proposed rulemaking includes a reference to the legal authority under which the rule is proposed and the terms and substances of the proposed rule or a description of the subjects and issues involved. This procedure can be waived, however, if an agency finds good cause that notice-and-comment procedure is impracticable, unnecessary, or contrary to the public interest and incorporates a statement of the finding and its reasons in the rule issued.
In our proposed rule, we did not propose to modify § 410.37. Still, we received a comment seeking to modify coverage for one particular type of colorectal cancer test, a fecal-occult blood test. As explained earlier in this preamble, we have agreed to modify this regulation in a manner that would permit broader Medicare coverage if that is determined to be appropriate. Consistent with this change, we are modifying § 410.37(a)(1)(v) to announce that we will consider approving new tests or procedures for use in the early detection of colorectal cancer through our process for making national coverage determinations.
The Congress has authorized the Secretary to cover additional tests or procedures that can be used for the early detection of colorectal cancer under the Colorectal Cancer Screening Test benefit in under part B in section 1861(pp)(1)(D) of the Act. The Secretary may determine that coverage of other tests or procedures are appropriate, in consultation with appropriate organizations. We are aware that new colorectal cancer screening tests are being developed. To determine whether it is appropriate to expand coverage to provide Medicare payment for additional tests or procedures, it will be necessary to compare the new tests to tests that are already covered. We are modifying § 410.37(a)(1)(v) to permit determinations on whether to cover (or not cover) additional tests or procedures to be made through NCDs.
Expanding Medicare coverage of additional, effective, and appropriate screening tests would be in the public interest because the tests may discover patients with cancer at an earlier stage, increasing the chances that the patient will obtain proper medical treatment. An NCD, authorized by section 1869(a)(2) of the Act, can be used to develop a national policy regarding the scope of benefits. Moreover, the process for making an NCD will permit public participation, as well as the participation of appropriate groups, as the agency determines whether or not expanded coverage for additional tests or procedures is appropriate. This process offers advantages to the public because it could permit an expansion in the scope of the colorectal cancer screening benefit more rapidly than the notice and comment procedures of the Administrative Procedure Act would normally permit.
In addition, we did not propose to modify § 485.618(d). A delay in implementation of this provision would hinder the ability of small CAHs (with no greater than 10 beds) in some frontier areas or remote locations to provide the necessary critical access hospital emergency services. It was brought to our attention that, in recent months, a number of small CAHs in very remote frontier areas have been struggling to comply with the CAH standard in § 485.618(d) that requires CAHs to have either a doctor of medicine or osteopathy, a physician's assistant, or a nurse practitioner, with training or experience in emergency care to ensure emergency coverage 24-hours-a-day, seven-days-a-week. These CAHs have 10 or less beds. In order to provide additional flexibility for other CAHs of virtually the same size, we believe 10 beds is an appropriate size limit for facilities that may be in the same situation and require potential relief from the existing staffing requirements. These facilities, located in isolated frontier communities, have only one medical practitioner and see a low volume of patients. For these providers the requirement referenced above results in a significant personal hardship to the sole practitioner who must be on call 24-hours-a-day, 52-weeks-a-year. In addition, it is a financial hardship for the facility to find a replacement for the currently required emergency services personnel because frequently the replacement costs far exceed what is recovered through the services provided. We believe that by allowing States to include RNs in the current critical access hospital emergency services personnel requirement, so that RNs may be on call for small CAHs in frontier areas or remote locations, we will help ensure that frontier communities will have continued access to CAH services. In addition, if small CAHs in frontier areas or remote locations close their doors there would be no access to care in these communities.
Accordingly, we find good cause for waiving the prior notice-and-comment procedures as unnecessary and contrary to the public interest. In addition, we note that rules of agency procedure are exempt from the notice and comment requirements of 5 U.S.C. 553.
XI. Collection of Information Requirements
Under the Paperwork Reduction Act of 1995, we are required to provide 60-days notice in the Federal Register and solicit public comment before a collection of information requirement is submitted to the Office of Management and Budget (OMB) for review and approval. In order to fairly evaluate whether an information collection should be approved by OMB, section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 requires that we solicit comment on the following issues:
• The need for the information collection and its usefulness in carrying out the proper functions of our agency.
• The accuracy of our estimate of the information collection burden.
• The quality, utility, and clarity of the information to be collected.
• Recommendations to minimize the information collection burden on the affected public, including automated collection techniques.
We are soliciting public comment on each of these issues for the following sections of this document that contain information collection requirements:
Section 485.618 permits a CAH located in an area designated as a frontier area or remote location described in paragraph (d)(1)(i) to include in the personnel requirement in paragraph (d) a RN, if the State in which the small CAH is located submits a letter to us, signed by the Governor, following consultation with the State Boards of Medicine and Nursing, and in accordance with State law, requesting that a RN be included temporarily in the list of personnel that must be on call and available on site within 60 minutes.
Since we anticipate that we will receive approximately five requests for an inclusion of RNs on an annual basis, this collection requirement is not subject to the PRA as stipulated under 5 CFR 1320.3(c).
If you comment on these information collection and recordkeeping requirements, please mail copies directly to the following:
Centers for Medicare Medicaid Services, Office of Strategic Operations Regulatory Affairs, RDIG, Attn.: John Burke, Room N2-14-26, 7500 Security Boulevard, Baltimore, MD 21244-1850.
Office of Information and Regulatory Affairs, Office of Management and Budget, Room 10235, New Executive Office Building, Washington, DC 20503,Attn: Brenda Aguilar, CMS Desk Officer.
XII. Response to Comments
Because of the large number of items of correspondence we normally receive on Federal Register documents published for comment, we are not able to acknowledge or respond to them individually. We will consider all comments we receive by the date and time specified in the DATES section of this preamble, and, if we proceed with a subsequent document, we will respond to the major comments in the preamble to that document.
XIII. Regulatory Impact Analysis
We have examined the impact of this rule as required by Executive Order 12866 (September 1993, Regulatory Planning and Review), the Regulatory Flexibility Act (RFA) (September 16, 1980 Pub. L. 96-354), section 1102(b) of the Social Security Act, the Unfunded Mandates Reform Act of 1995 (Pub. L. 104-4), and Executive order 13132.
Executive Order 12866 (as amended by Executive Order 13258, which reassigns responsibility of duties) directs agencies to assess all costs and benefits of available regulatory alternatives and, when regulation is necessary, to select regulatory approaches that maximize net benefits (including potential economic, environmental, public health and safety effects, distributive impacts, and equity). A regulatory impact analysis must be prepared for final rules with economically significant effects (that is, a final rule that would have an annual effect on the economy of $100 million or more in any 1 year, or would adversely affect in a material way the economy, a sector of the economy, productivity, competition, jobs, the environment, public health or safety, or State, local, or tribal governments or communities). We have simulated the effect of increases in payment for anesthesia work and the changes to practice expense RVUs described earlier. The net effect of the changes will not materially increase or decrease Medicare expenditures for physicians' services because the statute requires that these changes cannot increase or decrease expenditures more than $20 million. Since increases in payments resulting from the 5-year review anesthesia work and practice expense RVU changes cannot increase or decreases expenditures by more than $20 million, any increases or decreases in payment will result in a redistribution of payments among physician specialties. The proposed changes to the MEI would result in increases in Medicare expenditures for physicians' services of $150 million in fiscal year (FY) 2003, $340 million in FY 2004, and $550 million in FY 2005. Therefore, this rule is considered to be a major rule because it is economically significant, and, thus, we have prepared a regulatory impact analysis.
The RFA requires that we analyze regulatory options for small businesses and other entities. We prepare a Regulatory Flexibility Analysis unless we certify that a rule would not have a significant economic impact on a substantial number of small entities. The analysis must include a justification concerning the reason action is being taken, the kinds and number of small entities the rule affects, and an explanation of any meaningful options that achieve the objectives with less significant adverse economic impact on the small entities.
Section 1102(b) of the Act requires us to prepare a regulatory impact analysis for any proposed rule that may have a significant impact on the operations of a substantial number of small rural hospitals. This analysis must conform to the provisions of section 604 of the RFA. For purposes of section 1102(b) of the Act, we define a small rural hospital as a hospital that is located outside a Metropolitan Statistical Area and has fewer than 100 beds.
For purposes of the RFA, physicians, non-physician practitioners, and suppliers, are considered small businesses if they generate revenues of $8.5 million or less. Approximately 96 percent of physicians are considered to be small entities. There are about 700,000 physicians, other practitioners and medical suppliers that receive Medicare payment under the physician fee schedule. In addition, CAHs are considered small entities, either by nonprofit status or by having revenues of $6 to $29 million in any one year.
Section 202 of the Unfunded Mandates Reform Act of 1995 also requires that agencies assess anticipated costs and benefits before issuing any rule that may result in expenditure in any 1 year by State, local, or tribal governments, in the aggregate, or by the private sector, of $110 million. We have determined that this proposed rule will have no consequential effect on State, local, or tribal governments.
We have examined this final rule in accordance with Executive Order 13132 and have determined that this regulation would not have any negative impact on the rights, roles, or responsibilities of State, local, or tribal governments.
We have prepared the following analysis, which together with the rest of this preamble, meets all assessment requirements. It explains the rationale for, and purposes of, the rule, details the costs and benefits of the rule, analyzes alternatives, and presents the measures we are using to minimize the burden on small entities. As indicated elsewhere, we are making changes to the Medicare Economic Index, refining resource-based practice based practice expense RVUs, and making a variety of other changes to our regulations, payments, or payment policies to ensure that our payment systems are updated to reflect changes in medical practice and the relative value of services. We provide information for each of the policy changes in the relevant sections in this rule. In large part, the provisions of this rule are changing only Medicare payment rates for physician fee schedule services. While this rule allows physical and occupational therapists that are employed by physicians to separately enroll in the Medicare program, it does not impose reporting, recordkeeping, and other compliance requirements. We are unaware of any relevant Federal rules that duplicate, overlap, or conflict with this rule. The relevant sections of this contain a description of significant alternatives.
A. Resource-Based Practice Expense Relative Value Units
Under section 1848(c)(2) of the Act, adjustments to RVUs may not cause the amount of expenditures to differ by more than $20 million from the amount of expenditures that would have resulted without such adjustments. We are proposing several changes that would result in a change of expenditures that would exceed $20 million if we made no offsetting adjustments to either the CF or RVUs.
With respect to practice expense, our policy has been to meet the budget-neutrality requirements in the statute by incorporating a rescaling adjustment in the practice expense methodology. That is, we estimate the aggregate number of practice expense RVUs that would be paid under current policies and under the policies we will be using in 2003. We apply a uniform adjustment factor to make the aggregate number of proposed practice expense relative values equal the number estimated that would have been paid under current policy. Consistent with section 1848(c)(2)(B)(ii)(II) of the Act, we ensure that changes to practice expense RVUs do not increase or decrease payments more than $20 million. We are also applying a 0.49 percent (0.9951) reduction to the practice expense RVUs to account for an anticipated increase in the volume and intensity of services in response to payment reductions from refinement of practice expense RVUs.
Table 23 shows the specialty level impact of RVU changes on payment in 2003. As indicated in the June 2002 proposed rule (67 FR 43869), we are showing more specialty categories in our impact tables in this final rule than we have in the past. This change was well-received by the public, and we will continue to show impacts for the more detailed list of physician specialties, non-physician practitioners and medical suppliers. As indicated in the proposed rule, it is important to note that the payment impacts reflect averages for each specialty based on Medicare utilization. The payment impact for an individual physician would be different from the average, based on the mix of services the physician provides. The average change in total revenues would be less than the impact displayed here since physicians furnish services to both Medicare and non-Medicare patients and certain specialties may receive substantial Medicare revenues for services that are not paid under the physician fee schedule. For instance, independent laboratories receive more than 80 percent of their Medicare revenues from clinical laboratory services that are not paid under the physician fee schedule. Table 23 shows only the payment impact on physician fee schedule services.
We modeled the impact of several changes that will affect payment for physician fee schedule services in CY 2003. The column labeled "NPRM" shows the impacts of our proposed rule policies and reflects the figures shown in the June 28, 2002 proposed rule (67 FR 43867). The remaining columns show additional impacts that will result from changes made in this final rule in response to comments. The column labeled practice expense refinements shows the impact on payment resulting from changes to practice expense inputs that are described in section II.A. As indicated earlier, we are making refinements to over 1,100 procedure codes. These changes result in little or no impact for most specialties. Dermatology, nephrology, and audiology will experience an approximate reduction in payment of 3 percent as a result of these changes. Payment will decline by an estimated 2 percent for others (clinical social workers, independent diagnostic testing facilities) while reductions in payments will be more modest for a few other specialties (cardiac surgery, neurosurgery, clinical psychology, orthopedic surgery and physician assistants). Payment will increase by an estimated 4 percent for independent laboratories as a result of these changes and by 2 percent for plastic surgery. Other specialties will experience smaller increases in payments from the practice expense refinements (endocrinology, family practice, general practice, obstetrics, gynecology, pediatrics, physical medicine, rhematology, urology, chiropractor, and optometry).
The column labeled "5-Year Review" shows the impact revisions to payments for anesthesia services resulting from the 5-year review of physician work. As expected, the increase in anesthesia work results in a 1-percent increase in payment to anesthesiologists and a 2-percent increase to certified registered nurse anesthetists (CRNAs) that bill Medicare for anesthesia services. CRNAs bill Medicare almost exclusively for anesthesia services. Anesthesiologists bill Medicare for anesthesia services and other physician fee schedule services. The net increase in payment is slightly less for anesthesia services because it reflects the average increase in payment for anesthesia services and other physician fee schedule services that are not increasing as a result of the 5-year review
The column labeled "All Other Changes" reflects all changes that affect practice expense RVUs described in section II. A. These changes include: (1) As requested by the American Urology Association (AUA), removing several codes From the non-physician work pool; (2) incorporating supplemental data from the American Physical Therapy Association (APTA) and; (3) continuing to determine the global practice expense RVUs as the sum of the PC and TC practice expense RVUs for pathology services. While removing the codes requested by the AUA will increase payments to urologists, it will result in a somewhat smaller increase in payment than proposed for the services remaining in the non-physician work pool. As expected, incorporating supplemental survey data will increase payment to physical and occupational therapists. Payment reductions to pathology and independent laboratories resulting from determining the TC value as the difference between the global and PC will not occur in CY 2003 since we are not making this change for 1 year for pathology services paid using the physician fee schedule.
The column labeled "Total" shows the combined effect of all RVU changes on average Medicare payments for the specialties shown. The net effect of our final rule will continue to benefit several types of suppliers that provide services that are affected by the non-physician work pool methodology. Payments to Independent Diagnostic Testing Facilities will increase by approximately 4 percent. Portable x-ray suppliers will also receive an approximate increase of 4 percent in payments for services paid under the physician fee schedule. However, we note that only about 47 percent of Medicare revenues received by portable x-ray suppliers are attributable to physician fee schedule services. The other Medicare revenues received by portable x-ray suppliers are attributed to the transportation of x-ray equipment paid at rates determined by the Medicare carrier. Any change to the rates for carrier-priced services would be made at local carrier discretion. We recently asked our Medicare carriers to analyze payment for portable x-ray transportation since it has been a number of years since payment for this service has been reviewed.
Category | Medicare allowed charges ($ in billions) | NPRM (percent) | Practice expense refinements (percent) | 5-year review (percent) | All other changes (percent) | Total (percent) |
---|---|---|---|---|---|---|
Physicians: | ||||||
ALLERGY/IMMUNOLOGY | 0.14 | 2 | 0 | 0 | 0 | 1 |
ANESTHESIOLOGY | 1.24 | -1 | 0 | 1 | 0 | 1 |
CARDIAC SURGERY | 0.28 | 0 | -1 | 0 | 0 | -1 |
CARDIOLOGY | 4.75 | 1 | 0 | 0 | -1 | 1 |
CLINICS | 2.57 | 0 | 0 | 0 | 0 | 0 |
DERMATOLOGY | 1.55 | -2 | -3 | 0 | 1 | -4 |
EMERGENCY MEDICINE | 1.17 | 0 | 0 | 0 | 0 | 0 |
ENDOCRINOLOGY | 0.21 | 0 | 1 | 0 | -1 | 0 |
FAMILY PRACTICE | 3.43 | 0 | 1 | 0 | 0 | 0 |
GASTROENTEROLOGY | 1.34 | -1 | 0 | 0 | 0 | -1 |
GENERAL PRACTICE | 0.84 | 0 | 1 | 0 | 0 | 0 |
GENERAL SURGERY | 1.98 | -1 | 0 | 0 | 0 | -1 |
GERIATRICS | 0.08 | 0 | 0 | 0 | 0 | 0 |
HEMATOLOGY/ONCOLOGY | 0.95 | 1 | 0 | 0 | 0 | 1 |
INFECTIOUS DISEASE | 0.28 | -1 | 0 | 0 | 0 | -1 |
INTERNAL MEDICINE | 6.77 | 0 | 0 | 0 | 0 | 0 |
INTERVENTIONAL RADIOLOGY | 0.14 | 1 | 0 | 0 | -2 | -1 |
NEPHROLOGY | 1.09 | -1 | -3 | 0 | 0 | -4 |
NEUROLOGY | 0.91 | 2 | 0 | 0 | 0 | 2 |
NEUROSURGERY | 0.38 | -1 | -1 | 0 | 0 | -1 |
OBSTETRICS/GYNECOLOGY | 0.48 | 0 | 1 | 0 | 0 | 1 |
OPHTHALMOLOGY | 3.86 | -1 | 0 | 0 | 0 | -1 |
ORTHOPEDIC SURGERY | 2.40 | 0 | -1 | 0 | 0 | -2 |
OTOLARNGOLOGY | 0.66 | 0 | 0 | 0 | -1 | -1 |
PATHOLOGY | 0.69 | -2 | 0 | 0 | 2 | 0 |
PEDIATRICS | 0.05 | 0 | 1 | 0 | 0 | 1 |
PHYSICAL MEDICINE | 0.49 | 1 | 1 | 0 | 0 | 2 |
PLASTIC SURGERY | 0.25 | -1 | 2 | 0 | 0 | 0 |
PSYCHIATRY | 1.00 | 0 | 0 | 0 | 0 | -1 |
PULMONARY DISEASE | 1.12 | 0 | 0 | 0 | 0 | 0 |
RADIATION ONCOLOGY | 0.81 | 3 | 0 | 0 | -2 | 1 |
RADIOLOGY | 3.47 | 2 | 0 | 0 | -1 | 1 |
RHEUMATOLOGY | 0.30 | 0 | 1 | 0 | -1 | 0 |
THORACIC SURGERY | 0.43 | 0 | 0 | 0 | 0 | -1 |
UROLOGY | 1.36 | -1 | 1 | 0 | 2 | 2 |
VASCULAR SURGERY | 0.37 | 2 | 0 | 0 | 0 | 1 |
Other Practitioners: | ||||||
AUDIOLOGIST | 0.02 | 8 | -3 | 0 | -2 | 2 |
CHIROPRACTOR | 0.50 | -1 | 1 | 0 | 0 | -1 |
CLINICAL PSYCHOLOGIST | 0.40 | 1 | -1 | 0 | 0 | 0 |
CLINICAL SOCIAL WORKER | 0.23 | 0 | -2 | 0 | 0 | -1 |
NURSE ANESTHETIST | 0.38 | -1 | 0 | 2 | 0 | 1 |
NURSE PRACTITIONER | 0.30 | 0 | 0 | 0 | 0 | 0 |
OPTOMETRY | 0.54 | -2 | 1 | 0 | -1 | -1 |
PHYSICAL/OCCUPATIONAL THERAPY | 0.61 | 0 | 0 | 0 | 3 | 2 |
PHYSICIANS ASSISTANT | 0.23 | 0 | -1 | 0 | 0 | -1 |
PODIATRY | 1.17 | -1 | 0 | 0 | 0 | 0 |
Suppliers: | ||||||
DIAGNOSTIC TESTING FACILITY | 0.51 | 9 | -2 | 0 | -4 | 3 |
INDEPENDENT LABORATORY | 0.43 | -8 | 4 | 0 | 8 | 3 |
PORTABLE X-RAY SUPPLIER | 0.07 | 8 | 0 | 0 | -3 | 4 |
ALL OTHER | 0.29 | 0 | -1 | 0 | 0 | -1 |
ALL PHYSICIAN FEE SCHEDULE | 53.53 | 0 | 0 | 0 | 0 | 0 |
Table 24 shows the combined impact of changes in payment due to RVUs and the physician fee schedule update. As described in section V, section 1848(d)(4) of the Act requires the physician fee schedule update to be -4.4 percent. We do not have the authority to change the physician fee schedule update formula specified in the statute. Table 24 shows the estimated change in average payments by specialty based on the provisions of this final rule and the physician fee schedule update.
Category | Medicare allowed charges ($ in billions) | 5 Year review/RVU changes percent | Physician fee schedule update percent | Total percent |
---|---|---|---|---|
Physicians: | ||||
ALLERGY/IMMUNOLOGY | 0.14 | 1 | -4.4 | -3 |
ANESTHESIOLOGY | 1.24 | 1 | -4.4 | -3 |
CARDIAC SURGERY | 0.28 | -1 | -4.4 | -6 |
CARDIOLOGY | 4.75 | 1 | -4.4 | -4 |
CLINICS | 2.57 | 0 | -4.4 | -5 |
DERMATOLOGY | 1.55 | -4 | -4.4 | -8 |
EMERGENCY MEDICINE | 1.17 | 0 | -4.4 | -5 |
ENDOCRINOLOGY | 0.21 | 0 | -4.4 | -5 |
FAMILY PRACTICE | 3.43 | 0 | -4.4 | -5 |
GASTROENTEROLOGY | 1.34 | -1 | -4.4 | -5 |
GENERAL PRACTICE | 0.84 | 0 | -4.4 | -4 |
GENERAL SURGERY | 1.98 | -1 | -4.4 | -5 |
GERIATRICS | 0.08 | 0 | -4.4 | -5 |
HEMATOLOGY/ONCOLOGY | 0.95 | 1 | -4.4 | -3 |
INFECTIOUS DISEASE | 0.28 | -1 | -4.4 | -5 |
INTERNAL MEDICINE | 6.77 | 0 | -4.4 | -5 |
INTERVENTIONAL RADIOLOGY | 0.14 | -1 | -4.4 | -5 |
NEPHROLOGY | 1.09 | -4 | -4.4 | -8 |
NEUROLOGY | 0.91 | 2 | -4.4 | -2 |
NEUROSURGERY | 0.38 | -1 | -4.4 | -6 |
OBSTETRICS/GYNECOLOGY | 0.48 | 1 | -4.4 | -3 |
OPHTHALMOLOGY | 3.86 | -1 | -4.4 | -5 |
ORTHOPEDIC SURGERY | 2.40 | -2 | -4.4 | -7 |
OTOLARNGOLOGY | 0.66 | -1 | -4.4 | -5 |
PATHOLOGY | 0.69 | 0 | -4.4 | -5 |
PEDIATRICS | 0.05 | 1 | -4.4 | -4 |
PHYSICAL MEDICINE | 0.49 | 2 | -4.4 | -3 |
PLASTIC SURGERY | 0.25 | 0 | -4.4 | -4 |
PSYCHIATRY | 1.00 | -1 | -4.4 | -5 |
PULMONARY DISEASE | 1.12 | 0 | -4.4 | -4 |
RADIATION ONCOLOGY | 0.81 | 1 | -4.4 | -3 |
RADIOLOGY | 3.47 | 1 | -4.4 | -4 |
RHEUMATOLOGY | 0.30 | 0 | -4.4 | -4 |
THORACIC SURGERY | 0.43 | -1 | -4.4 | -5 |
UROLOGY | 1.36 | 2 | -4.4 | -3 |
VASCULAR SURGERY | 0.37 | 1 | -4.4 | -3 |
Other Practitioners: | ||||
AUDIOLOGIST | 0.02 | 2 | -4.4 | -2 |
CHIROPRACTOR | 0.50 | -1 | -4.4 | -5 |
CLINICAL PSYCHOLOGIST | 0.40 | 0 | -4.4 | -4 |
CLINICAL SOCIAL WORKER | 0.23 | -1 | -4.4 | -5 |
NURSE ANESTHETIST | 0.38 | 1 | -4.4 | -4 |
NURSE PRACTITIONER | 0.30 | 0 | -4.4 | -5 |
OPTOMETRY | 0.54 | -1 | -4.4 | -5 |
PHYSICAL/OCCUPATIONAL THERAPY | 0.61 | 2 | -4.4 | -3 |
PHYSICIANS ASSISTANT | 0.23 | -1 | -4.4 | -6 |
PODIATRY | 1.17 | 0 | -4.4 | -5 |
Suppliers: | ||||
DIAGNOSTIC TESTING FACILITY | 0.51 | 3 | -4.4 | -1 |
INDEPENDENT LABORATORY | 0.43 | 3 | -4.4 | -1 |
PORTABLE X-RAY SUPPLIER | 0.07 | 4 | -4.4 | 0 |
ALL OTHER | 0.29 | -1 | -4.4 | -6 |
ALL PHYSICIAN FEE SCHEDULE | 53.53 | 0 | -4.4 | -5 |
Table 25 shows the impact of all of the changes previously discussed on payments for selected high volume procedures. This table shows the combined impact of changes in RVUs and the physician fee schedule update on total payment for the procedure. There are separate columns that show the change in the facility rates and the nonfacility rates. For an explanation of facility and non-facility practice expense refer to § 414.22(b)(5)(i).
HCPCS | MOD | DESC | Non-Facility | Old | New | % Change | Facility | Old | New | % Change |
---|---|---|---|---|---|---|---|---|---|---|
11721 | Debride nail, 6 or more | $36.92 | $35.28 | ^4 | $28.96 | $27.33 | ^6 | |||
17000 | Destroy benign/premlg lesion | 62.62 | 57.77 | ^8 | 32.94 | 31.13 | ^5 | |||
27130 | Total hip arthroplasty | N/A | N/A | N/A | 1,452.31 | 1,263.30 | ^13 | |||
27236 | Treat thigh fracture | N/A | N/A | N/A | 1,113.85 | 1,005.24 | ^10 | |||
27244 | Treat thigh fracture | N/A | N/A | N/A | 1,137.38 | 1,086.53 | ^4 | |||
27447 | Total knee arthroplasty | N/A | N/A | N/A | 1,514.21 | 1,359.47 | ^10 | |||
33533 | CABG, arterial, single | N/A | N/A | N/A | 1,827.34 | 1,691.89 | ^7 | |||
35301 | Rechanneling of artery | N/A | N/A | N/A | 1,061.36 | 1,009.74 | ^5 | |||
43239 | Upper GI endoscopy, biopsy | 354.75 | 317.55 | ^10 | 154.93 | 146.67 | ^5 | |||
45385 | Lesion removal colonoscopy | 571.22 | 513.00 | ^10 | 287.78 | 273.28 | ^5 | |||
66821 | After cataract laser surgery | 229.50 | 215.51 | ^6 | 213.94 | 200.29 | ^6 | |||
66984 | Cataract surg w/iol, 1 stage | N/A | N/A | N/A | 669.32 | 630.61 | ^6 | |||
67210 | Treatment of retinal lesion | 603.08 | 568.35 | ^6 | 546.61 | 515.77 | ^6 | |||
71010 | 26 | Chest x-ray | 9.05 | 8.65 | ^4 | 9.05 | 8.65 | ^4 | ||
71020 | 26 | Chest x-ray | 11.22 | 10.38 | ^7 | 11.22 | 10.38 | ^7 | ||
76091 | Mammogram, both breasts | 90.50 | 88.21 | ^3 | N/A | N/A | N/A | |||
76091 | 26 | Mammogram, both breasts | 43.44 | 41.51 | ^4 | 43.44 | 41.51 | ^4 | ||
76092 | Mammogram, screening | 81.81 | 77.83 | ^5 | N/A | N/A | N/A | |||
76092 | 26 | Mammogram, screening | 35.48 | 33.90 | ^4 | 35.48 | 33.90 | ^4 | ||
77427 | Radiation tx management, 5 | 167.96 | 158.09 | ^6 | 167.96 | 158.09 | ^6 | |||
78465 | 26 | Heart image (3d), multiple | 74.93 | 70.91 | ^5 | 74.93 | 70.91 | ^5 | ||
88305 | 26 | Tissue exam by pathologist | 40.54 | 38.40 | ^5 | 40.54 | 38.40 | ^5 | ||
90801 | Psy dx interview | 144.80 | 140.10 | ^3 | 137.19 | 132.14 | ^4 | |||
90806 | Psytx, off, 45-50 min | 95.93 | 90.63 | ^6 | 91.22 | 87.17 | ^4 | |||
90807 | Psytx, off, 45-50 min w/em | 103.53 | 96.51 | ^7 | 98.82 | 94.09 | ^5 | |||
90862 | Medication management | 51.04 | 47.74 | ^6 | 46.33 | 44.97 | ^3 | |||
90921 | ESRD related services, month | 273.30 | 246.64 | ^10 | 273.30 | 246.64 | ^10 | |||
90935 | Hemodialysis, one evaluation | N/A | N/A | N/A | 76.38 | 67.11 | ^12 | |||
92004 | Eye exam, new patient | 123.44 | 116.23 | ^6 | 87.96 | 83.02 | ^6 | |||
92012 | Eye exam established pat | 61.18 | 57.77 | ^6 | 35.84 | 33.90 | ^5 | |||
92014 | Eye exam treatment | 91.22 | 85.44 | ^6 | 58.64 | 55.35 | ^6 | |||
92980 | Insert intracoronary stent | N/A | N/A | N/A | 788.06 | 752.72 | ^4 | |||
92982 | Coronary artery dilation | N/A | N/A | N/A | 582.45 | 559.01 | ^4 | |||
93000 | Electrocardiogram, complete | 25.34 | 24.91 | ^2 | N/A | N/A | N/A | |||
93010 | Electrocardiogram report | 9.05 | 8.30 | ^8 | 9.05 | 8.30 | ^8 | |||
93015 | Cardiovascular stress test | 99.91 | 97.55 | ^2 | N/A | N/A | N/A | |||
93307 | 26 | Echo exam of heart | 48.14 | 45.32 | ^6 | 48.14 | 45.32 | ^6 | ||
93510 | 26 | Left heart catheterization | 230.59 | 217.58 | ^6 | 230.59 | 217.58 | ^6 | ||
98941 | Chiropractic manipulation | 35.48 | 33.55 | ^5 | 31.13 | 29.40 | ^6 | |||
99202 | Office/outpatient visit, new | 61.54 | 58.81 | ^4 | 45.61 | 43.24 | ^5 | |||
99203 | Office/outpatient visit, new | 91.95 | 87.17 | ^5 | 69.50 | 66.07 | ^5 | |||
99204 | Office/outpatient visit, new | 130.68 | 124.19 | ^5 | 102.81 | 97.55 | ^5 | |||
99205 | Office/outpatient visit, new | 166.15 | 158.43 | ^5 | 136.47 | 129.37 | ^5 | |||
99211 | Office/outpatient visit, est | 20.27 | 19.37 | ^4 | 8.69 | 8.30 | ^4 | |||
99212 | Office/outpatient visit, est | 36.20 | 34.25 | ^5 | 23.17 | 21.79 | ^6 | |||
99213 | Office/outpatient visit, est | 50.32 | 48.08 | ^4 | 34.03 | 32.52 | ^4 | |||
99214 | Office/outpatient visit, est | 78.91 | 75.06 | ^5 | 56.11 | 53.27 | ^5 | |||
99215 | Office/outpatient visit, est | 115.84 | 110.00 | ^5 | 90.50 | 85.79 | ^5 | |||
99221 | Initial hospital care | N/A | N/A | N/A | 65.16 | 61.92 | ^5 | |||
99222 | Initial hospital care | N/A | N/A | N/A | 108.24 | 102.74 | ^5 | |||
99223 | Initial hospital care | N/A | N/A | N/A | 150.95 | 142.86 | ^5 | |||
99231 | Subsequent hospital care | N/A | N/A | N/A | 32.58 | 30.79 | ^5 | |||
99232 | Subsequent hospital care | N/A | N/A | N/A | 53.57 | 50.85 | ^5 | |||
99233 | Subsequent hospital care | N/A | N/A | N/A | 76.38 | 72.30 | ^5 | |||
99236 | Observ/hosp same date | N/A | N/A | N/A | 214.66 | 203.75 | ^5 | |||
99238 | Hospital discharge day | N/A | N/A | N/A | 66.24 | 65.03 | ^2 | |||
99239 | Hospital discharge day | N/A | N/A | N/A | 90.86 | 88.21 | ^3 | |||
99241 | Office consultation | 47.06 | 44.62 | ^5 | 33.30 | 31.13 | ^7 | |||
99242 | Office consultation | 87.24 | 83.02 | ^5 | 68.05 | 64.00 | ^6 | |||
99243 | Office consultation | 115.84 | 109.66 | ^5 | 90.14 | 85.10 | ^6 | |||
99244 | Office consultation | 164.34 | 156.01 | ^5 | 133.58 | 126.26 | ^5 | |||
99245 | Office consultation | 212.85 | 202.36 | ^5 | 177.01 | 167.08 | ^6 | |||
99251 | Initial inpatient consult | N/A | N/A | N/A | 34.75 | 32.86 | ^5 | |||
99252 | Initial inpatient consult | N/A | N/A | N/A | 69.86 | 66.07 | ^5 | |||
99253 | Initial inpatient consult | N/A | N/A | N/A | 95.20 | 90.29 | ^5 | |||
99254 | Initial inpatient consult | N/A | N/A | N/A | 136.83 | 129.72 | ^5 | |||
99255 | Initial inpatient consult | N/A | N/A | N/A | 188.60 | 178.49 | ^5 | |||
99261 | Follow^up inpatient consult | N/A | N/A | N/A | 21.72 | 20.76 | ^4 | |||
99262 | Follow^up inpatient consult | N/A | N/A | N/A | 43.44 | 41.16 | ^5 | |||
99263 | Follow^up inpatient consult | N/A | N/A | N/A | 64.80 | 61.23 | ^6 | |||
99282 | Emergency dept visit | N/A | N/A | N/A | 26.43 | 25.25 | ^4 | |||
99283 | Emergency dept visit | N/A | N/A | N/A | 59.37 | 56.73 | ^4 | |||
99284 | Emergency dept visit | N/A | N/A | N/A | 92.67 | 88.56 | ^4 | |||
99285 | Emergency dept visit | N/A | N/A | N/A | 144.80 | 138.02 | ^5 | |||
99291 | Critical care, first hour | 208.87 | 197.52 | ^5 | 198.37 | 188.18 | ^5 | |||
99292 | Critical care, addl 30 min | 108.24 | 101.35 | ^6 | 98.82 | 94.09 | ^5 | |||
99301 | Nursing facility care | 70.23 | 66.76 | ^5 | 60.09 | 57.42 | ^4 | |||
99302 | Nursing facility care | 95.57 | 90.98 | ^5 | 80.72 | 76.45 | ^5 | |||
99303 | Nursing facility care | 118.73 | 112.77 | ^5 | 100.27 | 95.13 | ^5 | |||
99311 | Nursing fac care, subseq | 40.18 | 38.40 | ^4 | 30.05 | 28.71 | ^4 | |||
99312 | Nursing fac care, subseq | 61.90 | 58.81 | ^5 | 49.95 | 47.39 | ^5 | |||
99313 | Nursing fac care, subseq | 84.34 | 80.60 | ^4 | 70.95 | 67.45 | ^5 | |||
99348 | Home visit, est patient | 73.85 | 69.88 | ^5 | N/A | N/A | N/A | |||
99350 | Home visit, est patient | 166.52 | 157.74 | ^5 | N/A | N/A | N/A | |||
G0008 | Admin influenza virus vac | 3.98 | 7.26 | 82 | N/A | N/A | N/A | |||
G0009 | Admin pneumococcal vaccine | 3.98 | 7.26 | 82 | N/A | N/A | N/A | |||
G0010 | Admin hepatitis b vaccine | 3.98 | 7.26 | 82 | N/A | N/A | N/A |
B. Proposed Productivity Adjustment to the MEI
As indicated in section VI.B. of this final rule, we are adopting the proposed change to the methodology for adjusting for productivity in the MEI. We will use the 10-year moving average of private nonfarm business (economy-wide) multifactor productivity applied to the entire index to calculate the MEI beginning in CY 2003. The prior method accounted for productivity by adjusting the labor portion of the MEI by the 10-year moving average change in private nonfarm business (economy-wide) labor productivity. Our reasons for proposing this change and the alternatives we considered are discussed in detail in section VI.
We believe that we have developed a revised MEI methodology that is technically superior to the current MEI and more adequately reflects annual changes in the cost of furnishing services in efficient physicians' practices. The change to the MEI will raise the index by 0.7 percentage points from 2.3 percent to 3.0 percent for 2003. We estimate that this change will increase Federal expenditures by $150 million in FY 2003. The outyear impact is a function of numerous economic variables that fluctuate unpredictably. Our estimate of the impact beyond FY 2003 is based on projections of both the current and revised index. We estimate the change would increase Federal expenditures by $340 million in FY 2004 and $550 million in FY 2005.
C. Site of Service
Relative values for practice expense are determined for both "facility" and "non-facility" settings. ( See Addendum B.) We are clarifying whether a given place of service is either a facility or non-facility site for purposes of determining Medicare payment. This clarification should benefit physicians, providers, and Medicare contractors by making the payment rules clearer. We are updating the facility and non-facility designations for several new place-of-service codes and changing the designations for several already in existence. The update for the new place-of-service codes will have no effect on Medicare spending. The place-of-service codes in which we are changing the designation are infrequently used for physician fee schedule services. This rule could result in a minor redistribution in payment among physician fee schedule services through the practice expense budget-neutrality adjustments.
D. Pricing of Technical Components (TC) for Positron Emission Tomography (PET) Scans
As stated earlier, to keep pricing consistent with the manner in which other PET scan services are paid, we are changing from national pricing to carrier pricing for the TC and global value for HCPCS code G0125 Lung Image PET scans. The budgetary impact on the Medicare program and providers would be uncertain since we do not know the payment amounts that carriers would use for this service.
E. Medicare Qualifications for Clinical Nurse Specialists (CNSs)
As previously stated, we are revising regulations regarding qualifications for CNSs by allowing flexibility as to certifying bodies. We believe this change will make the Medicare requirements more consistent with criteria for nurse practitioners. We also believe there will be additional enrollment of CNSs that will qualify for Medicare enrollment. We expect that this policy will have little effect on Medicare expenditures.
F. Process To Add or Delete Services to the Definition of Telehealth
We are finalizing a process for adding or deleting services from the list of telehealth services. In addition, we are adding psychiatric diagnostic interview examinations, CPT code 90801, to the list of Medicare telehealth services. We believe this will have little effect on Medicare expenditures.
G. Change in Global Period for CPT code 77789 (Surface Application of Radiation Source
We are changing the global period for CPT code 77789 (surface application of radiation source) from a 90-day global period to a 000-day global period. We believe physicians that furnish these services will benefit from this change because it will simplify their billing processes. We do not expect it will have a significant impact on the Medicare program because the change will reflect current practices.
H. New HCPCS G-Codes
In section K we discuss new G-codes for-treatment of peripheral neuropathy; current perception sensory nerve conduction threshold tests; PET codes for breast imaging; and home prothrombin time INR monitoring for anticoagulation management. We have withdrawn our proposal for a new G code for bone marrow aspiration and biopsy on the same date of service. All G codes except for the G code for bone marrow aspiration and biopsy on the same date of service have been implemented during CY 2002 through Program Memoranda as a result of national coverage decisions or the need to clarify payment policy. As stated, we are not proceeding with a G code for bone marrow aspiration and biopsy on the same date of service.
I. Endoscopic Base For Urology Codes
We are correcting the pricing of certain endoscopic services. As we previously indicated, we will use CPT procedure code 52000 as the endoscopic base code for CPT procedure codes 52234, 52235, and 52240. This will result in a reduction in payment in instances when these codes are billed in conjunction with either CPT procedure code 52000 or other codes that have CPT procedure code 52000 as the endscopic base code. We expect the savings will be negligible.
J. Physical Therapy and Occupational Therapy Caps
There were no proposals made in this area. The imposition of the physical and occupational therapy caps will occur as a result of application of section 4541(c) of the BBA. While section 221 of the BBRA and section 421 of BIPA placed a moratorium on application of these caps, the moratorium expires for physical and occupational therapy services furnished after December 31, 2002. We estimate that application of the caps will reduce Medicare expenditures for physical and occupational therapy services by $240 million in CY 2003.
K. Enrollment of Physical and Occupational Therapists as Therapists in Private Practice
This change will provide flexibility for therapists by allowing therapists that meet the enrollment criteria to enroll in Medicare without regard to how they are organized to provide services. We do not expect this will have a significant effect on Medicare expenditures because Medicare pays the same amount for these therapy services whether they are billed directly by a therapist or by a physician as an incident to service.
L. Screening Fecal Occult Blood Tests
As discussed in section II.N (1) of the preamble, we are modifying our regulations to allow us to expand coverage when appropriate for (1) screening fecal-occult blood tests for the early detection of colorectal cancer, and (2) additional colorectal cancer screening tests through our national coverage determination process. These changes will allow us to conduct more timely assessments of new types of colon cancer screening tests than is normally possible under the standard rulemaking process. There are no costs or savings to the Medicare program associated with this regulation change.
M. Add-on Anesthesia Codes
The add-on codes, two for obstetrical anesthesia (CPT codes 01968 and 01969) and one for burn excisions (CPT code 01953), represent low volume codes for the Medicare population. We believe the new policy for add-on codes will have a negligible impact on total anesthesia payments.
N. Physician Self-Referral Prohibitions
As discussed in section IV of this preamble, we are updating the list of codes used to define certain designated health services for the purposes of section 1877 of the Act. We are not making any substantive change to the description of any designated health service as set forth in the January 4, 2001 physician self-referral final rule (66 FR 856). Instead, we are merely updating our list of codes to conform to coding changes in the most recent publication of CPT and HCPCS codes.
For this reason, we certify that the changes we are making will not have a significant economic effect on a substantial number of small entities or on the operations of a substantial number of small rural hospitals.
O. Critical Access Hospital Emergency Services Requirement
We anticipate that this rule will reduce cost for small CAHs. Frontier area and remote location CAHs will no longer be limited to hiring only a physician, nurse practitioner or physician assistant to provide emergency coverage in the absence of the sole practitioner. This rule will provide relief to small CAHs in meeting the current emergency staffing requirement by allowing them to utilize a registered nurse to provide emergency care services once the State submits a letter to us, signed by the Governor, following consultation with the State Boards of Medicine and Nursing, and in accordance with State law, requesting that RNs be included as emergency personnel in § 485.618(d).
P. Alternatives Considered
This final rule contains a range of policies. The preamble identifies those policies when discretion has been exercised and presents rationale for our decisions, including a presentation of nonselected options (except for the critical access hospital emergency services requirement which is provided separately).
Critical Access Hospitals Emergency Services Personnel Requirement
We considered allowing each CAH in a frontier area or remote location to individually request a waiver of the requirements at § 485.618(a) and (d). The statute does not provide authority to waive the requirement for continuous emergency room coverage. Section 1820(c)(B)(ii) requires a qualifying CAH to make available the 24-hour emergency care services that a State determines are necessary for ensuring access to emergency care services in each area served by a CAH. However, we believe States may interpret emergency care services to allow CAHs to use a RN in order to comply with the emergency services personnel requirement stated in the regulations at § 485.618. This change is consistent with our policy of respecting State oversight of health care professions by deferring to State law to regulate professional practice.
Q. Impact on Beneficiaries
Although changes in physicians' payments were large when the physician fee schedule was implemented in 1992, we detected no problems with beneficiary access to care. We do not believe that there would be any problem with access to care as a result of the changes in this rule. While it has been suggested that the negative update for CY 2003 may affect beneficiary access to care, we note that the formula to determine this update is set by statute and this regulation cannot, and does not, change it.
As indicated above, the imposition of the physical and occupational therapy caps will occur as a result of application of section 4541(c) of the BBA. It is possible that application of physical and occupational therapy caps will have an impact on Medicare beneficiaries either through increased liability for services exceeding the cap or fewer services being provided. We contracted with the Urban Institute to perform analyses related to the implementation of the therapy caps, based on an analysis of a sample of therapy services provided from CYs 1998 through 2000. The draft reports are available on the CMS website. The contractor report indicated that in CY 2000, about 12 percent of patients who received therapy services would have exceeded the caps. The caps are more likely to be exceeded in skilled nursing facilities, comprehensive outpatient rehabilitation facilities, and other rehabilitation facility settings. The caps do not apply to outpatient therapy services provided in an outpatient hospital. The report does not make assumptions about changes in behavior in response to the caps. Without more experience with the caps, it is difficult to predict the precise impact on beneficiaries.
In addition, CAHs in frontier areas and remote locations will be able to satisfy the CAH emergency services personnel requirement, through the addition of RNs to our personnel requirements and beneficiaries will have greater access to care through the utilization of RNs providing emergency care services to patients.
In accordance with the provisions of Executive Order 12866, the Office of Management and Budget reviewed this regulation.
List of Subjects
42 CFR Part 410
Health facilities, Health professions, Kidney diseases, Laboratories, Medicare, Rural areas, X-rays.
42 CFR Part 414
Administrative practice and procedure, Health facilities, Health professions, Kidney diseases, Medicare, Reporting and recordkeeping requirements, Rural areas, X-rays.
42 CFR Part 485
Grant programs-health, Health facilities, Medicaid, Medicare, Reporting and recordkeeping requirements.
For the reasons set forth in the preamble, the Centers for Medicare Medicaid Services amends 42 CFR chapter IV as follows:
PART 410-SUPPLEMENTARY MEDICAL INSURANCE (SMI) BENEFITS
1. The authority citation for part 410 continues to read as follows:
Authority:
Secs. 1102 and 1871 of the Social Security Act (42 U.S.C. 1302 and 1395hh).
2. In § 410.37, paragraphs (a)(1)(v) and (a)(2) are revised to read as follows:
§ 410.37 Colorectal cancer screening tests: Conditions for and limitations on coverage.
(a) * * *
(1) * * *
(v) Other tests or procedures established by a national coverage determination, and modifications to tests under this paragraph, with such frequency and payment limits as CMS determines appropriate, in consultation with appropriate organizations
(2) Screening fecal-occult blood test means-
(i) A guaiac-based test for peroxidase activity, testing two samples from each of three consecutive stools, or,
(ii) Other tests as determined by the Secretary through a national coverage determination.
3. Section 410.59 is amended as follows:
A. Paragraph (c)(1)(ii)(C) is revised.
B. A new paragraph (c)(1)(ii)(D) is added.
C. A new paragraph (c)(1)(ii)(E) is added.
The revision and additions read as follows:
§ 410.59 Outpatient occupational therapy services: Conditions.
(c) * * *
(1) * * *
(ii) * * *
(C) An unincorporated solo practice, partnership, or group practice, or a professional corporation or other incorporated occupational therapy practice.
(D) An employee of a physician group.
(E) An employee of a group that is not a professional corporation.
4. Section 410.60 is amended as follows:
A. Paragraph (c)(1)(ii)(C) is revised.
B. A new paragraph (c)(1)(ii)(D) is added.
C. A new paragraph (c)(1)(ii)(E) is added
The revision and additions read as follows:
§ 410.60 Outpatient physical therapy services: Conditions
(c) * * *
(1) * * *
(ii) * * *
(C) An unincorporated solo practice, partnership, or group practice, or a professional corporation or other incorporated physical therapy practice.
(D) An employee of a physician group.
(E) An employee of a group that is not a professional corporation.
5. Section 410.61 is amended by revising paragraph (d)(1)(iii) to read as follows:
§ 410.61 Plan of treatment requirements for outpatient rehabilitation services.
(d) * * *
(1) * * *
(iii) The occupational therapist that furnishes the occupational therapy services.
6. Section 410.76 is amended by revising paragraph (b)(3) to read as follows:
§ 410.76 Clinical nurse specialists' services.
(b) * * *
(3) Be certified as a clinical nurse specialist by a national certifying body that has established standards for clinical nurse specialists and that is approved by the Secretary.
7. Section 410.78 is amended as follows:
a. Revise the heading of the section.
b. Revise the introductory text of paragraph (b).
c. Revise paragraph (b)(1).
d. Add a new paragraph (f).
The revisions and additions read as follows:
§ 410.78 Telehealth services.
(b) General rule. Medicare Part B pays for office and other outpatient visits, professional consultation, psychiatric diagnostic interview examination, individual psychotherapy, and pharmacologic management furnished by an interactive telecommunications system if the following conditions are met:
(1) The physician or practitioner at the distant site must be licensed to furnish the service under State law. The physician or practitioner at the distant site who is licensed under State law to furnish a covered telehealth service described in this section may bill, and receive payment for, the service when it is delivered via a telecommunications system.
(f) Process for adding or deleting services. Changes to the list of Medicare telehealth services are made through the annual physician fee schedule rulemaking process.
PART 414-PAYMENT FOR PART B MEDICAL AND OTHER HEALTH SERVICES
1. The authority citation for part 414 continues to read as follows:
Authority:
Secs. 1102, 1871, and 1881(b)(1) of the Social Security Act (42 U.S.C. 1302, 1395hh, and 1395rr(b)(1)).
2. Section 414.46 is amended by revising paragraph (g) to read as follows:
§ 414.46 Additional rules for payment of anesthesia services.
(g) Physician involved in multiple anesthesia services. If the physician is involved in multiple anesthesia services for the same patient during the same operative session, the carrier makes payment according to the base unit associated with the anesthesia service having the highest base unit value and anesthesia time that encompasses the multiple services. The carrier makes payment for add-on anesthesia codes according to program operating instructions.
3. Section 414.65, is amended as follows:
a. Revise the heading of the section.
b. Revise paragraph (a)(1).
c. Revise paragraph (b) introductory text.
The revisions read as follows:
§ 414.65 Payment for telehealth services.
(a) * * *
(1) The Medicare payment amount for office or other outpatient visits, consultation, individual psychotherapy, psychiatric diagnostic interview examination, and pharmacologic management furnished via an interactive telecommunications system is equal to the current fee schedule amount applicable for the service of the physician or practitioner.
(b) Originating site facility fee. For telehealth services furnished on or after October 1, 2001:
PART 485-CONDITIONS OF PARTICIPATION: SPECIALIZED PROVIDERS
Part 485 is amended as set forth below:
1. The authority citation for 485 continues to read as follows:
Authority:
Secs. 1102 and 1871 of the Act (42 U.S.C. 1302 and 1396hh).
2. Section 485.618 is amended by revising paragraph (d) to read as follows:
§ 485.618 Condition of participation: Emergency services.
(d) Standard: Personnel. (1) Except as specified in paragraph (d)(2) of this section, there must be a doctor of medicine or osteopathy, a physician assistant, or a nurse practitioner, with training or experience in emergency care on call and immediately available by telephone or radio contact, and available on site within the following timeframes:
(i) Within 30 minutes, on a 24-hour a day basis, if the CAH is located in an area other than an area described in paragraph (d)(1)(ii) of this section; or
(ii) Within 60 minutes, on a 24-hour a day basis, if all of the following requirements are met:
(A) The CAH is located in an area designated as a frontier area (that is, an area with fewer than six residents per square mile based on the latest population data published by the Bureau of the Census) or in an area that meets the criteria for a remote location adopted by the State in its rural health care plan, and approved by CMS, under section 1820(b) of the Act.
(B) The State has determined, under criteria in its rural health care plan, that allowing an emergency response time longer than 30 minutes is the only feasible method of providing emergency care to residents of the area served by the CAH.
(C) The State maintains documentation showing that the response time of up to 60 minutes at a particular CAH it designates is justified because other available alternatives would increase the time needed to stabilize a patient in an emergency.
(2) A registered nurse satisfies the personnel requirement specified in paragraph (d)(1) of this section for a temporary period if-
(i) The CAH has no greater than 10 beds;
(ii) The CAH is located in an area designated as a frontier area or remote location as described in paragraph (d)(1)(ii)(A) of this section;
(iii) The State in which the CAH is located submits a letter to CMS signed by the Governor, following consultation on the issue of using RNs on a temporary basis as part of their State rural healthcare plan with the State Boards of Medicine and Nursing, and in accordance with State law, requesting that a registered nurse with training and experience in emergency care be included in the list of personnel specified in paragraph (d)(1) of this section. The letter from the Governor must attest that he or she has consulted with State Boards of Medicine and Nursing about issues related to access to and the quality of emergency services in the States. The letter from the Governor must also describe the circumstances and duration of the temporary request to include the registered nurses on the list of personnel specified in paragraph (d)(1) of this section;
(iv) Once a Governor submits a letter, as specified in paragraph (d)(2)(ii) of this section, a CAH must submit documentation to the State survey agency demonstrating that it has been unable, due to the shortage of such personnel in the area, to provide adequate coverage as specified in this paragraph (d).
(3) The request, as specified in paragraph(d)(2)(ii) of this section, and the withdrawal of the request, may be submitted to us at any time, and are effective upon submission.
(Catalog of Federal Domestic Assistance Program No. 93.774, Medicare-Supplementary Medical Insurance Program)
Dated: November 26, 2002.
Thomas A. Scully,
Administrator, Centers for Medicare Medicaid Services.
Approved: December 12, 2002.Tommy G. Thompson,
Secretary.
Note:
These addenda will not appear in the Code of Federal Regulations.
Addendum A-Explanation and Use of Addenda B
The addenda on the following pages provide various data pertaining to the Medicare fee schedule for physicians' services furnished in 2003. Addendum B contains the RVUs for work, non-facility practice expense, facility practice expense, and malpractice expense, and other information for all services included in the physician fee schedule.
In previous years, we have listed many services in Addendum B that are not paid under the physician fee schedule. To avoid publishing as many pages of codes for these services, we are not including clinical laboratory codes and most alpha-numeric codes (Healthcare Common Procedure Coding System (HCPCS) codes not included in CPT) in Addendum B.
Addendum B-2003 Relative Value Units and Related Information Used in Determining Medicare Payments for 2003
This addendum contains the following information for each CPT code and alphanumeric HCPCS code for services that may be paid under the physician fee schedule as well as all G codes
1. CPT/HCPCS code . This is the CPT or alphanumeric HCPCS number for the service. Alphanumeric HCPCS codes are included at the end of this addendum.
2. Modifier. A modifier is shown if there is a technical component (modifier TC) and a professional component (PC) (modifier -26) for the service. If there is a PC and a TC for the service, Addendum B contains three entries for the code: One for the global values (both professional and technical); one for modifier -26 (PC); and one for modifier TC. The global service is not designated by a modifier, and physicians must bill using the code without a modifier if the physician furnishes both the PC and the TC of the service.
Modifier -53 is shown for a discontinued procedure. There will be RVUs for the code (CPT code 45378) with this modifier.
3. Status indicator. This indicator shows whether the CPT/HCPCS code is in the physician fee schedule and whether it is separately payable if the service is covered.
A = Active code. These codes are separately payable under the fee schedule if covered. There will be RVUs for codes with this status. The presence of an "A" indicator does not mean that Medicare has made a national decision regarding the coverage of the service. Carriers remain responsible for coverage decisions in the absence of a national Medicare policy.
B = Bundled code. Payment for covered services is always bundled into payment for other services not specified. If RVUs are shown, they are not used for Medicare payment. If these services are covered, payment for them is subsumed by the payment for the services to which they are incident. (An example is a telephone call from a hospital nurse regarding care of a patient.)
C = Carrier-priced code. Carriers will establish RVUs and payment amounts for these services, generally on a case-by-case basis following review of documentation, such as an operative report.
D = Deleted code. These codes are deleted effective with the beginning of the calendar year.
E = Excluded from physician fee schedule by regulation. These codes are for items or services that we chose to exclude from the physician fee schedule payment by regulation. No RVUs are shown, and no payment may be made under the physician fee schedule for these codes. Payment for them, if they are covered, continues under reasonable charge or other payment procedures.
F = Deleted/discontinued codes. Code not subject to a 90-day grace period.
G = Code not valid for Medicare purposes. Medicare does not recognize codes assigned this status. Medicare uses another code for reporting of, and payment for, these services.
H = Deleted modifier. Either the TC or PC component shown for the code has been deleted, and the deleted component is shown in the data base with the H status indicator. (Code subject to a 90-day grace period.)
I = Not valid for Medicare purposes. Medicare uses another code for the reporting of, and the payment for these services. (Code NOT subject to a 90-day grace period.)
N = Noncovered service. These codes are noncovered services. Medicare payment may not be made for these codes. If RVUs are shown, they are not used for Medicare payment.
P = Bundled or excluded code. There are no RVUs for these services. No separate payment should be made for them under the physician fee schedule.
-If the item or service is covered as incident to a physician's service and is furnished on the same day as a physician's service, payment for it is bundled into the payment for the physician's service to which it is incident (an example is an elastic bandage furnished by a physician incident to a physician's service).
-If the item or service is covered as other than incident to a physician's service, it is excluded from the physician fee schedule (for example, colostomy supplies) and is paid under the other payment provisions of the Act.
R = Restricted coverage. Special coverage instructions apply. If the service is covered and no RVUs are shown, it is carrier-priced.
T = Injections. There are RVUs for these services, but they are only paid if there are no other services payable under the physician fee schedule billed on the same date by the same provider. If any other services payable under the physician fee schedule are billed on the same date by the same provider, these services are bundled into the service(s) for which payment is made.
X = Exclusion by law. These codes represent an item or service that is not within the definition of "physicians' services" for physician fee schedule payment purposes. No RVUs are shown for these codes, and no payment may be made under the physician fee schedule. (Examples are ambulance services and clinical diagnostic laboratory services.)
4. Description of code. This is an abbreviated version of the narrative description of the code.
5. Physician work RVUs. These are the RVUs for the physician work for this
service in 2003. Codes that are not used for Medicare payment are identified with a "+."
6. Facility practice expense RVUs. These are the fully implemented resource-based practice expense RVUs for facility settings. An "NA" in the facility column means that we do not pay for the service in a facility setting. For instance, we do not pay using the physician fee schedule for the global or technical component of a radiology service or other diagnostic test in a facility setting. Also, there is no payment in a facility setting for "incident to" services (services that do not have physician work RVUs). Payment is included in our payment for institutional services.
7. Non-facility practice expense RVUs. These are the fully implemented resource-based practice expense RVUs for non-facility settings. An "NA" in the nonfacility column means that the service is generally not provided outside of hospitals and we do not have information upon which to determine a price. In most cases, these are major surgical services.
8. Malpractice expense RVUs. These are the RVUs for the malpractice expense for the service for 2003.
9. Facility total. This is the sum of the work, fully implemented facility practice expense, and malpractice expense RVUs.
10. Non-facility total. This is the sum of the work, fully implemented non-facility practice expense, and malpractice expense RVUs.
11. Global period. This indicator shows the number of days in the global period for the code (0, 10, or 90 days). An explanation of the alpha codes follows:
MMM = The code describes a service furnished in uncomplicated maternity cases including antepartum care, delivery, and postpartum care. The usual global surgical concept does not apply. See the 1999 Physicians' Current Procedural Terminology for specific definitions.
XXX = The global concept does not apply.
YYY = The global period is to be set by the carrier (for example, unlisted surgery codes).
ZZZ = Code related to another service and is always included in the global period of the other service. (Note: Physician work is associated with intra service time and in some instances the pre- and post-service time.)
----------
1 CPT codes and descriptions only are copyright 2002 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.2 Copyright 2002 American Dental Association. All rights reserved.3 + Indicates RVUs are not used for Medicare payment.
CPT1 / HCPCS2 | MOD | Status | Description | Physician Work RVUs3 | Non- Facility PE RVUs | Facility PE RVUs | Mal- Practice RVUs | Non- Facility Total | Facility Total | Global |
---|---|---|---|---|---|---|---|---|---|---|
0001T | C | Endovas repr abdo ao aneurys | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0002T | C | Endovas repr abdo ao aneurys | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0003T | C | Cervicography | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0005T | C | Perc cath stent/brain cv art | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0006T | C | Perc cath stent/brain cv art | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0007T | C | Perc cath stent/brain cv art | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0008T | C | Upper gi endoscopy w/suture | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0009T | C | Endometrial cryoablation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0010T | C | Tb test, gamma interferon | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0012T | C | Osteochondral knee autograft | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0013T | C | Osteochondral knee allograft | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0014T | C | Meniscal transplant, knee | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0016T | C | Thermotx choroid vasc lesion | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0017T | C | Photocoagulat macular drusen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0018T | C | Transcranial magnetic stimul | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0019T | C | Extracorp shock wave tx, ms | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0020T | A | Extracorp shock wave tx, ft | 0.06 | 1.46 | 0.02 | 0.01 | 1.53 | 0.09 | XXX | |
0021T | C | Fetal oximetry, trnsvag/cerv | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0023T | C | Phenotype drug test, hiv 1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0024T | C | Transcath cardiac reduction | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0025T | C | Ultrasonic pachymetry | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0026T | C | Measure remnant lipoproteins | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0027T | C | Endoscopic epidural lysis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0028T | C | Dexa body composition study | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0029T | C | Magnetic tx for incontinence | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0030T | C | Antiprothrombin antibody | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0031T | C | Speculoscopy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0032T | C | Speculoscopy w/direct sample | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0033T | C | Endovasc taa repr incl subcl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0034T | C | Endovasc taa repr w/o subcl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0035T | C | Insert endovasc prosth, taa | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0036T | C | Endovasc prosth, taa, add-on | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0037T | C | Artery transpose/endovas taa | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0038T | C | Rad endovasc taa rpr w/cover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0039T | C | Rad s/i, endovasc taa repair | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0040T | C | Rad s/i, endovasc taa prosth | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0041T | C | Detect ur infect agnt w/cpas | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0042T | C | Ct perfusion w/contrast, cbf | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0043T | C | Co expired gas analysis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
0044T | C | Whole body photography | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
10021 | A | Fna w/o image | 1.27 | 2.37 | NA | 0.07 | 3.71 | NA | XXX | |
10022 | A | Fna w/image | 1.27 | 2.66 | NA | 0.05 | 3.98 | NA | XXX | |
10040 | A | Acne surgery | 1.18 | 1.10 | 0.71 | 0.05 | 2.33 | 1.94 | 010 | |
10060 | A | Drainage of skin abscess | 1.17 | 1.49 | 0.67 | 0.08 | 2.74 | 1.92 | 010 | |
10061 | A | Drainage of skin abscess | 2.40 | 1.88 | 1.41 | 0.17 | 4.45 | 3.98 | 010 | |
10080 | A | Drainage of pilonidal cyst | 1.17 | 2.13 | 0.73 | 0.09 | 3.39 | 1.99 | 010 | |
10081 | A | Drainage of pilonidal cyst | 2.45 | 2.90 | 1.55 | 0.19 | 5.54 | 4.19 | 010 | |
10120 | A | Remove foreign body | 1.22 | 1.54 | 0.36 | 0.10 | 2.86 | 1.68 | 010 | |
10121 | A | Remove foreign body | 2.69 | 2.96 | 1.79 | 0.25 | 5.90 | 4.73 | 010 | |
10140 | A | Drainage of hematoma/fluid | 1.53 | 1.49 | 0.87 | 0.15 | 3.17 | 2.55 | 010 | |
10160 | A | Puncture drainage of lesion | 1.20 | 0.77 | 0.42 | 0.11 | 2.08 | 1.73 | 010 | |
10180 | A | Complex drainage, wound | 2.25 | 1.48 | 1.27 | 0.25 | 3.98 | 3.77 | 010 | |
11000 | A | Debride infected skin | 0.60 | 0.64 | 0.24 | 0.05 | 1.29 | 0.89 | 000 | |
11001 | A | Debride infected skin add-on | 0.30 | 0.38 | 0.11 | 0.02 | 0.70 | 0.43 | ZZZ | |
11010 | A | Debride skin, fx | 4.20 | 2.40 | 1.96 | 0.45 | 7.05 | 6.61 | 010 | |
11011 | A | Debride skin/muscle, fx | 4.95 | 3.83 | 2.60 | 0.53 | 9.31 | 8.08 | 000 | |
11012 | A | Debride skin/muscle/bone, fx | 6.88 | 5.51 | 4.23 | 0.89 | 13.28 | 12.00 | 000 | |
11040 | A | Debride skin, partial | 0.50 | 0.52 | 0.21 | 0.05 | 1.07 | 0.76 | 000 | |
11041 | A | Debride skin, full | 0.82 | 0.66 | 0.33 | 0.06 | 1.54 | 1.21 | 000 | |
11042 | A | Debride skin/tissue | 1.12 | 0.97 | 0.47 | 0.09 | 2.18 | 1.68 | 000 | |
11043 | A | Debride tissue/muscle | 2.38 | 3.57 | 2.64 | 0.24 | 6.19 | 5.26 | 010 | |
11044 | A | Debride tissue/muscle/bone | 3.06 | 4.73 | 3.91 | 0.34 | 8.13 | 7.31 | 010 | |
11055 | R | Trim skin lesion | 0.43 | 0.51 | 0.18 | 0.02 | 0.96 | 0.63 | 000 | |
11056 | R | Trim skin lesions, 2 to 4 | 0.61 | 0.58 | 0.26 | 0.03 | 1.22 | 0.90 | 000 | |
11057 | R | Trim skin lesions, over 4 | 0.79 | 0.65 | 0.33 | 0.04 | 1.48 | 1.16 | 000 | |
11100 | A | Biopsy of skin lesion | 0.81 | 1.24 | 0.38 | 0.04 | 2.09 | 1.23 | 000 | |
11101 | A | Biopsy, skin add-on | 0.41 | 0.38 | 0.20 | 0.02 | 0.81 | 0.63 | ZZZ | |
11200 | A | Removal of skin tags | 0.77 | 1.23 | 0.31 | 0.04 | 2.04 | 1.12 | 010 | |
11201 | A | Remove skin tags add-on | 0.29 | 0.56 | 0.12 | 0.02 | 0.87 | 0.43 | ZZZ | |
11300 | A | Shave skin lesion | 0.51 | 0.99 | 0.22 | 0.03 | 1.53 | 0.76 | 000 | |
11301 | A | Shave skin lesion | 0.85 | 1.10 | 0.39 | 0.04 | 1.99 | 1.28 | 000 | |
11302 | A | Shave skin lesion | 1.05 | 1.30 | 0.48 | 0.05 | 2.40 | 1.58 | 000 | |
11303 | A | Shave skin lesion | 1.24 | 1.59 | 0.54 | 0.06 | 2.89 | 1.84 | 000 | |
11305 | A | Shave skin lesion | 0.67 | 0.84 | 0.27 | 0.04 | 1.55 | 0.98 | 000 | |
11306 | A | Shave skin lesion | 0.99 | 1.10 | 0.43 | 0.05 | 2.14 | 1.47 | 000 | |
11307 | A | Shave skin lesion | 1.14 | 1.29 | 0.50 | 0.05 | 2.48 | 1.69 | 000 | |
11308 | A | Shave skin lesion | 1.41 | 1.45 | 0.61 | 0.07 | 2.93 | 2.09 | 000 | |
11310 | A | Shave skin lesion | 0.73 | 1.11 | 0.33 | 0.04 | 1.88 | 1.10 | 000 | |
11311 | A | Shave skin lesion | 1.05 | 1.23 | 0.50 | 0.05 | 2.33 | 1.60 | 000 | |
11312 | A | Shave skin lesion | 1.20 | 1.43 | 0.57 | 0.06 | 2.69 | 1.83 | 000 | |
11313 | A | Shave skin lesion | 1.62 | 1.81 | 0.74 | 0.09 | 3.52 | 2.45 | 000 | |
11400 | A | Exc tr-ext b9+marg 0.5 cm | 0.85 | 2.08 | 0.96 | 0.06 | 2.99 | 1.87 | 010 | |
11401 | A | Exc tr-ext b9+marg 0.6-1 cm | 1.23 | 2.12 | 1.08 | 0.09 | 3.44 | 2.40 | 010 | |
11402 | A | Exc tr-ext b9+marg 1.1-2 cm | 1.51 | 2.28 | 1.14 | 0.12 | 3.91 | 2.77 | 010 | |
11403 | A | Exc tr-ext b9+marg 2.1-3 cm | 1.79 | 2.50 | 1.35 | 0.16 | 4.45 | 3.30 | 010 | |
11404 | A | Exc tr-ext b9+marg 3.1-4 cm | 2.06 | 2.84 | 1.42 | 0.18 | 5.08 | 3.66 | 010 | |
11406 | A | Exc tr-ext b9+marg 4.0 cm | 2.76 | 3.24 | 1.68 | 0.25 | 6.25 | 4.69 | 010 | |
11420 | A | Exc h-f-nk-sp b9+marg 0.5 | 0.98 | 1.81 | 1.00 | 0.08 | 2.87 | 2.06 | 010 | |
11421 | A | Exc h-f-nk-sp b9+marg 0.6-1 | 1.42 | 2.12 | 1.18 | 0.11 | 3.65 | 2.71 | 010 | |
11422 | A | Exc h-f-nk-sp b9+marg 1.1-2 | 1.63 | 2.30 | 1.38 | 0.14 | 4.07 | 3.15 | 010 | |
11423 | A | Exc h-f-nk-sp b9+marg 2.1-3 | 2.01 | 2.66 | 1.49 | 0.17 | 4.84 | 3.67 | 010 | |
11424 | A | Exc h-f-nk-sp b9+marg 3.1-4 | 2.43 | 2.93 | 1.64 | 0.21 | 5.57 | 4.28 | 010 | |
11426 | A | Exc h-f-nk-sp b9+marg 4 cm | 3.78 | 3.75 | 2.15 | 0.34 | 7.87 | 6.27 | 010 | |
11440 | A | Exc face-mm b9+marg 0.5 cm | 1.06 | 2.27 | 1.41 | 0.08 | 3.41 | 2.55 | 010 | |
11441 | A | Exc face-mm b9+marg 0.6-1 cm | 1.48 | 2.40 | 1.59 | 0.11 | 3.99 | 3.18 | 010 | |
11442 | A | Exc face-mm b9+marg 1.1-2 cm | 1.72 | 2.66 | 1.66 | 0.14 | 4.52 | 3.52 | 010 | |
11443 | A | Exc face-mm b9+marg 2.1-3 cm | 2.29 | 3.04 | 1.90 | 0.18 | 5.51 | 4.37 | 010 | |
11444 | A | Exc face-mm b9+marg 3.1-4 cm | 3.14 | 3.64 | 2.28 | 0.25 | 7.03 | 5.67 | 010 | |
11446 | A | Exc face-mm b9+marg 4 cm | 4.49 | 4.26 | 2.88 | 0.30 | 9.05 | 7.67 | 010 | |
11450 | A | Removal, sweat gland lesion | 2.73 | 4.12 | 0.98 | 0.26 | 7.11 | 3.97 | 090 | |
11451 | A | Removal, sweat gland lesion | 3.95 | 4.98 | 1.43 | 0.39 | 9.32 | 5.77 | 090 | |
11462 | A | Removal, sweat gland lesion | 2.51 | 4.10 | 0.95 | 0.23 | 6.84 | 3.69 | 090 | |
11463 | A | Removal, sweat gland lesion | 3.95 | 5.60 | 1.57 | 0.40 | 9.95 | 5.92 | 090 | |
11470 | A | Removal, sweat gland lesion | 3.25 | 4.54 | 1.23 | 0.30 | 8.09 | 4.78 | 090 | |
11471 | A | Removal, sweat gland lesion | 4.41 | 5.69 | 1.72 | 0.40 | 10.50 | 6.53 | 090 | |
11600 | A | Exc tr-ext mlg+marg 0.5 cm | 1.31 | 2.53 | 0.99 | 0.09 | 3.93 | 2.39 | 010 | |
11601 | A | Exc tr-ext mlg+marg 0.6-1 cm | 1.80 | 2.60 | 1.24 | 0.12 | 4.52 | 3.16 | 010 | |
11602 | A | Exc tr-ext mlg+marg 1.1-2 cm | 1.95 | 2.73 | 1.29 | 0.13 | 4.81 | 3.37 | 010 | |
11603 | A | Exc tr-ext mlg+marg 2.1-3 cm | 2.19 | 2.96 | 1.35 | 0.16 | 5.31 | 3.70 | 010 | |
11604 | A | Exc tr-ext mlg+marg 3.1-4 cm | 2.40 | 3.27 | 1.41 | 0.18 | 5.85 | 3.99 | 010 | |
11606 | A | Exc tr-ext mlg+marg 4 cm | 3.43 | 3.96 | 1.76 | 0.28 | 7.67 | 5.47 | 010 | |
11620 | A | Exc h-f-nk-sp mlg+marg 0.5 | 1.19 | 2.49 | 0.97 | 0.09 | 3.77 | 2.25 | 010 | |
11621 | A | Exc h-f-nk-sp mlg+marg 0.6-1 | 1.76 | 2.60 | 1.27 | 0.12 | 4.48 | 3.15 | 010 | |
11622 | A | Exc h-f-nk-sp mlg+marg 1.1-2 | 2.09 | 2.87 | 1.42 | 0.15 | 5.11 | 3.66 | 010 | |
11623 | A | Exc h-f-nk-sp mlg+marg 2.1-3 | 2.61 | 3.22 | 1.62 | 0.20 | 6.03 | 4.43 | 010 | |
11624 | A | Exc h-f-nk-sp mlg+marg 3.1-4 | 3.06 | 3.61 | 1.81 | 0.25 | 6.92 | 5.12 | 010 | |
11626 | A | Exc h-f-nk-sp mlg+mar 4 cm | 4.30 | 4.56 | 2.44 | 0.35 | 9.21 | 7.09 | 010 | |
11640 | A | Exc face-mm malig+marg 0.5 | 1.35 | 2.54 | 1.14 | 0.10 | 3.99 | 2.59 | 010 | |
11641 | A | Exc face-mm malig+marg 0.6-1 | 2.16 | 2.92 | 1.57 | 0.15 | 5.23 | 3.88 | 010 | |
11642 | A | Exc face-mm malig+marg 1.1-2 | 2.59 | 3.30 | 1.77 | 0.18 | 6.07 | 4.54 | 010 | |
11643 | A | Exc face-mm malig+marg 2.1-3 | 3.10 | 3.70 | 2.01 | 0.24 | 7.04 | 5.35 | 010 | |
11644 | A | Exc face-mm malig+marg 3.1-4 | 4.03 | 4.63 | 2.56 | 0.33 | 8.99 | 6.92 | 010 | |
11646 | A | Exc face-mm mlg+marg 4 cm | 5.95 | 5.73 | 3.60 | 0.46 | 12.14 | 10.01 | 010 | |
11719 | R | Trim nail(s) | 0.17 | 0.25 | 0.07 | 0.01 | 0.43 | 0.25 | 000 | |
11720 | A | Debride nail, 1-5 | 0.32 | 0.34 | 0.13 | 0.02 | 0.68 | 0.47 | 000 | |
11721 | A | Debride nail, 6 or more | 0.54 | 0.44 | 0.21 | 0.04 | 1.02 | 0.79 | 000 | |
11730 | A | Removal of nail plate | 1.13 | 0.81 | 0.44 | 0.09 | 2.03 | 1.66 | 000 | |
11732 | A | Remove nail plate, add-on | 0.57 | 0.30 | 0.23 | 0.05 | 0.92 | 0.85 | ZZZ | |
11740 | A | Drain blood from under nail | 0.37 | 0.82 | 0.14 | 0.03 | 1.22 | 0.54 | 000 | |
11750 | A | Removal of nail bed | 1.86 | 1.72 | 0.77 | 0.16 | 3.74 | 2.79 | 010 | |
11752 | A | Remove nail bed/finger tip | 2.67 | 2.11 | 1.76 | 0.33 | 5.11 | 4.76 | 010 | |
11755 | A | Biopsy, nail unit | 1.31 | 1.11 | 0.56 | 0.06 | 2.48 | 1.93 | 000 | |
11760 | A | Repair of nail bed | 1.58 | 1.80 | 1.25 | 0.17 | 3.55 | 3.00 | 010 | |
11762 | A | Reconstruction of nail bed | 2.89 | 2.24 | 1.88 | 0.32 | 5.45 | 5.09 | 010 | |
11765 | A | Excision of nail fold, toe | 0.69 | 1.13 | 0.49 | 0.05 | 1.87 | 1.23 | 010 | |
11770 | A | Removal of pilonidal lesion | 2.61 | 2.98 | 1.23 | 0.24 | 5.83 | 4.08 | 010 | |
11771 | A | Removal of pilonidal lesion | 5.74 | 5.50 | 3.91 | 0.56 | 11.80 | 10.21 | 090 | |
11772 | A | Removal of pilonidal lesion | 6.98 | 6.41 | 4.36 | 0.68 | 14.07 | 12.02 | 090 | |
11900 | A | Injection into skin lesions | 0.52 | 0.75 | 0.22 | 0.02 | 1.29 | 0.76 | 000 | |
11901 | A | Added skin lesions injection | 0.80 | 0.72 | 0.36 | 0.03 | 1.55 | 1.19 | 000 | |
11920 | R | Correct skin color defects | 1.61 | 2.16 | 0.80 | 0.17 | 3.94 | 2.58 | 000 | |
11921 | R | Correct skin color defects | 1.93 | 2.52 | 1.00 | 0.21 | 4.66 | 3.14 | 000 | |
11922 | R | Correct skin color defects | 0.49 | 0.38 | 0.26 | 0.05 | 0.92 | 0.80 | ZZZ | |
11950 | R | Therapy for contour defects | 0.84 | 1.22 | 0.42 | 0.06 | 2.12 | 1.32 | 000 | |
11951 | R | Therapy for contour defects | 1.19 | 1.61 | 0.52 | 0.10 | 2.90 | 1.81 | 000 | |
11952 | R | Therapy for contour defects | 1.69 | 1.97 | 0.70 | 0.17 | 3.83 | 2.56 | 000 | |
11954 | R | Therapy for contour defects | 1.85 | 2.59 | 0.93 | 0.19 | 4.63 | 2.97 | 000 | |
11960 | A | Insert tissue expander(s) | 9.08 | NA | 10.94 | 0.88 | NA | 20.90 | 090 | |
11970 | A | Replace tissue expander | 7.06 | NA | 4.98 | 0.77 | NA | 12.81 | 090 | |
11971 | A | Remove tissue expander(s) | 2.13 | 6.33 | 3.86 | 0.21 | 8.67 | 6.20 | 090 | |
11975 | N | Insert contraceptive cap | +1.48 | 1.44 | 0.58 | 0.14 | 3.06 | 2.20 | XXX | |
11976 | R | Removal of contraceptive cap | 1.78 | 1.62 | 0.70 | 0.17 | 3.57 | 2.65 | 000 | |
11977 | N | Removal/reinsert contra cap | +3.30 | 2.30 | 1.28 | 0.31 | 5.91 | 4.89 | XXX | |
11980 | A | Implant hormone pellet(s) | 1.48 | 1.07 | 0.56 | 0.10 | 2.65 | 2.14 | 000 | |
11981 | A | Insert drug implant device | 1.48 | 1.59 | 0.58 | 0.14 | 3.21 | 2.20 | XXX | |
11982 | A | Remove drug implant device | 1.78 | 1.71 | 0.70 | 0.17 | 3.66 | 2.65 | XXX | |
11983 | A | Remove/insert drug implant | 3.30 | 2.30 | 1.28 | 0.31 | 5.91 | 4.89 | XXX | |
12001 | A | Repair superficial wound(s) | 1.70 | 2.16 | 0.44 | 0.13 | 3.99 | 2.27 | 010 | |
12002 | A | Repair superficial wound(s) | 1.86 | 2.23 | 0.92 | 0.15 | 4.24 | 2.93 | 010 | |
12004 | A | Repair superficial wound(s) | 2.24 | 2.51 | 1.03 | 0.17 | 4.92 | 3.44 | 010 | |
12005 | A | Repair superficial wound(s) | 2.86 | 3.07 | 1.22 | 0.23 | 6.16 | 4.31 | 010 | |
12006 | A | Repair superficial wound(s) | 3.67 | 3.69 | 1.53 | 0.31 | 7.67 | 5.51 | 010 | |
12007 | A | Repair superficial wound(s) | 4.12 | 4.16 | 1.83 | 0.37 | 8.65 | 6.32 | 010 | |
12011 | A | Repair superficial wound(s) | 1.76 | 2.34 | 0.44 | 0.14 | 4.24 | 2.34 | 010 | |
12013 | A | Repair superficial wound(s) | 1.99 | 2.49 | 0.96 | 0.16 | 4.64 | 3.11 | 010 | |
12014 | A | Repair superficial wound(s) | 2.46 | 2.77 | 1.08 | 0.18 | 5.41 | 3.72 | 010 | |
12015 | A | Repair superficial wound(s) | 3.19 | 3.38 | 1.27 | 0.24 | 6.81 | 4.70 | 010 | |
12016 | A | Repair superficial wound(s) | 3.93 | 3.81 | 1.55 | 0.32 | 8.06 | 5.80 | 010 | |
12017 | A | Repair superficial wound(s) | 4.71 | NA | 1.90 | 0.39 | NA | 7.00 | 010 | |
12018 | A | Repair superficial wound(s) | 5.53 | NA | 2.27 | 0.46 | NA | 8.26 | 010 | |
12020 | A | Closure of split wound | 2.62 | 2.55 | 1.42 | 0.24 | 5.41 | 4.28 | 010 | |
12021 | A | Closure of split wound | 1.84 | 1.70 | 1.02 | 0.19 | 3.73 | 3.05 | 010 | |
12031 | A | Layer closure of wound(s) | 2.15 | 2.29 | 0.77 | 0.15 | 4.59 | 3.07 | 010 | |
12032 | A | Layer closure of wound(s) | 2.47 | 2.98 | 1.28 | 0.15 | 5.60 | 3.90 | 010 | |
12034 | A | Layer closure of wound(s) | 2.92 | 3.21 | 1.44 | 0.21 | 6.34 | 4.57 | 010 | |
12035 | A | Layer closure of wound(s) | 3.43 | 3.15 | 1.67 | 0.30 | 6.88 | 5.40 | 010 | |
12036 | A | Layer closure of wound(s) | 4.05 | 5.26 | 2.46 | 0.41 | 9.72 | 6.92 | 010 | |
12037 | A | Layer closure of wound(s) | 4.67 | 5.62 | 2.80 | 0.49 | 10.78 | 7.96 | 010 | |
12041 | A | Layer closure of wound(s) | 2.37 | 2.48 | 0.83 | 0.17 | 5.02 | 3.37 | 010 | |
12042 | A | Layer closure of wound(s) | 2.74 | 3.17 | 1.41 | 0.17 | 6.08 | 4.32 | 010 | |
12044 | A | Layer closure of wound(s) | 3.14 | 3.26 | 1.60 | 0.24 | 6.64 | 4.98 | 010 | |
12045 | A | Layer closure of wound(s) | 3.64 | 3.58 | 1.87 | 0.34 | 7.56 | 5.85 | 010 | |
12046 | A | Layer closure of wound(s) | 4.25 | 5.53 | 2.55 | 0.40 | 10.18 | 7.20 | 010 | |
12047 | A | Layer closure of wound(s) | 4.65 | 6.15 | 2.89 | 0.41 | 11.21 | 7.95 | 010 | |
12051 | A | Layer closure of wound(s) | 2.47 | 3.16 | 1.41 | 0.16 | 5.79 | 4.04 | 010 | |
12052 | A | Layer closure of wound(s) | 2.77 | 3.12 | 1.38 | 0.17 | 6.06 | 4.32 | 010 | |
12053 | A | Layer closure of wound(s) | 3.12 | 3.26 | 1.54 | 0.20 | 6.58 | 4.86 | 010 | |
12054 | A | Layer closure of wound(s) | 3.46 | 3.60 | 1.64 | 0.25 | 7.31 | 5.35 | 010 | |
12055 | A | Layer closure of wound(s) | 4.43 | 4.60 | 2.19 | 0.35 | 9.38 | 6.97 | 010 | |
12056 | A | Layer closure of wound(s) | 5.24 | 6.62 | 3.05 | 0.43 | 12.29 | 8.72 | 010 | |
12057 | A | Layer closure of wound(s) | 5.96 | 6.14 | 3.73 | 0.50 | 12.60 | 10.19 | 010 | |
13100 | A | Repair of wound or lesion | 3.12 | 3.50 | 1.84 | 0.21 | 6.83 | 5.17 | 010 | |
13101 | A | Repair of wound or lesion | 3.92 | 3.76 | 2.29 | 0.22 | 7.90 | 6.43 | 010 | |
13102 | A | Repair wound/lesion add-on | 1.24 | 0.76 | 0.58 | 0.10 | 2.10 | 1.92 | ZZZ | |
13120 | A | Repair of wound or lesion | 3.30 | 3.60 | 1.88 | 0.23 | 7.13 | 5.41 | 010 | |
13121 | A | Repair of wound or lesion | 4.33 | 3.99 | 2.39 | 0.25 | 8.57 | 6.97 | 010 | |
13122 | A | Repair wound/lesion add-on | 1.44 | 0.89 | 0.65 | 0.12 | 2.45 | 2.21 | ZZZ | |
13131 | A | Repair of wound or lesion | 3.79 | 3.88 | 2.21 | 0.25 | 7.92 | 6.25 | 010 | |
13132 | A | Repair of wound or lesion | 5.95 | 4.72 | 3.25 | 0.32 | 10.99 | 9.52 | 010 | |
13133 | A | Repair wound/lesion add-on | 2.19 | 1.22 | 1.05 | 0.17 | 3.58 | 3.41 | ZZZ | |
13150 | A | Repair of wound or lesion | 3.81 | 5.29 | 2.64 | 0.29 | 9.39 | 6.74 | 010 | |
13151 | A | Repair of wound or lesion | 4.45 | 5.27 | 3.08 | 0.28 | 10.00 | 7.81 | 010 | |
13152 | A | Repair of wound or lesion | 6.33 | 6.01 | 3.98 | 0.38 | 12.72 | 10.69 | 010 | |
13153 | A | Repair wound/lesion add-on | 2.38 | 1.37 | 1.16 | 0.18 | 3.93 | 3.72 | ZZZ | |
13160 | A | Late closure of wound | 10.48 | NA | 6.33 | 1.19 | NA | 18.00 | 090 | |
14000 | A | Skin tissue rearrangement | 5.89 | 7.60 | 4.65 | 0.46 | 13.95 | 11.00 | 090 | |
14001 | A | Skin tissue rearrangement | 8.47 | 8.94 | 5.96 | 0.65 | 18.06 | 15.08 | 090 | |
14020 | A | Skin tissue rearrangement | 6.59 | 8.10 | 5.35 | 0.50 | 15.19 | 12.44 | 090 | |
14021 | A | Skin tissue rearrangement | 10.06 | 9.53 | 7.12 | 0.69 | 20.28 | 17.87 | 090 | |
14040 | A | Skin tissue rearrangement | 7.87 | 8.77 | 7.05 | 0.55 | 17.19 | 15.47 | 090 | |
14041 | A | Skin tissue rearrangement | 11.49 | 11.01 | 8.91 | 0.71 | 23.21 | 21.11 | 090 | |
14060 | A | Skin tissue rearrangement | 8.50 | 9.48 | 7.84 | 0.59 | 18.57 | 16.93 | 090 | |
14061 | A | Skin tissue rearrangement | 12.29 | 12.05 | 9.77 | 0.75 | 25.09 | 22.81 | 090 | |
14300 | A | Skin tissue rearrangement | 11.76 | 11.44 | 9.36 | 0.88 | 24.08 | 22.00 | 090 | |
14350 | A | Skin tissue rearrangement | 9.61 | NA | 6.36 | 1.09 | NA | 17.06 | 090 | |
15000 | A | Skin graft | 4.00 | 3.66 | 2.22 | 0.37 | 8.03 | 6.59 | 000 | |
15001 | A | Skin graft add-on | 1.00 | 1.26 | 0.42 | 0.11 | 2.37 | 1.53 | ZZZ | |
15050 | A | Skin pinch graft | 4.30 | 5.12 | 3.99 | 0.46 | 9.88 | 8.75 | 090 | |
15100 | A | Skin split graft | 9.05 | 11.70 | 8.09 | 0.94 | 21.69 | 18.08 | 090 | |
15101 | A | Skin split graft add-on | 1.72 | 3.27 | 1.48 | 0.18 | 5.17 | 3.38 | ZZZ | |
15120 | A | Skin split graft | 9.83 | 10.23 | 8.03 | 0.90 | 20.96 | 18.76 | 090 | |
15121 | A | Skin split graft add-on | 2.67 | 4.19 | 1.85 | 0.27 | 7.13 | 4.79 | ZZZ | |
15200 | A | Skin full graft | 8.03 | 9.60 | 5.54 | 0.73 | 18.36 | 14.30 | 090 | |
15201 | A | Skin full graft add-on | 1.32 | 1.05 | 0.64 | 0.14 | 2.51 | 2.10 | ZZZ | |
15220 | A | Skin full graft | 7.87 | 9.74 | 6.18 | 0.68 | 18.29 | 14.73 | 090 | |
15221 | A | Skin full graft add-on | 1.19 | 0.93 | 0.58 | 0.12 | 2.24 | 1.89 | ZZZ | |
15240 | A | Skin full graft | 9.04 | 9.25 | 7.01 | 0.80 | 19.09 | 16.85 | 090 | |
15241 | A | Skin full graft add-on | 1.86 | 1.47 | 0.94 | 0.17 | 3.50 | 2.97 | ZZZ | |
15260 | A | Skin full graft | 10.06 | 9.91 | 8.90 | 0.63 | 20.60 | 19.59 | 090 | |
15261 | A | Skin full graft add-on | 2.23 | 2.91 | 1.60 | 0.17 | 5.31 | 4.00 | ZZZ | |
15342 | A | Cultured skin graft, 25 cm | 1.00 | 2.06 | 0.75 | 0.09 | 3.15 | 1.84 | 010 | |
15343 | A | Culture skn graft addl 25 cm | 0.25 | 0.26 | 0.10 | 0.02 | 0.53 | 0.37 | ZZZ | |
15350 | A | Skin homograft | 4.00 | 8.44 | 4.34 | 0.42 | 12.86 | 8.76 | 090 | |
15351 | A | Skin homograft add-on | 1.00 | 0.95 | 0.41 | 0.11 | 2.06 | 1.52 | ZZZ | |
15400 | A | Skin heterograft | 4.00 | 4.84 | 4.84 | 0.40 | 9.24 | 9.24 | 090 | |
15401 | A | Skin heterograft add-on | 1.00 | 1.25 | 0.46 | 0.11 | 2.36 | 1.57 | ZZZ | |
15570 | A | Form skin pedicle flap | 9.21 | 8.16 | 6.07 | 0.96 | 18.33 | 16.24 | 090 | |
15572 | A | Form skin pedicle flap | 9.27 | 7.75 | 5.80 | 0.93 | 17.95 | 16.00 | 090 | |
15574 | A | Form skin pedicle flap | 9.88 | 8.32 | 6.84 | 0.92 | 19.12 | 17.64 | 090 | |
15576 | A | Form skin pedicle flap | 8.69 | 8.91 | 6.29 | 0.72 | 18.32 | 15.70 | 090 | |
15600 | A | Skin graft | 1.91 | 6.13 | 2.34 | 0.19 | 8.23 | 4.44 | 090 | |
15610 | A | Skin graft | 2.42 | 3.39 | 2.62 | 0.25 | 6.06 | 5.29 | 090 | |
15620 | A | Skin graft | 2.94 | 6.74 | 3.39 | 0.28 | 9.96 | 6.61 | 090 | |
15630 | A | Skin graft | 3.27 | 6.19 | 3.66 | 0.28 | 9.74 | 7.21 | 090 | |
15650 | A | Transfer skin pedicle flap | 3.97 | 6.17 | 3.73 | 0.36 | 10.50 | 8.06 | 090 | |
15732 | A | Muscle-skin graft, head/neck | 17.84 | NA | 12.70 | 1.50 | NA | 32.04 | 090 | |
15734 | A | Muscle-skin graft, trunk | 17.79 | NA | 12.73 | 1.91 | NA | 32.43 | 090 | |
15736 | A | Muscle-skin graft, arm | 16.27 | NA | 11.81 | 1.78 | NA | 29.86 | 090 | |
15738 | A | Muscle-skin graft, leg | 17.92 | NA | 12.25 | 1.95 | NA | 32.12 | 090 | |
15740 | A | Island pedicle flap graft | 10.25 | 9.00 | 7.05 | 0.62 | 19.87 | 17.92 | 090 | |
15750 | A | Neurovascular pedicle graft | 11.41 | NA | 8.20 | 1.16 | NA | 20.77 | 090 | |
15756 | A | Free myo/skin flap microvasc | 35.23 | NA | 20.85 | 3.11 | NA | 59.19 | 090 | |
15757 | A | Free skin flap, microvasc | 35.23 | NA | 21.96 | 3.37 | NA | 60.56 | 090 | |
15758 | A | Free fascial flap, microvasc | 35.10 | NA | 22.00 | 3.52 | NA | 60.62 | 090 | |
15760 | A | Composite skin graft | 8.74 | 9.10 | 6.62 | 0.72 | 18.56 | 16.08 | 090 | |
15770 | A | Derma-fat-fascia graft | 7.52 | NA | 6.08 | 0.78 | NA | 14.38 | 090 | |
15775 | R | Hair transplant punch grafts | 3.96 | 2.87 | 1.35 | 0.43 | 7.26 | 5.74 | 000 | |
15776 | R | Hair transplant punch grafts | 5.54 | 5.75 | 2.89 | 0.60 | 11.89 | 9.03 | 000 | |
15780 | A | Abrasion treatment of skin | 7.29 | 6.61 | 6.58 | 0.41 | 14.31 | 14.28 | 090 | |
15781 | A | Abrasion treatment of skin | 4.85 | 5.07 | 4.80 | 0.27 | 10.19 | 9.92 | 090 | |
15782 | A | Abrasion treatment of skin | 4.32 | 4.30 | 4.15 | 0.21 | 8.83 | 8.68 | 090 | |
15783 | A | Abrasion treatment of skin | 4.29 | 4.72 | 3.57 | 0.26 | 9.27 | 8.12 | 090 | |
15786 | A | Abrasion, lesion, single | 2.03 | 1.77 | 1.29 | 0.11 | 3.91 | 3.43 | 010 | |
15787 | A | Abrasion, lesions, add-on | 0.33 | 0.32 | 0.16 | 0.02 | 0.67 | 0.51 | ZZZ | |
15788 | R | Chemical peel, face, epiderm | 2.09 | 3.14 | 1.03 | 0.11 | 5.34 | 3.23 | 090 | |
15789 | R | Chemical peel, face, dermal | 4.92 | 6.17 | 3.51 | 0.27 | 11.36 | 8.70 | 090 | |
15792 | R | Chemical peel, nonfacial | 1.86 | 2.96 | 2.17 | 0.10 | 4.92 | 4.13 | 090 | |
15793 | A | Chemical peel, nonfacial | 3.74 | NA | 3.50 | 0.17 | NA | 7.41 | 090 | |
15810 | A | Salabrasion | 4.74 | 3.73 | 3.73 | 0.42 | 8.89 | 8.89 | 090 | |
15811 | A | Salabrasion | 5.39 | 6.09 | 4.73 | 0.52 | 12.00 | 10.64 | 090 | |
15819 | A | Plastic surgery, neck | 9.38 | NA | 6.67 | 0.77 | NA | 16.82 | 090 | |
15820 | A | Revision of lower eyelid | 5.15 | 7.12 | 5.25 | 0.30 | 12.57 | 10.70 | 090 | |
15821 | A | Revision of lower eyelid | 5.72 | 7.47 | 5.41 | 0.31 | 13.50 | 11.44 | 090 | |
15822 | A | Revision of upper eyelid | 4.45 | 6.06 | 4.23 | 0.22 | 10.73 | 8.90 | 090 | |
15823 | A | Revision of upper eyelid | 7.05 | 8.06 | 6.13 | 0.32 | 15.43 | 13.50 | 090 | |
15824 | R | Removal of forehead wrinkles | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | |
15825 | R | Removal of neck wrinkles | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | |
15826 | R | Removal of brow wrinkles | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | |
15828 | R | Removal of face wrinkles | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | |
15829 | R | Removal of skin wrinkles | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | |
15831 | A | Excise excessive skin tissue | 12.40 | NA | 7.69 | 1.30 | NA | 21.39 | 090 | |
15832 | A | Excise excessive skin tissue | 11.59 | NA | 7.68 | 1.21 | NA | 20.48 | 090 | |
15833 | A | Excise excessive skin tissue | 10.64 | NA | 7.06 | 1.17 | NA | 18.87 | 090 | |
15834 | A | Excise excessive skin tissue | 10.85 | NA | 6.95 | 1.18 | NA | 18.98 | 090 | |
15835 | A | Excise excessive skin tissue | 11.67 | NA | 6.93 | 1.13 | NA | 19.73 | 090 | |
15836 | A | Excise excessive skin tissue | 9.34 | NA | 6.18 | 0.95 | NA | 16.47 | 090 | |
15837 | A | Excise excessive skin tissue | 8.43 | 7.40 | 6.42 | 0.78 | 16.61 | 15.63 | 090 | |
15838 | A | Excise excessive skin tissue | 7.13 | NA | 5.68 | 0.58 | NA | 13.39 | 090 | |
15839 | A | Excise excessive skin tissue | 9.38 | 7.21 | 5.75 | 0.88 | 17.47 | 16.01 | 090 | |
15840 | A | Graft for face nerve palsy | 13.26 | NA | 9.75 | 1.15 | NA | 24.16 | 090 | |
15841 | A | Graft for face nerve palsy | 23.26 | NA | 14.51 | 2.65 | NA | 40.42 | 090 | |
15842 | A | Flap for face nerve palsy | 37.96 | NA | 22.78 | 3.99 | NA | 64.73 | 090 | |
15845 | A | Skin and muscle repair, face | 12.57 | NA | 8.47 | 0.80 | NA | 21.84 | 090 | |
15850 | B | Removal of sutures | +0.78 | 1.44 | 0.30 | 0.04 | 2.26 | 1.12 | XXX | |
15851 | A | Removal of sutures | 0.86 | 1.64 | 0.34 | 0.05 | 2.55 | 1.25 | 000 | |
15852 | A | Dressing change,not for burn | 0.86 | 1.75 | 0.36 | 0.07 | 2.68 | 1.29 | 000 | |
15860 | A | Test for blood flow in graft | 1.95 | 1.30 | 0.81 | 0.13 | 3.38 | 2.89 | 000 | |
15876 | R | Suction assisted lipectomy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | |
15877 | R | Suction assisted lipectomy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | |
15878 | R | Suction assisted lipectomy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | |
15879 | R | Suction assisted lipectomy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | |
15920 | A | Removal of tail bone ulcer | 7.95 | NA | 5.49 | 0.83 | NA | 14.27 | 090 | |
15922 | A | Removal of tail bone ulcer | 9.90 | NA | 7.31 | 1.06 | NA | 18.27 | 090 | |
15931 | A | Remove sacrum pressure sore | 9.24 | NA | 5.56 | 0.95 | NA | 15.75 | 090 | |
15933 | A | Remove sacrum pressure sore | 10.85 | NA | 7.98 | 1.14 | NA | 19.97 | 090 | |
15934 | A | Remove sacrum pressure sore | 12.69 | NA | 8.29 | 1.35 | NA | 22.33 | 090 | |
15935 | A | Remove sacrum pressure sore | 14.57 | NA | 9.96 | 1.56 | NA | 26.09 | 090 | |
15936 | A | Remove sacrum pressure sore | 12.38 | NA | 8.79 | 1.32 | NA | 22.49 | 090 | |
15937 | A | Remove sacrum pressure sore | 14.21 | NA | 10.25 | 1.51 | NA | 25.97 | 090 | |
15940 | A | Remove hip pressure sore | 9.34 | NA | 5.92 | 0.98 | NA | 16.24 | 090 | |
15941 | A | Remove hip pressure sore | 11.43 | NA | 9.80 | 1.23 | NA | 22.46 | 090 | |
15944 | A | Remove hip pressure sore | 11.46 | NA | 8.59 | 1.21 | NA | 21.26 | 090 | |
15945 | A | Remove hip pressure sore | 12.69 | NA | 9.51 | 1.38 | NA | 23.58 | 090 | |
15946 | A | Remove hip pressure sore | 21.57 | NA | 13.95 | 2.32 | NA | 37.84 | 090 | |
15950 | A | Remove thigh pressure sore | 7.54 | NA | 5.15 | 0.80 | NA | 13.49 | 090 | |
15951 | A | Remove thigh pressure sore | 10.72 | NA | 7.99 | 1.14 | NA | 19.85 | 090 | |
15952 | A | Remove thigh pressure sore | 11.39 | NA | 7.39 | 1.19 | NA | 19.97 | 090 | |
15953 | A | Remove thigh pressure sore | 12.63 | NA | 8.79 | 1.38 | NA | 22.80 | 090 | |
15956 | A | Remove thigh pressure sore | 15.52 | NA | 10.40 | 1.64 | NA | 27.56 | 090 | |
15958 | A | Remove thigh pressure sore | 15.48 | NA | 10.72 | 1.66 | NA | 27.86 | 090 | |
15999 | C | Removal of pressure sore | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
16000 | A | Initial treatment of burn(s) | 0.89 | 1.07 | 0.27 | 0.06 | 2.02 | 1.22 | 000 | |
16010 | A | Treatment of burn(s) | 0.87 | 1.19 | 0.36 | 0.07 | 2.13 | 1.30 | 000 | |
16015 | A | Treatment of burn(s) | 2.35 | 1.89 | 0.94 | 0.22 | 4.46 | 3.51 | 000 | |
16020 | A | Treatment of burn(s) | 0.80 | 1.13 | 0.26 | 0.06 | 1.99 | 1.12 | 000 | |
16025 | A | Treatment of burn(s) | 1.85 | 1.88 | 0.67 | 0.16 | 3.89 | 2.68 | 000 | |
16030 | A | Treatment of burn(s) | 2.08 | 3.05 | 0.91 | 0.18 | 5.31 | 3.17 | 000 | |
16035 | A | Incision of burn scab, initi | 3.75 | NA | 1.50 | 0.36 | NA | 5.61 | 090 | |
16036 | A | Incise burn scab, addl incis | 1.50 | NA | 0.62 | 0.11 | NA | 2.23 | ZZZ | |
17000 | A | Destroy benign/premlg lesion | 0.60 | 1.04 | 0.27 | 0.03 | 1.67 | 0.90 | 010 | |
17003 | A | Destroy lesions, 2-14 | 0.15 | 0.12 | 0.07 | 0.01 | 0.28 | 0.23 | ZZZ | |
17004 | A | Destroy lesions, 15 or more | 2.79 | 2.45 | 1.27 | 0.12 | 5.36 | 4.18 | 010 | |
17106 | A | Destruction of skin lesions | 4.59 | 4.77 | 3.21 | 0.28 | 9.64 | 8.08 | 090 | |
17107 | A | Destruction of skin lesions | 9.16 | 7.30 | 5.37 | 0.53 | 16.99 | 15.06 | 090 | |
17108 | A | Destruction of skin lesions | 13.20 | 9.35 | 7.66 | 0.89 | 23.44 | 21.75 | 090 | |
17110 | A | Destruct lesion, 1-14 | 0.65 | 1.71 | 0.45 | 0.04 | 2.40 | 1.14 | 010 | |
17111 | A | Destruct lesion, 15 or more | 0.92 | 1.75 | 0.56 | 0.04 | 2.71 | 1.52 | 010 | |
17250 | A | Chemical cautery, tissue | 0.50 | 1.23 | 0.34 | 0.04 | 1.77 | 0.88 | 000 | |
17260 | A | Destruction of skin lesions | 0.91 | 1.37 | 0.41 | 0.04 | 2.32 | 1.36 | 010 | |
17261 | A | Destruction of skin lesions | 1.17 | 1.62 | 0.55 | 0.05 | 2.84 | 1.77 | 010 | |
17262 | A | Destruction of skin lesions | 1.58 | 1.89 | 0.75 | 0.07 | 3.54 | 2.40 | 010 | |
17263 | A | Destruction of skin lesions | 1.79 | 2.07 | 0.82 | 0.08 | 3.94 | 2.69 | 010 | |
17264 | A | Destruction of skin lesions | 1.94 | 2.25 | 0.86 | 0.08 | 4.27 | 2.88 | 010 | |
17266 | A | Destruction of skin lesions | 2.34 | 2.57 | 0.96 | 0.11 | 5.02 | 3.41 | 010 | |
17270 | A | Destruction of skin lesions | 1.32 | 1.70 | 0.60 | 0.06 | 3.08 | 1.98 | 010 | |
17271 | A | Destruction of skin lesions | 1.49 | 1.79 | 0.71 | 0.06 | 3.34 | 2.26 | 010 | |
17272 | A | Destruction of skin lesions | 1.77 | 2.00 | 0.85 | 0.07 | 3.84 | 2.69 | 010 | |
17273 | A | Destruction of skin lesions | 2.05 | 2.23 | 0.96 | 0.09 | 4.37 | 3.10 | 010 | |
17274 | A | Destruction of skin lesions | 2.59 | 2.61 | 1.18 | 0.11 | 5.31 | 3.88 | 010 | |
17276 | A | Destruction of skin lesions | 3.20 | 3.03 | 1.42 | 0.15 | 6.38 | 4.77 | 010 | |
17280 | A | Destruction of skin lesions | 1.17 | 1.61 | 0.53 | 0.05 | 2.83 | 1.75 | 010 | |
17281 | A | Destruction of skin lesions | 1.72 | 1.92 | 0.82 | 0.07 | 3.71 | 2.61 | 010 | |
17282 | A | Destruction of skin lesions | 2.04 | 2.17 | 0.98 | 0.09 | 4.30 | 3.11 | 010 | |
17283 | A | Destruction of skin lesions | 2.64 | 2.58 | 1.23 | 0.11 | 5.33 | 3.98 | 010 | |
17284 | A | Destruction of skin lesions | 3.21 | 2.99 | 1.49 | 0.14 | 6.34 | 4.84 | 010 | |
17286 | A | Destruction of skin lesions | 4.44 | 3.78 | 2.18 | 0.22 | 8.44 | 6.84 | 010 | |
17304 | A | 1 stage mohs, up to 5 spec | 7.60 | 8.09 | 3.66 | 0.31 | 16.00 | 11.57 | 000 | |
17305 | A | 2 stage mohs, up to 5 spec | 2.85 | 3.81 | 1.37 | 0.12 | 6.78 | 4.34 | 000 | |
17306 | A | 3 stage mohs, up to 5 spec | 2.85 | 3.81 | 1.38 | 0.12 | 6.78 | 4.35 | 000 | |
17307 | A | Mohs addl stage up to 5 spec | 2.85 | 3.82 | 1.40 | 0.12 | 6.79 | 4.37 | 000 | |
17310 | A | Mohs any stage 5 spec each | 0.62 | 1.48 | 0.31 | 0.05 | 2.15 | 0.98 | ZZZ | |
17340 | A | Cryotherapy of skin | 0.76 | 0.38 | 0.26 | 0.04 | 1.18 | 1.06 | 010 | |
17360 | A | Skin peel therapy | 1.43 | 1.59 | 0.72 | 0.06 | 3.08 | 2.21 | 010 | |
17380 | R | Hair removal by electrolysis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | |
17999 | C | Skin tissue procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
19000 | A | Drainage of breast lesion | 0.84 | 1.20 | 0.29 | 0.07 | 2.11 | 1.20 | 000 | |
19001 | A | Drain breast lesion add-on | 0.42 | 0.82 | 0.14 | 0.03 | 1.27 | 0.59 | ZZZ | |
19020 | A | Incision of breast lesion | 3.57 | 6.81 | 3.39 | 0.35 | 10.73 | 7.31 | 090 | |
19030 | A | Injection for breast x-ray | 1.53 | 3.56 | 0.52 | 0.07 | 5.16 | 2.12 | 000 | |
19100 | A | Bx breast percut w/o image | 1.27 | 1.43 | 0.44 | 0.10 | 2.80 | 1.81 | 000 | |
19101 | A | Biopsy of breast, open | 3.18 | 5.02 | 1.89 | 0.20 | 8.40 | 5.27 | 010 | |
19102 | A | Bx breast percut w/image | 2.00 | 4.86 | 0.68 | 0.13 | 6.99 | 2.81 | 000 | |
19103 | A | Bx breast percut w/device | 3.70 | 12.31 | 1.27 | 0.16 | 16.17 | 5.13 | 000 | |
19110 | A | Nipple exploration | 4.30 | 8.62 | 4.43 | 0.44 | 13.36 | 9.17 | 090 | |
19112 | A | Excise breast duct fistula | 3.67 | 9.15 | 3.08 | 0.38 | 13.20 | 7.13 | 090 | |
19120 | A | Removal of breast lesion | 5.56 | 4.92 | 3.09 | 0.56 | 11.04 | 9.21 | 090 | |
19125 | A | Excision, breast lesion | 6.06 | 5.05 | 3.26 | 0.61 | 11.72 | 9.93 | 090 | |
19126 | A | Excision, addl breast lesion | 2.93 | NA | 1.02 | 0.30 | NA | 4.25 | ZZZ | |
19140 | A | Removal of breast tissue | 5.14 | 9.35 | 3.65 | 0.52 | 15.01 | 9.31 | 090 | |
19160 | A | Removal of breast tissue | 5.99 | NA | 4.52 | 0.61 | NA | 11.12 | 090 | |
19162 | A | Remove breast tissue, nodes | 13.53 | NA | 7.88 | 1.38 | NA | 22.79 | 090 | |
19180 | A | Removal of breast | 8.80 | NA | 5.93 | 0.88 | NA | 15.61 | 090 | |
19182 | A | Removal of breast | 7.73 | NA | 4.98 | 0.79 | NA | 13.50 | 090 | |
19200 | A | Removal of breast | 15.49 | NA | 9.07 | 1.51 | NA | 26.07 | 090 | |
19220 | A | Removal of breast | 15.72 | NA | 9.12 | 1.56 | NA | 26.40 | 090 | |
19240 | A | Removal of breast | 16.00 | NA | 8.74 | 1.62 | NA | 26.36 | 090 | |
19260 | A | Removal of chest wall lesion | 15.44 | NA | 9.13 | 1.64 | NA | 26.21 | 090 | |
19271 | A | Revision of chest wall | 18.90 | NA | 11.31 | 2.27 | NA | 32.48 | 090 | |
19272 | A | Extensive chest wall surgery | 21.55 | NA | 12.24 | 2.54 | NA | 36.33 | 090 | |
19290 | A | Place needle wire, breast | 1.27 | 2.89 | 0.43 | 0.06 | 4.22 | 1.76 | 000 | |
19291 | A | Place needle wire, breast | 0.63 | 1.69 | 0.21 | 0.03 | 2.35 | 0.87 | ZZZ | |
19295 | A | Place breast clip, percut | 0.00 | 2.65 | NA | 0.01 | 2.66 | NA | ZZZ | |
19316 | A | Suspension of breast | 10.69 | NA | 7.57 | 1.15 | NA | 19.41 | 090 | |
19318 | A | Reduction of large breast | 15.62 | NA | 11.72 | 1.69 | NA | 29.03 | 090 | |
19324 | A | Enlarge breast | 5.85 | NA | 4.25 | 0.63 | NA | 10.73 | 090 | |
19325 | A | Enlarge breast with implant | 8.45 | NA | 6.25 | 0.90 | NA | 15.60 | 090 | |
19328 | A | Removal of breast implant | 5.68 | NA | 4.54 | 0.61 | NA | 10.83 | 090 | |
19330 | A | Removal of implant material | 7.59 | NA | 5.20 | 0.81 | NA | 13.60 | 090 | |
19340 | A | Immediate breast prosthesis | 6.33 | NA | 3.19 | 0.68 | NA | 10.20 | ZZZ | |
19342 | A | Delayed breast prosthesis | 11.20 | NA | 7.83 | 1.21 | NA | 20.24 | 090 | |
19350 | A | Breast reconstruction | 8.92 | 13.45 | 6.80 | 0.95 | 23.32 | 16.67 | 090 | |
19355 | A | Correct inverted nipple(s) | 7.57 | 13.63 | 5.41 | 0.80 | 22.00 | 13.78 | 090 | |
19357 | A | Breast reconstruction | 18.16 | NA | 9.82 | 1.96 | NA | 29.94 | 090 | |
19361 | A | Breast reconstruction | 19.26 | NA | 10.27 | 2.08 | NA | 31.61 | 090 | |
19364 | A | Breast reconstruction | 41.00 | NA | 25.22 | 3.91 | NA | 70.13 | 090 | |
19366 | A | Breast reconstruction | 21.28 | NA | 10.27 | 2.27 | NA | 33.82 | 090 | |
19367 | A | Breast reconstruction | 25.73 | NA | 17.47 | 2.78 | NA | 45.98 | 090 | |
19368 | A | Breast reconstruction | 32.42 | NA | 21.08 | 3.51 | NA | 57.01 | 090 | |
19369 | A | Breast reconstruction | 29.82 | NA | 20.65 | 3.24 | NA | 53.71 | 090 | |
19370 | A | Surgery of breast capsule | 8.05 | NA | 6.08 | 0.86 | NA | 14.99 | 090 | |
19371 | A | Removal of breast capsule | 9.35 | NA | 7.15 | 1.01 | NA | 17.51 | 090 | |
19380 | A | Revise breast reconstruction | 9.14 | NA | 7.05 | 0.98 | NA | 17.17 | 090 | |
19396 | A | Design custom breast implant | 2.17 | 6.25 | 1.02 | 0.23 | 8.65 | 3.42 | 000 | |
19499 | C | Breast surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
20000 | A | Incision of abscess | 2.12 | 2.16 | 1.18 | 0.17 | 4.45 | 3.47 | 010 | |
20005 | A | Incision of deep abscess | 3.42 | 3.03 | 2.21 | 0.34 | 6.79 | 5.97 | 010 | |
20100 | A | Explore wound, neck | 10.08 | 5.82 | 4.37 | 0.99 | 16.89 | 15.44 | 010 | |
20101 | A | Explore wound, chest | 3.22 | 2.90 | 1.50 | 0.24 | 6.36 | 4.96 | 010 | |
20102 | A | Explore wound, abdomen | 3.94 | 3.39 | 1.75 | 0.35 | 7.68 | 6.04 | 010 | |
20103 | A | Explore wound, extremity | 5.30 | 4.26 | 3.02 | 0.57 | 10.13 | 8.89 | 010 | |
20150 | A | Excise epiphyseal bar | 13.69 | NA | 8.96 | 0.96 | NA | 23.61 | 090 | |
20200 | A | Muscle biopsy | 1.46 | 1.70 | 0.61 | 0.17 | 3.33 | 2.24 | 000 | |
20205 | A | Deep muscle biopsy | 2.35 | 3.87 | 0.96 | 0.23 | 6.45 | 3.54 | 000 | |
20206 | A | Needle biopsy, muscle | 0.99 | 3.15 | 0.35 | 0.06 | 4.20 | 1.40 | 000 | |
20220 | A | Bone biopsy, trocar/needle | 1.27 | 4.87 | 2.93 | 0.06 | 6.20 | 4.26 | 000 | |
20225 | A | Bone biopsy, trocar/needle | 1.87 | 4.37 | 3.02 | 0.11 | 6.35 | 5.00 | 000 | |
20240 | A | Bone biopsy, excisional | 3.23 | NA | 4.22 | 0.33 | NA | 7.78 | 010 | |
20245 | A | Bone biopsy, excisional | 7.78 | NA | 6.91 | 0.44 | NA | 15.13 | 010 | |
20250 | A | Open bone biopsy | 5.03 | NA | 4.37 | 0.50 | NA | 9.90 | 010 | |
20251 | A | Open bone biopsy | 5.56 | NA | 4.92 | 0.79 | NA | 11.27 | 010 | |
20500 | A | Injection of sinus tract | 1.23 | 5.89 | 3.82 | 0.10 | 7.22 | 5.15 | 010 | |
20501 | A | Inject sinus tract for x-ray | 0.76 | 3.14 | 0.26 | 0.03 | 3.93 | 1.05 | 000 | |
20520 | A | Removal of foreign body | 1.85 | 5.60 | 3.59 | 0.17 | 7.62 | 5.61 | 010 | |
20525 | A | Removal of foreign body | 3.50 | 6.84 | 4.38 | 0.40 | 10.74 | 8.28 | 010 | |
20526 | A | Ther injection, carp tunnel | 0.94 | 0.77 | 0.41 | 0.06 | 1.77 | 1.41 | 000 | |
20550 | A | Inj tendon sheath/ligament | 0.75 | 0.76 | 0.24 | 0.06 | 1.57 | 1.05 | 000 | |
20551 | A | Inject tendon origin/insert | 0.75 | 0.70 | 0.34 | 0.06 | 1.51 | 1.15 | 000 | |
20552 | A | Inject trigger point, 1 or 2 | 0.66 | 0.66 | 0.30 | 0.06 | 1.38 | 1.02 | 000 | |
20553 | A | Inject trigger points, =/ 3 | 0.75 | 0.75 | 0.34 | 0.06 | 1.56 | 1.15 | 000 | |
20600 | A | Drain/inject, joint/bursa | 0.66 | 0.66 | 0.36 | 0.06 | 1.38 | 1.08 | 000 | |
20605 | A | Drain/inject, joint/bursa | 0.68 | 0.78 | 0.37 | 0.06 | 1.52 | 1.11 | 000 | |
20610 | A | Drain/inject, joint/bursa | 0.79 | 0.97 | 0.42 | 0.08 | 1.84 | 1.29 | 000 | |
20612 | A | Aspirate/inj ganglion cyst | 0.70 | 0.77 | 0.28 | 0.06 | 1.53 | 1.04 | 000 | |
20615 | A | Treatment of bone cyst | 2.28 | 4.87 | 2.69 | 0.19 | 7.34 | 5.16 | 010 | |
20650 | A | Insert and remove bone pin | 2.23 | 5.08 | 3.29 | 0.28 | 7.59 | 5.80 | 010 | |
20660 | A | Apply, rem fixation device | 2.51 | NA | 2.28 | 0.48 | NA | 5.27 | 000 | |
20661 | A | Application of head brace | 4.89 | NA | 6.91 | 0.92 | NA | 12.72 | 090 | |
20662 | A | Application of pelvis brace | 6.07 | NA | 6.27 | 0.81 | NA | 13.15 | 090 | |
20663 | A | Application of thigh brace | 5.43 | NA | 5.58 | 0.77 | NA | 11.78 | 090 | |
20664 | A | Halo brace application | 8.06 | NA | 8.62 | 1.49 | NA | 18.17 | 090 | |
20665 | A | Removal of fixation device | 1.31 | 2.14 | 1.30 | 0.17 | 3.62 | 2.78 | 010 | |
20670 | A | Removal of support implant | 1.74 | 6.09 | 3.55 | 0.23 | 8.06 | 5.52 | 010 | |
20680 | A | Removal of support implant | 3.35 | 5.37 | 5.37 | 0.46 | 9.18 | 9.18 | 090 | |
20690 | A | Apply bone fixation device | 3.52 | NA | 1.82 | 0.47 | NA | 5.81 | 090 | |
20692 | A | Apply bone fixation device | 6.41 | NA | 3.05 | 0.60 | NA | 10.06 | 090 | |
20693 | A | Adjust bone fixation device | 5.86 | NA | 13.20 | 0.85 | NA | 19.91 | 090 | |
20694 | A | Remove bone fixation device | 4.16 | 9.45 | 6.56 | 0.57 | 14.18 | 11.29 | 090 | |
20802 | A | Replantation, arm, complete | 41.15 | NA | 27.57 | 5.81 | NA | 74.53 | 090 | |
20805 | A | Replant forearm, complete | 50.00 | NA | 43.16 | 3.95 | NA | 97.11 | 090 | |
20808 | A | Replantation hand, complete | 61.65 | NA | 49.60 | 6.49 | NA | 117.74 | 090 | |
20816 | A | Replantation digit, complete | 30.94 | NA | 46.54 | 3.01 | NA | 80.49 | 090 | |
20822 | A | Replantation digit, complete | 25.59 | NA | 42.54 | 3.07 | NA | 71.20 | 090 | |
20824 | A | Replantation thumb, complete | 30.94 | NA | 45.41 | 3.48 | NA | 79.83 | 090 | |
20827 | A | Replantation thumb, complete | 26.41 | NA | 45.08 | 3.21 | NA | 74.70 | 090 | |
20838 | A | Replantation foot, complete | 41.41 | NA | 28.58 | 5.85 | NA | 75.84 | 090 | |
20900 | A | Removal of bone for graft | 5.58 | 6.60 | 6.39 | 0.77 | 12.95 | 12.74 | 090 | |
20902 | A | Removal of bone for graft | 7.55 | NA | 9.17 | 1.06 | NA | 17.78 | 090 | |
20910 | A | Remove cartilage for graft | 5.34 | 8.85 | 6.69 | 0.50 | 14.69 | 12.53 | 090 | |
20912 | A | Remove cartilage for graft | 6.35 | NA | 7.49 | 0.55 | NA | 14.39 | 090 | |
20920 | A | Removal of fascia for graft | 5.31 | NA | 5.57 | 0.54 | NA | 11.42 | 090 | |
20922 | A | Removal of fascia for graft | 6.61 | 8.97 | 6.40 | 0.88 | 16.46 | 13.89 | 090 | |
20924 | A | Removal of tendon for graft | 6.48 | NA | 7.16 | 0.82 | NA | 14.46 | 090 | |
20926 | A | Removal of tissue for graft | 5.53 | NA | 6.42 | 0.73 | NA | 12.68 | 090 | |
20930 | B | Spinal bone allograft | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
20931 | A | Spinal bone allograft | 1.81 | NA | 0.96 | 0.34 | NA | 3.11 | ZZZ | |
20936 | B | Spinal bone autograft | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
20937 | A | Spinal bone autograft | 2.79 | NA | 1.49 | 0.43 | NA | 4.71 | ZZZ | |
20938 | A | Spinal bone autograft | 3.02 | NA | 1.59 | 0.52 | NA | 5.13 | ZZZ | |
20950 | A | Fluid pressure, muscle | 1.26 | NA | 2.24 | 0.16 | NA | 3.66 | 000 | |
20955 | A | Fibula bone graft, microvasc | 39.21 | NA | 29.76 | 4.35 | NA | 73.32 | 090 | |
20956 | A | Iliac bone graft, microvasc | 39.27 | NA | 28.79 | 5.77 | NA | 73.83 | 090 | |
20957 | A | Mt bone graft, microvasc | 40.65 | NA | 21.19 | 5.74 | NA | 67.58 | 090 | |
20962 | A | Other bone graft, microvasc | 39.27 | NA | 28.28 | 5.19 | NA | 72.74 | 090 | |
20969 | A | Bone/skin graft, microvasc | 43.92 | NA | 32.14 | 4.34 | NA | 80.40 | 090 | |
20970 | A | Bone/skin graft, iliac crest | 43.06 | NA | 30.05 | 4.64 | NA | 77.75 | 090 | |
20972 | A | Bone/skin graft, metatarsal | 42.99 | NA | 18.39 | 6.07 | NA | 67.45 | 090 | |
20973 | A | Bone/skin graft, great toe | 45.76 | NA | 28.24 | 4.65 | NA | 78.65 | 090 | |
20974 | A | Electrical bone stimulation | 0.62 | 0.42 | 0.33 | 0.09 | 1.13 | 1.04 | 000 | |
20975 | A | Electrical bone stimulation | 2.60 | NA | 1.38 | 0.42 | NA | 4.40 | 000 | |
20979 | A | Us bone stimulation | 0.62 | 0.73 | 0.35 | 0.04 | 1.39 | 1.01 | 000 | |
20999 | C | Musculoskeletal surgery | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
21010 | A | Incision of jaw joint | 10.14 | NA | 7.16 | 0.54 | NA | 17.84 | 090 | |
21015 | A | Resection of facial tumor | 5.29 | NA | 7.09 | 0.52 | NA | 12.90 | 090 | |
21025 | A | Excision of bone, lower jaw | 10.06 | 7.35 | 6.87 | 0.79 | 18.20 | 17.72 | 090 | |
21026 | A | Excision of facial bone(s) | 4.85 | 5.39 | 5.08 | 0.40 | 10.64 | 10.33 | 090 | |
21029 | A | Contour of face bone lesion | 7.71 | 6.96 | 6.15 | 0.74 | 15.41 | 14.60 | 090 | |
21030 | A | Excise max/zygoma b9 tumor | 3.89 | 4.36 | 3.64 | 0.60 | 8.85 | 8.13 | 090 | |
21031 | A | Remove exostosis, mandible | 3.24 | 3.35 | 2.17 | 0.28 | 6.87 | 5.69 | 090 | |
21032 | A | Remove exostosis, maxilla | 3.24 | 3.32 | 2.29 | 0.27 | 6.83 | 5.80 | 090 | |
21034 | A | Excise max/zygoma mlg tumor | 16.17 | 10.67 | 10.64 | 1.37 | 28.21 | 28.18 | 090 | |
21040 | A | Excise mandible lesion | 3.89 | 3.76 | 2.58 | 0.19 | 7.84 | 6.66 | 090 | |
21041 | D | Removal of jaw bone lesion | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 090 | |
21044 | A | Removal of jaw bone lesion | 11.86 | NA | 7.96 | 0.87 | NA | 20.69 | 090 | |
21045 | A | Extensive jaw surgery | 16.17 | NA | 10.29 | 1.20 | NA | 27.66 | 090 | |
21046 | A | Remove mandible cyst complex | 13.00 | NA | 10.42 | 1.01 | NA | 24.43 | 090 | |
21047 | A | Excise lwr jaw cyst w/repair | 18.75 | NA | 9.87 | 1.53 | NA | 30.15 | 090 | |
21048 | A | Remove maxilla cyst complex | 13.50 | NA | 10.63 | 1.01 | NA | 25.14 | 090 | |
21049 | A | Excis uppr jaw cyst w/repair | 18.00 | NA | 9.55 | 1.01 | NA | 28.56 | 090 | |
21050 | A | Removal of jaw joint | 10.77 | NA | 11.63 | 0.84 | NA | 23.24 | 090 | |
21060 | A | Remove jaw joint cartilage | 10.23 | NA | 10.09 | 1.16 | NA | 21.48 | 090 | |
21070 | A | Remove coronoid process | 8.20 | NA | 5.98 | 0.67 | NA | 14.85 | 090 | |
21076 | A | Prepare face/oral prosthesis | 13.42 | 9.49 | 7.13 | 1.36 | 24.27 | 21.91 | 010 | |
21077 | A | Prepare face/oral prosthesis | 33.75 | 23.88 | 17.94 | 3.43 | 61.06 | 55.12 | 090 | |
21079 | A | Prepare face/oral prosthesis | 22.34 | 16.88 | 12.41 | 1.59 | 40.81 | 36.34 | 090 | |
21080 | A | Prepare face/oral prosthesis | 25.10 | 18.97 | 13.94 | 2.55 | 46.62 | 41.59 | 090 | |
21081 | A | Prepare face/oral prosthesis | 22.88 | 17.28 | 12.71 | 1.87 | 42.03 | 37.46 | 090 | |
21082 | A | Prepare face/oral prosthesis | 20.87 | 14.77 | 11.10 | 1.46 | 37.10 | 33.43 | 090 | |
21083 | A | Prepare face/oral prosthesis | 19.30 | 14.58 | 10.72 | 1.96 | 35.84 | 31.98 | 090 | |
21084 | A | Prepare face/oral prosthesis | 22.51 | 17.01 | 12.51 | 1.57 | 41.09 | 36.59 | 090 | |
21085 | A | Prepare face/oral prosthesis | 9.00 | 6.37 | 4.79 | 0.65 | 16.02 | 14.44 | 010 | |
21086 | A | Prepare face/oral prosthesis | 24.92 | 18.83 | 13.84 | 1.86 | 45.61 | 40.62 | 090 | |
21087 | A | Prepare face/oral prosthesis | 24.92 | 17.63 | 13.24 | 2.22 | 44.77 | 40.38 | 090 | |
21088 | C | Prepare face/oral prosthesis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 090 | |
21089 | C | Prepare face/oral prosthesis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 090 | |
21100 | A | Maxillofacial fixation | 4.22 | 5.93 | 4.05 | 0.18 | 10.33 | 8.45 | 090 | |
21110 | A | Interdental fixation | 5.21 | 5.31 | 4.32 | 0.28 | 10.80 | 9.81 | 090 | |
21116 | A | Injection, jaw joint x-ray | 0.81 | 7.71 | 0.29 | 0.05 | 8.57 | 1.15 | 000 | |
21120 | A | Reconstruction of chin | 4.93 | 9.80 | 6.08 | 0.29 | 15.02 | 11.30 | 090 | |
21121 | A | Reconstruction of chin | 7.64 | 7.94 | 6.21 | 0.56 | 16.14 | 14.41 | 090 | |
21122 | A | Reconstruction of chin | 8.52 | NA | 7.63 | 0.59 | NA | 16.74 | 090 | |
21123 | A | Reconstruction of chin | 11.16 | NA | 8.08 | 1.16 | NA | 20.40 | 090 | |
21125 | A | Augmentation, lower jaw bone | 10.62 | 9.53 | 8.07 | 0.72 | 20.87 | 19.41 | 090 | |
21127 | A | Augmentation, lower jaw bone | 11.12 | 9.80 | 7.50 | 0.76 | 21.68 | 19.38 | 090 | |
21137 | A | Reduction of forehead | 9.82 | NA | 8.03 | 0.53 | NA | 18.38 | 090 | |
21138 | A | Reduction of forehead | 12.19 | NA | 9.40 | 1.47 | NA | 23.06 | 090 | |
21139 | A | Reduction of forehead | 14.61 | NA | 9.78 | 1.02 | NA | 25.41 | 090 | |
21141 | A | Reconstruct midface, lefort | 18.10 | NA | 10.79 | 1.63 | NA | 30.52 | 090 | |
21142 | A | Reconstruct midface, lefort | 18.81 | NA | 12.16 | 1.16 | NA | 32.13 | 090 | |
21143 | A | Reconstruct midface, lefort | 19.58 | NA | 11.10 | 0.90 | NA | 31.58 | 090 | |
21145 | A | Reconstruct midface, lefort | 19.94 | NA | 11.25 | 2.09 | NA | 33.28 | 090 | |
21146 | A | Reconstruct midface, lefort | 20.71 | NA | 11.92 | 2.13 | NA | 34.76 | 090 | |
21147 | A | Reconstruct midface, lefort | 21.77 | NA | 12.15 | 1.52 | NA | 35.44 | 090 | |
21150 | A | Reconstruct midface, lefort | 25.24 | NA | 16.33 | 1.09 | NA | 42.66 | 090 | |
21151 | A | Reconstruct midface, lefort | 28.30 | NA | 19.93 | 1.98 | NA | 50.21 | 090 | |
21154 | A | Reconstruct midface, lefort | 30.52 | NA | 19.84 | 4.86 | NA | 55.22 | 090 | |
21155 | A | Reconstruct midface, lefort | 34.45 | NA | 20.75 | 5.48 | NA | 60.68 | 090 | |
21159 | A | Reconstruct midface, lefort | 42.38 | NA | 25.58 | 6.74 | NA | 74.70 | 090 | |
21160 | A | Reconstruct midface, lefort | 46.44 | NA | 26.69 | 4.39 | NA | 77.52 | 090 | |
21172 | A | Reconstruct orbit/forehead | 27.80 | NA | 15.82 | 1.91 | NA | 45.53 | 090 | |
21175 | A | Reconstruct orbit/forehead | 33.17 | NA | 20.06 | 5.16 | NA | 58.39 | 090 | |
21179 | A | Reconstruct entire forehead | 22.25 | NA | 17.84 | 2.48 | NA | 42.57 | 090 | |
21180 | A | Reconstruct entire forehead | 25.19 | NA | 18.59 | 2.15 | NA | 45.93 | 090 | |
21181 | A | Contour cranial bone lesion | 9.90 | NA | 8.34 | 0.97 | NA | 19.21 | 090 | |
21182 | A | Reconstruct cranial bone | 32.19 | NA | 21.89 | 2.53 | NA | 56.61 | 090 | |
21183 | A | Reconstruct cranial bone | 35.31 | NA | 23.87 | 2.75 | NA | 61.93 | 090 | |
21184 | A | Reconstruct cranial bone | 38.24 | NA | 24.30 | 4.12 | NA | 66.66 | 090 | |
21188 | A | Reconstruction of midface | 22.46 | NA | 15.62 | 1.85 | NA | 39.93 | 090 | |
21193 | A | Reconst lwr jaw w/o graft | 17.15 | NA | 10.78 | 1.53 | NA | 29.46 | 090 | |
21194 | A | Reconst lwr jaw w/graft | 19.84 | NA | 12.72 | 1.39 | NA | 33.95 | 090 | |
21195 | A | Reconst lwr jaw w/o fixation | 17.24 | NA | 12.35 | 1.20 | NA | 30.79 | 090 | |
21196 | A | Reconst lwr jaw w/fixation | 18.91 | NA | 12.91 | 1.62 | NA | 33.44 | 090 | |
21198 | A | Reconstr lwr jaw segment | 14.16 | NA | 11.66 | 1.05 | NA | 26.87 | 090 | |
21199 | A | Reconstr lwr jaw w/advance | 16.00 | NA | 9.29 | 1.26 | NA | 26.55 | 090 | |
21206 | A | Reconstruct upper jaw bone | 14.10 | NA | 9.72 | 1.01 | NA | 24.83 | 090 | |
21208 | A | Augmentation of facial bones | 10.23 | 9.69 | 8.36 | 0.92 | 20.84 | 19.51 | 090 | |
21209 | A | Reduction of facial bones | 6.72 | 7.97 | 5.79 | 0.60 | 15.29 | 13.11 | 090 | |
21210 | A | Face bone graft | 10.23 | 8.99 | 8.14 | 0.88 | 20.10 | 19.25 | 090 | |
21215 | A | Lower jaw bone graft | 10.77 | 8.90 | 7.08 | 1.04 | 20.71 | 18.89 | 090 | |
21230 | A | Rib cartilage graft | 10.77 | NA | 10.06 | 0.96 | NA | 21.79 | 090 | |
21235 | A | Ear cartilage graft | 6.72 | 12.21 | 8.03 | 0.52 | 19.45 | 15.27 | 090 | |
21240 | A | Reconstruction of jaw joint | 14.05 | NA | 11.30 | 1.15 | NA | 26.50 | 090 | |
21242 | A | Reconstruction of jaw joint | 12.95 | NA | 11.07 | 1.40 | NA | 25.42 | 090 | |
21243 | A | Reconstruction of jaw joint | 20.79 | NA | 13.76 | 1.85 | NA | 36.40 | 090 | |
21244 | A | Reconstruction of lower jaw | 11.86 | NA | 9.17 | 0.95 | NA | 21.98 | 090 | |
21245 | A | Reconstruction of jaw | 11.86 | 12.18 | 10.18 | 0.88 | 24.92 | 22.92 | 090 | |
21246 | A | Reconstruction of jaw | 12.47 | 10.33 | 10.33 | 1.21 | 24.01 | 24.01 | 090 | |
21247 | A | Reconstruct lower jaw bone | 22.63 | NA | 16.39 | 2.21 | NA | 41.23 | 090 | |
21248 | A | Reconstruction of jaw | 11.48 | 8.99 | 7.76 | 1.01 | 21.48 | 20.25 | 090 | |
21249 | A | Reconstruction of jaw | 17.52 | 11.51 | 10.20 | 1.39 | 30.42 | 29.11 | 090 | |
21255 | A | Reconstruct lower jaw bone | 16.72 | NA | 11.44 | 1.13 | NA | 29.29 | 090 | |
21256 | A | Reconstruction of orbit | 16.19 | NA | 13.27 | 1.04 | NA | 30.50 | 090 | |
21260 | A | Revise eye sockets | 16.52 | NA | 10.71 | 1.25 | NA | 28.48 | 090 | |
21261 | A | Revise eye sockets | 31.49 | NA | 20.59 | 2.20 | NA | 54.28 | 090 | |
21263 | A | Revise eye sockets | 28.42 | NA | 12.98 | 2.16 | NA | 43.56 | 090 | |
21267 | A | Revise eye sockets | 18.90 | NA | 14.48 | 1.35 | NA | 34.73 | 090 | |
21268 | A | Revise eye sockets | 24.48 | NA | 16.12 | 0.79 | NA | 41.39 | 090 | |
21270 | A | Augmentation, cheek bone | 10.23 | 9.54 | 9.54 | 0.73 | 20.50 | 20.50 | 090 | |
21275 | A | Revision, orbitofacial bones | 11.24 | NA | 10.78 | 1.03 | NA | 23.05 | 090 | |
21280 | A | Revision of eyelid | 6.03 | NA | 6.07 | 0.27 | NA | 12.37 | 090 | |
21282 | A | Revision of eyelid | 3.49 | NA | 5.15 | 0.21 | NA | 8.85 | 090 | |
21295 | A | Revision of jaw muscle/bone | 1.53 | NA | 4.35 | 0.13 | NA | 6.01 | 090 | |
21296 | A | Revision of jaw muscle/bone | 4.25 | NA | 4.55 | 0.30 | NA | 9.10 | 090 | |
21299 | C | Cranio/maxillofacial surgery | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
21300 | A | Treatment of skull fracture | 0.72 | 2.73 | 0.26 | 0.09 | 3.54 | 1.07 | 000 | |
21310 | A | Treatment of nose fracture | 0.58 | 2.68 | 0.15 | 0.05 | 3.31 | 0.78 | 000 | |
21315 | A | Treatment of nose fracture | 1.51 | 3.43 | 1.27 | 0.12 | 5.06 | 2.90 | 010 | |
21320 | A | Treatment of nose fracture | 1.85 | 4.83 | 2.03 | 0.15 | 6.83 | 4.03 | 010 | |
21325 | A | Treatment of nose fracture | 3.77 | NA | 3.67 | 0.31 | NA | 7.75 | 090 | |
21330 | A | Treatment of nose fracture | 5.38 | NA | 5.51 | 0.48 | NA | 11.37 | 090 | |
21335 | A | Treatment of nose fracture | 8.61 | NA | 7.16 | 0.64 | NA | 16.41 | 090 | |
21336 | A | Treat nasal septal fracture | 5.72 | NA | 5.55 | 0.45 | NA | 11.72 | 090 | |
21337 | A | Treat nasal septal fracture | 2.70 | 5.23 | 3.25 | 0.22 | 8.15 | 6.17 | 090 | |
21338 | A | Treat nasoethmoid fracture | 6.46 | NA | 5.96 | 0.53 | NA | 12.95 | 090 | |
21339 | A | Treat nasoethmoid fracture | 8.09 | NA | 6.70 | 0.76 | NA | 15.55 | 090 | |
21340 | A | Treatment of nose fracture | 10.77 | NA | 9.09 | 0.85 | NA | 20.71 | 090 | |
21343 | A | Treatment of sinus fracture | 12.95 | NA | 9.77 | 1.06 | NA | 23.78 | 090 | |
21344 | A | Treatment of sinus fracture | 19.72 | NA | 13.44 | 1.72 | NA | 34.88 | 090 | |
21345 | A | Treat nose/jaw fracture | 8.16 | 9.73 | 7.91 | 0.60 | 18.49 | 16.67 | 090 | |
21346 | A | Treat nose/jaw fracture | 10.61 | NA | 10.05 | 0.85 | NA | 21.51 | 090 | |
21347 | A | Treat nose/jaw fracture | 12.69 | NA | 9.50 | 1.14 | NA | 23.33 | 090 | |
21348 | A | Treat nose/jaw fracture | 16.69 | NA | 10.93 | 1.50 | NA | 29.12 | 090 | |
21355 | A | Treat cheek bone fracture | 3.77 | 4.40 | 2.28 | 0.29 | 8.46 | 6.34 | 010 | |
21356 | A | Treat cheek bone fracture | 4.15 | NA | 3.23 | 0.36 | NA | 7.74 | 010 | |
21360 | A | Treat cheek bone fracture | 6.46 | NA | 5.63 | 0.52 | NA | 12.61 | 090 | |
21365 | A | Treat cheek bone fracture | 14.95 | NA | 11.31 | 1.30 | NA | 27.56 | 090 | |
21366 | A | Treat cheek bone fracture | 17.77 | NA | 11.90 | 1.41 | NA | 31.08 | 090 | |
21385 | A | Treat eye socket fracture | 9.16 | NA | 7.53 | 0.64 | NA | 17.33 | 090 | |
21386 | A | Treat eye socket fracture | 9.16 | NA | 7.97 | 0.76 | NA | 17.89 | 090 | |
21387 | A | Treat eye socket fracture | 9.70 | NA | 8.22 | 0.78 | NA | 18.70 | 090 | |
21390 | A | Treat eye socket fracture | 10.13 | NA | 8.47 | 0.70 | NA | 19.30 | 090 | |
21395 | A | Treat eye socket fracture | 12.68 | NA | 9.79 | 1.09 | NA | 23.56 | 090 | |
21400 | A | Treat eye socket fracture | 1.40 | 3.12 | 1.05 | 0.12 | 4.64 | 2.57 | 090 | |
21401 | A | Treat eye socket fracture | 3.26 | 4.83 | 3.11 | 0.34 | 8.43 | 6.71 | 090 | |
21406 | A | Treat eye socket fracture | 7.01 | NA | 6.75 | 0.59 | NA | 14.35 | 090 | |
21407 | A | Treat eye socket fracture | 8.61 | NA | 7.75 | 0.67 | NA | 17.03 | 090 | |
21408 | A | Treat eye socket fracture | 12.38 | NA | 10.01 | 1.24 | NA | 23.63 | 090 | |
21421 | A | Treat mouth roof fracture | 5.14 | 7.44 | 6.09 | 0.42 | 13.00 | 11.65 | 090 | |
21422 | A | Treat mouth roof fracture | 8.32 | NA | 7.49 | 0.69 | NA | 16.50 | 090 | |
21423 | A | Treat mouth roof fracture | 10.40 | NA | 8.02 | 0.95 | NA | 19.37 | 090 | |
21431 | A | Treat craniofacial fracture | 7.05 | NA | 6.68 | 0.58 | NA | 14.31 | 090 | |
21432 | A | Treat craniofacial fracture | 8.61 | NA | 7.74 | 0.55 | NA | 16.90 | 090 | |
21433 | A | Treat craniofacial fracture | 25.35 | NA | 17.10 | 2.46 | NA | 44.91 | 090 | |
21435 | A | Treat craniofacial fracture | 17.25 | NA | 12.56 | 1.66 | NA | 31.47 | 090 | |
21436 | A | Treat craniofacial fracture | 28.04 | NA | 17.16 | 2.32 | NA | 47.52 | 090 | |
21440 | A | Treat dental ridge fracture | 2.70 | 5.68 | 3.64 | 0.22 | 8.60 | 6.56 | 090 | |
21445 | A | Treat dental ridge fracture | 5.38 | 7.04 | 5.17 | 0.55 | 12.97 | 11.10 | 090 | |
21450 | A | Treat lower jaw fracture | 2.97 | 6.87 | 2.74 | 0.23 | 10.07 | 5.94 | 090 | |
21451 | A | Treat lower jaw fracture | 4.87 | 6.63 | 5.65 | 0.39 | 11.89 | 10.91 | 090 | |
21452 | A | Treat lower jaw fracture | 1.98 | 9.39 | 4.20 | 0.14 | 11.51 | 6.32 | 090 | |
21453 | A | Treat lower jaw fracture | 5.54 | 7.52 | 6.40 | 0.49 | 13.55 | 12.43 | 090 | |
21454 | A | Treat lower jaw fracture | 6.46 | NA | 5.78 | 0.55 | NA | 12.79 | 090 | |
21461 | A | Treat lower jaw fracture | 8.09 | 9.26 | 7.94 | 0.73 | 18.08 | 16.76 | 090 | |
21462 | A | Treat lower jaw fracture | 9.79 | 10.56 | 8.08 | 0.80 | 21.15 | 18.67 | 090 | |
21465 | A | Treat lower jaw fracture | 11.91 | NA | 7.87 | 0.84 | NA | 20.62 | 090 | |
21470 | A | Treat lower jaw fracture | 15.34 | NA | 9.93 | 1.36 | NA | 26.63 | 090 | |
21480 | A | Reset dislocated jaw | 0.61 | 1.58 | 0.18 | 0.05 | 2.24 | 0.84 | 000 | |
21485 | A | Reset dislocated jaw | 3.99 | 3.85 | 3.39 | 0.31 | 8.15 | 7.69 | 090 | |
21490 | A | Repair dislocated jaw | 11.86 | NA | 7.57 | 1.31 | NA | 20.74 | 090 | |
21493 | A | Treat hyoid bone fracture | 1.27 | NA | 3.38 | 0.10 | NA | 4.75 | 090 | |
21494 | A | Treat hyoid bone fracture | 6.28 | NA | 5.06 | 0.44 | NA | 11.78 | 090 | |
21495 | A | Treat hyoid bone fracture | 5.69 | NA | 5.00 | 0.41 | NA | 11.10 | 090 | |
21497 | A | Interdental wiring | 3.86 | 4.75 | 3.97 | 0.31 | 8.92 | 8.14 | 090 | |
21499 | C | Head surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
21501 | A | Drain neck/chest lesion | 3.81 | 4.39 | 3.59 | 0.36 | 8.56 | 7.76 | 090 | |
21502 | A | Drain chest lesion | 7.12 | NA | 7.44 | 0.79 | NA | 15.35 | 090 | |
21510 | A | Drainage of bone lesion | 5.74 | NA | 7.16 | 0.67 | NA | 13.57 | 090 | |
21550 | A | Biopsy of neck/chest | 2.06 | 2.33 | 1.22 | 0.13 | 4.52 | 3.41 | 010 | |
21555 | A | Remove lesion, neck/chest | 4.35 | 4.26 | 2.44 | 0.41 | 9.02 | 7.20 | 090 | |
21556 | A | Remove lesion, neck/chest | 5.57 | NA | 3.21 | 0.51 | NA | 9.29 | 090 | |
21557 | A | Remove tumor, neck/chest | 8.88 | NA | 7.68 | 0.85 | NA | 17.41 | 090 | |
21600 | A | Partial removal of rib | 6.89 | NA | 7.57 | 0.81 | NA | 15.27 | 090 | |
21610 | A | Partial removal of rib | 14.61 | NA | 11.24 | 1.85 | NA | 27.70 | 090 | |
21615 | A | Removal of rib | 9.87 | NA | 8.07 | 1.20 | NA | 19.14 | 090 | |
21616 | A | Removal of rib and nerves | 12.04 | NA | 9.27 | 1.31 | NA | 22.62 | 090 | |
21620 | A | Partial removal of sternum | 6.79 | NA | 8.04 | 0.77 | NA | 15.60 | 090 | |
21627 | A | Sternal debridement | 6.81 | NA | 12.58 | 0.82 | NA | 20.21 | 090 | |
21630 | A | Extensive sternum surgery | 17.38 | NA | 13.52 | 1.95 | NA | 32.85 | 090 | |
21632 | A | Extensive sternum surgery | 18.14 | NA | 12.17 | 2.16 | NA | 32.47 | 090 | |
21700 | A | Revision of neck muscle | 6.19 | 9.22 | 7.25 | 0.31 | 15.72 | 13.75 | 090 | |
21705 | A | Revision of neck muscle/rib | 9.60 | NA | 7.62 | 0.92 | NA | 18.14 | 090 | |
21720 | A | Revision of neck muscle | 5.68 | 7.95 | 7.01 | 0.80 | 14.43 | 13.49 | 090 | |
21725 | A | Revision of neck muscle | 6.99 | NA | 7.45 | 0.90 | NA | 15.34 | 090 | |
21740 | A | Reconstruction of sternum | 16.50 | NA | 12.48 | 2.03 | NA | 31.01 | 090 | |
21742 | C | Repair stern/nuss w/o scope | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 090 | |
21743 | C | Repair sternum/nuss w/scope | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 090 | |
21750 | A | Repair of sternum separation | 10.77 | NA | 9.85 | 1.35 | NA | 21.97 | 090 | |
21800 | A | Treatment of rib fracture | 0.96 | 2.38 | 1.08 | 0.09 | 3.43 | 2.13 | 090 | |
21805 | A | Treatment of rib fracture | 2.75 | NA | 4.71 | 0.29 | NA | 7.75 | 090 | |
21810 | A | Treatment of rib fracture(s) | 6.86 | NA | 7.06 | 0.60 | NA | 14.52 | 090 | |
21820 | A | Treat sternum fracture | 1.28 | 2.92 | 1.56 | 0.15 | 4.35 | 2.99 | 090 | |
21825 | A | Treat sternum fracture | 7.41 | NA | 10.26 | 0.84 | NA | 18.51 | 090 | |
21899 | C | Neck/chest surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
21920 | A | Biopsy soft tissue of back | 2.06 | 2.45 | 0.75 | 0.12 | 4.63 | 2.93 | 010 | |
21925 | A | Biopsy soft tissue of back | 4.49 | 11.93 | 4.68 | 0.44 | 16.86 | 9.61 | 090 | |
21930 | A | Remove lesion, back or flank | 5.00 | 4.60 | 2.62 | 0.49 | 10.09 | 8.11 | 090 | |
21935 | A | Remove tumor, back | 17.96 | NA | 13.01 | 1.87 | NA | 32.84 | 090 | |
22100 | A | Remove part of neck vertebra | 9.73 | NA | 8.38 | 1.55 | NA | 19.66 | 090 | |
22101 | A | Remove part, thorax vertebra | 9.81 | NA | 8.57 | 1.51 | NA | 19.89 | 090 | |
22102 | A | Remove part, lumbar vertebra | 9.81 | NA | 8.77 | 1.46 | NA | 20.04 | 090 | |
22103 | A | Remove extra spine segment | 2.34 | NA | 1.24 | 0.37 | NA | 3.95 | ZZZ | |
22110 | A | Remove part of neck vertebra | 12.74 | NA | 10.66 | 2.20 | NA | 25.60 | 090 | |
22112 | A | Remove part, thorax vertebra | 12.81 | NA | 10.54 | 1.96 | NA | 25.31 | 090 | |
22114 | A | Remove part, lumbar vertebra | 12.81 | NA | 10.45 | 1.98 | NA | 25.24 | 090 | |
22116 | A | Remove extra spine segment | 2.32 | NA | 1.19 | 0.40 | NA | 3.91 | ZZZ | |
22210 | A | Revision of neck spine | 23.82 | NA | 17.10 | 4.23 | NA | 45.15 | 090 | |
22212 | A | Revision of thorax spine | 19.42 | NA | 14.61 | 2.78 | NA | 36.81 | 090 | |
22214 | A | Revision of lumbar spine | 19.45 | NA | 15.09 | 2.78 | NA | 37.32 | 090 | |
22216 | A | Revise, extra spine segment | 6.04 | NA | 3.21 | 0.98 | NA | 10.23 | ZZZ | |
22220 | A | Revision of neck spine | 21.37 | NA | 15.50 | 3.65 | NA | 40.52 | 090 | |
22222 | A | Revision of thorax spine | 21.52 | NA | 13.08 | 3.08 | NA | 37.68 | 090 | |
22224 | A | Revision of lumbar spine | 21.52 | NA | 15.72 | 3.20 | NA | 40.44 | 090 | |
22226 | A | Revise, extra spine segment | 6.04 | NA | 3.17 | 1.01 | NA | 10.22 | ZZZ | |
22305 | A | Treat spine process fracture | 2.05 | 3.40 | 2.82 | 0.29 | 5.74 | 5.16 | 090 | |
22310 | A | Treat spine fracture | 2.61 | 5.04 | 4.44 | 0.37 | 8.02 | 7.42 | 090 | |
22315 | A | Treat spine fracture | 8.84 | NA | 8.64 | 1.37 | NA | 18.85 | 090 | |
22318 | A | Treat odontoid fx w/o graft | 21.50 | NA | 14.63 | 4.26 | NA | 40.39 | 090 | |
22319 | A | Treat odontoid fx w/graft | 24.00 | NA | 17.14 | 4.76 | NA | 45.90 | 090 | |
22325 | A | Treat spine fracture | 18.30 | NA | 13.88 | 2.61 | NA | 34.79 | 090 | |
22326 | A | Treat neck spine fracture | 19.59 | NA | 15.00 | 3.54 | NA | 38.13 | 090 | |
22327 | A | Treat thorax spine fracture | 19.20 | NA | 14.24 | 2.75 | NA | 36.19 | 090 | |
22328 | A | Treat each add spine fx | 4.61 | NA | 2.33 | 0.66 | NA | 7.60 | ZZZ | |
22505 | A | Manipulation of spine | 1.87 | 4.80 | 3.19 | 0.27 | 6.94 | 5.33 | 010 | |
22520 | A | Percut vertebroplasty thor | 8.91 | NA | 3.98 | 0.99 | NA | 13.88 | 010 | |
22521 | A | Percut vertebroplasty lumb | 8.34 | NA | 3.81 | 0.93 | NA | 13.08 | 010 | |
22522 | A | Percut vertebroplasty addl | 4.31 | NA | 1.73 | 0.33 | NA | 6.37 | ZZZ | |
22548 | A | Neck spine fusion | 25.82 | NA | 16.22 | 4.98 | NA | 47.02 | 090 | |
22554 | A | Neck spine fusion | 18.62 | NA | 12.63 | 3.51 | NA | 34.76 | 090 | |
22556 | A | Thorax spine fusion | 23.46 | NA | 14.89 | 3.78 | NA | 42.13 | 090 | |
22558 | A | Lumbar spine fusion | 22.28 | NA | 13.40 | 3.18 | NA | 38.86 | 090 | |
22585 | A | Additional spinal fusion | 5.53 | NA | 2.87 | 0.98 | NA | 9.38 | ZZZ | |
22590 | A | Spine skull spinal fusion | 20.51 | NA | 13.62 | 3.81 | NA | 37.94 | 090 | |
22595 | A | Neck spinal fusion | 19.39 | NA | 13.12 | 3.62 | NA | 36.13 | 090 | |
22600 | A | Neck spine fusion | 16.14 | NA | 11.40 | 2.89 | NA | 30.43 | 090 | |
22610 | A | Thorax spine fusion | 16.02 | NA | 11.56 | 2.66 | NA | 30.24 | 090 | |
22612 | A | Lumbar spine fusion | 21.00 | NA | 14.36 | 3.28 | NA | 38.64 | 090 | |
22614 | A | Spine fusion, extra segment | 6.44 | NA | 3.44 | 1.04 | NA | 10.92 | ZZZ | |
22630 | A | Lumbar spine fusion | 20.84 | NA | 14.01 | 3.79 | NA | 38.64 | 090 | |
22632 | A | Spine fusion, extra segment | 5.23 | NA | 2.74 | 0.90 | NA | 8.87 | ZZZ | |
22800 | A | Fusion of spine | 18.25 | NA | 13.02 | 2.71 | NA | 33.98 | 090 | |
22802 | A | Fusion of spine | 30.88 | NA | 19.99 | 4.42 | NA | 55.29 | 090 | |
22804 | A | Fusion of spine | 36.27 | NA | 23.15 | 5.23 | NA | 64.65 | 090 | |
22808 | A | Fusion of spine | 26.27 | NA | 16.72 | 4.36 | NA | 47.35 | 090 | |
22810 | A | Fusion of spine | 30.27 | NA | 18.75 | 4.49 | NA | 53.51 | 090 | |
22812 | A | Fusion of spine | 32.70 | NA | 20.27 | 4.67 | NA | 57.64 | 090 | |
22818 | A | Kyphectomy, 1-2 segments | 31.83 | NA | 19.49 | 5.01 | NA | 56.33 | 090 | |
22819 | A | Kyphectomy, 3 or more | 36.44 | NA | 20.58 | 5.20 | NA | 62.22 | 090 | |
22830 | A | Exploration of spinal fusion | 10.85 | NA | 8.32 | 1.73 | NA | 20.90 | 090 | |
22840 | A | Insert spine fixation device | 12.54 | NA | 6.67 | 2.03 | NA | 21.24 | ZZZ | |
22841 | B | Insert spine fixation device | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
22842 | A | Insert spine fixation device | 12.58 | NA | 6.69 | 2.04 | NA | 21.31 | ZZZ | |
22843 | A | Insert spine fixation device | 13.46 | NA | 6.78 | 2.10 | NA | 22.34 | ZZZ | |
22844 | A | Insert spine fixation device | 16.44 | NA | 8.99 | 2.42 | NA | 27.85 | ZZZ | |
22845 | A | Insert spine fixation device | 11.96 | NA | 6.24 | 2.22 | NA | 20.42 | ZZZ | |
22846 | A | Insert spine fixation device | 12.42 | NA | 6.51 | 2.26 | NA | 21.19 | ZZZ | |
22847 | A | Insert spine fixation device | 13.80 | NA | 7.21 | 2.36 | NA | 23.37 | ZZZ | |
22848 | A | Insert pelv fixation device | 6.00 | NA | 3.27 | 0.88 | NA | 10.15 | ZZZ | |
22849 | A | Reinsert spinal fixation | 18.51 | NA | 13.75 | 2.87 | NA | 35.13 | 090 | |
22850 | A | Remove spine fixation device | 9.52 | NA | 8.50 | 1.51 | NA | 19.53 | 090 | |
22851 | A | Apply spine prosth device | 6.71 | NA | 3.45 | 1.11 | NA | 11.27 | ZZZ | |
22852 | A | Remove spine fixation device | 9.01 | NA | 8.26 | 1.40 | NA | 18.67 | 090 | |
22855 | A | Remove spine fixation device | 15.13 | NA | 11.24 | 2.74 | NA | 29.11 | 090 | |
22899 | C | Spine surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
22900 | A | Remove abdominal wall lesion | 5.80 | NA | 4.29 | 0.58 | NA | 10.67 | 090 | |
22999 | C | Abdomen surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
23000 | A | Removal of calcium deposits | 4.36 | 8.97 | 7.38 | 0.50 | 13.83 | 12.24 | 090 | |
23020 | A | Release shoulder joint | 8.93 | NA | 10.95 | 1.23 | NA | 21.11 | 090 | |
23030 | A | Drain shoulder lesion | 3.43 | 6.24 | 4.54 | 0.42 | 10.09 | 8.39 | 010 | |
23031 | A | Drain shoulder bursa | 2.74 | 6.00 | 4.34 | 0.33 | 9.07 | 7.41 | 010 | |
23035 | A | Drain shoulder bone lesion | 8.61 | NA | 15.81 | 1.19 | NA | 25.61 | 090 | |
23040 | A | Exploratory shoulder surgery | 9.20 | NA | 12.15 | 1.28 | NA | 22.63 | 090 | |
23044 | A | Exploratory shoulder surgery | 7.12 | NA | 11.01 | 0.97 | NA | 19.10 | 090 | |
23065 | A | Biopsy shoulder tissues | 2.27 | 2.71 | 1.33 | 0.14 | 5.12 | 3.74 | 010 | |
23066 | A | Biopsy shoulder tissues | 4.16 | 7.96 | 6.49 | 0.50 | 12.62 | 11.15 | 090 | |
23075 | A | Removal of shoulder lesion | 2.39 | 5.36 | 3.21 | 0.25 | 8.00 | 5.85 | 010 | |
23076 | A | Removal of shoulder lesion | 7.63 | NA | 8.42 | 0.87 | NA | 16.92 | 090 | |
23077 | A | Remove tumor of shoulder | 16.09 | NA | 14.26 | 1.81 | NA | 32.16 | 090 | |
23100 | A | Biopsy of shoulder joint | 6.03 | NA | 9.13 | 0.81 | NA | 15.97 | 090 | |
23101 | A | Shoulder joint surgery | 5.58 | NA | 9.14 | 0.77 | NA | 15.49 | 090 | |
23105 | A | Remove shoulder joint lining | 8.23 | NA | 10.55 | 1.13 | NA | 19.91 | 090 | |
23106 | A | Incision of collarbone joint | 5.96 | NA | 9.25 | 0.82 | NA | 16.03 | 090 | |
23107 | A | Explore treat shoulder joint | 8.62 | NA | 10.74 | 1.19 | NA | 20.55 | 090 | |
23120 | A | Partial removal, collar bone | 7.11 | NA | 9.97 | 0.99 | NA | 18.07 | 090 | |
23125 | A | Removal of collar bone | 9.39 | NA | 11.08 | 1.27 | NA | 21.74 | 090 | |
23130 | A | Remove shoulder bone, part | 7.55 | NA | 10.20 | 1.06 | NA | 18.81 | 090 | |
23140 | A | Removal of bone lesion | 6.89 | NA | 8.64 | 0.82 | NA | 16.35 | 090 | |
23145 | A | Removal of bone lesion | 9.09 | NA | 12.05 | 1.24 | NA | 22.38 | 090 | |
23146 | A | Removal of bone lesion | 7.83 | NA | 11.37 | 1.11 | NA | 20.31 | 090 | |
23150 | A | Removal of humerus lesion | 8.48 | NA | 10.37 | 1.14 | NA | 19.99 | 090 | |
23155 | A | Removal of humerus lesion | 10.35 | NA | 12.62 | 1.20 | NA | 24.17 | 090 | |
23156 | A | Removal of humerus lesion | 8.68 | NA | 10.74 | 1.18 | NA | 20.60 | 090 | |
23170 | A | Remove collar bone lesion | 6.86 | NA | 11.17 | 0.84 | NA | 18.87 | 090 | |
23172 | A | Remove shoulder blade lesion | 6.90 | NA | 10.70 | 0.95 | NA | 18.55 | 090 | |
23174 | A | Remove humerus lesion | 9.51 | NA | 12.19 | 1.30 | NA | 23.00 | 090 | |
23180 | A | Remove collar bone lesion | 8.53 | NA | 16.82 | 1.18 | NA | 26.53 | 090 | |
23182 | A | Remove shoulder blade lesion | 8.15 | NA | 16.90 | 1.08 | NA | 26.13 | 090 | |
23184 | A | Remove humerus lesion | 9.38 | NA | 17.08 | 1.24 | NA | 27.70 | 090 | |
23190 | A | Partial removal of scapula | 7.24 | NA | 8.72 | 0.97 | NA | 16.93 | 090 | |
23195 | A | Removal of head of humerus | 9.81 | NA | 11.11 | 1.38 | NA | 22.30 | 090 | |
23200 | A | Removal of collar bone | 12.08 | NA | 14.52 | 1.48 | NA | 28.08 | 090 | |
23210 | A | Removal of shoulder blade | 12.49 | NA | 14.47 | 1.61 | NA | 28.57 | 090 | |
23220 | A | Partial removal of humerus | 14.56 | NA | 15.73 | 2.03 | NA | 32.32 | 090 | |
23221 | A | Partial removal of humerus | 17.74 | NA | 17.13 | 2.51 | NA | 37.38 | 090 | |
23222 | A | Partial removal of humerus | 23.92 | NA | 21.02 | 3.37 | NA | 48.31 | 090 | |
23330 | A | Remove shoulder foreign body | 1.85 | 5.75 | 3.77 | 0.18 | 7.78 | 5.80 | 010 | |
23331 | A | Remove shoulder foreign body | 7.38 | NA | 10.06 | 1.02 | NA | 18.46 | 090 | |
23332 | A | Remove shoulder foreign body | 11.62 | NA | 12.40 | 1.62 | NA | 25.64 | 090 | |
23350 | A | Injection for shoulder x-ray | 1.00 | 7.30 | 0.34 | 0.05 | 8.35 | 1.39 | 000 | |
23395 | A | Muscle transfer,shoulder/arm | 16.85 | NA | 14.27 | 2.29 | NA | 33.41 | 090 | |
23397 | A | Muscle transfers | 16.13 | NA | 14.61 | 2.24 | NA | 32.98 | 090 | |
23400 | A | Fixation of shoulder blade | 13.54 | NA | 14.58 | 1.91 | NA | 30.03 | 090 | |
23405 | A | Incision of tendon muscle | 8.37 | NA | 9.69 | 1.12 | NA | 19.18 | 090 | |
23406 | A | Incise tendon(s) muscle(s) | 10.79 | NA | 11.89 | 1.48 | NA | 24.16 | 090 | |
23410 | A | Repair rotator cuff, acute | 12.45 | NA | 12.81 | 1.72 | NA | 26.98 | 090 | |
23412 | A | Repair rotator cuff, chronic | 13.31 | NA | 13.32 | 1.86 | NA | 28.49 | 090 | |
23415 | A | Release of shoulder ligament | 9.97 | NA | 10.45 | 1.39 | NA | 21.81 | 090 | |
23420 | A | Repair of shoulder | 13.30 | NA | 14.31 | 1.86 | NA | 29.47 | 090 | |
23430 | A | Repair biceps tendon | 9.98 | NA | 11.50 | 1.40 | NA | 22.88 | 090 | |
23440 | A | Remove/transplant tendon | 10.48 | NA | 11.82 | 1.47 | NA | 23.77 | 090 | |
23450 | A | Repair shoulder capsule | 13.40 | NA | 13.30 | 1.86 | NA | 28.56 | 090 | |
23455 | A | Repair shoulder capsule | 14.37 | NA | 13.88 | 2.01 | NA | 30.26 | 090 | |
23460 | A | Repair shoulder capsule | 15.37 | NA | 14.46 | 2.17 | NA | 32.00 | 090 | |
23462 | A | Repair shoulder capsule | 15.30 | NA | 14.13 | 2.16 | NA | 31.59 | 090 | |
23465 | A | Repair shoulder capsule | 15.85 | NA | 14.31 | 1.61 | NA | 31.77 | 090 | |
23466 | A | Repair shoulder capsule | 14.22 | NA | 13.84 | 2.00 | NA | 30.06 | 090 | |
23470 | A | Reconstruct shoulder joint | 17.15 | NA | 12.42 | 2.40 | NA | 31.97 | 090 | |
23472 | A | Reconstruct shoulder joint | 21.10 | NA | 14.64 | 2.37 | NA | 38.11 | 090 | |
23480 | A | Revision of collar bone | 11.18 | NA | 12.16 | 1.56 | NA | 24.90 | 090 | |
23485 | A | Revision of collar bone | 13.43 | NA | 13.35 | 1.84 | NA | 28.62 | 090 | |
23490 | A | Reinforce clavicle | 11.86 | NA | 12.24 | 1.11 | NA | 25.21 | 090 | |
23491 | A | Reinforce shoulder bones | 14.21 | NA | 13.76 | 2.00 | NA | 29.97 | 090 | |
23500 | A | Treat clavicle fracture | 2.08 | 4.08 | 2.60 | 0.26 | 6.42 | 4.94 | 090 | |
23505 | A | Treat clavicle fracture | 3.69 | 6.20 | 4.12 | 0.50 | 10.39 | 8.31 | 090 | |
23515 | A | Treat clavicle fracture | 7.41 | NA | 8.43 | 1.03 | NA | 16.87 | 090 | |
23520 | A | Treat clavicle dislocation | 2.16 | 4.12 | 2.68 | 0.26 | 6.54 | 5.10 | 090 | |
23525 | A | Treat clavicle dislocation | 3.60 | 6.00 | 3.98 | 0.44 | 10.04 | 8.02 | 090 | |
23530 | A | Treat clavicle dislocation | 7.31 | NA | 8.20 | 0.85 | NA | 16.36 | 090 | |
23532 | A | Treat clavicle dislocation | 8.01 | NA | 8.60 | 1.13 | NA | 17.74 | 090 | |
23540 | A | Treat clavicle dislocation | 2.23 | 4.68 | 2.57 | 0.24 | 7.15 | 5.04 | 090 | |
23545 | A | Treat clavicle dislocation | 3.25 | 5.26 | 3.69 | 0.39 | 8.90 | 7.33 | 090 | |
23550 | A | Treat clavicle dislocation | 7.24 | NA | 8.37 | 0.94 | NA | 16.55 | 090 | |
23552 | A | Treat clavicle dislocation | 8.45 | NA | 9.03 | 1.18 | NA | 18.66 | 090 | |
23570 | A | Treat shoulder blade fx | 2.23 | 4.06 | 2.77 | 0.29 | 6.58 | 5.29 | 090 | |
23575 | A | Treat shoulder blade fx | 4.06 | 6.41 | 4.37 | 0.53 | 11.00 | 8.96 | 090 | |
23585 | A | Treat scapula fracture | 8.96 | NA | 9.58 | 1.25 | NA | 19.79 | 090 | |
23600 | A | Treat humerus fracture | 2.93 | 5.91 | 3.74 | 0.39 | 9.23 | 7.06 | 090 | |
23605 | A | Treat humerus fracture | 4.87 | 8.79 | 6.83 | 0.67 | 14.33 | 12.37 | 090 | |
23615 | A | Treat humerus fracture | 9.35 | NA | 10.47 | 1.31 | NA | 21.13 | 090 | |
23616 | A | Treat humerus fracture | 21.27 | NA | 16.24 | 2.98 | NA | 40.49 | 090 | |
23620 | A | Treat humerus fracture | 2.40 | 5.62 | 3.47 | 0.32 | 8.34 | 6.19 | 090 | |
23625 | A | Treat humerus fracture | 3.93 | 7.75 | 5.75 | 0.53 | 12.21 | 10.21 | 090 | |
23630 | A | Treat humerus fracture | 7.35 | NA | 8.44 | 1.03 | NA | 16.82 | 090 | |
23650 | A | Treat shoulder dislocation | 3.39 | 5.74 | 3.58 | 0.31 | 9.44 | 7.28 | 090 | |
23655 | A | Treat shoulder dislocation | 4.57 | NA | 4.38 | 0.52 | NA | 9.47 | 090 | |
23660 | A | Treat shoulder dislocation | 7.49 | NA | 8.24 | 1.01 | NA | 16.74 | 090 | |
23665 | A | Treat dislocation/fracture | 4.47 | 7.93 | 5.99 | 0.60 | 13.00 | 11.06 | 090 | |
23670 | A | Treat dislocation/fracture | 7.90 | NA | 8.93 | 1.10 | NA | 17.93 | 090 | |
23675 | A | Treat dislocation/fracture | 6.05 | 8.66 | 6.87 | 0.83 | 15.54 | 13.75 | 090 | |
23680 | A | Treat dislocation/fracture | 10.06 | NA | 10.06 | 1.39 | NA | 21.51 | 090 | |
23700 | A | Fixation of shoulder | 2.52 | NA | 3.65 | 0.35 | NA | 6.52 | 010 | |
23800 | A | Fusion of shoulder joint | 14.16 | NA | 14.66 | 1.97 | NA | 30.79 | 090 | |
23802 | A | Fusion of shoulder joint | 16.60 | NA | 13.91 | 2.34 | NA | 32.85 | 090 | |
23900 | A | Amputation of arm girdle | 19.72 | NA | 15.69 | 2.47 | NA | 37.88 | 090 | |
23920 | A | Amputation at shoulder joint | 14.61 | NA | 14.02 | 1.92 | NA | 30.55 | 090 | |
23921 | A | Amputation follow-up surgery | 5.49 | NA | 6.90 | 0.78 | NA | 13.17 | 090 | |
23929 | C | Shoulder surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
23930 | A | Drainage of arm lesion | 2.94 | 6.19 | 4.05 | 0.32 | 9.45 | 7.31 | 010 | |
23931 | A | Drainage of arm bursa | 1.79 | 5.97 | 3.88 | 0.21 | 7.97 | 5.88 | 010 | |
23935 | A | Drain arm/elbow bone lesion | 6.09 | NA | 13.61 | 0.84 | NA | 20.54 | 090 | |
24000 | A | Exploratory elbow surgery | 5.82 | NA | 6.17 | 0.77 | NA | 12.76 | 090 | |
24006 | A | Release elbow joint | 9.31 | NA | 8.70 | 1.27 | NA | 19.28 | 090 | |
24065 | A | Biopsy arm/elbow soft tissue | 2.08 | 5.87 | 3.35 | 0.14 | 8.09 | 5.57 | 010 | |
24066 | A | Biopsy arm/elbow soft tissue | 5.21 | 8.94 | 6.82 | 0.61 | 14.76 | 12.64 | 090 | |
24075 | A | Remove arm/elbow lesion | 3.92 | 8.20 | 6.14 | 0.43 | 12.55 | 10.49 | 090 | |
24076 | A | Remove arm/elbow lesion | 6.30 | NA | 7.34 | 0.70 | NA | 14.34 | 090 | |
24077 | A | Remove tumor of arm/elbow | 11.76 | NA | 13.78 | 1.32 | NA | 26.86 | 090 | |
24100 | A | Biopsy elbow joint lining | 4.93 | NA | 5.79 | 0.62 | NA | 11.34 | 090 | |
24101 | A | Explore/treat elbow joint | 6.13 | NA | 6.96 | 0.84 | NA | 13.93 | 090 | |
24102 | A | Remove elbow joint lining | 8.03 | NA | 7.95 | 1.09 | NA | 17.07 | 090 | |
24105 | A | Removal of elbow bursa | 3.61 | NA | 5.38 | 0.49 | NA | 9.48 | 090 | |
24110 | A | Remove humerus lesion | 7.39 | NA | 10.13 | 0.99 | NA | 18.51 | 090 | |
24115 | A | Remove/graft bone lesion | 9.63 | NA | 10.52 | 1.15 | NA | 21.30 | 090 | |
24116 | A | Remove/graft bone lesion | 11.81 | NA | 12.57 | 1.66 | NA | 26.04 | 090 | |
24120 | A | Remove elbow lesion | 6.65 | NA | 6.95 | 0.87 | NA | 14.47 | 090 | |
24125 | A | Remove/graft bone lesion | 7.89 | NA | 7.28 | 0.88 | NA | 16.05 | 090 | |
24126 | A | Remove/graft bone lesion | 8.31 | NA | 8.03 | 0.90 | NA | 17.24 | 090 | |
24130 | A | Removal of head of radius | 6.25 | NA | 7.05 | 0.87 | NA | 14.17 | 090 | |
24134 | A | Removal of arm bone lesion | 9.73 | NA | 16.46 | 1.31 | NA | 27.50 | 090 | |
24136 | A | Remove radius bone lesion | 7.99 | NA | 6.55 | 0.85 | NA | 15.39 | 090 | |
24138 | A | Remove elbow bone lesion | 8.05 | NA | 8.03 | 1.12 | NA | 17.20 | 090 | |
24140 | A | Partial removal of arm bone | 9.18 | NA | 17.56 | 1.23 | NA | 27.97 | 090 | |
24145 | A | Partial removal of radius | 7.58 | NA | 11.64 | 1.01 | NA | 20.23 | 090 | |
24147 | A | Partial removal of elbow | 7.54 | NA | 11.64 | 1.04 | NA | 20.22 | 090 | |
24149 | A | Radical resection of elbow | 14.20 | NA | 11.19 | 1.90 | NA | 27.29 | 090 | |
24150 | A | Extensive humerus surgery | 13.27 | NA | 15.23 | 1.81 | NA | 30.31 | 090 | |
24151 | A | Extensive humerus surgery | 15.58 | NA | 16.96 | 2.19 | NA | 34.73 | 090 | |
24152 | A | Extensive radius surgery | 10.06 | NA | 9.83 | 1.19 | NA | 21.08 | 090 | |
24153 | A | Extensive radius surgery | 11.54 | NA | 7.06 | 0.64 | NA | 19.24 | 090 | |
24155 | A | Removal of elbow joint | 11.73 | NA | 9.42 | 1.42 | NA | 22.57 | 090 | |
24160 | A | Remove elbow joint implant | 7.83 | NA | 6.95 | 1.07 | NA | 15.85 | 090 | |
24164 | A | Remove radius head implant | 6.23 | NA | 5.95 | 0.84 | NA | 13.02 | 090 | |
24200 | A | Removal of arm foreign body | 1.76 | 5.73 | 3.35 | 0.15 | 7.64 | 5.26 | 010 | |
24201 | A | Removal of arm foreign body | 4.56 | 8.91 | 7.06 | 0.56 | 14.03 | 12.18 | 090 | |
24220 | A | Injection for elbow x-ray | 1.31 | 11.02 | 0.46 | 0.07 | 12.40 | 1.84 | 000 | |
24300 | A | Manipulate elbow w/anesth | 3.75 | NA | 5.53 | 0.49 | NA | 9.77 | 090 | |
24301 | A | Muscle/tendon transfer | 10.20 | NA | 9.22 | 1.30 | NA | 20.72 | 090 | |
24305 | A | Arm tendon lengthening | 7.45 | NA | 7.79 | 0.98 | NA | 16.22 | 090 | |
24310 | A | Revision of arm tendon | 5.98 | NA | 8.53 | 0.74 | NA | 15.25 | 090 | |
24320 | A | Repair of arm tendon | 10.56 | NA | 11.05 | 1.00 | NA | 22.61 | 090 | |
24330 | A | Revision of arm muscles | 9.60 | NA | 8.87 | 1.21 | NA | 19.68 | 090 | |
24331 | A | Revision of arm muscles | 10.65 | NA | 9.48 | 1.41 | NA | 21.54 | 090 | |
24332 | A | Tenolysis, triceps | 7.45 | NA | 5.21 | 0.77 | NA | 13.43 | 090 | |
24340 | A | Repair of biceps tendon | 7.89 | NA | 7.86 | 1.08 | NA | 16.83 | 090 | |
24341 | A | Repair arm tendon/muscle | 7.90 | NA | 7.86 | 1.08 | NA | 16.84 | 090 | |
24342 | A | Repair of ruptured tendon | 10.62 | NA | 9.44 | 1.48 | NA | 21.54 | 090 | |
24343 | A | Repr elbow lat ligmnt w/tiss | 8.65 | NA | 7.89 | 1.13 | NA | 17.67 | 090 | |
24344 | A | Reconstruct elbow lat ligmnt | 14.00 | NA | 11.18 | 1.83 | NA | 27.01 | 090 | |
24345 | A | Repr elbw med ligmnt w/tissu | 8.65 | NA | 7.89 | 1.13 | NA | 17.67 | 090 | |
24346 | A | Reconstruct elbow med ligmnt | 14.00 | NA | 11.18 | 1.83 | NA | 27.01 | 090 | |
24350 | A | Repair of tennis elbow | 5.25 | NA | 6.44 | 0.72 | NA | 12.41 | 090 | |
24351 | A | Repair of tennis elbow | 5.91 | NA | 6.93 | 0.82 | NA | 13.66 | 090 | |
24352 | A | Repair of tennis elbow | 6.43 | NA | 7.19 | 0.90 | NA | 14.52 | 090 | |
24354 | A | Repair of tennis elbow | 6.48 | NA | 7.15 | 0.88 | NA | 14.51 | 090 | |
24356 | A | Revision of tennis elbow | 6.68 | NA | 7.33 | 0.90 | NA | 14.91 | 090 | |
24360 | A | Reconstruct elbow joint | 12.34 | NA | 9.65 | 1.69 | NA | 23.68 | 090 | |
24361 | A | Reconstruct elbow joint | 14.08 | NA | 10.64 | 1.95 | NA | 26.67 | 090 | |
24362 | A | Reconstruct elbow joint | 14.99 | NA | 12.41 | 1.92 | NA | 29.32 | 090 | |
24363 | A | Replace elbow joint | 18.49 | NA | 11.53 | 2.52 | NA | 32.54 | 090 | |
24365 | A | Reconstruct head of radius | 8.39 | NA | 7.31 | 1.11 | NA | 16.81 | 090 | |
24366 | A | Reconstruct head of radius | 9.13 | NA | 7.69 | 1.28 | NA | 18.10 | 090 | |
24400 | A | Revision of humerus | 11.06 | NA | 12.99 | 1.53 | NA | 25.58 | 090 | |
24410 | A | Revision of humerus | 14.82 | NA | 14.11 | 1.89 | NA | 30.82 | 090 | |
24420 | A | Revision of humerus | 13.44 | NA | 17.27 | 1.82 | NA | 32.53 | 090 | |
24430 | A | Repair of humerus | 12.81 | NA | 13.18 | 1.80 | NA | 27.79 | 090 | |
24435 | A | Repair humerus with graft | 13.17 | NA | 14.37 | 1.84 | NA | 29.38 | 090 | |
24470 | A | Revision of elbow joint | 8.74 | NA | 8.50 | 1.23 | NA | 18.47 | 090 | |
24495 | A | Decompression of forearm | 8.12 | NA | 10.28 | 0.92 | NA | 19.32 | 090 | |
24498 | A | Reinforce humerus | 11.92 | NA | 12.68 | 1.67 | NA | 26.27 | 090 | |
24500 | A | Treat humerus fracture | 3.21 | 5.31 | 3.38 | 0.41 | 8.93 | 7.00 | 090 | |
24505 | A | Treat humerus fracture | 5.17 | 9.31 | 7.10 | 0.72 | 15.20 | 12.99 | 090 | |
24515 | A | Treat humerus fracture | 11.65 | NA | 11.58 | 1.63 | NA | 24.86 | 090 | |
24516 | A | Treat humerus fracture | 11.65 | NA | 12.14 | 1.63 | NA | 25.42 | 090 | |
24530 | A | Treat humerus fracture | 3.50 | 6.52 | 4.97 | 0.47 | 10.49 | 8.94 | 090 | |
24535 | A | Treat humerus fracture | 6.87 | 9.14 | 6.89 | 0.96 | 16.97 | 14.72 | 090 | |
24538 | A | Treat humerus fracture | 9.43 | NA | 10.85 | 1.25 | NA | 21.53 | 090 | |
24545 | A | Treat humerus fracture | 10.46 | NA | 10.37 | 1.47 | NA | 22.30 | 090 | |
24546 | A | Treat humerus fracture | 15.69 | NA | 13.83 | 2.18 | NA | 31.70 | 090 | |
24560 | A | Treat humerus fracture | 2.80 | 5.10 | 3.16 | 0.35 | 8.25 | 6.31 | 090 | |
24565 | A | Treat humerus fracture | 5.56 | 8.24 | 6.05 | 0.74 | 14.54 | 12.35 | 090 | |
24566 | A | Treat humerus fracture | 7.79 | NA | 10.34 | 1.10 | NA | 19.23 | 090 | |
24575 | A | Treat humerus fracture | 10.66 | NA | 8.43 | 1.44 | NA | 20.53 | 090 | |
24576 | A | Treat humerus fracture | 2.86 | 4.85 | 3.31 | 0.38 | 8.09 | 6.55 | 090 | |
24577 | A | Treat humerus fracture | 5.79 | 8.47 | 6.32 | 0.81 | 15.07 | 12.92 | 090 | |
24579 | A | Treat humerus fracture | 11.60 | NA | 11.31 | 1.62 | NA | 24.53 | 090 | |
24582 | A | Treat humerus fracture | 8.55 | NA | 10.77 | 1.20 | NA | 20.52 | 090 | |
24586 | A | Treat elbow fracture | 15.21 | NA | 11.05 | 2.12 | NA | 28.38 | 090 | |
24587 | A | Treat elbow fracture | 15.16 | NA | 10.88 | 2.14 | NA | 28.18 | 090 | |
24600 | A | Treat elbow dislocation | 4.23 | 7.12 | 5.11 | 0.49 | 11.84 | 9.83 | 090 | |
24605 | A | Treat elbow dislocation | 5.42 | NA | 5.09 | 0.72 | NA | 11.23 | 090 | |
24615 | A | Treat elbow dislocation | 9.42 | NA | 7.97 | 1.31 | NA | 18.70 | 090 | |
24620 | A | Treat elbow fracture | 6.98 | NA | 6.71 | 0.90 | NA | 14.59 | 090 | |
24635 | A | Treat elbow fracture | 13.19 | NA | 16.64 | 1.84 | NA | 31.67 | 090 | |
24640 | A | Treat elbow dislocation | 1.20 | 3.54 | 1.84 | 0.11 | 4.85 | 3.15 | 010 | |
24650 | A | Treat radius fracture | 2.16 | 4.81 | 2.92 | 0.28 | 7.25 | 5.36 | 090 | |
24655 | A | Treat radius fracture | 4.40 | 7.66 | 5.41 | 0.58 | 12.64 | 10.39 | 090 | |
24665 | A | Treat radius fracture | 8.14 | NA | 9.72 | 1.13 | NA | 18.99 | 090 | |
24666 | A | Treat radius fracture | 9.49 | NA | 10.48 | 1.32 | NA | 21.29 | 090 | |
24670 | A | Treat ulnar fracture | 2.54 | 4.71 | 3.13 | 0.33 | 7.58 | 6.00 | 090 | |
24675 | A | Treat ulnar fracture | 4.72 | 7.86 | 5.68 | 0.65 | 13.23 | 11.05 | 090 | |
24685 | A | Treat ulnar fracture | 8.80 | NA | 10.08 | 1.23 | NA | 20.11 | 090 | |
24800 | A | Fusion of elbow joint | 11.20 | NA | 9.94 | 1.41 | NA | 22.55 | 090 | |
24802 | A | Fusion/graft of elbow joint | 13.69 | NA | 11.56 | 1.89 | NA | 27.14 | 090 | |
24900 | A | Amputation of upper arm | 9.60 | NA | 11.21 | 1.18 | NA | 21.99 | 090 | |
24920 | A | Amputation of upper arm | 9.54 | NA | 12.82 | 1.22 | NA | 23.58 | 090 | |
24925 | A | Amputation follow-up surgery | 7.07 | NA | 9.68 | 0.95 | NA | 17.70 | 090 | |
24930 | A | Amputation follow-up surgery | 10.25 | NA | 11.78 | 1.23 | NA | 23.26 | 090 | |
24931 | A | Amputate upper arm implant | 12.72 | NA | 9.23 | 1.56 | NA | 23.51 | 090 | |
24935 | A | Revision of amputation | 15.56 | NA | 12.63 | 1.58 | NA | 29.77 | 090 | |
24940 | C | Revision of upper arm | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 090 | |
24999 | C | Upper arm/elbow surgery | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
25000 | A | Incision of tendon sheath | 3.38 | NA | 7.59 | 0.45 | NA | 11.42 | 090 | |
25001 | A | Incise flexor carpi radialis | 3.38 | NA | 4.37 | 0.45 | NA | 8.20 | 090 | |
25020 | A | Decompress forearm 1 space | 5.92 | NA | 11.38 | 0.76 | NA | 18.06 | 090 | |
25023 | A | Decompress forearm 1 space | 12.96 | NA | 17.36 | 1.52 | NA | 31.84 | 090 | |
25024 | A | Decompress forearm 2 spaces | 9.50 | NA | 8.08 | 1.24 | NA | 18.82 | 090 | |
25025 | A | Decompress forarm 2 spaces | 16.54 | NA | 11.75 | 2.18 | NA | 30.47 | 090 | |
25028 | A | Drainage of forearm lesion | 5.25 | NA | 10.17 | 0.61 | NA | 16.03 | 090 | |
25031 | A | Drainage of forearm bursa | 4.14 | NA | 10.14 | 0.50 | NA | 14.78 | 090 | |
25035 | A | Treat forearm bone lesion | 7.36 | NA | 16.87 | 0.98 | NA | 25.21 | 090 | |
25040 | A | Explore/treat wrist joint | 7.18 | NA | 9.48 | 0.96 | NA | 17.62 | 090 | |
25065 | A | Biopsy forearm soft tissues | 1.99 | 2.58 | 2.58 | 0.12 | 4.69 | 4.69 | 010 | |
25066 | A | Biopsy forearm soft tissues | 4.13 | NA | 8.42 | 0.49 | NA | 13.04 | 090 | |
25075 | A | Removel forearm lesion subcu | 3.74 | NA | 7.39 | 0.40 | NA | 11.53 | 090 | |
25076 | A | Removel forearm lesion deep | 4.92 | NA | 12.88 | 0.59 | NA | 18.39 | 090 | |
25077 | A | Remove tumor, forearm/wrist | 9.76 | NA | 15.51 | 1.10 | NA | 26.37 | 090 | |
25085 | A | Incision of wrist capsule | 5.50 | NA | 11.29 | 0.71 | NA | 17.50 | 090 | |
25100 | A | Biopsy of wrist joint | 3.90 | NA | 7.66 | 0.50 | NA | 12.06 | 090 | |
25101 | A | Explore/treat wrist joint | 4.69 | NA | 8.02 | 0.60 | NA | 13.31 | 090 | |
25105 | A | Remove wrist joint lining | 5.85 | NA | 11.25 | 0.77 | NA | 17.87 | 090 | |
25107 | A | Remove wrist joint cartilage | 6.43 | NA | 11.62 | 0.82 | NA | 18.87 | 090 | |
25110 | A | Remove wrist tendon lesion | 3.92 | NA | 8.62 | 0.48 | NA | 13.02 | 090 | |
25111 | A | Remove wrist tendon lesion | 3.39 | NA | 6.67 | 0.42 | NA | 10.48 | 090 | |
25112 | A | Reremove wrist tendon lesion | 4.53 | NA | 7.49 | 0.54 | NA | 12.56 | 090 | |
25115 | A | Remove wrist/forearm lesion | 8.82 | NA | 17.36 | 1.11 | NA | 27.29 | 090 | |
25116 | A | Remove wrist/forearm lesion | 7.11 | NA | 16.36 | 0.90 | NA | 24.37 | 090 | |
25118 | A | Excise wrist tendon sheath | 4.37 | NA | 8.09 | 0.55 | NA | 13.01 | 090 | |
25119 | A | Partial removal of ulna | 6.04 | NA | 11.54 | 0.80 | NA | 18.38 | 090 | |
25120 | A | Removal of forearm lesion | 6.10 | NA | 15.31 | 0.81 | NA | 22.22 | 090 | |
25125 | A | Remove/graft forearm lesion | 7.48 | NA | 16.39 | 1.02 | NA | 24.89 | 090 | |
25126 | A | Remove/graft forearm lesion | 7.55 | NA | 15.93 | 1.00 | NA | 24.48 | 090 | |
25130 | A | Removal of wrist lesion | 5.26 | NA | 8.44 | 0.66 | NA | 14.36 | 090 | |
25135 | A | Remove graft wrist lesion | 6.89 | NA | 9.27 | 0.89 | NA | 17.05 | 090 | |
25136 | A | Remove graft wrist lesion | 5.97 | NA | 8.50 | 0.58 | NA | 15.05 | 090 | |
25145 | A | Remove forearm bone lesion | 6.37 | NA | 15.73 | 0.82 | NA | 22.92 | 090 | |
25150 | A | Partial removal of ulna | 7.09 | NA | 12.28 | 0.96 | NA | 20.33 | 090 | |
25151 | A | Partial removal of radius | 7.39 | NA | 16.28 | 0.93 | NA | 24.60 | 090 | |
25170 | A | Extensive forearm surgery | 11.09 | NA | 17.76 | 1.52 | NA | 30.37 | 090 | |
25210 | A | Removal of wrist bone | 5.95 | NA | 8.84 | 0.73 | NA | 15.52 | 090 | |
25215 | A | Removal of wrist bones | 7.89 | NA | 12.52 | 1.02 | NA | 21.43 | 090 | |
25230 | A | Partial removal of radius | 5.23 | NA | 8.35 | 0.66 | NA | 14.24 | 090 | |
25240 | A | Partial removal of ulna | 5.17 | NA | 11.07 | 0.69 | NA | 16.93 | 090 | |
25246 | A | Injection for wrist x-ray | 1.45 | 10.27 | 0.50 | 0.07 | 11.79 | 2.02 | 000 | |
25248 | A | Remove forearm foreign body | 5.14 | NA | 10.23 | 0.54 | NA | 15.91 | 090 | |
25250 | A | Removal of wrist prosthesis | 6.60 | NA | 6.19 | 0.84 | NA | 13.63 | 090 | |
25251 | A | Removal of wrist prosthesis | 9.57 | NA | 8.08 | 1.15 | NA | 18.80 | 090 | |
25259 | A | Manipulate wrist w/anesthes | 3.75 | NA | 5.46 | 0.50 | NA | 9.71 | 090 | |
25260 | A | Repair forearm tendon/muscle | 7.80 | NA | 17.12 | 0.97 | NA | 25.89 | 090 | |
25263 | A | Repair forearm tendon/muscle | 7.82 | NA | 16.99 | 0.94 | NA | 25.75 | 090 | |
25265 | A | Repair forearm tendon/muscle | 9.88 | NA | 17.71 | 1.19 | NA | 28.78 | 090 | |
25270 | A | Repair forearm tendon/muscle | 6.00 | NA | 16.17 | 0.76 | NA | 22.93 | 090 | |
25272 | A | Repair forearm tendon/muscle | 7.04 | NA | 16.74 | 0.89 | NA | 24.67 | 090 | |
25274 | A | Repair forearm tendon/muscle | 8.75 | NA | 17.17 | 1.14 | NA | 27.06 | 090 | |
25275 | A | Repair forearm tendon sheath | 8.50 | NA | 7.44 | 1.13 | NA | 17.07 | 090 | |
25280 | A | Revise wrist/forearm tendon | 7.22 | NA | 16.29 | 0.91 | NA | 24.42 | 090 | |
25290 | A | Incise wrist/forearm tendon | 5.29 | NA | 18.62 | 0.66 | NA | 24.57 | 090 | |
25295 | A | Release wrist/forearm tendon | 6.55 | NA | 15.93 | 0.86 | NA | 23.34 | 090 | |
25300 | A | Fusion of tendons at wrist | 8.80 | NA | 10.06 | 1.07 | NA | 19.93 | 090 | |
25301 | A | Fusion of tendons at wrist | 8.40 | NA | 9.98 | 1.08 | NA | 19.46 | 090 | |
25310 | A | Transplant forearm tendon | 8.14 | NA | 16.74 | 1.01 | NA | 25.89 | 090 | |
25312 | A | Transplant forearm tendon | 9.57 | NA | 17.49 | 1.22 | NA | 28.28 | 090 | |
25315 | A | Revise palsy hand tendon(s) | 10.20 | NA | 18.31 | 1.26 | NA | 29.77 | 090 | |
25316 | A | Revise palsy hand tendon(s) | 12.33 | NA | 19.71 | 1.74 | NA | 33.78 | 090 | |
25320 | A | Repair/revise wrist joint | 10.77 | NA | 11.50 | 1.32 | NA | 23.59 | 090 | |
25332 | A | Revise wrist joint | 11.41 | NA | 9.34 | 1.46 | NA | 22.21 | 090 | |
25335 | A | Realignment of hand | 12.88 | NA | 14.95 | 1.66 | NA | 29.49 | 090 | |
25337 | A | Reconstruct ulna/radioulnar | 10.17 | NA | 13.85 | 1.31 | NA | 25.33 | 090 | |
25350 | A | Revision of radius | 8.78 | NA | 16.98 | 1.17 | NA | 26.93 | 090 | |
25355 | A | Revision of radius | 10.17 | NA | 17.60 | 1.44 | NA | 29.21 | 090 | |
25360 | A | Revision of ulna | 8.43 | NA | 16.89 | 1.17 | NA | 26.49 | 090 | |
25365 | A | Revise radius ulna | 12.40 | NA | 18.51 | 1.67 | NA | 32.58 | 090 | |
25370 | A | Revise radius or ulna | 13.36 | NA | 18.42 | 1.88 | NA | 33.66 | 090 | |
25375 | A | Revise radius ulna | 13.04 | NA | 19.42 | 1.84 | NA | 34.30 | 090 | |
25390 | A | Shorten radius or ulna | 10.40 | NA | 17.69 | 1.38 | NA | 29.47 | 090 | |
25391 | A | Lengthen radius or ulna | 13.65 | NA | 19.37 | 1.73 | NA | 34.75 | 090 | |
25392 | A | Shorten radius ulna | 13.95 | NA | 18.37 | 1.73 | NA | 34.05 | 090 | |
25393 | A | Lengthen radius ulna | 15.87 | NA | 20.63 | 1.87 | NA | 38.37 | 090 | |
25394 | A | Repair carpal bone, shorten | 10.40 | NA | 8.29 | 1.40 | NA | 20.09 | 090 | |
25400 | A | Repair radius or ulna | 10.92 | NA | 18.22 | 1.50 | NA | 30.64 | 090 | |
25405 | A | Repair/graft radius or ulna | 14.38 | NA | 20.48 | 1.95 | NA | 36.81 | 090 | |
25415 | A | Repair radius ulna | 13.35 | NA | 19.39 | 1.87 | NA | 34.61 | 090 | |
25420 | A | Repair/graft radius ulna | 16.33 | NA | 21.34 | 2.20 | NA | 39.87 | 090 | |
25425 | A | Repair/graft radius or ulna | 13.21 | NA | 26.80 | 1.61 | NA | 41.62 | 090 | |
25426 | A | Repair/graft radius ulna | 15.82 | NA | 20.12 | 2.23 | NA | 38.17 | 090 | |
25430 | A | Vasc graft into carpal bone | 9.25 | NA | 7.62 | 1.07 | NA | 17.94 | 090 | |
25431 | A | Repair nonunion carpal bone | 10.44 | NA | 6.38 | 0.56 | NA | 17.38 | 090 | |
25440 | A | Repair/graft wrist bone | 10.44 | NA | 11.25 | 1.41 | NA | 23.10 | 090 | |
25441 | A | Reconstruct wrist joint | 12.90 | NA | 10.14 | 1.83 | NA | 24.87 | 090 | |
25442 | A | Reconstruct wrist joint | 10.85 | NA | 9.00 | 1.24 | NA | 21.09 | 090 | |
25443 | A | Reconstruct wrist joint | 10.39 | NA | 8.89 | 1.30 | NA | 20.58 | 090 | |
25444 | A | Reconstruct wrist joint | 11.15 | NA | 9.17 | 1.43 | NA | 21.75 | 090 | |
25445 | A | Reconstruct wrist joint | 9.69 | NA | 8.18 | 1.26 | NA | 19.13 | 090 | |
25446 | A | Wrist replacement | 16.55 | NA | 12.17 | 2.20 | NA | 30.92 | 090 | |
25447 | A | Repair wrist joint(s) | 10.37 | NA | 8.76 | 1.34 | NA | 20.47 | 090 | |
25449 | A | Remove wrist joint implant | 14.49 | NA | 10.89 | 1.77 | NA | 27.15 | 090 | |
25450 | A | Revision of wrist joint | 7.87 | NA | 13.09 | 0.88 | NA | 21.84 | 090 | |
25455 | A | Revision of wrist joint | 9.49 | NA | 14.28 | 1.07 | NA | 24.84 | 090 | |
25490 | A | Reinforce radius | 9.54 | NA | 16.71 | 1.19 | NA | 27.44 | 090 | |
25491 | A | Reinforce ulna | 9.96 | NA | 17.58 | 1.41 | NA | 28.95 | 090 | |
25492 | A | Reinforce radius and ulna | 12.33 | NA | 18.06 | 1.62 | NA | 32.01 | 090 | |
25500 | A | Treat fracture of radius | 2.45 | 4.37 | 2.93 | 0.28 | 7.10 | 5.66 | 090 | |
25505 | A | Treat fracture of radius | 5.21 | 8.04 | 5.81 | 0.69 | 13.94 | 11.71 | 090 | |
25515 | A | Treat fracture of radius | 9.18 | NA | 10.00 | 1.22 | NA | 20.40 | 090 | |
25520 | A | Treat fracture of radius | 6.26 | 8.23 | 6.43 | 0.85 | 15.34 | 13.54 | 090 | |
25525 | A | Treat fracture of radius | 12.24 | NA | 11.92 | 1.68 | NA | 25.84 | 090 | |
25526 | A | Treat fracture of radius | 12.98 | NA | 15.40 | 1.80 | NA | 30.18 | 090 | |
25530 | A | Treat fracture of ulna | 2.09 | 4.42 | 2.92 | 0.27 | 6.78 | 5.28 | 090 | |
25535 | A | Treat fracture of ulna | 5.14 | 7.81 | 5.86 | 0.68 | 13.63 | 11.68 | 090 | |
25545 | A | Treat fracture of ulna | 8.90 | NA | 10.14 | 1.23 | NA | 20.27 | 090 | |
25560 | A | Treat fracture radius ulna | 2.44 | 4.41 | 2.90 | 0.27 | 7.12 | 5.61 | 090 | |
25565 | A | Treat fracture radius ulna | 5.63 | 8.28 | 6.02 | 0.76 | 14.67 | 12.41 | 090 | |
25574 | A | Treat fracture radius ulna | 7.01 | NA | 9.05 | 0.96 | NA | 17.02 | 090 | |
25575 | A | Treat fracture radius/ulna | 10.45 | NA | 10.98 | 1.46 | NA | 22.89 | 090 | |
25600 | A | Treat fracture radius/ulna | 2.63 | 4.75 | 3.11 | 0.34 | 7.72 | 6.08 | 090 | |
25605 | A | Treat fracture radius/ulna | 5.81 | 8.51 | 6.27 | 0.81 | 15.13 | 12.89 | 090 | |
25611 | A | Treat fracture radius/ulna | 7.77 | NA | 10.37 | 1.08 | NA | 19.22 | 090 | |
25620 | A | Treat fracture radius/ulna | 8.55 | NA | 9.91 | 1.17 | NA | 19.63 | 090 | |
25622 | A | Treat wrist bone fracture | 2.61 | 4.70 | 3.08 | 0.33 | 7.64 | 6.02 | 090 | |
25624 | A | Treat wrist bone fracture | 4.53 | 7.73 | 5.49 | 0.61 | 12.87 | 10.63 | 090 | |
25628 | A | Treat wrist bone fracture | 8.43 | NA | 9.95 | 1.14 | NA | 19.52 | 090 | |
25630 | A | Treat wrist bone fracture | 2.88 | 4.86 | 3.14 | 0.37 | 8.11 | 6.39 | 090 | |
25635 | A | Treat wrist bone fracture | 4.39 | 7.68 | 4.75 | 0.39 | 12.46 | 9.53 | 090 | |
25645 | A | Treat wrist bone fracture | 7.25 | NA | 9.47 | 0.93 | NA | 17.65 | 090 | |
25650 | A | Treat wrist bone fracture | 3.05 | 4.91 | 3.21 | 0.37 | 8.33 | 6.63 | 090 | |
25651 | A | Pin ulnar styloid fracture | 5.36 | NA | 5.69 | 0.72 | NA | 11.77 | 090 | |
25652 | A | Treat fracture ulnar styloid | 7.60 | NA | 6.85 | 1.02 | NA | 15.47 | 090 | |
25660 | A | Treat wrist dislocation | 4.76 | NA | 5.49 | 0.59 | NA | 10.84 | 090 | |
25670 | A | Treat wrist dislocation | 7.92 | NA | 9.73 | 1.07 | NA | 18.72 | 090 | |
25671 | A | Pin radioulnar dislocation | 6.00 | NA | 6.02 | 0.81 | NA | 12.83 | 090 | |
25675 | A | Treat wrist dislocation | 4.67 | 7.52 | 5.43 | 0.57 | 12.76 | 10.67 | 090 | |
25676 | A | Treat wrist dislocation | 8.04 | NA | 9.78 | 1.10 | NA | 18.92 | 090 | |
25680 | A | Treat wrist fracture | 5.99 | NA | 6.48 | 0.61 | NA | 13.08 | 090 | |
25685 | A | Treat wrist fracture | 9.78 | NA | 10.44 | 1.25 | NA | 21.47 | 090 | |
25690 | A | Treat wrist dislocation | 5.50 | NA | 7.21 | 0.78 | NA | 13.49 | 090 | |
25695 | A | Treat wrist dislocation | 8.34 | NA | 9.86 | 1.07 | NA | 19.27 | 090 | |
25800 | A | Fusion of wrist joint | 9.76 | NA | 10.92 | 1.30 | NA | 21.98 | 090 | |
25805 | A | Fusion/graft of wrist joint | 11.28 | NA | 11.81 | 1.51 | NA | 24.60 | 090 | |
25810 | A | Fusion/graft of wrist joint | 10.57 | NA | 11.34 | 1.37 | NA | 23.28 | 090 | |
25820 | A | Fusion of hand bones | 7.45 | NA | 9.68 | 0.96 | NA | 18.09 | 090 | |
25825 | A | Fuse hand bones with graft | 9.27 | NA | 10.66 | 1.20 | NA | 21.13 | 090 | |
25830 | A | Fusion, radioulnar jnt/ulna | 10.06 | NA | 17.12 | 1.27 | NA | 28.45 | 090 | |
25900 | A | Amputation of forearm | 9.01 | NA | 14.48 | 1.08 | NA | 24.57 | 090 | |
25905 | A | Amputation of forearm | 9.12 | NA | 15.75 | 1.06 | NA | 25.93 | 090 | |
25907 | A | Amputation follow-up surgery | 7.80 | NA | 15.19 | 1.01 | NA | 24.00 | 090 | |
25909 | A | Amputation follow-up surgery | 8.96 | NA | 15.62 | 1.07 | NA | 25.65 | 090 | |
25915 | A | Amputation of forearm | 17.08 | NA | 23.14 | 2.41 | NA | 42.63 | 090 | |
25920 | A | Amputate hand at wrist | 8.68 | NA | 9.91 | 1.06 | NA | 19.65 | 090 | |
25922 | A | Amputate hand at wrist | 7.42 | NA | 9.06 | 0.93 | NA | 17.41 | 090 | |
25924 | A | Amputation follow-up surgery | 8.46 | NA | 10.25 | 1.07 | NA | 19.78 | 090 | |
25927 | A | Amputation of hand | 8.80 | NA | 14.18 | 1.02 | NA | 24.00 | 090 | |
25929 | A | Amputation follow-up surgery | 7.59 | NA | 7.83 | 0.89 | NA | 16.31 | 090 | |
25931 | A | Amputation follow-up surgery | 7.81 | NA | 15.09 | 0.88 | NA | 23.78 | 090 | |
25999 | C | Forearm or wrist surgery | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
26010 | A | Drainage of finger abscess | 1.54 | 5.97 | 1.78 | 0.14 | 7.65 | 3.46 | 010 | |
26011 | A | Drainage of finger abscess | 2.19 | 12.48 | 2.48 | 0.25 | 14.92 | 4.92 | 010 | |
26020 | A | Drain hand tendon sheath | 4.67 | NA | 5.31 | 0.59 | NA | 10.57 | 090 | |
26025 | A | Drainage of palm bursa | 4.82 | NA | 5.18 | 0.60 | NA | 10.60 | 090 | |
26030 | A | Drainage of palm bursa(s) | 5.93 | NA | 5.85 | 0.72 | NA | 12.50 | 090 | |
26034 | A | Treat hand bone lesion | 6.23 | NA | 6.04 | 0.79 | NA | 13.06 | 090 | |
26035 | A | Decompress fingers/hand | 9.51 | NA | 7.99 | 1.12 | NA | 18.62 | 090 | |
26037 | A | Decompress fingers/hand | 7.25 | NA | 6.48 | 0.87 | NA | 14.60 | 090 | |
26040 | A | Release palm contracture | 3.33 | NA | 3.75 | 0.45 | NA | 7.53 | 090 | |
26045 | A | Release palm contracture | 5.56 | NA | 5.30 | 0.74 | NA | 11.60 | 090 | |
26055 | A | Incise finger tendon sheath | 2.69 | 15.46 | 3.59 | 0.36 | 18.51 | 6.64 | 090 | |
26060 | A | Incision of finger tendon | 2.81 | NA | 3.28 | 0.35 | NA | 6.44 | 090 | |
26070 | A | Explore/treat hand joint | 3.69 | NA | 3.32 | 0.35 | NA | 7.36 | 090 | |
26075 | A | Explore/treat finger joint | 3.79 | NA | 3.67 | 0.40 | NA | 7.86 | 090 | |
26080 | A | Explore/treat finger joint | 4.24 | NA | 4.58 | 0.52 | NA | 9.34 | 090 | |
26100 | A | Biopsy hand joint lining | 3.67 | NA | 3.90 | 0.45 | NA | 8.02 | 090 | |
26105 | A | Biopsy finger joint lining | 3.71 | NA | 3.93 | 0.45 | NA | 8.09 | 090 | |
26110 | A | Biopsy finger joint lining | 3.53 | NA | 3.80 | 0.44 | NA | 7.77 | 090 | |
26115 | A | Removel hand lesion subcut | 3.86 | 14.42 | 4.43 | 0.48 | 18.76 | 8.77 | 090 | |
26116 | A | Removel hand lesion, deep | 5.53 | NA | 5.66 | 0.69 | NA | 11.88 | 090 | |
26117 | A | Remove tumor, hand/finger | 8.55 | NA | 6.94 | 1.01 | NA | 16.50 | 090 | |
26121 | A | Release palm contracture | 7.54 | NA | 6.72 | 0.94 | NA | 15.20 | 090 | |
26123 | A | Release palm contracture | 9.29 | NA | 8.65 | 1.17 | NA | 19.11 | 090 | |
26125 | A | Release palm contracture | 4.61 | NA | 2.51 | 0.57 | NA | 7.69 | ZZZ | |
26130 | A | Remove wrist joint lining | 5.42 | NA | 5.12 | 0.65 | NA | 11.19 | 090 | |
26135 | A | Revise finger joint, each | 6.96 | NA | 6.20 | 0.87 | NA | 14.03 | 090 | |
26140 | A | Revise finger joint, each | 6.17 | NA | 5.75 | 0.76 | NA | 12.68 | 090 | |
26145 | A | Tendon excision, palm/finger | 6.32 | NA | 5.78 | 0.77 | NA | 12.87 | 090 | |
26160 | A | Remove tendon sheath lesion | 3.15 | 18.94 | 3.86 | 0.39 | 22.48 | 7.40 | 090 | |
26170 | A | Removal of palm tendon, each | 4.77 | NA | 4.72 | 0.60 | NA | 10.09 | 090 | |
26180 | A | Removal of finger tendon | 5.18 | NA | 5.10 | 0.64 | NA | 10.92 | 090 | |
26185 | A | Remove finger bone | 5.25 | NA | 5.62 | 0.67 | NA | 11.54 | 090 | |
26200 | A | Remove hand bone lesion | 5.51 | NA | 5.14 | 0.71 | NA | 11.36 | 090 | |
26205 | A | Remove/graft bone lesion | 7.70 | NA | 6.69 | 0.95 | NA | 15.34 | 090 | |
26210 | A | Removal of finger lesion | 5.15 | NA | 5.12 | 0.64 | NA | 10.91 | 090 | |
26215 | A | Remove/graft finger lesion | 7.10 | NA | 6.07 | 0.77 | NA | 13.94 | 090 | |
26230 | A | Partial removal of hand bone | 6.33 | NA | 5.68 | 0.84 | NA | 12.85 | 090 | |
26235 | A | Partial removal, finger bone | 6.19 | NA | 5.62 | 0.78 | NA | 12.59 | 090 | |
26236 | A | Partial removal, finger bone | 5.32 | NA | 5.17 | 0.66 | NA | 11.15 | 090 | |
26250 | A | Extensive hand surgery | 7.55 | NA | 6.23 | 0.92 | NA | 14.70 | 090 | |
26255 | A | Extensive hand surgery | 12.43 | NA | 9.26 | 1.05 | NA | 22.74 | 090 | |
26260 | A | Extensive finger surgery | 7.03 | NA | 5.98 | 0.83 | NA | 13.84 | 090 | |
26261 | A | Extensive finger surgery | 9.09 | NA | 6.22 | 0.84 | NA | 16.15 | 090 | |
26262 | A | Partial removal of finger | 5.67 | NA | 5.18 | 0.70 | NA | 11.55 | 090 | |
26320 | A | Removal of implant from hand | 3.98 | NA | 4.50 | 0.49 | NA | 8.97 | 090 | |
26340 | A | Manipulate finger w/anesth | 2.50 | NA | 4.64 | 0.30 | NA | 7.44 | 090 | |
26350 | A | Repair finger/hand tendon | 5.99 | NA | 20.03 | 0.73 | NA | 26.75 | 090 | |
26352 | A | Repair/graft hand tendon | 7.68 | NA | 20.50 | 0.93 | NA | 29.11 | 090 | |
26356 | A | Repair finger/hand tendon | 8.07 | NA | 21.49 | 0.99 | NA | 30.55 | 090 | |
26357 | A | Repair finger/hand tendon | 8.58 | NA | 21.19 | 1.02 | NA | 30.79 | 090 | |
26358 | A | Repair/graft hand tendon | 9.14 | NA | 21.74 | 1.07 | NA | 31.95 | 090 | |
26370 | A | Repair finger/hand tendon | 7.11 | NA | 20.67 | 0.90 | NA | 28.68 | 090 | |
26372 | A | Repair/graft hand tendon | 8.76 | NA | 22.00 | 1.06 | NA | 31.82 | 090 | |
26373 | A | Repair finger/hand tendon | 8.16 | NA | 21.56 | 0.98 | NA | 30.70 | 090 | |
26390 | A | Revise hand/finger tendon | 9.19 | NA | 16.75 | 1.09 | NA | 27.03 | 090 | |
26392 | A | Repair/graft hand tendon | 10.26 | NA | 22.55 | 1.26 | NA | 34.07 | 090 | |
26410 | A | Repair hand tendon | 4.63 | NA | 16.30 | 0.57 | NA | 21.50 | 090 | |
26412 | A | Repair/graft hand tendon | 6.31 | NA | 17.39 | 0.80 | NA | 24.50 | 090 | |
26415 | A | Excision, hand/finger tendon | 8.34 | NA | 15.90 | 0.77 | NA | 25.01 | 090 | |
26416 | A | Graft hand or finger tendon | 9.37 | NA | 18.56 | 1.20 | NA | 29.13 | 090 | |
26418 | A | Repair finger tendon | 4.25 | NA | 16.13 | 0.50 | NA | 20.88 | 090 | |
26420 | A | Repair/graft finger tendon | 6.77 | NA | 17.69 | 0.83 | NA | 25.29 | 090 | |
26426 | A | Repair finger/hand tendon | 6.15 | NA | 17.16 | 0.77 | NA | 24.08 | 090 | |
26428 | A | Repair/graft finger tendon | 7.21 | NA | 18.24 | 0.84 | NA | 26.29 | 090 | |
26432 | A | Repair finger tendon | 4.02 | NA | 13.36 | 0.48 | NA | 17.86 | 090 | |
26433 | A | Repair finger tendon | 4.56 | NA | 14.27 | 0.56 | NA | 19.39 | 090 | |
26434 | A | Repair/graft finger tendon | 6.09 | NA | 14.67 | 0.71 | NA | 21.47 | 090 | |
26437 | A | Realignment of tendons | 5.82 | NA | 14.40 | 0.74 | NA | 20.96 | 090 | |
26440 | A | Release palm/finger tendon | 5.02 | NA | 18.87 | 0.62 | NA | 24.51 | 090 | |
26442 | A | Release palm finger tendon | 8.16 | NA | 20.31 | 0.94 | NA | 29.41 | 090 | |
26445 | A | Release hand/finger tendon | 4.31 | NA | 18.71 | 0.54 | NA | 23.56 | 090 | |
26449 | A | Release forearm/hand tendon | 7.00 | NA | 20.02 | 0.84 | NA | 27.86 | 090 | |
26450 | A | Incision of palm tendon | 3.67 | NA | 8.57 | 0.46 | NA | 12.70 | 090 | |
26455 | A | Incision of finger tendon | 3.64 | NA | 8.45 | 0.47 | NA | 12.56 | 090 | |
26460 | A | Incise hand/finger tendon | 3.46 | NA | 8.20 | 0.44 | NA | 12.10 | 090 | |
26471 | A | Fusion of finger tendons | 5.73 | NA | 14.06 | 0.73 | NA | 20.52 | 090 | |
26474 | A | Fusion of finger tendons | 5.32 | NA | 14.31 | 0.69 | NA | 20.32 | 090 | |
26476 | A | Tendon lengthening | 5.18 | NA | 13.80 | 0.62 | NA | 19.60 | 090 | |
26477 | A | Tendon shortening | 5.15 | NA | 14.01 | 0.60 | NA | 19.76 | 090 | |
26478 | A | Lengthening of hand tendon | 5.80 | NA | 14.65 | 0.77 | NA | 21.22 | 090 | |
26479 | A | Shortening of hand tendon | 5.74 | NA | 14.65 | 0.76 | NA | 21.15 | 090 | |
26480 | A | Transplant hand tendon | 6.69 | NA | 19.94 | 0.84 | NA | 27.47 | 090 | |
26483 | A | Transplant/graft hand tendon | 8.29 | NA | 20.43 | 1.03 | NA | 29.75 | 090 | |
26485 | A | Transplant palm tendon | 7.70 | NA | 20.34 | 0.94 | NA | 28.98 | 090 | |
26489 | A | Transplant/graft palm tendon | 9.55 | NA | 17.04 | 0.98 | NA | 27.57 | 090 | |
26490 | A | Revise thumb tendon | 8.41 | NA | 15.54 | 1.05 | NA | 25.00 | 090 | |
26492 | A | Tendon transfer with graft | 9.62 | NA | 16.15 | 1.19 | NA | 26.96 | 090 | |
26494 | A | Hand tendon/muscle transfer | 8.47 | NA | 16.14 | 1.13 | NA | 25.74 | 090 | |
26496 | A | Revise thumb tendon | 9.59 | NA | 15.87 | 1.17 | NA | 26.63 | 090 | |
26497 | A | Finger tendon transfer | 9.57 | NA | 16.32 | 1.17 | NA | 27.06 | 090 | |
26498 | A | Finger tendon transfer | 14.00 | NA | 18.71 | 1.74 | NA | 34.45 | 090 | |
26499 | A | Revision of finger | 8.98 | NA | 17.02 | 0.94 | NA | 26.94 | 090 | |
26500 | A | Hand tendon reconstruction | 5.96 | NA | 14.98 | 0.66 | NA | 21.60 | 090 | |
26502 | A | Hand tendon reconstruction | 7.14 | NA | 15.27 | 0.87 | NA | 23.28 | 090 | |
26504 | A | Hand tendon reconstruction | 7.47 | NA | 15.08 | 0.84 | NA | 23.39 | 090 | |
26508 | A | Release thumb contracture | 6.01 | NA | 14.59 | 0.76 | NA | 21.36 | 090 | |
26510 | A | Thumb tendon transfer | 5.43 | NA | 14.30 | 0.71 | NA | 20.44 | 090 | |
26516 | A | Fusion of knuckle joint | 7.15 | NA | 15.07 | 0.90 | NA | 23.12 | 090 | |
26517 | A | Fusion of knuckle joints | 8.83 | NA | 16.41 | 0.96 | NA | 26.20 | 090 | |
26518 | A | Fusion of knuckle joints | 9.02 | NA | 16.12 | 1.13 | NA | 26.27 | 090 | |
26520 | A | Release knuckle contracture | 5.30 | NA | 18.85 | 0.65 | NA | 24.80 | 090 | |
26525 | A | Release finger contracture | 5.33 | NA | 19.02 | 0.66 | NA | 25.01 | 090 | |
26530 | A | Revise knuckle joint | 6.69 | NA | 6.04 | 0.86 | NA | 13.59 | 090 | |
26531 | A | Revise knuckle with implant | 7.91 | NA | 6.95 | 1.01 | NA | 15.87 | 090 | |
26535 | A | Revise finger joint | 5.24 | NA | 3.69 | 0.66 | NA | 9.59 | 090 | |
26536 | A | Revise/implant finger joint | 6.37 | NA | 10.32 | 0.80 | NA | 17.49 | 090 | |
26540 | A | Repair hand joint | 6.43 | NA | 14.89 | 0.81 | NA | 22.13 | 090 | |
26541 | A | Repair hand joint with graft | 8.62 | NA | 16.25 | 1.12 | NA | 25.99 | 090 | |
26542 | A | Repair hand joint with graft | 6.78 | NA | 14.78 | 0.87 | NA | 22.43 | 090 | |
26545 | A | Reconstruct finger joint | 6.92 | NA | 15.52 | 0.79 | NA | 23.23 | 090 | |
26546 | A | Repair nonunion hand | 8.92 | NA | 16.15 | 1.14 | NA | 26.21 | 090 | |
26548 | A | Reconstruct finger joint | 8.03 | NA | 16.02 | 0.98 | NA | 25.03 | 090 | |
26550 | A | Construct thumb replacement | 21.24 | NA | 23.47 | 1.80 | NA | 46.51 | 090 | |
26551 | A | Great toe-hand transfer | 46.58 | NA | 36.90 | 6.57 | NA | 90.05 | 090 | |
26553 | A | Single transfer, toe-hand | 46.27 | NA | 28.16 | 1.99 | NA | 76.42 | 090 | |
26554 | A | Double transfer, toe-hand | 54.95 | NA | 38.79 | 7.76 | NA | 101.50 | 090 | |
26555 | A | Positional change of finger | 16.63 | NA | 22.51 | 2.13 | NA | 41.27 | 090 | |
26556 | A | Toe joint transfer | 47.26 | NA | 34.27 | 6.67 | NA | 88.20 | 090 | |
26560 | A | Repair of web finger | 5.38 | NA | 12.99 | 0.60 | NA | 18.97 | 090 | |
26561 | A | Repair of web finger | 10.92 | NA | 16.12 | 0.69 | NA | 27.73 | 090 | |
26562 | A | Repair of web finger | 15.00 | NA | 19.37 | 0.98 | NA | 35.35 | 090 | |
26565 | A | Correct metacarpal flaw | 6.74 | NA | 14.95 | 0.84 | NA | 22.53 | 090 | |
26567 | A | Correct finger deformity | 6.82 | NA | 14.88 | 0.84 | NA | 22.54 | 090 | |
26568 | A | Lengthen metacarpal/finger | 9.08 | NA | 20.41 | 1.10 | NA | 30.59 | 090 | |
26580 | A | Repair hand deformity | 18.18 | NA | 15.87 | 1.46 | NA | 35.51 | 090 | |
26587 | A | Reconstruct extra finger | 14.05 | 6.36 | NA | 1.12 | 21.53 | NA | 090 | |
26590 | A | Repair finger deformity | 17.96 | NA | 17.46 | 1.32 | NA | 36.74 | 090 | |
26591 | A | Repair muscles of hand | 3.25 | NA | 13.80 | 0.37 | NA | 17.42 | 090 | |
26593 | A | Release muscles of hand | 5.31 | NA | 13.78 | 0.64 | NA | 19.73 | 090 | |
26596 | A | Excision constricting tissue | 8.95 | NA | 9.86 | 0.87 | NA | 19.68 | 090 | |
26600 | A | Treat metacarpal fracture | 1.96 | 4.36 | 2.83 | 0.25 | 6.57 | 5.04 | 090 | |
26605 | A | Treat metacarpal fracture | 2.85 | 6.33 | 4.45 | 0.38 | 9.56 | 7.68 | 090 | |
26607 | A | Treat metacarpal fracture | 5.36 | NA | 8.46 | 0.70 | NA | 14.52 | 090 | |
26608 | A | Treat metacarpal fracture | 5.36 | NA | 9.07 | 0.73 | NA | 15.16 | 090 | |
26615 | A | Treat metacarpal fracture | 5.33 | NA | 8.49 | 0.70 | NA | 14.52 | 090 | |
26641 | A | Treat thumb dislocation | 3.94 | 6.70 | 4.86 | 0.42 | 11.06 | 9.22 | 090 | |
26645 | A | Treat thumb fracture | 4.41 | 7.51 | 5.35 | 0.54 | 12.46 | 10.30 | 090 | |
26650 | A | Treat thumb fracture | 5.72 | NA | 9.24 | 0.77 | NA | 15.73 | 090 | |
26665 | A | Treat thumb fracture | 7.60 | NA | 9.52 | 0.97 | NA | 18.09 | 090 | |
26670 | A | Treat hand dislocation | 3.69 | 6.53 | 4.75 | 0.36 | 10.58 | 8.80 | 090 | |
26675 | A | Treat hand dislocation | 4.64 | 6.66 | 4.57 | 0.56 | 11.86 | 9.77 | 090 | |
26676 | A | Pin hand dislocation | 5.52 | NA | 9.30 | 0.76 | NA | 15.58 | 090 | |
26685 | A | Treat hand dislocation | 6.98 | NA | 9.14 | 0.95 | NA | 17.07 | 090 | |
26686 | A | Treat hand dislocation | 7.94 | NA | 9.73 | 1.05 | NA | 18.72 | 090 | |
26700 | A | Treat knuckle dislocation | 3.69 | 5.13 | 2.96 | 0.35 | 9.17 | 7.00 | 090 | |
26705 | A | Treat knuckle dislocation | 4.19 | 6.47 | 4.41 | 0.50 | 11.16 | 9.10 | 090 | |
26706 | A | Pin knuckle dislocation | 5.12 | NA | 5.98 | 0.64 | NA | 11.74 | 090 | |
26715 | A | Treat knuckle dislocation | 5.74 | NA | 8.65 | 0.75 | NA | 15.14 | 090 | |
26720 | A | Treat finger fracture, each | 1.66 | 3.22 | 1.69 | 0.20 | 5.08 | 3.55 | 090 | |
26725 | A | Treat finger fracture, each | 3.33 | 5.47 | 3.28 | 0.43 | 9.23 | 7.04 | 090 | |
26727 | A | Treat finger fracture, each | 5.23 | NA | 9.18 | 0.69 | NA | 15.10 | 090 | |
26735 | A | Treat finger fracture, each | 5.98 | NA | 8.91 | 0.77 | NA | 15.66 | 090 | |
26740 | A | Treat finger fracture, each | 1.94 | 4.01 | 2.67 | 0.24 | 6.19 | 4.85 | 090 | |
26742 | A | Treat finger fracture, each | 3.85 | 7.41 | 5.28 | 0.49 | 11.75 | 9.62 | 090 | |
26746 | A | Treat finger fracture, each | 5.81 | NA | 8.98 | 0.74 | NA | 15.53 | 090 | |
26750 | A | Treat finger fracture, each | 1.70 | 3.82 | 2.41 | 0.19 | 5.71 | 4.30 | 090 | |
26755 | A | Treat finger fracture, each | 3.10 | 5.25 | 3.10 | 0.37 | 8.72 | 6.57 | 090 | |
26756 | A | Pin finger fracture, each | 4.39 | NA | 8.89 | 0.56 | NA | 13.84 | 090 | |
26765 | A | Treat finger fracture, each | 4.17 | NA | 7.97 | 0.51 | NA | 12.65 | 090 | |
26770 | A | Treat finger dislocation | 3.02 | 4.98 | 2.71 | 0.27 | 8.27 | 6.00 | 090 | |
26775 | A | Treat finger dislocation | 3.71 | 6.25 | 4.06 | 0.43 | 10.39 | 8.20 | 090 | |
26776 | A | Pin finger dislocation | 4.80 | NA | 9.01 | 0.63 | NA | 14.44 | 090 | |
26785 | A | Treat finger dislocation | 4.21 | NA | 7.94 | 0.54 | NA | 12.69 | 090 | |
26820 | A | Thumb fusion with graft | 8.26 | NA | 16.22 | 1.11 | NA | 25.59 | 090 | |
26841 | A | Fusion of thumb | 7.13 | NA | 15.46 | 0.97 | NA | 23.56 | 090 | |
26842 | A | Thumb fusion with graft | 8.24 | NA | 16.24 | 1.10 | NA | 25.58 | 090 | |
26843 | A | Fusion of hand joint | 7.61 | NA | 14.93 | 0.99 | NA | 23.53 | 090 | |
26844 | A | Fusion/graft of hand joint | 8.73 | NA | 16.20 | 1.12 | NA | 26.05 | 090 | |
26850 | A | Fusion of knuckle | 6.97 | NA | 14.89 | 0.89 | NA | 22.75 | 090 | |
26852 | A | Fusion of knuckle with graft | 8.46 | NA | 15.84 | 1.05 | NA | 25.35 | 090 | |
26860 | A | Fusion of finger joint | 4.69 | NA | 13.75 | 0.60 | NA | 19.04 | 090 | |
26861 | A | Fusion of finger jnt, add-on | 1.74 | NA | 0.96 | 0.22 | NA | 2.92 | ZZZ | |
26862 | A | Fusion/graft of finger joint | 7.37 | NA | 15.38 | 0.92 | NA | 23.67 | 090 | |
26863 | A | Fuse/graft added joint | 3.90 | NA | 2.17 | 0.51 | NA | 6.58 | ZZZ | |
26910 | A | Amputate metacarpal bone | 7.60 | NA | 14.07 | 0.90 | NA | 22.57 | 090 | |
26951 | A | Amputation of finger/thumb | 4.59 | NA | 13.06 | 0.56 | NA | 18.21 | 090 | |
26952 | A | Amputation of finger/thumb | 6.31 | NA | 14.25 | 0.74 | NA | 21.30 | 090 | |
26989 | C | Hand/finger surgery | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
26990 | A | Drainage of pelvis lesion | 7.48 | NA | 16.35 | 0.92 | NA | 24.75 | 090 | |
26991 | A | Drainage of pelvis bursa | 6.68 | 11.94 | 9.87 | 0.85 | 19.47 | 17.40 | 090 | |
26992 | A | Drainage of bone lesion | 13.02 | NA | 20.25 | 1.75 | NA | 35.02 | 090 | |
27000 | A | Incision of hip tendon | 5.62 | NA | 7.78 | 0.76 | NA | 14.16 | 090 | |
27001 | A | Incision of hip tendon | 6.94 | NA | 8.52 | 0.95 | NA | 16.41 | 090 | |
27003 | A | Incision of hip tendon | 7.34 | NA | 9.52 | 0.93 | NA | 17.79 | 090 | |
27005 | A | Incision of hip tendon | 9.66 | NA | 10.84 | 1.36 | NA | 21.86 | 090 | |
27006 | A | Incision of hip tendons | 9.68 | NA | 10.84 | 1.33 | NA | 21.85 | 090 | |
27025 | A | Incision of hip/thigh fascia | 11.16 | NA | 10.70 | 1.38 | NA | 23.24 | 090 | |
27030 | A | Drainage of hip joint | 13.01 | NA | 12.69 | 1.81 | NA | 27.51 | 090 | |
27033 | A | Exploration of hip joint | 13.39 | NA | 12.81 | 1.87 | NA | 28.07 | 090 | |
27035 | A | Denervation of hip joint | 16.69 | NA | 17.51 | 1.70 | NA | 35.90 | 090 | |
27036 | A | Excision of hip joint/muscle | 12.88 | NA | 14.25 | 1.80 | NA | 28.93 | 090 | |
27040 | A | Biopsy of soft tissues | 2.87 | 6.16 | 3.97 | 0.21 | 9.24 | 7.05 | 010 | |
27041 | A | Biopsy of soft tissues | 9.89 | NA | 8.60 | 1.01 | NA | 19.50 | 090 | |
27047 | A | Remove hip/pelvis lesion | 7.45 | 9.54 | 7.15 | 0.79 | 17.78 | 15.39 | 090 | |
27048 | A | Remove hip/pelvis lesion | 6.25 | NA | 8.06 | 0.73 | NA | 15.04 | 090 | |
27049 | A | Remove tumor, hip/pelvis | 13.66 | NA | 13.54 | 1.60 | NA | 28.80 | 090 | |
27050 | A | Biopsy of sacroiliac joint | 4.36 | NA | 7.42 | 0.53 | NA | 12.31 | 090 | |
27052 | A | Biopsy of hip joint | 6.23 | NA | 8.71 | 0.85 | NA | 15.79 | 090 | |
27054 | A | Removal of hip joint lining | 8.54 | NA | 11.05 | 1.17 | NA | 20.76 | 090 | |
27060 | A | Removal of ischial bursa | 5.43 | NA | 7.63 | 0.60 | NA | 13.66 | 090 | |
27062 | A | Remove femur lesion/bursa | 5.37 | NA | 7.59 | 0.74 | NA | 13.70 | 090 | |
27065 | A | Removal of hip bone lesion | 5.90 | NA | 9.09 | 0.76 | NA | 15.75 | 090 | |
27066 | A | Removal of hip bone lesion | 10.33 | NA | 12.88 | 1.42 | NA | 24.63 | 090 | |
27067 | A | Remove/graft hip bone lesion | 13.83 | NA | 14.91 | 1.95 | NA | 30.69 | 090 | |
27070 | A | Partial removal of hip bone | 10.72 | NA | 18.36 | 1.36 | NA | 30.44 | 090 | |
27071 | A | Partial removal of hip bone | 11.46 | NA | 19.32 | 1.51 | NA | 32.29 | 090 | |
27075 | A | Extensive hip surgery | 35.00 | NA | 25.82 | 2.22 | NA | 63.04 | 090 | |
27076 | A | Extensive hip surgery | 22.12 | NA | 20.29 | 2.86 | NA | 45.27 | 090 | |
27077 | A | Extensive hip surgery | 40.00 | NA | 29.14 | 3.18 | NA | 72.32 | 090 | |
27078 | A | Extensive hip surgery | 13.44 | NA | 15.81 | 1.67 | NA | 30.92 | 090 | |
27079 | A | Extensive hip surgery | 13.75 | NA | 15.34 | 1.86 | NA | 30.95 | 090 | |
27080 | A | Removal of tail bone | 6.39 | NA | 7.66 | 0.80 | NA | 14.85 | 090 | |
27086 | A | Remove hip foreign body | 1.87 | 5.13 | 3.97 | 0.17 | 7.17 | 6.01 | 010 | |
27087 | A | Remove hip foreign body | 8.54 | NA | 9.19 | 1.09 | NA | 18.82 | 090 | |
27090 | A | Removal of hip prosthesis | 11.15 | NA | 8.95 | 1.55 | NA | 21.65 | 090 | |
27091 | A | Removal of hip prosthesis | 22.14 | NA | 14.22 | 3.11 | NA | 39.47 | 090 | |
27093 | A | Injection for hip x-ray | 1.30 | 12.50 | 0.50 | 0.09 | 13.89 | 1.89 | 000 | |
27095 | A | Injection for hip x-ray | 1.50 | 11.47 | 0.54 | 0.10 | 13.07 | 2.14 | 000 | |
27096 | A | Inject sacroiliac joint | 1.40 | 10.28 | 0.34 | 0.08 | 11.76 | 1.82 | 000 | |
27097 | A | Revision of hip tendon | 8.80 | NA | 9.44 | 1.22 | NA | 19.46 | 090 | |
27098 | A | Transfer tendon to pelvis | 8.83 | NA | 9.88 | 1.24 | NA | 19.95 | 090 | |
27100 | A | Transfer of abdominal muscle | 11.08 | NA | 13.03 | 1.57 | NA | 25.68 | 090 | |
27105 | A | Transfer of spinal muscle | 11.77 | NA | 12.72 | 1.66 | NA | 26.15 | 090 | |
27110 | A | Transfer of iliopsoas muscle | 13.26 | NA | 13.59 | 1.38 | NA | 28.23 | 090 | |
27111 | A | Transfer of iliopsoas muscle | 12.15 | NA | 12.43 | 1.48 | NA | 26.06 | 090 | |
27120 | A | Reconstruction of hip socket | 18.01 | NA | 12.05 | 2.45 | NA | 32.51 | 090 | |
27122 | A | Reconstruction of hip socket | 14.98 | NA | 11.19 | 2.08 | NA | 28.25 | 090 | |
27125 | A | Partial hip replacement | 14.69 | NA | 10.75 | 2.05 | NA | 27.49 | 090 | |
27130 | A | Total hip arthroplasty | 20.12 | NA | 13.58 | 2.82 | NA | 36.52 | 090 | |
27132 | A | Total hip arthroplasty | 23.30 | NA | 15.87 | 3.26 | NA | 42.43 | 090 | |
27134 | A | Revise hip joint replacement | 28.52 | NA | 18.20 | 3.97 | NA | 50.69 | 090 | |
27137 | A | Revise hip joint replacement | 21.17 | NA | 14.24 | 2.97 | NA | 38.38 | 090 | |
27138 | A | Revise hip joint replacement | 22.17 | NA | 14.72 | 3.11 | NA | 40.00 | 090 | |
27140 | A | Transplant femur ridge | 12.24 | NA | 12.27 | 1.67 | NA | 26.18 | 090 | |
27146 | A | Incision of hip bone | 17.43 | NA | 16.51 | 2.27 | NA | 36.21 | 090 | |
27147 | A | Revision of hip bone | 20.58 | NA | 17.71 | 2.61 | NA | 40.90 | 090 | |
27151 | A | Incision of hip bones | 22.51 | NA | 12.83 | 3.12 | NA | 38.46 | 090 | |
27156 | A | Revision of hip bones | 24.63 | NA | 20.37 | 3.48 | NA | 48.48 | 090 | |
27158 | A | Revision of pelvis | 19.74 | NA | 16.00 | 2.60 | NA | 38.34 | 090 | |
27161 | A | Incision of neck of femur | 16.71 | NA | 14.57 | 2.32 | NA | 33.60 | 090 | |
27165 | A | Incision/fixation of femur | 17.91 | NA | 15.11 | 2.51 | NA | 35.53 | 090 | |
27170 | A | Repair/graft femur head/neck | 16.07 | NA | 14.30 | 2.20 | NA | 32.57 | 090 | |
27175 | A | Treat slipped epiphysis | 8.46 | NA | 7.39 | 1.19 | NA | 17.04 | 090 | |
27176 | A | Treat slipped epiphysis | 12.05 | NA | 10.20 | 1.68 | NA | 23.93 | 090 | |
27177 | A | Treat slipped epiphysis | 15.08 | NA | 11.88 | 2.11 | NA | 29.07 | 090 | |
27178 | A | Treat slipped epiphysis | 11.99 | NA | 9.63 | 1.68 | NA | 23.30 | 090 | |
27179 | A | Revise head/neck of femur | 12.98 | NA | 11.01 | 1.84 | NA | 25.83 | 090 | |
27181 | A | Treat slipped epiphysis | 14.68 | NA | 11.17 | 1.74 | NA | 27.59 | 090 | |
27185 | A | Revision of femur epiphysis | 9.18 | NA | 10.51 | 1.29 | NA | 20.98 | 090 | |
27187 | A | Reinforce hip bones | 13.54 | NA | 13.81 | 1.89 | NA | 29.24 | 090 | |
27193 | A | Treat pelvic ring fracture | 5.56 | 7.39 | 5.47 | 0.77 | 13.72 | 11.80 | 090 | |
27194 | A | Treat pelvic ring fracture | 9.65 | 9.40 | 7.71 | 1.32 | 20.37 | 18.68 | 090 | |
27200 | A | Treat tail bone fracture | 1.84 | 3.25 | 1.83 | 0.22 | 5.31 | 3.89 | 090 | |
27202 | A | Treat tail bone fracture | 7.04 | NA | 22.21 | 0.69 | NA | 29.94 | 090 | |
27215 | A | Treat pelvic fracture(s) | 10.05 | NA | 10.59 | 1.37 | NA | 22.01 | 090 | |
27216 | A | Treat pelvic ring fracture | 15.19 | NA | 14.82 | 2.15 | NA | 32.16 | 090 | |
27217 | A | Treat pelvic ring fracture | 14.11 | NA | 13.07 | 1.95 | NA | 29.13 | 090 | |
27218 | A | Treat pelvic ring fracture | 20.15 | NA | 14.41 | 2.85 | NA | 37.41 | 090 | |
27220 | A | Treat hip socket fracture | 6.18 | 7.73 | 5.82 | 0.85 | 14.76 | 12.85 | 090 | |
27222 | A | Treat hip socket fracture | 12.70 | NA | 10.44 | 1.77 | NA | 24.91 | 090 | |
27226 | A | Treat hip wall fracture | 14.91 | NA | 10.98 | 2.07 | NA | 27.96 | 090 | |
27227 | A | Treat hip fracture(s) | 23.45 | NA | 17.40 | 3.24 | NA | 44.09 | 090 | |
27228 | A | Treat hip fracture(s) | 27.16 | NA | 19.68 | 3.77 | NA | 50.61 | 090 | |
27230 | A | Treat thigh fracture | 5.50 | 8.01 | 6.44 | 0.73 | 14.24 | 12.67 | 090 | |
27232 | A | Treat thigh fracture | 10.68 | NA | 9.48 | 1.45 | NA | 21.61 | 090 | |
27235 | A | Treat thigh fracture | 12.16 | NA | 11.34 | 1.71 | NA | 25.21 | 090 | |
27236 | A | Treat thigh fracture | 15.60 | NA | 11.28 | 2.18 | NA | 29.06 | 090 | |
27238 | A | Treat thigh fracture | 5.52 | NA | 6.55 | 0.76 | NA | 12.83 | 090 | |
27240 | A | Treat thigh fracture | 12.50 | NA | 10.52 | 1.69 | NA | 24.71 | 090 | |
27244 | A | Treat thigh fracture | 15.94 | NA | 13.24 | 2.23 | NA | 31.41 | 090 | |
27245 | A | Treat thigh fracture | 20.31 | NA | 15.64 | 2.85 | NA | 38.80 | 090 | |
27246 | A | Treat thigh fracture | 4.71 | 7.73 | 6.19 | 0.66 | 13.10 | 11.56 | 090 | |
27248 | A | Treat thigh fracture | 10.45 | NA | 10.25 | 1.45 | NA | 22.15 | 090 | |
27250 | A | Treat hip dislocation | 6.95 | NA | 6.49 | 0.68 | NA | 14.12 | 090 | |
27252 | A | Treat hip dislocation | 10.39 | NA | 8.43 | 1.37 | NA | 20.19 | 090 | |
27253 | A | Treat hip dislocation | 12.92 | NA | 11.14 | 1.81 | NA | 25.87 | 090 | |
27254 | A | Treat hip dislocation | 18.26 | NA | 14.04 | 2.52 | NA | 34.82 | 090 | |
27256 | A | Treat hip dislocation | 4.12 | NA | 4.45 | 0.49 | NA | 9.06 | 010 | |
27257 | A | Treat hip dislocation | 5.22 | NA | 4.77 | 0.56 | NA | 10.55 | 010 | |
27258 | A | Treat hip dislocation | 15.43 | NA | 14.26 | 2.06 | NA | 31.75 | 090 | |
27259 | A | Treat hip dislocation | 21.55 | NA | 17.51 | 2.99 | NA | 42.05 | 090 | |
27265 | A | Treat hip dislocation | 5.05 | NA | 6.25 | 0.65 | NA | 11.95 | 090 | |
27266 | A | Treat hip dislocation | 7.49 | NA | 7.69 | 1.04 | NA | 16.22 | 090 | |
27275 | A | Manipulation of hip joint | 2.27 | NA | 3.75 | 0.31 | NA | 6.33 | 010 | |
27280 | A | Fusion of sacroiliac joint | 13.39 | NA | 14.60 | 1.98 | NA | 29.97 | 090 | |
27282 | A | Fusion of pubic bones | 11.34 | NA | 12.54 | 1.14 | NA | 25.02 | 090 | |
27284 | A | Fusion of hip joint | 23.45 | NA | 18.80 | 2.36 | NA | 44.61 | 090 | |
27286 | A | Fusion of hip joint | 23.45 | NA | 19.33 | 2.37 | NA | 45.15 | 090 | |
27290 | A | Amputation of leg at hip | 23.28 | NA | 17.03 | 2.94 | NA | 43.25 | 090 | |
27295 | A | Amputation of leg at hip | 18.65 | NA | 14.46 | 2.35 | NA | 35.46 | 090 | |
27299 | C | Pelvis/hip joint surgery | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
27301 | A | Drain thigh/knee lesion | 6.49 | 16.43 | 14.49 | 0.80 | 23.72 | 21.78 | 090 | |
27303 | A | Drainage of bone lesion | 8.28 | NA | 15.57 | 1.14 | NA | 24.99 | 090 | |
27305 | A | Incise thigh tendon fascia | 5.92 | NA | 9.50 | 0.77 | NA | 16.19 | 090 | |
27306 | A | Incision of thigh tendon | 4.62 | NA | 7.93 | 0.62 | NA | 13.17 | 090 | |
27307 | A | Incision of thigh tendons | 5.80 | NA | 8.53 | 0.78 | NA | 15.11 | 090 | |
27310 | A | Exploration of knee joint | 9.27 | NA | 10.40 | 1.29 | NA | 20.96 | 090 | |
27315 | A | Partial removal, thigh nerve | 6.97 | NA | 4.45 | 0.79 | NA | 12.21 | 090 | |
27320 | A | Partial removal, thigh nerve | 6.30 | NA | 4.68 | 0.78 | NA | 11.76 | 090 | |
27323 | A | Biopsy, thigh soft tissues | 2.28 | 6.01 | 3.57 | 0.17 | 8.46 | 6.02 | 010 | |
27324 | A | Biopsy, thigh soft tissues | 4.90 | NA | 7.14 | 0.59 | NA | 12.63 | 090 | |
27327 | A | Removal of thigh lesion | 4.47 | 8.59 | 6.51 | 0.50 | 13.56 | 11.48 | 090 | |
27328 | A | Removal of thigh lesion | 5.57 | NA | 7.28 | 0.66 | NA | 13.51 | 090 | |
27329 | A | Remove tumor, thigh/knee | 14.14 | NA | 14.74 | 1.68 | NA | 30.56 | 090 | |
27330 | A | Biopsy, knee joint lining | 4.97 | NA | 6.61 | 0.66 | NA | 12.24 | 090 | |
27331 | A | Explore/treat knee joint | 5.88 | NA | 7.83 | 0.81 | NA | 14.52 | 090 | |
27332 | A | Removal of knee cartilage | 8.27 | NA | 9.06 | 1.15 | NA | 18.48 | 090 | |
27333 | A | Removal of knee cartilage | 7.30 | NA | 8.59 | 1.03 | NA | 16.92 | 090 | |
27334 | A | Remove knee joint lining | 8.70 | NA | 9.97 | 1.21 | NA | 19.88 | 090 | |
27335 | A | Remove knee joint lining | 10.00 | NA | 10.83 | 1.41 | NA | 22.24 | 090 | |
27340 | A | Removal of kneecap bursa | 4.18 | NA | 6.26 | 0.58 | NA | 11.02 | 090 | |
27345 | A | Removal of knee cyst | 5.92 | NA | 7.70 | 0.81 | NA | 14.43 | 090 | |
27347 | A | Remove knee cyst | 5.78 | NA | 7.45 | 0.76 | NA | 13.99 | 090 | |
27350 | A | Removal of kneecap | 8.17 | NA | 9.17 | 1.15 | NA | 18.49 | 090 | |
27355 | A | Remove femur lesion | 7.65 | NA | 10.74 | 1.07 | NA | 19.46 | 090 | |
27356 | A | Remove femur lesion/graft | 9.48 | NA | 11.74 | 1.29 | NA | 22.51 | 090 | |
27357 | A | Remove femur lesion/graft | 10.53 | NA | 12.24 | 1.48 | NA | 24.25 | 090 | |
27358 | A | Remove femur lesion/fixation | 4.74 | NA | 2.59 | 0.67 | NA | 8.00 | ZZZ | |
27360 | A | Partial removal, leg bone(s) | 10.50 | NA | 18.97 | 1.42 | NA | 30.89 | 090 | |
27365 | A | Extensive leg surgery | 16.27 | NA | 14.68 | 2.26 | NA | 33.21 | 090 | |
27370 | A | Injection for knee x-ray | 0.96 | 11.98 | 0.33 | 0.06 | 13.00 | 1.35 | 000 | |
27372 | A | Removal of foreign body | 5.07 | 8.64 | 6.69 | 0.62 | 14.33 | 12.38 | 090 | |
27380 | A | Repair of kneecap tendon | 7.16 | NA | 8.67 | 1.00 | NA | 16.83 | 090 | |
27381 | A | Repair/graft kneecap tendon | 10.34 | NA | 10.37 | 1.44 | NA | 22.15 | 090 | |
27385 | A | Repair of thigh muscle | 7.76 | NA | 9.02 | 1.09 | NA | 17.87 | 090 | |
27386 | A | Repair/graft of thigh muscle | 10.56 | NA | 11.17 | 1.49 | NA | 23.22 | 090 | |
27390 | A | Incision of thigh tendon | 5.33 | NA | 8.20 | 0.69 | NA | 14.22 | 090 | |
27391 | A | Incision of thigh tendons | 7.20 | NA | 9.33 | 0.99 | NA | 17.52 | 090 | |
27392 | A | Incision of thigh tendons | 9.20 | NA | 11.43 | 1.23 | NA | 21.86 | 090 | |
27393 | A | Lengthening of thigh tendon | 6.39 | NA | 8.74 | 0.90 | NA | 16.03 | 090 | |
27394 | A | Lengthening of thigh tendons | 8.50 | NA | 11.13 | 1.17 | NA | 20.80 | 090 | |
27395 | A | Lengthening of thigh tendons | 11.73 | NA | 14.02 | 1.63 | NA | 27.38 | 090 | |
27396 | A | Transplant of thigh tendon | 7.86 | NA | 11.02 | 1.11 | NA | 19.99 | 090 | |
27397 | A | Transplants of thigh tendons | 11.28 | NA | 12.48 | 1.58 | NA | 25.34 | 090 | |
27400 | A | Revise thigh muscles/tendons | 9.02 | NA | 11.20 | 1.18 | NA | 21.40 | 090 | |
27403 | A | Repair of knee cartilage | 8.33 | NA | 9.19 | 1.16 | NA | 18.68 | 090 | |
27405 | A | Repair of knee ligament | 8.65 | NA | 10.04 | 1.21 | NA | 19.90 | 090 | |
27407 | A | Repair of knee ligament | 10.28 | NA | 10.74 | 1.38 | NA | 22.40 | 090 | |
27409 | A | Repair of knee ligaments | 12.90 | NA | 12.29 | 1.75 | NA | 26.94 | 090 | |
27418 | A | Repair degenerated kneecap | 10.85 | NA | 11.28 | 1.51 | NA | 23.64 | 090 | |
27420 | A | Revision of unstable kneecap | 9.83 | NA | 10.02 | 1.38 | NA | 21.23 | 090 | |
27422 | A | Revision of unstable kneecap | 9.78 | NA | 10.04 | 1.37 | NA | 21.19 | 090 | |
27424 | A | Revision/removal of kneecap | 9.81 | NA | 10.00 | 1.38 | NA | 21.19 | 090 | |
27425 | A | Lat retinacular release open | 5.22 | NA | 7.58 | 0.73 | NA | 13.53 | 090 | |
27427 | A | Reconstruction, knee | 9.36 | NA | 9.64 | 1.29 | NA | 20.29 | 090 | |
27428 | A | Reconstruction, knee | 14.00 | NA | 12.86 | 1.95 | NA | 28.81 | 090 | |
27429 | A | Reconstruction, knee | 15.52 | NA | 13.68 | 2.18 | NA | 31.38 | 090 | |
27430 | A | Revision of thigh muscles | 9.67 | NA | 10.08 | 1.35 | NA | 21.10 | 090 | |
27435 | A | Incision of knee joint | 9.49 | NA | 9.91 | 1.33 | NA | 20.73 | 090 | |
27437 | A | Revise kneecap | 8.46 | NA | 7.31 | 1.18 | NA | 16.95 | 090 | |
27438 | A | Revise kneecap with implant | 11.23 | NA | 8.71 | 1.56 | NA | 21.50 | 090 | |
27440 | A | Revision of knee joint | 10.43 | NA | 6.23 | 1.42 | NA | 18.08 | 090 | |
27441 | A | Revision of knee joint | 10.82 | NA | 6.90 | 1.49 | NA | 19.21 | 090 | |
27442 | A | Revision of knee joint | 11.89 | NA | 9.09 | 1.68 | NA | 22.66 | 090 | |
27443 | A | Revision of knee joint | 10.93 | NA | 8.85 | 1.52 | NA | 21.30 | 090 | |
27445 | A | Revision of knee joint | 17.68 | NA | 12.52 | 2.49 | NA | 32.69 | 090 | |
27446 | A | Revision of knee joint | 15.84 | NA | 11.50 | 2.22 | NA | 29.56 | 090 | |
27447 | A | Total knee arthroplasty | 21.48 | NA | 14.82 | 3.00 | NA | 39.30 | 090 | |
27448 | A | Incision of thigh | 11.06 | NA | 12.41 | 1.51 | NA | 24.98 | 090 | |
27450 | A | Incision of thigh | 13.98 | NA | 14.20 | 1.96 | NA | 30.14 | 090 | |
27454 | A | Realignment of thigh bone | 17.56 | NA | 16.02 | 2.46 | NA | 36.04 | 090 | |
27455 | A | Realignment of knee | 12.82 | NA | 12.70 | 1.78 | NA | 27.30 | 090 | |
27457 | A | Realignment of knee | 13.45 | NA | 11.87 | 1.88 | NA | 27.20 | 090 | |
27465 | A | Shortening of thigh bone | 13.87 | NA | 14.06 | 1.86 | NA | 29.79 | 090 | |
27466 | A | Lengthening of thigh bone | 16.33 | NA | 16.39 | 1.92 | NA | 34.64 | 090 | |
27468 | A | Shorten/lengthen thighs | 18.97 | NA | 16.56 | 2.68 | NA | 38.21 | 090 | |
27470 | A | Repair of thigh | 16.07 | NA | 16.45 | 2.24 | NA | 34.76 | 090 | |
27472 | A | Repair/graft of thigh | 17.72 | NA | 17.33 | 2.49 | NA | 37.54 | 090 | |
27475 | A | Surgery to stop leg growth | 8.64 | NA | 9.62 | 1.13 | NA | 19.39 | 090 | |
27477 | A | Surgery to stop leg growth | 9.85 | NA | 10.08 | 1.31 | NA | 21.24 | 090 | |
27479 | A | Surgery to stop leg growth | 12.80 | NA | 12.35 | 1.81 | NA | 26.96 | 090 | |
27485 | A | Surgery to stop leg growth | 8.84 | NA | 9.79 | 1.24 | NA | 19.87 | 090 | |
27486 | A | Revise/replace knee joint | 19.27 | NA | 13.67 | 2.70 | NA | 35.64 | 090 | |
27487 | A | Revise/replace knee joint | 25.27 | NA | 16.83 | 3.54 | NA | 45.64 | 090 | |
27488 | A | Removal of knee prosthesis | 15.74 | NA | 11.83 | 2.21 | NA | 29.78 | 090 | |
27495 | A | Reinforce thigh | 15.55 | NA | 16.19 | 2.18 | NA | 33.92 | 090 | |
27496 | A | Decompression of thigh/knee | 6.11 | NA | 8.25 | 0.77 | NA | 15.13 | 090 | |
27497 | A | Decompression of thigh/knee | 7.17 | NA | 8.28 | 0.84 | NA | 16.29 | 090 | |
27498 | A | Decompression of thigh/knee | 7.99 | NA | 8.67 | 0.97 | NA | 17.63 | 090 | |
27499 | A | Decompression of thigh/knee | 9.00 | NA | 9.28 | 1.18 | NA | 19.46 | 090 | |
27500 | A | Treatment of thigh fracture | 5.92 | 10.40 | 7.84 | 0.80 | 17.12 | 14.56 | 090 | |
27501 | A | Treatment of thigh fracture | 5.92 | 11.65 | 9.09 | 0.83 | 18.40 | 15.84 | 090 | |
27502 | A | Treatment of thigh fracture | 10.58 | NA | 11.60 | 1.49 | NA | 23.67 | 090 | |
27503 | A | Treatment of thigh fracture | 10.58 | NA | 11.64 | 1.49 | NA | 23.71 | 090 | |
27506 | A | Treatment of thigh fracture | 17.45 | NA | 14.57 | 2.33 | NA | 34.35 | 090 | |
27507 | A | Treatment of thigh fracture | 13.99 | NA | 12.74 | 1.95 | NA | 28.68 | 090 | |
27508 | A | Treatment of thigh fracture | 5.83 | 7.42 | 5.52 | 0.80 | 14.05 | 12.15 | 090 | |
27509 | A | Treatment of thigh fracture | 7.71 | NA | 9.50 | 1.08 | NA | 18.29 | 090 | |
27510 | A | Treatment of thigh fracture | 9.13 | NA | 7.39 | 1.26 | NA | 17.78 | 090 | |
27511 | A | Treatment of thigh fracture | 13.64 | NA | 13.34 | 1.91 | NA | 28.89 | 090 | |
27513 | A | Treatment of thigh fracture | 17.92 | NA | 15.66 | 2.51 | NA | 36.09 | 090 | |
27514 | A | Treatment of thigh fracture | 17.30 | NA | 14.78 | 2.41 | NA | 34.49 | 090 | |
27516 | A | Treat thigh fx growth plate | 5.37 | 8.20 | 6.00 | 0.74 | 14.31 | 12.11 | 090 | |
27517 | A | Treat thigh fx growth plate | 8.78 | 9.86 | 7.97 | 1.22 | 19.86 | 17.97 | 090 | |
27519 | A | Treat thigh fx growth plate | 15.02 | NA | 13.83 | 2.09 | NA | 30.94 | 090 | |
27520 | A | Treat kneecap fracture | 2.86 | 5.79 | 3.90 | 0.38 | 9.03 | 7.14 | 090 | |
27524 | A | Treat kneecap fracture | 10.00 | NA | 9.05 | 1.40 | NA | 20.45 | 090 | |
27530 | A | Treat knee fracture | 3.78 | 6.31 | 4.45 | 0.51 | 10.60 | 8.74 | 090 | |
27532 | A | Treat knee fracture | 7.30 | 7.79 | 5.87 | 1.02 | 16.11 | 14.19 | 090 | |
27535 | A | Treat knee fracture | 11.50 | NA | 12.23 | 1.61 | NA | 25.34 | 090 | |
27536 | A | Treat knee fracture | 15.65 | NA | 12.09 | 2.19 | NA | 29.93 | 090 | |
27538 | A | Treat knee fracture(s) | 4.87 | 7.97 | 5.73 | 0.67 | 13.51 | 11.27 | 090 | |
27540 | A | Treat knee fracture | 13.10 | NA | 10.55 | 1.80 | NA | 25.45 | 090 | |
27550 | A | Treat knee dislocation | 5.76 | 7.57 | 5.83 | 0.68 | 14.01 | 12.27 | 090 | |
27552 | A | Treat knee dislocation | 7.90 | NA | 8.23 | 1.10 | NA | 17.23 | 090 | |
27556 | A | Treat knee dislocation | 14.41 | NA | 14.69 | 2.01 | NA | 31.11 | 090 | |
27557 | A | Treat knee dislocation | 16.77 | NA | 15.93 | 2.37 | NA | 35.07 | 090 | |
27558 | A | Treat knee dislocation | 17.72 | NA | 16.13 | 2.51 | NA | 36.36 | 090 | |
27560 | A | Treat kneecap dislocation | 3.82 | 6.20 | 3.99 | 0.40 | 10.42 | 8.21 | 090 | |
27562 | A | Treat kneecap dislocation | 5.79 | NA | 5.85 | 0.69 | NA | 12.33 | 090 | |
27566 | A | Treat kneecap dislocation | 12.23 | NA | 10.20 | 1.73 | NA | 24.16 | 090 | |
27570 | A | Fixation of knee joint | 1.74 | NA | 3.45 | 0.24 | NA | 5.43 | 010 | |
27580 | A | Fusion of knee | 19.37 | NA | 16.57 | 2.70 | NA | 38.64 | 090 | |
27590 | A | Amputate leg at thigh | 12.03 | NA | 12.59 | 1.35 | NA | 25.97 | 090 | |
27591 | A | Amputate leg at thigh | 12.68 | NA | 14.63 | 1.63 | NA | 28.94 | 090 | |
27592 | A | Amputate leg at thigh | 10.02 | NA | 12.18 | 1.17 | NA | 23.37 | 090 | |
27594 | A | Amputation follow-up surgery | 6.92 | NA | 9.10 | 0.82 | NA | 16.84 | 090 | |
27596 | A | Amputation follow-up surgery | 10.60 | NA | 12.65 | 1.24 | NA | 24.49 | 090 | |
27598 | A | Amputate lower leg at knee | 10.53 | NA | 11.61 | 1.24 | NA | 23.38 | 090 | |
27599 | C | Leg surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
27600 | A | Decompression of lower leg | 5.65 | NA | 7.85 | 0.68 | NA | 14.18 | 090 | |
27601 | A | Decompression of lower leg | 5.64 | NA | 7.79 | 0.69 | NA | 14.12 | 090 | |
27602 | A | Decompression of lower leg | 7.35 | NA | 8.13 | 0.85 | NA | 16.33 | 090 | |
27603 | A | Drain lower leg lesion | 4.94 | 16.03 | 10.71 | 0.56 | 21.53 | 16.21 | 090 | |
27604 | A | Drain lower leg bursa | 4.47 | 11.74 | 8.69 | 0.54 | 16.75 | 13.70 | 090 | |
27605 | A | Incision of achilles tendon | 2.87 | 10.88 | 4.01 | 0.38 | 14.13 | 7.26 | 010 | |
27606 | A | Incision of achilles tendon | 4.14 | 13.17 | 5.24 | 0.57 | 17.88 | 9.95 | 010 | |
27607 | A | Treat lower leg bone lesion | 7.97 | NA | 14.85 | 1.08 | NA | 23.90 | 090 | |
27610 | A | Explore/treat ankle joint | 8.34 | NA | 10.90 | 1.15 | NA | 20.39 | 090 | |
27612 | A | Exploration of ankle joint | 7.33 | NA | 8.61 | 1.01 | NA | 16.95 | 090 | |
27613 | A | Biopsy lower leg soft tissue | 2.17 | 5.93 | 3.16 | 0.16 | 8.26 | 5.49 | 010 | |
27614 | A | Biopsy lower leg soft tissue | 5.66 | 11.55 | 7.39 | 0.62 | 17.83 | 13.67 | 090 | |
27615 | A | Remove tumor, lower leg | 12.56 | NA | 16.85 | 1.39 | NA | 30.80 | 090 | |
27618 | A | Remove lower leg lesion | 5.09 | 11.86 | 6.86 | 0.54 | 17.49 | 12.49 | 090 | |
27619 | A | Remove lower leg lesion | 8.40 | 13.36 | 9.46 | 1.01 | 22.77 | 18.87 | 090 | |
27620 | A | Explore/treat ankle joint | 5.98 | NA | 8.48 | 0.83 | NA | 15.29 | 090 | |
27625 | A | Remove ankle joint lining | 8.30 | NA | 10.10 | 1.16 | NA | 19.56 | 090 | |
27626 | A | Remove ankle joint lining | 8.91 | NA | 10.79 | 1.23 | NA | 20.93 | 090 | |
27630 | A | Removal of tendon lesion | 4.80 | 11.52 | 7.24 | 0.60 | 16.92 | 12.64 | 090 | |
27635 | A | Remove lower leg bone lesion | 7.78 | NA | 11.58 | 1.06 | NA | 20.42 | 090 | |
27637 | A | Remove/graft leg bone lesion | 9.85 | NA | 12.91 | 1.38 | NA | 24.14 | 090 | |
27638 | A | Remove/graft leg bone lesion | 10.57 | NA | 13.24 | 1.47 | NA | 25.28 | 090 | |
27640 | A | Partial removal of tibia | 11.37 | NA | 18.94 | 1.54 | NA | 31.85 | 090 | |
27641 | A | Partial removal of fibula | 9.24 | NA | 16.89 | 1.22 | NA | 27.35 | 090 | |
27645 | A | Extensive lower leg surgery | 14.17 | NA | 18.70 | 1.98 | NA | 34.85 | 090 | |
27646 | A | Extensive lower leg surgery | 12.66 | NA | 17.64 | 1.55 | NA | 31.85 | 090 | |
27647 | A | Extensive ankle/heel surgery | 12.24 | NA | 11.52 | 1.64 | NA | 25.40 | 090 | |
27648 | A | Injection for ankle x-ray | 0.96 | 9.75 | 0.34 | 0.05 | 10.76 | 1.35 | 000 | |
27650 | A | Repair achilles tendon | 9.69 | NA | 9.79 | 1.35 | NA | 20.83 | 090 | |
27652 | A | Repair/graft achilles tendon | 10.33 | NA | 10.02 | 1.45 | NA | 21.80 | 090 | |
27654 | A | Repair of achilles tendon | 10.02 | NA | 10.51 | 1.41 | NA | 21.94 | 090 | |
27656 | A | Repair leg fascia defect | 4.57 | 12.84 | 6.76 | 0.48 | 17.89 | 11.81 | 090 | |
27658 | A | Repair of leg tendon, each | 4.98 | 13.20 | 9.52 | 0.68 | 18.86 | 15.18 | 090 | |
27659 | A | Repair of leg tendon, each | 6.81 | 14.89 | 10.27 | 0.96 | 22.66 | 18.04 | 090 | |
27664 | A | Repair of leg tendon, each | 4.59 | 15.00 | 9.66 | 0.63 | 20.22 | 14.88 | 090 | |
27665 | A | Repair of leg tendon, each | 5.40 | 14.63 | 9.79 | 0.75 | 20.78 | 15.94 | 090 | |
27675 | A | Repair lower leg tendons | 7.18 | NA | 8.63 | 1.01 | NA | 16.82 | 090 | |
27676 | A | Repair lower leg tendons | 8.42 | NA | 9.68 | 1.15 | NA | 19.25 | 090 | |
27680 | A | Release of lower leg tendon | 5.74 | NA | 8.48 | 0.80 | NA | 15.02 | 090 | |
27681 | A | Release of lower leg tendons | 6.82 | NA | 8.98 | 0.92 | NA | 16.72 | 090 | |
27685 | A | Revision of lower leg tendon | 6.50 | 10.50 | 8.74 | 0.91 | 17.91 | 16.15 | 090 | |
27686 | A | Revise lower leg tendons | 7.46 | 15.11 | 10.39 | 1.05 | 23.62 | 18.90 | 090 | |
27687 | A | Revision of calf tendon | 6.24 | NA | 8.90 | 0.88 | NA | 16.02 | 090 | |
27690 | A | Revise lower leg tendon | 8.71 | NA | 9.75 | 1.22 | NA | 19.68 | 090 | |
27691 | A | Revise lower leg tendon | 9.96 | NA | 11.37 | 1.40 | NA | 22.73 | 090 | |
27692 | A | Revise additional leg tendon | 1.87 | NA | 0.95 | 0.26 | NA | 3.08 | ZZZ | |
27695 | A | Repair of ankle ligament | 6.51 | NA | 9.63 | 0.90 | NA | 17.04 | 090 | |
27696 | A | Repair of ankle ligaments | 8.27 | NA | 9.97 | 1.16 | NA | 19.40 | 090 | |
27698 | A | Repair of ankle ligament | 9.36 | NA | 9.72 | 1.31 | NA | 20.39 | 090 | |
27700 | A | Revision of ankle joint | 9.29 | NA | 5.81 | 1.24 | NA | 16.34 | 090 | |
27702 | A | Reconstruct ankle joint | 13.67 | NA | 10.57 | 1.92 | NA | 26.16 | 090 | |
27703 | A | Reconstruction, ankle joint | 15.87 | NA | 11.36 | 2.24 | NA | 29.47 | 090 | |
27704 | A | Removal of ankle implant | 7.62 | NA | 5.75 | 0.61 | NA | 13.98 | 090 | |
27705 | A | Incision of tibia | 10.38 | NA | 11.94 | 1.44 | NA | 23.76 | 090 | |
27707 | A | Incision of fibula | 4.37 | NA | 8.83 | 0.60 | NA | 13.80 | 090 | |
27709 | A | Incision of tibia fibula | 9.95 | NA | 11.93 | 1.39 | NA | 23.27 | 090 | |
27712 | A | Realignment of lower leg | 14.25 | NA | 14.10 | 2.00 | NA | 30.35 | 090 | |
27715 | A | Revision of lower leg | 14.39 | NA | 15.50 | 2.00 | NA | 31.89 | 090 | |
27720 | A | Repair of tibia | 11.79 | NA | 14.12 | 1.66 | NA | 27.57 | 090 | |
27722 | A | Repair/graft of tibia | 11.82 | NA | 13.88 | 1.65 | NA | 27.35 | 090 | |
27724 | A | Repair/graft of tibia | 18.20 | NA | 17.61 | 2.10 | NA | 37.91 | 090 | |
27725 | A | Repair of lower leg | 15.59 | NA | 16.06 | 2.20 | NA | 33.85 | 090 | |
27727 | A | Repair of lower leg | 14.01 | NA | 14.96 | 1.84 | NA | 30.81 | 090 | |
27730 | A | Repair of tibia epiphysis | 7.41 | 21.22 | 10.17 | 0.75 | 29.38 | 18.33 | 090 | |
27732 | A | Repair of fibula epiphysis | 5.32 | 14.21 | 8.71 | 0.63 | 20.16 | 14.66 | 090 | |
27734 | A | Repair lower leg epiphyses | 8.48 | NA | 9.91 | 0.85 | NA | 19.24 | 090 | |
27740 | A | Repair of leg epiphyses | 9.30 | 23.90 | 11.76 | 1.31 | 34.51 | 22.37 | 090 | |
27742 | A | Repair of leg epiphyses | 10.30 | 16.69 | 10.97 | 1.55 | 28.54 | 22.82 | 090 | |
27745 | A | Reinforce tibia | 10.07 | NA | 12.05 | 1.38 | NA | 23.50 | 090 | |
27750 | A | Treatment of tibia fracture | 3.19 | 5.93 | 4.10 | 0.43 | 9.55 | 7.72 | 090 | |
27752 | A | Treatment of tibia fracture | 5.84 | 8.53 | 6.34 | 0.82 | 15.19 | 13.00 | 090 | |
27756 | A | Treatment of tibia fracture | 6.78 | NA | 11.38 | 0.94 | NA | 19.10 | 090 | |
27758 | A | Treatment of tibia fracture | 11.67 | NA | 12.42 | 1.52 | NA | 25.61 | 090 | |
27759 | A | Treatment of tibia fracture | 13.76 | NA | 13.74 | 1.93 | NA | 29.43 | 090 | |
27760 | A | Treatment of ankle fracture | 3.01 | 5.69 | 3.91 | 0.39 | 9.09 | 7.31 | 090 | |
27762 | A | Treatment of ankle fracture | 5.25 | 7.99 | 5.87 | 0.71 | 13.95 | 11.83 | 090 | |
27766 | A | Treatment of ankle fracture | 8.36 | NA | 8.68 | 1.17 | NA | 18.21 | 090 | |
27780 | A | Treatment of fibula fracture | 2.65 | 5.61 | 3.71 | 0.33 | 8.59 | 6.69 | 090 | |
27781 | A | Treatment of fibula fracture | 4.40 | 6.84 | 4.69 | 0.57 | 11.81 | 9.66 | 090 | |
27784 | A | Treatment of fibula fracture | 7.11 | NA | 8.92 | 0.98 | NA | 17.01 | 090 | |
27786 | A | Treatment of ankle fracture | 2.84 | 5.66 | 3.83 | 0.37 | 8.87 | 7.04 | 090 | |
27788 | A | Treatment of ankle fracture | 4.45 | 6.92 | 4.75 | 0.61 | 11.98 | 9.81 | 090 | |
27792 | A | Treatment of ankle fracture | 7.66 | NA | 8.40 | 1.07 | NA | 17.13 | 090 | |
27808 | A | Treatment of ankle fracture | 2.83 | 6.81 | 4.62 | 0.38 | 10.02 | 7.83 | 090 | |
27810 | A | Treatment of ankle fracture | 5.13 | 8.08 | 5.88 | 0.71 | 13.92 | 11.72 | 090 | |
27814 | A | Treatment of ankle fracture | 10.68 | NA | 11.19 | 1.50 | NA | 23.37 | 090 | |
27816 | A | Treatment of ankle fracture | 2.89 | 6.27 | 4.63 | 0.37 | 9.53 | 7.89 | 090 | |
27818 | A | Treatment of ankle fracture | 5.50 | 8.22 | 6.02 | 0.74 | 14.46 | 12.26 | 090 | |
27822 | A | Treatment of ankle fracture | 11.00 | NA | 13.50 | 1.29 | NA | 25.79 | 090 | |
27823 | A | Treatment of ankle fracture | 13.00 | NA | 14.56 | 1.65 | NA | 29.21 | 090 | |
27824 | A | Treat lower leg fracture | 2.89 | 6.73 | 4.63 | 0.39 | 10.01 | 7.91 | 090 | |
27825 | A | Treat lower leg fracture | 6.19 | 8.70 | 6.50 | 0.85 | 15.74 | 13.54 | 090 | |
27826 | A | Treat lower leg fracture | 8.54 | NA | 12.17 | 1.19 | NA | 21.90 | 090 | |
27827 | A | Treat lower leg fracture | 14.06 | NA | 15.23 | 1.96 | NA | 31.25 | 090 | |
27828 | A | Treat lower leg fracture | 16.23 | NA | 15.93 | 2.27 | NA | 34.43 | 090 | |
27829 | A | Treat lower leg joint | 5.49 | NA | 8.94 | 0.77 | NA | 15.20 | 090 | |
27830 | A | Treat lower leg dislocation | 3.79 | 5.77 | 4.31 | 0.44 | 10.00 | 8.54 | 090 | |
27831 | A | Treat lower leg dislocation | 4.56 | NA | 5.53 | 0.61 | NA | 10.70 | 090 | |
27832 | A | Treat lower leg dislocation | 6.49 | NA | 8.61 | 0.91 | NA | 16.01 | 090 | |
27840 | A | Treat ankle dislocation | 4.58 | NA | 6.11 | 0.47 | NA | 11.16 | 090 | |
27842 | A | Treat ankle dislocation | 6.21 | NA | 5.25 | 0.76 | NA | 12.22 | 090 | |
27846 | A | Treat ankle dislocation | 9.79 | NA | 10.58 | 1.36 | NA | 21.73 | 090 | |
27848 | A | Treat ankle dislocation | 11.20 | NA | 11.92 | 1.55 | NA | 24.67 | 090 | |
27860 | A | Fixation of ankle joint | 2.34 | NA | 3.76 | 0.31 | NA | 6.41 | 010 | |
27870 | A | Fusion of ankle joint, open | 13.91 | NA | 14.08 | 1.95 | NA | 29.94 | 090 | |
27871 | A | Fusion of tibiofibular joint | 9.17 | NA | 11.36 | 1.29 | NA | 21.82 | 090 | |
27880 | A | Amputation of lower leg | 11.85 | NA | 11.88 | 1.38 | NA | 25.11 | 090 | |
27881 | A | Amputation of lower leg | 12.34 | NA | 13.55 | 1.59 | NA | 27.48 | 090 | |
27882 | A | Amputation of lower leg | 8.94 | NA | 12.97 | 1.03 | NA | 22.94 | 090 | |
27884 | A | Amputation follow-up surgery | 8.21 | NA | 10.83 | 0.95 | NA | 19.99 | 090 | |
27886 | A | Amputation follow-up surgery | 9.32 | NA | 11.37 | 1.13 | NA | 21.82 | 090 | |
27888 | A | Amputation of foot at ankle | 9.67 | NA | 11.23 | 1.26 | NA | 22.16 | 090 | |
27889 | A | Amputation of foot at ankle | 9.98 | NA | 10.58 | 1.19 | NA | 21.75 | 090 | |
27892 | A | Decompression of leg | 7.39 | NA | 8.26 | 0.86 | NA | 16.51 | 090 | |
27893 | A | Decompression of leg | 7.35 | NA | 8.11 | 0.90 | NA | 16.36 | 090 | |
27894 | A | Decompression of leg | 10.49 | NA | 9.56 | 1.25 | NA | 21.30 | 090 | |
27899 | C | Leg/ankle surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
28001 | A | Drainage of bursa of foot | 2.73 | 5.63 | 3.23 | 0.31 | 8.67 | 6.27 | 010 | |
28002 | A | Treatment of foot infection | 4.62 | 6.93 | 4.33 | 0.56 | 12.11 | 9.51 | 010 | |
28003 | A | Treatment of foot infection | 8.41 | 11.29 | 10.81 | 1.03 | 20.73 | 20.25 | 090 | |
28005 | A | Treat foot bone lesion | 8.68 | NA | 10.68 | 1.14 | NA | 20.50 | 090 | |
28008 | A | Incision of foot fascia | 4.45 | 8.11 | 6.33 | 0.56 | 13.12 | 11.34 | 090 | |
28010 | A | Incision of toe tendon | 2.84 | 7.56 | 5.29 | 0.39 | 10.79 | 8.52 | 090 | |
28011 | A | Incision of toe tendons | 4.14 | 9.37 | 7.07 | 0.58 | 14.09 | 11.79 | 090 | |
28020 | A | Exploration of foot joint | 5.01 | 9.32 | 6.74 | 0.64 | 14.97 | 12.39 | 090 | |
28022 | A | Exploration of foot joint | 4.67 | 8.13 | 6.33 | 0.62 | 13.42 | 11.62 | 090 | |
28024 | A | Exploration of toe joint | 4.38 | 8.30 | 6.56 | 0.50 | 13.18 | 11.44 | 090 | |
28030 | A | Removal of foot nerve | 6.15 | NA | 3.46 | 0.85 | NA | 10.46 | 090 | |
28035 | A | Decompression of tibia nerve | 5.09 | 9.32 | 5.50 | 0.71 | 15.12 | 11.30 | 090 | |
28043 | A | Excision of foot lesion | 3.54 | 7.53 | 5.21 | 0.45 | 11.52 | 9.20 | 090 | |
28045 | A | Excision of foot lesion | 4.72 | 8.14 | 5.91 | 0.62 | 13.48 | 11.25 | 090 | |
28046 | A | Resection of tumor, foot | 10.18 | 12.35 | 10.95 | 1.13 | 23.66 | 22.26 | 090 | |
28050 | A | Biopsy of foot joint lining | 4.25 | 7.78 | 6.03 | 0.55 | 12.58 | 10.83 | 090 | |
28052 | A | Biopsy of foot joint lining | 3.94 | 8.10 | 6.14 | 0.51 | 12.55 | 10.59 | 090 | |
28054 | A | Biopsy of toe joint lining | 3.45 | 8.01 | 5.96 | 0.45 | 11.91 | 9.86 | 090 | |
28060 | A | Partial removal, foot fascia | 5.23 | 8.76 | 6.63 | 0.69 | 14.68 | 12.55 | 090 | |
28062 | A | Removal of foot fascia | 6.52 | 9.62 | 6.52 | 0.85 | 16.99 | 13.89 | 090 | |
28070 | A | Removal of foot joint lining | 5.10 | 7.95 | 6.12 | 0.68 | 13.73 | 11.90 | 090 | |
28072 | A | Removal of foot joint lining | 4.58 | 8.50 | 7.07 | 0.64 | 13.72 | 12.29 | 090 | |
28080 | A | Removal of foot lesion | 3.58 | 7.89 | 5.68 | 0.50 | 11.97 | 9.76 | 090 | |
28086 | A | Excise foot tendon sheath | 4.78 | 11.42 | 7.64 | 0.66 | 16.86 | 13.08 | 090 | |
28088 | A | Excise foot tendon sheath | 3.86 | 9.48 | 6.95 | 0.52 | 13.86 | 11.33 | 090 | |
28090 | A | Removal of foot lesion | 4.41 | 8.05 | 5.73 | 0.57 | 13.03 | 10.71 | 090 | |
28092 | A | Removal of toe lesions | 3.64 | 8.48 | 6.17 | 0.46 | 12.58 | 10.27 | 090 | |
28100 | A | Removal of ankle/heel lesion | 5.66 | 11.90 | 7.91 | 0.76 | 18.32 | 14.33 | 090 | |
28102 | A | Remove/graft foot lesion | 7.73 | NA | 9.27 | 0.97 | NA | 17.97 | 090 | |
28103 | A | Remove/graft foot lesion | 6.50 | 10.07 | 7.46 | 0.89 | 17.46 | 14.85 | 090 | |
28104 | A | Removal of foot lesion | 5.12 | 8.79 | 6.99 | 0.69 | 14.60 | 12.80 | 090 | |
28106 | A | Remove/graft foot lesion | 7.16 | NA | 6.84 | 1.01 | NA | 15.01 | 090 | |
28107 | A | Remove/graft foot lesion | 5.56 | 10.01 | 7.09 | 0.74 | 16.31 | 13.39 | 090 | |
28108 | A | Removal of toe lesions | 4.16 | 7.42 | 5.44 | 0.52 | 12.10 | 10.12 | 090 | |
28110 | A | Part removal of metatarsal | 4.08 | 8.95 | 7.08 | 0.49 | 13.52 | 11.65 | 090 | |
28111 | A | Part removal of metatarsal | 5.01 | 10.65 | 7.86 | 0.63 | 16.29 | 13.50 | 090 | |
28112 | A | Part removal of metatarsal | 4.49 | 9.66 | 7.66 | 0.60 | 14.75 | 12.75 | 090 | |
28113 | A | Part removal of metatarsal | 4.79 | 9.24 | 7.32 | 0.63 | 14.66 | 12.74 | 090 | |
28114 | A | Removal of metatarsal heads | 9.79 | 14.07 | 11.12 | 1.36 | 25.22 | 22.27 | 090 | |
28116 | A | Revision of foot | 7.75 | 8.88 | 6.83 | 1.03 | 17.66 | 15.61 | 090 | |
28118 | A | Removal of heel bone | 5.96 | 9.52 | 7.26 | 0.79 | 16.27 | 14.01 | 090 | |
28119 | A | Removal of heel spur | 5.39 | 8.54 | 6.23 | 0.74 | 14.67 | 12.36 | 090 | |
28120 | A | Part removal of ankle/heel | 5.40 | 12.72 | 10.02 | 0.69 | 18.81 | 16.11 | 090 | |
28122 | A | Partial removal of foot bone | 7.29 | 11.28 | 9.68 | 0.96 | 19.53 | 17.93 | 090 | |
28124 | A | Partial removal of toe | 4.81 | 9.52 | 7.87 | 0.65 | 14.98 | 13.33 | 090 | |
28126 | A | Partial removal of toe | 3.52 | 8.27 | 7.11 | 0.49 | 12.28 | 11.12 | 090 | |
28130 | A | Removal of ankle bone | 8.11 | NA | 9.03 | 1.11 | NA | 18.25 | 090 | |
28140 | A | Removal of metatarsal | 6.91 | 10.80 | 7.99 | 0.84 | 18.55 | 15.74 | 090 | |
28150 | A | Removal of toe | 4.09 | 8.94 | 7.33 | 0.52 | 13.55 | 11.94 | 090 | |
28153 | A | Partial removal of toe | 3.66 | 8.27 | 5.96 | 0.49 | 12.42 | 10.11 | 090 | |
28160 | A | Partial removal of toe | 3.74 | 8.58 | 7.50 | 0.51 | 12.83 | 11.75 | 090 | |
28171 | A | Extensive foot surgery | 9.60 | NA | 8.48 | 1.13 | NA | 19.21 | 090 | |
28173 | A | Extensive foot surgery | 8.80 | 11.13 | 8.87 | 1.04 | 20.97 | 18.71 | 090 | |
28175 | A | Extensive foot surgery | 6.05 | 9.58 | 6.90 | 0.75 | 16.38 | 13.70 | 090 | |
28190 | A | Removal of foot foreign body | 1.96 | 6.41 | 3.42 | 0.16 | 8.53 | 5.54 | 010 | |
28192 | A | Removal of foot foreign body | 4.64 | 8.20 | 5.59 | 0.52 | 13.36 | 10.75 | 090 | |
28193 | A | Removal of foot foreign body | 5.73 | 8.77 | 6.70 | 0.63 | 15.13 | 13.06 | 090 | |
28200 | A | Repair of foot tendon | 4.60 | 8.41 | 6.53 | 0.59 | 13.60 | 11.72 | 090 | |
28202 | A | Repair/graft of foot tendon | 6.84 | 11.55 | 7.11 | 0.86 | 19.25 | 14.81 | 090 | |
28208 | A | Repair of foot tendon | 4.37 | 8.15 | 6.10 | 0.59 | 13.11 | 11.06 | 090 | |
28210 | A | Repair/graft of foot tendon | 6.35 | 9.60 | 6.56 | 0.77 | 16.72 | 13.68 | 090 | |
28220 | A | Release of foot tendon | 4.53 | 7.94 | 6.29 | 0.63 | 13.10 | 11.45 | 090 | |
28222 | A | Release of foot tendons | 5.62 | 8.34 | 7.12 | 0.77 | 14.73 | 13.51 | 090 | |
28225 | A | Release of foot tendon | 3.66 | 7.72 | 5.83 | 0.50 | 11.88 | 9.99 | 090 | |
28226 | A | Release of foot tendons | 4.53 | 7.99 | 6.80 | 0.62 | 13.14 | 11.95 | 090 | |
28230 | A | Incision of foot tendon(s) | 4.24 | 8.10 | 7.09 | 0.59 | 12.93 | 11.92 | 090 | |
28232 | A | Incision of toe tendon | 3.39 | 8.14 | 6.78 | 0.48 | 12.01 | 10.65 | 090 | |
28234 | A | Incision of foot tendon | 3.37 | 8.22 | 6.25 | 0.46 | 12.05 | 10.08 | 090 | |
28238 | A | Revision of foot tendon | 7.73 | 10.31 | 7.61 | 1.08 | 19.12 | 16.42 | 090 | |
28240 | A | Release of big toe | 4.36 | 8.05 | 6.67 | 0.61 | 13.02 | 11.64 | 090 | |
28250 | A | Revision of foot fascia | 5.92 | 9.00 | 7.08 | 0.81 | 15.73 | 13.81 | 090 | |
28260 | A | Release of midfoot joint | 7.96 | 9.47 | 7.73 | 1.08 | 18.51 | 16.77 | 090 | |
28261 | A | Revision of foot tendon | 11.73 | 11.02 | 9.66 | 1.66 | 24.41 | 23.05 | 090 | |
28262 | A | Revision of foot and ankle | 15.83 | 17.31 | 15.44 | 2.22 | 35.36 | 33.49 | 090 | |
28264 | A | Release of midfoot joint | 10.35 | 11.28 | 11.28 | 1.46 | 23.09 | 23.09 | 090 | |
28270 | A | Release of foot contracture | 4.76 | 8.70 | 7.46 | 0.67 | 14.13 | 12.89 | 090 | |
28272 | A | Release of toe joint, each | 3.80 | 7.59 | 5.63 | 0.52 | 11.91 | 9.95 | 090 | |
28280 | A | Fusion of toes | 5.19 | 9.25 | 7.16 | 0.72 | 15.16 | 13.07 | 090 | |
28285 | A | Repair of hammertoe | 4.59 | 8.76 | 6.85 | 0.64 | 13.99 | 12.08 | 090 | |
28286 | A | Repair of hammertoe | 4.56 | 8.62 | 6.80 | 0.64 | 13.82 | 12.00 | 090 | |
28288 | A | Partial removal of foot bone | 4.74 | 9.14 | 8.50 | 0.65 | 14.53 | 13.89 | 090 | |
28289 | A | Repair hallux rigidus | 7.04 | 11.61 | 9.63 | 0.96 | 19.61 | 17.63 | 090 | |
28290 | A | Correction of bunion | 5.66 | 9.89 | 9.25 | 0.79 | 16.34 | 15.70 | 090 | |
28292 | A | Correction of bunion | 7.04 | 9.86 | 7.77 | 0.98 | 17.88 | 15.79 | 090 | |
28293 | A | Correction of bunion | 9.15 | 8.28 | 5.99 | 1.28 | 18.71 | 16.42 | 090 | |
28294 | A | Correction of bunion | 8.56 | 10.47 | 7.96 | 1.16 | 20.19 | 17.68 | 090 | |
28296 | A | Correction of bunion | 9.18 | 10.94 | 8.74 | 1.28 | 21.40 | 19.20 | 090 | |
28297 | A | Correction of bunion | 9.18 | 11.96 | 10.51 | 1.31 | 22.45 | 21.00 | 090 | |
28298 | A | Correction of bunion | 7.94 | 10.07 | 8.40 | 1.12 | 19.13 | 17.46 | 090 | |
28299 | A | Correction of bunion | 10.58 | 11.36 | 9.11 | 1.24 | 23.18 | 20.93 | 090 | |
28300 | A | Incision of heel bone | 9.54 | 15.04 | 9.59 | 1.31 | 25.89 | 20.44 | 090 | |
28302 | A | Incision of ankle bone | 9.55 | 14.76 | 9.53 | 1.15 | 25.46 | 20.23 | 090 | |
28304 | A | Incision of midfoot bones | 9.16 | 10.31 | 7.89 | 1.00 | 20.47 | 18.05 | 090 | |
28305 | A | Incise/graft midfoot bones | 10.50 | 14.76 | 9.73 | 0.55 | 25.81 | 20.78 | 090 | |
28306 | A | Incision of metatarsal | 5.86 | 9.21 | 6.48 | 0.81 | 15.88 | 13.15 | 090 | |
28307 | A | Incision of metatarsal | 6.33 | 13.36 | 8.20 | 0.71 | 20.40 | 15.24 | 090 | |
28308 | A | Incision of metatarsal | 5.29 | 7.88 | 5.45 | 0.74 | 13.91 | 11.48 | 090 | |
28309 | A | Incision of metatarsals | 12.78 | NA | 10.66 | 1.64 | NA | 25.08 | 090 | |
28310 | A | Revision of big toe | 5.43 | 9.14 | 6.99 | 0.76 | 15.33 | 13.18 | 090 | |
28312 | A | Revision of toe | 4.55 | 8.87 | 7.70 | 0.62 | 14.04 | 12.87 | 090 | |
28313 | A | Repair deformity of toe | 5.01 | 9.36 | 9.36 | 0.68 | 15.05 | 15.05 | 090 | |
28315 | A | Removal of sesamoid bone | 4.86 | 7.91 | 5.75 | 0.66 | 13.43 | 11.27 | 090 | |
28320 | A | Repair of foot bones | 9.18 | NA | 9.14 | 1.27 | NA | 19.59 | 090 | |
28322 | A | Repair of metatarsals | 8.34 | 11.91 | 8.67 | 1.17 | 21.42 | 18.18 | 090 | |
28340 | A | Resect enlarged toe tissue | 6.98 | 9.40 | 6.86 | 0.98 | 17.36 | 14.82 | 090 | |
28341 | A | Resect enlarged toe | 8.41 | 9.50 | 7.14 | 1.18 | 19.09 | 16.73 | 090 | |
28344 | A | Repair extra toe(s) | 4.26 | 8.82 | 5.99 | 0.60 | 13.68 | 10.85 | 090 | |
28345 | A | Repair webbed toe(s) | 5.92 | 9.33 | 7.70 | 0.84 | 16.09 | 14.46 | 090 | |
28360 | A | Reconstruct cleft foot | 13.34 | NA | 13.96 | 1.88 | NA | 29.18 | 090 | |
28400 | A | Treatment of heel fracture | 2.16 | 6.16 | 4.90 | 0.29 | 8.61 | 7.35 | 090 | |
28405 | A | Treatment of heel fracture | 4.57 | 7.06 | 6.09 | 0.63 | 12.26 | 11.29 | 090 | |
28406 | A | Treatment of heel fracture | 6.31 | NA | 9.13 | 0.87 | NA | 16.31 | 090 | |
28415 | A | Treat heel fracture | 15.97 | NA | 15.68 | 2.24 | NA | 33.89 | 090 | |
28420 | A | Treat/graft heel fracture | 16.64 | NA | 16.03 | 2.29 | NA | 34.96 | 090 | |
28430 | A | Treatment of ankle fracture | 2.09 | 5.58 | 4.27 | 0.27 | 7.94 | 6.63 | 090 | |
28435 | A | Treatment of ankle fracture | 3.40 | 5.82 | 4.89 | 0.47 | 9.69 | 8.76 | 090 | |
28436 | A | Treatment of ankle fracture | 4.71 | NA | 8.17 | 0.66 | NA | 13.54 | 090 | |
28445 | A | Treat ankle fracture | 15.62 | NA | 14.08 | 1.29 | NA | 30.99 | 090 | |
28450 | A | Treat midfoot fracture, each | 1.90 | 5.53 | 4.16 | 0.25 | 7.68 | 6.31 | 090 | |
28455 | A | Treat midfoot fracture, each | 3.09 | 5.46 | 5.08 | 0.43 | 8.98 | 8.60 | 090 | |
28456 | A | Treat midfoot fracture | 2.68 | NA | 6.50 | 0.36 | NA | 9.54 | 090 | |
28465 | A | Treat midfoot fracture, each | 7.01 | NA | 8.48 | 0.87 | NA | 16.36 | 090 | |
28470 | A | Treat metatarsal fracture | 1.99 | 4.77 | 3.44 | 0.26 | 7.02 | 5.69 | 090 | |
28475 | A | Treat metatarsal fracture | 2.97 | 5.37 | 4.59 | 0.41 | 8.75 | 7.97 | 090 | |
28476 | A | Treat metatarsal fracture | 3.38 | NA | 7.01 | 0.46 | NA | 10.85 | 090 | |
28485 | A | Treat metatarsal fracture | 5.71 | NA | 8.18 | 0.80 | NA | 14.69 | 090 | |
28490 | A | Treat big toe fracture | 1.09 | 2.86 | 2.18 | 0.13 | 4.08 | 3.40 | 090 | |
28495 | A | Treat big toe fracture | 1.58 | 2.96 | 2.31 | 0.19 | 4.73 | 4.08 | 090 | |
28496 | A | Treat big toe fracture | 2.33 | 10.94 | 5.26 | 0.32 | 13.59 | 7.91 | 090 | |
28505 | A | Treat big toe fracture | 3.81 | 11.49 | 6.99 | 0.50 | 15.80 | 11.30 | 090 | |
28510 | A | Treatment of toe fracture | 1.09 | 2.55 | 2.17 | 0.13 | 3.77 | 3.39 | 090 | |
28515 | A | Treatment of toe fracture | 1.46 | 2.80 | 2.26 | 0.17 | 4.43 | 3.89 | 090 | |
28525 | A | Treat toe fracture | 3.32 | 11.14 | 6.62 | 0.44 | 14.90 | 10.38 | 090 | |
28530 | A | Treat sesamoid bone fracture | 1.06 | 3.07 | 2.81 | 0.13 | 4.26 | 4.00 | 090 | |
28531 | A | Treat sesamoid bone fracture | 2.35 | 11.17 | 4.20 | 0.33 | 13.85 | 6.88 | 090 | |
28540 | A | Treat foot dislocation | 2.04 | 3.82 | 3.82 | 0.24 | 6.10 | 6.10 | 090 | |
28545 | A | Treat foot dislocation | 2.45 | 4.11 | 4.11 | 0.33 | 6.89 | 6.89 | 090 | |
28546 | A | Treat foot dislocation | 3.20 | 9.17 | 6.25 | 0.46 | 12.83 | 9.91 | 090 | |
28555 | A | Repair foot dislocation | 6.30 | 13.38 | 8.67 | 0.88 | 20.56 | 15.85 | 090 | |
28570 | A | Treat foot dislocation | 1.66 | 4.23 | 4.00 | 0.22 | 6.11 | 5.88 | 090 | |
28575 | A | Treat foot dislocation | 3.31 | 6.02 | 5.69 | 0.45 | 9.78 | 9.45 | 090 | |
28576 | A | Treat foot dislocation | 4.17 | 11.89 | 6.88 | 0.56 | 16.62 | 11.61 | 090 | |
28585 | A | Repair foot dislocation | 7.99 | 9.70 | 8.46 | 1.13 | 18.82 | 17.58 | 090 | |
28600 | A | Treat foot dislocation | 1.89 | 4.58 | 4.15 | 0.24 | 6.71 | 6.28 | 090 | |
28605 | A | Treat foot dislocation | 2.71 | 5.24 | 5.20 | 0.35 | 8.30 | 8.26 | 090 | |
28606 | A | Treat foot dislocation | 4.90 | 16.53 | 7.41 | 0.68 | 22.11 | 12.99 | 090 | |
28615 | A | Repair foot dislocation | 7.77 | NA | 9.71 | 1.09 | NA | 18.57 | 090 | |
28630 | A | Treat toe dislocation | 1.70 | 2.39 | 2.39 | 0.17 | 4.26 | 4.26 | 010 | |
28635 | A | Treat toe dislocation | 1.91 | 2.60 | 2.60 | 0.24 | 4.75 | 4.75 | 010 | |
28636 | A | Treat toe dislocation | 2.77 | 7.15 | 3.21 | 0.39 | 10.31 | 6.37 | 010 | |
28645 | A | Repair toe dislocation | 4.22 | 6.72 | 4.42 | 0.58 | 11.52 | 9.22 | 090 | |
28660 | A | Treat toe dislocation | 1.23 | 3.15 | 2.47 | 0.11 | 4.49 | 3.81 | 010 | |
28665 | A | Treat toe dislocation | 1.92 | 2.63 | 2.63 | 0.24 | 4.79 | 4.79 | 010 | |
28666 | A | Treat toe dislocation | 2.66 | 7.78 | 2.94 | 0.38 | 10.82 | 5.98 | 010 | |
28675 | A | Repair of toe dislocation | 2.92 | 9.64 | 5.13 | 0.41 | 12.97 | 8.46 | 090 | |
28705 | A | Fusion of foot bones | 18.80 | NA | 15.42 | 2.13 | NA | 36.35 | 090 | |
28715 | A | Fusion of foot bones | 13.10 | NA | 12.85 | 1.84 | NA | 27.79 | 090 | |
28725 | A | Fusion of foot bones | 11.61 | NA | 11.67 | 1.63 | NA | 24.91 | 090 | |
28730 | A | Fusion of foot bones | 10.76 | NA | 11.03 | 1.51 | NA | 23.30 | 090 | |
28735 | A | Fusion of foot bones | 10.85 | NA | 10.81 | 1.51 | NA | 23.17 | 090 | |
28737 | A | Revision of foot bones | 9.64 | NA | 9.45 | 1.36 | NA | 20.45 | 090 | |
28740 | A | Fusion of foot bones | 8.02 | 13.73 | 9.19 | 1.13 | 22.88 | 18.34 | 090 | |
28750 | A | Fusion of big toe joint | 7.30 | 14.99 | 9.59 | 1.03 | 23.32 | 17.92 | 090 | |
28755 | A | Fusion of big toe joint | 4.74 | 9.24 | 6.76 | 0.66 | 14.64 | 12.16 | 090 | |
28760 | A | Fusion of big toe joint | 7.75 | 10.17 | 7.89 | 1.07 | 18.99 | 16.71 | 090 | |
28800 | A | Amputation of midfoot | 8.21 | NA | 9.11 | 0.98 | NA | 18.30 | 090 | |
28805 | A | Amputation thru metatarsal | 8.39 | NA | 9.05 | 0.97 | NA | 18.41 | 090 | |
28810 | A | Amputation toe metatarsal | 6.21 | NA | 7.96 | 0.70 | NA | 14.87 | 090 | |
28820 | A | Amputation of toe | 4.41 | 11.19 | 7.26 | 0.51 | 16.11 | 12.18 | 090 | |
28825 | A | Partial amputation of toe | 3.59 | 10.58 | 7.11 | 0.43 | 14.60 | 11.13 | 090 | |
28899 | C | Foot/toes surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
29000 | A | Application of body cast | 2.25 | 3.08 | 1.74 | 0.30 | 5.63 | 4.29 | 000 | |
29010 | A | Application of body cast | 2.06 | 3.07 | 1.72 | 0.27 | 5.40 | 4.05 | 000 | |
29015 | A | Application of body cast | 2.41 | 2.97 | 1.60 | 0.21 | 5.59 | 4.22 | 000 | |
29020 | A | Application of body cast | 2.11 | 3.27 | 1.44 | 0.16 | 5.54 | 3.71 | 000 | |
29025 | A | Application of body cast | 2.40 | 3.16 | 1.86 | 0.26 | 5.82 | 4.52 | 000 | |
29035 | A | Application of body cast | 1.77 | 3.10 | 1.53 | 0.24 | 5.11 | 3.54 | 000 | |
29040 | A | Application of body cast | 2.22 | 2.48 | 1.54 | 0.35 | 5.05 | 4.11 | 000 | |
29044 | A | Application of body cast | 2.12 | 3.42 | 1.83 | 0.29 | 5.83 | 4.24 | 000 | |
29046 | A | Application of body cast | 2.41 | 3.12 | 2.01 | 0.34 | 5.87 | 4.76 | 000 | |
29049 | A | Application of figure eight | 0.89 | 1.10 | 0.57 | 0.12 | 2.11 | 1.58 | 000 | |
29055 | A | Application of shoulder cast | 1.78 | 2.54 | 1.44 | 0.24 | 4.56 | 3.46 | 000 | |
29058 | A | Application of shoulder cast | 1.31 | 1.36 | 0.76 | 0.14 | 2.81 | 2.21 | 000 | |
29065 | A | Application of long arm cast | 0.87 | 1.15 | 0.70 | 0.12 | 2.14 | 1.69 | 000 | |
29075 | A | Application of forearm cast | 0.77 | 1.09 | 0.64 | 0.11 | 1.97 | 1.52 | 000 | |
29085 | A | Apply hand/wrist cast | 0.87 | 1.13 | 0.62 | 0.11 | 2.11 | 1.60 | 000 | |
29086 | A | Apply finger cast | 0.62 | 0.72 | 0.55 | 0.06 | 1.40 | 1.23 | 000 | |
29105 | A | Apply long arm splint | 0.87 | 1.08 | 0.51 | 0.11 | 2.06 | 1.49 | 000 | |
29125 | A | Apply forearm splint | 0.59 | 0.91 | 0.40 | 0.06 | 1.56 | 1.05 | 000 | |
29126 | A | Apply forearm splint | 0.77 | 1.13 | 0.47 | 0.06 | 1.96 | 1.30 | 000 | |
29130 | A | Application of finger splint | 0.50 | 0.44 | 0.17 | 0.05 | 0.99 | 0.72 | 000 | |
29131 | A | Application of finger splint | 0.55 | 0.71 | 0.24 | 0.03 | 1.29 | 0.82 | 000 | |
29200 | A | Strapping of chest | 0.65 | 0.80 | 0.36 | 0.04 | 1.49 | 1.05 | 000 | |
29220 | A | Strapping of low back | 0.64 | 0.75 | 0.40 | 0.07 | 1.46 | 1.11 | 000 | |
29240 | A | Strapping of shoulder | 0.71 | 0.88 | 0.39 | 0.05 | 1.64 | 1.15 | 000 | |
29260 | A | Strapping of elbow or wrist | 0.55 | 0.77 | 0.34 | 0.04 | 1.36 | 0.93 | 000 | |
29280 | A | Strapping of hand or finger | 0.51 | 0.81 | 0.34 | 0.04 | 1.36 | 0.89 | 000 | |
29305 | A | Application of hip cast | 2.03 | 2.91 | 1.65 | 0.29 | 5.23 | 3.97 | 000 | |
29325 | A | Application of hip casts | 2.32 | 3.09 | 1.83 | 0.31 | 5.72 | 4.46 | 000 | |
29345 | A | Application of long leg cast | 1.40 | 1.55 | 1.02 | 0.19 | 3.14 | 2.61 | 000 | |
29355 | A | Application of long leg cast | 1.53 | 1.53 | 1.07 | 0.20 | 3.26 | 2.80 | 000 | |
29358 | A | Apply long leg cast brace | 1.43 | 1.80 | 1.04 | 0.19 | 3.42 | 2.66 | 000 | |
29365 | A | Application of long leg cast | 1.18 | 1.44 | 0.90 | 0.17 | 2.79 | 2.25 | 000 | |
29405 | A | Apply short leg cast | 0.86 | 1.07 | 0.67 | 0.12 | 2.05 | 1.65 | 000 | |
29425 | A | Apply short leg cast | 1.01 | 1.08 | 0.70 | 0.14 | 2.23 | 1.85 | 000 | |
29435 | A | Apply short leg cast | 1.18 | 1.37 | 0.89 | 0.17 | 2.72 | 2.24 | 000 | |
29440 | A | Addition of walker to cast | 0.57 | 0.63 | 0.27 | 0.07 | 1.27 | 0.91 | 000 | |
29445 | A | Apply rigid leg cast | 1.78 | 1.64 | 0.95 | 0.24 | 3.66 | 2.97 | 000 | |
29450 | A | Application of leg cast | 2.08 | 1.39 | 1.08 | 0.13 | 3.60 | 3.29 | 000 | |
29505 | A | Application, long leg splint | 0.69 | 1.06 | 0.47 | 0.06 | 1.81 | 1.22 | 000 | |
29515 | A | Application lower leg splint | 0.73 | 0.80 | 0.47 | 0.07 | 1.60 | 1.27 | 000 | |
29520 | A | Strapping of hip | 0.54 | 0.88 | 0.44 | 0.02 | 1.44 | 1.00 | 000 | |
29530 | A | Strapping of knee | 0.57 | 0.82 | 0.35 | 0.04 | 1.43 | 0.96 | 000 | |
29540 | A | Strapping of ankle and/or ft | 0.51 | 0.39 | 0.32 | 0.04 | 0.94 | 0.87 | 000 | |
29550 | A | Strapping of toes | 0.47 | 0.40 | 0.27 | 0.05 | 0.92 | 0.79 | 000 | |
29580 | A | Application of paste boot | 0.57 | 0.60 | 0.35 | 0.05 | 1.22 | 0.97 | 000 | |
29590 | A | Application of foot splint | 0.76 | 0.49 | 0.30 | 0.06 | 1.31 | 1.12 | 000 | |
29700 | A | Removal/revision of cast | 0.57 | 0.81 | 0.29 | 0.07 | 1.45 | 0.93 | 000 | |
29705 | A | Removal/revision of cast | 0.76 | 0.74 | 0.39 | 0.10 | 1.60 | 1.25 | 000 | |
29710 | A | Removal/revision of cast | 1.34 | 1.41 | 0.71 | 0.17 | 2.92 | 2.22 | 000 | |
29715 | A | Removal/revision of cast | 0.94 | 1.08 | 0.41 | 0.08 | 2.10 | 1.43 | 000 | |
29720 | A | Repair of body cast | 0.68 | 1.00 | 0.39 | 0.10 | 1.78 | 1.17 | 000 | |
29730 | A | Windowing of cast | 0.75 | 0.73 | 0.35 | 0.10 | 1.58 | 1.20 | 000 | |
29740 | A | Wedging of cast | 1.12 | 1.04 | 0.50 | 0.15 | 2.31 | 1.77 | 000 | |
29750 | A | Wedging of clubfoot cast | 1.26 | 1.00 | 0.59 | 0.16 | 2.42 | 2.01 | 000 | |
29799 | C | Casting/strapping procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
29800 | A | Jaw arthroscopy/surgery | 6.43 | NA | 9.06 | 0.84 | NA | 16.33 | 090 | |
29804 | A | Jaw arthroscopy/surgery | 8.14 | NA | 8.53 | 0.66 | NA | 17.33 | 090 | |
29805 | A | Shoulder arthroscopy, dx | 5.89 | NA | 7.85 | 0.84 | NA | 14.58 | 090 | |
29806 | A | Shoulder arthroscopy/surgery | 14.37 | NA | 11.17 | 2.00 | NA | 27.54 | 090 | |
29807 | A | Shoulder arthroscopy/surgery | 13.90 | NA | 10.93 | 1.94 | NA | 26.77 | 090 | |
29819 | A | Shoulder arthroscopy/surgery | 7.62 | NA | 6.87 | 1.07 | NA | 15.56 | 090 | |
29820 | A | Shoulder arthroscopy/surgery | 7.07 | NA | 6.39 | 0.99 | NA | 14.45 | 090 | |
29821 | A | Shoulder arthroscopy/surgery | 7.72 | NA | 6.89 | 1.08 | NA | 15.69 | 090 | |
29822 | A | Shoulder arthroscopy/surgery | 7.43 | NA | 6.77 | 1.04 | NA | 15.24 | 090 | |
29823 | A | Shoulder arthroscopy/surgery | 8.17 | NA | 7.32 | 1.15 | NA | 16.64 | 090 | |
29824 | A | Shoulder arthroscopy/surgery | 8.25 | NA | 7.46 | 1.15 | NA | 16.86 | 090 | |
29825 | A | Shoulder arthroscopy/surgery | 7.62 | NA | 6.86 | 1.06 | NA | 15.54 | 090 | |
29826 | A | Shoulder arthroscopy/surgery | 8.99 | NA | 7.63 | 1.26 | NA | 17.88 | 090 | |
29827 | A | Arthroscop rotator cuff repr | 15.36 | NA | 11.55 | 1.86 | NA | 28.77 | 090 | |
29830 | A | Elbow arthroscopy | 5.76 | NA | 5.47 | 0.79 | NA | 12.02 | 090 | |
29834 | A | Elbow arthroscopy/surgery | 6.28 | NA | 5.96 | 0.86 | NA | 13.10 | 090 | |
29835 | A | Elbow arthroscopy/surgery | 6.48 | NA | 6.02 | 0.88 | NA | 13.38 | 090 | |
29836 | A | Elbow arthroscopy/surgery | 7.55 | NA | 6.83 | 1.06 | NA | 15.44 | 090 | |
29837 | A | Elbow arthroscopy/surgery | 6.87 | NA | 6.27 | 0.96 | NA | 14.10 | 090 | |
29838 | A | Elbow arthroscopy/surgery | 7.71 | NA | 6.98 | 1.07 | NA | 15.76 | 090 | |
29840 | A | Wrist arthroscopy | 5.54 | NA | 5.49 | 0.69 | NA | 11.72 | 090 | |
29843 | A | Wrist arthroscopy/surgery | 6.01 | NA | 5.74 | 0.82 | NA | 12.57 | 090 | |
29844 | A | Wrist arthroscopy/surgery | 6.37 | NA | 5.96 | 0.86 | NA | 13.19 | 090 | |
29845 | A | Wrist arthroscopy/surgery | 7.52 | NA | 6.61 | 0.84 | NA | 14.97 | 090 | |
29846 | A | Wrist arthroscopy/surgery | 6.75 | NA | 6.19 | 0.89 | NA | 13.83 | 090 | |
29847 | A | Wrist arthroscopy/surgery | 7.08 | NA | 6.33 | 0.91 | NA | 14.32 | 090 | |
29848 | A | Wrist endoscopy/surgery | 5.44 | NA | 5.69 | 0.72 | NA | 11.85 | 090 | |
29850 | A | Knee arthroscopy/surgery | 8.19 | NA | 5.27 | 0.74 | NA | 14.20 | 090 | |
29851 | A | Knee arthroscopy/surgery | 13.10 | NA | 9.94 | 1.81 | NA | 24.85 | 090 | |
29855 | A | Tibial arthroscopy/surgery | 10.62 | NA | 8.79 | 1.50 | NA | 20.91 | 090 | |
29856 | A | Tibial arthroscopy/surgery | 14.14 | NA | 10.74 | 2.00 | NA | 26.88 | 090 | |
29860 | A | Hip arthroscopy, dx | 8.05 | NA | 7.06 | 1.14 | NA | 16.25 | 090 | |
29861 | A | Hip arthroscopy/surgery | 9.15 | NA | 7.48 | 1.29 | NA | 17.92 | 090 | |
29862 | A | Hip arthroscopy/surgery | 9.90 | NA | 8.58 | 1.39 | NA | 19.87 | 090 | |
29863 | A | Hip arthroscopy/surgery | 9.90 | NA | 8.53 | 1.40 | NA | 19.83 | 090 | |
29870 | A | Knee arthroscopy, dx | 5.07 | NA | 5.00 | 0.67 | NA | 10.74 | 090 | |
29871 | A | Knee arthroscopy/drainage | 6.55 | NA | 5.98 | 0.88 | NA | 13.41 | 090 | |
29873 | A | Knee arthroscopy/surgery | 6.00 | NA | 6.56 | 0.73 | NA | 13.29 | 090 | |
29874 | A | Knee arthroscopy/surgery | 7.05 | NA | 6.27 | 0.87 | NA | 14.19 | 090 | |
29875 | A | Knee arthroscopy/surgery | 6.31 | NA | 5.98 | 0.88 | NA | 13.17 | 090 | |
29876 | A | Knee arthroscopy/surgery | 7.92 | NA | 7.12 | 1.11 | NA | 16.15 | 090 | |
29877 | A | Knee arthroscopy/surgery | 7.35 | NA | 6.81 | 1.03 | NA | 15.19 | 090 | |
29879 | A | Knee arthroscopy/surgery | 8.04 | NA | 7.21 | 1.13 | NA | 16.38 | 090 | |
29880 | A | Knee arthroscopy/surgery | 8.50 | NA | 7.46 | 1.19 | NA | 17.15 | 090 | |
29881 | A | Knee arthroscopy/surgery | 7.76 | NA | 7.04 | 1.09 | NA | 15.89 | 090 | |
29882 | A | Knee arthroscopy/surgery | 8.65 | NA | 7.34 | 1.09 | NA | 17.08 | 090 | |
29883 | A | Knee arthroscopy/surgery | 11.05 | NA | 9.16 | 1.33 | NA | 21.54 | 090 | |
29884 | A | Knee arthroscopy/surgery | 7.33 | NA | 6.76 | 1.03 | NA | 15.12 | 090 | |
29885 | A | Knee arthroscopy/surgery | 9.09 | NA | 7.98 | 1.27 | NA | 18.34 | 090 | |
29886 | A | Knee arthroscopy/surgery | 7.54 | NA | 6.94 | 1.06 | NA | 15.54 | 090 | |
29887 | A | Knee arthroscopy/surgery | 9.04 | NA | 7.95 | 1.27 | NA | 18.26 | 090 | |
29888 | A | Knee arthroscopy/surgery | 13.90 | NA | 10.42 | 1.95 | NA | 26.27 | 090 | |
29889 | A | Knee arthroscopy/surgery | 16.00 | NA | 12.48 | 2.11 | NA | 30.59 | 090 | |
29891 | A | Ankle arthroscopy/surgery | 8.40 | NA | 7.50 | 1.17 | NA | 17.07 | 090 | |
29892 | A | Ankle arthroscopy/surgery | 9.00 | NA | 7.77 | 1.26 | NA | 18.03 | 090 | |
29893 | A | Scope, plantar fasciotomy | 5.22 | NA | 3.88 | 0.74 | NA | 9.84 | 090 | |
29894 | A | Ankle arthroscopy/surgery | 7.21 | NA | 5.61 | 1.01 | NA | 13.83 | 090 | |
29895 | A | Ankle arthroscopy/surgery | 6.99 | NA | 5.60 | 0.97 | NA | 13.56 | 090 | |
29897 | A | Ankle arthroscopy/surgery | 7.18 | NA | 6.04 | 1.01 | NA | 14.23 | 090 | |
29898 | A | Ankle arthroscopy/surgery | 8.32 | NA | 6.28 | 1.14 | NA | 15.74 | 090 | |
29899 | A | Ankle arthroscopy/surgery | 13.91 | NA | 10.58 | 1.95 | NA | 26.44 | 090 | |
29900 | A | Mcp joint arthroscopy, dx | 5.42 | NA | 5.92 | 0.75 | NA | 12.09 | 090 | |
29901 | A | Mcp joint arthroscopy, surg | 6.13 | NA | 6.30 | 0.85 | NA | 13.28 | 090 | |
29902 | A | Mcp joint arthroscopy, surg | 6.70 | NA | 6.61 | 0.93 | NA | 14.24 | 090 | |
29999 | C | Arthroscopy of joint | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
30000 | A | Drainage of nose lesion | 1.43 | 2.52 | 1.47 | 0.10 | 4.05 | 3.00 | 010 | |
30020 | A | Drainage of nose lesion | 1.43 | 2.71 | 1.56 | 0.08 | 4.22 | 3.07 | 010 | |
30100 | A | Intranasal biopsy | 0.94 | 1.33 | 0.52 | 0.06 | 2.33 | 1.52 | 000 | |
30110 | A | Removal of nose polyp(s) | 1.63 | 2.80 | 0.87 | 0.12 | 4.55 | 2.62 | 010 | |
30115 | A | Removal of nose polyp(s) | 4.35 | NA | 4.49 | 0.31 | NA | 9.15 | 090 | |
30117 | A | Removal of intranasal lesion | 3.16 | 4.97 | 3.15 | 0.22 | 8.35 | 6.53 | 090 | |
30118 | A | Removal of intranasal lesion | 9.69 | NA | 8.17 | 0.66 | NA | 18.52 | 090 | |
30120 | A | Revision of nose | 5.27 | 5.97 | 5.97 | 0.41 | 11.65 | 11.65 | 090 | |
30124 | A | Removal of nose lesion | 3.10 | NA | 3.31 | 0.20 | NA | 6.61 | 090 | |
30125 | A | Removal of nose lesion | 7.16 | NA | 6.42 | 0.54 | NA | 14.12 | 090 | |
30130 | A | Removal of turbinate bones | 3.38 | NA | 3.94 | 0.22 | NA | 7.54 | 090 | |
30140 | A | Removal of turbinate bones | 3.43 | NA | 4.58 | 0.24 | NA | 8.25 | 090 | |
30150 | A | Partial removal of nose | 9.14 | NA | 8.56 | 0.76 | NA | 18.46 | 090 | |
30160 | A | Removal of nose | 9.58 | NA | 8.47 | 0.78 | NA | 18.83 | 090 | |
30200 | A | Injection treatment of nose | 0.78 | 1.21 | 0.44 | 0.06 | 2.05 | 1.28 | 000 | |
30210 | A | Nasal sinus therapy | 1.08 | 2.15 | 0.59 | 0.08 | 3.31 | 1.75 | 010 | |
30220 | A | Insert nasal septal button | 1.54 | 2.51 | 0.84 | 0.11 | 4.16 | 2.49 | 010 | |
30300 | A | Remove nasal foreign body | 1.04 | 2.60 | 0.38 | 0.07 | 3.71 | 1.49 | 010 | |
30310 | A | Remove nasal foreign body | 1.96 | NA | 1.88 | 0.14 | NA | 3.98 | 010 | |
30320 | A | Remove nasal foreign body | 4.52 | NA | 5.24 | 0.36 | NA | 10.12 | 090 | |
30400 | R | Reconstruction of nose | 9.83 | NA | 8.81 | 0.80 | NA | 19.44 | 090 | |
30410 | R | Reconstruction of nose | 12.98 | NA | 10.50 | 1.08 | NA | 24.56 | 090 | |
30420 | R | Reconstruction of nose | 15.88 | NA | 12.20 | 1.24 | NA | 29.32 | 090 | |
30430 | R | Revision of nose | 7.21 | NA | 7.14 | 0.62 | NA | 14.97 | 090 | |
30435 | R | Revision of nose | 11.71 | NA | 10.22 | 1.10 | NA | 23.03 | 090 | |
30450 | R | Revision of nose | 18.65 | NA | 13.82 | 1.53 | NA | 34.00 | 090 | |
30460 | A | Revision of nose | 9.96 | NA | 9.12 | 0.85 | NA | 19.93 | 090 | |
30462 | A | Revision of nose | 19.57 | NA | 14.40 | 1.92 | NA | 35.89 | 090 | |
30465 | A | Repair nasal stenosis | 11.64 | NA | 8.64 | 0.97 | NA | 21.25 | 090 | |
30520 | A | Repair of nasal septum | 5.70 | NA | 5.85 | 0.41 | NA | 11.96 | 090 | |
30540 | A | Repair nasal defect | 7.75 | NA | 6.43 | 0.53 | NA | 14.71 | 090 | |
30545 | A | Repair nasal defect | 11.38 | NA | 9.58 | 0.80 | NA | 21.76 | 090 | |
30560 | A | Release of nasal adhesions | 1.26 | 2.33 | 1.50 | 0.09 | 3.68 | 2.85 | 010 | |
30580 | A | Repair upper jaw fistula | 6.69 | 4.97 | 4.97 | 0.50 | 12.16 | 12.16 | 090 | |
30600 | A | Repair mouth/nose fistula | 6.02 | 4.93 | 4.93 | 0.70 | 11.65 | 11.65 | 090 | |
30620 | A | Intranasal reconstruction | 5.97 | NA | 6.54 | 0.45 | NA | 12.96 | 090 | |
30630 | A | Repair nasal septum defect | 7.12 | NA | 7.08 | 0.51 | NA | 14.71 | 090 | |
30801 | A | Cauterization, inner nose | 1.09 | 2.55 | 2.30 | 0.08 | 3.72 | 3.47 | 010 | |
30802 | A | Cauterization, inner nose | 2.03 | 3.10 | 2.84 | 0.15 | 5.28 | 5.02 | 010 | |
30901 | A | Control of nosebleed | 1.21 | 1.40 | 0.33 | 0.09 | 2.70 | 1.63 | 000 | |
30903 | A | Control of nosebleed | 1.54 | 3.14 | 0.51 | 0.12 | 4.80 | 2.17 | 000 | |
30905 | A | Control of nosebleed | 1.97 | 3.79 | 0.78 | 0.15 | 5.91 | 2.90 | 000 | |
30906 | A | Repeat control of nosebleed | 2.45 | 4.19 | 1.23 | 0.17 | 6.81 | 3.85 | 000 | |
30915 | A | Ligation, nasal sinus artery | 7.20 | NA | 7.03 | 0.50 | NA | 14.73 | 090 | |
30920 | A | Ligation, upper jaw artery | 9.83 | NA | 8.48 | 0.69 | NA | 19.00 | 090 | |
30930 | A | Therapy, fracture of nose | 1.26 | NA | 2.16 | 0.09 | NA | 3.51 | 010 | |
30999 | C | Nasal surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
31000 | A | Irrigation, maxillary sinus | 1.15 | 2.43 | 0.64 | 0.08 | 3.66 | 1.87 | 010 | |
31002 | A | Irrigation, sphenoid sinus | 1.91 | NA | 2.03 | 0.14 | NA | 4.08 | 010 | |
31020 | A | Exploration, maxillary sinus | 2.94 | 4.30 | 3.64 | 0.20 | 7.44 | 6.78 | 090 | |
31030 | A | Exploration, maxillary sinus | 5.92 | 4.77 | 4.60 | 0.42 | 11.11 | 10.94 | 090 | |
31032 | A | Explore sinus, remove polyps | 6.57 | NA | 6.06 | 0.47 | NA | 13.10 | 090 | |
31040 | A | Exploration behind upper jaw | 9.42 | NA | 6.97 | 0.71 | NA | 17.10 | 090 | |
31050 | A | Exploration, sphenoid sinus | 5.28 | NA | 5.04 | 0.39 | NA | 10.71 | 090 | |
31051 | A | Sphenoid sinus surgery | 7.11 | NA | 6.51 | 0.55 | NA | 14.17 | 090 | |
31070 | A | Exploration of frontal sinus | 4.28 | NA | 5.00 | 0.30 | NA | 9.58 | 090 | |
31075 | A | Exploration of frontal sinus | 9.16 | NA | 8.16 | 0.64 | NA | 17.96 | 090 | |
31080 | A | Removal of frontal sinus | 11.42 | NA | 8.78 | 0.78 | NA | 20.98 | 090 | |
31081 | A | Removal of frontal sinus | 12.75 | NA | 9.73 | 1.84 | NA | 24.32 | 090 | |
31084 | A | Removal of frontal sinus | 13.51 | NA | 10.49 | 0.96 | NA | 24.96 | 090 | |
31085 | A | Removal of frontal sinus | 14.20 | NA | 10.73 | 1.18 | NA | 26.11 | 090 | |
31086 | A | Removal of frontal sinus | 12.86 | NA | 10.42 | 0.90 | NA | 24.18 | 090 | |
31087 | A | Removal of frontal sinus | 13.10 | NA | 10.43 | 1.15 | NA | 24.68 | 090 | |
31090 | A | Exploration of sinuses | 9.53 | NA | 8.89 | 0.66 | NA | 19.08 | 090 | |
31200 | A | Removal of ethmoid sinus | 4.97 | NA | 5.70 | 0.25 | NA | 10.92 | 090 | |
31201 | A | Removal of ethmoid sinus | 8.37 | NA | 7.76 | 0.58 | NA | 16.71 | 090 | |
31205 | A | Removal of ethmoid sinus | 10.24 | NA | 8.39 | 0.58 | NA | 19.21 | 090 | |
31225 | A | Removal of upper jaw | 19.23 | NA | 15.01 | 1.38 | NA | 35.62 | 090 | |
31230 | A | Removal of upper jaw | 21.94 | NA | 16.66 | 1.57 | NA | 40.17 | 090 | |
31231 | A | Nasal endoscopy, dx | 1.10 | 1.99 | 0.59 | 0.08 | 3.17 | 1.77 | 000 | |
31233 | A | Nasal/sinus endoscopy, dx | 2.18 | 2.63 | 1.19 | 0.16 | 4.97 | 3.53 | 000 | |
31235 | A | Nasal/sinus endoscopy, dx | 2.64 | 2.90 | 1.45 | 0.18 | 5.72 | 4.27 | 000 | |
31237 | A | Nasal/sinus endoscopy, surg | 2.98 | 3.17 | 1.61 | 0.21 | 6.36 | 4.80 | 000 | |
31238 | A | Nasal/sinus endoscopy, surg | 3.26 | 3.71 | 1.82 | 0.23 | 7.20 | 5.31 | 000 | |
31239 | A | Nasal/sinus endoscopy, surg | 8.70 | NA | 6.51 | 0.46 | NA | 15.67 | 010 | |
31240 | A | Nasal/sinus endoscopy, surg | 2.61 | NA | 1.55 | 0.18 | NA | 4.34 | 000 | |
31254 | A | Revision of ethmoid sinus | 4.65 | NA | 2.71 | 0.32 | NA | 7.68 | 000 | |
31255 | A | Removal of ethmoid sinus | 6.96 | NA | 4.01 | 0.49 | NA | 11.46 | 000 | |
31256 | A | Exploration maxillary sinus | 3.29 | NA | 1.95 | 0.23 | NA | 5.47 | 000 | |
31267 | A | Endoscopy, maxillary sinus | 5.46 | NA | 3.16 | 0.38 | NA | 9.00 | 000 | |
31276 | A | Sinus endoscopy, surgical | 8.85 | NA | 5.05 | 0.62 | NA | 14.52 | 000 | |
31287 | A | Nasal/sinus endoscopy, surg | 3.92 | NA | 2.30 | 0.27 | NA | 6.49 | 000 | |
31288 | A | Nasal/sinus endoscopy, surg | 4.58 | NA | 2.67 | 0.32 | NA | 7.57 | 000 | |
31290 | A | Nasal/sinus endoscopy, surg | 17.24 | NA | 11.56 | 1.20 | NA | 30.00 | 010 | |
31291 | A | Nasal/sinus endoscopy, surg | 18.19 | NA | 11.87 | 1.73 | NA | 31.79 | 010 | |
31292 | A | Nasal/sinus endoscopy, surg | 14.76 | NA | 10.05 | 0.99 | NA | 25.80 | 010 | |
31293 | A | Nasal/sinus endoscopy, surg | 16.21 | NA | 10.76 | 0.97 | NA | 27.94 | 010 | |
31294 | A | Nasal/sinus endoscopy, surg | 19.06 | NA | 12.32 | 1.04 | NA | 32.42 | 010 | |
31299 | C | Sinus surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
31300 | A | Removal of larynx lesion | 14.29 | NA | 17.26 | 0.99 | NA | 32.54 | 090 | |
31320 | A | Diagnostic incision, larynx | 5.26 | NA | 12.98 | 0.40 | NA | 18.64 | 090 | |
31360 | A | Removal of larynx | 17.08 | NA | 19.03 | 1.20 | NA | 37.31 | 090 | |
31365 | A | Removal of larynx | 24.16 | NA | 22.76 | 1.72 | NA | 48.64 | 090 | |
31367 | A | Partial removal of larynx | 21.86 | NA | 23.63 | 1.57 | NA | 47.06 | 090 | |
31368 | A | Partial removal of larynx | 27.09 | NA | 28.25 | 1.90 | NA | 57.24 | 090 | |
31370 | A | Partial removal of larynx | 21.38 | NA | 23.28 | 1.51 | NA | 46.17 | 090 | |
31375 | A | Partial removal of larynx | 20.21 | NA | 20.86 | 1.43 | NA | 42.50 | 090 | |
31380 | A | Partial removal of larynx | 20.21 | NA | 20.88 | 1.40 | NA | 42.49 | 090 | |
31382 | A | Partial removal of larynx | 20.52 | NA | 22.86 | 1.44 | NA | 44.82 | 090 | |
31390 | A | Removal of larynx pharynx | 27.53 | NA | 28.42 | 1.95 | NA | 57.90 | 090 | |
31395 | A | Reconstruct larynx pharynx | 31.09 | NA | 34.27 | 2.27 | NA | 67.63 | 090 | |
31400 | A | Revision of larynx | 10.31 | NA | 15.66 | 0.72 | NA | 26.69 | 090 | |
31420 | A | Removal of epiglottis | 10.22 | NA | 15.35 | 0.71 | NA | 26.28 | 090 | |
31500 | A | Insert emergency airway | 2.33 | NA | 0.67 | 0.15 | NA | 3.15 | 000 | |
31502 | A | Change of windpipe airway | 0.65 | 1.98 | 0.26 | 0.04 | 2.67 | 0.95 | 000 | |
31505 | A | Diagnostic laryngoscopy | 0.61 | 0.67 | 0.23 | 0.04 | 1.32 | 0.88 | 000 | |
31510 | A | Laryngoscopy with biopsy | 1.92 | 2.83 | 0.98 | 0.15 | 4.90 | 3.05 | 000 | |
31511 | A | Remove foreign body, larynx | 2.16 | 3.12 | 0.75 | 0.16 | 5.44 | 3.07 | 000 | |
31512 | A | Removal of larynx lesion | 2.07 | 3.07 | 1.07 | 0.16 | 5.30 | 3.30 | 000 | |
31513 | A | Injection into vocal cord | 2.10 | NA | 1.28 | 0.15 | NA | 3.53 | 000 | |
31515 | A | Laryngoscopy for aspiration | 1.80 | 2.39 | 0.85 | 0.12 | 4.31 | 2.77 | 000 | |
31520 | A | Diagnostic laryngoscopy | 2.56 | NA | 1.38 | 0.17 | NA | 4.11 | 000 | |
31525 | A | Diagnostic laryngoscopy | 2.63 | 2.91 | 1.48 | 0.18 | 5.72 | 4.29 | 000 | |
31526 | A | Diagnostic laryngoscopy | 2.57 | NA | 1.54 | 0.18 | NA | 4.29 | 000 | |
31527 | A | Laryngoscopy for treatment | 3.27 | NA | 1.71 | 0.21 | NA | 5.19 | 000 | |
31528 | A | Laryngoscopy and dilation | 2.37 | NA | 1.26 | 0.16 | NA | 3.79 | 000 | |
31529 | A | Laryngoscopy and dilation | 2.68 | NA | 1.55 | 0.18 | NA | 4.41 | 000 | |
31530 | A | Operative laryngoscopy | 3.39 | NA | 1.75 | 0.24 | NA | 5.38 | 000 | |
31531 | A | Operative laryngoscopy | 3.59 | NA | 2.12 | 0.25 | NA | 5.96 | 000 | |
31535 | A | Operative laryngoscopy | 3.16 | NA | 1.82 | 0.22 | NA | 5.20 | 000 | |
31536 | A | Operative laryngoscopy | 3.56 | NA | 2.09 | 0.25 | NA | 5.90 | 000 | |
31540 | A | Operative laryngoscopy | 4.13 | NA | 2.40 | 0.29 | NA | 6.82 | 000 | |
31541 | A | Operative laryngoscopy | 4.53 | NA | 2.64 | 0.32 | NA | 7.49 | 000 | |
31560 | A | Operative laryngoscopy | 5.46 | NA | 3.05 | 0.38 | NA | 8.89 | 000 | |
31561 | A | Operative laryngoscopy | 6.00 | NA | 3.26 | 0.42 | NA | 9.68 | 000 | |
31570 | A | Laryngoscopy with injection | 3.87 | 4.16 | 2.23 | 0.24 | 8.27 | 6.34 | 000 | |
31571 | A | Laryngoscopy with injection | 4.27 | NA | 2.45 | 0.30 | NA | 7.02 | 000 | |
31575 | A | Diagnostic laryngoscopy | 1.10 | 2.07 | 0.57 | 0.08 | 3.25 | 1.75 | 000 | |
31576 | A | Laryngoscopy with biopsy | 1.97 | 2.45 | 1.02 | 0.13 | 4.55 | 3.12 | 000 | |
31577 | A | Remove foreign body, larynx | 2.47 | 2.93 | 1.25 | 0.17 | 5.57 | 3.89 | 000 | |
31578 | A | Removal of larynx lesion | 2.84 | 3.19 | 1.24 | 0.20 | 6.23 | 4.28 | 000 | |
31579 | A | Diagnostic laryngoscopy | 2.26 | 2.94 | 1.20 | 0.16 | 5.36 | 3.62 | 000 | |
31580 | A | Revision of larynx | 12.38 | NA | 16.18 | 0.87 | NA | 29.43 | 090 | |
31582 | A | Revision of larynx | 21.62 | NA | 21.69 | 1.52 | NA | 44.83 | 090 | |
31584 | A | Treat larynx fracture | 19.64 | NA | 18.64 | 1.42 | NA | 39.70 | 090 | |
31585 | A | Treat larynx fracture | 4.64 | NA | 8.94 | 0.30 | NA | 13.88 | 090 | |
31586 | A | Treat larynx fracture | 8.03 | NA | 12.77 | 0.56 | NA | 21.36 | 090 | |
31587 | A | Revision of larynx | 11.99 | NA | 14.23 | 0.88 | NA | 27.10 | 090 | |
31588 | A | Revision of larynx | 13.11 | NA | 17.11 | 0.92 | NA | 31.14 | 090 | |
31590 | A | Reinnervate larynx | 6.97 | NA | 12.52 | 0.50 | NA | 19.99 | 090 | |
31595 | A | Larynx nerve surgery | 8.34 | NA | 11.32 | 0.62 | NA | 20.28 | 090 | |
31599 | C | Larynx surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
31600 | A | Incision of windpipe | 7.18 | NA | 3.05 | 0.34 | NA | 10.57 | 000 | |
31601 | A | Incision of windpipe | 4.45 | NA | 2.15 | 0.39 | NA | 6.99 | 000 | |
31603 | A | Incision of windpipe | 4.15 | NA | 1.75 | 0.35 | NA | 6.25 | 000 | |
31605 | A | Incision of windpipe | 3.58 | NA | 1.21 | 0.33 | NA | 5.12 | 000 | |
31610 | A | Incision of windpipe | 8.76 | NA | 10.79 | 0.69 | NA | 20.24 | 090 | |
31611 | A | Surgery/speech prosthesis | 5.64 | NA | 10.19 | 0.40 | NA | 16.23 | 090 | |
31612 | A | Puncture/clear windpipe | 0.91 | 1.49 | 0.42 | 0.06 | 2.46 | 1.39 | 000 | |
31613 | A | Repair windpipe opening | 4.59 | NA | 8.88 | 0.37 | NA | 13.84 | 090 | |
31614 | A | Repair windpipe opening | 7.12 | NA | 12.24 | 0.51 | NA | 19.87 | 090 | |
31615 | A | Visualization of windpipe | 2.09 | 3.74 | 1.17 | 0.14 | 5.97 | 3.40 | 000 | |
31622 | A | Dx bronchoscope/wash | 2.78 | 3.44 | 1.15 | 0.14 | 6.36 | 4.07 | 000 | |
31623 | A | Dx bronchoscope/brush | 2.88 | 3.18 | 1.14 | 0.14 | 6.20 | 4.16 | 000 | |
31624 | A | Dx bronchoscope/lavage | 2.88 | 2.89 | 1.14 | 0.13 | 5.90 | 4.15 | 000 | |
31625 | A | Bronchoscopy w/biopsy(s) | 3.37 | NA | 1.30 | 0.16 | NA | 4.83 | 000 | |
31628 | A | Bronchoscopy/lung bx, each | 3.81 | 3.36 | 1.40 | 0.14 | 7.31 | 5.35 | 000 | |
31629 | A | Bronchoscopy/needle bx, each | 3.37 | NA | 1.27 | 0.13 | NA | 4.77 | 000 | |
31630 | A | Bronchoscopy dilate/fx repr | 3.82 | NA | 1.97 | 0.30 | NA | 6.09 | 000 | |
31631 | A | Bronchoscopy, dilate w/stent | 4.37 | NA | 2.01 | 0.31 | NA | 6.69 | 000 | |
31635 | A | Bronchoscopy w/fb removal | 3.68 | NA | 1.67 | 0.21 | NA | 5.56 | 000 | |
31640 | A | Bronchoscopy w/tumor excise | 4.94 | NA | 2.34 | 0.37 | NA | 7.65 | 000 | |
31641 | A | Bronchoscopy, treat blockage | 5.03 | NA | 2.13 | 0.30 | NA | 7.46 | 000 | |
31643 | A | Diag bronchoscope/catheter | 3.50 | NA | 1.32 | 0.15 | NA | 4.97 | 000 | |
31645 | A | Bronchoscopy, clear airways | 3.16 | NA | 1.22 | 0.13 | NA | 4.51 | 000 | |
31646 | A | Bronchoscopy, reclear airway | 2.72 | NA | 1.09 | 0.12 | NA | 3.93 | 000 | |
31656 | A | Bronchoscopy, inj for x-ray | 2.17 | NA | 0.93 | 0.10 | NA | 3.20 | 000 | |
31700 | A | Insertion of airway catheter | 1.34 | 2.34 | 0.69 | 0.07 | 3.75 | 2.10 | 000 | |
31708 | A | Instill airway contrast dye | 1.41 | NA | 0.60 | 0.06 | NA | 2.07 | 000 | |
31710 | A | Insertion of airway catheter | 1.30 | NA | 0.71 | 0.06 | NA | 2.07 | 000 | |
31715 | A | Injection for bronchus x-ray | 1.11 | NA | 0.61 | 0.06 | NA | 1.78 | 000 | |
31717 | A | Bronchial brush biopsy | 2.12 | 3.40 | 0.88 | 0.09 | 5.61 | 3.09 | 000 | |
31720 | A | Clearance of airways | 1.06 | 1.86 | 0.33 | 0.06 | 2.98 | 1.45 | 000 | |
31725 | A | Clearance of airways | 1.96 | NA | 0.60 | 0.10 | NA | 2.66 | 000 | |
31730 | A | Intro, windpipe wire/tube | 2.85 | 2.42 | 1.10 | 0.15 | 5.42 | 4.10 | 000 | |
31750 | A | Repair of windpipe | 13.02 | NA | 16.00 | 1.02 | NA | 30.04 | 090 | |
31755 | A | Repair of windpipe | 15.93 | NA | 19.11 | 1.15 | NA | 36.19 | 090 | |
31760 | A | Repair of windpipe | 22.35 | NA | 12.34 | 1.48 | NA | 36.17 | 090 | |
31766 | A | Reconstruction of windpipe | 30.43 | NA | 16.11 | 3.16 | NA | 49.70 | 090 | |
31770 | A | Repair/graft of bronchus | 22.51 | NA | 14.25 | 2.27 | NA | 39.03 | 090 | |
31775 | A | Reconstruct bronchus | 23.54 | NA | 15.35 | 2.91 | NA | 41.80 | 090 | |
31780 | A | Reconstruct windpipe | 17.72 | NA | 12.85 | 1.55 | NA | 32.12 | 090 | |
31781 | A | Reconstruct windpipe | 23.53 | NA | 14.74 | 2.04 | NA | 40.31 | 090 | |
31785 | A | Remove windpipe lesion | 17.23 | NA | 12.68 | 1.36 | NA | 31.27 | 090 | |
31786 | A | Remove windpipe lesion | 23.98 | NA | 15.62 | 2.20 | NA | 41.80 | 090 | |
31800 | A | Repair of windpipe injury | 7.43 | NA | 6.79 | 0.67 | NA | 14.89 | 090 | |
31805 | A | Repair of windpipe injury | 13.13 | NA | 10.71 | 1.45 | NA | 25.29 | 090 | |
31820 | A | Closure of windpipe lesion | 4.49 | 8.08 | 7.96 | 0.35 | 12.92 | 12.80 | 090 | |
31825 | A | Repair of windpipe defect | 6.81 | 11.16 | 11.16 | 0.50 | 18.47 | 18.47 | 090 | |
31830 | A | Revise windpipe scar | 4.50 | 7.97 | 7.97 | 0.36 | 12.83 | 12.83 | 090 | |
31899 | C | Airways surgical procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
32000 | A | Drainage of chest | 1.54 | 3.11 | 0.50 | 0.07 | 4.72 | 2.11 | 000 | |
32002 | A | Treatment of collapsed lung | 2.19 | NA | 0.85 | 0.11 | NA | 3.15 | 000 | |
32005 | A | Treat lung lining chemically | 2.19 | NA | 0.87 | 0.17 | NA | 3.23 | 000 | |
32020 | A | Insertion of chest tube | 3.98 | NA | 1.44 | 0.36 | NA | 5.78 | 000 | |
32035 | A | Exploration of chest | 8.67 | NA | 7.97 | 1.02 | NA | 17.66 | 090 | |
32036 | A | Exploration of chest | 9.68 | NA | 8.69 | 1.20 | NA | 19.57 | 090 | |
32095 | A | Biopsy through chest wall | 8.36 | NA | 8.13 | 0.99 | NA | 17.48 | 090 | |
32100 | A | Exploration/biopsy of chest | 15.24 | NA | 10.39 | 1.45 | NA | 27.08 | 090 | |
32110 | A | Explore/repair chest | 23.00 | NA | 12.89 | 1.63 | NA | 37.52 | 090 | |
32120 | A | Re-exploration of chest | 11.54 | NA | 9.49 | 1.42 | NA | 22.45 | 090 | |
32124 | A | Explore chest free adhesions | 12.72 | NA | 9.42 | 1.51 | NA | 23.65 | 090 | |
32140 | A | Removal of lung lesion(s) | 13.93 | NA | 9.97 | 1.68 | NA | 25.58 | 090 | |
32141 | A | Remove/treat lung lesions | 14.00 | NA | 9.87 | 1.72 | NA | 25.59 | 090 | |
32150 | A | Removal of lung lesion(s) | 14.15 | NA | 9.84 | 1.60 | NA | 25.59 | 090 | |
32151 | A | Remove lung foreign body | 14.21 | NA | 10.50 | 1.49 | NA | 26.20 | 090 | |
32160 | A | Open chest heart massage | 9.30 | NA | 6.31 | 1.01 | NA | 16.62 | 090 | |
32200 | A | Drain, open, lung lesion | 15.29 | NA | 10.04 | 1.46 | NA | 26.79 | 090 | |
32201 | A | Drain, percut, lung lesion | 4.00 | NA | 5.54 | 0.18 | NA | 9.72 | 000 | |
32215 | A | Treat chest lining | 11.33 | NA | 9.44 | 1.34 | NA | 22.11 | 090 | |
32220 | A | Release of lung | 24.00 | NA | 13.45 | 2.39 | NA | 39.84 | 090 | |
32225 | A | Partial release of lung | 13.96 | NA | 10.11 | 1.70 | NA | 25.77 | 090 | |
32310 | A | Removal of chest lining | 13.44 | NA | 9.75 | 1.65 | NA | 24.84 | 090 | |
32320 | A | Free/remove chest lining | 24.00 | NA | 13.18 | 2.50 | NA | 39.68 | 090 | |
32400 | A | Needle biopsy chest lining | 1.76 | 1.86 | 0.57 | 0.07 | 3.69 | 2.40 | 000 | |
32402 | A | Open biopsy chest lining | 7.56 | NA | 8.06 | 0.91 | NA | 16.53 | 090 | |
32405 | A | Biopsy, lung or mediastinum | 1.93 | 2.38 | 0.65 | 0.09 | 4.40 | 2.67 | 000 | |
32420 | A | Puncture/clear lung | 2.18 | NA | 0.85 | 0.11 | NA | 3.14 | 000 | |
32440 | A | Removal of lung | 25.00 | NA | 12.43 | 2.56 | NA | 39.99 | 090 | |
32442 | A | Sleeve pneumonectomy | 26.24 | NA | 14.04 | 3.12 | NA | 43.40 | 090 | |
32445 | A | Removal of lung | 25.09 | NA | 13.48 | 3.11 | NA | 41.68 | 090 | |
32480 | A | Partial removal of lung | 23.75 | NA | 12.47 | 2.24 | NA | 38.46 | 090 | |
32482 | A | Bilobectomy | 25.00 | NA | 12.50 | 2.35 | NA | 39.85 | 090 | |
32484 | A | Segmentectomy | 20.69 | NA | 10.93 | 2.54 | NA | 34.16 | 090 | |
32486 | A | Sleeve lobectomy | 23.92 | NA | 12.63 | 3.00 | NA | 39.55 | 090 | |
32488 | A | Completion pneumonectomy | 25.71 | NA | 13.20 | 3.18 | NA | 42.09 | 090 | |
32491 | R | Lung volume reduction | 21.25 | NA | 11.97 | 2.66 | NA | 35.88 | 090 | |
32500 | A | Partial removal of lung | 22.00 | NA | 11.79 | 1.77 | NA | 35.56 | 090 | |
32501 | A | Repair bronchus add-on | 4.69 | NA | 1.54 | 0.56 | NA | 6.79 | ZZZ | |
32520 | A | Remove lung revise chest | 21.68 | NA | 10.87 | 2.71 | NA | 35.26 | 090 | |
32522 | A | Remove lung revise chest | 24.20 | NA | 11.71 | 2.84 | NA | 38.75 | 090 | |
32525 | A | Remove lung revise chest | 26.50 | NA | 12.42 | 3.25 | NA | 42.17 | 090 | |
32540 | A | Removal of lung lesion | 14.64 | NA | 9.12 | 1.84 | NA | 25.60 | 090 | |
32601 | A | Thoracoscopy, diagnostic | 5.46 | NA | 3.61 | 0.63 | NA | 9.70 | 000 | |
32602 | A | Thoracoscopy, diagnostic | 5.96 | NA | 3.76 | 0.70 | NA | 10.42 | 000 | |
32603 | A | Thoracoscopy, diagnostic | 7.81 | NA | 4.19 | 0.76 | NA | 12.76 | 000 | |
32604 | A | Thoracoscopy, diagnostic | 8.78 | NA | 4.74 | 0.97 | NA | 14.49 | 000 | |
32605 | A | Thoracoscopy, diagnostic | 6.93 | NA | 4.26 | 0.86 | NA | 12.05 | 000 | |
32606 | A | Thoracoscopy, diagnostic | 8.40 | NA | 4.57 | 0.99 | NA | 13.96 | 000 | |
32650 | A | Thoracoscopy, surgical | 10.75 | NA | 6.50 | 1.25 | NA | 18.50 | 090 | |
32651 | A | Thoracoscopy, surgical | 12.91 | NA | 7.05 | 1.50 | NA | 21.46 | 090 | |
32652 | A | Thoracoscopy, surgical | 18.66 | NA | 9.74 | 2.30 | NA | 30.70 | 090 | |
32653 | A | Thoracoscopy, surgical | 12.87 | NA | 6.78 | 1.55 | NA | 21.20 | 090 | |
32654 | A | Thoracoscopy, surgical | 12.44 | NA | 7.20 | 1.51 | NA | 21.15 | 090 | |
32655 | A | Thoracoscopy, surgical | 13.10 | NA | 7.07 | 1.53 | NA | 21.70 | 090 | |
32656 | A | Thoracoscopy, surgical | 12.91 | NA | 7.53 | 1.61 | NA | 22.05 | 090 | |
32657 | A | Thoracoscopy, surgical | 13.65 | NA | 7.42 | 1.64 | NA | 22.71 | 090 | |
32658 | A | Thoracoscopy, surgical | 11.63 | NA | 7.01 | 1.47 | NA | 20.11 | 090 | |
32659 | A | Thoracoscopy, surgical | 11.59 | NA | 7.12 | 1.39 | NA | 20.10 | 090 | |
32660 | A | Thoracoscopy, surgical | 17.43 | NA | 9.05 | 2.09 | NA | 28.57 | 090 | |
32661 | A | Thoracoscopy, surgical | 13.25 | NA | 7.47 | 1.66 | NA | 22.38 | 090 | |
32662 | A | Thoracoscopy, surgical | 16.44 | NA | 8.51 | 2.01 | NA | 26.96 | 090 | |
32663 | A | Thoracoscopy, surgical | 18.47 | NA | 10.22 | 2.28 | NA | 30.97 | 090 | |
32664 | A | Thoracoscopy, surgical | 14.20 | NA | 7.48 | 1.70 | NA | 23.38 | 090 | |
32665 | A | Thoracoscopy, surgical | 15.54 | NA | 8.02 | 1.79 | NA | 25.35 | 090 | |
32800 | A | Repair lung hernia | 13.69 | NA | 9.82 | 1.51 | NA | 25.02 | 090 | |
32810 | A | Close chest after drainage | 13.05 | NA | 10.08 | 1.55 | NA | 24.68 | 090 | |
32815 | A | Close bronchial fistula | 23.15 | NA | 13.56 | 2.84 | NA | 39.55 | 090 | |
32820 | A | Reconstruct injured chest | 21.48 | NA | 13.98 | 2.31 | NA | 37.77 | 090 | |
32850 | X | Donor pneumonectomy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
32851 | A | Lung transplant, single | 38.63 | NA | 20.19 | 4.90 | NA | 63.72 | 090 | |
32852 | A | Lung transplant with bypass | 41.80 | NA | 21.70 | 5.17 | NA | 68.67 | 090 | |
32853 | A | Lung transplant, double | 47.81 | NA | 23.60 | 6.13 | NA | 77.54 | 090 | |
32854 | A | Lung transplant with bypass | 50.98 | NA | 24.25 | 6.41 | NA | 81.64 | 090 | |
32900 | A | Removal of rib(s) | 20.27 | NA | 12.20 | 2.42 | NA | 34.89 | 090 | |
32905 | A | Revise repair chest wall | 20.75 | NA | 12.57 | 2.54 | NA | 35.86 | 090 | |
32906 | A | Revise repair chest wall | 26.77 | NA | 14.61 | 3.30 | NA | 44.68 | 090 | |
32940 | A | Revision of lung | 19.43 | NA | 11.85 | 2.47 | NA | 33.75 | 090 | |
32960 | A | Therapeutic pneumothorax | 1.84 | 2.15 | 0.57 | 0.12 | 4.11 | 2.53 | 000 | |
32997 | A | Total lung lavage | 6.00 | NA | 1.93 | 0.55 | NA | 8.48 | 000 | |
32999 | C | Chest surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
33010 | A | Drainage of heart sac | 2.24 | NA | 0.98 | 0.13 | NA | 3.35 | 000 | |
33011 | A | Repeat drainage of heart sac | 2.24 | NA | 1.02 | 0.13 | NA | 3.39 | 000 | |
33015 | A | Incision of heart sac | 6.80 | NA | 4.52 | 0.64 | NA | 11.96 | 090 | |
33020 | A | Incision of heart sac | 12.61 | NA | 8.01 | 1.50 | NA | 22.12 | 090 | |
33025 | A | Incision of heart sac | 12.09 | NA | 7.88 | 1.50 | NA | 21.47 | 090 | |
33030 | A | Partial removal of heart sac | 18.71 | NA | 12.30 | 2.40 | NA | 33.41 | 090 | |
33031 | A | Partial removal of heart sac | 21.79 | NA | 13.57 | 2.78 | NA | 38.14 | 090 | |
33050 | A | Removal of heart sac lesion | 14.36 | NA | 10.31 | 1.73 | NA | 26.40 | 090 | |
33120 | A | Removal of heart lesion | 24.56 | NA | 16.05 | 3.06 | NA | 43.67 | 090 | |
33130 | A | Removal of heart lesion | 21.39 | NA | 12.74 | 2.51 | NA | 36.64 | 090 | |
33140 | A | Heart revascularize (tmr) | 20.00 | NA | 10.67 | 2.27 | NA | 32.94 | 090 | |
33141 | A | Heart tmr w/other procedure | 4.84 | NA | 1.57 | 0.55 | NA | 6.96 | ZZZ | |
33200 | A | Insertion of heart pacemaker | 12.48 | NA | 9.72 | 1.17 | NA | 23.37 | 090 | |
33201 | A | Insertion of heart pacemaker | 10.18 | NA | 9.71 | 1.21 | NA | 21.10 | 090 | |
33206 | A | Insertion of heart pacemaker | 6.67 | NA | 5.69 | 0.50 | NA | 12.86 | 090 | |
33207 | A | Insertion of heart pacemaker | 8.04 | NA | 6.23 | 0.57 | NA | 14.84 | 090 | |
33208 | A | Insertion of heart pacemaker | 8.13 | NA | 6.43 | 0.54 | NA | 15.10 | 090 | |
33210 | A | Insertion of heart electrode | 3.30 | NA | 1.28 | 0.17 | NA | 4.75 | 000 | |
33211 | A | Insertion of heart electrode | 3.40 | NA | 1.34 | 0.17 | NA | 4.91 | 000 | |
33212 | A | Insertion of pulse generator | 5.52 | NA | 4.62 | 0.44 | NA | 10.58 | 090 | |
33213 | A | Insertion of pulse generator | 6.37 | NA | 5.06 | 0.46 | NA | 11.89 | 090 | |
33214 | A | Upgrade of pacemaker system | 7.75 | NA | 6.19 | 0.52 | NA | 14.46 | 090 | |
33215 | A | Reposition pacing-defib lead | 4.76 | NA | 3.15 | 0.36 | NA | 8.27 | 090 | |
33216 | A | Insert lead pace-defib, one | 5.78 | NA | 5.32 | 0.36 | NA | 11.46 | 090 | |
33217 | A | Insert lead pace-defib, dual | 5.75 | NA | 5.58 | 0.36 | NA | 11.69 | 090 | |
33218 | A | Repair lead pace-defib, one | 5.44 | NA | 4.68 | 0.40 | NA | 10.52 | 090 | |
33220 | A | Repair lead pace-defib, dual | 5.52 | NA | 4.69 | 0.39 | NA | 10.60 | 090 | |
33222 | A | Revise pocket, pacemaker | 4.96 | NA | 4.08 | 0.39 | NA | 9.43 | 090 | |
33223 | A | Revise pocket, pacing-defib | 6.46 | NA | 5.41 | 0.44 | NA | 12.31 | 090 | |
33224 | A | Insert pacing lead connect | 9.05 | NA | 3.92 | 0.36 | NA | 13.33 | 090 | |
33225 | A | L ventric pacing lead add-on | 8.34 | NA | 3.11 | 0.36 | NA | 11.81 | ZZZ | |
33226 | A | Reposition l ventric lead | 8.69 | NA | 3.79 | 0.36 | NA | 12.84 | 000 | |
33233 | A | Removal of pacemaker system | 3.29 | NA | 4.12 | 0.22 | NA | 7.63 | 090 | |
33234 | A | Removal of pacemaker system | 7.82 | NA | 5.66 | 0.56 | NA | 14.04 | 090 | |
33235 | A | Removal pacemaker electrode | 9.40 | NA | 6.50 | 0.68 | NA | 16.58 | 090 | |
33236 | A | Remove electrode/thoracotomy | 12.60 | NA | 9.38 | 1.49 | NA | 23.47 | 090 | |
33237 | A | Remove electrode/thoracotomy | 13.71 | NA | 9.78 | 1.57 | NA | 25.06 | 090 | |
33238 | A | Remove electrode/thoracotomy | 15.22 | NA | 9.27 | 1.56 | NA | 26.05 | 090 | |
33240 | A | Insert pulse generator | 7.60 | NA | 5.77 | 0.53 | NA | 13.90 | 090 | |
33241 | A | Remove pulse generator | 3.24 | NA | 3.71 | 0.21 | NA | 7.16 | 090 | |
33243 | A | Remove eltrd/thoracotomy | 22.64 | NA | 10.90 | 2.53 | NA | 36.07 | 090 | |
33244 | A | Remove eltrd, transven | 13.76 | NA | 8.43 | 1.05 | NA | 23.24 | 090 | |
33245 | A | Insert epic eltrd pace-defib | 14.30 | NA | 11.02 | 1.28 | NA | 26.60 | 090 | |
33246 | A | Insert epic eltrd/generator | 20.71 | NA | 14.36 | 2.22 | NA | 37.29 | 090 | |
33249 | A | Eltrd/insert pace-defib | 14.23 | NA | 9.27 | 0.80 | NA | 24.30 | 090 | |
33250 | A | Ablate heart dysrhythm focus | 21.85 | NA | 14.42 | 1.01 | NA | 37.28 | 090 | |
33251 | A | Ablate heart dysrhythm focus | 24.88 | NA | 14.53 | 2.41 | NA | 41.82 | 090 | |
33253 | A | Reconstruct atria | 31.06 | NA | 16.79 | 3.68 | NA | 51.53 | 090 | |
33261 | A | Ablate heart dysrhythm focus | 24.88 | NA | 14.79 | 2.82 | NA | 42.49 | 090 | |
33282 | A | Implant pat-active ht record | 4.17 | NA | 4.91 | 0.39 | NA | 9.47 | 090 | |
33284 | A | Remove pat-active ht record | 2.50 | NA | 4.39 | 0.23 | NA | 7.12 | 090 | |
33300 | A | Repair of heart wound | 17.92 | NA | 12.08 | 1.91 | NA | 31.91 | 090 | |
33305 | A | Repair of heart wound | 21.44 | NA | 13.53 | 2.68 | NA | 37.65 | 090 | |
33310 | A | Exploratory heart surgery | 18.51 | NA | 12.43 | 2.26 | NA | 33.20 | 090 | |
33315 | A | Exploratory heart surgery | 22.37 | NA | 13.74 | 2.90 | NA | 39.01 | 090 | |
33320 | A | Repair major blood vessel(s) | 16.79 | NA | 11.44 | 1.66 | NA | 29.89 | 090 | |
33321 | A | Repair major vessel | 20.20 | NA | 12.72 | 2.70 | NA | 35.62 | 090 | |
33322 | A | Repair major blood vessel(s) | 20.62 | NA | 13.32 | 2.51 | NA | 36.45 | 090 | |
33330 | A | Insert major vessel graft | 21.43 | NA | 12.93 | 2.49 | NA | 36.85 | 090 | |
33332 | A | Insert major vessel graft | 23.96 | NA | 13.18 | 2.45 | NA | 39.59 | 090 | |
33335 | A | Insert major vessel graft | 30.01 | NA | 16.23 | 3.79 | NA | 50.03 | 090 | |
33400 | A | Repair of aortic valve | 28.50 | NA | 15.00 | 3.09 | NA | 46.59 | 090 | |
33401 | A | Valvuloplasty, open | 23.91 | NA | 13.33 | 2.71 | NA | 39.95 | 090 | |
33403 | A | Valvuloplasty, w/cp bypass | 24.89 | NA | 13.71 | 2.48 | NA | 41.08 | 090 | |
33404 | A | Prepare heart-aorta conduit | 28.54 | NA | 13.94 | 3.31 | NA | 45.79 | 090 | |
33405 | A | Replacement of aortic valve | 35.00 | NA | 17.52 | 3.86 | NA | 56.38 | 090 | |
33406 | A | Replacement of aortic valve | 37.50 | NA | 18.31 | 4.07 | NA | 59.88 | 090 | |
33410 | A | Replacement of aortic valve | 32.46 | NA | 16.00 | 4.11 | NA | 52.57 | 090 | |
33411 | A | Replacement of aortic valve | 36.25 | NA | 17.97 | 4.16 | NA | 58.38 | 090 | |
33412 | A | Replacement of aortic valve | 42.00 | NA | 19.77 | 4.66 | NA | 66.43 | 090 | |
33413 | A | Replacement of aortic valve | 43.50 | NA | 20.10 | 4.26 | NA | 67.86 | 090 | |
33414 | A | Repair of aortic valve | 30.35 | NA | 17.98 | 3.79 | NA | 52.12 | 090 | |
33415 | A | Revision, subvalvular tissue | 27.15 | NA | 16.05 | 3.25 | NA | 46.45 | 090 | |
33416 | A | Revise ventricle muscle | 30.35 | NA | 16.41 | 3.85 | NA | 50.61 | 090 | |
33417 | A | Repair of aortic valve | 28.53 | NA | 17.51 | 3.58 | NA | 49.62 | 090 | |
33420 | A | Revision of mitral valve | 22.70 | NA | 10.12 | 1.48 | NA | 34.30 | 090 | |
33422 | A | Revision of mitral valve | 25.94 | NA | 13.03 | 3.30 | NA | 42.27 | 090 | |
33425 | A | Repair of mitral valve | 27.00 | NA | 12.58 | 3.00 | NA | 42.58 | 090 | |
33426 | A | Repair of mitral valve | 33.00 | NA | 16.42 | 3.87 | NA | 53.29 | 090 | |
33427 | A | Repair of mitral valve | 40.00 | NA | 18.59 | 4.30 | NA | 62.89 | 090 | |
33430 | A | Replacement of mitral valve | 33.50 | NA | 16.54 | 3.95 | NA | 53.99 | 090 | |
33460 | A | Revision of tricuspid valve | 23.60 | NA | 14.13 | 3.02 | NA | 40.75 | 090 | |
33463 | A | Valvuloplasty, tricuspid | 25.62 | NA | 14.87 | 3.17 | NA | 43.66 | 090 | |
33464 | A | Valvuloplasty, tricuspid | 27.33 | NA | 15.47 | 3.47 | NA | 46.27 | 090 | |
33465 | A | Replace tricuspid valve | 28.79 | NA | 15.80 | 3.61 | NA | 48.20 | 090 | |
33468 | A | Revision of tricuspid valve | 30.12 | NA | 20.10 | 4.00 | NA | 54.22 | 090 | |
33470 | A | Revision of pulmonary valve | 20.81 | NA | 13.67 | 2.81 | NA | 37.29 | 090 | |
33471 | A | Valvotomy, pulmonary valve | 22.25 | NA | 12.72 | 3.00 | NA | 37.97 | 090 | |
33472 | A | Revision of pulmonary valve | 22.25 | NA | 15.25 | 2.92 | NA | 40.42 | 090 | |
33474 | A | Revision of pulmonary valve | 23.04 | NA | 13.42 | 2.84 | NA | 39.30 | 090 | |
33475 | A | Replacement, pulmonary valve | 33.00 | NA | 18.87 | 2.64 | NA | 54.51 | 090 | |
33476 | A | Revision of heart chamber | 25.77 | NA | 14.07 | 2.40 | NA | 42.24 | 090 | |
33478 | A | Revision of heart chamber | 26.74 | NA | 15.15 | 3.56 | NA | 45.45 | 090 | |
33496 | A | Repair, prosth valve clot | 27.25 | NA | 17.18 | 3.44 | NA | 47.87 | 090 | |
33500 | A | Repair heart vessel fistula | 25.55 | NA | 13.86 | 2.80 | NA | 42.21 | 090 | |
33501 | A | Repair heart vessel fistula | 17.78 | NA | 10.55 | 2.05 | NA | 30.38 | 090 | |
33502 | A | Coronary artery correction | 21.04 | NA | 17.04 | 2.51 | NA | 40.59 | 090 | |
33503 | A | Coronary artery graft | 21.78 | NA | 14.05 | 1.42 | NA | 37.25 | 090 | |
33504 | A | Coronary artery graft | 24.66 | NA | 16.92 | 3.04 | NA | 44.62 | 090 | |
33505 | A | Repair artery w/tunnel | 26.84 | NA | 18.36 | 1.52 | NA | 46.72 | 090 | |
33506 | A | Repair artery, translocation | 35.50 | NA | 19.69 | 3.19 | NA | 58.38 | 090 | |
33508 | A | Endoscopic vein harvest | 0.31 | NA | 0.11 | 0.03 | NA | 0.45 | ZZZ | |
33510 | A | CABG, vein, single | 29.00 | NA | 15.52 | 3.13 | NA | 47.65 | 090 | |
33511 | A | CABG, vein, two | 30.00 | NA | 16.21 | 3.34 | NA | 49.55 | 090 | |
33512 | A | CABG, vein, three | 31.80 | NA | 16.75 | 3.70 | NA | 52.25 | 090 | |
33513 | A | CABG, vein, four | 32.00 | NA | 16.91 | 3.99 | NA | 52.90 | 090 | |
33514 | A | CABG, vein, five | 32.75 | NA | 17.16 | 4.37 | NA | 54.28 | 090 | |
33516 | A | Cabg, vein, six or more | 35.00 | NA | 17.91 | 4.62 | NA | 57.53 | 090 | |
33517 | A | CABG, artery-vein, single | 2.57 | NA | 0.84 | 0.32 | NA | 3.73 | ZZZ | |
33518 | A | CABG, artery-vein, two | 4.85 | NA | 1.58 | 0.61 | NA | 7.04 | ZZZ | |
33519 | A | CABG, artery-vein, three | 7.12 | NA | 2.31 | 0.89 | NA | 10.32 | ZZZ | |
33521 | A | CABG, artery-vein, four | 9.40 | NA | 3.05 | 1.18 | NA | 13.63 | ZZZ | |
33522 | A | CABG, artery-vein, five | 11.67 | NA | 3.79 | 1.48 | NA | 16.94 | ZZZ | |
33523 | A | Cabg, art-vein, six or more | 13.95 | NA | 4.50 | 1.78 | NA | 20.23 | ZZZ | |
33530 | A | Coronary artery, bypass/reop | 5.86 | NA | 1.90 | 0.73 | NA | 8.49 | ZZZ | |
33533 | A | CABG, arterial, single | 30.00 | NA | 15.67 | 3.24 | NA | 48.91 | 090 | |
33534 | A | CABG, arterial, two | 32.20 | NA | 16.81 | 3.63 | NA | 52.64 | 090 | |
33535 | A | CABG, arterial, three | 34.50 | NA | 17.30 | 3.97 | NA | 55.77 | 090 | |
33536 | A | Cabg, arterial, four or more | 37.50 | NA | 17.63 | 3.29 | NA | 58.42 | 090 | |
33542 | A | Removal of heart lesion | 28.85 | NA | 17.43 | 3.61 | NA | 49.89 | 090 | |
33545 | A | Repair of heart damage | 36.78 | NA | 20.01 | 4.40 | NA | 61.19 | 090 | |
33572 | A | Open coronary endarterectomy | 4.45 | NA | 1.44 | 0.55 | NA | 6.44 | ZZZ | |
33600 | A | Closure of valve | 29.51 | NA | 16.89 | 2.30 | NA | 48.70 | 090 | |
33602 | A | Closure of valve | 28.54 | NA | 16.43 | 2.90 | NA | 47.87 | 090 | |
33606 | A | Anastomosis/artery-aorta | 30.74 | NA | 18.23 | 3.59 | NA | 52.56 | 090 | |
33608 | A | Repair anomaly w/conduit | 31.09 | NA | 17.62 | 4.17 | NA | 52.88 | 090 | |
33610 | A | Repair by enlargement | 30.61 | NA | 18.66 | 4.02 | NA | 53.29 | 090 | |
33611 | A | Repair double ventricle | 34.00 | NA | 19.21 | 3.28 | NA | 56.49 | 090 | |
33612 | A | Repair double ventricle | 35.00 | NA | 19.97 | 4.44 | NA | 59.41 | 090 | |
33615 | A | Repair, modified fontan | 34.00 | NA | 18.80 | 3.15 | NA | 55.95 | 090 | |
33617 | A | Repair single ventricle | 37.00 | NA | 21.91 | 4.09 | NA | 63.00 | 090 | |
33619 | A | Repair single ventricle | 45.00 | NA | 27.24 | 4.71 | NA | 76.95 | 090 | |
33641 | A | Repair heart septum defect | 21.39 | NA | 11.95 | 2.67 | NA | 36.01 | 090 | |
33645 | A | Revision of heart veins | 24.82 | NA | 14.27 | 3.27 | NA | 42.36 | 090 | |
33647 | A | Repair heart septum defects | 28.73 | NA | 17.65 | 3.37 | NA | 49.75 | 090 | |
33660 | A | Repair of heart defects | 30.00 | NA | 17.37 | 2.82 | NA | 50.19 | 090 | |
33665 | A | Repair of heart defects | 28.60 | NA | 17.67 | 3.81 | NA | 50.08 | 090 | |
33670 | A | Repair of heart chambers | 35.00 | NA | 16.19 | 2.18 | NA | 53.37 | 090 | |
33681 | A | Repair heart septum defect | 30.61 | NA | 18.07 | 3.53 | NA | 52.21 | 090 | |
33684 | A | Repair heart septum defect | 29.65 | NA | 16.93 | 3.77 | NA | 50.35 | 090 | |
33688 | A | Repair heart septum defect | 30.62 | NA | 14.40 | 3.89 | NA | 48.91 | 090 | |
33690 | A | Reinforce pulmonary artery | 19.55 | NA | 13.65 | 2.56 | NA | 35.76 | 090 | |
33692 | A | Repair of heart defects | 30.75 | NA | 17.47 | 3.77 | NA | 51.99 | 090 | |
33694 | A | Repair of heart defects | 34.00 | NA | 18.41 | 4.27 | NA | 56.68 | 090 | |
33697 | A | Repair of heart defects | 36.00 | NA | 19.61 | 4.54 | NA | 60.15 | 090 | |
33702 | A | Repair of heart defects | 26.54 | NA | 16.85 | 3.45 | NA | 46.84 | 090 | |
33710 | A | Repair of heart defects | 29.71 | NA | 18.23 | 3.85 | NA | 51.79 | 090 | |
33720 | A | Repair of heart defect | 26.56 | NA | 16.34 | 3.21 | NA | 46.11 | 090 | |
33722 | A | Repair of heart defect | 28.41 | NA | 17.91 | 3.80 | NA | 50.12 | 090 | |
33730 | A | Repair heart-vein defect(s) | 34.25 | NA | 18.02 | 2.85 | NA | 55.12 | 090 | |
33732 | A | Repair heart-vein defect | 28.16 | NA | 17.20 | 2.78 | NA | 48.14 | 090 | |
33735 | A | Revision of heart chamber | 21.39 | NA | 12.25 | 1.12 | NA | 34.76 | 090 | |
33736 | A | Revision of heart chamber | 23.52 | NA | 15.56 | 2.70 | NA | 41.78 | 090 | |
33737 | A | Revision of heart chamber | 21.76 | NA | 14.86 | 2.93 | NA | 39.55 | 090 | |
33750 | A | Major vessel shunt | 21.41 | NA | 13.38 | 1.74 | NA | 36.53 | 090 | |
33755 | A | Major vessel shunt | 21.79 | NA | 12.25 | 2.93 | NA | 36.97 | 090 | |
33762 | A | Major vessel shunt | 21.79 | NA | 13.40 | 1.59 | NA | 36.78 | 090 | |
33764 | A | Major vessel shunt graft | 21.79 | NA | 13.15 | 1.93 | NA | 36.87 | 090 | |
33766 | A | Major vessel shunt | 22.76 | NA | 15.33 | 3.04 | NA | 41.13 | 090 | |
33767 | A | Major vessel shunt | 24.50 | NA | 15.19 | 3.14 | NA | 42.83 | 090 | |
33770 | A | Repair great vessels defect | 37.00 | NA | 17.97 | 4.49 | NA | 59.46 | 090 | |
33771 | A | Repair great vessels defect | 34.65 | NA | 14.95 | 4.67 | NA | 54.27 | 090 | |
33774 | A | Repair great vessels defect | 30.98 | NA | 16.58 | 4.18 | NA | 51.74 | 090 | |
33775 | A | Repair great vessels defect | 32.20 | NA | 16.92 | 4.34 | NA | 53.46 | 090 | |
33776 | A | Repair great vessels defect | 34.04 | NA | 18.41 | 4.58 | NA | 57.03 | 090 | |
33777 | A | Repair great vessels defect | 33.46 | NA | 17.41 | 4.51 | NA | 55.38 | 090 | |
33778 | A | Repair great vessels defect | 40.00 | NA | 20.72 | 4.83 | NA | 65.55 | 090 | |
33779 | A | Repair great vessels defect | 36.21 | NA | 18.16 | 2.40 | NA | 56.77 | 090 | |
33780 | A | Repair great vessels defect | 41.75 | NA | 22.40 | 5.21 | NA | 69.36 | 090 | |
33781 | A | Repair great vessels defect | 36.45 | NA | 15.41 | 4.91 | NA | 56.77 | 090 | |
33786 | A | Repair arterial trunk | 39.00 | NA | 20.17 | 4.69 | NA | 63.86 | 090 | |
33788 | A | Revision of pulmonary artery | 26.62 | NA | 15.38 | 3.32 | NA | 45.32 | 090 | |
33800 | A | Aortic suspension | 16.24 | NA | 12.45 | 1.11 | NA | 29.80 | 090 | |
33802 | A | Repair vessel defect | 17.66 | NA | 13.02 | 1.56 | NA | 32.24 | 090 | |
33803 | A | Repair vessel defect | 19.60 | NA | 13.51 | 2.63 | NA | 35.74 | 090 | |
33813 | A | Repair septal defect | 20.65 | NA | 14.94 | 2.78 | NA | 38.37 | 090 | |
33814 | A | Repair septal defect | 25.77 | NA | 16.47 | 2.52 | NA | 44.76 | 090 | |
33820 | A | Revise major vessel | 16.29 | NA | 11.45 | 2.10 | NA | 29.84 | 090 | |
33822 | A | Revise major vessel | 17.32 | NA | 13.84 | 2.33 | NA | 33.49 | 090 | |
33824 | A | Revise major vessel | 19.52 | NA | 12.63 | 2.61 | NA | 34.76 | 090 | |
33840 | A | Remove aorta constriction | 20.63 | NA | 13.95 | 2.36 | NA | 36.94 | 090 | |
33845 | A | Remove aorta constriction | 22.12 | NA | 15.13 | 2.90 | NA | 40.15 | 090 | |
33851 | A | Remove aorta constriction | 21.27 | NA | 14.80 | 2.86 | NA | 38.93 | 090 | |
33852 | A | Repair septal defect | 23.71 | NA | 15.34 | 3.19 | NA | 42.24 | 090 | |
33853 | A | Repair septal defect | 31.72 | NA | 18.90 | 4.23 | NA | 54.85 | 090 | |
33860 | A | Ascending aortic graft | 38.00 | NA | 18.90 | 4.30 | NA | 61.20 | 090 | |
33861 | A | Ascending aortic graft | 42.00 | NA | 20.18 | 4.24 | NA | 66.42 | 090 | |
33863 | A | Ascending aortic graft | 45.00 | NA | 21.14 | 4.60 | NA | 70.74 | 090 | |
33870 | A | Transverse aortic arch graft | 44.00 | NA | 20.83 | 5.09 | NA | 69.92 | 090 | |
33875 | A | Thoracic aortic graft | 33.06 | NA | 17.10 | 4.08 | NA | 54.24 | 090 | |
33877 | A | Thoracoabdominal graft | 42.60 | NA | 21.75 | 5.07 | NA | 69.42 | 090 | |
33910 | A | Remove lung artery emboli | 24.59 | NA | 14.28 | 3.06 | NA | 41.93 | 090 | |
33915 | A | Remove lung artery emboli | 21.02 | NA | 12.37 | 1.20 | NA | 34.59 | 090 | |
33916 | A | Surgery of great vessel | 25.83 | NA | 14.94 | 3.04 | NA | 43.81 | 090 | |
33917 | A | Repair pulmonary artery | 24.50 | NA | 15.94 | 3.17 | NA | 43.61 | 090 | |
33918 | A | Repair pulmonary atresia | 26.45 | NA | 15.59 | 3.42 | NA | 45.46 | 090 | |
33919 | A | Repair pulmonary atresia | 40.00 | NA | 21.68 | 3.48 | NA | 65.16 | 090 | |
33920 | A | Repair pulmonary atresia | 31.95 | NA | 16.90 | 3.61 | NA | 52.46 | 090 | |
33922 | A | Transect pulmonary artery | 23.52 | NA | 14.38 | 2.30 | NA | 40.20 | 090 | |
33924 | A | Remove pulmonary shunt | 5.50 | NA | 1.82 | 0.74 | NA | 8.06 | ZZZ | |
33930 | X | Removal of donor heart/lung | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
33935 | R | Transplantation, heart/lung | 60.96 | NA | 27.89 | 8.15 | NA | 97.00 | 090 | |
33940 | X | Removal of donor heart | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
33945 | R | Transplantation of heart | 42.10 | NA | 21.79 | 5.42 | NA | 69.31 | 090 | |
33960 | A | External circulation assist | 19.36 | NA | 4.96 | 2.14 | NA | 26.46 | 000 | |
33961 | A | External circulation assist | 10.93 | NA | 3.65 | 1.47 | NA | 16.05 | ZZZ | |
33967 | A | Insert ia percut device | 4.85 | 1.90 | 1.87 | 0.28 | 7.03 | 7.00 | 000 | |
33968 | A | Remove aortic assist device | 0.64 | NA | 0.23 | 0.07 | NA | 0.94 | 000 | |
33970 | A | Aortic circulation assist | 6.75 | NA | 2.29 | 0.70 | NA | 9.74 | 000 | |
33971 | A | Aortic circulation assist | 9.69 | NA | 8.18 | 0.97 | NA | 18.84 | 090 | |
33973 | A | Insert balloon device | 9.76 | NA | 3.31 | 1.01 | NA | 14.08 | 000 | |
33974 | A | Remove intra-aortic balloon | 14.41 | NA | 10.98 | 1.48 | NA | 26.87 | 090 | |
33975 | A | Implant ventricular device | 21.00 | NA | 6.28 | 1.72 | NA | 29.00 | XXX | |
33976 | A | Implant ventricular device | 23.00 | NA | 7.52 | 2.82 | NA | 33.34 | XXX | |
33977 | A | Remove ventricular device | 19.29 | NA | 10.50 | 2.44 | NA | 32.23 | 090 | |
33978 | A | Remove ventricular device | 21.73 | NA | 11.37 | 2.66 | NA | 35.76 | 090 | |
33979 | A | Insert intracorporeal device | 46.00 | 17.88 | 17.88 | 3.98 | 67.86 | 67.86 | XXX | |
33980 | A | Remove intracorporeal device | 56.25 | NA | 26.47 | 4.60 | NA | 87.32 | 090 | |
33999 | C | Cardiac surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
34001 | A | Removal of artery clot | 12.91 | NA | 5.85 | 1.46 | NA | 20.22 | 090 | |
34051 | A | Removal of artery clot | 15.21 | NA | 6.91 | 1.90 | NA | 24.02 | 090 | |
34101 | A | Removal of artery clot | 10.00 | NA | 4.71 | 1.11 | NA | 15.82 | 090 | |
34111 | A | Removal of arm artery clot | 10.00 | NA | 4.77 | 0.85 | NA | 15.62 | 090 | |
34151 | A | Removal of artery clot | 25.00 | NA | 10.24 | 1.84 | NA | 37.08 | 090 | |
34201 | A | Removal of artery clot | 10.03 | NA | 5.03 | 1.02 | NA | 16.08 | 090 | |
34203 | A | Removal of leg artery clot | 16.50 | NA | 7.46 | 1.37 | NA | 25.33 | 090 | |
34401 | A | Removal of vein clot | 25.00 | NA | 10.05 | 1.20 | NA | 36.25 | 090 | |
34421 | A | Removal of vein clot | 12.00 | NA | 5.88 | 0.95 | NA | 18.83 | 090 | |
34451 | A | Removal of vein clot | 27.00 | NA | 10.76 | 1.59 | NA | 39.35 | 090 | |
34471 | A | Removal of vein clot | 10.18 | NA | 4.93 | 0.90 | NA | 16.01 | 090 | |
34490 | A | Removal of vein clot | 9.86 | NA | 6.12 | 0.73 | NA | 16.71 | 090 | |
34501 | A | Repair valve, femoral vein | 16.00 | NA | 9.25 | 1.37 | NA | 26.62 | 090 | |
34502 | A | Reconstruct vena cava | 26.95 | NA | 10.98 | 2.99 | NA | 40.92 | 090 | |
34510 | A | Transposition of vein valve | 18.95 | NA | 10.27 | 1.60 | NA | 30.82 | 090 | |
34520 | A | Cross-over vein graft | 17.95 | NA | 9.30 | 1.41 | NA | 28.66 | 090 | |
34530 | A | Leg vein fusion | 16.64 | NA | 8.74 | 2.06 | NA | 27.44 | 090 | |
34800 | A | Endovasc abdo repair w/tube | 20.75 | NA | 8.94 | 1.49 | NA | 31.18 | 090 | |
34802 | A | Endovasc abdo repr w/device | 23.00 | NA | 9.69 | 1.65 | NA | 34.34 | 090 | |
34804 | A | Endovasc abdo repr w/device | 23.00 | NA | 9.69 | 1.65 | NA | 34.34 | 090 | |
34808 | A | Endovasc abdo occlud device | 4.13 | NA | 1.40 | 0.29 | NA | 5.82 | ZZZ | |
34812 | A | Xpose for endoprosth, femorl | 6.75 | NA | 2.29 | 0.49 | NA | 9.53 | 000 | |
34813 | A | Femoral endovas graft add-on | 4.80 | NA | 1.60 | 0.34 | NA | 6.74 | ZZZ | |
34820 | A | Xpose for endoprosth, iliac | 9.75 | NA | 3.30 | 0.70 | NA | 13.75 | 000 | |
34825 | A | Endovasc extend prosth, init | 12.00 | NA | 5.95 | 0.86 | NA | 18.81 | 090 | |
34826 | A | Endovasc exten prosth, addl | 4.13 | NA | 1.41 | 0.29 | NA | 5.83 | ZZZ | |
34830 | A | Open aortic tube prosth repr | 32.59 | NA | 13.31 | 2.34 | NA | 48.24 | 090 | |
34831 | A | Open aortoiliac prosth repr | 35.34 | NA | 11.68 | 2.53 | NA | 49.55 | 090 | |
34832 | A | Open aortofemor prosth repr | 35.34 | NA | 14.38 | 2.53 | NA | 52.25 | 090 | |
34833 | A | Xpose for endoprosth, iliac | 12.00 | NA | 4.98 | 0.70 | NA | 17.68 | 000 | |
34834 | A | Xpose, endoprosth, brachial | 5.35 | NA | 2.48 | 0.49 | NA | 8.32 | 000 | |
34900 | A | Endovasc iliac repr w/graft | 16.38 | NA | 8.24 | 1.49 | NA | 26.11 | 090 | |
35001 | A | Repair defect of artery | 19.64 | NA | 8.39 | 2.44 | NA | 30.47 | 090 | |
35002 | A | Repair artery rupture, neck | 21.00 | NA | 9.07 | 1.82 | NA | 31.89 | 090 | |
35005 | A | Repair defect of artery | 18.12 | NA | 7.79 | 1.35 | NA | 27.26 | 090 | |
35011 | A | Repair defect of artery | 18.00 | NA | 7.40 | 1.30 | NA | 26.70 | 090 | |
35013 | A | Repair artery rupture, arm | 22.00 | NA | 8.74 | 1.91 | NA | 32.65 | 090 | |
35021 | A | Repair defect of artery | 19.65 | NA | 8.61 | 1.93 | NA | 30.19 | 090 | |
35022 | A | Repair artery rupture, chest | 23.18 | NA | 9.43 | 1.99 | NA | 34.60 | 090 | |
35045 | A | Repair defect of arm artery | 17.57 | NA | 8.61 | 1.25 | NA | 27.43 | 090 | |
35081 | A | Repair defect of artery | 28.01 | NA | 11.65 | 3.20 | NA | 42.86 | 090 | |
35082 | A | Repair artery rupture, aorta | 38.50 | NA | 14.60 | 4.07 | NA | 57.17 | 090 | |
35091 | A | Repair defect of artery | 35.40 | NA | 13.91 | 4.09 | NA | 53.40 | 090 | |
35092 | A | Repair artery rupture, aorta | 45.00 | NA | 16.93 | 4.31 | NA | 66.24 | 090 | |
35102 | A | Repair defect of artery | 30.76 | NA | 12.33 | 3.44 | NA | 46.53 | 090 | |
35103 | A | Repair artery rupture, groin | 40.50 | NA | 15.39 | 3.79 | NA | 59.68 | 090 | |
35111 | A | Repair defect of artery | 25.00 | NA | 10.18 | 1.81 | NA | 36.99 | 090 | |
35112 | A | Repair artery rupture,spleen | 30.00 | NA | 11.65 | 1.95 | NA | 43.60 | 090 | |
35121 | A | Repair defect of artery | 30.00 | NA | 12.07 | 2.93 | NA | 45.00 | 090 | |
35122 | A | Repair artery rupture, belly | 35.00 | NA | 13.46 | 3.54 | NA | 52.00 | 090 | |
35131 | A | Repair defect of artery | 25.00 | NA | 10.38 | 2.11 | NA | 37.49 | 090 | |
35132 | A | Repair artery rupture, groin | 30.00 | NA | 11.82 | 2.48 | NA | 44.30 | 090 | |
35141 | A | Repair defect of artery | 20.00 | NA | 8.50 | 1.65 | NA | 30.15 | 090 | |
35142 | A | Repair artery rupture, thigh | 23.30 | NA | 9.56 | 1.75 | NA | 34.61 | 090 | |
35151 | A | Repair defect of artery | 22.64 | NA | 9.54 | 1.93 | NA | 34.11 | 090 | |
35152 | A | Repair artery rupture, knee | 25.62 | NA | 10.42 | 1.93 | NA | 37.97 | 090 | |
35161 | A | Repair defect of artery | 18.76 | NA | 8.70 | 2.21 | NA | 29.67 | 090 | |
35162 | A | Repair artery rupture | 19.78 | NA | 8.86 | 2.21 | NA | 30.85 | 090 | |
35180 | A | Repair blood vessel lesion | 13.62 | NA | 6.35 | 1.44 | NA | 21.41 | 090 | |
35182 | A | Repair blood vessel lesion | 30.00 | NA | 12.30 | 1.88 | NA | 44.18 | 090 | |
35184 | A | Repair blood vessel lesion | 18.00 | NA | 7.79 | 1.34 | NA | 27.13 | 090 | |
35188 | A | Repair blood vessel lesion | 14.28 | NA | 6.58 | 1.53 | NA | 22.39 | 090 | |
35189 | A | Repair blood vessel lesion | 28.00 | NA | 11.46 | 2.12 | NA | 41.58 | 090 | |
35190 | A | Repair blood vessel lesion | 12.75 | NA | 5.88 | 1.33 | NA | 19.96 | 090 | |
35201 | A | Repair blood vessel lesion | 16.14 | NA | 7.02 | 1.17 | NA | 24.33 | 090 | |
35206 | A | Repair blood vessel lesion | 13.25 | NA | 7.51 | 1.04 | NA | 21.80 | 090 | |
35207 | A | Repair blood vessel lesion | 10.15 | NA | 9.76 | 1.15 | NA | 21.06 | 090 | |
35211 | A | Repair blood vessel lesion | 22.12 | NA | 13.77 | 2.83 | NA | 38.72 | 090 | |
35216 | A | Repair blood vessel lesion | 18.75 | NA | 11.67 | 2.17 | NA | 32.59 | 090 | |
35221 | A | Repair blood vessel lesion | 24.39 | NA | 10.09 | 1.79 | NA | 36.27 | 090 | |
35226 | A | Repair blood vessel lesion | 14.50 | NA | 8.95 | 0.84 | NA | 24.29 | 090 | |
35231 | A | Repair blood vessel lesion | 20.00 | NA | 9.24 | 1.32 | NA | 30.56 | 090 | |
35236 | A | Repair blood vessel lesion | 17.11 | NA | 8.89 | 1.19 | NA | 27.19 | 090 | |
35241 | A | Repair blood vessel lesion | 23.12 | NA | 14.42 | 2.90 | NA | 40.44 | 090 | |
35246 | A | Repair blood vessel lesion | 26.45 | NA | 14.23 | 2.22 | NA | 42.90 | 090 | |
35251 | A | Repair blood vessel lesion | 30.20 | NA | 12.03 | 1.87 | NA | 44.10 | 090 | |
35256 | A | Repair blood vessel lesion | 18.36 | NA | 9.43 | 1.32 | NA | 29.11 | 090 | |
35261 | A | Repair blood vessel lesion | 17.80 | NA | 7.43 | 1.34 | NA | 26.57 | 090 | |
35266 | A | Repair blood vessel lesion | 14.91 | NA | 7.98 | 1.16 | NA | 24.05 | 090 | |
35271 | A | Repair blood vessel lesion | 22.12 | NA | 13.57 | 2.77 | NA | 38.46 | 090 | |
35276 | A | Repair blood vessel lesion | 24.25 | NA | 13.84 | 2.37 | NA | 40.46 | 090 | |
35281 | A | Repair blood vessel lesion | 28.00 | NA | 11.41 | 1.82 | NA | 41.23 | 090 | |
35286 | A | Repair blood vessel lesion | 16.16 | NA | 8.73 | 1.36 | NA | 26.25 | 090 | |
35301 | A | Rechanneling of artery | 18.70 | NA | 8.26 | 2.23 | NA | 29.19 | 090 | |
35311 | A | Rechanneling of artery | 27.00 | NA | 10.92 | 2.75 | NA | 40.67 | 090 | |
35321 | A | Rechanneling of artery | 16.00 | NA | 6.72 | 1.36 | NA | 24.08 | 090 | |
35331 | A | Rechanneling of artery | 26.20 | NA | 10.82 | 2.71 | NA | 39.73 | 090 | |
35341 | A | Rechanneling of artery | 25.11 | NA | 10.41 | 2.87 | NA | 38.39 | 090 | |
35351 | A | Rechanneling of artery | 23.00 | NA | 9.63 | 2.29 | NA | 34.92 | 090 | |
35355 | A | Rechanneling of artery | 18.50 | NA | 8.12 | 1.80 | NA | 28.42 | 090 | |
35361 | A | Rechanneling of artery | 28.20 | NA | 11.37 | 2.66 | NA | 42.23 | 090 | |
35363 | A | Rechanneling of artery | 30.20 | NA | 12.12 | 2.77 | NA | 45.09 | 090 | |
35371 | A | Rechanneling of artery | 14.72 | NA | 6.58 | 1.32 | NA | 22.62 | 090 | |
35372 | A | Rechanneling of artery | 18.00 | NA | 7.73 | 1.53 | NA | 27.26 | 090 | |
35381 | A | Rechanneling of artery | 15.81 | NA | 7.21 | 1.80 | NA | 24.82 | 090 | |
35390 | A | Reoperation, carotid add-on | 3.19 | NA | 1.07 | 0.38 | NA | 4.64 | ZZZ | |
35400 | A | Angioscopy | 3.00 | NA | 1.05 | 0.34 | NA | 4.39 | ZZZ | |
35450 | A | Repair arterial blockage | 10.07 | NA | 4.02 | 0.84 | NA | 14.93 | 000 | |
35452 | A | Repair arterial blockage | 6.91 | NA | 3.09 | 0.76 | NA | 10.76 | 000 | |
35454 | A | Repair arterial blockage | 6.04 | NA | 2.77 | 0.67 | NA | 9.48 | 000 | |
35456 | A | Repair arterial blockage | 7.35 | NA | 3.21 | 0.82 | NA | 11.38 | 000 | |
35458 | A | Repair arterial blockage | 9.49 | NA | 3.92 | 1.09 | NA | 14.50 | 000 | |
35459 | A | Repair arterial blockage | 8.63 | NA | 3.59 | 0.96 | NA | 13.18 | 000 | |
35460 | A | Repair venous blockage | 6.04 | NA | 2.63 | 0.66 | NA | 9.33 | 000 | |
35470 | A | Repair arterial blockage | 8.63 | NA | 3.89 | 0.50 | NA | 13.02 | 000 | |
35471 | A | Repair arterial blockage | 10.07 | NA | 4.53 | 0.50 | NA | 15.10 | 000 | |
35472 | A | Repair arterial blockage | 6.91 | NA | 3.26 | 0.39 | NA | 10.56 | 000 | |
35473 | A | Repair arterial blockage | 6.04 | NA | 2.95 | 0.34 | NA | 9.33 | 000 | |
35474 | A | Repair arterial blockage | 7.36 | NA | 2.94 | 0.40 | NA | 10.70 | 000 | |
35475 | R | Repair arterial blockage | 9.49 | NA | 4.12 | 0.47 | NA | 14.08 | 000 | |
35476 | A | Repair venous blockage | 6.04 | NA | 2.88 | 0.27 | NA | 9.19 | 000 | |
35480 | A | Atherectomy, open | 11.08 | NA | 4.50 | 1.13 | NA | 16.71 | 000 | |
35481 | A | Atherectomy, open | 7.61 | NA | 3.38 | 0.84 | NA | 11.83 | 000 | |
35482 | A | Atherectomy, open | 6.65 | NA | 3.04 | 0.75 | NA | 10.44 | 000 | |
35483 | A | Atherectomy, open | 8.10 | NA | 3.47 | 0.81 | NA | 12.38 | 000 | |
35484 | A | Atherectomy, open | 10.44 | NA | 4.19 | 1.13 | NA | 15.76 | 000 | |
35485 | A | Atherectomy, open | 9.49 | NA | 4.02 | 1.06 | NA | 14.57 | 000 | |
35490 | A | Atherectomy, percutaneous | 11.08 | NA | 4.80 | 0.55 | NA | 16.43 | 000 | |
35491 | A | Atherectomy, percutaneous | 7.61 | NA | 3.32 | 0.49 | NA | 11.42 | 000 | |
35492 | A | Atherectomy, percutaneous | 6.65 | NA | 3.20 | 0.43 | NA | 10.28 | 000 | |
35493 | A | Atherectomy, percutaneous | 8.10 | NA | 3.86 | 0.47 | NA | 12.43 | 000 | |
35494 | A | Atherectomy, percutaneous | 10.44 | NA | 4.46 | 0.48 | NA | 15.38 | 000 | |
35495 | A | Atherectomy, percutaneous | 9.49 | NA | 4.46 | 0.51 | NA | 14.46 | 000 | |
35500 | A | Harvest vein for bypass | 6.45 | NA | 2.07 | 0.63 | NA | 9.15 | ZZZ | |
35501 | A | Artery bypass graft | 19.19 | NA | 7.43 | 2.33 | NA | 28.95 | 090 | |
35506 | A | Artery bypass graft | 19.67 | NA | 8.13 | 2.33 | NA | 30.13 | 090 | |
35507 | A | Artery bypass graft | 19.67 | NA | 8.09 | 2.27 | NA | 30.03 | 090 | |
35508 | A | Artery bypass graft | 18.65 | NA | 7.85 | 2.34 | NA | 28.84 | 090 | |
35509 | A | Artery bypass graft | 18.07 | NA | 7.54 | 2.12 | NA | 27.73 | 090 | |
35511 | A | Artery bypass graft | 21.20 | NA | 8.69 | 1.74 | NA | 31.63 | 090 | |
35515 | A | Artery bypass graft | 18.65 | NA | 7.93 | 2.26 | NA | 28.84 | 090 | |
35516 | A | Artery bypass graft | 16.32 | NA | 5.80 | 1.88 | NA | 24.00 | 090 | |
35518 | A | Artery bypass graft | 21.20 | NA | 8.49 | 1.78 | NA | 31.47 | 090 | |
35521 | A | Artery bypass graft | 22.20 | NA | 9.33 | 1.82 | NA | 33.35 | 090 | |
35526 | A | Artery bypass graft | 29.95 | NA | 12.00 | 2.18 | NA | 44.13 | 090 | |
35531 | A | Artery bypass graft | 36.20 | NA | 14.13 | 2.91 | NA | 53.24 | 090 | |
35533 | A | Artery bypass graft | 28.00 | NA | 11.36 | 2.35 | NA | 41.71 | 090 | |
35536 | A | Artery bypass graft | 31.70 | NA | 12.58 | 2.62 | NA | 46.90 | 090 | |
35541 | A | Artery bypass graft | 25.80 | NA | 10.72 | 2.74 | NA | 39.26 | 090 | |
35546 | A | Artery bypass graft | 25.54 | NA | 10.48 | 2.84 | NA | 38.86 | 090 | |
35548 | A | Artery bypass graft | 21.57 | NA | 9.06 | 2.45 | NA | 33.08 | 090 | |
35549 | A | Artery bypass graft | 23.35 | NA | 9.81 | 2.77 | NA | 35.93 | 090 | |
35551 | A | Artery bypass graft | 26.67 | NA | 10.89 | 3.19 | NA | 40.75 | 090 | |
35556 | A | Artery bypass graft | 21.76 | NA | 9.24 | 2.48 | NA | 33.48 | 090 | |
35558 | A | Artery bypass graft | 21.20 | NA | 8.99 | 1.58 | NA | 31.77 | 090 | |
35560 | A | Artery bypass graft | 32.00 | NA | 12.78 | 2.73 | NA | 47.51 | 090 | |
35563 | A | Artery bypass graft | 24.20 | NA | 10.09 | 1.68 | NA | 35.97 | 090 | |
35565 | A | Artery bypass graft | 23.20 | NA | 9.71 | 1.71 | NA | 34.62 | 090 | |
35566 | A | Artery bypass graft | 26.92 | NA | 11.67 | 3.02 | NA | 41.61 | 090 | |
35571 | A | Artery bypass graft | 24.06 | NA | 11.90 | 2.14 | NA | 38.10 | 090 | |
35572 | A | Harvest femoropopliteal vein | 6.82 | NA | 2.57 | 0.63 | NA | 10.02 | ZZZ | |
35582 | A | Vein bypass graft | 27.13 | NA | 11.09 | 3.11 | NA | 41.33 | 090 | |
35583 | A | Vein bypass graft | 22.37 | NA | 10.39 | 2.53 | NA | 35.29 | 090 | |
35585 | A | Vein bypass graft | 28.39 | NA | 14.29 | 3.21 | NA | 45.89 | 090 | |
35587 | A | Vein bypass graft | 24.75 | NA | 12.58 | 2.17 | NA | 39.50 | 090 | |
35600 | A | Harvest artery for cabg | 4.95 | NA | 1.62 | 0.60 | NA | 7.17 | ZZZ | |
35601 | A | Artery bypass graft | 17.50 | NA | 7.33 | 2.08 | NA | 26.91 | 090 | |
35606 | A | Artery bypass graft | 18.71 | NA | 7.75 | 2.17 | NA | 28.63 | 090 | |
35612 | A | Artery bypass graft | 15.76 | NA | 6.72 | 1.72 | NA | 24.20 | 090 | |
35616 | A | Artery bypass graft | 15.70 | NA | 6.78 | 1.84 | NA | 24.32 | 090 | |
35621 | A | Artery bypass graft | 20.00 | NA | 8.67 | 1.68 | NA | 30.35 | 090 | |
35623 | A | Bypass graft, not vein | 24.00 | NA | 9.98 | 1.91 | NA | 35.89 | 090 | |
35626 | A | Artery bypass graft | 27.75 | NA | 10.93 | 2.89 | NA | 41.57 | 090 | |
35631 | A | Artery bypass graft | 34.00 | NA | 13.41 | 2.83 | NA | 50.24 | 090 | |
35636 | A | Artery bypass graft | 29.50 | NA | 12.11 | 2.37 | NA | 43.98 | 090 | |
35641 | A | Artery bypass graft | 24.57 | NA | 10.27 | 2.83 | NA | 37.67 | 090 | |
35642 | A | Artery bypass graft | 17.98 | NA | 7.86 | 1.84 | NA | 27.68 | 090 | |
35645 | A | Artery bypass graft | 17.47 | NA | 7.69 | 1.91 | NA | 27.07 | 090 | |
35646 | A | Artery bypass graft | 31.00 | NA | 13.00 | 3.63 | NA | 47.63 | 090 | |
35647 | A | Artery bypass graft | 28.00 | NA | 11.76 | 3.28 | NA | 43.04 | 090 | |
35650 | A | Artery bypass graft | 19.00 | NA | 7.77 | 1.64 | NA | 28.41 | 090 | |
35651 | A | Artery bypass graft | 25.04 | NA | 10.50 | 2.53 | NA | 38.07 | 090 | |
35654 | A | Artery bypass graft | 25.00 | NA | 10.34 | 2.10 | NA | 37.44 | 090 | |
35656 | A | Artery bypass graft | 19.53 | NA | 8.22 | 2.21 | NA | 29.96 | 090 | |
35661 | A | Artery bypass graft | 19.00 | NA | 8.09 | 1.50 | NA | 28.59 | 090 | |
35663 | A | Artery bypass graft | 22.00 | NA | 9.44 | 1.55 | NA | 32.99 | 090 | |
35665 | A | Artery bypass graft | 21.00 | NA | 8.98 | 1.76 | NA | 31.74 | 090 | |
35666 | A | Artery bypass graft | 22.19 | NA | 11.72 | 2.19 | NA | 36.10 | 090 | |
35671 | A | Artery bypass graft | 19.33 | NA | 10.39 | 1.68 | NA | 31.40 | 090 | |
35681 | A | Composite bypass graft | 1.60 | NA | 0.55 | 0.18 | NA | 2.33 | ZZZ | |
35682 | A | Composite bypass graft | 7.20 | NA | 2.44 | 0.83 | NA | 10.47 | ZZZ | |
35683 | A | Composite bypass graft | 8.50 | NA | 2.88 | 0.98 | NA | 12.36 | ZZZ | |
35685 | A | Bypass graft patency/patch | 4.05 | NA | 1.52 | 0.25 | NA | 5.82 | ZZZ | |
35686 | A | Bypass graft/av fist patency | 3.35 | NA | 1.26 | 0.21 | NA | 4.82 | ZZZ | |
35691 | A | Arterial transposition | 18.05 | NA | 7.54 | 2.06 | NA | 27.65 | 090 | |
35693 | A | Arterial transposition | 15.36 | NA | 6.59 | 1.80 | NA | 23.75 | 090 | |
35694 | A | Arterial transposition | 19.16 | NA | 7.83 | 2.13 | NA | 29.12 | 090 | |
35695 | A | Arterial transposition | 19.16 | NA | 7.78 | 2.19 | NA | 29.13 | 090 | |
35700 | A | Reoperation, bypass graft | 3.08 | NA | 1.03 | 0.36 | NA | 4.47 | ZZZ | |
35701 | A | Exploration, carotid artery | 8.50 | NA | 4.59 | 0.64 | NA | 13.73 | 090 | |
35721 | A | Exploration, femoral artery | 7.18 | NA | 5.13 | 0.59 | NA | 12.90 | 090 | |
35741 | A | Exploration popliteal artery | 8.00 | NA | 5.34 | 0.60 | NA | 13.94 | 090 | |
35761 | A | Exploration of artery/vein | 5.37 | NA | 4.42 | 0.60 | NA | 10.39 | 090 | |
35800 | A | Explore neck vessels | 7.02 | NA | 3.90 | 0.79 | NA | 11.71 | 090 | |
35820 | A | Explore chest vessels | 12.88 | NA | 4.19 | 1.61 | NA | 18.68 | 090 | |
35840 | A | Explore abdominal vessels | 9.77 | NA | 5.10 | 1.06 | NA | 15.93 | 090 | |
35860 | A | Explore limb vessels | 5.55 | NA | 3.54 | 0.63 | NA | 9.72 | 090 | |
35870 | A | Repair vessel graft defect | 22.17 | NA | 9.95 | 2.47 | NA | 34.59 | 090 | |
35875 | A | Removal of clot in graft | 10.13 | NA | 6.30 | 0.97 | NA | 17.40 | 090 | |
35876 | A | Removal of clot in graft | 17.00 | NA | 8.80 | 1.88 | NA | 27.68 | 090 | |
35879 | A | Revise graft w/vein | 16.00 | NA | 7.61 | 1.35 | NA | 24.96 | 090 | |
35881 | A | Revise graft w/vein | 18.00 | NA | 8.46 | 1.44 | NA | 27.90 | 090 | |
35901 | A | Excision, graft, neck | 8.19 | NA | 5.82 | 0.90 | NA | 14.91 | 090 | |
35903 | A | Excision, graft, extremity | 9.39 | NA | 8.08 | 1.03 | NA | 18.50 | 090 | |
35905 | A | Excision, graft, thorax | 31.25 | NA | 15.12 | 2.15 | NA | 48.52 | 090 | |
35907 | A | Excision, graft, abdomen | 35.00 | NA | 14.57 | 2.17 | NA | 51.74 | 090 | |
36000 | A | Place needle in vein | 0.18 | 0.66 | 0.05 | 0.01 | 0.85 | 0.24 | XXX | |
36002 | A | Pseudoaneurysm injection trt | 1.96 | 2.45 | 1.00 | 0.10 | 4.51 | 3.06 | 000 | |
36005 | A | Injection ext venography | 0.95 | 8.51 | 0.32 | 0.04 | 9.50 | 1.31 | 000 | |
36010 | A | Place catheter in vein | 2.43 | NA | 0.81 | 0.16 | NA | 3.40 | XXX | |
36011 | A | Place catheter in vein | 3.14 | NA | 1.05 | 0.17 | NA | 4.36 | XXX | |
36012 | A | Place catheter in vein | 3.52 | NA | 1.18 | 0.17 | NA | 4.87 | XXX | |
36013 | A | Place catheter in artery | 2.52 | NA | 0.67 | 0.17 | NA | 3.36 | XXX | |
36014 | A | Place catheter in artery | 3.02 | NA | 1.02 | 0.14 | NA | 4.18 | XXX | |
36015 | A | Place catheter in artery | 3.52 | NA | 1.18 | 0.16 | NA | 4.86 | XXX | |
36100 | A | Establish access to artery | 3.02 | NA | 1.12 | 0.18 | NA | 4.32 | XXX | |
36120 | A | Establish access to artery | 2.01 | NA | 0.67 | 0.11 | NA | 2.79 | XXX | |
36140 | A | Establish access to artery | 2.01 | NA | 0.66 | 0.12 | NA | 2.79 | XXX | |
36145 | A | Artery to vein shunt | 2.01 | NA | 0.68 | 0.10 | NA | 2.79 | XXX | |
36160 | A | Establish access to aorta | 2.52 | NA | 0.86 | 0.20 | NA | 3.58 | XXX | |
36200 | A | Place catheter in aorta | 3.02 | NA | 1.04 | 0.15 | NA | 4.21 | XXX | |
36215 | A | Place catheter in artery | 4.68 | NA | 1.62 | 0.22 | NA | 6.52 | XXX | |
36216 | A | Place catheter in artery | 5.28 | NA | 1.81 | 0.24 | NA | 7.33 | XXX | |
36217 | A | Place catheter in artery | 6.30 | NA | 2.21 | 0.32 | NA | 8.83 | XXX | |
36218 | A | Place catheter in artery | 1.01 | NA | 0.35 | 0.05 | NA | 1.41 | ZZZ | |
36245 | A | Place catheter in artery | 4.68 | NA | 1.69 | 0.23 | NA | 6.60 | XXX | |
36246 | A | Place catheter in artery | 5.28 | NA | 1.83 | 0.26 | NA | 7.37 | XXX | |
36247 | A | Place catheter in artery | 6.30 | NA | 2.17 | 0.32 | NA | 8.79 | XXX | |
36248 | A | Place catheter in artery | 1.01 | NA | 0.36 | 0.06 | NA | 1.43 | ZZZ | |
36260 | A | Insertion of infusion pump | 9.71 | NA | 5.50 | 1.00 | NA | 16.21 | 090 | |
36261 | A | Revision of infusion pump | 5.45 | NA | 3.33 | 0.50 | NA | 9.28 | 090 | |
36262 | A | Removal of infusion pump | 4.02 | NA | 2.48 | 0.43 | NA | 6.93 | 090 | |
36299 | C | Vessel injection procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
36400 | A | Bl draw 3 yrs fem/jugular | 0.38 | 0.89 | 0.10 | 0.01 | 1.28 | 0.49 | XXX | |
36405 | A | Bl draw 3 yrs scalp vein | 0.31 | 0.33 | 0.08 | 0.01 | 0.65 | 0.40 | XXX | |
36406 | A | Bl draw 3 yrs other vein | 0.18 | 0.37 | 0.05 | 0.01 | 0.56 | 0.24 | XXX | |
36410 | A | Non-routine bl draw 3 yrs | 0.18 | 0.39 | 0.05 | 0.01 | 0.58 | 0.24 | XXX | |
36415 | I | Routine venipuncture | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
36416 | I | Capillary blood draw | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
36420 | A | Vein access cutdown 1 yr | 1.01 | NA | 0.31 | 0.09 | NA | 1.41 | XXX | |
36425 | A | Vein access cutdown 1 yr | 0.76 | NA | 0.22 | 0.05 | NA | 1.03 | XXX | |
36430 | A | Blood transfusion service | 0.00 | 1.01 | NA | 0.05 | 1.06 | NA | XXX | |
36440 | A | Bl push transfuse, 2 yr or | 1.03 | NA | 0.29 | 0.08 | NA | 1.40 | XXX | |
36450 | A | Bl exchange/transfuse, nb | 2.23 | NA | 0.72 | 0.16 | NA | 3.11 | XXX | |
36455 | A | Bl exchange/transfuse non-nb | 2.43 | NA | 0.85 | 0.10 | NA | 3.38 | XXX | |
36460 | A | Transfusion service, fetal | 6.59 | NA | 2.27 | 0.56 | NA | 9.42 | XXX | |
36468 | R | Injection(s), spider veins | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | |
36469 | R | Injection(s), spider veins | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | |
36470 | A | Injection therapy of vein | 1.09 | 2.33 | 0.39 | 0.10 | 3.52 | 1.58 | 010 | |
36471 | A | Injection therapy of veins | 1.57 | 2.68 | 0.55 | 0.15 | 4.40 | 2.27 | 010 | |
36481 | A | Insertion of catheter, vein | 6.99 | NA | 2.80 | 0.40 | NA | 10.19 | 000 | |
36488 | A | Insertion of catheter, vein | 1.35 | NA | 0.74 | 0.09 | NA | 2.18 | 000 | |
36489 | A | Insertion of catheter, vein | 2.50 | 4.11 | 1.04 | 0.08 | 6.69 | 3.62 | 000 | |
36490 | A | Insertion of catheter, vein | 1.67 | NA | 0.83 | 0.17 | NA | 2.67 | 000 | |
36491 | A | Insertion of catheter, vein | 1.43 | NA | 0.76 | 0.13 | NA | 2.32 | 000 | |
36493 | A | Repositioning of cvc | 1.21 | NA | 0.86 | 0.06 | NA | 2.13 | 000 | |
36500 | A | Insertion of catheter, vein | 3.52 | NA | 1.26 | 0.14 | NA | 4.92 | 000 | |
36510 | A | Insertion of catheter, vein | 1.09 | NA | 0.72 | 0.06 | NA | 1.87 | 000 | |
36511 | A | Apheresis wbc | 1.74 | NA | 0.70 | 0.06 | NA | 2.50 | 000 | |
36512 | A | Apheresis rbc | 1.74 | NA | 0.70 | 0.06 | NA | 2.50 | 000 | |
36513 | A | Apheresis platelets | 1.74 | NA | 0.70 | 0.06 | NA | 2.50 | 000 | |
36514 | A | Apheresis plasma | 1.74 | NA | 0.70 | 0.06 | NA | 2.50 | 000 | |
36515 | A | Apheresis, adsorp/reinfuse | 1.74 | NA | 0.70 | 0.06 | NA | 2.50 | 000 | |
36516 | A | Apheresis, selective | 1.74 | NA | 0.70 | 0.06 | NA | 2.50 | 000 | |
36520 | D | Plasma and/or cell exchange | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | |
36521 | D | Apheresis w/ adsorp/reinfuse | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | |
36522 | A | Photopheresis | 1.67 | 6.77 | 1.15 | 0.07 | 8.51 | 2.89 | 000 | |
36530 | R | Insertion of infusion pump | 6.20 | NA | 3.70 | 0.56 | NA | 10.46 | 010 | |
36531 | R | Revision of infusion pump | 4.87 | NA | 3.25 | 0.44 | NA | 8.56 | 010 | |
36532 | R | Removal of infusion pump | 3.30 | NA | 1.52 | 0.34 | NA | 5.16 | 010 | |
36533 | A | Insertion of access device | 5.32 | 13.55 | 3.38 | 0.49 | 19.36 | 9.19 | 010 | |
36534 | A | Revision of access device | 2.80 | NA | 1.46 | 0.19 | NA | 4.45 | 010 | |
36535 | A | Removal of access device | 2.27 | 2.81 | 1.82 | 0.21 | 5.29 | 4.30 | 010 | |
36536 | A | Remove cva device obstruct | 3.60 | 33.54 | 1.47 | 0.23 | 37.37 | 5.30 | 000 | |
36537 | A | Remove cva lumen obstruct | 0.75 | 7.69 | 0.49 | 0.04 | 8.48 | 1.28 | 000 | |
36540 | B | Collect blood venous device | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
36550 | A | Declot vascular device | 0.00 | 0.38 | NA | 0.31 | 0.69 | NA | XXX | |
36600 | A | Withdrawal of arterial blood | 0.32 | 0.41 | 0.09 | 0.02 | 0.75 | 0.43 | XXX | |
36620 | A | Insertion catheter, artery | 1.15 | NA | 0.24 | 0.06 | NA | 1.45 | 000 | |
36625 | A | Insertion catheter, artery | 2.11 | NA | 0.53 | 0.16 | NA | 2.80 | 000 | |
36640 | A | Insertion catheter, artery | 2.10 | NA | 0.72 | 0.18 | NA | 3.00 | 000 | |
36660 | A | Insertion catheter, artery | 1.40 | NA | 0.45 | 0.08 | NA | 1.93 | 000 | |
36680 | A | Insert needle, bone cavity | 1.20 | NA | 0.62 | 0.08 | NA | 1.90 | 000 | |
36800 | A | Insertion of cannula | 2.43 | NA | 1.76 | 0.17 | NA | 4.36 | 000 | |
36810 | A | Insertion of cannula | 3.97 | NA | 2.24 | 0.40 | NA | 6.61 | 000 | |
36815 | A | Insertion of cannula | 2.62 | NA | 1.26 | 0.26 | NA | 4.14 | 000 | |
36819 | A | Av fusion/uppr arm vein | 14.00 | NA | 6.41 | 1.56 | NA | 21.97 | 090 | |
36820 | A | Av fusion/forearm vein | 14.00 | NA | 6.43 | 1.56 | NA | 21.99 | 090 | |
36821 | A | Av fusion direct any site | 8.93 | NA | 4.94 | 0.97 | NA | 14.84 | 090 | |
36822 | A | Insertion of cannula(s) | 5.42 | NA | 7.14 | 0.63 | NA | 13.19 | 090 | |
36823 | A | Insertion of cannula(s) | 21.00 | NA | 10.38 | 2.18 | NA | 33.56 | 090 | |
36825 | A | Artery-vein autograft | 9.84 | NA | 5.48 | 1.09 | NA | 16.41 | 090 | |
36830 | A | Artery-vein nonautograft | 12.00 | NA | 6.04 | 1.32 | NA | 19.36 | 090 | |
36831 | A | Open thrombect av fistula | 8.00 | NA | 3.93 | 0.79 | NA | 12.72 | 090 | |
36832 | A | Av fistula revision, open | 10.50 | NA | 5.53 | 1.13 | NA | 17.16 | 090 | |
36833 | A | Av fistula revision | 11.95 | NA | 6.00 | 1.29 | NA | 19.24 | 090 | |
36834 | A | Repair A-V aneurysm | 9.93 | NA | 3.79 | 1.06 | NA | 14.78 | 090 | |
36835 | A | Artery to vein shunt | 7.15 | NA | 4.52 | 0.80 | NA | 12.47 | 090 | |
36860 | A | External cannula declotting | 2.01 | 2.62 | 1.34 | 0.10 | 4.73 | 3.45 | 000 | |
36861 | A | Cannula declotting | 2.52 | NA | 1.46 | 0.14 | NA | 4.12 | 000 | |
36870 | A | Percut thrombect av fistula | 5.16 | 42.32 | 2.39 | 0.23 | 47.71 | 7.78 | 090 | |
37140 | A | Revision of circulation | 23.60 | NA | 10.31 | 1.21 | NA | 35.12 | 090 | |
37145 | A | Revision of circulation | 24.61 | NA | 10.93 | 2.48 | NA | 38.02 | 090 | |
37160 | A | Revision of circulation | 21.60 | NA | 9.14 | 2.16 | NA | 32.90 | 090 | |
37180 | A | Revision of circulation | 24.61 | NA | 10.27 | 2.63 | NA | 37.51 | 090 | |
37181 | A | Splice spleen/kidney veins | 26.68 | NA | 10.86 | 2.67 | NA | 40.21 | 090 | |
37182 | A | Insert hepatic shunt (tips) | 17.00 | NA | 6.37 | 1.49 | NA | 24.86 | 000 | |
37183 | A | Remove hepatic shunt (tips) | 8.00 | NA | 3.12 | 0.43 | NA | 11.55 | 000 | |
37195 | A | Thrombolytic therapy, stroke | 0.00 | 8.02 | NA | 0.38 | 8.40 | NA | XXX | |
37200 | A | Transcatheter biopsy | 4.56 | NA | 1.55 | 0.19 | NA | 6.30 | 000 | |
37201 | A | Transcatheter therapy infuse | 5.00 | NA | 2.53 | 0.24 | NA | 7.77 | 000 | |
37202 | A | Transcatheter therapy infuse | 5.68 | NA | 3.10 | 0.38 | NA | 9.16 | 000 | |
37203 | A | Transcatheter retrieval | 5.03 | NA | 2.55 | 0.23 | NA | 7.81 | 000 | |
37204 | A | Transcatheter occlusion | 18.14 | NA | 6.11 | 0.91 | NA | 25.16 | 000 | |
37205 | A | Transcatheter stent | 8.28 | NA | 3.79 | 0.43 | NA | 12.50 | 000 | |
37206 | A | Transcatheter stent add-on | 4.13 | NA | 1.48 | 0.22 | NA | 5.83 | ZZZ | |
37207 | A | Transcatheter stent | 8.28 | NA | 3.53 | 0.89 | NA | 12.70 | 000 | |
37208 | A | Transcatheter stent add-on | 4.13 | NA | 1.41 | 0.44 | NA | 5.98 | ZZZ | |
37209 | A | Exchange arterial catheter | 2.27 | NA | 0.77 | 0.11 | NA | 3.15 | 000 | |
37250 | A | Iv us first vessel add-on | 2.10 | NA | 0.77 | 0.17 | NA | 3.04 | ZZZ | |
37251 | A | Iv us each add vessel add-on | 1.60 | NA | 0.57 | 0.14 | NA | 2.31 | ZZZ | |
37500 | A | Endoscopy ligate perf veins | 11.00 | NA | 8.70 | 0.40 | NA | 20.10 | 090 | |
37501 | C | Vascular endoscopy procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
37565 | A | Ligation of neck vein | 10.88 | NA | 5.08 | 0.45 | NA | 16.41 | 090 | |
37600 | A | Ligation of neck artery | 11.25 | NA | 6.30 | 0.40 | NA | 17.95 | 090 | |
37605 | A | Ligation of neck artery | 13.11 | NA | 6.48 | 0.77 | NA | 20.36 | 090 | |
37606 | A | Ligation of neck artery | 6.28 | NA | 3.98 | 0.79 | NA | 11.05 | 090 | |
37607 | A | Ligation of a-v fistula | 6.16 | NA | 3.65 | 0.67 | NA | 10.48 | 090 | |
37609 | A | Temporal artery procedure | 3.00 | 7.02 | 2.52 | 0.21 | 10.23 | 5.73 | 010 | |
37615 | A | Ligation of neck artery | 5.73 | NA | 3.64 | 0.57 | NA | 9.94 | 090 | |
37616 | A | Ligation of chest artery | 16.49 | NA | 10.58 | 1.93 | NA | 29.00 | 090 | |
37617 | A | Ligation of abdomen artery | 22.06 | NA | 9.42 | 1.69 | NA | 33.17 | 090 | |
37618 | A | Ligation of extremity artery | 4.84 | NA | 3.49 | 0.54 | NA | 8.87 | 090 | |
37620 | A | Revision of major vein | 10.56 | NA | 5.40 | 0.75 | NA | 16.71 | 090 | |
37650 | A | Revision of major vein | 7.80 | NA | 4.65 | 0.56 | NA | 13.01 | 090 | |
37660 | A | Revision of major vein | 21.00 | NA | 9.32 | 1.17 | NA | 31.49 | 090 | |
37700 | A | Revise leg vein | 3.73 | NA | 3.14 | 0.40 | NA | 7.27 | 090 | |
37720 | A | Removal of leg vein | 5.66 | NA | 3.63 | 0.61 | NA | 9.90 | 090 | |
37730 | A | Removal of leg veins | 7.33 | NA | 4.51 | 0.77 | NA | 12.61 | 090 | |
37735 | A | Removal of leg veins/lesion | 10.53 | NA | 5.77 | 1.17 | NA | 17.47 | 090 | |
37760 | A | Ligation, leg veins, open | 10.47 | NA | 5.63 | 1.11 | NA | 17.21 | 090 | |
37780 | A | Revision of leg vein | 3.84 | NA | 2.96 | 0.41 | NA | 7.21 | 090 | |
37785 | A | Revise secondary varicosity | 3.84 | 6.98 | 2.85 | 0.41 | 11.23 | 7.10 | 090 | |
37788 | A | Revascularization, penis | 22.01 | NA | 11.50 | 1.35 | NA | 34.86 | 090 | |
37790 | A | Penile venous occlusion | 8.34 | NA | 6.11 | 0.63 | NA | 15.08 | 090 | |
37799 | C | Vascular surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
38100 | A | Removal of spleen, total | 14.50 | NA | 6.56 | 1.30 | NA | 22.36 | 090 | |
38101 | A | Removal of spleen, partial | 15.31 | NA | 6.94 | 1.38 | NA | 23.63 | 090 | |
38102 | A | Removal of spleen, total | 4.80 | NA | 1.68 | 0.49 | NA | 6.97 | ZZZ | |
38115 | A | Repair of ruptured spleen | 15.82 | NA | 7.04 | 1.40 | NA | 24.26 | 090 | |
38120 | A | Laparoscopy, splenectomy | 17.00 | NA | 7.37 | 1.73 | NA | 26.10 | 090 | |
38129 | C | Laparoscope proc, spleen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
38200 | A | Injection for spleen x-ray | 2.64 | NA | 0.92 | 0.12 | NA | 3.68 | 000 | |
38204 | B | Bl donor search management | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
38205 | R | Harvest allogenic stem cells | 1.50 | NA | 0.61 | 0.05 | NA | 2.16 | 000 | |
38206 | R | Harvest auto stem cells | 1.50 | NA | 0.61 | 0.05 | NA | 2.16 | 000 | |
38207 | I | Cryopreserve stem cells | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
38208 | I | Thaw preserved stem cells | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
38209 | I | Wash harvest stem cells | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
38210 | I | T-cell depletion of harvest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
38211 | I | Tumor cell deplete of harvst | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
38212 | I | Rbc depletion of harvest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
38213 | I | Platelet deplete of harvest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
38214 | I | Volume deplete of harvest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
38215 | I | Harvest stem cell concentrte | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
38220 | A | Bone marrow aspiration | 1.08 | 4.64 | 0.43 | 0.03 | 5.75 | 1.54 | XXX | |
38221 | A | Bone marrow biopsy | 1.37 | 4.79 | 0.54 | 0.04 | 6.20 | 1.95 | XXX | |
38230 | R | Bone marrow collection | 4.54 | NA | 2.42 | 0.25 | NA | 7.21 | 010 | |
38231 | D | Stem cell collection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | |
38240 | R | Bone marrow/stem transplant | 2.24 | NA | 0.84 | 0.08 | NA | 3.16 | XXX | |
38241 | R | Bone marrow/stem transplant | 2.24 | NA | 0.84 | 0.08 | NA | 3.16 | XXX | |
38242 | A | Lymphocyte infuse transplant | 1.71 | NA | 0.70 | 0.05 | NA | 2.46 | 000 | |
38300 | A | Drainage, lymph node lesion | 1.99 | 4.51 | 2.59 | 0.15 | 6.65 | 4.73 | 010 | |
38305 | A | Drainage, lymph node lesion | 6.00 | 8.72 | 6.29 | 0.36 | 15.08 | 12.65 | 090 | |
38308 | A | Incision of lymph channels | 6.45 | NA | 5.70 | 0.51 | NA | 12.66 | 090 | |
38380 | A | Thoracic duct procedure | 7.46 | NA | 7.55 | 0.68 | NA | 15.69 | 090 | |
38381 | A | Thoracic duct procedure | 12.88 | NA | 9.83 | 1.58 | NA | 24.29 | 090 | |
38382 | A | Thoracic duct procedure | 10.08 | NA | 9.18 | 1.08 | NA | 20.34 | 090 | |
38500 | A | Biopsy/removal, lymph nodes | 3.75 | 3.04 | 2.56 | 0.28 | 7.07 | 6.59 | 010 | |
38505 | A | Needle biopsy, lymph nodes | 1.14 | 3.13 | 1.09 | 0.09 | 4.36 | 2.32 | 000 | |
38510 | A | Biopsy/removal, lymph nodes | 6.43 | NA | 5.41 | 0.38 | NA | 12.22 | 010 | |
38520 | A | Biopsy/removal, lymph nodes | 6.67 | NA | 5.55 | 0.52 | NA | 12.74 | 090 | |
38525 | A | Biopsy/removal, lymph nodes | 6.07 | NA | 4.40 | 0.48 | NA | 10.95 | 090 | |
38530 | A | Biopsy/removal, lymph nodes | 7.98 | NA | 5.84 | 0.63 | NA | 14.45 | 090 | |
38542 | A | Explore deep node(s), neck | 5.91 | NA | 6.00 | 0.50 | NA | 12.41 | 090 | |
38550 | A | Removal, neck/armpit lesion | 6.92 | NA | 4.90 | 0.69 | NA | 12.51 | 090 | |
38555 | A | Removal, neck/armpit lesion | 14.14 | NA | 10.28 | 1.46 | NA | 25.88 | 090 | |
38562 | A | Removal, pelvic lymph nodes | 10.49 | NA | 6.53 | 0.97 | NA | 17.99 | 090 | |
38564 | A | Removal, abdomen lymph nodes | 10.83 | NA | 6.27 | 1.06 | NA | 18.16 | 090 | |
38570 | A | Laparoscopy, lymph node biop | 9.25 | NA | 4.47 | 0.89 | NA | 14.61 | 010 | |
38571 | A | Laparoscopy, lymphadenectomy | 14.68 | NA | 6.10 | 0.80 | NA | 21.58 | 010 | |
38572 | A | Laparoscopy, lymphadenectomy | 16.59 | NA | 7.40 | 1.32 | NA | 25.31 | 010 | |
38589 | C | Laparoscope proc, lymphatic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
38700 | A | Removal of lymph nodes, neck | 8.24 | NA | 13.43 | 0.60 | NA | 22.27 | 090 | |
38720 | A | Removal of lymph nodes, neck | 13.61 | NA | 15.95 | 1.03 | NA | 30.59 | 090 | |
38724 | A | Removal of lymph nodes, neck | 14.54 | NA | 16.51 | 1.10 | NA | 32.15 | 090 | |
38740 | A | Remove armpit lymph nodes | 10.03 | NA | 5.79 | 0.69 | NA | 16.51 | 090 | |
38745 | A | Remove armpit lymph nodes | 13.10 | NA | 8.25 | 0.90 | NA | 22.25 | 090 | |
38746 | A | Remove thoracic lymph nodes | 4.89 | NA | 1.60 | 0.55 | NA | 7.04 | ZZZ | |
38747 | A | Remove abdominal lymph nodes | 4.89 | NA | 1.70 | 0.50 | NA | 7.09 | ZZZ | |
38760 | A | Remove groin lymph nodes | 12.95 | NA | 7.14 | 0.88 | NA | 20.97 | 090 | |
38765 | A | Remove groin lymph nodes | 19.98 | NA | 11.22 | 1.50 | NA | 32.70 | 090 | |
38770 | A | Remove pelvis lymph nodes | 13.23 | NA | 6.79 | 0.99 | NA | 21.01 | 090 | |
38780 | A | Remove abdomen lymph nodes | 16.59 | NA | 9.28 | 1.60 | NA | 27.47 | 090 | |
38790 | A | Inject for lymphatic x-ray | 1.29 | 31.59 | 0.45 | 0.09 | 32.97 | 1.83 | 000 | |
38792 | A | Identify sentinel node | 0.52 | NA | 0.18 | 0.04 | NA | 0.74 | 000 | |
38794 | A | Access thoracic lymph duct | 4.45 | NA | 1.54 | 0.17 | NA | 6.16 | 090 | |
38999 | C | Blood/lymph system procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
39000 | A | Exploration of chest | 6.10 | NA | 7.58 | 0.73 | NA | 14.41 | 090 | |
39010 | A | Exploration of chest | 11.79 | NA | 7.19 | 1.46 | NA | 20.44 | 090 | |
39200 | A | Removal chest lesion | 13.62 | NA | 7.30 | 1.65 | NA | 22.57 | 090 | |
39220 | A | Removal chest lesion | 17.42 | NA | 9.05 | 2.10 | NA | 28.57 | 090 | |
39400 | A | Visualization of chest | 5.61 | NA | 4.59 | 0.69 | NA | 10.89 | 010 | |
39499 | C | Chest procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
39501 | A | Repair diaphragm laceration | 13.19 | NA | 7.73 | 1.38 | NA | 22.30 | 090 | |
39502 | A | Repair paraesophageal hernia | 16.33 | NA | 8.22 | 1.68 | NA | 26.23 | 090 | |
39503 | A | Repair of diaphragm hernia | 95.00 | NA | 34.45 | 3.52 | NA | 132.97 | 090 | |
39520 | A | Repair of diaphragm hernia | 16.10 | NA | 9.68 | 1.83 | NA | 27.61 | 090 | |
39530 | A | Repair of diaphragm hernia | 15.41 | NA | 8.56 | 1.66 | NA | 25.63 | 090 | |
39531 | A | Repair of diaphragm hernia | 16.42 | NA | 8.75 | 1.83 | NA | 27.00 | 090 | |
39540 | A | Repair of diaphragm hernia | 13.32 | NA | 7.77 | 1.38 | NA | 22.47 | 090 | |
39541 | A | Repair of diaphragm hernia | 14.41 | NA | 7.86 | 1.52 | NA | 23.79 | 090 | |
39545 | A | Revision of diaphragm | 13.37 | NA | 9.29 | 1.55 | NA | 24.21 | 090 | |
39560 | A | Resect diaphragm, simple | 12.00 | NA | 7.53 | 1.35 | NA | 20.88 | 090 | |
39561 | A | Resect diaphragm, complex | 17.50 | NA | 9.76 | 1.97 | NA | 29.23 | 090 | |
39599 | C | Diaphragm surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
40490 | A | Biopsy of lip | 1.22 | 1.73 | 0.62 | 0.06 | 3.01 | 1.90 | 000 | |
40500 | A | Partial excision of lip | 4.28 | 5.89 | 5.69 | 0.31 | 10.48 | 10.28 | 090 | |
40510 | A | Partial excision of lip | 4.70 | 6.76 | 6.51 | 0.38 | 11.84 | 11.59 | 090 | |
40520 | A | Partial excision of lip | 4.67 | 7.77 | 6.87 | 0.42 | 12.86 | 11.96 | 090 | |
40525 | A | Reconstruct lip with flap | 7.55 | NA | 8.36 | 0.68 | NA | 16.59 | 090 | |
40527 | A | Reconstruct lip with flap | 9.13 | NA | 9.24 | 0.82 | NA | 19.19 | 090 | |
40530 | A | Partial removal of lip | 5.40 | 6.60 | 6.24 | 0.47 | 12.47 | 12.11 | 090 | |
40650 | A | Repair lip | 3.64 | 5.44 | 4.81 | 0.31 | 9.39 | 8.76 | 090 | |
40652 | A | Repair lip | 4.26 | 6.83 | 6.80 | 0.39 | 11.48 | 11.45 | 090 | |
40654 | A | Repair lip | 5.31 | 7.71 | 7.50 | 0.48 | 13.50 | 13.29 | 090 | |
40700 | A | Repair cleft lip/nasal | 12.79 | NA | 10.32 | 0.93 | NA | 24.04 | 090 | |
40701 | A | Repair cleft lip/nasal | 15.85 | NA | 12.70 | 1.36 | NA | 29.91 | 090 | |
40702 | A | Repair cleft lip/nasal | 13.04 | NA | 9.54 | 1.01 | NA | 23.59 | 090 | |
40720 | A | Repair cleft lip/nasal | 13.55 | NA | 11.93 | 1.31 | NA | 26.79 | 090 | |
40761 | A | Repair cleft lip/nasal | 14.72 | NA | 12.39 | 1.41 | NA | 28.52 | 090 | |
40799 | C | Lip surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
40800 | A | Drainage of mouth lesion | 1.17 | 1.82 | 0.87 | 0.09 | 3.08 | 2.13 | 010 | |
40801 | A | Drainage of mouth lesion | 2.53 | 2.42 | 1.55 | 0.18 | 5.13 | 4.26 | 010 | |
40804 | A | Removal, foreign body, mouth | 1.24 | 2.31 | 1.03 | 0.09 | 3.64 | 2.36 | 010 | |
40805 | A | Removal, foreign body, mouth | 2.69 | 2.75 | 1.75 | 0.17 | 5.61 | 4.61 | 010 | |
40806 | A | Incision of lip fold | 0.31 | 0.96 | 0.86 | 0.02 | 1.29 | 1.19 | 000 | |
40808 | A | Biopsy of mouth lesion | 0.96 | 1.94 | 1.02 | 0.07 | 2.97 | 2.05 | 010 | |
40810 | A | Excision of mouth lesion | 1.31 | 2.07 | 1.16 | 0.09 | 3.47 | 2.56 | 010 | |
40812 | A | Excise/repair mouth lesion | 2.31 | 2.43 | 1.72 | 0.17 | 4.91 | 4.20 | 010 | |
40814 | A | Excise/repair mouth lesion | 3.42 | 3.34 | 2.98 | 0.26 | 7.02 | 6.66 | 090 | |
40816 | A | Excision of mouth lesion | 3.67 | 3.46 | 3.17 | 0.27 | 7.40 | 7.11 | 090 | |
40818 | A | Excise oral mucosa for graft | 2.41 | 4.11 | 4.11 | 0.14 | 6.66 | 6.66 | 090 | |
40819 | A | Excise lip or cheek fold | 2.41 | 3.57 | 3.55 | 0.17 | 6.15 | 6.13 | 090 | |
40820 | A | Treatment of mouth lesion | 1.28 | 2.47 | 2.30 | 0.08 | 3.83 | 3.66 | 010 | |
40830 | A | Repair mouth laceration | 1.76 | 2.53 | 2.50 | 0.14 | 4.43 | 4.40 | 010 | |
40831 | A | Repair mouth laceration | 2.46 | 2.78 | 2.78 | 0.21 | 5.45 | 5.45 | 010 | |
40840 | R | Reconstruction of mouth | 8.73 | 6.14 | 6.14 | 0.79 | 15.66 | 15.66 | 090 | |
40842 | R | Reconstruction of mouth | 8.73 | 6.00 | 6.00 | 0.65 | 15.38 | 15.38 | 090 | |
40843 | R | Reconstruction of mouth | 12.10 | 7.31 | 7.31 | 0.84 | 20.25 | 20.25 | 090 | |
40844 | R | Reconstruction of mouth | 16.01 | 8.98 | 8.95 | 1.63 | 26.62 | 26.59 | 090 | |
40845 | R | Reconstruction of mouth | 18.58 | 10.94 | 10.94 | 1.47 | 30.99 | 30.99 | 090 | |
40899 | C | Mouth surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
41000 | A | Drainage of mouth lesion | 1.30 | 2.38 | 1.50 | 0.09 | 3.77 | 2.89 | 010 | |
41005 | A | Drainage of mouth lesion | 1.26 | 2.26 | 1.47 | 0.09 | 3.61 | 2.82 | 010 | |
41006 | A | Drainage of mouth lesion | 3.24 | 3.75 | 3.40 | 0.25 | 7.24 | 6.89 | 090 | |
41007 | A | Drainage of mouth lesion | 3.10 | 3.87 | 3.19 | 0.22 | 7.19 | 6.51 | 090 | |
41008 | A | Drainage of mouth lesion | 3.37 | 3.60 | 3.28 | 0.24 | 7.21 | 6.89 | 090 | |
41009 | A | Drainage of mouth lesion | 3.59 | 3.67 | 3.27 | 0.25 | 7.51 | 7.11 | 090 | |
41010 | A | Incision of tongue fold | 1.06 | 3.26 | 3.26 | 0.06 | 4.38 | 4.38 | 010 | |
41015 | A | Drainage of mouth lesion | 3.96 | 4.22 | 3.23 | 0.29 | 8.47 | 7.48 | 090 | |
41016 | A | Drainage of mouth lesion | 4.07 | 4.15 | 3.38 | 0.28 | 8.50 | 7.73 | 090 | |
41017 | A | Drainage of mouth lesion | 4.07 | 4.16 | 3.32 | 0.32 | 8.55 | 7.71 | 090 | |
41018 | A | Drainage of mouth lesion | 5.10 | 4.55 | 3.79 | 0.35 | 10.00 | 9.24 | 090 | |
41100 | A | Biopsy of tongue | 1.63 | 2.36 | 1.40 | 0.12 | 4.11 | 3.15 | 010 | |
41105 | A | Biopsy of tongue | 1.42 | 2.18 | 1.32 | 0.10 | 3.70 | 2.84 | 010 | |
41108 | A | Biopsy of floor of mouth | 1.05 | 2.04 | 1.10 | 0.08 | 3.17 | 2.23 | 010 | |
41110 | A | Excision of tongue lesion | 1.51 | 2.44 | 1.31 | 0.11 | 4.06 | 2.93 | 010 | |
41112 | A | Excision of tongue lesion | 2.73 | 3.38 | 2.71 | 0.20 | 6.31 | 5.64 | 090 | |
41113 | A | Excision of tongue lesion | 3.19 | 3.40 | 2.94 | 0.23 | 6.82 | 6.36 | 090 | |
41114 | A | Excision of tongue lesion | 8.47 | NA | 5.44 | 0.64 | NA | 14.55 | 090 | |
41115 | A | Excision of tongue fold | 1.74 | 2.61 | 2.54 | 0.13 | 4.48 | 4.41 | 010 | |
41116 | A | Excision of mouth lesion | 2.44 | 3.40 | 3.40 | 0.17 | 6.01 | 6.01 | 090 | |
41120 | A | Partial removal of tongue | 9.77 | NA | 8.88 | 0.70 | NA | 19.35 | 090 | |
41130 | A | Partial removal of tongue | 11.15 | NA | 9.66 | 0.81 | NA | 21.62 | 090 | |
41135 | A | Tongue and neck surgery | 23.09 | NA | 15.99 | 1.66 | NA | 40.74 | 090 | |
41140 | A | Removal of tongue | 25.50 | NA | 17.32 | 1.85 | NA | 44.67 | 090 | |
41145 | A | Tongue removal, neck surgery | 30.06 | NA | 21.30 | 2.11 | NA | 53.47 | 090 | |
41150 | A | Tongue, mouth, jaw surgery | 23.04 | NA | 17.16 | 1.67 | NA | 41.87 | 090 | |
41153 | A | Tongue, mouth, neck surgery | 23.77 | NA | 17.77 | 1.71 | NA | 43.25 | 090 | |
41155 | A | Tongue, jaw, neck surgery | 27.72 | NA | 19.97 | 2.02 | NA | 49.71 | 090 | |
41250 | A | Repair tongue laceration | 1.91 | 2.88 | 1.71 | 0.15 | 4.94 | 3.77 | 010 | |
41251 | A | Repair tongue laceration | 2.27 | 2.72 | 2.00 | 0.18 | 5.17 | 4.45 | 010 | |
41252 | A | Repair tongue laceration | 2.97 | 3.50 | 2.34 | 0.23 | 6.70 | 5.54 | 010 | |
41500 | A | Fixation of tongue | 3.71 | NA | 4.33 | 0.26 | NA | 8.30 | 090 | |
41510 | A | Tongue to lip surgery | 3.42 | NA | 4.80 | 0.24 | NA | 8.46 | 090 | |
41520 | A | Reconstruction, tongue fold | 2.73 | 3.03 | 3.03 | 0.19 | 5.95 | 5.95 | 090 | |
41599 | C | Tongue and mouth surgery | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
41800 | A | Drainage of gum lesion | 1.17 | 1.97 | 1.37 | 0.09 | 3.23 | 2.63 | 010 | |
41805 | A | Removal foreign body, gum | 1.24 | 1.95 | 1.95 | 0.09 | 3.28 | 3.28 | 010 | |
41806 | A | Removal foreign body,jawbone | 2.69 | 2.57 | 2.45 | 0.22 | 5.48 | 5.36 | 010 | |
41820 | R | Excision, gum, each quadrant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | |
41821 | R | Excision of gum flap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | |
41822 | R | Excision of gum lesion | 2.31 | 2.83 | 0.96 | 0.24 | 5.38 | 3.51 | 010 | |
41823 | R | Excision of gum lesion | 3.30 | 3.58 | 3.00 | 0.29 | 7.17 | 6.59 | 090 | |
41825 | A | Excision of gum lesion | 1.31 | 2.40 | 2.36 | 0.10 | 3.81 | 3.77 | 010 | |
41826 | A | Excision of gum lesion | 2.31 | 2.64 | 2.64 | 0.17 | 5.12 | 5.12 | 010 | |
41827 | A | Excision of gum lesion | 3.42 | 3.58 | 3.58 | 0.25 | 7.25 | 7.25 | 090 | |
41828 | R | Excision of gum lesion | 3.09 | 3.01 | 2.40 | 0.22 | 6.32 | 5.71 | 010 | |
41830 | R | Removal of gum tissue | 3.35 | 3.30 | 2.94 | 0.23 | 6.88 | 6.52 | 010 | |
41850 | R | Treatment of gum lesion | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | |
41870 | R | Gum graft | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | |
41872 | R | Repair gum | 2.59 | 2.88 | 2.88 | 0.18 | 5.65 | 5.65 | 090 | |
41874 | R | Repair tooth socket | 3.09 | 2.88 | 2.40 | 0.23 | 6.20 | 5.72 | 090 | |
41899 | C | Dental surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
42000 | A | Drainage mouth roof lesion | 1.23 | 2.53 | 1.53 | 0.10 | 3.86 | 2.86 | 010 | |
42100 | A | Biopsy roof of mouth | 1.31 | 2.51 | 2.50 | 0.10 | 3.92 | 3.91 | 010 | |
42104 | A | Excision lesion, mouth roof | 1.64 | 2.57 | 2.57 | 0.12 | 4.33 | 4.33 | 010 | |
42106 | A | Excision lesion, mouth roof | 2.10 | 2.64 | 2.64 | 0.16 | 4.90 | 4.90 | 010 | |
42107 | A | Excision lesion, mouth roof | 4.44 | 4.11 | 4.11 | 0.32 | 8.87 | 8.87 | 090 | |
42120 | A | Remove palate/lesion | 6.17 | NA | 6.11 | 0.44 | NA | 12.72 | 090 | |
42140 | A | Excision of uvula | 1.62 | 3.91 | 3.37 | 0.12 | 5.65 | 5.11 | 090 | |
42145 | A | Repair palate, pharynx/uvula | 8.05 | NA | 7.50 | 0.56 | NA | 16.11 | 090 | |
42160 | A | Treatment mouth roof lesion | 1.80 | 3.28 | 2.70 | 0.13 | 5.21 | 4.63 | 010 | |
42180 | A | Repair palate | 2.50 | 2.99 | 2.11 | 0.19 | 5.68 | 4.80 | 010 | |
42182 | A | Repair palate | 3.83 | 3.47 | 3.06 | 0.27 | 7.57 | 7.16 | 010 | |
42200 | A | Reconstruct cleft palate | 12.00 | NA | 10.14 | 0.97 | NA | 23.11 | 090 | |
42205 | A | Reconstruct cleft palate | 13.29 | NA | 9.23 | 0.82 | NA | 23.34 | 090 | |
42210 | A | Reconstruct cleft palate | 14.50 | NA | 9.51 | 1.24 | NA | 25.25 | 090 | |
42215 | A | Reconstruct cleft palate | 8.82 | NA | 8.69 | 0.96 | NA | 18.47 | 090 | |
42220 | A | Reconstruct cleft palate | 7.02 | NA | 6.73 | 0.41 | NA | 14.16 | 090 | |
42225 | A | Reconstruct cleft palate | 9.54 | NA | 9.15 | 0.75 | NA | 19.44 | 090 | |
42226 | A | Lengthening of palate | 10.01 | NA | 9.52 | 0.73 | NA | 20.26 | 090 | |
42227 | A | Lengthening of palate | 9.52 | NA | 8.09 | 0.70 | NA | 18.31 | 090 | |
42235 | A | Repair palate | 7.87 | NA | 6.18 | 0.49 | NA | 14.54 | 090 | |
42260 | A | Repair nose to lip fistula | 9.80 | 6.99 | 6.99 | 0.85 | 17.64 | 17.64 | 090 | |
42280 | A | Preparation, palate mold | 1.54 | 1.43 | 0.75 | 0.12 | 3.09 | 2.41 | 010 | |
42281 | A | Insertion, palate prosthesis | 1.93 | 1.81 | 0.97 | 0.14 | 3.88 | 3.04 | 010 | |
42299 | C | Palate/uvula surgery | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
42300 | A | Drainage of salivary gland | 1.93 | 2.65 | 1.89 | 0.15 | 4.73 | 3.97 | 010 | |
42305 | A | Drainage of salivary gland | 6.07 | NA | 5.29 | 0.46 | NA | 11.82 | 090 | |
42310 | A | Drainage of salivary gland | 1.56 | 2.32 | 1.65 | 0.11 | 3.99 | 3.32 | 010 | |
42320 | A | Drainage of salivary gland | 2.35 | 2.77 | 2.13 | 0.17 | 5.29 | 4.65 | 010 | |
42325 | A | Create salivary cyst drain | 2.75 | 3.36 | 1.15 | 0.17 | 6.28 | 4.07 | 090 | |
42326 | A | Create salivary cyst drain | 3.78 | 3.34 | 1.76 | 0.34 | 7.46 | 5.88 | 090 | |
42330 | A | Removal of salivary stone | 2.21 | 2.78 | 1.05 | 0.16 | 5.15 | 3.42 | 010 | |
42335 | A | Removal of salivary stone | 3.31 | 3.66 | 3.66 | 0.23 | 7.20 | 7.20 | 090 | |
42340 | A | Removal of salivary stone | 4.60 | 4.80 | 4.80 | 0.34 | 9.74 | 9.74 | 090 | |
42400 | A | Biopsy of salivary gland | 0.78 | 2.49 | 0.39 | 0.06 | 3.33 | 1.23 | 000 | |
42405 | A | Biopsy of salivary gland | 3.29 | 3.40 | 3.34 | 0.24 | 6.93 | 6.87 | 010 | |
42408 | A | Excision of salivary cyst | 4.54 | 4.54 | 4.54 | 0.34 | 9.42 | 9.42 | 090 | |
42409 | A | Drainage of salivary cyst | 2.81 | 3.39 | 3.39 | 0.20 | 6.40 | 6.40 | 090 | |
42410 | A | Excise parotid gland/lesion | 9.34 | NA | 7.87 | 0.77 | NA | 17.98 | 090 | |
42415 | A | Excise parotid gland/lesion | 16.89 | NA | 12.47 | 1.26 | NA | 30.62 | 090 | |
42420 | A | Excise parotid gland/lesion | 19.59 | NA | 14.03 | 1.45 | NA | 35.07 | 090 | |
42425 | A | Excise parotid gland/lesion | 13.02 | NA | 10.46 | 0.98 | NA | 24.46 | 090 | |
42426 | A | Excise parotid gland/lesion | 21.26 | NA | 14.83 | 1.57 | NA | 37.66 | 090 | |
42440 | A | Excise submaxillary gland | 6.97 | NA | 5.98 | 0.51 | NA | 13.46 | 090 | |
42450 | A | Excise sublingual gland | 4.62 | 4.78 | 4.78 | 0.34 | 9.74 | 9.74 | 090 | |
42500 | A | Repair salivary duct | 4.30 | 4.84 | 4.84 | 0.30 | 9.44 | 9.44 | 090 | |
42505 | A | Repair salivary duct | 6.18 | 5.46 | 5.46 | 0.44 | 12.08 | 12.08 | 090 | |
42507 | A | Parotid duct diversion | 6.11 | NA | 5.98 | 0.66 | NA | 12.75 | 090 | |
42508 | A | Parotid duct diversion | 9.10 | NA | 8.12 | 0.64 | NA | 17.86 | 090 | |
42509 | A | Parotid duct diversion | 11.54 | NA | 9.65 | 1.24 | NA | 22.43 | 090 | |
42510 | A | Parotid duct diversion | 8.15 | NA | 7.09 | 0.57 | NA | 15.81 | 090 | |
42550 | A | Injection for salivary x-ray | 1.25 | 12.74 | 0.43 | 0.06 | 14.05 | 1.74 | 000 | |
42600 | A | Closure of salivary fistula | 4.82 | 6.30 | 5.67 | 0.34 | 11.46 | 10.83 | 090 | |
42650 | A | Dilation of salivary duct | 0.77 | 1.09 | 0.40 | 0.06 | 1.92 | 1.23 | 000 | |
42660 | A | Dilation of salivary duct | 1.13 | 1.18 | 1.18 | 0.07 | 2.38 | 2.38 | 000 | |
42665 | A | Ligation of salivary duct | 2.53 | 3.51 | 3.51 | 0.17 | 6.21 | 6.21 | 090 | |
42699 | C | Salivary surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
42700 | A | Drainage of tonsil abscess | 1.62 | 3.27 | 1.88 | 0.12 | 5.01 | 3.62 | 010 | |
42720 | A | Drainage of throat abscess | 5.42 | 4.88 | 4.76 | 0.39 | 10.69 | 10.57 | 010 | |
42725 | A | Drainage of throat abscess | 10.72 | NA | 8.52 | 0.80 | NA | 20.04 | 090 | |
42800 | A | Biopsy of throat | 1.39 | 3.09 | 2.62 | 0.10 | 4.58 | 4.11 | 010 | |
42802 | A | Biopsy of throat | 1.54 | 3.18 | 2.70 | 0.11 | 4.83 | 4.35 | 010 | |
42804 | A | Biopsy of upper nose/throat | 1.24 | 3.05 | 2.57 | 0.09 | 4.38 | 3.90 | 010 | |
42806 | A | Biopsy of upper nose/throat | 1.58 | 3.52 | 2.76 | 0.12 | 5.22 | 4.46 | 010 | |
42808 | A | Excise pharynx lesion | 2.30 | 5.06 | 3.15 | 0.17 | 7.53 | 5.62 | 010 | |
42809 | A | Remove pharynx foreign body | 1.81 | 3.50 | 1.74 | 0.13 | 5.44 | 3.68 | 010 | |
42810 | A | Excision of neck cyst | 3.25 | 5.52 | 4.50 | 0.25 | 9.02 | 8.00 | 090 | |
42815 | A | Excision of neck cyst | 7.07 | NA | 6.58 | 0.53 | NA | 14.18 | 090 | |
42820 | A | Remove tonsils and adenoids | 3.91 | NA | 3.35 | 0.28 | NA | 7.54 | 090 | |
42821 | A | Remove tonsils and adenoids | 4.29 | NA | 4.23 | 0.30 | NA | 8.82 | 090 | |
42825 | A | Removal of tonsils | 3.42 | NA | 3.69 | 0.24 | NA | 7.35 | 090 | |
42826 | A | Removal of tonsils | 3.38 | NA | 3.75 | 0.23 | NA | 7.36 | 090 | |
42830 | A | Removal of adenoids | 2.57 | NA | 2.42 | 0.18 | NA | 5.17 | 090 | |
42831 | A | Removal of adenoids | 2.71 | NA | 2.55 | 0.19 | NA | 5.45 | 090 | |
42835 | A | Removal of adenoids | 2.30 | NA | 3.15 | 0.17 | NA | 5.62 | 090 | |
42836 | A | Removal of adenoids | 3.18 | NA | 3.68 | 0.22 | NA | 7.08 | 090 | |
42842 | A | Extensive surgery of throat | 8.76 | NA | 7.82 | 0.61 | NA | 17.19 | 090 | |
42844 | A | Extensive surgery of throat | 14.31 | NA | 11.36 | 1.04 | NA | 26.71 | 090 | |
42845 | A | Extensive surgery of throat | 24.29 | NA | 17.44 | 1.76 | NA | 43.49 | 090 | |
42860 | A | Excision of tonsil tags | 2.22 | NA | 3.08 | 0.16 | NA | 5.46 | 090 | |
42870 | A | Excision of lingual tonsil | 5.40 | NA | 6.10 | 0.38 | NA | 11.88 | 090 | |
42890 | A | Partial removal of pharynx | 12.94 | NA | 10.82 | 0.91 | NA | 24.67 | 090 | |
42892 | A | Revision of pharyngeal walls | 15.83 | NA | 12.34 | 1.14 | NA | 29.31 | 090 | |
42894 | A | Revision of pharyngeal walls | 22.88 | NA | 16.97 | 1.64 | NA | 41.49 | 090 | |
42900 | A | Repair throat wound | 5.25 | NA | 3.76 | 0.39 | NA | 9.40 | 010 | |
42950 | A | Reconstruction of throat | 8.10 | NA | 7.52 | 0.58 | NA | 16.20 | 090 | |
42953 | A | Repair throat, esophagus | 8.96 | NA | 8.99 | 0.73 | NA | 18.68 | 090 | |
42955 | A | Surgical opening of throat | 7.39 | NA | 6.53 | 0.63 | NA | 14.55 | 090 | |
42960 | A | Control throat bleeding | 2.33 | NA | 2.11 | 0.17 | NA | 4.61 | 010 | |
42961 | A | Control throat bleeding | 5.59 | NA | 5.27 | 0.40 | NA | 11.26 | 090 | |
42962 | A | Control throat bleeding | 7.14 | NA | 6.18 | 0.51 | NA | 13.83 | 090 | |
42970 | A | Control nose/throat bleeding | 5.43 | NA | 3.77 | 0.37 | NA | 9.57 | 090 | |
42971 | A | Control nose/throat bleeding | 6.21 | NA | 5.81 | 0.45 | NA | 12.47 | 090 | |
42972 | A | Control nose/throat bleeding | 7.20 | NA | 5.54 | 0.54 | NA | 13.28 | 090 | |
42999 | C | Throat surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
43020 | A | Incision of esophagus | 8.09 | NA | 6.46 | 0.70 | NA | 15.25 | 090 | |
43030 | A | Throat muscle surgery | 7.69 | NA | 6.93 | 0.60 | NA | 15.22 | 090 | |
43045 | A | Incision of esophagus | 20.12 | NA | 11.08 | 2.15 | NA | 33.35 | 090 | |
43100 | A | Excision of esophagus lesion | 9.19 | NA | 7.20 | 0.79 | NA | 17.18 | 090 | |
43101 | A | Excision of esophagus lesion | 16.24 | NA | 8.62 | 1.81 | NA | 26.67 | 090 | |
43107 | A | Removal of esophagus | 40.00 | NA | 18.02 | 3.29 | NA | 61.31 | 090 | |
43108 | A | Removal of esophagus | 34.19 | NA | 15.85 | 3.78 | NA | 53.82 | 090 | |
43112 | A | Removal of esophagus | 43.50 | NA | 19.49 | 3.67 | NA | 66.66 | 090 | |
43113 | A | Removal of esophagus | 35.27 | NA | 16.48 | 4.33 | NA | 56.08 | 090 | |
43116 | A | Partial removal of esophagus | 31.22 | NA | 18.82 | 2.62 | NA | 52.66 | 090 | |
43117 | A | Partial removal of esophagus | 40.00 | NA | 17.09 | 3.51 | NA | 60.60 | 090 | |
43118 | A | Partial removal of esophagus | 33.20 | NA | 15.40 | 3.56 | NA | 52.16 | 090 | |
43121 | A | Partial removal of esophagus | 29.19 | NA | 13.36 | 3.44 | NA | 45.99 | 090 | |
43122 | A | Partial removal of esophagus | 40.00 | NA | 17.29 | 3.27 | NA | 60.56 | 090 | |
43123 | A | Partial removal of esophagus | 33.20 | NA | 15.82 | 3.96 | NA | 52.98 | 090 | |
43124 | A | Removal of esophagus | 27.32 | NA | 14.94 | 2.95 | NA | 45.21 | 090 | |
43130 | A | Removal of esophagus pouch | 11.75 | NA | 8.86 | 1.06 | NA | 21.67 | 090 | |
43135 | A | Removal of esophagus pouch | 16.10 | NA | 9.91 | 1.85 | NA | 27.86 | 090 | |
43200 | A | Esophagus endoscopy | 1.59 | 7.97 | 1.18 | 0.11 | 9.67 | 2.88 | 000 | |
43201 | A | Esoph scope w/submucous inj | 2.09 | 4.44 | 1.27 | 0.12 | 6.65 | 3.48 | 000 | |
43202 | A | Esophagus endoscopy, biopsy | 1.89 | 6.25 | 1.13 | 0.12 | 8.26 | 3.14 | 000 | |
43204 | A | Esoph scope w/sclerosis inj | 3.77 | NA | 1.67 | 0.18 | NA | 5.62 | 000 | |
43205 | A | Esophagus endoscopy/ligation | 3.79 | NA | 1.68 | 0.17 | NA | 5.64 | 000 | |
43215 | A | Esophagus endoscopy | 2.60 | NA | 1.23 | 0.17 | NA | 4.00 | 000 | |
43216 | A | Esophagus endoscopy/lesion | 2.40 | NA | 1.18 | 0.15 | NA | 3.73 | 000 | |
43217 | A | Esophagus endoscopy | 2.90 | NA | 1.33 | 0.17 | NA | 4.40 | 000 | |
43219 | A | Esophagus endoscopy | 2.80 | NA | 1.40 | 0.16 | NA | 4.36 | 000 | |
43220 | A | Esoph endoscopy, dilation | 2.10 | NA | 1.10 | 0.12 | NA | 3.32 | 000 | |
43226 | A | Esoph endoscopy, dilation | 2.34 | NA | 1.17 | 0.12 | NA | 3.63 | 000 | |
43227 | A | Esoph endoscopy, repair | 3.60 | NA | 1.60 | 0.18 | NA | 5.38 | 000 | |
43228 | A | Esoph endoscopy, ablation | 3.77 | NA | 1.72 | 0.25 | NA | 5.74 | 000 | |
43231 | A | Esoph endoscopy w/us exam | 3.19 | NA | 1.57 | 0.20 | NA | 4.96 | 000 | |
43232 | A | Esoph endoscopy w/us fn bx | 4.48 | NA | 2.10 | 0.26 | NA | 6.84 | 000 | |
43234 | A | Upper GI endoscopy, exam | 2.01 | 4.28 | 1.04 | 0.13 | 6.42 | 3.18 | 000 | |
43235 | A | Uppr gi endoscopy, diagnosis | 2.39 | 5.85 | 1.06 | 0.13 | 8.37 | 3.58 | 000 | |
43236 | A | Uppr gi scope w/submuc inj | 2.92 | 4.70 | 1.26 | 0.14 | 7.76 | 4.32 | 000 | |
43239 | A | Upper GI endoscopy, biopsy | 2.87 | 6.17 | 1.23 | 0.14 | 9.18 | 4.24 | 000 | |
43240 | A | Esoph endoscope w/drain cyst | 6.86 | NA | 2.70 | 0.36 | NA | 9.92 | 000 | |
43241 | A | Upper GI endoscopy with tube | 2.59 | NA | 1.14 | 0.14 | NA | 3.87 | 000 | |
43242 | A | Uppr gi endoscopy w/us fn bx | 7.31 | NA | 2.83 | 0.29 | NA | 10.43 | 000 | |
43243 | A | Upper gi endoscopy inject | 4.57 | NA | 1.86 | 0.21 | NA | 6.64 | 000 | |
43244 | A | Upper GI endoscopy/ligation | 5.05 | NA | 2.03 | 0.21 | NA | 7.29 | 000 | |
43245 | A | Uppr gi scope dilate strictr | 3.18 | 13.87 | 1.34 | 0.18 | 17.23 | 4.70 | 000 | |
43246 | A | Place gastrostomy tube | 4.33 | NA | 1.75 | 0.24 | NA | 6.32 | 000 | |
43247 | A | Operative upper GI endoscopy | 3.39 | NA | 1.42 | 0.17 | NA | 4.98 | 000 | |
43248 | A | Uppr gi endoscopy/guide wire | 3.15 | NA | 1.35 | 0.15 | NA | 4.65 | 000 | |
43249 | A | Esoph endoscopy, dilation | 2.90 | NA | 1.26 | 0.15 | NA | 4.31 | 000 | |
43250 | A | Upper GI endoscopy/tumor | 3.20 | NA | 1.35 | 0.17 | NA | 4.72 | 000 | |
43251 | A | Operative upper GI endoscopy | 3.70 | NA | 1.53 | 0.19 | NA | 5.42 | 000 | |
43255 | A | Operative upper GI endoscopy | 4.82 | NA | 1.95 | 0.20 | NA | 6.97 | 000 | |
43256 | A | Uppr gi endoscopy w stent | 4.35 | NA | 1.77 | 0.23 | NA | 6.35 | 000 | |
43258 | A | Operative upper GI endoscopy | 4.55 | NA | 1.85 | 0.22 | NA | 6.62 | 000 | |
43259 | A | Endoscopic ultrasound exam | 4.89 | NA | 1.95 | 0.22 | NA | 7.06 | 000 | |
43260 | A | Endo cholangiopancreatograph | 5.96 | NA | 2.44 | 0.27 | NA | 8.67 | 000 | |
43261 | A | Endo cholangiopancreatograph | 6.27 | NA | 2.55 | 0.29 | NA | 9.11 | 000 | |
43262 | A | Endo cholangiopancreatograph | 7.39 | NA | 2.96 | 0.34 | NA | 10.69 | 000 | |
43263 | A | Endo cholangiopancreatograph | 7.29 | NA | 2.93 | 0.28 | NA | 10.50 | 000 | |
43264 | A | Endo cholangiopancreatograph | 8.90 | NA | 3.49 | 0.41 | NA | 12.80 | 000 | |
43265 | A | Endo cholangiopancreatograph | 10.02 | NA | 3.89 | 0.42 | NA | 14.33 | 000 | |
43267 | A | Endo cholangiopancreatograph | 7.39 | NA | 2.96 | 0.34 | NA | 10.69 | 000 | |
43268 | A | Endo cholangiopancreatograph | 7.39 | NA | 2.96 | 0.34 | NA | 10.69 | 000 | |
43269 | A | Endo cholangiopancreatograph | 8.21 | NA | 3.24 | 0.28 | NA | 11.73 | 000 | |
43271 | A | Endo cholangiopancreatograph | 7.39 | NA | 2.95 | 0.34 | NA | 10.68 | 000 | |
43272 | A | Endo cholangiopancreatograph | 7.39 | NA | 2.96 | 0.34 | NA | 10.69 | 000 | |
43280 | A | Laparoscopy, fundoplasty | 17.25 | NA | 8.20 | 1.76 | NA | 27.21 | 090 | |
43289 | C | Laparoscope proc, esoph | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
43300 | A | Repair of esophagus | 9.14 | NA | 7.25 | 0.85 | NA | 17.24 | 090 | |
43305 | A | Repair esophagus and fistula | 17.39 | NA | 12.70 | 1.36 | NA | 31.45 | 090 | |
43310 | A | Repair of esophagus | 25.39 | NA | 14.66 | 3.18 | NA | 43.23 | 090 | |
43312 | A | Repair esophagus and fistula | 28.42 | NA | 18.20 | 3.38 | NA | 50.00 | 090 | |
43313 | A | Esophagoplasty congenital | 45.28 | NA | 21.66 | 5.43 | NA | 72.37 | 090 | |
43314 | A | Tracheo-esophagoplasty cong | 50.27 | NA | 23.68 | 5.53 | NA | 79.48 | 090 | |
43320 | A | Fuse esophagus stomach | 19.93 | NA | 10.45 | 1.59 | NA | 31.97 | 090 | |
43324 | A | Revise esophagus stomach | 20.57 | NA | 9.48 | 1.72 | NA | 31.77 | 090 | |
43325 | A | Revise esophagus stomach | 20.06 | NA | 9.85 | 1.65 | NA | 31.56 | 090 | |
43326 | A | Revise esophagus stomach | 19.74 | NA | 10.49 | 1.84 | NA | 32.07 | 090 | |
43330 | A | Repair of esophagus | 19.77 | NA | 9.56 | 1.52 | NA | 30.85 | 090 | |
43331 | A | Repair of esophagus | 20.13 | NA | 11.13 | 1.93 | NA | 33.19 | 090 | |
43340 | A | Fuse esophagus intestine | 19.61 | NA | 10.61 | 1.53 | NA | 31.75 | 090 | |
43341 | A | Fuse esophagus intestine | 20.85 | NA | 12.08 | 2.14 | NA | 35.07 | 090 | |
43350 | A | Surgical opening, esophagus | 15.78 | NA | 10.17 | 1.15 | NA | 27.10 | 090 | |
43351 | A | Surgical opening, esophagus | 18.35 | NA | 10.61 | 1.51 | NA | 30.47 | 090 | |
43352 | A | Surgical opening, esophagus | 15.26 | NA | 9.72 | 1.28 | NA | 26.26 | 090 | |
43360 | A | Gastrointestinal repair | 35.70 | NA | 16.54 | 3.00 | NA | 55.24 | 090 | |
43361 | A | Gastrointestinal repair | 40.50 | NA | 18.38 | 3.52 | NA | 62.40 | 090 | |
43400 | A | Ligate esophagus veins | 21.20 | NA | 10.34 | 0.99 | NA | 32.53 | 090 | |
43401 | A | Esophagus surgery for veins | 22.09 | NA | 10.35 | 1.73 | NA | 34.17 | 090 | |
43405 | A | Ligate/staple esophagus | 20.01 | NA | 9.51 | 1.63 | NA | 31.15 | 090 | |
43410 | A | Repair esophagus wound | 13.47 | NA | 8.93 | 1.15 | NA | 23.55 | 090 | |
43415 | A | Repair esophagus wound | 25.00 | NA | 12.26 | 1.92 | NA | 39.18 | 090 | |
43420 | A | Repair esophagus opening | 14.35 | NA | 8.92 | 0.86 | NA | 24.13 | 090 | |
43425 | A | Repair esophagus opening | 21.03 | NA | 11.22 | 2.03 | NA | 34.28 | 090 | |
43450 | A | Dilate esophagus | 1.38 | 1.38 | 0.62 | 0.07 | 2.83 | 2.07 | 000 | |
43453 | A | Dilate esophagus | 1.51 | NA | 0.67 | 0.08 | NA | 2.26 | 000 | |
43456 | A | Dilate esophagus | 2.57 | NA | 1.04 | 0.14 | NA | 3.75 | 000 | |
43458 | A | Dilate esophagus | 3.06 | NA | 1.23 | 0.17 | NA | 4.46 | 000 | |
43460 | A | Pressure treatment esophagus | 3.80 | NA | 1.50 | 0.21 | NA | 5.51 | 000 | |
43496 | C | Free jejunum flap, microvasc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 090 | |
43499 | C | Esophagus surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
43500 | A | Surgical opening of stomach | 11.05 | NA | 5.08 | 0.84 | NA | 16.97 | 090 | |
43501 | A | Surgical repair of stomach | 20.04 | NA | 8.60 | 1.55 | NA | 30.19 | 090 | |
43502 | A | Surgical repair of stomach | 23.13 | NA | 9.77 | 1.83 | NA | 34.73 | 090 | |
43510 | A | Surgical opening of stomach | 13.08 | NA | 7.53 | 0.90 | NA | 21.51 | 090 | |
43520 | A | Incision of pyloric muscle | 9.99 | NA | 5.81 | 0.84 | NA | 16.64 | 090 | |
43600 | A | Biopsy of stomach | 1.91 | NA | 1.02 | 0.11 | NA | 3.04 | 000 | |
43605 | A | Biopsy of stomach | 11.98 | NA | 5.39 | 0.93 | NA | 18.30 | 090 | |
43610 | A | Excision of stomach lesion | 14.60 | NA | 6.69 | 1.14 | NA | 22.43 | 090 | |
43611 | A | Excision of stomach lesion | 17.84 | NA | 7.93 | 1.38 | NA | 27.15 | 090 | |
43620 | A | Removal of stomach | 30.04 | NA | 12.69 | 2.29 | NA | 45.02 | 090 | |
43621 | A | Removal of stomach | 30.73 | NA | 12.88 | 2.36 | NA | 45.97 | 090 | |
43622 | A | Removal of stomach | 32.53 | NA | 13.48 | 2.48 | NA | 48.49 | 090 | |
43631 | A | Removal of stomach, partial | 22.59 | NA | 9.45 | 1.99 | NA | 34.03 | 090 | |
43632 | A | Removal of stomach, partial | 22.59 | NA | 9.46 | 2.00 | NA | 34.05 | 090 | |
43633 | A | Removal of stomach, partial | 23.10 | NA | 9.64 | 2.05 | NA | 34.79 | 090 | |
43634 | A | Removal of stomach, partial | 25.12 | NA | 10.41 | 2.18 | NA | 37.71 | 090 | |
43635 | A | Removal of stomach, partial | 2.06 | NA | 0.72 | 0.21 | NA | 2.99 | ZZZ | |
43638 | A | Removal of stomach, partial | 29.00 | NA | 11.77 | 2.24 | NA | 43.01 | 090 | |
43639 | A | Removal of stomach, partial | 29.65 | NA | 12.01 | 2.31 | NA | 43.97 | 090 | |
43640 | A | Vagotomy pylorus repair | 17.02 | NA | 7.52 | 1.51 | NA | 26.05 | 090 | |
43641 | A | Vagotomy pylorus repair | 17.27 | NA | 7.63 | 1.53 | NA | 26.43 | 090 | |
43651 | A | Laparoscopy, vagus nerve | 10.15 | NA | 4.59 | 1.03 | NA | 15.77 | 090 | |
43652 | A | Laparoscopy, vagus nerve | 12.15 | NA | 5.37 | 1.25 | NA | 18.77 | 090 | |
43653 | A | Laparoscopy, gastrostomy | 7.73 | NA | 4.23 | 0.78 | NA | 12.74 | 090 | |
43659 | C | Laparoscope proc, stom | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
43750 | A | Place gastrostomy tube | 4.49 | NA | 2.62 | 0.33 | NA | 7.44 | 010 | |
43752 | B | Nasal/orogastric w/stent | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
43760 | A | Change gastrostomy tube | 1.10 | 1.42 | 0.46 | 0.07 | 2.59 | 1.63 | 000 | |
43761 | A | Reposition gastrostomy tube | 2.01 | NA | 0.80 | 0.10 | NA | 2.91 | 000 | |
43800 | A | Reconstruction of pylorus | 13.69 | NA | 6.44 | 1.07 | NA | 21.20 | 090 | |
43810 | A | Fusion of stomach and bowel | 14.65 | NA | 6.74 | 1.10 | NA | 22.49 | 090 | |
43820 | A | Fusion of stomach and bowel | 15.37 | NA | 6.96 | 1.18 | NA | 23.51 | 090 | |
43825 | A | Fusion of stomach and bowel | 19.22 | NA | 8.30 | 1.50 | NA | 29.02 | 090 | |
43830 | A | Place gastrostomy tube | 9.53 | NA | 4.91 | 0.69 | NA | 15.13 | 090 | |
43831 | A | Place gastrostomy tube | 7.84 | NA | 4.28 | 0.81 | NA | 12.93 | 090 | |
43832 | A | Place gastrostomy tube | 15.60 | NA | 7.46 | 1.13 | NA | 24.19 | 090 | |
43840 | A | Repair of stomach lesion | 15.56 | NA | 7.02 | 1.20 | NA | 23.78 | 090 | |
43842 | A | Gastroplasty for obesity | 18.47 | NA | 11.21 | 1.51 | NA | 31.19 | 090 | |
43843 | A | Gastroplasty for obesity | 18.65 | NA | 10.81 | 1.53 | NA | 30.99 | 090 | |
43846 | A | Gastric bypass for obesity | 24.05 | NA | 13.23 | 1.96 | NA | 39.24 | 090 | |
43847 | A | Gastric bypass for obesity | 26.92 | NA | 14.86 | 2.14 | NA | 43.92 | 090 | |
43848 | A | Revision gastroplasty | 29.39 | NA | 15.91 | 2.39 | NA | 47.69 | 090 | |
43850 | A | Revise stomach-bowel fusion | 24.72 | NA | 10.14 | 1.97 | NA | 36.83 | 090 | |
43855 | A | Revise stomach-bowel fusion | 26.16 | NA | 10.73 | 2.01 | NA | 38.90 | 090 | |
43860 | A | Revise stomach-bowel fusion | 25.00 | NA | 10.30 | 2.03 | NA | 37.33 | 090 | |
43865 | A | Revise stomach-bowel fusion | 26.52 | NA | 10.85 | 2.15 | NA | 39.52 | 090 | |
43870 | A | Repair stomach opening | 9.69 | NA | 5.05 | 0.71 | NA | 15.45 | 090 | |
43880 | A | Repair stomach-bowel fistula | 24.65 | NA | 10.67 | 1.94 | NA | 37.26 | 090 | |
43999 | C | Stomach surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
44005 | A | Freeing of bowel adhesion | 16.23 | NA | 7.20 | 1.39 | NA | 24.82 | 090 | |
44010 | A | Incision of small bowel | 12.52 | NA | 6.32 | 1.05 | NA | 19.89 | 090 | |
44015 | A | Insert needle cath bowel | 2.62 | NA | 0.91 | 0.25 | NA | 3.78 | ZZZ | |
44020 | A | Explore small intestine | 13.99 | NA | 6.40 | 1.20 | NA | 21.59 | 090 | |
44021 | A | Decompress small bowel | 14.08 | NA | 6.84 | 1.18 | NA | 22.10 | 090 | |
44025 | A | Incision of large bowel | 14.28 | NA | 6.49 | 1.21 | NA | 21.98 | 090 | |
44050 | A | Reduce bowel obstruction | 14.03 | NA | 6.42 | 1.15 | NA | 21.60 | 090 | |
44055 | A | Correct malrotation of bowel | 22.00 | NA | 9.20 | 1.32 | NA | 32.52 | 090 | |
44100 | A | Biopsy of bowel | 2.01 | NA | 1.06 | 0.12 | NA | 3.19 | 000 | |
44110 | A | Excise intestine lesion(s) | 11.81 | NA | 5.69 | 1.00 | NA | 18.50 | 090 | |
44111 | A | Excision of bowel lesion(s) | 14.29 | NA | 7.05 | 1.22 | NA | 22.56 | 090 | |
44120 | A | Removal of small intestine | 17.00 | NA | 7.45 | 1.46 | NA | 25.91 | 090 | |
44121 | A | Removal of small intestine | 4.45 | NA | 1.56 | 0.46 | NA | 6.47 | ZZZ | |
44125 | A | Removal of small intestine | 17.54 | NA | 7.64 | 1.49 | NA | 26.67 | 090 | |
44126 | A | Enterectomy w/o taper, cong | 35.50 | NA | 17.79 | 0.36 | NA | 53.65 | 090 | |
44127 | A | Enterectomy w/taper, cong | 41.00 | NA | 20.28 | 0.41 | NA | 61.69 | 090 | |
44128 | A | Enterectomy cong, add-on | 4.45 | NA | 1.73 | 0.45 | NA | 6.63 | ZZZ | |
44130 | A | Bowel to bowel fusion | 14.49 | NA | 6.57 | 1.23 | NA | 22.29 | 090 | |
44132 | R | Enterectomy, cadaver donor | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
44133 | R | Enterectomy, live donor | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
44135 | R | Intestine transplnt, cadaver | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
44136 | R | Intestine transplant, live | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
44139 | A | Mobilization of colon | 2.23 | NA | 0.78 | 0.21 | NA | 3.22 | ZZZ | |
44140 | A | Partial removal of colon | 21.00 | NA | 8.86 | 2.14 | NA | 32.00 | 090 | |
44141 | A | Partial removal of colon | 19.51 | NA | 10.20 | 1.95 | NA | 31.66 | 090 | |
44143 | A | Partial removal of colon | 22.99 | NA | 10.89 | 2.02 | NA | 35.90 | 090 | |
44144 | A | Partial removal of colon | 21.53 | NA | 9.70 | 1.89 | NA | 33.12 | 090 | |
44145 | A | Partial removal of colon | 26.42 | NA | 11.04 | 2.22 | NA | 39.68 | 090 | |
44146 | A | Partial removal of colon | 27.54 | NA | 13.12 | 2.20 | NA | 42.86 | 090 | |
44147 | A | Partial removal of colon | 20.71 | NA | 8.85 | 1.74 | NA | 31.30 | 090 | |
44150 | A | Removal of colon | 23.95 | NA | 12.20 | 2.05 | NA | 38.20 | 090 | |
44151 | A | Removal of colon/ileostomy | 26.88 | NA | 13.55 | 1.97 | NA | 42.40 | 090 | |
44152 | A | Removal of colon/ileostomy | 27.83 | NA | 11.94 | 2.36 | NA | 42.13 | 090 | |
44153 | A | Removal of colon/ileostomy | 30.59 | NA | 14.74 | 2.33 | NA | 47.66 | 090 | |
44155 | A | Removal of colon/ileostomy | 27.86 | NA | 13.56 | 2.26 | NA | 43.68 | 090 | |
44156 | A | Removal of colon/ileostomy | 30.79 | NA | 15.19 | 2.19 | NA | 48.17 | 090 | |
44160 | A | Removal of colon | 18.62 | NA | 7.93 | 1.86 | NA | 28.41 | 090 | |
44200 | A | Laparoscopy, enterolysis | 14.44 | NA | 6.38 | 1.46 | NA | 22.28 | 090 | |
44201 | A | Laparoscopy, jejunostomy | 9.78 | NA | 4.63 | 0.97 | NA | 15.38 | 090 | |
44202 | A | Lap resect s/intestine singl | 22.04 | NA | 9.14 | 2.16 | NA | 33.34 | 090 | |
44203 | A | Lap resect s/intestine, addl | 4.45 | NA | 1.56 | 0.46 | NA | 6.47 | ZZZ | |
44204 | A | Laparo partial colectomy | 25.08 | NA | 10.21 | 2.55 | NA | 37.84 | 090 | |
44205 | A | Lap colectomy part w/ileum | 22.23 | NA | 9.07 | 2.23 | NA | 33.53 | 090 | |
44206 | A | Lap part colectomy w/stoma | 27.00 | NA | 11.22 | 2.02 | NA | 40.24 | 090 | |
44207 | A | L colectomy/coloproctostomy | 30.00 | NA | 11.82 | 2.22 | NA | 44.04 | 090 | |
44208 | A | L colectomy/coloproctostomy | 32.00 | NA | 13.42 | 2.20 | NA | 47.62 | 090 | |
44209 | D | Laparoscope proc, intestine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
44210 | A | Laparo total proctocolectomy | 28.00 | NA | 12.11 | 2.05 | NA | 42.16 | 090 | |
44211 | A | Laparo total proctocolectomy | 35.00 | NA | 15.02 | 2.33 | NA | 52.35 | 090 | |
44212 | A | Laparo total proctocolectomy | 32.50 | NA | 14.16 | 2.26 | NA | 48.92 | 090 | |
44238 | C | Laparoscope proc, intestine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
44239 | C | Laparoscope proc, rectum | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
44300 | A | Open bowel to skin | 12.11 | NA | 5.63 | 0.88 | NA | 18.62 | 090 | |
44310 | A | Ileostomy/jejunostomy | 15.95 | NA | 6.88 | 1.13 | NA | 23.96 | 090 | |
44312 | A | Revision of ileostomy | 8.02 | NA | 4.09 | 0.54 | NA | 12.65 | 090 | |
44314 | A | Revision of ileostomy | 15.05 | NA | 6.71 | 0.99 | NA | 22.75 | 090 | |
44316 | A | Devise bowel pouch | 21.09 | NA | 8.71 | 1.41 | NA | 31.21 | 090 | |
44320 | A | Colostomy | 17.64 | NA | 7.83 | 1.28 | NA | 26.75 | 090 | |
44322 | A | Colostomy with biopsies | 11.98 | NA | 8.75 | 1.18 | NA | 21.91 | 090 | |
44340 | A | Revision of colostomy | 7.72 | NA | 4.35 | 0.56 | NA | 12.63 | 090 | |
44345 | A | Revision of colostomy | 15.43 | NA | 7.03 | 1.11 | NA | 23.57 | 090 | |
44346 | A | Revision of colostomy | 16.99 | NA | 7.54 | 1.20 | NA | 25.73 | 090 | |
44360 | A | Small bowel endoscopy | 2.59 | NA | 1.36 | 0.14 | NA | 4.09 | 000 | |
44361 | A | Small bowel endoscopy/biopsy | 2.87 | NA | 1.45 | 0.15 | NA | 4.47 | 000 | |
44363 | A | Small bowel endoscopy | 3.50 | NA | 1.64 | 0.19 | NA | 5.33 | 000 | |
44364 | A | Small bowel endoscopy | 3.74 | NA | 1.76 | 0.21 | NA | 5.71 | 000 | |
44365 | A | Small bowel endoscopy | 3.31 | NA | 1.63 | 0.18 | NA | 5.12 | 000 | |
44366 | A | Small bowel endoscopy | 4.41 | NA | 2.01 | 0.22 | NA | 6.64 | 000 | |
44369 | A | Small bowel endoscopy | 4.52 | NA | 2.01 | 0.23 | NA | 6.76 | 000 | |
44370 | A | Small bowel endoscopy/stent | 4.80 | NA | 2.15 | 0.21 | NA | 7.16 | 000 | |
44372 | A | Small bowel endoscopy | 4.41 | NA | 2.00 | 0.27 | NA | 6.68 | 000 | |
44373 | A | Small bowel endoscopy | 3.50 | NA | 1.72 | 0.19 | NA | 5.41 | 000 | |
44376 | A | Small bowel endoscopy | 5.26 | NA | 2.30 | 0.29 | NA | 7.85 | 000 | |
44377 | A | Small bowel endoscopy/biopsy | 5.53 | NA | 2.43 | 0.28 | NA | 8.24 | 000 | |
44378 | A | Small bowel endoscopy | 7.13 | NA | 2.99 | 0.37 | NA | 10.49 | 000 | |
44379 | A | S bowel endoscope w/stent | 7.47 | NA | 3.11 | 0.38 | NA | 10.96 | 000 | |
44380 | A | Small bowel endoscopy | 1.05 | NA | 0.78 | 0.08 | NA | 1.91 | 000 | |
44382 | A | Small bowel endoscopy | 1.27 | NA | 0.87 | 0.09 | NA | 2.23 | 000 | |
44383 | A | Ileoscopy w/stent | 2.94 | NA | 1.42 | 0.13 | NA | 4.49 | 000 | |
44385 | A | Endoscopy of bowel pouch | 1.82 | 4.53 | 0.96 | 0.12 | 6.47 | 2.90 | 000 | |
44386 | A | Endoscopy, bowel pouch/biop | 2.12 | 5.99 | 1.09 | 0.15 | 8.26 | 3.36 | 000 | |
44388 | A | Colon endoscopy | 2.82 | 6.49 | 1.38 | 0.18 | 9.49 | 4.38 | 000 | |
44389 | A | Colonoscopy with biopsy | 3.13 | 7.24 | 1.51 | 0.18 | 10.55 | 4.82 | 000 | |
44390 | A | Colonoscopy for foreign body | 3.83 | 6.96 | 1.73 | 0.22 | 11.01 | 5.78 | 000 | |
44391 | A | Colonoscopy for bleeding | 4.32 | 6.01 | 1.73 | 0.23 | 10.56 | 6.28 | 000 | |
44392 | A | Colonoscopy polypectomy | 3.82 | 7.44 | 1.74 | 0.23 | 11.49 | 5.79 | 000 | |
44393 | A | Colonoscopy, lesion removal | 4.84 | 7.76 | 2.12 | 0.27 | 12.87 | 7.23 | 000 | |
44394 | A | Colonoscopy w/snare | 4.43 | 7.96 | 1.98 | 0.26 | 12.65 | 6.67 | 000 | |
44397 | A | Colonoscopy w/stent | 4.71 | NA | 2.06 | 0.28 | NA | 7.05 | 000 | |
44500 | A | Intro, gastrointestinal tube | 0.49 | NA | 0.36 | 0.02 | NA | 0.87 | 000 | |
44602 | A | Suture, small intestine | 16.03 | NA | 6.63 | 1.07 | NA | 23.73 | 090 | |
44603 | A | Suture, small intestine | 18.66 | NA | 7.52 | 1.39 | NA | 27.57 | 090 | |
44604 | A | Suture, large intestine | 16.03 | NA | 6.69 | 1.42 | NA | 24.14 | 090 | |
44605 | A | Repair of bowel lesion | 19.53 | NA | 8.66 | 1.54 | NA | 29.73 | 090 | |
44615 | A | Intestinal stricturoplasty | 15.93 | NA | 6.89 | 1.39 | NA | 24.21 | 090 | |
44620 | A | Repair bowel opening | 12.20 | NA | 5.48 | 1.05 | NA | 18.73 | 090 | |
44625 | A | Repair bowel opening | 15.05 | NA | 6.49 | 1.30 | NA | 22.84 | 090 | |
44626 | A | Repair bowel opening | 25.36 | NA | 10.09 | 2.53 | NA | 37.98 | 090 | |
44640 | A | Repair bowel-skin fistula | 21.65 | NA | 8.82 | 1.46 | NA | 31.93 | 090 | |
44650 | A | Repair bowel fistula | 22.57 | NA | 9.13 | 1.49 | NA | 33.19 | 090 | |
44660 | A | Repair bowel-bladder fistula | 21.36 | NA | 8.56 | 1.14 | NA | 31.06 | 090 | |
44661 | A | Repair bowel-bladder fistula | 24.81 | NA | 9.80 | 1.53 | NA | 36.14 | 090 | |
44680 | A | Surgical revision, intestine | 15.40 | NA | 6.64 | 1.37 | NA | 23.41 | 090 | |
44700 | A | Suspend bowel w/prosthesis | 16.11 | NA | 6.88 | 1.21 | NA | 24.20 | 090 | |
44701 | A | Intraop colon lavage add-on | 3.10 | NA | 1.07 | 0.21 | NA | 4.38 | ZZZ | |
44799 | C | Intestine surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
44800 | A | Excision of bowel pouch | 11.23 | NA | 5.50 | 1.11 | NA | 17.84 | 090 | |
44820 | A | Excision of mesentery lesion | 12.09 | NA | 5.63 | 1.03 | NA | 18.75 | 090 | |
44850 | A | Repair of mesentery | 10.74 | NA | 5.13 | 0.99 | NA | 16.86 | 090 | |
44899 | C | Bowel surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
44900 | A | Drain app abscess, open | 10.14 | NA | 4.87 | 0.84 | NA | 15.85 | 090 | |
44901 | A | Drain app abscess, percut | 3.38 | NA | 4.51 | 0.17 | NA | 8.06 | 000 | |
44950 | A | Appendectomy | 10.00 | NA | 4.50 | 0.88 | NA | 15.38 | 090 | |
44955 | A | Appendectomy add-on | 1.53 | NA | 0.55 | 0.16 | NA | 2.24 | ZZZ | |
44960 | A | Appendectomy | 12.34 | NA | 5.52 | 1.09 | NA | 18.95 | 090 | |
44970 | A | Laparoscopy, appendectomy | 8.70 | NA | 4.22 | 0.88 | NA | 13.80 | 090 | |
44979 | C | Laparoscope proc, app | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
45000 | A | Drainage of pelvic abscess | 4.52 | NA | 3.08 | 0.37 | NA | 7.97 | 090 | |
45005 | A | Drainage of rectal abscess | 1.99 | 4.51 | 1.57 | 0.18 | 6.68 | 3.74 | 010 | |
45020 | A | Drainage of rectal abscess | 4.72 | NA | 3.38 | 0.41 | NA | 8.51 | 090 | |
45100 | A | Biopsy of rectum | 3.68 | NA | 2.49 | 0.33 | NA | 6.50 | 090 | |
45108 | A | Removal of anorectal lesion | 4.76 | NA | 3.02 | 0.46 | NA | 8.24 | 090 | |
45110 | A | Removal of rectum | 28.00 | NA | 12.51 | 2.26 | NA | 42.77 | 090 | |
45111 | A | Partial removal of rectum | 16.48 | NA | 7.35 | 1.60 | NA | 25.43 | 090 | |
45112 | A | Removal of rectum | 30.54 | NA | 12.07 | 2.35 | NA | 44.96 | 090 | |
45113 | A | Partial proctectomy | 30.58 | NA | 12.98 | 2.13 | NA | 45.69 | 090 | |
45114 | A | Partial removal of rectum | 27.32 | NA | 11.19 | 2.28 | NA | 40.79 | 090 | |
45116 | A | Partial removal of rectum | 24.58 | NA | 10.22 | 2.00 | NA | 36.80 | 090 | |
45119 | A | Remove rectum w/reservoir | 30.84 | NA | 12.85 | 2.13 | NA | 45.82 | 090 | |
45120 | A | Removal of rectum | 24.60 | NA | 10.31 | 2.28 | NA | 37.19 | 090 | |
45121 | A | Removal of rectum and colon | 27.04 | NA | 11.34 | 2.66 | NA | 41.04 | 090 | |
45123 | A | Partial proctectomy | 16.71 | NA | 7.02 | 1.04 | NA | 24.77 | 090 | |
45126 | A | Pelvic exenteration | 45.16 | NA | 19.41 | 3.23 | NA | 67.80 | 090 | |
45130 | A | Excision of rectal prolapse | 16.44 | NA | 6.93 | 1.12 | NA | 24.49 | 090 | |
45135 | A | Excision of rectal prolapse | 19.28 | NA | 8.54 | 1.52 | NA | 29.34 | 090 | |
45136 | A | Excise ileoanal reservior | 27.30 | NA | 12.31 | 2.72 | NA | 42.33 | 090 | |
45150 | A | Excision of rectal stricture | 5.67 | NA | 3.08 | 0.46 | NA | 9.21 | 090 | |
45160 | A | Excision of rectal lesion | 15.32 | NA | 6.78 | 1.07 | NA | 23.17 | 090 | |
45170 | A | Excision of rectal lesion | 11.49 | NA | 5.39 | 0.89 | NA | 17.77 | 090 | |
45190 | A | Destruction, rectal tumor | 9.74 | NA | 5.12 | 0.76 | NA | 15.62 | 090 | |
45300 | A | Proctosigmoidoscopy dx | 0.38 | 1.33 | 0.23 | 0.05 | 1.76 | 0.66 | 000 | |
45303 | A | Proctosigmoidoscopy dilate | 0.44 | 1.58 | 0.26 | 0.06 | 2.08 | 0.76 | 000 | |
45305 | A | Proctosigmoidoscopy w/bx | 1.01 | 1.58 | 0.45 | 0.09 | 2.68 | 1.55 | 000 | |
45307 | A | Proctosigmoidoscopy fb | 0.94 | 2.52 | 0.42 | 0.15 | 3.61 | 1.51 | 000 | |
45308 | A | Proctosigmoidoscopy removal | 0.83 | 1.52 | 0.39 | 0.13 | 2.48 | 1.35 | 000 | |
45309 | A | Proctosigmoidoscopy removal | 2.01 | 2.39 | 0.79 | 0.17 | 4.57 | 2.97 | 000 | |
45315 | A | Proctosigmoidoscopy removal | 1.40 | 2.55 | 0.59 | 0.20 | 4.15 | 2.19 | 000 | |
45317 | A | Proctosigmoidoscopy bleed | 1.50 | 1.84 | 0.62 | 0.20 | 3.54 | 2.32 | 000 | |
45320 | A | Proctosigmoidoscopy ablate | 1.58 | 1.80 | 0.66 | 0.20 | 3.58 | 2.44 | 000 | |
45321 | A | Proctosigmoidoscopy volvul | 1.17 | NA | 0.51 | 0.17 | NA | 1.85 | 000 | |
45327 | A | Proctosigmoidoscopy w/stent | 1.65 | NA | 0.86 | 0.10 | NA | 2.61 | 000 | |
45330 | A | Diagnostic sigmoidoscopy | 0.96 | 1.82 | 0.52 | 0.05 | 2.83 | 1.53 | 000 | |
45331 | A | Sigmoidoscopy and biopsy | 1.15 | 2.24 | 0.53 | 0.07 | 3.46 | 1.75 | 000 | |
45332 | A | Sigmoidoscopy w/fb removal | 1.79 | 3.96 | 0.75 | 0.11 | 5.86 | 2.65 | 000 | |
45333 | A | Sigmoidoscopy polypectomy | 1.79 | 3.57 | 0.75 | 0.12 | 5.48 | 2.66 | 000 | |
45334 | A | Sigmoidoscopy for bleeding | 2.73 | NA | 1.08 | 0.16 | NA | 3.97 | 000 | |
45335 | A | Sigmoidoscope w/submuc inj | 1.36 | 2.48 | 0.65 | 0.07 | 3.91 | 2.08 | 000 | |
45337 | A | Sigmoidoscopy decompress | 2.36 | NA | 0.95 | 0.15 | NA | 3.46 | 000 | |
45338 | A | Sigmoidoscpy w/tumr remove | 2.34 | 4.29 | 0.95 | 0.15 | 6.78 | 3.44 | 000 | |
45339 | A | Sigmoidoscopy w/ablate tumr | 3.14 | 3.26 | 1.23 | 0.17 | 6.57 | 4.54 | 000 | |
45340 | A | Sig w/balloon dilation | 1.66 | 7.19 | 0.76 | 0.07 | 8.92 | 2.49 | 000 | |
45341 | A | Sigmoidoscopy w/ultrasound | 2.60 | NA | 1.37 | 0.20 | NA | 4.17 | 000 | |
45342 | A | Sigmoidoscopy w/us guide bx | 4.06 | NA | 1.81 | 0.23 | NA | 6.10 | 000 | |
45345 | A | Sigmoidoscopy w/stent | 2.92 | NA | 1.40 | 0.15 | NA | 4.47 | 000 | |
45355 | A | Surgical colonoscopy | 3.52 | NA | 1.24 | 0.26 | NA | 5.02 | 000 | |
45378 | A | Diagnostic colonoscopy | 3.70 | 8.03 | 1.72 | 0.20 | 11.93 | 5.62 | 000 | |
45378 | 53 | A | Diagnostic colonoscopy | 0.96 | 1.82 | 0.52 | 0.05 | 2.83 | 1.53 | 000 |
45379 | A | Colonoscopy w/fb removal | 4.69 | 8.34 | 2.08 | 0.25 | 13.28 | 7.02 | 000 | |
45380 | A | Colonoscopy and biopsy | 4.44 | 8.46 | 2.00 | 0.21 | 13.11 | 6.65 | 000 | |
45381 | A | Colonoscope, submucous inj | 4.20 | 6.15 | 1.70 | 0.21 | 10.56 | 6.11 | 000 | |
45382 | A | Colonoscopy/control bleeding | 5.69 | 9.73 | 2.23 | 0.27 | 15.69 | 8.19 | 000 | |
45383 | A | Lesion removal colonoscopy | 5.87 | 9.34 | 2.50 | 0.32 | 15.53 | 8.69 | 000 | |
45384 | A | Lesion remove colonoscopy | 4.70 | 9.07 | 2.09 | 0.24 | 14.01 | 7.03 | 000 | |
45385 | A | Lesion removal colonoscopy | 5.31 | 9.24 | 2.31 | 0.28 | 14.83 | 7.90 | 000 | |
45386 | A | Colonoscope dilate stricture | 4.58 | 15.29 | 1.84 | 0.21 | 20.08 | 6.63 | 000 | |
45387 | A | Colonoscopy w/stent | 5.91 | NA | 2.52 | 0.33 | NA | 8.76 | 000 | |
45500 | A | Repair of rectum | 7.29 | NA | 4.14 | 0.56 | NA | 11.99 | 090 | |
45505 | A | Repair of rectum | 7.58 | NA | 3.70 | 0.50 | NA | 11.78 | 090 | |
45520 | A | Treatment of rectal prolapse | 0.55 | 0.77 | 0.19 | 0.04 | 1.36 | 0.78 | 000 | |
45540 | A | Correct rectal prolapse | 16.27 | NA | 7.90 | 1.17 | NA | 25.34 | 090 | |
45541 | A | Correct rectal prolapse | 13.40 | NA | 6.78 | 0.88 | NA | 21.06 | 090 | |
45550 | A | Repair rectum/remove sigmoid | 23.00 | NA | 10.15 | 1.58 | NA | 34.73 | 090 | |
45560 | A | Repair of rectocele | 10.58 | NA | 5.89 | 0.73 | NA | 17.20 | 090 | |
45562 | A | Exploration/repair of rectum | 15.38 | NA | 7.30 | 1.15 | NA | 23.83 | 090 | |
45563 | A | Exploration/repair of rectum | 23.47 | NA | 10.90 | 1.84 | NA | 36.21 | 090 | |
45800 | A | Repair rect/bladder fistula | 17.77 | NA | 7.91 | 1.14 | NA | 26.82 | 090 | |
45805 | A | Repair fistula w/colostomy | 20.78 | NA | 9.91 | 1.47 | NA | 32.16 | 090 | |
45820 | A | Repair rectourethral fistula | 18.48 | NA | 8.15 | 1.17 | NA | 27.80 | 090 | |
45825 | A | Repair fistula w/colostomy | 21.25 | NA | 10.13 | 0.97 | NA | 32.35 | 090 | |
45900 | A | Reduction of rectal prolapse | 2.61 | NA | 1.02 | 0.17 | NA | 3.80 | 010 | |
45905 | A | Dilation of anal sphincter | 2.30 | 11.46 | 0.94 | 0.14 | 13.90 | 3.38 | 010 | |
45910 | A | Dilation of rectal narrowing | 2.80 | 15.87 | 1.12 | 0.14 | 18.81 | 4.06 | 010 | |
45915 | A | Remove rectal obstruction | 3.14 | 4.65 | 1.10 | 0.17 | 7.96 | 4.41 | 010 | |
45999 | C | Rectum surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
46020 | A | Placement of seton | 2.90 | 3.12 | 2.38 | 0.22 | 6.24 | 5.50 | 010 | |
46030 | A | Removal of rectal marker | 1.23 | 3.00 | 1.19 | 0.11 | 4.34 | 2.53 | 010 | |
46040 | A | Incision of rectal abscess | 4.96 | 5.34 | 3.05 | 0.48 | 10.78 | 8.49 | 090 | |
46045 | A | Incision of rectal abscess | 4.32 | NA | 2.77 | 0.40 | NA | 7.49 | 090 | |
46050 | A | Incision of anal abscess | 1.19 | 3.52 | 1.32 | 0.11 | 4.82 | 2.62 | 010 | |
46060 | A | Incision of rectal abscess | 5.69 | NA | 3.71 | 0.52 | NA | 9.92 | 090 | |
46070 | A | Incision of anal septum | 2.71 | NA | 2.40 | 0.27 | NA | 5.38 | 090 | |
46080 | A | Incision of anal sphincter | 2.49 | 3.61 | 1.60 | 0.23 | 6.33 | 4.32 | 010 | |
46083 | A | Incise external hemorrhoid | 1.40 | 4.66 | 1.53 | 0.12 | 6.18 | 3.05 | 010 | |
46200 | A | Removal of anal fissure | 3.42 | 3.84 | 2.35 | 0.30 | 7.56 | 6.07 | 090 | |
46210 | A | Removal of anal crypt | 2.67 | 5.08 | 2.17 | 0.26 | 8.01 | 5.10 | 090 | |
46211 | A | Removal of anal crypts | 4.25 | 5.20 | 2.88 | 0.37 | 9.82 | 7.50 | 090 | |
46220 | A | Removal of anal tag | 1.56 | 1.26 | 0.55 | 0.14 | 2.96 | 2.25 | 010 | |
46221 | A | Ligation of hemorrhoid(s) | 2.04 | 1.71 | 1.07 | 0.12 | 3.87 | 3.23 | 010 | |
46230 | A | Removal of anal tags | 2.57 | 4.26 | 1.65 | 0.22 | 7.05 | 4.44 | 010 | |
46250 | A | Hemorrhoidectomy | 3.89 | 5.32 | 2.65 | 0.43 | 9.64 | 6.97 | 090 | |
46255 | A | Hemorrhoidectomy | 4.60 | 6.00 | 2.87 | 0.51 | 11.11 | 7.98 | 090 | |
46257 | A | Remove hemorrhoids fissure | 5.40 | NA | 3.05 | 0.59 | NA | 9.04 | 090 | |
46258 | A | Remove hemorrhoids fistula | 5.73 | NA | 3.19 | 0.64 | NA | 9.56 | 090 | |
46260 | A | Hemorrhoidectomy | 6.37 | NA | 3.92 | 0.68 | NA | 10.97 | 090 | |
46261 | A | Remove hemorrhoids fissure | 7.08 | NA | 4.04 | 0.70 | NA | 11.82 | 090 | |
46262 | A | Remove hemorrhoids fistula | 7.50 | NA | 4.26 | 0.76 | NA | 12.52 | 090 | |
46270 | A | Removal of anal fistula | 3.72 | 5.01 | 2.56 | 0.36 | 9.09 | 6.64 | 090 | |
46275 | A | Removal of anal fistula | 4.56 | 4.66 | 2.76 | 0.40 | 9.62 | 7.72 | 090 | |
46280 | A | Removal of anal fistula | 5.98 | NA | 3.69 | 0.50 | NA | 10.17 | 090 | |
46285 | A | Removal of anal fistula | 4.09 | 4.07 | 2.60 | 0.34 | 8.50 | 7.03 | 090 | |
46288 | A | Repair anal fistula | 7.13 | NA | 4.19 | 0.60 | NA | 11.92 | 090 | |
46320 | A | Removal of hemorrhoid clot | 1.61 | 3.86 | 1.54 | 0.14 | 5.61 | 3.29 | 010 | |
46500 | A | Injection into hemorrhoid(s) | 1.61 | 2.71 | 0.57 | 0.12 | 4.44 | 2.30 | 010 | |
46600 | A | Diagnostic anoscopy | 0.50 | 0.80 | 0.15 | 0.04 | 1.34 | 0.69 | 000 | |
46604 | A | Anoscopy and dilation | 1.31 | 0.96 | 0.46 | 0.09 | 2.36 | 1.86 | 000 | |
46606 | A | Anoscopy and biopsy | 0.81 | 0.87 | 0.28 | 0.07 | 1.75 | 1.16 | 000 | |
46608 | A | Anoscopy, remove for body | 1.51 | 1.83 | 0.47 | 0.13 | 3.47 | 2.11 | 000 | |
46610 | A | Anoscopy, remove lesion | 1.32 | 1.42 | 0.47 | 0.12 | 2.86 | 1.91 | 000 | |
46611 | A | Anoscopy | 1.81 | 2.00 | 0.64 | 0.15 | 3.96 | 2.60 | 000 | |
46612 | A | Anoscopy, remove lesions | 2.34 | 2.45 | 0.84 | 0.18 | 4.97 | 3.36 | 000 | |
46614 | A | Anoscopy, control bleeding | 2.01 | 1.79 | 0.69 | 0.14 | 3.94 | 2.84 | 000 | |
46615 | A | Anoscopy | 2.68 | 1.73 | 0.94 | 0.23 | 4.64 | 3.85 | 000 | |
46700 | A | Repair of anal stricture | 9.13 | NA | 4.64 | 0.56 | NA | 14.33 | 090 | |
46705 | A | Repair of anal stricture | 6.90 | NA | 4.06 | 0.73 | NA | 11.69 | 090 | |
46706 | A | Repr of anal fistula w/glue | 2.39 | NA | 1.24 | 0.17 | NA | 3.80 | 010 | |
46715 | A | Repair of anovaginal fistula | 7.20 | NA | 4.23 | 0.76 | NA | 12.19 | 090 | |
46716 | A | Repair of anovaginal fistula | 15.07 | NA | 7.38 | 1.30 | NA | 23.75 | 090 | |
46730 | A | Construction of absent anus | 26.75 | NA | 12.23 | 2.03 | NA | 41.01 | 090 | |
46735 | A | Construction of absent anus | 32.17 | NA | 14.08 | 2.64 | NA | 48.89 | 090 | |
46740 | A | Construction of absent anus | 30.00 | NA | 12.54 | 1.99 | NA | 44.53 | 090 | |
46742 | A | Repair of imperforated anus | 35.80 | NA | 18.00 | 2.63 | NA | 56.43 | 090 | |
46744 | A | Repair of cloacal anomaly | 52.63 | NA | 21.43 | 2.27 | NA | 76.33 | 090 | |
46746 | A | Repair of cloacal anomaly | 58.22 | NA | 25.90 | 2.51 | NA | 86.63 | 090 | |
46748 | A | Repair of cloacal anomaly | 64.21 | NA | 25.75 | 2.77 | NA | 92.73 | 090 | |
46750 | A | Repair of anal sphincter | 10.25 | NA | 5.63 | 0.69 | NA | 16.57 | 090 | |
46751 | A | Repair of anal sphincter | 8.77 | NA | 6.38 | 0.78 | NA | 15.93 | 090 | |
46753 | A | Reconstruction of anus | 8.29 | NA | 4.01 | 0.58 | NA | 12.88 | 090 | |
46754 | A | Removal of suture from anus | 2.20 | 5.44 | 1.36 | 0.12 | 7.76 | 3.68 | 010 | |
46760 | A | Repair of anal sphincter | 14.43 | NA | 7.07 | 0.86 | NA | 22.36 | 090 | |
46761 | A | Repair of anal sphincter | 13.84 | NA | 6.57 | 0.84 | NA | 21.25 | 090 | |
46762 | A | Implant artificial sphincter | 12.71 | NA | 5.72 | 0.71 | NA | 19.14 | 090 | |
46900 | A | Destruction, anal lesion(s) | 1.91 | 3.44 | 0.75 | 0.13 | 5.48 | 2.79 | 010 | |
46910 | A | Destruction, anal lesion(s) | 1.86 | 3.74 | 1.46 | 0.14 | 5.74 | 3.46 | 010 | |
46916 | A | Cryosurgery, anal lesion(s) | 1.86 | 3.36 | 1.67 | 0.09 | 5.31 | 3.62 | 010 | |
46917 | A | Laser surgery, anal lesions | 1.86 | 4.72 | 1.52 | 0.16 | 6.74 | 3.54 | 010 | |
46922 | A | Excision of anal lesion(s) | 1.86 | 3.86 | 1.43 | 0.17 | 5.89 | 3.46 | 010 | |
46924 | A | Destruction, anal lesion(s) | 2.76 | 5.09 | 1.69 | 0.20 | 8.05 | 4.65 | 010 | |
46934 | A | Destruction of hemorrhoids | 3.51 | 6.23 | 3.58 | 0.26 | 10.00 | 7.35 | 090 | |
46935 | A | Destruction of hemorrhoids | 2.43 | 4.23 | 0.86 | 0.17 | 6.83 | 3.46 | 010 | |
46936 | A | Destruction of hemorrhoids | 3.69 | 5.91 | 3.43 | 0.30 | 9.90 | 7.42 | 090 | |
46937 | A | Cryotherapy of rectal lesion | 2.69 | 4.41 | 1.77 | 0.12 | 7.22 | 4.58 | 010 | |
46938 | A | Cryotherapy of rectal lesion | 4.66 | 5.03 | 3.25 | 0.40 | 10.09 | 8.31 | 090 | |
46940 | A | Treatment of anal fissure | 2.32 | 3.14 | 0.81 | 0.17 | 5.63 | 3.30 | 010 | |
46942 | A | Treatment of anal fissure | 2.04 | 2.86 | 0.69 | 0.14 | 5.04 | 2.87 | 010 | |
46945 | A | Ligation of hemorrhoids | 1.84 | 3.93 | 2.15 | 0.17 | 5.94 | 4.16 | 090 | |
46946 | A | Ligation of hemorrhoids | 2.58 | 4.99 | 2.45 | 0.22 | 7.79 | 5.25 | 090 | |
46999 | C | Anus surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
47000 | A | Needle biopsy of liver | 1.90 | 8.24 | 0.65 | 0.09 | 10.23 | 2.64 | 000 | |
47001 | A | Needle biopsy, liver add-on | 1.90 | NA | 0.67 | 0.18 | NA | 2.75 | ZZZ | |
47010 | A | Open drainage, liver lesion | 16.01 | NA | 9.66 | 0.65 | NA | 26.32 | 090 | |
47011 | A | Percut drain, liver lesion | 3.70 | NA | 4.38 | 0.17 | NA | 8.25 | 000 | |
47015 | A | Inject/aspirate liver cyst | 15.11 | NA | 7.84 | 0.86 | NA | 23.81 | 090 | |
47100 | A | Wedge biopsy of liver | 11.67 | NA | 6.30 | 0.75 | NA | 18.72 | 090 | |
47120 | A | Partial removal of liver | 35.50 | NA | 16.55 | 2.29 | NA | 54.34 | 090 | |
47122 | A | Extensive removal of liver | 55.13 | NA | 23.43 | 3.60 | NA | 82.16 | 090 | |
47125 | A | Partial removal of liver | 49.19 | NA | 21.42 | 3.18 | NA | 73.79 | 090 | |
47130 | A | Partial removal of liver | 53.35 | NA | 22.88 | 3.47 | NA | 79.70 | 090 | |
47133 | X | Removal of donor liver | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
47134 | R | Partial removal, donor liver | 39.15 | NA | 13.56 | 3.98 | NA | 56.69 | XXX | |
47135 | R | Transplantation of liver | 81.52 | NA | 42.52 | 8.13 | NA | 132.17 | 090 | |
47136 | R | Transplantation of liver | 68.60 | NA | 41.83 | 6.93 | NA | 117.36 | 090 | |
47300 | A | Surgery for liver lesion | 15.08 | NA | 7.53 | 0.97 | NA | 23.58 | 090 | |
47350 | A | Repair liver wound | 19.56 | NA | 9.21 | 1.25 | NA | 30.02 | 090 | |
47360 | A | Repair liver wound | 26.92 | NA | 12.51 | 1.71 | NA | 41.14 | 090 | |
47361 | A | Repair liver wound | 47.12 | NA | 19.57 | 3.11 | NA | 69.80 | 090 | |
47362 | A | Repair liver wound | 18.51 | NA | 9.54 | 1.22 | NA | 29.27 | 090 | |
47370 | A | Laparo ablate liver tumor rf | 19.69 | NA | 9.72 | 0.85 | NA | 30.26 | 090 | |
47371 | A | Laparo ablate liver cryosurg | 19.69 | NA | 9.72 | 0.85 | NA | 30.26 | 090 | |
47379 | C | Laparoscope procedure, liver | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
47380 | A | Open ablate liver tumor rf | 23.00 | NA | 11.01 | 0.85 | NA | 34.86 | 090 | |
47381 | A | Open ablate liver tumor cryo | 23.27 | NA | 11.12 | 0.85 | NA | 35.24 | 090 | |
47382 | A | Percut ablate liver rf | 15.19 | NA | 6.25 | 1.14 | NA | 22.58 | 010 | |
47399 | C | Liver surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
47400 | A | Incision of liver duct | 32.49 | NA | 14.44 | 1.82 | NA | 48.75 | 090 | |
47420 | A | Incision of bile duct | 19.88 | NA | 9.15 | 1.70 | NA | 30.73 | 090 | |
47425 | A | Incision of bile duct | 19.83 | NA | 9.22 | 1.60 | NA | 30.65 | 090 | |
47460 | A | Incise bile duct sphincter | 18.04 | NA | 8.96 | 1.24 | NA | 28.24 | 090 | |
47480 | A | Incision of gallbladder | 10.82 | NA | 6.58 | 0.85 | NA | 18.25 | 090 | |
47490 | A | Incision of gallbladder | 7.23 | NA | 7.49 | 0.33 | NA | 15.05 | 090 | |
47500 | A | Injection for liver x-rays | 1.96 | NA | 0.66 | 0.09 | NA | 2.71 | 000 | |
47505 | A | Injection for liver x-rays | 0.76 | 2.65 | 0.26 | 0.03 | 3.44 | 1.05 | 000 | |
47510 | A | Insert catheter, bile duct | 7.83 | NA | 4.69 | 0.36 | NA | 12.88 | 090 | |
47511 | A | Insert bile duct drain | 10.50 | NA | 10.37 | 0.47 | NA | 21.34 | 090 | |
47525 | A | Change bile duct catheter | 5.55 | NA | 3.25 | 0.24 | NA | 9.04 | 010 | |
47530 | A | Revise/reinsert bile tube | 5.85 | NA | 4.93 | 0.29 | NA | 11.07 | 090 | |
47550 | A | Bile duct endoscopy add-on | 3.02 | NA | 1.04 | 0.30 | NA | 4.36 | ZZZ | |
47552 | A | Biliary endoscopy thru skin | 6.04 | NA | 2.44 | 0.42 | NA | 8.90 | 000 | |
47553 | A | Biliary endoscopy thru skin | 6.35 | NA | 2.64 | 0.30 | NA | 9.29 | 000 | |
47554 | A | Biliary endoscopy thru skin | 9.06 | NA | 3.44 | 0.74 | NA | 13.24 | 000 | |
47555 | A | Biliary endoscopy thru skin | 7.56 | NA | 3.05 | 0.35 | NA | 10.96 | 000 | |
47556 | A | Biliary endoscopy thru skin | 8.56 | NA | 3.39 | 0.38 | NA | 12.33 | 000 | |
47560 | A | Laparoscopy w/cholangio | 4.89 | NA | 1.84 | 0.49 | NA | 7.22 | 000 | |
47561 | A | Laparo w/cholangio/biopsy | 5.18 | NA | 2.13 | 0.49 | NA | 7.80 | 000 | |
47562 | A | Laparoscopic cholecystectomy | 11.09 | NA | 5.01 | 1.13 | NA | 17.23 | 090 | |
47563 | A | Laparo cholecystectomy/graph | 11.94 | NA | 5.27 | 1.21 | NA | 18.42 | 090 | |
47564 | A | Laparo cholecystectomy/explr | 14.23 | NA | 6.08 | 1.44 | NA | 21.75 | 090 | |
47570 | A | Laparo cholecystoenterostomy | 12.58 | NA | 5.50 | 1.28 | NA | 19.36 | 090 | |
47579 | C | Laparoscope proc, biliary | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
47600 | A | Removal of gallbladder | 13.58 | NA | 6.67 | 1.16 | NA | 21.41 | 090 | |
47605 | A | Removal of gallbladder | 14.69 | NA | 7.03 | 1.25 | NA | 22.97 | 090 | |
47610 | A | Removal of gallbladder | 18.82 | NA | 8.59 | 1.61 | NA | 29.02 | 090 | |
47612 | A | Removal of gallbladder | 18.78 | NA | 8.45 | 1.60 | NA | 28.83 | 090 | |
47620 | A | Removal of gallbladder | 20.64 | NA | 9.12 | 1.77 | NA | 31.53 | 090 | |
47630 | A | Remove bile duct stone | 9.11 | NA | 3.08 | 0.46 | NA | 12.65 | 090 | |
47700 | A | Exploration of bile ducts | 15.62 | NA | 8.51 | 1.40 | NA | 25.53 | 090 | |
47701 | A | Bile duct revision | 27.81 | NA | 13.06 | 3.00 | NA | 43.87 | 090 | |
47711 | A | Excision of bile duct tumor | 23.03 | NA | 11.02 | 1.98 | NA | 36.03 | 090 | |
47712 | A | Excision of bile duct tumor | 30.24 | NA | 13.63 | 2.67 | NA | 46.54 | 090 | |
47715 | A | Excision of bile duct cyst | 18.80 | NA | 8.75 | 1.59 | NA | 29.14 | 090 | |
47716 | A | Fusion of bile duct cyst | 16.44 | NA | 8.20 | 1.41 | NA | 26.05 | 090 | |
47720 | A | Fuse gallbladder bowel | 15.91 | NA | 8.48 | 1.37 | NA | 25.76 | 090 | |
47721 | A | Fuse upper gi structures | 19.12 | NA | 9.60 | 1.63 | NA | 30.35 | 090 | |
47740 | A | Fuse gallbladder bowel | 18.48 | NA | 9.40 | 1.59 | NA | 29.47 | 090 | |
47741 | A | Fuse gallbladder bowel | 21.34 | NA | 10.33 | 1.82 | NA | 33.49 | 090 | |
47760 | A | Fuse bile ducts and bowel | 25.85 | NA | 11.93 | 2.21 | NA | 39.99 | 090 | |
47765 | A | Fuse liver ducts bowel | 24.88 | NA | 12.37 | 2.18 | NA | 39.43 | 090 | |
47780 | A | Fuse bile ducts and bowel | 26.50 | NA | 12.17 | 2.27 | NA | 40.94 | 090 | |
47785 | A | Fuse bile ducts and bowel | 31.18 | NA | 14.49 | 2.69 | NA | 48.36 | 090 | |
47800 | A | Reconstruction of bile ducts | 23.30 | NA | 11.15 | 1.95 | NA | 36.40 | 090 | |
47801 | A | Placement, bile duct support | 15.17 | NA | 10.03 | 0.69 | NA | 25.89 | 090 | |
47802 | A | Fuse liver duct intestine | 21.55 | NA | 11.13 | 1.84 | NA | 34.52 | 090 | |
47900 | A | Suture bile duct injury | 19.90 | NA | 9.91 | 1.65 | NA | 31.46 | 090 | |
47999 | C | Bile tract surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
48000 | A | Drainage of abdomen | 28.07 | NA | 12.40 | 1.32 | NA | 41.79 | 090 | |
48001 | A | Placement of drain, pancreas | 35.45 | NA | 14.70 | 1.90 | NA | 52.05 | 090 | |
48005 | A | Resect/debride pancreas | 42.17 | NA | 16.99 | 2.26 | NA | 61.42 | 090 | |
48020 | A | Removal of pancreatic stone | 15.70 | NA | 7.38 | 1.36 | NA | 24.44 | 090 | |
48100 | A | Biopsy of pancreas, open | 12.23 | NA | 6.83 | 1.08 | NA | 20.14 | 090 | |
48102 | A | Needle biopsy, pancreas | 4.68 | 8.84 | 2.38 | 0.20 | 13.72 | 7.26 | 010 | |
48120 | A | Removal of pancreas lesion | 15.85 | NA | 7.36 | 1.35 | NA | 24.56 | 090 | |
48140 | A | Partial removal of pancreas | 22.94 | NA | 10.51 | 2.12 | NA | 35.57 | 090 | |
48145 | A | Partial removal of pancreas | 24.02 | NA | 11.18 | 2.25 | NA | 37.45 | 090 | |
48146 | A | Pancreatectomy | 26.40 | NA | 13.29 | 2.43 | NA | 42.12 | 090 | |
48148 | A | Removal of pancreatic duct | 17.34 | NA | 8.98 | 1.61 | NA | 27.93 | 090 | |
48150 | A | Partial removal of pancreas | 48.00 | NA | 21.38 | 4.43 | NA | 73.81 | 090 | |
48152 | A | Pancreatectomy | 43.75 | NA | 20.25 | 4.07 | NA | 68.07 | 090 | |
48153 | A | Pancreatectomy | 47.89 | NA | 21.58 | 4.40 | NA | 73.87 | 090 | |
48154 | A | Pancreatectomy | 44.10 | NA | 20.13 | 4.10 | NA | 68.33 | 090 | |
48155 | A | Removal of pancreas | 24.64 | NA | 13.48 | 2.30 | NA | 40.42 | 090 | |
48160 | N | Pancreas removal/transplant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
48180 | A | Fuse pancreas and bowel | 24.72 | NA | 10.85 | 2.24 | NA | 37.81 | 090 | |
48400 | A | Injection, intraop add-on | 1.95 | NA | 0.67 | 0.10 | NA | 2.72 | ZZZ | |
48500 | A | Surgery of pancreatic cyst | 15.28 | NA | 7.24 | 1.35 | NA | 23.87 | 090 | |
48510 | A | Drain pancreatic pseudocyst | 14.31 | NA | 7.49 | 1.07 | NA | 22.87 | 090 | |
48511 | A | Drain pancreatic pseudocyst | 4.00 | NA | 3.72 | 0.17 | NA | 7.89 | 000 | |
48520 | A | Fuse pancreas cyst and bowel | 15.59 | NA | 7.21 | 1.41 | NA | 24.21 | 090 | |
48540 | A | Fuse pancreas cyst and bowel | 19.72 | NA | 8.62 | 1.82 | NA | 30.16 | 090 | |
48545 | A | Pancreatorrhaphy | 18.18 | NA | 8.68 | 1.61 | NA | 28.47 | 090 | |
48547 | A | Duodenal exclusion | 25.83 | NA | 10.79 | 2.30 | NA | 38.92 | 090 | |
48550 | X | Donor pancreatectomy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
48554 | R | Transpl allograft pancreas | 34.17 | NA | 11.94 | 3.30 | NA | 49.41 | 090 | |
48556 | A | Removal, allograft pancreas | 15.71 | NA | 8.46 | 1.52 | NA | 25.69 | 090 | |
48999 | C | Pancreas surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
49000 | A | Exploration of abdomen | 11.68 | NA | 6.06 | 1.17 | NA | 18.91 | 090 | |
49002 | A | Reopening of abdomen | 10.49 | NA | 5.96 | 1.06 | NA | 17.51 | 090 | |
49010 | A | Exploration behind abdomen | 12.28 | NA | 6.93 | 1.22 | NA | 20.43 | 090 | |
49020 | A | Drain abdominal abscess | 22.84 | NA | 11.41 | 1.31 | NA | 35.56 | 090 | |
49021 | A | Drain abdominal abscess | 3.38 | NA | 5.28 | 0.16 | NA | 8.82 | 000 | |
49040 | A | Drain, open, abdom abscess | 13.52 | NA | 8.19 | 0.84 | NA | 22.55 | 090 | |
49041 | A | Drain, percut, abdom abscess | 4.00 | NA | 5.61 | 0.18 | NA | 9.79 | 000 | |
49060 | A | Drain, open, retrop abscess | 15.86 | NA | 9.58 | 0.77 | NA | 26.21 | 090 | |
49061 | A | Drain, percut, retroper absc | 3.70 | NA | 5.62 | 0.17 | NA | 9.49 | 000 | |
49062 | A | Drain to peritoneal cavity | 11.36 | NA | 7.07 | 1.08 | NA | 19.51 | 090 | |
49080 | A | Puncture, peritoneal cavity | 1.35 | 4.39 | 0.47 | 0.07 | 5.81 | 1.89 | 000 | |
49081 | A | Removal of abdominal fluid | 1.26 | 3.07 | 0.58 | 0.06 | 4.39 | 1.90 | 000 | |
49085 | A | Remove abdomen foreign body | 12.14 | NA | 6.56 | 0.88 | NA | 19.58 | 090 | |
49180 | A | Biopsy, abdominal mass | 1.73 | 8.22 | 0.59 | 0.08 | 10.03 | 2.40 | 000 | |
49200 | A | Removal of abdominal lesion | 10.25 | NA | 6.27 | 0.92 | NA | 17.44 | 090 | |
49201 | A | Remove abdom lesion, complex | 14.84 | NA | 8.56 | 1.47 | NA | 24.87 | 090 | |
49215 | A | Excise sacral spine tumor | 33.50 | NA | 14.74 | 2.48 | NA | 50.72 | 090 | |
49220 | A | Multiple surgery, abdomen | 14.88 | NA | 7.63 | 1.51 | NA | 24.02 | 090 | |
49250 | A | Excision of umbilicus | 8.35 | NA | 5.08 | 0.84 | NA | 14.27 | 090 | |
49255 | A | Removal of omentum | 11.14 | NA | 6.49 | 1.12 | NA | 18.75 | 090 | |
49320 | A | Diag laparo separate proc | 5.10 | NA | 3.01 | 0.50 | NA | 8.61 | 010 | |
49321 | A | Laparoscopy, biopsy | 5.40 | NA | 2.99 | 0.53 | NA | 8.92 | 010 | |
49322 | A | Laparoscopy, aspiration | 5.70 | NA | 3.42 | 0.57 | NA | 9.69 | 010 | |
49323 | A | Laparo drain lymphocele | 9.48 | NA | 4.03 | 0.88 | NA | 14.39 | 090 | |
49329 | C | Laparo proc, abdm/per/oment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
49400 | A | Air injection into abdomen | 1.88 | NA | 0.80 | 0.11 | NA | 2.79 | 000 | |
49419 | A | Insrt abdom cath for chemotx | 6.65 | NA | 3.81 | 0.55 | NA | 11.01 | 090 | |
49420 | A | Insert abdom drain, temp | 2.22 | NA | 0.97 | 0.13 | NA | 3.32 | 000 | |
49421 | A | Insert abdom drain, perm | 5.54 | NA | 4.06 | 0.55 | NA | 10.15 | 090 | |
49422 | A | Remove perm cannula/catheter | 6.25 | NA | 2.93 | 0.63 | NA | 9.81 | 010 | |
49423 | A | Exchange drainage catheter | 1.46 | NA | 0.68 | 0.07 | NA | 2.21 | 000 | |
49424 | A | Assess cyst, contrast inject | 0.76 | NA | 0.44 | 0.03 | NA | 1.23 | 000 | |
49425 | A | Insert abdomen-venous drain | 11.37 | NA | 6.69 | 1.21 | NA | 19.27 | 090 | |
49426 | A | Revise abdomen-venous shunt | 9.63 | NA | 6.07 | 0.93 | NA | 16.63 | 090 | |
49427 | A | Injection, abdominal shunt | 0.89 | NA | 0.48 | 0.05 | NA | 1.42 | 000 | |
49428 | A | Ligation of shunt | 6.06 | NA | 3.16 | 0.31 | NA | 9.53 | 010 | |
49429 | A | Removal of shunt | 7.40 | NA | 3.44 | 0.81 | NA | 11.65 | 010 | |
49491 | A | Rpr hern preemie reduc | 11.13 | NA | 5.51 | 1.10 | NA | 17.74 | 090 | |
49492 | A | Rpr ing hern premie, blocked | 14.03 | NA | 6.28 | 1.47 | NA | 21.78 | 090 | |
49495 | A | Rpr ing hernia baby, reduc | 5.89 | NA | 3.48 | 0.58 | NA | 9.95 | 090 | |
49496 | A | Rpr ing hernia baby, blocked | 8.79 | NA | 6.11 | 0.92 | NA | 15.82 | 090 | |
49500 | A | Rpr ing hernia, init, reduce | 5.48 | NA | 3.34 | 0.46 | NA | 9.28 | 090 | |
49501 | A | Rpr ing hernia, init blocked | 8.88 | NA | 4.43 | 0.76 | NA | 14.07 | 090 | |
49505 | A | Prp i/hern init reduc5 yr | 7.60 | 4.48 | 4.01 | 0.65 | 12.73 | 12.26 | 090 | |
49507 | A | Prp i/hern init block5 yr | 9.57 | NA | 6.01 | 0.83 | NA | 16.41 | 090 | |
49520 | A | Rerepair ing hernia, reduce | 9.63 | NA | 5.34 | 0.84 | NA | 15.81 | 090 | |
49521 | A | Rerepair ing hernia, blocked | 11.97 | NA | 5.68 | 1.04 | NA | 18.69 | 090 | |
49525 | A | Repair ing hernia, sliding | 8.57 | NA | 4.83 | 0.74 | NA | 14.14 | 090 | |
49540 | A | Repair lumbar hernia | 10.39 | NA | 5.51 | 0.90 | NA | 16.80 | 090 | |
49550 | A | Rpr rem hernia, init, reduce | 8.63 | NA | 4.42 | 0.75 | NA | 13.80 | 090 | |
49553 | A | Rpr fem hernia, init blocked | 9.44 | NA | 4.84 | 0.83 | NA | 15.11 | 090 | |
49555 | A | Rerepair fem hernia, reduce | 9.03 | NA | 5.17 | 0.79 | NA | 14.99 | 090 | |
49557 | A | Rerepair fem hernia, blocked | 11.15 | NA | 5.42 | 0.97 | NA | 17.54 | 090 | |
49560 | A | Rpr ventral hern init, reduc | 11.57 | NA | 5.95 | 1.00 | NA | 18.52 | 090 | |
49561 | A | Rpr ventral hern init, block | 14.25 | NA | 6.53 | 1.23 | NA | 22.01 | 090 | |
49565 | A | Rerepair ventrl hern, reduce | 11.57 | NA | 6.11 | 1.00 | NA | 18.68 | 090 | |
49566 | A | Rerepair ventrl hern, block | 14.40 | NA | 6.60 | 1.24 | NA | 22.24 | 090 | |
49568 | A | Hernia repair w/mesh | 4.89 | NA | 1.71 | 0.50 | NA | 7.10 | ZZZ | |
49570 | A | Rpr epigastric hern, reduce | 5.69 | NA | 3.43 | 0.50 | NA | 9.62 | 090 | |
49572 | A | Rpr epigastric hern, blocked | 6.73 | NA | 3.91 | 0.58 | NA | 11.22 | 090 | |
49580 | A | Rpr umbil hern, reduc 5 yr | 4.11 | NA | 2.92 | 0.34 | NA | 7.37 | 090 | |
49582 | A | Rpr umbil hern, block 5 yr | 6.65 | NA | 4.86 | 0.57 | NA | 12.08 | 090 | |
49585 | A | Rpr umbil hern, reduc 5 yr | 6.23 | NA | 4.04 | 0.53 | NA | 10.80 | 090 | |
49587 | A | Rpr umbil hern, block 5 yr | 7.56 | NA | 4.15 | 0.65 | NA | 12.36 | 090 | |
49590 | A | Repair spigilian hernia | 8.54 | NA | 4.85 | 0.74 | NA | 14.13 | 090 | |
49600 | A | Repair umbilical lesion | 10.96 | NA | 6.07 | 1.13 | NA | 18.16 | 090 | |
49605 | A | Repair umbilical lesion | 76.00 | NA | 29.89 | 2.57 | NA | 108.46 | 090 | |
49606 | A | Repair umbilical lesion | 18.60 | NA | 9.06 | 2.22 | NA | 29.88 | 090 | |
49610 | A | Repair umbilical lesion | 10.50 | NA | 6.77 | 0.77 | NA | 18.04 | 090 | |
49611 | A | Repair umbilical lesion | 8.92 | NA | 9.64 | 0.65 | NA | 19.21 | 090 | |
49650 | A | Laparo hernia repair initial | 6.27 | NA | 3.23 | 0.64 | NA | 10.14 | 090 | |
49651 | A | Laparo hernia repair recur | 8.24 | NA | 4.28 | 0.84 | NA | 13.36 | 090 | |
49659 | C | Laparo proc, hernia repair | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
49900 | A | Repair of abdominal wall | 12.28 | NA | 6.65 | 1.23 | NA | 20.16 | 090 | |
49904 | A | Omental flap, extra-abdom | 20.00 | NA | 15.98 | 1.91 | NA | 37.89 | 090 | |
49905 | A | Omental flap, intra-abdom | 6.55 | NA | 2.34 | 0.61 | NA | 9.50 | ZZZ | |
49906 | C | Free omental flap, microvasc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 090 | |
49999 | C | Abdomen surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
50010 | A | Exploration of kidney | 10.98 | NA | 6.48 | 0.79 | NA | 18.25 | 090 | |
50020 | A | Renal abscess, open drain | 14.66 | NA | 13.74 | 0.80 | NA | 29.20 | 090 | |
50021 | A | Renal abscess, percut drain | 3.38 | NA | 9.98 | 0.15 | NA | 13.51 | 000 | |
50040 | A | Drainage of kidney | 14.94 | NA | 10.83 | 0.82 | NA | 26.59 | 090 | |
50045 | A | Exploration of kidney | 15.46 | NA | 7.88 | 1.06 | NA | 24.40 | 090 | |
50060 | A | Removal of kidney stone | 19.30 | NA | 9.13 | 1.14 | NA | 29.57 | 090 | |
50065 | A | Incision of kidney | 20.79 | NA | 8.01 | 1.13 | NA | 29.93 | 090 | |
50070 | A | Incision of kidney | 20.32 | NA | 9.53 | 1.20 | NA | 31.05 | 090 | |
50075 | A | Removal of kidney stone | 25.34 | NA | 11.61 | 1.51 | NA | 38.46 | 090 | |
50080 | A | Removal of kidney stone | 14.71 | NA | 9.63 | 0.86 | NA | 25.20 | 090 | |
50081 | A | Removal of kidney stone | 21.80 | NA | 11.66 | 1.30 | NA | 34.76 | 090 | |
50100 | A | Revise kidney blood vessels | 16.09 | NA | 9.66 | 1.64 | NA | 27.39 | 090 | |
50120 | A | Exploration of kidney | 15.91 | NA | 8.08 | 1.04 | NA | 25.03 | 090 | |
50125 | A | Explore and drain kidney | 16.52 | NA | 8.36 | 1.07 | NA | 25.95 | 090 | |
50130 | A | Removal of kidney stone | 17.29 | NA | 8.41 | 1.04 | NA | 26.74 | 090 | |
50135 | A | Exploration of kidney | 19.18 | NA | 9.05 | 1.18 | NA | 29.41 | 090 | |
50200 | A | Biopsy of kidney | 2.63 | NA | 0.93 | 0.12 | NA | 3.68 | 000 | |
50205 | A | Biopsy of kidney | 11.31 | NA | 6.20 | 0.94 | NA | 18.45 | 090 | |
50220 | A | Remove kidney, open | 17.15 | NA | 8.57 | 1.16 | NA | 26.88 | 090 | |
50225 | A | Removal kidney open, complex | 20.23 | NA | 9.46 | 1.26 | NA | 30.95 | 090 | |
50230 | A | Removal kidney open, radical | 22.07 | NA | 10.04 | 1.35 | NA | 33.46 | 090 | |
50234 | A | Removal of kidney ureter | 22.40 | NA | 10.14 | 1.37 | NA | 33.91 | 090 | |
50236 | A | Removal of kidney ureter | 24.86 | NA | 12.69 | 1.50 | NA | 39.05 | 090 | |
50240 | A | Partial removal of kidney | 22.00 | NA | 11.82 | 1.36 | NA | 35.18 | 090 | |
50280 | A | Removal of kidney lesion | 15.67 | NA | 7.95 | 0.99 | NA | 24.61 | 090 | |
50290 | A | Removal of kidney lesion | 14.73 | NA | 7.80 | 1.11 | NA | 23.64 | 090 | |
50300 | X | Removal of donor kidney | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
50320 | A | Removal of donor kidney | 22.21 | NA | 10.24 | 1.78 | NA | 34.23 | 090 | |
50340 | A | Removal of kidney | 12.15 | NA | 9.07 | 1.15 | NA | 22.37 | 090 | |
50360 | A | Transplantation of kidney | 31.53 | NA | 17.43 | 2.97 | NA | 51.93 | 090 | |
50365 | A | Transplantation of kidney | 36.81 | NA | 21.07 | 3.51 | NA | 61.39 | 090 | |
50370 | A | Remove transplanted kidney | 13.72 | NA | 9.47 | 1.26 | NA | 24.45 | 090 | |
50380 | A | Reimplantation of kidney | 20.76 | NA | 13.49 | 1.80 | NA | 36.05 | 090 | |
50390 | A | Drainage of kidney lesion | 1.96 | NA | 0.66 | 0.09 | NA | 2.71 | 000 | |
50392 | A | Insert kidney drain | 3.38 | NA | 1.13 | 0.15 | NA | 4.66 | 000 | |
50393 | A | Insert ureteral tube | 4.16 | NA | 1.39 | 0.18 | NA | 5.73 | 000 | |
50394 | A | Injection for kidney x-ray | 0.76 | 2.44 | 0.26 | 0.04 | 3.24 | 1.06 | 000 | |
50395 | A | Create passage to kidney | 3.38 | NA | 1.13 | 0.16 | NA | 4.67 | 000 | |
50396 | A | Measure kidney pressure | 2.09 | NA | 0.87 | 0.10 | NA | 3.06 | 000 | |
50398 | A | Change kidney tube | 1.46 | 1.19 | 0.49 | 0.07 | 2.72 | 2.02 | 000 | |
50400 | A | Revision of kidney/ureter | 19.50 | NA | 9.19 | 1.21 | NA | 29.90 | 090 | |
50405 | A | Revision of kidney/ureter | 23.93 | NA | 11.44 | 1.45 | NA | 36.82 | 090 | |
50500 | A | Repair of kidney wound | 19.57 | NA | 10.59 | 1.45 | NA | 31.61 | 090 | |
50520 | A | Close kidney-skin fistula | 17.23 | NA | 10.04 | 1.26 | NA | 28.53 | 090 | |
50525 | A | Repair renal-abdomen fistula | 22.27 | NA | 11.99 | 1.51 | NA | 35.77 | 090 | |
50526 | A | Repair renal-abdomen fistula | 24.02 | NA | 13.43 | 1.62 | NA | 39.07 | 090 | |
50540 | A | Revision of horseshoe kidney | 19.93 | NA | 9.97 | 1.28 | NA | 31.18 | 090 | |
50541 | A | Laparo ablate renal cyst | 16.00 | NA | 6.37 | 0.99 | NA | 23.36 | 090 | |
50542 | A | Laparo ablate renal mass | 20.00 | NA | 8.34 | 1.36 | NA | 29.70 | 090 | |
50543 | A | Laparo partial nephrectomy | 25.50 | NA | 10.48 | 1.36 | NA | 37.34 | 090 | |
50544 | A | Laparoscopy, pyeloplasty | 22.40 | NA | 8.56 | 1.41 | NA | 32.37 | 090 | |
50545 | A | Laparo radical nephrectomy | 24.00 | NA | 9.14 | 1.53 | NA | 34.67 | 090 | |
50546 | A | Laparoscopic nephrectomy | 20.48 | NA | 7.95 | 1.37 | NA | 29.80 | 090 | |
50547 | A | Laparo removal donor kidney | 25.50 | NA | 10.79 | 2.04 | NA | 38.33 | 090 | |
50548 | A | Laparo remove k/ureter | 24.40 | NA | 9.18 | 1.49 | NA | 35.07 | 090 | |
50549 | C | Laparoscope proc, renal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
50551 | A | Kidney endoscopy | 5.60 | 4.06 | 1.84 | 0.33 | 9.99 | 7.77 | 000 | |
50553 | A | Kidney endoscopy | 5.99 | 11.31 | 2.00 | 0.35 | 17.65 | 8.34 | 000 | |
50555 | A | Kidney endoscopy biopsy | 6.53 | 13.90 | 2.17 | 0.38 | 20.81 | 9.08 | 000 | |
50557 | A | Kidney endoscopy treatment | 6.62 | 11.67 | 2.18 | 0.39 | 18.68 | 9.19 | 000 | |
50559 | A | Renal endoscopy/radiotracer | 6.78 | NA | 2.31 | 0.27 | NA | 9.36 | 000 | |
50561 | A | Kidney endoscopy treatment | 7.59 | 11.94 | 2.51 | 0.44 | 19.97 | 10.54 | 000 | |
50562 | A | Renal scope w/tumor resect | 10.92 | NA | 4.02 | 0.84 | NA | 15.78 | 090 | |
50570 | A | Kidney endoscopy | 9.54 | NA | 3.13 | 0.56 | NA | 13.23 | 000 | |
50572 | A | Kidney endoscopy | 10.35 | NA | 3.41 | 0.64 | NA | 14.40 | 000 | |
50574 | A | Kidney endoscopy biopsy | 11.02 | NA | 3.64 | 0.65 | NA | 15.31 | 000 | |
50575 | A | Kidney endoscopy | 13.98 | NA | 4.60 | 0.84 | NA | 19.42 | 000 | |
50576 | A | Kidney endoscopy treatment | 10.99 | NA | 3.60 | 0.66 | NA | 15.25 | 000 | |
50578 | A | Renal endoscopy/radiotracer | 11.35 | NA | 3.73 | 0.67 | NA | 15.75 | 000 | |
50580 | A | Kidney endoscopy treatment | 11.86 | NA | 3.90 | 0.70 | NA | 16.46 | 000 | |
50590 | A | Fragmenting of kidney stone | 9.09 | 10.73 | 4.94 | 0.54 | 20.36 | 14.57 | 090 | |
50600 | A | Exploration of ureter | 15.84 | NA | 8.11 | 0.99 | NA | 24.94 | 090 | |
50605 | A | Insert ureteral support | 15.46 | NA | 8.26 | 1.13 | NA | 24.85 | 090 | |
50610 | A | Removal of ureter stone | 15.92 | NA | 8.44 | 1.08 | NA | 25.44 | 090 | |
50620 | A | Removal of ureter stone | 15.16 | NA | 7.64 | 0.91 | NA | 23.71 | 090 | |
50630 | A | Removal of ureter stone | 14.94 | NA | 7.60 | 0.90 | NA | 23.44 | 090 | |
50650 | A | Removal of ureter | 17.41 | NA | 8.83 | 1.07 | NA | 27.31 | 090 | |
50660 | A | Removal of ureter | 19.55 | NA | 9.57 | 1.19 | NA | 30.31 | 090 | |
50684 | A | Injection for ureter x-ray | 0.76 | 11.21 | 0.25 | 0.04 | 12.01 | 1.05 | 000 | |
50686 | A | Measure ureter pressure | 1.51 | 2.45 | 0.67 | 0.09 | 4.05 | 2.27 | 000 | |
50688 | A | Change of ureter tube | 1.17 | NA | 1.69 | 0.06 | NA | 2.92 | 010 | |
50690 | A | Injection for ureter x-ray | 1.16 | 11.17 | 0.39 | 0.06 | 12.39 | 1.61 | 000 | |
50700 | A | Revision of ureter | 15.21 | NA | 8.75 | 0.86 | NA | 24.82 | 090 | |
50715 | A | Release of ureter | 18.90 | NA | 11.71 | 1.68 | NA | 32.29 | 090 | |
50722 | A | Release of ureter | 16.35 | NA | 9.56 | 1.41 | NA | 27.32 | 090 | |
50725 | A | Release/revise ureter | 18.49 | NA | 9.86 | 1.44 | NA | 29.79 | 090 | |
50727 | A | Revise ureter | 8.18 | NA | 5.79 | 0.51 | NA | 14.48 | 090 | |
50728 | A | Revise ureter | 12.02 | NA | 7.55 | 0.88 | NA | 20.45 | 090 | |
50740 | A | Fusion of ureter kidney | 18.42 | NA | 9.09 | 1.49 | NA | 29.00 | 090 | |
50750 | A | Fusion of ureter kidney | 19.51 | NA | 9.63 | 1.24 | NA | 30.38 | 090 | |
50760 | A | Fusion of ureters | 18.42 | NA | 9.37 | 1.25 | NA | 29.04 | 090 | |
50770 | A | Splicing of ureters | 19.51 | NA | 9.55 | 1.25 | NA | 30.31 | 090 | |
50780 | A | Reimplant ureter in bladder | 18.36 | NA | 9.22 | 1.20 | NA | 28.78 | 090 | |
50782 | A | Reimplant ureter in bladder | 19.54 | NA | 11.06 | 1.13 | NA | 31.73 | 090 | |
50783 | A | Reimplant ureter in bladder | 20.55 | NA | 10.18 | 1.35 | NA | 32.08 | 090 | |
50785 | A | Reimplant ureter in bladder | 20.52 | NA | 9.96 | 1.30 | NA | 31.78 | 090 | |
50800 | A | Implant ureter in bowel | 14.52 | NA | 8.99 | 0.92 | NA | 24.43 | 090 | |
50810 | A | Fusion of ureter bowel | 20.05 | NA | 12.28 | 1.78 | NA | 34.11 | 090 | |
50815 | A | Urine shunt to intestine | 19.93 | NA | 10.98 | 1.31 | NA | 32.22 | 090 | |
50820 | A | Construct bowel bladder | 21.89 | NA | 11.33 | 1.38 | NA | 34.60 | 090 | |
50825 | A | Construct bowel bladder | 28.18 | NA | 14.12 | 1.81 | NA | 44.11 | 090 | |
50830 | A | Revise urine flow | 31.28 | NA | 14.80 | 2.20 | NA | 48.28 | 090 | |
50840 | A | Replace ureter by bowel | 20.00 | NA | 10.92 | 1.26 | NA | 32.18 | 090 | |
50845 | A | Appendico-vesicostomy | 20.89 | NA | 9.62 | 1.26 | NA | 31.77 | 090 | |
50860 | A | Transplant ureter to skin | 15.36 | NA | 8.23 | 1.01 | NA | 24.60 | 090 | |
50900 | A | Repair of ureter | 13.62 | NA | 7.40 | 0.98 | NA | 22.00 | 090 | |
50920 | A | Closure ureter/skin fistula | 14.33 | NA | 7.95 | 0.84 | NA | 23.12 | 090 | |
50930 | A | Closure ureter/bowel fistula | 18.72 | NA | 9.48 | 1.57 | NA | 29.77 | 090 | |
50940 | A | Release of ureter | 14.51 | NA | 7.65 | 1.04 | NA | 23.20 | 090 | |
50945 | A | Laparoscopy ureterolithotomy | 17.00 | NA | 6.99 | 1.15 | NA | 25.14 | 090 | |
50947 | A | Laparo new ureter/bladder | 24.50 | NA | 9.90 | 1.99 | NA | 36.39 | 090 | |
50948 | A | Laparo new ureter/bladder | 22.50 | NA | 8.85 | 1.83 | NA | 33.18 | 090 | |
50949 | C | Laparoscope proc, ureter | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
50951 | A | Endoscopy of ureter | 5.84 | 4.50 | 1.92 | 0.35 | 10.69 | 8.11 | 000 | |
50953 | A | Endoscopy of ureter | 6.24 | 11.22 | 2.06 | 0.37 | 17.83 | 8.67 | 000 | |
50955 | A | Ureter endoscopy biopsy | 6.75 | 16.74 | 2.26 | 0.38 | 23.87 | 9.39 | 000 | |
50957 | A | Ureter endoscopy treatment | 6.79 | 11.23 | 2.24 | 0.40 | 18.42 | 9.43 | 000 | |
50959 | A | Ureter endoscopy tracer | 4.40 | NA | 1.45 | 0.18 | NA | 6.03 | 000 | |
50961 | A | Ureter endoscopy treatment | 6.05 | 13.85 | 1.99 | 0.35 | 20.25 | 8.39 | 000 | |
50970 | A | Ureter endoscopy | 7.14 | NA | 2.36 | 0.43 | NA | 9.93 | 000 | |
50972 | A | Ureter endoscopy catheter | 6.89 | NA | 2.32 | 0.39 | NA | 9.60 | 000 | |
50974 | A | Ureter endoscopy biopsy | 9.17 | NA | 3.01 | 0.53 | NA | 12.71 | 000 | |
50976 | A | Ureter endoscopy treatment | 9.04 | NA | 2.99 | 0.53 | NA | 12.56 | 000 | |
50978 | A | Ureter endoscopy tracer | 5.10 | NA | 1.74 | 0.30 | NA | 7.14 | 000 | |
50980 | A | Ureter endoscopy treatment | 6.85 | NA | 2.26 | 0.41 | NA | 9.52 | 000 | |
51000 | A | Drainage of bladder | 0.78 | 1.87 | 0.25 | 0.05 | 2.70 | 1.08 | 000 | |
51005 | A | Drainage of bladder | 1.02 | 3.05 | 0.35 | 0.08 | 4.15 | 1.45 | 000 | |
51010 | A | Drainage of bladder | 3.53 | 4.87 | 1.93 | 0.23 | 8.63 | 5.69 | 010 | |
51020 | A | Incise treat bladder | 6.71 | NA | 5.08 | 0.42 | NA | 12.21 | 090 | |
51030 | A | Incise treat bladder | 6.77 | NA | 5.36 | 0.42 | NA | 12.55 | 090 | |
51040 | A | Incise drain bladder | 4.40 | NA | 3.80 | 0.27 | NA | 8.47 | 090 | |
51045 | A | Incise bladder/drain ureter | 6.77 | NA | 5.46 | 0.47 | NA | 12.70 | 090 | |
51050 | A | Removal of bladder stone | 6.92 | NA | 4.53 | 0.42 | NA | 11.87 | 090 | |
51060 | A | Removal of ureter stone | 8.85 | NA | 5.65 | 0.54 | NA | 15.04 | 090 | |
51065 | A | Remove ureter calculus | 8.85 | NA | 5.50 | 0.53 | NA | 14.88 | 090 | |
51080 | A | Drainage of bladder abscess | 5.96 | NA | 5.14 | 0.35 | NA | 11.45 | 090 | |
51500 | A | Removal of bladder cyst | 10.14 | NA | 5.85 | 0.88 | NA | 16.87 | 090 | |
51520 | A | Removal of bladder lesion | 9.29 | NA | 5.87 | 0.58 | NA | 15.74 | 090 | |
51525 | A | Removal of bladder lesion | 13.97 | NA | 7.28 | 0.85 | NA | 22.10 | 090 | |
51530 | A | Removal of bladder lesion | 12.38 | NA | 7.08 | 0.82 | NA | 20.28 | 090 | |
51535 | A | Repair of ureter lesion | 12.57 | NA | 7.63 | 0.90 | NA | 21.10 | 090 | |
51550 | A | Partial removal of bladder | 15.66 | NA | 7.97 | 1.05 | NA | 24.68 | 090 | |
51555 | A | Partial removal of bladder | 21.23 | NA | 10.19 | 1.37 | NA | 32.79 | 090 | |
51565 | A | Revise bladder ureter(s) | 21.62 | NA | 10.66 | 1.40 | NA | 33.68 | 090 | |
51570 | A | Removal of bladder | 24.24 | NA | 11.71 | 1.59 | NA | 37.54 | 090 | |
51575 | A | Removal of bladder nodes | 30.45 | NA | 14.33 | 1.88 | NA | 46.66 | 090 | |
51580 | A | Remove bladder/revise tract | 31.08 | NA | 14.97 | 1.94 | NA | 47.99 | 090 | |
51585 | A | Removal of bladder nodes | 35.23 | NA | 16.07 | 2.18 | NA | 53.48 | 090 | |
51590 | A | Remove bladder/revise tract | 32.66 | NA | 14.90 | 2.01 | NA | 49.57 | 090 | |
51595 | A | Remove bladder/revise tract | 37.14 | NA | 16.33 | 2.23 | NA | 55.70 | 090 | |
51596 | A | Remove bladder/create pouch | 39.52 | NA | 17.60 | 2.39 | NA | 59.51 | 090 | |
51597 | A | Removal of pelvic structures | 38.35 | NA | 17.28 | 2.49 | NA | 58.12 | 090 | |
51600 | A | Injection for bladder x-ray | 0.88 | 4.76 | 0.30 | 0.04 | 5.68 | 1.22 | 000 | |
51605 | A | Preparation for bladder xray | 0.64 | 12.01 | 0.22 | 0.04 | 12.69 | 0.90 | 000 | |
51610 | A | Injection for bladder x-ray | 1.05 | 12.17 | 0.35 | 0.05 | 13.27 | 1.45 | 000 | |
51700 | A | Irrigation of bladder | 0.88 | 1.16 | 0.29 | 0.05 | 2.09 | 1.22 | 000 | |
51701 | A | Insert bladder catheter | 0.50 | 1.06 | 0.20 | 0.03 | 1.59 | 0.73 | 000 | |
51702 | A | Insert temp bladder cath | 0.50 | 1.97 | 0.27 | 0.03 | 2.50 | 0.80 | 000 | |
51703 | A | Insert bladder cath, complex | 1.47 | 1.91 | 0.59 | 0.09 | 3.47 | 2.15 | 000 | |
51705 | A | Change of bladder tube | 1.02 | 1.40 | 0.54 | 0.06 | 2.48 | 1.62 | 010 | |
51710 | A | Change of bladder tube | 1.49 | 3.24 | 1.21 | 0.09 | 4.82 | 2.79 | 010 | |
51715 | A | Endoscopic injection/implant | 3.74 | 3.64 | 1.24 | 0.24 | 7.62 | 5.22 | 000 | |
51720 | A | Treatment of bladder lesion | 1.96 | 1.41 | 0.73 | 0.12 | 3.49 | 2.81 | 000 | |
51725 | A | Simple cystometrogram | 1.51 | 7.29 | NA | 0.13 | 8.93 | NA | 000 | |
51725 | 26 | A | Simple cystometrogram | 1.51 | 0.51 | 0.51 | 0.10 | 2.12 | 2.12 | 000 |
51725 | TC | A | Simple cystometrogram | 0.00 | 6.78 | NA | 0.03 | 6.81 | NA | 000 |
51726 | A | Complex cystometrogram | 1.71 | 9.35 | NA | 0.15 | 11.21 | NA | 000 | |
51726 | 26 | A | Complex cystometrogram | 1.71 | 0.58 | 0.58 | 0.11 | 2.40 | 2.40 | 000 |
51726 | TC | A | Complex cystometrogram | 0.00 | 8.77 | NA | 0.04 | 8.81 | NA | 000 |
51736 | A | Urine flow measurement | 0.61 | 0.55 | NA | 0.05 | 1.21 | NA | 000 | |
51736 | 26 | A | Urine flow measurement | 0.61 | 0.21 | 0.21 | 0.04 | 0.86 | 0.86 | 000 |
51736 | TC | A | Urine flow measurement | 0.00 | 0.34 | NA | 0.01 | 0.35 | NA | 000 |
51741 | A | Electro-uroflowmetry, first | 1.14 | 0.79 | NA | 0.09 | 2.02 | NA | 000 | |
51741 | 26 | A | Electro-uroflowmetry, first | 1.14 | 0.38 | 0.38 | 0.07 | 1.59 | 1.59 | 000 |
51741 | TC | A | Electro-uroflowmetry, first | 0.00 | 0.41 | NA | 0.02 | 0.43 | NA | 000 |
51772 | A | Urethra pressure profile | 1.61 | 8.81 | NA | 0.16 | 10.58 | NA | 000 | |
51772 | 26 | A | Urethra pressure profile | 1.61 | 0.57 | 0.57 | 0.12 | 2.30 | 2.30 | 000 |
51772 | TC | A | Urethra pressure profile | 0.00 | 8.24 | NA | 0.04 | 8.28 | NA | 000 |
51784 | A | Anal/urinary muscle study | 1.53 | 4.56 | NA | 0.13 | 6.22 | NA | 000 | |
51784 | 26 | A | Anal/urinary muscle study | 1.53 | 0.52 | 0.52 | 0.10 | 2.15 | 2.15 | 000 |
51784 | TC | A | Anal/urinary muscle study | 0.00 | 4.04 | NA | 0.03 | 4.07 | NA | 000 |
51785 | A | Anal/urinary muscle study | 1.53 | 4.68 | NA | 0.12 | 6.33 | NA | 000 | |
51785 | 26 | A | Anal/urinary muscle study | 1.53 | 0.52 | 0.52 | 0.09 | 2.14 | 2.14 | 000 |
51785 | TC | A | Anal/urinary muscle study | 0.00 | 4.16 | NA | 0.03 | 4.19 | NA | 000 |
51792 | A | Urinary reflex study | 1.10 | 23.28 | NA | 0.20 | 24.58 | NA | 000 | |
51792 | 26 | A | Urinary reflex study | 1.10 | 0.43 | 0.43 | 0.09 | 1.62 | 1.62 | 000 |
51792 | TC | A | Urinary reflex study | 0.00 | 22.85 | NA | 0.11 | 22.96 | NA | 000 |
51795 | A | Urine voiding pressure study | 1.53 | 8.93 | NA | 0.18 | 10.64 | NA | 000 | |
51795 | 26 | A | Urine voiding pressure study | 1.53 | 0.52 | 0.52 | 0.10 | 2.15 | 2.15 | 000 |
51795 | TC | A | Urine voiding pressure study | 0.00 | 8.41 | NA | 0.08 | 8.49 | NA | 000 |
51797 | A | Intraabdominal pressure test | 1.60 | 4.31 | NA | 0.14 | 6.05 | NA | 000 | |
51797 | 26 | A | Intraabdominal pressure test | 1.60 | 0.54 | 0.54 | 0.10 | 2.24 | 2.24 | 000 |
51797 | TC | A | Intraabdominal pressure test | 0.00 | 3.77 | NA | 0.04 | 3.81 | NA | 000 |
51798 | A | Us urine capacity measure | 0.00 | 0.48 | NA | 0.07 | 0.55 | NA | XXX | |
51800 | A | Revision of bladder/urethra | 17.42 | NA | 8.79 | 1.17 | NA | 27.38 | 090 | |
51820 | A | Revision of urinary tract | 17.89 | NA | 10.56 | 1.45 | NA | 29.90 | 090 | |
51840 | A | Attach bladder/urethra | 10.71 | NA | 6.31 | 0.87 | NA | 17.89 | 090 | |
51841 | A | Attach bladder/urethra | 13.03 | NA | 7.98 | 1.04 | NA | 22.05 | 090 | |
51845 | A | Repair bladder neck | 9.73 | NA | 6.13 | 0.62 | NA | 16.48 | 090 | |
51860 | A | Repair of bladder wound | 12.02 | NA | 7.34 | 0.89 | NA | 20.25 | 090 | |
51865 | A | Repair of bladder wound | 15.04 | NA | 8.18 | 1.01 | NA | 24.23 | 090 | |
51880 | A | Repair of bladder opening | 7.66 | NA | 5.30 | 0.54 | NA | 13.50 | 090 | |
51900 | A | Repair bladder/vagina lesion | 12.97 | NA | 7.62 | 0.87 | NA | 21.46 | 090 | |
51920 | A | Close bladder-uterus fistula | 11.81 | NA | 6.82 | 0.86 | NA | 19.49 | 090 | |
51925 | A | Hysterectomy/bladder repair | 15.58 | NA | 9.31 | 1.48 | NA | 26.37 | 090 | |
51940 | A | Correction of bladder defect | 28.43 | NA | 15.43 | 1.97 | NA | 45.83 | 090 | |
51960 | A | Revision of bladder bowel | 23.01 | NA | 12.19 | 1.41 | NA | 36.61 | 090 | |
51980 | A | Construct bladder opening | 11.36 | NA | 6.56 | 0.74 | NA | 18.66 | 090 | |
51990 | A | Laparo urethral suspension | 12.50 | NA | 6.53 | 1.02 | NA | 20.05 | 090 | |
51992 | A | Laparo sling operation | 14.01 | NA | 6.44 | 0.93 | NA | 21.38 | 090 | |
52000 | A | Cystoscopy | 2.01 | 5.22 | 0.78 | 0.12 | 7.35 | 2.91 | 000 | |
52001 | A | Cystoscopy, removal of clots | 5.45 | 7.89 | 2.33 | 0.32 | 13.66 | 8.10 | 000 | |
52005 | A | Cystoscopy ureter catheter | 2.37 | 9.91 | 0.92 | 0.15 | 12.43 | 3.44 | 000 | |
52007 | A | Cystoscopy and biopsy | 3.02 | NA | 1.17 | 0.18 | NA | 4.37 | 000 | |
52010 | A | Cystoscopy duct catheter | 3.02 | 11.79 | 1.14 | 0.18 | 14.99 | 4.34 | 000 | |
52204 | A | Cystoscopy | 2.37 | 15.85 | 0.93 | 0.15 | 18.37 | 3.45 | 000 | |
52214 | A | Cystoscopy and treatment | 3.71 | 46.64 | 1.36 | 0.22 | 50.57 | 5.29 | 000 | |
52224 | A | Cystoscopy and treatment | 3.14 | 46.25 | 1.18 | 0.18 | 49.57 | 4.50 | 000 | |
52234 | A | Cystoscopy and treatment | 4.63 | NA | 1.67 | 0.27 | NA | 6.57 | 000 | |
52235 | A | Cystoscopy and treatment | 5.45 | NA | 1.95 | 0.32 | NA | 7.72 | 000 | |
52240 | A | Cystoscopy and treatment | 9.72 | NA | 3.37 | 0.58 | NA | 13.67 | 000 | |
52250 | A | Cystoscopy and radiotracer | 4.50 | NA | 1.70 | 0.27 | NA | 6.47 | 000 | |
52260 | A | Cystoscopy and treatment | 3.92 | NA | 1.46 | 0.23 | NA | 5.61 | 000 | |
52265 | A | Cystoscopy and treatment | 2.94 | 16.04 | 1.14 | 0.18 | 19.16 | 4.26 | 000 | |
52270 | A | Cystoscopy revise urethra | 3.37 | 23.02 | 1.32 | 0.20 | 26.59 | 4.89 | 000 | |
52275 | A | Cystoscopy revise urethra | 4.70 | 17.12 | 1.76 | 0.28 | 22.10 | 6.74 | 000 | |
52276 | A | Cystoscopy and treatment | 5.00 | 23.83 | 1.88 | 0.30 | 29.13 | 7.18 | 000 | |
52277 | A | Cystoscopy and treatment | 6.17 | NA | 2.31 | 0.38 | NA | 8.86 | 000 | |
52281 | A | Cystoscopy and treatment | 2.80 | 8.59 | 1.10 | 0.17 | 11.56 | 4.07 | 000 | |
52282 | A | Cystoscopy, implant stent | 6.40 | 81.32 | 2.29 | 0.38 | 88.10 | 9.07 | 000 | |
52283 | A | Cystoscopy and treatment | 3.74 | 13.84 | 1.41 | 0.22 | 17.80 | 5.37 | 000 | |
52285 | A | Cystoscopy and treatment | 3.61 | 9.79 | 1.37 | 0.22 | 13.62 | 5.20 | 000 | |
52290 | A | Cystoscopy and treatment | 4.59 | NA | 1.69 | 0.27 | NA | 6.55 | 000 | |
52300 | A | Cystoscopy and treatment | 5.31 | NA | 1.95 | 0.32 | NA | 7.58 | 000 | |
52301 | A | Cystoscopy and treatment | 5.51 | NA | 2.04 | 0.39 | NA | 7.94 | 000 | |
52305 | A | Cystoscopy and treatment | 5.31 | NA | 1.90 | 0.31 | NA | 7.52 | 000 | |
52310 | A | Cystoscopy and treatment | 2.81 | 5.38 | 1.05 | 0.17 | 8.36 | 4.03 | 000 | |
52315 | A | Cystoscopy and treatment | 5.21 | 7.67 | 1.88 | 0.31 | 13.19 | 7.40 | 000 | |
52317 | A | Remove bladder stone | 6.72 | 37.82 | 2.34 | 0.40 | 44.94 | 9.46 | 000 | |
52318 | A | Remove bladder stone | 9.19 | NA | 3.17 | 0.54 | NA | 12.90 | 000 | |
52320 | A | Cystoscopy and treatment | 4.70 | NA | 1.68 | 0.28 | NA | 6.66 | 000 | |
52325 | A | Cystoscopy, stone removal | 6.16 | NA | 2.17 | 0.37 | NA | 8.70 | 000 | |
52327 | A | Cystoscopy, inject material | 5.19 | NA | 1.87 | 0.32 | NA | 7.38 | 000 | |
52330 | A | Cystoscopy and treatment | 5.04 | 18.51 | 1.79 | 0.30 | 23.85 | 7.13 | 000 | |
52332 | A | Cystoscopy and treatment | 2.83 | 14.97 | 1.07 | 0.17 | 17.97 | 4.07 | 000 | |
52334 | A | Create passage to kidney | 4.83 | NA | 1.80 | 0.28 | NA | 6.91 | 000 | |
52341 | A | Cysto w/ureter stricture tx | 6.00 | NA | 2.26 | 0.37 | NA | 8.63 | 000 | |
52342 | A | Cysto w/up stricture tx | 6.50 | NA | 2.41 | 0.40 | NA | 9.31 | 000 | |
52343 | A | Cysto w/renal stricture tx | 7.20 | NA | 2.69 | 0.44 | NA | 10.33 | 000 | |
52344 | A | Cysto/uretero, stone remove | 7.70 | NA | 2.87 | 0.47 | NA | 11.04 | 000 | |
52345 | A | Cysto/uretero w/up stricture | 8.20 | NA | 3.03 | 0.50 | NA | 11.73 | 000 | |
52346 | A | Cystouretero w/renal strict | 9.23 | NA | 3.38 | 0.57 | NA | 13.18 | 000 | |
52347 | A | Cystoscopy, resect ducts | 5.28 | NA | 2.09 | 0.33 | NA | 7.70 | 000 | |
52351 | A | Cystouretero or pyeloscope | 5.86 | NA | 2.19 | 0.36 | NA | 8.41 | 000 | |
52352 | A | Cystouretero w/stone remove | 6.88 | NA | 2.57 | 0.42 | NA | 9.87 | 000 | |
52353 | A | Cystouretero w/lithotripsy | 7.97 | NA | 2.93 | 0.49 | NA | 11.39 | 000 | |
52354 | A | Cystouretero w/biopsy | 7.34 | NA | 2.74 | 0.45 | NA | 10.53 | 000 | |
52355 | A | Cystouretero w/excise tumor | 8.82 | NA | 3.22 | 0.55 | NA | 12.59 | 000 | |
52400 | A | Cystouretero w/congen repr | 9.68 | NA | 4.31 | 0.60 | NA | 14.59 | 090 | |
52450 | A | Incision of prostate | 7.64 | NA | 3.65 | 0.46 | NA | 11.75 | 090 | |
52500 | A | Revision of bladder neck | 8.47 | NA | 3.91 | 0.50 | NA | 12.88 | 090 | |
52510 | A | Dilation prostatic urethra | 6.72 | NA | 3.24 | 0.40 | NA | 10.36 | 090 | |
52601 | A | Prostatectomy (TURP) | 12.37 | NA | 5.23 | 0.74 | NA | 18.34 | 090 | |
52606 | A | Control postop bleeding | 8.13 | NA | 3.56 | 0.49 | NA | 12.18 | 090 | |
52612 | A | Prostatectomy, first stage | 7.98 | NA | 3.83 | 0.48 | NA | 12.29 | 090 | |
52614 | A | Prostatectomy, second stage | 6.84 | NA | 3.42 | 0.41 | NA | 10.67 | 090 | |
52620 | A | Remove residual prostate | 6.61 | NA | 3.08 | 0.39 | NA | 10.08 | 090 | |
52630 | A | Remove prostate regrowth | 7.26 | NA | 3.20 | 0.43 | NA | 10.89 | 090 | |
52640 | A | Relieve bladder contracture | 6.62 | NA | 3.10 | 0.39 | NA | 10.11 | 090 | |
52647 | A | Laser surgery of prostate | 10.36 | 33.41 | 4.66 | 0.61 | 44.38 | 15.63 | 090 | |
52648 | A | Laser surgery of prostate | 11.21 | NA | 4.78 | 0.66 | NA | 16.65 | 090 | |
52700 | A | Drainage of prostate abscess | 6.80 | NA | 3.24 | 0.41 | NA | 10.45 | 090 | |
53000 | A | Incision of urethra | 2.28 | 7.31 | 2.23 | 0.13 | 9.72 | 4.64 | 010 | |
53010 | A | Incision of urethra | 3.64 | NA | 4.08 | 0.20 | NA | 7.92 | 090 | |
53020 | A | Incision of urethra | 1.77 | 3.05 | 0.66 | 0.11 | 4.93 | 2.54 | 000 | |
53025 | A | Incision of urethra | 1.13 | 3.04 | 0.45 | 0.07 | 4.24 | 1.65 | 000 | |
53040 | A | Drainage of urethra abscess | 6.40 | 10.66 | 6.47 | 0.41 | 17.47 | 13.28 | 090 | |
53060 | A | Drainage of urethra abscess | 2.63 | 5.91 | 2.67 | 0.23 | 8.77 | 5.53 | 010 | |
53080 | A | Drainage of urinary leakage | 6.29 | NA | 6.48 | 0.42 | NA | 13.19 | 090 | |
53085 | A | Drainage of urinary leakage | 10.27 | NA | 7.86 | 0.67 | NA | 18.80 | 090 | |
53200 | A | Biopsy of urethra | 2.59 | 4.18 | 0.95 | 0.17 | 6.94 | 3.71 | 000 | |
53210 | A | Removal of urethra | 12.57 | NA | 7.49 | 0.81 | NA | 20.87 | 090 | |
53215 | A | Removal of urethra | 15.58 | NA | 8.08 | 0.93 | NA | 24.59 | 090 | |
53220 | A | Treatment of urethra lesion | 7.00 | NA | 5.08 | 0.44 | NA | 12.52 | 090 | |
53230 | A | Removal of urethra lesion | 9.58 | NA | 5.80 | 0.60 | NA | 15.98 | 090 | |
53235 | A | Removal of urethra lesion | 10.14 | NA | 6.00 | 0.60 | NA | 16.74 | 090 | |
53240 | A | Surgery for urethra pouch | 6.45 | NA | 4.85 | 0.42 | NA | 11.72 | 090 | |
53250 | A | Removal of urethra gland | 5.89 | NA | 4.24 | 0.35 | NA | 10.48 | 090 | |
53260 | A | Treatment of urethra lesion | 2.98 | 5.30 | 2.24 | 0.23 | 8.51 | 5.45 | 010 | |
53265 | A | Treatment of urethra lesion | 3.12 | 5.13 | 2.19 | 0.20 | 8.45 | 5.51 | 010 | |
53270 | A | Removal of urethra gland | 3.09 | 5.05 | 2.45 | 0.21 | 8.35 | 5.75 | 010 | |
53275 | A | Repair of urethra defect | 4.53 | NA | 3.04 | 0.28 | NA | 7.85 | 010 | |
53400 | A | Revise urethra, stage 1 | 12.77 | NA | 7.42 | 0.85 | NA | 21.04 | 090 | |
53405 | A | Revise urethra, stage 2 | 14.48 | NA | 7.70 | 0.91 | NA | 23.09 | 090 | |
53410 | A | Reconstruction of urethra | 16.44 | NA | 8.43 | 0.99 | NA | 25.86 | 090 | |
53415 | A | Reconstruction of urethra | 19.41 | NA | 8.99 | 1.16 | NA | 29.56 | 090 | |
53420 | A | Reconstruct urethra, stage 1 | 14.08 | NA | 8.53 | 0.90 | NA | 23.51 | 090 | |
53425 | A | Reconstruct urethra, stage 2 | 15.98 | NA | 8.49 | 0.97 | NA | 25.44 | 090 | |
53430 | A | Reconstruction of urethra | 16.34 | NA | 8.62 | 1.01 | NA | 25.97 | 090 | |
53431 | A | Reconstruct urethra/bladder | 19.89 | NA | 9.04 | 1.30 | NA | 30.23 | 090 | |
53440 | A | Male sling procedure | 13.62 | NA | 6.33 | 0.73 | NA | 20.68 | 090 | |
53442 | A | Remove/revise male sling | 11.57 | NA | 5.93 | 0.55 | NA | 18.05 | 090 | |
53444 | A | Insert tandem cuff | 13.40 | NA | 6.14 | 0.88 | NA | 20.42 | 090 | |
53445 | A | Insert uro/ves nck sphincter | 14.06 | NA | 7.76 | 0.84 | NA | 22.66 | 090 | |
53446 | A | Remove uro sphincter | 10.23 | NA | 5.82 | 0.67 | NA | 16.72 | 090 | |
53447 | A | Remove/replace ur sphincter | 13.49 | NA | 6.55 | 0.79 | NA | 20.83 | 090 | |
53448 | A | Remov/replc ur sphinctr comp | 21.15 | NA | 9.85 | 1.39 | NA | 32.39 | 090 | |
53449 | A | Repair uro sphincter | 9.70 | NA | 5.90 | 0.57 | NA | 16.17 | 090 | |
53450 | A | Revision of urethra | 6.14 | NA | 4.53 | 0.37 | NA | 11.04 | 090 | |
53460 | A | Revision of urethra | 7.12 | NA | 4.90 | 0.43 | NA | 12.45 | 090 | |
53502 | A | Repair of urethra injury | 7.63 | NA | 5.32 | 0.50 | NA | 13.45 | 090 | |
53505 | A | Repair of urethra injury | 7.63 | NA | 5.04 | 0.46 | NA | 13.13 | 090 | |
53510 | A | Repair of urethra injury | 10.11 | NA | 6.43 | 0.60 | NA | 17.14 | 090 | |
53515 | A | Repair of urethra injury | 13.31 | NA | 7.05 | 0.83 | NA | 21.19 | 090 | |
53520 | A | Repair of urethra defect | 8.68 | NA | 5.50 | 0.53 | NA | 14.71 | 090 | |
53600 | A | Dilate urethra stricture | 1.21 | 0.87 | 0.45 | 0.07 | 2.15 | 1.73 | 000 | |
53601 | A | Dilate urethra stricture | 0.98 | 0.95 | 0.39 | 0.06 | 1.99 | 1.43 | 000 | |
53605 | A | Dilate urethra stricture | 1.28 | NA | 0.42 | 0.08 | NA | 1.78 | 000 | |
53620 | A | Dilate urethra stricture | 1.62 | 1.30 | 0.62 | 0.10 | 3.02 | 2.34 | 000 | |
53621 | A | Dilate urethra stricture | 1.35 | 1.33 | 0.51 | 0.08 | 2.76 | 1.94 | 000 | |
53660 | A | Dilation of urethra | 0.71 | 1.01 | 0.33 | 0.04 | 1.76 | 1.08 | 000 | |
53661 | A | Dilation of urethra | 0.72 | 0.97 | 0.31 | 0.04 | 1.73 | 1.07 | 000 | |
53665 | A | Dilation of urethra | 0.76 | NA | 0.26 | 0.05 | NA | 1.07 | 000 | |
53670 | D | Insert urinary catheter | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | |
53675 | D | Insert urinary catheter | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | |
53850 | A | Prostatic microwave thermotx | 9.45 | 52.02 | 4.16 | 0.56 | 62.03 | 14.17 | 090 | |
53852 | A | Prostatic rf thermotx | 9.88 | 40.46 | 4.32 | 0.58 | 50.92 | 14.78 | 090 | |
53853 | A | Prostatic water thermother | 4.14 | 29.01 | 3.22 | 0.27 | 33.42 | 7.63 | 090 | |
53899 | C | Urology surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
54000 | A | Slitting of prepuce | 1.54 | 4.11 | 1.34 | 0.10 | 5.75 | 2.98 | 010 | |
54001 | A | Slitting of prepuce | 2.19 | 4.67 | 1.92 | 0.14 | 7.00 | 4.25 | 010 | |
54015 | A | Drain penis lesion | 5.32 | 5.91 | 2.97 | 0.33 | 11.56 | 8.62 | 010 | |
54050 | A | Destruction, penis lesion(s) | 1.24 | 2.78 | 0.50 | 0.07 | 4.09 | 1.81 | 010 | |
54055 | A | Destruction, penis lesion(s) | 1.22 | 4.91 | 1.34 | 0.07 | 6.20 | 2.63 | 010 | |
54056 | A | Cryosurgery, penis lesion(s) | 1.24 | 3.12 | 0.54 | 0.06 | 4.42 | 1.84 | 010 | |
54057 | A | Laser surg, penis lesion(s) | 1.24 | 3.09 | 1.24 | 0.08 | 4.41 | 2.56 | 010 | |
54060 | A | Excision of penis lesion(s) | 1.93 | 4.38 | 1.49 | 0.12 | 6.43 | 3.54 | 010 | |
54065 | A | Destruction, penis lesion(s) | 2.42 | 5.24 | 2.02 | 0.13 | 7.79 | 4.57 | 010 | |
54100 | A | Biopsy of penis | 1.90 | 3.32 | 0.76 | 0.10 | 5.32 | 2.76 | 000 | |
54105 | A | Biopsy of penis | 3.50 | 4.86 | 2.00 | 0.21 | 8.57 | 5.71 | 010 | |
54110 | A | Treatment of penis lesion | 10.13 | NA | 6.86 | 0.60 | NA | 17.59 | 090 | |
54111 | A | Treat penis lesion, graft | 13.57 | NA | 7.86 | 0.79 | NA | 22.22 | 090 | |
54112 | A | Treat penis lesion, graft | 15.86 | NA | 8.86 | 0.94 | NA | 25.66 | 090 | |
54115 | A | Treatment of penis lesion | 6.15 | 8.40 | 5.58 | 0.39 | 14.94 | 12.12 | 090 | |
54120 | A | Partial removal of penis | 9.97 | NA | 6.73 | 0.60 | NA | 17.30 | 090 | |
54125 | A | Removal of penis | 13.53 | NA | 7.92 | 0.81 | NA | 22.26 | 090 | |
54130 | A | Remove penis nodes | 20.14 | NA | 10.42 | 1.19 | NA | 31.75 | 090 | |
54135 | A | Remove penis nodes | 26.36 | NA | 12.50 | 1.58 | NA | 40.44 | 090 | |
54150 | A | Circumcision | 1.81 | 5.45 | 1.88 | 0.17 | 7.43 | 3.86 | 010 | |
54152 | A | Circumcision | 2.31 | NA | 1.65 | 0.16 | NA | 4.12 | 010 | |
54160 | A | Circumcision | 2.48 | 4.40 | 1.70 | 0.16 | 7.04 | 4.34 | 010 | |
54161 | A | Circumcision | 3.27 | NA | 1.92 | 0.20 | NA | 5.39 | 010 | |
54162 | A | Lysis penil circumic lesion | 3.00 | NA | 2.30 | 0.20 | NA | 5.50 | 010 | |
54163 | A | Repair of circumcision | 3.00 | NA | 2.07 | 0.20 | NA | 5.27 | 010 | |
54164 | A | Frenulotomy of penis | 2.50 | NA | 1.90 | 0.16 | NA | 4.56 | 010 | |
54200 | A | Treatment of penis lesion | 1.06 | 2.40 | 0.37 | 0.06 | 3.52 | 1.49 | 010 | |
54205 | A | Treatment of penis lesion | 7.93 | NA | 5.95 | 0.47 | NA | 14.35 | 090 | |
54220 | A | Treatment of penis lesion | 2.42 | 1.89 | 1.02 | 0.15 | 4.46 | 3.59 | 000 | |
54230 | A | Prepare penis study | 1.34 | NA | 0.44 | 0.08 | NA | 1.86 | 000 | |
54231 | A | Dynamic cavernosometry | 2.04 | 2.14 | 0.81 | 0.14 | 4.32 | 2.99 | 000 | |
54235 | A | Penile injection | 1.19 | 1.12 | 0.40 | 0.07 | 2.38 | 1.66 | 000 | |
54240 | A | Penis study | 1.31 | 1.85 | NA | 0.13 | 3.29 | NA | 000 | |
54240 | 26 | A | Penis study | 1.31 | 0.44 | 0.44 | 0.08 | 1.83 | 1.83 | 000 |
54240 | TC | A | Penis study | 0.00 | 1.41 | NA | 0.05 | 1.46 | NA | 000 |
54250 | A | Penis study | 2.22 | 2.85 | NA | 0.16 | 5.23 | NA | 000 | |
54250 | 26 | A | Penis study | 2.22 | 0.73 | 0.73 | 0.14 | 3.09 | 3.09 | 000 |
54250 | TC | A | Penis study | 0.00 | 2.12 | NA | 0.02 | 2.14 | NA | 000 |
54300 | A | Revision of penis | 10.41 | NA | 7.53 | 0.64 | NA | 18.58 | 090 | |
54304 | A | Revision of penis | 12.49 | NA | 8.72 | 0.74 | NA | 21.95 | 090 | |
54308 | A | Reconstruction of urethra | 11.83 | NA | 8.29 | 0.70 | NA | 20.82 | 090 | |
54312 | A | Reconstruction of urethra | 13.57 | NA | 9.35 | 0.81 | NA | 23.73 | 090 | |
54316 | A | Reconstruction of urethra | 16.82 | NA | 10.83 | 1.00 | NA | 28.65 | 090 | |
54318 | A | Reconstruction of urethra | 11.25 | NA | 8.64 | 1.15 | NA | 21.04 | 090 | |
54322 | A | Reconstruction of urethra | 13.01 | NA | 8.06 | 0.77 | NA | 21.84 | 090 | |
54324 | A | Reconstruction of urethra | 16.31 | NA | 10.56 | 1.03 | NA | 27.90 | 090 | |
54326 | A | Reconstruction of urethra | 15.72 | NA | 10.15 | 0.93 | NA | 26.80 | 090 | |
54328 | A | Revise penis/urethra | 15.65 | NA | 9.53 | 0.92 | NA | 26.10 | 090 | |
54332 | A | Revise penis/urethra | 17.08 | NA | 10.06 | 1.01 | NA | 28.15 | 090 | |
54336 | A | Revise penis/urethra | 20.04 | NA | 14.12 | 1.90 | NA | 36.06 | 090 | |
54340 | A | Secondary urethral surgery | 8.91 | NA | 7.34 | 0.72 | NA | 16.97 | 090 | |
54344 | A | Secondary urethral surgery | 15.94 | NA | 9.83 | 1.10 | NA | 26.87 | 090 | |
54348 | A | Secondary urethral surgery | 17.15 | NA | 11.25 | 1.02 | NA | 29.42 | 090 | |
54352 | A | Reconstruct urethra/penis | 24.74 | NA | 14.53 | 1.62 | NA | 40.89 | 090 | |
54360 | A | Penis plastic surgery | 11.93 | NA | 7.33 | 0.72 | NA | 19.98 | 090 | |
54380 | A | Repair penis | 13.18 | NA | 9.50 | 1.16 | NA | 23.84 | 090 | |
54385 | A | Repair penis | 15.39 | NA | 12.19 | 0.71 | NA | 28.29 | 090 | |
54390 | A | Repair penis and bladder | 21.61 | NA | 13.02 | 1.28 | NA | 35.91 | 090 | |
54400 | A | Insert semi-rigid prosthesis | 8.99 | NA | 5.68 | 0.53 | NA | 15.20 | 090 | |
54401 | A | Insert self-contd prosthesis | 10.28 | NA | 6.46 | 0.61 | NA | 17.35 | 090 | |
54405 | A | Insert multi-comp penis pros | 13.43 | NA | 7.53 | 0.80 | NA | 21.76 | 090 | |
54406 | A | Remove muti-comp penis pros | 12.10 | NA | 5.50 | 0.75 | NA | 18.35 | 090 | |
54408 | A | Repair multi-comp penis pros | 12.75 | NA | 5.86 | 0.79 | NA | 19.40 | 090 | |
54410 | A | Remove/replace penis prosth | 15.50 | NA | 6.77 | 0.96 | NA | 23.23 | 090 | |
54411 | A | Remov/replc penis pros, comp | 16.00 | NA | 8.90 | 0.80 | NA | 25.70 | 090 | |
54415 | A | Remove self-contd penis pros | 8.20 | NA | 4.61 | 0.54 | NA | 13.35 | 090 | |
54416 | A | Remv/repl penis contain pros | 10.87 | NA | 6.91 | 0.55 | NA | 18.33 | 090 | |
54417 | A | Remv/replc penis pros, compl | 14.19 | NA | 7.81 | 0.55 | NA | 22.55 | 090 | |
54420 | A | Revision of penis | 11.42 | NA | 7.47 | 0.72 | NA | 19.61 | 090 | |
54430 | A | Revision of penis | 10.15 | NA | 6.77 | 0.60 | NA | 17.52 | 090 | |
54435 | A | Revision of penis | 6.12 | NA | 5.01 | 0.36 | NA | 11.49 | 090 | |
54440 | C | Repair of penis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 090 | |
54450 | A | Preputial stretching | 1.12 | 1.00 | 0.48 | 0.07 | 2.19 | 1.67 | 000 | |
54500 | A | Biopsy of testis | 1.31 | 4.86 | 0.44 | 0.08 | 6.25 | 1.83 | 000 | |
54505 | A | Biopsy of testis | 3.46 | NA | 2.28 | 0.21 | NA | 5.95 | 010 | |
54512 | A | Excise lesion testis | 8.58 | NA | 4.50 | 0.56 | NA | 13.64 | 090 | |
54520 | A | Removal of testis | 5.23 | NA | 3.24 | 0.33 | NA | 8.80 | 090 | |
54522 | A | Orchiectomy, partial | 9.50 | NA | 5.12 | 0.62 | NA | 15.24 | 090 | |
54530 | A | Removal of testis | 8.58 | NA | 4.86 | 0.53 | NA | 13.97 | 090 | |
54535 | A | Extensive testis surgery | 12.16 | NA | 6.72 | 0.83 | NA | 19.71 | 090 | |
54550 | A | Exploration for testis | 7.78 | NA | 4.38 | 0.49 | NA | 12.65 | 090 | |
54560 | A | Exploration for testis | 11.13 | NA | 6.34 | 0.79 | NA | 18.26 | 090 | |
54600 | A | Reduce testis torsion | 7.01 | NA | 3.88 | 0.45 | NA | 11.34 | 090 | |
54620 | A | Suspension of testis | 4.90 | NA | 2.77 | 0.31 | NA | 7.98 | 010 | |
54640 | A | Suspension of testis | 6.90 | NA | 3.94 | 0.49 | NA | 11.33 | 090 | |
54650 | A | Orchiopexy (Fowler-Stephens) | 11.45 | NA | 6.59 | 0.81 | NA | 18.85 | 090 | |
54660 | A | Revision of testis | 5.11 | NA | 3.11 | 0.35 | NA | 8.57 | 090 | |
54670 | A | Repair testis injury | 6.41 | NA | 3.83 | 0.41 | NA | 10.65 | 090 | |
54680 | A | Relocation of testis(es) | 12.65 | NA | 7.06 | 0.94 | NA | 20.65 | 090 | |
54690 | A | Laparoscopy, orchiectomy | 10.96 | NA | 6.32 | 0.99 | NA | 18.27 | 090 | |
54692 | A | Laparoscopy, orchiopexy | 12.88 | NA | 5.47 | 0.87 | NA | 19.22 | 090 | |
54699 | C | Laparoscope proc, testis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
54700 | A | Drainage of scrotum | 3.43 | 6.06 | 2.82 | 0.23 | 9.72 | 6.48 | 010 | |
54800 | A | Biopsy of epididymis | 2.33 | 4.98 | 0.79 | 0.14 | 7.45 | 3.26 | 000 | |
54820 | A | Exploration of epididymis | 5.14 | NA | 3.26 | 0.33 | NA | 8.73 | 090 | |
54830 | A | Remove epididymis lesion | 5.38 | NA | 3.33 | 0.34 | NA | 9.05 | 090 | |
54840 | A | Remove epididymis lesion | 5.20 | NA | 3.24 | 0.31 | NA | 8.75 | 090 | |
54860 | A | Removal of epididymis | 6.32 | NA | 3.80 | 0.38 | NA | 10.50 | 090 | |
54861 | A | Removal of epididymis | 8.90 | NA | 4.64 | 0.52 | NA | 14.06 | 090 | |
54900 | A | Fusion of spermatic ducts | 13.20 | NA | 6.22 | 1.34 | NA | 20.76 | 090 | |
54901 | A | Fusion of spermatic ducts | 17.94 | NA | 8.49 | 1.83 | NA | 28.26 | 090 | |
55000 | A | Drainage of hydrocele | 1.43 | 2.17 | 0.48 | 0.10 | 3.70 | 2.01 | 000 | |
55040 | A | Removal of hydrocele | 5.36 | NA | 3.10 | 0.35 | NA | 8.81 | 090 | |
55041 | A | Removal of hydroceles | 7.74 | NA | 4.11 | 0.50 | NA | 12.35 | 090 | |
55060 | A | Repair of hydrocele | 5.52 | NA | 3.19 | 0.37 | NA | 9.08 | 090 | |
55100 | A | Drainage of scrotum abscess | 2.13 | 6.59 | 2.91 | 0.15 | 8.87 | 5.19 | 010 | |
55110 | A | Explore scrotum | 5.70 | NA | 3.22 | 0.36 | NA | 9.28 | 090 | |
55120 | A | Removal of scrotum lesion | 5.09 | NA | 3.05 | 0.33 | NA | 8.47 | 090 | |
55150 | A | Removal of scrotum | 7.22 | NA | 4.22 | 0.47 | NA | 11.91 | 090 | |
55175 | A | Revision of scrotum | 5.24 | NA | 3.31 | 0.33 | NA | 8.88 | 090 | |
55180 | A | Revision of scrotum | 10.72 | NA | 5.99 | 0.72 | NA | 17.43 | 090 | |
55200 | A | Incision of sperm duct | 4.24 | NA | 2.79 | 0.25 | NA | 7.28 | 090 | |
55250 | A | Removal of sperm duct(s) | 3.29 | 6.56 | 2.74 | 0.21 | 10.06 | 6.24 | 090 | |
55300 | A | Prepare, sperm duct x-ray | 3.51 | NA | 1.54 | 0.20 | NA | 5.25 | 000 | |
55400 | A | Repair of sperm duct | 8.49 | NA | 4.80 | 0.50 | NA | 13.79 | 090 | |
55450 | A | Ligation of sperm duct | 4.12 | 5.09 | 2.36 | 0.24 | 9.45 | 6.72 | 010 | |
55500 | A | Removal of hydrocele | 5.59 | NA | 3.44 | 0.43 | NA | 9.46 | 090 | |
55520 | A | Removal of sperm cord lesion | 6.03 | NA | 3.64 | 0.56 | NA | 10.23 | 090 | |
55530 | A | Revise spermatic cord veins | 5.66 | NA | 3.43 | 0.36 | NA | 9.45 | 090 | |
55535 | A | Revise spermatic cord veins | 6.56 | NA | 3.71 | 0.42 | NA | 10.69 | 090 | |
55540 | A | Revise hernia sperm veins | 7.67 | NA | 4.20 | 0.74 | NA | 12.61 | 090 | |
55550 | A | Laparo ligate spermatic vein | 6.57 | NA | 3.50 | 0.47 | NA | 10.54 | 090 | |
55559 | C | Laparo proc, spermatic cord | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
55600 | A | Incise sperm duct pouch | 6.38 | NA | 3.82 | 0.38 | NA | 10.58 | 090 | |
55605 | A | Incise sperm duct pouch | 7.96 | NA | 4.90 | 0.54 | NA | 13.40 | 090 | |
55650 | A | Remove sperm duct pouch | 11.80 | NA | 5.81 | 0.72 | NA | 18.33 | 090 | |
55680 | A | Remove sperm pouch lesion | 5.19 | NA | 3.48 | 0.31 | NA | 8.98 | 090 | |
55700 | A | Biopsy of prostate | 1.57 | 2.83 | 0.73 | 0.10 | 4.50 | 2.40 | 000 | |
55705 | A | Biopsy of prostate | 4.57 | NA | 3.30 | 0.26 | NA | 8.13 | 010 | |
55720 | A | Drainage of prostate abscess | 7.64 | NA | 5.30 | 0.44 | NA | 13.38 | 090 | |
55725 | A | Drainage of prostate abscess | 8.68 | NA | 5.85 | 0.51 | NA | 15.04 | 090 | |
55801 | A | Removal of prostate | 17.80 | NA | 8.82 | 1.08 | NA | 27.70 | 090 | |
55810 | A | Extensive prostate surgery | 22.58 | NA | 10.79 | 1.35 | NA | 34.72 | 090 | |
55812 | A | Extensive prostate surgery | 27.51 | NA | 12.97 | 1.69 | NA | 42.17 | 090 | |
55815 | A | Extensive prostate surgery | 30.46 | NA | 13.85 | 1.84 | NA | 46.15 | 090 | |
55821 | A | Removal of prostate | 14.25 | NA | 7.33 | 0.85 | NA | 22.43 | 090 | |
55831 | A | Removal of prostate | 15.62 | NA | 7.81 | 0.94 | NA | 24.37 | 090 | |
55840 | A | Extensive prostate surgery | 22.69 | NA | 11.27 | 1.37 | NA | 35.33 | 090 | |
55842 | A | Extensive prostate surgery | 24.38 | NA | 11.85 | 1.48 | NA | 37.71 | 090 | |
55845 | A | Extensive prostate surgery | 28.55 | NA | 13.14 | 1.71 | NA | 43.40 | 090 | |
55859 | A | Percut/needle insert, pros | 12.52 | NA | 6.86 | 0.74 | NA | 20.12 | 090 | |
55860 | A | Surgical exposure, prostate | 14.45 | NA | 7.58 | 0.82 | NA | 22.85 | 090 | |
55862 | A | Extensive prostate surgery | 18.39 | NA | 9.19 | 1.14 | NA | 28.72 | 090 | |
55865 | A | Extensive prostate surgery | 22.87 | NA | 10.50 | 1.37 | NA | 34.74 | 090 | |
55866 | A | Laparo radical prostatectomy | 30.74 | NA | 11.79 | 1.37 | NA | 43.90 | 090 | |
55870 | A | Vag hyst w/enterocele repair | 2.58 | 1.94 | 1.04 | 0.14 | 4.66 | 3.76 | 000 | |
55873 | A | Cryoablate prostate | 19.47 | NA | 8.91 | 1.02 | NA | 29.40 | 090 | |
55899 | C | Genital surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
55970 | N | Sex transformation, M to F | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
55980 | N | Sex transformation, F to M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
56405 | A | I D of vulva/perineum | 1.44 | 2.29 | 1.23 | 0.14 | 3.87 | 2.81 | 010 | |
56420 | A | Drainage of gland abscess | 1.39 | 2.29 | 1.24 | 0.13 | 3.81 | 2.76 | 010 | |
56440 | A | Surgery for vulva lesion | 2.84 | 3.45 | 2.22 | 0.28 | 6.57 | 5.34 | 010 | |
56441 | A | Lysis of labial lesion(s) | 1.97 | 2.33 | 1.81 | 0.17 | 4.47 | 3.95 | 010 | |
56501 | A | Destroy, vulva lesions, sim | 1.53 | 2.24 | 1.29 | 0.15 | 3.92 | 2.97 | 010 | |
56515 | A | Destroy vulva lesion/s compl | 2.76 | 3.01 | 2.24 | 0.18 | 5.95 | 5.18 | 010 | |
56605 | A | Biopsy of vulva/perineum | 1.10 | 1.09 | 0.47 | 0.11 | 2.30 | 1.68 | 000 | |
56606 | A | Biopsy of vulva/perineum | 0.55 | 0.51 | 0.22 | 0.06 | 1.12 | 0.83 | ZZZ | |
56620 | A | Partial removal of vulva | 7.47 | NA | 4.85 | 0.76 | NA | 13.08 | 090 | |
56625 | A | Complete removal of vulva | 8.40 | NA | 5.78 | 0.84 | NA | 15.02 | 090 | |
56630 | A | Extensive vulva surgery | 12.36 | NA | 7.60 | 1.23 | NA | 21.19 | 090 | |
56631 | A | Extensive vulva surgery | 16.20 | NA | 10.27 | 1.63 | NA | 28.10 | 090 | |
56632 | A | Extensive vulva surgery | 20.29 | NA | 10.23 | 2.03 | NA | 32.55 | 090 | |
56633 | A | Extensive vulva surgery | 16.47 | NA | 9.27 | 1.66 | NA | 27.40 | 090 | |
56634 | A | Extensive vulva surgery | 17.88 | NA | 10.95 | 1.78 | NA | 30.61 | 090 | |
56637 | A | Extensive vulva surgery | 21.97 | NA | 12.64 | 2.18 | NA | 36.79 | 090 | |
56640 | A | Extensive vulva surgery | 22.17 | NA | 12.24 | 2.26 | NA | 36.67 | 090 | |
56700 | A | Partial removal of hymen | 2.52 | NA | 1.70 | 0.24 | NA | 4.46 | 010 | |
56720 | A | Incision of hymen | 0.68 | NA | 0.41 | 0.07 | NA | 1.16 | 000 | |
56740 | A | Remove vagina gland lesion | 4.57 | NA | 2.58 | 0.37 | NA | 7.52 | 010 | |
56800 | A | Repair of vagina | 3.89 | NA | 2.61 | 0.37 | NA | 6.87 | 010 | |
56805 | A | Repair clitoris | 18.86 | NA | 9.12 | 1.82 | NA | 29.80 | 090 | |
56810 | A | Repair of perineum | 4.13 | NA | 2.72 | 0.41 | NA | 7.26 | 010 | |
56820 | A | Exam of vulva w/scope | 1.50 | 1.64 | 0.65 | 0.10 | 3.24 | 2.25 | 000 | |
56821 | A | Exam/biopsy of vulva w/scope | 2.05 | 2.02 | 0.92 | 0.13 | 4.20 | 3.10 | 000 | |
57000 | A | Exploration of vagina | 2.97 | NA | 2.19 | 0.28 | NA | 5.44 | 010 | |
57010 | A | Drainage of pelvic abscess | 6.03 | NA | 3.79 | 0.57 | NA | 10.39 | 090 | |
57020 | A | Drainage of pelvic fluid | 1.50 | 1.56 | 0.63 | 0.15 | 3.21 | 2.28 | 000 | |
57022 | A | I d vaginal hematoma, pp | 2.56 | NA | 2.03 | 0.24 | NA | 4.83 | 010 | |
57023 | A | I d vag hematoma, non-ob | 4.75 | NA | 2.89 | 0.24 | NA | 7.88 | 010 | |
57061 | A | Destroy vag lesions, simple | 1.25 | 2.16 | 1.16 | 0.13 | 3.54 | 2.54 | 010 | |
57065 | A | Destroy vag lesions, complex | 2.61 | 2.88 | 2.23 | 0.26 | 5.75 | 5.10 | 010 | |
57100 | A | Biopsy of vagina | 1.20 | 1.11 | 0.50 | 0.10 | 2.41 | 1.80 | 000 | |
57105 | A | Biopsy of vagina | 1.69 | 2.00 | 1.31 | 0.17 | 3.86 | 3.17 | 010 | |
57106 | A | Remove vagina wall, partial | 6.36 | NA | 3.87 | 0.58 | NA | 10.81 | 090 | |
57107 | A | Remove vagina tissue, part | 23.00 | NA | 10.28 | 2.17 | NA | 35.45 | 090 | |
57109 | A | Vaginectomy partial w/nodes | 27.00 | NA | 11.53 | 1.97 | NA | 40.50 | 090 | |
57110 | A | Remove vagina wall, complete | 14.29 | NA | 7.21 | 1.43 | NA | 22.93 | 090 | |
57111 | A | Remove vagina tissue, compl | 27.00 | NA | 12.30 | 2.71 | NA | 42.01 | 090 | |
57112 | A | Vaginectomy w/nodes, compl | 29.00 | NA | 12.39 | 2.19 | NA | 43.58 | 090 | |
57120 | A | Closure of vagina | 7.41 | NA | 4.59 | 0.75 | NA | 12.75 | 090 | |
57130 | A | Remove vagina lesion | 2.43 | NA | 2.03 | 0.23 | NA | 4.69 | 010 | |
57135 | A | Remove vagina lesion | 2.67 | 2.87 | 2.13 | 0.26 | 5.80 | 5.06 | 010 | |
57150 | A | Treat vagina infection | 0.55 | 0.99 | 0.22 | 0.06 | 1.60 | 0.83 | 000 | |
57155 | A | Insert uteri tandems/ovoids | 6.27 | NA | 3.68 | 0.59 | NA | 10.54 | 090 | |
57160 | A | Insert pessary/other device | 0.89 | 1.10 | 0.40 | 0.09 | 2.08 | 1.38 | 000 | |
57170 | A | Fitting of diaphragm/cap | 0.91 | 1.38 | 0.34 | 0.09 | 2.38 | 1.34 | 000 | |
57180 | A | Treat vaginal bleeding | 1.58 | 2.22 | 1.41 | 0.16 | 3.96 | 3.15 | 010 | |
57200 | A | Repair of vagina | 3.94 | NA | 3.11 | 0.38 | NA | 7.43 | 090 | |
57210 | A | Repair vagina/perineum | 5.17 | NA | 3.67 | 0.50 | NA | 9.34 | 090 | |
57220 | A | Revision of urethra | 4.31 | NA | 3.34 | 0.42 | NA | 8.07 | 090 | |
57230 | A | Repair of urethral lesion | 5.64 | NA | 3.54 | 0.50 | NA | 9.68 | 090 | |
57240 | A | Repair bladder vagina | 6.07 | NA | 3.90 | 0.53 | NA | 10.50 | 090 | |
57250 | A | Repair rectum vagina | 5.53 | NA | 3.81 | 0.54 | NA | 9.88 | 090 | |
57260 | A | Repair of vagina | 8.27 | NA | 5.14 | 0.83 | NA | 14.24 | 090 | |
57265 | A | Extensive repair of vagina | 11.34 | NA | 6.38 | 1.14 | NA | 18.86 | 090 | |
57268 | A | Repair of bowel bulge | 6.76 | NA | 4.48 | 0.66 | NA | 11.90 | 090 | |
57270 | A | Repair of bowel pouch | 12.11 | NA | 6.60 | 1.17 | NA | 19.88 | 090 | |
57280 | A | Suspension of vagina | 15.04 | NA | 7.73 | 1.44 | NA | 24.21 | 090 | |
57282 | A | Repair of vaginal prolapse | 8.86 | NA | 5.58 | 0.86 | NA | 15.30 | 090 | |
57284 | A | Repair paravaginal defect | 12.70 | NA | 7.12 | 1.17 | NA | 20.99 | 090 | |
57287 | A | Revise/remove sling repair | 10.71 | NA | 5.60 | 0.74 | NA | 17.05 | 090 | |
57288 | A | Repair bladder defect | 13.02 | NA | 6.05 | 0.86 | NA | 19.93 | 090 | |
57289 | A | Repair bladder vagina | 11.58 | NA | 6.26 | 0.95 | NA | 18.79 | 090 | |
57291 | A | Construction of vagina | 7.95 | NA | 5.29 | 0.78 | NA | 14.02 | 090 | |
57292 | A | Construct vagina with graft | 13.09 | NA | 7.38 | 1.29 | NA | 21.76 | 090 | |
57300 | A | Repair rectum-vagina fistula | 7.61 | NA | 4.85 | 0.70 | NA | 13.16 | 090 | |
57305 | A | Repair rectum-vagina fistula | 13.77 | NA | 6.49 | 1.33 | NA | 21.59 | 090 | |
57307 | A | Fistula repair colostomy | 15.93 | NA | 7.55 | 1.59 | NA | 25.07 | 090 | |
57308 | A | Fistula repair, transperine | 9.94 | NA | 5.89 | 0.91 | NA | 16.74 | 090 | |
57310 | A | Repair urethrovaginal lesion | 6.78 | NA | 4.29 | 0.45 | NA | 11.52 | 090 | |
57311 | A | Repair urethrovaginal lesion | 7.98 | NA | 4.85 | 0.51 | NA | 13.34 | 090 | |
57320 | A | Repair bladder-vagina lesion | 8.01 | NA | 4.95 | 0.60 | NA | 13.56 | 090 | |
57330 | A | Repair bladder-vagina lesion | 12.35 | NA | 6.29 | 0.86 | NA | 19.50 | 090 | |
57335 | A | Repair vagina | 18.73 | NA | 8.97 | 1.66 | NA | 29.36 | 090 | |
57400 | A | Dilation of vagina | 2.27 | NA | 1.14 | 0.22 | NA | 3.63 | 000 | |
57410 | A | Pelvic examination | 1.75 | 2.55 | 1.03 | 0.14 | 4.44 | 2.92 | 000 | |
57415 | A | Remove vaginal foreign body | 2.17 | 3.21 | 1.87 | 0.19 | 5.57 | 4.23 | 010 | |
57420 | A | Exam of vagina w/scope | 1.60 | 1.68 | 0.69 | 0.10 | 3.38 | 2.39 | 000 | |
57421 | A | Exam/biopsy of vag w/scope | 2.20 | 2.08 | 0.98 | 0.13 | 4.41 | 3.31 | 000 | |
57452 | A | Exam of cervix w/scope | 1.50 | 1.70 | 0.65 | 0.10 | 3.30 | 2.25 | 000 | |
57454 | A | Bx/curett of cervix w/scope | 2.33 | 2.05 | 1.02 | 0.13 | 4.51 | 3.48 | 000 | |
57455 | A | Biopsy of cervix w/scope | 1.99 | 1.94 | 0.89 | 0.13 | 4.06 | 3.01 | 000 | |
57456 | A | Endocerv curettage w/scope | 1.85 | 1.86 | 0.84 | 0.13 | 3.84 | 2.82 | 000 | |
57460 | A | Bx of cervix w/scope, leep | 2.83 | 5.01 | 1.25 | 0.28 | 8.12 | 4.36 | 000 | |
57461 | A | Conz of cervix w/scope, leep | 3.44 | 5.32 | 1.50 | 0.28 | 9.04 | 5.22 | 000 | |
57500 | A | Biopsy of cervix | 0.97 | 2.02 | 0.49 | 0.10 | 3.09 | 1.56 | 000 | |
57505 | A | Endocervical curettage | 1.14 | 1.90 | 1.21 | 0.12 | 3.16 | 2.47 | 010 | |
57510 | A | Cauterization of cervix | 1.90 | 3.01 | 1.51 | 0.18 | 5.09 | 3.59 | 010 | |
57511 | A | Cryocautery of cervix | 1.90 | 2.36 | 0.75 | 0.18 | 4.44 | 2.83 | 010 | |
57513 | A | Laser surgery of cervix | 1.90 | 2.57 | 1.50 | 0.19 | 4.66 | 3.59 | 010 | |
57520 | A | Conization of cervix | 4.04 | 4.13 | 2.76 | 0.41 | 8.58 | 7.21 | 090 | |
57522 | A | Conization of cervix | 3.36 | 3.66 | 2.49 | 0.34 | 7.36 | 6.19 | 090 | |
57530 | A | Removal of cervix | 4.79 | NA | 3.53 | 0.48 | NA | 8.80 | 090 | |
57531 | A | Removal of cervix, radical | 28.00 | NA | 13.53 | 2.46 | NA | 43.99 | 090 | |
57540 | A | Removal of residual cervix | 12.22 | NA | 6.14 | 1.21 | NA | 19.57 | 090 | |
57545 | A | Remove cervix/repair pelvis | 13.03 | NA | 6.59 | 1.30 | NA | 20.92 | 090 | |
57550 | A | Removal of residual cervix | 5.53 | NA | 3.78 | 0.55 | NA | 9.86 | 090 | |
57555 | A | Remove cervix/repair vagina | 8.95 | NA | 5.60 | 0.89 | NA | 15.44 | 090 | |
57556 | A | Remove cervix, repair bowel | 8.37 | NA | 4.83 | 0.80 | NA | 14.00 | 090 | |
57700 | A | Revision of cervix | 3.55 | NA | 2.44 | 0.33 | NA | 6.32 | 090 | |
57720 | A | Revision of cervix | 4.13 | NA | 3.20 | 0.41 | NA | 7.74 | 090 | |
57800 | A | Dilation of cervical canal | 0.77 | 0.77 | 0.48 | 0.08 | 1.62 | 1.33 | 000 | |
57820 | A | D c of residual cervix | 1.67 | 1.51 | 1.11 | 0.17 | 3.35 | 2.95 | 010 | |
58100 | A | Biopsy of uterus lining | 1.53 | 1.45 | 0.75 | 0.07 | 3.05 | 2.35 | 000 | |
58120 | A | Dilation and curettage | 3.27 | 2.35 | 1.97 | 0.33 | 5.95 | 5.57 | 010 | |
58140 | A | Myomectomy abdom method | 14.60 | NA | 7.01 | 1.46 | NA | 23.07 | 090 | |
58145 | A | Myomectomy vag method | 8.04 | NA | 4.84 | 0.80 | NA | 13.68 | 090 | |
58146 | A | Myomectomy abdom complex | 19.00 | NA | 9.15 | 1.46 | NA | 29.61 | 090 | |
58150 | A | Total hysterectomy | 15.24 | NA | 7.89 | 1.57 | NA | 24.70 | 090 | |
58152 | A | Total hysterectomy | 20.60 | NA | 10.28 | 1.52 | NA | 32.40 | 090 | |
58180 | A | Partial hysterectomy | 15.29 | NA | 7.85 | 1.54 | NA | 24.68 | 090 | |
58200 | A | Extensive hysterectomy | 21.59 | NA | 10.60 | 2.15 | NA | 34.34 | 090 | |
58210 | A | Extensive hysterectomy | 28.85 | NA | 13.96 | 2.91 | NA | 45.72 | 090 | |
58240 | A | Removal of pelvis contents | 38.39 | NA | 18.48 | 3.76 | NA | 60.63 | 090 | |
58260 | A | Vaginal hysterectomy | 12.98 | NA | 6.68 | 1.23 | NA | 20.89 | 090 | |
58262 | A | Vag hyst including t/o | 14.77 | NA | 7.43 | 1.42 | NA | 23.62 | 090 | |
58263 | A | Vag hyst w/t/o vag repair | 16.06 | NA | 7.95 | 1.55 | NA | 25.56 | 090 | |
58267 | A | Vag hyst w/urinary repair | 17.04 | NA | 8.52 | 1.51 | NA | 27.07 | 090 | |
58270 | A | Vag hyst w/enterocele repair | 14.26 | NA | 7.19 | 1.37 | NA | 22.82 | 090 | |
58275 | A | Hysterectomy/revise vagina | 15.76 | NA | 7.72 | 1.51 | NA | 24.99 | 090 | |
58280 | A | Hysterectomy/revise vagina | 17.01 | NA | 8.21 | 1.54 | NA | 26.76 | 090 | |
58285 | A | Extensive hysterectomy | 22.26 | NA | 10.85 | 1.88 | NA | 34.99 | 090 | |
58290 | A | Vag hyst complex | 19.00 | NA | 9.37 | 1.23 | NA | 29.60 | 090 | |
58291 | A | Vag hyst incl t/o, complex | 20.79 | NA | 10.34 | 1.42 | NA | 32.55 | 090 | |
58292 | A | Vag hyst t/o repair, compl | 22.08 | NA | 10.85 | 1.55 | NA | 34.48 | 090 | |
58293 | A | Vag hyst w/uro repair, compl | 23.06 | NA | 11.25 | 1.51 | NA | 35.82 | 090 | |
58294 | A | Vag hyst w/enterocele, compl | 20.28 | NA | 10.10 | 1.37 | NA | 31.75 | 090 | |
58300 | N | Insert intrauterine device | +1.01 | 1.44 | 0.39 | 0.10 | 2.55 | 1.50 | XXX | |
58301 | A | Remove intrauterine device | 1.27 | 1.54 | 0.50 | 0.13 | 2.94 | 1.90 | 000 | |
58321 | A | Artificial insemination | 0.92 | 0.94 | 0.38 | 0.10 | 1.96 | 1.40 | 000 | |
58322 | A | Artificial insemination | 1.10 | 1.00 | 0.43 | 0.11 | 2.21 | 1.64 | 000 | |
58323 | A | Sperm washing | 0.23 | 0.54 | 0.10 | 0.02 | 0.79 | 0.35 | 000 | |
58340 | A | Catheter for hysterography | 0.88 | 12.10 | 0.33 | 0.08 | 13.06 | 1.29 | 000 | |
58345 | A | Reopen fallopian tube | 4.66 | NA | 1.73 | 0.36 | NA | 6.75 | 010 | |
58346 | A | Insert heyman uteri capsule | 6.75 | NA | 3.87 | 0.64 | NA | 11.26 | 090 | |
58350 | A | Reopen fallopian tube | 1.01 | 1.93 | 1.05 | 0.10 | 3.04 | 2.16 | 010 | |
58353 | A | Endometr ablate, thermal | 3.56 | NA | 2.23 | 0.37 | NA | 6.16 | 010 | |
58400 | A | Suspension of uterus | 6.36 | NA | 3.93 | 0.62 | NA | 10.91 | 090 | |
58410 | A | Suspension of uterus | 12.73 | NA | 6.55 | 1.09 | NA | 20.37 | 090 | |
58520 | A | Repair of ruptured uterus | 11.92 | NA | 5.93 | 1.17 | NA | 19.02 | 090 | |
58540 | A | Revision of uterus | 14.64 | NA | 6.90 | 1.28 | NA | 22.82 | 090 | |
58545 | A | Laparoscopic myomectomy | 14.60 | NA | 7.76 | 1.45 | NA | 23.81 | 090 | |
58546 | A | Laparo-myomectomy, complex | 19.00 | NA | 9.55 | 1.45 | NA | 30.00 | 090 | |
58550 | A | Laparo-asst vag hysterectomy | 14.19 | NA | 7.21 | 1.44 | NA | 22.84 | 010 | |
58551 | D | Laparoscopy, remove myoma | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 010 | |
58552 | A | Laparo-vag hyst incl t/o | 14.19 | NA | 7.56 | 1.44 | NA | 23.19 | 090 | |
58553 | A | Laparo-vag hyst, complex | 19.00 | NA | 9.57 | 1.23 | NA | 29.80 | 090 | |
58554 | A | Laparo-vag hyst w/t/o, compl | 19.00 | NA | 9.26 | 1.23 | NA | 29.49 | 090 | |
58555 | A | Hysteroscopy, dx, sep proc | 3.33 | 2.10 | 1.49 | 0.34 | 5.77 | 5.16 | 000 | |
58558 | A | Hysteroscopy, biopsy | 4.75 | NA | 2.12 | 0.49 | NA | 7.36 | 000 | |
58559 | A | Hysteroscopy, lysis | 6.17 | NA | 2.69 | 0.62 | NA | 9.48 | 000 | |
58560 | A | Hysteroscopy, resect septum | 7.00 | NA | 3.05 | 0.71 | NA | 10.76 | 000 | |
58561 | A | Hysteroscopy, remove myoma | 10.00 | NA | 4.28 | 1.02 | NA | 15.30 | 000 | |
58562 | A | Hysteroscopy, remove fb | 5.21 | NA | 2.27 | 0.52 | NA | 8.00 | 000 | |
58563 | A | Hysteroscopy, ablation | 6.17 | NA | 2.71 | 0.62 | NA | 9.50 | 000 | |
58578 | C | Laparo proc, uterus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
58579 | C | Hysteroscope procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
58600 | A | Division of fallopian tube | 5.60 | NA | 3.28 | 0.39 | NA | 9.27 | 090 | |
58605 | A | Division of fallopian tube | 5.00 | NA | 3.12 | 0.33 | NA | 8.45 | 090 | |
58611 | A | Ligate oviduct(s) add-on | 1.45 | NA | 0.59 | 0.07 | NA | 2.11 | ZZZ | |
58615 | A | Occlude fallopian tube(s) | 3.90 | NA | 3.11 | 0.40 | NA | 7.41 | 010 | |
58660 | A | Laparoscopy, lysis | 11.29 | NA | 5.60 | 1.14 | NA | 18.03 | 090 | |
58661 | A | Laparoscopy, remove adnexa | 11.05 | NA | 5.27 | 1.12 | NA | 17.44 | 010 | |
58662 | A | Laparoscopy, excise lesions | 11.79 | NA | 5.54 | 1.18 | NA | 18.51 | 090 | |
58670 | A | Laparoscopy, tubal cautery | 5.60 | NA | 3.62 | 0.55 | NA | 9.77 | 090 | |
58671 | A | Laparoscopy, tubal block | 5.60 | NA | 3.63 | 0.56 | NA | 9.79 | 090 | |
58672 | A | Laparoscopy, fimbrioplasty | 12.88 | NA | 6.52 | 1.22 | NA | 20.62 | 090 | |
58673 | A | Laparoscopy, salpingostomy | 13.74 | NA | 6.86 | 1.40 | NA | 22.00 | 090 | |
58679 | C | Laparo proc, oviduct-ovary | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
58700 | A | Removal of fallopian tube | 12.05 | NA | 5.80 | 0.64 | NA | 18.49 | 090 | |
58720 | A | Removal of ovary/tube(s) | 11.36 | NA | 5.75 | 1.14 | NA | 18.25 | 090 | |
58740 | A | Revise fallopian tube(s) | 14.00 | NA | 6.99 | 0.59 | NA | 21.58 | 090 | |
58750 | A | Repair oviduct | 14.84 | NA | 7.37 | 1.52 | NA | 23.73 | 090 | |
58752 | A | Revise ovarian tube(s) | 14.84 | NA | 7.06 | 1.51 | NA | 23.41 | 090 | |
58760 | A | Remove tubal obstruction | 13.13 | NA | 6.67 | 1.34 | NA | 21.14 | 090 | |
58770 | A | Create new tubal opening | 13.97 | NA | 6.97 | 1.42 | NA | 22.36 | 090 | |
58800 | A | Drainage of ovarian cyst(s) | 4.14 | 4.39 | 4.36 | 0.36 | 8.89 | 8.86 | 090 | |
58805 | A | Drainage of ovarian cyst(s) | 5.88 | NA | 3.47 | 0.56 | NA | 9.91 | 090 | |
58820 | A | Drain ovary abscess, open | 4.22 | NA | 3.34 | 0.29 | NA | 7.85 | 090 | |
58822 | A | Drain ovary abscess, percut | 10.13 | NA | 5.04 | 0.92 | NA | 16.09 | 090 | |
58823 | A | Drain pelvic abscess, percut | 3.38 | NA | 2.32 | 0.18 | NA | 5.88 | 000 | |
58825 | A | Transposition, ovary(s) | 10.98 | NA | 5.74 | 0.62 | NA | 17.34 | 090 | |
58900 | A | Biopsy of ovary(s) | 5.99 | NA | 3.53 | 0.56 | NA | 10.08 | 090 | |
58920 | A | Partial removal of ovary(s) | 11.36 | NA | 5.58 | 0.68 | NA | 17.62 | 090 | |
58925 | A | Removal of ovarian cyst(s) | 11.36 | NA | 5.54 | 1.14 | NA | 18.04 | 090 | |
58940 | A | Removal of ovary(s) | 7.29 | NA | 3.94 | 0.73 | NA | 11.96 | 090 | |
58943 | A | Removal of ovary(s) | 18.43 | NA | 9.44 | 1.86 | NA | 29.73 | 090 | |
58950 | A | Resect ovarian malignancy | 16.93 | NA | 9.00 | 1.55 | NA | 27.48 | 090 | |
58951 | A | Resect ovarian malignancy | 22.38 | NA | 11.32 | 2.20 | NA | 35.90 | 090 | |
58952 | A | Resect ovarian malignancy | 25.01 | NA | 12.41 | 2.57 | NA | 39.99 | 090 | |
58953 | A | Tah, rad dissect for debulk | 32.00 | NA | 15.08 | 3.30 | NA | 50.38 | 090 | |
58954 | A | Tah rad debulk/lymph remove | 35.00 | NA | 16.15 | 3.56 | NA | 54.71 | 090 | |
58960 | A | Exploration of abdomen | 14.65 | NA | 8.12 | 1.47 | NA | 24.24 | 090 | |
58970 | A | Retrieval of oocyte | 3.53 | 8.36 | 1.67 | 0.36 | 12.25 | 5.56 | 000 | |
58974 | C | Transfer of embryo | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | |
58976 | A | Transfer of embryo | 3.83 | 2.29 | 1.59 | 0.39 | 6.51 | 5.81 | 000 | |
58999 | C | Genital surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
59000 | A | Amniocentesis, diagnostic | 1.30 | 1.88 | 0.71 | 0.23 | 3.41 | 2.24 | 000 | |
59001 | A | Amniocentesis, therapeutic | 3.00 | NA | 1.35 | 0.23 | NA | 4.58 | 000 | |
59012 | A | Fetal cord puncture,prenatal | 3.45 | NA | 1.60 | 0.62 | NA | 5.67 | 000 | |
59015 | A | Chorion biopsy | 2.20 | 1.59 | 1.08 | 0.40 | 4.19 | 3.68 | 000 | |
59020 | A | Fetal contract stress test | 0.66 | 0.79 | NA | 0.20 | 1.65 | NA | 000 | |
59020 | 26 | A | Fetal contract stress test | 0.66 | 0.27 | 0.27 | 0.12 | 1.05 | 1.05 | 000 |
59020 | TC | A | Fetal contract stress test | 0.00 | 0.52 | NA | 0.08 | 0.60 | NA | 000 |
59025 | A | Fetal non-stress test | 0.53 | 0.45 | NA | 0.12 | 1.10 | NA | 000 | |
59025 | 26 | A | Fetal non-stress test | 0.53 | 0.22 | 0.22 | 0.10 | 0.85 | 0.85 | 000 |
59025 | TC | A | Fetal non-stress test | 0.00 | 0.23 | NA | 0.02 | 0.25 | NA | 000 |
59030 | A | Fetal scalp blood sample | 1.99 | NA | 1.06 | 0.36 | NA | 3.41 | 000 | |
59050 | A | Fetal monitor w/report | 0.89 | NA | 0.36 | 0.16 | NA | 1.41 | XXX | |
59051 | A | Fetal monitor/interpret only | 0.74 | NA | 0.30 | 0.14 | NA | 1.18 | XXX | |
59100 | A | Remove uterus lesion | 12.35 | NA | 6.29 | 2.21 | NA | 20.85 | 090 | |
59120 | A | Treat ectopic pregnancy | 11.49 | NA | 6.06 | 2.06 | NA | 19.61 | 090 | |
59121 | A | Treat ectopic pregnancy | 11.67 | NA | 6.19 | 2.09 | NA | 19.95 | 090 | |
59130 | A | Treat ectopic pregnancy | 14.22 | NA | 5.81 | 2.54 | NA | 22.57 | 090 | |
59135 | A | Treat ectopic pregnancy | 13.88 | NA | 7.04 | 2.49 | NA | 23.41 | 090 | |
59136 | A | Treat ectopic pregnancy | 13.18 | NA | 6.61 | 2.36 | NA | 22.15 | 090 | |
59140 | A | Treat ectopic pregnancy | 5.46 | NA | 3.36 | 0.98 | NA | 9.80 | 090 | |
59150 | A | Treat ectopic pregnancy | 11.67 | NA | 6.40 | 1.23 | NA | 19.30 | 090 | |
59151 | A | Treat ectopic pregnancy | 11.49 | NA | 5.84 | 1.41 | NA | 18.74 | 090 | |
59160 | A | D c after delivery | 2.71 | 3.48 | 2.15 | 0.49 | 6.68 | 5.35 | 010 | |
59200 | A | Insert cervical dilator | 0.79 | 1.32 | 0.31 | 0.15 | 2.26 | 1.25 | 000 | |
59300 | A | Episiotomy or vaginal repair | 2.41 | 2.08 | 0.99 | 0.43 | 4.92 | 3.83 | 000 | |
59320 | A | Revision of cervix | 2.48 | NA | 1.29 | 0.45 | NA | 4.22 | 000 | |
59325 | A | Revision of cervix | 4.07 | NA | 1.96 | 0.73 | NA | 6.76 | 000 | |
59350 | A | Repair of uterus | 4.95 | NA | 2.00 | 0.88 | NA | 7.83 | 000 | |
59400 | A | Obstetrical care | 23.06 | NA | 16.09 | 4.14 | NA | 43.29 | MMM | |
59409 | A | Obstetrical care | 13.50 | NA | 5.44 | 2.42 | NA | 21.36 | MMM | |
59410 | A | Obstetrical care | 14.78 | NA | 6.48 | 2.65 | NA | 23.91 | MMM | |
59412 | A | Antepartum manipulation | 1.71 | NA | 0.84 | 0.31 | NA | 2.86 | MMM | |
59414 | A | Deliver placenta | 1.61 | NA | 0.65 | 0.29 | NA | 2.55 | MMM | |
59425 | A | Antepartum care only | 4.81 | 4.46 | 1.90 | 0.86 | 10.13 | 7.57 | MMM | |
59426 | A | Antepartum care only | 8.28 | 8.04 | 3.30 | 1.49 | 17.81 | 13.07 | MMM | |
59430 | A | Care after delivery | 2.13 | NA | 0.98 | 0.38 | NA | 3.49 | MMM | |
59510 | A | Cesarean delivery | 26.22 | NA | 18.21 | 4.70 | NA | 49.13 | MMM | |
59514 | A | Cesarean delivery only | 15.97 | NA | 6.38 | 2.86 | NA | 25.21 | MMM | |
59515 | A | Cesarean delivery | 17.37 | NA | 8.05 | 3.12 | NA | 28.54 | MMM | |
59525 | A | Remove uterus after cesarean | 8.54 | NA | 3.39 | 1.53 | NA | 13.46 | ZZZ | |
59610 | A | Vbac delivery | 24.62 | NA | 16.66 | 4.41 | NA | 45.69 | MMM | |
59612 | A | Vbac delivery only | 15.06 | NA | 6.21 | 2.70 | NA | 23.97 | MMM | |
59614 | A | Vbac care after delivery | 16.34 | NA | 7.12 | 2.93 | NA | 26.39 | MMM | |
59618 | A | Attempted vbac delivery | 27.78 | NA | 19.52 | 4.98 | NA | 52.28 | MMM | |
59620 | A | Attempted vbac delivery only | 17.53 | NA | 6.94 | 3.15 | NA | 27.62 | MMM | |
59622 | A | Attempted vbac after care | 18.93 | NA | 8.87 | 3.39 | NA | 31.19 | MMM | |
59812 | A | Treatment of miscarriage | 4.01 | 3.60 | 2.53 | 0.58 | 8.19 | 7.12 | 090 | |
59820 | A | Care of miscarriage | 4.01 | 3.62 | 2.66 | 0.72 | 8.35 | 7.39 | 090 | |
59821 | A | Treatment of miscarriage | 4.47 | 3.79 | 2.85 | 0.80 | 9.06 | 8.12 | 090 | |
59830 | A | Treat uterus infection | 6.11 | NA | 3.94 | 1.10 | NA | 11.15 | 090 | |
59840 | R | Abortion | 3.01 | 3.98 | 2.24 | 0.54 | 7.53 | 5.79 | 010 | |
59841 | R | Abortion | 5.24 | 5.60 | 3.55 | 0.94 | 11.78 | 9.73 | 010 | |
59850 | R | Abortion | 5.91 | NA | 2.73 | 1.06 | NA | 9.70 | 090 | |
59851 | R | Abortion | 5.93 | NA | 3.13 | 1.06 | NA | 10.12 | 090 | |
59852 | R | Abortion | 8.24 | NA | 4.57 | 1.48 | NA | 14.29 | 090 | |
59855 | R | Abortion | 6.12 | NA | 3.24 | 1.10 | NA | 10.46 | 090 | |
59856 | R | Abortion | 7.48 | NA | 3.83 | 1.34 | NA | 12.65 | 090 | |
59857 | R | Abortion | 9.29 | NA | 4.39 | 1.66 | NA | 15.34 | 090 | |
59866 | R | Abortion (mpr) | 4.00 | NA | 1.55 | 0.72 | NA | 6.27 | 000 | |
59870 | A | Evacuate mole of uterus | 6.01 | NA | 3.78 | 0.77 | NA | 10.56 | 090 | |
59871 | A | Remove cerclage suture | 2.13 | 2.00 | 0.90 | 0.38 | 4.51 | 3.41 | 000 | |
59898 | C | Laparo proc, ob care/deliver | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
59899 | C | Maternity care procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
60000 | A | Drain thyroid/tongue cyst | 1.76 | 2.36 | 2.15 | 0.14 | 4.26 | 4.05 | 010 | |
60001 | A | Aspirate/inject thyriod cyst | 0.97 | 1.64 | 0.35 | 0.06 | 2.67 | 1.38 | 000 | |
60100 | A | Biopsy of thyroid | 1.56 | 1.86 | 0.55 | 0.05 | 3.47 | 2.16 | 000 | |
60200 | A | Remove thyroid lesion | 9.55 | NA | 6.57 | 0.84 | NA | 16.96 | 090 | |
60210 | A | Partial thyroid excision | 10.88 | NA | 6.45 | 1.01 | NA | 18.34 | 090 | |
60212 | A | Partial thyroid excision | 16.03 | NA | 8.23 | 1.51 | NA | 25.77 | 090 | |
60220 | A | Partial removal of thyroid | 11.90 | NA | 6.99 | 0.97 | NA | 19.86 | 090 | |
60225 | A | Partial removal of thyroid | 14.19 | NA | 7.82 | 1.31 | NA | 23.32 | 090 | |
60240 | A | Removal of thyroid | 16.06 | NA | 9.05 | 1.50 | NA | 26.61 | 090 | |
60252 | A | Removal of thyroid | 20.57 | NA | 11.39 | 1.63 | NA | 33.59 | 090 | |
60254 | A | Extensive thyroid surgery | 26.99 | NA | 15.79 | 1.96 | NA | 44.74 | 090 | |
60260 | A | Repeat thyroid surgery | 17.47 | NA | 10.30 | 1.39 | NA | 29.16 | 090 | |
60270 | A | Removal of thyroid | 20.27 | NA | 11.50 | 1.78 | NA | 33.55 | 090 | |
60271 | A | Removal of thyroid | 16.83 | NA | 9.82 | 1.35 | NA | 28.00 | 090 | |
60280 | A | Remove thyroid duct lesion | 5.87 | NA | 5.16 | 0.45 | NA | 11.48 | 090 | |
60281 | A | Remove thyroid duct lesion | 8.53 | NA | 6.35 | 0.67 | NA | 15.55 | 090 | |
60500 | A | Explore parathyroid glands | 16.23 | NA | 7.75 | 1.61 | NA | 25.59 | 090 | |
60502 | A | Re-explore parathyroids | 20.35 | NA | 9.59 | 2.00 | NA | 31.94 | 090 | |
60505 | A | Explore parathyroid glands | 21.49 | NA | 11.42 | 2.14 | NA | 35.05 | 090 | |
60512 | A | Autotransplant parathyroid | 4.45 | NA | 1.66 | 0.44 | NA | 6.55 | ZZZ | |
60520 | A | Removal of thymus gland | 16.81 | NA | 9.84 | 1.84 | NA | 28.49 | 090 | |
60521 | A | Removal of thymus gland | 18.87 | NA | 11.77 | 2.34 | NA | 32.98 | 090 | |
60522 | A | Removal of thymus gland | 23.09 | NA | 13.01 | 2.83 | NA | 38.93 | 090 | |
60540 | A | Explore adrenal gland | 17.03 | NA | 7.64 | 1.42 | NA | 26.09 | 090 | |
60545 | A | Explore adrenal gland | 19.88 | NA | 9.33 | 1.75 | NA | 30.96 | 090 | |
60600 | A | Remove carotid body lesion | 17.93 | NA | 13.24 | 1.87 | NA | 33.04 | 090 | |
60605 | A | Remove carotid body lesion | 20.24 | NA | 18.11 | 2.28 | NA | 40.63 | 090 | |
60650 | A | Laparoscopy adrenalectomy | 20.00 | NA | 8.06 | 1.98 | NA | 30.04 | 090 | |
60659 | C | Laparo proc, endocrine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
60699 | C | Endocrine surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
61000 | A | Remove cranial cavity fluid | 1.58 | NA | 0.98 | 0.13 | NA | 2.69 | 000 | |
61001 | A | Remove cranial cavity fluid | 1.49 | NA | 1.08 | 0.15 | NA | 2.72 | 000 | |
61020 | A | Remove brain cavity fluid | 1.51 | NA | 1.38 | 0.26 | NA | 3.15 | 000 | |
61026 | A | Injection into brain canal | 1.69 | NA | 1.45 | 0.21 | NA | 3.35 | 000 | |
61050 | A | Remove brain canal fluid | 1.51 | NA | 1.27 | 0.13 | NA | 2.91 | 000 | |
61055 | A | Injection into brain canal | 2.10 | NA | 1.42 | 0.13 | NA | 3.65 | 000 | |
61070 | A | Brain canal shunt procedure | 0.89 | NA | 1.04 | 0.09 | NA | 2.02 | 000 | |
61105 | A | Twist drill hole | 5.14 | NA | 4.04 | 1.05 | NA | 10.23 | 090 | |
61107 | A | Drill skull for implantation | 5.00 | NA | 3.38 | 1.02 | NA | 9.40 | 000 | |
61108 | A | Drill skull for drainage | 10.19 | NA | 7.29 | 2.04 | NA | 19.52 | 090 | |
61120 | A | Burr hole for puncture | 8.76 | NA | 6.12 | 1.81 | NA | 16.69 | 090 | |
61140 | A | Pierce skull for biopsy | 15.90 | NA | 10.11 | 3.15 | NA | 29.16 | 090 | |
61150 | A | Pierce skull for drainage | 17.57 | NA | 10.66 | 3.52 | NA | 31.75 | 090 | |
61151 | A | Pierce skull for drainage | 12.42 | NA | 8.01 | 2.45 | NA | 22.88 | 090 | |
61154 | A | Pierce skull remove clot | 14.99 | NA | 9.70 | 3.05 | NA | 27.74 | 090 | |
61156 | A | Pierce skull for drainage | 16.32 | NA | 10.07 | 3.42 | NA | 29.81 | 090 | |
61210 | A | Pierce skull, implant device | 5.84 | NA | 3.78 | 1.16 | NA | 10.78 | 000 | |
61215 | A | Insert brain-fluid device | 4.89 | NA | 4.09 | 0.99 | NA | 9.97 | 090 | |
61250 | A | Pierce skull explore | 10.42 | NA | 7.01 | 2.02 | NA | 19.45 | 090 | |
61253 | A | Pierce skull explore | 12.36 | NA | 7.87 | 2.26 | NA | 22.49 | 090 | |
61304 | A | Open skull for exploration | 21.96 | NA | 13.18 | 4.33 | NA | 39.47 | 090 | |
61305 | A | Open skull for exploration | 26.61 | NA | 15.70 | 5.25 | NA | 47.56 | 090 | |
61312 | A | Open skull for drainage | 24.57 | NA | 15.42 | 4.99 | NA | 44.98 | 090 | |
61313 | A | Open skull for drainage | 24.93 | NA | 15.20 | 5.07 | NA | 45.20 | 090 | |
61314 | A | Open skull for drainage | 24.23 | NA | 13.34 | 4.00 | NA | 41.57 | 090 | |
61315 | A | Open skull for drainage | 27.68 | NA | 16.42 | 5.62 | NA | 49.72 | 090 | |
61316 | A | Implt cran bone flap to abdo | 1.39 | NA | 0.57 | 0.43 | NA | 2.39 | ZZZ | |
61320 | A | Open skull for drainage | 25.62 | NA | 15.16 | 5.20 | NA | 45.98 | 090 | |
61321 | A | Open skull for drainage | 28.50 | NA | 16.55 | 5.35 | NA | 50.40 | 090 | |
61322 | A | Decompressive craniotomy | 29.50 | NA | 13.88 | 4.99 | NA | 48.37 | 090 | |
61323 | A | Decompressive lobectomy | 31.00 | NA | 14.08 | 4.99 | NA | 50.07 | 090 | |
61330 | A | Decompress eye socket | 23.32 | NA | 14.10 | 2.58 | NA | 40.00 | 090 | |
61332 | A | Explore/biopsy eye socket | 27.28 | NA | 15.97 | 4.15 | NA | 47.40 | 090 | |
61333 | A | Explore orbit/remove lesion | 27.95 | NA | 16.02 | 2.24 | NA | 46.21 | 090 | |
61334 | A | Explore orbit/remove object | 18.27 | NA | 10.93 | 3.02 | NA | 32.22 | 090 | |
61340 | A | Subtemporal decompression | 18.66 | NA | 11.41 | 3.66 | NA | 33.73 | 090 | |
61343 | A | Incise skull (press relief) | 29.77 | NA | 17.97 | 6.04 | NA | 53.78 | 090 | |
61345 | A | Relieve cranial pressure | 27.20 | NA | 16.51 | 5.23 | NA | 48.94 | 090 | |
61440 | A | Incise skull for surgery | 26.63 | NA | 15.30 | 5.57 | NA | 47.50 | 090 | |
61450 | A | Incise skull for surgery | 25.95 | NA | 15.53 | 5.11 | NA | 46.59 | 090 | |
61458 | A | Incise skull for brain wound | 27.29 | NA | 16.59 | 5.28 | NA | 49.16 | 090 | |
61460 | A | Incise skull for surgery | 28.39 | NA | 17.53 | 5.13 | NA | 51.05 | 090 | |
61470 | A | Incise skull for surgery | 26.06 | NA | 15.06 | 4.65 | NA | 45.77 | 090 | |
61480 | A | Incise skull for surgery | 26.49 | NA | 15.99 | 5.54 | NA | 48.02 | 090 | |
61490 | A | Incise skull for surgery | 25.66 | NA | 15.56 | 5.37 | NA | 46.59 | 090 | |
61500 | A | Removal of skull lesion | 17.92 | NA | 11.76 | 3.26 | NA | 32.94 | 090 | |
61501 | A | Remove infected skull bone | 14.84 | NA | 9.97 | 2.63 | NA | 27.44 | 090 | |
61510 | A | Removal of brain lesion | 28.45 | NA | 17.22 | 5.77 | NA | 51.44 | 090 | |
61512 | A | Remove brain lining lesion | 35.09 | NA | 20.72 | 7.14 | NA | 62.95 | 090 | |
61514 | A | Removal of brain abscess | 25.26 | NA | 15.47 | 5.12 | NA | 45.85 | 090 | |
61516 | A | Removal of brain lesion | 24.61 | NA | 14.92 | 4.94 | NA | 44.47 | 090 | |
61517 | A | Implt brain chemotx add-on | 1.38 | NA | 0.56 | 0.08 | NA | 2.02 | ZZZ | |
61518 | A | Removal of brain lesion | 37.32 | NA | 22.22 | 7.53 | NA | 67.07 | 090 | |
61519 | A | Remove brain lining lesion | 41.39 | NA | 24.21 | 8.15 | NA | 73.75 | 090 | |
61520 | A | Removal of brain lesion | 54.84 | NA | 31.73 | 10.10 | NA | 96.67 | 090 | |
61521 | A | Removal of brain lesion | 44.48 | NA | 25.76 | 8.85 | NA | 79.09 | 090 | |
61522 | A | Removal of brain abscess | 29.45 | NA | 17.56 | 5.30 | NA | 52.31 | 090 | |
61524 | A | Removal of brain lesion | 27.86 | NA | 16.79 | 5.01 | NA | 49.66 | 090 | |
61526 | A | Removal of brain lesion | 52.17 | NA | 30.71 | 6.72 | NA | 89.60 | 090 | |
61530 | A | Removal of brain lesion | 43.86 | NA | 26.94 | 6.17 | NA | 76.97 | 090 | |
61531 | A | Implant brain electrodes | 14.63 | NA | 9.66 | 2.84 | NA | 27.13 | 090 | |
61533 | A | Implant brain electrodes | 19.71 | NA | 12.32 | 3.80 | NA | 35.83 | 090 | |
61534 | A | Removal of brain lesion | 20.97 | NA | 13.13 | 4.15 | NA | 38.25 | 090 | |
61535 | A | Remove brain electrodes | 11.63 | NA | 8.10 | 2.29 | NA | 22.02 | 090 | |
61536 | A | Removal of brain lesion | 35.52 | NA | 21.02 | 6.68 | NA | 63.22 | 090 | |
61538 | A | Removal of brain tissue | 26.81 | NA | 16.32 | 5.38 | NA | 48.51 | 090 | |
61539 | A | Removal of brain tissue | 32.08 | NA | 18.97 | 6.62 | NA | 57.67 | 090 | |
61541 | A | Incision of brain tissue | 28.85 | NA | 16.91 | 5.50 | NA | 51.26 | 090 | |
61542 | A | Removal of brain tissue | 31.02 | NA | 19.07 | 6.49 | NA | 56.58 | 090 | |
61543 | A | Removal of brain tissue | 29.22 | NA | 17.52 | 6.11 | NA | 52.85 | 090 | |
61544 | A | Remove treat brain lesion | 25.50 | NA | 14.52 | 4.91 | NA | 44.93 | 090 | |
61545 | A | Excision of brain tumor | 43.80 | NA | 25.02 | 8.88 | NA | 77.70 | 090 | |
61546 | A | Removal of pituitary gland | 31.30 | NA | 18.68 | 6.06 | NA | 56.04 | 090 | |
61548 | A | Removal of pituitary gland | 21.53 | NA | 13.64 | 3.63 | NA | 38.80 | 090 | |
61550 | A | Release of skull seams | 14.65 | NA | 7.34 | 1.14 | NA | 23.13 | 090 | |
61552 | A | Release of skull seams | 19.56 | NA | 9.84 | 0.88 | NA | 30.28 | 090 | |
61556 | A | Incise skull/sutures | 22.26 | NA | 12.01 | 3.57 | NA | 37.84 | 090 | |
61557 | A | Incise skull/sutures | 22.38 | NA | 13.86 | 4.68 | NA | 40.92 | 090 | |
61558 | A | Excision of skull/sutures | 25.58 | NA | 15.13 | 2.61 | NA | 43.32 | 090 | |
61559 | A | Excision of skull/sutures | 32.79 | NA | 19.67 | 6.86 | NA | 59.32 | 090 | |
61563 | A | Excision of skull tumor | 26.83 | NA | 16.07 | 4.46 | NA | 47.36 | 090 | |
61564 | A | Excision of skull tumor | 33.83 | NA | 18.72 | 7.08 | NA | 59.63 | 090 | |
61570 | A | Remove foreign body, brain | 24.60 | NA | 14.37 | 4.60 | NA | 43.57 | 090 | |
61571 | A | Incise skull for brain wound | 26.39 | NA | 15.70 | 5.23 | NA | 47.32 | 090 | |
61575 | A | Skull base/brainstem surgery | 34.36 | NA | 21.20 | 5.02 | NA | 60.58 | 090 | |
61576 | A | Skull base/brainstem surgery | 52.43 | NA | 30.80 | 4.68 | NA | 87.91 | 090 | |
61580 | A | Craniofacial approach, skull | 30.35 | NA | 19.15 | 2.75 | NA | 52.25 | 090 | |
61581 | A | Craniofacial approach, skull | 34.60 | NA | 15.39 | 3.37 | NA | 53.36 | 090 | |
61582 | A | Craniofacial approach, skull | 31.66 | NA | 19.26 | 6.30 | NA | 57.22 | 090 | |
61583 | A | Craniofacial approach, skull | 36.21 | NA | 22.62 | 6.94 | NA | 65.77 | 090 | |
61584 | A | Orbitocranial approach/skull | 34.65 | NA | 20.92 | 6.53 | NA | 62.10 | 090 | |
61585 | A | Orbitocranial approach/skull | 38.61 | NA | 22.58 | 6.19 | NA | 67.38 | 090 | |
61586 | A | Resect nasopharynx, skull | 25.10 | NA | 16.22 | 3.52 | NA | 44.84 | 090 | |
61590 | A | Infratemporal approach/skull | 41.78 | NA | 25.53 | 4.28 | NA | 71.59 | 090 | |
61591 | A | Infratemporal approach/skull | 43.68 | NA | 26.34 | 5.26 | NA | 75.28 | 090 | |
61592 | A | Orbitocranial approach/skull | 39.64 | NA | 23.61 | 7.55 | NA | 70.80 | 090 | |
61595 | A | Transtemporal approach/skull | 29.57 | NA | 19.32 | 3.05 | NA | 51.94 | 090 | |
61596 | A | Transcochlear approach/skull | 35.63 | NA | 22.01 | 4.25 | NA | 61.89 | 090 | |
61597 | A | Transcondylar approach/skull | 37.96 | NA | 21.20 | 6.65 | NA | 65.81 | 090 | |
61598 | A | Transpetrosal approach/skull | 33.41 | NA | 20.65 | 4.60 | NA | 58.66 | 090 | |
61600 | A | Resect/excise cranial lesion | 25.85 | NA | 15.96 | 3.12 | NA | 44.93 | 090 | |
61601 | A | Resect/excise cranial lesion | 27.89 | NA | 17.32 | 5.29 | NA | 50.50 | 090 | |
61605 | A | Resect/excise cranial lesion | 29.33 | NA | 18.50 | 2.51 | NA | 50.34 | 090 | |
61606 | A | Resect/excise cranial lesion | 38.83 | NA | 23.37 | 6.81 | NA | 69.01 | 090 | |
61607 | A | Resect/excise cranial lesion | 36.27 | NA | 22.05 | 5.69 | NA | 64.01 | 090 | |
61608 | A | Resect/excise cranial lesion | 42.10 | NA | 24.77 | 8.31 | NA | 75.18 | 090 | |
61609 | A | Transect artery, sinus | 9.89 | NA | 4.91 | 2.07 | NA | 16.87 | ZZZ | |
61610 | A | Transect artery, sinus | 29.67 | NA | 13.48 | 3.52 | NA | 46.67 | ZZZ | |
61611 | A | Transect artery, sinus | 7.42 | NA | 3.40 | 1.55 | NA | 12.37 | ZZZ | |
61612 | A | Transect artery, sinus | 27.88 | NA | 13.67 | 3.55 | NA | 45.10 | ZZZ | |
61613 | A | Remove aneurysm, sinus | 40.86 | NA | 23.95 | 8.32 | NA | 73.13 | 090 | |
61615 | A | Resect/excise lesion, skull | 32.07 | NA | 20.58 | 4.64 | NA | 57.29 | 090 | |
61616 | A | Resect/excise lesion, skull | 43.33 | NA | 26.87 | 7.02 | NA | 77.22 | 090 | |
61618 | A | Repair dura | 16.99 | NA | 11.45 | 2.92 | NA | 31.36 | 090 | |
61619 | A | Repair dura | 20.71 | NA | 13.38 | 3.42 | NA | 37.51 | 090 | |
61623 | A | Endovasc tempory vessel occl | 9.96 | NA | 4.23 | 0.50 | NA | 14.69 | 000 | |
61624 | A | Transcath occlusion, cns | 20.15 | NA | 7.13 | 1.15 | NA | 28.43 | 000 | |
61626 | A | Transcath occlusion, non-cns | 16.62 | NA | 5.70 | 0.84 | NA | 23.16 | 000 | |
61680 | A | Intracranial vessel surgery | 30.71 | NA | 18.44 | 6.04 | NA | 55.19 | 090 | |
61682 | A | Intracranial vessel surgery | 61.57 | NA | 34.01 | 12.69 | NA | 108.27 | 090 | |
61684 | A | Intracranial vessel surgery | 39.81 | NA | 23.12 | 7.87 | NA | 70.80 | 090 | |
61686 | A | Intracranial vessel surgery | 64.49 | NA | 36.02 | 13.20 | NA | 113.71 | 090 | |
61690 | A | Intracranial vessel surgery | 29.31 | NA | 17.76 | 5.51 | NA | 52.58 | 090 | |
61692 | A | Intracranial vessel surgery | 51.87 | NA | 28.84 | 10.17 | NA | 90.88 | 090 | |
61697 | A | Brain aneurysm repr, complx | 50.52 | NA | 28.73 | 10.31 | NA | 89.56 | 090 | |
61698 | A | Brain aneurysm repr, complx | 48.41 | NA | 27.36 | 9.99 | NA | 85.76 | 090 | |
61700 | A | Brain aneurysm repr, simple | 50.52 | NA | 28.68 | 10.18 | NA | 89.38 | 090 | |
61702 | A | Inner skull vessel surgery | 48.41 | NA | 27.66 | 9.75 | NA | 85.82 | 090 | |
61703 | A | Clamp neck artery | 17.47 | NA | 11.24 | 3.62 | NA | 32.33 | 090 | |
61705 | A | Revise circulation to head | 36.20 | NA | 20.05 | 6.67 | NA | 62.92 | 090 | |
61708 | A | Revise circulation to head | 35.30 | NA | 15.87 | 2.18 | NA | 53.35 | 090 | |
61710 | A | Revise circulation to head | 29.67 | NA | 14.53 | 2.42 | NA | 46.62 | 090 | |
61711 | A | Fusion of skull arteries | 36.33 | NA | 20.63 | 7.39 | NA | 64.35 | 090 | |
61720 | A | Incise skull/brain surgery | 16.77 | NA | 10.74 | 3.51 | NA | 31.02 | 090 | |
61735 | A | Incise skull/brain surgery | 20.43 | NA | 12.76 | 4.16 | NA | 37.35 | 090 | |
61750 | A | Incise skull/brain biopsy | 18.20 | NA | 10.96 | 3.71 | NA | 32.87 | 090 | |
61751 | A | Brain biopsy w/ct/mr guide | 17.62 | NA | 10.77 | 3.57 | NA | 31.96 | 090 | |
61760 | A | Implant brain electrodes | 22.27 | NA | 8.83 | 4.59 | NA | 35.69 | 090 | |
61770 | A | Incise skull for treatment | 21.44 | NA | 13.05 | 4.09 | NA | 38.58 | 090 | |
61790 | A | Treat trigeminal nerve | 10.86 | NA | 6.02 | 1.82 | NA | 18.70 | 090 | |
61791 | A | Treat trigeminal tract | 14.61 | NA | 9.26 | 3.03 | NA | 26.90 | 090 | |
61793 | A | Focus radiation beam | 17.24 | NA | 10.93 | 3.51 | NA | 31.68 | 090 | |
61795 | A | Brain surgery using computer | 4.04 | NA | 2.09 | 0.81 | NA | 6.94 | ZZZ | |
61850 | A | Implant neuroelectrodes | 12.39 | NA | 8.08 | 2.23 | NA | 22.70 | 090 | |
61860 | A | Implant neuroelectrodes | 20.87 | NA | 12.88 | 4.04 | NA | 37.79 | 090 | |
61862 | A | Implant neurostimul, subcort | 19.34 | NA | 12.08 | 3.97 | NA | 35.39 | 090 | |
61870 | A | Implant neuroelectrodes | 14.94 | NA | 10.85 | 1.70 | NA | 27.49 | 090 | |
61875 | A | Implant neuroelectrodes | 15.06 | NA | 9.28 | 2.42 | NA | 26.76 | 090 | |
61880 | A | Revise/remove neuroelectrode | 6.29 | NA | 5.34 | 1.31 | NA | 12.94 | 090 | |
61885 | A | Implant neurostim one array | 5.85 | NA | 5.09 | 1.22 | NA | 12.16 | 090 | |
61886 | A | Implant neurostim arrays | 8.00 | NA | 6.15 | 1.64 | NA | 15.79 | 090 | |
61888 | A | Revise/remove neuroreceiver | 5.07 | NA | 3.90 | 1.04 | NA | 10.01 | 010 | |
62000 | A | Treat skull fracture | 12.53 | NA | 5.65 | 0.87 | NA | 19.05 | 090 | |
62005 | A | Treat skull fracture | 16.17 | NA | 9.46 | 2.33 | NA | 27.96 | 090 | |
62010 | A | Treatment of head injury | 19.81 | NA | 12.28 | 4.05 | NA | 36.14 | 090 | |
62100 | A | Repair brain fluid leakage | 22.03 | NA | 13.85 | 4.07 | NA | 39.95 | 090 | |
62115 | A | Reduction of skull defect | 21.66 | NA | 11.69 | 4.53 | NA | 37.88 | 090 | |
62116 | A | Reduction of skull defect | 23.59 | NA | 13.79 | 4.85 | NA | 42.23 | 090 | |
62117 | A | Reduction of skull defect | 26.60 | NA | 15.87 | 5.56 | NA | 48.03 | 090 | |
62120 | A | Repair skull cavity lesion | 23.35 | NA | 14.38 | 3.07 | NA | 40.80 | 090 | |
62121 | A | Incise skull repair | 21.58 | NA | 13.55 | 2.47 | NA | 37.60 | 090 | |
62140 | A | Repair of skull defect | 13.51 | NA | 8.61 | 2.60 | NA | 24.72 | 090 | |
62141 | A | Repair of skull defect | 14.91 | NA | 9.78 | 2.85 | NA | 27.54 | 090 | |
62142 | A | Remove skull plate/flap | 10.79 | NA | 7.24 | 2.10 | NA | 20.13 | 090 | |
62143 | A | Replace skull plate/flap | 13.05 | NA | 8.75 | 2.55 | NA | 24.35 | 090 | |
62145 | A | Repair of skull brain | 18.82 | NA | 11.69 | 3.81 | NA | 34.32 | 090 | |
62146 | A | Repair of skull with graft | 16.12 | NA | 10.40 | 2.94 | NA | 29.46 | 090 | |
62147 | A | Repair of skull with graft | 19.34 | NA | 12.14 | 3.64 | NA | 35.12 | 090 | |
62148 | A | Retr bone flap to fix skull | 2.00 | NA | 0.82 | 0.43 | NA | 3.25 | ZZZ | |
62160 | A | Neuroendoscopy add-on | 3.00 | NA | 1.16 | 0.52 | NA | 4.68 | ZZZ | |
62161 | A | Dissect brain w/scope | 20.00 | NA | 9.71 | 3.70 | NA | 33.41 | 090 | |
62162 | A | Remove colloid cyst w/scope | 25.25 | NA | 11.89 | 5.77 | NA | 42.91 | 090 | |
62163 | A | Neuroendoscopy w/fb removal | 15.50 | NA | 7.97 | 3.70 | NA | 27.17 | 090 | |
62164 | A | Remove brain tumor w/scope | 27.50 | NA | 13.12 | 5.77 | NA | 46.39 | 090 | |
62165 | A | Remove pituit tumor w/scope | 22.00 | NA | 10.68 | 3.63 | NA | 36.31 | 090 | |
62180 | A | Establish brain cavity shunt | 21.06 | NA | 12.90 | 4.32 | NA | 38.28 | 090 | |
62190 | A | Establish brain cavity shunt | 11.07 | NA | 7.73 | 2.18 | NA | 20.98 | 090 | |
62192 | A | Establish brain cavity shunt | 12.25 | NA | 8.27 | 2.46 | NA | 22.98 | 090 | |
62194 | A | Replace/irrigate catheter | 5.03 | NA | 2.77 | 0.50 | NA | 8.30 | 010 | |
62200 | A | Establish brain cavity shunt | 18.32 | NA | 11.59 | 3.70 | NA | 33.61 | 090 | |
62201 | A | Brain cavity shunt w/scope | 14.86 | NA | 9.77 | 2.52 | NA | 27.15 | 090 | |
62220 | A | Establish brain cavity shunt | 13.00 | NA | 8.65 | 2.53 | NA | 24.18 | 090 | |
62223 | A | Establish brain cavity shunt | 12.87 | NA | 8.51 | 2.58 | NA | 23.96 | 090 | |
62225 | A | Replace/irrigate catheter | 5.41 | NA | 4.81 | 1.09 | NA | 11.31 | 090 | |
62230 | A | Replace/revise brain shunt | 10.54 | NA | 7.23 | 2.10 | NA | 19.87 | 090 | |
62252 | A | Csf shunt reprogram | 0.74 | 1.47 | NA | 0.18 | 2.39 | NA | XXX | |
62252 | 26 | A | Csf shunt reprogram | 0.74 | 0.38 | 0.38 | 0.16 | 1.28 | 1.28 | XXX |
62252 | TC | A | Csf shunt reprogram | 0.00 | 1.09 | NA | 0.02 | 1.11 | NA | XXX |
62256 | A | Remove brain cavity shunt | 6.60 | NA | 5.45 | 1.34 | NA | 13.39 | 090 | |
62258 | A | Replace brain cavity shunt | 14.54 | NA | 9.34 | 2.91 | NA | 26.79 | 090 | |
62263 | A | Epidural lysis mult sessions | 6.14 | 13.45 | 2.43 | 0.42 | 20.01 | 8.99 | 010 | |
62264 | A | Epidural lysis on single day | 4.43 | 11.38 | 1.32 | 0.30 | 16.11 | 6.05 | 010 | |
62268 | A | Drain spinal cord cyst | 4.74 | NA | 2.71 | 0.29 | NA | 7.74 | 000 | |
62269 | A | Needle biopsy, spinal cord | 5.02 | NA | 2.37 | 0.29 | NA | 7.68 | 000 | |
62270 | A | Spinal fluid tap, diagnostic | 1.13 | 3.78 | 0.50 | 0.06 | 4.97 | 1.69 | 000 | |
62272 | A | Drain cerebro spinal fluid | 1.35 | 4.85 | 0.65 | 0.13 | 6.33 | 2.13 | 000 | |
62273 | A | Treat epidural spine lesion | 2.15 | 2.79 | 0.58 | 0.14 | 5.08 | 2.87 | 000 | |
62280 | A | Treat spinal cord lesion | 2.63 | 9.34 | 0.82 | 0.17 | 12.14 | 3.62 | 010 | |
62281 | A | Treat spinal cord lesion | 2.66 | 7.92 | 0.72 | 0.16 | 10.74 | 3.54 | 010 | |
62282 | A | Treat spinal canal lesion | 2.33 | 11.43 | 0.73 | 0.14 | 13.90 | 3.20 | 010 | |
62284 | A | Injection for myelogram | 1.54 | 5.07 | 0.61 | 0.10 | 6.71 | 2.25 | 000 | |
62287 | A | Percutaneous diskectomy | 8.08 | NA | 5.04 | 0.66 | NA | 13.78 | 090 | |
62290 | A | Inject for spine disk x-ray | 3.00 | 8.54 | 1.29 | 0.20 | 11.74 | 4.49 | 000 | |
62291 | A | Inject for spine disk x-ray | 2.91 | 7.28 | 1.15 | 0.17 | 10.36 | 4.23 | 000 | |
62292 | A | Injection into disk lesion | 7.86 | NA | 5.04 | 0.65 | NA | 13.55 | 090 | |
62294 | A | Injection into spinal artery | 11.83 | NA | 6.68 | 0.85 | NA | 19.36 | 090 | |
62310 | A | Inject spine c/t | 1.91 | 4.91 | 0.51 | 0.11 | 6.93 | 2.53 | 000 | |
62311 | A | Inject spine l/s (cd) | 1.54 | 5.02 | 0.45 | 0.09 | 6.65 | 2.08 | 000 | |
62318 | A | Inject spine w/cath, c/t | 2.04 | 5.53 | 0.52 | 0.12 | 7.69 | 2.68 | 000 | |
62319 | A | Inject spine w/cath l/s (cd) | 1.87 | 4.90 | 0.48 | 0.11 | 6.88 | 2.46 | 000 | |
62350 | A | Implant spinal canal cath | 6.87 | NA | 3.64 | 0.64 | NA | 11.15 | 090 | |
62351 | A | Implant spinal canal cath | 10.00 | NA | 6.72 | 1.79 | NA | 18.51 | 090 | |
62355 | A | Remove spinal canal catheter | 5.45 | NA | 2.82 | 0.47 | NA | 8.74 | 090 | |
62360 | A | Insert spine infusion device | 2.62 | NA | 2.28 | 0.21 | NA | 5.11 | 090 | |
62361 | A | Implant spine infusion pump | 5.42 | NA | 3.50 | 0.50 | NA | 9.42 | 090 | |
62362 | A | Implant spine infusion pump | 7.04 | NA | 4.06 | 0.86 | NA | 11.96 | 090 | |
62365 | A | Remove spine infusion device | 5.42 | NA | 4.09 | 0.58 | NA | 10.09 | 090 | |
62367 | C | Analyze spine infusion pump | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
62367 | 26 | A | Analyze spine infusion pump | 0.48 | 0.13 | 0.13 | 0.03 | 0.64 | 0.64 | XXX |
62367 | TC | C | Analyze spine infusion pump | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
62368 | C | Analyze spine infusion pump | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
62368 | 26 | A | Analyze spine infusion pump | 0.75 | 0.19 | 0.19 | 0.05 | 0.99 | 0.99 | XXX |
62368 | TC | C | Analyze spine infusion pump | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
63001 | A | Removal of spinal lamina | 15.82 | NA | 9.93 | 3.03 | NA | 28.78 | 090 | |
63003 | A | Removal of spinal lamina | 15.95 | NA | 10.28 | 2.98 | NA | 29.21 | 090 | |
63005 | A | Removal of spinal lamina | 14.92 | NA | 10.31 | 2.62 | NA | 27.85 | 090 | |
63011 | A | Removal of spinal lamina | 14.52 | NA | 8.60 | 1.43 | NA | 24.55 | 090 | |
63012 | A | Removal of spinal lamina | 15.40 | NA | 10.45 | 2.71 | NA | 28.56 | 090 | |
63015 | A | Removal of spinal lamina | 19.35 | NA | 12.36 | 3.84 | NA | 35.55 | 090 | |
63016 | A | Removal of spinal lamina | 19.20 | NA | 12.22 | 3.62 | NA | 35.04 | 090 | |
63017 | A | Removal of spinal lamina | 15.94 | NA | 10.77 | 2.91 | NA | 29.62 | 090 | |
63020 | A | Neck spine disk surgery | 14.81 | NA | 10.08 | 2.89 | NA | 27.78 | 090 | |
63030 | A | Low back disk surgery | 12.00 | NA | 8.75 | 2.21 | NA | 22.96 | 090 | |
63035 | A | Spinal disk surgery add-on | 3.15 | NA | 1.63 | 0.57 | NA | 5.35 | ZZZ | |
63040 | A | Laminotomy, single cervical | 18.81 | NA | 11.91 | 3.36 | NA | 34.08 | 090 | |
63042 | A | Laminotomy, single lumbar | 17.47 | NA | 11.71 | 3.11 | NA | 32.29 | 090 | |
63043 | C | Laminotomy, addl cervical | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | |
63044 | C | Laminotomy, addl lumbar | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | |
63045 | A | Removal of spinal lamina | 16.50 | NA | 10.76 | 3.19 | NA | 30.45 | 090 | |
63046 | A | Removal of spinal lamina | 15.80 | NA | 10.54 | 2.89 | NA | 29.23 | 090 | |
63047 | A | Removal of spinal lamina | 14.61 | NA | 10.23 | 2.61 | NA | 27.45 | 090 | |
63048 | A | Remove spinal lamina add-on | 3.26 | NA | 1.71 | 0.58 | NA | 5.55 | ZZZ | |
63055 | A | Decompress spinal cord | 21.99 | NA | 13.60 | 4.09 | NA | 39.68 | 090 | |
63056 | A | Decompress spinal cord | 20.36 | NA | 12.98 | 3.34 | NA | 36.68 | 090 | |
63057 | A | Decompress spine cord add-on | 5.26 | NA | 2.71 | 0.81 | NA | 8.78 | ZZZ | |
63064 | A | Decompress spinal cord | 24.61 | NA | 14.93 | 4.72 | NA | 44.26 | 090 | |
63066 | A | Decompress spine cord add-on | 3.26 | NA | 1.71 | 0.63 | NA | 5.60 | ZZZ | |
63075 | A | Neck spine disk surgery | 19.41 | NA | 12.53 | 3.73 | NA | 35.67 | 090 | |
63076 | A | Neck spine disk surgery | 4.05 | NA | 2.11 | 0.78 | NA | 6.94 | ZZZ | |
63077 | A | Spine disk surgery, thorax | 21.44 | NA | 13.08 | 3.44 | NA | 37.96 | 090 | |
63078 | A | Spine disk surgery, thorax | 3.28 | NA | 1.67 | 0.50 | NA | 5.45 | ZZZ | |
63081 | A | Removal of vertebral body | 23.73 | NA | 14.80 | 4.46 | NA | 42.99 | 090 | |
63082 | A | Remove vertebral body add-on | 4.37 | NA | 2.29 | 0.82 | NA | 7.48 | ZZZ | |
63085 | A | Removal of vertebral body | 26.92 | NA | 15.83 | 4.70 | NA | 47.45 | 090 | |
63086 | A | Remove vertebral body add-on | 3.19 | NA | 1.63 | 0.55 | NA | 5.37 | ZZZ | |
63087 | A | Removal of vertebral body | 35.57 | NA | 19.93 | 5.87 | NA | 61.37 | 090 | |
63088 | A | Remove vertebral body add-on | 4.33 | NA | 2.23 | 0.77 | NA | 7.33 | ZZZ | |
63090 | A | Removal of vertebral body | 28.16 | NA | 16.40 | 4.27 | NA | 48.83 | 090 | |
63091 | A | Remove vertebral body add-on | 3.03 | NA | 1.49 | 0.45 | NA | 4.97 | ZZZ | |
63170 | A | Incise spinal cord tract(s) | 19.83 | NA | 13.69 | 3.89 | NA | 37.41 | 090 | |
63172 | A | Drainage of spinal cyst | 17.66 | NA | 13.21 | 3.46 | NA | 34.33 | 090 | |
63173 | A | Drainage of spinal cyst | 21.99 | NA | 15.22 | 4.14 | NA | 41.35 | 090 | |
63180 | A | Revise spinal cord ligaments | 18.27 | NA | 13.27 | 3.83 | NA | 35.37 | 090 | |
63182 | A | Revise spinal cord ligaments | 20.50 | NA | 12.93 | 3.48 | NA | 36.91 | 090 | |
63185 | A | Incise spinal column/nerves | 15.04 | NA | 9.82 | 2.08 | NA | 26.94 | 090 | |
63190 | A | Incise spinal column/nerves | 17.45 | NA | 11.92 | 2.88 | NA | 32.25 | 090 | |
63191 | A | Incise spinal column/nerves | 17.54 | NA | 12.31 | 3.50 | NA | 33.35 | 090 | |
63194 | A | Incise spinal column cord | 19.19 | NA | 13.35 | 4.01 | NA | 36.55 | 090 | |
63195 | A | Incise spinal column cord | 18.84 | NA | 12.97 | 3.44 | NA | 35.25 | 090 | |
63196 | A | Incise spinal column cord | 22.30 | NA | 13.65 | 4.66 | NA | 40.61 | 090 | |
63197 | A | Incise spinal column cord | 21.11 | NA | 13.85 | 4.42 | NA | 39.38 | 090 | |
63198 | A | Incise spinal column cord | 25.38 | NA | 10.80 | 5.31 | NA | 41.49 | 090 | |
63199 | A | Incise spinal column cord | 26.89 | NA | 16.29 | 5.62 | NA | 48.80 | 090 | |
63200 | A | Release of spinal cord | 19.18 | NA | 13.10 | 3.61 | NA | 35.89 | 090 | |
63250 | A | Revise spinal cord vessels | 40.76 | NA | 20.69 | 7.65 | NA | 69.10 | 090 | |
63251 | A | Revise spinal cord vessels | 41.20 | NA | 23.26 | 7.98 | NA | 72.44 | 090 | |
63252 | A | Revise spinal cord vessels | 41.19 | NA | 22.90 | 7.75 | NA | 71.84 | 090 | |
63265 | A | Excise intraspinal lesion | 21.56 | NA | 13.30 | 4.29 | NA | 39.15 | 090 | |
63266 | A | Excise intraspinal lesion | 22.30 | NA | 13.73 | 4.47 | NA | 40.50 | 090 | |
63267 | A | Excise intraspinal lesion | 17.95 | NA | 11.53 | 3.50 | NA | 32.98 | 090 | |
63268 | A | Excise intraspinal lesion | 18.52 | NA | 10.86 | 3.18 | NA | 32.56 | 090 | |
63270 | A | Excise intraspinal lesion | 26.80 | NA | 16.10 | 5.41 | NA | 48.31 | 090 | |
63271 | A | Excise intraspinal lesion | 26.92 | NA | 16.20 | 5.56 | NA | 48.68 | 090 | |
63272 | A | Excise intraspinal lesion | 25.32 | NA | 15.27 | 5.07 | NA | 45.66 | 090 | |
63273 | A | Excise intraspinal lesion | 24.29 | NA | 14.89 | 5.08 | NA | 44.26 | 090 | |
63275 | A | Biopsy/excise spinal tumor | 23.68 | NA | 14.35 | 4.68 | NA | 42.71 | 090 | |
63276 | A | Biopsy/excise spinal tumor | 23.45 | NA | 14.23 | 4.63 | NA | 42.31 | 090 | |
63277 | A | Biopsy/excise spinal tumor | 20.83 | NA | 13.01 | 4.03 | NA | 37.87 | 090 | |
63278 | A | Biopsy/excise spinal tumor | 20.56 | NA | 12.84 | 4.02 | NA | 37.42 | 090 | |
63280 | A | Biopsy/excise spinal tumor | 28.35 | NA | 16.80 | 5.80 | NA | 50.95 | 090 | |
63281 | A | Biopsy/excise spinal tumor | 28.05 | NA | 16.64 | 5.67 | NA | 50.36 | 090 | |
63282 | A | Biopsy/excise spinal tumor | 26.39 | NA | 15.77 | 5.33 | NA | 47.49 | 090 | |
63283 | A | Biopsy/excise spinal tumor | 25.00 | NA | 15.09 | 5.12 | NA | 45.21 | 090 | |
63285 | A | Biopsy/excise spinal tumor | 36.00 | NA | 20.53 | 7.31 | NA | 63.84 | 090 | |
63286 | A | Biopsy/excise spinal tumor | 35.63 | NA | 20.47 | 7.07 | NA | 63.17 | 090 | |
63287 | A | Biopsy/excise spinal tumor | 36.70 | NA | 21.04 | 7.48 | NA | 65.22 | 090 | |
63290 | A | Biopsy/excise spinal tumor | 37.38 | NA | 21.18 | 7.65 | NA | 66.21 | 090 | |
63300 | A | Removal of vertebral body | 24.43 | NA | 14.84 | 4.78 | NA | 44.05 | 090 | |
63301 | A | Removal of vertebral body | 27.60 | NA | 15.84 | 5.03 | NA | 48.47 | 090 | |
63302 | A | Removal of vertebral body | 27.81 | NA | 16.16 | 5.25 | NA | 49.22 | 090 | |
63303 | A | Removal of vertebral body | 30.50 | NA | 17.39 | 5.21 | NA | 53.10 | 090 | |
63304 | A | Removal of vertebral body | 30.33 | NA | 17.77 | 4.72 | NA | 52.82 | 090 | |
63305 | A | Removal of vertebral body | 32.03 | NA | 18.30 | 5.39 | NA | 55.72 | 090 | |
63306 | A | Removal of vertebral body | 32.22 | NA | 18.04 | 2.39 | NA | 52.65 | 090 | |
63307 | A | Removal of vertebral body | 31.63 | NA | 17.33 | 4.23 | NA | 53.19 | 090 | |
63308 | A | Remove vertebral body add-on | 5.25 | NA | 2.67 | 1.01 | NA | 8.93 | ZZZ | |
63600 | A | Remove spinal cord lesion | 14.02 | NA | 6.03 | 1.22 | NA | 21.27 | 090 | |
63610 | A | Stimulation of spinal cord | 8.73 | NA | 3.79 | 0.43 | NA | 12.95 | 000 | |
63615 | A | Remove lesion of spinal cord | 16.28 | NA | 9.99 | 2.85 | NA | 29.12 | 090 | |
63650 | A | Implant neuroelectrodes | 6.74 | NA | 2.96 | 0.48 | NA | 10.18 | 090 | |
63655 | A | Implant neuroelectrodes | 10.29 | NA | 7.23 | 1.85 | NA | 19.37 | 090 | |
63660 | A | Revise/remove neuroelectrode | 6.16 | NA | 3.74 | 0.65 | NA | 10.55 | 090 | |
63685 | A | Implant neuroreceiver | 7.04 | NA | 4.28 | 0.96 | NA | 12.28 | 090 | |
63688 | A | Revise/remove neuroreceiver | 5.39 | NA | 3.68 | 0.70 | NA | 9.77 | 090 | |
63700 | A | Repair of spinal herniation | 16.53 | NA | 10.45 | 2.69 | NA | 29.67 | 090 | |
63702 | A | Repair of spinal herniation | 18.48 | NA | 10.71 | 1.36 | NA | 30.55 | 090 | |
63704 | A | Repair of spinal herniation | 21.18 | NA | 12.61 | 3.84 | NA | 37.63 | 090 | |
63706 | A | Repair of spinal herniation | 24.11 | NA | 13.52 | 4.73 | NA | 42.36 | 090 | |
63707 | A | Repair spinal fluid leakage | 11.26 | NA | 8.01 | 1.96 | NA | 21.23 | 090 | |
63709 | A | Repair spinal fluid leakage | 14.32 | NA | 9.70 | 2.49 | NA | 26.51 | 090 | |
63710 | A | Graft repair of spine defect | 14.07 | NA | 9.43 | 2.61 | NA | 26.11 | 090 | |
63740 | A | Install spinal shunt | 11.36 | NA | 7.76 | 2.15 | NA | 21.27 | 090 | |
63741 | A | Install spinal shunt | 8.25 | NA | 4.86 | 1.05 | NA | 14.16 | 090 | |
63744 | A | Revision of spinal shunt | 8.10 | NA | 5.58 | 1.51 | NA | 15.19 | 090 | |
63746 | A | Removal of spinal shunt | 6.43 | NA | 4.04 | 1.15 | NA | 11.62 | 090 | |
64400 | A | N block inj, trigeminal | 1.11 | 1.96 | 0.36 | 0.06 | 3.13 | 1.53 | 000 | |
64402 | A | N block inj, facial | 1.25 | 1.57 | 0.54 | 0.07 | 2.89 | 1.86 | 000 | |
64405 | A | N block inj, occipital | 1.32 | 1.70 | 0.40 | 0.08 | 3.10 | 1.80 | 000 | |
64408 | A | N block inj, vagus | 1.41 | 2.60 | 0.67 | 0.09 | 4.10 | 2.17 | 000 | |
64410 | A | N block inj, phrenic | 1.43 | 2.48 | 0.40 | 0.08 | 3.99 | 1.91 | 000 | |
64412 | A | N block inj, spinal accessor | 1.18 | 2.62 | 0.37 | 0.08 | 3.88 | 1.63 | 000 | |
64413 | A | N block inj, cervical plexus | 1.40 | 1.99 | 0.44 | 0.09 | 3.48 | 1.93 | 000 | |
64415 | A | N block inj, brachial plexus | 1.48 | 3.05 | 0.39 | 0.08 | 4.61 | 1.95 | 000 | |
64416 | A | N block cont infuse, b plex | 3.50 | NA | 0.75 | 0.08 | NA | 4.33 | 010 | |
64417 | A | N block inj, axillary | 1.44 | 3.25 | 0.43 | 0.09 | 4.78 | 1.96 | 000 | |
64418 | A | N block inj, suprascapular | 1.32 | 2.67 | 0.37 | 0.07 | 4.06 | 1.76 | 000 | |
64420 | A | N block inj, intercost, sng | 1.18 | 3.56 | 0.35 | 0.07 | 4.81 | 1.60 | 000 | |
64421 | A | N block inj, intercost, mlt | 1.68 | 5.30 | 0.46 | 0.10 | 7.08 | 2.24 | 000 | |
64425 | A | N block inj ilio-ing/hypogi | 1.75 | 1.60 | 0.48 | 0.11 | 3.46 | 2.34 | 000 | |
64430 | A | N block inj, pudendal | 1.46 | 2.09 | 0.50 | 0.11 | 3.66 | 2.07 | 000 | |
64435 | A | N block inj, paracervical | 1.45 | 2.24 | 0.65 | 0.15 | 3.84 | 2.25 | 000 | |
64445 | A | N block inj, sciatic, sng | 1.48 | 2.78 | 0.38 | 0.08 | 4.34 | 1.94 | 000 | |
64446 | A | N blk inj, sciatic, cont inf | 3.25 | NA | 1.15 | 0.08 | NA | 4.48 | 010 | |
64447 | A | N block inj fem, single | 1.50 | NA | 0.52 | 0.08 | NA | 2.10 | 000 | |
64448 | A | N block inj fem, cont inf | 3.00 | NA | 1.04 | 0.08 | NA | 4.12 | 010 | |
64450 | A | N block, other peripheral | 1.27 | 1.30 | 0.42 | 0.08 | 2.65 | 1.77 | 000 | |
64470 | A | Inj paravertebral c/t | 1.85 | 4.99 | 0.57 | 0.12 | 6.96 | 2.54 | 000 | |
64472 | A | Inj paravertebral c/t add-on | 1.29 | 1.99 | 0.32 | 0.09 | 3.37 | 1.70 | ZZZ | |
64475 | A | Inj paravertebral l/s | 1.41 | 4.65 | 0.48 | 0.09 | 6.15 | 1.98 | 000 | |
64476 | A | Inj paravertebral l/s add-on | 0.98 | 1.86 | 0.25 | 0.06 | 2.90 | 1.29 | ZZZ | |
64479 | A | Inj foramen epidural c/t | 2.20 | 7.32 | 0.73 | 0.14 | 9.66 | 3.07 | 000 | |
64480 | A | Inj foramen epidural add-on | 1.54 | 2.36 | 0.48 | 0.09 | 3.99 | 2.11 | ZZZ | |
64483 | A | Inj foramen epidural l/s | 1.90 | 7.75 | 0.67 | 0.12 | 9.77 | 2.69 | 000 | |
64484 | A | Inj foramen epidural add-on | 1.33 | 2.70 | 0.38 | 0.08 | 4.11 | 1.79 | ZZZ | |
64505 | A | N block, spenopalatine gangl | 1.36 | 1.89 | 0.49 | 0.08 | 3.33 | 1.93 | 000 | |
64508 | A | N block, carotid sinus s/p | 1.12 | 4.79 | 0.52 | 0.06 | 5.97 | 1.70 | 000 | |
64510 | A | N block, stellate ganglion | 1.22 | 3.19 | 0.38 | 0.07 | 4.48 | 1.67 | 000 | |
64520 | A | N block, lumbar/thoracic | 1.35 | 4.54 | 0.42 | 0.08 | 5.97 | 1.85 | 000 | |
64530 | A | N block inj, celiac pelus | 1.58 | 5.83 | 0.48 | 0.09 | 7.50 | 2.15 | 000 | |
64550 | A | Apply neurostimulator | 0.18 | 0.56 | 0.05 | 0.01 | 0.75 | 0.24 | 000 | |
64553 | A | Implant neuroelectrodes | 2.31 | 1.89 | 1.27 | 0.17 | 4.37 | 3.75 | 010 | |
64555 | A | Implant neuroelectrodes | 2.27 | 2.47 | 0.64 | 0.11 | 4.85 | 3.02 | 010 | |
64560 | A | Implant neuroelectrodes | 2.36 | 2.43 | 0.71 | 0.17 | 4.96 | 3.24 | 010 | |
64561 | A | Implant neuroelectrodes | 6.74 | 15.24 | 3.78 | 0.11 | 22.09 | 10.63 | 010 | |
64565 | A | Implant neuroelectrodes | 1.76 | 3.26 | 0.66 | 0.08 | 5.10 | 2.50 | 010 | |
64573 | A | Implant neuroelectrodes | 7.50 | NA | 5.40 | 1.48 | NA | 14.38 | 090 | |
64575 | A | Implant neuroelectrodes | 4.35 | NA | 3.01 | 0.37 | NA | 7.73 | 090 | |
64577 | A | Implant neuroelectrodes | 4.62 | NA | 3.63 | 0.50 | NA | 8.75 | 090 | |
64580 | A | Implant neuroelectrodes | 4.12 | NA | 4.01 | 0.21 | NA | 8.34 | 090 | |
64581 | A | Implant neuroelectrodes | 13.50 | NA | 6.61 | 0.37 | NA | 20.48 | 090 | |
64585 | A | Revise/remove neuroelectrode | 2.06 | 3.38 | 2.09 | 0.29 | 5.73 | 4.44 | 010 | |
64590 | A | Implant neuroreceiver | 2.40 | NA | 2.24 | 0.40 | NA | 5.04 | 010 | |
64595 | A | Revise/remove neuroreceiver | 1.73 | NA | 1.91 | 0.22 | NA | 3.86 | 010 | |
64600 | A | Injection treatment of nerve | 3.45 | 9.19 | 1.50 | 0.28 | 12.92 | 5.23 | 010 | |
64605 | A | Injection treatment of nerve | 5.61 | 10.60 | 2.01 | 0.53 | 16.74 | 8.15 | 010 | |
64610 | A | Injection treatment of nerve | 7.16 | NA | 3.58 | 1.12 | NA | 11.86 | 010 | |
64612 | A | Destroy nerve, face muscle | 1.96 | 2.29 | 1.03 | 0.09 | 4.34 | 3.08 | 010 | |
64613 | A | Destroy nerve, spine muscle | 1.96 | 2.96 | 0.96 | 0.10 | 5.02 | 3.02 | 010 | |
64614 | A | Destroy nerve, extrem musc | 2.20 | 4.40 | 1.04 | 0.09 | 6.69 | 3.33 | 010 | |
64620 | A | Injection treatment of nerve | 2.84 | 6.13 | 1.10 | 0.17 | 9.14 | 4.11 | 010 | |
64622 | A | Destr paravertebrl nerve l/s | 3.00 | 8.53 | 1.17 | 0.17 | 11.70 | 4.34 | 010 | |
64623 | A | Destr paravertebral n add-on | 0.99 | 2.49 | 0.23 | 0.06 | 3.54 | 1.28 | ZZZ | |
64626 | A | Destr paravertebrl nerve c/t | 3.28 | 8.46 | 1.84 | 0.22 | 11.96 | 5.34 | 010 | |
64627 | A | Destr paravertebral n add-on | 1.16 | 2.70 | 0.27 | 0.08 | 3.94 | 1.51 | ZZZ | |
64630 | A | Injection treatment of nerve | 3.00 | 4.46 | 1.22 | 0.16 | 7.62 | 4.38 | 010 | |
64640 | A | Injection treatment of nerve | 2.76 | 6.72 | 1.70 | 0.11 | 9.59 | 4.57 | 010 | |
64680 | A | Injection treatment of nerve | 2.62 | 7.28 | 1.21 | 0.15 | 10.05 | 3.98 | 010 | |
64702 | A | Revise finger/toe nerve | 4.23 | NA | 3.99 | 0.51 | NA | 8.73 | 090 | |
64704 | A | Revise hand/foot nerve | 4.57 | NA | 3.22 | 0.59 | NA | 8.38 | 090 | |
64708 | A | Revise arm/leg nerve | 6.12 | NA | 5.12 | 0.82 | NA | 12.06 | 090 | |
64712 | A | Revision of sciatic nerve | 7.75 | NA | 5.27 | 0.54 | NA | 13.56 | 090 | |
64713 | A | Revision of arm nerve(s) | 11.00 | NA | 5.80 | 1.01 | NA | 17.81 | 090 | |
64714 | A | Revise low back nerve(s) | 10.33 | NA | 4.22 | 0.64 | NA | 15.19 | 090 | |
64716 | A | Revision of cranial nerve | 6.31 | NA | 4.97 | 0.59 | NA | 11.87 | 090 | |
64718 | A | Revise ulnar nerve at elbow | 5.99 | NA | 5.30 | 0.87 | NA | 12.16 | 090 | |
64719 | A | Revise ulnar nerve at wrist | 4.85 | NA | 4.77 | 0.63 | NA | 10.25 | 090 | |
64721 | A | Carpal tunnel surgery | 4.29 | 5.97 | 5.64 | 0.59 | 10.85 | 10.52 | 090 | |
64722 | A | Relieve pressure on nerve(s) | 4.70 | NA | 3.33 | 0.32 | NA | 8.35 | 090 | |
64726 | A | Release foot/toe nerve | 4.18 | NA | 3.09 | 0.57 | NA | 7.84 | 090 | |
64727 | A | Internal nerve revision | 3.10 | NA | 1.54 | 0.40 | NA | 5.04 | ZZZ | |
64732 | A | Incision of brow nerve | 4.41 | NA | 3.64 | 0.77 | NA | 8.82 | 090 | |
64734 | A | Incision of cheek nerve | 4.92 | NA | 3.65 | 0.83 | NA | 9.40 | 090 | |
64736 | A | Incision of chin nerve | 4.60 | NA | 2.95 | 0.71 | NA | 8.26 | 090 | |
64738 | A | Incision of jaw nerve | 5.73 | NA | 3.65 | 0.84 | NA | 10.22 | 090 | |
64740 | A | Incision of tongue nerve | 5.59 | NA | 3.82 | 0.43 | NA | 9.84 | 090 | |
64742 | A | Incision of facial nerve | 6.22 | NA | 4.71 | 0.69 | NA | 11.62 | 090 | |
64744 | A | Incise nerve, back of head | 5.24 | NA | 4.00 | 0.98 | NA | 10.22 | 090 | |
64746 | A | Incise diaphragm nerve | 5.93 | NA | 4.49 | 0.75 | NA | 11.17 | 090 | |
64752 | A | Incision of vagus nerve | 7.06 | NA | 4.70 | 0.83 | NA | 12.59 | 090 | |
64755 | A | Incision of stomach nerves | 13.52 | NA | 6.17 | 1.16 | NA | 20.85 | 090 | |
64760 | A | Incision of vagus nerve | 6.96 | NA | 4.02 | 0.51 | NA | 11.49 | 090 | |
64761 | A | Incision of pelvis nerve | 6.41 | NA | 3.63 | 0.26 | NA | 10.30 | 090 | |
64763 | A | Incise hip/thigh nerve | 6.93 | NA | 6.07 | 0.77 | NA | 13.77 | 090 | |
64766 | A | Incise hip/thigh nerve | 8.67 | NA | 5.68 | 0.99 | NA | 15.34 | 090 | |
64771 | A | Sever cranial nerve | 7.35 | NA | 5.62 | 1.32 | NA | 14.29 | 090 | |
64772 | A | Incision of spinal nerve | 7.21 | NA | 4.89 | 1.20 | NA | 13.30 | 090 | |
64774 | A | Remove skin nerve lesion | 5.17 | NA | 3.78 | 0.60 | NA | 9.55 | 090 | |
64776 | A | Remove digit nerve lesion | 5.12 | NA | 3.84 | 0.63 | NA | 9.59 | 090 | |
64778 | A | Digit nerve surgery add-on | 3.11 | NA | 1.54 | 0.38 | NA | 5.03 | ZZZ | |
64782 | A | Remove limb nerve lesion | 6.23 | NA | 3.72 | 0.79 | NA | 10.74 | 090 | |
64783 | A | Limb nerve surgery add-on | 3.72 | NA | 1.89 | 0.48 | NA | 6.09 | ZZZ | |
64784 | A | Remove nerve lesion | 9.82 | NA | 6.68 | 1.17 | NA | 17.67 | 090 | |
64786 | A | Remove sciatic nerve lesion | 15.46 | NA | 10.13 | 2.22 | NA | 27.81 | 090 | |
64787 | A | Implant nerve end | 4.30 | NA | 2.18 | 0.56 | NA | 7.04 | ZZZ | |
64788 | A | Remove skin nerve lesion | 4.61 | NA | 3.48 | 0.54 | NA | 8.63 | 090 | |
64790 | A | Removal of nerve lesion | 11.31 | NA | 7.29 | 1.68 | NA | 20.28 | 090 | |
64792 | A | Removal of nerve lesion | 14.92 | NA | 8.85 | 1.88 | NA | 25.65 | 090 | |
64795 | A | Biopsy of nerve | 3.01 | NA | 1.80 | 0.40 | NA | 5.21 | 000 | |
64802 | A | Remove sympathetic nerves | 9.15 | NA | 5.43 | 0.87 | NA | 15.45 | 090 | |
64804 | A | Remove sympathetic nerves | 14.64 | NA | 7.42 | 1.79 | NA | 23.85 | 090 | |
64809 | A | Remove sympathetic nerves | 13.67 | NA | 6.31 | 0.96 | NA | 20.94 | 090 | |
64818 | A | Remove sympathetic nerves | 10.30 | NA | 5.77 | 1.08 | NA | 17.15 | 090 | |
64820 | A | Remove sympathetic nerves | 10.37 | NA | 7.44 | 1.17 | NA | 18.98 | 090 | |
64821 | A | Remove sympathestic nerves | 8.75 | NA | 9.23 | 0.99 | NA | 18.97 | 090 | |
64822 | A | Remove sympathetic nerves | 8.75 | NA | 9.23 | 0.99 | NA | 18.97 | 090 | |
64823 | A | Remove sympathetic nerves | 10.37 | NA | 10.03 | 1.17 | NA | 21.57 | 090 | |
64831 | A | Repair of digit nerve | 9.44 | NA | 7.24 | 1.14 | NA | 17.82 | 090 | |
64832 | A | Repair nerve add-on | 5.66 | NA | 3.02 | 0.68 | NA | 9.36 | ZZZ | |
64834 | A | Repair of hand or foot nerve | 10.19 | NA | 7.18 | 1.23 | NA | 18.60 | 090 | |
64835 | A | Repair of hand or foot nerve | 10.94 | NA | 7.86 | 1.36 | NA | 20.16 | 090 | |
64836 | A | Repair of hand or foot nerve | 10.94 | NA | 7.83 | 1.32 | NA | 20.09 | 090 | |
64837 | A | Repair nerve add-on | 6.26 | NA | 3.31 | 0.80 | NA | 10.37 | ZZZ | |
64840 | A | Repair of leg nerve | 13.02 | NA | 8.34 | 0.86 | NA | 22.22 | 090 | |
64856 | A | Repair/transpose nerve | 13.80 | NA | 9.40 | 1.71 | NA | 24.91 | 090 | |
64857 | A | Repair arm/leg nerve | 14.49 | NA | 9.87 | 1.76 | NA | 26.12 | 090 | |
64858 | A | Repair sciatic nerve | 16.49 | NA | 10.82 | 2.78 | NA | 30.09 | 090 | |
64859 | A | Nerve surgery | 4.26 | NA | 2.25 | 0.50 | NA | 7.01 | ZZZ | |
64861 | A | Repair of arm nerves | 19.24 | NA | 12.64 | 2.45 | NA | 34.33 | 090 | |
64862 | A | Repair of low back nerves | 19.44 | NA | 12.26 | 2.47 | NA | 34.17 | 090 | |
64864 | A | Repair of facial nerve | 12.55 | NA | 8.52 | 1.13 | NA | 22.20 | 090 | |
64865 | A | Repair of facial nerve | 15.24 | NA | 10.09 | 1.37 | NA | 26.70 | 090 | |
64866 | A | Fusion of facial/other nerve | 15.74 | NA | 9.99 | 1.06 | NA | 26.79 | 090 | |
64868 | A | Fusion of facial/other nerve | 14.04 | NA | 9.32 | 1.40 | NA | 24.76 | 090 | |
64870 | A | Fusion of facial/other nerve | 15.99 | NA | 9.09 | 1.08 | NA | 26.16 | 090 | |
64872 | A | Subsequent repair of nerve | 1.99 | NA | 1.08 | 0.24 | NA | 3.31 | ZZZ | |
64874 | A | Repair revise nerve add-on | 2.98 | NA | 1.54 | 0.34 | NA | 4.86 | ZZZ | |
64876 | A | Repair nerve/shorten bone | 3.38 | NA | 1.31 | 0.39 | NA | 5.08 | ZZZ | |
64885 | A | Nerve graft, head or neck | 17.53 | NA | 11.16 | 1.51 | NA | 30.20 | 090 | |
64886 | A | Nerve graft, head or neck | 20.75 | NA | 13.07 | 1.73 | NA | 35.55 | 090 | |
64890 | A | Nerve graft, hand or foot | 15.15 | NA | 10.25 | 1.74 | NA | 27.14 | 090 | |
64891 | A | Nerve graft, hand or foot | 16.14 | NA | 7.75 | 1.38 | NA | 25.27 | 090 | |
64892 | A | Nerve graft, arm or leg | 14.65 | NA | 9.10 | 1.65 | NA | 25.40 | 090 | |
64893 | A | Nerve graft, arm or leg | 15.60 | NA | 10.05 | 1.77 | NA | 27.42 | 090 | |
64895 | A | Nerve graft, hand or foot | 19.25 | NA | 9.82 | 2.04 | NA | 31.11 | 090 | |
64896 | A | Nerve graft, hand or foot | 20.49 | NA | 11.11 | 1.85 | NA | 33.45 | 090 | |
64897 | A | Nerve graft, arm or leg | 18.24 | NA | 10.91 | 2.64 | NA | 31.79 | 090 | |
64898 | A | Nerve graft, arm or leg | 19.50 | NA | 11.88 | 2.71 | NA | 34.09 | 090 | |
64901 | A | Nerve graft add-on | 10.22 | NA | 5.41 | 0.99 | NA | 16.62 | ZZZ | |
64902 | A | Nerve graft add-on | 11.83 | NA | 6.13 | 1.10 | NA | 19.06 | ZZZ | |
64905 | A | Nerve pedicle transfer | 14.02 | NA | 8.94 | 1.52 | NA | 24.48 | 090 | |
64907 | A | Nerve pedicle transfer | 18.83 | NA | 12.38 | 1.79 | NA | 33.00 | 090 | |
64999 | C | Nervous system surgery | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
65091 | A | Revise eye | 6.46 | NA | 11.28 | 0.26 | NA | 18.00 | 090 | |
65093 | A | Revise eye with implant | 6.87 | NA | 11.50 | 0.28 | NA | 18.65 | 090 | |
65101 | A | Removal of eye | 7.03 | NA | 11.59 | 0.28 | NA | 18.90 | 090 | |
65103 | A | Remove eye/insert implant | 7.57 | NA | 11.74 | 0.30 | NA | 19.61 | 090 | |
65105 | A | Remove eye/attach implant | 8.49 | NA | 12.24 | 0.34 | NA | 21.07 | 090 | |
65110 | A | Removal of eye | 13.95 | NA | 15.29 | 0.68 | NA | 29.92 | 090 | |
65112 | A | Remove eye/revise socket | 16.38 | NA | 17.54 | 0.96 | NA | 34.88 | 090 | |
65114 | A | Remove eye/revise socket | 17.53 | NA | 17.50 | 0.94 | NA | 35.97 | 090 | |
65125 | A | Revise ocular implant | 3.12 | 5.96 | 1.45 | 0.15 | 9.23 | 4.72 | 090 | |
65130 | A | Insert ocular implant | 7.15 | NA | 11.22 | 0.28 | NA | 18.65 | 090 | |
65135 | A | Insert ocular implant | 7.33 | NA | 11.43 | 0.29 | NA | 19.05 | 090 | |
65140 | A | Attach ocular implant | 8.02 | NA | 11.71 | 0.31 | NA | 20.04 | 090 | |
65150 | A | Revise ocular implant | 6.26 | NA | 10.75 | 0.25 | NA | 17.26 | 090 | |
65155 | A | Reinsert ocular implant | 8.66 | NA | 12.54 | 0.40 | NA | 21.60 | 090 | |
65175 | A | Removal of ocular implant | 6.28 | NA | 10.82 | 0.26 | NA | 17.36 | 090 | |
65205 | A | Remove foreign body from eye | 0.71 | 0.62 | 0.19 | 0.03 | 1.36 | 0.93 | 000 | |
65210 | A | Remove foreign body from eye | 0.84 | 0.77 | 0.30 | 0.03 | 1.64 | 1.17 | 000 | |
65220 | A | Remove foreign body from eye | 0.71 | 8.06 | 0.18 | 0.05 | 8.82 | 0.94 | 000 | |
65222 | A | Remove foreign body from eye | 0.93 | 0.78 | 0.28 | 0.04 | 1.75 | 1.25 | 000 | |
65235 | A | Remove foreign body from eye | 7.57 | NA | 6.84 | 0.30 | NA | 14.71 | 090 | |
65260 | A | Remove foreign body from eye | 10.96 | NA | 12.38 | 0.43 | NA | 23.77 | 090 | |
65265 | A | Remove foreign body from eye | 12.59 | NA | 13.88 | 0.50 | NA | 26.97 | 090 | |
65270 | A | Repair of eye wound | 1.90 | 3.97 | 2.31 | 0.08 | 5.95 | 4.29 | 010 | |
65272 | A | Repair of eye wound | 3.82 | 5.59 | 4.64 | 0.16 | 9.57 | 8.62 | 090 | |
65273 | A | Repair of eye wound | 4.36 | NA | 4.98 | 0.17 | NA | 9.51 | 090 | |
65275 | A | Repair of eye wound | 5.34 | 5.56 | 5.08 | 0.27 | 11.17 | 10.69 | 090 | |
65280 | A | Repair of eye wound | 7.66 | NA | 7.64 | 0.30 | NA | 15.60 | 090 | |
65285 | A | Repair of eye wound | 12.90 | NA | 13.46 | 0.51 | NA | 26.87 | 090 | |
65286 | A | Repair of eye wound | 5.51 | 8.82 | 7.61 | 0.21 | 14.54 | 13.33 | 090 | |
65290 | A | Repair of eye socket wound | 5.41 | NA | 6.27 | 0.26 | NA | 11.94 | 090 | |
65400 | A | Removal of eye lesion | 6.06 | 8.38 | 6.91 | 0.24 | 14.68 | 13.21 | 090 | |
65410 | A | Biopsy of cornea | 1.47 | 1.71 | 0.67 | 0.06 | 3.24 | 2.20 | 000 | |
65420 | A | Removal of eye lesion | 4.17 | 8.08 | 6.97 | 0.17 | 12.42 | 11.31 | 090 | |
65426 | A | Removal of eye lesion | 5.25 | 7.80 | 6.54 | 0.20 | 13.25 | 11.99 | 090 | |
65430 | A | Corneal smear | 1.47 | 8.34 | 0.68 | 0.06 | 9.87 | 2.21 | 000 | |
65435 | A | Curette/treat cornea | 0.92 | 1.33 | 0.40 | 0.04 | 2.29 | 1.36 | 000 | |
65436 | A | Curette/treat cornea | 4.19 | 5.81 | 4.86 | 0.17 | 10.17 | 9.22 | 090 | |
65450 | A | Treatment of corneal lesion | 3.27 | 7.76 | 6.57 | 0.13 | 11.16 | 9.97 | 090 | |
65600 | A | Revision of cornea | 3.40 | 5.39 | 1.43 | 0.14 | 8.93 | 4.97 | 090 | |
65710 | A | Corneal transplant | 12.35 | NA | 12.72 | 0.49 | NA | 25.56 | 090 | |
65730 | A | Corneal transplant | 14.25 | NA | 11.77 | 0.56 | NA | 26.58 | 090 | |
65750 | A | Corneal transplant | 15.00 | NA | 14.13 | 0.59 | NA | 29.72 | 090 | |
65755 | A | Corneal transplant | 14.89 | NA | 14.04 | 0.58 | NA | 29.51 | 090 | |
65760 | N | Revision of cornea | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
65765 | N | Revision of cornea | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
65767 | N | Corneal tissue transplant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
65770 | A | Revise cornea with implant | 17.56 | NA | 15.06 | 0.69 | NA | 33.31 | 090 | |
65771 | N | Radial keratotomy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
65772 | A | Correction of astigmatism | 4.29 | 7.24 | 6.24 | 0.17 | 11.70 | 10.70 | 090 | |
65775 | A | Correction of astigmatism | 5.79 | NA | 8.38 | 0.22 | NA | 14.39 | 090 | |
65800 | A | Drainage of eye | 1.91 | 2.26 | 1.40 | 0.08 | 4.25 | 3.39 | 000 | |
65805 | A | Drainage of eye | 1.91 | 2.26 | 1.41 | 0.08 | 4.25 | 3.40 | 000 | |
65810 | A | Drainage of eye | 4.87 | NA | 8.65 | 0.19 | NA | 13.71 | 090 | |
65815 | A | Drainage of eye | 5.05 | 9.08 | 7.88 | 0.20 | 14.33 | 13.13 | 090 | |
65820 | A | Relieve inner eye pressure | 8.13 | NA | 10.64 | 0.32 | NA | 19.09 | 090 | |
65850 | A | Incision of eye | 10.52 | NA | 9.99 | 0.41 | NA | 20.92 | 090 | |
65855 | A | Laser surgery of eye | 3.85 | 5.01 | 3.56 | 0.17 | 9.03 | 7.58 | 010 | |
65860 | A | Incise inner eye adhesions | 3.55 | 4.01 | 3.07 | 0.14 | 7.70 | 6.76 | 090 | |
65865 | A | Incise inner eye adhesions | 5.60 | NA | 6.69 | 0.22 | NA | 12.51 | 090 | |
65870 | A | Incise inner eye adhesions | 6.27 | NA | 7.02 | 0.24 | NA | 13.53 | 090 | |
65875 | A | Incise inner eye adhesions | 6.54 | NA | 7.12 | 0.25 | NA | 13.91 | 090 | |
65880 | A | Incise inner eye adhesions | 7.09 | NA | 7.38 | 0.28 | NA | 14.75 | 090 | |
65900 | A | Remove eye lesion | 10.93 | NA | 12.48 | 0.46 | NA | 23.87 | 090 | |
65920 | A | Remove implant of eye | 8.40 | NA | 7.99 | 0.33 | NA | 16.72 | 090 | |
65930 | A | Remove blood clot from eye | 7.44 | NA | 8.56 | 0.29 | NA | 16.29 | 090 | |
66020 | A | Injection treatment of eye | 1.59 | 2.36 | 1.52 | 0.07 | 4.02 | 3.18 | 010 | |
66030 | A | Injection treatment of eye | 1.25 | 2.20 | 1.35 | 0.05 | 3.50 | 2.65 | 010 | |
66130 | A | Remove eye lesion | 7.69 | 7.39 | 6.48 | 0.31 | 15.39 | 14.48 | 090 | |
66150 | A | Glaucoma surgery | 8.30 | NA | 10.61 | 0.33 | NA | 19.24 | 090 | |
66155 | A | Glaucoma surgery | 8.29 | NA | 10.58 | 0.32 | NA | 19.19 | 090 | |
66160 | A | Glaucoma surgery | 10.17 | NA | 11.44 | 0.41 | NA | 22.02 | 090 | |
66165 | A | Glaucoma surgery | 8.01 | NA | 10.44 | 0.31 | NA | 18.76 | 090 | |
66170 | A | Glaucoma surgery | 12.16 | NA | 16.52 | 0.48 | NA | 29.16 | 090 | |
66172 | A | Incision of eye | 15.04 | NA | 15.12 | 0.59 | NA | 30.75 | 090 | |
66180 | A | Implant eye shunt | 14.55 | NA | 12.04 | 0.57 | NA | 27.16 | 090 | |
66185 | A | Revise eye shunt | 8.14 | NA | 8.23 | 0.32 | NA | 16.69 | 090 | |
66220 | A | Repair eye lesion | 7.77 | NA | 9.93 | 0.32 | NA | 18.02 | 090 | |
66225 | A | Repair/graft eye lesion | 11.05 | NA | 9.31 | 0.44 | NA | 20.80 | 090 | |
66250 | A | Follow-up surgery of eye | 5.98 | 7.79 | 6.33 | 0.23 | 14.00 | 12.54 | 090 | |
66500 | A | Incision of iris | 3.71 | NA | 4.65 | 0.15 | NA | 8.51 | 090 | |
66505 | A | Incision of iris | 4.08 | NA | 4.80 | 0.17 | NA | 9.05 | 090 | |
66600 | A | Remove iris and lesion | 8.68 | NA | 8.62 | 0.34 | NA | 17.64 | 090 | |
66605 | A | Removal of iris | 12.79 | NA | 12.14 | 0.61 | NA | 25.54 | 090 | |
66625 | A | Removal of iris | 5.13 | 7.62 | 6.59 | 0.20 | 12.95 | 11.92 | 090 | |
66630 | A | Removal of iris | 6.16 | NA | 7.50 | 0.24 | NA | 13.90 | 090 | |
66635 | A | Removal of iris | 6.25 | NA | 6.46 | 0.24 | NA | 12.95 | 090 | |
66680 | A | Repair iris ciliary body | 5.44 | NA | 6.06 | 0.21 | NA | 11.71 | 090 | |
66682 | A | Repair iris ciliary body | 6.21 | NA | 7.51 | 0.24 | NA | 13.96 | 090 | |
66700 | A | Destruction, ciliary body | 4.78 | 5.44 | 4.27 | 0.19 | 10.41 | 9.24 | 090 | |
66710 | A | Destruction, ciliary body | 4.78 | 5.14 | 3.81 | 0.18 | 10.11 | 8.76 | 090 | |
66720 | A | Destruction, ciliary body | 4.78 | 5.45 | 4.49 | 0.19 | 10.42 | 9.34 | 090 | |
66740 | A | Destruction, ciliary body | 4.78 | NA | 4.84 | 0.18 | NA | 10.76 | 090 | |
66761 | A | Revision of iris | 4.07 | 5.25 | 3.98 | 0.16 | 10.48 | 9.18 | 090 | |
66762 | A | Revision of iris | 4.58 | 5.33 | 3.97 | 0.18 | 9.99 | 9.70 | 090 | |
66770 | A | Removal of inner eye lesion | 5.18 | 5.76 | 4.48 | 0.20 | 12.14 | 10.84 | 090 | |
66820 | A | Incision, secondary cataract | 3.89 | NA | 8.19 | 0.16 | NA | 12.24 | 090 | |
66821 | A | After cataract laser surgery | 2.35 | 3.78 | 3.34 | 0.10 | 6.23 | 5.79 | 090 | |
66825 | A | Reposition intraocular lens | 8.23 | NA | 10.19 | 0.32 | NA | 18.74 | 090 | |
66830 | A | Removal of lens lesion | 8.20 | NA | 6.83 | 0.32 | NA | 15.35 | 090 | |
66840 | A | Removal of lens material | 7.91 | NA | 6.74 | 0.31 | NA | 14.96 | 090 | |
66850 | A | Removal of lens material | 9.11 | NA | 7.26 | 0.36 | NA | 16.73 | 090 | |
66852 | A | Removal of lens material | 9.97 | NA | 7.72 | 0.39 | NA | 18.08 | 090 | |
66920 | A | Extraction of lens | 8.86 | NA | 7.19 | 0.35 | NA | 16.40 | 090 | |
66930 | A | Extraction of lens | 10.18 | NA | 8.68 | 0.41 | NA | 19.27 | 090 | |
66940 | A | Extraction of lens | 8.93 | NA | 8.12 | 0.35 | NA | 17.40 | 090 | |
66982 | A | Cataract surgery, complex | 13.50 | NA | 9.09 | 0.56 | NA | 23.15 | 090 | |
66983 | A | Cataract surg w/iol, 1 stage | 8.99 | NA | 5.88 | 0.37 | NA | 15.24 | 090 | |
66984 | A | Cataract surg w/iol, 1 stage | 10.23 | NA | 7.59 | 0.41 | NA | 18.23 | 090 | |
66985 | A | Insert lens prosthesis | 8.39 | NA | 6.82 | 0.33 | NA | 15.54 | 090 | |
66986 | A | Exchange lens prosthesis | 12.28 | NA | 8.57 | 0.49 | NA | 21.34 | 090 | |
66990 | A | Ophthalmic endoscope add-on | 1.51 | NA | 0.70 | 0.06 | NA | 2.27 | ZZZ | |
66999 | C | Eye surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
67005 | A | Partial removal of eye fluid | 5.70 | NA | 2.65 | 0.22 | NA | 8.57 | 090 | |
67010 | A | Partial removal of eye fluid | 6.87 | NA | 3.20 | 0.27 | NA | 10.34 | 090 | |
67015 | A | Release of eye fluid | 6.92 | NA | 8.12 | 0.27 | NA | 15.31 | 090 | |
67025 | A | Replace eye fluid | 6.84 | 16.76 | 7.51 | 0.27 | 23.87 | 14.62 | 090 | |
67027 | A | Implant eye drug system | 10.85 | 14.10 | 8.71 | 0.46 | 25.41 | 20.02 | 090 | |
67028 | A | Injection eye drug | 2.52 | 10.43 | 1.16 | 0.11 | 13.06 | 3.79 | 000 | |
67030 | A | Incise inner eye strands | 4.84 | NA | 6.72 | 0.19 | NA | 11.75 | 090 | |
67031 | A | Laser surgery, eye strands | 3.67 | 4.08 | 3.13 | 0.15 | 7.90 | 6.95 | 090 | |
67036 | A | Removal of inner eye fluid | 11.89 | NA | 8.99 | 0.47 | NA | 21.35 | 090 | |
67038 | A | Strip retinal membrane | 21.24 | NA | 15.45 | 0.84 | NA | 37.53 | 090 | |
67039 | A | Laser treatment of retina | 14.52 | NA | 12.33 | 0.57 | NA | 27.42 | 090 | |
67040 | A | Laser treatment of retina | 17.23 | NA | 13.59 | 0.68 | NA | 31.50 | 090 | |
67101 | A | Repair detached retina | 7.53 | 10.94 | 8.87 | 0.29 | 18.76 | 16.69 | 090 | |
67105 | A | Repair detached retina | 7.41 | 7.56 | 5.54 | 0.29 | 15.26 | 13.24 | 090 | |
67107 | A | Repair detached retina | 14.84 | NA | 13.18 | 0.58 | NA | 28.60 | 090 | |
67108 | A | Repair detached retina | 20.82 | NA | 17.69 | 0.82 | NA | 39.33 | 090 | |
67110 | A | Repair detached retina | 8.81 | 20.18 | 10.29 | 0.35 | 29.34 | 19.45 | 090 | |
67112 | A | Rerepair detached retina | 16.86 | NA | 15.69 | 0.66 | NA | 33.21 | 090 | |
67115 | A | Release encircling material | 4.99 | NA | 6.81 | 0.19 | NA | 11.99 | 090 | |
67120 | A | Remove eye implant material | 5.98 | 16.07 | 7.12 | 0.23 | 22.28 | 13.33 | 090 | |
67121 | A | Remove eye implant material | 10.67 | NA | 12.10 | 0.42 | NA | 23.19 | 090 | |
67141 | A | Treatment of retina | 5.20 | 8.03 | 6.95 | 0.20 | 13.43 | 12.35 | 090 | |
67145 | A | Treatment of retina | 5.37 | 5.27 | 4.16 | 0.21 | 10.85 | 9.74 | 090 | |
67208 | A | Treatment of retinal lesion | 6.70 | 8.36 | 7.13 | 0.26 | 15.32 | 14.09 | 090 | |
67210 | A | Treatment of retinal lesion | 8.82 | 7.26 | 5.74 | 0.35 | 16.43 | 14.91 | 090 | |
67218 | A | Treatment of retinal lesion | 18.53 | NA | 15.79 | 0.53 | NA | 34.85 | 090 | |
67220 | A | Treatment of choroid lesion | 13.13 | 10.81 | 9.62 | 0.51 | 24.45 | 23.26 | 090 | |
67221 | A | Ocular photodynamic ther | 4.01 | 4.63 | 1.88 | 0.16 | 8.80 | 6.05 | 000 | |
67225 | A | Eye photodynamic ther add-on | 0.47 | 0.28 | 0.21 | 0.01 | 0.76 | 0.69 | ZZZ | |
67227 | A | Treatment of retinal lesion | 6.58 | 9.10 | 7.15 | 0.26 | 15.94 | 13.99 | 090 | |
67228 | A | Treatment of retinal lesion | 12.74 | 9.84 | 7.21 | 0.50 | 23.08 | 20.45 | 090 | |
67250 | A | Reinforce eye wall | 8.66 | NA | 11.67 | 0.36 | NA | 20.69 | 090 | |
67255 | A | Reinforce/graft eye wall | 8.90 | NA | 11.84 | 0.35 | NA | 21.09 | 090 | |
67299 | C | Eye surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
67311 | A | Revise eye muscle | 6.65 | NA | 6.15 | 0.27 | NA | 13.07 | 090 | |
67312 | A | Revise two eye muscles | 8.54 | NA | 7.20 | 0.35 | NA | 16.09 | 090 | |
67314 | A | Revise eye muscle | 7.52 | NA | 6.72 | 0.30 | NA | 14.54 | 090 | |
67316 | A | Revise two eye muscles | 9.66 | NA | 7.70 | 0.40 | NA | 17.76 | 090 | |
67318 | A | Revise eye muscle(s) | 7.85 | NA | 7.11 | 0.31 | NA | 15.27 | 090 | |
67320 | A | Revise eye muscle(s) add-on | 4.33 | NA | 2.01 | 0.17 | NA | 6.51 | ZZZ | |
67331 | A | Eye surgery follow-up add-on | 4.06 | NA | 1.94 | 0.17 | NA | 6.17 | ZZZ | |
67332 | A | Rerevise eye muscles add-on | 4.49 | NA | 2.08 | 0.18 | NA | 6.75 | ZZZ | |
67334 | A | Revise eye muscle w/suture | 3.98 | NA | 1.84 | 0.16 | NA | 5.98 | ZZZ | |
67335 | A | Eye suture during surgery | 2.49 | NA | 1.15 | 0.10 | NA | 3.74 | ZZZ | |
67340 | A | Revise eye muscle add-on | 4.93 | NA | 2.28 | 0.19 | NA | 7.40 | ZZZ | |
67343 | A | Release eye tissue | 7.35 | NA | 7.00 | 0.30 | NA | 14.65 | 090 | |
67345 | A | Destroy nerve of eye muscle | 2.96 | 4.33 | 1.34 | 0.13 | 7.42 | 4.43 | 010 | |
67350 | A | Biopsy eye muscle | 2.87 | NA | 1.93 | 0.13 | NA | 4.93 | 000 | |
67399 | C | Eye muscle surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
67400 | A | Explore/biopsy eye socket | 9.76 | NA | 13.39 | 0.43 | NA | 23.58 | 090 | |
67405 | A | Explore/drain eye socket | 7.93 | NA | 12.30 | 0.36 | NA | 20.59 | 090 | |
67412 | A | Explore/treat eye socket | 9.50 | NA | 15.45 | 0.41 | NA | 25.36 | 090 | |
67413 | A | Explore/treat eye socket | 10.00 | NA | 13.35 | 0.43 | NA | 23.78 | 090 | |
67414 | A | Explr/decompress eye socket | 11.13 | NA | 16.37 | 0.48 | NA | 27.98 | 090 | |
67415 | A | Aspiration, orbital contents | 1.76 | NA | 0.79 | 0.09 | NA | 2.64 | 000 | |
67420 | A | Explore/treat eye socket | 20.06 | NA | 20.10 | 0.84 | NA | 41.00 | 090 | |
67430 | A | Explore/treat eye socket | 13.39 | NA | 17.12 | 0.97 | NA | 31.48 | 090 | |
67440 | A | Explore/drain eye socket | 13.09 | NA | 16.53 | 0.58 | NA | 30.20 | 090 | |
67445 | A | Explr/decompress eye socket | 14.42 | NA | 17.65 | 0.63 | NA | 32.70 | 090 | |
67450 | A | Explore/biopsy eye socket | 13.51 | NA | 16.68 | 0.56 | NA | 30.75 | 090 | |
67500 | A | Inject/treat eye socket | 0.79 | 0.84 | 0.19 | 0.04 | 1.67 | 1.02 | 000 | |
67505 | A | Inject/treat eye socket | 0.82 | 0.93 | 0.21 | 0.04 | 1.79 | 1.07 | 000 | |
67515 | A | Inject/treat eye socket | 0.61 | 0.84 | 0.28 | 0.02 | 1.47 | 0.91 | 000 | |
67550 | A | Insert eye socket implant | 10.19 | NA | 13.19 | 0.50 | NA | 23.88 | 090 | |
67560 | A | Revise eye socket implant | 10.60 | NA | 13.05 | 0.47 | NA | 24.12 | 090 | |
67570 | A | Decompress optic nerve | 13.58 | NA | 17.13 | 0.69 | NA | 31.40 | 090 | |
67599 | C | Orbit surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
67700 | A | Drainage of eyelid abscess | 1.35 | 7.46 | 0.58 | 0.06 | 8.87 | 1.99 | 010 | |
67710 | A | Incision of eyelid | 1.02 | 7.61 | 0.48 | 0.04 | 8.67 | 1.54 | 010 | |
67715 | A | Incision of eyelid fold | 1.22 | NA | 0.57 | 0.05 | NA | 1.84 | 010 | |
67800 | A | Remove eyelid lesion | 1.38 | 2.58 | 0.64 | 0.06 | 4.02 | 2.08 | 010 | |
67801 | A | Remove eyelid lesions | 1.88 | 7.91 | 0.88 | 0.08 | 9.87 | 2.84 | 010 | |
67805 | A | Remove eyelid lesions | 2.22 | 8.08 | 1.03 | 0.09 | 10.39 | 3.34 | 010 | |
67808 | A | Remove eyelid lesion(s) | 3.80 | NA | 4.16 | 0.17 | NA | 8.13 | 090 | |
67810 | A | Biopsy of eyelid | 1.48 | 5.52 | 0.70 | 0.06 | 7.06 | 2.24 | 000 | |
67820 | A | Revise eyelashes | 0.89 | 1.96 | 0.38 | 0.04 | 2.89 | 1.31 | 000 | |
67825 | A | Revise eyelashes | 1.38 | 5.49 | 1.03 | 0.06 | 6.93 | 2.47 | 010 | |
67830 | A | Revise eyelashes | 1.70 | 11.06 | 2.11 | 0.07 | 12.83 | 3.88 | 010 | |
67835 | A | Revise eyelashes | 5.56 | NA | 4.65 | 0.22 | NA | 10.43 | 090 | |
67840 | A | Remove eyelid lesion | 2.04 | 7.87 | 0.96 | 0.08 | 9.99 | 3.08 | 010 | |
67850 | A | Treat eyelid lesion | 1.69 | 9.04 | 2.06 | 0.07 | 10.80 | 3.82 | 010 | |
67875 | A | Closure of eyelid by suture | 1.35 | 11.20 | 2.08 | 0.06 | 12.61 | 3.49 | 000 | |
67880 | A | Revision of eyelid | 3.80 | 12.26 | 3.13 | 0.16 | 16.22 | 7.09 | 090 | |
67882 | A | Revision of eyelid | 5.07 | 14.08 | 4.62 | 0.21 | 19.36 | 9.90 | 090 | |
67900 | A | Repair brow defect | 6.14 | 10.96 | 6.46 | 0.30 | 17.40 | 12.90 | 090 | |
67901 | A | Repair eyelid defect | 6.97 | NA | 6.80 | 0.32 | NA | 14.09 | 090 | |
67902 | A | Repair eyelid defect | 7.03 | NA | 6.88 | 0.34 | NA | 14.25 | 090 | |
67903 | A | Repair eyelid defect | 6.37 | 12.11 | 7.18 | 0.39 | 18.87 | 13.94 | 090 | |
67904 | A | Repair eyelid defect | 6.26 | 14.38 | 8.10 | 0.26 | 20.90 | 14.62 | 090 | |
67906 | A | Repair eyelid defect | 6.79 | 9.57 | 6.37 | 0.42 | 16.78 | 13.58 | 090 | |
67908 | A | Repair eyelid defect | 5.13 | 9.32 | 6.10 | 0.20 | 14.65 | 11.43 | 090 | |
67909 | A | Revise eyelid defect | 5.40 | 9.94 | 6.58 | 0.25 | 15.59 | 12.23 | 090 | |
67911 | A | Revise eyelid defect | 5.27 | NA | 6.68 | 0.23 | NA | 12.18 | 090 | |
67914 | A | Repair eyelid defect | 3.68 | 12.71 | 3.56 | 0.16 | 16.55 | 7.40 | 090 | |
67915 | A | Repair eyelid defect | 3.18 | 11.26 | 1.48 | 0.13 | 14.57 | 4.79 | 090 | |
67916 | A | Repair eyelid defect | 5.31 | 15.80 | 5.33 | 0.22 | 21.33 | 10.86 | 090 | |
67917 | A | Repair eyelid defect | 6.02 | 10.26 | 6.60 | 0.25 | 16.53 | 12.87 | 090 | |
67921 | A | Repair eyelid defect | 3.40 | 12.44 | 3.35 | 0.14 | 15.98 | 6.89 | 090 | |
67922 | A | Repair eyelid defect | 3.06 | 11.23 | 3.16 | 0.13 | 14.42 | 6.35 | 090 | |
67923 | A | Repair eyelid defect | 5.88 | 14.92 | 5.42 | 0.24 | 21.04 | 11.54 | 090 | |
67924 | A | Repair eyelid defect | 5.79 | 9.60 | 5.96 | 0.23 | 15.62 | 11.98 | 090 | |
67930 | A | Repair eyelid wound | 3.61 | 12.28 | 3.05 | 0.17 | 16.06 | 6.83 | 010 | |
67935 | A | Repair eyelid wound | 6.22 | 15.02 | 5.40 | 0.29 | 21.53 | 11.91 | 090 | |
67938 | A | Remove eyelid foreign body | 1.33 | 9.40 | 0.51 | 0.06 | 10.79 | 1.90 | 010 | |
67950 | A | Revision of eyelid | 5.82 | 8.75 | 7.27 | 0.30 | 14.87 | 13.39 | 090 | |
67961 | A | Revision of eyelid | 5.69 | 9.12 | 5.75 | 0.26 | 15.07 | 11.70 | 090 | |
67966 | A | Revision of eyelid | 6.57 | 8.80 | 5.89 | 0.33 | 15.70 | 12.79 | 090 | |
67971 | A | Reconstruction of eyelid | 9.79 | NA | 7.53 | 0.42 | NA | 17.74 | 090 | |
67973 | A | Reconstruction of eyelid | 12.87 | NA | 9.54 | 0.59 | NA | 23.00 | 090 | |
67974 | A | Reconstruction of eyelid | 12.84 | NA | 9.45 | 0.54 | NA | 22.83 | 090 | |
67975 | A | Reconstruction of eyelid | 9.13 | NA | 7.20 | 0.38 | NA | 16.71 | 090 | |
67999 | C | Revision of eyelid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
68020 | A | Incise/drain eyelid lining | 1.37 | 7.52 | 0.63 | 0.06 | 8.95 | 2.06 | 010 | |
68040 | A | Treatment of eyelid lesions | 0.85 | 7.38 | 0.39 | 0.03 | 8.26 | 1.27 | 000 | |
68100 | A | Biopsy of eyelid lining | 1.35 | 7.59 | 0.62 | 0.06 | 9.00 | 2.03 | 000 | |
68110 | A | Remove eyelid lining lesion | 1.77 | 8.64 | 1.35 | 0.07 | 10.48 | 3.19 | 010 | |
68115 | A | Remove eyelid lining lesion | 2.36 | 8.14 | 1.09 | 0.10 | 10.60 | 3.55 | 010 | |
68130 | A | Remove eyelid lining lesion | 4.93 | NA | 2.30 | 0.19 | NA | 7.42 | 090 | |
68135 | A | Remove eyelid lining lesion | 1.84 | 7.89 | 0.86 | 0.07 | 9.80 | 2.77 | 010 | |
68200 | A | Treat eyelid by injection | 0.49 | 0.74 | 0.23 | 0.02 | 1.25 | 0.74 | 000 | |
68320 | A | Revise/graft eyelid lining | 5.37 | 5.56 | 5.14 | 0.21 | 11.14 | 10.72 | 090 | |
68325 | A | Revise/graft eyelid lining | 7.36 | NA | 6.16 | 0.30 | NA | 13.82 | 090 | |
68326 | A | Revise/graft eyelid lining | 7.15 | NA | 6.03 | 0.30 | NA | 13.48 | 090 | |
68328 | A | Revise/graft eyelid lining | 8.18 | NA | 6.79 | 0.40 | NA | 15.37 | 090 | |
68330 | A | Revise eyelid lining | 4.83 | 7.04 | 5.53 | 0.19 | 12.06 | 10.55 | 090 | |
68335 | A | Revise/graft eyelid lining | 7.19 | NA | 5.48 | 0.29 | NA | 12.96 | 090 | |
68340 | A | Separate eyelid adhesions | 4.17 | 14.49 | 4.17 | 0.17 | 18.83 | 8.51 | 090 | |
68360 | A | Revise eyelid lining | 4.37 | 6.58 | 5.23 | 0.17 | 11.12 | 9.77 | 090 | |
68362 | A | Revise eyelid lining | 7.34 | NA | 7.82 | 0.29 | NA | 15.45 | 090 | |
68399 | C | Eyelid lining surgery | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
68400 | A | Incise/drain tear gland | 1.69 | 11.17 | 2.13 | 0.07 | 12.93 | 3.89 | 010 | |
68420 | A | Incise/drain tear sac | 2.30 | 11.50 | 2.44 | 0.10 | 13.90 | 4.84 | 010 | |
68440 | A | Incise tear duct opening | 0.94 | 7.52 | 0.44 | 0.04 | 8.50 | 1.42 | 010 | |
68500 | A | Removal of tear gland | 11.02 | NA | 9.59 | 0.60 | NA | 21.21 | 090 | |
68505 | A | Partial removal, tear gland | 10.94 | NA | 10.69 | 0.57 | NA | 22.20 | 090 | |
68510 | A | Biopsy of tear gland | 4.61 | 12.31 | 2.15 | 0.19 | 17.11 | 6.95 | 000 | |
68520 | A | Removal of tear sac | 7.51 | NA | 7.17 | 0.33 | NA | 15.01 | 090 | |
68525 | A | Biopsy of tear sac | 4.43 | NA | 2.07 | 0.18 | NA | 6.68 | 000 | |
68530 | A | Clearance of tear duct | 3.66 | 13.81 | 3.00 | 0.16 | 17.63 | 6.82 | 010 | |
68540 | A | Remove tear gland lesion | 10.60 | NA | 9.17 | 0.46 | NA | 20.23 | 090 | |
68550 | A | Remove tear gland lesion | 13.26 | NA | 11.19 | 0.66 | NA | 25.11 | 090 | |
68700 | A | Repair tear ducts | 6.60 | NA | 6.64 | 0.27 | NA | 13.51 | 090 | |
68705 | A | Revise tear duct opening | 2.06 | 8.07 | 0.97 | 0.08 | 10.21 | 3.11 | 010 | |
68720 | A | Create tear sac drain | 8.96 | NA | 7.78 | 0.38 | NA | 17.12 | 090 | |
68745 | A | Create tear duct drain | 8.63 | NA | 7.66 | 0.38 | NA | 16.67 | 090 | |
68750 | A | Create tear duct drain | 8.66 | NA | 8.17 | 0.37 | NA | 17.20 | 090 | |
68760 | A | Close tear duct opening | 1.73 | 6.49 | 1.19 | 0.07 | 8.29 | 2.99 | 010 | |
68761 | A | Close tear duct opening | 1.36 | 3.00 | 0.95 | 0.06 | 4.42 | 2.37 | 010 | |
68770 | A | Close tear system fistula | 7.02 | 16.24 | 5.98 | 0.28 | 23.54 | 13.28 | 090 | |
68801 | A | Dilate tear duct opening | 0.94 | 0.85 | 0.56 | 0.04 | 1.83 | 1.54 | 010 | |
68810 | A | Probe nasolacrimal duct | 1.90 | 2.40 | 0.88 | 0.08 | 4.38 | 2.86 | 010 | |
68811 | A | Probe nasolacrimal duct | 2.35 | NA | 2.39 | 0.10 | NA | 4.84 | 010 | |
68815 | A | Probe nasolacrimal duct | 3.20 | 12.25 | 2.83 | 0.14 | 15.59 | 6.17 | 010 | |
68840 | A | Explore/irrigate tear ducts | 1.25 | 1.56 | 0.93 | 0.05 | 2.86 | 2.23 | 010 | |
68850 | A | Injection for tear sac x-ray | 0.80 | 14.94 | 0.31 | 0.03 | 15.77 | 1.14 | 000 | |
68899 | C | Tear duct system surgery | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
69000 | A | Drain external ear lesion | 1.45 | 2.10 | 0.55 | 0.10 | 3.65 | 2.10 | 010 | |
69005 | A | Drain external ear lesion | 2.11 | 2.53 | 2.01 | 0.16 | 4.80 | 4.28 | 010 | |
69020 | A | Drain outer ear canal lesion | 1.48 | 2.22 | 0.71 | 0.11 | 3.81 | 2.30 | 010 | |
69090 | N | Pierce earlobes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
69100 | A | Biopsy of external ear | 0.81 | 1.59 | 0.41 | 0.04 | 2.44 | 1.26 | 000 | |
69105 | A | Biopsy of external ear canal | 0.85 | 1.51 | 1.02 | 0.06 | 2.42 | 1.93 | 000 | |
69110 | A | Remove external ear, partial | 3.44 | 3.53 | 2.78 | 0.24 | 7.21 | 6.46 | 090 | |
69120 | A | Removal of external ear | 4.05 | NA | 4.45 | 0.31 | NA | 8.81 | 090 | |
69140 | A | Remove ear canal lesion(s) | 7.97 | NA | 8.07 | 0.56 | NA | 16.60 | 090 | |
69145 | A | Remove ear canal lesion(s) | 2.62 | 3.37 | 2.52 | 0.18 | 6.17 | 5.32 | 090 | |
69150 | A | Extensive ear canal surgery | 13.43 | NA | 11.17 | 1.07 | NA | 25.67 | 090 | |
69155 | A | Extensive ear/neck surgery | 20.80 | NA | 15.26 | 1.51 | NA | 37.57 | 090 | |
69200 | A | Clear outer ear canal | 0.77 | 1.44 | 0.76 | 0.05 | 2.26 | 1.58 | 000 | |
69205 | A | Clear outer ear canal | 1.20 | NA | 1.56 | 0.09 | NA | 2.85 | 010 | |
69210 | A | Remove impacted ear wax | 0.61 | 0.58 | 0.24 | 0.04 | 1.23 | 0.89 | 000 | |
69220 | A | Clean out mastoid cavity | 0.83 | 1.52 | 0.43 | 0.06 | 2.41 | 1.32 | 000 | |
69222 | A | Clean out mastoid cavity | 1.40 | 2.23 | 1.70 | 0.10 | 3.73 | 3.20 | 010 | |
69300 | R | Revise external ear | 6.36 | NA | 4.37 | 0.43 | NA | 11.16 | YYY | |
69310 | A | Rebuild outer ear canal | 10.79 | NA | 9.71 | 0.77 | NA | 21.27 | 090 | |
69320 | A | Rebuild outer ear canal | 16.96 | NA | 13.79 | 1.17 | NA | 31.92 | 090 | |
69399 | C | Outer ear surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
69400 | A | Inflate middle ear canal | 0.83 | 1.51 | 0.40 | 0.06 | 2.40 | 1.29 | 000 | |
69401 | A | Inflate middle ear canal | 0.63 | 1.41 | 0.35 | 0.04 | 2.08 | 1.02 | 000 | |
69405 | A | Catheterize middle ear canal | 2.63 | 3.09 | 1.46 | 0.18 | 5.90 | 4.27 | 010 | |
69410 | A | Inset middle ear (baffle) | 0.33 | 1.42 | 0.16 | 0.02 | 1.77 | 0.51 | 000 | |
69420 | A | Incision of eardrum | 1.33 | 2.36 | 0.71 | 0.10 | 3.79 | 2.14 | 010 | |
69421 | A | Incision of eardrum | 1.73 | 2.58 | 1.90 | 0.13 | 4.44 | 3.76 | 010 | |
69424 | A | Remove ventilating tube | 0.85 | 1.69 | 0.90 | 0.06 | 2.60 | 1.81 | 000 | |
69433 | A | Create eardrum opening | 1.52 | 2.31 | 0.85 | 0.11 | 3.94 | 2.48 | 010 | |
69436 | A | Create eardrum opening | 1.96 | NA | 2.04 | 0.14 | NA | 4.14 | 010 | |
69440 | A | Exploration of middle ear | 7.57 | NA | 7.30 | 0.53 | NA | 15.40 | 090 | |
69450 | A | Eardrum revision | 5.57 | NA | 6.11 | 0.39 | NA | 12.07 | 090 | |
69501 | A | Mastoidectomy | 9.07 | NA | 8.07 | 0.65 | NA | 17.79 | 090 | |
69502 | A | Mastoidectomy | 12.38 | NA | 10.64 | 0.86 | NA | 23.88 | 090 | |
69505 | A | Remove mastoid structures | 12.99 | NA | 10.89 | 0.92 | NA | 24.80 | 090 | |
69511 | A | Extensive mastoid surgery | 13.52 | NA | 11.23 | 0.96 | NA | 25.71 | 090 | |
69530 | A | Extensive mastoid surgery | 19.19 | NA | 14.75 | 1.32 | NA | 35.26 | 090 | |
69535 | A | Remove part of temporal bone | 36.14 | NA | 24.17 | 2.59 | NA | 62.90 | 090 | |
69540 | A | Remove ear lesion | 1.20 | 2.27 | 1.59 | 0.09 | 3.56 | 2.88 | 010 | |
69550 | A | Remove ear lesion | 10.99 | NA | 9.75 | 0.80 | NA | 21.54 | 090 | |
69552 | A | Remove ear lesion | 19.46 | NA | 14.32 | 1.36 | NA | 35.14 | 090 | |
69554 | A | Remove ear lesion | 33.16 | NA | 21.82 | 2.32 | NA | 57.30 | 090 | |
69601 | A | Mastoid surgery revision | 13.24 | NA | 11.82 | 0.92 | NA | 25.98 | 090 | |
69602 | A | Mastoid surgery revision | 13.58 | NA | 11.36 | 0.94 | NA | 25.88 | 090 | |
69603 | A | Mastoid surgery revision | 14.02 | NA | 11.55 | 1.00 | NA | 26.57 | 090 | |
69604 | A | Mastoid surgery revision | 14.02 | NA | 11.48 | 0.98 | NA | 26.48 | 090 | |
69605 | A | Mastoid surgery revision | 18.49 | NA | 14.48 | 1.29 | NA | 34.26 | 090 | |
69610 | A | Repair of eardrum | 4.43 | 4.22 | 3.40 | 0.31 | 8.96 | 8.14 | 010 | |
69620 | A | Repair of eardrum | 5.89 | 6.87 | 3.19 | 0.40 | 13.16 | 9.48 | 090 | |
69631 | A | Repair eardrum structures | 9.86 | NA | 9.19 | 0.69 | NA | 19.74 | 090 | |
69632 | A | Rebuild eardrum structures | 12.75 | NA | 11.54 | 0.89 | NA | 25.18 | 090 | |
69633 | A | Rebuild eardrum structures | 12.10 | NA | 11.19 | 0.84 | NA | 24.13 | 090 | |
69635 | A | Repair eardrum structures | 13.33 | NA | 10.74 | 0.87 | NA | 24.94 | 090 | |
69636 | A | Rebuild eardrum structures | 15.22 | NA | 13.01 | 1.07 | NA | 29.30 | 090 | |
69637 | A | Rebuild eardrum structures | 15.11 | NA | 12.92 | 1.06 | NA | 29.09 | 090 | |
69641 | A | Revise middle ear mastoid | 12.71 | NA | 10.87 | 0.89 | NA | 24.47 | 090 | |
69642 | A | Revise middle ear mastoid | 16.84 | NA | 13.86 | 1.18 | NA | 31.88 | 090 | |
69643 | A | Revise middle ear mastoid | 15.32 | NA | 13.01 | 1.08 | NA | 29.41 | 090 | |
69644 | A | Revise middle ear mastoid | 16.97 | NA | 13.94 | 1.19 | NA | 32.10 | 090 | |
69645 | A | Revise middle ear mastoid | 16.38 | NA | 13.57 | 1.16 | NA | 31.11 | 090 | |
69646 | A | Revise middle ear mastoid | 17.99 | NA | 14.53 | 1.26 | NA | 33.78 | 090 | |
69650 | A | Release middle ear bone | 9.66 | NA | 8.43 | 0.68 | NA | 18.77 | 090 | |
69660 | A | Revise middle ear bone | 11.90 | NA | 9.65 | 0.84 | NA | 22.39 | 090 | |
69661 | A | Revise middle ear bone | 15.74 | NA | 12.44 | 1.10 | NA | 29.28 | 090 | |
69662 | A | Revise middle ear bone | 15.44 | NA | 12.31 | 1.08 | NA | 28.83 | 090 | |
69666 | A | Repair middle ear structures | 9.75 | NA | 8.51 | 0.68 | NA | 18.94 | 090 | |
69667 | A | Repair middle ear structures | 9.76 | NA | 8.49 | 0.72 | NA | 18.97 | 090 | |
69670 | A | Remove mastoid air cells | 11.51 | NA | 10.11 | 0.78 | NA | 22.40 | 090 | |
69676 | A | Remove middle ear nerve | 9.52 | NA | 9.03 | 0.69 | NA | 19.24 | 090 | |
69700 | A | Close mastoid fistula | 8.23 | NA | 5.53 | 0.55 | NA | 14.31 | 090 | |
69710 | N | Implant/replace hearing aid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
69711 | A | Remove/repair hearing aid | 10.44 | NA | 9.35 | 0.62 | NA | 20.41 | 090 | |
69714 | A | Implant temple bone w/stimul | 14.00 | NA | 11.17 | 1.01 | NA | 26.18 | 090 | |
69715 | A | Temple bne implnt w/stimulat | 18.25 | NA | 13.73 | 1.32 | NA | 33.30 | 090 | |
69717 | A | Temple bone implant revision | 14.98 | NA | 10.55 | 1.08 | NA | 26.61 | 090 | |
69718 | A | Revise temple bone implant | 18.50 | NA | 13.61 | 1.34 | NA | 33.45 | 090 | |
69720 | A | Release facial nerve | 14.38 | NA | 12.47 | 1.03 | NA | 27.88 | 090 | |
69725 | A | Release facial nerve | 25.38 | NA | 18.04 | 1.78 | NA | 45.20 | 090 | |
69740 | A | Repair facial nerve | 15.96 | NA | 11.27 | 1.13 | NA | 28.36 | 090 | |
69745 | A | Repair facial nerve | 16.69 | NA | 12.77 | 1.00 | NA | 30.46 | 090 | |
69799 | C | Middle ear surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
69801 | A | Incise inner ear | 8.56 | NA | 7.84 | 0.60 | NA | 17.00 | 090 | |
69802 | A | Incise inner ear | 13.10 | NA | 11.13 | 0.91 | NA | 25.14 | 090 | |
69805 | A | Explore inner ear | 13.82 | NA | 10.80 | 0.97 | NA | 25.59 | 090 | |
69806 | A | Explore inner ear | 12.35 | NA | 10.68 | 0.86 | NA | 23.89 | 090 | |
69820 | A | Establish inner ear window | 10.34 | NA | 8.97 | 0.66 | NA | 19.97 | 090 | |
69840 | A | Revise inner ear window | 10.26 | NA | 7.64 | 0.64 | NA | 18.54 | 090 | |
69905 | A | Remove inner ear | 11.10 | NA | 9.73 | 0.77 | NA | 21.60 | 090 | |
69910 | A | Remove inner ear mastoid | 13.63 | NA | 11.19 | 0.94 | NA | 25.76 | 090 | |
69915 | A | Incise inner ear nerve | 21.23 | NA | 15.65 | 1.54 | NA | 38.42 | 090 | |
69930 | A | Implant cochlear device | 16.81 | NA | 12.70 | 1.19 | NA | 30.70 | 090 | |
69949 | C | Inner ear surgery procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
69950 | A | Incise inner ear nerve | 25.64 | NA | 16.46 | 2.90 | NA | 45.00 | 090 | |
69955 | A | Release facial nerve | 27.04 | NA | 18.64 | 1.89 | NA | 47.57 | 090 | |
69960 | A | Release inner ear canal | 27.04 | NA | 18.13 | 2.43 | NA | 47.60 | 090 | |
69970 | A | Remove inner ear lesion | 30.04 | NA | 18.91 | 2.34 | NA | 51.29 | 090 | |
69979 | C | Temporal bone surgery | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
69990 | R | Microsurgery add-on | 3.47 | NA | 1.84 | 0.56 | NA | 5.87 | ZZZ | |
70010 | A | Contrast x-ray of brain | 1.19 | 4.72 | NA | 0.24 | 6.15 | NA | XXX | |
70010 | 26 | A | Contrast x-ray of brain | 1.19 | 0.41 | 0.41 | 0.06 | 1.66 | 1.66 | XXX |
70010 | TC | A | Contrast x-ray of brain | 0.00 | 4.31 | NA | 0.18 | 4.49 | NA | XXX |
70015 | A | Contrast x-ray of brain | 1.19 | 1.75 | NA | 0.12 | 3.06 | NA | XXX | |
70015 | 26 | A | Contrast x-ray of brain | 1.19 | 0.41 | 0.41 | 0.05 | 1.65 | 1.65 | XXX |
70015 | TC | A | Contrast x-ray of brain | 0.00 | 1.34 | NA | 0.07 | 1.41 | NA | XXX |
70030 | A | X-ray eye for foreign body | 0.17 | 0.48 | NA | 0.03 | 0.68 | NA | XXX | |
70030 | 26 | A | X-ray eye for foreign body | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX |
70030 | TC | A | X-ray eye for foreign body | 0.00 | 0.42 | NA | 0.02 | 0.44 | NA | XXX |
70100 | A | X-ray exam of jaw | 0.18 | 0.58 | NA | 0.03 | 0.79 | NA | XXX | |
70100 | 26 | A | X-ray exam of jaw | 0.18 | 0.06 | 0.06 | 0.01 | 0.25 | 0.25 | XXX |
70100 | TC | A | X-ray exam of jaw | 0.00 | 0.52 | NA | 0.02 | 0.54 | NA | XXX |
70110 | A | X-ray exam of jaw | 0.25 | 0.70 | NA | 0.04 | 0.99 | NA | XXX | |
70110 | 26 | A | X-ray exam of jaw | 0.25 | 0.08 | 0.08 | 0.01 | 0.34 | 0.34 | XXX |
70110 | TC | A | X-ray exam of jaw | 0.00 | 0.62 | NA | 0.03 | 0.65 | NA | XXX |
70120 | A | X-ray exam of mastoids | 0.18 | 0.68 | NA | 0.04 | 0.90 | NA | XXX | |
70120 | 26 | A | X-ray exam of mastoids | 0.18 | 0.06 | 0.06 | 0.01 | 0.25 | 0.25 | XXX |
70120 | TC | A | X-ray exam of mastoids | 0.00 | 0.62 | NA | 0.03 | 0.65 | NA | XXX |
70130 | A | X-ray exam of mastoids | 0.34 | 0.90 | NA | 0.05 | 1.29 | NA | XXX | |
70130 | 26 | A | X-ray exam of mastoids | 0.34 | 0.12 | 0.12 | 0.01 | 0.47 | 0.47 | XXX |
70130 | TC | A | X-ray exam of mastoids | 0.00 | 0.78 | NA | 0.04 | 0.82 | NA | XXX |
70134 | A | X-ray exam of middle ear | 0.34 | 0.86 | NA | 0.05 | 1.25 | NA | XXX | |
70134 | 26 | A | X-ray exam of middle ear | 0.34 | 0.12 | 0.12 | 0.01 | 0.47 | 0.47 | XXX |
70134 | TC | A | X-ray exam of middle ear | 0.00 | 0.74 | NA | 0.04 | 0.78 | NA | XXX |
70140 | A | X-ray exam of facial bones | 0.19 | 0.68 | NA | 0.04 | 0.91 | NA | XXX | |
70140 | 26 | A | X-ray exam of facial bones | 0.19 | 0.06 | 0.06 | 0.01 | 0.26 | 0.26 | XXX |
70140 | TC | A | X-ray exam of facial bones | 0.00 | 0.62 | NA | 0.03 | 0.65 | NA | XXX |
70150 | A | X-ray exam of facial bones | 0.26 | 0.87 | NA | 0.05 | 1.18 | NA | XXX | |
70150 | 26 | A | X-ray exam of facial bones | 0.26 | 0.09 | 0.09 | 0.01 | 0.36 | 0.36 | XXX |
70150 | TC | A | X-ray exam of facial bones | 0.00 | 0.78 | NA | 0.04 | 0.82 | NA | XXX |
70160 | A | X-ray exam of nasal bones | 0.17 | 0.58 | NA | 0.03 | 0.78 | NA | XXX | |
70160 | 26 | A | X-ray exam of nasal bones | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX |
70160 | TC | A | X-ray exam of nasal bones | 0.00 | 0.52 | NA | 0.02 | 0.54 | NA | XXX |
70170 | A | X-ray exam of tear duct | 0.30 | 1.05 | NA | 0.06 | 1.41 | NA | XXX | |
70170 | 26 | A | X-ray exam of tear duct | 0.30 | 0.10 | 0.10 | 0.01 | 0.41 | 0.41 | XXX |
70170 | TC | A | X-ray exam of tear duct | 0.00 | 0.95 | NA | 0.05 | 1.00 | NA | XXX |
70190 | A | X-ray exam of eye sockets | 0.21 | 0.69 | NA | 0.04 | 0.94 | NA | XXX | |
70190 | 26 | A | X-ray exam of eye sockets | 0.21 | 0.07 | 0.07 | 0.01 | 0.29 | 0.29 | XXX |
70190 | TC | A | X-ray exam of eye sockets | 0.00 | 0.62 | NA | 0.03 | 0.65 | NA | XXX |
70200 | A | X-ray exam of eye sockets | 0.28 | 0.88 | NA | 0.05 | 1.21 | NA | XXX | |
70200 | 26 | A | X-ray exam of eye sockets | 0.28 | 0.10 | 0.10 | 0.01 | 0.39 | 0.39 | XXX |
70200 | TC | A | X-ray exam of eye sockets | 0.00 | 0.78 | NA | 0.04 | 0.82 | NA | XXX |
70210 | A | X-ray exam of sinuses | 0.17 | 0.68 | NA | 0.04 | 0.89 | NA | XXX | |
70210 | 26 | A | X-ray exam of sinuses | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX |
70210 | TC | A | X-ray exam of sinuses | 0.00 | 0.62 | NA | 0.03 | 0.65 | NA | XXX |
70220 | A | X-ray exam of sinuses | 0.25 | 0.87 | NA | 0.05 | 1.17 | NA | XXX | |
70220 | 26 | A | X-ray exam of sinuses | 0.25 | 0.09 | 0.09 | 0.01 | 0.35 | 0.35 | XXX |
70220 | TC | A | X-ray exam of sinuses | 0.00 | 0.78 | NA | 0.04 | 0.82 | NA | XXX |
70240 | A | X-ray exam, pituitary saddle | 0.19 | 0.48 | NA | 0.03 | 0.70 | NA | XXX | |
70240 | 26 | A | X-ray exam, pituitary saddle | 0.19 | 0.06 | 0.06 | 0.01 | 0.26 | 0.26 | XXX |
70240 | TC | A | X-ray exam, pituitary saddle | 0.00 | 0.42 | NA | 0.02 | 0.44 | NA | XXX |
70250 | A | X-ray exam of skull | 0.24 | 0.70 | NA | 0.04 | 0.98 | NA | XXX | |
70250 | 26 | A | X-ray exam of skull | 0.24 | 0.08 | 0.08 | 0.01 | 0.33 | 0.33 | XXX |
70250 | TC | A | X-ray exam of skull | 0.00 | 0.62 | NA | 0.03 | 0.65 | NA | XXX |
70260 | A | X-ray exam of skull | 0.34 | 1.01 | NA | 0.06 | 1.41 | NA | XXX | |
70260 | 26 | A | X-ray exam of skull | 0.34 | 0.12 | 0.12 | 0.01 | 0.47 | 0.47 | XXX |
70260 | TC | A | X-ray exam of skull | 0.00 | 0.89 | NA | 0.05 | 0.94 | NA | XXX |
70300 | A | X-ray exam of teeth | 0.10 | 0.30 | NA | 0.03 | 0.43 | NA | XXX | |
70300 | 26 | A | X-ray exam of teeth | 0.10 | 0.04 | 0.04 | 0.01 | 0.15 | 0.15 | XXX |
70300 | TC | A | X-ray exam of teeth | 0.00 | 0.26 | NA | 0.02 | 0.28 | NA | XXX |
70310 | A | X-ray exam of teeth | 0.16 | 0.48 | NA | 0.03 | 0.67 | NA | XXX | |
70310 | 26 | A | X-ray exam of teeth | 0.16 | 0.06 | 0.06 | 0.01 | 0.23 | 0.23 | XXX |
70310 | TC | A | X-ray exam of teeth | 0.00 | 0.42 | NA | 0.02 | 0.44 | NA | XXX |
70320 | A | Full mouth x-ray of teeth | 0.22 | 0.86 | NA | 0.05 | 1.13 | NA | XXX | |
70320 | 26 | A | Full mouth x-ray of teeth | 0.22 | 0.08 | 0.08 | 0.01 | 0.31 | 0.31 | XXX |
70320 | TC | A | Full mouth x-ray of teeth | 0.00 | 0.78 | NA | 0.04 | 0.82 | NA | XXX |
70328 | A | X-ray exam of jaw joint | 0.18 | 0.55 | NA | 0.03 | 0.76 | NA | XXX | |
70328 | 26 | A | X-ray exam of jaw joint | 0.18 | 0.06 | 0.06 | 0.01 | 0.25 | 0.25 | XXX |
70328 | TC | A | X-ray exam of jaw joint | 0.00 | 0.49 | NA | 0.02 | 0.51 | NA | XXX |
70330 | A | X-ray exam of jaw joints | 0.24 | 0.92 | NA | 0.05 | 1.21 | NA | XXX | |
70330 | 26 | A | X-ray exam of jaw joints | 0.24 | 0.08 | 0.08 | 0.01 | 0.33 | 0.33 | XXX |
70330 | TC | A | X-ray exam of jaw joints | 0.00 | 0.84 | NA | 0.04 | 0.88 | NA | XXX |
70332 | A | X-ray exam of jaw joint | 0.54 | 2.28 | NA | 0.12 | 2.94 | NA | XXX | |
70332 | 26 | A | X-ray exam of jaw joint | 0.54 | 0.19 | 0.19 | 0.02 | 0.75 | 0.75 | XXX |
70332 | TC | A | X-ray exam of jaw joint | 0.00 | 2.09 | NA | 0.10 | 2.19 | NA | XXX |
70336 | A | Magnetic image, jaw joint | 1.48 | 11.67 | NA | 0.56 | 13.71 | NA | XXX | |
70336 | 26 | A | Magnetic image, jaw joint | 1.48 | 0.51 | 0.51 | 0.07 | 2.06 | 2.06 | XXX |
70336 | TC | A | Magnetic image, jaw joint | 0.00 | 11.16 | NA | 0.49 | 11.65 | NA | XXX |
70350 | A | X-ray head for orthodontia | 0.17 | 0.44 | NA | 0.03 | 0.64 | NA | XXX | |
70350 | 26 | A | X-ray head for orthodontia | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX |
70350 | TC | A | X-ray head for orthodontia | 0.00 | 0.38 | NA | 0.02 | 0.40 | NA | XXX |
70355 | A | Panoramic x-ray of jaws | 0.20 | 0.64 | NA | 0.04 | 0.88 | NA | XXX | |
70355 | 26 | A | Panoramic x-ray of jaws | 0.20 | 0.07 | 0.07 | 0.01 | 0.28 | 0.28 | XXX |
70355 | TC | A | Panoramic x-ray of jaws | 0.00 | 0.57 | NA | 0.03 | 0.60 | NA | XXX |
70360 | A | X-ray exam of neck | 0.17 | 0.48 | NA | 0.03 | 0.68 | NA | XXX | |
70360 | 26 | A | X-ray exam of neck | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX |
70360 | TC | A | X-ray exam of neck | 0.00 | 0.42 | NA | 0.02 | 0.44 | NA | XXX |
70370 | A | Throat x-ray fluoroscopy | 0.32 | 1.41 | NA | 0.07 | 1.80 | NA | XXX | |
70370 | 26 | A | Throat x-ray fluoroscopy | 0.32 | 0.11 | 0.11 | 0.01 | 0.44 | 0.44 | XXX |
70370 | TC | A | Throat x-ray fluoroscopy | 0.00 | 1.30 | NA | 0.06 | 1.36 | NA | XXX |
70371 | A | Speech evaluation, complex | 0.84 | 2.38 | NA | 0.14 | 3.36 | NA | XXX | |
70371 | 26 | A | Speech evaluation, complex | 0.84 | 0.29 | 0.29 | 0.04 | 1.17 | 1.17 | XXX |
70371 | TC | A | Speech evaluation, complex | 0.00 | 2.09 | NA | 0.10 | 2.19 | NA | XXX |
70373 | A | Contrast x-ray of larynx | 0.44 | 1.92 | NA | 0.11 | 2.47 | NA | XXX | |
70373 | 26 | A | Contrast x-ray of larynx | 0.44 | 0.15 | 0.15 | 0.02 | 0.61 | 0.61 | XXX |
70373 | TC | A | Contrast x-ray of larynx | 0.00 | 1.77 | NA | 0.09 | 1.86 | NA | XXX |
70380 | A | X-ray exam of salivary gland | 0.17 | 0.73 | NA | 0.04 | 0.94 | NA | XXX | |
70380 | 26 | A | X-ray exam of salivary gland | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX |
70380 | TC | A | X-ray exam of salivary gland | 0.00 | 0.67 | NA | 0.03 | 0.70 | NA | XXX |
70390 | A | X-ray exam of salivary duct | 0.38 | 1.90 | NA | 0.11 | 2.39 | NA | XXX | |
70390 | 26 | A | X-ray exam of salivary duct | 0.38 | 0.13 | 0.13 | 0.02 | 0.53 | 0.53 | XXX |
70390 | TC | A | X-ray exam of salivary duct | 0.00 | 1.77 | NA | 0.09 | 1.86 | NA | XXX |
70450 | A | Ct head/brain w/o dye | 0.85 | 4.99 | NA | 0.25 | 6.09 | NA | XXX | |
70450 | 26 | A | Ct head/brain w/o dye | 0.85 | 0.29 | 0.29 | 0.04 | 1.18 | 1.18 | XXX |
70450 | TC | A | Ct head/brain w/o dye | 0.00 | 4.70 | NA | 0.21 | 4.91 | NA | XXX |
70460 | A | Ct head/brain w/dye | 1.13 | 6.02 | NA | 0.30 | 7.45 | NA | XXX | |
70460 | 26 | A | Ct head/brain w/dye | 1.13 | 0.39 | 0.39 | 0.05 | 1.57 | 1.57 | XXX |
70460 | TC | A | Ct head/brain w/dye | 0.00 | 5.63 | NA | 0.25 | 5.88 | NA | XXX |
70470 | A | Ct head/brain w/ow dye | 1.27 | 7.47 | NA | 0.37 | 9.11 | NA | XXX | |
70470 | 26 | A | Ct head/brain w/ow dye | 1.27 | 0.43 | 0.43 | 0.06 | 1.76 | 1.76 | XXX |
70470 | TC | A | Ct head/brain w/ow dye | 0.00 | 7.04 | NA | 0.31 | 7.35 | NA | XXX |
70480 | A | Ct orbit/ear/fossa w/o dye | 1.28 | 5.14 | NA | 0.27 | 6.69 | NA | XXX | |
70480 | 26 | A | Ct orbit/ear/fossa w/o dye | 1.28 | 0.44 | 0.44 | 0.06 | 1.78 | 1.78 | XXX |
70480 | TC | A | Ct orbit/ear/fossa w/o dye | 0.00 | 4.70 | NA | 0.21 | 4.91 | NA | XXX |
70481 | A | Ct orbit/ear/fossa w/dye | 1.38 | 6.10 | NA | 0.31 | 7.79 | NA | XXX | |
70481 | 26 | A | Ct orbit/ear/fossa w/dye | 1.38 | 0.47 | 0.47 | 0.06 | 1.91 | 1.91 | XXX |
70481 | TC | A | Ct orbit/ear/fossa w/dye | 0.00 | 5.63 | NA | 0.25 | 5.88 | NA | XXX |
70482 | A | Ct orbit/ear/fossa w/ow dye | 1.45 | 7.53 | NA | 0.37 | 9.35 | NA | XXX | |
70482 | 26 | A | Ct orbit/ear/fossa w/ow dye | 1.45 | 0.49 | 0.49 | 0.06 | 2.00 | 2.00 | XXX |
70482 | TC | A | Ct orbit/ear/fossa w/ow dye | 0.00 | 7.04 | NA | 0.31 | 7.35 | NA | XXX |
70486 | A | Ct maxillofacial w/o dye | 1.14 | 5.09 | NA | 0.26 | 6.49 | NA | XXX | |
70486 | 26 | A | Ct maxillofacial w/o dye | 1.14 | 0.39 | 0.39 | 0.05 | 1.58 | 1.58 | XXX |
70486 | TC | A | Ct maxillofacial w/o dye | 0.00 | 4.70 | NA | 0.21 | 4.91 | NA | XXX |
70487 | A | Ct maxillofacial w/dye | 1.30 | 6.07 | NA | 0.31 | 7.68 | NA | XXX | |
70487 | 26 | A | Ct maxillofacial w/dye | 1.30 | 0.44 | 0.44 | 0.06 | 1.80 | 1.80 | XXX |
70487 | TC | A | Ct maxillofacial w/dye | 0.00 | 5.63 | NA | 0.25 | 5.88 | NA | XXX |
70488 | A | Ct maxillofacial w/ow dye | 1.42 | 7.52 | NA | 0.37 | 9.31 | NA | XXX | |
70488 | 26 | A | Ct maxillofacial w/ow dye | 1.42 | 0.48 | 0.48 | 0.06 | 1.96 | 1.96 | XXX |
70488 | TC | A | Ct maxillofacial w/ow dye | 0.00 | 7.04 | NA | 0.31 | 7.35 | NA | XXX |
70490 | A | Ct soft tissue neck w/o dye | 1.28 | 5.13 | NA | 0.27 | 6.68 | NA | XXX | |
70490 | 26 | A | Ct soft tissue neck w/o dye | 1.28 | 0.43 | 0.43 | 0.06 | 1.77 | 1.77 | XXX |
70490 | TC | A | Ct soft tissue neck w/o dye | 0.00 | 4.70 | NA | 0.21 | 4.91 | NA | XXX |
70491 | A | Ct soft tissue neck w/dye | 1.38 | 6.10 | NA | 0.31 | 7.79 | NA | XXX | |
70491 | 26 | A | Ct soft tissue neck w/dye | 1.38 | 0.47 | 0.47 | 0.06 | 1.91 | 1.91 | XXX |
70491 | TC | A | Ct soft tissue neck w/dye | 0.00 | 5.63 | NA | 0.25 | 5.88 | NA | XXX |
70492 | A | Ct sft tsue nck w/o w/dye | 1.45 | 7.53 | NA | 0.37 | 9.35 | NA | XXX | |
70492 | 26 | A | Ct sft tsue nck w/o w/dye | 1.45 | 0.49 | 0.49 | 0.06 | 2.00 | 2.00 | XXX |
70492 | TC | A | Ct sft tsue nck w/o w/dye | 0.00 | 7.04 | NA | 0.31 | 7.35 | NA | XXX |
70496 | A | Ct angiography, head | 1.75 | 11.15 | NA | 0.56 | 13.46 | NA | XXX | |
70496 | 26 | A | Ct angiography, head | 1.75 | 0.59 | 0.59 | 0.08 | 2.42 | 2.42 | XXX |
70496 | TC | A | Ct angiography, head | 0.00 | 10.56 | NA | 0.48 | 11.04 | NA | XXX |
70498 | A | Ct angiography, neck | 1.75 | 11.16 | NA | 0.56 | 13.47 | NA | XXX | |
70498 | 26 | A | Ct angiography, neck | 1.75 | 0.60 | 0.60 | 0.08 | 2.43 | 2.43 | XXX |
70498 | TC | A | Ct angiography, neck | 0.00 | 10.56 | NA | 0.48 | 11.04 | NA | XXX |
70540 | A | Mri orbit/face/neck w/o dye | 1.35 | 11.62 | NA | 0.36 | 13.33 | NA | XXX | |
70540 | 26 | A | Mri orbit/face/neck w/o dye | 1.35 | 0.46 | 0.46 | 0.04 | 1.85 | 1.85 | XXX |
70540 | TC | A | Mri orbit/face/neck w/o dye | 0.00 | 11.16 | NA | 0.32 | 11.48 | NA | XXX |
70542 | A | Mri orbit/face/neck w/dye | 1.62 | 13.94 | NA | 0.44 | 16.00 | NA | XXX | |
70542 | 26 | A | Mri orbit/face/neck w/dye | 1.62 | 0.56 | 0.56 | 0.05 | 2.23 | 2.23 | XXX |
70542 | TC | A | Mri orbit/face/neck w/dye | 0.00 | 13.38 | NA | 0.39 | 13.77 | NA | XXX |
70543 | A | Mri orbt/fac/nck w/ow dye | 2.15 | 25.51 | NA | 0.77 | 28.43 | NA | XXX | |
70543 | 26 | A | Mri orbt/fac/nck w/ow dye | 2.15 | 0.73 | 0.73 | 0.07 | 2.95 | 2.95 | XXX |
70543 | TC | A | Mri orbt/fac/nck w/ow dye | 0.00 | 24.78 | NA | 0.70 | 25.48 | NA | XXX |
70544 | A | Mr angiography head w/o dye | 1.20 | 11.57 | NA | 0.54 | 13.31 | NA | XXX | |
70544 | 26 | A | Mr angiography head w/o dye | 1.20 | 0.41 | 0.41 | 0.05 | 1.66 | 1.66 | XXX |
70544 | TC | A | Mr angiography head w/o dye | 0.00 | 11.16 | NA | 0.49 | 11.65 | NA | XXX |
70545 | A | Mr angiography head w/dye | 1.20 | 11.57 | NA | 0.54 | 13.31 | NA | XXX | |
70545 | 26 | A | Mr angiography head w/dye | 1.20 | 0.41 | 0.41 | 0.05 | 1.66 | 1.66 | XXX |
70545 | TC | A | Mr angiography head w/dye | 0.00 | 11.16 | NA | 0.49 | 11.65 | NA | XXX |
70546 | A | Mr angiograph head w/ow dye | 1.80 | 22.93 | NA | 0.57 | 25.30 | NA | XXX | |
70546 | 26 | A | Mr angiograph head w/ow dye | 1.80 | 0.62 | 0.62 | 0.08 | 2.50 | 2.50 | XXX |
70546 | TC | A | Mr angiograph head w/ow dye | 0.00 | 22.31 | NA | 0.49 | 22.80 | NA | XXX |
70547 | A | Mr angiography neck w/o dye | 1.20 | 11.57 | NA | 0.54 | 13.31 | NA | XXX | |
70547 | 26 | A | Mr angiography neck w/o dye | 1.20 | 0.41 | 0.41 | 0.05 | 1.66 | 1.66 | XXX |
70547 | TC | A | Mr angiography neck w/o dye | 0.00 | 11.16 | NA | 0.49 | 11.65 | NA | XXX |
70548 | A | Mr angiography neck w/dye | 1.20 | 11.57 | NA | 0.54 | 13.31 | NA | XXX | |
70548 | 26 | A | Mr angiography neck w/dye | 1.20 | 0.41 | 0.41 | 0.05 | 1.66 | 1.66 | XXX |
70548 | TC | A | Mr angiography neck w/dye | 0.00 | 11.16 | NA | 0.49 | 11.65 | NA | XXX |
70549 | A | Mr angiograph neck w/ow dye | 1.80 | 22.93 | NA | 0.57 | 25.30 | NA | XXX | |
70549 | 26 | A | Mr angiograph neck w/ow dye | 1.80 | 0.62 | 0.62 | 0.08 | 2.50 | 2.50 | XXX |
70549 | TC | A | Mr angiograph neck w/ow dye | 0.00 | 22.31 | NA | 0.49 | 22.80 | NA | XXX |
70551 | A | Mri brain w/o dye | 1.48 | 11.67 | NA | 0.56 | 13.71 | NA | XXX | |
70551 | 26 | A | Mri brain w/o dye | 1.48 | 0.51 | 0.51 | 0.07 | 2.06 | 2.06 | XXX |
70551 | TC | A | Mri brain w/o dye | 0.00 | 11.16 | NA | 0.49 | 11.65 | NA | XXX |
70552 | A | Mri brain w/dye | 1.78 | 14.00 | NA | 0.66 | 16.44 | NA | XXX | |
70552 | 26 | A | Mri brain w/dye | 1.78 | 0.62 | 0.62 | 0.08 | 2.48 | 2.48 | XXX |
70552 | TC | A | Mri brain w/dye | 0.00 | 13.38 | NA | 0.58 | 13.96 | NA | XXX |
70553 | A | Mri brain w/ow dye | 2.36 | 25.59 | NA | 1.19 | 29.14 | NA | XXX | |
70553 | 26 | A | Mri brain w/ow dye | 2.36 | 0.81 | 0.81 | 0.10 | 3.27 | 3.27 | XXX |
70553 | TC | A | Mri brain w/ow dye | 0.00 | 24.78 | NA | 1.09 | 25.87 | NA | XXX |
71010 | A | Chest x-ray | 0.18 | 0.53 | NA | 0.03 | 0.74 | NA | XXX | |
71010 | 26 | A | Chest x-ray | 0.18 | 0.06 | 0.06 | 0.01 | 0.25 | 0.25 | XXX |
71010 | TC | A | Chest x-ray | 0.00 | 0.47 | NA | 0.02 | 0.49 | NA | XXX |
71015 | A | Chest x-ray | 0.21 | 0.59 | NA | 0.03 | 0.83 | NA | XXX | |
71015 | 26 | A | Chest x-ray | 0.21 | 0.07 | 0.07 | 0.01 | 0.29 | 0.29 | XXX |
71015 | TC | A | Chest x-ray | 0.00 | 0.52 | NA | 0.02 | 0.54 | NA | XXX |
71020 | A | Chest x-ray | 0.22 | 0.69 | NA | 0.04 | 0.95 | NA | XXX | |
71020 | 26 | A | Chest x-ray | 0.22 | 0.07 | 0.07 | 0.01 | 0.30 | 0.30 | XXX |
71020 | TC | A | Chest x-ray | 0.00 | 0.62 | NA | 0.03 | 0.65 | NA | XXX |
71021 | A | Chest x-ray | 0.27 | 0.83 | NA | 0.05 | 1.15 | NA | XXX | |
71021 | 26 | A | Chest x-ray | 0.27 | 0.09 | 0.09 | 0.01 | 0.37 | 0.37 | XXX |
71021 | TC | A | Chest x-ray | 0.00 | 0.74 | NA | 0.04 | 0.78 | NA | XXX |
71022 | A | Chest x-ray | 0.31 | 0.85 | NA | 0.06 | 1.22 | NA | XXX | |
71022 | 26 | A | Chest x-ray | 0.31 | 0.11 | 0.11 | 0.02 | 0.44 | 0.44 | XXX |
71022 | TC | A | Chest x-ray | 0.00 | 0.74 | NA | 0.04 | 0.78 | NA | XXX |
71023 | A | Chest x-ray and fluoroscopy | 0.38 | 0.92 | NA | 0.06 | 1.36 | NA | XXX | |
71023 | 26 | A | Chest x-ray and fluoroscopy | 0.38 | 0.14 | 0.14 | 0.02 | 0.54 | 0.54 | XXX |
71023 | TC | A | Chest x-ray and fluoroscopy | 0.00 | 0.78 | NA | 0.04 | 0.82 | NA | XXX |
71030 | A | Chest x-ray | 0.31 | 0.88 | NA | 0.05 | 1.24 | NA | XXX | |
71030 | 26 | A | Chest x-ray | 0.31 | 0.10 | 0.10 | 0.01 | 0.42 | 0.42 | XXX |
71030 | TC | A | Chest x-ray | 0.00 | 0.78 | NA | 0.04 | 0.82 | NA | XXX |
71034 | A | Chest x-ray and fluoroscopy | 0.46 | 1.60 | NA | 0.09 | 2.15 | NA | XXX | |
71034 | 26 | A | Chest x-ray and fluoroscopy | 0.46 | 0.17 | 0.17 | 0.02 | 0.65 | 0.65 | XXX |
71034 | TC | A | Chest x-ray and fluoroscopy | 0.00 | 1.43 | NA | 0.07 | 1.50 | NA | XXX |
71035 | A | Chest x-ray | 0.18 | 0.58 | NA | 0.03 | 0.79 | NA | XXX | |
71035 | 26 | A | Chest x-ray | 0.18 | 0.06 | 0.06 | 0.01 | 0.25 | 0.25 | XXX |
71035 | TC | A | Chest x-ray | 0.00 | 0.52 | NA | 0.02 | 0.54 | NA | XXX |
71040 | A | Contrast x-ray of bronchi | 0.58 | 1.65 | NA | 0.10 | 2.33 | NA | XXX | |
71040 | 26 | A | Contrast x-ray of bronchi | 0.58 | 0.20 | 0.20 | 0.03 | 0.81 | 0.81 | XXX |
71040 | TC | A | Contrast x-ray of bronchi | 0.00 | 1.45 | NA | 0.07 | 1.52 | NA | XXX |
71060 | A | Contrast x-ray of bronchi | 0.74 | 2.45 | NA | 0.14 | 3.33 | NA | XXX | |
71060 | 26 | A | Contrast x-ray of bronchi | 0.74 | 0.25 | 0.25 | 0.03 | 1.02 | 1.02 | XXX |
71060 | TC | A | Contrast x-ray of bronchi | 0.00 | 2.20 | NA | 0.11 | 2.31 | NA | XXX |
71090 | A | X-ray pacemaker insertion | 0.54 | 1.88 | NA | 0.11 | 2.53 | NA | XXX | |
71090 | 26 | A | X-ray pacemaker insertion | 0.54 | 0.21 | 0.21 | 0.02 | 0.77 | 0.77 | XXX |
71090 | TC | A | X-ray pacemaker insertion | 0.00 | 1.67 | NA | 0.09 | 1.76 | NA | XXX |
71100 | A | X-ray exam of ribs | 0.22 | 0.64 | NA | 0.04 | 0.90 | NA | XXX | |
71100 | 26 | A | X-ray exam of ribs | 0.22 | 0.07 | 0.07 | 0.01 | 0.30 | 0.30 | XXX |
71100 | TC | A | X-ray exam of ribs | 0.00 | 0.57 | NA | 0.03 | 0.60 | NA | XXX |
71101 | A | X-ray exam of ribs/chest | 0.27 | 0.76 | NA | 0.04 | 1.07 | NA | XXX | |
71101 | 26 | A | X-ray exam of ribs/chest | 0.27 | 0.09 | 0.09 | 0.01 | 0.37 | 0.37 | XXX |
71101 | TC | A | X-ray exam of ribs/chest | 0.00 | 0.67 | NA | 0.03 | 0.70 | NA | XXX |
71110 | A | X-ray exam of ribs | 0.27 | 0.87 | NA | 0.05 | 1.19 | NA | XXX | |
71110 | 26 | A | X-ray exam of ribs | 0.27 | 0.09 | 0.09 | 0.01 | 0.37 | 0.37 | XXX |
71110 | TC | A | X-ray exam of ribs | 0.00 | 0.78 | NA | 0.04 | 0.82 | NA | XXX |
71111 | A | X-ray exam of ribs/ chest | 0.32 | 1.00 | NA | 0.06 | 1.38 | NA | XXX | |
71111 | 26 | A | X-ray exam of ribs/ chest | 0.32 | 0.11 | 0.11 | 0.01 | 0.44 | 0.44 | XXX |
71111 | TC | A | X-ray exam of ribs/ chest | 0.00 | 0.89 | NA | 0.05 | 0.94 | NA | XXX |
71120 | A | X-ray exam of breastbone | 0.20 | 0.72 | NA | 0.04 | 0.96 | NA | XXX | |
71120 | 26 | A | X-ray exam of breastbone | 0.20 | 0.07 | 0.07 | 0.01 | 0.28 | 0.28 | XXX |
71120 | TC | A | X-ray exam of breastbone | 0.00 | 0.65 | NA | 0.03 | 0.68 | NA | XXX |
71130 | A | X-ray exam of breastbone | 0.22 | 0.78 | NA | 0.04 | 1.04 | NA | XXX | |
71130 | 26 | A | X-ray exam of breastbone | 0.22 | 0.07 | 0.07 | 0.01 | 0.30 | 0.30 | XXX |
71130 | TC | A | X-ray exam of breastbone | 0.00 | 0.71 | NA | 0.03 | 0.74 | NA | XXX |
71250 | A | Ct thorax w/o dye | 1.16 | 6.27 | NA | 0.31 | 7.74 | NA | XXX | |
71250 | 26 | A | Ct thorax w/o dye | 1.16 | 0.39 | 0.39 | 0.05 | 1.60 | 1.60 | XXX |
71250 | TC | A | Ct thorax w/o dye | 0.00 | 5.88 | NA | 0.26 | 6.14 | NA | XXX |
71260 | A | Ct thorax w/dye | 1.24 | 7.46 | NA | 0.36 | 9.06 | NA | XXX | |
71260 | 26 | A | Ct thorax w/dye | 1.24 | 0.42 | 0.42 | 0.05 | 1.71 | 1.71 | XXX |
71260 | TC | A | Ct thorax w/dye | 0.00 | 7.04 | NA | 0.31 | 7.35 | NA | XXX |
71270 | A | Ct thorax w/ow dye | 1.38 | 9.28 | NA | 0.44 | 11.10 | NA | XXX | |
71270 | 26 | A | Ct thorax w/ow dye | 1.38 | 0.47 | 0.47 | 0.06 | 1.91 | 1.91 | XXX |
71270 | TC | A | Ct thorax w/ow dye | 0.00 | 8.81 | NA | 0.38 | 9.19 | NA | XXX |
71275 | A | Ct angiography, chest | 1.92 | 9.46 | NA | 0.38 | 11.76 | NA | XXX | |
71275 | 26 | A | Ct angiography, chest | 1.92 | 0.65 | 0.65 | 0.06 | 2.63 | 2.63 | XXX |
71275 | TC | A | Ct angiography, chest | 0.00 | 8.81 | NA | 0.32 | 9.13 | NA | XXX |
71550 | A | Mri chest w/o dye | 1.46 | 11.66 | NA | 0.41 | 13.53 | NA | XXX | |
71550 | 26 | A | Mri chest w/o dye | 1.46 | 0.50 | 0.50 | 0.04 | 2.00 | 2.00 | XXX |
71550 | TC | A | Mri chest w/o dye | 0.00 | 11.16 | NA | 0.37 | 11.53 | NA | XXX |
71551 | A | Mri chest w/dye | 1.73 | 13.97 | NA | 0.49 | 16.19 | NA | XXX | |
71551 | 26 | A | Mri chest w/dye | 1.73 | 0.59 | 0.59 | 0.06 | 2.38 | 2.38 | XXX |
71551 | TC | A | Mri chest w/dye | 0.00 | 13.38 | NA | 0.43 | 13.81 | NA | XXX |
71552 | A | Mri chest w/ow/dye | 2.26 | 25.55 | NA | 0.64 | 28.45 | NA | XXX | |
71552 | 26 | A | Mri chest w/ow/dye | 2.26 | 0.77 | 0.77 | 0.08 | 3.11 | 3.11 | XXX |
71552 | TC | A | Mri chest w/ow/dye | 0.00 | 24.78 | NA | 0.56 | 25.34 | NA | XXX |
71555 | R | Mri angio chest w or w/o dye | 1.81 | 11.78 | NA | 0.57 | 14.16 | NA | XXX | |
71555 | 26 | R | Mri angio chest w or w/o dye | 1.81 | 0.62 | 0.62 | 0.08 | 2.51 | 2.51 | XXX |
71555 | TC | R | Mri angio chest w or w/o dye | 0.00 | 11.16 | NA | 0.49 | 11.65 | NA | XXX |
72010 | A | X-ray exam of spine | 0.45 | 1.17 | NA | 0.08 | 1.70 | NA | XXX | |
72010 | 26 | A | X-ray exam of spine | 0.45 | 0.15 | 0.15 | 0.03 | 0.63 | 0.63 | XXX |
72010 | TC | A | X-ray exam of spine | 0.00 | 1.02 | NA | 0.05 | 1.07 | NA | XXX |
72020 | A | X-ray exam of spine | 0.15 | 0.47 | NA | 0.03 | 0.65 | NA | XXX | |
72020 | 26 | A | X-ray exam of spine | 0.15 | 0.05 | 0.05 | 0.01 | 0.21 | 0.21 | XXX |
72020 | TC | A | X-ray exam of spine | 0.00 | 0.42 | NA | 0.02 | 0.44 | NA | XXX |
72040 | A | X-ray exam of neck spine | 0.22 | 0.67 | NA | 0.04 | 0.93 | NA | XXX | |
72040 | 26 | A | X-ray exam of neck spine | 0.22 | 0.07 | 0.07 | 0.01 | 0.30 | 0.30 | XXX |
72040 | TC | A | X-ray exam of neck spine | 0.00 | 0.60 | NA | 0.03 | 0.63 | NA | XXX |
72050 | A | X-ray exam of neck spine | 0.31 | 1.00 | NA | 0.07 | 1.38 | NA | XXX | |
72050 | 26 | A | X-ray exam of neck spine | 0.31 | 0.11 | 0.11 | 0.02 | 0.44 | 0.44 | XXX |
72050 | TC | A | X-ray exam of neck spine | 0.00 | 0.89 | NA | 0.05 | 0.94 | NA | XXX |
72052 | A | X-ray exam of neck spine | 0.36 | 1.24 | NA | 0.07 | 1.67 | NA | XXX | |
72052 | 26 | A | X-ray exam of neck spine | 0.36 | 0.12 | 0.12 | 0.02 | 0.50 | 0.50 | XXX |
72052 | TC | A | X-ray exam of neck spine | 0.00 | 1.12 | NA | 0.05 | 1.17 | NA | XXX |
72069 | A | X-ray exam of trunk spine | 0.22 | 0.57 | NA | 0.04 | 0.83 | NA | XXX | |
72069 | 26 | A | X-ray exam of trunk spine | 0.22 | 0.08 | 0.08 | 0.02 | 0.32 | 0.32 | XXX |
72069 | TC | A | X-ray exam of trunk spine | 0.00 | 0.49 | NA | 0.02 | 0.51 | NA | XXX |
72070 | A | X-ray exam of thoracic spine | 0.22 | 0.72 | NA | 0.04 | 0.98 | NA | XXX | |
72070 | 26 | A | X-ray exam of thoracic spine | 0.22 | 0.07 | 0.07 | 0.01 | 0.30 | 0.30 | XXX |
72070 | TC | A | X-ray exam of thoracic spine | 0.00 | 0.65 | NA | 0.03 | 0.68 | NA | XXX |
72072 | A | X-ray exam of thoracic spine | 0.22 | 0.81 | NA | 0.05 | 1.08 | NA | XXX | |
72072 | 26 | A | X-ray exam of thoracic spine | 0.22 | 0.07 | 0.07 | 0.01 | 0.30 | 0.30 | XXX |
72072 | TC | A | X-ray exam of thoracic spine | 0.00 | 0.74 | NA | 0.04 | 0.78 | NA | XXX |
72074 | A | X-ray exam of thoracic spine | 0.22 | 0.98 | NA | 0.06 | 1.26 | NA | XXX | |
72074 | 26 | A | X-ray exam of thoracic spine | 0.22 | 0.07 | 0.07 | 0.01 | 0.30 | 0.30 | XXX |
72074 | TC | A | X-ray exam of thoracic spine | 0.00 | 0.91 | NA | 0.05 | 0.96 | NA | XXX |
72080 | A | X-ray exam of trunk spine | 0.22 | 0.75 | NA | 0.05 | 1.02 | NA | XXX | |
72080 | 26 | A | X-ray exam of trunk spine | 0.22 | 0.08 | 0.08 | 0.02 | 0.32 | 0.32 | XXX |
72080 | TC | A | X-ray exam of trunk spine | 0.00 | 0.67 | NA | 0.03 | 0.70 | NA | XXX |
72090 | A | X-ray exam of trunk spine | 0.28 | 0.77 | NA | 0.05 | 1.10 | NA | XXX | |
72090 | 26 | A | X-ray exam of trunk spine | 0.28 | 0.10 | 0.10 | 0.02 | 0.40 | 0.40 | XXX |
72090 | TC | A | X-ray exam of trunk spine | 0.00 | 0.67 | NA | 0.03 | 0.70 | NA | XXX |
72100 | A | X-ray exam of lower spine | 0.22 | 0.75 | NA | 0.05 | 1.02 | NA | XXX | |
72100 | 26 | A | X-ray exam of lower spine | 0.22 | 0.08 | 0.08 | 0.02 | 0.32 | 0.32 | XXX |
72100 | TC | A | X-ray exam of lower spine | 0.00 | 0.67 | NA | 0.03 | 0.70 | NA | XXX |
72110 | A | X-ray exam of lower spine | 0.31 | 1.02 | NA | 0.07 | 1.40 | NA | XXX | |
72110 | 26 | A | X-ray exam of lower spine | 0.31 | 0.11 | 0.11 | 0.02 | 0.44 | 0.44 | XXX |
72110 | TC | A | X-ray exam of lower spine | 0.00 | 0.91 | NA | 0.05 | 0.96 | NA | XXX |
72114 | A | X-ray exam of lower spine | 0.36 | 1.30 | NA | 0.08 | 1.74 | NA | XXX | |
72114 | 26 | A | X-ray exam of lower spine | 0.36 | 0.12 | 0.12 | 0.03 | 0.51 | 0.51 | XXX |
72114 | TC | A | X-ray exam of lower spine | 0.00 | 1.18 | NA | 0.05 | 1.23 | NA | XXX |
72120 | A | X-ray exam of lower spine | 0.22 | 0.97 | NA | 0.07 | 1.26 | NA | XXX | |
72120 | 26 | A | X-ray exam of lower spine | 0.22 | 0.08 | 0.08 | 0.02 | 0.32 | 0.32 | XXX |
72120 | TC | A | X-ray exam of lower spine | 0.00 | 0.89 | NA | 0.05 | 0.94 | NA | XXX |
72125 | A | Ct neck spine w/o dye | 1.16 | 6.27 | NA | 0.31 | 7.74 | NA | XXX | |
72125 | 26 | A | Ct neck spine w/o dye | 1.16 | 0.39 | 0.39 | 0.05 | 1.60 | 1.60 | XXX |
72125 | TC | A | Ct neck spine w/o dye | 0.00 | 5.88 | NA | 0.26 | 6.14 | NA | XXX |
72126 | A | Ct neck spine w/dye | 1.22 | 7.45 | NA | 0.36 | 9.03 | NA | XXX | |
72126 | 26 | A | Ct neck spine w/dye | 1.22 | 0.41 | 0.41 | 0.05 | 1.68 | 1.68 | XXX |
72126 | TC | A | Ct neck spine w/dye | 0.00 | 7.04 | NA | 0.31 | 7.35 | NA | XXX |
72127 | A | Ct neck spine w/ow/dye | 1.27 | 9.24 | NA | 0.44 | 10.95 | NA | XXX | |
72127 | 26 | A | Ct neck spine w/ow/dye | 1.27 | 0.43 | 0.43 | 0.06 | 1.76 | 1.76 | XXX |
72127 | TC | A | Ct neck spine w/ow/dye | 0.00 | 8.81 | NA | 0.38 | 9.19 | NA | XXX |
72128 | A | Ct chest spine w/o dye | 1.16 | 6.27 | NA | 0.31 | 7.74 | NA | XXX | |
72128 | 26 | A | Ct chest spine w/o dye | 1.16 | 0.39 | 0.39 | 0.05 | 1.60 | 1.60 | XXX |
72128 | TC | A | Ct chest spine w/o dye | 0.00 | 5.88 | NA | 0.26 | 6.14 | NA | XXX |
72129 | A | Ct chest spine w/dye | 1.22 | 7.45 | NA | 0.36 | 9.03 | NA | XXX | |
72129 | 26 | A | Ct chest spine w/dye | 1.22 | 0.41 | 0.41 | 0.05 | 1.68 | 1.68 | XXX |
72129 | TC | A | Ct chest spine w/dye | 0.00 | 7.04 | NA | 0.31 | 7.35 | NA | XXX |
72130 | A | Ct chest spine w/ow/dye | 1.27 | 9.24 | NA | 0.44 | 10.95 | NA | XXX | |
72130 | 26 | A | Ct chest spine w/ow/dye | 1.27 | 0.43 | 0.43 | 0.06 | 1.76 | 1.76 | XXX |
72130 | TC | A | Ct chest spine w/ow/dye | 0.00 | 8.81 | NA | 0.38 | 9.19 | NA | XXX |
72131 | A | Ct lumbar spine w/o dye | 1.16 | 6.28 | NA | 0.31 | 7.75 | NA | XXX | |
72131 | 26 | A | Ct lumbar spine w/o dye | 1.16 | 0.40 | 0.40 | 0.05 | 1.61 | 1.61 | XXX |
72131 | TC | A | Ct lumbar spine w/o dye | 0.00 | 5.88 | NA | 0.26 | 6.14 | NA | XXX |
72132 | A | Ct lumbar spine w/dye | 1.22 | 7.45 | NA | 0.37 | 9.04 | NA | XXX | |
72132 | 26 | A | Ct lumbar spine w/dye | 1.22 | 0.41 | 0.41 | 0.06 | 1.69 | 1.69 | XXX |
72132 | TC | A | Ct lumbar spine w/dye | 0.00 | 7.04 | NA | 0.31 | 7.35 | NA | XXX |
72133 | A | Ct lumbar spine w/ow/dye | 1.27 | 9.25 | NA | 0.44 | 10.96 | NA | XXX | |
72133 | 26 | A | Ct lumbar spine w/ow/dye | 1.27 | 0.44 | 0.44 | 0.06 | 1.77 | 1.77 | XXX |
72133 | TC | A | Ct lumbar spine w/ow/dye | 0.00 | 8.81 | NA | 0.38 | 9.19 | NA | XXX |
72141 | A | Mri neck spine w/o dye | 1.60 | 11.71 | NA | 0.56 | 13.87 | NA | XXX | |
72141 | 26 | A | Mri neck spine w/o dye | 1.60 | 0.55 | 0.55 | 0.07 | 2.22 | 2.22 | XXX |
72141 | TC | A | Mri neck spine w/o dye | 0.00 | 11.16 | NA | 0.49 | 11.65 | NA | XXX |
72142 | A | Mri neck spine w/dye | 1.92 | 14.05 | NA | 0.67 | 16.64 | NA | XXX | |
72142 | 26 | A | Mri neck spine w/dye | 1.92 | 0.67 | 0.67 | 0.09 | 2.68 | 2.68 | XXX |
72142 | TC | A | Mri neck spine w/dye | 0.00 | 13.38 | NA | 0.58 | 13.96 | NA | XXX |
72146 | A | Mri chest spine w/o dye | 1.60 | 12.94 | NA | 0.60 | 15.14 | NA | XXX | |
72146 | 26 | A | Mri chest spine w/o dye | 1.60 | 0.55 | 0.55 | 0.07 | 2.22 | 2.22 | XXX |
72146 | TC | A | Mri chest spine w/o dye | 0.00 | 12.39 | NA | 0.53 | 12.92 | NA | XXX |
72147 | A | Mri chest spine w/dye | 1.92 | 14.04 | NA | 0.67 | 16.63 | NA | XXX | |
72147 | 26 | A | Mri chest spine w/dye | 1.92 | 0.66 | 0.66 | 0.09 | 2.67 | 2.67 | XXX |
72147 | TC | A | Mri chest spine w/dye | 0.00 | 13.38 | NA | 0.58 | 13.96 | NA | XXX |
72148 | A | Mri lumbar spine w/o dye | 1.48 | 12.90 | NA | 0.60 | 14.98 | NA | XXX | |
72148 | 26 | A | Mri lumbar spine w/o dye | 1.48 | 0.51 | 0.51 | 0.07 | 2.06 | 2.06 | XXX |
72148 | TC | A | Mri lumbar spine w/o dye | 0.00 | 12.39 | NA | 0.53 | 12.92 | NA | XXX |
72149 | A | Mri lumbar spine w/dye | 1.78 | 14.00 | NA | 0.67 | 16.45 | NA | XXX | |
72149 | 26 | A | Mri lumbar spine w/dye | 1.78 | 0.62 | 0.62 | 0.09 | 2.49 | 2.49 | XXX |
72149 | TC | A | Mri lumbar spine w/dye | 0.00 | 13.38 | NA | 0.58 | 13.96 | NA | XXX |
72156 | A | Mri neck spine w/ow/dye | 2.57 | 25.66 | NA | 1.20 | 29.43 | NA | XXX | |
72156 | 26 | A | Mri neck spine w/ow/dye | 2.57 | 0.88 | 0.88 | 0.11 | 3.56 | 3.56 | XXX |
72156 | TC | A | Mri neck spine w/ow/dye | 0.00 | 24.78 | NA | 1.09 | 25.87 | NA | XXX |
72157 | A | Mri chest spine w/ow/dye | 2.57 | 25.66 | NA | 1.20 | 29.43 | NA | XXX | |
72157 | 26 | A | Mri chest spine w/ow/dye | 2.57 | 0.88 | 0.88 | 0.11 | 3.56 | 3.56 | XXX |
72157 | TC | A | Mri chest spine w/ow/dye | 0.00 | 24.78 | NA | 1.09 | 25.87 | NA | XXX |
72158 | A | Mri lumbar spine w/ow/dye | 2.36 | 25.59 | NA | 1.20 | 29.15 | NA | XXX | |
72158 | 26 | A | Mri lumbar spine w/ow/dye | 2.36 | 0.81 | 0.81 | 0.11 | 3.28 | 3.28 | XXX |
72158 | TC | A | Mri lumbar spine w/ow/dye | 0.00 | 24.78 | NA | 1.09 | 25.87 | NA | XXX |
72159 | N | Mr angio spine w/ow/dye | +1.80 | 13.09 | NA | 0.61 | 15.50 | NA | XXX | |
72159 | 26 | N | Mr angio spine w/ow/dye | +1.80 | 0.70 | 0.70 | 0.08 | 2.58 | 2.58 | XXX |
72159 | TC | N | Mr angio spine w/ow/dye | +0.00 | 12.39 | NA | 0.53 | 12.92 | NA | XXX |
72170 | A | X-ray exam of pelvis | 0.17 | 0.58 | NA | 0.03 | 0.78 | NA | XXX | |
72170 | 26 | A | X-ray exam of pelvis | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX |
72170 | TC | A | X-ray exam of pelvis | 0.00 | 0.52 | NA | 0.02 | 0.54 | NA | XXX |
72190 | A | X-ray exam of pelvis | 0.21 | 0.74 | NA | 0.04 | 0.99 | NA | XXX | |
72190 | 26 | A | X-ray exam of pelvis | 0.21 | 0.07 | 0.07 | 0.01 | 0.29 | 0.29 | XXX |
72190 | TC | A | X-ray exam of pelvis | 0.00 | 0.67 | NA | 0.03 | 0.70 | NA | XXX |
72191 | A | Ct angiograph pelv w/ow/dye | 1.81 | 9.07 | NA | 0.38 | 11.26 | NA | XXX | |
72191 | 26 | A | Ct angiograph pelv w/ow/dye | 1.81 | 0.62 | 0.62 | 0.06 | 2.49 | 2.49 | XXX |
72191 | TC | A | Ct angiograph pelv w/ow/dye | 0.00 | 8.45 | NA | 0.32 | 8.77 | NA | XXX |
72192 | A | Ct pelvis w/o dye | 1.09 | 6.25 | NA | 0.31 | 7.65 | NA | XXX | |
72192 | 26 | A | Ct pelvis w/o dye | 1.09 | 0.37 | 0.37 | 0.05 | 1.51 | 1.51 | XXX |
72192 | TC | A | Ct pelvis w/o dye | 0.00 | 5.88 | NA | 0.26 | 6.14 | NA | XXX |
72193 | A | Ct pelvis w/dye | 1.16 | 7.21 | NA | 0.35 | 8.72 | NA | XXX | |
72193 | 26 | A | Ct pelvis w/dye | 1.16 | 0.39 | 0.39 | 0.05 | 1.60 | 1.60 | XXX |
72193 | TC | A | Ct pelvis w/dye | 0.00 | 6.82 | NA | 0.30 | 7.12 | NA | XXX |
72194 | A | Ct pelvis w/ow/dye | 1.22 | 8.86 | NA | 0.41 | 10.49 | NA | XXX | |
72194 | 26 | A | Ct pelvis w/ow/dye | 1.22 | 0.41 | 0.41 | 0.05 | 1.68 | 1.68 | XXX |
72194 | TC | A | Ct pelvis w/ow/dye | 0.00 | 8.45 | NA | 0.36 | 8.81 | NA | XXX |
72195 | A | Mri pelvis w/o dye | 1.46 | 11.66 | NA | 0.42 | 13.54 | NA | XXX | |
72195 | 26 | A | Mri pelvis w/o dye | 1.46 | 0.50 | 0.50 | 0.05 | 2.01 | 2.01 | XXX |
72195 | TC | A | Mri pelvis w/o dye | 0.00 | 11.16 | NA | 0.37 | 11.53 | NA | XXX |
72196 | A | Mri pelvis w/dye | 1.73 | 13.97 | NA | 0.48 | 16.18 | NA | XXX | |
72196 | 26 | A | Mri pelvis w/dye | 1.73 | 0.59 | 0.59 | 0.05 | 2.37 | 2.37 | XXX |
72196 | TC | A | Mri pelvis w/dye | 0.00 | 13.38 | NA | 0.43 | 13.81 | NA | XXX |
72197 | A | Mri pelvis w/o w/dye | 2.26 | 25.55 | NA | 0.84 | 28.65 | NA | XXX | |
72197 | 26 | A | Mri pelvis w/o w/dye | 2.26 | 0.77 | 0.77 | 0.08 | 3.11 | 3.11 | XXX |
72197 | TC | A | Mri pelvis w/o w/dye | 0.00 | 24.78 | NA | 0.76 | 25.54 | NA | XXX |
72198 | N | Mr angio pelvis w/ow/dye | +1.80 | 11.86 | NA | 0.57 | 14.23 | NA | XXX | |
72198 | 26 | N | Mr angio pelvis w/ow/dye | +1.80 | 0.70 | 0.70 | 0.08 | 2.58 | 2.58 | XXX |
72198 | TC | N | Mr angio pelvis w/ow/dye | +0.00 | 11.16 | NA | 0.49 | 11.65 | NA | XXX |
72200 | A | X-ray exam sacroiliac joints | 0.17 | 0.58 | NA | 0.03 | 0.78 | NA | XXX | |
72200 | 26 | A | X-ray exam sacroiliac joints | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX |
72200 | TC | A | X-ray exam sacroiliac joints | 0.00 | 0.52 | NA | 0.02 | 0.54 | NA | XXX |
72202 | A | X-ray exam sacroiliac joints | 0.19 | 0.68 | NA | 0.04 | 0.91 | NA | XXX | |
72202 | 26 | A | X-ray exam sacroiliac joints | 0.19 | 0.06 | 0.06 | 0.01 | 0.26 | 0.26 | XXX |
72202 | TC | A | X-ray exam sacroiliac joints | 0.00 | 0.62 | NA | 0.03 | 0.65 | NA | XXX |
72220 | A | X-ray exam of tailbone | 0.17 | 0.63 | NA | 0.04 | 0.84 | NA | XXX | |
72220 | 26 | A | X-ray exam of tailbone | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX |
72220 | TC | A | X-ray exam of tailbone | 0.00 | 0.57 | NA | 0.03 | 0.60 | NA | XXX |
72240 | A | Contrast x-ray of neck spine | 0.91 | 5.03 | NA | 0.25 | 6.19 | NA | XXX | |
72240 | 26 | A | Contrast x-ray of neck spine | 0.91 | 0.30 | 0.30 | 0.04 | 1.25 | 1.25 | XXX |
72240 | TC | A | Contrast x-ray of neck spine | 0.00 | 4.73 | NA | 0.21 | 4.94 | NA | XXX |
72255 | A | Contrast x-ray, thorax spine | 0.91 | 4.59 | NA | 0.22 | 5.72 | NA | XXX | |
72255 | 26 | A | Contrast x-ray, thorax spine | 0.91 | 0.28 | 0.28 | 0.04 | 1.23 | 1.23 | XXX |
72255 | TC | A | Contrast x-ray, thorax spine | 0.00 | 4.31 | NA | 0.18 | 4.49 | NA | XXX |
72265 | A | Contrast x-ray, lower spine | 0.83 | 4.31 | NA | 0.22 | 5.36 | NA | XXX | |
72265 | 26 | A | Contrast x-ray, lower spine | 0.83 | 0.26 | 0.26 | 0.04 | 1.13 | 1.13 | XXX |
72265 | TC | A | Contrast x-ray, lower spine | 0.00 | 4.05 | NA | 0.18 | 4.23 | NA | XXX |
72270 | A | Contrast x-ray of spine | 1.33 | 6.50 | NA | 0.34 | 8.17 | NA | XXX | |
72270 | 26 | A | Contrast x-ray of spine | 1.33 | 0.43 | 0.43 | 0.07 | 1.83 | 1.83 | XXX |
72270 | TC | A | Contrast x-ray of spine | 0.00 | 6.07 | NA | 0.27 | 6.34 | NA | XXX |
72275 | A | Epidurography | 0.76 | 2.29 | NA | 0.21 | 3.26 | NA | XXX | |
72275 | 26 | A | Epidurography | 0.76 | 0.20 | 0.20 | 0.03 | 0.99 | 0.99 | XXX |
72275 | TC | A | Epidurography | 0.00 | 2.09 | NA | 0.18 | 2.27 | NA | XXX |
72285 | A | X-ray c/t spine disk | 1.16 | 8.72 | NA | 0.42 | 10.30 | NA | XXX | |
72285 | 26 | A | X-ray c/t spine disk | 1.16 | 0.37 | 0.37 | 0.06 | 1.59 | 1.59 | XXX |
72285 | TC | A | X-ray c/t spine disk | 0.00 | 8.35 | NA | 0.36 | 8.71 | NA | XXX |
72295 | A | X-ray of lower spine disk | 0.83 | 8.10 | NA | 0.37 | 9.30 | NA | XXX | |
72295 | 26 | A | X-ray of lower spine disk | 0.83 | 0.28 | 0.28 | 0.04 | 1.15 | 1.15 | XXX |
72295 | TC | A | X-ray of lower spine disk | 0.00 | 7.82 | NA | 0.33 | 8.15 | NA | XXX |
73000 | A | X-ray exam of collar bone | 0.16 | 0.57 | NA | 0.03 | 0.76 | NA | XXX | |
73000 | 26 | A | X-ray exam of collar bone | 0.16 | 0.05 | 0.05 | 0.01 | 0.22 | 0.22 | XXX |
73000 | TC | A | X-ray exam of collar bone | 0.00 | 0.52 | NA | 0.02 | 0.54 | NA | XXX |
73010 | A | X-ray exam of shoulder blade | 0.17 | 0.58 | NA | 0.03 | 0.78 | NA | XXX | |
73010 | 26 | A | X-ray exam of shoulder blade | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX |
73010 | TC | A | X-ray exam of shoulder blade | 0.00 | 0.52 | NA | 0.02 | 0.54 | NA | XXX |
73020 | A | X-ray exam of shoulder | 0.15 | 0.52 | NA | 0.03 | 0.70 | NA | XXX | |
73020 | 26 | A | X-ray exam of shoulder | 0.15 | 0.05 | 0.05 | 0.01 | 0.21 | 0.21 | XXX |
73020 | TC | A | X-ray exam of shoulder | 0.00 | 0.47 | NA | 0.02 | 0.49 | NA | XXX |
73030 | A | X-ray exam of shoulder | 0.18 | 0.63 | NA | 0.04 | 0.85 | NA | XXX | |
73030 | 26 | A | X-ray exam of shoulder | 0.18 | 0.06 | 0.06 | 0.01 | 0.25 | 0.25 | XXX |
73030 | TC | A | X-ray exam of shoulder | 0.00 | 0.57 | NA | 0.03 | 0.60 | NA | XXX |
73040 | A | Contrast x-ray of shoulder | 0.54 | 2.27 | NA | 0.13 | 2.94 | NA | XXX | |
73040 | 26 | A | Contrast x-ray of shoulder | 0.54 | 0.18 | 0.18 | 0.03 | 0.75 | 0.75 | XXX |
73040 | TC | A | Contrast x-ray of shoulder | 0.00 | 2.09 | NA | 0.10 | 2.19 | NA | XXX |
73050 | A | X-ray exam of shoulders | 0.20 | 0.74 | NA | 0.05 | 0.99 | NA | XXX | |
73050 | 26 | A | X-ray exam of shoulders | 0.20 | 0.07 | 0.07 | 0.02 | 0.29 | 0.29 | XXX |
73050 | TC | A | X-ray exam of shoulders | 0.00 | 0.67 | NA | 0.03 | 0.70 | NA | XXX |
73060 | A | X-ray exam of humerus | 0.17 | 0.63 | NA | 0.04 | 0.84 | NA | XXX | |
73060 | 26 | A | X-ray exam of humerus | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX |
73060 | TC | A | X-ray exam of humerus | 0.00 | 0.57 | NA | 0.03 | 0.60 | NA | XXX |
73070 | A | X-ray exam of elbow | 0.15 | 0.57 | NA | 0.03 | 0.75 | NA | XXX | |
73070 | 26 | A | X-ray exam of elbow | 0.15 | 0.05 | 0.05 | 0.01 | 0.21 | 0.21 | XXX |
73070 | TC | A | X-ray exam of elbow | 0.00 | 0.52 | NA | 0.02 | 0.54 | NA | XXX |
73080 | A | X-ray exam of elbow | 0.17 | 0.63 | NA | 0.04 | 0.84 | NA | XXX | |
73080 | 26 | A | X-ray exam of elbow | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX |
73080 | TC | A | X-ray exam of elbow | 0.00 | 0.57 | NA | 0.03 | 0.60 | NA | XXX |
73085 | A | Contrast x-ray of elbow | 0.54 | 2.28 | NA | 0.13 | 2.95 | NA | XXX | |
73085 | 26 | A | Contrast x-ray of elbow | 0.54 | 0.19 | 0.19 | 0.03 | 0.76 | 0.76 | XXX |
73085 | TC | A | Contrast x-ray of elbow | 0.00 | 2.09 | NA | 0.10 | 2.19 | NA | XXX |
73090 | A | X-ray exam of forearm | 0.16 | 0.57 | NA | 0.03 | 0.76 | NA | XXX | |
73090 | 26 | A | X-ray exam of forearm | 0.16 | 0.05 | 0.05 | 0.01 | 0.22 | 0.22 | XXX |
73090 | TC | A | X-ray exam of forearm | 0.00 | 0.52 | NA | 0.02 | 0.54 | NA | XXX |
73092 | A | X-ray exam of arm, infant | 0.16 | 0.54 | NA | 0.03 | 0.73 | NA | XXX | |
73092 | 26 | A | X-ray exam of arm, infant | 0.16 | 0.05 | 0.05 | 0.01 | 0.22 | 0.22 | XXX |
73092 | TC | A | X-ray exam of arm, infant | 0.00 | 0.49 | NA | 0.02 | 0.51 | NA | XXX |
73100 | A | X-ray exam of wrist | 0.16 | 0.55 | NA | 0.04 | 0.75 | NA | XXX | |
73100 | 26 | A | X-ray exam of wrist | 0.16 | 0.06 | 0.06 | 0.02 | 0.24 | 0.24 | XXX |
73100 | TC | A | X-ray exam of wrist | 0.00 | 0.49 | NA | 0.02 | 0.51 | NA | XXX |
73110 | A | X-ray exam of wrist | 0.17 | 0.59 | NA | 0.03 | 0.79 | NA | XXX | |
73110 | 26 | A | X-ray exam of wrist | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX |
73110 | TC | A | X-ray exam of wrist | 0.00 | 0.53 | NA | 0.02 | 0.55 | NA | XXX |
73115 | A | Contrast x-ray of wrist | 0.54 | 1.76 | NA | 0.11 | 2.41 | NA | XXX | |
73115 | 26 | A | Contrast x-ray of wrist | 0.54 | 0.19 | 0.19 | 0.03 | 0.76 | 0.76 | XXX |
73115 | TC | A | Contrast x-ray of wrist | 0.00 | 1.57 | NA | 0.08 | 1.65 | NA | XXX |
73120 | A | X-ray exam of hand | 0.16 | 0.55 | NA | 0.03 | 0.74 | NA | XXX | |
73120 | 26 | A | X-ray exam of hand | 0.16 | 0.06 | 0.06 | 0.01 | 0.23 | 0.23 | XXX |
73120 | TC | A | X-ray exam of hand | 0.00 | 0.49 | NA | 0.02 | 0.51 | NA | XXX |
73130 | A | X-ray exam of hand | 0.17 | 0.59 | NA | 0.03 | 0.79 | NA | XXX | |
73130 | 26 | A | X-ray exam of hand | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX |
73130 | TC | A | X-ray exam of hand | 0.00 | 0.53 | NA | 0.02 | 0.55 | NA | XXX |
73140 | A | X-ray exam of finger(s) | 0.13 | 0.46 | NA | 0.03 | 0.62 | NA | XXX | |
73140 | 26 | A | X-ray exam of finger(s) | 0.13 | 0.04 | 0.04 | 0.01 | 0.18 | 0.18 | XXX |
73140 | TC | A | X-ray exam of finger(s) | 0.00 | 0.42 | NA | 0.02 | 0.44 | NA | XXX |
73200 | A | Ct upper extremity w/o dye | 1.09 | 5.31 | NA | 0.26 | 6.66 | NA | XXX | |
73200 | 26 | A | Ct upper extremity w/o dye | 1.09 | 0.37 | 0.37 | 0.05 | 1.51 | 1.51 | XXX |
73200 | TC | A | Ct upper extremity w/o dye | 0.00 | 4.94 | NA | 0.21 | 5.15 | NA | XXX |
73201 | A | Ct upper extremity w/dye | 1.16 | 6.28 | NA | 0.31 | 7.75 | NA | XXX | |
73201 | 26 | A | Ct upper extremity w/dye | 1.16 | 0.40 | 0.40 | 0.05 | 1.61 | 1.61 | XXX |
73201 | TC | A | Ct upper extremity w/dye | 0.00 | 5.88 | NA | 0.26 | 6.14 | NA | XXX |
73202 | A | Ct uppr extremity w/ow/dye | 1.22 | 7.81 | NA | 0.38 | 9.41 | NA | XXX | |
73202 | 26 | A | Ct uppr extremity w/ow/dye | 1.22 | 0.42 | 0.42 | 0.06 | 1.70 | 1.70 | XXX |
73202 | TC | A | Ct uppr extremity w/ow/dye | 0.00 | 7.39 | NA | 0.32 | 7.71 | NA | XXX |
73206 | A | Ct angio upr extrm w/ow/dye | 1.81 | 8.01 | NA | 0.38 | 10.20 | NA | XXX | |
73206 | 26 | A | Ct angio upr extrm w/ow/dye | 1.81 | 0.62 | 0.62 | 0.06 | 2.49 | 2.49 | XXX |
73206 | TC | A | Ct angio upr extrm w/ow/dye | 0.00 | 7.39 | NA | 0.32 | 7.71 | NA | XXX |
73218 | A | Mri upper extremity w/o dye | 1.35 | 11.62 | NA | 0.36 | 13.33 | NA | XXX | |
73218 | 26 | A | Mri upper extremity w/o dye | 1.35 | 0.46 | 0.46 | 0.04 | 1.85 | 1.85 | XXX |
73218 | TC | A | Mri upper extremity w/o dye | 0.00 | 11.16 | NA | 0.32 | 11.48 | NA | XXX |
73219 | A | Mri upper extremity w/dye | 1.62 | 13.94 | NA | 0.44 | 16.00 | NA | XXX | |
73219 | 26 | A | Mri upper extremity w/dye | 1.62 | 0.56 | 0.56 | 0.05 | 2.23 | 2.23 | XXX |
73219 | TC | A | Mri upper extremity w/dye | 0.00 | 13.38 | NA | 0.39 | 13.77 | NA | XXX |
73220 | A | Mri uppr extremity w/ow/dye | 2.15 | 25.52 | NA | 0.78 | 28.45 | NA | XXX | |
73220 | 26 | A | Mri uppr extremity w/ow/dye | 2.15 | 0.74 | 0.74 | 0.08 | 2.97 | 2.97 | XXX |
73220 | TC | A | Mri uppr extremity w/ow/dye | 0.00 | 24.78 | NA | 0.70 | 25.48 | NA | XXX |
73221 | A | Mri joint upr extrem w/o dye | 1.35 | 11.62 | NA | 0.36 | 13.33 | NA | XXX | |
73221 | 26 | A | Mri joint upr extrem w/o dye | 1.35 | 0.46 | 0.46 | 0.04 | 1.85 | 1.85 | XXX |
73221 | TC | A | Mri joint upr extrem w/o dye | 0.00 | 11.16 | NA | 0.32 | 11.48 | NA | XXX |
73222 | A | Mri joint upr extrem w/dye | 1.62 | 13.93 | NA | 0.44 | 15.99 | NA | XXX | |
73222 | 26 | A | Mri joint upr extrem w/dye | 1.62 | 0.55 | 0.55 | 0.05 | 2.22 | 2.22 | XXX |
73222 | TC | A | Mri joint upr extrem w/dye | 0.00 | 13.38 | NA | 0.39 | 13.77 | NA | XXX |
73223 | A | Mri joint upr extr w/ow/dye | 2.15 | 25.52 | NA | 0.77 | 28.44 | NA | XXX | |
73223 | 26 | A | Mri joint upr extr w/ow/dye | 2.15 | 0.74 | 0.74 | 0.07 | 2.96 | 2.96 | XXX |
73223 | TC | A | Mri joint upr extr w/ow/dye | 0.00 | 24.78 | NA | 0.70 | 25.48 | NA | XXX |
73225 | N | Mr angio upr extr w/ow/dye | +1.73 | 11.84 | NA | 0.57 | 14.14 | NA | XXX | |
73225 | 26 | N | Mr angio upr extr w/ow/dye | +1.73 | 0.68 | 0.68 | 0.08 | 2.49 | 2.49 | XXX |
73225 | TC | N | Mr angio upr extr w/ow/dye | +0.00 | 11.16 | NA | 0.49 | 11.65 | NA | XXX |
73500 | A | X-ray exam of hip | 0.17 | 0.53 | NA | 0.03 | 0.73 | NA | XXX | |
73500 | 26 | A | X-ray exam of hip | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX |
73500 | TC | A | X-ray exam of hip | 0.00 | 0.47 | NA | 0.02 | 0.49 | NA | XXX |
73510 | A | X-ray exam of hip | 0.21 | 0.64 | NA | 0.05 | 0.90 | NA | XXX | |
73510 | 26 | A | X-ray exam of hip | 0.21 | 0.07 | 0.07 | 0.02 | 0.30 | 0.30 | XXX |
73510 | TC | A | X-ray exam of hip | 0.00 | 0.57 | NA | 0.03 | 0.60 | NA | XXX |
73520 | A | X-ray exam of hips | 0.26 | 0.76 | NA | 0.05 | 1.07 | NA | XXX | |
73520 | 26 | A | X-ray exam of hips | 0.26 | 0.09 | 0.09 | 0.02 | 0.37 | 0.37 | XXX |
73520 | TC | A | X-ray exam of hips | 0.00 | 0.67 | NA | 0.03 | 0.70 | NA | XXX |
73525 | A | Contrast x-ray of hip | 0.54 | 2.27 | NA | 0.13 | 2.94 | NA | XXX | |
73525 | 26 | A | Contrast x-ray of hip | 0.54 | 0.18 | 0.18 | 0.03 | 0.75 | 0.75 | XXX |
73525 | TC | A | Contrast x-ray of hip | 0.00 | 2.09 | NA | 0.10 | 2.19 | NA | XXX |
73530 | A | X-ray exam of hip | 0.29 | 0.62 | NA | 0.03 | 0.94 | NA | XXX | |
73530 | 26 | A | X-ray exam of hip | 0.29 | 0.10 | 0.10 | 0.01 | 0.40 | 0.40 | XXX |
73530 | TC | A | X-ray exam of hip | 0.00 | 0.52 | NA | 0.02 | 0.54 | NA | XXX |
73540 | A | X-ray exam of pelvis hips | 0.20 | 0.64 | NA | 0.05 | 0.89 | NA | XXX | |
73540 | 26 | A | X-ray exam of pelvis hips | 0.20 | 0.07 | 0.07 | 0.02 | 0.29 | 0.29 | XXX |
73540 | TC | A | X-ray exam of pelvis hips | 0.00 | 0.57 | NA | 0.03 | 0.60 | NA | XXX |
73542 | A | X-ray exam, sacroiliac joint | 0.59 | 2.26 | NA | 0.13 | 2.98 | NA | XXX | |
73542 | 26 | A | X-ray exam, sacroiliac joint | 0.59 | 0.17 | 0.17 | 0.03 | 0.79 | 0.79 | XXX |
73542 | TC | A | X-ray exam, sacroiliac joint | 0.00 | 2.09 | NA | 0.10 | 2.19 | NA | XXX |
73550 | A | X-ray exam of thigh | 0.17 | 0.63 | NA | 0.04 | 0.84 | NA | XXX | |
73550 | 26 | A | X-ray exam of thigh | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX |
73550 | TC | A | X-ray exam of thigh | 0.00 | 0.57 | NA | 0.03 | 0.60 | NA | XXX |
73560 | A | X-ray exam of knee, 1 or 2 | 0.17 | 0.58 | NA | 0.04 | 0.79 | NA | XXX | |
73560 | 26 | A | X-ray exam of knee, 1 or 2 | 0.17 | 0.06 | 0.06 | 0.02 | 0.25 | 0.25 | XXX |
73560 | TC | A | X-ray exam of knee, 1 or 2 | 0.00 | 0.52 | NA | 0.02 | 0.54 | NA | XXX |
73562 | A | X-ray exam of knee, 3 | 0.18 | 0.63 | NA | 0.05 | 0.86 | NA | XXX | |
73562 | 26 | A | X-ray exam of knee, 3 | 0.18 | 0.06 | 0.06 | 0.02 | 0.26 | 0.26 | XXX |
73562 | TC | A | X-ray exam of knee, 3 | 0.00 | 0.57 | NA | 0.03 | 0.60 | NA | XXX |
73564 | A | X-ray exam, knee, 4 or more | 0.22 | 0.70 | NA | 0.05 | 0.97 | NA | XXX | |
73564 | 26 | A | X-ray exam, knee, 4 or more | 0.22 | 0.08 | 0.08 | 0.02 | 0.32 | 0.32 | XXX |
73564 | TC | A | X-ray exam, knee, 4 or more | 0.00 | 0.62 | NA | 0.03 | 0.65 | NA | XXX |
73565 | A | X-ray exam of knees | 0.17 | 0.55 | NA | 0.04 | 0.76 | NA | XXX | |
73565 | 26 | A | X-ray exam of knees | 0.17 | 0.06 | 0.06 | 0.02 | 0.25 | 0.25 | XXX |
73565 | TC | A | X-ray exam of knees | 0.00 | 0.49 | NA | 0.02 | 0.51 | NA | XXX |
73580 | A | Contrast x-ray of knee joint | 0.54 | 2.79 | NA | 0.15 | 3.48 | NA | XXX | |
73580 | 26 | A | Contrast x-ray of knee joint | 0.54 | 0.18 | 0.18 | 0.03 | 0.75 | 0.75 | XXX |
73580 | TC | A | Contrast x-ray of knee joint | 0.00 | 2.61 | NA | 0.12 | 2.73 | NA | XXX |
73590 | A | X-ray exam of lower leg | 0.17 | 0.58 | NA | 0.03 | 0.78 | NA | XXX | |
73590 | 26 | A | X-ray exam of lower leg | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX |
73590 | TC | A | X-ray exam of lower leg | 0.00 | 0.52 | NA | 0.02 | 0.54 | NA | XXX |
73592 | A | X-ray exam of leg, infant | 0.16 | 0.55 | NA | 0.03 | 0.74 | NA | XXX | |
73592 | 26 | A | X-ray exam of leg, infant | 0.16 | 0.06 | 0.06 | 0.01 | 0.23 | 0.23 | XXX |
73592 | TC | A | X-ray exam of leg, infant | 0.00 | 0.49 | NA | 0.02 | 0.51 | NA | XXX |
73600 | A | X-ray exam of ankle | 0.16 | 0.55 | NA | 0.03 | 0.74 | NA | XXX | |
73600 | 26 | A | X-ray exam of ankle | 0.16 | 0.06 | 0.06 | 0.01 | 0.23 | 0.23 | XXX |
73600 | TC | A | X-ray exam of ankle | 0.00 | 0.49 | NA | 0.02 | 0.51 | NA | XXX |
73610 | A | X-ray exam of ankle | 0.17 | 0.59 | NA | 0.03 | 0.79 | NA | XXX | |
73610 | 26 | A | X-ray exam of ankle | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX |
73610 | TC | A | X-ray exam of ankle | 0.00 | 0.53 | NA | 0.02 | 0.55 | NA | XXX |
73615 | A | Contrast x-ray of ankle | 0.54 | 2.28 | NA | 0.13 | 2.95 | NA | XXX | |
73615 | 26 | A | Contrast x-ray of ankle | 0.54 | 0.19 | 0.19 | 0.03 | 0.76 | 0.76 | XXX |
73615 | TC | A | Contrast x-ray of ankle | 0.00 | 2.09 | NA | 0.10 | 2.19 | NA | XXX |
73620 | A | X-ray exam of foot | 0.16 | 0.55 | NA | 0.03 | 0.74 | NA | XXX | |
73620 | 26 | A | X-ray exam of foot | 0.16 | 0.06 | 0.06 | 0.01 | 0.23 | 0.23 | XXX |
73620 | TC | A | X-ray exam of foot | 0.00 | 0.49 | NA | 0.02 | 0.51 | NA | XXX |
73630 | A | X-ray exam of foot | 0.17 | 0.59 | NA | 0.03 | 0.79 | NA | XXX | |
73630 | 26 | A | X-ray exam of foot | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX |
73630 | TC | A | X-ray exam of foot | 0.00 | 0.53 | NA | 0.02 | 0.55 | NA | XXX |
73650 | A | X-ray exam of heel | 0.16 | 0.53 | NA | 0.03 | 0.72 | NA | XXX | |
73650 | 26 | A | X-ray exam of heel | 0.16 | 0.06 | 0.06 | 0.01 | 0.23 | 0.23 | XXX |
73650 | TC | A | X-ray exam of heel | 0.00 | 0.47 | NA | 0.02 | 0.49 | NA | XXX |
73660 | A | X-ray exam of toe(s) | 0.13 | 0.46 | NA | 0.03 | 0.62 | NA | XXX | |
73660 | 26 | A | X-ray exam of toe(s) | 0.13 | 0.04 | 0.04 | 0.01 | 0.18 | 0.18 | XXX |
73660 | TC | A | X-ray exam of toe(s) | 0.00 | 0.42 | NA | 0.02 | 0.44 | NA | XXX |
73700 | A | Ct lower extremity w/o dye | 1.09 | 5.31 | NA | 0.26 | 6.66 | NA | XXX | |
73700 | 26 | A | Ct lower extremity w/o dye | 1.09 | 0.37 | 0.37 | 0.05 | 1.51 | 1.51 | XXX |
73700 | TC | A | Ct lower extremity w/o dye | 0.00 | 4.94 | NA | 0.21 | 5.15 | NA | XXX |
73701 | A | Ct lower extremity w/dye | 1.16 | 6.27 | NA | 0.31 | 7.74 | NA | XXX | |
73701 | 26 | A | Ct lower extremity w/dye | 1.16 | 0.39 | 0.39 | 0.05 | 1.60 | 1.60 | XXX |
73701 | TC | A | Ct lower extremity w/dye | 0.00 | 5.88 | NA | 0.26 | 6.14 | NA | XXX |
73702 | A | Ct lwr extremity w/ow/dye | 1.22 | 7.80 | NA | 0.37 | 9.39 | NA | XXX | |
73702 | 26 | A | Ct lwr extremity w/ow/dye | 1.22 | 0.41 | 0.41 | 0.05 | 1.68 | 1.68 | XXX |
73702 | TC | A | Ct lwr extremity w/ow/dye | 0.00 | 7.39 | NA | 0.32 | 7.71 | NA | XXX |
73706 | A | Ct angio lwr extr w/ow/dye | 1.90 | 8.04 | NA | 0.38 | 10.32 | NA | XXX | |
73706 | 26 | A | Ct angio lwr extr w/ow/dye | 1.90 | 0.65 | 0.65 | 0.06 | 2.61 | 2.61 | XXX |
73706 | TC | A | Ct angio lwr extr w/ow/dye | 0.00 | 7.39 | NA | 0.32 | 7.71 | NA | XXX |
73718 | A | Mri lower extremity w/o dye | 1.35 | 11.62 | NA | 0.36 | 13.33 | NA | XXX | |
73718 | 26 | A | Mri lower extremity w/o dye | 1.35 | 0.46 | 0.46 | 0.04 | 1.85 | 1.85 | XXX |
73718 | TC | A | Mri lower extremity w/o dye | 0.00 | 11.16 | NA | 0.32 | 11.48 | NA | XXX |
73719 | A | Mri lower extremity w/dye | 1.62 | 13.93 | NA | 0.44 | 15.99 | NA | XXX | |
73719 | 26 | A | Mri lower extremity w/dye | 1.62 | 0.55 | 0.55 | 0.05 | 2.22 | 2.22 | XXX |
73719 | TC | A | Mri lower extremity w/dye | 0.00 | 13.38 | NA | 0.39 | 13.77 | NA | XXX |
73720 | A | Mri lwr extremity w/ow/dye | 2.15 | 25.51 | NA | 0.78 | 28.44 | NA | XXX | |
73720 | 26 | A | Mri lwr extremity w/ow/dye | 2.15 | 0.73 | 0.73 | 0.08 | 2.96 | 2.96 | XXX |
73720 | TC | A | Mri lwr extremity w/ow/dye | 0.00 | 24.78 | NA | 0.70 | 25.48 | NA | XXX |
73721 | A | Mri jnt of lwr extre w/o dye | 1.35 | 11.62 | NA | 0.36 | 13.33 | NA | XXX | |
73721 | 26 | A | Mri jnt of lwr extre w/o dye | 1.35 | 0.46 | 0.46 | 0.04 | 1.85 | 1.85 | XXX |
73721 | TC | A | Mri jnt of lwr extre w/o dye | 0.00 | 11.16 | NA | 0.32 | 11.48 | NA | XXX |
73722 | A | Mri joint of lwr extr w/dye | 1.62 | 13.94 | NA | 0.45 | 16.01 | NA | XXX | |
73722 | 26 | A | Mri joint of lwr extr w/dye | 1.62 | 0.56 | 0.56 | 0.06 | 2.24 | 2.24 | XXX |
73722 | TC | A | Mri joint of lwr extr w/dye | 0.00 | 13.38 | NA | 0.39 | 13.77 | NA | XXX |
73723 | A | Mri joint lwr extr w/ow/dye | 2.15 | 25.52 | NA | 0.77 | 28.44 | NA | XXX | |
73723 | 26 | A | Mri joint lwr extr w/ow/dye | 2.15 | 0.74 | 0.74 | 0.07 | 2.96 | 2.96 | XXX |
73723 | TC | A | Mri joint lwr extr w/ow/dye | 0.00 | 24.78 | NA | 0.70 | 25.48 | NA | XXX |
73725 | R | Mr ang lwr ext w or w/o dye | 1.82 | 11.78 | NA | 0.57 | 14.17 | NA | XXX | |
73725 | 26 | R | Mr ang lwr ext w or w/o dye | 1.82 | 0.62 | 0.62 | 0.08 | 2.52 | 2.52 | XXX |
73725 | TC | R | Mr ang lwr ext w or w/o dye | 0.00 | 11.16 | NA | 0.49 | 11.65 | NA | XXX |
74000 | A | X-ray exam of abdomen | 0.18 | 0.58 | NA | 0.03 | 0.79 | NA | XXX | |
74000 | 26 | A | X-ray exam of abdomen | 0.18 | 0.06 | 0.06 | 0.01 | 0.25 | 0.25 | XXX |
74000 | TC | A | X-ray exam of abdomen | 0.00 | 0.52 | NA | 0.02 | 0.54 | NA | XXX |
74010 | A | X-ray exam of abdomen | 0.23 | 0.65 | NA | 0.04 | 0.92 | NA | XXX | |
74010 | 26 | A | X-ray exam of abdomen | 0.23 | 0.08 | 0.08 | 0.01 | 0.32 | 0.32 | XXX |
74010 | TC | A | X-ray exam of abdomen | 0.00 | 0.57 | NA | 0.03 | 0.60 | NA | XXX |
74020 | A | X-ray exam of abdomen | 0.27 | 0.71 | NA | 0.04 | 1.02 | NA | XXX | |
74020 | 26 | A | X-ray exam of abdomen | 0.27 | 0.09 | 0.09 | 0.01 | 0.37 | 0.37 | XXX |
74020 | TC | A | X-ray exam of abdomen | 0.00 | 0.62 | NA | 0.03 | 0.65 | NA | XXX |
74022 | A | X-ray exam series, abdomen | 0.32 | 0.85 | NA | 0.05 | 1.22 | NA | XXX | |
74022 | 26 | A | X-ray exam series, abdomen | 0.32 | 0.11 | 0.11 | 0.01 | 0.44 | 0.44 | XXX |
74022 | TC | A | X-ray exam series, abdomen | 0.00 | 0.74 | NA | 0.04 | 0.78 | NA | XXX |
74150 | A | Ct abdomen w/o dye | 1.19 | 6.03 | NA | 0.30 | 7.52 | NA | XXX | |
74150 | 26 | A | Ct abdomen w/o dye | 1.19 | 0.40 | 0.40 | 0.05 | 1.64 | 1.64 | XXX |
74150 | TC | A | Ct abdomen w/o dye | 0.00 | 5.63 | NA | 0.25 | 5.88 | NA | XXX |
74160 | A | Ct abdomen w/dye | 1.27 | 7.25 | NA | 0.36 | 8.88 | NA | XXX | |
74160 | 26 | A | Ct abdomen w/dye | 1.27 | 0.43 | 0.43 | 0.06 | 1.76 | 1.76 | XXX |
74160 | TC | A | Ct abdomen w/dye | 0.00 | 6.82 | NA | 0.30 | 7.12 | NA | XXX |
74170 | A | Ct abdomen w/ow/dye | 1.40 | 8.93 | NA | 0.42 | 10.75 | NA | XXX | |
74170 | 26 | A | Ct abdomen w/ow/dye | 1.40 | 0.48 | 0.48 | 0.06 | 1.94 | 1.94 | XXX |
74170 | TC | A | Ct abdomen w/ow/dye | 0.00 | 8.45 | NA | 0.36 | 8.81 | NA | XXX |
74175 | A | Ct angio abdom w/ow/dye | 1.90 | 9.10 | NA | 0.38 | 11.38 | NA | XXX | |
74175 | 26 | A | Ct angio abdom w/ow/dye | 1.90 | 0.65 | 0.65 | 0.06 | 2.61 | 2.61 | XXX |
74175 | TC | A | Ct angio abdom w/ow/dye | 0.00 | 8.45 | NA | 0.32 | 8.77 | NA | XXX |
74181 | A | Mri abdomen w/o dye | 1.46 | 11.66 | NA | 0.43 | 13.55 | NA | XXX | |
74181 | 26 | A | Mri abdomen w/o dye | 1.46 | 0.50 | 0.50 | 0.06 | 2.02 | 2.02 | XXX |
74181 | TC | A | Mri abdomen w/o dye | 0.00 | 11.16 | NA | 0.37 | 11.53 | NA | XXX |
74182 | A | Mri abdomen w/dye | 1.73 | 13.97 | NA | 0.49 | 16.19 | NA | XXX | |
74182 | 26 | A | Mri abdomen w/dye | 1.73 | 0.59 | 0.59 | 0.06 | 2.38 | 2.38 | XXX |
74182 | TC | A | Mri abdomen w/dye | 0.00 | 13.38 | NA | 0.43 | 13.81 | NA | XXX |
74183 | A | Mri abdomen w/ow/dye | 2.26 | 25.55 | NA | 0.84 | 28.65 | NA | XXX | |
74183 | 26 | A | Mri abdomen w/ow/dye | 2.26 | 0.77 | 0.77 | 0.08 | 3.11 | 3.11 | XXX |
74183 | TC | A | Mri abdomen w/ow/dye | 0.00 | 24.78 | NA | 0.76 | 25.54 | NA | XXX |
74185 | R | Mri angio, abdom w or w/o dy | 1.80 | 11.77 | NA | 0.57 | 14.14 | NA | XXX | |
74185 | 26 | R | Mri angio, abdom w or w/o dy | 1.80 | 0.61 | 0.61 | 0.08 | 2.49 | 2.49 | XXX |
74185 | TC | R | Mri angio, abdom w or w/o dy | 0.00 | 11.16 | NA | 0.49 | 11.65 | NA | XXX |
74190 | A | X-ray exam of peritoneum | 0.48 | 1.46 | NA | 0.08 | 2.02 | NA | XXX | |
74190 | 26 | A | X-ray exam of peritoneum | 0.48 | 0.16 | 0.16 | 0.02 | 0.66 | 0.66 | XXX |
74190 | TC | A | X-ray exam of peritoneum | 0.00 | 1.30 | NA | 0.06 | 1.36 | NA | XXX |
74210 | A | Contrst x-ray exam of throat | 0.36 | 1.30 | NA | 0.07 | 1.73 | NA | XXX | |
74210 | 26 | A | Contrst x-ray exam of throat | 0.36 | 0.12 | 0.12 | 0.02 | 0.50 | 0.50 | XXX |
74210 | TC | A | Contrst x-ray exam of throat | 0.00 | 1.18 | NA | 0.05 | 1.23 | NA | XXX |
74220 | A | Contrast x-ray, esophagus | 0.46 | 1.34 | NA | 0.07 | 1.87 | NA | XXX | |
74220 | 26 | A | Contrast x-ray, esophagus | 0.46 | 0.16 | 0.16 | 0.02 | 0.64 | 0.64 | XXX |
74220 | TC | A | Contrast x-ray, esophagus | 0.00 | 1.18 | NA | 0.05 | 1.23 | NA | XXX |
74230 | A | Cine/vid x-ray, throat/esoph | 0.53 | 1.48 | NA | 0.08 | 2.09 | NA | XXX | |
74230 | 26 | A | Cine/vid x-ray, throat/esoph | 0.53 | 0.18 | 0.18 | 0.02 | 0.73 | 0.73 | XXX |
74230 | TC | A | Cine/vid x-ray, throat/esoph | 0.00 | 1.30 | NA | 0.06 | 1.36 | NA | XXX |
74235 | A | Remove esophagus obstruction | 1.19 | 3.02 | NA | 0.17 | 4.38 | NA | XXX | |
74235 | 26 | A | Remove esophagus obstruction | 1.19 | 0.41 | 0.41 | 0.05 | 1.65 | 1.65 | XXX |
74235 | TC | A | Remove esophagus obstruction | 0.00 | 2.61 | NA | 0.12 | 2.73 | NA | XXX |
74240 | A | X-ray exam, upper gi tract | 0.69 | 1.68 | NA | 0.10 | 2.47 | NA | XXX | |
74240 | 26 | A | X-ray exam, upper gi tract | 0.69 | 0.23 | 0.23 | 0.03 | 0.95 | 0.95 | XXX |
74240 | TC | A | X-ray exam, upper gi tract | 0.00 | 1.45 | NA | 0.07 | 1.52 | NA | XXX |
74241 | A | X-ray exam, upper gi tract | 0.69 | 1.71 | NA | 0.10 | 2.50 | NA | XXX | |
74241 | 26 | A | X-ray exam, upper gi tract | 0.69 | 0.23 | 0.23 | 0.03 | 0.95 | 0.95 | XXX |
74241 | TC | A | X-ray exam, upper gi tract | 0.00 | 1.48 | NA | 0.07 | 1.55 | NA | XXX |
74245 | A | X-ray exam, upper gi tract | 0.91 | 2.68 | NA | 0.15 | 3.74 | NA | XXX | |
74245 | 26 | A | X-ray exam, upper gi tract | 0.91 | 0.31 | 0.31 | 0.04 | 1.26 | 1.26 | XXX |
74245 | TC | A | X-ray exam, upper gi tract | 0.00 | 2.37 | NA | 0.11 | 2.48 | NA | XXX |
74246 | A | Contrst x-ray uppr gi tract | 0.69 | 1.86 | NA | 0.11 | 2.66 | NA | XXX | |
74246 | 26 | A | Contrst x-ray uppr gi tract | 0.69 | 0.23 | 0.23 | 0.03 | 0.95 | 0.95 | XXX |
74246 | TC | A | Contrst x-ray uppr gi tract | 0.00 | 1.63 | NA | 0.08 | 1.71 | NA | XXX |
74247 | A | Contrst x-ray uppr gi tract | 0.69 | 1.90 | NA | 0.12 | 2.71 | NA | XXX | |
74247 | 26 | A | Contrst x-ray uppr gi tract | 0.69 | 0.23 | 0.23 | 0.03 | 0.95 | 0.95 | XXX |
74247 | TC | A | Contrst x-ray uppr gi tract | 0.00 | 1.67 | NA | 0.09 | 1.76 | NA | XXX |
74249 | A | Contrst x-ray uppr gi tract | 0.91 | 2.87 | NA | 0.16 | 3.94 | NA | XXX | |
74249 | 26 | A | Contrst x-ray uppr gi tract | 0.91 | 0.31 | 0.31 | 0.04 | 1.26 | 1.26 | XXX |
74249 | TC | A | Contrst x-ray uppr gi tract | 0.00 | 2.56 | NA | 0.12 | 2.68 | NA | XXX |
74250 | A | X-ray exam of small bowel | 0.47 | 1.46 | NA | 0.08 | 2.01 | NA | XXX | |
74250 | 26 | A | X-ray exam of small bowel | 0.47 | 0.16 | 0.16 | 0.02 | 0.65 | 0.65 | XXX |
74250 | TC | A | X-ray exam of small bowel | 0.00 | 1.30 | NA | 0.06 | 1.36 | NA | XXX |
74251 | A | X-ray exam of small bowel | 0.69 | 1.53 | NA | 0.09 | 2.31 | NA | XXX | |
74251 | 26 | A | X-ray exam of small bowel | 0.69 | 0.23 | 0.23 | 0.03 | 0.95 | 0.95 | XXX |
74251 | TC | A | X-ray exam of small bowel | 0.00 | 1.30 | NA | 0.06 | 1.36 | NA | XXX |
74260 | A | X-ray exam of small bowel | 0.50 | 1.65 | NA | 0.09 | 2.24 | NA | XXX | |
74260 | 26 | A | X-ray exam of small bowel | 0.50 | 0.17 | 0.17 | 0.02 | 0.69 | 0.69 | XXX |
74260 | TC | A | X-ray exam of small bowel | 0.00 | 1.48 | NA | 0.07 | 1.55 | NA | XXX |
74270 | A | Contrast x-ray exam of colon | 0.69 | 1.92 | NA | 0.12 | 2.73 | NA | XXX | |
74270 | 26 | A | Contrast x-ray exam of colon | 0.69 | 0.23 | 0.23 | 0.03 | 0.95 | 0.95 | XXX |
74270 | TC | A | Contrast x-ray exam of colon | 0.00 | 1.69 | NA | 0.09 | 1.78 | NA | XXX |
74280 | A | Contrast x-ray exam of colon | 0.99 | 2.56 | NA | 0.15 | 3.70 | NA | XXX | |
74280 | 26 | A | Contrast x-ray exam of colon | 0.99 | 0.34 | 0.34 | 0.04 | 1.37 | 1.37 | XXX |
74280 | TC | A | Contrast x-ray exam of colon | 0.00 | 2.22 | NA | 0.11 | 2.33 | NA | XXX |
74283 | A | Contrast x-ray exam of colon | 2.02 | 3.24 | NA | 0.21 | 5.47 | NA | XXX | |
74283 | 26 | A | Contrast x-ray exam of colon | 2.02 | 0.69 | 0.69 | 0.09 | 2.80 | 2.80 | XXX |
74283 | TC | A | Contrast x-ray exam of colon | 0.00 | 2.55 | NA | 0.12 | 2.67 | NA | XXX |
74290 | A | Contrast x-ray, gallbladder | 0.32 | 0.85 | NA | 0.05 | 1.22 | NA | XXX | |
74290 | 26 | A | Contrast x-ray, gallbladder | 0.32 | 0.11 | 0.11 | 0.01 | 0.44 | 0.44 | XXX |
74290 | TC | A | Contrast x-ray, gallbladder | 0.00 | 0.74 | NA | 0.04 | 0.78 | NA | XXX |
74291 | A | Contrast x-rays, gallbladder | 0.20 | 0.49 | NA | 0.03 | 0.72 | NA | XXX | |
74291 | 26 | A | Contrast x-rays, gallbladder | 0.20 | 0.07 | 0.07 | 0.01 | 0.28 | 0.28 | XXX |
74291 | TC | A | Contrast x-rays, gallbladder | 0.00 | 0.42 | NA | 0.02 | 0.44 | NA | XXX |
74300 | C | X-ray bile ducts/pancreas | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
74300 | 26 | A | X-ray bile ducts/pancreas | 0.36 | 0.12 | 0.12 | 0.02 | 0.50 | 0.50 | XXX |
74300 | TC | C | X-ray bile ducts/pancreas | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
74301 | C | X-rays at surgery add-on | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | |
74301 | 26 | A | X-rays at surgery add-on | 0.21 | 0.07 | 0.07 | 0.01 | 0.29 | 0.29 | ZZZ |
74301 | TC | C | X-rays at surgery add-on | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ |
74305 | A | X-ray bile ducts/pancreas | 0.42 | 0.92 | NA | 0.06 | 1.40 | NA | XXX | |
74305 | 26 | A | X-ray bile ducts/pancreas | 0.42 | 0.14 | 0.14 | 0.02 | 0.58 | 0.58 | XXX |
74305 | TC | A | X-ray bile ducts/pancreas | 0.00 | 0.78 | NA | 0.04 | 0.82 | NA | XXX |
74320 | A | Contrast x-ray of bile ducts | 0.54 | 3.31 | NA | 0.16 | 4.01 | NA | XXX | |
74320 | 26 | A | Contrast x-ray of bile ducts | 0.54 | 0.18 | 0.18 | 0.02 | 0.74 | 0.74 | XXX |
74320 | TC | A | Contrast x-ray of bile ducts | 0.00 | 3.13 | NA | 0.14 | 3.27 | NA | XXX |
74327 | A | X-ray bile stone removal | 0.70 | 1.99 | NA | 0.12 | 2.81 | NA | XXX | |
74327 | 26 | A | X-ray bile stone removal | 0.70 | 0.24 | 0.24 | 0.03 | 0.97 | 0.97 | XXX |
74327 | TC | A | X-ray bile stone removal | 0.00 | 1.75 | NA | 0.09 | 1.84 | NA | XXX |
74328 | A | X-ray bile duct endoscopy | 0.70 | 3.37 | NA | 0.17 | 4.24 | NA | XXX | |
74328 | 26 | A | X-ray bile duct endoscopy | 0.70 | 0.24 | 0.24 | 0.03 | 0.97 | 0.97 | XXX |
74328 | TC | A | X-ray bile duct endoscopy | 0.00 | 3.13 | NA | 0.14 | 3.27 | NA | XXX |
74329 | A | X-ray for pancreas endoscopy | 0.70 | 3.37 | NA | 0.17 | 4.24 | NA | XXX | |
74329 | 26 | A | X-ray for pancreas endoscopy | 0.70 | 0.24 | 0.24 | 0.03 | 0.97 | 0.97 | XXX |
74329 | TC | A | X-ray for pancreas endoscopy | 0.00 | 3.13 | NA | 0.14 | 3.27 | NA | XXX |
74330 | A | X-ray bile/panc endoscopy | 0.90 | 3.44 | NA | 0.18 | 4.52 | NA | XXX | |
74330 | 26 | A | X-ray bile/panc endoscopy | 0.90 | 0.31 | 0.31 | 0.04 | 1.25 | 1.25 | XXX |
74330 | TC | A | X-ray bile/panc endoscopy | 0.00 | 3.13 | NA | 0.14 | 3.27 | NA | XXX |
74340 | A | X-ray guide for GI tube | 0.54 | 2.79 | NA | 0.14 | 3.47 | NA | XXX | |
74340 | 26 | A | X-ray guide for GI tube | 0.54 | 0.18 | 0.18 | 0.02 | 0.74 | 0.74 | XXX |
74340 | TC | A | X-ray guide for GI tube | 0.00 | 2.61 | NA | 0.12 | 2.73 | NA | XXX |
74350 | A | X-ray guide, stomach tube | 0.76 | 3.39 | NA | 0.17 | 4.32 | NA | XXX | |
74350 | 26 | A | X-ray guide, stomach tube | 0.76 | 0.26 | 0.26 | 0.03 | 1.05 | 1.05 | XXX |
74350 | TC | A | X-ray guide, stomach tube | 0.00 | 3.13 | NA | 0.14 | 3.27 | NA | XXX |
74355 | A | X-ray guide, intestinal tube | 0.76 | 2.87 | NA | 0.15 | 3.78 | NA | XXX | |
74355 | 26 | A | X-ray guide, intestinal tube | 0.76 | 0.26 | 0.26 | 0.03 | 1.05 | 1.05 | XXX |
74355 | TC | A | X-ray guide, intestinal tube | 0.00 | 2.61 | NA | 0.12 | 2.73 | NA | XXX |
74360 | A | X-ray guide, GI dilation | 0.54 | 3.32 | NA | 0.16 | 4.02 | NA | XXX | |
74360 | 26 | A | X-ray guide, GI dilation | 0.54 | 0.19 | 0.19 | 0.02 | 0.75 | 0.75 | XXX |
74360 | TC | A | X-ray guide, GI dilation | 0.00 | 3.13 | NA | 0.14 | 3.27 | NA | XXX |
74363 | A | X-ray, bile duct dilation | 0.88 | 6.37 | NA | 0.31 | 7.56 | NA | XXX | |
74363 | 26 | A | X-ray, bile duct dilation | 0.88 | 0.30 | 0.30 | 0.04 | 1.22 | 1.22 | XXX |
74363 | TC | A | X-ray, bile duct dilation | 0.00 | 6.07 | NA | 0.27 | 6.34 | NA | XXX |
74400 | A | Contrst x-ray, urinary tract | 0.49 | 1.84 | NA | 0.11 | 2.44 | NA | XXX | |
74400 | 26 | A | Contrst x-ray, urinary tract | 0.49 | 0.17 | 0.17 | 0.02 | 0.68 | 0.68 | XXX |
74400 | TC | A | Contrst x-ray, urinary tract | 0.00 | 1.67 | NA | 0.09 | 1.76 | NA | XXX |
74410 | A | Contrst x-ray, urinary tract | 0.49 | 2.11 | NA | 0.11 | 2.71 | NA | XXX | |
74410 | 26 | A | Contrst x-ray, urinary tract | 0.49 | 0.17 | 0.17 | 0.02 | 0.68 | 0.68 | XXX |
74410 | TC | A | Contrst x-ray, urinary tract | 0.00 | 1.94 | NA | 0.09 | 2.03 | NA | XXX |
74415 | A | Contrst x-ray, urinary tract | 0.49 | 2.28 | NA | 0.12 | 2.89 | NA | XXX | |
74415 | 26 | A | Contrst x-ray, urinary tract | 0.49 | 0.17 | 0.17 | 0.02 | 0.68 | 0.68 | XXX |
74415 | TC | A | Contrst x-ray, urinary tract | 0.00 | 2.11 | NA | 0.10 | 2.21 | NA | XXX |
74420 | A | Contrst x-ray, urinary tract | 0.36 | 2.73 | NA | 0.14 | 3.23 | NA | XXX | |
74420 | 26 | A | Contrst x-ray, urinary tract | 0.36 | 0.12 | 0.12 | 0.02 | 0.50 | 0.50 | XXX |
74420 | TC | A | Contrst x-ray, urinary tract | 0.00 | 2.61 | NA | 0.12 | 2.73 | NA | XXX |
74425 | A | Contrst x-ray, urinary tract | 0.36 | 1.42 | NA | 0.08 | 1.86 | NA | XXX | |
74425 | 26 | A | Contrst x-ray, urinary tract | 0.36 | 0.12 | 0.12 | 0.02 | 0.50 | 0.50 | XXX |
74425 | TC | A | Contrst x-ray, urinary tract | 0.00 | 1.30 | NA | 0.06 | 1.36 | NA | XXX |
74430 | A | Contrast x-ray, bladder | 0.32 | 1.15 | NA | 0.07 | 1.54 | NA | XXX | |
74430 | 26 | A | Contrast x-ray, bladder | 0.32 | 0.11 | 0.11 | 0.02 | 0.45 | 0.45 | XXX |
74430 | TC | A | Contrast x-ray, bladder | 0.00 | 1.04 | NA | 0.05 | 1.09 | NA | XXX |
74440 | A | X-ray, male genital tract | 0.38 | 1.25 | NA | 0.07 | 1.70 | NA | XXX | |
74440 | 26 | A | X-ray, male genital tract | 0.38 | 0.13 | 0.13 | 0.02 | 0.53 | 0.53 | XXX |
74440 | TC | A | X-ray, male genital tract | 0.00 | 1.12 | NA | 0.05 | 1.17 | NA | XXX |
74445 | A | X-ray exam of penis | 1.14 | 1.50 | NA | 0.10 | 2.74 | NA | XXX | |
74445 | 26 | A | X-ray exam of penis | 1.14 | 0.38 | 0.38 | 0.05 | 1.57 | 1.57 | XXX |
74445 | TC | A | X-ray exam of penis | 0.00 | 1.12 | NA | 0.05 | 1.17 | NA | XXX |
74450 | A | X-ray, urethra/bladder | 0.33 | 1.56 | NA | 0.09 | 1.98 | NA | XXX | |
74450 | 26 | A | X-ray, urethra/bladder | 0.33 | 0.11 | 0.11 | 0.02 | 0.46 | 0.46 | XXX |
74450 | TC | A | X-ray, urethra/bladder | 0.00 | 1.45 | NA | 0.07 | 1.52 | NA | XXX |
74455 | A | X-ray, urethra/bladder | 0.33 | 1.68 | NA | 0.10 | 2.11 | NA | XXX | |
74455 | 26 | A | X-ray, urethra/bladder | 0.33 | 0.11 | 0.11 | 0.02 | 0.46 | 0.46 | XXX |
74455 | TC | A | X-ray, urethra/bladder | 0.00 | 1.57 | NA | 0.08 | 1.65 | NA | XXX |
74470 | A | X-ray exam of kidney lesion | 0.54 | 1.42 | NA | 0.08 | 2.04 | NA | XXX | |
74470 | 26 | A | X-ray exam of kidney lesion | 0.54 | 0.18 | 0.18 | 0.02 | 0.74 | 0.74 | XXX |
74470 | TC | A | X-ray exam of kidney lesion | 0.00 | 1.24 | NA | 0.06 | 1.30 | NA | XXX |
74475 | A | X-ray control, cath insert | 0.54 | 4.23 | NA | 0.20 | 4.97 | NA | XXX | |
74475 | 26 | A | X-ray control, cath insert | 0.54 | 0.18 | 0.18 | 0.02 | 0.74 | 0.74 | XXX |
74475 | TC | A | X-ray control, cath insert | 0.00 | 4.05 | NA | 0.18 | 4.23 | NA | XXX |
74480 | A | X-ray control, cath insert | 0.54 | 4.23 | NA | 0.20 | 4.97 | NA | XXX | |
74480 | 26 | A | X-ray control, cath insert | 0.54 | 0.18 | 0.18 | 0.02 | 0.74 | 0.74 | XXX |
74480 | TC | A | X-ray control, cath insert | 0.00 | 4.05 | NA | 0.18 | 4.23 | NA | XXX |
74485 | A | X-ray guide, GU dilation | 0.54 | 3.31 | NA | 0.17 | 4.02 | NA | XXX | |
74485 | 26 | A | X-ray guide, GU dilation | 0.54 | 0.18 | 0.18 | 0.03 | 0.75 | 0.75 | XXX |
74485 | TC | A | X-ray guide, GU dilation | 0.00 | 3.13 | NA | 0.14 | 3.27 | NA | XXX |
74710 | A | X-ray measurement of pelvis | 0.34 | 1.16 | NA | 0.07 | 1.57 | NA | XXX | |
74710 | 26 | A | X-ray measurement of pelvis | 0.34 | 0.12 | 0.12 | 0.02 | 0.48 | 0.48 | XXX |
74710 | TC | A | X-ray measurement of pelvis | 0.00 | 1.04 | NA | 0.05 | 1.09 | NA | XXX |
74740 | A | X-ray, female genital tract | 0.38 | 1.43 | NA | 0.08 | 1.89 | NA | XXX | |
74740 | 26 | A | X-ray, female genital tract | 0.38 | 0.13 | 0.13 | 0.02 | 0.53 | 0.53 | XXX |
74740 | TC | A | X-ray, female genital tract | 0.00 | 1.30 | NA | 0.06 | 1.36 | NA | XXX |
74742 | A | X-ray, fallopian tube | 0.61 | 3.34 | NA | 0.16 | 4.11 | NA | XXX | |
74742 | 26 | A | X-ray, fallopian tube | 0.61 | 0.21 | 0.21 | 0.02 | 0.84 | 0.84 | XXX |
74742 | TC | A | X-ray, fallopian tube | 0.00 | 3.13 | NA | 0.14 | 3.27 | NA | XXX |
74775 | A | X-ray exam of perineum | 0.62 | 1.67 | NA | 0.10 | 2.39 | NA | XXX | |
74775 | 26 | A | X-ray exam of perineum | 0.62 | 0.22 | 0.22 | 0.03 | 0.87 | 0.87 | XXX |
74775 | TC | A | X-ray exam of perineum | 0.00 | 1.45 | NA | 0.07 | 1.52 | NA | XXX |
75552 | A | Heart mri for morph w/o dye | 1.60 | 11.71 | NA | 0.56 | 13.87 | NA | XXX | |
75552 | 26 | A | Heart mri for morph w/o dye | 1.60 | 0.55 | 0.55 | 0.07 | 2.22 | 2.22 | XXX |
75552 | TC | A | Heart mri for morph w/o dye | 0.00 | 11.16 | NA | 0.49 | 11.65 | NA | XXX |
75553 | A | Heart mri for morph w/dye | 2.00 | 11.84 | NA | 0.58 | 14.42 | NA | XXX | |
75553 | 26 | A | Heart mri for morph w/dye | 2.00 | 0.68 | 0.68 | 0.09 | 2.77 | 2.77 | XXX |
75553 | TC | A | Heart mri for morph w/dye | 0.00 | 11.16 | NA | 0.49 | 11.65 | NA | XXX |
75554 | A | Cardiac MRI/function | 1.83 | 11.83 | NA | 0.56 | 14.22 | NA | XXX | |
75554 | 26 | A | Cardiac MRI/function | 1.83 | 0.67 | 0.67 | 0.07 | 2.57 | 2.57 | XXX |
75554 | TC | A | Cardiac MRI/function | 0.00 | 11.16 | NA | 0.49 | 11.65 | NA | XXX |
75555 | A | Cardiac MRI/limited study | 1.74 | 11.82 | NA | 0.56 | 14.12 | NA | XXX | |
75555 | 26 | A | Cardiac MRI/limited study | 1.74 | 0.66 | 0.66 | 0.07 | 2.47 | 2.47 | XXX |
75555 | TC | A | Cardiac MRI/limited study | 0.00 | 11.16 | NA | 0.49 | 11.65 | NA | XXX |
75556 | N | Cardiac MRI/flow mapping | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
75600 | A | Contrast x-ray exam of aorta | 0.49 | 12.74 | NA | 0.56 | 13.79 | NA | XXX | |
75600 | 26 | A | Contrast x-ray exam of aorta | 0.49 | 0.19 | 0.19 | 0.02 | 0.70 | 0.70 | XXX |
75600 | TC | A | Contrast x-ray exam of aorta | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75605 | A | Contrast x-ray exam of aorta | 1.14 | 12.96 | NA | 0.59 | 14.69 | NA | XXX | |
75605 | 26 | A | Contrast x-ray exam of aorta | 1.14 | 0.41 | 0.41 | 0.05 | 1.60 | 1.60 | XXX |
75605 | TC | A | Contrast x-ray exam of aorta | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75625 | A | Contrast x-ray exam of aorta | 1.14 | 12.94 | NA | 0.59 | 14.67 | NA | XXX | |
75625 | 26 | A | Contrast x-ray exam of aorta | 1.14 | 0.39 | 0.39 | 0.05 | 1.58 | 1.58 | XXX |
75625 | TC | A | Contrast x-ray exam of aorta | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75630 | A | X-ray aorta, leg arteries | 1.79 | 13.72 | NA | 0.65 | 16.16 | NA | XXX | |
75630 | 26 | A | X-ray aorta, leg arteries | 1.79 | 0.64 | 0.64 | 0.08 | 2.51 | 2.51 | XXX |
75630 | TC | A | X-ray aorta, leg arteries | 0.00 | 13.08 | NA | 0.57 | 13.65 | NA | XXX |
75635 | A | Ct angio abdominal arteries | 2.40 | 16.66 | NA | 0.41 | 19.47 | NA | XXX | |
75635 | 26 | A | Ct angio abdominal arteries | 2.40 | 0.82 | 0.82 | 0.09 | 3.31 | 3.31 | XXX |
75635 | TC | A | Ct angio abdominal arteries | 0.00 | 15.84 | NA | 0.32 | 16.16 | NA | XXX |
75650 | A | Artery x-rays, head neck | 1.49 | 13.06 | NA | 0.61 | 15.16 | NA | XXX | |
75650 | 26 | A | Artery x-rays, head neck | 1.49 | 0.51 | 0.51 | 0.07 | 2.07 | 2.07 | XXX |
75650 | TC | A | Artery x-rays, head neck | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75658 | A | Artery x-rays, arm | 1.31 | 13.04 | NA | 0.60 | 14.95 | NA | XXX | |
75658 | 26 | A | Artery x-rays, arm | 1.31 | 0.49 | 0.49 | 0.06 | 1.86 | 1.86 | XXX |
75658 | TC | A | Artery x-rays, arm | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75660 | A | Artery x-rays, head neck | 1.31 | 13.01 | NA | 0.60 | 14.92 | NA | XXX | |
75660 | 26 | A | Artery x-rays, head neck | 1.31 | 0.46 | 0.46 | 0.06 | 1.83 | 1.83 | XXX |
75660 | TC | A | Artery x-rays, head neck | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75662 | A | Artery x-rays, head neck | 1.66 | 13.16 | NA | 0.62 | 15.44 | NA | XXX | |
75662 | 26 | A | Artery x-rays, head neck | 1.66 | 0.61 | 0.61 | 0.08 | 2.35 | 2.35 | XXX |
75662 | TC | A | Artery x-rays, head neck | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75665 | A | Artery x-rays, head neck | 1.31 | 13.00 | NA | 0.61 | 14.92 | NA | XXX | |
75665 | 26 | A | Artery x-rays, head neck | 1.31 | 0.45 | 0.45 | 0.07 | 1.83 | 1.83 | XXX |
75665 | TC | A | Artery x-rays, head neck | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75671 | A | Artery x-rays, head neck | 1.66 | 13.12 | NA | 0.62 | 15.40 | NA | XXX | |
75671 | 26 | A | Artery x-rays, head neck | 1.66 | 0.57 | 0.57 | 0.08 | 2.31 | 2.31 | XXX |
75671 | TC | A | Artery x-rays, head neck | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75676 | A | Artery x-rays, neck | 1.31 | 13.01 | NA | 0.61 | 14.93 | NA | XXX | |
75676 | 26 | A | Artery x-rays, neck | 1.31 | 0.46 | 0.46 | 0.07 | 1.84 | 1.84 | XXX |
75676 | TC | A | Artery x-rays, neck | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75680 | A | Artery x-rays, neck | 1.66 | 13.12 | NA | 0.62 | 15.40 | NA | XXX | |
75680 | 26 | A | Artery x-rays, neck | 1.66 | 0.57 | 0.57 | 0.08 | 2.31 | 2.31 | XXX |
75680 | TC | A | Artery x-rays, neck | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75685 | A | Artery x-rays, spine | 1.31 | 13.00 | NA | 0.60 | 14.91 | NA | XXX | |
75685 | 26 | A | Artery x-rays, spine | 1.31 | 0.45 | 0.45 | 0.06 | 1.82 | 1.82 | XXX |
75685 | TC | A | Artery x-rays, spine | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75705 | A | Artery x-rays, spine | 2.18 | 13.31 | NA | 0.65 | 16.14 | NA | XXX | |
75705 | 26 | A | Artery x-rays, spine | 2.18 | 0.76 | 0.76 | 0.11 | 3.05 | 3.05 | XXX |
75705 | TC | A | Artery x-rays, spine | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75710 | A | Artery x-rays, arm/leg | 1.14 | 12.95 | NA | 0.60 | 14.69 | NA | XXX | |
75710 | 26 | A | Artery x-rays, arm/leg | 1.14 | 0.40 | 0.40 | 0.06 | 1.60 | 1.60 | XXX |
75710 | TC | A | Artery x-rays, arm/leg | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75716 | A | Artery x-rays, arms/legs | 1.31 | 13.00 | NA | 0.60 | 14.91 | NA | XXX | |
75716 | 26 | A | Artery x-rays, arms/legs | 1.31 | 0.45 | 0.45 | 0.06 | 1.82 | 1.82 | XXX |
75716 | TC | A | Artery x-rays, arms/legs | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75722 | A | Artery x-rays, kidney | 1.14 | 12.96 | NA | 0.59 | 14.69 | NA | XXX | |
75722 | 26 | A | Artery x-rays, kidney | 1.14 | 0.41 | 0.41 | 0.05 | 1.60 | 1.60 | XXX |
75722 | TC | A | Artery x-rays, kidney | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75724 | A | Artery x-rays, kidneys | 1.49 | 13.13 | NA | 0.59 | 15.21 | NA | XXX | |
75724 | 26 | A | Artery x-rays, kidneys | 1.49 | 0.58 | 0.58 | 0.05 | 2.12 | 2.12 | XXX |
75724 | TC | A | Artery x-rays, kidneys | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75726 | A | Artery x-rays, abdomen | 1.14 | 12.94 | NA | 0.59 | 14.67 | NA | XXX | |
75726 | 26 | A | Artery x-rays, abdomen | 1.14 | 0.39 | 0.39 | 0.05 | 1.58 | 1.58 | XXX |
75726 | TC | A | Artery x-rays, abdomen | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75731 | A | Artery x-rays, adrenal gland | 1.14 | 12.94 | NA | 0.59 | 14.67 | NA | XXX | |
75731 | 26 | A | Artery x-rays, adrenal gland | 1.14 | 0.39 | 0.39 | 0.05 | 1.58 | 1.58 | XXX |
75731 | TC | A | Artery x-rays, adrenal gland | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75733 | A | Artery x-rays, adrenals | 1.31 | 13.00 | NA | 0.60 | 14.91 | NA | XXX | |
75733 | 26 | A | Artery x-rays, adrenals | 1.31 | 0.45 | 0.45 | 0.06 | 1.82 | 1.82 | XXX |
75733 | TC | A | Artery x-rays, adrenals | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75736 | A | Artery x-rays, pelvis | 1.14 | 12.94 | NA | 0.59 | 14.67 | NA | XXX | |
75736 | 26 | A | Artery x-rays, pelvis | 1.14 | 0.39 | 0.39 | 0.05 | 1.58 | 1.58 | XXX |
75736 | TC | A | Artery x-rays, pelvis | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75741 | A | Artery x-rays, lung | 1.31 | 13.00 | NA | 0.60 | 14.91 | NA | XXX | |
75741 | 26 | A | Artery x-rays, lung | 1.31 | 0.45 | 0.45 | 0.06 | 1.82 | 1.82 | XXX |
75741 | TC | A | Artery x-rays, lung | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75743 | A | Artery x-rays, lungs | 1.66 | 13.11 | NA | 0.61 | 15.38 | NA | XXX | |
75743 | 26 | A | Artery x-rays, lungs | 1.66 | 0.56 | 0.56 | 0.07 | 2.29 | 2.29 | XXX |
75743 | TC | A | Artery x-rays, lungs | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75746 | A | Artery x-rays, lung | 1.14 | 12.94 | NA | 0.59 | 14.67 | NA | XXX | |
75746 | 26 | A | Artery x-rays, lung | 1.14 | 0.39 | 0.39 | 0.05 | 1.58 | 1.58 | XXX |
75746 | TC | A | Artery x-rays, lung | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75756 | A | Artery x-rays, chest | 1.14 | 13.01 | NA | 0.58 | 14.73 | NA | XXX | |
75756 | 26 | A | Artery x-rays, chest | 1.14 | 0.46 | 0.46 | 0.04 | 1.64 | 1.64 | XXX |
75756 | TC | A | Artery x-rays, chest | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75774 | A | Artery x-ray, each vessel | 0.36 | 12.68 | NA | 0.56 | 13.60 | NA | ZZZ | |
75774 | 26 | A | Artery x-ray, each vessel | 0.36 | 0.13 | 0.13 | 0.02 | 0.51 | 0.51 | ZZZ |
75774 | TC | A | Artery x-ray, each vessel | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | ZZZ |
75790 | A | Visualize A-V shunt | 1.84 | 1.96 | NA | 0.16 | 3.96 | NA | XXX | |
75790 | 26 | A | Visualize A-V shunt | 1.84 | 0.62 | 0.62 | 0.09 | 2.55 | 2.55 | XXX |
75790 | TC | A | Visualize A-V shunt | 0.00 | 1.34 | NA | 0.07 | 1.41 | NA | XXX |
75801 | A | Lymph vessel x-ray, arm/leg | 0.81 | 5.67 | NA | 0.29 | 6.77 | NA | XXX | |
75801 | 26 | A | Lymph vessel x-ray, arm/leg | 0.81 | 0.28 | 0.28 | 0.05 | 1.14 | 1.14 | XXX |
75801 | TC | A | Lymph vessel x-ray, arm/leg | 0.00 | 5.39 | NA | 0.24 | 5.63 | NA | XXX |
75803 | A | Lymph vessel x-ray,arms/legs | 1.17 | 5.79 | NA | 0.29 | 7.25 | NA | XXX | |
75803 | 26 | A | Lymph vessel x-ray,arms/legs | 1.17 | 0.40 | 0.40 | 0.05 | 1.62 | 1.62 | XXX |
75803 | TC | A | Lymph vessel x-ray,arms/legs | 0.00 | 5.39 | NA | 0.24 | 5.63 | NA | XXX |
75805 | A | Lymph vessel x-ray, trunk | 0.81 | 6.35 | NA | 0.31 | 7.47 | NA | XXX | |
75805 | 26 | A | Lymph vessel x-ray, trunk | 0.81 | 0.28 | 0.28 | 0.04 | 1.13 | 1.13 | XXX |
75805 | TC | A | Lymph vessel x-ray, trunk | 0.00 | 6.07 | NA | 0.27 | 6.34 | NA | XXX |
75807 | A | Lymph vessel x-ray, trunk | 1.17 | 6.47 | NA | 0.32 | 7.96 | NA | XXX | |
75807 | 26 | A | Lymph vessel x-ray, trunk | 1.17 | 0.40 | 0.40 | 0.05 | 1.62 | 1.62 | XXX |
75807 | TC | A | Lymph vessel x-ray, trunk | 0.00 | 6.07 | NA | 0.27 | 6.34 | NA | XXX |
75809 | A | Nonvascular shunt, x-ray | 0.47 | 0.94 | NA | 0.06 | 1.47 | NA | XXX | |
75809 | 26 | A | Nonvascular shunt, x-ray | 0.47 | 0.16 | 0.16 | 0.02 | 0.65 | 0.65 | XXX |
75809 | TC | A | Nonvascular shunt, x-ray | 0.00 | 0.78 | NA | 0.04 | 0.82 | NA | XXX |
75810 | A | Vein x-ray, spleen/liver | 1.14 | 12.94 | NA | 0.60 | 14.68 | NA | XXX | |
75810 | 26 | A | Vein x-ray, spleen/liver | 1.14 | 0.39 | 0.39 | 0.06 | 1.59 | 1.59 | XXX |
75810 | TC | A | Vein x-ray, spleen/liver | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75820 | A | Vein x-ray, arm/leg | 0.70 | 1.19 | NA | 0.08 | 1.97 | NA | XXX | |
75820 | 26 | A | Vein x-ray, arm/leg | 0.70 | 0.24 | 0.24 | 0.03 | 0.97 | 0.97 | XXX |
75820 | TC | A | Vein x-ray, arm/leg | 0.00 | 0.95 | NA | 0.05 | 1.00 | NA | XXX |
75822 | A | Vein x-ray, arms/legs | 1.06 | 1.83 | NA | 0.12 | 3.01 | NA | XXX | |
75822 | 26 | A | Vein x-ray, arms/legs | 1.06 | 0.36 | 0.36 | 0.05 | 1.47 | 1.47 | XXX |
75822 | TC | A | Vein x-ray, arms/legs | 0.00 | 1.47 | NA | 0.07 | 1.54 | NA | XXX |
75825 | A | Vein x-ray, trunk | 1.14 | 12.94 | NA | 0.60 | 14.68 | NA | XXX | |
75825 | 26 | A | Vein x-ray, trunk | 1.14 | 0.39 | 0.39 | 0.06 | 1.59 | 1.59 | XXX |
75825 | TC | A | Vein x-ray, trunk | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75827 | A | Vein x-ray, chest | 1.14 | 12.93 | NA | 0.59 | 14.66 | NA | XXX | |
75827 | 26 | A | Vein x-ray, chest | 1.14 | 0.38 | 0.38 | 0.05 | 1.57 | 1.57 | XXX |
75827 | TC | A | Vein x-ray, chest | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75831 | A | Vein x-ray, kidney | 1.14 | 12.93 | NA | 0.59 | 14.66 | NA | XXX | |
75831 | 26 | A | Vein x-ray, kidney | 1.14 | 0.38 | 0.38 | 0.05 | 1.57 | 1.57 | XXX |
75831 | TC | A | Vein x-ray, kidney | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75833 | A | Vein x-ray, kidneys | 1.49 | 13.06 | NA | 0.61 | 15.16 | NA | XXX | |
75833 | 26 | A | Vein x-ray, kidneys | 1.49 | 0.51 | 0.51 | 0.07 | 2.07 | 2.07 | XXX |
75833 | TC | A | Vein x-ray, kidneys | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75840 | A | Vein x-ray, adrenal gland | 1.14 | 12.94 | NA | 0.61 | 14.69 | NA | XXX | |
75840 | 26 | A | Vein x-ray, adrenal gland | 1.14 | 0.39 | 0.39 | 0.07 | 1.60 | 1.60 | XXX |
75840 | TC | A | Vein x-ray, adrenal gland | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75842 | A | Vein x-ray, adrenal glands | 1.49 | 13.05 | NA | 0.61 | 15.15 | NA | XXX | |
75842 | 26 | A | Vein x-ray, adrenal glands | 1.49 | 0.50 | 0.50 | 0.07 | 2.06 | 2.06 | XXX |
75842 | TC | A | Vein x-ray, adrenal glands | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75860 | A | Vein x-ray, neck | 1.14 | 12.95 | NA | 0.60 | 14.69 | NA | XXX | |
75860 | 26 | A | Vein x-ray, neck | 1.14 | 0.40 | 0.40 | 0.06 | 1.60 | 1.60 | XXX |
75860 | TC | A | Vein x-ray, neck | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75870 | A | Vein x-ray, skull | 1.14 | 12.95 | NA | 0.60 | 14.69 | NA | XXX | |
75870 | 26 | A | Vein x-ray, skull | 1.14 | 0.40 | 0.40 | 0.06 | 1.60 | 1.60 | XXX |
75870 | TC | A | Vein x-ray, skull | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75872 | A | Vein x-ray, skull | 1.14 | 12.94 | NA | 0.59 | 14.67 | NA | XXX | |
75872 | 26 | A | Vein x-ray, skull | 1.14 | 0.39 | 0.39 | 0.05 | 1.58 | 1.58 | XXX |
75872 | TC | A | Vein x-ray, skull | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75880 | A | Vein x-ray, eye socket | 0.70 | 1.19 | NA | 0.08 | 1.97 | NA | XXX | |
75880 | 26 | A | Vein x-ray, eye socket | 0.70 | 0.24 | 0.24 | 0.03 | 0.97 | 0.97 | XXX |
75880 | TC | A | Vein x-ray, eye socket | 0.00 | 0.95 | NA | 0.05 | 1.00 | NA | XXX |
75885 | A | Vein x-ray, liver | 1.44 | 13.04 | NA | 0.60 | 15.08 | NA | XXX | |
75885 | 26 | A | Vein x-ray, liver | 1.44 | 0.49 | 0.49 | 0.06 | 1.99 | 1.99 | XXX |
75885 | TC | A | Vein x-ray, liver | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75887 | A | Vein x-ray, liver | 1.44 | 13.04 | NA | 0.60 | 15.08 | NA | XXX | |
75887 | 26 | A | Vein x-ray, liver | 1.44 | 0.49 | 0.49 | 0.06 | 1.99 | 1.99 | XXX |
75887 | TC | A | Vein x-ray, liver | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75889 | A | Vein x-ray, liver | 1.14 | 12.93 | NA | 0.59 | 14.66 | NA | XXX | |
75889 | 26 | A | Vein x-ray, liver | 1.14 | 0.38 | 0.38 | 0.05 | 1.57 | 1.57 | XXX |
75889 | TC | A | Vein x-ray, liver | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75891 | A | Vein x-ray, liver | 1.14 | 12.93 | NA | 0.59 | 14.66 | NA | XXX | |
75891 | 26 | A | Vein x-ray, liver | 1.14 | 0.38 | 0.38 | 0.05 | 1.57 | 1.57 | XXX |
75891 | TC | A | Vein x-ray, liver | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75893 | A | Venous sampling by catheter | 0.54 | 12.74 | NA | 0.56 | 13.84 | NA | XXX | |
75893 | 26 | A | Venous sampling by catheter | 0.54 | 0.19 | 0.19 | 0.02 | 0.75 | 0.75 | XXX |
75893 | TC | A | Venous sampling by catheter | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75894 | A | X-rays, transcath therapy | 1.31 | 24.48 | NA | 1.12 | 26.91 | NA | XXX | |
75894 | 26 | A | X-rays, transcath therapy | 1.31 | 0.45 | 0.45 | 0.07 | 1.83 | 1.83 | XXX |
75894 | TC | A | X-rays, transcath therapy | 0.00 | 24.03 | NA | 1.05 | 25.08 | NA | XXX |
75896 | A | X-rays, transcath therapy | 1.31 | 21.37 | NA | 0.97 | 23.65 | NA | XXX | |
75896 | 26 | A | X-rays, transcath therapy | 1.31 | 0.47 | 0.47 | 0.06 | 1.84 | 1.84 | XXX |
75896 | TC | A | X-rays, transcath therapy | 0.00 | 20.90 | NA | 0.91 | 21.81 | NA | XXX |
75898 | A | Follow-up angiography | 1.65 | 1.61 | NA | 0.12 | 3.38 | NA | XXX | |
75898 | 26 | A | Follow-up angiography | 1.65 | 0.57 | 0.57 | 0.07 | 2.29 | 2.29 | XXX |
75898 | TC | A | Follow-up angiography | 0.00 | 1.04 | NA | 0.05 | 1.09 | NA | XXX |
75900 | A | Arterial catheter exchange | 0.49 | 21.05 | NA | 0.94 | 22.48 | NA | XXX | |
75900 | 26 | A | Arterial catheter exchange | 0.49 | 0.17 | 0.17 | 0.02 | 0.68 | 0.68 | XXX |
75900 | TC | A | Arterial catheter exchange | 0.00 | 20.88 | NA | 0.92 | 21.80 | NA | XXX |
75901 | A | Remove cva device obstruct | 0.49 | 1.47 | NA | 0.71 | 2.67 | NA | XXX | |
75901 | 26 | A | Remove cva device obstruct | 0.49 | 0.17 | 0.17 | 0.02 | 0.68 | 0.68 | XXX |
75901 | TC | A | Remove cva device obstruct | 0.00 | 1.30 | NA | 0.69 | 1.99 | NA | XXX |
75902 | A | Remove cva lumen obstruct | 0.39 | 1.43 | NA | 0.71 | 2.53 | NA | XXX | |
75902 | 26 | A | Remove cva lumen obstruct | 0.39 | 0.13 | 0.13 | 0.02 | 0.54 | 0.54 | XXX |
75902 | TC | A | Remove cva lumen obstruct | 0.00 | 1.30 | NA | 0.69 | 1.99 | NA | XXX |
75940 | A | X-ray placement, vein filter | 0.54 | 12.73 | NA | 0.57 | 13.84 | NA | XXX | |
75940 | 26 | A | X-ray placement, vein filter | 0.54 | 0.18 | 0.18 | 0.03 | 0.75 | 0.75 | XXX |
75940 | TC | A | X-ray placement, vein filter | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | XXX |
75945 | A | Intravascular us | 0.40 | 4.70 | NA | 0.23 | 5.33 | NA | XXX | |
75945 | 26 | A | Intravascular us | 0.40 | 0.15 | 0.15 | 0.03 | 0.58 | 0.58 | XXX |
75945 | TC | A | Intravascular us | 0.00 | 4.55 | NA | 0.20 | 4.75 | NA | XXX |
75946 | A | Intravascular us add-on | 0.40 | 2.42 | NA | 0.14 | 2.96 | NA | ZZZ | |
75946 | 26 | A | Intravascular us add-on | 0.40 | 0.14 | 0.14 | 0.03 | 0.57 | 0.57 | ZZZ |
75946 | TC | A | Intravascular us add-on | 0.00 | 2.28 | NA | 0.11 | 2.39 | NA | ZZZ |
75952 | C | Endovasc repair abdom aorta | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
75952 | 26 | A | Endovasc repair abdom aorta | 4.50 | 1.75 | 1.75 | 0.68 | 6.93 | 6.93 | XXX |
75952 | TC | C | Endovasc repair abdom aorta | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
75953 | C | Abdom aneurysm endovas rpr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
75953 | 26 | A | Abdom aneurysm endovas rpr | 1.36 | 0.53 | 0.53 | 0.68 | 2.57 | 2.57 | XXX |
75953 | TC | C | Abdom aneurysm endovas rpr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
75954 | C | Iliac aneurysm endovas rpr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
75954 | 26 | A | Iliac aneurysm endovas rpr | 1.36 | 0.48 | 0.48 | 0.68 | 2.52 | 2.52 | XXX |
75954 | TC | C | Iliac aneurysm endovas rpr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
75960 | A | Transcatheter intro, stent | 0.82 | 15.13 | NA | 0.68 | 16.63 | NA | XXX | |
75960 | 26 | A | Transcatheter intro, stent | 0.82 | 0.29 | 0.29 | 0.04 | 1.15 | 1.15 | XXX |
75960 | TC | A | Transcatheter intro, stent | 0.00 | 14.84 | NA | 0.64 | 15.48 | NA | XXX |
75961 | A | Retrieval, broken catheter | 4.25 | 11.90 | NA | 0.64 | 16.79 | NA | XXX | |
75961 | 26 | A | Retrieval, broken catheter | 4.25 | 1.44 | 1.44 | 0.18 | 5.87 | 5.87 | XXX |
75961 | TC | A | Retrieval, broken catheter | 0.00 | 10.46 | NA | 0.46 | 10.92 | NA | XXX |
75962 | A | Repair arterial blockage | 0.54 | 15.86 | NA | 0.72 | 17.12 | NA | XXX | |
75962 | 26 | A | Repair arterial blockage | 0.54 | 0.19 | 0.19 | 0.03 | 0.76 | 0.76 | XXX |
75962 | TC | A | Repair arterial blockage | 0.00 | 15.67 | NA | 0.69 | 16.36 | NA | XXX |
75964 | A | Repair artery blockage, each | 0.36 | 8.49 | NA | 0.38 | 9.23 | NA | ZZZ | |
75964 | 26 | A | Repair artery blockage, each | 0.36 | 0.13 | 0.13 | 0.02 | 0.51 | 0.51 | ZZZ |
75964 | TC | A | Repair artery blockage, each | 0.00 | 8.36 | NA | 0.36 | 8.72 | NA | ZZZ |
75966 | A | Repair arterial blockage | 1.31 | 16.15 | NA | 0.75 | 18.21 | NA | XXX | |
75966 | 26 | A | Repair arterial blockage | 1.31 | 0.48 | 0.48 | 0.06 | 1.85 | 1.85 | XXX |
75966 | TC | A | Repair arterial blockage | 0.00 | 15.67 | NA | 0.69 | 16.36 | NA | XXX |
75968 | A | Repair artery blockage, each | 0.36 | 8.49 | NA | 0.37 | 9.22 | NA | ZZZ | |
75968 | 26 | A | Repair artery blockage, each | 0.36 | 0.13 | 0.13 | 0.01 | 0.50 | 0.50 | ZZZ |
75968 | TC | A | Repair artery blockage, each | 0.00 | 8.36 | NA | 0.36 | 8.72 | NA | ZZZ |
75970 | A | Vascular biopsy | 0.83 | 11.78 | NA | 0.54 | 13.15 | NA | XXX | |
75970 | 26 | A | Vascular biopsy | 0.83 | 0.29 | 0.29 | 0.04 | 1.16 | 1.16 | XXX |
75970 | TC | A | Vascular biopsy | 0.00 | 11.49 | NA | 0.50 | 11.99 | NA | XXX |
75978 | A | Repair venous blockage | 0.54 | 15.85 | NA | 0.71 | 17.10 | NA | XXX | |
75978 | 26 | A | Repair venous blockage | 0.54 | 0.18 | 0.18 | 0.02 | 0.74 | 0.74 | XXX |
75978 | TC | A | Repair venous blockage | 0.00 | 15.67 | NA | 0.69 | 16.36 | NA | XXX |
75980 | A | Contrast xray exam bile duct | 1.44 | 5.88 | NA | 0.30 | 7.62 | NA | XXX | |
75980 | 26 | A | Contrast xray exam bile duct | 1.44 | 0.49 | 0.49 | 0.06 | 1.99 | 1.99 | XXX |
75980 | TC | A | Contrast xray exam bile duct | 0.00 | 5.39 | NA | 0.24 | 5.63 | NA | XXX |
75982 | A | Contrast xray exam bile duct | 1.44 | 6.55 | NA | 0.33 | 8.32 | NA | XXX | |
75982 | 26 | A | Contrast xray exam bile duct | 1.44 | 0.48 | 0.48 | 0.06 | 1.98 | 1.98 | XXX |
75982 | TC | A | Contrast xray exam bile duct | 0.00 | 6.07 | NA | 0.27 | 6.34 | NA | XXX |
75984 | A | Xray control catheter change | 0.72 | 2.18 | NA | 0.12 | 3.02 | NA | XXX | |
75984 | 26 | A | Xray control catheter change | 0.72 | 0.24 | 0.24 | 0.03 | 0.99 | 0.99 | XXX |
75984 | TC | A | Xray control catheter change | 0.00 | 1.94 | NA | 0.09 | 2.03 | NA | XXX |
75989 | A | Abscess drainage under x-ray | 1.19 | 3.53 | NA | 0.19 | 4.91 | NA | XXX | |
75989 | 26 | A | Abscess drainage under x-ray | 1.19 | 0.40 | 0.40 | 0.05 | 1.64 | 1.64 | XXX |
75989 | TC | A | Abscess drainage under x-ray | 0.00 | 3.13 | NA | 0.14 | 3.27 | NA | XXX |
75992 | A | Atherectomy, x-ray exam | 0.54 | 15.87 | NA | 0.71 | 17.12 | NA | XXX | |
75992 | 26 | A | Atherectomy, x-ray exam | 0.54 | 0.20 | 0.20 | 0.02 | 0.76 | 0.76 | XXX |
75992 | TC | A | Atherectomy, x-ray exam | 0.00 | 15.67 | NA | 0.69 | 16.36 | NA | XXX |
75993 | A | Atherectomy, x-ray exam | 0.36 | 8.50 | NA | 0.37 | 9.23 | NA | ZZZ | |
75993 | 26 | A | Atherectomy, x-ray exam | 0.36 | 0.14 | 0.14 | 0.01 | 0.51 | 0.51 | ZZZ |
75993 | TC | A | Atherectomy, x-ray exam | 0.00 | 8.36 | NA | 0.36 | 8.72 | NA | ZZZ |
75994 | A | Atherectomy, x-ray exam | 1.31 | 16.15 | NA | 0.75 | 18.21 | NA | XXX | |
75994 | 26 | A | Atherectomy, x-ray exam | 1.31 | 0.48 | 0.48 | 0.06 | 1.85 | 1.85 | XXX |
75994 | TC | A | Atherectomy, x-ray exam | 0.00 | 15.67 | NA | 0.69 | 16.36 | NA | XXX |
75995 | A | Atherectomy, x-ray exam | 1.31 | 16.16 | NA | 0.75 | 18.22 | NA | XXX | |
75995 | 26 | A | Atherectomy, x-ray exam | 1.31 | 0.49 | 0.49 | 0.06 | 1.86 | 1.86 | XXX |
75995 | TC | A | Atherectomy, x-ray exam | 0.00 | 15.67 | NA | 0.69 | 16.36 | NA | XXX |
75996 | A | Atherectomy, x-ray exam | 0.36 | 8.48 | NA | 0.37 | 9.21 | NA | ZZZ | |
75996 | 26 | A | Atherectomy, x-ray exam | 0.36 | 0.12 | 0.12 | 0.01 | 0.49 | 0.49 | ZZZ |
75996 | TC | A | Atherectomy, x-ray exam | 0.00 | 8.36 | NA | 0.36 | 8.72 | NA | ZZZ |
76000 | A | Fluoroscope examination | 0.17 | 1.35 | NA | 0.07 | 1.59 | NA | XXX | |
76000 | 26 | A | Fluoroscope examination | 0.17 | 0.05 | 0.05 | 0.01 | 0.23 | 0.23 | XXX |
76000 | TC | A | Fluoroscope examination | 0.00 | 1.30 | NA | 0.06 | 1.36 | NA | XXX |
76001 | A | Fluoroscope exam, extensive | 0.67 | 2.84 | NA | 0.15 | 3.66 | NA | XXX | |
76001 | 26 | A | Fluoroscope exam, extensive | 0.67 | 0.23 | 0.23 | 0.03 | 0.93 | 0.93 | XXX |
76001 | TC | A | Fluoroscope exam, extensive | 0.00 | 2.61 | NA | 0.12 | 2.73 | NA | XXX |
76003 | A | Needle localization by x-ray | 0.54 | 1.48 | NA | 0.09 | 2.11 | NA | XXX | |
76003 | 26 | A | Needle localization by x-ray | 0.54 | 0.18 | 0.18 | 0.03 | 0.75 | 0.75 | XXX |
76003 | TC | A | Needle localization by x-ray | 0.00 | 1.30 | NA | 0.06 | 1.36 | NA | XXX |
76005 | A | Fluoroguide for spine inject | 0.60 | 1.46 | NA | 0.09 | 2.15 | NA | XXX | |
76005 | 26 | A | Fluoroguide for spine inject | 0.60 | 0.16 | 0.16 | 0.03 | 0.79 | 0.79 | XXX |
76005 | TC | A | Fluoroguide for spine inject | 0.00 | 1.30 | NA | 0.06 | 1.36 | NA | XXX |
76006 | A | X-ray stress view | 0.41 | 0.19 | 0.19 | 0.04 | 0.64 | 0.64 | XXX | |
76010 | A | X-ray, nose to rectum | 0.18 | 0.58 | NA | 0.03 | 0.79 | NA | XXX | |
76010 | 26 | A | X-ray, nose to rectum | 0.18 | 0.06 | 0.06 | 0.01 | 0.25 | 0.25 | XXX |
76010 | TC | A | X-ray, nose to rectum | 0.00 | 0.52 | NA | 0.02 | 0.54 | NA | XXX |
76012 | C | Percut vertebroplasty fluor | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
76012 | 26 | A | Percut vertebroplasty fluor | 1.31 | 0.51 | 0.51 | 0.23 | 2.05 | 2.05 | XXX |
76012 | TC | C | Percut vertebroplasty fluor | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
76013 | C | Percut vertebroplasty, ct | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
76013 | 26 | A | Percut vertebroplasty, ct | 1.38 | 0.54 | 0.54 | 0.48 | 2.40 | 2.40 | XXX |
76013 | TC | C | Percut vertebroplasty, ct | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
76020 | A | X-rays for bone age | 0.19 | 0.58 | NA | 0.03 | 0.80 | NA | XXX | |
76020 | 26 | A | X-rays for bone age | 0.19 | 0.06 | 0.06 | 0.01 | 0.26 | 0.26 | XXX |
76020 | TC | A | X-rays for bone age | 0.00 | 0.52 | NA | 0.02 | 0.54 | NA | XXX |
76040 | A | X-rays, bone evaluation | 0.27 | 0.87 | NA | 0.07 | 1.21 | NA | XXX | |
76040 | 26 | A | X-rays, bone evaluation | 0.27 | 0.09 | 0.09 | 0.03 | 0.39 | 0.39 | XXX |
76040 | TC | A | X-rays, bone evaluation | 0.00 | 0.78 | NA | 0.04 | 0.82 | NA | XXX |
76061 | A | X-rays, bone survey | 0.45 | 1.15 | NA | 0.07 | 1.67 | NA | XXX | |
76061 | 26 | A | X-rays, bone survey | 0.45 | 0.15 | 0.15 | 0.02 | 0.62 | 0.62 | XXX |
76061 | TC | A | X-rays, bone survey | 0.00 | 1.00 | NA | 0.05 | 1.05 | NA | XXX |
76062 | A | X-rays, bone survey | 0.54 | 1.61 | NA | 0.09 | 2.24 | NA | XXX | |
76062 | 26 | A | X-rays, bone survey | 0.54 | 0.18 | 0.18 | 0.02 | 0.74 | 0.74 | XXX |
76062 | TC | A | X-rays, bone survey | 0.00 | 1.43 | NA | 0.07 | 1.50 | NA | XXX |
76065 | A | X-rays, bone evaluation | 0.70 | 0.98 | NA | 0.05 | 1.73 | NA | XXX | |
76065 | 26 | A | X-rays, bone evaluation | 0.70 | 0.24 | 0.24 | 0.01 | 0.95 | 0.95 | XXX |
76065 | TC | A | X-rays, bone evaluation | 0.00 | 0.74 | NA | 0.04 | 0.78 | NA | XXX |
76066 | A | Joint survey, single view | 0.31 | 1.21 | NA | 0.07 | 1.59 | NA | XXX | |
76066 | 26 | A | Joint survey, single view | 0.31 | 0.11 | 0.11 | 0.02 | 0.44 | 0.44 | XXX |
76066 | TC | A | Joint survey, single view | 0.00 | 1.10 | NA | 0.05 | 1.15 | NA | XXX |
76070 | A | Ct bone density, axial | 0.25 | 3.02 | NA | 0.14 | 3.41 | NA | XXX | |
76070 | 26 | A | Ct bone density, axial | 0.25 | 0.08 | 0.08 | 0.01 | 0.34 | 0.34 | XXX |
76070 | TC | A | Ct bone density, axial | 0.00 | 2.94 | NA | 0.13 | 3.07 | NA | XXX |
76071 | A | Ct bone density, peripheral | 0.22 | 3.01 | NA | 0.05 | 3.28 | NA | XXX | |
76071 | 26 | A | Ct bone density, peripheral | 0.22 | 0.07 | 0.07 | 0.01 | 0.30 | 0.30 | XXX |
76071 | TC | A | Ct bone density, peripheral | 0.00 | 2.94 | NA | 0.04 | 2.98 | NA | XXX |
76075 | A | Dexa, axial skeleton study | 0.30 | 3.19 | NA | 0.15 | 3.64 | NA | XXX | |
76075 | 26 | A | Dexa, axial skeleton study | 0.30 | 0.11 | 0.11 | 0.01 | 0.42 | 0.42 | XXX |
76075 | TC | A | Dexa, axial skeleton study | 0.00 | 3.08 | NA | 0.14 | 3.22 | NA | XXX |
76076 | A | Dexa, peripheral study | 0.22 | 0.83 | NA | 0.05 | 1.10 | NA | XXX | |
76076 | 26 | A | Dexa, peripheral study | 0.22 | 0.08 | 0.08 | 0.01 | 0.31 | 0.31 | XXX |
76076 | TC | A | Dexa, peripheral study | 0.00 | 0.75 | NA | 0.04 | 0.79 | NA | XXX |
76078 | A | Radiographic absorptiometry | 0.20 | 0.82 | NA | 0.05 | 1.07 | NA | XXX | |
76078 | 26 | A | Radiographic absorptiometry | 0.20 | 0.07 | 0.07 | 0.01 | 0.28 | 0.28 | XXX |
76078 | TC | A | Radiographic absorptiometry | 0.00 | 0.75 | NA | 0.04 | 0.79 | NA | XXX |
76080 | A | X-ray exam of fistula | 0.54 | 1.22 | NA | 0.07 | 1.83 | NA | XXX | |
76080 | 26 | A | X-ray exam of fistula | 0.54 | 0.18 | 0.18 | 0.02 | 0.74 | 0.74 | XXX |
76080 | TC | A | X-ray exam of fistula | 0.00 | 1.04 | NA | 0.05 | 1.09 | NA | XXX |
76085 | A | Computer mammogram add-on | 0.06 | 0.44 | NA | 0.02 | 0.52 | NA | ZZZ | |
76085 | 26 | A | Computer mammogram add-on | 0.06 | 0.02 | 0.02 | 0.01 | 0.09 | 0.09 | ZZZ |
76085 | TC | A | Computer mammogram add-on | 0.00 | 0.42 | NA | 0.01 | 0.43 | NA | ZZZ |
76086 | A | X-ray of mammary duct | 0.36 | 2.73 | NA | 0.14 | 3.23 | NA | XXX | |
76086 | 26 | A | X-ray of mammary duct | 0.36 | 0.12 | 0.12 | 0.02 | 0.50 | 0.50 | XXX |
76086 | TC | A | X-ray of mammary duct | 0.00 | 2.61 | NA | 0.12 | 2.73 | NA | XXX |
76088 | A | X-ray of mammary ducts | 0.45 | 3.80 | NA | 0.18 | 4.43 | NA | XXX | |
76088 | 26 | A | X-ray of mammary ducts | 0.45 | 0.15 | 0.15 | 0.02 | 0.62 | 0.62 | XXX |
76088 | TC | A | X-ray of mammary ducts | 0.00 | 3.65 | NA | 0.16 | 3.81 | NA | XXX |
76090 | A | Mammogram, one breast | 0.70 | 1.28 | NA | 0.08 | 2.06 | NA | XXX | |
76090 | 26 | A | Mammogram, one breast | 0.70 | 0.24 | 0.24 | 0.03 | 0.97 | 0.97 | XXX |
76090 | TC | A | Mammogram, one breast | 0.00 | 1.04 | NA | 0.05 | 1.09 | NA | XXX |
76091 | A | Mammogram, both breasts | 0.87 | 1.60 | NA | 0.09 | 2.56 | NA | XXX | |
76091 | 26 | A | Mammogram, both breasts | 0.87 | 0.30 | 0.30 | 0.03 | 1.20 | 1.20 | XXX |
76091 | TC | A | Mammogram, both breasts | 0.00 | 1.30 | NA | 0.06 | 1.36 | NA | XXX |
76092 | A | Mammogram, screening | 0.70 | 1.46 | NA | 0.09 | 2.25 | NA | XXX | |
76092 | 26 | A | Mammogram, screening | 0.70 | 0.25 | 0.25 | 0.03 | 0.98 | 0.98 | XXX |
76092 | TC | A | Mammogram, screening | 0.00 | 1.21 | NA | 0.06 | 1.27 | NA | XXX |
76093 | A | Magnetic image, breast | 1.63 | 18.11 | NA | 0.83 | 20.57 | NA | XXX | |
76093 | 26 | A | Magnetic image, breast | 1.63 | 0.56 | 0.56 | 0.07 | 2.26 | 2.26 | XXX |
76093 | TC | A | Magnetic image, breast | 0.00 | 17.55 | NA | 0.76 | 18.31 | NA | XXX |
76094 | A | Magnetic image, both breasts | 1.63 | 24.35 | NA | 1.10 | 27.08 | NA | XXX | |
76094 | 26 | A | Magnetic image, both breasts | 1.63 | 0.55 | 0.55 | 0.07 | 2.25 | 2.25 | XXX |
76094 | TC | A | Magnetic image, both breasts | 0.00 | 23.80 | NA | 1.03 | 24.83 | NA | XXX |
76095 | A | Stereotactic breast biopsy | 1.59 | 7.67 | NA | 0.40 | 9.66 | NA | XXX | |
76095 | 26 | A | Stereotactic breast biopsy | 1.59 | 0.54 | 0.54 | 0.09 | 2.22 | 2.22 | XXX |
76095 | TC | A | Stereotactic breast biopsy | 0.00 | 7.13 | NA | 0.31 | 7.44 | NA | XXX |
76096 | A | X-ray of needle wire, breast | 0.56 | 1.49 | NA | 0.09 | 2.14 | NA | XXX | |
76096 | 26 | A | X-ray of needle wire, breast | 0.56 | 0.19 | 0.19 | 0.03 | 0.78 | 0.78 | XXX |
76096 | TC | A | X-ray of needle wire, breast | 0.00 | 1.30 | NA | 0.06 | 1.36 | NA | XXX |
76098 | A | X-ray exam, breast specimen | 0.16 | 0.48 | NA | 0.03 | 0.67 | NA | XXX | |
76098 | 26 | A | X-ray exam, breast specimen | 0.16 | 0.06 | 0.06 | 0.01 | 0.23 | 0.23 | XXX |
76098 | TC | A | X-ray exam, breast specimen | 0.00 | 0.42 | NA | 0.02 | 0.44 | NA | XXX |
76100 | A | X-ray exam of body section | 0.58 | 1.44 | NA | 0.09 | 2.11 | NA | XXX | |
76100 | 26 | A | X-ray exam of body section | 0.58 | 0.20 | 0.20 | 0.03 | 0.81 | 0.81 | XXX |
76100 | TC | A | X-ray exam of body section | 0.00 | 1.24 | NA | 0.06 | 1.30 | NA | XXX |
76101 | A | Complex body section x-ray | 0.58 | 1.61 | NA | 0.10 | 2.29 | NA | XXX | |
76101 | 26 | A | Complex body section x-ray | 0.58 | 0.20 | 0.20 | 0.03 | 0.81 | 0.81 | XXX |
76101 | TC | A | Complex body section x-ray | 0.00 | 1.41 | NA | 0.07 | 1.48 | NA | XXX |
76102 | A | Complex body section x-rays | 0.58 | 1.92 | NA | 0.12 | 2.62 | NA | XXX | |
76102 | 26 | A | Complex body section x-rays | 0.58 | 0.20 | 0.20 | 0.03 | 0.81 | 0.81 | XXX |
76102 | TC | A | Complex body section x-rays | 0.00 | 1.72 | NA | 0.09 | 1.81 | NA | XXX |
76120 | A | Cine/video x-rays | 0.38 | 1.17 | NA | 0.07 | 1.62 | NA | XXX | |
76120 | 26 | A | Cine/video x-rays | 0.38 | 0.13 | 0.13 | 0.02 | 0.53 | 0.53 | XXX |
76120 | TC | A | Cine/video x-rays | 0.00 | 1.04 | NA | 0.05 | 1.09 | NA | XXX |
76125 | A | Cine/video x-rays add-on | 0.27 | 0.88 | NA | 0.05 | 1.20 | NA | ZZZ | |
76125 | 26 | A | Cine/video x-rays add-on | 0.27 | 0.10 | 0.10 | 0.01 | 0.38 | 0.38 | ZZZ |
76125 | TC | A | Cine/video x-rays add-on | 0.00 | 0.78 | NA | 0.04 | 0.82 | NA | ZZZ |
76140 | I | X-ray consultation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
76150 | A | X-ray exam, dry process | 0.00 | 0.42 | NA | 0.02 | 0.44 | NA | XXX | |
76350 | C | Special x-ray contrast study | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
76355 | A | CAT scan for localization | 1.21 | 8.64 | NA | 0.41 | 10.26 | NA | XXX | |
76355 | 26 | A | CAT scan for localization | 1.21 | 0.42 | 0.42 | 0.06 | 1.69 | 1.69 | XXX |
76355 | TC | A | CAT scan for localization | 0.00 | 8.22 | NA | 0.35 | 8.57 | NA | XXX |
76360 | A | CAT scan for needle biopsy | 1.16 | 8.61 | NA | 0.40 | 10.17 | NA | XXX | |
76360 | 26 | A | CAT scan for needle biopsy | 1.16 | 0.39 | 0.39 | 0.05 | 1.60 | 1.60 | XXX |
76360 | TC | A | CAT scan for needle biopsy | 0.00 | 8.22 | NA | 0.35 | 8.57 | NA | XXX |
76362 | A | Cat scan for tissue ablation | 4.00 | 9.57 | NA | 1.39 | 14.96 | NA | XXX | |
76362 | 26 | A | Cat scan for tissue ablation | 4.00 | 1.35 | 1.35 | 0.18 | 5.53 | 5.53 | XXX |
76362 | TC | A | Cat scan for tissue ablation | 0.00 | 8.22 | NA | 1.21 | 9.43 | NA | XXX |
76370 | A | CAT scan for therapy guide | 0.85 | 3.23 | NA | 0.17 | 4.25 | NA | XXX | |
76370 | 26 | A | CAT scan for therapy guide | 0.85 | 0.29 | 0.29 | 0.04 | 1.18 | 1.18 | XXX |
76370 | TC | A | CAT scan for therapy guide | 0.00 | 2.94 | NA | 0.13 | 3.07 | NA | XXX |
76375 | A | 3d/holograph reconstr add-on | 0.16 | 3.57 | NA | 0.16 | 3.89 | NA | XXX | |
76375 | 26 | A | 3d/holograph reconstr add-on | 0.16 | 0.05 | 0.05 | 0.01 | 0.22 | 0.22 | XXX |
76375 | TC | A | 3d/holograph reconstr add-on | 0.00 | 3.52 | NA | 0.15 | 3.67 | NA | XXX |
76380 | A | CAT scan follow-up study | 0.98 | 3.81 | NA | 0.19 | 4.98 | NA | XXX | |
76380 | 26 | A | CAT scan follow-up study | 0.98 | 0.33 | 0.33 | 0.04 | 1.35 | 1.35 | XXX |
76380 | TC | A | CAT scan follow-up study | 0.00 | 3.48 | NA | 0.15 | 3.63 | NA | XXX |
76390 | N | Mr spectroscopy | +1.40 | 11.64 | NA | 0.55 | 13.59 | NA | XXX | |
76390 | 26 | N | Mr spectroscopy | +1.40 | 0.48 | 0.48 | 0.06 | 1.94 | 1.94 | XXX |
76390 | TC | N | Mr spectroscopy | +0.00 | 11.16 | NA | 0.49 | 11.65 | NA | XXX |
76393 | A | Mr guidance for needle place | 1.50 | 11.68 | NA | 0.53 | 13.71 | NA | XXX | |
76393 | 26 | A | Mr guidance for needle place | 1.50 | 0.52 | 0.52 | 0.07 | 2.09 | 2.09 | XXX |
76393 | TC | A | Mr guidance for needle place | 0.00 | 11.16 | NA | 0.46 | 11.62 | NA | XXX |
76394 | A | Mri for tissue ablation | 4.25 | 12.60 | NA | 1.48 | 18.33 | NA | XXX | |
76394 | 26 | A | Mri for tissue ablation | 4.25 | 1.44 | 1.44 | 0.19 | 5.88 | 5.88 | XXX |
76394 | TC | A | Mri for tissue ablation | 0.00 | 11.16 | NA | 1.29 | 12.45 | NA | XXX |
76400 | A | Magnetic image, bone marrow | 1.60 | 11.70 | NA | 0.56 | 13.86 | NA | XXX | |
76400 | 26 | A | Magnetic image, bone marrow | 1.60 | 0.54 | 0.54 | 0.07 | 2.21 | 2.21 | XXX |
76400 | TC | A | Magnetic image, bone marrow | 0.00 | 11.16 | NA | 0.49 | 11.65 | NA | XXX |
76490 | A | Us for tissue ablation | 4.00 | 2.85 | NA | 0.35 | 7.20 | NA | XXX | |
76490 | 26 | A | Us for tissue ablation | 4.00 | 1.34 | 1.34 | 0.11 | 5.45 | 5.45 | XXX |
76490 | TC | A | Us for tissue ablation | 0.00 | 1.51 | NA | 0.24 | 1.75 | NA | XXX |
76496 | C | Fluoroscopic procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
76496 | 26 | C | Fluoroscopic procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
76496 | TC | C | Fluoroscopic procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
76497 | C | Ct procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
76497 | 26 | C | Ct procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
76497 | TC | C | Ct procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
76498 | C | Mri procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
76498 | 26 | C | Mri procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
76498 | TC | C | Mri procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
76499 | C | Radiographic procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
76499 | 26 | C | Radiographic procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
76499 | TC | C | Radiographic procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
76506 | A | Echo exam of head | 0.63 | 1.66 | NA | 0.10 | 2.39 | NA | XXX | |
76506 | 26 | A | Echo exam of head | 0.63 | 0.25 | 0.25 | 0.03 | 0.91 | 0.91 | XXX |
76506 | TC | A | Echo exam of head | 0.00 | 1.41 | NA | 0.07 | 1.48 | NA | XXX |
76511 | A | Echo exam of eye | 0.94 | 2.59 | NA | 0.08 | 3.61 | NA | XXX | |
76511 | 26 | A | Echo exam of eye | 0.94 | 0.41 | 0.41 | 0.02 | 1.37 | 1.37 | XXX |
76511 | TC | A | Echo exam of eye | 0.00 | 2.18 | NA | 0.06 | 2.24 | NA | XXX |
76512 | A | Echo exam of eye | 0.66 | 2.54 | NA | 0.09 | 3.29 | NA | XXX | |
76512 | 26 | A | Echo exam of eye | 0.66 | 0.30 | 0.30 | 0.01 | 0.97 | 0.97 | XXX |
76512 | TC | A | Echo exam of eye | 0.00 | 2.24 | NA | 0.08 | 2.32 | NA | XXX |
76513 | A | Echo exam of eye, water bath | 0.66 | 2.80 | NA | 0.09 | 3.55 | NA | XXX | |
76513 | 26 | A | Echo exam of eye, water bath | 0.66 | 0.30 | 0.30 | 0.01 | 0.97 | 0.97 | XXX |
76513 | TC | A | Echo exam of eye, water bath | 0.00 | 2.50 | NA | 0.08 | 2.58 | NA | XXX |
76516 | A | Echo exam of eye | 0.54 | 2.13 | NA | 0.07 | 2.74 | NA | XXX | |
76516 | 26 | A | Echo exam of eye | 0.54 | 0.25 | 0.25 | 0.01 | 0.80 | 0.80 | XXX |
76516 | TC | A | Echo exam of eye | 0.00 | 1.88 | NA | 0.06 | 1.94 | NA | XXX |
76519 | A | Echo exam of eye | 0.54 | 1.86 | NA | 0.07 | 2.47 | NA | XXX | |
76519 | 26 | A | Echo exam of eye | 0.54 | 0.25 | 0.25 | 0.01 | 0.80 | 0.80 | XXX |
76519 | TC | A | Echo exam of eye | 0.00 | 1.61 | NA | 0.06 | 1.67 | NA | XXX |
76529 | A | Echo exam of eye | 0.57 | 2.42 | NA | 0.08 | 3.07 | NA | XXX | |
76529 | 26 | A | Echo exam of eye | 0.57 | 0.25 | 0.25 | 0.01 | 0.83 | 0.83 | XXX |
76529 | TC | A | Echo exam of eye | 0.00 | 2.17 | NA | 0.07 | 2.24 | NA | XXX |
76536 | A | Us exam of head and neck | 0.56 | 1.60 | NA | 0.09 | 2.25 | NA | XXX | |
76536 | 26 | A | Us exam of head and neck | 0.56 | 0.19 | 0.19 | 0.02 | 0.77 | 0.77 | XXX |
76536 | TC | A | Us exam of head and neck | 0.00 | 1.41 | NA | 0.07 | 1.48 | NA | XXX |
76604 | A | Us exam, chest, b-scan | 0.55 | 1.49 | NA | 0.08 | 2.12 | NA | XXX | |
76604 | 26 | A | Us exam, chest, b-scan | 0.55 | 0.19 | 0.19 | 0.02 | 0.76 | 0.76 | XXX |
76604 | TC | A | Us exam, chest, b-scan | 0.00 | 1.30 | NA | 0.06 | 1.36 | NA | XXX |
76645 | A | Us exam, breast(s) | 0.54 | 1.22 | NA | 0.08 | 1.84 | NA | XXX | |
76645 | 26 | A | Us exam, breast(s) | 0.54 | 0.18 | 0.18 | 0.03 | 0.75 | 0.75 | XXX |
76645 | TC | A | Us exam, breast(s) | 0.00 | 1.04 | NA | 0.05 | 1.09 | NA | XXX |
76700 | A | Us exam, abdom, complete | 0.81 | 2.24 | NA | 0.13 | 3.18 | NA | XXX | |
76700 | 26 | A | Us exam, abdom, complete | 0.81 | 0.28 | 0.28 | 0.04 | 1.13 | 1.13 | XXX |
76700 | TC | A | Us exam, abdom, complete | 0.00 | 1.96 | NA | 0.09 | 2.05 | NA | XXX |
76705 | A | Echo exam of abdomen | 0.59 | 1.61 | NA | 0.10 | 2.30 | NA | XXX | |
76705 | 26 | A | Echo exam of abdomen | 0.59 | 0.20 | 0.20 | 0.03 | 0.82 | 0.82 | XXX |
76705 | TC | A | Echo exam of abdomen | 0.00 | 1.41 | NA | 0.07 | 1.48 | NA | XXX |
76770 | A | Us exam abdo back wall, comp | 0.74 | 2.21 | NA | 0.12 | 3.07 | NA | XXX | |
76770 | 26 | A | Us exam abdo back wall, comp | 0.74 | 0.25 | 0.25 | 0.03 | 1.02 | 1.02 | XXX |
76770 | TC | A | Us exam abdo back wall, comp | 0.00 | 1.96 | NA | 0.09 | 2.05 | NA | XXX |
76775 | A | Us eam abdo back wall, lim | 0.58 | 1.61 | NA | 0.10 | 2.29 | NA | XXX | |
76775 | 26 | A | Us eam abdo back wall, lim | 0.58 | 0.20 | 0.20 | 0.03 | 0.81 | 0.81 | XXX |
76775 | TC | A | Us eam abdo back wall, lim | 0.00 | 1.41 | NA | 0.07 | 1.48 | NA | XXX |
76778 | A | Us exam kidney transplant | 0.74 | 2.21 | NA | 0.12 | 3.07 | NA | XXX | |
76778 | 26 | A | Us exam kidney transplant | 0.74 | 0.25 | 0.25 | 0.03 | 1.02 | 1.02 | XXX |
76778 | TC | A | Us exam kidney transplant | 0.00 | 1.96 | NA | 0.09 | 2.05 | NA | XXX |
76800 | A | Us exam, spinal canal | 1.13 | 1.76 | NA | 0.11 | 3.00 | NA | XXX | |
76800 | 26 | A | Us exam, spinal canal | 1.13 | 0.35 | 0.35 | 0.04 | 1.52 | 1.52 | XXX |
76800 | TC | A | Us exam, spinal canal | 0.00 | 1.41 | NA | 0.07 | 1.48 | NA | XXX |
76801 | A | Ob us 14 wks, single fetus | 0.99 | 1.40 | NA | 0.14 | 2.53 | NA | XXX | |
76801 | 26 | A | Ob us 14 wks, single fetus | 0.99 | 0.36 | 0.36 | 0.04 | 1.39 | 1.39 | XXX |
76801 | TC | A | Ob us 14 wks, single fetus | 0.00 | 1.04 | NA | 0.10 | 1.14 | NA | XXX |
76802 | A | Ob us 14 wks, addl fetus | 0.83 | 1.01 | NA | 0.14 | 1.98 | NA | ZZZ | |
76802 | 26 | A | Ob us 14 wks, addl fetus | 0.83 | 0.30 | 0.30 | 0.04 | 1.17 | 1.17 | ZZZ |
76802 | TC | A | Ob us 14 wks, addl fetus | 0.00 | 0.71 | NA | 0.10 | 0.81 | NA | ZZZ |
76805 | A | Ob us /= 14 wks, sngl fetus | 0.99 | 2.44 | NA | 0.14 | 3.57 | NA | XXX | |
76805 | 26 | A | Ob us /= 14 wks, sngl fetus | 0.99 | 0.35 | 0.35 | 0.04 | 1.38 | 1.38 | XXX |
76805 | TC | A | Ob us /= 14 wks, sngl fetus | 0.00 | 2.09 | NA | 0.10 | 2.19 | NA | XXX |
76810 | A | Ob us /= 14 wks, addl fetus | 0.98 | 1.40 | NA | 0.25 | 2.63 | NA | ZZZ | |
76810 | 26 | A | Ob us /= 14 wks, addl fetus | 0.98 | 0.36 | 0.36 | 0.07 | 1.41 | 1.41 | ZZZ |
76810 | TC | A | Ob us /= 14 wks, addl fetus | 0.00 | 1.04 | NA | 0.18 | 1.22 | NA | ZZZ |
76811 | A | Ob us, detailed, sngl fetus | 1.90 | 4.19 | NA | 0.51 | 6.60 | NA | XXX | |
76811 | 26 | A | Ob us, detailed, sngl fetus | 1.90 | 0.68 | 0.68 | 0.15 | 2.73 | 2.73 | XXX |
76811 | TC | A | Ob us, detailed, sngl fetus | 0.00 | 3.51 | NA | 0.36 | 3.87 | NA | XXX |
76812 | A | Ob us, detailed, addl fetus | 1.78 | 1.69 | NA | 0.46 | 3.93 | NA | ZZZ | |
76812 | 26 | A | Ob us, detailed, addl fetus | 1.78 | 0.65 | 0.65 | 0.12 | 2.55 | 2.55 | ZZZ |
76812 | TC | A | Ob us, detailed, addl fetus | 0.00 | 1.04 | NA | 0.34 | 1.38 | NA | ZZZ |
76815 | A | Ob us, limited, fetus(s) | 0.65 | 1.65 | NA | 0.09 | 2.39 | NA | XXX | |
76815 | 26 | A | Ob us, limited, fetus(s) | 0.65 | 0.24 | 0.24 | 0.02 | 0.91 | 0.91 | XXX |
76815 | TC | A | Ob us, limited, fetus(s) | 0.00 | 1.41 | NA | 0.07 | 1.48 | NA | XXX |
76816 | A | Ob us, follow-up, per fetus | 0.85 | 1.43 | NA | 0.07 | 2.35 | NA | XXX | |
76816 | 26 | A | Ob us, follow-up, per fetus | 0.85 | 0.33 | 0.33 | 0.02 | 1.20 | 1.20 | XXX |
76816 | TC | A | Ob us, follow-up, per fetus | 0.00 | 1.10 | NA | 0.05 | 1.15 | NA | XXX |
76817 | A | Transvaginal us, obstetric | 0.75 | 1.79 | NA | 0.07 | 2.61 | NA | XXX | |
76817 | 26 | A | Transvaginal us, obstetric | 0.75 | 0.28 | 0.28 | 0.02 | 1.05 | 1.05 | XXX |
76817 | TC | A | Transvaginal us, obstetric | 0.00 | 1.51 | NA | 0.05 | 1.56 | NA | XXX |
76818 | A | Fetal biophys profile w/nst | 1.05 | 2.01 | NA | 0.12 | 3.18 | NA | XXX | |
76818 | 26 | A | Fetal biophys profile w/nst | 1.05 | 0.40 | 0.40 | 0.04 | 1.49 | 1.49 | XXX |
76818 | TC | A | Fetal biophys profile w/nst | 0.00 | 1.61 | NA | 0.08 | 1.69 | NA | XXX |
76819 | A | Fetal biophys profil w/o nst | 0.77 | 1.90 | NA | 0.10 | 2.77 | NA | XXX | |
76819 | 26 | A | Fetal biophys profil w/o nst | 0.77 | 0.29 | 0.29 | 0.02 | 1.08 | 1.08 | XXX |
76819 | TC | A | Fetal biophys profil w/o nst | 0.00 | 1.61 | NA | 0.08 | 1.69 | NA | XXX |
76825 | A | Echo exam of fetal heart | 1.67 | 2.58 | NA | 0.15 | 4.40 | NA | XXX | |
76825 | 26 | A | Echo exam of fetal heart | 1.67 | 0.62 | 0.62 | 0.06 | 2.35 | 2.35 | XXX |
76825 | TC | A | Echo exam of fetal heart | 0.00 | 1.96 | NA | 0.09 | 2.05 | NA | XXX |
76826 | A | Echo exam of fetal heart | 0.83 | 1.01 | NA | 0.07 | 1.91 | NA | XXX | |
76826 | 26 | A | Echo exam of fetal heart | 0.83 | 0.30 | 0.30 | 0.03 | 1.16 | 1.16 | XXX |
76826 | TC | A | Echo exam of fetal heart | 0.00 | 0.71 | NA | 0.04 | 0.75 | NA | XXX |
76827 | A | Echo exam of fetal heart | 0.58 | 1.93 | NA | 0.12 | 2.63 | NA | XXX | |
76827 | 26 | A | Echo exam of fetal heart | 0.58 | 0.22 | 0.22 | 0.02 | 0.82 | 0.82 | XXX |
76827 | TC | A | Echo exam of fetal heart | 0.00 | 1.71 | NA | 0.10 | 1.81 | NA | XXX |
76828 | A | Echo exam of fetal heart | 0.56 | 1.32 | NA | 0.09 | 1.97 | NA | XXX | |
76828 | 26 | A | Echo exam of fetal heart | 0.56 | 0.22 | 0.22 | 0.02 | 0.80 | 0.80 | XXX |
76828 | TC | A | Echo exam of fetal heart | 0.00 | 1.10 | NA | 0.07 | 1.17 | NA | XXX |
76830 | A | Transvaginal us, non-ob | 0.69 | 1.75 | NA | 0.11 | 2.55 | NA | XXX | |
76830 | 26 | A | Transvaginal us, non-ob | 0.69 | 0.24 | 0.24 | 0.03 | 0.96 | 0.96 | XXX |
76830 | TC | A | Transvaginal us, non-ob | 0.00 | 1.51 | NA | 0.08 | 1.59 | NA | XXX |
76831 | A | Echo exam, uterus | 0.72 | 1.77 | NA | 0.10 | 2.59 | NA | XXX | |
76831 | 26 | A | Echo exam, uterus | 0.72 | 0.26 | 0.26 | 0.02 | 1.00 | 1.00 | XXX |
76831 | TC | A | Echo exam, uterus | 0.00 | 1.51 | NA | 0.08 | 1.59 | NA | XXX |
76856 | A | Us exam, pelvic, complete | 0.69 | 1.75 | NA | 0.11 | 2.55 | NA | XXX | |
76856 | 26 | A | Us exam, pelvic, complete | 0.69 | 0.24 | 0.24 | 0.03 | 0.96 | 0.96 | XXX |
76856 | TC | A | Us exam, pelvic, complete | 0.00 | 1.51 | NA | 0.08 | 1.59 | NA | XXX |
76857 | A | Us exam, pelvic, limited | 0.38 | 2.09 | NA | 0.07 | 2.54 | NA | XXX | |
76857 | 26 | A | Us exam, pelvic, limited | 0.38 | 0.13 | 0.13 | 0.02 | 0.53 | 0.53 | XXX |
76857 | TC | A | Us exam, pelvic, limited | 0.00 | 1.96 | NA | 0.05 | 2.01 | NA | XXX |
76870 | A | Us exam, scrotum | 0.64 | 1.73 | NA | 0.11 | 2.48 | NA | XXX | |
76870 | 26 | A | Us exam, scrotum | 0.64 | 0.22 | 0.22 | 0.03 | 0.89 | 0.89 | XXX |
76870 | TC | A | Us exam, scrotum | 0.00 | 1.51 | NA | 0.08 | 1.59 | NA | XXX |
76872 | A | Echo exam, transrectal | 0.69 | 1.81 | NA | 0.12 | 2.62 | NA | XXX | |
76872 | 26 | A | Echo exam, transrectal | 0.69 | 0.23 | 0.23 | 0.04 | 0.96 | 0.96 | XXX |
76872 | TC | A | Echo exam, transrectal | 0.00 | 1.58 | NA | 0.08 | 1.66 | NA | XXX |
76873 | A | Echograp trans r, pros study | 1.55 | 2.61 | NA | 0.21 | 4.37 | NA | XXX | |
76873 | 26 | A | Echograp trans r, pros study | 1.55 | 0.52 | 0.52 | 0.08 | 2.15 | 2.15 | XXX |
76873 | TC | A | Echograp trans r, pros study | 0.00 | 2.09 | NA | 0.13 | 2.22 | NA | XXX |
76880 | A | Us exam, extremity | 0.59 | 1.61 | NA | 0.10 | 2.30 | NA | XXX | |
76880 | 26 | A | Us exam, extremity | 0.59 | 0.20 | 0.20 | 0.03 | 0.82 | 0.82 | XXX |
76880 | TC | A | Us exam, extremity | 0.00 | 1.41 | NA | 0.07 | 1.48 | NA | XXX |
76885 | A | Us exam infant hips, dynamic | 0.74 | 1.76 | NA | 0.11 | 2.61 | NA | XXX | |
76885 | 26 | A | Us exam infant hips, dynamic | 0.74 | 0.25 | 0.25 | 0.03 | 1.02 | 1.02 | XXX |
76885 | TC | A | Us exam infant hips, dynamic | 0.00 | 1.51 | NA | 0.08 | 1.59 | NA | XXX |
76886 | A | Us exam infant hips, static | 0.62 | 1.62 | NA | 0.10 | 2.34 | NA | XXX | |
76886 | 26 | A | Us exam infant hips, static | 0.62 | 0.21 | 0.21 | 0.03 | 0.86 | 0.86 | XXX |
76886 | TC | A | Us exam infant hips, static | 0.00 | 1.41 | NA | 0.07 | 1.48 | NA | XXX |
76930 | A | Echo guide, cardiocentesis | 0.67 | 1.77 | NA | 0.10 | 2.54 | NA | XXX | |
76930 | 26 | A | Echo guide, cardiocentesis | 0.67 | 0.26 | 0.26 | 0.02 | 0.95 | 0.95 | XXX |
76930 | TC | A | Echo guide, cardiocentesis | 0.00 | 1.51 | NA | 0.08 | 1.59 | NA | XXX |
76932 | A | Echo guide for heart biopsy | 0.67 | 1.77 | NA | 0.10 | 2.54 | NA | XXX | |
76932 | 26 | A | Echo guide for heart biopsy | 0.67 | 0.26 | 0.26 | 0.02 | 0.95 | 0.95 | XXX |
76932 | TC | A | Echo guide for heart biopsy | 0.00 | 1.51 | NA | 0.08 | 1.59 | NA | XXX |
76936 | A | Echo guide for artery repair | 1.99 | 6.95 | NA | 0.39 | 9.33 | NA | XXX | |
76936 | 26 | A | Echo guide for artery repair | 1.99 | 0.68 | 0.68 | 0.11 | 2.78 | 2.78 | XXX |
76936 | TC | A | Echo guide for artery repair | 0.00 | 6.27 | NA | 0.28 | 6.55 | NA | XXX |
76941 | A | Echo guide for transfusion | 1.34 | 2.01 | NA | 0.13 | 3.48 | NA | XXX | |
76941 | 26 | A | Echo guide for transfusion | 1.34 | 0.49 | 0.49 | 0.06 | 1.89 | 1.89 | XXX |
76941 | TC | A | Echo guide for transfusion | 0.00 | 1.52 | NA | 0.07 | 1.59 | NA | XXX |
76942 | A | Echo guide for biopsy | 0.67 | 3.18 | NA | 0.12 | 3.97 | NA | XXX | |
76942 | 26 | A | Echo guide for biopsy | 0.67 | 0.23 | 0.23 | 0.04 | 0.94 | 0.94 | XXX |
76942 | TC | A | Echo guide for biopsy | 0.00 | 2.95 | NA | 0.08 | 3.03 | NA | XXX |
76945 | A | Echo guide, villus sampling | 0.67 | 1.75 | NA | 0.10 | 2.52 | NA | XXX | |
76945 | 26 | A | Echo guide, villus sampling | 0.67 | 0.23 | 0.23 | 0.03 | 0.93 | 0.93 | XXX |
76945 | TC | A | Echo guide, villus sampling | 0.00 | 1.52 | NA | 0.07 | 1.59 | NA | XXX |
76946 | A | Echo guide for amniocentesis | 0.38 | 1.65 | NA | 0.09 | 2.12 | NA | XXX | |
76946 | 26 | A | Echo guide for amniocentesis | 0.38 | 0.14 | 0.14 | 0.01 | 0.53 | 0.53 | XXX |
76946 | TC | A | Echo guide for amniocentesis | 0.00 | 1.51 | NA | 0.08 | 1.59 | NA | XXX |
76948 | A | Echo guide, ova aspiration | 0.38 | 1.64 | NA | 0.10 | 2.12 | NA | XXX | |
76948 | 26 | A | Echo guide, ova aspiration | 0.38 | 0.13 | 0.13 | 0.02 | 0.53 | 0.53 | XXX |
76948 | TC | A | Echo guide, ova aspiration | 0.00 | 1.51 | NA | 0.08 | 1.59 | NA | XXX |
76950 | A | Echo guidance radiotherapy | 0.58 | 1.50 | NA | 0.09 | 2.17 | NA | XXX | |
76950 | 26 | A | Echo guidance radiotherapy | 0.58 | 0.20 | 0.20 | 0.03 | 0.81 | 0.81 | XXX |
76950 | TC | A | Echo guidance radiotherapy | 0.00 | 1.30 | NA | 0.06 | 1.36 | NA | XXX |
76965 | A | Echo guidance radiotherapy | 1.34 | 5.99 | NA | 0.31 | 7.64 | NA | XXX | |
76965 | 26 | A | Echo guidance radiotherapy | 1.34 | 0.45 | 0.45 | 0.07 | 1.86 | 1.86 | XXX |
76965 | TC | A | Echo guidance radiotherapy | 0.00 | 5.54 | NA | 0.24 | 5.78 | NA | XXX |
76970 | A | Ultrasound exam follow-up | 0.40 | 1.18 | NA | 0.07 | 1.65 | NA | XXX | |
76970 | 26 | A | Ultrasound exam follow-up | 0.40 | 0.14 | 0.14 | 0.02 | 0.56 | 0.56 | XXX |
76970 | TC | A | Ultrasound exam follow-up | 0.00 | 1.04 | NA | 0.05 | 1.09 | NA | XXX |
76975 | A | GI endoscopic ultrasound | 0.81 | 1.80 | NA | 0.11 | 2.72 | NA | XXX | |
76975 | 26 | A | GI endoscopic ultrasound | 0.81 | 0.29 | 0.29 | 0.03 | 1.13 | 1.13 | XXX |
76975 | TC | A | GI endoscopic ultrasound | 0.00 | 1.51 | NA | 0.08 | 1.59 | NA | XXX |
76977 | A | Us bone density measure | 0.05 | 0.84 | NA | 0.05 | 0.94 | NA | XXX | |
76977 | 26 | A | Us bone density measure | 0.05 | 0.02 | 0.02 | 0.01 | 0.08 | 0.08 | XXX |
76977 | TC | A | Us bone density measure | 0.00 | 0.82 | NA | 0.04 | 0.86 | NA | XXX |
76986 | A | Ultrasound guide intraoper | 1.20 | 3.02 | NA | 0.19 | 4.41 | NA | XXX | |
76986 | 26 | A | Ultrasound guide intraoper | 1.20 | 0.41 | 0.41 | 0.07 | 1.68 | 1.68 | XXX |
76986 | TC | A | Ultrasound guide intraoper | 0.00 | 2.61 | NA | 0.12 | 2.73 | NA | XXX |
76999 | C | Echo examination procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
76999 | 26 | C | Echo examination procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
76999 | TC | C | Echo examination procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
77261 | A | Radiation therapy planning | 1.39 | 0.54 | 0.54 | 0.06 | 1.99 | 1.99 | XXX | |
77262 | A | Radiation therapy planning | 2.11 | 0.80 | 0.80 | 0.09 | 3.00 | 3.00 | XXX | |
77263 | A | Radiation therapy planning | 3.14 | 1.17 | 1.17 | 0.13 | 4.44 | 4.44 | XXX | |
77280 | A | Set radiation therapy field | 0.70 | 3.69 | NA | 0.18 | 4.57 | NA | XXX | |
77280 | 26 | A | Set radiation therapy field | 0.70 | 0.24 | 0.24 | 0.03 | 0.97 | 0.97 | XXX |
77280 | TC | A | Set radiation therapy field | 0.00 | 3.45 | NA | 0.15 | 3.60 | NA | XXX |
77285 | A | Set radiation therapy field | 1.05 | 5.90 | NA | 0.29 | 7.24 | NA | XXX | |
77285 | 26 | A | Set radiation therapy field | 1.05 | 0.36 | 0.36 | 0.04 | 1.45 | 1.45 | XXX |
77285 | TC | A | Set radiation therapy field | 0.00 | 5.54 | NA | 0.25 | 5.79 | NA | XXX |
77290 | A | Set radiation therapy field | 1.56 | 7.01 | NA | 0.35 | 8.92 | NA | XXX | |
77290 | 26 | A | Set radiation therapy field | 1.56 | 0.53 | 0.53 | 0.06 | 2.15 | 2.15 | XXX |
77290 | TC | A | Set radiation therapy field | 0.00 | 6.48 | NA | 0.29 | 6.77 | NA | XXX |
77295 | A | Set radiation therapy field | 4.57 | 29.35 | NA | 1.41 | 35.33 | NA | XXX | |
77295 | 26 | A | Set radiation therapy field | 4.57 | 1.54 | 1.54 | 0.18 | 6.29 | 6.29 | XXX |
77295 | TC | A | Set radiation therapy field | 0.00 | 27.81 | NA | 1.23 | 29.04 | NA | XXX |
77299 | C | Radiation therapy planning | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
77299 | 26 | C | Radiation therapy planning | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
77299 | TC | C | Radiation therapy planning | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
77300 | A | Radiation therapy dose plan | 0.62 | 1.54 | NA | 0.09 | 2.25 | NA | XXX | |
77300 | 26 | A | Radiation therapy dose plan | 0.62 | 0.21 | 0.21 | 0.03 | 0.86 | 0.86 | XXX |
77300 | TC | A | Radiation therapy dose plan | 0.00 | 1.33 | NA | 0.06 | 1.39 | NA | XXX |
77301 | A | Radiotherapy dose plan, imrt | 8.00 | 30.92 | NA | 1.41 | 40.33 | NA | XXX | |
77301 | 26 | A | Radiotherapy dose plan, imrt | 8.00 | 3.11 | 3.11 | 0.18 | 11.29 | 11.29 | XXX |
77301 | TC | A | Radiotherapy dose plan, imrt | 0.00 | 27.81 | NA | 1.23 | 29.04 | NA | XXX |
77305 | A | Teletx isodose plan simple | 0.70 | 2.09 | NA | 0.12 | 2.91 | NA | XXX | |
77305 | 26 | A | Teletx isodose plan simple | 0.70 | 0.24 | 0.24 | 0.03 | 0.97 | 0.97 | XXX |
77305 | TC | A | Teletx isodose plan simple | 0.00 | 1.85 | NA | 0.09 | 1.94 | NA | XXX |
77310 | A | Teletx isodose plan intermed | 1.05 | 2.68 | NA | 0.15 | 3.88 | NA | XXX | |
77310 | 26 | A | Teletx isodose plan intermed | 1.05 | 0.36 | 0.36 | 0.04 | 1.45 | 1.45 | XXX |
77310 | TC | A | Teletx isodose plan intermed | 0.00 | 2.32 | NA | 0.11 | 2.43 | NA | XXX |
77315 | A | Teletx isodose plan complex | 1.56 | 3.18 | NA | 0.18 | 4.92 | NA | XXX | |
77315 | 26 | A | Teletx isodose plan complex | 1.56 | 0.53 | 0.53 | 0.06 | 2.15 | 2.15 | XXX |
77315 | TC | A | Teletx isodose plan complex | 0.00 | 2.65 | NA | 0.12 | 2.77 | NA | XXX |
77321 | A | Special teletx port plan | 0.95 | 4.34 | NA | 0.21 | 5.50 | NA | XXX | |
77321 | 26 | A | Special teletx port plan | 0.95 | 0.32 | 0.32 | 0.04 | 1.31 | 1.31 | XXX |
77321 | TC | A | Special teletx port plan | 0.00 | 4.02 | NA | 0.17 | 4.19 | NA | XXX |
77326 | A | Brachytx isodose calc simp | 0.93 | 2.66 | NA | 0.15 | 3.74 | NA | XXX | |
77326 | 26 | A | Brachytx isodose calc simp | 0.93 | 0.31 | 0.31 | 0.04 | 1.28 | 1.28 | XXX |
77326 | TC | A | Brachytx isodose calc simp | 0.00 | 2.35 | NA | 0.11 | 2.46 | NA | XXX |
77327 | A | Brachytx isodose calc interm | 1.39 | 3.92 | NA | 0.21 | 5.52 | NA | XXX | |
77327 | 26 | A | Brachytx isodose calc interm | 1.39 | 0.47 | 0.47 | 0.06 | 1.92 | 1.92 | XXX |
77327 | TC | A | Brachytx isodose calc interm | 0.00 | 3.45 | NA | 0.15 | 3.60 | NA | XXX |
77328 | A | Brachytx isodose plan compl | 2.09 | 5.65 | NA | 0.30 | 8.04 | NA | XXX | |
77328 | 26 | A | Brachytx isodose plan compl | 2.09 | 0.71 | 0.71 | 0.09 | 2.89 | 2.89 | XXX |
77328 | TC | A | Brachytx isodose plan compl | 0.00 | 4.94 | NA | 0.21 | 5.15 | NA | XXX |
77331 | A | Special radiation dosimetry | 0.87 | 0.80 | NA | 0.06 | 1.73 | NA | XXX | |
77331 | 26 | A | Special radiation dosimetry | 0.87 | 0.30 | 0.30 | 0.04 | 1.21 | 1.21 | XXX |
77331 | TC | A | Special radiation dosimetry | 0.00 | 0.50 | NA | 0.02 | 0.52 | NA | XXX |
77332 | A | Radiation treatment aid(s) | 0.54 | 1.51 | NA | 0.08 | 2.13 | NA | XXX | |
77332 | 26 | A | Radiation treatment aid(s) | 0.54 | 0.18 | 0.18 | 0.02 | 0.74 | 0.74 | XXX |
77332 | TC | A | Radiation treatment aid(s) | 0.00 | 1.33 | NA | 0.06 | 1.39 | NA | XXX |
77333 | A | Radiation treatment aid(s) | 0.84 | 2.18 | NA | 0.13 | 3.15 | NA | XXX | |
77333 | 26 | A | Radiation treatment aid(s) | 0.84 | 0.29 | 0.29 | 0.04 | 1.17 | 1.17 | XXX |
77333 | TC | A | Radiation treatment aid(s) | 0.00 | 1.89 | NA | 0.09 | 1.98 | NA | XXX |
77334 | A | Radiation treatment aid(s) | 1.24 | 3.65 | NA | 0.19 | 5.08 | NA | XXX | |
77334 | 26 | A | Radiation treatment aid(s) | 1.24 | 0.42 | 0.42 | 0.05 | 1.71 | 1.71 | XXX |
77334 | TC | A | Radiation treatment aid(s) | 0.00 | 3.23 | NA | 0.14 | 3.37 | NA | XXX |
77336 | A | Radiation physics consult | 0.00 | 2.97 | NA | 0.13 | 3.10 | NA | XXX | |
77370 | A | Radiation physics consult | 0.00 | 3.47 | NA | 0.15 | 3.62 | NA | XXX | |
77399 | C | External radiation dosimetry | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
77399 | 26 | C | External radiation dosimetry | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
77399 | TC | C | External radiation dosimetry | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
77401 | A | Radiation treatment delivery | 0.00 | 1.76 | NA | 0.09 | 1.85 | NA | XXX | |
77402 | A | Radiation treatment delivery | 0.00 | 1.76 | NA | 0.09 | 1.85 | NA | XXX | |
77403 | A | Radiation treatment delivery | 0.00 | 1.76 | NA | 0.09 | 1.85 | NA | XXX | |
77404 | A | Radiation treatment delivery | 0.00 | 1.76 | NA | 0.09 | 1.85 | NA | XXX | |
77406 | A | Radiation treatment delivery | 0.00 | 1.76 | NA | 0.09 | 1.85 | NA | XXX | |
77407 | A | Radiation treatment delivery | 0.00 | 2.08 | NA | 0.10 | 2.18 | NA | XXX | |
77408 | A | Radiation treatment delivery | 0.00 | 2.08 | NA | 0.10 | 2.18 | NA | XXX | |
77409 | A | Radiation treatment delivery | 0.00 | 2.08 | NA | 0.10 | 2.18 | NA | XXX | |
77411 | A | Radiation treatment delivery | 0.00 | 2.08 | NA | 0.10 | 2.18 | NA | XXX | |
77412 | A | Radiation treatment delivery | 0.00 | 2.32 | NA | 0.11 | 2.43 | NA | XXX | |
77413 | A | Radiation treatment delivery | 0.00 | 2.32 | NA | 0.11 | 2.43 | NA | XXX | |
77414 | A | Radiation treatment delivery | 0.00 | 2.32 | NA | 0.11 | 2.43 | NA | XXX | |
77416 | A | Radiation treatment delivery | 0.00 | 2.32 | NA | 0.11 | 2.43 | NA | XXX | |
77417 | A | Radiology port film(s) | 0.00 | 0.59 | NA | 0.03 | 0.62 | NA | XXX | |
77418 | A | Radiation tx delivery, imrt | 0.00 | 17.97 | NA | 0.11 | 18.08 | NA | XXX | |
77427 | A | Radiation tx management, x5 | 3.31 | 1.12 | 1.12 | 0.14 | 4.57 | 4.57 | XXX | |
77431 | A | Radiation therapy management | 1.81 | 0.71 | 0.71 | 0.07 | 2.59 | 2.59 | XXX | |
77432 | A | Stereotactic radiation trmt | 7.93 | 3.06 | 3.06 | 0.33 | 11.32 | 11.32 | XXX | |
77470 | A | Special radiation treatment | 2.09 | 11.81 | NA | 0.58 | 14.48 | NA | XXX | |
77470 | 26 | A | Special radiation treatment | 2.09 | 0.71 | 0.71 | 0.09 | 2.89 | 2.89 | XXX |
77470 | TC | A | Special radiation treatment | 0.00 | 11.10 | NA | 0.49 | 11.59 | NA | XXX |
77499 | C | Radiation therapy management | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
77499 | 26 | C | Radiation therapy management | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
77499 | TC | C | Radiation therapy management | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
77520 | C | Proton trmt, simple w/o comp | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
77522 | C | Proton trmt, simple w/comp | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
77523 | C | Proton trmt, intermediate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
77525 | C | Proton treatment, complex | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
77600 | R | Hyperthermia treatment | 1.56 | 3.57 | NA | 0.21 | 5.34 | NA | XXX | |
77600 | 26 | R | Hyperthermia treatment | 1.56 | 0.53 | 0.53 | 0.08 | 2.17 | 2.17 | XXX |
77600 | TC | R | Hyperthermia treatment | 0.00 | 3.04 | NA | 0.13 | 3.17 | NA | XXX |
77605 | R | Hyperthermia treatment | 2.09 | 4.75 | NA | 0.31 | 7.15 | NA | XXX | |
77605 | 26 | R | Hyperthermia treatment | 2.09 | 0.71 | 0.71 | 0.13 | 2.93 | 2.93 | XXX |
77605 | TC | R | Hyperthermia treatment | 0.00 | 4.04 | NA | 0.18 | 4.22 | NA | XXX |
77610 | R | Hyperthermia treatment | 1.56 | 3.57 | NA | 0.20 | 5.33 | NA | XXX | |
77610 | 26 | R | Hyperthermia treatment | 1.56 | 0.53 | 0.53 | 0.07 | 2.16 | 2.16 | XXX |
77610 | TC | R | Hyperthermia treatment | 0.00 | 3.04 | NA | 0.13 | 3.17 | NA | XXX |
77615 | R | Hyperthermia treatment | 2.09 | 4.75 | NA | 0.27 | 7.11 | NA | XXX | |
77615 | 26 | R | Hyperthermia treatment | 2.09 | 0.71 | 0.71 | 0.09 | 2.89 | 2.89 | XXX |
77615 | TC | R | Hyperthermia treatment | 0.00 | 4.04 | NA | 0.18 | 4.22 | NA | XXX |
77620 | R | Hyperthermia treatment | 1.56 | 3.58 | NA | 0.19 | 5.33 | NA | XXX | |
77620 | 26 | R | Hyperthermia treatment | 1.56 | 0.54 | 0.54 | 0.06 | 2.16 | 2.16 | XXX |
77620 | TC | R | Hyperthermia treatment | 0.00 | 3.04 | NA | 0.13 | 3.17 | NA | XXX |
77750 | A | Infuse radioactive materials | 4.91 | 3.00 | NA | 0.23 | 8.14 | NA | 090 | |
77750 | 26 | A | Infuse radioactive materials | 4.91 | 1.67 | 1.67 | 0.17 | 6.75 | 6.75 | 090 |
77750 | TC | A | Infuse radioactive materials | 0.00 | 1.33 | NA | 0.06 | 1.39 | NA | 090 |
77761 | A | Apply intrcav radiat simple | 3.81 | 3.64 | NA | 0.28 | 7.73 | NA | 090 | |
77761 | 26 | A | Apply intrcav radiat simple | 3.81 | 1.14 | 1.14 | 0.16 | 5.11 | 5.11 | 090 |
77761 | TC | A | Apply intrcav radiat simple | 0.00 | 2.50 | NA | 0.12 | 2.62 | NA | 090 |
77762 | A | Apply intrcav radiat interm | 5.72 | 5.51 | NA | 0.38 | 11.61 | NA | 090 | |
77762 | 26 | A | Apply intrcav radiat interm | 5.72 | 1.92 | 1.92 | 0.22 | 7.86 | 7.86 | 090 |
77762 | TC | A | Apply intrcav radiat interm | 0.00 | 3.59 | NA | 0.16 | 3.75 | NA | 090 |
77763 | A | Apply intrcav radiat compl | 8.57 | 7.35 | NA | 0.53 | 16.45 | NA | 090 | |
77763 | 26 | A | Apply intrcav radiat compl | 8.57 | 2.88 | 2.88 | 0.34 | 11.79 | 11.79 | 090 |
77763 | TC | A | Apply intrcav radiat compl | 0.00 | 4.47 | NA | 0.19 | 4.66 | NA | 090 |
77776 | A | Apply interstit radiat simpl | 4.66 | 3.15 | NA | 0.35 | 8.16 | NA | 090 | |
77776 | 26 | A | Apply interstit radiat simpl | 4.66 | 0.98 | 0.98 | 0.24 | 5.88 | 5.88 | 090 |
77776 | TC | A | Apply interstit radiat simpl | 0.00 | 2.17 | NA | 0.11 | 2.28 | NA | 090 |
77777 | A | Apply interstit radiat inter | 7.48 | 6.70 | NA | 0.50 | 14.68 | NA | 090 | |
77777 | 26 | A | Apply interstit radiat inter | 7.48 | 2.48 | 2.48 | 0.32 | 10.28 | 10.28 | 090 |
77777 | TC | A | Apply interstit radiat inter | 0.00 | 4.22 | NA | 0.18 | 4.40 | NA | 090 |
77778 | A | Apply interstit radiat compl | 11.19 | 8.88 | NA | 0.69 | 20.76 | NA | 090 | |
77778 | 26 | A | Apply interstit radiat compl | 11.19 | 3.77 | 3.77 | 0.47 | 15.43 | 15.43 | 090 |
77778 | TC | A | Apply interstit radiat compl | 0.00 | 5.11 | NA | 0.22 | 5.33 | NA | 090 |
77781 | A | High intensity brachytherapy | 1.66 | 20.79 | NA | 0.95 | 23.40 | NA | 090 | |
77781 | 26 | A | High intensity brachytherapy | 1.66 | 0.57 | 0.57 | 0.07 | 2.30 | 2.30 | 090 |
77781 | TC | A | High intensity brachytherapy | 0.00 | 20.22 | NA | 0.88 | 21.10 | NA | 090 |
77782 | A | High intensity brachytherapy | 2.49 | 21.07 | NA | 0.98 | 24.54 | NA | 090 | |
77782 | 26 | A | High intensity brachytherapy | 2.49 | 0.85 | 0.85 | 0.10 | 3.44 | 3.44 | 090 |
77782 | TC | A | High intensity brachytherapy | 0.00 | 20.22 | NA | 0.88 | 21.10 | NA | 090 |
77783 | A | High intensity brachytherapy | 3.73 | 21.48 | NA | 1.03 | 26.24 | NA | 090 | |
77783 | 26 | A | High intensity brachytherapy | 3.73 | 1.26 | 1.26 | 0.15 | 5.14 | 5.14 | 090 |
77783 | TC | A | High intensity brachytherapy | 0.00 | 20.22 | NA | 0.88 | 21.10 | NA | 090 |
77784 | A | High intensity brachytherapy | 5.61 | 22.11 | NA | 1.10 | 28.82 | NA | 090 | |
77784 | 26 | A | High intensity brachytherapy | 5.61 | 1.89 | 1.89 | 0.22 | 7.72 | 7.72 | 090 |
77784 | TC | A | High intensity brachytherapy | 0.00 | 20.22 | NA | 0.88 | 21.10 | NA | 090 |
77789 | A | Apply surface radiation | 1.12 | 0.84 | NA | 0.05 | 2.01 | NA | 090 | |
77789 | 26 | A | Apply surface radiation | 1.12 | 0.39 | 0.39 | 0.03 | 1.54 | 1.54 | 090 |
77789 | TC | A | Apply surface radiation | 0.00 | 0.45 | NA | 0.02 | 0.47 | NA | 090 |
77790 | A | Radiation handling | 1.05 | 0.86 | NA | 0.06 | 1.97 | NA | XXX | |
77790 | 26 | A | Radiation handling | 1.05 | 0.36 | 0.36 | 0.04 | 1.45 | 1.45 | XXX |
77790 | TC | A | Radiation handling | 0.00 | 0.50 | NA | 0.02 | 0.52 | NA | XXX |
77799 | C | Radium/radioisotope therapy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
77799 | 26 | C | Radium/radioisotope therapy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
77799 | TC | C | Radium/radioisotope therapy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
78000 | A | Thyroid, single uptake | 0.19 | 1.04 | NA | 0.06 | 1.29 | NA | XXX | |
78000 | 26 | A | Thyroid, single uptake | 0.19 | 0.07 | 0.07 | 0.01 | 0.27 | 0.27 | XXX |
78000 | TC | A | Thyroid, single uptake | 0.00 | 0.97 | NA | 0.05 | 1.02 | NA | XXX |
78001 | A | Thyroid, multiple uptakes | 0.26 | 1.39 | NA | 0.07 | 1.72 | NA | XXX | |
78001 | 26 | A | Thyroid, multiple uptakes | 0.26 | 0.09 | 0.09 | 0.01 | 0.36 | 0.36 | XXX |
78001 | TC | A | Thyroid, multiple uptakes | 0.00 | 1.30 | NA | 0.06 | 1.36 | NA | XXX |
78003 | A | Thyroid suppress/stimul | 0.33 | 1.08 | NA | 0.06 | 1.47 | NA | XXX | |
78003 | 26 | A | Thyroid suppress/stimul | 0.33 | 0.11 | 0.11 | 0.01 | 0.45 | 0.45 | XXX |
78003 | TC | A | Thyroid suppress/stimul | 0.00 | 0.97 | NA | 0.05 | 1.02 | NA | XXX |
78006 | A | Thyroid imaging with uptake | 0.49 | 2.54 | NA | 0.13 | 3.16 | NA | XXX | |
78006 | 26 | A | Thyroid imaging with uptake | 0.49 | 0.17 | 0.17 | 0.02 | 0.68 | 0.68 | XXX |
78006 | TC | A | Thyroid imaging with uptake | 0.00 | 2.37 | NA | 0.11 | 2.48 | NA | XXX |
78007 | A | Thyroid image, mult uptakes | 0.50 | 2.73 | NA | 0.14 | 3.37 | NA | XXX | |
78007 | 26 | A | Thyroid image, mult uptakes | 0.50 | 0.17 | 0.17 | 0.02 | 0.69 | 0.69 | XXX |
78007 | TC | A | Thyroid image, mult uptakes | 0.00 | 2.56 | NA | 0.12 | 2.68 | NA | XXX |
78010 | A | Thyroid imaging | 0.39 | 1.95 | NA | 0.11 | 2.45 | NA | XXX | |
78010 | 26 | A | Thyroid imaging | 0.39 | 0.14 | 0.14 | 0.02 | 0.55 | 0.55 | XXX |
78010 | TC | A | Thyroid imaging | 0.00 | 1.81 | NA | 0.09 | 1.90 | NA | XXX |
78011 | A | Thyroid imaging with flow | 0.45 | 2.56 | NA | 0.13 | 3.14 | NA | XXX | |
78011 | 26 | A | Thyroid imaging with flow | 0.45 | 0.16 | 0.16 | 0.02 | 0.63 | 0.63 | XXX |
78011 | TC | A | Thyroid imaging with flow | 0.00 | 2.40 | NA | 0.11 | 2.51 | NA | XXX |
78015 | A | Thyroid met imaging | 0.67 | 2.79 | NA | 0.15 | 3.61 | NA | XXX | |
78015 | 26 | A | Thyroid met imaging | 0.67 | 0.23 | 0.23 | 0.03 | 0.93 | 0.93 | XXX |
78015 | TC | A | Thyroid met imaging | 0.00 | 2.56 | NA | 0.12 | 2.68 | NA | XXX |
78016 | A | Thyroid met imaging/studies | 0.82 | 3.76 | NA | 0.18 | 4.76 | NA | XXX | |
78016 | 26 | A | Thyroid met imaging/studies | 0.82 | 0.30 | 0.30 | 0.03 | 1.15 | 1.15 | XXX |
78016 | TC | A | Thyroid met imaging/studies | 0.00 | 3.46 | NA | 0.15 | 3.61 | NA | XXX |
78018 | A | Thyroid met imaging, body | 0.86 | 5.71 | NA | 0.27 | 6.84 | NA | XXX | |
78018 | 26 | A | Thyroid met imaging, body | 0.86 | 0.31 | 0.31 | 0.03 | 1.20 | 1.20 | XXX |
78018 | TC | A | Thyroid met imaging, body | 0.00 | 5.40 | NA | 0.24 | 5.64 | NA | XXX |
78020 | A | Thyroid met uptake | 0.60 | 1.52 | NA | 0.14 | 2.26 | NA | ZZZ | |
78020 | 26 | A | Thyroid met uptake | 0.60 | 0.22 | 0.22 | 0.02 | 0.84 | 0.84 | ZZZ |
78020 | TC | A | Thyroid met uptake | 0.00 | 1.30 | NA | 0.12 | 1.42 | NA | ZZZ |
78070 | A | Parathyroid nuclear imaging | 0.82 | 2.10 | NA | 0.12 | 3.04 | NA | XXX | |
78070 | 26 | A | Parathyroid nuclear imaging | 0.82 | 0.29 | 0.29 | 0.03 | 1.14 | 1.14 | XXX |
78070 | TC | A | Parathyroid nuclear imaging | 0.00 | 1.81 | NA | 0.09 | 1.90 | NA | XXX |
78075 | A | Adrenal nuclear imaging | 0.74 | 5.67 | NA | 0.27 | 6.68 | NA | XXX | |
78075 | 26 | A | Adrenal nuclear imaging | 0.74 | 0.27 | 0.27 | 0.03 | 1.04 | 1.04 | XXX |
78075 | TC | A | Adrenal nuclear imaging | 0.00 | 5.40 | NA | 0.24 | 5.64 | NA | XXX |
78099 | C | Endocrine nuclear procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
78099 | 26 | C | Endocrine nuclear procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
78099 | TC | C | Endocrine nuclear procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
78102 | A | Bone marrow imaging, ltd | 0.55 | 2.23 | NA | 0.12 | 2.90 | NA | XXX | |
78102 | 26 | A | Bone marrow imaging, ltd | 0.55 | 0.20 | 0.20 | 0.02 | 0.77 | 0.77 | XXX |
78102 | TC | A | Bone marrow imaging, ltd | 0.00 | 2.03 | NA | 0.10 | 2.13 | NA | XXX |
78103 | A | Bone marrow imaging, mult | 0.75 | 3.42 | NA | 0.17 | 4.34 | NA | XXX | |
78103 | 26 | A | Bone marrow imaging, mult | 0.75 | 0.27 | 0.27 | 0.03 | 1.05 | 1.05 | XXX |
78103 | TC | A | Bone marrow imaging, mult | 0.00 | 3.15 | NA | 0.14 | 3.29 | NA | XXX |
78104 | A | Bone marrow imaging, body | 0.80 | 4.33 | NA | 0.21 | 5.34 | NA | XXX | |
78104 | 26 | A | Bone marrow imaging, body | 0.80 | 0.28 | 0.28 | 0.03 | 1.11 | 1.11 | XXX |
78104 | TC | A | Bone marrow imaging, body | 0.00 | 4.05 | NA | 0.18 | 4.23 | NA | XXX |
78110 | A | Plasma volume, single | 0.19 | 1.02 | NA | 0.06 | 1.27 | NA | XXX | |
78110 | 26 | A | Plasma volume, single | 0.19 | 0.07 | 0.07 | 0.01 | 0.27 | 0.27 | XXX |
78110 | TC | A | Plasma volume, single | 0.00 | 0.95 | NA | 0.05 | 1.00 | NA | XXX |
78111 | A | Plasma volume, multiple | 0.22 | 2.64 | NA | 0.13 | 2.99 | NA | XXX | |
78111 | 26 | A | Plasma volume, multiple | 0.22 | 0.08 | 0.08 | 0.01 | 0.31 | 0.31 | XXX |
78111 | TC | A | Plasma volume, multiple | 0.00 | 2.56 | NA | 0.12 | 2.68 | NA | XXX |
78120 | A | Red cell mass, single | 0.23 | 1.80 | NA | 0.10 | 2.13 | NA | XXX | |
78120 | 26 | A | Red cell mass, single | 0.23 | 0.08 | 0.08 | 0.01 | 0.32 | 0.32 | XXX |
78120 | TC | A | Red cell mass, single | 0.00 | 1.72 | NA | 0.09 | 1.81 | NA | XXX |
78121 | A | Red cell mass, multiple | 0.32 | 3.02 | NA | 0.13 | 3.47 | NA | XXX | |
78121 | 26 | A | Red cell mass, multiple | 0.32 | 0.12 | 0.12 | 0.01 | 0.45 | 0.45 | XXX |
78121 | TC | A | Red cell mass, multiple | 0.00 | 2.90 | NA | 0.12 | 3.02 | NA | XXX |
78122 | A | Blood volume | 0.45 | 4.74 | NA | 0.22 | 5.41 | NA | XXX | |
78122 | 26 | A | Blood volume | 0.45 | 0.16 | 0.16 | 0.02 | 0.63 | 0.63 | XXX |
78122 | TC | A | Blood volume | 0.00 | 4.58 | NA | 0.20 | 4.78 | NA | XXX |
78130 | A | Red cell survival study | 0.61 | 3.06 | NA | 0.15 | 3.82 | NA | XXX | |
78130 | 26 | A | Red cell survival study | 0.61 | 0.22 | 0.22 | 0.03 | 0.86 | 0.86 | XXX |
78130 | TC | A | Red cell survival study | 0.00 | 2.84 | NA | 0.12 | 2.96 | NA | XXX |
78135 | A | Red cell survival kinetics | 0.64 | 5.09 | NA | 0.24 | 5.97 | NA | XXX | |
78135 | 26 | A | Red cell survival kinetics | 0.64 | 0.23 | 0.23 | 0.03 | 0.90 | 0.90 | XXX |
78135 | TC | A | Red cell survival kinetics | 0.00 | 4.86 | NA | 0.21 | 5.07 | NA | XXX |
78140 | A | Red cell sequestration | 0.61 | 4.13 | NA | 0.20 | 4.94 | NA | XXX | |
78140 | 26 | A | Red cell sequestration | 0.61 | 0.21 | 0.21 | 0.03 | 0.85 | 0.85 | XXX |
78140 | TC | A | Red cell sequestration | 0.00 | 3.92 | NA | 0.17 | 4.09 | NA | XXX |
78160 | A | Plasma iron turnover | 0.33 | 3.77 | NA | 0.19 | 4.29 | NA | XXX | |
78160 | 26 | A | Plasma iron turnover | 0.33 | 0.12 | 0.12 | 0.03 | 0.48 | 0.48 | XXX |
78160 | TC | A | Plasma iron turnover | 0.00 | 3.65 | NA | 0.16 | 3.81 | NA | XXX |
78162 | A | Radioiron absorption exam | 0.45 | 3.37 | NA | 0.15 | 3.97 | NA | XXX | |
78162 | 26 | A | Radioiron absorption exam | 0.45 | 0.19 | 0.19 | 0.01 | 0.65 | 0.65 | XXX |
78162 | TC | A | Radioiron absorption exam | 0.00 | 3.18 | NA | 0.14 | 3.32 | NA | XXX |
78170 | A | Red cell iron utilization | 0.41 | 5.42 | NA | 0.27 | 6.10 | NA | XXX | |
78170 | 26 | A | Red cell iron utilization | 0.41 | 0.14 | 0.14 | 0.04 | 0.59 | 0.59 | XXX |
78170 | TC | A | Red cell iron utilization | 0.00 | 5.28 | NA | 0.23 | 5.51 | NA | XXX |
78172 | C | Total body iron estimation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
78172 | 26 | A | Total body iron estimation | 0.53 | 0.18 | 0.18 | 0.02 | 0.73 | 0.73 | XXX |
78172 | TC | C | Total body iron estimation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
78185 | A | Spleen imaging | 0.40 | 2.49 | NA | 0.13 | 3.02 | NA | XXX | |
78185 | 26 | A | Spleen imaging | 0.40 | 0.14 | 0.14 | 0.02 | 0.56 | 0.56 | XXX |
78185 | TC | A | Spleen imaging | 0.00 | 2.35 | NA | 0.11 | 2.46 | NA | XXX |
78190 | A | Platelet survival, kinetics | 1.09 | 6.09 | NA | 0.31 | 7.49 | NA | XXX | |
78190 | 26 | A | Platelet survival, kinetics | 1.09 | 0.40 | 0.40 | 0.06 | 1.55 | 1.55 | XXX |
78190 | TC | A | Platelet survival, kinetics | 0.00 | 5.69 | NA | 0.25 | 5.94 | NA | XXX |
78191 | A | Platelet survival | 0.61 | 7.51 | NA | 0.34 | 8.46 | NA | XXX | |
78191 | 26 | A | Platelet survival | 0.61 | 0.21 | 0.21 | 0.03 | 0.85 | 0.85 | XXX |
78191 | TC | A | Platelet survival | 0.00 | 7.30 | NA | 0.31 | 7.61 | NA | XXX |
78195 | A | Lymph system imaging | 1.20 | 4.48 | NA | 0.23 | 5.91 | NA | XXX | |
78195 | 26 | A | Lymph system imaging | 1.20 | 0.43 | 0.43 | 0.05 | 1.68 | 1.68 | XXX |
78195 | TC | A | Lymph system imaging | 0.00 | 4.05 | NA | 0.18 | 4.23 | NA | XXX |
78199 | C | Blood/lymph nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
78199 | 26 | C | Blood/lymph nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
78199 | TC | C | Blood/lymph nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
78201 | A | Liver imaging | 0.44 | 2.50 | NA | 0.13 | 3.07 | NA | XXX | |
78201 | 26 | A | Liver imaging | 0.44 | 0.15 | 0.15 | 0.02 | 0.61 | 0.61 | XXX |
78201 | TC | A | Liver imaging | 0.00 | 2.35 | NA | 0.11 | 2.46 | NA | XXX |
78202 | A | Liver imaging with flow | 0.51 | 3.05 | NA | 0.14 | 3.70 | NA | XXX | |
78202 | 26 | A | Liver imaging with flow | 0.51 | 0.18 | 0.18 | 0.02 | 0.71 | 0.71 | XXX |
78202 | TC | A | Liver imaging with flow | 0.00 | 2.87 | NA | 0.12 | 2.99 | NA | XXX |
78205 | A | Liver imaging (3D) | 0.71 | 6.13 | NA | 0.29 | 7.13 | NA | XXX | |
78205 | 26 | A | Liver imaging (3D) | 0.71 | 0.25 | 0.25 | 0.03 | 0.99 | 0.99 | XXX |
78205 | TC | A | Liver imaging (3D) | 0.00 | 5.88 | NA | 0.26 | 6.14 | NA | XXX |
78206 | A | Liver image (3d) with flow | 0.96 | 6.22 | NA | 0.13 | 7.31 | NA | XXX | |
78206 | 26 | A | Liver image (3d) with flow | 0.96 | 0.34 | 0.34 | 0.04 | 1.34 | 1.34 | XXX |
78206 | TC | A | Liver image (3d) with flow | 0.00 | 5.88 | NA | 0.09 | 5.97 | NA | XXX |
78215 | A | Liver and spleen imaging | 0.49 | 3.10 | NA | 0.14 | 3.73 | NA | XXX | |
78215 | 26 | A | Liver and spleen imaging | 0.49 | 0.17 | 0.17 | 0.02 | 0.68 | 0.68 | XXX |
78215 | TC | A | Liver and spleen imaging | 0.00 | 2.93 | NA | 0.12 | 3.05 | NA | XXX |
78216 | A | Liver spleen image/flow | 0.57 | 3.66 | NA | 0.17 | 4.40 | NA | XXX | |
78216 | 26 | A | Liver spleen image/flow | 0.57 | 0.20 | 0.20 | 0.02 | 0.79 | 0.79 | XXX |
78216 | TC | A | Liver spleen image/flow | 0.00 | 3.46 | NA | 0.15 | 3.61 | NA | XXX |
78220 | A | Liver function study | 0.49 | 3.87 | NA | 0.18 | 4.54 | NA | XXX | |
78220 | 26 | A | Liver function study | 0.49 | 0.17 | 0.17 | 0.02 | 0.68 | 0.68 | XXX |
78220 | TC | A | Liver function study | 0.00 | 3.70 | NA | 0.16 | 3.86 | NA | XXX |
78223 | A | Hepatobiliary imaging | 0.84 | 3.94 | NA | 0.20 | 4.98 | NA | XXX | |
78223 | 26 | A | Hepatobiliary imaging | 0.84 | 0.29 | 0.29 | 0.04 | 1.17 | 1.17 | XXX |
78223 | TC | A | Hepatobiliary imaging | 0.00 | 3.65 | NA | 0.16 | 3.81 | NA | XXX |
78230 | A | Salivary gland imaging | 0.45 | 2.32 | NA | 0.13 | 2.90 | NA | XXX | |
78230 | 26 | A | Salivary gland imaging | 0.45 | 0.15 | 0.15 | 0.02 | 0.62 | 0.62 | XXX |
78230 | TC | A | Salivary gland imaging | 0.00 | 2.17 | NA | 0.11 | 2.28 | NA | XXX |
78231 | A | Serial salivary imaging | 0.52 | 3.34 | NA | 0.16 | 4.02 | NA | XXX | |
78231 | 26 | A | Serial salivary imaging | 0.52 | 0.19 | 0.19 | 0.02 | 0.73 | 0.73 | XXX |
78231 | TC | A | Serial salivary imaging | 0.00 | 3.15 | NA | 0.14 | 3.29 | NA | XXX |
78232 | A | Salivary gland function exam | 0.47 | 3.69 | NA | 0.16 | 4.32 | NA | XXX | |
78232 | 26 | A | Salivary gland function exam | 0.47 | 0.17 | 0.17 | 0.01 | 0.65 | 0.65 | XXX |
78232 | TC | A | Salivary gland function exam | 0.00 | 3.52 | NA | 0.15 | 3.67 | NA | XXX |
78258 | A | Esophageal motility study | 0.74 | 3.13 | NA | 0.15 | 4.02 | NA | XXX | |
78258 | 26 | A | Esophageal motility study | 0.74 | 0.26 | 0.26 | 0.03 | 1.03 | 1.03 | XXX |
78258 | TC | A | Esophageal motility study | 0.00 | 2.87 | NA | 0.12 | 2.99 | NA | XXX |
78261 | A | Gastric mucosa imaging | 0.69 | 4.33 | NA | 0.21 | 5.23 | NA | XXX | |
78261 | 26 | A | Gastric mucosa imaging | 0.69 | 0.25 | 0.25 | 0.03 | 0.97 | 0.97 | XXX |
78261 | TC | A | Gastric mucosa imaging | 0.00 | 4.08 | NA | 0.18 | 4.26 | NA | XXX |
78262 | A | Gastroesophageal reflux exam | 0.68 | 4.48 | NA | 0.21 | 5.37 | NA | XXX | |
78262 | 26 | A | Gastroesophageal reflux exam | 0.68 | 0.24 | 0.24 | 0.03 | 0.95 | 0.95 | XXX |
78262 | TC | A | Gastroesophageal reflux exam | 0.00 | 4.24 | NA | 0.18 | 4.42 | NA | XXX |
78264 | A | Gastric emptying study | 0.78 | 4.38 | NA | 0.21 | 5.37 | NA | XXX | |
78264 | 26 | A | Gastric emptying study | 0.78 | 0.27 | 0.27 | 0.03 | 1.08 | 1.08 | XXX |
78264 | TC | A | Gastric emptying study | 0.00 | 4.11 | NA | 0.18 | 4.29 | NA | XXX |
78267 | X | Breath tst attain/anal c-14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
78268 | X | Breath test analysis, c-14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
78270 | A | Vit B-12 absorption exam | 0.20 | 1.61 | NA | 0.09 | 1.90 | NA | XXX | |
78270 | 26 | A | Vit B-12 absorption exam | 0.20 | 0.07 | 0.07 | 0.01 | 0.28 | 0.28 | XXX |
78270 | TC | A | Vit B-12 absorption exam | 0.00 | 1.54 | NA | 0.08 | 1.62 | NA | XXX |
78271 | A | Vit b-12 absrp exam, int fac | 0.20 | 1.70 | NA | 0.09 | 1.99 | NA | XXX | |
78271 | 26 | A | Vit b-12 absrp exam, int fac | 0.20 | 0.07 | 0.07 | 0.01 | 0.28 | 0.28 | XXX |
78271 | TC | A | Vit b-12 absrp exam, int fac | 0.00 | 1.63 | NA | 0.08 | 1.71 | NA | XXX |
78272 | A | Vit B-12 absorp, combined | 0.27 | 2.41 | NA | 0.12 | 2.80 | NA | XXX | |
78272 | 26 | A | Vit B-12 absorp, combined | 0.27 | 0.10 | 0.10 | 0.01 | 0.38 | 0.38 | XXX |
78272 | TC | A | Vit B-12 absorp, combined | 0.00 | 2.31 | NA | 0.11 | 2.42 | NA | XXX |
78278 | A | Acute GI blood loss imaging | 0.99 | 5.20 | NA | 0.25 | 6.44 | NA | XXX | |
78278 | 26 | A | Acute GI blood loss imaging | 0.99 | 0.34 | 0.34 | 0.04 | 1.37 | 1.37 | XXX |
78278 | TC | A | Acute GI blood loss imaging | 0.00 | 4.86 | NA | 0.21 | 5.07 | NA | XXX |
78282 | C | GI protein loss exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
78282 | 26 | A | GI protein loss exam | 0.38 | 0.14 | 0.14 | 0.02 | 0.54 | 0.54 | XXX |
78282 | TC | C | GI protein loss exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
78290 | A | Meckel's divert exam | 0.68 | 3.28 | NA | 0.16 | 4.12 | NA | XXX | |
78290 | 26 | A | Meckel's divert exam | 0.68 | 0.24 | 0.24 | 0.03 | 0.95 | 0.95 | XXX |
78290 | TC | A | Meckel's divert exam | 0.00 | 3.04 | NA | 0.13 | 3.17 | NA | XXX |
78291 | A | Leveen/shunt patency exam | 0.88 | 3.36 | NA | 0.17 | 4.41 | NA | XXX | |
78291 | 26 | A | Leveen/shunt patency exam | 0.88 | 0.31 | 0.31 | 0.04 | 1.23 | 1.23 | XXX |
78291 | TC | A | Leveen/shunt patency exam | 0.00 | 3.05 | NA | 0.13 | 3.18 | NA | XXX |
78299 | C | GI nuclear procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
78299 | 26 | C | GI nuclear procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
78299 | TC | C | GI nuclear procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
78300 | A | Bone imaging, limited area | 0.62 | 2.69 | NA | 0.15 | 3.46 | NA | XXX | |
78300 | 26 | A | Bone imaging, limited area | 0.62 | 0.21 | 0.21 | 0.03 | 0.86 | 0.86 | XXX |
78300 | TC | A | Bone imaging, limited area | 0.00 | 2.48 | NA | 0.12 | 2.60 | NA | XXX |
78305 | A | Bone imaging, multiple areas | 0.83 | 3.94 | NA | 0.19 | 4.96 | NA | XXX | |
78305 | 26 | A | Bone imaging, multiple areas | 0.83 | 0.29 | 0.29 | 0.03 | 1.15 | 1.15 | XXX |
78305 | TC | A | Bone imaging, multiple areas | 0.00 | 3.65 | NA | 0.16 | 3.81 | NA | XXX |
78306 | A | Bone imaging, whole body | 0.86 | 4.56 | NA | 0.22 | 5.64 | NA | XXX | |
78306 | 26 | A | Bone imaging, whole body | 0.86 | 0.30 | 0.30 | 0.04 | 1.20 | 1.20 | XXX |
78306 | TC | A | Bone imaging, whole body | 0.00 | 4.26 | NA | 0.18 | 4.44 | NA | XXX |
78315 | A | Bone imaging, 3 phase | 1.02 | 5.12 | NA | 0.25 | 6.39 | NA | XXX | |
78315 | 26 | A | Bone imaging, 3 phase | 1.02 | 0.36 | 0.36 | 0.04 | 1.42 | 1.42 | XXX |
78315 | TC | A | Bone imaging, 3 phase | 0.00 | 4.76 | NA | 0.21 | 4.97 | NA | XXX |
78320 | A | Bone imaging (3D) | 1.04 | 6.25 | NA | 0.30 | 7.59 | NA | XXX | |
78320 | 26 | A | Bone imaging (3D) | 1.04 | 0.37 | 0.37 | 0.04 | 1.45 | 1.45 | XXX |
78320 | TC | A | Bone imaging (3D) | 0.00 | 5.88 | NA | 0.26 | 6.14 | NA | XXX |
78350 | A | Bone mineral, single photon | 0.22 | 0.83 | NA | 0.05 | 1.10 | NA | XXX | |
78350 | 26 | A | Bone mineral, single photon | 0.22 | 0.08 | 0.08 | 0.01 | 0.31 | 0.31 | XXX |
78350 | TC | A | Bone mineral, single photon | 0.00 | 0.75 | NA | 0.04 | 0.79 | NA | XXX |
78351 | N | Bone mineral, dual photon | +0.30 | 1.74 | 0.12 | 0.01 | 2.05 | 0.43 | XXX | |
78399 | C | Musculoskeletal nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
78399 | 26 | C | Musculoskeletal nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
78399 | TC | C | Musculoskeletal nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
78414 | C | Non-imaging heart function | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
78414 | 26 | A | Non-imaging heart function | 0.45 | 0.16 | 0.16 | 0.02 | 0.63 | 0.63 | XXX |
78414 | TC | C | Non-imaging heart function | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
78428 | A | Cardiac shunt imaging | 0.78 | 2.54 | NA | 0.14 | 3.46 | NA | XXX | |
78428 | 26 | A | Cardiac shunt imaging | 0.78 | 0.30 | 0.30 | 0.03 | 1.11 | 1.11 | XXX |
78428 | TC | A | Cardiac shunt imaging | 0.00 | 2.24 | NA | 0.11 | 2.35 | NA | XXX |
78445 | A | Vascular flow imaging | 0.49 | 2.03 | NA | 0.11 | 2.63 | NA | XXX | |
78445 | 26 | A | Vascular flow imaging | 0.49 | 0.18 | 0.18 | 0.02 | 0.69 | 0.69 | XXX |
78445 | TC | A | Vascular flow imaging | 0.00 | 1.85 | NA | 0.09 | 1.94 | NA | XXX |
78455 | A | Venous thrombosis study | 0.73 | 4.23 | NA | 0.20 | 5.16 | NA | XXX | |
78455 | 26 | A | Venous thrombosis study | 0.73 | 0.26 | 0.26 | 0.03 | 1.02 | 1.02 | XXX |
78455 | TC | A | Venous thrombosis study | 0.00 | 3.97 | NA | 0.17 | 4.14 | NA | XXX |
78456 | A | Acute venous thrombus image | 1.00 | 4.33 | NA | 0.28 | 5.61 | NA | XXX | |
78456 | 26 | A | Acute venous thrombus image | 1.00 | 0.36 | 0.36 | 0.04 | 1.40 | 1.40 | XXX |
78456 | TC | A | Acute venous thrombus image | 0.00 | 3.97 | NA | 0.24 | 4.21 | NA | XXX |
78457 | A | Venous thrombosis imaging | 0.77 | 2.92 | NA | 0.15 | 3.84 | NA | XXX | |
78457 | 26 | A | Venous thrombosis imaging | 0.77 | 0.27 | 0.27 | 0.03 | 1.07 | 1.07 | XXX |
78457 | TC | A | Venous thrombosis imaging | 0.00 | 2.65 | NA | 0.12 | 2.77 | NA | XXX |
78458 | A | Ven thrombosis images, bilat | 0.90 | 4.33 | NA | 0.20 | 5.43 | NA | XXX | |
78458 | 26 | A | Ven thrombosis images, bilat | 0.90 | 0.33 | 0.33 | 0.03 | 1.26 | 1.26 | XXX |
78458 | TC | A | Ven thrombosis images, bilat | 0.00 | 4.00 | NA | 0.17 | 4.17 | NA | XXX |
78459 | C | Heart muscle imaging (PET) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
78459 | 26 | R | Heart muscle imaging (PET) | 1.50 | 0.59 | 0.59 | 0.04 | 2.13 | 2.13 | XXX |
78459 | TC | C | Heart muscle imaging (PET) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
78460 | A | Heart muscle blood, single | 0.86 | 2.65 | NA | 0.14 | 3.65 | NA | XXX | |
78460 | 26 | A | Heart muscle blood, single | 0.86 | 0.30 | 0.30 | 0.03 | 1.19 | 1.19 | XXX |
78460 | TC | A | Heart muscle blood, single | 0.00 | 2.35 | NA | 0.11 | 2.46 | NA | XXX |
78461 | A | Heart muscle blood, multiple | 1.23 | 5.15 | NA | 0.26 | 6.64 | NA | XXX | |
78461 | 26 | A | Heart muscle blood, multiple | 1.23 | 0.45 | 0.45 | 0.05 | 1.73 | 1.73 | XXX |
78461 | TC | A | Heart muscle blood, multiple | 0.00 | 4.70 | NA | 0.21 | 4.91 | NA | XXX |
78464 | A | Heart image (3d), single | 1.09 | 7.43 | NA | 0.35 | 8.87 | NA | XXX | |
78464 | 26 | A | Heart image (3d), single | 1.09 | 0.39 | 0.39 | 0.04 | 1.52 | 1.52 | XXX |
78464 | TC | A | Heart image (3d), single | 0.00 | 7.04 | NA | 0.31 | 7.35 | NA | XXX |
78465 | A | Heart image (3d), multiple | 1.46 | 12.28 | NA | 0.56 | 14.30 | NA | XXX | |
78465 | 26 | A | Heart image (3d), multiple | 1.46 | 0.54 | 0.54 | 0.05 | 2.05 | 2.05 | XXX |
78465 | TC | A | Heart image (3d), multiple | 0.00 | 11.74 | NA | 0.51 | 12.25 | NA | XXX |
78466 | A | Heart infarct image | 0.69 | 2.86 | NA | 0.15 | 3.70 | NA | XXX | |
78466 | 26 | A | Heart infarct image | 0.69 | 0.25 | 0.25 | 0.03 | 0.97 | 0.97 | XXX |
78466 | TC | A | Heart infarct image | 0.00 | 2.61 | NA | 0.12 | 2.73 | NA | XXX |
78468 | A | Heart infarct image (ef) | 0.80 | 3.93 | NA | 0.19 | 4.92 | NA | XXX | |
78468 | 26 | A | Heart infarct image (ef) | 0.80 | 0.28 | 0.28 | 0.03 | 1.11 | 1.11 | XXX |
78468 | TC | A | Heart infarct image (ef) | 0.00 | 3.65 | NA | 0.16 | 3.81 | NA | XXX |
78469 | A | Heart infarct image (3D) | 0.92 | 5.51 | NA | 0.26 | 6.69 | NA | XXX | |
78469 | 26 | A | Heart infarct image (3D) | 0.92 | 0.32 | 0.32 | 0.03 | 1.27 | 1.27 | XXX |
78469 | TC | A | Heart infarct image (3D) | 0.00 | 5.19 | NA | 0.23 | 5.42 | NA | XXX |
78472 | A | Gated heart, planar, single | 0.98 | 5.83 | NA | 0.29 | 7.10 | NA | XXX | |
78472 | 26 | A | Gated heart, planar, single | 0.98 | 0.35 | 0.35 | 0.04 | 1.37 | 1.37 | XXX |
78472 | TC | A | Gated heart, planar, single | 0.00 | 5.48 | NA | 0.25 | 5.73 | NA | XXX |
78473 | A | Gated heart, multiple | 1.47 | 8.75 | NA | 0.40 | 10.62 | NA | XXX | |
78473 | 26 | A | Gated heart, multiple | 1.47 | 0.53 | 0.53 | 0.05 | 2.05 | 2.05 | XXX |
78473 | TC | A | Gated heart, multiple | 0.00 | 8.22 | NA | 0.35 | 8.57 | NA | XXX |
78478 | A | Heart wall motion add-on | 0.62 | 1.78 | NA | 0.10 | 2.50 | NA | XXX | |
78478 | 26 | A | Heart wall motion add-on | 0.62 | 0.23 | 0.23 | 0.02 | 0.87 | 0.87 | XXX |
78478 | TC | A | Heart wall motion add-on | 0.00 | 1.55 | NA | 0.08 | 1.63 | NA | XXX |
78480 | A | Heart function add-on | 0.62 | 1.78 | NA | 0.10 | 2.50 | NA | XXX | |
78480 | 26 | A | Heart function add-on | 0.62 | 0.23 | 0.23 | 0.02 | 0.87 | 0.87 | XXX |
78480 | TC | A | Heart function add-on | 0.00 | 1.55 | NA | 0.08 | 1.63 | NA | XXX |
78481 | A | Heart first pass, single | 0.98 | 5.56 | NA | 0.26 | 6.80 | NA | XXX | |
78481 | 26 | A | Heart first pass, single | 0.98 | 0.37 | 0.37 | 0.03 | 1.38 | 1.38 | XXX |
78481 | TC | A | Heart first pass, single | 0.00 | 5.19 | NA | 0.23 | 5.42 | NA | XXX |
78483 | A | Heart first pass, multiple | 1.47 | 8.39 | NA | 0.39 | 10.25 | NA | XXX | |
78483 | 26 | A | Heart first pass, multiple | 1.47 | 0.56 | 0.56 | 0.05 | 2.08 | 2.08 | XXX |
78483 | TC | A | Heart first pass, multiple | 0.00 | 7.83 | NA | 0.34 | 8.17 | NA | XXX |
78491 | I | Heart image (pet), single | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
78491 | 26 | I | Heart image (pet), single | +1.50 | 0.60 | 0.60 | 0.05 | 2.15 | 2.15 | XXX |
78491 | TC | I | Heart image (pet), single | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
78492 | I | Heart image (pet), multiple | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
78492 | 26 | I | Heart image (pet), multiple | +1.87 | 0.75 | 0.75 | 0.06 | 2.68 | 2.68 | XXX |
78492 | TC | I | Heart image (pet), multiple | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
78494 | A | Heart image, spect | 1.19 | 7.47 | NA | 0.29 | 8.95 | NA | XXX | |
78494 | 26 | A | Heart image, spect | 1.19 | 0.43 | 0.43 | 0.04 | 1.66 | 1.66 | XXX |
78494 | TC | A | Heart image, spect | 0.00 | 7.04 | NA | 0.25 | 7.29 | NA | XXX |
78496 | A | Heart first pass add-on | 0.50 | 7.23 | NA | 0.27 | 8.00 | NA | ZZZ | |
78496 | 26 | A | Heart first pass add-on | 0.50 | 0.19 | 0.19 | 0.02 | 0.71 | 0.71 | ZZZ |
78496 | TC | A | Heart first pass add-on | 0.00 | 7.04 | NA | 0.25 | 7.29 | NA | ZZZ |
78499 | C | Cardiovascular nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
78499 | 26 | C | Cardiovascular nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
78499 | TC | C | Cardiovascular nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
78580 | A | Lung perfusion imaging | 0.74 | 3.67 | NA | 0.18 | 4.59 | NA | XXX | |
78580 | 26 | A | Lung perfusion imaging | 0.74 | 0.26 | 0.26 | 0.03 | 1.03 | 1.03 | XXX |
78580 | TC | A | Lung perfusion imaging | 0.00 | 3.41 | NA | 0.15 | 3.56 | NA | XXX |
78584 | A | Lung V/Q image single breath | 0.99 | 3.52 | NA | 0.18 | 4.69 | NA | XXX | |
78584 | 26 | A | Lung V/Q image single breath | 0.99 | 0.34 | 0.34 | 0.04 | 1.37 | 1.37 | XXX |
78584 | TC | A | Lung V/Q image single breath | 0.00 | 3.18 | NA | 0.14 | 3.32 | NA | XXX |
78585 | A | Lung V/Q imaging | 1.09 | 5.99 | NA | 0.30 | 7.38 | NA | XXX | |
78585 | 26 | A | Lung V/Q imaging | 1.09 | 0.38 | 0.38 | 0.05 | 1.52 | 1.52 | XXX |
78585 | TC | A | Lung V/Q imaging | 0.00 | 5.61 | NA | 0.25 | 5.86 | NA | XXX |
78586 | A | Aerosol lung image, single | 0.40 | 2.72 | NA | 0.14 | 3.26 | NA | XXX | |
78586 | 26 | A | Aerosol lung image, single | 0.40 | 0.14 | 0.14 | 0.02 | 0.56 | 0.56 | XXX |
78586 | TC | A | Aerosol lung image, single | 0.00 | 2.58 | NA | 0.12 | 2.70 | NA | XXX |
78587 | A | Aerosol lung image, multiple | 0.49 | 2.97 | NA | 0.14 | 3.60 | NA | XXX | |
78587 | 26 | A | Aerosol lung image, multiple | 0.49 | 0.17 | 0.17 | 0.02 | 0.68 | 0.68 | XXX |
78587 | TC | A | Aerosol lung image, multiple | 0.00 | 2.80 | NA | 0.12 | 2.92 | NA | XXX |
78588 | A | Perfusion lung image | 1.09 | 3.56 | NA | 0.20 | 4.85 | NA | XXX | |
78588 | 26 | A | Perfusion lung image | 1.09 | 0.38 | 0.38 | 0.05 | 1.52 | 1.52 | XXX |
78588 | TC | A | Perfusion lung image | 0.00 | 3.18 | NA | 0.15 | 3.33 | NA | XXX |
78591 | A | Vent image, 1 breath, 1 proj | 0.40 | 2.98 | NA | 0.14 | 3.52 | NA | XXX | |
78591 | 26 | A | Vent image, 1 breath, 1 proj | 0.40 | 0.14 | 0.14 | 0.02 | 0.56 | 0.56 | XXX |
78591 | TC | A | Vent image, 1 breath, 1 proj | 0.00 | 2.84 | NA | 0.12 | 2.96 | NA | XXX |
78593 | A | Vent image, 1 proj, gas | 0.49 | 3.60 | NA | 0.17 | 4.26 | NA | XXX | |
78593 | 26 | A | Vent image, 1 proj, gas | 0.49 | 0.17 | 0.17 | 0.02 | 0.68 | 0.68 | XXX |
78593 | TC | A | Vent image, 1 proj, gas | 0.00 | 3.43 | NA | 0.15 | 3.58 | NA | XXX |
78594 | A | Vent image, mult proj, gas | 0.53 | 5.15 | NA | 0.23 | 5.91 | NA | XXX | |
78594 | 26 | A | Vent image, mult proj, gas | 0.53 | 0.19 | 0.19 | 0.02 | 0.74 | 0.74 | XXX |
78594 | TC | A | Vent image, mult proj, gas | 0.00 | 4.96 | NA | 0.21 | 5.17 | NA | XXX |
78596 | A | Lung differential function | 1.27 | 7.48 | NA | 0.36 | 9.11 | NA | XXX | |
78596 | 26 | A | Lung differential function | 1.27 | 0.44 | 0.44 | 0.05 | 1.76 | 1.76 | XXX |
78596 | TC | A | Lung differential function | 0.00 | 7.04 | NA | 0.31 | 7.35 | NA | XXX |
78599 | C | Respiratory nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
78599 | 26 | C | Respiratory nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
78599 | TC | C | Respiratory nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
78600 | A | Brain imaging, ltd static | 0.44 | 3.03 | NA | 0.14 | 3.61 | NA | XXX | |
78600 | 26 | A | Brain imaging, ltd static | 0.44 | 0.16 | 0.16 | 0.02 | 0.62 | 0.62 | XXX |
78600 | TC | A | Brain imaging, ltd static | 0.00 | 2.87 | NA | 0.12 | 2.99 | NA | XXX |
78601 | A | Brain imaging, ltd w/ flow | 0.51 | 3.57 | NA | 0.17 | 4.25 | NA | XXX | |
78601 | 26 | A | Brain imaging, ltd w/ flow | 0.51 | 0.18 | 0.18 | 0.02 | 0.71 | 0.71 | XXX |
78601 | TC | A | Brain imaging, ltd w/ flow | 0.00 | 3.39 | NA | 0.15 | 3.54 | NA | XXX |
78605 | A | Brain imaging, complete | 0.53 | 3.58 | NA | 0.17 | 4.28 | NA | XXX | |
78605 | 26 | A | Brain imaging, complete | 0.53 | 0.19 | 0.19 | 0.02 | 0.74 | 0.74 | XXX |
78605 | TC | A | Brain imaging, complete | 0.00 | 3.39 | NA | 0.15 | 3.54 | NA | XXX |
78606 | A | Brain imaging, compl w/flow | 0.64 | 4.07 | NA | 0.20 | 4.91 | NA | XXX | |
78606 | 26 | A | Brain imaging, compl w/flow | 0.64 | 0.22 | 0.22 | 0.03 | 0.89 | 0.89 | XXX |
78606 | TC | A | Brain imaging, compl w/flow | 0.00 | 3.85 | NA | 0.17 | 4.02 | NA | XXX |
78607 | A | Brain imaging (3D) | 1.23 | 6.98 | NA | 0.34 | 8.55 | NA | XXX | |
78607 | 26 | A | Brain imaging (3D) | 1.23 | 0.45 | 0.45 | 0.05 | 1.73 | 1.73 | XXX |
78607 | TC | A | Brain imaging (3D) | 0.00 | 6.53 | NA | 0.29 | 6.82 | NA | XXX |
78608 | N | Brain imaging (PET) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
78609 | N | Brain imaging (PET) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
78610 | A | Brain flow imaging only | 0.30 | 1.68 | NA | 0.09 | 2.07 | NA | XXX | |
78610 | 26 | A | Brain flow imaging only | 0.30 | 0.11 | 0.11 | 0.01 | 0.42 | 0.42 | XXX |
78610 | TC | A | Brain flow imaging only | 0.00 | 1.57 | NA | 0.08 | 1.65 | NA | XXX |
78615 | A | Cerebral vascular flow image | 0.42 | 3.99 | NA | 0.19 | 4.60 | NA | XXX | |
78615 | 26 | A | Cerebral vascular flow image | 0.42 | 0.16 | 0.16 | 0.02 | 0.60 | 0.60 | XXX |
78615 | TC | A | Cerebral vascular flow image | 0.00 | 3.83 | NA | 0.17 | 4.00 | NA | XXX |
78630 | A | Cerebrospinal fluid scan | 0.68 | 5.26 | NA | 0.25 | 6.19 | NA | XXX | |
78630 | 26 | A | Cerebrospinal fluid scan | 0.68 | 0.24 | 0.24 | 0.03 | 0.95 | 0.95 | XXX |
78630 | TC | A | Cerebrospinal fluid scan | 0.00 | 5.02 | NA | 0.22 | 5.24 | NA | XXX |
78635 | A | CSF ventriculography | 0.61 | 2.77 | NA | 0.14 | 3.52 | NA | XXX | |
78635 | 26 | A | CSF ventriculography | 0.61 | 0.24 | 0.24 | 0.02 | 0.87 | 0.87 | XXX |
78635 | TC | A | CSF ventriculography | 0.00 | 2.53 | NA | 0.12 | 2.65 | NA | XXX |
78645 | A | CSF shunt evaluation | 0.57 | 3.61 | NA | 0.17 | 4.35 | NA | XXX | |
78645 | 26 | A | CSF shunt evaluation | 0.57 | 0.20 | 0.20 | 0.02 | 0.79 | 0.79 | XXX |
78645 | TC | A | CSF shunt evaluation | 0.00 | 3.41 | NA | 0.15 | 3.56 | NA | XXX |
78647 | A | Cerebrospinal fluid scan | 0.90 | 6.21 | NA | 0.29 | 7.40 | NA | XXX | |
78647 | 26 | A | Cerebrospinal fluid scan | 0.90 | 0.33 | 0.33 | 0.03 | 1.26 | 1.26 | XXX |
78647 | TC | A | Cerebrospinal fluid scan | 0.00 | 5.88 | NA | 0.26 | 6.14 | NA | XXX |
78650 | A | CSF leakage imaging | 0.61 | 4.84 | NA | 0.22 | 5.67 | NA | XXX | |
78650 | 26 | A | CSF leakage imaging | 0.61 | 0.22 | 0.22 | 0.02 | 0.85 | 0.85 | XXX |
78650 | TC | A | CSF leakage imaging | 0.00 | 4.62 | NA | 0.20 | 4.82 | NA | XXX |
78660 | A | Nuclear exam of tear flow | 0.53 | 2.30 | NA | 0.12 | 2.95 | NA | XXX | |
78660 | 26 | A | Nuclear exam of tear flow | 0.53 | 0.19 | 0.19 | 0.02 | 0.74 | 0.74 | XXX |
78660 | TC | A | Nuclear exam of tear flow | 0.00 | 2.11 | NA | 0.10 | 2.21 | NA | XXX |
78699 | C | Nervous system nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
78699 | 26 | C | Nervous system nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
78699 | TC | C | Nervous system nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
78700 | A | Kidney imaging, static | 0.45 | 3.20 | NA | 0.15 | 3.80 | NA | XXX | |
78700 | 26 | A | Kidney imaging, static | 0.45 | 0.16 | 0.16 | 0.02 | 0.63 | 0.63 | XXX |
78700 | TC | A | Kidney imaging, static | 0.00 | 3.04 | NA | 0.13 | 3.17 | NA | XXX |
78701 | A | Kidney imaging with flow | 0.49 | 3.71 | NA | 0.17 | 4.37 | NA | XXX | |
78701 | 26 | A | Kidney imaging with flow | 0.49 | 0.17 | 0.17 | 0.02 | 0.68 | 0.68 | XXX |
78701 | TC | A | Kidney imaging with flow | 0.00 | 3.54 | NA | 0.15 | 3.69 | NA | XXX |
78704 | A | Imaging renogram | 0.74 | 4.20 | NA | 0.20 | 5.14 | NA | XXX | |
78704 | 26 | A | Imaging renogram | 0.74 | 0.26 | 0.26 | 0.03 | 1.03 | 1.03 | XXX |
78704 | TC | A | Imaging renogram | 0.00 | 3.94 | NA | 0.17 | 4.11 | NA | XXX |
78707 | A | Kidney flow/function image | 0.96 | 4.79 | NA | 0.23 | 5.98 | NA | XXX | |
78707 | 26 | A | Kidney flow/function image | 0.96 | 0.34 | 0.34 | 0.04 | 1.34 | 1.34 | XXX |
78707 | TC | A | Kidney flow/function image | 0.00 | 4.45 | NA | 0.19 | 4.64 | NA | XXX |
78708 | A | Kidney flow/function image | 1.21 | 4.88 | NA | 0.24 | 6.33 | NA | XXX | |
78708 | 26 | A | Kidney flow/function image | 1.21 | 0.43 | 0.43 | 0.05 | 1.69 | 1.69 | XXX |
78708 | TC | A | Kidney flow/function image | 0.00 | 4.45 | NA | 0.19 | 4.64 | NA | XXX |
78709 | A | Kidney flow/function image | 1.41 | 4.94 | NA | 0.25 | 6.60 | NA | XXX | |
78709 | 26 | A | Kidney flow/function image | 1.41 | 0.49 | 0.49 | 0.06 | 1.96 | 1.96 | XXX |
78709 | TC | A | Kidney flow/function image | 0.00 | 4.45 | NA | 0.19 | 4.64 | NA | XXX |
78710 | A | Kidney imaging (3D) | 0.66 | 6.11 | NA | 0.29 | 7.06 | NA | XXX | |
78710 | 26 | A | Kidney imaging (3D) | 0.66 | 0.23 | 0.23 | 0.03 | 0.92 | 0.92 | XXX |
78710 | TC | A | Kidney imaging (3D) | 0.00 | 5.88 | NA | 0.26 | 6.14 | NA | XXX |
78715 | A | Renal vascular flow exam | 0.30 | 1.68 | NA | 0.09 | 2.07 | NA | XXX | |
78715 | 26 | A | Renal vascular flow exam | 0.30 | 0.11 | 0.11 | 0.01 | 0.42 | 0.42 | XXX |
78715 | TC | A | Renal vascular flow exam | 0.00 | 1.57 | NA | 0.08 | 1.65 | NA | XXX |
78725 | A | Kidney function study | 0.38 | 1.90 | NA | 0.10 | 2.38 | NA | XXX | |
78725 | 26 | A | Kidney function study | 0.38 | 0.13 | 0.13 | 0.01 | 0.52 | 0.52 | XXX |
78725 | TC | A | Kidney function study | 0.00 | 1.77 | NA | 0.09 | 1.86 | NA | XXX |
78730 | A | Urinary bladder retention | 0.36 | 1.58 | NA | 0.09 | 2.03 | NA | XXX | |
78730 | 26 | A | Urinary bladder retention | 0.36 | 0.13 | 0.13 | 0.02 | 0.51 | 0.51 | XXX |
78730 | TC | A | Urinary bladder retention | 0.00 | 1.45 | NA | 0.07 | 1.52 | NA | XXX |
78740 | A | Ureteral reflux study | 0.57 | 2.30 | NA | 0.12 | 2.99 | NA | XXX | |
78740 | 26 | A | Ureteral reflux study | 0.57 | 0.19 | 0.19 | 0.02 | 0.78 | 0.78 | XXX |
78740 | TC | A | Ureteral reflux study | 0.00 | 2.11 | NA | 0.10 | 2.21 | NA | XXX |
78760 | A | Testicular imaging | 0.66 | 2.90 | NA | 0.15 | 3.71 | NA | XXX | |
78760 | 26 | A | Testicular imaging | 0.66 | 0.23 | 0.23 | 0.03 | 0.92 | 0.92 | XXX |
78760 | TC | A | Testicular imaging | 0.00 | 2.67 | NA | 0.12 | 2.79 | NA | XXX |
78761 | A | Testicular imaging/flow | 0.71 | 3.43 | NA | 0.17 | 4.31 | NA | XXX | |
78761 | 26 | A | Testicular imaging/flow | 0.71 | 0.25 | 0.25 | 0.03 | 0.99 | 0.99 | XXX |
78761 | TC | A | Testicular imaging/flow | 0.00 | 3.18 | NA | 0.14 | 3.32 | NA | XXX |
78799 | C | Genitourinary nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
78799 | 26 | C | Genitourinary nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
78799 | TC | C | Genitourinary nuclear exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
78800 | A | Tumor imaging, limited area | 0.66 | 3.62 | NA | 0.18 | 4.46 | NA | XXX | |
78800 | 26 | A | Tumor imaging, limited area | 0.66 | 0.23 | 0.23 | 0.03 | 0.92 | 0.92 | XXX |
78800 | TC | A | Tumor imaging, limited area | 0.00 | 3.39 | NA | 0.15 | 3.54 | NA | XXX |
78801 | A | Tumor imaging, mult areas | 0.79 | 4.49 | NA | 0.21 | 5.49 | NA | XXX | |
78801 | 26 | A | Tumor imaging, mult areas | 0.79 | 0.28 | 0.28 | 0.03 | 1.10 | 1.10 | XXX |
78801 | TC | A | Tumor imaging, mult areas | 0.00 | 4.21 | NA | 0.18 | 4.39 | NA | XXX |
78802 | A | Tumor imaging, whole body | 0.86 | 5.81 | NA | 0.28 | 6.95 | NA | XXX | |
78802 | 26 | A | Tumor imaging, whole body | 0.86 | 0.31 | 0.31 | 0.03 | 1.20 | 1.20 | XXX |
78802 | TC | A | Tumor imaging, whole body | 0.00 | 5.50 | NA | 0.25 | 5.75 | NA | XXX |
78803 | A | Tumor imaging (3D) | 1.09 | 6.93 | NA | 0.33 | 8.35 | NA | XXX | |
78803 | 26 | A | Tumor imaging (3D) | 1.09 | 0.40 | 0.40 | 0.04 | 1.53 | 1.53 | XXX |
78803 | TC | A | Tumor imaging (3D) | 0.00 | 6.53 | NA | 0.29 | 6.82 | NA | XXX |
78805 | A | Abscess imaging, ltd area | 0.73 | 3.65 | NA | 0.18 | 4.56 | NA | XXX | |
78805 | 26 | A | Abscess imaging, ltd area | 0.73 | 0.26 | 0.26 | 0.03 | 1.02 | 1.02 | XXX |
78805 | TC | A | Abscess imaging, ltd area | 0.00 | 3.39 | NA | 0.15 | 3.54 | NA | XXX |
78806 | A | Abscess imaging, whole body | 0.86 | 6.71 | NA | 0.32 | 7.89 | NA | XXX | |
78806 | 26 | A | Abscess imaging, whole body | 0.86 | 0.31 | 0.31 | 0.03 | 1.20 | 1.20 | XXX |
78806 | TC | A | Abscess imaging, whole body | 0.00 | 6.40 | NA | 0.29 | 6.69 | NA | XXX |
78807 | A | Nuclear localization/abscess | 1.09 | 6.94 | NA | 0.33 | 8.36 | NA | XXX | |
78807 | 26 | A | Nuclear localization/abscess | 1.09 | 0.41 | 0.41 | 0.04 | 1.54 | 1.54 | XXX |
78807 | TC | A | Nuclear localization/abscess | 0.00 | 6.53 | NA | 0.29 | 6.82 | NA | XXX |
78810 | N | Tumor imaging (PET) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
78810 | 26 | N | Tumor imaging (PET) | +1.93 | 0.75 | 0.75 | 0.09 | 2.77 | 2.77 | XXX |
78810 | TC | N | Tumor imaging (PET) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
78890 | B | Nuclear medicine data proc | +0.05 | 1.32 | NA | 0.06 | 1.43 | NA | XXX | |
78890 | 26 | B | Nuclear medicine data proc | +0.05 | 0.02 | 0.02 | 0.01 | 0.08 | 0.08 | XXX |
78890 | TC | B | Nuclear medicine data proc | +0.00 | 1.30 | NA | 0.05 | 1.35 | NA | XXX |
78891 | B | Nuclear med data proc | +0.10 | 2.65 | NA | 0.12 | 2.87 | NA | XXX | |
78891 | 26 | B | Nuclear med data proc | +0.10 | 0.04 | 0.04 | 0.01 | 0.15 | 0.15 | XXX |
78891 | TC | B | Nuclear med data proc | +0.00 | 2.61 | NA | 0.11 | 2.72 | NA | XXX |
78990 | I | Provide diag radionuclide(s) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
78999 | C | Nuclear diagnostic exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
78999 | 26 | C | Nuclear diagnostic exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
78999 | TC | C | Nuclear diagnostic exam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
79000 | A | Init hyperthyroid therapy | 1.80 | 3.24 | NA | 0.19 | 5.23 | NA | XXX | |
79000 | 26 | A | Init hyperthyroid therapy | 1.80 | 0.63 | 0.63 | 0.07 | 2.50 | 2.50 | XXX |
79000 | TC | A | Init hyperthyroid therapy | 0.00 | 2.61 | NA | 0.12 | 2.73 | NA | XXX |
79001 | A | Repeat hyperthyroid therapy | 1.05 | 1.67 | NA | 0.10 | 2.82 | NA | XXX | |
79001 | 26 | A | Repeat hyperthyroid therapy | 1.05 | 0.37 | 0.37 | 0.04 | 1.46 | 1.46 | XXX |
79001 | TC | A | Repeat hyperthyroid therapy | 0.00 | 1.30 | NA | 0.06 | 1.36 | NA | XXX |
79020 | A | Thyroid ablation | 1.81 | 3.23 | NA | 0.19 | 5.23 | NA | XXX | |
79020 | 26 | A | Thyroid ablation | 1.81 | 0.62 | 0.62 | 0.07 | 2.50 | 2.50 | XXX |
79020 | TC | A | Thyroid ablation | 0.00 | 2.61 | NA | 0.12 | 2.73 | NA | XXX |
79030 | A | Thyroid ablation, carcinoma | 2.10 | 3.35 | NA | 0.20 | 5.65 | NA | XXX | |
79030 | 26 | A | Thyroid ablation, carcinoma | 2.10 | 0.74 | 0.74 | 0.08 | 2.92 | 2.92 | XXX |
79030 | TC | A | Thyroid ablation, carcinoma | 0.00 | 2.61 | NA | 0.12 | 2.73 | NA | XXX |
79035 | A | Thyroid metastatic therapy | 2.52 | 3.52 | NA | 0.21 | 6.25 | NA | XXX | |
79035 | 26 | A | Thyroid metastatic therapy | 2.52 | 0.91 | 0.91 | 0.09 | 3.52 | 3.52 | XXX |
79035 | TC | A | Thyroid metastatic therapy | 0.00 | 2.61 | NA | 0.12 | 2.73 | NA | XXX |
79100 | A | Hematopoetic nuclear therapy | 1.32 | 3.09 | NA | 0.17 | 4.58 | NA | XXX | |
79100 | 26 | A | Hematopoetic nuclear therapy | 1.32 | 0.48 | 0.48 | 0.05 | 1.85 | 1.85 | XXX |
79100 | TC | A | Hematopoetic nuclear therapy | 0.00 | 2.61 | NA | 0.12 | 2.73 | NA | XXX |
79200 | A | Intracavitary nuclear trmt | 1.99 | 3.33 | NA | 0.19 | 5.51 | NA | XXX | |
79200 | 26 | A | Intracavitary nuclear trmt | 1.99 | 0.72 | 0.72 | 0.07 | 2.78 | 2.78 | XXX |
79200 | TC | A | Intracavitary nuclear trmt | 0.00 | 2.61 | NA | 0.12 | 2.73 | NA | XXX |
79300 | C | Interstitial nuclear therapy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
79300 | 26 | A | Interstitial nuclear therapy | 1.60 | 0.59 | 0.59 | 0.07 | 2.26 | 2.26 | XXX |
79300 | TC | C | Interstitial nuclear therapy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
79400 | A | Nonhemato nuclear therapy | 1.96 | 3.31 | NA | 0.20 | 5.47 | NA | XXX | |
79400 | 26 | A | Nonhemato nuclear therapy | 1.96 | 0.70 | 0.70 | 0.08 | 2.74 | 2.74 | XXX |
79400 | TC | A | Nonhemato nuclear therapy | 0.00 | 2.61 | NA | 0.12 | 2.73 | NA | XXX |
79420 | C | Intravascular nuclear ther | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
79420 | 26 | A | Intravascular nuclear ther | 1.51 | 0.52 | 0.52 | 0.06 | 2.09 | 2.09 | XXX |
79420 | TC | C | Intravascular nuclear ther | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
79440 | A | Nuclear joint therapy | 1.99 | 3.36 | NA | 0.20 | 5.55 | NA | XXX | |
79440 | 26 | A | Nuclear joint therapy | 1.99 | 0.75 | 0.75 | 0.08 | 2.82 | 2.82 | XXX |
79440 | TC | A | Nuclear joint therapy | 0.00 | 2.61 | NA | 0.12 | 2.73 | NA | XXX |
79900 | C | Provide ther radiopharm(s) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
79999 | C | Nuclear medicine therapy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
79999 | 26 | C | Nuclear medicine therapy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
79999 | TC | C | Nuclear medicine therapy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
80500 | A | Lab pathology consultation | 0.37 | 0.22 | 0.17 | 0.01 | 0.60 | 0.55 | XXX | |
80502 | A | Lab pathology consultation | 1.33 | 0.65 | 0.60 | 0.05 | 2.03 | 1.98 | XXX | |
83020 | 26 | A | Hemoglobin electrophoresis | 0.37 | 0.16 | 0.16 | 0.01 | 0.54 | 0.54 | XXX |
83912 | 26 | A | Genetic examination | 0.37 | 0.15 | 0.15 | 0.01 | 0.53 | 0.53 | XXX |
84165 | 26 | A | Assay of serum proteins | 0.37 | 0.16 | 0.16 | 0.01 | 0.54 | 0.54 | XXX |
84181 | 26 | A | Western blot test | 0.37 | 0.14 | 0.14 | 0.01 | 0.52 | 0.52 | XXX |
84182 | 26 | A | Protein, western blot test | 0.37 | 0.17 | 0.17 | 0.01 | 0.55 | 0.55 | XXX |
85060 | A | Blood smear interpretation | 0.45 | 0.19 | 0.19 | 0.02 | 0.66 | 0.66 | XXX | |
85097 | A | Bone marrow interpretation | 0.94 | 1.81 | 0.41 | 0.03 | 2.78 | 1.38 | XXX | |
85390 | 26 | A | Fibrinolysins screen | 0.37 | 0.13 | 0.13 | 0.01 | 0.51 | 0.51 | XXX |
85576 | 26 | A | Blood platelet aggregation | 0.37 | 0.16 | 0.16 | 0.01 | 0.54 | 0.54 | XXX |
86077 | A | Physician blood bank service | 0.94 | 0.47 | 0.42 | 0.03 | 1.44 | 1.39 | XXX | |
86078 | A | Physician blood bank service | 0.94 | 0.51 | 0.42 | 0.03 | 1.48 | 1.39 | XXX | |
86079 | A | Physician blood bank service | 0.94 | 0.50 | 0.42 | 0.03 | 1.47 | 1.39 | XXX | |
86255 | 26 | A | Fluorescent antibody, screen | 0.37 | 0.17 | 0.17 | 0.01 | 0.55 | 0.55 | XXX |
86256 | 26 | A | Fluorescent antibody, titer | 0.37 | 0.16 | 0.16 | 0.01 | 0.54 | 0.54 | XXX |
86320 | 26 | A | Serum immunoelectrophoresis | 0.37 | 0.17 | 0.16 | 0.01 | 0.55 | 0.54 | XXX |
86325 | 26 | A | Other immunoelectrophoresis | 0.37 | 0.16 | 0.16 | 0.01 | 0.54 | 0.54 | XXX |
86327 | 26 | A | Immunoelectrophoresis assay | 0.42 | 0.19 | 0.19 | 0.01 | 0.62 | 0.62 | XXX |
86334 | 26 | A | Immunofixation procedure | 0.37 | 0.16 | 0.16 | 0.01 | 0.54 | 0.54 | XXX |
86485 | C | Skin test, candida | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
86490 | A | Coccidioidomycosis skin test | 0.00 | 0.29 | NA | 0.02 | 0.31 | NA | XXX | |
86510 | A | Histoplasmosis skin test | 0.00 | 0.32 | NA | 0.02 | 0.34 | NA | XXX | |
86580 | A | TB intradermal test | 0.00 | 0.25 | NA | 0.02 | 0.27 | NA | XXX | |
86585 | A | TB tine test | 0.00 | 0.20 | NA | 0.01 | 0.21 | NA | XXX | |
86586 | C | Skin test, unlisted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
87164 | 26 | A | Dark field examination | 0.37 | 0.12 | 0.12 | 0.01 | 0.50 | 0.50 | XXX |
87207 | 26 | A | Smear, special stain | 0.37 | 0.17 | 0.17 | 0.01 | 0.55 | 0.55 | XXX |
88104 | A | Cytopathology, fluids | 0.56 | 0.79 | NA | 0.04 | 1.39 | NA | XXX | |
88104 | 26 | A | Cytopathology, fluids | 0.56 | 0.25 | 0.25 | 0.02 | 0.83 | 0.83 | XXX |
88104 | TC | A | Cytopathology, fluids | 0.00 | 0.54 | NA | 0.02 | 0.56 | NA | XXX |
88106 | A | Cytopathology, fluids | 0.56 | 0.62 | NA | 0.04 | 1.22 | NA | XXX | |
88106 | 26 | A | Cytopathology, fluids | 0.56 | 0.25 | 0.25 | 0.02 | 0.83 | 0.83 | XXX |
88106 | TC | A | Cytopathology, fluids | 0.00 | 0.37 | NA | 0.02 | 0.39 | NA | XXX |
88107 | A | Cytopathology, fluids | 0.76 | 1.00 | NA | 0.05 | 1.81 | NA | XXX | |
88107 | 26 | A | Cytopathology, fluids | 0.76 | 0.34 | 0.34 | 0.03 | 1.13 | 1.13 | XXX |
88107 | TC | A | Cytopathology, fluids | 0.00 | 0.66 | NA | 0.02 | 0.68 | NA | XXX |
88108 | A | Cytopath, concentrate tech | 0.56 | 0.83 | NA | 0.04 | 1.43 | NA | XXX | |
88108 | 26 | A | Cytopath, concentrate tech | 0.56 | 0.25 | 0.25 | 0.02 | 0.83 | 0.83 | XXX |
88108 | TC | A | Cytopath, concentrate tech | 0.00 | 0.58 | NA | 0.02 | 0.60 | NA | XXX |
88125 | A | Forensic cytopathology | 0.26 | 0.30 | NA | 0.02 | 0.58 | NA | XXX | |
88125 | 26 | A | Forensic cytopathology | 0.26 | 0.12 | 0.12 | 0.01 | 0.39 | 0.39 | XXX |
88125 | TC | A | Forensic cytopathology | 0.00 | 0.18 | NA | 0.01 | 0.19 | NA | XXX |
88141 | A | Cytopath, c/v, interpret | 0.42 | 0.99 | 0.99 | 0.01 | 1.42 | 1.42 | XXX | |
88160 | A | Cytopath smear, other source | 0.50 | 0.98 | NA | 0.04 | 1.52 | NA | XXX | |
88160 | 26 | A | Cytopath smear, other source | 0.50 | 0.22 | 0.22 | 0.02 | 0.74 | 0.74 | XXX |
88160 | TC | A | Cytopath smear, other source | 0.00 | 0.76 | NA | 0.02 | 0.78 | NA | XXX |
88161 | A | Cytopath smear, other source | 0.50 | 0.93 | NA | 0.04 | 1.47 | NA | XXX | |
88161 | 26 | A | Cytopath smear, other source | 0.50 | 0.22 | 0.22 | 0.02 | 0.74 | 0.74 | XXX |
88161 | TC | A | Cytopath smear, other source | 0.00 | 0.71 | NA | 0.02 | 0.73 | NA | XXX |
88162 | A | Cytopath smear, other source | 0.76 | 0.71 | NA | 0.05 | 1.52 | NA | XXX | |
88162 | 26 | A | Cytopath smear, other source | 0.76 | 0.34 | 0.34 | 0.03 | 1.13 | 1.13 | XXX |
88162 | TC | A | Cytopath smear, other source | 0.00 | 0.37 | NA | 0.02 | 0.39 | NA | XXX |
88172 | A | Cytopathology eval of fna | 0.60 | 0.69 | NA | 0.04 | 1.33 | NA | XXX | |
88172 | 26 | A | Cytopathology eval of fna | 0.60 | 0.27 | 0.27 | 0.02 | 0.89 | 0.89 | XXX |
88172 | TC | A | Cytopathology eval of fna | 0.00 | 0.42 | NA | 0.02 | 0.44 | NA | XXX |
88173 | A | Cytopath eval, fna, report | 1.39 | 1.83 | NA | 0.07 | 3.29 | NA | XXX | |
88173 | 26 | A | Cytopath eval, fna, report | 1.39 | 0.62 | 0.62 | 0.05 | 2.06 | 2.06 | XXX |
88173 | TC | A | Cytopath eval, fna, report | 0.00 | 1.21 | NA | 0.02 | 1.23 | NA | XXX |
88180 | A | Cell marker study | 0.36 | 1.20 | NA | 0.03 | 1.59 | NA | XXX | |
88180 | 26 | A | Cell marker study | 0.36 | 0.16 | 0.16 | 0.01 | 0.53 | 0.53 | XXX |
88180 | TC | A | Cell marker study | 0.00 | 1.04 | NA | 0.02 | 1.06 | NA | XXX |
88182 | A | Cell marker study | 0.77 | 1.56 | NA | 0.06 | 2.39 | NA | XXX | |
88182 | 26 | A | Cell marker study | 0.77 | 0.35 | 0.35 | 0.03 | 1.15 | 1.15 | XXX |
88182 | TC | A | Cell marker study | 0.00 | 1.21 | NA | 0.03 | 1.24 | NA | XXX |
88199 | C | Cytopathology procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
88199 | 26 | C | Cytopathology procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
88199 | TC | C | Cytopathology procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
88291 | A | Cyto/molecular report | 0.52 | 0.30 | 0.30 | 0.02 | 0.84 | 0.84 | XXX | |
88299 | C | Cytogenetic study | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
88300 | A | Surgical path, gross | 0.08 | 0.30 | NA | 0.02 | 0.40 | NA | XXX | |
88300 | 26 | A | Surgical path, gross | 0.08 | 0.04 | 0.04 | 0.01 | 0.13 | 0.13 | XXX |
88300 | TC | A | Surgical path, gross | 0.00 | 0.26 | NA | 0.01 | 0.27 | NA | XXX |
88302 | A | Tissue exam by pathologist | 0.13 | 0.73 | NA | 0.03 | 0.89 | NA | XXX | |
88302 | 26 | A | Tissue exam by pathologist | 0.13 | 0.06 | 0.06 | 0.01 | 0.20 | 0.20 | XXX |
88302 | TC | A | Tissue exam by pathologist | 0.00 | 0.67 | NA | 0.02 | 0.69 | NA | XXX |
88304 | A | Tissue exam by pathologist | 0.22 | 0.90 | NA | 0.03 | 1.15 | NA | XXX | |
88304 | 26 | A | Tissue exam by pathologist | 0.22 | 0.10 | 0.10 | 0.01 | 0.33 | 0.33 | XXX |
88304 | TC | A | Tissue exam by pathologist | 0.00 | 0.80 | NA | 0.02 | 0.82 | NA | XXX |
88305 | A | Tissue exam by pathologist | 0.75 | 1.77 | NA | 0.05 | 2.57 | NA | XXX | |
88305 | 26 | A | Tissue exam by pathologist | 0.75 | 0.34 | 0.34 | 0.02 | 1.11 | 1.11 | XXX |
88305 | TC | A | Tissue exam by pathologist | 0.00 | 1.43 | NA | 0.03 | 1.46 | NA | XXX |
88307 | A | Tissue exam by pathologist | 1.59 | 2.72 | NA | 0.11 | 4.42 | NA | XXX | |
88307 | 26 | A | Tissue exam by pathologist | 1.59 | 0.71 | 0.71 | 0.06 | 2.36 | 2.36 | XXX |
88307 | TC | A | Tissue exam by pathologist | 0.00 | 2.01 | NA | 0.05 | 2.06 | NA | XXX |
88309 | A | Tissue exam by pathologist | 2.28 | 3.33 | NA | 0.13 | 5.74 | NA | XXX | |
88309 | 26 | A | Tissue exam by pathologist | 2.28 | 1.02 | 1.02 | 0.08 | 3.38 | 3.38 | XXX |
88309 | TC | A | Tissue exam by pathologist | 0.00 | 2.31 | NA | 0.05 | 2.36 | NA | XXX |
88311 | A | Decalcify tissue | 0.24 | 0.20 | NA | 0.02 | 0.46 | NA | XXX | |
88311 | 26 | A | Decalcify tissue | 0.24 | 0.11 | 0.11 | 0.01 | 0.36 | 0.36 | XXX |
88311 | TC | A | Decalcify tissue | 0.00 | 0.09 | NA | 0.01 | 0.10 | NA | XXX |
88312 | A | Special stains | 0.54 | 1.61 | NA | 0.03 | 2.18 | NA | XXX | |
88312 | 26 | A | Special stains | 0.54 | 0.24 | 0.24 | 0.02 | 0.80 | 0.80 | XXX |
88312 | TC | A | Special stains | 0.00 | 1.37 | NA | 0.01 | 1.38 | NA | XXX |
88313 | A | Special stains | 0.24 | 1.19 | NA | 0.02 | 1.45 | NA | XXX | |
88313 | 26 | A | Special stains | 0.24 | 0.11 | 0.11 | 0.01 | 0.36 | 0.36 | XXX |
88313 | TC | A | Special stains | 0.00 | 1.08 | NA | 0.01 | 1.09 | NA | XXX |
88314 | A | Histochemical stain | 0.45 | 0.84 | NA | 0.04 | 1.33 | NA | XXX | |
88314 | 26 | A | Histochemical stain | 0.45 | 0.20 | 0.20 | 0.02 | 0.67 | 0.67 | XXX |
88314 | TC | A | Histochemical stain | 0.00 | 0.64 | NA | 0.02 | 0.66 | NA | XXX |
88318 | A | Chemical histochemistry | 0.42 | 0.74 | NA | 0.02 | 1.18 | NA | XXX | |
88318 | 26 | A | Chemical histochemistry | 0.42 | 0.19 | 0.19 | 0.01 | 0.62 | 0.62 | XXX |
88318 | TC | A | Chemical histochemistry | 0.00 | 0.55 | NA | 0.01 | 0.56 | NA | XXX |
88319 | A | Enzyme histochemistry | 0.53 | 2.18 | NA | 0.04 | 2.75 | NA | XXX | |
88319 | 26 | A | Enzyme histochemistry | 0.53 | 0.24 | 0.24 | 0.02 | 0.79 | 0.79 | XXX |
88319 | TC | A | Enzyme histochemistry | 0.00 | 1.94 | NA | 0.02 | 1.96 | NA | XXX |
88321 | A | Microslide consultation | 1.30 | 0.83 | 0.58 | 0.04 | 2.17 | 1.92 | XXX | |
88323 | A | Microslide consultation | 1.35 | 1.42 | NA | 0.07 | 2.84 | NA | XXX | |
88323 | 26 | A | Microslide consultation | 1.35 | 0.61 | 0.61 | 0.05 | 2.01 | 2.01 | XXX |
88323 | TC | A | Microslide consultation | 0.00 | 0.81 | NA | 0.02 | 0.83 | NA | XXX |
88325 | A | Comprehensive review of data | 2.22 | 2.93 | 0.99 | 0.08 | 5.23 | 3.29 | XXX | |
88329 | A | Path consult introp | 0.67 | 0.66 | 0.30 | 0.02 | 1.35 | 0.99 | XXX | |
88331 | A | Path consult intraop, 1 bloc | 1.19 | 1.03 | NA | 0.07 | 2.29 | NA | XXX | |
88331 | 26 | A | Path consult intraop, 1 bloc | 1.19 | 0.54 | 0.54 | 0.04 | 1.77 | 1.77 | XXX |
88331 | TC | A | Path consult intraop, 1 bloc | 0.00 | 0.49 | NA | 0.03 | 0.52 | NA | XXX |
88332 | A | Path consult intraop, addl | 0.59 | 0.52 | NA | 0.04 | 1.15 | NA | XXX | |
88332 | 26 | A | Path consult intraop, addl | 0.59 | 0.27 | 0.27 | 0.02 | 0.88 | 0.88 | XXX |
88332 | TC | A | Path consult intraop, addl | 0.00 | 0.25 | NA | 0.02 | 0.27 | NA | XXX |
88342 | A | Immunocytochemistry | 0.85 | 1.31 | NA | 0.05 | 2.21 | NA | XXX | |
88342 | 26 | A | Immunocytochemistry | 0.85 | 0.38 | 0.38 | 0.03 | 1.26 | 1.26 | XXX |
88342 | TC | A | Immunocytochemistry | 0.00 | 0.93 | NA | 0.02 | 0.95 | NA | XXX |
88346 | A | Immunofluorescent study | 0.86 | 1.46 | NA | 0.05 | 2.37 | NA | XXX | |
88346 | 26 | A | Immunofluorescent study | 0.86 | 0.38 | 0.38 | 0.03 | 1.27 | 1.27 | XXX |
88346 | TC | A | Immunofluorescent study | 0.00 | 1.08 | NA | 0.02 | 1.10 | NA | XXX |
88347 | A | Immunofluorescent study | 0.86 | 1.86 | NA | 0.05 | 2.77 | NA | XXX | |
88347 | 26 | A | Immunofluorescent study | 0.86 | 0.36 | 0.36 | 0.03 | 1.25 | 1.25 | XXX |
88347 | TC | A | Immunofluorescent study | 0.00 | 1.50 | NA | 0.02 | 1.52 | NA | XXX |
88348 | A | Electron microscopy | 1.51 | 8.09 | NA | 0.11 | 9.71 | NA | XXX | |
88348 | 26 | A | Electron microscopy | 1.51 | 0.67 | 0.67 | 0.05 | 2.23 | 2.23 | XXX |
88348 | TC | A | Electron microscopy | 0.00 | 7.42 | NA | 0.06 | 7.48 | NA | XXX |
88349 | A | Scanning electron microscopy | 0.76 | 9.38 | NA | 0.08 | 10.22 | NA | XXX | |
88349 | 26 | A | Scanning electron microscopy | 0.76 | 0.34 | 0.34 | 0.03 | 1.13 | 1.13 | XXX |
88349 | TC | A | Scanning electron microscopy | 0.00 | 9.04 | NA | 0.05 | 9.09 | NA | XXX |
88355 | A | Analysis, skeletal muscle | 1.85 | 2.55 | NA | 0.12 | 4.52 | NA | XXX | |
88355 | 26 | A | Analysis, skeletal muscle | 1.85 | 0.83 | 0.83 | 0.07 | 2.75 | 2.75 | XXX |
88355 | TC | A | Analysis, skeletal muscle | 0.00 | 1.72 | NA | 0.05 | 1.77 | NA | XXX |
88356 | A | Analysis, nerve | 3.02 | 2.83 | NA | 0.16 | 6.01 | NA | XXX | |
88356 | 26 | A | Analysis, nerve | 3.02 | 1.30 | 1.30 | 0.10 | 4.42 | 4.42 | XXX |
88356 | TC | A | Analysis, nerve | 0.00 | 1.53 | NA | 0.06 | 1.59 | NA | XXX |
88358 | A | Analysis, tumor | 2.82 | 1.72 | NA | 0.16 | 4.70 | NA | XXX | |
88358 | 26 | A | Analysis, tumor | 2.82 | 1.25 | 1.25 | 0.10 | 4.17 | 4.17 | XXX |
88358 | TC | A | Analysis, tumor | 0.00 | 0.47 | NA | 0.06 | 0.53 | NA | XXX |
88362 | A | Nerve teasing preparations | 2.17 | 4.54 | NA | 0.12 | 6.83 | NA | XXX | |
88362 | 26 | A | Nerve teasing preparations | 2.17 | 0.95 | 0.95 | 0.07 | 3.19 | 3.19 | XXX |
88362 | TC | A | Nerve teasing preparations | 0.00 | 3.59 | NA | 0.05 | 3.64 | NA | XXX |
88365 | A | Tissue hybridization | 0.93 | 2.03 | NA | 0.05 | 3.01 | NA | XXX | |
88365 | 26 | A | Tissue hybridization | 0.93 | 0.41 | 0.41 | 0.03 | 1.37 | 1.37 | XXX |
88365 | TC | A | Tissue hybridization | 0.00 | 1.62 | NA | 0.02 | 1.64 | NA | XXX |
88371 | 26 | A | Protein, western blot tissue | 0.37 | 0.13 | 0.13 | 0.01 | 0.51 | 0.51 | XXX |
88372 | 26 | A | Protein analysis w/probe | 0.37 | 0.17 | 0.17 | 0.01 | 0.55 | 0.55 | XXX |
88380 | C | Microdissection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
88380 | 26 | C | Microdissection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
88380 | TC | C | Microdissection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
88399 | C | Surgical pathology procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
88399 | 26 | C | Surgical pathology procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
88399 | TC | C | Surgical pathology procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
89060 | 26 | A | Exam,synovial fluid crystals | 0.37 | 0.17 | 0.17 | 0.01 | 0.55 | 0.55 | XXX |
89100 | A | Sample intestinal contents | 0.60 | 1.72 | 0.22 | 0.02 | 2.34 | 0.84 | XXX | |
89105 | A | Sample intestinal contents | 0.50 | 2.28 | 0.18 | 0.02 | 2.80 | 0.70 | XXX | |
89130 | A | Sample stomach contents | 0.45 | 1.97 | 0.13 | 0.02 | 2.44 | 0.60 | XXX | |
89132 | A | Sample stomach contents | 0.19 | 1.76 | 0.07 | 0.01 | 1.96 | 0.27 | XXX | |
89135 | A | Sample stomach contents | 0.79 | 1.75 | 0.26 | 0.03 | 2.57 | 1.08 | XXX | |
89136 | A | Sample stomach contents | 0.21 | 1.77 | 0.08 | 0.01 | 1.99 | 0.30 | XXX | |
89140 | A | Sample stomach contents | 0.94 | 2.22 | 0.28 | 0.03 | 3.19 | 1.25 | XXX | |
89141 | A | Sample stomach contents | 0.85 | 2.80 | 0.35 | 0.03 | 3.68 | 1.23 | XXX | |
89350 | A | Sputum specimen collection | 0.00 | 0.41 | NA | 0.02 | 0.43 | NA | XXX | |
89360 | A | Collect sweat for test | 0.00 | 0.45 | NA | 0.02 | 0.47 | NA | XXX | |
89399 | C | Pathology lab procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
89399 | 26 | C | Pathology lab procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
89399 | TC | C | Pathology lab procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
90281 | I | Human ig, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90283 | I | Human ig, iv | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90287 | I | Botulinum antitoxin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90288 | I | Botulism ig, iv | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90291 | I | Cmv ig, iv | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90296 | E | Diphtheria antitoxin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90371 | E | Hep b ig, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90375 | E | Rabies ig, im/sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90376 | E | Rabies ig, heat treated | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90378 | X | Rsv ig, im, 50mg | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90379 | I | Rsv ig, iv | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90384 | I | Rh ig, full-dose, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90385 | E | Rh ig, minidose, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90386 | I | Rh ig, iv | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90389 | I | Tetanus ig, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90393 | E | Vaccina ig, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90396 | E | Varicella-zoster ig, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90399 | I | Immune globulin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90471 | A | Immunization admin | 0.00 | 0.20 | NA | 0.01 | 0.21 | NA | XXX | |
90472 | A | Immunization admin, each add | 0.00 | 0.14 | NA | 0.01 | 0.15 | NA | ZZZ | |
90473 | N | Immune admin oral/nasal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90474 | N | Immune admin oral/nasal addl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | |
90476 | E | Adenovirus vaccine, type 4 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90477 | E | Adenovirus vaccine, type 7 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90581 | E | Anthrax vaccine, sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90585 | E | Bcg vaccine, percut | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90586 | E | Bcg vaccine, intravesical | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90632 | E | Hep a vaccine, adult im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90633 | E | Hep a vacc, ped/adol, 2 dose | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90634 | E | Hep a vacc, ped/adol, 3 dose | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90636 | E | Hep a/hep b vacc, adult im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90645 | E | Hib vaccine, hboc, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90646 | E | Hib vaccine, prp-d, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90647 | E | Hib vaccine, prp-omp, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90648 | E | Hib vaccine, prp-t, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90657 | X | Flu vaccine, 6-35 mo, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90658 | X | Flu vaccine, 3 yrs, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90659 | X | Flu vaccine, whole, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90660 | X | Flu vaccine, nasal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90665 | E | Lyme disease vaccine, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90669 | N | Pneumococcal vacc, ped 5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90675 | E | Rabies vaccine, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90676 | E | Rabies vaccine, id | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90680 | E | Rotovirus vaccine, oral | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90690 | E | Typhoid vaccine, oral | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90691 | E | Typhoid vaccine, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90692 | E | Typhoid vaccine, h-p, sc/id | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90693 | E | Typhoid vaccine, akd, sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90700 | E | Dtap vaccine, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90701 | E | Dtp vaccine, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90702 | E | Dt vaccine 7, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90703 | E | Tetanus vaccine, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90704 | E | Mumps vaccine, sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90705 | E | Measles vaccine, sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90706 | E | Rubella vaccine, sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90707 | E | Mmr vaccine, sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90708 | E | Measles-rubella vaccine, sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90709 | D | Rubella mumps vaccine, sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90710 | E | Mmrv vaccine, sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90712 | E | Oral poliovirus vaccine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90713 | E | Poliovirus, ipv, sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90716 | E | Chicken pox vaccine, sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90717 | E | Yellow fever vaccine, sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90718 | E | Td vaccine 7, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90719 | E | Diphtheria vaccine, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90720 | E | Dtp/hib vaccine, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90721 | E | Dtap/hib vaccine, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90723 | X | Dtap-hep b-ipv vaccine, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90725 | E | Cholera vaccine, injectable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90727 | E | Plague vaccine, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90732 | X | Pneumococcal vaccine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90733 | E | Meningococcal vaccine, sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90735 | E | Encephalitis vaccine, sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90740 | I | Hepb vacc, ill pat 3 dose im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90743 | I | Hep b vacc, adol, 2 dose, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90744 | I | Hepb vacc ped/adol 3 dose im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90746 | I | Hep b vaccine, adult, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90747 | I | Hepb vacc, ill pat 4 dose im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90748 | E | Hep b/hib vaccine, im | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90749 | E | Vaccine toxoid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90780 | A | IV infusion therapy, 1 hour | 0.00 | 1.10 | NA | 0.06 | 1.16 | NA | XXX | |
90781 | A | IV infusion, additional hour | 0.00 | 0.56 | NA | 0.03 | 0.59 | NA | ZZZ | |
90782 | T | Injection, sc/im | 0.00 | 0.11 | NA | 0.01 | 0.12 | NA | XXX | |
90783 | T | Injection, ia | 0.00 | 0.41 | NA | 0.02 | 0.43 | NA | XXX | |
90784 | T | Injection, iv | 0.00 | 0.47 | NA | 0.03 | 0.50 | NA | XXX | |
90788 | T | Injection of antibiotic | 0.00 | 0.12 | NA | 0.01 | 0.13 | NA | XXX | |
90799 | C | Ther/prophylactic/dx inject | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90801 | A | Psy dx interview | 2.80 | 1.19 | 0.96 | 0.06 | 4.05 | 3.82 | XXX | |
90802 | A | Intac psy dx interview | 3.01 | 1.23 | 1.01 | 0.07 | 4.31 | 4.09 | XXX | |
90804 | A | Psytx, office, 20-30 min | 1.21 | 0.51 | 0.39 | 0.03 | 1.75 | 1.63 | XXX | |
90805 | A | Psytx, off, 20-30 min w/em | 1.37 | 0.52 | 0.44 | 0.03 | 1.92 | 1.84 | XXX | |
90806 | A | Psytx, off, 45-50 min | 1.86 | 0.72 | 0.62 | 0.04 | 2.62 | 2.52 | XXX | |
90807 | A | Psytx, off, 45-50 min w/em | 2.02 | 0.72 | 0.65 | 0.05 | 2.79 | 2.72 | XXX | |
90808 | A | Psytx, office, 75-80 min | 2.79 | 1.05 | 0.93 | 0.07 | 3.91 | 3.79 | XXX | |
90809 | A | Psytx, off, 75-80, w/em | 2.95 | 1.02 | 0.95 | 0.07 | 4.04 | 3.97 | XXX | |
90810 | A | Intac psytx, off, 20-30 min | 1.32 | 0.53 | 0.43 | 0.03 | 1.88 | 1.78 | XXX | |
90811 | A | Intac psytx, 20-30, w/em | 1.48 | 0.59 | 0.48 | 0.03 | 2.10 | 1.99 | XXX | |
90812 | A | Intac psytx, off, 45-50 min | 1.97 | 0.82 | 0.66 | 0.05 | 2.84 | 2.68 | XXX | |
90813 | A | Intac psytx, 45-50 min w/em | 2.13 | 0.79 | 0.69 | 0.05 | 2.97 | 2.87 | XXX | |
90814 | A | Intac psytx, off, 75-80 min | 2.90 | 1.13 | 1.01 | 0.07 | 4.10 | 3.98 | XXX | |
90815 | A | Intac psytx, 75-80 w/em | 3.06 | 1.08 | 0.98 | 0.07 | 4.21 | 4.11 | XXX | |
90816 | A | Psytx, hosp, 20-30 min | 1.25 | NA | 0.48 | 0.03 | NA | 1.76 | XXX | |
90817 | A | Psytx, hosp, 20-30 min w/em | 1.41 | NA | 0.47 | 0.03 | NA | 1.91 | XXX | |
90818 | A | Psytx, hosp, 45-50 min | 1.89 | NA | 0.71 | 0.04 | NA | 2.64 | XXX | |
90819 | A | Psytx, hosp, 45-50 min w/em | 2.05 | NA | 0.67 | 0.05 | NA | 2.77 | XXX | |
90821 | A | Psytx, hosp, 75-80 min | 2.83 | NA | 1.03 | 0.06 | NA | 3.92 | XXX | |
90822 | A | Psytx, hosp, 75-80 min w/em | 2.99 | NA | 0.97 | 0.07 | NA | 4.03 | XXX | |
90823 | A | Intac psytx, hosp, 20-30 min | 1.36 | NA | 0.49 | 0.03 | NA | 1.88 | XXX | |
90824 | A | Intac psytx, hsp 20-30 w/em | 1.52 | NA | 0.51 | 0.03 | NA | 2.06 | XXX | |
90826 | A | Intac psytx, hosp, 45-50 min | 2.01 | NA | 0.75 | 0.04 | NA | 2.80 | XXX | |
90827 | A | Intac psytx, hsp 45-50 w/em | 2.16 | NA | 0.71 | 0.05 | NA | 2.92 | XXX | |
90828 | A | Intac psytx, hosp, 75-80 min | 2.94 | NA | 1.09 | 0.07 | NA | 4.10 | XXX | |
90829 | A | Intac psytx, hsp 75-80 w/em | 3.10 | NA | 1.01 | 0.07 | NA | 4.18 | XXX | |
90845 | A | Psychoanalysis | 1.79 | 0.60 | 0.57 | 0.04 | 2.43 | 2.40 | XXX | |
90846 | R | Family psytx w/o patient | 1.83 | 0.67 | 0.66 | 0.04 | 2.54 | 2.53 | XXX | |
90847 | R | Family psytx w/patient | 2.21 | 0.84 | 0.78 | 0.05 | 3.10 | 3.04 | XXX | |
90849 | R | Multiple family group psytx | 0.59 | 0.28 | 0.25 | 0.01 | 0.88 | 0.85 | XXX | |
90853 | A | Group psychotherapy | 0.59 | 0.26 | 0.24 | 0.01 | 0.86 | 0.84 | XXX | |
90857 | A | Intac group psytx | 0.63 | 0.31 | 0.26 | 0.02 | 0.96 | 0.91 | XXX | |
90862 | A | Medication management | 0.95 | 0.41 | 0.33 | 0.02 | 1.38 | 1.30 | XXX | |
90865 | A | Narcosynthesis | 2.84 | 1.62 | 0.91 | 0.07 | 4.53 | 3.82 | XXX | |
90870 | A | Electroconvulsive therapy | 1.88 | 0.81 | 0.81 | 0.04 | 2.73 | 2.73 | 000 | |
90871 | A | Electroconvulsive therapy | 2.72 | NA | 1.08 | 0.06 | NA | 3.86 | 000 | |
90875 | N | Psychophysiological therapy | +1.20 | 0.91 | 0.47 | 0.03 | 2.14 | 1.70 | XXX | |
90876 | N | Psychophysiological therapy | +1.90 | 1.18 | 0.74 | 0.04 | 3.12 | 2.68 | XXX | |
90880 | A | Hypnotherapy | 2.19 | 1.06 | 0.71 | 0.05 | 3.30 | 2.95 | XXX | |
90882 | N | Environmental manipulation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90885 | B | Psy evaluation of records | +0.97 | 0.38 | 0.38 | 0.02 | 1.37 | 1.37 | XXX | |
90887 | B | Consultation with family | +1.48 | 0.83 | 0.58 | 0.03 | 2.34 | 2.09 | XXX | |
90889 | B | Preparation of report | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90899 | C | Psychiatric service/therapy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90901 | A | Biofeedback train, any meth | 0.41 | 0.86 | 0.19 | 0.02 | 1.29 | 0.62 | 000 | |
90911 | A | Biofeedback peri/uro/rectal | 0.89 | 0.88 | 0.36 | 0.04 | 1.81 | 1.29 | 000 | |
90918 | A | ESRD related services, month | 11.18 | 7.56 | 7.56 | 0.30 | 19.04 | 19.04 | XXX | |
90919 | A | ESRD related services, month | 8.54 | 4.18 | 4.18 | 0.24 | 12.96 | 12.96 | XXX | |
90920 | A | ESRD related services, month | 7.27 | 3.92 | 3.92 | 0.19 | 11.38 | 11.38 | XXX | |
90921 | A | ESRD related services, month | 4.47 | 2.54 | 2.54 | 0.12 | 7.13 | 7.13 | XXX | |
90922 | A | ESRD related services, day | 0.37 | 0.22 | 0.22 | 0.01 | 0.60 | 0.60 | XXX | |
90923 | A | Esrd related services, day | 0.28 | 0.13 | 0.13 | 0.01 | 0.42 | 0.42 | XXX | |
90924 | A | Esrd related services, day | 0.24 | 0.12 | 0.12 | 0.01 | 0.37 | 0.37 | XXX | |
90925 | A | Esrd related services, day | 0.15 | 0.08 | 0.08 | 0.01 | 0.24 | 0.24 | XXX | |
90935 | A | Hemodialysis, one evaluation | 1.22 | NA | 0.69 | 0.03 | NA | 1.94 | 000 | |
90937 | A | Hemodialysis, repeated eval | 2.11 | NA | 1.00 | 0.06 | NA | 3.17 | 000 | |
90939 | X | Hemodialysis study, transcut | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90940 | X | Hemodialysis access study | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90945 | A | Dialysis, one evaluation | 1.28 | NA | 0.72 | 0.04 | NA | 2.04 | 000 | |
90947 | A | Dialysis, repeated eval | 2.16 | NA | 1.02 | 0.06 | NA | 3.24 | 000 | |
90989 | X | Dialysis training, complete | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90993 | X | Dialysis training, incompl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
90997 | A | Hemoperfusion | 1.84 | NA | 1.43 | 0.05 | NA | 3.32 | 000 | |
90999 | C | Dialysis procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
91000 | A | Esophageal intubation | 0.73 | 0.33 | NA | 0.04 | 1.10 | NA | 000 | |
91000 | 26 | A | Esophageal intubation | 0.73 | 0.25 | 0.25 | 0.03 | 1.01 | 1.01 | 000 |
91000 | TC | A | Esophageal intubation | 0.00 | 0.08 | NA | 0.01 | 0.09 | NA | 000 |
91010 | A | Esophagus motility study | 1.25 | 2.75 | NA | 0.10 | 4.10 | NA | 000 | |
91010 | 26 | A | Esophagus motility study | 1.25 | 0.45 | 0.45 | 0.05 | 1.75 | 1.75 | 000 |
91010 | TC | A | Esophagus motility study | 0.00 | 2.30 | NA | 0.05 | 2.35 | NA | 000 |
91011 | A | Esophagus motility study | 1.50 | 3.18 | NA | 0.10 | 4.78 | NA | 000 | |
91011 | 26 | A | Esophagus motility study | 1.50 | 0.54 | 0.54 | 0.05 | 2.09 | 2.09 | 000 |
91011 | TC | A | Esophagus motility study | 0.00 | 2.64 | NA | 0.05 | 2.69 | NA | 000 |
91012 | A | Esophagus motility study | 1.46 | 3.31 | NA | 0.12 | 4.89 | NA | 000 | |
91012 | 26 | A | Esophagus motility study | 1.46 | 0.53 | 0.53 | 0.06 | 2.05 | 2.05 | 000 |
91012 | TC | A | Esophagus motility study | 0.00 | 2.78 | NA | 0.06 | 2.84 | NA | 000 |
91020 | A | Gastric motility | 1.44 | 3.05 | NA | 0.11 | 4.60 | NA | 000 | |
91020 | 26 | A | Gastric motility | 1.44 | 0.50 | 0.50 | 0.06 | 2.00 | 2.00 | 000 |
91020 | TC | A | Gastric motility | 0.00 | 2.55 | NA | 0.05 | 2.60 | NA | 000 |
91030 | A | Acid perfusion of esophagus | 0.91 | 2.57 | NA | 0.05 | 3.53 | NA | 000 | |
91030 | 26 | A | Acid perfusion of esophagus | 0.91 | 0.33 | 0.33 | 0.03 | 1.27 | 1.27 | 000 |
91030 | TC | A | Acid perfusion of esophagus | 0.00 | 2.24 | NA | 0.02 | 2.26 | NA | 000 |
91032 | A | Esophagus, acid reflux test | 1.21 | 2.43 | NA | 0.10 | 3.74 | NA | 000 | |
91032 | 26 | A | Esophagus, acid reflux test | 1.21 | 0.43 | 0.43 | 0.05 | 1.69 | 1.69 | 000 |
91032 | TC | A | Esophagus, acid reflux test | 0.00 | 2.00 | NA | 0.05 | 2.05 | NA | 000 |
91033 | A | Prolonged acid reflux test | 1.30 | 2.64 | NA | 0.14 | 4.08 | NA | 000 | |
91033 | 26 | A | Prolonged acid reflux test | 1.30 | 0.47 | 0.47 | 0.05 | 1.82 | 1.82 | 000 |
91033 | TC | A | Prolonged acid reflux test | 0.00 | 2.17 | NA | 0.09 | 2.26 | NA | 000 |
91052 | A | Gastric analysis test | 0.79 | 2.38 | NA | 0.05 | 3.22 | NA | 000 | |
91052 | 26 | A | Gastric analysis test | 0.79 | 0.28 | 0.28 | 0.03 | 1.10 | 1.10 | 000 |
91052 | TC | A | Gastric analysis test | 0.00 | 2.10 | NA | 0.02 | 2.12 | NA | 000 |
91055 | A | Gastric intubation for smear | 0.94 | 2.17 | NA | 0.06 | 3.17 | NA | 000 | |
91055 | 26 | A | Gastric intubation for smear | 0.94 | 0.27 | 0.27 | 0.04 | 1.25 | 1.25 | 000 |
91055 | TC | A | Gastric intubation for smear | 0.00 | 1.90 | NA | 0.02 | 1.92 | NA | 000 |
91060 | A | Gastric saline load test | 0.45 | 0.30 | NA | 0.04 | 0.79 | NA | 000 | |
91060 | 26 | A | Gastric saline load test | 0.45 | 0.14 | 0.14 | 0.02 | 0.61 | 0.61 | 000 |
91060 | TC | A | Gastric saline load test | 0.00 | 0.16 | NA | 0.02 | 0.18 | NA | 000 |
91065 | A | Breath hydrogen test | 0.20 | 3.88 | NA | 0.03 | 4.11 | NA | 000 | |
91065 | 26 | A | Breath hydrogen test | 0.20 | 0.07 | 0.07 | 0.01 | 0.28 | 0.28 | 000 |
91065 | TC | A | Breath hydrogen test | 0.00 | 3.81 | NA | 0.02 | 3.83 | NA | 000 |
91100 | A | Pass intestine bleeding tube | 1.08 | NA | 0.29 | 0.06 | NA | 1.43 | 000 | |
91105 | A | Gastric intubation treatment | 0.37 | NA | 0.10 | 0.02 | NA | 0.49 | 000 | |
91122 | A | Anal pressure record | 1.77 | 3.85 | NA | 0.17 | 5.79 | NA | 000 | |
91122 | 26 | A | Anal pressure record | 1.77 | 0.62 | 0.62 | 0.10 | 2.49 | 2.49 | 000 |
91122 | TC | A | Anal pressure record | 0.00 | 3.23 | NA | 0.07 | 3.30 | NA | 000 |
91123 | B | Irrigate fecal impaction | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
91132 | C | Electrogastrography | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
91132 | 26 | A | Electrogastrography | 0.52 | 0.19 | NA | 0.03 | 0.74 | NA | XXX |
91132 | TC | C | Electrogastrography | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
91133 | C | Electrogastrography w/test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
91133 | 26 | A | Electrogastrography w/test | 0.66 | 0.24 | NA | 0.03 | 0.93 | NA | XXX |
91133 | TC | C | Electrogastrography w/test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
91299 | C | Gastroenterology procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
91299 | 26 | C | Gastroenterology procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
91299 | TC | C | Gastroenterology procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
92002 | A | Eye exam, new patient | 0.88 | 0.94 | 0.35 | 0.02 | 1.84 | 1.25 | XXX | |
92004 | A | Eye exam, new patient | 1.67 | 1.66 | 0.70 | 0.03 | 3.36 | 2.40 | XXX | |
92012 | A | Eye exam established pat | 0.67 | 0.99 | 0.30 | 0.01 | 1.67 | 0.98 | XXX | |
92014 | A | Eye exam treatment | 1.10 | 1.35 | 0.48 | 0.02 | 2.47 | 1.60 | XXX | |
92015 | N | Refraction | +0.38 | 1.51 | 0.15 | 0.01 | 1.90 | 0.54 | XXX | |
92018 | A | New eye exam treatment | 2.50 | NA | 1.10 | 0.03 | NA | 3.63 | XXX | |
92019 | A | Eye exam treatment | 1.31 | NA | 0.58 | 0.03 | NA | 1.92 | XXX | |
92020 | A | Special eye evaluation | 0.37 | 0.92 | 0.16 | 0.01 | 1.30 | 0.54 | XXX | |
92060 | A | Special eye evaluation | 0.69 | 0.74 | NA | 0.02 | 1.45 | NA | XXX | |
92060 | 26 | A | Special eye evaluation | 0.69 | 0.30 | 0.30 | 0.01 | 1.00 | 1.00 | XXX |
92060 | TC | A | Special eye evaluation | 0.00 | 0.44 | NA | 0.01 | 0.45 | NA | XXX |
92065 | A | Orthoptic/pleoptic training | 0.37 | 0.56 | NA | 0.02 | 0.95 | NA | XXX | |
92065 | 26 | A | Orthoptic/pleoptic training | 0.37 | 0.16 | 0.16 | 0.01 | 0.54 | 0.54 | XXX |
92065 | TC | A | Orthoptic/pleoptic training | 0.00 | 0.40 | NA | 0.01 | 0.41 | NA | XXX |
92070 | A | Fitting of contact lens | 0.70 | 1.04 | 0.33 | 0.01 | 1.75 | 1.04 | XXX | |
92081 | A | Visual field examination(s) | 0.36 | 2.04 | NA | 0.02 | 2.42 | NA | XXX | |
92081 | 26 | A | Visual field examination(s) | 0.36 | 0.16 | 0.16 | 0.01 | 0.53 | 0.53 | XXX |
92081 | TC | A | Visual field examination(s) | 0.00 | 1.88 | NA | 0.01 | 1.89 | NA | XXX |
92082 | A | Visual field examination(s) | 0.44 | 1.06 | NA | 0.02 | 1.52 | NA | XXX | |
92082 | 26 | A | Visual field examination(s) | 0.44 | 0.19 | 0.19 | 0.01 | 0.64 | 0.64 | XXX |
92082 | TC | A | Visual field examination(s) | 0.00 | 0.87 | NA | 0.01 | 0.88 | NA | XXX |
92083 | A | Visual field examination(s) | 0.50 | 1.59 | NA | 0.02 | 2.11 | NA | XXX | |
92083 | 26 | A | Visual field examination(s) | 0.50 | 0.23 | 0.23 | 0.01 | 0.74 | 0.74 | XXX |
92083 | TC | A | Visual field examination(s) | 0.00 | 1.36 | NA | 0.01 | 1.37 | NA | XXX |
92100 | A | Serial tonometry exam(s) | 0.92 | 0.73 | 0.38 | 0.02 | 1.67 | 1.32 | XXX | |
92120 | A | Tonography eye evaluation | 0.81 | 0.80 | 0.33 | 0.02 | 1.63 | 1.16 | XXX | |
92130 | A | Water provocation tonography | 0.81 | 0.91 | 0.38 | 0.02 | 1.74 | 1.21 | XXX | |
92135 | A | Opthalmic dx imaging | 0.35 | 1.54 | NA | 0.02 | 1.91 | NA | XXX | |
92135 | 26 | A | Opthalmic dx imaging | 0.35 | 0.16 | 0.16 | 0.01 | 0.52 | 0.52 | XXX |
92135 | TC | A | Opthalmic dx imaging | 0.00 | 1.38 | NA | 0.01 | 1.39 | NA | XXX |
92136 | A | Ophthalmic biometry | 0.54 | 1.88 | NA | 0.07 | 2.49 | NA | XXX | |
92136 | 26 | A | Ophthalmic biometry | 0.54 | 0.25 | 0.25 | 0.01 | 0.80 | 0.80 | XXX |
92136 | TC | A | Ophthalmic biometry | 0.00 | 1.63 | NA | 0.06 | 1.69 | NA | XXX |
92140 | A | Glaucoma provocative tests | 0.50 | 0.99 | 0.22 | 0.01 | 1.50 | 0.73 | XXX | |
92225 | A | Special eye exam, initial | 0.38 | 0.22 | 0.16 | 0.01 | 0.61 | 0.55 | XXX | |
92226 | A | Special eye exam, subsequent | 0.33 | 0.21 | 0.15 | 0.01 | 0.55 | 0.49 | XXX | |
92230 | A | Eye exam with photos | 0.60 | 1.69 | 0.20 | 0.02 | 2.31 | 0.82 | XXX | |
92235 | A | Eye exam with photos | 0.81 | 2.61 | NA | 0.07 | 3.49 | NA | XXX | |
92235 | 26 | A | Eye exam with photos | 0.81 | 0.38 | 0.38 | 0.02 | 1.21 | 1.21 | XXX |
92235 | TC | A | Eye exam with photos | 0.00 | 2.23 | NA | 0.05 | 2.28 | NA | XXX |
92240 | A | Icg angiography | 1.10 | 5.09 | NA | 0.07 | 6.26 | NA | XXX | |
92240 | 26 | A | Icg angiography | 1.10 | 0.51 | 0.51 | 0.02 | 1.63 | 1.63 | XXX |
92240 | TC | A | Icg angiography | 0.00 | 4.58 | NA | 0.05 | 4.63 | NA | XXX |
92250 | A | Eye exam with photos | 0.44 | 1.49 | NA | 0.02 | 1.95 | NA | XXX | |
92250 | 26 | A | Eye exam with photos | 0.44 | 0.20 | 0.20 | 0.01 | 0.65 | 0.65 | XXX |
92250 | TC | A | Eye exam with photos | 0.00 | 1.29 | NA | 0.01 | 1.30 | NA | XXX |
92260 | A | Ophthalmoscopy/dynamometry | 0.20 | 0.24 | 0.09 | 0.01 | 0.45 | 0.30 | XXX | |
92265 | A | Eye muscle evaluation | 0.81 | 1.89 | NA | 0.04 | 2.74 | NA | XXX | |
92265 | 26 | A | Eye muscle evaluation | 0.81 | 0.29 | 0.29 | 0.02 | 1.12 | 1.12 | XXX |
92265 | TC | A | Eye muscle evaluation | 0.00 | 1.60 | NA | 0.02 | 1.62 | NA | XXX |
92270 | A | Electro-oculography | 0.81 | 1.76 | NA | 0.05 | 2.62 | NA | XXX | |
92270 | 26 | A | Electro-oculography | 0.81 | 0.35 | 0.35 | 0.03 | 1.19 | 1.19 | XXX |
92270 | TC | A | Electro-oculography | 0.00 | 1.41 | NA | 0.02 | 1.43 | NA | XXX |
92275 | A | Electroretinography | 1.01 | 1.98 | NA | 0.04 | 3.03 | NA | XXX | |
92275 | 26 | A | Electroretinography | 1.01 | 0.44 | 0.44 | 0.02 | 1.47 | 1.47 | XXX |
92275 | TC | A | Electroretinography | 0.00 | 1.54 | NA | 0.02 | 1.56 | NA | XXX |
92283 | A | Color vision examination | 0.17 | 0.86 | NA | 0.02 | 1.05 | NA | XXX | |
92283 | 26 | A | Color vision examination | 0.17 | 0.07 | 0.07 | 0.01 | 0.25 | 0.25 | XXX |
92283 | TC | A | Color vision examination | 0.00 | 0.79 | NA | 0.01 | 0.80 | NA | XXX |
92284 | A | Dark adaptation eye exam | 0.24 | 2.28 | NA | 0.02 | 2.54 | NA | XXX | |
92284 | 26 | A | Dark adaptation eye exam | 0.24 | 0.09 | 0.09 | 0.01 | 0.34 | 0.34 | XXX |
92284 | TC | A | Dark adaptation eye exam | 0.00 | 2.19 | NA | 0.01 | 2.20 | NA | XXX |
92285 | A | Eye photography | 0.20 | 0.85 | NA | 0.02 | 1.07 | NA | XXX | |
92285 | 26 | A | Eye photography | 0.20 | 0.09 | 0.09 | 0.01 | 0.30 | 0.30 | XXX |
92285 | TC | A | Eye photography | 0.00 | 0.76 | NA | 0.01 | 0.77 | NA | XXX |
92286 | A | Internal eye photography | 0.66 | 2.86 | NA | 0.03 | 3.55 | NA | XXX | |
92286 | 26 | A | Internal eye photography | 0.66 | 0.30 | 0.30 | 0.01 | 0.97 | 0.97 | XXX |
92286 | TC | A | Internal eye photography | 0.00 | 2.56 | NA | 0.02 | 2.58 | NA | XXX |
92287 | A | Internal eye photography | 0.81 | 2.70 | 0.32 | 0.02 | 3.53 | 1.15 | XXX | |
92310 | N | Contact lens fitting | +1.17 | 1.13 | 0.46 | 0.03 | 2.33 | 1.66 | XXX | |
92311 | A | Contact lens fitting | 1.08 | 1.14 | 0.36 | 0.03 | 2.25 | 1.47 | XXX | |
92312 | A | Contact lens fitting | 1.26 | 1.13 | 0.51 | 0.03 | 2.42 | 1.80 | XXX | |
92313 | A | Contact lens fitting | 0.92 | 1.11 | 0.29 | 0.02 | 2.05 | 1.23 | XXX | |
92314 | N | Prescription of contact lens | +0.69 | 0.95 | 0.27 | 0.01 | 1.65 | 0.97 | XXX | |
92315 | A | Prescription of contact lens | 0.45 | 0.90 | 0.17 | 0.01 | 1.36 | 0.63 | XXX | |
92316 | A | Prescription of contact lens | 0.68 | 0.96 | 0.30 | 0.01 | 1.65 | 0.99 | XXX | |
92317 | A | Prescription of contact lens | 0.45 | 0.99 | 0.14 | 0.01 | 1.45 | 0.60 | XXX | |
92325 | A | Modification of contact lens | 0.00 | 0.40 | NA | 0.01 | 0.41 | NA | XXX | |
92326 | A | Replacement of contact lens | 0.00 | 1.62 | NA | 0.05 | 1.67 | NA | XXX | |
92330 | A | Fitting of artificial eye | 1.08 | 1.03 | 0.33 | 0.04 | 2.15 | 1.45 | XXX | |
92335 | A | Fitting of artificial eye | 0.45 | 0.96 | 0.17 | 0.01 | 1.42 | 0.63 | XXX | |
92340 | N | Fitting of spectacles | +0.37 | 0.71 | 0.14 | 0.01 | 1.09 | 0.52 | XXX | |
92341 | N | Fitting of spectacles | +0.47 | 0.75 | 0.18 | 0.01 | 1.23 | 0.66 | XXX | |
92342 | N | Fitting of spectacles | +0.53 | 0.77 | 0.21 | 0.01 | 1.31 | 0.75 | XXX | |
92352 | B | Special spectacles fitting | +0.37 | 0.71 | 0.14 | 0.01 | 1.09 | 0.52 | XXX | |
92353 | B | Special spectacles fitting | +0.50 | 0.76 | 0.20 | 0.02 | 1.28 | 0.72 | XXX | |
92354 | B | Special spectacles fitting | +0.00 | 8.82 | NA | 0.08 | 8.90 | NA | XXX | |
92355 | B | Special spectacles fitting | +0.00 | 4.31 | NA | 0.01 | 4.32 | NA | XXX | |
92358 | B | Eye prosthesis service | +0.00 | 0.97 | NA | 0.04 | 1.01 | NA | XXX | |
92370 | N | Repair adjust spectacles | +0.32 | 0.56 | 0.13 | 0.02 | 0.90 | 0.47 | XXX | |
92371 | B | Repair adjust spectacles | +0.00 | 0.62 | NA | 0.02 | 0.64 | NA | XXX | |
92390 | N | Supply of spectacles | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
92391 | N | Supply of contact lenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
92392 | I | Supply of low vision aids | +0.00 | 3.84 | 3.84 | 0.02 | 3.86 | 3.86 | XXX | |
92393 | I | Supply of artificial eye | +0.00 | 11.92 | 11.92 | 0.47 | 12.39 | 12.39 | XXX | |
92395 | I | Supply of spectacles | +0.00 | 1.30 | 1.30 | 0.08 | 1.38 | 1.38 | XXX | |
92396 | I | Supply of contact lenses | +0.00 | 2.19 | 2.19 | 0.06 | 2.25 | 2.25 | XXX | |
92499 | C | Eye service or procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
92499 | 26 | C | Eye service or procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
92499 | TC | C | Eye service or procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
92502 | A | Ear and throat examination | 1.51 | NA | 1.24 | 0.06 | NA | 2.81 | 000 | |
92504 | A | Ear microscopy examination | 0.18 | 0.51 | 0.09 | 0.01 | 0.70 | 0.28 | XXX | |
92506 | A | Speech/hearing evaluation | 0.86 | 1.63 | 0.41 | 0.04 | 2.53 | 1.31 | XXX | |
92507 | A | Speech/hearing therapy | 0.52 | 1.56 | 0.24 | 0.02 | 2.10 | 0.78 | XXX | |
92508 | A | Speech/hearing therapy | 0.26 | 1.45 | 0.12 | 0.01 | 1.72 | 0.39 | XXX | |
92510 | I | Rehab for ear implant | +1.50 | 2.11 | 0.83 | 0.06 | 3.67 | 2.39 | XXX | |
92511 | A | Nasopharyngoscopy | 0.84 | 1.38 | 0.42 | 0.03 | 2.25 | 1.29 | 000 | |
92512 | A | Nasal function studies | 0.55 | 1.10 | 0.18 | 0.02 | 1.67 | 0.75 | XXX | |
92516 | A | Facial nerve function test | 0.43 | 0.97 | 0.22 | 0.02 | 1.42 | 0.67 | XXX | |
92520 | A | Laryngeal function studies | 0.76 | 0.55 | 0.40 | 0.03 | 1.34 | 1.19 | XXX | |
92525 | F | Oral function evaluation | +0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
92526 | A | Oral function therapy | 0.55 | 1.62 | 0.21 | 0.02 | 2.19 | 0.78 | XXX | |
92531 | B | Spontaneous nystagmus study | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
92532 | B | Positional nystagmus test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
92533 | B | Caloric vestibular test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
92534 | B | Optokinetic nystagmus test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
92541 | A | Spontaneous nystagmus test | 0.40 | 1.11 | NA | 0.04 | 1.55 | NA | XXX | |
92541 | 26 | A | Spontaneous nystagmus test | 0.40 | 0.20 | 0.20 | 0.02 | 0.62 | 0.62 | XXX |
92541 | TC | A | Spontaneous nystagmus test | 0.00 | 0.91 | NA | 0.02 | 0.93 | NA | XXX |
92542 | A | Positional nystagmus test | 0.33 | 1.20 | NA | 0.03 | 1.56 | NA | XXX | |
92542 | 26 | A | Positional nystagmus test | 0.33 | 0.16 | 0.16 | 0.01 | 0.50 | 0.50 | XXX |
92542 | TC | A | Positional nystagmus test | 0.00 | 1.04 | NA | 0.02 | 1.06 | NA | XXX |
92543 | A | Caloric vestibular test | 0.10 | 0.63 | NA | 0.02 | 0.75 | NA | XXX | |
92543 | 26 | A | Caloric vestibular test | 0.10 | 0.05 | 0.05 | 0.01 | 0.16 | 0.16 | XXX |
92543 | TC | A | Caloric vestibular test | 0.00 | 0.58 | NA | 0.01 | 0.59 | NA | XXX |
92544 | A | Optokinetic nystagmus test | 0.26 | 0.97 | NA | 0.03 | 1.26 | NA | XXX | |
92544 | 26 | A | Optokinetic nystagmus test | 0.26 | 0.13 | 0.13 | 0.01 | 0.40 | 0.40 | XXX |
92544 | TC | A | Optokinetic nystagmus test | 0.00 | 0.84 | NA | 0.02 | 0.86 | NA | XXX |
92545 | A | Oscillating tracking test | 0.23 | 0.90 | NA | 0.03 | 1.16 | NA | XXX | |
92545 | 26 | A | Oscillating tracking test | 0.23 | 0.11 | 0.11 | 0.01 | 0.35 | 0.35 | XXX |
92545 | TC | A | Oscillating tracking test | 0.00 | 0.79 | NA | 0.02 | 0.81 | NA | XXX |
92546 | A | Sinusoidal rotational test | 0.29 | 2.25 | NA | 0.03 | 2.57 | NA | XXX | |
92546 | 26 | A | Sinusoidal rotational test | 0.29 | 0.14 | 0.14 | 0.01 | 0.44 | 0.44 | XXX |
92546 | TC | A | Sinusoidal rotational test | 0.00 | 2.11 | NA | 0.02 | 2.13 | NA | XXX |
92547 | A | Supplemental electrical test | 0.00 | 1.34 | NA | 0.05 | 1.39 | NA | ZZZ | |
92548 | A | Posturography | 0.50 | 3.98 | NA | 0.13 | 4.61 | NA | XXX | |
92548 | 26 | A | Posturography | 0.50 | 0.27 | 0.27 | 0.02 | 0.79 | 0.79 | XXX |
92548 | TC | A | Posturography | 0.00 | 3.71 | NA | 0.11 | 3.82 | NA | XXX |
92551 | N | Pure tone hearing test, air | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
92552 | A | Pure tone audiometry, air | 0.00 | 0.45 | NA | 0.03 | 0.48 | NA | XXX | |
92553 | A | Audiometry, air bone | 0.00 | 0.66 | NA | 0.05 | 0.71 | NA | XXX | |
92555 | A | Speech threshold audiometry | 0.00 | 0.38 | NA | 0.03 | 0.41 | NA | XXX | |
92556 | A | Speech audiometry, complete | 0.00 | 0.57 | NA | 0.05 | 0.62 | NA | XXX | |
92557 | A | Comprehensive hearing test | 0.00 | 1.18 | NA | 0.10 | 1.28 | NA | XXX | |
92559 | N | Group audiometric testing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
92560 | N | Bekesy audiometry, screen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
92561 | A | Bekesy audiometry, diagnosis | 0.00 | 0.72 | NA | 0.05 | 0.77 | NA | XXX | |
92562 | A | Loudness balance test | 0.00 | 0.41 | NA | 0.03 | 0.44 | NA | XXX | |
92563 | A | Tone decay hearing test | 0.00 | 0.38 | NA | 0.03 | 0.41 | NA | XXX | |
92564 | A | Sisi hearing test | 0.00 | 0.47 | NA | 0.04 | 0.51 | NA | XXX | |
92565 | A | Stenger test, pure tone | 0.00 | 0.40 | NA | 0.03 | 0.43 | NA | XXX | |
92567 | A | Tympanometry | 0.00 | 0.52 | NA | 0.05 | 0.57 | NA | XXX | |
92568 | A | Acoustic reflex testing | 0.00 | 0.38 | NA | 0.03 | 0.41 | NA | XXX | |
92569 | A | Acoustic reflex decay test | 0.00 | 0.41 | NA | 0.03 | 0.44 | NA | XXX | |
92571 | A | Filtered speech hearing test | 0.00 | 0.39 | NA | 0.03 | 0.42 | NA | XXX | |
92572 | A | Staggered spondaic word test | 0.00 | 0.09 | NA | 0.01 | 0.10 | NA | XXX | |
92573 | A | Lombard test | 0.00 | 0.35 | NA | 0.03 | 0.38 | NA | XXX | |
92575 | A | Sensorineural acuity test | 0.00 | 0.30 | NA | 0.02 | 0.32 | NA | XXX | |
92576 | A | Synthetic sentence test | 0.00 | 0.45 | NA | 0.04 | 0.49 | NA | XXX | |
92577 | A | Stenger test, speech | 0.00 | 0.72 | NA | 0.06 | 0.78 | NA | XXX | |
92579 | A | Visual audiometry (vra) | 0.00 | 0.73 | NA | 0.05 | 0.78 | NA | XXX | |
92582 | A | Conditioning play audiometry | 0.00 | 0.73 | NA | 0.05 | 0.78 | NA | XXX | |
92583 | A | Select picture audiometry | 0.00 | 0.89 | NA | 0.07 | 0.96 | NA | XXX | |
92584 | A | Electrocochleography | 0.00 | 2.47 | NA | 0.17 | 2.64 | NA | XXX | |
92585 | A | Auditor evoke potent, compre | 0.50 | 2.06 | NA | 0.14 | 2.70 | NA | XXX | |
92585 | 26 | A | Auditor evoke potent, compre | 0.50 | 0.22 | 0.22 | 0.02 | 0.74 | 0.74 | XXX |
92585 | TC | A | Auditor evoke potent, compre | 0.00 | 1.84 | NA | 0.12 | 1.96 | NA | XXX |
92586 | A | Auditor evoke potent, limit | 0.00 | 1.84 | NA | 0.12 | 1.96 | NA | XXX | |
92587 | A | Evoked auditory test | 0.13 | 1.37 | NA | 0.10 | 1.60 | NA | XXX | |
92587 | 26 | A | Evoked auditory test | 0.13 | 0.07 | 0.07 | 0.01 | 0.21 | 0.21 | XXX |
92587 | TC | A | Evoked auditory test | 0.00 | 1.30 | NA | 0.09 | 1.39 | NA | XXX |
92588 | A | Evoked auditory test | 0.36 | 1.63 | NA | 0.12 | 2.11 | NA | XXX | |
92588 | 26 | A | Evoked auditory test | 0.36 | 0.17 | 0.17 | 0.01 | 0.54 | 0.54 | XXX |
92588 | TC | A | Evoked auditory test | 0.00 | 1.46 | NA | 0.11 | 1.57 | NA | XXX |
92589 | A | Auditory function test(s) | 0.00 | 0.53 | NA | 0.05 | 0.58 | NA | XXX | |
92590 | N | Hearing aid exam, one ear | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
92591 | N | Hearing aid exam, both ears | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
92592 | N | Hearing aid check, one ear | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
92593 | N | Hearing aid check, both ears | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
92594 | N | Electro hearng aid test, one | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
92595 | N | Electro hearng aid tst, both | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
92596 | A | Ear protector evaluation | 0.00 | 0.59 | NA | 0.05 | 0.64 | NA | XXX | |
92597 | I | Oral speech device eval | +1.35 | 1.49 | 0.54 | 0.05 | 2.89 | 1.94 | XXX | |
92598 | F | Modify oral speech device | +0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
92599 | D | ENT procedure/service | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
92599 | 26 | D | ENT procedure/service | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
92599 | TC | D | ENT procedure/service | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
92601 | A | Cochlear implt f/up exam 7 | 0.00 | 3.50 | NA | 0.06 | 3.56 | NA | XXX | |
92602 | A | Reprogram cochlear implt 7 | 0.00 | 2.44 | NA | 0.06 | 2.50 | NA | XXX | |
92603 | A | Cochlear implt f/up exam 7 | 0.00 | 2.34 | NA | 0.06 | 2.40 | NA | XXX | |
92604 | A | Reprogram cochlear implt 7 | 0.00 | 1.58 | NA | 0.06 | 1.64 | NA | XXX | |
92605 | B | Eval for nonspeech device rx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
92606 | B | Non-speech device service | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
92607 | A | Ex for speech device rx, 1hr | 0.00 | 2.93 | NA | 0.04 | 2.97 | NA | XXX | |
92608 | A | Ex for speech device rx addl | 0.00 | 0.55 | NA | 0.04 | 0.59 | NA | XXX | |
92609 | A | Use of speech device service | 0.00 | 1.58 | NA | 0.03 | 1.61 | NA | XXX | |
92610 | A | Evaluate swallowing function | 0.00 | 1.08 | NA | 0.07 | 1.15 | NA | XXX | |
92611 | A | Motion fluoroscopy/swallow | 0.00 | 1.18 | NA | 0.07 | 1.25 | NA | XXX | |
92612 | A | Endoscopy swallow tst (fees) | 1.27 | 3.36 | 0.50 | 0.07 | 4.70 | 1.84 | XXX | |
92613 | B | Endoscopy swallow tst (fees) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
92614 | A | Laryngoscopic sensory test | 1.27 | 2.29 | 0.50 | 0.07 | 3.63 | 1.84 | XXX | |
92615 | B | Eval laryngoscopy sense tst | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
92616 | A | Fees w/laryngeal sense test | 1.88 | 3.02 | 0.73 | 0.07 | 4.97 | 2.68 | XXX | |
92617 | B | Interprt fees/laryngeal test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
92700 | C | Ent procedure/service | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
92950 | A | Heart/lung resuscitation cpr | 3.80 | NA | 1.01 | 0.21 | NA | 5.02 | 000 | |
92953 | A | Temporary external pacing | 0.23 | NA | 0.23 | 0.01 | NA | 0.47 | 000 | |
92960 | A | Cardioversion electric, ext | 2.25 | 2.28 | 0.86 | 0.08 | 4.61 | 3.19 | 000 | |
92961 | A | Cardioversion, electric, int | 4.60 | NA | 1.77 | 0.17 | NA | 6.54 | 000 | |
92970 | A | Cardioassist, internal | 3.52 | NA | 1.08 | 0.17 | NA | 4.77 | 000 | |
92971 | A | Cardioassist, external | 1.77 | NA | 0.88 | 0.06 | NA | 2.71 | 000 | |
92973 | A | Percut coronary thrombectomy | 3.28 | NA | 1.32 | 0.12 | NA | 4.72 | ZZZ | |
92974 | A | Cath place, cardio brachytx | 3.00 | NA | 1.20 | 0.14 | NA | 4.34 | ZZZ | |
92975 | A | Dissolve clot, heart vessel | 7.25 | NA | 2.88 | 0.22 | NA | 10.35 | 000 | |
92977 | A | Dissolve clot, heart vessel | 0.00 | 8.02 | NA | 0.38 | 8.40 | NA | XXX | |
92978 | A | Intravasc us, heart add-on | 1.80 | 5.28 | NA | 0.26 | 7.34 | NA | ZZZ | |
92978 | 26 | A | Intravasc us, heart add-on | 1.80 | 0.73 | 0.73 | 0.06 | 2.59 | 2.59 | ZZZ |
92978 | TC | A | Intravasc us, heart add-on | 0.00 | 4.55 | NA | 0.20 | 4.75 | NA | ZZZ |
92979 | A | Intravasc us, heart add-on | 1.44 | 2.86 | NA | 0.15 | 4.45 | NA | ZZZ | |
92979 | 26 | A | Intravasc us, heart add-on | 1.44 | 0.58 | 0.58 | 0.04 | 2.06 | 2.06 | ZZZ |
92979 | TC | A | Intravasc us, heart add-on | 0.00 | 2.28 | NA | 0.11 | 2.39 | NA | ZZZ |
92980 | A | Insert intracoronary stent | 14.84 | NA | 6.21 | 0.71 | NA | 21.76 | 000 | |
92981 | A | Insert intracoronary stent | 4.17 | NA | 1.68 | 0.20 | NA | 6.05 | ZZZ | |
92982 | A | Coronary artery dilation | 10.98 | NA | 4.66 | 0.52 | NA | 16.16 | 000 | |
92984 | A | Coronary artery dilation | 2.97 | NA | 1.19 | 0.14 | NA | 4.30 | ZZZ | |
92986 | A | Revision of aortic valve | 21.80 | NA | 10.27 | 1.14 | NA | 33.21 | 090 | |
92987 | A | Revision of mitral valve | 22.70 | NA | 10.66 | 1.18 | NA | 34.54 | 090 | |
92990 | A | Revision of pulmonary valve | 17.34 | NA | 8.24 | 0.90 | NA | 26.48 | 090 | |
92992 | C | Revision of heart chamber | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 090 | |
92993 | C | Revision of heart chamber | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 090 | |
92995 | A | Coronary atherectomy | 12.09 | NA | 5.10 | 0.58 | NA | 17.77 | 000 | |
92996 | A | Coronary atherectomy add-on | 3.26 | NA | 1.30 | 0.16 | NA | 4.72 | ZZZ | |
92997 | A | Pul art balloon repr, percut | 12.00 | NA | 4.96 | 0.63 | NA | 17.59 | 000 | |
92998 | A | Pul art balloon repr, percut | 6.00 | NA | 2.26 | 0.31 | NA | 8.57 | ZZZ | |
93000 | A | Electrocardiogram, complete | 0.17 | 0.51 | NA | 0.03 | 0.71 | NA | XXX | |
93005 | A | Electrocardiogram, tracing | 0.00 | 0.45 | NA | 0.02 | 0.47 | NA | XXX | |
93010 | A | Electrocardiogram report | 0.17 | 0.06 | 0.06 | 0.01 | 0.24 | 0.24 | XXX | |
93012 | A | Transmission of ecg | 0.00 | 2.35 | NA | 0.15 | 2.50 | NA | XXX | |
93014 | A | Report on transmitted ecg | 0.52 | 0.19 | 0.19 | 0.02 | 0.73 | 0.73 | XXX | |
93015 | A | Cardiovascular stress test | 0.75 | 1.97 | NA | 0.11 | 2.83 | NA | XXX | |
93016 | A | Cardiovascular stress test | 0.45 | 0.18 | 0.18 | 0.01 | 0.64 | 0.64 | XXX | |
93017 | A | Cardiovascular stress test | 0.00 | 1.67 | NA | 0.09 | 1.76 | NA | XXX | |
93018 | A | Cardiovascular stress test | 0.30 | 0.12 | 0.12 | 0.01 | 0.43 | 0.43 | XXX | |
93024 | A | Cardiac drug stress test | 1.17 | 1.57 | NA | 0.11 | 2.85 | NA | XXX | |
93024 | 26 | A | Cardiac drug stress test | 1.17 | 0.46 | 0.46 | 0.04 | 1.67 | 1.67 | XXX |
93024 | TC | A | Cardiac drug stress test | 0.00 | 1.11 | NA | 0.07 | 1.18 | NA | XXX |
93025 | A | Microvolt t-wave assess | 0.75 | 10.73 | NA | 0.11 | 11.59 | NA | XXX | |
93025 | 26 | A | Microvolt t-wave assess | 0.75 | 0.31 | 0.31 | 0.02 | 1.08 | 1.08 | XXX |
93025 | TC | A | Microvolt t-wave assess | 0.00 | 10.42 | NA | 0.09 | 10.51 | NA | XXX |
93040 | A | Rhythm ECG with report | 0.16 | 0.20 | NA | 0.02 | 0.38 | NA | XXX | |
93041 | A | Rhythm ECG, tracing | 0.00 | 0.15 | NA | 0.01 | 0.16 | NA | XXX | |
93042 | A | Rhythm ECG, report | 0.16 | 0.05 | 0.05 | 0.01 | 0.22 | 0.22 | XXX | |
93224 | A | ECG monitor/report, 24 hrs | 0.52 | 3.61 | NA | 0.21 | 4.34 | NA | XXX | |
93225 | A | ECG monitor/record, 24 hrs | 0.00 | 1.23 | NA | 0.07 | 1.30 | NA | XXX | |
93226 | A | ECG monitor/report, 24 hrs | 0.00 | 2.18 | NA | 0.12 | 2.30 | NA | XXX | |
93227 | A | ECG monitor/review, 24 hrs | 0.52 | 0.20 | 0.20 | 0.02 | 0.74 | 0.74 | XXX | |
93230 | A | ECG monitor/report, 24 hrs | 0.52 | 3.88 | NA | 0.22 | 4.62 | NA | XXX | |
93231 | A | Ecg monitor/record, 24 hrs | 0.00 | 1.51 | NA | 0.09 | 1.60 | NA | XXX | |
93232 | A | ECG monitor/report, 24 hrs | 0.00 | 2.17 | NA | 0.11 | 2.28 | NA | XXX | |
93233 | A | ECG monitor/review, 24 hrs | 0.52 | 0.20 | 0.20 | 0.02 | 0.74 | 0.74 | XXX | |
93235 | A | ECG monitor/report, 24 hrs | 0.45 | 2.78 | NA | 0.13 | 3.36 | NA | XXX | |
93236 | A | ECG monitor/report, 24 hrs | 0.00 | 2.61 | NA | 0.12 | 2.73 | NA | XXX | |
93237 | A | ECG monitor/review, 24 hrs | 0.45 | 0.17 | 0.17 | 0.01 | 0.63 | 0.63 | XXX | |
93268 | A | ECG record/review | 0.52 | 7.41 | NA | 0.24 | 8.17 | NA | XXX | |
93270 | A | ECG recording | 0.00 | 1.23 | NA | 0.07 | 1.30 | NA | XXX | |
93271 | A | Ecg/monitoring and analysis | 0.00 | 5.99 | NA | 0.15 | 6.14 | NA | XXX | |
93272 | A | Ecg/review, interpret only | 0.52 | 0.19 | 0.19 | 0.02 | 0.73 | 0.73 | XXX | |
93278 | A | ECG/signal-averaged | 0.25 | 1.24 | NA | 0.10 | 1.59 | NA | XXX | |
93278 | 26 | A | ECG/signal-averaged | 0.25 | 0.10 | 0.10 | 0.01 | 0.36 | 0.36 | XXX |
93278 | TC | A | ECG/signal-averaged | 0.00 | 1.14 | NA | 0.09 | 1.23 | NA | XXX |
93303 | A | Echo transthoracic | 1.30 | 4.33 | NA | 0.23 | 5.86 | NA | XXX | |
93303 | 26 | A | Echo transthoracic | 1.30 | 0.49 | 0.49 | 0.04 | 1.83 | 1.83 | XXX |
93303 | TC | A | Echo transthoracic | 0.00 | 3.84 | NA | 0.19 | 4.03 | NA | XXX |
93304 | A | Echo transthoracic | 0.75 | 2.22 | NA | 0.13 | 3.10 | NA | XXX | |
93304 | 26 | A | Echo transthoracic | 0.75 | 0.29 | 0.29 | 0.02 | 1.06 | 1.06 | XXX |
93304 | TC | A | Echo transthoracic | 0.00 | 1.93 | NA | 0.11 | 2.04 | NA | XXX |
93307 | A | Echo exam of heart | 0.92 | 4.20 | NA | 0.22 | 5.34 | NA | XXX | |
93307 | 26 | A | Echo exam of heart | 0.92 | 0.36 | 0.36 | 0.03 | 1.31 | 1.31 | XXX |
93307 | TC | A | Echo exam of heart | 0.00 | 3.84 | NA | 0.19 | 4.03 | NA | XXX |
93308 | A | Echo exam of heart | 0.53 | 2.14 | NA | 0.13 | 2.80 | NA | XXX | |
93308 | 26 | A | Echo exam of heart | 0.53 | 0.21 | 0.21 | 0.02 | 0.76 | 0.76 | XXX |
93308 | TC | A | Echo exam of heart | 0.00 | 1.93 | NA | 0.11 | 2.04 | NA | XXX |
93312 | A | Echo transesophageal | 2.20 | 4.57 | NA | 0.32 | 7.09 | NA | XXX | |
93312 | 26 | A | Echo transesophageal | 2.20 | 0.81 | 0.81 | 0.08 | 3.09 | 3.09 | XXX |
93312 | TC | A | Echo transesophageal | 0.00 | 3.76 | NA | 0.24 | 4.00 | NA | XXX |
93313 | A | Echo transesophageal | 0.95 | 0.22 | 0.21 | 0.05 | 1.22 | 1.21 | XXX | |
93314 | A | Echo transesophageal | 1.25 | 4.24 | NA | 0.28 | 5.77 | NA | XXX | |
93314 | 26 | A | Echo transesophageal | 1.25 | 0.48 | 0.48 | 0.04 | 1.77 | 1.77 | XXX |
93314 | TC | A | Echo transesophageal | 0.00 | 3.76 | NA | 0.24 | 4.00 | NA | XXX |
93315 | A | Echo transesophageal | 2.78 | 4.79 | NA | 0.34 | 7.91 | NA | XXX | |
93315 | 26 | A | Echo transesophageal | 2.78 | 1.03 | 1.03 | 0.10 | 3.91 | 3.91 | XXX |
93315 | TC | A | Echo transesophageal | 0.00 | 3.76 | NA | 0.24 | 4.00 | NA | XXX |
93316 | A | Echo transesophageal | 0.95 | NA | 0.24 | 0.05 | NA | 1.24 | XXX | |
93317 | A | Echo transesophageal | 1.83 | 4.45 | NA | 0.30 | 6.58 | NA | XXX | |
93317 | 26 | A | Echo transesophageal | 1.83 | 0.69 | 0.69 | 0.06 | 2.58 | 2.58 | XXX |
93317 | TC | A | Echo transesophageal | 0.00 | 3.76 | NA | 0.24 | 4.00 | NA | XXX |
93318 | C | Echo transesophageal intraop | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
93318 | 26 | A | Echo transesophageal intraop | 2.20 | 0.49 | NA | 0.06 | 2.75 | NA | XXX |
93318 | TC | C | Echo transesophageal intraop | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
93320 | A | Doppler echo exam, heart | 0.38 | 1.85 | NA | 0.11 | 2.34 | NA | ZZZ | |
93320 | 26 | A | Doppler echo exam, heart | 0.38 | 0.15 | 0.15 | 0.01 | 0.54 | 0.54 | ZZZ |
93320 | TC | A | Doppler echo exam, heart | 0.00 | 1.70 | NA | 0.10 | 1.80 | NA | ZZZ |
93321 | A | Doppler echo exam, heart | 0.15 | 1.16 | NA | 0.08 | 1.39 | NA | ZZZ | |
93321 | 26 | A | Doppler echo exam, heart | 0.15 | 0.06 | 0.06 | 0.01 | 0.22 | 0.22 | ZZZ |
93321 | TC | A | Doppler echo exam, heart | 0.00 | 1.10 | NA | 0.07 | 1.17 | NA | ZZZ |
93325 | A | Doppler color flow add-on | 0.07 | 2.92 | NA | 0.18 | 3.17 | NA | ZZZ | |
93325 | 26 | A | Doppler color flow add-on | 0.07 | 0.03 | 0.03 | 0.01 | 0.11 | 0.11 | ZZZ |
93325 | TC | A | Doppler color flow add-on | 0.00 | 2.89 | NA | 0.17 | 3.06 | NA | ZZZ |
93350 | A | Echo transthoracic | 1.48 | 2.33 | NA | 0.13 | 3.94 | NA | XXX | |
93350 | 26 | A | Echo transthoracic | 1.48 | 0.58 | 0.58 | 0.02 | 2.08 | 2.08 | XXX |
93350 | TC | A | Echo transthoracic | 0.00 | 1.75 | NA | 0.11 | 1.86 | NA | XXX |
93501 | A | Right heart catheterization | 3.02 | 18.01 | NA | 1.03 | 22.06 | NA | 000 | |
93501 | 26 | A | Right heart catheterization | 3.02 | 1.18 | 1.18 | 0.16 | 4.36 | 4.36 | 000 |
93501 | TC | A | Right heart catheterization | 0.00 | 16.83 | NA | 0.87 | 17.70 | NA | 000 |
93503 | A | Insert/place heart catheter | 2.91 | NA | 0.69 | 0.16 | NA | 3.76 | 000 | |
93505 | A | Biopsy of heart lining | 4.38 | 3.69 | NA | 0.36 | 8.43 | NA | 000 | |
93505 | 26 | A | Biopsy of heart lining | 4.38 | 1.72 | 1.72 | 0.23 | 6.33 | 6.33 | 000 |
93505 | TC | A | Biopsy of heart lining | 0.00 | 1.97 | NA | 0.13 | 2.10 | NA | 000 |
93508 | A | Cath placement, angiography | 4.10 | 14.19 | NA | 0.75 | 19.04 | NA | 000 | |
93508 | 26 | A | Cath placement, angiography | 4.10 | 1.64 | 1.64 | 0.21 | 5.95 | 5.95 | 000 |
93508 | TC | A | Cath placement, angiography | 0.00 | 12.55 | NA | 0.54 | 13.09 | NA | 000 |
93510 | A | Left heart catheterization | 4.33 | 38.53 | NA | 2.13 | 44.99 | NA | 000 | |
93510 | 26 | A | Left heart catheterization | 4.33 | 1.74 | 1.74 | 0.22 | 6.29 | 6.29 | 000 |
93510 | TC | A | Left heart catheterization | 0.00 | 36.79 | NA | 1.91 | 38.70 | NA | 000 |
93511 | A | Left heart catheterization | 5.03 | 37.84 | NA | 2.11 | 44.98 | NA | 000 | |
93511 | 26 | A | Left heart catheterization | 5.03 | 2.02 | 2.02 | 0.26 | 7.31 | 7.31 | 000 |
93511 | TC | A | Left heart catheterization | 0.00 | 35.82 | NA | 1.85 | 37.67 | NA | 000 |
93514 | A | Left heart catheterization | 7.05 | 38.58 | NA | 2.22 | 47.85 | NA | 000 | |
93514 | 26 | A | Left heart catheterization | 7.05 | 2.76 | 2.76 | 0.37 | 10.18 | 10.18 | 000 |
93514 | TC | A | Left heart catheterization | 0.00 | 35.82 | NA | 1.85 | 37.67 | NA | 000 |
93524 | A | Left heart catheterization | 6.95 | 49.57 | NA | 2.79 | 59.31 | NA | 000 | |
93524 | 26 | A | Left heart catheterization | 6.95 | 2.77 | 2.77 | 0.36 | 10.08 | 10.08 | 000 |
93524 | TC | A | Left heart catheterization | 0.00 | 46.80 | NA | 2.43 | 49.23 | NA | 000 |
93526 | A | Rt Lt heart catheters | 5.99 | 50.48 | NA | 2.81 | 59.28 | NA | 000 | |
93526 | 26 | A | Rt Lt heart catheters | 5.99 | 2.40 | 2.40 | 0.31 | 8.70 | 8.70 | 000 |
93526 | TC | A | Rt Lt heart catheters | 0.00 | 48.08 | NA | 2.50 | 50.58 | NA | 000 |
93527 | A | Rt Lt heart catheters | 7.28 | 49.72 | NA | 2.81 | 59.81 | NA | 000 | |
93527 | 26 | A | Rt Lt heart catheters | 7.28 | 2.92 | 2.92 | 0.38 | 10.58 | 10.58 | 000 |
93527 | TC | A | Rt Lt heart catheters | 0.00 | 46.80 | NA | 2.43 | 49.23 | NA | 000 |
93528 | A | Rt Lt heart catheters | 9.00 | 50.44 | NA | 2.90 | 62.34 | NA | 000 | |
93528 | 26 | A | Rt Lt heart catheters | 9.00 | 3.64 | 3.64 | 0.47 | 13.11 | 13.11 | 000 |
93528 | TC | A | Rt Lt heart catheters | 0.00 | 46.80 | NA | 2.43 | 49.23 | NA | 000 |
93529 | A | Rt, lt heart catheterization | 4.80 | 48.67 | NA | 2.68 | 56.15 | NA | 000 | |
93529 | 26 | A | Rt, lt heart catheterization | 4.80 | 1.87 | 1.87 | 0.25 | 6.92 | 6.92 | 000 |
93529 | TC | A | Rt, lt heart catheterization | 0.00 | 46.80 | NA | 2.43 | 49.23 | NA | 000 |
93530 | A | Rt heart cath, congenital | 4.23 | 18.37 | NA | 1.11 | 23.71 | NA | 000 | |
93530 | 26 | A | Rt heart cath, congenital | 4.23 | 1.54 | 1.54 | 0.24 | 6.01 | 6.01 | 000 |
93530 | TC | A | Rt heart cath, congenital | 0.00 | 16.83 | NA | 0.87 | 17.70 | NA | 000 |
93531 | A | R l heart cath, congenital | 8.35 | 51.30 | NA | 2.96 | 62.61 | NA | 000 | |
93531 | 26 | A | R l heart cath, congenital | 8.35 | 3.22 | 3.22 | 0.46 | 12.03 | 12.03 | 000 |
93531 | TC | A | R l heart cath, congenital | 0.00 | 48.08 | NA | 2.50 | 50.58 | NA | 000 |
93532 | A | R l heart cath, congenital | 10.00 | 50.70 | NA | 2.95 | 63.65 | NA | 000 | |
93532 | 26 | A | R l heart cath, congenital | 10.00 | 3.90 | 3.90 | 0.52 | 14.42 | 14.42 | 000 |
93532 | TC | A | R l heart cath, congenital | 0.00 | 46.80 | NA | 2.43 | 49.23 | NA | 000 |
93533 | A | R l heart cath, congenital | 6.70 | 49.24 | NA | 2.86 | 58.80 | NA | 000 | |
93533 | 26 | A | R l heart cath, congenital | 6.70 | 2.44 | 2.44 | 0.43 | 9.57 | 9.57 | 000 |
93533 | TC | A | R l heart cath, congenital | 0.00 | 46.80 | NA | 2.43 | 49.23 | NA | 000 |
93539 | A | Injection, cardiac cath | 0.40 | 0.16 | 0.16 | 0.01 | 0.57 | 0.57 | 000 | |
93540 | A | Injection, cardiac cath | 0.43 | 0.17 | 0.17 | 0.01 | 0.61 | 0.61 | 000 | |
93541 | A | Injection for lung angiogram | 0.29 | NA | 0.12 | 0.01 | NA | 0.42 | 000 | |
93542 | A | Injection for heart x-rays | 0.29 | NA | 0.12 | 0.01 | NA | 0.42 | 000 | |
93543 | A | Injection for heart x-rays | 0.29 | 0.12 | 0.12 | 0.01 | 0.42 | 0.42 | 000 | |
93544 | A | Injection for aortography | 0.25 | 0.10 | 0.10 | 0.01 | 0.36 | 0.36 | 000 | |
93545 | A | Inject for coronary x-rays | 0.40 | 0.16 | 0.16 | 0.01 | 0.57 | 0.57 | 000 | |
93555 | A | Imaging, cardiac cath | 0.81 | 6.58 | NA | 0.31 | 7.70 | NA | XXX | |
93555 | 26 | A | Imaging, cardiac cath | 0.81 | 0.33 | 0.33 | 0.03 | 1.17 | 1.17 | XXX |
93555 | TC | A | Imaging, cardiac cath | 0.00 | 6.25 | NA | 0.28 | 6.53 | NA | XXX |
93556 | A | Imaging, cardiac cath | 0.83 | 10.18 | NA | 0.45 | 11.46 | NA | XXX | |
93556 | 26 | A | Imaging, cardiac cath | 0.83 | 0.33 | 0.33 | 0.03 | 1.19 | 1.19 | XXX |
93556 | TC | A | Imaging, cardiac cath | 0.00 | 9.85 | NA | 0.42 | 10.27 | NA | XXX |
93561 | A | Cardiac output measurement | 0.50 | 0.68 | NA | 0.07 | 1.25 | NA | 000 | |
93561 | 26 | A | Cardiac output measurement | 0.50 | 0.16 | 0.16 | 0.02 | 0.68 | 0.68 | 000 |
93561 | TC | A | Cardiac output measurement | 0.00 | 0.52 | NA | 0.05 | 0.57 | NA | 000 |
93562 | A | Cardiac output measurement | 0.16 | 0.37 | NA | 0.04 | 0.57 | NA | 000 | |
93562 | 26 | A | Cardiac output measurement | 0.16 | 0.05 | 0.05 | 0.01 | 0.22 | 0.22 | 000 |
93562 | TC | A | Cardiac output measurement | 0.00 | 0.32 | NA | 0.03 | 0.35 | NA | 000 |
93571 | A | Heart flow reserve measure | 1.80 | 5.25 | NA | 0.31 | 7.36 | NA | ZZZ | |
93571 | 26 | A | Heart flow reserve measure | 1.80 | 0.70 | 0.70 | 0.11 | 2.61 | 2.61 | ZZZ |
93571 | TC | A | Heart flow reserve measure | 0.00 | 4.55 | NA | 0.20 | 4.75 | NA | ZZZ |
93572 | A | Heart flow reserve measure | 1.44 | 2.78 | NA | 0.28 | 4.50 | NA | ZZZ | |
93572 | 26 | A | Heart flow reserve measure | 1.44 | 0.50 | 0.50 | 0.17 | 2.11 | 2.11 | ZZZ |
93572 | TC | A | Heart flow reserve measure | 0.00 | 2.28 | NA | 0.11 | 2.39 | NA | ZZZ |
93580 | A | Transcath closure of asd | 18.00 | NA | 7.34 | 1.14 | NA | 26.48 | 000 | |
93581 | A | Transcath closure of vsd | 24.43 | NA | 9.84 | 1.14 | NA | 35.41 | 000 | |
93600 | A | Bundle of His recording | 2.12 | 2.79 | NA | 0.22 | 5.13 | NA | 000 | |
93600 | 26 | A | Bundle of His recording | 2.12 | 0.85 | 0.85 | 0.11 | 3.08 | 3.08 | 000 |
93600 | TC | A | Bundle of His recording | 0.00 | 1.94 | NA | 0.11 | 2.05 | NA | 000 |
93602 | A | Intra-atrial recording | 2.12 | 1.94 | NA | 0.18 | 4.24 | NA | 000 | |
93602 | 26 | A | Intra-atrial recording | 2.12 | 0.84 | 0.84 | 0.12 | 3.08 | 3.08 | 000 |
93602 | TC | A | Intra-atrial recording | 0.00 | 1.10 | NA | 0.06 | 1.16 | NA | 000 |
93603 | A | Right ventricular recording | 2.12 | 2.51 | NA | 0.20 | 4.83 | NA | 000 | |
93603 | 26 | A | Right ventricular recording | 2.12 | 0.84 | 0.84 | 0.11 | 3.07 | 3.07 | 000 |
93603 | TC | A | Right ventricular recording | 0.00 | 1.67 | NA | 0.09 | 1.76 | NA | 000 |
93609 | A | Map tachycardia, add-on | 5.00 | 4.71 | NA | 0.66 | 10.37 | NA | ZZZ | |
93609 | 26 | A | Map tachycardia, add-on | 5.00 | 2.00 | 2.00 | 0.52 | 7.52 | 7.52 | ZZZ |
93609 | TC | A | Map tachycardia, add-on | 0.00 | 2.71 | NA | 0.14 | 2.85 | NA | ZZZ |
93610 | A | Intra-atrial pacing | 3.02 | 2.52 | NA | 0.25 | 5.79 | NA | 000 | |
93610 | 26 | A | Intra-atrial pacing | 3.02 | 1.18 | 1.18 | 0.17 | 4.37 | 4.37 | 000 |
93610 | TC | A | Intra-atrial pacing | 0.00 | 1.34 | NA | 0.08 | 1.42 | NA | 000 |
93612 | A | Intraventricular pacing | 3.02 | 2.79 | NA | 0.26 | 6.07 | NA | 000 | |
93612 | 26 | A | Intraventricular pacing | 3.02 | 1.18 | 1.18 | 0.17 | 4.37 | 4.37 | 000 |
93612 | TC | A | Intraventricular pacing | 0.00 | 1.61 | NA | 0.09 | 1.70 | NA | 000 |
93613 | A | Electrophys map 3d, add-on | 7.00 | 2.72 | 2.72 | 0.52 | 10.24 | 10.24 | ZZZ | |
93615 | A | Esophageal recording | 0.99 | 0.59 | NA | 0.05 | 1.63 | NA | 000 | |
93615 | 26 | A | Esophageal recording | 0.99 | 0.27 | 0.27 | 0.03 | 1.29 | 1.29 | 000 |
93615 | TC | A | Esophageal recording | 0.00 | 0.32 | NA | 0.02 | 0.34 | NA | 000 |
93616 | A | Esophageal recording | 1.49 | 0.76 | NA | 0.08 | 2.33 | NA | 000 | |
93616 | 26 | A | Esophageal recording | 1.49 | 0.44 | 0.44 | 0.06 | 1.99 | 1.99 | 000 |
93616 | TC | A | Esophageal recording | 0.00 | 0.32 | NA | 0.02 | 0.34 | NA | 000 |
93618 | A | Heart rhythm pacing | 4.26 | 5.66 | NA | 0.42 | 10.34 | NA | 000 | |
93618 | 26 | A | Heart rhythm pacing | 4.26 | 1.71 | 1.71 | 0.22 | 6.19 | 6.19 | 000 |
93618 | TC | A | Heart rhythm pacing | 0.00 | 3.95 | NA | 0.20 | 4.15 | NA | 000 |
93619 | A | Electrophysiology evaluation | 7.32 | 10.59 | NA | 0.77 | 18.68 | NA | 000 | |
93619 | 26 | A | Electrophysiology evaluation | 7.32 | 2.92 | 2.92 | 0.38 | 10.62 | 10.62 | 000 |
93619 | TC | A | Electrophysiology evaluation | 0.00 | 7.67 | NA | 0.39 | 8.06 | NA | 000 |
93620 | C | Electrophysiology evaluation | +0.00 | 0.00 | NA | 0.00 | 0.00 | NA | 000 | |
93620 | 26 | A | Electrophysiology evaluation | 11.59 | 4.62 | 4.62 | 0.60 | 16.81 | 16.81 | 000 |
93620 | TC | C | Electrophysiology evaluation | +0.00 | 0.00 | NA | 0.00 | 0.00 | NA | 000 |
93621 | C | Electrophysiology evaluation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | |
93621 | 26 | A | Electrophysiology evaluation | 2.10 | 0.84 | 0.84 | 0.15 | 3.09 | 3.09 | ZZZ |
93621 | TC | C | Electrophysiology evaluation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ |
93622 | C | Electrophysiology evaluation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | |
93622 | 26 | A | Electrophysiology evaluation | 3.10 | 1.23 | 1.23 | 0.67 | 5.00 | 5.00 | ZZZ |
93622 | TC | C | Electrophysiology evaluation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ |
93623 | C | Stimulation, pacing heart | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | |
93623 | 26 | A | Stimulation, pacing heart | 2.85 | 1.13 | 1.13 | 0.15 | 4.13 | 4.13 | ZZZ |
93623 | TC | C | Stimulation, pacing heart | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ |
93624 | A | Electrophysiologic study | 4.81 | 3.88 | NA | 0.36 | 9.05 | NA | 000 | |
93624 | 26 | A | Electrophysiologic study | 4.81 | 1.91 | 1.91 | 0.25 | 6.97 | 6.97 | 000 |
93624 | TC | A | Electrophysiologic study | 0.00 | 1.97 | NA | 0.11 | 2.08 | NA | 000 |
93631 | A | Heart pacing, mapping | 7.60 | 8.93 | NA | 1.17 | 17.70 | NA | 000 | |
93631 | 26 | A | Heart pacing, mapping | 7.60 | 2.81 | 2.81 | 0.66 | 11.07 | 11.07 | 000 |
93631 | TC | A | Heart pacing, mapping | 0.00 | 6.12 | NA | 0.51 | 6.63 | NA | 000 |
93640 | A | Evaluation heart device | 3.52 | 8.53 | NA | 0.53 | 12.58 | NA | 000 | |
93640 | 26 | A | Evaluation heart device | 3.52 | 1.39 | 1.39 | 0.18 | 5.09 | 5.09 | 000 |
93640 | TC | A | Evaluation heart device | 0.00 | 7.14 | NA | 0.35 | 7.49 | NA | 000 |
93641 | A | Electrophysiology evaluation | 5.93 | 9.51 | NA | 0.66 | 16.10 | NA | 000 | |
93641 | 26 | A | Electrophysiology evaluation | 5.93 | 2.37 | 2.37 | 0.31 | 8.61 | 8.61 | 000 |
93641 | TC | A | Electrophysiology evaluation | 0.00 | 7.14 | NA | 0.35 | 7.49 | NA | 000 |
93642 | A | Electrophysiology evaluation | 4.89 | 9.07 | NA | 0.51 | 14.47 | NA | 000 | |
93642 | 26 | A | Electrophysiology evaluation | 4.89 | 1.93 | 1.93 | 0.16 | 6.98 | 6.98 | 000 |
93642 | TC | A | Electrophysiology evaluation | 0.00 | 7.14 | NA | 0.35 | 7.49 | NA | 000 |
93650 | A | Ablate heart dysrhythm focus | 10.51 | NA | 4.19 | 0.55 | NA | 15.25 | 000 | |
93651 | A | Ablate heart dysrhythm focus | 16.25 | NA | 6.49 | 0.85 | NA | 23.59 | 000 | |
93652 | A | Ablate heart dysrhythm focus | 17.68 | NA | 7.07 | 0.92 | NA | 25.67 | 000 | |
93660 | A | Tilt table evaluation | 1.89 | 2.43 | NA | 0.08 | 4.40 | NA | 000 | |
93660 | 26 | A | Tilt table evaluation | 1.89 | 0.76 | 0.76 | 0.06 | 2.71 | 2.71 | 000 |
93660 | TC | A | Tilt table evaluation | 0.00 | 1.67 | NA | 0.02 | 1.69 | NA | 000 |
93662 | C | Intracardiac ecg (ice) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | |
93662 | 26 | A | Intracardiac ecg (ice) | 2.80 | 1.08 | 1.08 | 0.41 | 4.29 | 4.29 | ZZZ |
93662 | TC | C | Intracardiac ecg (ice) | 0.00 | 0.00 | NA | 0.00 | 0.00 | NA | ZZZ |
93668 | N | Peripheral vascular rehab | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
93701 | A | Bioimpedance, thoracic | 0.17 | 1.14 | NA | 0.02 | 1.33 | NA | XXX | |
93701 | 26 | A | Bioimpedance, thoracic | 0.17 | 0.07 | 0.07 | 0.01 | 0.25 | 0.25 | XXX |
93701 | TC | A | Bioimpedance, thoracic | 0.00 | 1.07 | NA | 0.01 | 1.08 | NA | XXX |
93720 | A | Total body plethysmography | 0.17 | 0.76 | NA | 0.06 | 0.99 | NA | XXX | |
93721 | A | Plethysmography tracing | 0.00 | 0.71 | NA | 0.05 | 0.76 | NA | XXX | |
93722 | A | Plethysmography report | 0.17 | 0.05 | 0.05 | 0.01 | 0.23 | 0.23 | XXX | |
93724 | A | Analyze pacemaker system | 4.89 | 5.91 | NA | 0.38 | 11.18 | NA | 000 | |
93724 | 26 | A | Analyze pacemaker system | 4.89 | 1.96 | 1.96 | 0.18 | 7.03 | 7.03 | 000 |
93724 | TC | A | Analyze pacemaker system | 0.00 | 3.95 | NA | 0.20 | 4.15 | NA | 000 |
93727 | A | Analyze ilr system | 0.52 | 0.20 | 0.20 | 0.05 | 0.77 | 0.77 | XXX | |
93731 | A | Analyze pacemaker system | 0.45 | 0.67 | NA | 0.05 | 1.17 | NA | XXX | |
93731 | 26 | A | Analyze pacemaker system | 0.45 | 0.18 | 0.18 | 0.02 | 0.65 | 0.65 | XXX |
93731 | TC | A | Analyze pacemaker system | 0.00 | 0.49 | NA | 0.03 | 0.52 | NA | XXX |
93732 | A | Analyze pacemaker system | 0.92 | 0.87 | NA | 0.06 | 1.85 | NA | XXX | |
93732 | 26 | A | Analyze pacemaker system | 0.92 | 0.36 | 0.36 | 0.03 | 1.31 | 1.31 | XXX |
93732 | TC | A | Analyze pacemaker system | 0.00 | 0.51 | NA | 0.03 | 0.54 | NA | XXX |
93733 | A | Telephone analy, pacemaker | 0.17 | 0.80 | NA | 0.06 | 1.03 | NA | XXX | |
93733 | 26 | A | Telephone analy, pacemaker | 0.17 | 0.07 | 0.07 | 0.01 | 0.25 | 0.25 | XXX |
93733 | TC | A | Telephone analy, pacemaker | 0.00 | 0.73 | NA | 0.05 | 0.78 | NA | XXX |
93734 | A | Analyze pacemaker system | 0.38 | 0.50 | NA | 0.03 | 0.91 | NA | XXX | |
93734 | 26 | A | Analyze pacemaker system | 0.38 | 0.15 | 0.15 | 0.01 | 0.54 | 0.54 | XXX |
93734 | TC | A | Analyze pacemaker system | 0.00 | 0.35 | NA | 0.02 | 0.37 | NA | XXX |
93735 | A | Analyze pacemaker system | 0.74 | 0.74 | NA | 0.06 | 1.54 | NA | XXX | |
93735 | 26 | A | Analyze pacemaker system | 0.74 | 0.29 | 0.29 | 0.03 | 1.06 | 1.06 | XXX |
93735 | TC | A | Analyze pacemaker system | 0.00 | 0.45 | NA | 0.03 | 0.48 | NA | XXX |
93736 | A | Telephone analy, pacemaker | 0.15 | 0.69 | NA | 0.06 | 0.90 | NA | XXX | |
93736 | 26 | A | Telephone analy, pacemaker | 0.15 | 0.06 | 0.06 | 0.01 | 0.22 | 0.22 | XXX |
93736 | TC | A | Telephone analy, pacemaker | 0.00 | 0.63 | NA | 0.05 | 0.68 | NA | XXX |
93740 | B | Temperature gradient studies | +0.16 | 0.19 | NA | 0.02 | 0.37 | NA | XXX | |
93740 | 26 | B | Temperature gradient studies | +0.16 | 0.04 | 0.04 | 0.01 | 0.21 | 0.21 | XXX |
93740 | TC | B | Temperature gradient studies | +0.00 | 0.15 | NA | 0.01 | 0.16 | NA | XXX |
93741 | A | Analyze ht pace device sngl | 0.80 | 0.99 | NA | 0.05 | 1.84 | NA | XXX | |
93741 | 26 | A | Analyze ht pace device sngl | 0.80 | 0.32 | 0.32 | 0.02 | 1.14 | 1.14 | XXX |
93741 | TC | A | Analyze ht pace device sngl | 0.00 | 0.67 | NA | 0.03 | 0.70 | NA | XXX |
93742 | A | Analyze ht pace device sngl | 0.91 | 1.04 | NA | 0.05 | 2.00 | NA | XXX | |
93742 | 26 | A | Analyze ht pace device sngl | 0.91 | 0.37 | 0.37 | 0.02 | 1.30 | 1.30 | XXX |
93742 | TC | A | Analyze ht pace device sngl | 0.00 | 0.67 | NA | 0.03 | 0.70 | NA | XXX |
93743 | A | Analyze ht pace device dual | 1.03 | 1.15 | NA | 0.06 | 2.24 | NA | XXX | |
93743 | 26 | A | Analyze ht pace device dual | 1.03 | 0.41 | 0.41 | 0.03 | 1.47 | 1.47 | XXX |
93743 | TC | A | Analyze ht pace device dual | 0.00 | 0.74 | NA | 0.03 | 0.77 | NA | XXX |
93744 | A | Analyze ht pace device dual | 1.18 | 1.14 | NA | 0.06 | 2.38 | NA | XXX | |
93744 | 26 | A | Analyze ht pace device dual | 1.18 | 0.47 | 0.47 | 0.03 | 1.68 | 1.68 | XXX |
93744 | TC | A | Analyze ht pace device dual | 0.00 | 0.67 | NA | 0.03 | 0.70 | NA | XXX |
93760 | N | Cephalic thermogram | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
93762 | N | Peripheral thermogram | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
93770 | B | Measure venous pressure | +0.16 | 0.08 | NA | 0.02 | 0.26 | NA | XXX | |
93770 | 26 | B | Measure venous pressure | +0.16 | 0.05 | 0.05 | 0.01 | 0.22 | 0.22 | XXX |
93770 | TC | B | Measure venous pressure | +0.00 | 0.03 | NA | 0.01 | 0.04 | NA | XXX |
93784 | A | Ambulatory BP monitoring | 0.17 | 0.98 | NA | 0.02 | 1.17 | NA | XXX | |
93786 | A | Ambulatory BP recording | 0.00 | 0.91 | NA | 0.01 | 0.92 | NA | XXX | |
93788 | N | Ambulatory BP analysis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
93790 | A | Review/report BP recording | 0.17 | 0.07 | 0.07 | 0.01 | 0.25 | 0.25 | XXX | |
93797 | A | Cardiac rehab | 0.18 | 0.39 | 0.07 | 0.01 | 0.58 | 0.26 | 000 | |
93798 | A | Cardiac rehab/monitor | 0.28 | 0.50 | 0.11 | 0.01 | 0.79 | 0.40 | 000 | |
93799 | C | Cardiovascular procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
93799 | 26 | C | Cardiovascular procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
93799 | TC | C | Cardiovascular procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
93875 | A | Extracranial study | 0.22 | 1.65 | NA | 0.10 | 1.97 | NA | XXX | |
93875 | 26 | A | Extracranial study | 0.22 | 0.08 | 0.08 | 0.01 | 0.31 | 0.31 | XXX |
93875 | TC | A | Extracranial study | 0.00 | 1.57 | NA | 0.09 | 1.66 | NA | XXX |
93880 | A | Extracranial study | 0.60 | 4.30 | NA | 0.33 | 5.23 | NA | XXX | |
93880 | 26 | A | Extracranial study | 0.60 | 0.21 | 0.21 | 0.04 | 0.85 | 0.85 | XXX |
93880 | TC | A | Extracranial study | 0.00 | 4.09 | NA | 0.29 | 4.38 | NA | XXX |
93882 | A | Extracranial study | 0.40 | 2.95 | NA | 0.22 | 3.57 | NA | XXX | |
93882 | 26 | A | Extracranial study | 0.40 | 0.14 | 0.14 | 0.04 | 0.58 | 0.58 | XXX |
93882 | TC | A | Extracranial study | 0.00 | 2.81 | NA | 0.18 | 2.99 | NA | XXX |
93886 | A | Intracranial study | 0.94 | 4.73 | NA | 0.37 | 6.04 | NA | XXX | |
93886 | 26 | A | Intracranial study | 0.94 | 0.38 | 0.38 | 0.05 | 1.37 | 1.37 | XXX |
93886 | TC | A | Intracranial study | 0.00 | 4.35 | NA | 0.32 | 4.67 | NA | XXX |
93888 | A | Intracranial study | 0.62 | 3.14 | NA | 0.26 | 4.02 | NA | XXX | |
93888 | 26 | A | Intracranial study | 0.62 | 0.23 | 0.23 | 0.04 | 0.89 | 0.89 | XXX |
93888 | TC | A | Intracranial study | 0.00 | 2.91 | NA | 0.22 | 3.13 | NA | XXX |
93922 | A | Extremity study | 0.25 | 1.88 | NA | 0.13 | 2.26 | NA | XXX | |
93922 | 26 | A | Extremity study | 0.25 | 0.09 | 0.09 | 0.02 | 0.36 | 0.36 | XXX |
93922 | TC | A | Extremity study | 0.00 | 1.79 | NA | 0.11 | 1.90 | NA | XXX |
93923 | A | Extremity study | 0.45 | 2.95 | NA | 0.22 | 3.62 | NA | XXX | |
93923 | 26 | A | Extremity study | 0.45 | 0.16 | 0.16 | 0.04 | 0.65 | 0.65 | XXX |
93923 | TC | A | Extremity study | 0.00 | 2.79 | NA | 0.18 | 2.97 | NA | XXX |
93924 | A | Extremity study | 0.50 | 3.67 | NA | 0.26 | 4.43 | NA | XXX | |
93924 | 26 | A | Extremity study | 0.50 | 0.17 | 0.17 | 0.05 | 0.72 | 0.72 | XXX |
93924 | TC | A | Extremity study | 0.00 | 3.50 | NA | 0.21 | 3.71 | NA | XXX |
93925 | A | Lower extremity study | 0.58 | 4.95 | NA | 0.33 | 5.86 | NA | XXX | |
93925 | 26 | A | Lower extremity study | 0.58 | 0.20 | 0.20 | 0.04 | 0.82 | 0.82 | XXX |
93925 | TC | A | Lower extremity study | 0.00 | 4.75 | NA | 0.29 | 5.04 | NA | XXX |
93926 | A | Lower extremity study | 0.39 | 3.39 | NA | 0.22 | 4.00 | NA | XXX | |
93926 | 26 | A | Lower extremity study | 0.39 | 0.13 | 0.13 | 0.03 | 0.55 | 0.55 | XXX |
93926 | TC | A | Lower extremity study | 0.00 | 3.26 | NA | 0.19 | 3.45 | NA | XXX |
93930 | A | Upper extremity study | 0.46 | 3.94 | NA | 0.34 | 4.74 | NA | XXX | |
93930 | 26 | A | Upper extremity study | 0.46 | 0.16 | 0.16 | 0.03 | 0.65 | 0.65 | XXX |
93930 | TC | A | Upper extremity study | 0.00 | 3.78 | NA | 0.31 | 4.09 | NA | XXX |
93931 | A | Upper extremity study | 0.31 | 2.83 | NA | 0.22 | 3.36 | NA | XXX | |
93931 | 26 | A | Upper extremity study | 0.31 | 0.11 | 0.11 | 0.02 | 0.44 | 0.44 | XXX |
93931 | TC | A | Upper extremity study | 0.00 | 2.72 | NA | 0.20 | 2.92 | NA | XXX |
93965 | A | Extremity study | 0.35 | 1.85 | NA | 0.12 | 2.32 | NA | XXX | |
93965 | 26 | A | Extremity study | 0.35 | 0.12 | 0.12 | 0.02 | 0.49 | 0.49 | XXX |
93965 | TC | A | Extremity study | 0.00 | 1.73 | NA | 0.10 | 1.83 | NA | XXX |
93970 | A | Extremity study | 0.68 | 4.05 | NA | 0.38 | 5.11 | NA | XXX | |
93970 | 26 | A | Extremity study | 0.68 | 0.24 | 0.24 | 0.05 | 0.97 | 0.97 | XXX |
93970 | TC | A | Extremity study | 0.00 | 3.81 | NA | 0.33 | 4.14 | NA | XXX |
93971 | A | Extremity study | 0.45 | 2.87 | NA | 0.25 | 3.57 | NA | XXX | |
93971 | 26 | A | Extremity study | 0.45 | 0.15 | 0.15 | 0.03 | 0.63 | 0.63 | XXX |
93971 | TC | A | Extremity study | 0.00 | 2.72 | NA | 0.22 | 2.94 | NA | XXX |
93975 | A | Vascular study | 1.80 | 5.92 | NA | 0.47 | 8.19 | NA | XXX | |
93975 | 26 | A | Vascular study | 1.80 | 0.62 | 0.62 | 0.11 | 2.53 | 2.53 | XXX |
93975 | TC | A | Vascular study | 0.00 | 5.30 | NA | 0.36 | 5.66 | NA | XXX |
93976 | A | Vascular study | 1.21 | 3.49 | NA | 0.31 | 5.01 | NA | XXX | |
93976 | 26 | A | Vascular study | 1.21 | 0.41 | 0.41 | 0.06 | 1.68 | 1.68 | XXX |
93976 | TC | A | Vascular study | 0.00 | 3.08 | NA | 0.25 | 3.33 | NA | XXX |
93978 | A | Vascular study | 0.65 | 3.63 | NA | 0.36 | 4.64 | NA | XXX | |
93978 | 26 | A | Vascular study | 0.65 | 0.23 | 0.23 | 0.05 | 0.93 | 0.93 | XXX |
93978 | TC | A | Vascular study | 0.00 | 3.40 | NA | 0.31 | 3.71 | NA | XXX |
93979 | A | Vascular study | 0.44 | 2.63 | NA | 0.24 | 3.31 | NA | XXX | |
93979 | 26 | A | Vascular study | 0.44 | 0.16 | 0.16 | 0.04 | 0.64 | 0.64 | XXX |
93979 | TC | A | Vascular study | 0.00 | 2.47 | NA | 0.20 | 2.67 | NA | XXX |
93980 | A | Penile vascular study | 1.25 | 4.50 | NA | 0.35 | 6.10 | NA | XXX | |
93980 | 26 | A | Penile vascular study | 1.25 | 0.42 | 0.42 | 0.07 | 1.74 | 1.74 | XXX |
93980 | TC | A | Penile vascular study | 0.00 | 4.08 | NA | 0.28 | 4.36 | NA | XXX |
93981 | A | Penile vascular study | 0.44 | 4.82 | NA | 0.28 | 5.54 | NA | XXX | |
93981 | 26 | A | Penile vascular study | 0.44 | 0.15 | 0.15 | 0.02 | 0.61 | 0.61 | XXX |
93981 | TC | A | Penile vascular study | 0.00 | 4.67 | NA | 0.26 | 4.93 | NA | XXX |
93990 | A | Doppler flow testing | 0.25 | 3.35 | NA | 0.21 | 3.81 | NA | XXX | |
93990 | 26 | A | Doppler flow testing | 0.25 | 0.09 | 0.09 | 0.02 | 0.36 | 0.36 | XXX |
93990 | TC | A | Doppler flow testing | 0.00 | 3.26 | NA | 0.19 | 3.45 | NA | XXX |
94010 | A | Breathing capacity test | 0.17 | 0.88 | NA | 0.03 | 1.08 | NA | XXX | |
94010 | 26 | A | Breathing capacity test | 0.17 | 0.05 | 0.05 | 0.01 | 0.23 | 0.23 | XXX |
94010 | TC | A | Breathing capacity test | 0.00 | 0.83 | NA | 0.02 | 0.85 | NA | XXX |
94014 | A | Patient recorded spirometry | 0.52 | 0.46 | NA | 0.03 | 1.01 | NA | XXX | |
94015 | A | Patient recorded spirometry | 0.00 | 0.29 | NA | 0.01 | 0.30 | NA | XXX | |
94016 | A | Review patient spirometry | 0.52 | 0.17 | 0.17 | 0.02 | 0.71 | 0.71 | XXX | |
94060 | A | Evaluation of wheezing | 0.31 | 1.52 | NA | 0.06 | 1.89 | NA | XXX | |
94060 | 26 | A | Evaluation of wheezing | 0.31 | 0.10 | 0.10 | 0.01 | 0.42 | 0.42 | XXX |
94060 | TC | A | Evaluation of wheezing | 0.00 | 1.42 | NA | 0.05 | 1.47 | NA | XXX |
94070 | A | Evaluation of wheezing | 0.60 | 4.34 | NA | 0.10 | 5.04 | NA | XXX | |
94070 | 26 | A | Evaluation of wheezing | 0.60 | 0.19 | 0.19 | 0.02 | 0.81 | 0.81 | XXX |
94070 | TC | A | Evaluation of wheezing | 0.00 | 4.15 | NA | 0.08 | 4.23 | NA | XXX |
94150 | B | Vital capacity test | +0.07 | 0.66 | NA | 0.02 | 0.75 | NA | XXX | |
94150 | 26 | B | Vital capacity test | +0.07 | 0.03 | 0.03 | 0.01 | 0.11 | 0.11 | XXX |
94150 | TC | B | Vital capacity test | +0.00 | 0.63 | NA | 0.01 | 0.64 | NA | XXX |
94200 | A | Lung function test (MBC/MVV) | 0.11 | 0.63 | NA | 0.03 | 0.77 | NA | XXX | |
94200 | 26 | A | Lung function test (MBC/MVV) | 0.11 | 0.03 | 0.03 | 0.01 | 0.15 | 0.15 | XXX |
94200 | TC | A | Lung function test (MBC/MVV) | 0.00 | 0.60 | NA | 0.02 | 0.62 | NA | XXX |
94240 | A | Residual lung capacity | 0.26 | 1.89 | NA | 0.05 | 2.20 | NA | XXX | |
94240 | 26 | A | Residual lung capacity | 0.26 | 0.08 | 0.08 | 0.01 | 0.35 | 0.35 | XXX |
94240 | TC | A | Residual lung capacity | 0.00 | 1.81 | NA | 0.04 | 1.85 | NA | XXX |
94250 | A | Expired gas collection | 0.11 | 0.70 | NA | 0.02 | 0.83 | NA | XXX | |
94250 | 26 | A | Expired gas collection | 0.11 | 0.03 | 0.03 | 0.01 | 0.15 | 0.15 | XXX |
94250 | TC | A | Expired gas collection | 0.00 | 0.67 | NA | 0.01 | 0.68 | NA | XXX |
94260 | A | Thoracic gas volume | 0.13 | 0.55 | NA | 0.04 | 0.72 | NA | XXX | |
94260 | 26 | A | Thoracic gas volume | 0.13 | 0.04 | 0.04 | 0.01 | 0.18 | 0.18 | XXX |
94260 | TC | A | Thoracic gas volume | 0.00 | 0.51 | NA | 0.03 | 0.54 | NA | XXX |
94350 | A | Lung nitrogen washout curve | 0.26 | 1.96 | NA | 0.04 | 2.26 | NA | XXX | |
94350 | 26 | A | Lung nitrogen washout curve | 0.26 | 0.08 | 0.08 | 0.01 | 0.35 | 0.35 | XXX |
94350 | TC | A | Lung nitrogen washout curve | 0.00 | 1.88 | NA | 0.03 | 1.91 | NA | XXX |
94360 | A | Measure airflow resistance | 0.26 | 0.57 | NA | 0.06 | 0.89 | NA | XXX | |
94360 | 26 | A | Measure airflow resistance | 0.26 | 0.08 | 0.08 | 0.01 | 0.35 | 0.35 | XXX |
94360 | TC | A | Measure airflow resistance | 0.00 | 0.49 | NA | 0.05 | 0.54 | NA | XXX |
94370 | A | Breath airway closing volume | 0.26 | 1.96 | NA | 0.03 | 2.25 | NA | XXX | |
94370 | 26 | A | Breath airway closing volume | 0.26 | 0.08 | 0.08 | 0.01 | 0.35 | 0.35 | XXX |
94370 | TC | A | Breath airway closing volume | 0.00 | 1.88 | NA | 0.02 | 1.90 | NA | XXX |
94375 | A | Respiratory flow volume loop | 0.31 | 0.67 | NA | 0.03 | 1.01 | NA | XXX | |
94375 | 26 | A | Respiratory flow volume loop | 0.31 | 0.10 | 0.10 | 0.01 | 0.42 | 0.42 | XXX |
94375 | TC | A | Respiratory flow volume loop | 0.00 | 0.57 | NA | 0.02 | 0.59 | NA | XXX |
94400 | A | CO2 breathing response curve | 0.40 | 0.89 | NA | 0.06 | 1.35 | NA | XXX | |
94400 | 26 | A | CO2 breathing response curve | 0.40 | 0.13 | 0.13 | 0.01 | 0.54 | 0.54 | XXX |
94400 | TC | A | CO2 breathing response curve | 0.00 | 0.76 | NA | 0.05 | 0.81 | NA | XXX |
94450 | A | Hypoxia response curve | 0.40 | 0.68 | NA | 0.04 | 1.12 | NA | XXX | |
94450 | 26 | A | Hypoxia response curve | 0.40 | 0.12 | 0.12 | 0.02 | 0.54 | 0.54 | XXX |
94450 | TC | A | Hypoxia response curve | 0.00 | 0.56 | NA | 0.02 | 0.58 | NA | XXX |
94620 | A | Pulmonary stress test/simple | 0.64 | 2.47 | NA | 0.10 | 3.21 | NA | XXX | |
94620 | 26 | A | Pulmonary stress test/simple | 0.64 | 0.20 | 0.20 | 0.02 | 0.86 | 0.86 | XXX |
94620 | TC | A | Pulmonary stress test/simple | 0.00 | 2.27 | NA | 0.08 | 2.35 | NA | XXX |
94621 | A | Pulm stress test/complex | 1.42 | 2.12 | NA | 0.13 | 3.67 | NA | XXX | |
94621 | 26 | A | Pulm stress test/complex | 1.42 | 0.45 | 0.45 | 0.05 | 1.92 | 1.92 | XXX |
94621 | TC | A | Pulm stress test/complex | 0.00 | 1.67 | NA | 0.08 | 1.75 | NA | XXX |
94640 | A | Airway inhalation treatment | 0.00 | 0.70 | NA | 0.02 | 0.72 | NA | XXX | |
94642 | C | Aerosol inhalation treatment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
94650 | D | Pressure breathing (IPPB) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
94651 | D | Pressure breathing (IPPB) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
94652 | D | Pressure breathing (IPPB) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
94656 | A | Initial ventilator mgmt | 1.22 | NA | 0.32 | 0.06 | NA | 1.60 | XXX | |
94657 | A | Continued ventilator mgmt | 0.83 | NA | 0.26 | 0.03 | NA | 1.12 | XXX | |
94660 | A | Pos airway pressure, CPAP | 0.76 | 0.68 | 0.24 | 0.03 | 1.47 | 1.03 | XXX | |
94662 | A | Neg press ventilation, cnp | 0.76 | NA | 0.24 | 0.02 | NA | 1.02 | XXX | |
94664 | A | Evaluate pt use of inhaler | 0.00 | 0.52 | NA | 0.03 | 0.55 | NA | XXX | |
94665 | D | Aerosol or vapor inhalations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
94667 | A | Chest wall manipulation | 0.00 | 0.81 | NA | 0.04 | 0.85 | NA | XXX | |
94668 | A | Chest wall manipulation | 0.00 | 0.71 | NA | 0.02 | 0.73 | NA | XXX | |
94680 | A | Exhaled air analysis, o2 | 0.26 | 1.91 | NA | 0.06 | 2.23 | NA | XXX | |
94680 | 26 | A | Exhaled air analysis, o2 | 0.26 | 0.09 | 0.09 | 0.01 | 0.36 | 0.36 | XXX |
94680 | TC | A | Exhaled air analysis, o2 | 0.00 | 1.82 | NA | 0.05 | 1.87 | NA | XXX |
94681 | A | Exhaled air analysis, o2/co2 | 0.20 | 2.80 | NA | 0.11 | 3.11 | NA | XXX | |
94681 | 26 | A | Exhaled air analysis, o2/co2 | 0.20 | 0.07 | 0.07 | 0.01 | 0.28 | 0.28 | XXX |
94681 | TC | A | Exhaled air analysis, o2/co2 | 0.00 | 2.73 | NA | 0.10 | 2.83 | NA | XXX |
94690 | A | Exhaled air analysis | 0.07 | 2.13 | NA | 0.04 | 2.24 | NA | XXX | |
94690 | 26 | A | Exhaled air analysis | 0.07 | 0.02 | 0.02 | 0.01 | 0.10 | 0.10 | XXX |
94690 | TC | A | Exhaled air analysis | 0.00 | 2.11 | NA | 0.03 | 2.14 | NA | XXX |
94720 | A | Monoxide diffusing capacity | 0.26 | 1.55 | NA | 0.06 | 1.87 | NA | XXX | |
94720 | 26 | A | Monoxide diffusing capacity | 0.26 | 0.08 | 0.08 | 0.01 | 0.35 | 0.35 | XXX |
94720 | TC | A | Monoxide diffusing capacity | 0.00 | 1.47 | NA | 0.05 | 1.52 | NA | XXX |
94725 | A | Membrane diffusion capacity | 0.26 | 2.56 | NA | 0.11 | 2.93 | NA | XXX | |
94725 | 26 | A | Membrane diffusion capacity | 0.26 | 0.08 | 0.08 | 0.01 | 0.35 | 0.35 | XXX |
94725 | TC | A | Membrane diffusion capacity | 0.00 | 2.48 | NA | 0.10 | 2.58 | NA | XXX |
94750 | A | Pulmonary compliance study | 0.23 | 2.07 | NA | 0.04 | 2.34 | NA | XXX | |
94750 | 26 | A | Pulmonary compliance study | 0.23 | 0.07 | 0.07 | 0.01 | 0.31 | 0.31 | XXX |
94750 | TC | A | Pulmonary compliance study | 0.00 | 2.00 | NA | 0.03 | 2.03 | NA | XXX |
94760 | T | Measure blood oxygen level | 0.00 | 0.09 | NA | 0.02 | 0.11 | NA | XXX | |
94761 | T | Measure blood oxygen level | 0.00 | 0.17 | NA | 0.05 | 0.22 | NA | XXX | |
94762 | A | Measure blood oxygen level | 0.00 | 0.74 | NA | 0.08 | 0.82 | NA | XXX | |
94770 | A | Exhaled carbon dioxide test | 0.15 | 1.68 | NA | 0.07 | 1.90 | NA | XXX | |
94770 | 26 | A | Exhaled carbon dioxide test | 0.15 | 0.04 | 0.04 | 0.01 | 0.20 | 0.20 | XXX |
94770 | TC | A | Exhaled carbon dioxide test | 0.00 | 1.64 | NA | 0.06 | 1.70 | NA | XXX |
94772 | C | Breath recording, infant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
94772 | 26 | C | Breath recording, infant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
94772 | TC | C | Breath recording, infant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
94799 | C | Pulmonary service/procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
94799 | 26 | C | Pulmonary service/procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
94799 | TC | C | Pulmonary service/procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
95004 | A | Percut allergy skin tests | 0.00 | 0.10 | NA | 0.01 | 0.11 | NA | XXX | |
95010 | A | Percut allergy titrate test | 0.15 | 0.44 | 0.06 | 0.01 | 0.60 | 0.22 | XXX | |
95015 | A | Id allergy titrate-drug/bug | 0.15 | 0.38 | 0.06 | 0.01 | 0.54 | 0.22 | XXX | |
95024 | A | Id allergy test, drug/bug | 0.00 | 0.15 | NA | 0.01 | 0.16 | NA | XXX | |
95027 | A | Id allergy titrate-airborne | 0.00 | 0.15 | NA | 0.01 | 0.16 | NA | XXX | |
95028 | A | Id allergy test-delayed type | 0.00 | 0.23 | NA | 0.01 | 0.24 | NA | XXX | |
95044 | A | Allergy patch tests | 0.00 | 0.20 | NA | 0.01 | 0.21 | NA | XXX | |
95052 | A | Photo patch test | 0.00 | 0.25 | NA | 0.01 | 0.26 | NA | XXX | |
95056 | A | Photosensitivity tests | 0.00 | 0.17 | NA | 0.01 | 0.18 | NA | XXX | |
95060 | A | Eye allergy tests | 0.00 | 0.35 | NA | 0.02 | 0.37 | NA | XXX | |
95065 | A | Nose allergy test | 0.00 | 0.20 | NA | 0.01 | 0.21 | NA | XXX | |
95070 | A | Bronchial allergy tests | 0.00 | 2.27 | NA | 0.02 | 2.29 | NA | XXX | |
95071 | A | Bronchial allergy tests | 0.00 | 2.91 | NA | 0.02 | 2.93 | NA | XXX | |
95075 | A | Ingestion challenge test | 0.95 | 0.84 | 0.40 | 0.03 | 1.82 | 1.38 | XXX | |
95078 | A | Provocative testing | 0.00 | 0.25 | NA | 0.02 | 0.27 | NA | XXX | |
95115 | A | Immunotherapy, one injection | 0.00 | 0.39 | NA | 0.02 | 0.41 | NA | 000 | |
95117 | A | Immunotherapy injections | 0.00 | 0.50 | NA | 0.02 | 0.52 | NA | 000 | |
95120 | I | Immunotherapy, one injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
95125 | I | Immunotherapy, many antigens | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
95130 | I | Immunotherapy, insect venom | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
95131 | I | Immunotherapy, insect venoms | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
95132 | I | Immunotherapy, insect venoms | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
95133 | I | Immunotherapy, insect venoms | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
95134 | I | Immunotherapy, insect venoms | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
95144 | A | Antigen therapy services | 0.06 | 0.25 | 0.02 | 0.01 | 0.32 | 0.09 | 000 | |
95145 | A | Antigen therapy services | 0.06 | 0.49 | 0.02 | 0.01 | 0.56 | 0.09 | 000 | |
95146 | A | Antigen therapy services | 0.06 | 0.61 | 0.03 | 0.01 | 0.68 | 0.10 | 000 | |
95147 | A | Antigen therapy services | 0.06 | 0.83 | 0.02 | 0.01 | 0.90 | 0.09 | 000 | |
95148 | A | Antigen therapy services | 0.06 | 0.81 | 0.03 | 0.01 | 0.88 | 0.10 | 000 | |
95149 | A | Antigen therapy services | 0.06 | 1.02 | 0.03 | 0.01 | 1.09 | 0.10 | 000 | |
95165 | A | Antigen therapy services | 0.06 | 0.20 | 0.02 | 0.01 | 0.27 | 0.09 | 000 | |
95170 | A | Antigen therapy services | 0.06 | 0.26 | 0.02 | 0.01 | 0.33 | 0.09 | 000 | |
95180 | A | Rapid desensitization | 2.01 | 1.60 | 0.84 | 0.04 | 3.65 | 2.89 | 000 | |
95199 | C | Allergy immunology services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | |
95250 | A | Glucose monitoring, cont | 0.00 | 3.22 | NA | 0.01 | 3.23 | NA | XXX | |
95805 | A | Multiple sleep latency test | 1.88 | 17.11 | NA | 0.34 | 19.33 | NA | XXX | |
95805 | 26 | A | Multiple sleep latency test | 1.88 | 0.68 | 0.68 | 0.06 | 2.62 | 2.62 | XXX |
95805 | TC | A | Multiple sleep latency test | 0.00 | 16.43 | NA | 0.28 | 16.71 | NA | XXX |
95806 | A | Sleep study, unattended | 1.66 | 4.10 | NA | 0.32 | 6.08 | NA | XXX | |
95806 | 26 | A | Sleep study, unattended | 1.66 | 0.55 | 0.55 | 0.06 | 2.27 | 2.27 | XXX |
95806 | TC | A | Sleep study, unattended | 0.00 | 3.55 | NA | 0.26 | 3.81 | NA | XXX |
95807 | A | Sleep study, attended | 1.66 | 12.00 | NA | 0.40 | 14.06 | NA | XXX | |
95807 | 26 | A | Sleep study, attended | 1.66 | 0.54 | 0.54 | 0.05 | 2.25 | 2.25 | XXX |
95807 | TC | A | Sleep study, attended | 0.00 | 11.46 | NA | 0.35 | 11.81 | NA | XXX |
95808 | A | Polysomnography, 1-3 | 2.65 | 13.10 | NA | 0.44 | 16.19 | NA | XXX | |
95808 | 26 | A | Polysomnography, 1-3 | 2.65 | 0.95 | 0.95 | 0.09 | 3.69 | 3.69 | XXX |
95808 | TC | A | Polysomnography, 1-3 | 0.00 | 12.15 | NA | 0.35 | 12.50 | NA | XXX |
95810 | A | Polysomnography, 4 or more | 3.53 | 17.29 | NA | 0.47 | 21.29 | NA | XXX | |
95810 | 26 | A | Polysomnography, 4 or more | 3.53 | 1.21 | 1.21 | 0.12 | 4.86 | 4.86 | XXX |
95810 | TC | A | Polysomnography, 4 or more | 0.00 | 16.08 | NA | 0.35 | 16.43 | NA | XXX |
95811 | A | Polysomnography w/cpap | 3.80 | 17.67 | NA | 0.49 | 21.96 | NA | XXX | |
95811 | 26 | A | Polysomnography w/cpap | 3.80 | 1.30 | 1.30 | 0.13 | 5.23 | 5.23 | XXX |
95811 | TC | A | Polysomnography w/cpap | 0.00 | 16.37 | NA | 0.36 | 16.73 | NA | XXX |
95812 | A | Eeg, 41-60 minutes | 1.08 | 4.72 | NA | 0.13 | 5.93 | NA | XXX | |
95812 | 26 | A | Eeg, 41-60 minutes | 1.08 | 0.46 | 0.46 | 0.04 | 1.58 | 1.58 | XXX |
95812 | TC | A | Eeg, 41-60 minutes | 0.00 | 4.26 | NA | 0.09 | 4.35 | NA | XXX |
95813 | A | Eeg, over 1 hour | 1.73 | 5.80 | NA | 0.15 | 7.68 | NA | XXX | |
95813 | 26 | A | Eeg, over 1 hour | 1.73 | 0.72 | 0.72 | 0.06 | 2.51 | 2.51 | XXX |
95813 | TC | A | Eeg, over 1 hour | 0.00 | 5.08 | NA | 0.09 | 5.17 | NA | XXX |
95816 | A | Eeg, awake and drowsy | 1.08 | 3.67 | NA | 0.12 | 4.87 | NA | XXX | |
95816 | 26 | A | Eeg, awake and drowsy | 1.08 | 0.47 | 0.47 | 0.04 | 1.59 | 1.59 | XXX |
95816 | TC | A | Eeg, awake and drowsy | 0.00 | 3.20 | NA | 0.08 | 3.28 | NA | XXX |
95819 | A | Eeg, awake and asleep | 1.08 | 4.31 | NA | 0.12 | 5.51 | NA | XXX | |
95819 | 26 | A | Eeg, awake and asleep | 1.08 | 0.47 | 0.47 | 0.04 | 1.59 | 1.59 | XXX |
95819 | TC | A | Eeg, awake and asleep | 0.00 | 3.84 | NA | 0.08 | 3.92 | NA | XXX |
95822 | A | Eeg, coma or sleep only | 1.08 | 5.11 | NA | 0.15 | 6.34 | NA | XXX | |
95822 | 26 | A | Eeg, coma or sleep only | 1.08 | 0.47 | 0.47 | 0.04 | 1.59 | 1.59 | XXX |
95822 | TC | A | Eeg, coma or sleep only | 0.00 | 4.64 | NA | 0.11 | 4.75 | NA | XXX |
95824 | C | Eeg, cerebral death only | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
95824 | 26 | A | Eeg, cerebral death only | 0.74 | 0.32 | 0.32 | 0.05 | 1.11 | 1.11 | XXX |
95824 | TC | C | Eeg, cerebral death only | 0.00 | 0.00 | NA | 0.00 | 0.00 | NA | XXX |
95827 | A | Eeg, all night recording | 1.08 | 2.70 | NA | 0.15 | 3.93 | NA | XXX | |
95827 | 26 | A | Eeg, all night recording | 1.08 | 0.42 | 0.42 | 0.03 | 1.53 | 1.53 | XXX |
95827 | TC | A | Eeg, all night recording | 0.00 | 2.28 | NA | 0.12 | 2.40 | NA | XXX |
95829 | A | Surgery electrocorticogram | 6.21 | 40.12 | NA | 0.33 | 46.66 | NA | XXX | |
95829 | 26 | A | Surgery electrocorticogram | 6.21 | 2.38 | 2.38 | 0.31 | 8.90 | 8.90 | XXX |
95829 | TC | A | Surgery electrocorticogram | 0.00 | 37.74 | NA | 0.02 | 37.76 | NA | XXX |
95830 | A | Insert electrodes for EEG | 1.70 | 3.55 | 0.75 | 0.07 | 5.32 | 2.52 | XXX | |
95831 | A | Limb muscle testing, manual | 0.28 | 0.53 | 0.13 | 0.01 | 0.82 | 0.42 | XXX | |
95832 | A | Hand muscle testing, manual | 0.29 | 0.45 | 0.12 | 0.01 | 0.75 | 0.42 | XXX | |
95833 | A | Body muscle testing, manual | 0.47 | 0.61 | 0.23 | 0.01 | 1.09 | 0.71 | XXX | |
95834 | A | Body muscle testing, manual | 0.60 | 0.58 | 0.28 | 0.02 | 1.20 | 0.90 | XXX | |
95851 | A | Range of motion measurements | 0.16 | 0.57 | 0.08 | 0.01 | 0.74 | 0.25 | XXX | |
95852 | A | Range of motion measurements | 0.11 | 0.47 | 0.05 | 0.01 | 0.59 | 0.17 | XXX | |
95857 | A | Tensilon test | 0.53 | 0.65 | 0.23 | 0.02 | 1.20 | 0.78 | XXX | |
95858 | A | Tensilon test myogram | 1.56 | 1.09 | NA | 0.07 | 2.72 | NA | XXX | |
95858 | 26 | A | Tensilon test myogram | 1.56 | 0.69 | 0.69 | 0.04 | 2.29 | 2.29 | XXX |
95858 | TC | A | Tensilon test myogram | 0.00 | 0.40 | NA | 0.03 | 0.43 | NA | XXX |
95860 | A | Muscle test, one limb | 0.96 | 1.62 | NA | 0.05 | 2.63 | NA | XXX | |
95860 | 26 | A | Muscle test, one limb | 0.96 | 0.43 | 0.43 | 0.03 | 1.42 | 1.42 | XXX |
95860 | TC | A | Muscle test, one limb | 0.00 | 1.19 | NA | 0.02 | 1.21 | NA | XXX |
95861 | A | Muscle test, 2 limbs | 1.54 | 1.44 | NA | 0.10 | 3.08 | NA | XXX | |
95861 | 26 | A | Muscle test, 2 limbs | 1.54 | 0.70 | 0.70 | 0.05 | 2.29 | 2.29 | XXX |
95861 | TC | A | Muscle test, 2 limbs | 0.00 | 0.74 | NA | 0.05 | 0.79 | NA | XXX |
95863 | A | Muscle test, 3 limbs | 1.87 | 1.77 | NA | 0.11 | 3.75 | NA | XXX | |
95863 | 26 | A | Muscle test, 3 limbs | 1.87 | 0.83 | 0.83 | 0.06 | 2.76 | 2.76 | XXX |
95863 | TC | A | Muscle test, 3 limbs | 0.00 | 0.94 | NA | 0.05 | 0.99 | NA | XXX |
95864 | A | Muscle test, 4 limbs | 1.99 | 2.66 | NA | 0.16 | 4.81 | NA | XXX | |
95864 | 26 | A | Muscle test, 4 limbs | 1.99 | 0.89 | 0.89 | 0.06 | 2.94 | 2.94 | XXX |
95864 | TC | A | Muscle test, 4 limbs | 0.00 | 1.77 | NA | 0.10 | 1.87 | NA | XXX |
95867 | A | Muscle test cran nerv unilat | 0.79 | 0.94 | NA | 0.06 | 1.79 | NA | XXX | |
95867 | 26 | A | Muscle test cran nerv unilat | 0.79 | 0.36 | 0.36 | 0.03 | 1.18 | 1.18 | XXX |
95867 | TC | A | Muscle test cran nerv unilat | 0.00 | 0.58 | NA | 0.03 | 0.61 | NA | XXX |
95868 | A | Muscle test cran nerve bilat | 1.18 | 1.23 | NA | 0.08 | 2.49 | NA | XXX | |
95868 | 26 | A | Muscle test cran nerve bilat | 1.18 | 0.53 | 0.53 | 0.04 | 1.75 | 1.75 | XXX |
95868 | TC | A | Muscle test cran nerve bilat | 0.00 | 0.70 | NA | 0.04 | 0.74 | NA | XXX |
95869 | A | Muscle test, thor paraspinal | 0.37 | 0.38 | NA | 0.03 | 0.78 | NA | XXX | |
95869 | 26 | A | Muscle test, thor paraspinal | 0.37 | 0.17 | 0.17 | 0.01 | 0.55 | 0.55 | XXX |
95869 | TC | A | Muscle test, thor paraspinal | 0.00 | 0.21 | NA | 0.02 | 0.23 | NA | XXX |
95870 | A | Muscle test, nonparaspinal | 0.37 | 0.37 | NA | 0.03 | 0.77 | NA | XXX | |
95870 | 26 | A | Muscle test, nonparaspinal | 0.37 | 0.16 | 0.16 | 0.01 | 0.54 | 0.54 | XXX |
95870 | TC | A | Muscle test, nonparaspinal | 0.00 | 0.21 | NA | 0.02 | 0.23 | NA | XXX |
95872 | A | Muscle test, one fiber | 1.50 | 1.25 | NA | 0.08 | 2.83 | NA | XXX | |
95872 | 26 | A | Muscle test, one fiber | 1.50 | 0.65 | 0.65 | 0.04 | 2.19 | 2.19 | XXX |
95872 | TC | A | Muscle test, one fiber | 0.00 | 0.60 | NA | 0.04 | 0.64 | NA | XXX |
95875 | A | Limb exercise test | 1.10 | 1.72 | NA | 0.09 | 2.91 | NA | XXX | |
95875 | 26 | A | Limb exercise test | 1.10 | 0.48 | 0.48 | 0.04 | 1.62 | 1.62 | XXX |
95875 | TC | A | Limb exercise test | 0.00 | 1.24 | NA | 0.05 | 1.29 | NA | XXX |
95900 | A | Motor nerve conduction test | 0.42 | 1.12 | NA | 0.03 | 1.57 | NA | XXX | |
95900 | 26 | A | Motor nerve conduction test | 0.42 | 0.19 | 0.19 | 0.01 | 0.62 | 0.62 | XXX |
95900 | TC | A | Motor nerve conduction test | 0.00 | 0.93 | NA | 0.02 | 0.95 | NA | XXX |
95903 | A | Motor nerve conduction test | 0.60 | 1.07 | NA | 0.04 | 1.71 | NA | XXX | |
95903 | 26 | A | Motor nerve conduction test | 0.60 | 0.27 | 0.27 | 0.02 | 0.89 | 0.89 | XXX |
95903 | TC | A | Motor nerve conduction test | 0.00 | 0.80 | NA | 0.02 | 0.82 | NA | XXX |
95904 | A | Sense nerve conduction test | 0.34 | 0.95 | NA | 0.03 | 1.32 | NA | XXX | |
95904 | 26 | A | Sense nerve conduction test | 0.34 | 0.15 | 0.15 | 0.01 | 0.50 | 0.50 | XXX |
95904 | TC | A | Sense nerve conduction test | 0.00 | 0.80 | NA | 0.02 | 0.82 | NA | XXX |
95920 | A | Intraop nerve test add-on | 2.11 | 2.26 | NA | 0.20 | 4.57 | NA | ZZZ | |
95920 | 26 | A | Intraop nerve test add-on | 2.11 | 0.96 | 0.96 | 0.14 | 3.21 | 3.21 | ZZZ |
95920 | TC | A | Intraop nerve test add-on | 0.00 | 1.30 | NA | 0.06 | 1.36 | NA | ZZZ |
95921 | A | Autonomic nerv function test | 0.90 | 0.72 | NA | 0.05 | 1.67 | NA | XXX | |
95921 | 26 | A | Autonomic nerv function test | 0.90 | 0.34 | 0.34 | 0.03 | 1.27 | 1.27 | XXX |
95921 | TC | A | Autonomic nerv function test | 0.00 | 0.38 | NA | 0.02 | 0.40 | NA | XXX |
95922 | A | Autonomic nerv function test | 0.96 | 0.79 | NA | 0.05 | 1.80 | NA | XXX | |
95922 | 26 | A | Autonomic nerv function test | 0.96 | 0.41 | 0.41 | 0.03 | 1.40 | 1.40 | XXX |
95922 | TC | A | Autonomic nerv function test | 0.00 | 0.38 | NA | 0.02 | 0.40 | NA | XXX |
95923 | A | Autonomic nerv function test | 0.90 | 2.92 | NA | 0.05 | 3.87 | NA | XXX | |
95923 | 26 | A | Autonomic nerv function test | 0.90 | 0.39 | 0.39 | 0.03 | 1.32 | 1.32 | XXX |
95923 | TC | A | Autonomic nerv function test | 0.00 | 2.53 | NA | 0.02 | 2.55 | NA | XXX |
95925 | A | Somatosensory testing | 0.54 | 1.14 | NA | 0.07 | 1.75 | NA | XXX | |
95925 | 26 | A | Somatosensory testing | 0.54 | 0.23 | 0.23 | 0.02 | 0.79 | 0.79 | XXX |
95925 | TC | A | Somatosensory testing | 0.00 | 0.91 | NA | 0.05 | 0.96 | NA | XXX |
95926 | A | Somatosensory testing | 0.54 | 1.15 | NA | 0.07 | 1.76 | NA | XXX | |
95926 | 26 | A | Somatosensory testing | 0.54 | 0.24 | 0.24 | 0.02 | 0.80 | 0.80 | XXX |
95926 | TC | A | Somatosensory testing | 0.00 | 0.91 | NA | 0.05 | 0.96 | NA | XXX |
95927 | A | Somatosensory testing | 0.54 | 1.17 | NA | 0.08 | 1.79 | NA | XXX | |
95927 | 26 | A | Somatosensory testing | 0.54 | 0.26 | 0.26 | 0.03 | 0.83 | 0.83 | XXX |
95927 | TC | A | Somatosensory testing | 0.00 | 0.91 | NA | 0.05 | 0.96 | NA | XXX |
95930 | A | Visual evoked potential test | 0.35 | 1.18 | NA | 0.02 | 1.55 | NA | XXX | |
95930 | 26 | A | Visual evoked potential test | 0.35 | 0.15 | 0.15 | 0.01 | 0.51 | 0.51 | XXX |
95930 | TC | A | Visual evoked potential test | 0.00 | 1.03 | NA | 0.01 | 1.04 | NA | XXX |
95933 | A | Blink reflex test | 0.59 | 1.03 | NA | 0.07 | 1.69 | NA | XXX | |
95933 | 26 | A | Blink reflex test | 0.59 | 0.25 | 0.25 | 0.02 | 0.86 | 0.86 | XXX |
95933 | TC | A | Blink reflex test | 0.00 | 0.78 | NA | 0.05 | 0.83 | NA | XXX |
95934 | A | H-reflex test | 0.51 | 0.44 | NA | 0.04 | 0.99 | NA | XXX | |
95934 | 26 | A | H-reflex test | 0.51 | 0.23 | 0.23 | 0.02 | 0.76 | 0.76 | XXX |
95934 | TC | A | H-reflex test | 0.00 | 0.21 | NA | 0.02 | 0.23 | NA | XXX |
95936 | A | H-reflex test | 0.55 | 0.46 | NA | 0.04 | 1.05 | NA | XXX | |
95936 | 26 | A | H-reflex test | 0.55 | 0.25 | 0.25 | 0.02 | 0.82 | 0.82 | XXX |
95936 | TC | A | H-reflex test | 0.00 | 0.21 | NA | 0.02 | 0.23 | NA | XXX |
95937 | A | Neuromuscular junction test | 0.65 | 0.61 | NA | 0.04 | 1.30 | NA | XXX | |
95937 | 26 | A | Neuromuscular junction test | 0.65 | 0.27 | 0.27 | 0.02 | 0.94 | 0.94 | XXX |
95937 | TC | A | Neuromuscular junction test | 0.00 | 0.34 | NA | 0.02 | 0.36 | NA | XXX |
95950 | A | Ambulatory eeg monitoring | 1.51 | 6.79 | NA | 0.44 | 8.74 | NA | XXX | |
95950 | 26 | A | Ambulatory eeg monitoring | 1.51 | 0.65 | 0.65 | 0.08 | 2.24 | 2.24 | XXX |
95950 | TC | A | Ambulatory eeg monitoring | 0.00 | 6.14 | NA | 0.36 | 6.50 | NA | XXX |
95951 | A | EEG monitoring/videorecord | 6.00 | 2.63 | NA | 0.58 | 9.21 | NA | XXX | |
95951 | 26 | A | EEG monitoring/videorecord | 6.00 | 2.62 | 2.62 | 0.20 | 8.82 | 8.82 | XXX |
95951 | TC | A | EEG monitoring/videorecord | 0.00 | 0.01 | NA | 0.38 | 0.39 | NA | XXX |
95953 | A | EEG monitoring/computer | 3.08 | 7.63 | NA | 0.46 | 11.17 | NA | XXX | |
95953 | 26 | A | EEG monitoring/computer | 3.08 | 1.32 | 1.32 | 0.10 | 4.50 | 4.50 | XXX |
95953 | TC | A | EEG monitoring/computer | 0.00 | 6.31 | NA | 0.36 | 6.67 | NA | XXX |
95954 | A | EEG monitoring/giving drugs | 2.45 | 5.04 | NA | 0.15 | 7.64 | NA | XXX | |
95954 | 26 | A | EEG monitoring/giving drugs | 2.45 | 1.06 | 1.06 | 0.10 | 3.61 | 3.61 | XXX |
95954 | TC | A | EEG monitoring/giving drugs | 0.00 | 3.98 | NA | 0.05 | 4.03 | NA | XXX |
95955 | A | EEG during surgery | 1.01 | 2.32 | NA | 0.19 | 3.52 | NA | XXX | |
95955 | 26 | A | EEG during surgery | 1.01 | 0.37 | 0.37 | 0.05 | 1.43 | 1.43 | XXX |
95955 | TC | A | EEG during surgery | 0.00 | 1.95 | NA | 0.14 | 2.09 | NA | XXX |
95956 | A | Eeg monitoring, cable/radio | 3.08 | 15.69 | NA | 0.47 | 19.24 | NA | XXX | |
95956 | 26 | A | Eeg monitoring, cable/radio | 3.08 | 1.33 | 1.33 | 0.11 | 4.52 | 4.52 | XXX |
95956 | TC | A | Eeg monitoring, cable/radio | 0.00 | 14.36 | NA | 0.36 | 14.72 | NA | XXX |
95957 | A | EEG digital analysis | 1.98 | 2.56 | NA | 0.17 | 4.71 | NA | XXX | |
95957 | 26 | A | EEG digital analysis | 1.98 | 0.87 | 0.87 | 0.07 | 2.92 | 2.92 | XXX |
95957 | TC | A | EEG digital analysis | 0.00 | 1.69 | NA | 0.10 | 1.79 | NA | XXX |
95958 | A | EEG monitoring/function test | 4.25 | 3.51 | NA | 0.29 | 8.05 | NA | XXX | |
95958 | 26 | A | EEG monitoring/function test | 4.25 | 1.78 | 1.78 | 0.18 | 6.21 | 6.21 | XXX |
95958 | TC | A | EEG monitoring/function test | 0.00 | 1.73 | NA | 0.11 | 1.84 | NA | XXX |
95961 | A | Electrode stimulation, brain | 2.97 | 2.65 | NA | 0.24 | 5.86 | NA | XXX | |
95961 | 26 | A | Electrode stimulation, brain | 2.97 | 1.35 | 1.35 | 0.18 | 4.50 | 4.50 | XXX |
95961 | TC | A | Electrode stimulation, brain | 0.00 | 1.30 | NA | 0.06 | 1.36 | NA | XXX |
95962 | A | Electrode stim, brain add-on | 3.21 | 2.72 | NA | 0.23 | 6.16 | NA | ZZZ | |
95962 | 26 | A | Electrode stim, brain add-on | 3.21 | 1.42 | 1.42 | 0.17 | 4.80 | 4.80 | ZZZ |
95962 | TC | A | Electrode stim, brain add-on | 0.00 | 1.30 | NA | 0.06 | 1.36 | NA | ZZZ |
95965 | C | Meg, spontaneous | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
95965 | 26 | A | Meg, spontaneous | 8.00 | 3.11 | 3.11 | 0.31 | 11.42 | 11.42 | XXX |
95965 | TC | C | Meg, spontaneous | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
95966 | C | Meg, evoked, single | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
95966 | 26 | A | Meg, evoked, single | 4.00 | 1.55 | 1.55 | 0.15 | 5.70 | 5.70 | XXX |
95966 | TC | C | Meg, evoked, single | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
95967 | C | Meg, evoked, each addl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | |
95967 | 26 | A | Meg, evoked, each addl | 3.50 | 1.36 | 1.36 | 0.13 | 4.99 | 4.99 | ZZZ |
95967 | TC | C | Meg, evoked, each addl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ |
95970 | A | Analyze neurostim, no prog | 0.45 | 0.17 | 0.15 | 0.03 | 0.65 | 0.63 | XXX | |
95971 | A | Analyze neurostim, simple | 0.78 | 0.28 | 0.23 | 0.06 | 1.12 | 1.07 | XXX | |
95972 | A | Analyze neurostim, complex | 1.50 | 0.61 | 0.51 | 0.17 | 2.28 | 2.18 | XXX | |
95973 | A | Analyze neurostim, complex | 0.92 | 0.41 | 0.35 | 0.07 | 1.40 | 1.34 | ZZZ | |
95974 | A | Cranial neurostim, complex | 3.00 | 1.32 | 1.32 | 0.15 | 4.47 | 4.47 | XXX | |
95975 | A | Cranial neurostim, complex | 1.70 | 0.75 | 0.75 | 0.07 | 2.52 | 2.52 | ZZZ | |
95990 | A | Spin/brain pump refil main | 0.00 | 1.49 | NA | 0.05 | 1.54 | NA | XXX | |
95999 | C | Neurological procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
96000 | A | Motion analysis, video/3d | 1.80 | NA | 0.70 | 0.02 | NA | 2.52 | XXX | |
96001 | A | Motion test w/ft press meas | 2.15 | NA | 0.84 | 0.02 | NA | 3.01 | XXX | |
96002 | A | Dynamic surface emg | 0.41 | NA | 0.16 | 0.02 | NA | 0.59 | XXX | |
96003 | A | Dynamic fine wire emg | 0.37 | NA | 0.14 | 0.03 | NA | 0.54 | XXX | |
96004 | A | Phys review of motion tests | 2.14 | 0.84 | 0.84 | 0.08 | 3.06 | 3.06 | XXX | |
96100 | A | Psychological testing | 0.00 | 1.75 | NA | 0.15 | 1.90 | NA | XXX | |
96105 | A | Assessment of aphasia | 0.00 | 1.75 | NA | 0.15 | 1.90 | NA | XXX | |
96110 | C | Developmental test, lim | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
96111 | A | Developmental test, extend | 0.00 | 1.75 | NA | 0.15 | 1.90 | NA | XXX | |
96115 | A | Neurobehavior status exam | 0.00 | 1.75 | NA | 0.15 | 1.90 | NA | XXX | |
96117 | A | Neuropsych test battery | 0.00 | 1.75 | NA | 0.15 | 1.90 | NA | XXX | |
96150 | A | Assess lth/behave, init | 0.50 | 0.21 | 0.20 | 0.02 | 0.73 | 0.72 | XXX | |
96151 | A | Assess hlth/behave, subseq | 0.48 | 0.20 | 0.19 | 0.02 | 0.70 | 0.69 | XXX | |
96152 | A | Intervene hlth/behave, indiv | 0.46 | 0.19 | 0.18 | 0.02 | 0.67 | 0.66 | XXX | |
96153 | A | Intervene hlth/behave, group | 0.10 | 0.04 | 0.04 | 0.01 | 0.15 | 0.15 | XXX | |
96154 | A | Interv hlth/behav, fam w/pt | 0.45 | 0.19 | 0.18 | 0.02 | 0.66 | 0.65 | XXX | |
96155 | A | Interv hlth/behav fam no pt | 0.44 | 0.18 | 0.17 | 0.02 | 0.64 | 0.63 | XXX | |
96400 | A | Chemotherapy, sc/im | 0.00 | 1.01 | NA | 0.01 | 1.02 | NA | XXX | |
96405 | A | Intralesional chemo admin | 0.52 | 1.68 | 0.23 | 0.02 | 2.22 | 0.77 | 000 | |
96406 | A | Intralesional chemo admin | 0.80 | 2.54 | 0.30 | 0.02 | 3.36 | 1.12 | 000 | |
96408 | A | Chemotherapy, push technique | 0.00 | 0.97 | NA | 0.05 | 1.02 | NA | XXX | |
96410 | A | Chemotherapy,infusion method | 0.00 | 1.54 | NA | 0.07 | 1.61 | NA | XXX | |
96412 | A | Chemo, infuse method add-on | 0.00 | 1.14 | NA | 0.06 | 1.20 | NA | ZZZ | |
96414 | A | Chemo, infuse method add-on | 0.00 | 1.33 | NA | 0.07 | 1.40 | NA | XXX | |
96420 | A | Chemotherapy, push technique | 0.00 | 1.24 | NA | 0.07 | 1.31 | NA | XXX | |
96422 | A | Chemotherapy,infusion method | 0.00 | 1.22 | NA | 0.07 | 1.29 | NA | XXX | |
96423 | A | Chemo, infuse method add-on | 0.00 | 0.48 | NA | 0.02 | 0.50 | NA | ZZZ | |
96425 | A | Chemotherapy,infusion method | 0.00 | 1.42 | NA | 0.07 | 1.49 | NA | XXX | |
96440 | A | Chemotherapy, intracavitary | 2.37 | 7.92 | 1.04 | 0.12 | 10.41 | 3.53 | 000 | |
96445 | A | Chemotherapy, intracavitary | 2.20 | 7.97 | 1.02 | 0.07 | 10.24 | 3.29 | 000 | |
96450 | A | Chemotherapy, into CNS | 1.89 | 6.30 | 0.93 | 0.06 | 8.25 | 2.88 | 000 | |
96520 | A | Port pump refill main | 0.00 | 0.89 | NA | 0.05 | 0.94 | NA | XXX | |
96530 | A | Syst pump refill main | 0.00 | 1.05 | NA | 0.05 | 1.10 | NA | XXX | |
96542 | A | Chemotherapy injection | 1.42 | 3.99 | 0.55 | 0.05 | 5.46 | 2.02 | XXX | |
96545 | B | Provide chemotherapy agent | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
96549 | C | Chemotherapy, unspecified | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
96567 | A | Photodynamic tx, skin | 0.00 | 5.10 | NA | 0.03 | 5.13 | NA | XXX | |
96570 | A | Photodynamic tx, 30 min | 1.10 | 0.38 | 0.37 | 0.04 | 1.52 | 1.51 | ZZZ | |
96571 | A | Photodynamic tx, addl 15 min | 0.55 | 0.21 | 0.20 | 0.02 | 0.78 | 0.77 | ZZZ | |
96900 | A | Ultraviolet light therapy | 0.00 | 0.49 | NA | 0.02 | 0.51 | NA | XXX | |
96902 | B | Trichogram | +0.41 | 0.25 | 0.16 | 0.01 | 0.67 | 0.58 | XXX | |
96910 | A | Photochemotherapy with UV-B | 0.00 | 1.57 | NA | 0.03 | 1.60 | NA | XXX | |
96912 | A | Photochemotherapy with UV-A | 0.00 | 1.80 | NA | 0.04 | 1.84 | NA | XXX | |
96913 | A | Photochemotherapy, UV-A or B | 0.00 | 2.71 | NA | 0.08 | 2.79 | NA | XXX | |
96920 | A | Laser tx, skin 250 sq cm | 1.15 | 2.88 | 0.45 | 0.09 | 4.12 | 1.69 | 000 | |
96921 | A | Laser tx, skin 250-500 sq cm | 1.17 | 2.96 | 0.46 | 0.09 | 4.22 | 1.72 | 000 | |
96922 | A | Laser tx, skin 500 sq cm | 2.10 | 3.56 | 0.82 | 0.16 | 5.82 | 3.08 | 000 | |
96999 | C | Dermatological procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
97001 | A | Pt evaluation | 1.20 | 0.74 | 0.46 | 0.05 | 1.99 | 1.71 | XXX | |
97002 | A | Pt re-evaluation | 0.60 | 0.45 | 0.24 | 0.02 | 1.07 | 0.86 | XXX | |
97003 | A | Ot evaluation | 1.20 | 0.87 | 0.41 | 0.05 | 2.12 | 1.66 | XXX | |
97004 | A | Ot re-evaluation | 0.60 | 0.68 | 0.20 | 0.02 | 1.30 | 0.82 | XXX | |
97005 | I | Athletic train eval | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
97006 | I | Athletic train reeval | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
97010 | B | Hot or cold packs therapy | +0.06 | 0.05 | NA | 0.01 | 0.12 | NA | XXX | |
97012 | A | Mechanical traction therapy | 0.25 | 0.14 | NA | 0.01 | 0.40 | NA | XXX | |
97014 | I | Electric stimulation therapy | +0.18 | 0.19 | 0.19 | 0.01 | 0.38 | 0.38 | XXX | |
97016 | A | Vasopneumatic device therapy | 0.18 | 0.19 | NA | 0.01 | 0.38 | NA | XXX | |
97018 | A | Paraffin bath therapy | 0.06 | 0.11 | NA | 0.01 | 0.18 | NA | XXX | |
97020 | A | Microwave therapy | 0.06 | 0.06 | NA | 0.01 | 0.13 | NA | XXX | |
97022 | A | Whirlpool therapy | 0.17 | 0.22 | NA | 0.01 | 0.40 | NA | XXX | |
97024 | A | Diathermy treatment | 0.06 | 0.06 | NA | 0.01 | 0.13 | NA | XXX | |
97026 | A | Infrared therapy | 0.06 | 0.06 | NA | 0.01 | 0.13 | NA | XXX | |
97028 | A | Ultraviolet therapy | 0.08 | 0.07 | NA | 0.01 | 0.16 | NA | XXX | |
97032 | A | Electrical stimulation | 0.25 | 0.18 | NA | 0.01 | 0.44 | NA | XXX | |
97033 | A | Electric current therapy | 0.26 | 0.27 | NA | 0.02 | 0.55 | NA | XXX | |
97034 | A | Contrast bath therapy | 0.21 | 0.16 | NA | 0.01 | 0.38 | NA | XXX | |
97035 | A | Ultrasound therapy | 0.21 | 0.11 | NA | 0.01 | 0.33 | NA | XXX | |
97036 | A | Hydrotherapy | 0.28 | 0.33 | NA | 0.01 | 0.62 | NA | XXX | |
97039 | A | Physical therapy treatment | 0.20 | 0.11 | NA | 0.01 | 0.32 | NA | XXX | |
97110 | A | Therapeutic exercises | 0.45 | 0.28 | NA | 0.03 | 0.76 | NA | XXX | |
97112 | A | Neuromuscular reeducation | 0.45 | 0.31 | NA | 0.02 | 0.78 | NA | XXX | |
97113 | A | Aquatic therapy/exercises | 0.44 | 0.34 | NA | 0.03 | 0.81 | NA | XXX | |
97116 | A | Gait training therapy | 0.40 | 0.25 | NA | 0.02 | 0.67 | NA | XXX | |
97124 | A | Massage therapy | 0.35 | 0.24 | NA | 0.01 | 0.60 | NA | XXX | |
97139 | A | Physical medicine procedure | 0.21 | 0.21 | NA | 0.01 | 0.43 | NA | XXX | |
97140 | A | Manual therapy | 0.43 | 0.27 | NA | 0.02 | 0.72 | NA | XXX | |
97150 | A | Group therapeutic procedures | 0.27 | 0.21 | NA | 0.02 | 0.50 | NA | XXX | |
97504 | A | Orthotic training | 0.45 | 0.29 | NA | 0.03 | 0.77 | NA | XXX | |
97520 | A | Prosthetic training | 0.45 | 0.28 | NA | 0.02 | 0.75 | NA | XXX | |
97530 | A | Therapeutic activities | 0.44 | 0.31 | NA | 0.02 | 0.77 | NA | XXX | |
97532 | A | Cognitive skills development | 0.44 | 0.20 | NA | 0.01 | 0.65 | NA | XXX | |
97533 | A | Sensory integration | 0.44 | 0.24 | NA | 0.01 | 0.69 | NA | XXX | |
97535 | A | Self care mngment training | 0.45 | 0.36 | NA | 0.02 | 0.83 | NA | XXX | |
97537 | A | Community/work reintegration | 0.45 | 0.27 | NA | 0.01 | 0.73 | NA | XXX | |
97542 | A | Wheelchair mngment training | 0.45 | 0.29 | NA | 0.01 | 0.75 | NA | XXX | |
97545 | R | Work hardening | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
97546 | R | Work hardening add-on | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | |
97601 | A | Wound(s) care, selective | 0.50 | 0.53 | NA | 0.04 | 1.07 | NA | XXX | |
97602 | B | Wound(s) care non-selective | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
97703 | A | Prosthetic checkout | 0.25 | 0.33 | NA | 0.02 | 0.60 | NA | XXX | |
97750 | A | Physical performance test | 0.45 | 0.31 | NA | 0.02 | 0.78 | NA | XXX | |
97780 | N | Acupuncture w/o stimul | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
97781 | N | Acupuncture w/stimul | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
97799 | C | Physical medicine procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
97802 | A | Medical nutrition, indiv, in | 0.00 | 0.47 | NA | 0.01 | 0.48 | NA | XXX | |
97803 | A | Med nutrition, indiv, subseq | 0.00 | 0.47 | NA | 0.01 | 0.48 | NA | XXX | |
97804 | A | Medical nutrition, group | 0.00 | 0.18 | NA | 0.01 | 0.19 | NA | XXX | |
98925 | A | Osteopathic manipulation | 0.45 | 0.37 | 0.15 | 0.01 | 0.83 | 0.61 | 000 | |
98926 | A | Osteopathic manipulation | 0.65 | 0.44 | 0.26 | 0.02 | 1.11 | 0.93 | 000 | |
98927 | A | Osteopathic manipulation | 0.87 | 0.51 | 0.30 | 0.03 | 1.41 | 1.20 | 000 | |
98928 | A | Osteopathic manipulation | 1.03 | 0.59 | 0.35 | 0.03 | 1.65 | 1.41 | 000 | |
98929 | A | Osteopathic manipulation | 1.19 | 0.65 | 0.38 | 0.04 | 1.88 | 1.61 | 000 | |
98940 | A | Chiropractic manipulation | 0.45 | 0.24 | 0.13 | 0.01 | 0.70 | 0.59 | 000 | |
98941 | A | Chiropractic manipulation | 0.65 | 0.30 | 0.18 | 0.02 | 0.97 | 0.85 | 000 | |
98942 | A | Chiropractic manipulation | 0.87 | 0.37 | 0.24 | 0.03 | 1.27 | 1.14 | 000 | |
98943 | N | Chiropractic manipulation | +0.40 | 0.24 | 0.16 | 0.01 | 0.65 | 0.57 | XXX | |
99000 | B | Specimen handling | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99001 | B | Specimen handling | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99002 | B | Device handling | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99024 | B | Postop follow-up visit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99025 | B | Initial surgical evaluation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99026 | I | In-hospital on call service | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99027 | I | Out-of-hosp on call service | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99050 | B | Medical services after hrs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99052 | B | Medical services at night | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99054 | B | Medical servcs, unusual hrs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99056 | B | Non-office medical services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99058 | B | Office emergency care | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99070 | B | Special supplies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99071 | B | Patient education materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99075 | N | Medical testimony | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99078 | B | Group health education | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99080 | B | Special reports or forms | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99082 | C | Unusual physician travel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99090 | B | Computer data analysis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99091 | B | Collect/review data from pt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99100 | B | Special anesthesia service | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | |
99116 | B | Anesthesia with hypothermia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | |
99135 | B | Special anesthesia procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | |
99140 | B | Emergency anesthesia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | |
99141 | B | Sedation, iv/im or inhalant | +0.80 | 2.15 | 0.39 | 0.04 | 2.99 | 1.23 | XXX | |
99142 | B | Sedation, oral/rectal/nasal | +0.60 | 1.25 | 0.31 | 0.03 | 1.88 | 0.94 | XXX | |
99170 | A | Anogenital exam, child | 1.75 | 2.07 | 0.53 | 0.07 | 3.89 | 2.35 | 000 | |
99172 | N | Ocular function screen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99173 | N | Visual acuity screen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99175 | A | Induction of vomiting | 0.00 | 1.38 | NA | 0.08 | 1.46 | NA | XXX | |
99183 | A | Hyperbaric oxygen therapy | 2.34 | NA | 0.75 | 0.12 | NA | 3.21 | XXX | |
99185 | A | Regional hypothermia | 0.00 | 0.64 | NA | 0.03 | 0.67 | NA | XXX | |
99186 | A | Total body hypothermia | 0.00 | 1.77 | NA | 0.37 | 2.14 | NA | XXX | |
99190 | X | Special pump services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99191 | X | Special pump services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99192 | X | Special pump services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99195 | A | Phlebotomy | 0.00 | 0.45 | NA | 0.02 | 0.47 | NA | XXX | |
99199 | C | Special service/proc/report | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99201 | A | Office/outpatient visit, new | 0.45 | 0.48 | 0.16 | 0.02 | 0.95 | 0.63 | XXX | |
99202 | A | Office/outpatient visit, new | 0.88 | 0.77 | 0.32 | 0.05 | 1.70 | 1.25 | XXX | |
99203 | A | Office/outpatient visit, new | 1.34 | 1.10 | 0.49 | 0.08 | 2.52 | 1.91 | XXX | |
99204 | A | Office/outpatient visit, new | 2.00 | 1.49 | 0.72 | 0.10 | 3.59 | 2.82 | XXX | |
99205 | A | Office/outpatient visit, new | 2.67 | 1.79 | 0.95 | 0.12 | 4.58 | 3.74 | XXX | |
99211 | A | Office/outpatient visit, est | 0.17 | 0.38 | 0.06 | 0.01 | 0.56 | 0.24 | XXX | |
99212 | A | Office/outpatient visit, est | 0.45 | 0.52 | 0.16 | 0.02 | 0.99 | 0.63 | XXX | |
99213 | A | Office/outpatient visit, est | 0.67 | 0.69 | 0.24 | 0.03 | 1.39 | 0.94 | XXX | |
99214 | A | Office/outpatient visit, est | 1.10 | 1.03 | 0.40 | 0.04 | 2.17 | 1.54 | XXX | |
99215 | A | Office/outpatient visit, est | 1.77 | 1.34 | 0.64 | 0.07 | 3.18 | 2.48 | XXX | |
99217 | A | Observation care discharge | 1.28 | NA | 0.44 | 0.05 | NA | 1.77 | XXX | |
99218 | A | Observation care | 1.28 | NA | 0.44 | 0.05 | NA | 1.77 | XXX | |
99219 | A | Observation care | 2.14 | NA | 0.73 | 0.08 | NA | 2.95 | XXX | |
99220 | A | Observation care | 2.99 | NA | 1.03 | 0.11 | NA | 4.13 | XXX | |
99221 | A | Initial hospital care | 1.28 | NA | 0.46 | 0.05 | NA | 1.79 | XXX | |
99222 | A | Initial hospital care | 2.14 | NA | 0.75 | 0.08 | NA | 2.97 | XXX | |
99223 | A | Initial hospital care | 2.99 | NA | 1.04 | 0.10 | NA | 4.13 | XXX | |
99231 | A | Subsequent hospital care | 0.64 | NA | 0.23 | 0.02 | NA | 0.89 | XXX | |
99232 | A | Subsequent hospital care | 1.06 | NA | 0.38 | 0.03 | NA | 1.47 | XXX | |
99233 | A | Subsequent hospital care | 1.51 | NA | 0.53 | 0.05 | NA | 2.09 | XXX | |
99234 | A | Observ/hosp same date | 2.56 | NA | 0.89 | 0.11 | NA | 3.56 | XXX | |
99235 | A | Observ/hosp same date | 3.42 | NA | 1.16 | 0.13 | NA | 4.71 | XXX | |
99236 | A | Observ/hosp same date | 4.27 | NA | 1.45 | 0.17 | NA | 5.89 | XXX | |
99238 | A | Hospital discharge day | 1.28 | NA | 0.56 | 0.04 | NA | 1.88 | XXX | |
99239 | A | Hospital discharge day | 1.75 | NA | 0.75 | 0.05 | NA | 2.55 | XXX | |
99241 | A | Office consultation | 0.64 | 0.61 | 0.22 | 0.04 | 1.29 | 0.90 | XXX | |
99242 | A | Office consultation | 1.29 | 1.02 | 0.47 | 0.09 | 2.40 | 1.85 | XXX | |
99243 | A | Office consultation | 1.72 | 1.35 | 0.64 | 0.10 | 3.17 | 2.46 | XXX | |
99244 | A | Office consultation | 2.58 | 1.80 | 0.94 | 0.13 | 4.51 | 3.65 | XXX | |
99245 | A | Office consultation | 3.43 | 2.26 | 1.24 | 0.16 | 5.85 | 4.83 | XXX | |
99251 | A | Initial inpatient consult | 0.66 | NA | 0.25 | 0.04 | NA | 0.95 | XXX | |
99252 | A | Initial inpatient consult | 1.32 | NA | 0.51 | 0.08 | NA | 1.91 | XXX | |
99253 | A | Initial inpatient consult | 1.82 | NA | 0.70 | 0.09 | NA | 2.61 | XXX | |
99254 | A | Initial inpatient consult | 2.64 | NA | 1.00 | 0.11 | NA | 3.75 | XXX | |
99255 | A | Initial inpatient consult | 3.65 | NA | 1.36 | 0.15 | NA | 5.16 | XXX | |
99261 | A | Follow-up inpatient consult | 0.42 | NA | 0.16 | 0.02 | NA | 0.60 | XXX | |
99262 | A | Follow-up inpatient consult | 0.85 | NA | 0.31 | 0.03 | NA | 1.19 | XXX | |
99263 | A | Follow-up inpatient consult | 1.27 | NA | 0.46 | 0.04 | NA | 1.77 | XXX | |
99271 | A | Confirmatory consultation | 0.45 | 0.66 | 0.16 | 0.03 | 1.14 | 0.64 | XXX | |
99272 | A | Confirmatory consultation | 0.84 | 0.89 | 0.32 | 0.06 | 1.79 | 1.22 | XXX | |
99273 | A | Confirmatory consultation | 1.19 | 1.09 | 0.45 | 0.07 | 2.35 | 1.71 | XXX | |
99274 | A | Confirmatory consultation | 1.73 | 1.39 | 0.65 | 0.09 | 3.21 | 2.47 | XXX | |
99275 | A | Confirmatory consultation | 2.31 | 1.64 | 0.84 | 0.10 | 4.05 | 3.25 | XXX | |
99281 | A | Emergency dept visit | 0.33 | NA | 0.09 | 0.02 | NA | 0.44 | XXX | |
99282 | A | Emergency dept visit | 0.55 | NA | 0.15 | 0.03 | NA | 0.73 | XXX | |
99283 | A | Emergency dept visit | 1.24 | NA | 0.32 | 0.08 | NA | 1.64 | XXX | |
99284 | A | Emergency dept visit | 1.95 | NA | 0.49 | 0.12 | NA | 2.56 | XXX | |
99285 | A | Emergency dept visit | 3.06 | NA | 0.74 | 0.19 | NA | 3.99 | XXX | |
99288 | B | Direct advanced life support | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99289 | A | Ped crit care transport | 4.80 | NA | 1.87 | 0.14 | NA | 6.81 | XXX | |
99290 | A | Ped crit care transport addl | 2.40 | NA | 0.94 | 0.07 | NA | 3.41 | ZZZ | |
99291 | A | Critical care, first hour | 4.00 | 1.57 | 1.30 | 0.14 | 5.71 | 5.44 | XXX | |
99292 | A | Critical care, addl 30 min | 2.00 | 0.86 | 0.65 | 0.07 | 2.93 | 2.72 | ZZZ | |
99293 | A | Ped critical care, initial | 16.00 | NA | 5.13 | 0.70 | NA | 21.83 | XXX | |
99294 | A | Ped critical care, subseq | 8.00 | NA | 2.57 | 0.23 | NA | 10.80 | XXX | |
99295 | A | Neonate crit care, initial | 18.49 | NA | 5.48 | 0.70 | NA | 24.67 | XXX | |
99296 | A | Neonate critical care subseq | 8.00 | NA | 2.61 | 0.23 | NA | 10.84 | XXX | |
99297 | D | Neonatal critical care | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99298 | A | Ic for lbw infant 1500 gm | 2.75 | NA | 0.96 | 0.10 | NA | 3.81 | XXX | |
99299 | A | Ic, lbw infant 1500-2500 gm | 2.50 | NA | 0.98 | 0.10 | NA | 3.58 | XXX | |
99301 | A | Nursing facility care | 1.20 | 0.69 | 0.42 | 0.04 | 1.93 | 1.66 | XXX | |
99302 | A | Nursing facility care | 1.61 | 0.97 | 0.55 | 0.05 | 2.63 | 2.21 | XXX | |
99303 | A | Nursing facility care | 2.01 | 1.19 | 0.68 | 0.06 | 3.26 | 2.75 | XXX | |
99311 | A | Nursing fac care, subseq | 0.60 | 0.49 | 0.21 | 0.02 | 1.11 | 0.83 | XXX | |
99312 | A | Nursing fac care, subseq | 1.00 | 0.67 | 0.34 | 0.03 | 1.70 | 1.37 | XXX | |
99313 | A | Nursing fac care, subseq | 1.42 | 0.87 | 0.49 | 0.04 | 2.33 | 1.95 | XXX | |
99315 | A | Nursing fac discharge day | 1.13 | 0.73 | 0.38 | 0.04 | 1.90 | 1.55 | XXX | |
99316 | A | Nursing fac discharge day | 1.50 | 0.93 | 0.52 | 0.05 | 2.48 | 2.07 | XXX | |
99321 | A | Rest home visit, new patient | 0.71 | 0.45 | NA | 0.02 | 1.18 | NA | XXX | |
99322 | A | Rest home visit, new patient | 1.01 | 0.70 | NA | 0.03 | 1.74 | NA | XXX | |
99323 | A | Rest home visit, new patient | 1.28 | 0.92 | NA | 0.04 | 2.24 | NA | XXX | |
99331 | A | Rest home visit, est pat | 0.60 | 0.47 | NA | 0.02 | 1.09 | NA | XXX | |
99332 | A | Rest home visit, est pat | 0.80 | 0.58 | NA | 0.03 | 1.41 | NA | XXX | |
99333 | A | Rest home visit, est pat | 1.00 | 0.71 | NA | 0.03 | 1.74 | NA | XXX | |
99341 | A | Home visit, new patient | 1.01 | 0.55 | NA | 0.05 | 1.61 | NA | XXX | |
99342 | A | Home visit, new patient | 1.52 | 0.85 | NA | 0.05 | 2.42 | NA | XXX | |
99343 | A | Home visit, new patient | 2.27 | 1.26 | NA | 0.07 | 3.60 | NA | XXX | |
99344 | A | Home visit, new patient | 3.03 | 1.55 | NA | 0.10 | 4.68 | NA | XXX | |
99345 | A | Home visit, new patient | 3.79 | 1.81 | NA | 0.12 | 5.72 | NA | XXX | |
99347 | A | Home visit, est patient | 0.76 | 0.48 | NA | 0.03 | 1.27 | NA | XXX | |
99348 | A | Home visit, est patient | 1.26 | 0.72 | NA | 0.04 | 2.02 | NA | XXX | |
99349 | A | Home visit, est patient | 2.02 | 1.05 | NA | 0.06 | 3.13 | NA | XXX | |
99350 | A | Home visit, est patient | 3.03 | 1.43 | NA | 0.10 | 4.56 | NA | XXX | |
99354 | A | Prolonged service, office | 1.77 | 1.46 | 0.61 | 0.06 | 3.29 | 2.44 | ZZZ | |
99355 | A | Prolonged service, office | 1.77 | 1.24 | 0.59 | 0.06 | 3.07 | 2.42 | ZZZ | |
99356 | A | Prolonged service, inpatient | 1.71 | NA | 0.60 | 0.06 | NA | 2.37 | ZZZ | |
99357 | A | Prolonged service, inpatient | 1.71 | NA | 0.61 | 0.06 | NA | 2.38 | ZZZ | |
99358 | B | Prolonged serv, w/o contact | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | |
99359 | B | Prolonged serv, w/o contact | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | |
99360 | X | Physician standby services | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99361 | B | Physician/team conference | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99362 | B | Physician/team conference | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99371 | B | Physician phone consultation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99372 | B | Physician phone consultation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99373 | B | Physician phone consultation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99374 | B | Home health care supervision | +1.10 | 1.49 | 0.43 | 0.04 | 2.63 | 1.57 | XXX | |
99375 | I | Home health care supervision | +1.73 | 1.57 | 1.57 | 0.06 | 3.36 | 3.36 | XXX | |
99377 | B | Hospice care supervision | +1.10 | 1.49 | 0.43 | 0.04 | 2.63 | 1.57 | XXX | |
99378 | I | Hospice care supervision | +1.73 | 1.97 | 1.97 | 0.06 | 3.76 | 3.76 | XXX | |
99379 | B | Nursing fac care supervision | +1.10 | 1.49 | 0.43 | 0.03 | 2.62 | 1.56 | XXX | |
99380 | B | Nursing fac care supervision | +1.73 | 1.74 | 0.68 | 0.05 | 3.52 | 2.46 | XXX | |
99381 | N | Prev visit, new, infant | +1.19 | 1.52 | 0.46 | 0.04 | 2.75 | 1.69 | XXX | |
99382 | N | Prev visit, new, age 1-4 | +1.36 | 1.56 | 0.53 | 0.04 | 2.96 | 1.93 | XXX | |
99383 | N | Prev visit, new, age 5-11 | +1.36 | 1.50 | 0.53 | 0.04 | 2.90 | 1.93 | XXX | |
99384 | N | Prev visit, new, age 12-17 | +1.53 | 1.57 | 0.60 | 0.05 | 3.15 | 2.18 | XXX | |
99385 | N | Prev visit, new, age 18-39 | +1.53 | 1.57 | 0.60 | 0.05 | 3.15 | 2.18 | XXX | |
99386 | N | Prev visit, new, age 40-64 | +1.88 | 1.76 | 0.73 | 0.06 | 3.70 | 2.67 | XXX | |
99387 | N | Prev visit, new, 65 over | +2.06 | 1.89 | 0.80 | 0.06 | 4.01 | 2.92 | XXX | |
99391 | N | Prev visit, est, infant | +1.02 | 1.03 | 0.40 | 0.03 | 2.08 | 1.45 | XXX | |
99392 | N | Prev visit, est, age 1-4 | +1.19 | 1.10 | 0.46 | 0.04 | 2.33 | 1.69 | XXX | |
99393 | N | Prev visit, est, age 5-11 | +1.19 | 1.07 | 0.46 | 0.04 | 2.30 | 1.69 | XXX | |
99394 | N | Prev visit, est, age 12-17 | +1.36 | 1.15 | 0.53 | 0.04 | 2.55 | 1.93 | XXX | |
99395 | N | Prev visit, est, age 18-39 | +1.36 | 1.18 | 0.53 | 0.04 | 2.58 | 1.93 | XXX | |
99396 | N | Prev visit, est, age 40-64 | +1.53 | 1.27 | 0.60 | 0.05 | 2.85 | 2.18 | XXX | |
99397 | N | Prev visit, est, 65 over | +1.71 | 1.38 | 0.67 | 0.05 | 3.14 | 2.43 | XXX | |
99401 | N | Preventive counseling, indiv | +0.48 | 0.63 | 0.19 | 0.01 | 1.12 | 0.68 | XXX | |
99402 | N | Preventive counseling, indiv | +0.98 | 0.88 | 0.38 | 0.02 | 1.88 | 1.38 | XXX | |
99403 | N | Preventive counseling, indiv | +1.46 | 1.10 | 0.57 | 0.03 | 2.59 | 2.06 | XXX | |
99404 | N | Preventive counseling, indiv | +1.95 | 1.34 | 0.76 | 0.04 | 3.33 | 2.75 | XXX | |
99411 | N | Preventive counseling, group | +0.15 | 0.18 | 0.06 | 0.01 | 0.34 | 0.22 | XXX | |
99412 | N | Preventive counseling, group | +0.25 | 0.25 | 0.10 | 0.01 | 0.51 | 0.36 | XXX | |
99420 | N | Health risk assessment test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99429 | N | Unlisted preventive service | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99431 | A | Initial care, normal newborn | 1.17 | NA | 0.39 | 0.04 | NA | 1.60 | XXX | |
99432 | A | Newborn care, not in hosp | 1.26 | 0.84 | 0.41 | 0.06 | 2.16 | 1.73 | XXX | |
99433 | A | Normal newborn care/hospital | 0.62 | NA | 0.20 | 0.02 | NA | 0.84 | XXX | |
99435 | A | Newborn discharge day hosp | 1.50 | NA | 0.51 | 0.05 | NA | 2.06 | XXX | |
99436 | A | Attendance, birth | 1.50 | 0.49 | 0.48 | 0.05 | 2.04 | 2.03 | XXX | |
99440 | A | Newborn resuscitation | 2.93 | NA | 0.95 | 0.11 | NA | 3.99 | XXX | |
99450 | N | Life/disability evaluation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99455 | R | Disability examination | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99456 | R | Disability examination | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99499 | C | Unlisted em service | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99500 | I | Home visit, prenatal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99501 | I | Home visit, postnatal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99502 | I | Home visit, nb care | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99503 | I | Home visit, resp therapy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99504 | I | Home visit mech ventilator | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99505 | I | Home visit, stoma care | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99506 | I | Home visit, im injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99507 | I | Home visit, cath maintain | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99508 | F | Home visit, sleep studies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99509 | I | Home visit day life activity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99510 | I | Home visit, sing/m/fam couns | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99511 | I | Home visit, fecal/enema mgmt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99512 | I | Home visit, hemodialysis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99539 | F | Home visit, nos | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99551 | I | Home infus, pain mgmt, iv/sc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99552 | I | Hm infus pain mgmt, epid/ith | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99553 | I | Home infuse, tocolytic tx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99554 | I | Home infus, hormone/platelet | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99555 | I | Home infuse, chemotheraphy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99556 | I | Home infus, antibio/fung/vir | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99557 | I | Home infuse, anticoagulant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99558 | I | Home infuse, immunotherapy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99559 | I | Home infus, periton dialysis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99560 | I | Home infus, entero nutrition | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99561 | I | Home infuse, hydration tx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99562 | I | Home infus, parent nutrition | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99563 | I | Home admin, pentamidine | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99564 | I | Hme infus, antihemophil agnt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99565 | I | Home infus, proteinase inhib | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99566 | I | Home infuse, iv therapy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99567 | I | Home infuse, sympath agent | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99568 | I | Home infus, misc drug, daily | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99569 | I | Home infuse, each addl tx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99600 | I | Home visit nos | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
A4890 | R | Repair/maint cont hemo equip | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
D0150 | R | Comprehensve oral evaluation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D0240 | R | Intraoral occlusal film | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D0250 | R | Extraoral first film | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D0260 | R | Extraoral ea additional film | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D0270 | R | Dental bitewing single film | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D0272 | R | Dental bitewings two films | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D0274 | R | Dental bitewings four films | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D0277 | R | Vert bitewings-sev to eight | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
D0460 | R | Pulp vitality test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D0472 | R | Gross exam, prep report | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
D0473 | R | Micro exam, prep report | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
D0474 | R | Micro w exam of surg margins | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
D0480 | R | Cytopath smear prep report | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
D0502 | R | Other oral pathology procedu | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D0999 | R | Unspecified diagnostic proce | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D1510 | R | Space maintainer fxd unilat | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D1515 | R | Fixed bilat space maintainer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D1520 | R | Remove unilat space maintain | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D1525 | R | Remove bilat space maintain | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D1550 | R | Recement space maintainer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D2970 | R | Temporary- fractured tooth | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D2999 | R | Dental unspec restorative pr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D3460 | R | Endodontic endosseous implan | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D3999 | R | Endodontic procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D4260 | R | Osseous surgery per quadrant | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D4263 | R | Bone replce graft first site | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D4264 | R | Bone replce graft each add | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D4268 | R | Surgical revision procedure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
D4270 | R | Pedicle soft tissue graft pr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D4271 | R | Free soft tissue graft proc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D4273 | R | Subepithelial tissue graft | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D4355 | R | Full mouth debridement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D4381 | R | Localized chemo delivery | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D5911 | R | Facial moulage sectional | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D5912 | R | Facial moulage complete | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D5951 | R | Feeding aid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D5983 | R | Radiation applicator | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D5984 | R | Radiation shield | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D5985 | R | Radiation cone locator | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D5987 | R | Commissure splint | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D6920 | R | Dental connector bar | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D7111 | R | Coronal remnants deciduous t | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
D7140 | R | Extraction erupted tooth/exr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
D7210 | R | Rem imp tooth w mucoper flp | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D7220 | R | Impact tooth remov soft tiss | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D7230 | R | Impact tooth remov part bony | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D7240 | R | Impact tooth remov comp bony | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D7241 | R | Impact tooth rem bony w/comp | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D7250 | R | Tooth root removal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D7260 | R | Oral antral fistula closure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D7261 | R | Primary closure sinus perf | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
D7291 | R | Transseptal fiberotomy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D7940 | R | Reshaping bone orthognathic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D9110 | R | Tx dental pain minor proc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D9230 | R | Analgesia | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D9248 | R | Sedation (non-iv) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
D9630 | R | Other drugs/medicaments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D9930 | R | Treatment of complications | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D9940 | R | Dental occlusal guard | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D9950 | R | Occlusion analysis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D9951 | R | Limited occlusal adjustment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
D9952 | R | Complete occlusal adjustment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
G0001 | X | Drawing blood for specimen | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0002 | D | Temporary urinary catheter | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 000 | |
G0004 | D | ECG transm phys review int | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0005 | D | ECG 24 hour recording | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0006 | D | ECG transmission analysis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0007 | D | ECG phy review interpret | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0008 | X | Admin influenza virus vac | 0.00 | 0.00 | NA | 0.00 | 0.00 | NA | XXX | |
G0009 | X | Admin pneumococcal vaccine | 0.00 | 0.00 | NA | 0.00 | 0.00 | NA | XXX | |
G0010 | X | Admin hepatitis b vaccine | 0.00 | 0.00 | NA | 0.00 | 0.00 | NA | XXX | |
G0015 | D | Post symptom ECG tracing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0025 | B | Collagen skin test kit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0026 | D | Fecal leukocyte examination | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0027 | D | Semen analysis | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0030 | C | PET imaging prev PET single | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0030 | 26 | A | PET imaging prev PET single | 1.50 | 0.52 | 0.52 | 0.04 | 2.06 | 2.06 | XXX |
G0030 | TC | C | PET imaging prev PET single | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0031 | C | PET imaging prev PET multple | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0031 | 26 | A | PET imaging prev PET multple | 1.87 | 0.70 | 0.70 | 0.06 | 2.63 | 2.63 | XXX |
G0031 | TC | C | PET imaging prev PET multple | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0032 | C | PET follow SPECT 78464 singl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0032 | 26 | A | PET follow SPECT 78464 singl | 1.50 | 0.52 | 0.52 | 0.05 | 2.07 | 2.07 | XXX |
G0032 | TC | C | PET follow SPECT 78464 singl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0033 | C | PET follow SPECT 78464 mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0033 | 26 | A | PET follow SPECT 78464 mult | 1.87 | 0.70 | 0.70 | 0.06 | 2.63 | 2.63 | XXX |
G0033 | TC | C | PET follow SPECT 78464 mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0034 | C | PET follow SPECT 76865 singl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0034 | 26 | A | PET follow SPECT 76865 singl | 1.50 | 0.52 | 0.52 | 0.05 | 2.07 | 2.07 | XXX |
G0034 | TC | C | PET follow SPECT 76865 singl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0035 | C | PET follow SPECT 78465 mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0035 | 26 | A | PET follow SPECT 78465 mult | 1.87 | 0.70 | 0.70 | 0.06 | 2.63 | 2.63 | XXX |
G0035 | TC | C | PET follow SPECT 78465 mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0036 | C | PET follow cornry angio sing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0036 | 26 | A | PET follow cornry angio sing | 1.50 | 0.52 | 0.52 | 0.04 | 2.06 | 2.06 | XXX |
G0036 | TC | C | PET follow cornry angio sing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0037 | C | PET follow cornry angio mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0037 | 26 | A | PET follow cornry angio mult | 1.87 | 0.70 | 0.70 | 0.06 | 2.63 | 2.63 | XXX |
G0037 | TC | C | PET follow cornry angio mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0038 | C | PET follow myocard perf sing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0038 | 26 | A | PET follow myocard perf sing | 1.50 | 0.52 | 0.52 | 0.04 | 2.06 | 2.06 | XXX |
G0038 | TC | C | PET follow myocard perf sing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0039 | C | PET follow myocard perf mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0039 | 26 | A | PET follow myocard perf mult | 1.87 | 0.70 | 0.70 | 0.07 | 2.64 | 2.64 | XXX |
G0039 | TC | C | PET follow myocard perf mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0040 | C | PET follow stress echo singl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0040 | 26 | A | PET follow stress echo singl | 1.50 | 0.52 | 0.52 | 0.04 | 2.06 | 2.06 | XXX |
G0040 | TC | C | PET follow stress echo singl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0041 | C | PET follow stress echo mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0041 | 26 | A | PET follow stress echo mult | 1.87 | 0.70 | 0.70 | 0.05 | 2.62 | 2.62 | XXX |
G0041 | TC | C | PET follow stress echo mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0042 | C | PET follow ventriculogm sing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0042 | 26 | A | PET follow ventriculogm sing | 1.50 | 0.52 | 0.52 | 0.04 | 2.06 | 2.06 | XXX |
G0042 | TC | C | PET follow ventriculogm sing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0043 | C | PET follow ventriculogm mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0043 | 26 | A | PET follow ventriculogm mult | 1.87 | 0.70 | 0.70 | 0.06 | 2.63 | 2.63 | XXX |
G0043 | TC | C | PET follow ventriculogm mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0044 | C | PET following rest ECG singl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0044 | 26 | A | PET following rest ECG singl | 1.50 | 0.52 | 0.52 | 0.04 | 2.06 | 2.06 | XXX |
G0044 | TC | C | PET following rest ECG singl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0045 | C | PET following rest ECG mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0045 | 26 | A | PET following rest ECG mult | 1.87 | 0.70 | 0.70 | 0.06 | 2.63 | 2.63 | XXX |
G0045 | TC | C | PET following rest ECG mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0046 | C | PET follow stress ECG singl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0046 | 26 | A | PET follow stress ECG singl | 1.50 | 0.52 | 0.52 | 0.04 | 2.06 | 2.06 | XXX |
G0046 | TC | C | PET follow stress ECG singl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0047 | C | PET follow stress ECG mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0047 | 26 | A | PET follow stress ECG mult | 1.87 | 0.70 | 0.70 | 0.06 | 2.63 | 2.63 | XXX |
G0047 | TC | C | PET follow stress ECG mult | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0050 | D | Residual urine by ultrasound | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0101 | A | CA screen;pelvic/breast exam | 0.45 | 0.51 | 0.17 | 0.01 | 0.97 | 0.63 | XXX | |
G0102 | A | Prostate ca screening; dre | 0.17 | 0.38 | 0.06 | 0.01 | 0.56 | 0.24 | XXX | |
G0103 | X | Psa, total screening | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0104 | A | CA screen;flexi sigmoidscope | 0.96 | 1.82 | 0.52 | 0.05 | 2.83 | 1.53 | 000 | |
G0105 | A | Colorectal scrn; hi risk ind | 3.70 | 8.03 | 1.72 | 0.20 | 11.93 | 5.62 | 000 | |
G0106 | A | Colon CA screen;barium enema | 0.99 | 2.56 | NA | 0.15 | 3.70 | NA | XXX | |
G0106 | 26 | A | Colon CA screen;barium enema | 0.99 | 0.34 | 0.34 | 0.04 | 1.37 | 1.37 | XXX |
G0106 | TC | A | Colon CA screen;barium enema | 0.00 | 2.22 | NA | 0.11 | 2.33 | NA | XXX |
G0107 | X | CA screen; fecal blood test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0108 | A | Diab manage trn per indiv | 0.00 | 0.82 | NA | 0.01 | 0.83 | NA | XXX | |
G0109 | A | Diab manage trn ind/group | 0.00 | 0.48 | NA | 0.01 | 0.49 | NA | XXX | |
G0110 | R | Nett pulm-rehab educ; ind | 0.90 | 0.71 | 0.30 | 0.03 | 1.64 | 1.23 | XXX | |
G0111 | R | Nett pulm-rehab educ; group | 0.27 | 0.29 | 0.14 | 0.01 | 0.57 | 0.42 | XXX | |
G0112 | R | Nett;nutrition guid, initial | 1.72 | 1.22 | 0.67 | 0.05 | 2.99 | 2.44 | XXX | |
G0113 | R | Nett;nutrition guid,subseqnt | 1.29 | 0.84 | 0.42 | 0.04 | 2.17 | 1.75 | XXX | |
G0114 | R | Nett; psychosocial consult | 1.20 | 0.50 | 0.38 | 0.03 | 1.73 | 1.61 | XXX | |
G0115 | R | Nett; psychological testing | 1.20 | 0.65 | 0.38 | 0.04 | 1.89 | 1.62 | XXX | |
G0116 | R | Nett; psychosocial counsel | 1.11 | 1.02 | 0.34 | 0.04 | 2.17 | 1.49 | XXX | |
G0117 | T | Glaucoma scrn hgh risk direc | 0.45 | 0.94 | 0.21 | 0.02 | 1.41 | 0.68 | XXX | |
G0118 | T | Glaucoma scrn hgh risk direc | 0.17 | 0.81 | 0.08 | 0.01 | 0.99 | 0.26 | XXX | |
G0120 | A | Colon ca scrn; barium enema | 0.99 | 2.56 | NA | 0.15 | 3.70 | NA | XXX | |
G0120 | 26 | A | Colon ca scrn; barium enema | 0.99 | 0.34 | 0.34 | 0.04 | 1.37 | 1.37 | XXX |
G0120 | TC | A | Colon ca scrn; barium enema | 0.00 | 2.22 | NA | 0.11 | 2.33 | NA | XXX |
G0121 | A | Colon ca scrn not hi rsk ind | 3.70 | 8.03 | 1.72 | 0.20 | 11.93 | 5.62 | 000 | |
G0122 | N | Colon ca scrn; barium enema | +0.99 | 2.61 | NA | 0.15 | 3.75 | NA | XXX | |
G0122 | 26 | N | Colon ca scrn; barium enema | +0.99 | 0.39 | 0.39 | 0.04 | 1.42 | 1.42 | XXX |
G0122 | TC | N | Colon ca scrn; barium enema | +0.00 | 2.22 | NA | 0.11 | 2.33 | NA | XXX |
G0123 | X | Screen cerv/vag thin layer | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0124 | A | Screen c/v thin layer by MD | 0.42 | 0.99 | 0.99 | 0.01 | 1.42 | 1.42 | XXX | |
G0125 | A | PET image pulmonary nodule | 1.50 | 55.83 | NA | 2.00 | 59.33 | NA | XXX | |
G0125 | 26 | A | PET image pulmonary nodule | 1.50 | 0.52 | 0.52 | 0.05 | 2.07 | 2.07 | XXX |
G0125 | TC | A | PET image pulmonary nodule | 0.00 | 55.31 | NA | 1.95 | 57.26 | NA | XXX |
G0127 | R | Trim nail(s) | 0.17 | 0.26 | 0.07 | 0.01 | 0.44 | 0.25 | 000 | |
G0128 | R | CORF skilled nursing service | 0.08 | 0.03 | 0.03 | 0.01 | 0.12 | 0.12 | XXX | |
G0130 | A | Single energy x-ray study | 0.22 | 0.90 | NA | 0.05 | 1.17 | NA | XXX | |
G0130 | 26 | A | Single energy x-ray study | 0.22 | 0.11 | 0.11 | 0.01 | 0.34 | 0.34 | XXX |
G0130 | TC | A | Single energy x-ray study | 0.00 | 0.79 | NA | 0.04 | 0.83 | NA | XXX |
G0131 | D | CT scan, bone density study | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0131 | 26 | D | CT scan, bone density study | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0131 | TC | D | CT scan, bone density study | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0132 | D | CT scan, bone density study | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0132 | 26 | D | CT scan, bone density study | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0132 | TC | D | CT scan, bone density study | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0141 | A | Scr c/v cyto,autosys and md | 0.42 | 0.99 | 0.99 | 0.01 | 1.42 | 1.42 | XXX | |
G0143 | X | Scr c/v cyto,thinlayer,rescr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0144 | X | Scr c/v cyto,thinlayer,rescr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0145 | X | Scr c/v cyto,thinlayer,rescr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0147 | X | Scr c/v cyto, automated sys | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0148 | X | Scr c/v cyto, autosys, rescr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0166 | A | Extrnl counterpulse, per tx | 0.07 | 5.57 | 0.03 | 0.01 | 5.65 | 0.11 | XXX | |
G0167 | C | Hyperbaric oz tx;no md reqrd | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0168 | A | Wound closure by adhesive | 0.45 | 2.24 | 0.18 | 0.01 | 2.70 | 0.64 | 000 | |
G0173 | X | Stereo radoisurgery,complete | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0175 | X | OPPS Service,sched team conf | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0176 | X | OPPS/PHP;activity therapy | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0177 | X | OPPS/PHP; train educ serv | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0179 | A | MD recertification HHA PT | 0.45 | 1.09 | NA | 0.01 | 1.55 | NA | XXX | |
G0180 | A | MD certification HHA patient | 0.67 | 1.31 | NA | 0.02 | 2.00 | NA | XXX | |
G0181 | A | Home health care supervision | 1.73 | 1.56 | NA | 0.06 | 3.35 | NA | XXX | |
G0182 | A | Hospice care supervision | 1.73 | 1.75 | NA | 0.06 | 3.54 | NA | XXX | |
G0185 | D | Transpuppillary thermotx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
G0186 | C | Dstry eye lesn,fdr vssl tech | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
G0187 | D | Dstry mclr drusen,photocoag | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | YYY | |
G0192 | F | Immunization oral/intranasal | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0193 | D | Endoscopicstudyswallowfunctn | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0194 | D | Sensorytestingendoscopicstud | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0195 | D | Clinicalevalswallowingfunct | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0196 | D | Evalofswallowingwithradioopa | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0197 | D | Evalofptforprescipspeechdevi | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0198 | D | Patientadapationtrainforspe | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0199 | D | Reevaluationofpatientusespec | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0200 | D | Evalofpatientprescipofvoicep | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0201 | D | Modifortraininginusevoicepro | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0202 | A | Screeningmammographydigital | 0.70 | 2.80 | NA | 0.09 | 3.59 | NA | XXX | |
G0202 | 26 | A | Screeningmammographydigital | 0.70 | 0.27 | 0.27 | 0.03 | 1.00 | 1.00 | XXX |
G0202 | TC | A | Screeningmammographydigital | 0.00 | 2.53 | NA | 0.06 | 2.59 | NA | XXX |
G0204 | A | Diagnosticmammographydigital | 0.87 | 2.84 | NA | 0.10 | 3.81 | NA | XXX | |
G0204 | 26 | A | Diagnosticmammographydigital | 0.87 | 0.34 | 0.34 | 0.04 | 1.25 | 1.25 | XXX |
G0204 | TC | A | Diagnosticmammographydigital | 0.00 | 2.50 | NA | 0.06 | 2.56 | NA | XXX |
G0206 | A | Diagnosticmammographydigital | 0.70 | 2.28 | NA | 0.09 | 3.07 | NA | XXX | |
G0206 | 26 | A | Diagnosticmammographydigital | 0.70 | 0.27 | 0.27 | 0.04 | 1.01 | 1.01 | XXX |
G0206 | TC | A | Diagnosticmammographydigital | 0.00 | 2.01 | NA | 0.05 | 2.06 | NA | XXX |
G0210 | C | PET img wholebody dxlung | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0210 | 26 | A | PET img wholebody dxlung | 1.50 | 0.59 | 0.59 | 0.04 | 2.13 | 2.13 | XXX |
G0210 | TC | C | PET img wholebody dxlung | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0211 | C | PET img wholbody init lung | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0211 | 26 | A | PET img wholbody init lung | 1.50 | 0.59 | 0.59 | 0.04 | 2.13 | 2.13 | XXX |
G0211 | TC | C | PET img wholbody init lung | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0212 | C | PET img wholebod restag lung | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0212 | 26 | A | PET img wholebod restag lung | 1.50 | 0.59 | 0.59 | 0.04 | 2.13 | 2.13 | XXX |
G0212 | TC | C | PET img wholebod restag lung | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0213 | C | PET img wholbody dx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0213 | 26 | A | PET img wholbody dx | 1.50 | 0.59 | 0.59 | 0.04 | 2.13 | 2.13 | XXX |
G0213 | TC | C | PET img wholbody dx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0214 | C | PET img wholebod init | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0214 | 26 | A | PET img wholebod init | 1.50 | 0.59 | 0.59 | 0.04 | 2.13 | 2.13 | XXX |
G0214 | TC | C | PET img wholebod init | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0215 | C | PETimg wholebod restag | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0215 | 26 | A | PETimg wholebod restag | 1.50 | 0.59 | 0.59 | 0.04 | 2.13 | 2.13 | XXX |
G0215 | TC | C | PETimg wholebod restag | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0216 | C | PET img wholebod dx melanoma | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0216 | 26 | A | PET img wholebod dx melanoma | 1.50 | 0.59 | 0.59 | 0.04 | 2.13 | 2.13 | XXX |
G0216 | TC | C | PET img wholebod dx melanoma | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0217 | C | PET img wholebod init melan | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0217 | 26 | A | PET img wholebod init melan | 1.50 | 0.59 | 0.59 | 0.04 | 2.13 | 2.13 | XXX |
G0217 | TC | C | PET img wholebod init melan | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0218 | C | PET img wholebod restag mela | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0218 | 26 | A | PET img wholebod restag mela | 1.50 | 0.59 | 0.59 | 0.04 | 2.13 | 2.13 | XXX |
G0218 | TC | C | PET img wholebod restag mela | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0219 | N | PET img wholbod melano nonco | +1.50 | 0.59 | 0.59 | 0.04 | 2.13 | 2.13 | XXX | |
G0219 | 26 | N | PET img wholbod melano nonco | +1.50 | 0.59 | 0.59 | 0.04 | 2.13 | 2.13 | XXX |
G0219 | TC | N | PET img wholbod melano nonco | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0220 | C | PET img wholebod dx lymphoma | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0220 | 26 | A | PET img wholebod dx lymphoma | 1.50 | 0.59 | 0.59 | 0.04 | 2.13 | 2.13 | XXX |
G0220 | TC | C | PET img wholebod dx lymphoma | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0221 | C | PET imag wholbod init lympho | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0221 | 26 | A | PET imag wholbod init lympho | 1.50 | 0.59 | 0.59 | 0.04 | 2.13 | 2.13 | XXX |
G0221 | TC | C | PET imag wholbod init lympho | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0222 | C | PET imag wholbod resta lymph | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0222 | 26 | A | PET imag wholbod resta lymph | 1.50 | 0.59 | 0.59 | 0.04 | 2.13 | 2.13 | XXX |
G0222 | TC | C | PET imag wholbod resta lymph | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0223 | C | PET imag wholbod reg dx head | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0223 | 26 | A | PET imag wholbod reg dx head | 1.50 | 0.59 | 0.59 | 0.04 | 2.13 | 2.13 | XXX |
G0223 | TC | C | PET imag wholbod reg dx head | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0224 | C | PET imag wholbod reg ini hea | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0224 | 26 | A | PET imag wholbod reg ini hea | 1.50 | 0.59 | 0.59 | 0.04 | 2.13 | 2.13 | XXX |
G0224 | TC | C | PET imag wholbod reg ini hea | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0225 | C | PET whol restag headneckonly | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0225 | 26 | A | PET whol restag headneckonly | 1.50 | 0.59 | 0.59 | 0.04 | 2.13 | 2.13 | XXX |
G0225 | TC | C | PET whol restag headneckonly | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0226 | C | PET img wholbody dx esophagl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0226 | 26 | A | PET img wholbody dx esophagl | 1.50 | 0.59 | 0.59 | 0.04 | 2.13 | 2.13 | XXX |
G0226 | TC | C | PET img wholbody dx esophagl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0227 | C | PET img wholbod ini esophage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0227 | 26 | A | PET img wholbod ini esophage | 1.50 | 0.59 | 0.59 | 0.04 | 2.13 | 2.13 | XXX |
G0227 | TC | C | PET img wholbod ini esophage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0228 | C | PET img wholbod restg esopha | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0228 | 26 | A | PET img wholbod restg esopha | 1.50 | 0.59 | 0.59 | 0.04 | 2.13 | 2.13 | XXX |
G0228 | TC | C | PET img wholbod restg esopha | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0229 | C | PET img metaboloc brain pres | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0229 | 26 | A | PET img metaboloc brain pres | 1.50 | 0.59 | 0.59 | 0.04 | 2.13 | 2.13 | XXX |
G0229 | TC | C | PET img metaboloc brain pres | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0230 | C | PET myocard viability post | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0230 | 26 | A | PET myocard viability post | 1.50 | 0.59 | 0.59 | 0.04 | 2.13 | 2.13 | XXX |
G0230 | TC | C | PET myocard viability post | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0231 | C | PET WhBD colorec; gamma cam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0231 | 26 | A | PET WhBD colorec; gamma cam | 1.50 | 0.59 | 0.59 | 0.04 | 2.13 | 2.13 | XXX |
G0231 | TC | C | PET WhBD colorec; gamma cam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0232 | C | PET whbd lymphoma; gamma cam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0232 | 26 | A | PET whbd lymphoma; gamma cam | 1.50 | 0.59 | 0.59 | 0.04 | 2.13 | 2.13 | XXX |
G0232 | TC | C | PET whbd lymphoma; gamma cam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0233 | C | PET whbd melanoma; gamma cam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0233 | 26 | A | PET whbd melanoma; gamma cam | 1.50 | 0.59 | 0.59 | 0.04 | 2.13 | 2.13 | XXX |
G0233 | TC | C | PET whbd melanoma; gamma cam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0234 | C | PET WhBD pulm nod; gamma cam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0234 | 26 | A | PET WhBD pulm nod; gamma cam | 1.50 | 0.59 | 0.59 | 0.04 | 2.13 | 2.13 | XXX |
G0234 | TC | C | PET WhBD pulm nod; gamma cam | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0236 | A | Digital film convert diag ma | 0.06 | 0.44 | NA | 0.02 | 0.52 | NA | ZZZ | |
G0236 | 26 | A | Digital film convert diag ma | 0.06 | 0.02 | 0.02 | 0.01 | 0.09 | 0.09 | ZZZ |
G0236 | TC | A | Digital film convert diag ma | 0.00 | 0.42 | NA | 0.01 | 0.43 | NA | ZZZ |
G0237 | A | Therapeutic procd strg endur | 0.00 | 0.47 | NA | 0.02 | 0.49 | NA | XXX | |
G0238 | C | Oth resp proc, indiv | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0239 | C | Oth resp proc, group | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0240 | D | Critic care by MD transport | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0241 | D | Each additional 30 minutes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ZZZ | |
G0242 | X | Multisource photon ster plan | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0243 | X | Multisour photon stero treat | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0244 | E | Observ care by facility topt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0245 | R | Initial foot exam pt lops | 0.88 | 0.77 | 0.32 | 0.05 | 1.70 | 1.25 | XXX | |
G0246 | R | Followup eval of foot pt lop | 0.45 | 0.52 | 0.16 | 0.02 | 0.99 | 0.63 | XXX | |
G0247 | R | Routine footcare pt w lops | 0.50 | 0.52 | 0.21 | 0.05 | 1.07 | 0.76 | ZZZ | |
G0248 | R | Demonstrate use home inr mon | 0.00 | 4.30 | NA | 0.01 | 4.31 | NA | XXX | |
G0249 | R | Provide test material,equipm | 0.00 | 3.35 | NA | 0.01 | 3.36 | NA | XXX | |
G0250 | R | MD review interpret of test | 0.18 | 0.07 | 0.07 | 0.01 | 0.26 | 0.26 | XXX | |
G0251 | E | Linear acc based stero radio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0252 | N | PET imaging initial dx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0252 | 26 | N | PET imaging initial dx | +1.50 | 0.60 | 0.60 | 0.04 | 2.14 | 2.14 | XXX |
G0252 | TC | N | PET imaging initial dx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0253 | C | PET image brst dection recur | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0253 | 26 | A | PET image brst dection recur | 1.87 | 0.73 | 0.73 | 0.07 | 2.67 | 2.67 | XXX |
G0253 | TC | C | PET image brst dection recur | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0254 | C | PET image brst eval to tx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0254 | 26 | A | PET image brst eval to tx | 1.87 | 0.73 | 0.73 | 0.07 | 2.67 | 2.67 | XXX |
G0254 | TC | C | PET image brst eval to tx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0255 | N | Current percep threshold tst | +1.50 | 0.59 | 0.59 | 0.04 | 2.13 | 2.13 | XXX | |
G0255 | 26 | N | Current percep threshold tst | +1.50 | 0.59 | 0.59 | 0.04 | 2.13 | 2.13 | XXX |
G0255 | TC | N | Current percep threshold tst | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX |
G0256 | E | Prostate brachy w palladium | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0257 | E | Unsched dialysis ESRD pt hos | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0258 | E | IV infusion during obs stay | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0259 | E | Inject for sacroiliac joint | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0260 | E | Inj for sacroiliac jt anesth | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0261 | E | Prostate brachy w iodine see | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0262 | A | Sm intestinal image capsule | 2.12 | 18.67 | NA | 0.08 | 20.87 | NA | XXX | |
G0262 | 26 | A | Sm intestinal image capsule | 2.12 | 0.83 | 0.83 | 0.02 | 2.97 | 2.97 | XXX |
G0262 | TC | A | Sm intestinal image capsule | 0.00 | 17.84 | NA | 0.06 | 17.90 | NA | XXX |
G0263 | E | Adm with CHF, CP, asthma | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0264 | E | Assmt otr CHF, CP, asthma | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0265 | X | Cryopresevation Freeze+stora | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0266 | X | Thawing + expansion froz cel | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0267 | X | Bone marrow or psc harvest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0268 | A | Removal of impacted wax md | 0.61 | 0.57 | 0.24 | 0.04 | 1.22 | 0.89 | 000 | |
G0269 | B | Occlusive device in vein art | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0270 | A | MNT subs tx for change dx | 0.00 | 0.47 | NA | 0.01 | 0.48 | NA | XXX | |
G0271 | A | Group MNT 2 or more 30 mins | 0.00 | 0.18 | NA | 0.01 | 0.19 | NA | XXX | |
G0272 | A | Naso/oro gastric tube pl MD | 0.32 | 0.13 | NA | 0.02 | 0.47 | NA | 000 | |
G0273 | A | Pretx planning, non-Hodgkins | 0.86 | 11.36 | NA | 0.28 | 12.50 | NA | XXX | |
G0273 | 26 | A | Pretx planning, non-Hodgkins | 0.86 | 0.34 | 0.34 | 0.03 | 1.23 | 1.23 | XXX |
G0273 | TC | A | Pretx planning, non-Hodgkins | 0.00 | 11.02 | NA | 0.25 | 11.27 | NA | XXX |
G0274 | A | Radiopharm tx, non-Hodgkins | 2.07 | 3.42 | NA | 0.20 | 5.69 | NA | XXX | |
G0274 | 26 | A | Radiopharm tx, non-Hodgkins | 2.07 | 0.81 | 0.81 | 0.08 | 2.96 | 2.96 | XXX |
G0274 | TC | A | Radiopharm tx, non-Hodgkins | 0.00 | 2.61 | NA | 0.12 | 2.73 | NA | XXX |
G0275 | A | Renal angio, cardiac cath | 0.25 | 0.10 | NA | 0.01 | 0.36 | NA | ZZZ | |
G0278 | A | Iliac art angio,cardiac cath | 0.25 | 0.10 | NA | 0.01 | 0.36 | NA | ZZZ | |
G0279 | A | Excorp shock tx, elbow epi | 0.06 | 1.46 | NA | 0.01 | 1.53 | NA | XXX | |
G0280 | A | Excorp shock tx other than | 0.06 | 1.46 | NA | 0.01 | 1.53 | NA | XXX | |
G0281 | A | Elec stim unattend for press | 0.18 | 0.35 | 0.07 | 0.01 | 0.54 | 0.26 | XXX | |
G0282 | N | Elect stim wound care not pd | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0283 | A | Elec stim other than wound | 0.18 | 0.35 | 0.07 | 0.01 | 0.54 | 0.26 | XXX | |
G0288 | A | Recon, CTA for surg plan | 0.00 | 10.57 | NA | 0.15 | 10.72 | NA | XXX | |
G0289 | A | Arthro, loose body + chondro | 1.48 | 0.58 | NA | 0.27 | 2.33 | NA | ZZZ | |
G0290 | E | Drug-eluting stents, single | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0291 | E | Drug-eluting stents,each add | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0292 | E | Adm exp drugs,clinical trial | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0293 | E | Non-cov surg proc,clin trial | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0294 | E | Non-cov proc, clinical trial | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0295 | N | Electromagnetic therapy onc | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G9001 | X | MCCD, initial rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G9002 | X | MCCD,maintenance rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G9003 | X | MCCD, risk adj hi, initial | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G9004 | X | MCCD, risk adj lo, initial | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G9005 | X | MCCD, risk adj, maintenance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G9006 | X | MCCD, Home monitoring | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G9007 | X | MCCD, sch team conf | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G9008 | X | Mccd,phys coor-care ovrsght | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G9009 | X | MCCD, risk adj, level 3 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G9010 | X | MCCD, risk adj, level 4 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G9011 | X | MCCD, risk adj, level 5 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G9012 | X | Other Specified Case Mgmt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G9016 | N | Demo-smoking cessation coun | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
J3370 | R | Vancomycin hcl injection | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
M0064 | A | Visit for drug monitoring | 0.37 | 0.35 | 0.12 | 0.01 | 0.73 | 0.50 | XXX | |
P3001 | A | Screening pap smear by phys | 0.42 | 0.99 | 0.99 | 0.01 | 1.42 | 1.42 | XXX | |
Q0035 | A | Cardiokymography | 0.17 | 0.46 | NA | 0.03 | 0.66 | NA | XXX | |
Q0035 | 26 | A | Cardiokymography | 0.17 | 0.07 | 0.07 | 0.01 | 0.25 | 0.25 | XXX |
Q0035 | TC | A | Cardiokymography | 0.00 | 0.39 | NA | 0.02 | 0.41 | NA | XXX |
Q0091 | A | Obtaining screen pap smear | 0.37 | 0.68 | 0.14 | 0.01 | 1.06 | 0.52 | XXX | |
Q0092 | A | Set up port xray equipment | 0.00 | 0.32 | NA | 0.01 | 0.33 | NA | XXX | |
Q3014 | X | Telehealth facility fee | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
R0070 | C | Transport portable x-ray | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
R0075 | C | Transport port x-ray multipl | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
R0076 | B | Transport portable EKG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
V5299 | R | Hearing service | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
V5362 | R | Speech screening | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
V5363 | R | Language screening | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
V5364 | R | Dysphagia screening | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
1 CPT codes and descriptions only are copyright 2002 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply. | ||||||||||
2 Copyright 2002 American Dental Association. All rights reserved. | ||||||||||
3 + Indicates RVUs are not used for Medicare payment. |
----------
1 CPT codes and descriptions only are copyright 2002 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.2 Copyright 2002 American Dental Association. All rights reserved.3 + Indicates RVUs are not used for Medicare payment.
CPT1 /HCPCS2 | MOD | Status | Description | Physician Work RVUs3 | Non- Facility PE RVUs | Facility PE RVUs | Mal- Practice RVUs | Non- Facility Total | Facility Total | Global |
---|---|---|---|---|---|---|---|---|---|---|
11400 | A | Exc tr-ext b9+marg 0.5 cm | 0.85 | 2.08 | 0.96 | 0.06 | 2.99 | 1.87 | 010 | |
11401 | A | Exc tr-ext b9+marg 0.6-1 cm | 1.23 | 2.12 | 1.08 | 0.09 | 3.44 | 2.40 | 010 | |
11402 | A | Exc tr-ext b9+marg 1.1-2 cm | 1.51 | 2.28 | 1.14 | 0.12 | 3.91 | 2.77 | 010 | |
11403 | A | Exc tr-ext b9+marg 2.1-3 cm | 1.79 | 2.50 | 1.35 | 0.16 | 4.45 | 3.30 | 010 | |
11404 | A | Exc tr-ext b9+marg 3.1-4 cm | 2.06 | 2.84 | 1.42 | 0.18 | 5.08 | 3.66 | 010 | |
11406 | A | Exc tr-ext b9+marg 4.0 cm | 2.76 | 3.24 | 1.68 | 0.25 | 6.25 | 4.69 | 010 | |
11420 | A | Exc h-f-nk-sp b9+marg 0.5 | 0.98 | 1.81 | 1.00 | 0.08 | 2.87 | 2.06 | 010 | |
11421 | A | Exc h-f-nk-sp b9+marg 0.6-1 | 1.42 | 2.12 | 1.18 | 0.11 | 3.65 | 2.71 | 010 | |
11422 | A | Exc h-f-nk-sp b9+marg 1.1-2 | 1.63 | 2.30 | 1.38 | 0.14 | 4.07 | 3.15 | 010 | |
11423 | A | Exc h-f-nk-sp b9+marg 2.1-3 | 2.01 | 2.66 | 1.49 | 0.17 | 4.84 | 3.67 | 010 | |
11424 | A | Exc h-f-nk-sp b9+marg 3.1-4 | 2.43 | 2.93 | 1.64 | 0.21 | 5.57 | 4.28 | 010 | |
11426 | A | Exc h-f-nk-sp b9+marg 4 cm | 3.78 | 3.75 | 2.15 | 0.34 | 7.87 | 6.27 | 010 | |
11440 | A | Exc face-mm b9+marg 0.5 cm | 1.06 | 2.27 | 1.41 | 0.08 | 3.41 | 2.55 | 010 | |
11441 | A | Exc face-mm b9+marg 0.6-1 cm | 1.48 | 2.40 | 1.59 | 0.11 | 3.99 | 3.18 | 010 | |
11442 | A | Exc face-mm b9+marg 1.1-2 cm | 1.72 | 2.66 | 1.66 | 0.14 | 4.52 | 3.52 | 010 | |
11443 | A | Exc face-mm b9+marg 2.1-3 cm | 2.29 | 3.04 | 1.90 | 0.18 | 5.51 | 4.37 | 010 | |
11444 | A | Exc face-mm b9+marg 3.1-4 cm | 3.14 | 3.64 | 2.28 | 0.25 | 7.03 | 5.67 | 010 | |
11446 | A | Exc face-mm b9+marg 4 cm | 4.49 | 4.26 | 2.88 | 0.30 | 9.05 | 7.67 | 010 | |
11600 | A | Exc tr-ext mlg+marg 0.5 cm | 1.31 | 2.53 | 0.99 | 0.09 | 3.93 | 2.39 | 010 | |
11601 | A | Exc tr-ext mlg+marg 0.6-1 cm | 1.80 | 2.60 | 1.24 | 0.12 | 4.52 | 3.16 | 010 | |
11602 | A | Exc tr-ext mlg+marg 1.1-2 cm | 1.95 | 2.73 | 1.29 | 0.13 | 4.81 | 3.37 | 010 | |
11603 | A | Exc tr-ext mlg+marg 2.1-3 cm | 2.19 | 2.96 | 1.35 | 0.16 | 5.31 | 3.70 | 010 | |
11604 | A | Exc tr-ext mlg+marg 3.1-4 cm | 2.40 | 3.27 | 1.41 | 0.18 | 5.85 | 3.99 | 010 | |
11606 | A | Exc tr-ext mlg+marg 4 cm | 3.43 | 3.96 | 1.76 | 0.28 | 7.67 | 5.47 | 010 | |
11620 | A | Exc h-f-nk-sp mlg+marg 0.5 | 1.19 | 2.49 | 0.97 | 0.09 | 3.77 | 2.25 | 010 | |
11621 | A | Exc h-f-nk-sp mlg+marg 0.6-1 | 1.76 | 2.60 | 1.27 | 0.12 | 4.48 | 3.15 | 010 | |
11622 | A | Exc h-f-nk-sp mlg+marg 1.1-2 | 2.09 | 2.87 | 1.42 | 0.15 | 5.11 | 3.66 | 010 | |
11623 | A | Exc h-f-nk-sp mlg+marg 2.1-3 | 2.61 | 3.22 | 1.62 | 0.20 | 6.03 | 4.43 | 010 | |
11624 | A | Exc h-f-nk-sp mlg+marg 3.1-4 | 3.06 | 3.61 | 1.81 | 0.25 | 6.92 | 5.12 | 010 | |
11626 | A | Exc h-f-nk-sp mlg+mar 4 cm | 4.30 | 4.56 | 2.44 | 0.35 | 9.21 | 7.09 | 010 | |
11640 | A | Exc face-mm malig+marg 0.5 | 1.35 | 2.54 | 1.14 | 0.10 | 3.99 | 2.59 | 010 | |
11641 | A | Exc face-mm malig+marg 0.6-1 | 2.16 | 2.92 | 1.57 | 0.15 | 5.23 | 3.88 | 010 | |
11642 | A | Exc face-mm malig+marg 1.1-2 | 2.59 | 3.30 | 1.77 | 0.18 | 6.07 | 4.54 | 010 | |
11643 | A | Exc face-mm malig+marg 2.1-3 | 3.10 | 3.70 | 2.01 | 0.24 | 7.04 | 5.35 | 010 | |
11644 | A | Exc face-mm malig+marg 3.1-4 | 4.03 | 4.63 | 2.56 | 0.33 | 8.99 | 6.92 | 010 | |
11646 | A | Exc face-mm mlg+marg 4 cm | 5.95 | 5.73 | 3.60 | 0.46 | 12.14 | 10.01 | 010 | |
11981 | A | Insert drug implant device | 1.48 | 1.59 | 0.58 | 0.14 | 3.21 | 2.20 | XXX | |
11982 | A | Remove drug implant device | 1.78 | 1.71 | 0.70 | 0.17 | 3.66 | 2.65 | XXX | |
11983 | A | Remove/insert drug implant | 3.30 | 2.30 | 1.28 | 0.31 | 5.91 | 4.89 | XXX | |
17304 | A | 1 stage mohs, up to 5 spec | 7.60 | 8.09 | 3.66 | 0.31 | 16.00 | 11.57 | 000 | |
17305 | A | 2 stage mohs, up to 5 spec | 2.85 | 3.81 | 1.37 | 0.12 | 6.78 | 4.34 | 000 | |
17306 | A | 3 stage mohs, up to 5 spec | 2.85 | 3.81 | 1.38 | 0.12 | 6.78 | 4.35 | 000 | |
17307 | A | Mohs addl stage up to 5 spec | 2.85 | 3.82 | 1.40 | 0.12 | 6.79 | 4.37 | 000 | |
17310 | A | Mohs any stage 5 spec each | 0.62 | 1.48 | 0.31 | 0.05 | 2.15 | 0.98 | ZZZ | |
20526 | A | Ther injection, carp tunnel | 0.94 | 0.77 | 0.41 | 0.06 | 1.77 | 1.41 | 000 | |
20550 | A | Inj tendon sheath/ligament | 0.75 | 0.76 | 0.24 | 0.06 | 1.57 | 1.05 | 000 | |
20551 | A | Inject tendon origin/insert | 0.75 | 0.70 | 0.34 | 0.06 | 1.51 | 1.15 | 000 | |
20552 | A | Inject trigger point, 1 or 2 | 0.66 | 0.66 | 0.30 | 0.06 | 1.38 | 1.02 | 000 | |
20553 | A | Inject trigger points, =/ 3 | 0.75 | 0.75 | 0.34 | 0.06 | 1.56 | 1.15 | 000 | |
20600 | A | Drain/inject, joint/bursa | 0.66 | 0.66 | 0.36 | 0.06 | 1.38 | 1.08 | 000 | |
20605 | A | Drain/inject, joint/bursa | 0.68 | 0.78 | 0.37 | 0.06 | 1.52 | 1.11 | 000 | |
20612 | A | Aspirate/inj ganglion cyst | 0.70 | 0.77 | 0.28 | 0.06 | 1.53 | 1.04 | 000 | |
21030 | A | Excise max/zygoma b9 tumor | 3.89 | 4.36 | 3.64 | 0.60 | 8.85 | 8.13 | 090 | |
21034 | A | Excise max/zygoma mlg tumor | 16.17 | 10.67 | 10.64 | 1.37 | 28.21 | 28.18 | 090 | |
21040 | A | Excise mandible lesion | 3.89 | 3.76 | 2.58 | 0.19 | 7.84 | 6.66 | 090 | |
21046 | A | Remove mandible cyst complex | 13.00 | NA | 10.42 | 1.01 | NA | 24.43 | 090 | |
21047 | A | Excise lwr jaw cyst w/repair | 18.75 | NA | 9.87 | 1.53 | NA | 30.15 | 090 | |
21048 | A | Remove maxilla cyst complex | 13.50 | NA | 10.63 | 1.01 | NA | 25.14 | 090 | |
21049 | A | Excis uppr jaw cyst w/repair | 18.00 | NA | 9.55 | 1.01 | NA | 28.56 | 090 | |
21740 | A | Reconstruction of sternum | 16.50 | NA | 12.48 | 2.03 | NA | 31.01 | 090 | |
21742 | C | Repair stern/nuss w/o scope | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 090 | |
21743 | C | Repair sternum/nuss w/scope | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 090 | |
23410 | A | Repair rotator cuff, acute | 12.45 | NA | 12.81 | 1.72 | NA | 26.98 | 090 | |
23412 | A | Repair rotator cuff, chronic | 13.31 | NA | 13.32 | 1.86 | NA | 28.49 | 090 | |
24344 | A | Reconstruct elbow lat ligmnt | 14.00 | NA | 11.18 | 1.83 | NA | 27.01 | 090 | |
24346 | A | Reconstruct elbow med ligmnt | 14.00 | NA | 11.18 | 1.83 | NA | 27.01 | 090 | |
25320 | A | Repair/revise wrist joint | 10.77 | NA | 11.50 | 1.32 | NA | 23.59 | 090 | |
27425 | A | Lat retinacular release open | 5.22 | NA | 7.58 | 0.73 | NA | 13.53 | 090 | |
27730 | A | Repair of tibia epiphysis | 7.41 | 21.22 | 10.17 | 0.75 | 29.38 | 18.33 | 090 | |
27732 | A | Repair of fibula epiphysis | 5.32 | 14.21 | 8.71 | 0.63 | 20.16 | 14.66 | 090 | |
27734 | A | Repair lower leg epiphyses | 8.48 | NA | 9.91 | 0.85 | NA | 19.24 | 090 | |
27870 | A | Fusion of ankle joint, open | 13.91 | NA | 14.08 | 1.95 | NA | 29.94 | 090 | |
29806 | A | Shoulder arthroscopy/surgery | 14.37 | NA | 11.17 | 2.00 | NA | 27.54 | 090 | |
29827 | A | Arthroscop rotator cuff repr | 15.36 | NA | 11.55 | 1.86 | NA | 28.77 | 090 | |
29873 | A | Knee arthroscopy/surgery | 6.00 | NA | 6.56 | 0.73 | NA | 13.29 | 090 | |
29899 | A | Ankle arthroscopy/surgery | 13.91 | NA | 10.58 | 1.95 | NA | 26.44 | 090 | |
33215 | A | Reposition pacing-defib lead | 4.76 | NA | 3.15 | 0.36 | NA | 8.27 | 090 | |
33216 | A | Insert lead pace-defib, one | 5.78 | NA | 5.32 | 0.36 | NA | 11.46 | 090 | |
33217 | A | Insert lead pace-defib, dual | 5.75 | NA | 5.58 | 0.36 | NA | 11.69 | 090 | |
33224 | A | Insert pacing lead connect | 9.05 | NA | 3.92 | 0.36 | NA | 13.33 | 090 | |
33225 | A | L ventric pacing lead add-on | 8.34 | NA | 3.11 | 0.36 | NA | 11.81 | ZZZ | |
33226 | A | Reposition l ventric lead | 8.69 | NA | 3.79 | 0.36 | NA | 12.84 | 000 | |
33508 | A | Endoscopic vein harvest | 0.31 | NA | 0.11 | 0.03 | NA | 0.45 | ZZZ | |
33979 | A | Insert intracorporeal device | 46.00 | 17.88 | 17.88 | 3.98 | 67.86 | 67.86 | XXX | |
33980 | A | Remove intracorporeal device | 56.25 | NA | 26.47 | 4.60 | NA | 87.32 | 090 | |
34812 | A | Xpose for endoprosth, femorl | 6.75 | NA | 2.29 | 0.49 | NA | 9.53 | 000 | |
34825 | A | Endovasc extend prosth, init | 12.00 | NA | 5.95 | 0.86 | NA | 18.81 | 090 | |
34826 | A | Endovasc exten prosth, addl | 4.13 | NA | 1.41 | 0.29 | NA | 5.83 | ZZZ | |
34833 | A | Xpose for endoprosth, iliac | 12.00 | NA | 4.98 | 0.70 | NA | 17.68 | 000 | |
34834 | A | Xpose, endoprosth, brachial | 5.35 | NA | 2.48 | 0.49 | NA | 8.32 | 000 | |
34900 | A | Endovasc iliac repr w/graft | 16.38 | NA | 8.24 | 1.49 | NA | 26.11 | 090 | |
35572 | A | Harvest femoropopliteal vein | 6.82 | NA | 2.57 | 0.63 | NA | 10.02 | ZZZ | |
36415 | I | Routine venipuncture | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
36416 | I | Capillary blood draw | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
36511 | A | Apheresis wbc | 1.74 | NA | 0.70 | 0.06 | NA | 2.50 | 000 | |
36512 | A | Apheresis rbc | 1.74 | NA | 0.70 | 0.06 | NA | 2.50 | 000 | |
36513 | A | Apheresis platelets | 1.74 | NA | 0.70 | 0.06 | NA | 2.50 | 000 | |
36514 | A | Apheresis plasma | 1.74 | NA | 0.70 | 0.06 | NA | 2.50 | 000 | |
36515 | A | Apheresis, adsorp/reinfuse | 1.74 | NA | 0.70 | 0.06 | NA | 2.50 | 000 | |
36516 | A | Apheresis, selective | 1.74 | NA | 0.70 | 0.06 | NA | 2.50 | 000 | |
36536 | A | Remove cva device obstruct | 3.60 | 33.54 | 1.47 | 0.23 | 37.37 | 5.30 | 000 | |
36537 | A | Remove cva lumen obstruct | 0.75 | 7.69 | 0.49 | 0.04 | 8.48 | 1.28 | 000 | |
36540 | B | Collect blood venous device | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
37182 | A | Insert hepatic shunt (tips) | 17.00 | NA | 6.37 | 1.49 | NA | 24.86 | 000 | |
37183 | A | Remove hepatic shunt (tips) | 8.00 | NA | 3.12 | 0.43 | NA | 11.55 | 000 | |
37500 | A | Endoscopy ligate perf veins | 11.00 | NA | 8.70 | 0.40 | NA | 20.10 | 090 | |
37760 | A | Ligation, leg veins, open | 10.47 | NA | 5.63 | 1.11 | NA | 17.21 | 090 | |
38204 | B | Bl donor search management | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
38205 | R | Harvest allogenic stem cells | 1.50 | NA | 0.61 | 0.05 | NA | 2.16 | 000 | |
38206 | R | Harvest auto stem cells | 1.50 | NA | 0.61 | 0.05 | NA | 2.16 | 000 | |
38207 | I | Cryopreserve stem cells | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
38208 | I | Thaw preserved stem cells | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
38209 | I | Wash harvest stem cells | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
38210 | I | T-cell depletion of harvest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
38211 | I | Tumor cell deplete of harvst | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
38212 | I | Rbc depletion of harvest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
38213 | I | Platelet deplete of harvest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
38214 | I | Volume deplete of harvest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
38215 | I | Harvest stem cell concentrte | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
38242 | A | Lymphocyte infuse transplant | 1.71 | NA | 0.70 | 0.05 | NA | 2.46 | 000 | |
43201 | A | Esoph scope w/submucous inj | 2.09 | 4.44 | 1.27 | 0.12 | 6.65 | 3.48 | 000 | |
43219 | A | Esophagus endoscopy | 2.80 | NA | 1.40 | 0.16 | NA | 4.36 | 000 | |
43236 | A | Uppr gi scope w/submuc inj | 2.92 | 4.70 | 1.26 | 0.14 | 7.76 | 4.32 | 000 | |
43245 | A | Uppr gi scope dilate strictr | 3.18 | 13.87 | 1.34 | 0.18 | 17.23 | 4.70 | 000 | |
43256 | A | Uppr gi endoscopy w stent | 4.35 | NA | 1.77 | 0.23 | NA | 6.35 | 000 | |
44206 | A | Lap part colectomy w/stoma | 27.00 | NA | 11.22 | 2.02 | NA | 40.24 | 090 | |
44207 | A | L colectomy/coloproctostomy | 30.00 | NA | 11.82 | 2.22 | NA | 44.04 | 090 | |
44208 | A | L colectomy/coloproctostomy | 32.00 | NA | 13.42 | 2.20 | NA | 47.62 | 090 | |
44210 | A | Laparo total proctocolectomy | 28.00 | NA | 12.11 | 2.05 | NA | 42.16 | 090 | |
44211 | A | Laparo total proctocolectomy | 35.00 | NA | 15.02 | 2.33 | NA | 52.35 | 090 | |
44212 | A | Laparo total proctocolectomy | 32.50 | NA | 14.16 | 2.26 | NA | 48.92 | 090 | |
44383 | A | Ileoscopy w/stent | 2.94 | NA | 1.42 | 0.13 | NA | 4.49 | 000 | |
44701 | A | Intraop colon lavage add-on | 3.10 | NA | 1.07 | 0.21 | NA | 4.38 | ZZZ | |
45335 | A | Sigmoidoscope w/submuc inj | 1.36 | 2.48 | 0.65 | 0.07 | 3.91 | 2.08 | 000 | |
45340 | A | Sig w/balloon dilation | 1.66 | 7.19 | 0.76 | 0.07 | 8.92 | 2.49 | 000 | |
45381 | A | Colonoscope, submucous inj | 4.20 | 6.15 | 1.70 | 0.21 | 10.56 | 6.11 | 000 | |
45386 | A | Colonoscope dilate stricture | 4.58 | 15.29 | 1.84 | 0.21 | 20.08 | 6.63 | 000 | |
46706 | A | Repr of anal fistula w/glue | 2.39 | NA | 1.24 | 0.17 | NA | 3.80 | 010 | |
47370 | A | Laparo ablate liver tumor rf | 19.69 | NA | 9.72 | 0.85 | NA | 30.26 | 090 | |
47371 | A | Laparo ablate liver cryosurg | 19.69 | NA | 9.72 | 0.85 | NA | 30.26 | 090 | |
47380 | A | Open ablate liver tumor rf | 23.00 | NA | 11.01 | 0.85 | NA | 34.86 | 090 | |
47381 | A | Open ablate liver tumor cryo | 23.27 | NA | 11.12 | 0.85 | NA | 35.24 | 090 | |
47382 | A | Percut ablate liver rf | 15.19 | NA | 6.25 | 1.14 | NA | 22.58 | 010 | |
49419 | A | Insrt abdom cath for chemotx | 6.65 | NA | 3.81 | 0.55 | NA | 11.01 | 090 | |
49904 | A | Omental flap, extra-abdom | 20.00 | NA | 15.98 | 1.91 | NA | 37.89 | 090 | |
49905 | A | Omental flap, intra-abdom | 6.55 | NA | 2.34 | 0.61 | NA | 9.50 | ZZZ | |
50542 | A | Laparo ablate renal mass | 20.00 | NA | 8.34 | 1.36 | NA | 29.70 | 090 | |
50543 | A | Laparo partial nephrectomy | 25.50 | NA | 10.48 | 1.36 | NA | 37.34 | 090 | |
50562 | A | Renal scope w/tumor resect | 10.92 | NA | 4.02 | 0.84 | NA | 15.78 | 090 | |
51701 | A | Insert bladder catheter | 0.50 | 1.06 | 0.20 | 0.03 | 1.59 | 0.73 | 000 | |
51702 | A | Insert temp bladder cath | 0.50 | 1.97 | 0.27 | 0.03 | 2.50 | 0.80 | 000 | |
51703 | A | Insert bladder cath, complex | 1.47 | 1.91 | 0.59 | 0.09 | 3.47 | 2.15 | 000 | |
51798 | A | Us urine capacity measure | 0.00 | 0.48 | NA | 0.07 | 0.55 | NA | XXX | |
52001 | A | Cystoscopy, removal of clots | 5.45 | 7.89 | 2.33 | 0.32 | 13.66 | 8.10 | 000 | |
53440 | A | Male sling procedure | 13.62 | NA | 6.33 | 0.73 | NA | 20.68 | 090 | |
53442 | A | Remove/revise male sling | 11.57 | NA | 5.93 | 0.55 | NA | 18.05 | 090 | |
55866 | A | Laparo radical prostatectomy | 30.74 | NA | 11.79 | 1.37 | NA | 43.90 | 090 | |
56820 | A | Exam of vulva w/scope | 1.50 | 1.64 | 0.65 | 0.10 | 3.24 | 2.25 | 000 | |
56821 | A | Exam/biopsy of vulva w/scope | 2.05 | 2.02 | 0.92 | 0.13 | 4.20 | 3.10 | 000 | |
57420 | A | Exam of vagina w/scope | 1.60 | 1.68 | 0.69 | 0.10 | 3.38 | 2.39 | 000 | |
57421 | A | Exam/biopsy of vag w/scope | 2.20 | 2.08 | 0.98 | 0.13 | 4.41 | 3.31 | 000 | |
57452 | A | Exam of cervix w/scope | 1.50 | 1.70 | 0.65 | 0.10 | 3.30 | 2.25 | 000 | |
57454 | A | Bx/curett of cervix w/scope | 2.33 | 2.05 | 1.02 | 0.13 | 4.51 | 3.48 | 000 | |
57455 | A | Biopsy of cervix w/scope | 1.99 | 1.94 | 0.89 | 0.13 | 4.06 | 3.01 | 000 | |
57456 | A | Endocerv curettage w/scope | 1.85 | 1.86 | 0.84 | 0.13 | 3.84 | 2.82 | 000 | |
57460 | A | Bx of cervix w/scope, leep | 2.83 | 5.01 | 1.25 | 0.28 | 8.12 | 4.36 | 000 | |
57461 | A | Conz of cervix w/scope, leep | 3.44 | 5.32 | 1.50 | 0.28 | 9.04 | 5.22 | 000 | |
58140 | A | Myomectomy abdom method | 14.60 | NA | 7.01 | 1.46 | NA | 23.07 | 090 | |
58145 | A | Myomectomy vag method | 8.04 | NA | 4.84 | 0.80 | NA | 13.68 | 090 | |
58146 | A | Myomectomy abdom complex | 19.00 | NA | 9.15 | 1.46 | NA | 29.61 | 090 | |
58260 | A | Vaginal hysterectomy | 12.98 | NA | 6.68 | 1.23 | NA | 20.89 | 090 | |
58262 | A | Vag hyst including t/o | 14.77 | NA | 7.43 | 1.42 | NA | 23.62 | 090 | |
58263 | A | Vag hyst w/t/o vag repair | 16.06 | NA | 7.95 | 1.55 | NA | 25.56 | 090 | |
58267 | A | Vag hyst w/urinary repair | 17.04 | NA | 8.52 | 1.51 | NA | 27.07 | 090 | |
58270 | A | Vag hyst w/enterocele repair | 14.26 | NA | 7.19 | 1.37 | NA | 22.82 | 090 | |
58290 | A | Vag hyst complex | 19.00 | NA | 9.37 | 1.23 | NA | 29.60 | 090 | |
58291 | A | Vag hyst incl t/o, complex | 20.79 | NA | 10.34 | 1.42 | NA | 32.55 | 090 | |
58292 | A | Vag hyst t/o repair, compl | 22.08 | NA | 10.85 | 1.55 | NA | 34.48 | 090 | |
58293 | A | Vag hyst w/uro repair, compl | 23.06 | NA | 11.25 | 1.51 | NA | 35.82 | 090 | |
58294 | A | Vag hyst w/enterocele, compl | 20.28 | NA | 10.10 | 1.37 | NA | 31.75 | 090 | |
58545 | A | Laparoscopic myomectomy | 14.60 | NA | 7.76 | 1.45 | NA | 23.81 | 090 | |
58546 | A | Laparo-myomectomy, complex | 19.00 | NA | 9.55 | 1.45 | NA | 30.00 | 090 | |
58550 | A | Laparo-asst vag hysterectomy | 14.19 | NA | 7.21 | 1.44 | NA | 22.84 | 010 | |
58552 | A | Laparo-vag hyst incl t/o | 14.19 | NA | 7.56 | 1.44 | NA | 23.19 | 090 | |
58553 | A | Laparo-vag hyst, complex | 19.00 | NA | 9.57 | 1.23 | NA | 29.80 | 090 | |
58554 | A | Laparo-vag hyst w/t/o, compl | 19.00 | NA | 9.26 | 1.23 | NA | 29.49 | 090 | |
61316 | A | Implt cran bone flap to abdo | 1.39 | NA | 0.57 | 0.43 | NA | 2.39 | ZZZ | |
61322 | A | Decompressive craniotomy | 29.50 | NA | 13.88 | 4.99 | NA | 48.37 | 090 | |
61323 | A | Decompressive lobectomy | 31.00 | NA | 14.08 | 4.99 | NA | 50.07 | 090 | |
61340 | A | Subtemporal decompression | 18.66 | NA | 11.41 | 3.66 | NA | 33.73 | 090 | |
61517 | A | Implt brain chemotx add-on | 1.38 | NA | 0.56 | 0.08 | NA | 2.02 | ZZZ | |
61623 | A | Endovasc tempory vessel occl | 9.96 | NA | 4.23 | 0.50 | NA | 14.69 | 000 | |
61624 | A | Transcath occlusion, cns | 20.15 | NA | 7.13 | 1.15 | NA | 28.43 | 000 | |
62148 | A | Retr bone flap to fix skull | 2.00 | NA | 0.82 | 0.43 | NA | 3.25 | ZZZ | |
62160 | A | Neuroendoscopy add-on | 3.00 | NA | 1.16 | 0.52 | NA | 4.68 | ZZZ | |
62161 | A | Dissect brain w/scope | 20.00 | NA | 9.71 | 3.70 | NA | 33.41 | 090 | |
62162 | A | Remove colloid cyst w/scope | 25.25 | NA | 11.89 | 5.77 | NA | 42.91 | 090 | |
62163 | A | Neuroendoscopy w/fb removal | 15.50 | NA | 7.97 | 3.70 | NA | 27.17 | 090 | |
62164 | A | Remove brain tumor w/scope | 27.50 | NA | 13.12 | 5.77 | NA | 46.39 | 090 | |
62165 | A | Remove pituit tumor w/scope | 22.00 | NA | 10.68 | 3.63 | NA | 36.31 | 090 | |
62201 | A | Brain cavity shunt w/scope | 14.86 | NA | 9.77 | 2.52 | NA | 27.15 | 090 | |
62263 | A | Epidural lysis mult sessions | 6.14 | 13.45 | 2.43 | 0.42 | 20.01 | 8.99 | 010 | |
62264 | A | Epidural lysis on single day | 4.43 | 11.38 | 1.32 | 0.30 | 16.11 | 6.05 | 010 | |
64415 | A | N block inj, brachial plexus | 1.48 | 3.05 | 0.39 | 0.08 | 4.61 | 1.95 | 000 | |
64416 | A | N block cont infuse, b plex | 3.50 | NA | 0.75 | 0.08 | NA | 4.33 | 010 | |
64445 | A | N block inj, sciatic, sng | 1.48 | 2.78 | 0.38 | 0.08 | 4.34 | 1.94 | 000 | |
64446 | A | N blk inj, sciatic, cont inf | 3.25 | NA | 1.15 | 0.08 | NA | 4.48 | 010 | |
64447 | A | N block inj fem, single | 1.50 | NA | 0.52 | 0.08 | NA | 2.10 | 000 | |
64448 | A | N block inj fem, cont inf | 3.00 | NA | 1.04 | 0.08 | NA | 4.12 | 010 | |
64450 | A | N block, other peripheral | 1.27 | 1.30 | 0.42 | 0.08 | 2.65 | 1.77 | 000 | |
66990 | A | Ophthalmic endoscope add-on | 1.51 | NA | 0.70 | 0.06 | NA | 2.27 | ZZZ | |
75901 | 26 | A | Remove cva device obstruct | 0.49 | 0.17 | 0.17 | 0.02 | 0.68 | 0.68 | XXX |
75902 | 26 | A | Remove cva lumen obstruct | 0.39 | 0.13 | 0.13 | 0.02 | 0.54 | 0.54 | XXX |
75953 | 26 | A | Abdom aneurysm endovas rpr | 1.36 | 0.53 | 0.53 | 0.68 | 2.57 | 2.57 | XXX |
75954 | 26 | A | Iliac aneurysm endovas rpr | 1.36 | 0.48 | 0.48 | 0.68 | 2.52 | 2.52 | XXX |
76070 | 26 | A | Ct bone density, axial | 0.25 | 0.08 | 0.08 | 0.01 | 0.34 | 0.34 | XXX |
76071 | 26 | A | Ct bone density, peripheral | 0.22 | 0.07 | 0.07 | 0.01 | 0.30 | 0.30 | XXX |
76085 | 26 | A | Computer mammogram add-on | 0.06 | 0.02 | 0.02 | 0.01 | 0.09 | 0.09 | ZZZ |
76362 | 26 | A | Cat scan for tissue ablation | 4.00 | 1.35 | 1.35 | 0.18 | 5.53 | 5.53 | XXX |
76394 | 26 | A | Mri for tissue ablation | 4.25 | 1.44 | 1.44 | 0.19 | 5.88 | 5.88 | XXX |
76490 | 26 | A | Us for tissue ablation | 4.00 | 1.34 | 1.34 | 0.11 | 5.45 | 5.45 | XXX |
76801 | 26 | A | Ob us 14 wks, single fetus | 0.99 | 0.36 | 0.36 | 0.04 | 1.39 | 1.39 | XXX |
76802 | 26 | A | Ob us 14 wks, addl fetus | 0.83 | 0.30 | 0.30 | 0.04 | 1.17 | 1.17 | XXX |
76805 | 26 | A | Ob us /= 14 wks, sngl fetus | 0.99 | 0.35 | 0.35 | 0.04 | 1.38 | 1.38 | XXX |
76810 | 26 | A | Ob us /= 14 wks, addl fetus | 0.98 | 0.36 | 0.36 | 0.07 | 1.41 | 1.41 | ZZZ |
76811 | 26 | A | Ob us, detailed, sngl fetus | 1.90 | 0.68 | 0.68 | 0.15 | 2.73 | 2.73 | XXX |
76812 | 26 | A | Ob us, detailed, addl fetus | 1.78 | 0.65 | 0.65 | 0.12 | 2.55 | 2.55 | ZZZ |
76815 | 26 | A | Ob us, limited, fetus(s) | 0.65 | 0.24 | 0.24 | 0.02 | 0.91 | 0.91 | XXX |
76816 | 26 | A | Ob us, follow-up, per fetus | 0.85 | 0.33 | 0.33 | 0.02 | 1.20 | 1.20 | XXX |
76817 | 26 | A | Transvaginal us, obstetric | 0.75 | 0.28 | 0.28 | 0.02 | 1.05 | 1.05 | XXX |
92601 | A | Cochlear implt f/up exam 7 | 0.00 | 3.50 | NA | 0.06 | 3.56 | NA | XXX | |
92602 | A | Reprogram cochlear implt 7 | 0.00 | 2.44 | NA | 0.06 | 2.50 | NA | XXX | |
92603 | A | Cochlear implt f/up exam 7 | 0.00 | 2.34 | NA | 0.06 | 2.40 | NA | XXX | |
92604 | A | Reprogram cochlear implt 7 | 0.00 | 1.58 | NA | 0.06 | 1.64 | NA | XXX | |
92605 | B | Eval for nonspeech device rx | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
92606 | B | Non-speech device service | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
92607 | A | Ex for speech device rx, 1hr | 0.00 | 2.93 | NA | 0.04 | 2.97 | NA | XXX | |
92608 | A | Ex for speech device rx addl | 0.00 | 0.55 | NA | 0.04 | 0.59 | NA | XXX | |
92609 | A | Use of speech device service | 0.00 | 1.58 | NA | 0.03 | 1.61 | NA | XXX | |
92610 | A | Evaluate swallowing function | 0.00 | 1.08 | NA | 0.07 | 1.15 | NA | XXX | |
92611 | A | Motion fluoroscopy/swallow | 0.00 | 1.18 | NA | 0.07 | 1.25 | NA | XXX | |
92612 | A | Endoscopy swallow tst (fees) | 1.27 | 3.36 | 0.50 | 0.07 | 4.70 | 1.84 | XXX | |
92613 | B | Endoscopy swallow tst (fees) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
92614 | A | Laryngoscopic sensory test | 1.27 | 2.29 | 0.50 | 0.07 | 3.63 | 1.84 | XXX | |
92615 | B | Eval laryngoscopy sense tst | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
92616 | A | Fees w/laryngeal sense test | 1.88 | 3.02 | 0.73 | 0.07 | 4.97 | 2.68 | XXX | |
92617 | B | Interprt fees/laryngeal test | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
93580 | A | Transcath closure of asd | 18.00 | NA | 7.34 | 1.14 | NA | 26.48 | 000 | |
93581 | A | Transcath closure of vsd | 24.43 | NA | 9.84 | 1.14 | NA | 35.41 | 000 | |
93609 | 26 | A | Map tachycardia, add-on | 5.00 | 2.00 | 2.00 | 0.52 | 7.52 | 7.52 | ZZZ |
93613 | A | Electrophys map 3d, add-on | 7.00 | 2.72 | 2.72 | 0.52 | 10.24 | 10.24 | ZZZ | |
93619 | 26 | A | Electrophysiology evaluation | 7.32 | 2.92 | 2.92 | 0.38 | 10.62 | 10.62 | 000 |
93620 | 26 | A | Electrophysiology evaluation | 11.59 | 4.62 | 4.62 | 0.60 | 16.81 | 16.81 | 000 |
93621 | 26 | A | Electrophysiology evaluation | 2.10 | 0.84 | 0.84 | 0.15 | 3.09 | 3.09 | ZZZ |
93622 | 26 | A | Electrophysiology evaluation | 3.10 | 1.23 | 1.23 | 0.67 | 5.00 | 5.00 | ZZZ |
95990 | A | Spin/brain pump refil main | 0.00 | 1.49 | NA | 0.05 | 1.54 | NA | XXX | |
96000 | A | Motion analysis, video/3d | 1.80 | NA | 0.70 | 0.02 | NA | 2.52 | XXX | |
96001 | A | Motion test w/ft press meas | 2.15 | NA | 0.84 | 0.02 | NA | 3.01 | XXX | |
96002 | A | Dynamic surface emg | 0.41 | NA | 0.16 | 0.02 | NA | 0.59 | XXX | |
96003 | A | Dynamic fine wire emg | 0.37 | NA | 0.14 | 0.03 | NA | 0.54 | XXX | |
96004 | A | Phys review of motion tests | 2.14 | 0.84 | 0.84 | 0.08 | 3.06 | 3.06 | XXX | |
96530 | A | Syst pump refill main | 0.00 | 1.05 | NA | 0.05 | 1.10 | NA | XXX | |
96920 | A | Laser tx, skin 250 sq cm | 1.15 | 2.88 | 0.45 | 0.09 | 4.12 | 1.69 | 000 | |
96921 | A | Laser tx, skin 250-500 sq cm | 1.17 | 2.96 | 0.46 | 0.09 | 4.22 | 1.72 | 000 | |
96922 | A | Laser tx, skin 500 sq cm | 2.10 | 3.56 | 0.82 | 0.16 | 5.82 | 3.08 | 000 | |
99026 | I | In-hospital on call service | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99027 | I | Out-of-hosp on call service | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
99289 | A | Ped crit care transport | 4.80 | NA | 1.87 | 0.14 | NA | 6.81 | XXX | |
99290 | A | Ped crit care transport addl | 2.40 | NA | 0.94 | 0.07 | NA | 3.41 | ZZZ | |
99293 | A | Ped critical care, initial | 16.00 | NA | 5.13 | 0.70 | NA | 21.83 | XXX | |
99294 | A | Ped critical care, subseq | 8.00 | NA | 2.57 | 0.23 | NA | 10.80 | XXX | |
99295 | A | Neonate crit care, initial | 18.49 | NA | 5.48 | 0.70 | NA | 24.67 | XXX | |
99296 | A | Neonate critical care subseq | 8.00 | NA | 2.61 | 0.23 | NA | 10.84 | XXX | |
99298 | A | Ic for lbw infant 1500 gm | 2.75 | NA | 0.96 | 0.10 | NA | 3.81 | XXX | |
99299 | A | Ic, lbw infant 1500-2500 gm | 2.50 | NA | 0.98 | 0.10 | NA | 3.58 | XXX | |
G0262 | 26 | A | Sm intestinal image capsule | 2.12 | 0.83 | 0.83 | 0.02 | 2.97 | 2.97 | XXX |
G0268 | A | Removal of impacted wax md | 0.61 | 0.57 | 0.24 | 0.04 | 1.22 | 0.89 | 000 | |
G0269 | B | Occlusive device in vein art | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | XXX | |
G0270 | A | MNT subs tx for change dx | 0.00 | 0.47 | NA | 0.01 | 0.48 | NA | XXX | |
G0271 | A | Group MNT 2 or more 30 mins | 0.00 | 0.18 | NA | 0.01 | 0.19 | NA | XXX | |
G0272 | A | Naso/oro gastric tube pl MD | 0.32 | 0.13 | NA | 0.02 | 0.47 | NA | 000 | |
G0273 | 26 | A | Pretx planning, non-Hodgkins | 0.86 | 0.34 | 0.34 | 0.03 | 1.23 | 1.23 | XXX |
G0274 | 26 | A | Radiopharm tx, non-Hodgkins | 2.07 | 0.81 | 0.81 | 0.08 | 2.96 | 2.96 | XXX |
G0275 | A | Renal angio, cardiac cath | 0.25 | 0.10 | NA | 0.01 | 0.36 | NA | ZZZ | |
G0278 | A | Iliac art angio,cardiac cath | 0.25 | 0.10 | NA | 0.01 | 0.36 | NA | ZZZ | |
G0279 | A | Excorp shock tx, elbow epi | 0.06 | 1.46 | NA | 0.01 | 1.53 | NA | XXX | |
G0280 | A | Excorp shock tx other than | 0.06 | 1.46 | NA | 0.01 | 1.53 | NA | XXX | |
G0281 | A | Elec stim unattend for press | 0.18 | 0.35 | 0.07 | 0.01 | 0.54 | 0.26 | XXX | |
G0283 | A | Elec stim other than wound | 0.18 | 0.35 | 0.07 | 0.01 | 0.54 | 0.26 | XXX | |
G0288 | A | Recon, CTA for surg plan | 0.00 | 10.57 | NA | 0.15 | 10.72 | NA | XXX | |
G0289 | A | Arthro, loose body + chondro | 1.48 | 0.58 | NA | 0.27 | 2.33 | NA | ZZZ | |
1 CPT codes and descriptions only are copyright 2002 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply. | ||||||||||
2 Copyright 2002 American Dental Association. All rights reserved. | ||||||||||
3 + Indicates RVUs are not used for Medicare payment. |
Carrier No. | Locality No. - | Locality name | Work | Practice expense | Mal- practice |
---|---|---|---|---|---|
00510 | 00 | ALABAMA | 0.978 | 0.870 | 0.807 |
00831 | 01 | ALASKA | 1.064 | 1.172 | 1.223 |
00832 | 00 | ARIZONA | 0.994 | 0.978 | 1.111 |
00520 | 13 | ARKANSAS | 0.953 | 0.847 | 0.340 |
31146 | 26 | ANAHEIM/SANTA ANA, CA | 1.037 | 1.184 | 0.955 |
31146 | 18 | LOS ANGELES, CA | 1.056 | 1.139 | 0.955 |
31140 | 03 | MARIN/NAPA/SOLANO, CA | 1.015 | 1.248 | 0.687 |
31140 | 07 | OAKLAND/BERKELEY, CA | 1.041 | 1.235 | 0.687 |
31140 | 05 | SAN FRANCISCO, CA | 1.068 | 1.458 | 0.687 |
31140 | 06 | SAN MATEO, CA | 1.048 | 1.432 | 0.687 |
31140 | 09 | SANTA CLARA, CA | 1.063 | 1.380 | 0.639 |
31146 | 17 | VENTURA, CA | 1.028 | 1.125 | 0.783 |
31146 | 99 | REST OF CALIFORNIA* | 1.007 | 1.034 | 0.748 |
31140 | 99 | REST OF CALIFORNIA* | 1.007 | 1.034 | 0.748 |
00824 | 01 | COLORADO | 0.985 | 0.992 | 0.840 |
00591 | 00 | CONNECTICUT | 1.050 | 1.156 | 0.966 |
00902 | 01 | DELAWARE | 1.019 | 1.035 | 0.712 |
00903 | 01 | DC + MD/VA SUBURBS | 1.050 | 1.166 | 0.909 |
00590 | 03 | FORT LAUDERDALE, FL | 0.996 | 1.018 | 1.877 |
00590 | 04 | MIAMI, FL | 1.015 | 1.052 | 2.528 |
00590 | 99 | REST OF FLORIDA | 0.975 | 0.946 | 1.265 |
00511 | 01 | ATLANTA, GA | 1.006 | 1.059 | 0.935 |
00511 | 99 | REST OF GEORGIA | 0.970 | 0.892 | 0.935 |
00833 | 01 | HAWAII/GUAM | 0.997 | 1.124 | 0.834 |
05130 | 00 | IDAHO | 0.960 | 0.881 | 0.497 |
00952 | 16 | CHICAGO, IL | 1.028 | 1.092 | 1.797 |
00952 | 12 | EAST ST. LOUIS, IL | 0.988 | 0.924 | 1.691 |
00952 | 15 | SUBURBAN CHICAGO, IL | 1.006 | 1.071 | 1.645 |
00952 | 99 | REST OF ILLINOIS | 0.964 | 0.889 | 1.157 |
00630 | 00 | INDIANA | 0.981 | 0.922 | 0.481 |
00826 | 00 | IOWA | 0.959 | 0.876 | 0.596 |
00650 | 00 | KANSAS* | 0.963 | 0.895 | 0.756 |
00740 | 04 | KANSAS* | 0.963 | 0.895 | 0.756 |
00660 | 00 | KENTUCKY | 0.970 | 0.866 | 0.877 |
00528 | 01 | NEW ORLEANS, LA | 0.998 | 0.945 | 1.283 |
00528 | 99 | REST OF LOUISIANA | 0.968 | 0.870 | 1.073 |
31142 | 03 | SOUTHERN MAINE | 0.979 | 0.999 | 0.666 |
31142 | 99 | REST OF MAINE | 0.961 | 0.910 | 0.666 |
00901 | 01 | BALTIMORE/SURR. CNTYS, MD | 1.021 | 1.038 | 0.916 |
00901 | 99 | REST OF MARYLAND | 0.984 | 0.972 | 0.774 |
31143 | 01 | METROPOLITAN BOSTON | 1.041 | 1.239 | 0.784 |
31143 | 99 | REST OF MASSACHUSETTS | 1.010 | 1.129 | 0.784 |
00953 | 01 | DETROIT, MI | 1.043 | 1.038 | 2.738 |
00953 | 99 | REST OF MICHIGAN | 0.997 | 0.938 | 1.571 |
00954 | 00 | MINNESOTA | 0.990 | 0.974 | 0.452 |
00512 | 00 | MISSISSIPPI | 0.957 | 0.837 | 0.779 |
00740 | 02 | METROPOLITAN KANSAS CITY, MO | 0.988 | 0.967 | 0.846 |
00523 | 01 | METROPOLITAN ST. LOUIS, MO | 0.994 | 0.938 | 0.846 |
00740 | 99 | REST OF MISSOURI* | 0.946 | 0.825 | 0.793 |
00523 | 99 | REST OF MISSOURI* | 0.946 | 0.825 | 0.793 |
00751 | 01 | MONTANA | 0.950 | 0.876 | 0.727 |
00655 | 00 | NEBRASKA | 0.948 | 0.877 | 0.430 |
00834 | 00 | NEVADA | 1.005 | 1.039 | 1.209 |
31144 | 40 | NEW HAMPSHIRE | 0.986 | 1.030 | 0.825 |
00805 | 01 | NORTHERN NJ | 1.058 | 1.193 | 0.860 |
00805 | 99 | REST OF NEW JERSEY | 1.029 | 1.110 | 0.860 |
00521 | 05 | NEW MEXICO | 0.973 | 0.900 | 0.902 |
00803 | 01 | MANHATTAN, NY | 1.094 | 1.351 | 1.668 |
00803 | 02 | NYC SUBURBS/LONG I., NY | 1.068 | 1.251 | 1.952 |
00803 | 03 | POUGHKPSIE/N NYC SUBURBS, NY | 1.011 | 1.075 | 1.275 |
14330 | 04 | QUEENS, NY | 1.058 | 1.228 | 1.871 |
00801 | 99 | REST OF NEW YORK | 0.998 | 0.944 | 0.764 |
05535 | 00 | NORTH CAROLINA | 0.970 | 0.931 | 0.595 |
00820 | 01 | NORTH DAKOTA | 0.950 | 0.880 | 0.657 |
16360 | 00 | OHIO | 0.988 | 0.944 | 0.957 |
00522 | 00 | OKLAHOMA | 0.968 | 0.876 | 0.444 |
00835 | 01 | PORTLAND, OR | 0.996 | 1.049 | 0.436 |
00835 | 99 | REST OF OREGON | 0.961 | 0.933 | 0.436 |
00865 | 01 | METROPOLITAN PHILADELPHIA, PA | 1.023 | 1.092 | 1.413 |
00865 | 99 | REST OF PENNSYLVANIA | 0.989 | 0.929 | 0.774 |
00973 | 20 | PUERTO RICO | 0.881 | 0.712 | 0.275 |
00870 | 01 | RHODE ISLAND | 1.017 | 1.065 | 0.883 |
00880 | 01 | SOUTH CAROLINA | 0.974 | 0.904 | 0.279 |
00820 | 02 | SOUTH DAKOTA | 0.935 | 0.878 | 0.406 |
05440 | 35 | TENNESSEE | 0.975 | 0.900 | 0.592 |
00900 | 31 | AUSTIN, TX | 0.986 | 0.996 | 0.859 |
00900 | 20 | BEAUMONT, TX | 0.992 | 0.890 | 1.338 |
00900 | 09 | BRAZORIA, TX | 0.992 | 0.978 | 1.338 |
00900 | 11 | DALLAS, TX | 1.010 | 1.065 | 0.931 |
00900 | 28 | FORT WORTH, TX | 0.987 | 0.981 | 0.931 |
00900 | 15 | GALVESTON, TX | 0.988 | 0.969 | 1.338 |
00900 | 18 | HOUSTON, TX | 1.020 | 1.007 | 1.336 |
00900 | 99 | REST OF TEXAS | 0.966 | 0.880 | 0.956 |
00910 | 09 | UTAH | 0.976 | 0.941 | 0.644 |
31145 | 50 | VERMONT | 0.973 | 0.986 | 0.539 |
00973 | 50 | VIRGIN ISLANDS | 0.965 | 1.023 | 1.002 |
00904 | 00 | VIRGINIA | 0.984 | 0.938 | 0.500 |
00836 | 02 | SEATTLE (KING CNTY), WA | 1.005 | 1.100 | 0.788 |
00836 | 99 | REST OF WASHINGTON | 0.981 | 0.972 | 0.788 |
16510 | 16 | WEST VIRGINIA | 0.963 | 0.850 | 1.378 |
00951 | 00 | WISCONSIN | 0.981 | 0.929 | 0.939 |
00825 | 21 | WYOMING | 0.967 | 0.895 | 1.005 |
*Payment locality is serviced by two carriers. | |||||
Note: Work GPCI is the 1/4 work GPCI required by Section 1848(e)(1)(A)(iii) of the Social Security Act. GPCIs rescaled by the following factors for budget netrality: Work = 0.99699; Practice Expense = 0.99235; Malpractice Expense = 1.00215. |
CLINICAL LABORATORY SERVICES | |
INCLUDE CPT codes for all clinical laboratory services in the 80000 series, except EXCLUDE CPT codes for the following blood component collection services: | |
86890 | Autologous blood process |
86891 | Autologous blood, op salvage |
86927 | Plasma, fresh frozen |
86930 | Frozen blood prep |
86931 | Frozen blood thaw |
86932 | Frozen blood freeze/thaw |
86945 | Blood product/irradiation |
86950 | Leukacyte transfusion |
86965 | Pooling blood platelets |
86985 | Split blood or products |
INCLUDE the following CPT and HCPCS level 2 codes for other clinical laboratory services: | |
0010T | TB test,gamma interferon- |
0023T | Phenotype drug test, hiv 1 |
0026T | Measure remnant lipoproteins |
0030T | Antiprothrombin antibody |
0041T | Detect ur infect agent w/cpas |
0043T | Co expired gas analysis |
G0001 | Drawing blood for specimen |
G0103 | Psa, total screening |
G0107 | CA screen; fecal blood test |
G0123 | Screen cerv/vag thin layer |
G0124 | Screen c/v thin layer by MD |
G0141 | Scr c/v cyto,autosys and md |
G0143 | Scr c/v cyto,thinlayer,rescr |
G0144 | Scr c/v cyto,thinlayer,rescr |
G0145 | Scr c/v cyto,thinlayer,rescr |
G0147 | Scr c/v cyto, automated sys |
G0148 | Scr c/v cyto, autosys, rescr |
P2028 | Cephalin floculation test |
P2029 | Congo red blood test |
P2031 | Hair analysis |
P2033 | Blood thymol turbidity |
P2038 | Blood mucoprotein |
P3000 | Screen pap by tech w md supv |
P3001 | Screening pap smear by phys |
P7001 | Culture bacterial urine |
P9612 | Catheterize for urine spec |
P9615 | Urine specimen collect mult |
Q0111 | Wet mounts/ w preparations |
Q0112 | Potassium hydroxide preps |
Q0113 | Pinworm examinations |
Q0114 | Fern test |
Q0115 | Post-coital mucous exam |
PHYSICAL THERAPY, OCCUPATIONAL THERAPY, AND SPEECH-LANGUAGE PATHOLOGY | |
INCLUDE the following CPT codes for the physical therapy/occupational therapy/speech-language pathology services in the 97000 series: | |
97001 | Pt evaluation |
97002 | Pt re-evaluation |
97003 | Ot evaluation |
97004 | Ot re-evaluation |
97010 | Hot or cold packs therapy |
97012 | Mechanical traction therapy |
97016 | Vasopneumatic device therapy |
97018 | Paraffin bath therapy |
97020 | Microwave therapy |
97022 | Whirlpool therapy |
97024 | Diathermy treatment |
97026 | Infrared therapy |
97028 | Ultraviolet therapy |
97032 | Electrical stimulation |
97033 | Electric current therapy |
97034 | Contrast bath therapy |
97035 | Ultrasound therapy |
97036 | Hydrotherapy |
97039 | Physical therapy treatment |
97110 | Therapeutic exercises |
97112 | Neuromuscular reeducation |
97113 | Aquatic therapy/exercises |
97116 | Gait training therapy |
97124 | Massage therapy |
97139 | Physical medicine procedure |
97140 | Manual therapy |
97150 | Group therapeutic procedures |
97504 | Orthotic training |
97520 | Prosthetic training |
97530 | Therapeutic activities |
97532 | Cognitive skills development |
97533 | Sensory integration |
97535 | Self care mngment training |
97537 | Community/work reintegration |
97542 | Wheelchair mngment training |
97545 | Work hardening |
97546 | Work hardening add-on |
97703 | Prosthetic checkout |
97750 | Physical performance test |
97799 | Physical medicine procedure |
INCLUDE CPT codes for physical therapy/occupational therapy/speech-language pathology services not in the 97000 series: | |
64550 | Apply neurostimulator |
90901 | Biofeedback train, any meth |
90911 | Biofeedback peri/uro/rectal |
92506 | Speech/hearing evaluation |
92507 | Speech/hearing therapy |
92508 | Speech/hearing therapy- |
92526 | Oral function therapy |
92601 | Cochlear implt f/up exam 7 |
92602 | Reprogram cochlear implt 7 |
92603 | Cochlear implt f/up exam 7 |
92604 | Reprogram cochlear implt 7 - |
92607 | Ex for speech device rx, 1hr |
92608 | Ex for speech device rx addl |
92609 | Use of speech device service |
92610 | Evaluate swallowing function |
92611 | Motion fluoroscopy/swallow |
92612 | Endoscopy swallow tst (fees) |
92614 | Laryngoscopic sensory test |
92616 | Fees w/laryngeal sense test |
93797 | Cardiac rehab |
93798 | Cardiac rehab/monitor |
94667 | Chest wall manipulation |
94668 | Chest wall manipulation |
94762 | Measure blood oxygen level |
95831 | Limb muscle testing, manual |
95832 | Hand muscle testing, manual |
95833 | Body muscle testing, manual |
95834 | Body muscle testing, manual |
95851 | Range of motion measurements |
95852 | Range of motion measurements |
96000 | Motion analysis, video/3d |
96001 | Motion test w/ft press meas |
96002 | Dynamic surface emg |
96003 | Dynamic fine wire emg |
96105 | Assessment of aphasia |
96110 | Developmental test, lim |
96111 | Developmental test, extend |
96115 | Neurobehavior status exam |
0019T | Extracorp shock wave tx, ms- |
0020T | Extracorp shock wave tx, ft |
0029T | Magnetic tx for incontinence |
INCLUDE HCPCS level 2 codes for the following physical therapy/occupational therapy/speech-language pathology service: | |
G0279 | Excorp shock tx, elbow epi |
G0280 | Excorp shock tx other than |
G0281 | Elec stim unattend for press |
G0283 | Elec stim other than wound |
Q0086 | Physical therapy evaluation/ |
RADIOLOGY AND CERTAIN OTHER IMAGING SERVICES | |
INCLUDE the following codes in the CPT 70000 series: | |
70100 | X-ray exam of jaw |
70110 | X-ray exam of jaw |
70120 | X-ray exam of mastoids |
70130 | X-ray exam of mastoids |
70134 | X-ray exam of middle ear |
70140 | X-ray exam of facial bones |
70150 | X-ray exam of facial bones |
70160 | X-ray exam of nasal bones |
70190 | X-ray exam of eye sockets |
70200 | X-ray exam of eye sockets |
70210 | X-ray exam of sinuses |
70220 | X-ray exam of sinuses |
70240 | X-ray exam, pituitary saddle |
70250 | X-ray exam of skull |
70260 | X-ray exam of skull |
70300 | X-ray exam of teeth |
70310 | X-ray exam of teeth |
70320 | Full mouth x-ray of teeth |
70328 | X-ray exam of jaw joint |
70330 | X-ray exam of jaw joints |
70336 | Magnetic image, jaw joint |
70350 | X-ray head for orthodontia |
70355 | Panoramic x-ray of jaws |
70360 | X-ray exam of neck |
70370 | Throat x-ray fluoroscopy |
70371 | Speech evaluation, complex |
70380 | X-ray exam of salivary gland |
70450 | Ct head/brain w/o dye |
70460 | Ct head/brain w/dye |
70470 | Ct head/brain w/ow dye |
70480 | Ct orbit/ear/fossa w/o dye |
70481 | Ct orbit/ear/fossa w/dye |
70482 | Ct orbit/ear/fossa w/ow dye |
70486 | Ct maxillofacial w/o dye |
70487 | Ct maxillofacial w/dye |
70488 | Ct maxillofacial w/ow dye |
70490 | Ct soft tissue neck w/o dye |
70491 | Ct soft tissue neck w/dye |
70492 | Ct sft tsue nck w/o w/dye |
70496 | Ct angiography, head |
70498 | Ct angiography, neck |
70540 | Mri orbit/face/neck w/o dye |
70542 | Mri orbit/face/neck w/dye |
70543 | Mri orbt/fac/nck w/ow dye |
70544 | Mr angiography head w/o dye |
70545 | Mr angiography head w/dye |
70546 | Mr angiograph head w/ow dye |
70547 | Mr angiography neck w/o dye |
70548 | Mr angiography neck w/dye |
70549 | Mr angiograph neck w/ow dye |
70551 | Mri brain w/o dye |
70552 | Mri brain w/dye |
70553 | Mri brain w/ow dye |
71010 | Chest x-ray |
71015 | Chest x-ray |
71020 | Chest x-ray |
71021 | Chest x-ray |
71022 | Chest x-ray |
71023 | Chest x-ray and fluoroscopy |
71030 | Chest x-ray |
71034 | Chest x-ray and fluoroscopy |
71035 | Chest x-ray- |
71100 | X-ray exam of ribs |
71101 | X-ray exam of ribs/chest |
71110 | X-ray exam of ribs |
71111 | X-ray exam of ribs/ chest |
71120 | X-ray exam of breastbone |
71130 | X-ray exam of breastbone |
71250 | Ct thorax w/o dye |
71260 | Ct thorax w/dye |
71270 | Ct thorax w/ow dye |
71275 | Ct angiography, chest |
71550 | Mri chest w/o dye |
71551 | Mri chest w/dye |
71552 | Mri chest w/ow/dye |
71555 | Mri angio chest w or w/o dye |
72010 | X-ray exam of spine |
72020 | X-ray exam of spine |
72040 | X-ray exam of neck spine |
72050 | X-ray exam of neck spine |
72052 | X-ray exam of neck spine |
72069 | X-ray exam of trunk spine |
72070 | X-ray exam of thoracic spine |
72072 | X-ray exam of thoracic spine |
72074 | X-ray exam of thoracic spine |
72080 | X-ray exam of trunk spine |
72090 | X-ray exam of trunk spine |
72100 | X-ray exam of lower spine |
72110 | X-ray exam of lower spine |
72114 | X-ray exam of lower spine |
72120 | X-ray exam of lower spine |
72125 | Ct neck spine w/o dye |
72126 | Ct neck spine w/dye |
72127 | Ct neck spine w/ow/dye |
72128 | Ct chest spine w/o dye |
72129 | Ct chest spine w/dye |
72130 | Ct chest spine w/ow/dye |
72131 | Ct lumbar spine w/o dye |
72132 | Ct lumbar spine w/dye |
72133 | Ct lumbar spine w/ow/dye |
72141 | Mri neck spine w/o dye |
72142 | Mri neck spine w/dye |
72146 | Mri chest spine w/o dye |
72147 | Mri chest spine w/dye |
72148 | Mri lumbar spine w/o dye |
72149 | Mri lumbar spine w/dye |
72156 | Mri neck spine w/ow/dye |
72157 | Mri chest spine w/ow/dye |
72158 | Mri lumbar spine w/ow/dye |
72170 | X-ray exam of pelvis |
72190 | X-ray exam of pelvis |
72191 | Ct angiograph pelv w/ow/dye |
72192 | Ct pelvis w/o dye |
72193 | Ct pelvis w/dye |
72194 | Ct pelvis w/ow/dye |
72195 | Mri pelvis w/o dye |
72196 | Mri pelvis w/dye |
72197 | Mri pelvis w/o w dye |
72200 | X-ray exam sacroiliac joints |
72202 | X-ray exam sacroiliac joints |
72220 | X-ray exam of tailbone |
73000 | X-ray exam of collar bone |
73010 | X-ray exam of shoulder blade |
73020 | X-ray exam of shoulder |
73030 | X-ray exam of shoulder |
73050 | X-ray exam of shoulders |
73060 | X-ray exam of humerus |
73070 | X-ray exam of elbow |
73080 | X-ray exam of elbow |
73090 | X-ray exam of forearm |
73092 | X-ray exam of arm, infant |
73100 | X-ray exam of wrist |
73110 | X-ray exam of wrist |
73120 | X-ray exam of hand |
73130 | X-ray exam of hand |
73140 | X-ray exam of finger(s) |
73200 | Ct upper extremity w/o dye |
73201 | Ct upper extremity w/dye |
73202 | Ct uppr extremity w/ow/dye |
73206 | Ct angio upr extrm w/ow/dye |
73218 | Mri upper extremity w/o dye |
73219 | Mri upper extremity w/dye |
73220 | Mri uppr extremity w/ow/dye |
73221 | Mri joint upr extrem w/o dye |
73222 | Mri joint upr extrem w/dye |
73223 | Mri joint upr extr w/ow/dye |
73500 | X-ray exam of hip |
73510 | X-ray exam of hip |
73520 | X-ray exam of hips |
73540 | X-ray exam of pelvis hips |
73550 | X-ray exam of thigh |
73560 | X-ray exam of knee, 1 or 2 |
73562 | X-ray exam of knee, 3 |
73564 | X-ray exam, knee, 4 or more |
73565 | X-ray exam of knees |
73590 | X-ray exam of lower leg |
73592 | X-ray exam of leg, infant |
73600 | X-ray exam of ankle |
73610 | X-ray exam of ankle |
73620 | X-ray exam of foot |
73630 | X-ray exam of foot |
73650 | X-ray exam of heel |
73660 | X-ray exam of toe(s) |
73700 | Ct lower extremity w/o dye |
73701 | Ct lower extremity w/dye |
73702 | Ct lwr extremity w/ow/dye |
73706 | Ct angio lwr extr w/ow/dye |
73718 | Mri lower extremity w/o dye |
73719 | Mri lower extremity w/dye |
73720 | Mri lwr extremity w/ow/dye |
73721 | Mri jnt of lwr extre w/o dye |
73722 | Mri joint of lwr extr w/dye |
73723 | Mri joint lwr extr w/ow/dye |
73725 | Mr ang lwr ext w or w/o dye |
74000 | X-ray exam of abdomen |
74010 | X-ray exam of abdomen |
74020 | X-ray exam of abdomen |
74022 | X-ray exam series, abdomen |
74150 | Ct abdomen w/o dye |
74160 | Ct abdomen w/dye |
74170 | Ct abdomen w/ow/dye |
74175 | Ct angio abdom w/ow/dye |
74181 | Mri abdomen w/o dye |
74182 | Mri abdomen w/dye |
74183 | Mri abdomen w/ow/dye |
74185 | Mri angio, abdom w or w/o dy |
74210 | Contrst x-ray exam of throat |
74220 | Contrast x-ray, esophagus |
74230 | Cine/vid x-ray, throat/esoph |
74240 | X-ray exam, upper gi tract |
74241 | X-ray exam, upper gi tract |
74245 | X-ray exam, upper gi tract |
74246 | Contrst x-ray uppr gi tract |
74247 | Contrst x-ray uppr gi tract |
74249 | Contrst x-ray uppr gi tract |
74250 | X-ray exam of small bowel |
74290 | Contrast x-ray, gallbladder |
74291 | Contrast x-rays, gallbladder |
74710 | X-ray measurement of pelvis |
75552 | Heart mri for morph w/o dye |
75553 | Heart mri for morph w/dye |
75554 | Cardiac MRI/function |
75555 | Cardiac MRI/limited study |
75635 | Ct angio abdominal arteries |
76000 | Fluoroscope examination |
76006 | X-ray stress view |
76010 | X-ray, nose to rectum |
76020 | X-rays for bone age |
76040 | X-rays, bone evaluation |
76061 | X-rays, bone survey |
76062 | X-rays, bone survey |
76065 | X-rays, bone evaluation |
76066 | Joint survey, single view |
76070 | Ct bone density, axial |
76071 | Ct bone density, peripheral |
76085 | Computer mammogram add-on |
76090 | Mammogram, one breast |
76091 | Mammogram, both breasts |
76092 | Mammogram, screening |
76093 | Magnetic image, breast |
76094 | Magnetic image, both breasts |
76100 | X-ray exam of body section |
76101 | Complex body section x-ray |
76102 | Complex body section x-rays |
76120 | Cine/video x-rays |
76125 | Cine/video x-rays add-on |
76150 | X-ray exam, dry process |
76370 | CAT scan for therapy guide |
76375 | 3d/holograph reconstr add-on |
76380 | CAT scan follow-up study |
76400 | Magnetic image, bone marrow |
76499 | Radiographic procedure |
76506 | Echo exam of head |
76511 | Echo exam of eye |
76512 | Echo exam of eye |
76513 | Echo exam of eye, water bath |
76516 | Echo exam of eye |
76519 | Echo exam of eye |
76536 | Us exam of head and neck |
76604 | Us exam, chest, b-scan |
76645 | Us exam, breast(s) |
76700 | Us exam, abdom, complete |
76705 | Echo exam of abdomen |
76770 | Us exam abdo back wall, comp |
76775 | Us eam abdo back wall,lim |
76778 | Us exam kidney transplant |
76800 | Us exam, spinal canal |
76801 | Ob us 14 wks, single fetus- |
76802 | Ob us 14 wks, addl fetus |
76805 | Ob us /= 14 wks, sngl fetus |
76810 | Ob us /= 14 wks, addl fetus |
76811 | Ob us, detailed, sngl fetus |
76812 | Ob us, detailed, addl fetus |
76815 | Ob us, limited, fetus(s) |
76816 | Ob us, follow-up, per fetus |
76818 | Fetal biophys profile w/nst |
76819 | Fetal biophys profil w/o nst |
76825 | Echo exam of fetal heart |
76826 | Echo exam of fetal heart |
76827 | Echo exam of fetal heart |
76828 | Echo exam of fetal heart |
76831 | Echo exam, uterus |
76856 | Us exam, pelvic, complete |
76857 | Us exam, pelvic, limited |
76870 | Us exam, scrotum |
76880 | Us exam, extremity |
76885 | Us exam infant hips, dynamic |
76886 | Us exam infant hips, static |
76970 | Ultrasound exam follow-up |
76977 | Us bone density measure |
76999 | Echo examination procedure |
INCLUDE the following CPT codes for echocardiography and vascular ultrasound: | |
93303 | Echo transthoracic |
93304 | Echo transthoracic |
93307 | Echo exam of heart |
93308 | Echo exam of heart |
93320 | Doppler echo exam, heart [if used in conjunction with 9330393308] |
93321 | Doppler echo exam, heart [if used in conjunction with 9330393308] |
93325 | Doppler color flow add-on [if used in conjunction with 9330393308] |
93875 | Extracranial study |
93880 | Extracranial study |
93882 | Extracranial study |
93886 | Intracranial study |
93888 | Intracranial study |
93922 | Extremity study |
93923 | Extremity study |
93924 | Extremity study |
93925 | Lower extremity study |
93926 | Lower extremity study |
93930 | Upper extremity study |
93931 | Upper extremity study |
93965 | Extremity study |
93970 | Extremity study |
93971 | Extremity study |
93975 | Vascular study |
93976 | Vascular study |
93978 | Vascular study |
93979 | Vascular study |
93980 | Penile vascular study |
93981 | Penile vascular study |
93990 | Doppler flow testing |
INCLUDE the following CPT and HCPCS level 2 codes: | |
51798 | Us urine capacity measure |
0028T | Dexa body composition study |
0042T | Ct perfusion w/contrast, cbf |
G0202 | Screeningmammographydigital |
G0204 | Diagnosticmammographydigital |
G0206 | Diagnosticmammographydigital |
G0236 | digital film convert diag ma |
G0262 | Sm intestinal image capsule |
G0288 | Recon, CTA for surg plan |
R0070 | Transport portable x-ray |
R0075 | Transport port x-ray multipl |
RADIATION THERAPY SERVICES AND SUPPLIES | |
INCLUDE the following codes in the CPT 70000 series: | |
77261 | Radiation therapy planning |
77262 | Radiation therapy planning |
77263 | Radiation therapy planning |
77280 | Set radiation therapy field |
77285 | Set radiation therapy field |
77290 | Set radiation therapy field |
77295 | Set radiation therapy field |
77299 | Radiation therapy planning |
77300 | Radiation therapy dose plan |
77301 | Radiotherapy dose plan, imrt |
77305 | Teletx isodose plan simple |
77310 | Teletx isodose plan intermed |
77315 | Teletx isodose plan complex |
77321 | Special teletx port plan |
77326 | Brachytx isodose calc simp |
77327 | Brachytx isodose calc interm |
77328 | Brachytx isodose plan compl |
77331 | Special radiation dosimetry |
77332 | Radiation treatment aid(s) |
77333 | Radiation treatment aid(s) |
77334 | Radiation treatment aid(s) |
77336 | Radiation physics consult |
77370 | Radiation physics consult |
77399 | External radiation dosimetry |
77401 | Radiation treatment delivery |
77402 | Radiation treatment delivery |
77403 | Radiation treatment delivery |
77404 | Radiation treatment delivery |
77406 | Radiation treatment delivery |
77407 | Radiation treatment delivery |
77408 | Radiation treatment delivery- |
77409 | Radiation treatment delivery |
77411 | Radiation treatment delivery |
77412 | Radiation treatment delivery |
77413 | Radiation treatment delivery |
77414 | Radiation treatment delivery |
77416 | Radiation treatment delivery |
77417 | Radiology port film(s) |
77418 | Radiation tx delivery, imrt |
77427 | Radiation tx management, x5 |
77431 | Radiation therapy management |
77432 | Stereotactic radiation trmt |
77470 | Special radiation treatment |
77499 | Radiation therapy management |
77520 | Proton trmt, simple w/o comp |
77522 | Proton trmt, simple w/comp |
77523 | Proton trmt, intermediate |
77525 | Proton treatment, complex |
77600 | Hyperthermia treatment |
77605 | Hyperthermia treatment |
77610 | Hyperthermia treatment |
77615 | Hyperthermia treatment |
77620 | Hyperthermia treatment |
77750 | Infuse radioactive materials |
77761 | Apply intrcav radiat simple |
77762 | Apply intrcav radiat interm |
77763 | Apply intrcav radiat compl |
77776 | Apply interstit radiat simpl |
77777 | Apply interstit radiat inter |
77778 | Apply interstit radiat compl |
77781 | High intensity brachytherapy |
77782 | High intensity brachytherapy |
77783 | High intensity brachytherapy |
77784 | High intensity brachytherapy |
77789 | Apply surface radiation |
77790 | Radiation handling |
77799 | Radium/radioisotope therapy |
INCLUDE the following CPT and HCPCS level 2 codes classified elsewhere: | |
31643 | Diag bronchoscope/catheter |
50559 | Renal endoscopy/radiotracer |
55859 | Percut/needle insert, pros |
61770 | Incise skull for treatment |
61793 | Focus radiation beam |
92974 | Cath place, cardio brachytx |
G0242 | Multisource photon ster plan- |
G0243 | Multisour photon stero treat |
G0256 | Prostate brachy w palladium |
G0261 | Prostate brachytherapy w/rad |
G0274 | Radiopharm tx, non-Hodgkins |
PREVENTIVE SCREENING TESTS, IMMUNIZATIONS AND VACCINES | |
The physician self-referral prohibition does not apply to the following tests if they are performed for screening purposes and satisfy the conditions in § 411.355(h): | |
76085 | Computer mammogram add-on [when used in conjunction with 76092] |
76092 | Mammogram, screening |
76977 | Us bone density measure |
G0103 | Psa, total screening |
G0107 | CA screen; fecal blood test |
G0123 | Screen cerv/vag thin layer |
G0124 | Screen c/v thin layer by MD |
G0141 | Scr c/v cyto,autosys and md |
G0143 | Scr c/v cyto,thinlayer,rescr |
G0144 | Scr c/v cyto,thinlayer,rescr |
G0145 | Scr c/v cyto,thinlayer,rescr |
G0147 | Scr c/v cyto, automated sys |
G0148 | Scr c/v cyto, autosys, rescr |
G0202 | Screeningmammographydigital |
P3000 | Screen pap by tech w md supv |
P3001 | Screening pap smear by phys |
The physician self-referral prohibition does not apply to the following immunization and vaccine codes if they satisfy the conditions in § 411.355(h): | |
90657 | Flu vaccine, 635 mo, im |
90658 | Flu vaccine, 3 yrs, im |
90659 | Flu vacine, whole, im |
90732 | Pneumococcal vaccine |
90748 | Hep b/hib vaccine, im |
Q3021 | Ped hepatitis b vaccine inj |
Q3022 | Hepatitis b vaccine adult ds |
Q3023 | Injection hepatitis Bvaccine |
DRUGS USED BY PATIENTS UNDERGOING DIALYSIS | |
The physician self-referral prohibition does not apply to the following EPO and other dialysis-related outpatient prescription drugs furnished in or by an ESRD facility if the conditions in § 411.355(g) are satisfied: | |
J0636 | Inj calcitriol per 0.1 mcg |
J0895 | Deferoxamine mesylate inj |
J1270 | Injection, doxercalciferol |
J1750 | Iron dextran |
J1756 | Iron sucrose injection |
J2501 | Paricalcitol |
J2916 | Na ferric gluconate complex |
J2997 | Alteplase recombinant |
Q9920 | Epoetin with hct =20 |
Q9921 | Epoetin with hct = 21 |
Q9922 | Epoetin with hct = 22 |
Q9923 | Epoetin with hct = 23 |
Q9924 | Epoetin with hct = 24 |
Q9925 | Epoetin with hct = 25 |
Q9926 | Epoetin with hct = 26 |
Q9927 | Epoetin with hct = 27 |
Q9928 | Epoetin with hct = 28 |
Q9929 | Epoetin with hct = 29 |
Q9930 | Epoetin with hct = 30 |
Q9931 | Epoetin with hct = 31 |
Q9932 | Epoetin with hct = 32 |
Q9933 | Epoetin with hct = 33 |
Q9934 | Epoetin with hct = 34 |
Q9935 | Epoetin with hct = 35 |
Q9936 | Epoetin with hct = 36 |
Q9937 | Epoetin with hct = 37 |
Q9938 | Epoetin with hct = 38 |
Q9939 | Epoetin with hct = 39 |
Q9940 | Epoetin with hct = 40 |
1 CPT codes and descriptions only are copyright 2002 American Medical Association. All rights are reserved and applicable FARS/DFARS clauses apply. |
CPT code | Short descriptors | CPT code | Short descriptors |
---|---|---|---|
11043 | DEBRIDE TISSUE/MUSCLE | 15736 | MUSCLE-SKIN GRAFT, ARM |
11044 | DEBRIDE TISSUE/MUSCLE/BONE | 15738 | MUSCLE-SKIN GRAFT, LEG |
11100 | BIOPSY OF SKIN LESION | 15820 | REVISION OF LOWER EYELID |
11101 | BIOPSY, SKIN ADD-ON | 15821 | REVISION OF LOWER EYELID |
11300 | SHAVE SKIN LESION | 15822 | REVISION OF UPPER EYELID |
11301 | SHAVE SKIN LESION | 15823 | REVISION OF UPPER EYELID |
11302 | SHAVE SKIN LESION | 17000 | DETROY BENIGN/PREMLG LESION |
11303 | SHAVE SKIN LESION | 17003 | DESTROY LESIONS, 2-14 |
11305 | SHAVE SKIN LESION | 17004 | DESTROY LESIONS, 15 OR MORE |
11306 | SHAVE SKIN LESION | 17106 | DESTRUCTION OF SKIN LESIONS |
11307 | SHAVE SKIN LESION | 17107 | DESTRUCTION OF SKIN LESIONS |
11308 | SHAVE SKIN LESION | 17108 | DESTRUCTION OF SKIN LESIONS |
11310 | SHAVE SKIN LESION | 17110 | DESTRUCT LESION, 1-14 |
11311 | SHAVE SKIN LESION | 17111 | DESTRUCT LESION, 15 OR MORE |
11312 | SHAVE SKIN LESION | 17250 | CHEMICAL CAUTERY, TISSUE |
11313 | SHAVE SKIN LESION | 17260 | DESTRUCTION OF SKIN LESIONS |
11400 | EXC TR -EXT B9+MARG 0.5 CM | 17261 | DESTRUCTION OF SKIN LESIONS |
11401 | EXC TR -EXT B9+MARG 0.6-1 CM | 17262 | DESTRUCTION OF SKIN LESIONS |
11402 | EXC TR -EXT B9+MARG 1.1-2 CM | 17263 | DESTRUCTION OF SKIN LESIONS |
11403 | EXC TR -EXT B9+MARG 2.1-3 CM | 17264 | DESTRUCTION OF SKIN LESIONS |
11404 | EXC TR - EXT B9+MARG 3.1-4 CM | 17266 | DESTRUCTION OF SKIN LESIONS |
11406 | EXC TR -EXT B9=MARG 4.0 CM | 17270 | DESTRUCTION OF SKIN LESIONS |
11420 | EXC H-F-NK-SP B9+MARG 0.5 | 17271 | DESTRUCTION OF SKIN LESIONS |
11421 | EXC H-F-NK-SP B9+MARG 0.6-1 | 17272 | DESTRUCTION OF SKIN LESIONS |
11422 | EXC H-F-NK-SP B9+MARG 1.1-2 | 17273 | DESTRUCTION OF SKIN LESIONS |
11423 | EXC H-F-NK-SP B9+MARG 2.1-3 | 17274 | DESTRUCTION OF SKIN LESIONS |
11424 | EXC H-F-NK-SP B9+MARG 3.1-4 | 17276 | DESTRUCTION OF SKIN LESIONS |
11426 | EXC H-F-NK-SP B9+MARG 4 CM | 17280 | DESTRUCTION OF SKIN LESIONS |
11440 | EXC FACE-MM B9+MARG 0.5 CM | 17281 | DESTRUCTION OF SKIN LESIONS |
11441 | EXC FACE-MM B9+MARG 0.6-1 CM | 17282 | DESTRUCTION OF SKIN LESIONS |
11442 | EXC FACE-MM B9+MARG 1.1-2 CM | 17283 | DESTRUCTION OF SKIN LESIONS |
11443 | EXC FACE-MM B9+MARG 2.1-3 CM | 17284 | DESTRUCTION OF SKIN LESIONS |
11444 | EXC FACE-MM B9+MARG 3.1-4 CM | 17286 | DESTRUCTION OF SKIN LESIONS |
11446 | EXC FACE-MM B9+MARG 4 CM | 19318 | REDUCTION OF LARGE BREAST |
11900 | INJECTION INTO SKIN LESIONS | 19357 | BREAST RECONSTRUCTION |
11901 | ADDED SKIN LESIONS INJECTIONS | 19361 | BREAST RECONSTRUCTION |
14040 | SKIN TISSUE REARRANGEMENT | 19364 | BREAST RECONSTRUCTION |
14041 | SKIN TISSUE REARRANGEMENT | 19366 | BREAST RECONSTRUCTION |
14060 | SKIN TISSUE REARRANGEMENT | 19367 | BREAST RECONSTRUCTION |
14061 | SKIN TISSUE REARRANGEMENT | 19368 | BREAST RECONSTRUCTION |
14300 | SKIN TISSUE REARRANGEMENT | 19369 | BREAST RECONSTRUCTION |
15000 | SKIN GRAFT | 22548 | NECK SPINE FUSION |
15001 | SKIN GRAFT ADD-ON | 22554 | NECK SPINE FUSION |
15100 | SKIN SPLIT GRAFT | 22556 | THORAX SPINE FUSION |
15101 | SKIN SPLIT GRAFT ADD-ON | 22558 | LUMBAR SPINE FUSION |
15120 | SKIN SPLIT GRAFT | 22590 | SPINE SKULL SPINAL FUSION |
15121 | SKIN SPLIT GRAFT ADD-ON | 22595 | NECK SPINAL FUSION |
15260 | SKIN FULL GRAFT | 22600 | NECK SPINE FUSION |
15261 | SKIN FULL GRAFT ADD-ON | 22610 | THORAX SPINE FUSION |
15732 | MUSCLE-SKIN GRAFT, HEAD/NECK | 22612 | LUMBAR SPINE FUSION |
15734 | MUSCLE-SKIN GRAFT, TRUNK | 22630 | LUMBAR SPINE FUSION |
*PEAC refined in office inputs only. | |||
CPT Codes and descriptions are copyright 2002 by the Amercian Medical Association, all rights reserved. |
CPT code | Short descriptors | CPT code | Short descriptors |
---|---|---|---|
22800 | FUSION OF SPINE | 26121 | RELEASE PALM CONTRACTURE |
22802 | FUSION OF SPINE | 26123 | RELEASE PALM CONTRACTURE |
22804 | FUSION OF SPINE | 26130 | REMOVE WRIST JOINT LINING |
22808 | FUSION OF SPINE | 26135 | REVISE FINGER JOINT, EACH |
22810 | FUSION OF SPINE | 26140 | REVISE FINGER JOINT, EACH |
22812 | FUSION OF SPINE | 26145 | TENDON EXCISION, PALM/FINGER |
22818 | KYPHECTOMY, 1-2 SEGMENTS | 26160 | REMOVE TENDON SHEATH LESION |
22819 | KYPHECTOMY, 3 OR MORE | 26170 | REMOVAL OF PALM TENDON, EACH |
22830 | EXPLORATION OF SPINAL FUSION | 26180 | REMOVAL OF FINGER TENDON |
23470 | RECONSTRUCT SHOULDER JOINT | 26185 | REMOVE FINGER BONE |
23472 | RECONSTRUCT SHOULDER JOINT | 26200 | REMOVE HAND BONE LESION |
24160 | REMOVE ELBOW JOINT IMPLANT | 26205 | REMOVE/GRAFT BONE LESION |
24164 | REMOVE RADIUS HEAD IMPLANT | 26210 | REMOVAL OF FINGER LESION |
24360 | RECONSTRUCT ELBOW JOINT | 26215 | REMOVE/GRAFT FINGER LESION |
24361 | RECONSTRUCT ELBOW JOINT | 26230 | PARTIAL REMOVAL OF HAND BONE |
24362 | RECONSTRUCT ELBOW JOINT | 26235 | PARTIAL REMOVAL, FINGER BONE |
24363 | REPLACE ELBOW JOINT | 26236 | PARTIAL REMOVAL, FINGER BONE |
24365 | RECONSTRUCT HEAD OF RADIUS | 26250 | EXTENSIVE HAND SURGERY |
24366 | RECONSTRUCT HEAD OF RADIUS | 26255 | EXTENSIVE HAND SURGERY |
25250 | REMOVAL OF WRIST PROSTHESIS | 26260 | EXTENSIVE FINGER SURGERY |
25251 | REMOVAL OF WRIST PROSTHESIS | 26261 | EXTENSIVE FINGER SURGERY |
25332 | REVISE WRIST JOINT | 26262 | PARTIAL REMOVAL OF FINGER |
25441 | RECONSTRUCT WRIST JOINT | 26320 | REMOVAL OF IMPLANT FROM HAND |
25442 | RECONSTRUCT WRIST JOINT | 26530 | REVISE KNUCKLE JOINT |
25443 | RECONSTRUCT WRIST JOINT | 26531 | REVISE KNUCKLE WITH IMPLANT |
25444 | RECONSTRUCT WRIST JOINT | 26535 | REVISE FINGER JOINT |
25445 | RECONSTRUCT WRIST JOINT | 26536 | REVISE/IMPLANT FINGER JOINT |
25446 | WRIST REPLACEMENT | 27090 | REMOVAL OF HIP PROSTHESIS |
25447 | REPAIR WRIST JOINT(S) | 27091 | REMOVAL OF HIP PROSTHESIS |
25449 | REMOVE WRIST JOINT IMPLANT | 27120 | RECONSTRUCTION OF HIP SOCKET |
26010 | DRAINAGE OF FINGER ABSCESS | 27122 | RECONSTRUCTION OF HIP SOCKET |
26011 | DRAINAGE OF FINGER ABSCESS | 27125 | PARTIAL HIP REPLACEMENT |
26020 | DRAIN HAND TENDON SHEATH | 27130 | TOTAL HIP ARTHROPLASTY |
26025 | DRAINAGE OF PALM BURSA | 27132 | TOTAL HIP ARTHROPLASTY |
26030 | DRAINAGE OF PALM BURSA(S) | 27134 | REVISE HIP JOINT REPLACEMENT |
26034 | TREAT HAND BONE LESION | 27137 | REVISE HIP JOINT REPLACEMENT |
26035 | DECOMPRESS FINGERS/HAND | 27138 | REVISE HIP JOINT REPLACEMENT |
26037 | DECOMPRESS FINGERS/HAND | 27236 | TREAT THIGH FRACTURE |
26040 | RELEASE PALM CONTRACTURE | 27437 | REVISE KNEECAP |
26045 | RELEASE PALM CONTRACTURE | 27438 | REVISE KNEECAP WITH IMPLANT |
26055 | INCISE FINGER TENDON SHEATH | 27440 | REVISION OF KNEE JOINT |
26060 | INCISION OF FINGER TENDON | 27441 | REVISION OF KNEE JOINT |
26070 | EXPLORE/TREAT HAND JOINT | 27442 | REVISION OF KNEE JOINT |
26075 | EXPLORE/TREAT FINGER JOINT | 27443 | REVISION OF KNEE JOINT |
26080 | EXPLORE/TREAT FINGER JOINT | 27445 | REVISION OF KNEE JOINT |
26100 | BIOPSY HAND JOINT LINING | 27446 | REVISION OF KNEE JOINT |
26105 | BIOPSY FINGER JOINT LINING | 27447 | TOTAL KNEE ARTHROPLASTY |
26110 | BIOPSY FINGER JOINT LINING | 27486 | REVISE/REPLACE KNEE JOINT |
26115 | REMOVEL HAND LESION SUBCUT | 27487 | REVISE/REPLACE KNEE JOINT |
26116 | REMOVEL HAND LESION, DEEP | 27488 | REMOVAL OF KNEE PROSTHESIS |
26117 | REMOVE TUMOR, HAND/FINGER | 27700 | REVISION OF ANKLE JOINT |
*PEAC refined in office inputs only. | |||
CPT Codes and descriptions are copyright 2002 by the Amercian Medical Association, all rights reserved. |
CPT code | Short descriptors | CPT code | Short descriptors |
---|---|---|---|
27702 | RECONSTRUCT ANKLE JOINT | 29889 | KNEE ARTHROSCOPY/SURGERY |
27703 | RECONSTRUCTION, ANKLE JOINT | 29891 | ANKLE ARTHROSCOPY/SURGERY |
27704 | REMOVAL OF ANKLE IMPLANT | 29892 | ANKLE ARTHROSCOPY/SURGERY |
28293 | CORRECTION OF BUNION | 29894 | ANKLE ARTHROSCOPY/SURGERY |
29800 | JAW ARTHROSCOPY/SURGERY | 29895 | ANKLE ARTHROSCOPY/SURGERY |
29804 | JAW ARTHROSCOPY/SURGERY | 29897 | ANKLE ARTHROSCOPY/SURGERY |
29819 | SHOULDER ARTHROSCOPY/SURGERY | 29898 | ANKLE ARTHROSCOPY/SURGERY |
29820 | SHOULDER ARTHROSCOPY/SURGERY | 31505 | DIAGNOSTIC LARYNGOSCOPY |
29821 | SHOULDER ARTHROSCOPY/SURGERY | 32440 | REMOVAL OF LUNG |
29822 | SHOULDER ARTHROSCOPY/SURGERY | 32442 | SLEEVE PNEUMONECTOMY |
29823 | SHOULDER ARTHROSCOPY/SURGERY | 32445 | REMOVAL OF LUNG |
29825 | SHOULDER ARTHROSCOPY/SURGERY | 32480 | PARTIAL REMOVAL OF LUNG |
29826 | SHOULDER ARTHROSCOPY/SURGERY | 32482 | BILOBECTOMY |
29830 | ELBOW ARTHROSCOPY | 32484 | SEGMENTECTOMY |
29834 | ELBOW ARTHROSCOPY/SURGERY | 32486 | SLEEVE LOBECTOMY |
29835 | ELBOW ARTHROSCOPY/SURGERY | 32488 | COMPLETION PNEUMONECTOMY |
29836 | ELBOW ARTHROSCOPY/SURGERY | 32491 | LUNG VOLUME REDUCTION |
29837 | ELBOW ARTHROSCOPY/SURGERY | 32500 | PARTIAL REMOVAL OF LUNG |
29838 | ELBOW ARTHROSCOPY/SURGERY | 32501 | REPAIR BRONCHUS ADD-ON |
29840 | WRIST ARTHROSCOPY | 32520 | REMOVE LUNG REVISE CHEST |
29843 | WRIST ARTHROSCOPY/SURGERY | 32522 | REMOVE LUNG REVISE CHEST |
29844 | WRIST ARTHROSCOPY/SURGERY | 32525 | REMOVE LUNG REVISE CHEST |
29845 | WRIST ARTHROSCOPY/SURGERY | 32540 | REMOVAL OF LUNG LESION |
29846 | WRIST ARTHROSCOPY/SURGERY | 32650 | THORACOSCOPY, SURGICAL |
29847 | WRIST ARTHROSCOPY/SURGERY | 32651 | THORACOSCOPY, SURGICAL |
29848 | WRIST ENDOSCOPY/SURGERY | 32652 | THORACOSCOPY, SURGICAL |
29850 | KNEE ARTHROSCOPY/SURGERY | 32653 | THORACOSCOPY, SURGICAL |
29851 | KNEE ARTHROSCOPY/SURGERY | 32654 | THORACOSCOPY, SURGICAL |
29855 | TIBIAL ARTHROSCOPY/SURGERY | 32655 | THORACOSCOPY, SURGICAL |
29856 | TIBIAL ARTHROSCOPY/SURGERY | 32656 | THORACOSCOPY, SURGICAL |
29860 | HIP ARTHROSCOPY, DX | 32657 | THORACOSCOPY, SURGICAL |
29861 | HIP ARTHROSCOPY/SURGERY | 32658 | THORACOSCOPY, SURGICAL |
29862 | HIP ARTHROSCOPY/SURGERY | 32659 | THORACOSCOPY, SURGICAL |
29863 | HIP ARTHROSCOPY/SURGERY | 32660 | THORACOSCOPY, SURGICAL |
29870 | KNEE ARTHROSCOPY, DX | 32661 | THORACOSCOPY, SURGICAL |
29871 | KNEE ARTHROSCOPY/DRAINAGE | 32662 | THORACOSCOPY, SURGICAL |
29874 | KNEE ARTHROSCOPY/SURGERY | 32663 | THORACOSCOPY, SURGICAL |
29875 | KNEE ARTHROSCOPY/SURGERY | 32664 | THORACOSCOPY, SURGICAL |
29876 | KNEE ARTHROSCOPY/SURGERY | 32665 | THORACOSCOPY, SURGICAL |
29877 | KNEE ARTHROSCOPY/SURGERY | 33400 | REPAIR OF AORTIC VALVE |
29879 | KNEE ARTHROSCOPY/SURGERY | 33401 | VALVULOPLASTY, OPEN |
29880 | KNEE ARTHROSCOPY/SURGERY | 33403 | VALVULOPLASTY, W/CP BYPASS |
29881 | KNEE ARTHROSCOPY/SURGERY | 33404 | PREPARE HEART-AORTA CONDUIT |
29882 | KNEE ARTHROSCOPY/SURGERY | 33405 | REPLACEMENT OF AORTIC VALVE |
29883 | KNEE ARTHROSCOPY/SURGERY | 33406 | REPLACEMENT OF AORTIC VALVE |
29884 | KNEE ARTHROSCOPY/SURGERY | 33410 | REPLACEMENT OF AORTIC VALVE |
29885 | KNEE ARTHROSCOPY/SURGERY | 33411 | REPLACEMENT OF AORTIC VALVE |
29886 | KNEE ARTHROSCOPY/SURGERY | 33412 | REPLACEMENT OF AORTIC VALVE |
29887 | KNEE ARTHROSCOPY/SURGERY | 33413 | REPLACEMENT OF AORTIC VALVE |
29888 | KNEE ARTHROSCOPY/SURGERY | 33420 | REVISION OF MITRAL VALVE |
*PEAC refined in office inputs only. | |||
CPT Codes and descriptions are copyright 2002 by the Amercian Medical Association, all rights reserved. |
CPT code | Short descriptors | CPT code | Short descriptors |
---|---|---|---|
33422 | REVISION OF MITRAL VALVE | 43239 | UPPER GI ENDOSCOPY, BIOPSY* |
33425 | REPAIR OF MITRAL VALVE | 43240 | ESOPH ENDOSCOPE W/DRAIN CYST* |
33426 | REPAIR OF MITRAL VALVE | 43241 | UPPER GI ENDOSCOPY WITH TUBE* |
33427 | REPAIR OF MITRAL VALVE | 43242 | UPPR GI ENDOSCOPY W/US FN BX* |
33430 | REPLACEMENT OF MITRAL VALVE | 43243 | UPPER GI ENDOSCOPY INJECT* |
33510 | CABG, VEIN, SINGLE | 43244 | UPPER GI ENSOSCOPY/LIGATION* |
33511 | CABG, VEIN, TWO | 43245 | UPPR GI SCOPY DILATE STRICTR* |
33512 | CABG, VEIN, THREE | 43246 | PLACE GASTROSTOMY TUBE* |
33513 | CABG, VEIN, FOUR | 43247 | OPERATIVE UPPER GI ENDOSCOPY* |
33514 | CABG, VEIN, FIVE | 43248 | UPPR GI ENDOSCOPY/GUIDE WIRE* |
33516 | CABG, VEIN, SIX OR MORE | 43249 | ESOPH ENDOSCOPY, DILATION* |
33533 | CABG, ARTERIAL, SINGLE | 43250 | UPPER GI ENDOSCOPY/TUMOR* |
33534 | CABG, ARTERIAL, TWO | 43251 | OPERATIVE UPPER GI ENDOSCOPY* |
33535 | CABG, ARTERIAL, THREE | 43255 | OPERATIVE UPPER GI ENDOSCOPY* |
33536 | CABG, ARTERIAL, FOUR OR MORE | 43256 | UPPR GI ENDOSCOPY W STENT* |
35474 | REPAIR ARTERIAL BLOCKAGE | 43258 | OPERATIVE UPPER GI ENDOSCOPY* |
36400 | BL DRAW 3 YRS FEM/JUGULAR | 43259 | ENDOSCOPIC ULTRASOUND EXAM* |
36405 | BL DRAW 3 YRS SCALP VEIN | 43752 | NASAL/OROGASTRIC W/STENT |
36406 | BL DRAW 3 YRS OTHER VEIN | 44140 | PARTIAL REMOVAL OF COLON |
36410 | NON-ROUTINE BL DRAW 3 YRS | 44141 | PARTIAL REMOVAL OF COLON |
36415 | ROUTINE VENIPUNCTURE | 44143 | PARTIAL REMOVAL OF COLON |
36416 | CAPILLARY BLOOD DRAW | 44144 | PARTIAL REMOVAL OF COLON |
36420 | VEIN ACCESS CUTDOWN 1 YR | 44145 | PARTIAL REMOVAL OF COLON |
36425 | VEIN ACCESS CUTDOWN 1 YR | 44146 | PARTIAL REMOVAL OF COLON |
36540 | COLLECT BLOOD VENOUS DEVICE | 44147 | PARTIAL REMOVAL OF COLON |
36660 | INSERTION CATHETER, ARTERY | 44150 | REMOVAL OF COLON |
39010 | EXPLORATION OF CHEST | 44151 | REMOVAL OF COLON/ILEOSTOMY |
39200 | REMOVAL CHEST LESION | 44152 | REMOVAL OF COLON/ILEOSTOMY |
39220 | REMOVAL CHEST LESION | 44153 | REMOVAL OF COLON/ILEOSTOMY |
39400 | VISUALIZATION OF CHEST | 44155 | REMOVAL OF COLON/ILEOSTOMY |
40800 | DRAINAGE OF MOUTH LESION | 44156 | REMOVAL OF COLON/ILEOSTOMY |
40801 | DRAINAGE OF MOUTH LESION | 44160 | REMOVAL OF COLON |
40804 | REMOVAL, FOREIGN BODY, MOUTH | 44200 | LAPAROSCOPY, ENTEROLYSIS |
40805 | REMOVAL, FOREIGN BODY, MOUTH | 44201 | LAPAROSCOPY, JEJUNOSTOMY |
40808 | BIOPSY OF MOUTH LESION | 44202 | LAP RESECT S/INTESTINE SINGL |
40810 | EXCISION OF MOUTH LESION | 44300 | OPEN BOWEL TO SKIN |
40812 | EXCISE/REPAIR MOUTH LESION | 44310 | ILEOSTOMY/JEJUNOSTOMY |
40814 | EXCISE/REPAIR MOUTH LESION | 44312 | REVISION OF ILEOSTOMY |
40816 | EXCISION OF MOUTH LESION | 44314 | REVISION OF ILEOSTOMY |
41100 | BIOPSY OF TONGUE | 44316 | DEVISE BOWEL POUCH |
41105 | BIOPSY OF TONGUE | 44320 | COLOSTOMY |
41108 | BIOPSY OF FLOOR OF MOUTH | 44322 | COLOSTOMY WITH BIOPSIES |
41110 | EXCISION OF TONGUE LESION | 44340 | REVISION OF COLOSTOMY |
41112 | EXCISION OF TONGUE LESION | 44345 | REVISION OF COLOSTOMY |
41113 | EXCISION OF TONGUE LESION | 44346 | REVISION OF COLOSTOMY |
41114 | EXCISION OF TONGUE LESION | 44602 | SUTURE, SMALL INTESTINE |
43107 | REMOVAL OF ESOPHAGUS | 44603 | SUTURE, SMALL INTESTINE |
43112 | REMOVAL OF ESOPHAGUS | 44604 | SUTURE, LARGE INTESTINE |
43117 | PARTIAL REMOVAL OF ESOPHAGUS | 44605 | REPAIR OF BOWEL LESION |
43121 | PARTIAL REMOVAL OF ESOPHAGUS | 44615 | INTESTINAL STRICTUROPLASTY |
43122 | PARTIAL REMOVAL OF ESOPHAGUS | 44620 | REPAIR BOWEL OPENING |
43235 | UPPR GI ENDOSCOPY, DIAGNOSIS* | ||
*PEAC refined in office inputs only. | |||
CPT Codes and descriptions are copyright 2002 by the Amercian Medical Association, all rights reserved. |
CPT code | Short descriptors | CPT code | Short descriptors |
---|---|---|---|
44625 | REPAIR BOWEL OPENING | 52007 | CYSTOSCOPY AND BIOPSY |
44626 | REPAIR BOWEL OPENING | 52010 | CYSTOSCOPY DUCT CATHETER |
44640 | REPAIR BOWEL-SKIN FISTULA | 52204 | CYSTOSCOPY |
44650 | REPAIR BOWEL FISTULA | 52214 | CYSTOSCOPY AND TREATMENT |
44660 | REPAIR BOWEL-BLADDER FISTULA | 52224 | CYSTOSCOPY AND TREATMENT |
44661 | REPAIR BOWEL-BLADDER FISTULA | 52234 | CYSTOSCOPY AND TREATMENT |
44680 | SURGICAL REVISION, INTESTINE | 52235 | CYSTOSCOPY AND TREATMENT |
44700 | SUSPEND BOWEL W/PROSTHESIS | 52240 | CYSTOSCOPY AND TREATMENT |
44800 | EXCISION OF BOWEL POUCH | 52250 | CYSTOSCOPY AND RADIOTRACER |
44820 | EXCISION OF MESENTERY LESION | 52260 | CYSTOSCOPY AND TREATMENT |
44850 | REPAIR OF MESENTERY | 52265 | CYSTOSCOPY AND TREATMENT |
44900 | DRAIN APP ABSCESS, OPEN | 52270 | CYSTOSCOPY REVISE URETHRA |
44950 | APPENDECTOMY | 52275 | CYSTOSCOPY REVISE URETHRA |
44955 | APPENDECTOMY ADD-ON | 52276 | CYSTOSCOPY AND TREATMENT |
44960 | APPENDECTOMY | 52277 | CYSTOSCOPY AND TREATMENT |
44970 | LAPAROSCOPY, APPENDECTOMY | 52281 | CYSTOSCOPY AND TREATMENT |
45000 | DRAINAGE OF PELVIC ABSCESS | 52282 | CYSTOSCOPY, IMPLANT STENT |
45020 | DRAINAGE OF RECTAL ABSCESS | 52283 | CYSTOSCOPY AND TREATMENT |
45100 | BIOPSY OF RECTUM | 52285 | CYSTOSCOPY AND TREATMENT |
45108 | REMOVAL OF ANORECTAL LESION | 52290 | CYSTOSCOPY AND TREATMENT |
45110 | REMOVAL OF RECTUM | 52300 | CYSTOSCOPY AND TREATMENT |
45111 | PARTIAL REMOVAL OF RECTUM | 52301 | CYSTOSCOPY AND TREATMENT |
45112 | REMOVAL OF RECTUM | 52305 | CYSTOSCOPY AND TREATMENT |
45113 | PARTIAL PROCTECTOMY | 52310 | CYSTOSCOPY AND TREATMENT |
45114 | PARTIAL REMOVAL OF RECTUM | 52315 | CYSTOSCOPY AND TREATMENT |
45116 | PARTIAL REMOVAL OF RECTUM | 52317 | REMOVE BLADDER STONE |
45119 | REMOVE RECTUM W/RESERVOIR | 52318 | REMOVE BLADDER STONE |
45120 | REMOVAL OF RECTUM | 52320 | CYSTOSCOPY AND TREATMENT |
45121 | REMOVAL OF RECTUM AND COLON | 52325 | CYSTOSCOPY, STONE REMOVAL |
45123 | PARTIAL PROCTECTOMY | 52327 | CYSTOSCOPY, INJECT MATERIAL |
45126 | PELVIC EXENTERATION | 52330 | CYSTOSCOPY AND TREATMENT |
45130 | EXCISION OF RECTAL PROLAPSE | 52332 | CYSTOSCOPY AND TREATMENT |
45135 | EXCISION OF RECTAL PROLAPSE | 52334 | CREATE PASSAGE TO KIDNEY |
45150 | EXCISION OF RECTAL STRICTURE | 52341 | CYSTO W/URETER STRICTURE TX |
45160 | EXCISION OF RECTAL LESION | 52342 | CYSTO W/UP STRICTURE TX |
45170 | EXCISION OF RECTAL LESION | 52343 | CYSTO W/RENAL STRICTURE TX |
45190 | DESTRUCTION, RECTAL TUMOR | 52344 | CYSTO/URETERO, STONE REMOVE |
47510 | INSERT CATHETER, BILE DUCT | 52345 | CYSTO/URETERO W/UP STRICTURE |
51725 | SIMPLE CYSTOMETROGRAM | 52346 | CYSTOURETERO W/RENAL STRICT |
51726 | COMPLEX CYSTOMETROGRAM | 52351 | CYSTOURETRO OR PYELOSCOPE |
51736 | URINE FLOW MEASUREMENT | 52352 | CYSTOURETRO W/STONE REMOVE |
51741 | ELECTRO-UROFLOWMETRY, FIRST | 52353 | CYSTOURETERO W/LITHOTRIPSY |
51772 | URETHRA PRESSURE PROFILE | 52354 | CYSTOURETERO W/BIOPSY |
51784 | ANAL/URINARY MUSCLE STUDY | 52355 | CYSTOURETERO W/EXCISE TUMOR |
51785 | ANAL/URINARY MUSCLE STUDY | 52400 | CYSTOURETERO W/CONGEN REPR |
51792 | URINARY REFLEX STUDY | 52450 | INCISION OF PROSTATE |
51795 | URINE VOIDING PRESSURE STUDY | 52500 | REVISION OF BLADDER NECK |
51797 | INTRAABDOMINAL PRESSURE TEST | 52510 | DILATION PROSTATIC URETHRA |
52000 | CYSTOSCOPY | 52601 | PROSTATECTOMY (TURP) |
52001 | CYSTOSCOPY, REMOVAL OF CLOTS | 52606 | CONTROL POSTOP BLEEDING |
52005 | CYSTOSCOPY URETER CATHETER | 52612 | PROSTATECTOMY, FIRST STAGE |
*PEAC refined in office inputs only. | |||
CPT Codes and descriptions are copyright 2002 by the Amercian Medical Association, all rights reserved. |
CPT code | Short descriptors | CPT code | Short descriptors |
---|---|---|---|
52614 | PROSTATECTOMY, SECOND | 58555 | HYSTEROSCOPY, DX, SEP PROC |
52620 | REMOVE RESIDUAL PROSTATE | 58558 | HYSTEROSCOPY, BIOPSY |
52630 | REMOVE PROSTATE REGROWTH | 58559 | HYSTEROSCOPY, LYSIS |
52640 | RELIEVE BLADDER CONTRACTURE | 58560 | HYSTEROSCOPY, RESECT SPECTUM |
52647 | LASER SURGERY OF PROSTATE | 58561 | HYSTEROSCOPY, REMOVE MYOMA |
52648 | LASER SURGERY OF PROSTATE | 58563 | HYSTEROSCOPY, ABLATION |
52700 | DRAINAGE OF PROSTATE ABSCESS | 59400 | OBSTETRICAL CARE |
56605 | BIOPSY OF VULVA/PERINEUM | 59409 | OBSTETRICAL CARE |
56606 | BIOPSY OF VULVA/PERINEUM | 59410 | OBSTETRICAL CARE |
56700 | PARTIAL REMOVAL OF HYMEN | 59412 | ANTEPARTUM MANIPULATION |
56720 | INCISION OF HYMEN | 59414 | DELIVER PLACENTA |
56740 | REMOVE VAGINA GLAND LESION | 59425 | ANTEPARTUM CARE ONLY |
57100 | BIOPSY OF VAGINA | 59426 | ANTEPARTUM CARE ONLY |
57105 | BIOPSY OF VAGINA | 59430 | CARE AFTER DELIVERY |
57200 | REPAIR OF VAGINA | 59510 | CESAREAN DELIVERY |
57210 | REPAIR VAGINA/PERINEUM | 59514 | CESAREAN DELIVERY ONLY |
57220 | REVISION OF URETHRA | 59515 | CESAREAN DELIVERY |
57230 | REPAIR OF URETHRAL LESION | 59525 | REMOVE UTERUS AFTER CESAREAN |
57240 | REPAIR BLADDER VAGINA | 59610 | VBAC DELIVERY |
57250 | REPAIR RECTUM VAGINA | 59612 | VBAC DELIVERY ONLY |
57260 | REPAIR OF VAGINA | 59614 | VBAC CARE AFTER DELIVERY |
57265 | EXTENSIVE REPAIR OF VAGINA | 59618 | ATTEMPTED VBAC DELIVERY |
57268 | REPAIR OF BOWEL BULGE | 59620 | ATTEMPTED VBAC DELIVERY ONLY |
57270 | REPAIR OF BOWEL POUCH | 59622 | ATTEMPTED VBAC AFTER CARE |
57280 | SUSPENSION OF VAGINA | 60100 | BIOPSY OF THYROID |
57282 | REPAIR OF VAGINAL PROLAPSE | 61000 | REMOVE CRANIAL CAVITY FLUID |
57284 | REPAIR PARAVAGINAL DEFECT | 61001 | REMOVE CRANIAL CAVITY FLUID |
57287 | REVISE/REMOVE SLING REPAIR | 61020 | REMOVE BRAIN CAVITY FLUID |
57288 | REPAIR BLADDER DEFECT | 61026 | INJECTION INTO BRAIN CANAL |
57289 | REPAIR BLADDER VAGINA | 61050 | REMOVE BRAIN CANAL FLUID |
57291 | CONSTRUCTION OF VAGINA | 61055 | INJECTION INTO BRAIN CANAL |
57292 | CONSTRUCT VAGINA WITH GRAFT | 61070 | BRAIN CANAL SHUNT PROCEDURE |
57300 | REPAIR RECTUM-VAGINA FISTULA | 61105 | TWIST DRILL HOLE |
57305 | REPAIR RECTUM-VAGINA FISTULA | 61108 | DRILL SKULL FOR DRAINAGE |
57307 | FISTULA REPAIR COLOSTOMY | 61120 | BURR HOLE FOR PUNCTURE |
57308 | FISTULA REPAIR, TRANSPERINE | 61140 | PIERCE SKULL FOR BIOPSY |
57310 | REPAIR URETHROVAGINAL LESION | 61150 | PIERCE SKULL FOR DRAINAGE |
57311 | REPAIR URETHROVAGINAL LESION | 61151 | PIERCE SKULL FOR DRAINAGE |
57320 | REPAIR BLADDER-VAGINA LESION | 61154 | PIERCE SKULL REMOVE CLOT |
57330 | REPAIR BLADDER-VAGINA LESION | 61156 | PIERCE SKULL FOR DRAINAGE |
57335 | REPAIR VAGINA | 61215 | INSERT BRAIN-FLUID DEVICE |
57460 | BX OF CERVIX W/SCOPE, LEEP | 61250 | PIERCE SKULL EXPLORE |
57800 | DILATION OF CERVICAL CANAL | 61253 | PIERCE SKULL EXPLORE |
57820 | D C OF RESIDUAL CERVIX | 61304 | OPEN SKULL FOR EXPLORATION |
58120 | DILATION AND CURETTAGE | 61305 | OPEN SKULL FOR EXPLORATION |
58150 | TOTAL HYSTERECTOMY | 61312 | OPEN SKULL FOR DRAINAGE |
58152 | TOTAL HYSTERECTOMY | 61313 | OPEN SKULL FOR DRAINAGE |
58180 | PARTIAL HYSTERECTOMY | 61314 | OPEN SKULL FOR DRAINAGE |
58200 | EXTENSIVE HYSTERECTOMY | 61315 | OPEN SKULL FOR DRAINAGE |
58210 | EXTENSIVE HYSTERECTOMY | 61320 | OPEN SKULL FOR DRAINAGE |
58240 | REMOVAL OF PELVIS CONTENTS | 61321 | OPEN SKULL FOR DRAINAGE |
*PEAC refined in office inputs only. | |||
CPT Codes and descriptions are copyright 2002 by the Amercian Medical Association, all rights reserved. |
CPT code | Short descriptors | CPT code | Short descriptors |
---|---|---|---|
61330 | DECOMPRESS EYE SOCKET | 64418 | N BLOCK INJ, SUPRASCAPULAR |
61332 | EXPLORE/BIOPSY EYE SOCKET | 64420 | N BLOCK INJ, INTERCOST, SNG |
61333 | EXPLORE ORBIT/REMOVE LESION | 64421 | N BLOCK INJ, INTERCOST, MLT |
61334 | EXPLORE ORBIT/REMOVE OBJECT | 64425 | N BLOCK INJ ILIO-ING/HYPOGI |
61340 | SUBTEMPORAL DECOMPRESSION | 64430 | N BLOCK INJ, PUDENDAL |
62270 | SPINAL FLUID TAP, DIAGNOSTIC | 64435 | N BLOCK INJ, PARACERVICAL |
62272 | DRAIN CEREBRO SPINAL FLUID | 64445 | N BLOCK INJ, SCIATIC, SNG |
62273 | TREAT EPIDURAL SPINE LESION | 64450 | N BLOCK, OTHER PERIPHERAL |
62280 | TREAT SPINAL CORD LESION | 64470 | INJ PARAVERTEBRAL C/T |
62281 | TREAT SPINAL CORD LESION | 64472 | INJ PARAVERTEBRAL C/T ADD-ON |
62282 | TREAT SPINAL CANAL LESION | 64475 | INJ PARAVERTEBRAL L/S |
62284 | INJECTION FOR MYELOGRAM | 64476 | INJ PARAVERTEBRAL L/S ADD-ON |
62290 | INJECT FOR SPINE DISK X-RAY | 64479 | INJ FORAMEN EPIDURAL C/T |
62291 | INJECT FOR SPINE DISK X-RAY | 64480 | INJ FORAMEN EPIDURAL ADD-ON |
62310 | INJECT SPINE C/T | 64483 | INJ FORAMEN EPIDURAL L/S |
62311 | INJECT SPINE L/S (CD) | 64484 | INJ FORAMEN EPIDURAL ADD-ON |
62318 | INJECT SPINE W/CATH, C/T | 64505 | N BLOCK, SPENOPALATINE GANGL |
62319 | INJECT SPINE W/CATH L/S (CD) | 64508 | N BLOCK, CAROTID SINUS S/P |
63001 | REMOVAL OF SPINAL LAMINA | 64510 | N BLOCK, STELLATE GANGLION |
63003 | REMOVAL OF SPINAL LAMINA | 64520 | N BLOCK, LUMBAR/THORACIC |
63005 | REMOVAL OF SPINAL LAMINA | 64530 | N BLOCK INJ, CELIAC PELUS |
63011 | REMOVAL OF SPINAL LAMINA | 64600 | INJECTION TREATMENT OF NERVE |
63012 | REMOVAL OF SPINAL LAMINA | 64605 | INJECTION TREATMENT OF NERVE |
63015 | REMOVAL OF SPINAL LAMINA | 64610 | INJECTION TREATMENT OF NERVE |
63016 | REMOVAL OF SPINAL LAMINA | 64612 | DESTROY NERVE, FACE MUSCLE |
63017 | REMOVAL OF SPINAL LAMINA | 64613 | DESTROY NERVE, SPINE MUSCLE |
63020 | NECK SPINE DISK SURGERY | 64614 | DESTROY NERVE, EXTREM MUSC |
63030 | LOW BACK DISK SURGERY | 64620 | INJECTION TREATMENT OF NERVE |
63040 | LAMINOTOMY, SINGLE CERVICAL | 64622 | DESTR PARAVERTEBRL NERVE L/S |
63042 | LAMINOTOMY, SINGLE LUMBAR | 64623 | DESTR PARAVERTEBRAL N ADD-ON |
63045 | REMOVAL OF SPINAL LAMINA | 64626 | DESTR PARAVERTEBRL NERVE C/T |
63046 | REMOVAL OF SPINAL LAMINA | 64627 | DESTR PARAVERTEBRAL N ADD-ON |
63047 | REMOVAL OF SPINAL LAMINA | 64630 | INJECTION TREATMENT OF NERVE |
63055 | DECOMPRESS SPINAL CORD | 64640 | INJECTION TREATMENT OF NERVE |
63056 | DECOMPRESS SPINAL CORD | 64680 | INJECTION TREATMENT OF NERVE |
63064 | DECOMPRESS SPINAL CORD | 66700 | DESTRUCTION, CILIARY BODY |
63075 | NECK SPINE DISK SURGERY | 66710 | DESTRUCTION, CILIARY BODY |
63077 | SPINE DISK SURGERY, THORAX | 66720 | DESTRUCTION, CILIARY BODY |
63081 | REMOVAL OF VERTEBRAL BODY | 66740 | DESTRUCTION, CILIARY BODY |
63085 | REMOVAL OF VERTEBRAL BODY | 66761 | REVISION OF IRIS |
63087 | REMOVAL OF VERTEBRAL BODY | 66762 | REVISION OF IRIS |
63090 | REMOVAL OF VERTEBRAL BODY | 66770 | REMOVAL OF INNER EYE LESION |
64400 | N BLOCK INJ, TRIGEMINAL | 70336 | MAGNETIC IMAGE, JAW JOINT |
64402 | N BLOCK INJ, FACIAL | 70540 | MRI ORBIT/FACE/NECK W/O DYE |
64405 | N BLOCK INJ, OCCIPITAL | 70551 | MRI BRAIN W/O DYE |
64408 | N BLOCK INJ, VAGUS | 71550 | MRI CHEST W/O DYE |
64410 | N BLOCK INJ, PHRENIC | 72141 | MRI NECK SPINE W/O DYE |
64412 | N BLOCK INJ, SPINAL ACCESSOR | 72146 | MRI CHEST SPINE W/O DYE |
64413 | N BLOCK INJ, CERVICAL PLEXUS | 72148 | MRI LUMBAR SPINE W/O DYE |
64415 | N BLOCK INJ, BRACHIAL PLEXUS | 72195 | MRI PELVIS W/O DYE |
64417 | N BLOCK INJ, AXILLARY | 73218 | MRI UPPER EXTREMITY W/O |
*PEAC refined in office inputs only. | |||
CPT Codes and descriptions are copyright 2002 by the Amercian Medical Association, all rights reserved. |
CPT code | Short descriptors | CPT code | Short descriptors |
---|---|---|---|
73221 | MRI JOINT UPR EXTREM W/O DYE | 88332 | PATH CONSULT INTRAOP, ADDL |
73718 | MRI LOWER EXTREMITY W/O DYE | 88342 | IMMUNOCYTOCHEMISTRY |
73721 | MRI JOINT OF LWR EXTRE W/O DYE | 88346 | IMMUNOFLUORESCENT STUDY |
74181 | MRI ABDOMEN W/O DYE | 88347 | IMMUNOFLUORESCENT STUDY |
75552 | HEART MRI FOR MORPH W/O DYE | 88362 | NERVE TEASING PREPARATIONS |
75554 | CARDIAC MRI/FUNCTION | 90471 | IMMUNIZATION ADMIN |
75555 | CARDIAC MRI/LIMITED STUDY | 90472 | IMMUNIZATION ADMIN, EACH ADD |
76075 | DEXA, AXIAL SKELETON STUDY | 90780 | IV INFUSION THERAPY, 1 HOUR |
76076 | DEXA, PERIPHERAL STUDY | 90781 | IV INFUSION, ADDITIONAL HOUR |
76400 | MAGNETIC IMAGE, BONE MARROW | 90782 | INJECTION, SC/IM |
76506 | ECHO EXAM OF HEAD | 90783 | INJECTION, IA |
76536 | US EXAM OF HEAD AND NECK | 90784 | INJECTION, IV |
76700 | US EXAM, ABDOM, COMPLETE | 90788 | INJECTION OF ANTIBIOTIC |
76770 | US EXAM ABDO BACK WALL, COMP | 90801 | PSY DX INTERVIEW |
76778 | US EXAM KIDNEY TRANSPLANT | 90802 | INTAC PSY DX INTERVIEW |
76818 | FETAL BIOPHYS PROFILE W/NST | 90804 | PSYTX, OFFICE, 20-30 MIN |
76819 | FETAL BIOPHYS PROFIL W/O NST | 90805 | PSYTX, OFF, 20-30 MIN W/EM |
76825 | ECHO EXAM OF FETAL HEART | 90806 | PSYTX, OFF, 45-50 MIN |
76826 | ECHO EXAM OF FETAL HEART | 90807 | PSYTX, OFF, 45-50 MIN W/EM |
76827 | ECHO EXAM OF FETAL HEART | 90808 | PSYTX, OFFICE, 75-80 MIN |
76828 | ECHO EXAM OF FETAL HEART | 90809 | PSYTX, OFF, 75-80, W/EM |
76830 | TRANSVAGINAL US, NON-OB | 90810 | INTAC PSYTX, OFF, 20-30 MIN |
76831 | ECHO EXAM, UTERUS | 90811 | INTAC PSYTX, 20-30, W/EM |
76856 | US EXAM, PELVIC, COMPLETE | 90812 | INTAC PSYTX, OFF, 45-50 MIN |
76857 | US EXAM, PELVIC, LIMITED | 90813 | INTAC PSYTX, 45-50 MIN W/EM |
76870 | US EXAM, SCROTUM | 90814 | INTAC PSYTX, OFF, 75-80 MIN |
76872 | ECHO EXAM, TRANSRECTAL | 90815 | INTAC PSYTX, 75-80 W/EM |
76873 | ECHOGRAP TRANS R, PROS STUDY | 90816 | PSYTX, HOSP, 20-30 MIN |
76880 | US EXAM, EXTREMITY | 90817 | PSYTX, HOSP, 20-30 MIN W/EM |
76885 | US EXAM INFANT HIPS, DYNAMIC | 90818 | PSYTX, HOSP, 45-50 MIN |
76942 | ECHO GUIDE FOR BIOPSY | 90819 | PSYTX, HOSP, 45-50 MIN W/EM |
77789 | APPLY SURFACE RADIATION | 90821 | PSYTX, HOSP, 75-80 MIN |
78070 | PARATHYROID NUCLEAR IMAGING | 90822 | PSYTX, HOSP, 75-80 MIN W/EM |
78306 | BONE IMAGING, WHOLE BODY | 90823 | INTAC PSYTX, HOSP, 20-30 MIN |
78315 | BONE IMAGING, 3 PHASE | 90824 | INTAC PSYTX, HSP 20-30 W/EM |
78460 | HEART MUSCLE BLOOD, SINGLE | 90826 | INTAC PSYTX, HOSP, 45-50 MIN |
78461 | HEART MUSCLE BLOOD, MULTIPLE | 90827 | INTAC PSYTX, HSP 45-50 W/EM |
78464 | HEART IMAGE (3D), SINGLE | 90828 | INTAC PSYTX, HOSP, 75-80 MIN |
78465 | HEART IMAGE (3D), MULTIPLE | 90829 | INTAC PSYTX, HSP 75-80 W/EM |
78478 | HEART WALL MOTION ADD-ON | 90845 | PSYCHOANALYSIS |
78480 | HEART FUNCTION ADD-ON | 90846 | FAMILY PSYTX W/O PATIENT |
78580 | LUNG PERFUSION IMAGING | 90847 | FAMILY PSYTX W/PATIENT |
88180 | CELL MARKER STUDY | 90849 | MULTIPLE FAMILY GROUP PSYTX |
88182 | CELL MARKER STUDY | 90853 | GROUP PSYCHOTHERAPY |
88291 | CYTO/MOLECULAR REPORT | 90857 | INTAC GROUP PSYTX |
88321 | MICROSLIDE CONSULTATION | 90862 | MEDICATION MANAGEMENT |
88323 | MICROSLIDE CONSULTATION | 90918 | ESRD RELATED SERVICES, MONTH |
88325 | COMPREHENSIVE REVIEW OF DATA | 90919 | ESRD RELATED SERVICES, MONTH |
88329 | PATH CONSULT INTROP | 90920 | ESRD RELATED SERVICES, MONTH |
88331 | PATH CONSULT INTRAOP, 1 BLOC | 90921 | ESRD RELATED SERVICES, MONTH |
*PEAC refined in office inputs only. | |||
CPT Codes and descriptions are copyright 2002 by the Amercian Medical Association, all rights reserved. |
CPT code | Short descriptors | CPT code | Short descriptors |
---|---|---|---|
90922 | ESRD RELATED SERVICES, DAY | 93314 | ECHO TRANSESOPHAGEAL |
90923 | ESRD RELATED SERVICES, DAY | 93315 | ECHO TRANSESOPHAGEAL |
90924 | ESRD RELATED SERVICES, DAY | 93317 | ECHO TRANSESOPHAGEAL |
90925 | ESRD RELATED SERVICES, DAY | 93320 | DOPPLER ECHO EXAM, HEART |
90935 | HEMODIALYSIS, ONE EVALUATION | 93321 | DOPPLER ECHO EXAM, HEART |
90937 | HEMODIALYSIS, REPEATED EVAL | 93325 | DOPPLER COLOR FLOW ADD-ON |
90945 | DIALYSIS, ONE EVALUATION | 93350 | ECHO TRANSTHORACIC |
90947 | DIALYSIS, REPEATED EVAL | 93508 | CATH PLACEMENT, ANGIOGRAPHY |
91100 | PASS INTESTINE BLEEDING TUBE | 93510 | LEFT HEART CATHETERIZATION |
91105 | GASTRIC INTUBATION TREATMENT | 93511 | LEFT HEART CATHETERIZATION |
92065 | ORTHOPTIC/PLEOPTIC TRAINING | 93514 | LEFT HEART CATHETERIZATION |
92070 | FITTING OF CONTACT LENS | 93524 | LEFT HEART CATHETERIZATION |
92283 | COLOR VISION EXAMINATION | 93526 | RT LT HEART CATHETERS |
92504 | EAR MICROSCOPY EXAMINATION | 93527 | RT LT HEART CATHETERS |
92541 | SPONTANEOUS NYSTAGMUS TEST | 93528 | RT LT HEART CATHETERS |
92542 | POSITIONAL NYSTAGMUS TEST | 93529 | RT LT HEART CATHETERIZATION |
92543 | CALORIC VESTIBULAR TEST | 93530 | RT HEART CATH, CONGENITAL |
92544 | OPTOKINETIC NYSTAGMUS TEST | 93531 | R L HEART CATH, CONGENITAL |
92545 | OSCILLATING TRACKING TEST | 93532 | R L HEART CATH, CONGENITAL |
92546 | SINUSOIDAL ROTATIONAL TEST | 93533 | R L HEART CATH, CONGENITAL |
92552 | PURE TONE AUDIOMETRY, AIR | 93539 | INJECTION, CARDIAC CATH |
92553 | AUDIOMETRY, AIR BONE | 93540 | INJECTION, CARDIAC CATH |
92555 | SPEECH THRESHOLD AUDIOMETRY | 93541 | INJECTION FOR LUNG ANGIOGRAM |
92556 | SPEECH AUDIOMETRY, COMPLETE | 93542 | INJECTION FOR HEART X-RAYS |
92557 | COMPREHENSIVE HEARING TEST | 93543 | INJECTION FOR HEART X-RAYS |
92567 | TYMPANOMETRY | 93544 | INJECTION FOR AORTOGRAPHY |
92568 | ACOUSTIC REFLEX TESTING | 93545 | INJECT FOR CORONARY X-RAYS |
92569 | ACOUSTIC REFLEX DECAY TEST | 93555 | IMAGING, CARDIAC CATH |
92980 | INSERT INTRACORONARY STENT | 93556 | IMAGING, CARDIAC CATH |
92981 | INSERT INTRACORONARY STENT | 93733 | TELEPHONE ANALY, PACEMAKER |
92982 | CORONARY ARTERY DILATION | 93736 | TELEPHONE ANALY, PACEMAKER |
92984 | CORONARY ARTERY DILATION | 93740 | TEMPERATURE GRADIENT STUDIES |
92995 | CORONARY ATHERECTOMY | 93770 | MEASURE VENOUS PRESSURE |
92996 | CORONARY ATHERECTOMY ADD-ON | 93875 TC | EXTRACRANIAL STUDY |
92997 | PUL ART BALLOON REPR, PERCUT | 93880 TC | EXTRACRANIAL STUDY |
92998 | PUL ART BALLOON REPR, PERCUT | 93882 TC | EXTRACRANIAL STUDY |
93000 | ELECTROCARDIOGRAM, COMPLETE | 93886 TC | INTRACRANIAL STUDY |
93005 | ELECTROCARDIOGRAM, TRACING | 93888 TC | INTRACRANIAL STUDY |
93010 | ELECTROCARDIOGRAM REPORT | 93922 TC | EXTREMITY STUDY |
93015 | CARDIOVASCULAR STRESS TEST | 93923 TC | EXTREMITY STUDY |
93016 | CARDIOVASCULAR STRESS TEST | 93924 TC | EXTREMITY STUDY |
93017 | CARDIOVASCULAR STRESS TEST | 93925 TC | LOWER EXTREMITY STUDY |
93018 | CARDIOVASCULAR STRESS TEST | 93926 TC | LOWER EXTREMITY STUDY |
93040 | RHYTHM ECG WITH REPORT | 93930 TC | UPPER EXTREMITY STUDY |
93041 | RHYTHM ECG, TRACING | 93931 TC | UPPER EXTREMITY STUDY |
93042 | RHYTHM ECG, REPORT | 93965 TC | EXTREMITY STUDY |
93303 | ECHO TRANSTHORACIC | 93970 TC | EXTREMITY STUDY |
93304 | ECHO TRANSTHORACIC | 93971 TC | EXTREMITY STUDY |
93307 | ECHO EXAM OF HEART | 93975 TC | VASCULAR STUDY |
93308 | ECHO EXAM OF HEART | 93976 TC | VASCULAR STUDY |
93312 | ECHO TRANSESOPHAGEAL | 93978 TC | VASCULAR STUDY |
*PEAC refined in office inputs only. | |||
CPT Codes and descriptions are copyright 2002 by the Amercian Medical Association, all rights reserved. |
CPT code | Short descriptors | CPT code | Short descriptors |
---|---|---|---|
93979 TC | VASCULAR STUDY | ||
93990 TC | DOPPLER FLOW TESTING | ||
95807 | SLEEP STUDY, ATTENDED | ||
95808 | POLYSOMNOGRAPHY, 1-3 | ||
95810 | POLYSOMNOGRAPHY, 4 OR MORE | ||
95811 | POLYSOMNOGRAPHY W/CPAP | ||
95951 | EEG MONITORING/VIDEORECORD | ||
96400 | CHEMOTHERAPY, SC/IM | ||
96408 | CHEMOTHERAPY, PUSH TECHNIQUE | ||
96410 | CHEMOTHERAPY, INFUSION METHOD | ||
96412 | CHEMO, INFUSE METHOD ADD-ON | ||
96414 | CHEMO, INFUSE METHOD ADD-ON | ||
96420 | CHEMOTHERAPY, PUSH TECHNIQUE | ||
96422 | CHEMOTHERAPY, INFUSION METHOD | ||
96423 | CHEMO, INFUSE METHOD ADD-ON | ||
96425 | CHEMOTHERAPY, INFUSION METHOD | ||
96520 | PORT PUMP REFILL MAIN | ||
96530 | SYST PUMP REFILL MAIN | ||
98940 | CHIROPRACTIC MANIPULATION | ||
98941 | CHIROPRACTIC MANIPULATION | ||
98942 | CHIROPRACTIC MANIPULATION | ||
98943 | CHIROPRACTIC MANIPULATION | ||
99183 | HYPERBARIC OXYGEN THERAPY | ||
99195 | PHLEBOTOMY | ||
99199 | SPECIAL SERVICE/PROC/REPORT | ||
99431 | INITIAL CARE, NORMAL NEWBORN | ||
99432 | NEWBORN CARE, NOT IN HOSP | ||
99433 | NORMAL NEWBORN CARE/HOSPITAL | ||
99435 | NEWBORN DISCHARGE DAY HOSP | ||
99436 | ATTENDANCE, BIRTH | ||
99440 | NEWBORN RESUSCITATION | ||
*PEAC refined in office inputs only. | |||
CPT Codes and descriptions are copyright 2002 by the Amercian Medical Association, all rights reserved. |
[FR Doc. 02-32503 Filed 12-20-02; 11:52 am]
BILLING CODE 4120-01-P